Citrus Sinensis ID: 041096
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 645 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FHG4 | 681 | Probable L-type lectin-do | yes | no | 0.993 | 0.941 | 0.655 | 0.0 | |
| Q9LYX1 | 711 | L-type lectin-domain cont | no | no | 0.989 | 0.897 | 0.465 | 1e-159 | |
| Q9LFH9 | 715 | L-type lectin-domain cont | no | no | 0.976 | 0.881 | 0.460 | 1e-154 | |
| Q9FHX3 | 691 | L-type lectin-domain cont | no | no | 0.955 | 0.891 | 0.392 | 1e-121 | |
| O81292 | 674 | L-type lectin-domain cont | no | no | 0.902 | 0.863 | 0.375 | 1e-104 | |
| Q9M2S4 | 684 | L-type lectin-domain cont | no | no | 0.886 | 0.836 | 0.388 | 1e-103 | |
| Q9FG33 | 652 | Probable L-type lectin-do | no | no | 0.888 | 0.878 | 0.36 | 1e-100 | |
| O80939 | 675 | L-type lectin-domain cont | no | no | 0.913 | 0.872 | 0.35 | 1e-97 | |
| Q9LXA5 | 651 | L-type lectin-domain cont | no | no | 0.905 | 0.897 | 0.364 | 8e-97 | |
| O81291 | 669 | L-type lectin-domain cont | no | no | 0.922 | 0.889 | 0.353 | 2e-96 |
| >sp|Q9FHG4|LRKS7_ARATH Probable L-type lectin-domain containing receptor kinase S.7 OS=Arabidopsis thaliana GN=LECRKS7 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 890 bits (2300), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/671 (65%), Positives = 532/671 (79%), Gaps = 30/671 (4%)
Query: 4 KKLLVFFSIFLLNFS-----FVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGV 58
+KLLV F ++ S FV S+NMNF F SF +RN+T LGDS+LRNGV+GLTRELGV
Sbjct: 5 RKLLVIFFTWITALSMSKPIFVSSDNMNFTFKSFTIRNLTFLGDSHLRNGVVGLTRELGV 64
Query: 59 PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNP--SSFGDGLAFFISPDNQIL 116
P +SSG++IYNNP+ F+D ++NTTASF++ FSF++ N+NP +S GDGLAFF+S DN L
Sbjct: 65 PDTSSGTVIYNNPIRFYDPDSNTTASFSTHFSFTVQNLNPDPTSAGDGLAFFLSHDNDTL 124
Query: 117 GSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176
GS GG LGLVNSSQ KN+FVAIEFDT+LDPHF+DP+ NHIGLD+DSL SI T+DP+L
Sbjct: 125 GSPGGYLGLVNSSQPMKNRFVAIEFDTKLDPHFNDPNGNHIGLDVDSLNSISTSDPLLSS 184
Query: 177 -IDLKSGNVITAWIDYKNDLRMLKVFMSYSN-----LKPVTPLLKVNIDLSGYLKGNMYV 230
IDLKSG IT+WIDYKNDLR+L VF+SY++ KP PLL VNIDLS +L G MYV
Sbjct: 185 QIDLKSGKSITSWIDYKNDLRLLNVFLSYTDPVTTTKKPEKPLLSVNIDLSPFLNGEMYV 244
Query: 231 GFSASTEGSTELHMIQSWSFQTSGFRPVRPKL-HPHNVSDSSVVVETDFPTSNSTNKHHN 289
GFS STEGSTE+H+I++WSF+TSGF PVR K H HNVSDSSVV + + +H +
Sbjct: 245 GFSGSTEGSTEIHLIENWSFKTSGFLPVRSKSNHLHNVSDSSVVNDDPVVIPSKKRRHRH 304
Query: 290 KIGLGLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRG 349
+ +GLGI+ P C+ L VFGY ++KKWK+++ L+ +L+ G REFSY+EL +AT+G
Sbjct: 305 NLAIGLGISCPVLICLALFVFGYFTLKKWKSVKAEKELKTELITGLREFSYKELYTATKG 364
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQ 408
FHS+R++GRGAFGNVY+A F SSG+++AVKRS+H S EGKTEFLAELSIIACLRHKNLVQ
Sbjct: 365 FHSSRVIGRGAFGNVYRAMFVSSGTISAVKRSRHNSTEGKTEFLAELSIIACLRHKNLVQ 424
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENG-VLLSWYHRLNIVVGLASALTYLHQE 467
L GWC EKGELLLVYE+MPNGSLD++LYQ+S+ G V L W HRLNI +GLASAL+YLH E
Sbjct: 425 LQGWCNEKGELLLVYEFMPNGSLDKILYQESQTGAVALDWSHRLNIAIGLASALSYLHHE 484
Query: 468 CEQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYG 514
CEQQV+HRDIK SNIMLD NFNARL TLTAGTMGYLAPEYLQYG
Sbjct: 485 CEQQVVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKSPVSTLTAGTMGYLAPEYLQYG 544
Query: 515 TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574
TATEKTD FSYGVV+LEVACGRRPI++E E K VNLVDWVW L++EGR++EA D+RL G
Sbjct: 545 TATEKTDAFSYGVVILEVACGRRPIDKEPESQKTVNLVDWVWRLHSEGRVLEAVDERLKG 604
Query: 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLTFSSVSLTL 634
F+E+ MK+LLLVGL CA+PDS+ RPSMRRV QILNNE EP VPK+KP L+F S L+L
Sbjct: 605 EFDEEMMKKLLLVGLKCAHPDSNERPSMRRVLQILNNEIEPSPVPKMKPTLSF-SCGLSL 663
Query: 635 EDIVSEDEESD 645
+DIVSEDEE D
Sbjct: 664 DDIVSEDEEGD 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LYX1|LRK82_ARATH L-type lectin-domain containing receptor kinase VIII.2 OS=Arabidopsis thaliana GN=LECRK82 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1445), Expect = e-159, Method: Compositional matrix adjust.
Identities = 320/687 (46%), Positives = 425/687 (61%), Gaps = 49/687 (7%)
Query: 1 MPPKKLLVFFSIFLLNFSFVLSNNMNFDF--TSFNL-----RNITLLGDSYLRNGVIGLT 53
+PP+ V+ ++ + SF+ S+++ DF T F+L ++ LLGD++L NG I LT
Sbjct: 4 LPPRFFSVYSTLIHILASFLCSSDVRGDFPATRFDLGTLTLSSLKLLGDAHLNNGTIKLT 63
Query: 54 RELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDN 113
REL VP S++G +Y PV F ET + ASFT+ FSFS+ N+NPSS G GLAF ISPD
Sbjct: 64 RELSVPTSTAGKALYGKPVKFRHPETKSPASFTTYFSFSVTNLNPSSIGGGLAFVISPDE 123
Query: 114 QILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPI 173
LGS GG LGL + + + FVA+EFDT +D F D + NH+GLD++++ S AD
Sbjct: 124 DYLGSTGGFLGLTEETG-SGSGFVAVEFDTLMDVQFKDVNGNHVGLDLNAVVSAAVADLG 182
Query: 174 LQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFS 233
IDLKSGN + +WI Y R+L V++SYSNLKP +P+L V +DL Y+ +M+VGFS
Sbjct: 183 NVDIDLKSGNAVNSWITYDGSGRVLTVYVSYSNLKPKSPILSVPLDLDRYVSDSMFVGFS 242
Query: 234 ASTEGSTELHMIQSWSFQTSGFRPVRPKLHPHNVSDS------------SVVVETDFPTS 281
ST+GSTE+H + WSF +S N +V +T P+S
Sbjct: 243 GSTQGSTEIHSVDWWSFSSSFEESSESPPPMPNSPPPSSPSSSITPSLSTVRRKTADPSS 302
Query: 282 NSTNKHHNK---IGLGLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREF 338
+ NK K G+ AG F + V ++ KK K R L ++++ PREF
Sbjct: 303 SCRNKLCKKSPAAVAGVVTAGAFFLALFAGVIIWVYSKKIKYTRKSESLASEIMKSPREF 362
Query: 339 SYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSII 398
+Y+EL+ AT F S+R++G GAFG VYK SG + A+KR H +G TEFL+ELS+I
Sbjct: 363 TYKELKLATDCFSSSRVIGNGAFGTVYKGILQDSGEIIAIKRCSHISQGNTEFLSELSLI 422
Query: 399 ACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLA 458
LRH+NL++L G+C EKGE+LL+Y+ MPNGSLD+ LY E+ L W HR I++G+A
Sbjct: 423 GTLRHRNLLRLQGYCREKGEILLIYDLMPNGSLDKALY---ESPTTLPWPHRRKILLGVA 479
Query: 459 SALTYLHQECEQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGY 505
SAL YLHQECE Q+IHRD+K SNIMLDANFN +L T AGTMGY
Sbjct: 480 SALAYLHQECENQIIHRDVKTSNIMLDANFNPKLGDFGLARQTEHDKSPDATAAAGTMGY 539
Query: 506 LAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKM-----VNLVDWVWGLYA 560
LAPEYL G ATEKTDVFSYG VVLEV GRRPI R + +LVDWVWGLY
Sbjct: 540 LAPEYLLTGRATEKTDVFSYGAVVLEVCTGRRPITRPEPEPGLRPGLRSSLVDWVWGLYR 599
Query: 561 EGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPK 620
EG+++ A D+RL+ FN +EM R+++VGL+C+ PD RP+MR V QIL EA+ VP
Sbjct: 600 EGKLLTAVDERLS-EFNPEEMSRVMMVGLACSQPDPVTRPTMRSVVQILVGEADVPEVPI 658
Query: 621 LKPCLTFSSVS----LTLEDIVSEDEE 643
KP + S + LTL+D VS+ E
Sbjct: 659 AKPSSSMSFSTSELLLTLQDSVSDCNE 685
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFH9|LRK81_ARATH L-type lectin-domain containing receptor kinase VIII.1 OS=Arabidopsis thaliana GN=LECRK81 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 546 bits (1407), Expect = e-154, Method: Compositional matrix adjust.
Identities = 316/686 (46%), Positives = 429/686 (62%), Gaps = 56/686 (8%)
Query: 6 LLVFFSIFLLNFSFVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGS 65
L FF LL F F + FDF++ + N+ LLGD+ L NG++GLTR+L VP S +G
Sbjct: 4 FLSFFISILLCF-FNGATTTQFDFSTLAISNLKLLGDARLSNGIVGLTRDLSVPNSGAGK 62
Query: 66 LIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGL 125
++Y+NP+ F T+ SF+S FSFSI NVNPSS G GLAF ISPD +G AGG LGL
Sbjct: 63 VLYSNPIRFRQPGTHFPTSFSSFFSFSITNVNPSSIGGGLAFVISPDANSIGIAGGSLGL 122
Query: 126 VNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVI 185
+ + +KFVA+EFDT +D F D + NH+G D++ + S + D IDLKSGN I
Sbjct: 123 TGPNG-SGSKFVAVEFDTLMDVDFKDINSNHVGFDVNGVVSSVSGDLGTVNIDLKSGNTI 181
Query: 186 TAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMI 245
+WI+Y R+ V +SYSNLKP P+L +DL Y+ M+VGFS ST+GSTE+H I
Sbjct: 182 NSWIEYDGLTRVFNVSVSYSNLKPKVPILSFPLDLDRYVNDFMFVGFSGSTQGSTEIHSI 241
Query: 246 QSWSFQTSGFRPVR-------PKLHPHNVSDSSV-----------------VVETDFPTS 281
+ WSF +S + P+ + N +SV T TS
Sbjct: 242 EWWSFSSSFGSSLGSGSGSPPPRANLMNPKANSVKSPPPLASQPSSSAIPISSNTQLKTS 301
Query: 282 NSTNKHHNKIG------LGLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGP 335
+S++ H G+ AG F + ++ KK+K + ++++ P
Sbjct: 302 SSSSCHSRFCKENPGTIAGVVTAGAFFLALFAGALFWVYSKKFKRVERSDSFASEIIKAP 361
Query: 336 REFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAE 394
+EFSY+EL++ T+ F+ +RI+G GAFG VY+ +G + AVKR H S + K EFL+E
Sbjct: 362 KEFSYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQDKKNEFLSE 421
Query: 395 LSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIV 454
LSII LRH+NLV+L GWC EKGE+LLVY+ MPNGSLD+ L+ E+ L W HR I+
Sbjct: 422 LSIIGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF---ESRFTLPWDHRKKIL 478
Query: 455 VGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAG 501
+G+ASAL YLH+ECE QVIHRD+K+SNIMLD +FNA+L T+ AG
Sbjct: 479 LGVASALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPEATVAAG 538
Query: 502 TMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERE--TEGHKM---VNLVDWVW 556
TMGYLAPEYL G A+EKTDVFSYG VVLEV GRRPIE++ + H + NLV+WVW
Sbjct: 539 TMGYLAPEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRHNVGVNPNLVEWVW 598
Query: 557 GLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616
GLY EG++ AAD RL G F+E EM R+L+VGL+C++PD + RP+MR V Q+L EA+
Sbjct: 599 GLYKEGKVSAAADSRLEGKFDEGEMWRVLVVGLACSHPDPAFRPTMRSVVQMLIGEADVP 658
Query: 617 VVPKLKPCLTFSS--VSLTLEDIVSE 640
VVPK +P ++FS+ + L+L+D +S+
Sbjct: 659 VVPKSRPTMSFSTSHLLLSLQDTLSD 684
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FHX3|LRKS6_ARATH L-type lectin-domain containing receptor kinase S.6 OS=Arabidopsis thaliana GN=LECRKS6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1120), Expect = e-121, Method: Compositional matrix adjust.
Identities = 268/683 (39%), Positives = 384/683 (56%), Gaps = 67/683 (9%)
Query: 6 LLVFFSIFLLNFSF-VLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGV------ 58
L++F I L+ F LS+ S L+N+TL GD++ R+ I LT++
Sbjct: 8 LVIFHLILFLSLDFPTLSHRF-----SPPLQNLTLYGDAFFRDRTISLTQQQPCFPSVTT 62
Query: 59 ----PASSS-GSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDN 113
P+SS G +Y P+ F + TNTTASF+ RFSFSI FGDG AF I+ +
Sbjct: 63 PPSKPSSSGIGRALYVYPIKFLEPSTNTTASFSCRFSFSIIASPSCPFGDGFAFLITSNA 122
Query: 114 QILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPI 173
+ G LGL N + F+A+EFDTR DP D ++NH+G+D+ S+ S+ + D I
Sbjct: 123 DSFVFSNGFLGLPNPD----DSFIAVEFDTRFDPVHGDINDNHVGIDVSSIFSVSSVDAI 178
Query: 174 LQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFS 233
+G DLKSG + AWI+Y + L++++V++ YS +KP +P+L IDLSG +K M+VGFS
Sbjct: 179 SKGFDLKSGKKMMAWIEYSDVLKLIRVWVGYSRVKPTSPVLSTQIDLSGKVKEYMHVGFS 238
Query: 234 ASTEG-STELHMIQSWSFQTSGFRPVRPKLHPHNVSDSSVVVETDFPTSNSTNKHHNK-- 290
AS G + LH+++ W F+T G + + +V + S + + H K
Sbjct: 239 ASNAGIGSALHIVERWKFRTFGSHSDAIQEEEEEKDEECLVCSGE--VSENPKEIHRKGF 296
Query: 291 ------IGLGLGI----AGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSY 340
+GL + + G A +++A + I K + + LV P S
Sbjct: 297 NFRVTVVGLKIPVWSLLPGLAAIVILVAFIVFSLICGKKRISEEADSNSGLVRMPGRLSL 356
Query: 341 RELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---GKTEFLAEL-S 396
E++SAT GF+ N I+G+GA VY+ S GSV AVKR H + F E +
Sbjct: 357 AEIKSATSGFNENAIVGQGASATVYRGSIPSIGSV-AVKRFDREHWPQCNRNPFTTEFTT 415
Query: 397 IIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQD-----SENGVLLSWYHRL 451
+ LRHKNLVQ GWC+E E LV+EY+PNGSL L++ SE ++LSW R+
Sbjct: 416 MTGYLRHKNLVQFQGWCSEGTETALVFEYLPNGSLSEFLHKKPSSDPSEEIIVLSWKQRV 475
Query: 452 NIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES----------------S 495
NI++G+ASALTYLH+ECE+Q+IHRD+K NIMLDA FNA+L +
Sbjct: 476 NIILGVASALTYLHEECERQIIHRDVKTCNIMLDAEFNAKLGDFGLAEIYEHSALLAGRA 535
Query: 496 FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV 555
TL AGTMGYLAPEY+ G +EKTDV+S+GVVVLEV GRRP+ G LVD +
Sbjct: 536 ATLPAGTMGYLAPEYVYTGVPSEKTDVYSFGVVVLEVCTGRRPV-----GDDGAVLVDLM 590
Query: 556 WGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615
W + G++++ AD L F+ +EM+R+L+VG+ CA+PDS RP ++ +I+ EA
Sbjct: 591 WSHWETGKVLDGADIMLREEFDAEEMERVLMVGMVCAHPDSEKRPRVKDAVRIIRGEAPL 650
Query: 616 LVVPKLKPCLTFSSVSLTLEDIV 638
V+P +P L + E IV
Sbjct: 651 PVLPARRPLLRIRPANEAEEMIV 673
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 378 bits (970), Expect = e-104, Method: Compositional matrix adjust.
Identities = 238/634 (37%), Positives = 351/634 (55%), Gaps = 52/634 (8%)
Query: 22 SNNMNFDFTSFNL--RNITLLGDSYL-RNGVIGLTRELGVPASSSGSLIYNNPVPFFDQE 78
S ++NF + SF+ NI++ G + + NG++ LT + + S+G Y P+ F D
Sbjct: 24 SQSLNFTYNSFHRPPTNISIQGIATVTSNGILKLTDKTVI---STGHAFYTEPIRFKDSP 80
Query: 79 TNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGC--LGLVNSSQL--TKN 134
+T +SF++ F I + P+ G G+AFFI+P N +L SA LGL +S+ N
Sbjct: 81 NDTVSSFSTTFVIGIYSGIPTISGHGMAFFIAP-NPVLSSAMASQYLGLFSSTNNGNDTN 139
Query: 135 KFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTA-----DPILQ--GIDLKSGNVITA 187
+A+EFDT ++P FDD ++NH+G++I+SL S+K++ D I Q + L S +
Sbjct: 140 HILAVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGYWDEINQFNNLTLISRKRMQV 199
Query: 188 WIDYKNDLRMLKVFMS-YSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQ 246
W+DY + + V M+ + +KP L+ V DLS +MY+GFSA+T H +
Sbjct: 200 WVDYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYLGFSAATGYVLSEHFVF 259
Query: 247 SWSFQTSGFRPVRPKLHPHNVSDSSVVVETDFPTSNSTNK---HHNKIGLGLGIAGPAFF 303
WSF G P L V FP T+ + N++ L + P F
Sbjct: 260 GWSFMVKG--KTAPPLTLSKVP--------KFPRVGPTSLQRFYKNRMPLFSLLLIPVLF 309
Query: 304 CVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGFHSNRILGRGAFGN 363
V L +++ + + G +++L AT+GF +LG G FG
Sbjct: 310 VVSLIFLVRFIVRRRRKFAEEFE-DWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGR 368
Query: 364 VYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422
VY+ ++ AVKR S S +G EF+AE+ I + H+NLV LLG+C + ELLLV
Sbjct: 369 VYRGVMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLV 428
Query: 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNI 482
Y+YMPNGSLD+ LY E V L W R N+++G+AS L YLH+E EQ VIHRDIKASN+
Sbjct: 429 YDYMPNGSLDKYLYDCPE--VTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNV 486
Query: 483 MLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVV 529
+LDA +N RL + T GT GYLAP++++ G AT TDVF++GV++
Sbjct: 487 LLDAEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLL 546
Query: 530 LEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGL 589
LEVACGRRPIE E E + V LVD V+G + EG I++A D L +++ E++ +L +GL
Sbjct: 547 LEVACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGL 606
Query: 590 SCANPDSSARPSMRRVFQILNNEAEPLVVPKLKP 623
C++ D RP+MR+V Q L +A +P L P
Sbjct: 607 LCSHSDPQVRPTMRQVLQYLRGDA---TLPDLSP 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 377 bits (969), Expect = e-103, Method: Compositional matrix adjust.
Identities = 243/626 (38%), Positives = 336/626 (53%), Gaps = 54/626 (8%)
Query: 26 NFDFTSFNLR--NITLLGDSYLR-NGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTT 82
+F F F N+TL G + + G I LT E G Y+ P+ F N
Sbjct: 25 DFSFIGFKKASPNLTLNGVAEIAPTGAIRLTTET---QRVIGHAFYSLPIRFKPIGVNRA 81
Query: 83 ASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGS-AGGCLGLVNSSQLT-KNKFVAIE 140
SF++ F+ ++ + G GLAF I+P + GS LGL+NSS++ + F A+E
Sbjct: 82 LSFSTSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYLGLLNSSRVNFSSHFFAVE 141
Query: 141 FDTRLDPHFDDPDENHIGLDIDSLES-IKT------ADPILQGIDLKSGNVITAWIDYKN 193
FDT D F+D ++NH+G+DI+S+ES I T A+ + + L G VI AWIDY +
Sbjct: 142 FDTVRDLEFEDINDNHVGIDINSMESSISTPAGYFLANSTKKELFLDGGRVIQAWIDYDS 201
Query: 194 DLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTS 253
+ + L V +S + KP LL ++DLS L MYVGFSAST H I W+F S
Sbjct: 202 NKKRLDVKLSPFSEKPKLSLLSYDVDLSSVLGDEMYVGFSASTGLLASSHYILGWNFNMS 261
Query: 254 GFR-----PVRPKLHPHNVSDSSVVVETDFPTSNSTNKHHNKIGLGLGIAGPAFFCVVLA 308
G P P++ P ++ ++ + LG+ + VL
Sbjct: 262 GEAFSLSLPSLPRI-PSSIKKRKKKRQS--------------LILGVSLLCSLLIFAVLV 306
Query: 309 VFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGFHSNRILGRGAFGNVYKAY 368
++K K+ D GP FSYREL+ AT GF +LG G FG VYK
Sbjct: 307 AASLFVVRKVKDEDRVEEWELDF--GPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGK 364
Query: 369 FASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427
S AVKR H S +G EF++E+S I LRH+NLVQLLGWC + +LLLVY++MP
Sbjct: 365 LPGSDEFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMP 424
Query: 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN 487
NGSLD L+ D V+L+W R I+ G+AS L YLH+ EQ VIHRDIKA+N++LD+
Sbjct: 425 NGSLDMYLF-DENPEVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSE 483
Query: 488 FNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC 534
N R+ + T GT GYLAPE + G T TDV+++G V+LEVAC
Sbjct: 484 MNGRVGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVAC 543
Query: 535 GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANP 594
GRRPIE ++V +VDWVW + G I + D+RLNG F+E+E+ ++ +GL C+N
Sbjct: 544 GRRPIETSALPEELV-MVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNN 602
Query: 595 DSSARPSMRRVFQILNNE-AEPLVVP 619
RP+MR+V L + P VVP
Sbjct: 603 SPEVRPTMRQVVMYLEKQFPSPEVVP 628
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FG33|LRKS5_ARATH Probable L-type lectin-domain containing receptor kinase S.5 OS=Arabidopsis thaliana GN=LECRKS5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 366 bits (939), Expect = e-100, Method: Compositional matrix adjust.
Identities = 234/650 (36%), Positives = 369/650 (56%), Gaps = 77/650 (11%)
Query: 25 MNFDFTSFNLRN-ITLLGD-SYLRNGVIGLTREL-----GVPASSSGSLIYNNPVPFFDQ 77
+ FDF FN+ N + L+ D SY+ G I +T ++ G A+ +G +Y P + +
Sbjct: 25 LKFDFPGFNVSNELELIRDNSYIVFGAIQVTPDVTGGPGGTIANQAGRALYKKPFRLWSK 84
Query: 78 ETNTTASFTSRFSFSINN-VNPSSFGDGLAFFISPDNQI-LGSAGGCLGLVN--SSQLTK 133
+ +A+F + F +I+N +P G+GLAF ++P+ S+G LG+VN +++ +
Sbjct: 85 --HKSATFNTTFVINISNKTDPG--GEGLAFVLTPEETAPQNSSGMWLGMVNERTNRNNE 140
Query: 134 NKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKN 193
++ V++EFDTR H DD D NH+ L+++++ S+ +GI + SG +TA + Y
Sbjct: 141 SRIVSVEFDTR-KSHSDDLDGNHVALNVNNINSVVQESLSGRGIKIDSGLDLTAHVRY-- 197
Query: 194 DLRMLKVFMSYS--NLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQ 251
D + L V++S + + + IDLS YL +YVGF+AST TEL+ ++SWSF+
Sbjct: 198 DGKNLSVYVSRNLDVFEQRNLVFSRAIDLSAYLPETVYVGFTASTSNFTELNCVRSWSFE 257
Query: 252 TSGFRPVRPKLHPHNVSDSSVVVETDFPTSNSTNKHHNKIGLGLGIAGPAFFCVVLAVF- 310
+ ++ D L L I P F V + F
Sbjct: 258 -------------------GLKIDGDGNM------------LWLWITIPIVFIVGIGAFL 286
Query: 311 GYISIK-KWKNMRTGICLRADL---VPGPREFSYRELRSATRGFHSNRILGRGAFGNVYK 366
G + ++ + K T + A+L P++F REL+ AT F + LG+G FG V+K
Sbjct: 287 GALYLRSRSKAGETNPDIEAELDNCAANPQKFKLRELKRATGNFGAENKLGQGGFGMVFK 346
Query: 367 AYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425
+ G AVKR S+ SH+GK EF+AE++ I L H+NLV+LLGWC E+ E LLVYEY
Sbjct: 347 GKW--QGRDIAVKRVSEKSHQGKQEFIAEITTIGNLNHRNLVKLLGWCYERKEYLLVYEY 404
Query: 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485
MPNGSLD+ L+ + ++ L+W R NI+ GL+ AL YLH CE++++HRDIKASN+MLD
Sbjct: 405 MPNGSLDKYLFLEDKSRSNLTWETRKNIITGLSQALEYLHNGCEKRILHRDIKASNVMLD 464
Query: 486 ANFNARL---------------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVL 530
++FNA+L S AGT GY+APE G AT +TDV+++GV++L
Sbjct: 465 SDFNAKLGDFGLARMIQQSEMTHHSTKEIAGTPGYMAPETFLNGRATVETDVYAFGVLML 524
Query: 531 EVACGRRP---IERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLV 587
EV G++P + ++ + + ++V+W+W LY G I +AAD + F+++EMK +LL+
Sbjct: 525 EVVSGKKPSYVLVKDNQNNYNNSIVNWLWELYRNGTITDAADPGMGNLFDKEEMKSVLLL 584
Query: 588 GLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLTFSSVSLTLEDI 637
GL+C +P+ + RPSM+ V ++L E P VP +P + ++ + DI
Sbjct: 585 GLACCHPNPNQRPSMKTVLKVLTGETSPPDVPTERPAFVWPAMPPSFSDI 634
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 357 bits (917), Expect = 1e-97, Method: Compositional matrix adjust.
Identities = 231/660 (35%), Positives = 346/660 (52%), Gaps = 71/660 (10%)
Query: 15 LNFSFVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPF 74
LNF++ NN T +++ IT + NG++ LT +G Y P+ F
Sbjct: 25 LNFAY---NNGFNPPTDLSIQGIT----TVTPNGLLKLTN---TTVQKTGHAFYTKPIRF 74
Query: 75 FDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQI-LGSAGGCLGLVN--SSQL 131
D T +SF++ F F+I++ G G+AF ++P+ + G+ +GL N ++
Sbjct: 75 KDSPNGTVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIGLFNLANNGN 134
Query: 132 TKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADP-------ILQGIDLKSGNV 184
N A+E DT L F+D ++NH+G+DI+SL+S++++ + + L S
Sbjct: 135 ETNHVFAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYWDEKGQFKNLTLISRKP 194
Query: 185 ITAWIDYKNDLRMLKVFMS-YSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELH 243
+ W+DY + V M+ ++ KP PL+ DLS L +MYVGFS++T H
Sbjct: 195 MQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDMYVGFSSATGSVLSEH 254
Query: 244 MIQSWSFQTS--------GFRPVRPKLHPHNVSDSSVVVETDFPTSNSTNKHHNKIGLGL 295
I WSF + P P+ P +S+ KIG+ L
Sbjct: 255 YILGWSFGLNEKAPPLALSRLPKLPRFEPKRISE------------------FYKIGMPL 296
Query: 296 GIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGFHSNRI 355
+ F + +F I + + + G F +++L AT+GF +
Sbjct: 297 ----ISLFLIFSFIFLVCYIVRRRRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGL 352
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQLLGWCA 414
LG G FG+VYK + AVKR H S +G EF+AE+ I + H+NLV LLG+C
Sbjct: 353 LGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCR 412
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
+GELLLVY+YMPNGSLD+ LY E V L+W R+ +++G+AS L YLH+E EQ VIH
Sbjct: 413 RRGELLLVYDYMPNGSLDKYLYNTPE--VTLNWKQRIKVILGVASGLFYLHEEWEQVVIH 470
Query: 475 RDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEKTD 521
RD+KASN++LD N RL + T GT+GYLAPE+ + G AT TD
Sbjct: 471 RDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATD 530
Query: 522 VFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEM 581
VF++G +LEVACGRRPIE + E + LVDWV+GL+ +G I+ A D + +E E+
Sbjct: 531 VFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEV 590
Query: 582 KRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPC-LTFSSVSLTLEDIVSE 640
+ +L +GL C++ D ARPSMR+V L +A+ +P+L P L+ S + + D SE
Sbjct: 591 EMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAK---LPELSPLDLSGSGMMFGVHDGFSE 647
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LXA5|LRK91_ARATH L-type lectin-domain containing receptor kinase IX.1 OS=Arabidopsis thaliana GN=LECRK91 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 355 bits (910), Expect = 8e-97, Method: Compositional matrix adjust.
Identities = 240/658 (36%), Positives = 354/658 (53%), Gaps = 74/658 (11%)
Query: 7 LVFFSIFLLNFSFVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSL 66
++ FS F+L FV S N ++ I GD+ NG + LT +G
Sbjct: 5 ILLFS-FVLVLPFVCSVQFNISRFGSDVSEIAYQGDARA-NGAVELTNI--DYTCRAGWA 60
Query: 67 IYNNPVPFFDQETNTTASFTSRFSFSIN--NVNPSSFGDGLAFFISPDNQIL--GSAGGC 122
Y VP ++ T+ + F++RFSF I+ NV ++G G AFF++P L SAGG
Sbjct: 61 TYGKQVPLWNPGTSKPSDFSTRFSFRIDTRNVGYGNYGHGFAFFLAPARIQLPPNSAGGF 120
Query: 123 LGLVNSSQLTKNKF--VAIEFDTRLDPHFDDPD-ENHIGLDIDSLESIKTADPILQGIDL 179
LGL N + + F V +EFDT +P +D D ++H+G++ +SL S +
Sbjct: 121 LGLFNGTNNQSSAFPLVYVEFDTFTNPEWDPLDVKSHVGINNNSLVSSNYTSWNATSHNQ 180
Query: 180 KSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPL----LKVNIDLSGYLKGNMYVGFSAS 235
G V+ I Y + R L V +Y PL L IDLS L + +GFSA+
Sbjct: 181 DIGRVL---IFYDSARRNLSVSWTYDLTS--DPLENSSLSYIIDLSKVLPSEVTIGFSAT 235
Query: 236 TEGSTELHMIQSWSFQTSGFRPVRPKLHPHNVSDSSVVVETDFPTSNSTNKHHNKIGLGL 295
+ G TE + + SW F +S L ++ S ++K G+ +
Sbjct: 236 SGGVTEGNRLLSWEFSSS--------LELIDIKKS----------------QNDKKGMII 271
Query: 296 GIAGPAFFCVVLAVFGYISIKKWKNMR---------TGICLRADLVPGPREFSYRELRSA 346
GI+ F + + I K K + T I + GPR+F+Y++L SA
Sbjct: 272 GISVSGFVLLTFFITSLIVFLKRKQQKKKAEETENLTSINEDLERGAGPRKFTYKDLASA 331
Query: 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKN 405
F +R LG G FG VY+ Y S + A+K+ + S +GK EF+ E+ II+ LRH+N
Sbjct: 332 ANNFADDRKLGEGGFGAVYRGYLNSLDMMVAIKKFAGGSKQGKREFVTEVKIISSLRHRN 391
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
LVQL+GWC EK E L++YE+MPNGSLD L+ + L+W+ R I +GLASAL YLH
Sbjct: 392 LVQLIGWCHEKDEFLMIYEFMPNGSLDAHLFGKKPH---LAWHVRCKITLGLASALLYLH 448
Query: 466 QECEQQVIHRDIKASNIMLDANFNARLESSFTLT--------------AGTMGYLAPEYL 511
+E EQ V+HRDIKASN+MLD+NFNA+L F L AGT GY+APEY+
Sbjct: 449 EEWEQCVVHRDIKASNVMLDSNFNAKL-GDFGLARLMDHELGPQTTGLAGTFGYMAPEYI 507
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPIE-RETEGHKMVNLVDWVWGLYAEGRIIEAADK 570
G A++++DV+S+GVV LE+ GR+ ++ R+ + NLV+ +W LY +G +I A D+
Sbjct: 508 STGRASKESDVYSFGVVTLEIVTGRKSVDRRQGRVEPVTNLVEKMWDLYGKGEVITAIDE 567
Query: 571 RLN-GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLTF 627
+L G F+E + + L++VGL CA+PD + RPS+++ Q+LN EA +P P T+
Sbjct: 568 KLRIGGFDEKQAECLMIVGLWCAHPDVNTRPSIKQAIQVLNLEAPVPHLPTKMPVATY 625
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 353 bits (906), Expect = 2e-96, Method: Compositional matrix adjust.
Identities = 229/647 (35%), Positives = 348/647 (53%), Gaps = 52/647 (8%)
Query: 9 FFSIFLLNFSF--VLSNNMNFDFTSFNLR----NITLLGDSYLR-NGVIGLTRELGVPAS 61
F+IF L+F + + S++ DFT R +I++LG + + NG++ LT
Sbjct: 6 LFTIFFLSFFWQSLKSSSQIIDFTYNGFRPPPTDISILGIATITPNGLLKLT---NTTMQ 62
Query: 62 SSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQI-LGSAG 120
S+G Y P+ F D T +SF++ F F+I++ P G+AF I+P+ ++ GS
Sbjct: 63 STGHAFYTKPIRFKDSPNGTVSSFSTTFVFAIHSQIP--IAHGMAFVIAPNPRLPFGSPL 120
Query: 121 GCLGLVNSSQL--TKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTA-------D 171
LGL N + +N A+E DT ++ F+D + NH+G+DI+SL S+K++ +
Sbjct: 121 QYLGLFNVTNNGNVRNHVFAVELDTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYWDEN 180
Query: 172 PILQGIDLKSGNVITAWIDYKNDLRMLKVFMS-YSNLKPVTPLLKVNIDLSGYLKGNMYV 230
+ L S + W+D+ ++ V M+ + +KP PL+ + DLS L +M+V
Sbjct: 181 DQFHNLTLISSKRMQVWVDFDGPTHLIDVTMAPFGEVKPRKPLVSIVRDLSSVLLQDMFV 240
Query: 231 GFSASTEGSTELHMIQSWSFQTSGFRPVRPKLHPHNVSDSSVVVETDFPTSNSTNKHHNK 290
GFS++T + WSF +G + P +S + D + + N
Sbjct: 241 GFSSATGNIVSEIFVLGWSFGVNG------EAQPLALSKLPRLPVWDLKPTRVYRFYKNW 294
Query: 291 IGLGLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGF 350
+ L + P + L F I K + + G +++L AT+GF
Sbjct: 295 VPLISLLLIPFLLIIFLVRF----IMKRRRKFAEEVEDWETEFGKNRLRFKDLYYATKGF 350
Query: 351 HSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQL 409
ILG G FG+VYK + AVKR S S +G EF+AE+ I + H+NLV L
Sbjct: 351 KDKNILGSGGFGSVYKGIMPKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPL 410
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
+G+C + ELLLVY+YMPNGSLD+ LY E V L W R ++ G+ASAL YLH+E E
Sbjct: 411 VGYCRRRDELLLVYDYMPNGSLDKYLYNSPE--VTLDWKQRFKVINGVASALFYLHEEWE 468
Query: 470 QQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTA 516
Q VIHRD+KASN++LDA N RL + T GT GYLAP++++ G A
Sbjct: 469 QVVIHRDVKASNVLLDAELNGRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRA 528
Query: 517 TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576
T TDVF++GV++LEVACGRRPIE + + V LVDWV+ + E I++A D L +
Sbjct: 529 TTTTDVFAFGVLLLEVACGRRPIEINNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEY 588
Query: 577 NEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKP 623
++ E++ +L +GL C++ D ARP+MR+V Q L +A ++P L P
Sbjct: 589 DQKEVEMVLKLGLLCSHSDPLARPTMRQVLQYLRGDA---MLPDLSP 632
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 645 | ||||||
| 255563468 | 663 | kinase, putative [Ricinus communis] gi|2 | 0.992 | 0.965 | 0.720 | 0.0 | |
| 147799284 | 2665 | hypothetical protein VITISV_007763 [Viti | 0.967 | 0.234 | 0.705 | 0.0 | |
| 225461937 | 679 | PREDICTED: probable L-type lectin-domain | 0.967 | 0.918 | 0.705 | 0.0 | |
| 224114497 | 663 | predicted protein [Populus trichocarpa] | 0.989 | 0.962 | 0.703 | 0.0 | |
| 296089928 | 878 | unnamed protein product [Vitis vinifera] | 0.959 | 0.705 | 0.705 | 0.0 | |
| 224056469 | 664 | predicted protein [Populus trichocarpa] | 0.992 | 0.963 | 0.690 | 0.0 | |
| 449461104 | 671 | PREDICTED: probable L-type lectin-domain | 0.984 | 0.946 | 0.684 | 0.0 | |
| 15241048 | 681 | concanavalin A-like lectin kinase-like p | 0.993 | 0.941 | 0.655 | 0.0 | |
| 297793053 | 680 | hypothetical protein ARALYDRAFT_495664 [ | 0.989 | 0.938 | 0.653 | 0.0 | |
| 356553507 | 716 | PREDICTED: probable L-type lectin-domain | 0.924 | 0.832 | 0.6 | 0.0 |
| >gi|255563468|ref|XP_002522736.1| kinase, putative [Ricinus communis] gi|223537974|gb|EEF39587.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 963 bits (2489), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/665 (72%), Positives = 552/665 (83%), Gaps = 25/665 (3%)
Query: 1 MPP-KKLLVFFSIFLLNFSF------VLSN-NMNFDFTSFNLRNITLLGDSYLRNGVIGL 52
MPP +KLLVF +F + FSF VL+N N+ FDF+S LRN+TLLGDS+LR+G +GL
Sbjct: 1 MPPSRKLLVFLFLFTI-FSFKDNPFLVLANKNVIFDFSSLTLRNLTLLGDSFLRHGAVGL 59
Query: 53 TRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPD 112
TR++ VP+SSSG++IYN P+PFFD ETN TASF+++F+FSI NVNPSSFGDGL FF+S D
Sbjct: 60 TRDVTVPSSSSGTVIYNYPIPFFDSETNITASFSTKFTFSITNVNPSSFGDGLTFFLSQD 119
Query: 113 NQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADP 172
NQ LGS GG LGLVNSSQLTKN FVAIEFDTRLD HFDDP+ENH+GLDIDS++S+KTA+P
Sbjct: 120 NQTLGSPGGFLGLVNSSQLTKNNFVAIEFDTRLDAHFDDPNENHVGLDIDSVDSVKTANP 179
Query: 173 ILQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGF 232
ILQ IDLKSGN ITAWIDYKND R+LKV++SY+NLKP P+L V IDLSGYLK MYVGF
Sbjct: 180 ILQDIDLKSGNSITAWIDYKNDFRVLKVYLSYTNLKPEKPVLTVGIDLSGYLKEVMYVGF 239
Query: 233 SASTEGSTELHMIQSWSFQTSGFRPVRPKLHPHNVSDSSVVVET-DFPTSNSTNKHHNKI 291
S STEGSTELH+I+SWSF+TSGF P RPKL PHNVSDSSV+ T P S S +KH+ +
Sbjct: 240 SGSTEGSTELHLIESWSFKTSGFLPPRPKL-PHNVSDSSVITTTPSIPISRSADKHNKGL 298
Query: 292 GLGLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGFH 351
GLGLGIAGPAFFCV L FGY SIKKW+ ++ L+ +LV GPR++SY+EL ATRGFH
Sbjct: 299 GLGLGIAGPAFFCVFLVAFGYFSIKKWQKIKMVNSLKTELVAGPRQYSYKELSLATRGFH 358
Query: 352 SNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
S+RI+G+G+FG+VYKAYF S+G +AAVKRSKHSHEGK +FLAELSIIACLRHKNLVQL G
Sbjct: 359 SSRIIGKGSFGDVYKAYFVSTGDIAAVKRSKHSHEGKADFLAELSIIACLRHKNLVQLQG 418
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
WC EK ELLLVYE MP GSLD+MLYQ+SE+G LLSW HR NI +GLASALTYLHQECEQQ
Sbjct: 419 WCVEKSELLLVYELMPYGSLDKMLYQESEHGTLLSWSHRKNIAIGLASALTYLHQECEQQ 478
Query: 472 VIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATE 518
VIHRDIK SN+MLDANFNARL TLTAGTMGYLAPEYL YG ATE
Sbjct: 479 VIHRDIKTSNVMLDANFNARLGDFGLARLMDHDKSPVSTLTAGTMGYLAPEYLHYGKATE 538
Query: 519 KTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNE 578
+TDVFSYGVV+LE+ACG RPIERE + +MVNLVDWVWGLY EG+IIEAADKRLNG F E
Sbjct: 539 RTDVFSYGVVMLELACGMRPIEREPQSQEMVNLVDWVWGLYGEGKIIEAADKRLNGEFEE 598
Query: 579 DEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLTFS-SVSLTLEDI 637
DEM+ LLL+GLSCANPDS RP+MRRV QILN EAE +VVPK+KP LTFS ++LTLEDI
Sbjct: 599 DEMRNLLLIGLSCANPDSMERPTMRRVLQILNGEAELVVVPKMKPTLTFSCGLTLTLEDI 658
Query: 638 VSEDE 642
VSE E
Sbjct: 659 VSECE 663
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799284|emb|CAN76998.1| hypothetical protein VITISV_007763 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 959 bits (2479), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/641 (70%), Positives = 540/641 (84%), Gaps = 17/641 (2%)
Query: 20 VLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQET 79
V + N++FDF+SF LRN TLLGDSYLRNGVIGLTR LGVP+SSSG++I N P+ FFD E+
Sbjct: 1690 VSAQNVDFDFSSFTLRNFTLLGDSYLRNGVIGLTRNLGVPSSSSGTVICNAPIAFFDSES 1749
Query: 80 NTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAI 139
NTTASF++RFSFSI NVNPSS+GDGLAFF+SP+N+ LGS GG LGLVNSSQLTKN+FVA+
Sbjct: 1750 NTTASFSTRFSFSITNVNPSSYGDGLAFFLSPENETLGSPGGYLGLVNSSQLTKNRFVAV 1809
Query: 140 EFDTRLDPHFDDPDENHIGLDIDSLESIKTADPIL-QGIDLKSGNVITAWIDYKNDLRML 198
EFDTRLDPHF+DP++NH+GLDIDSL S+KTADP+L + IDLKSG ITAWI+YKND L
Sbjct: 1810 EFDTRLDPHFNDPNDNHVGLDIDSLNSMKTADPVLDENIDLKSGKSITAWIEYKNDQMKL 1869
Query: 199 KVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTSGFRPV 258
KVF+S S KP P+L V+IDLS YLK YVGFSASTEGSTELH+I++WSF+T G P
Sbjct: 1870 KVFLSSSRSKPERPVLIVDIDLSEYLKELKYVGFSASTEGSTELHLIENWSFKTFGLVPA 1929
Query: 259 RPKLH--PHNVSDSSVVVETDFPTSNSTNKHHNKIGLGLGIAGPAFFCVVLAVFGYISIK 316
P+LH PHNVSD++V++ S+S NK H ++GLG GIAGP FFC+VL+VFGY+S+K
Sbjct: 1930 PPRLHFPPHNVSDNTVMIPPPSAVSDSGNKGHKRLGLGFGIAGPVFFCIVLSVFGYVSMK 1989
Query: 317 KWKNMRTGICLRADLVPGPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVA 376
KW+ MR +AD++ GPREFSY+EL+ AT+GFHS+RI+G GAFG VYKA+F ++G+++
Sbjct: 1990 KWRGMRWEKSFKADILAGPREFSYKELKGATKGFHSSRIIGNGAFGTVYKAFFITTGTIS 2049
Query: 377 AVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLY 436
AVKRSKHSHEGK+EFLAELSIIACLRHKNLVQL GWC EKG+LLLVYE+MPNGSLD+MLY
Sbjct: 2050 AVKRSKHSHEGKSEFLAELSIIACLRHKNLVQLQGWCVEKGDLLLVYEFMPNGSLDKMLY 2109
Query: 437 QDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL---- 492
Q+SE G LL W HR NI+VG+AS LTYLHQECEQQVIHRDIK SNIMLD NFNARL
Sbjct: 2110 QESEEGTLLKWSHRYNIIVGMASVLTYLHQECEQQVIHRDIKTSNIMLDGNFNARLGDFG 2169
Query: 493 ---------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERET 543
TLTAGTMGYLAPEYLQYG ATEKTDVFSYGVV+LEVACGRRPIE++T
Sbjct: 2170 LARLMDHDKSPVSTLTAGTMGYLAPEYLQYGKATEKTDVFSYGVVILEVACGRRPIEKDT 2229
Query: 544 EGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMR 603
+ KM+NLVDWVWGLY++G I+EAADKRLN F E+EM++LLLVGLSCANPD + RPSMR
Sbjct: 2230 DSQKMMNLVDWVWGLYSQGNILEAADKRLNREFKEEEMRKLLLVGLSCANPDCNVRPSMR 2289
Query: 604 RVFQILNNEAEPLVVPKLKPCLTFS-SVSLTLEDIVSEDEE 643
RV QILN+EAEPL+VP++KP LTFS S+ L+++DIVS+ E+
Sbjct: 2290 RVLQILNDEAEPLLVPRMKPSLTFSLSLPLSIDDIVSDGED 2330
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225461937|ref|XP_002268825.1| PREDICTED: probable L-type lectin-domain containing receptor kinase S.7-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2454), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/641 (70%), Positives = 540/641 (84%), Gaps = 17/641 (2%)
Query: 20 VLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQET 79
V + N++FDF+SF LRN TLLGDSYLRNGVIGLTR LGVP+SSSG++I N P+ FFD E+
Sbjct: 26 VSAQNVDFDFSSFTLRNFTLLGDSYLRNGVIGLTRNLGVPSSSSGTVICNAPIAFFDSES 85
Query: 80 NTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAI 139
NTTASF++RFSFSI NVNPSS+GDGLAFF+SP+N+ LGS GG LGLVNSSQLTKN+FVA+
Sbjct: 86 NTTASFSTRFSFSITNVNPSSYGDGLAFFLSPENETLGSPGGYLGLVNSSQLTKNRFVAV 145
Query: 140 EFDTRLDPHFDDPDENHIGLDIDSLESIKTADPIL-QGIDLKSGNVITAWIDYKNDLRML 198
EFDTRLDPHF+DP++NH+GLDIDSL S+KTADP+L + IDLKSG ITAWI+YKND L
Sbjct: 146 EFDTRLDPHFNDPNDNHVGLDIDSLNSMKTADPVLDENIDLKSGKSITAWIEYKNDQMKL 205
Query: 199 KVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTSGFRPV 258
KVF+S S KP P+L V+IDLS YLK YVGFSASTEGSTELH+I++WSF+T G P
Sbjct: 206 KVFLSSSRSKPERPVLIVDIDLSEYLKELKYVGFSASTEGSTELHLIENWSFKTFGLVPA 265
Query: 259 RPKLH--PHNVSDSSVVVETDFPTSNSTNKHHNKIGLGLGIAGPAFFCVVLAVFGYISIK 316
P+LH PHNVSD++V++ S+S NK H ++GLG GIAGP FFC+VL+VFGY+S+K
Sbjct: 266 PPRLHFPPHNVSDNTVMIPPPSAVSDSGNKGHKRLGLGFGIAGPVFFCIVLSVFGYVSMK 325
Query: 317 KWKNMRTGICLRADLVPGPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVA 376
KW+ MR +AD++ GPREFSY+EL+ AT+GFHS+RI+G GAFG VYKA+F ++G+++
Sbjct: 326 KWRGMRWEKSFKADILAGPREFSYKELKGATKGFHSSRIIGNGAFGTVYKAFFITTGTIS 385
Query: 377 AVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLY 436
AVKRSKHSHEGK+EFLAELSIIACLRHKNLVQL GWC EKG+LLLVYE+MPNGSLD+MLY
Sbjct: 386 AVKRSKHSHEGKSEFLAELSIIACLRHKNLVQLQGWCVEKGDLLLVYEFMPNGSLDKMLY 445
Query: 437 QDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL---- 492
Q+SE G LL W HR NI+VG+AS LTYLHQECEQQVIHRDIK SNIMLD NFNARL
Sbjct: 446 QESEEGTLLKWSHRYNIIVGMASVLTYLHQECEQQVIHRDIKTSNIMLDGNFNARLGDFG 505
Query: 493 ---------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERET 543
TLTAGTMGYLAPEYLQYG ATEKTDVFSYGVV+LEVACGRRPIE++T
Sbjct: 506 LARLMDHDKSPVSTLTAGTMGYLAPEYLQYGKATEKTDVFSYGVVILEVACGRRPIEKDT 565
Query: 544 EGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMR 603
+ KM+NLVDWVWGLY++G I+EAADKRLN F E+EM++LLLVGLSCANPD + RPSMR
Sbjct: 566 DSQKMMNLVDWVWGLYSQGNILEAADKRLNREFKEEEMRKLLLVGLSCANPDCNVRPSMR 625
Query: 604 RVFQILNNEAEPLVVPKLKPCLTFS-SVSLTLEDIVSEDEE 643
RV QILN+EAEPL+VP++KP LTFS S+ L+++DIVS+ E+
Sbjct: 626 RVLQILNDEAEPLLVPRMKPSLTFSLSLPLSIDDIVSDGED 666
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114497|ref|XP_002316778.1| predicted protein [Populus trichocarpa] gi|222859843|gb|EEE97390.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 946 bits (2446), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 465/661 (70%), Positives = 544/661 (82%), Gaps = 23/661 (3%)
Query: 1 MPPKK------LLVFFSIFLLNFSFVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTR 54
M P+K L + F++ + S+N++F+F SFNLRN+TLLGDSYLRNGVIGLTR
Sbjct: 1 MSPRKIQFCIFLFILFNLKVSPLVLASSSNVSFEFPSFNLRNLTLLGDSYLRNGVIGLTR 60
Query: 55 ELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQ 114
++ VP+SSSG+++YNNPVPFFDQE+NTTASF++RFSFSI VN +S+GDGL+FF+S DNQ
Sbjct: 61 DVTVPSSSSGTVVYNNPVPFFDQESNTTASFSTRFSFSILGVNENSYGDGLSFFLSQDNQ 120
Query: 115 ILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPIL 174
LGS GG LGLVNSSQLTKNKFVAIEFDTRLD HF+DP+++H+GLDIDSL SIKTADPIL
Sbjct: 121 TLGSPGGYLGLVNSSQLTKNKFVAIEFDTRLDAHFNDPNDHHVGLDIDSLNSIKTADPIL 180
Query: 175 QGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSA 234
Q IDLKSG++IT+WIDYKNDLR+LKV+MSYS+LKP P+L V+IDLS YLK +MYVGFS
Sbjct: 181 QDIDLKSGDLITSWIDYKNDLRVLKVYMSYSSLKPGNPILTVDIDLSEYLKRDMYVGFSG 240
Query: 235 STEGSTELHMIQSWSFQTSGFRPVRPKLHPHNVSDSSVVVETD-FPTSNSTNKHHNKIGL 293
STEGSTE H+I +WSF+TS F PV P + HNVSDSSV V T P SN+ NK H ++GL
Sbjct: 241 STEGSTERHLIANWSFRTSWFLPVNPNSNRHNVSDSSVTVTTPVIPISNAANKRHKRLGL 300
Query: 294 GLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGFHSN 353
GLGIAGPAFFC L FGY S++KW+ ++ L+A+LV GP+EFSY+EL+ ATRGFHS+
Sbjct: 301 GLGIAGPAFFCAFLVAFGYFSVRKWQKIKRVKSLKAELVTGPKEFSYKELKLATRGFHSS 360
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
RI+GRGAFGNVYKA F SSG++AAVKRSKHSHEGKTEFLAELSIIACLRHKNL+ LLGWC
Sbjct: 361 RIIGRGAFGNVYKALFNSSGTLAAVKRSKHSHEGKTEFLAELSIIACLRHKNLIPLLGWC 420
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQD-SENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
EKGE+LLVYE+MP GSLDRMLY++ SE G+ L+W HR I VGLAS+LTYLH ECEQQV
Sbjct: 421 VEKGEVLLVYEFMPYGSLDRMLYEEGSELGIFLNWAHRQKIAVGLASSLTYLHHECEQQV 480
Query: 473 IHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEK 519
IHRDIK SNIMLD N NARL + TLTAGTMGYLAPEYL YG ATEK
Sbjct: 481 IHRDIKTSNIMLDGNLNARLGDFGLARLMEHDKSPASTLTAGTMGYLAPEYLHYGKATEK 540
Query: 520 TDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED 579
TDVFSYGVV+LE+ CG+RPIERE KMVNLVDWVWGLY EG IIEAAD RLNG F E+
Sbjct: 541 TDVFSYGVVILELVCGKRPIEREPVSQKMVNLVDWVWGLYGEGNIIEAADPRLNGEF-EE 599
Query: 580 EMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLTFS-SVSLTLEDIV 638
EM++LLLVGLSCANPDS+ RP+MRRV QILN EAEP+ VP+ KP LTFS ++LTLEDI
Sbjct: 600 EMRKLLLVGLSCANPDSTGRPTMRRVLQILNGEAEPIAVPRKKPSLTFSCGLALTLEDIF 659
Query: 639 S 639
S
Sbjct: 660 S 660
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296089928|emb|CBI39747.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 942 bits (2436), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/636 (70%), Positives = 536/636 (84%), Gaps = 17/636 (2%)
Query: 20 VLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQET 79
V + N++FDF+SF LRN TLLGDSYLRNGVIGLTR LGVP+SSSG++I N P+ FFD E+
Sbjct: 24 VSAQNVDFDFSSFTLRNFTLLGDSYLRNGVIGLTRNLGVPSSSSGTVICNAPIAFFDSES 83
Query: 80 NTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAI 139
NTTASF++RFSFSI NVNPSS+GDGLAFF+SP+N+ LGS GG LGLVNSSQLTKN+FVA+
Sbjct: 84 NTTASFSTRFSFSITNVNPSSYGDGLAFFLSPENETLGSPGGYLGLVNSSQLTKNRFVAV 143
Query: 140 EFDTRLDPHFDDPDENHIGLDIDSLESIKTADPIL-QGIDLKSGNVITAWIDYKNDLRML 198
EFDTRLDPHF+DP++NH+GLDIDSL S+KTADP+L + IDLKSG ITAWI+YKND L
Sbjct: 144 EFDTRLDPHFNDPNDNHVGLDIDSLNSMKTADPVLDENIDLKSGKSITAWIEYKNDQMKL 203
Query: 199 KVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTSGFRPV 258
KVF+S S KP P+L V+IDLS YLK YVGFSASTEGSTELH+I++WSF+T G P
Sbjct: 204 KVFLSSSRSKPERPVLIVDIDLSEYLKELKYVGFSASTEGSTELHLIENWSFKTFGLVPA 263
Query: 259 RPKLH--PHNVSDSSVVVETDFPTSNSTNKHHNKIGLGLGIAGPAFFCVVLAVFGYISIK 316
P+LH PHNVSD++V++ S+S NK H ++GLG GIAGP FFC+VL+VFGY+S+K
Sbjct: 264 PPRLHFPPHNVSDNTVMIPPPSAVSDSGNKGHKRLGLGFGIAGPVFFCIVLSVFGYVSMK 323
Query: 317 KWKNMRTGICLRADLVPGPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVA 376
KW+ MR +AD++ GPREFSY+EL+ AT+GFHS+RI+G GAFG VYKA+F ++G+++
Sbjct: 324 KWRGMRWEKSFKADILAGPREFSYKELKGATKGFHSSRIIGNGAFGTVYKAFFITTGTIS 383
Query: 377 AVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLY 436
AVKRSKHSHEGK+EFLAELSIIACLRHKNLVQL GWC EKG+LLLVYE+MPNGSLD+MLY
Sbjct: 384 AVKRSKHSHEGKSEFLAELSIIACLRHKNLVQLQGWCVEKGDLLLVYEFMPNGSLDKMLY 443
Query: 437 QDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL---- 492
Q+SE G LL W HR NI+VG+AS LTYLHQECEQQVIHRDIK SNIMLD NFNARL
Sbjct: 444 QESEEGTLLKWSHRYNIIVGMASVLTYLHQECEQQVIHRDIKTSNIMLDGNFNARLGDFG 503
Query: 493 ---------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERET 543
TLTAGTMGYLAPEYLQYG ATEKTDVFSYGVV+LEVACGRRPIE++T
Sbjct: 504 LARLMDHDKSPVSTLTAGTMGYLAPEYLQYGKATEKTDVFSYGVVILEVACGRRPIEKDT 563
Query: 544 EGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMR 603
+ KM+NLVDWVWGLY++G I+EAADKRLN F E+EM++LLLVGLSCANPD + RPSMR
Sbjct: 564 DSQKMMNLVDWVWGLYSQGNILEAADKRLNREFKEEEMRKLLLVGLSCANPDCNVRPSMR 623
Query: 604 RVFQILNNEAEPLVVPKLKPCLTFS-SVSLTLEDIV 638
RV QILN+EAEPL+VP++KP LTFS S+ L+++DI+
Sbjct: 624 RVLQILNDEAEPLLVPRMKPSLTFSLSLPLSIDDIL 659
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224056469|ref|XP_002298872.1| predicted protein [Populus trichocarpa] gi|222846130|gb|EEE83677.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 936 bits (2419), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/662 (69%), Positives = 535/662 (80%), Gaps = 22/662 (3%)
Query: 1 MPPKK------LLVFFSIFLLNFSFVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTR 54
M P+K L V FS F + N++ +F SFNLRN+TLLGDSYLRNGVIGLTR
Sbjct: 1 MSPRKIHFCIFLFVLFSFKDPPFVLASTRNVSLEFPSFNLRNLTLLGDSYLRNGVIGLTR 60
Query: 55 ELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQ 114
++ VP+SSSG++IYNNP+ FFDQE+NTTASF++RFSFSI + N +SFGDGL+FF+S DNQ
Sbjct: 61 DVTVPSSSSGTVIYNNPISFFDQESNTTASFSTRFSFSIRSANENSFGDGLSFFLSQDNQ 120
Query: 115 ILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPIL 174
LGS GG LGLVNSSQLTKNKFVAIEFDTRLD HF+DP+++HIGLDI SL SIKTADPIL
Sbjct: 121 TLGSPGGYLGLVNSSQLTKNKFVAIEFDTRLDAHFNDPNDHHIGLDIGSLNSIKTADPIL 180
Query: 175 QGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSA 234
Q IDLKSG++ITAWIDYKNDLR+LKV+MSYS+LKP+ LL V+IDLS YLKG+MYVGFS
Sbjct: 181 QDIDLKSGDLITAWIDYKNDLRVLKVYMSYSSLKPINSLLTVHIDLSEYLKGDMYVGFSG 240
Query: 235 STEGSTELHMIQSWSFQTSGFRPVRPKLHPHNVSDSSVVVETD-FPTSNSTNKHHNKIGL 293
STEGSTELH++ +WSF+ SGF P+ P P+NVSDSSV V T P SN+ NK H +G
Sbjct: 241 STEGSTELHLVTNWSFRISGFLPLSPNSDPYNVSDSSVTVTTPVIPISNAANKRHKSLGF 300
Query: 294 GLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGFHSN 353
GLGI GPA FC L FGYIS +KW+ + L+A+L+ GP+EFSY+EL+ ATRGF S+
Sbjct: 301 GLGITGPAIFCTFLVAFGYISFRKWQKIERVKSLKAELMTGPKEFSYKELKLATRGFQSS 360
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
RI+GRGAFGNVYKA+F SSG++AAVKRSKHSHEGKTEFLAELSIIACLRHKNL+ L GWC
Sbjct: 361 RIIGRGAFGNVYKAFFKSSGTIAAVKRSKHSHEGKTEFLAELSIIACLRHKNLIPLQGWC 420
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQD-SENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
EKGE+LLVYE+MP GSLDRMLY++ SE + L+W HR VGLAS+LTYLH ECEQ+V
Sbjct: 421 VEKGEVLLVYEFMPYGSLDRMLYEEGSEREIFLNWAHRQKTAVGLASSLTYLHHECEQKV 480
Query: 473 IHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEK 519
IHRDIK SNIMLD NFNARL TLTAGTMGYLAPEYL G ATEK
Sbjct: 481 IHRDIKTSNIMLDGNFNARLGDFGLARIMEHDKSPVSTLTAGTMGYLAPEYLHCGKATEK 540
Query: 520 TDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED 579
TDVFSYGVV+LE+ACG+RPIE+E G KMVNLVDWVWGLY EG+IIEAAD RLNG F E+
Sbjct: 541 TDVFSYGVVILELACGKRPIEKEPVGQKMVNLVDWVWGLYGEGKIIEAADSRLNGEFEEE 600
Query: 580 EMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLTFS-SVSLTLEDIV 638
EM++LLLVGLSCANPD + RP+MRRV QILN EAEP+ VP+ KP LTFS ++ TLE+IV
Sbjct: 601 EMRKLLLVGLSCANPDDTGRPTMRRVLQILNGEAEPIAVPRKKPSLTFSCGLAFTLENIV 660
Query: 639 SE 640
S+
Sbjct: 661 SD 662
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449461104|ref|XP_004148283.1| PREDICTED: probable L-type lectin-domain containing receptor kinase S.7-like [Cucumis sativus] gi|449524569|ref|XP_004169294.1| PREDICTED: probable L-type lectin-domain containing receptor kinase S.7-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 924 bits (2389), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/650 (68%), Positives = 534/650 (82%), Gaps = 15/650 (2%)
Query: 1 MPPKKLLVFFSIFLLNFSFVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPA 60
M PK +L ++FLL F+ + + FDFTSFN+RN+TLLGDS+LR+GVIGLT+ELGVP+
Sbjct: 1 MTPKIILPL-TLFLLIFTTPRTECIGFDFTSFNIRNLTLLGDSHLRDGVIGLTKELGVPS 59
Query: 61 SSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAG 120
SS+G++IYN P+ F+D + N TASF++RFSFSI N+NP+S GDGL+FF+SPDNQ LGS G
Sbjct: 60 SSAGTVIYNKPIGFYDADANFTASFSTRFSFSITNINPTSSGDGLSFFLSPDNQTLGSPG 119
Query: 121 GCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLK 180
G LGLVNSSQLTKNKF+A+EFDTRLD F DP+ +H+G DI+SL SIKTA+P QG++LK
Sbjct: 120 GYLGLVNSSQLTKNKFLAVEFDTRLDSVFKDPNAHHVGFDIESLISIKTANPASQGVNLK 179
Query: 181 SGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGST 240
SG ITAWI+YKN+ L+VF+S S+LKP LL V IDLS YLK M+VGFS STEGST
Sbjct: 180 SGKSITAWIEYKNEECRLRVFLSNSSLKPSKALLDVGIDLSSYLKEVMFVGFSGSTEGST 239
Query: 241 ELHMIQSWSFQTSGFRPVRPKLHPHNVSDSSVVVETDFPTSNSTNKHHNKIGLGLGIAGP 300
ELH+I++W+F TSGF RP+ +PHNVSDSSV+V + S+S N H+++GLGLGIAGP
Sbjct: 240 ELHLIENWTFNTSGFVSARPRFNPHNVSDSSVIVSPNISLSDSGNGRHSRLGLGLGIAGP 299
Query: 301 AFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGFHSNRILGRGA 360
AFFC V+AVFG+ S+ KW+ +RT ++A+L+ GPREFSY+EL++AT+GFHS+RI+G GA
Sbjct: 300 AFFCAVIAVFGFFSLMKWRRIRTQKSIKAELLTGPREFSYKELKTATKGFHSSRIIGNGA 359
Query: 361 FGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420
FG VYKA+ SSG+++AVKRSKHSHEGKTEFLAELSIIA LRHKNLVQL GWC EKGELL
Sbjct: 360 FGTVYKAFCISSGNISAVKRSKHSHEGKTEFLAELSIIARLRHKNLVQLQGWCVEKGELL 419
Query: 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKAS 480
LVY++MPNGSLD++LYQ+S LL+W HR NI VGLAS LTYLHQECEQQVIHRDIK
Sbjct: 420 LVYDFMPNGSLDKLLYQESSEASLLNWSHRYNIAVGLASVLTYLHQECEQQVIHRDIKTG 479
Query: 481 NIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGV 527
N++LD NFNARL TLTAGTMGYLAPEYLQYG ATEKTDVFSYGV
Sbjct: 480 NVLLDGNFNARLGDFGLAKLMDHDKSPVSTLTAGTMGYLAPEYLQYGKATEKTDVFSYGV 539
Query: 528 VVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLV 587
V+LEVACGRRPIERE KMVNLVDWVWGL+++G+IIEAAD RLNG F EDEMK+LLLV
Sbjct: 540 VILEVACGRRPIEREPGTQKMVNLVDWVWGLHSQGKIIEAADSRLNGEFKEDEMKKLLLV 599
Query: 588 GLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLTFS-SVSLTLED 636
GLSCANPDSS RPSMR+V QILNNEAEP +VPK+KP LTFS SLT++D
Sbjct: 600 GLSCANPDSSTRPSMRKVLQILNNEAEPALVPKMKPSLTFSCGFSLTVDD 649
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15241048|ref|NP_200394.1| concanavalin A-like lectin kinase-like protein [Arabidopsis thaliana] gi|75333861|sp|Q9FHG4.1|LRKS7_ARATH RecName: Full=Probable L-type lectin-domain containing receptor kinase S.7; Short=LecRK-S.7; Flags: Precursor gi|10176937|dbj|BAB10136.1| serine/threonine-specific kinase like protein [Arabidopsis thaliana] gi|332009302|gb|AED96685.1| concanavalin A-like lectin kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2300), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/671 (65%), Positives = 532/671 (79%), Gaps = 30/671 (4%)
Query: 4 KKLLVFFSIFLLNFS-----FVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGV 58
+KLLV F ++ S FV S+NMNF F SF +RN+T LGDS+LRNGV+GLTRELGV
Sbjct: 5 RKLLVIFFTWITALSMSKPIFVSSDNMNFTFKSFTIRNLTFLGDSHLRNGVVGLTRELGV 64
Query: 59 PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNP--SSFGDGLAFFISPDNQIL 116
P +SSG++IYNNP+ F+D ++NTTASF++ FSF++ N+NP +S GDGLAFF+S DN L
Sbjct: 65 PDTSSGTVIYNNPIRFYDPDSNTTASFSTHFSFTVQNLNPDPTSAGDGLAFFLSHDNDTL 124
Query: 117 GSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176
GS GG LGLVNSSQ KN+FVAIEFDT+LDPHF+DP+ NHIGLD+DSL SI T+DP+L
Sbjct: 125 GSPGGYLGLVNSSQPMKNRFVAIEFDTKLDPHFNDPNGNHIGLDVDSLNSISTSDPLLSS 184
Query: 177 -IDLKSGNVITAWIDYKNDLRMLKVFMSYSN-----LKPVTPLLKVNIDLSGYLKGNMYV 230
IDLKSG IT+WIDYKNDLR+L VF+SY++ KP PLL VNIDLS +L G MYV
Sbjct: 185 QIDLKSGKSITSWIDYKNDLRLLNVFLSYTDPVTTTKKPEKPLLSVNIDLSPFLNGEMYV 244
Query: 231 GFSASTEGSTELHMIQSWSFQTSGFRPVRPKL-HPHNVSDSSVVVETDFPTSNSTNKHHN 289
GFS STEGSTE+H+I++WSF+TSGF PVR K H HNVSDSSVV + + +H +
Sbjct: 245 GFSGSTEGSTEIHLIENWSFKTSGFLPVRSKSNHLHNVSDSSVVNDDPVVIPSKKRRHRH 304
Query: 290 KIGLGLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRG 349
+ +GLGI+ P C+ L VFGY ++KKWK+++ L+ +L+ G REFSY+EL +AT+G
Sbjct: 305 NLAIGLGISCPVLICLALFVFGYFTLKKWKSVKAEKELKTELITGLREFSYKELYTATKG 364
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQ 408
FHS+R++GRGAFGNVY+A F SSG+++AVKRS+H S EGKTEFLAELSIIACLRHKNLVQ
Sbjct: 365 FHSSRVIGRGAFGNVYRAMFVSSGTISAVKRSRHNSTEGKTEFLAELSIIACLRHKNLVQ 424
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENG-VLLSWYHRLNIVVGLASALTYLHQE 467
L GWC EKGELLLVYE+MPNGSLD++LYQ+S+ G V L W HRLNI +GLASAL+YLH E
Sbjct: 425 LQGWCNEKGELLLVYEFMPNGSLDKILYQESQTGAVALDWSHRLNIAIGLASALSYLHHE 484
Query: 468 CEQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYG 514
CEQQV+HRDIK SNIMLD NFNARL TLTAGTMGYLAPEYLQYG
Sbjct: 485 CEQQVVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKSPVSTLTAGTMGYLAPEYLQYG 544
Query: 515 TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574
TATEKTD FSYGVV+LEVACGRRPI++E E K VNLVDWVW L++EGR++EA D+RL G
Sbjct: 545 TATEKTDAFSYGVVILEVACGRRPIDKEPESQKTVNLVDWVWRLHSEGRVLEAVDERLKG 604
Query: 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLTFSSVSLTL 634
F+E+ MK+LLLVGL CA+PDS+ RPSMRRV QILNNE EP VPK+KP L+F S L+L
Sbjct: 605 EFDEEMMKKLLLVGLKCAHPDSNERPSMRRVLQILNNEIEPSPVPKMKPTLSF-SCGLSL 663
Query: 635 EDIVSEDEESD 645
+DIVSEDEE D
Sbjct: 664 DDIVSEDEEGD 674
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793053|ref|XP_002864411.1| hypothetical protein ARALYDRAFT_495664 [Arabidopsis lyrata subsp. lyrata] gi|297310246|gb|EFH40670.1| hypothetical protein ARALYDRAFT_495664 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 883 bits (2281), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/673 (65%), Positives = 530/673 (78%), Gaps = 35/673 (5%)
Query: 4 KKLLVFFSIFLLNFS-----FVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGV 58
+KLLV F ++ S FV S+N+NF F SF +RN+T LGDS+LRNGV+GLTRELGV
Sbjct: 5 RKLLVLFFTWITALSMAKPIFVSSDNVNFTFKSFTIRNLTFLGDSHLRNGVVGLTRELGV 64
Query: 59 PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNP--SSFGDGLAFFISPDNQIL 116
P +SSG++IYN P+ F+D ++NTTASF++ FSFS+ N+NP +S GDGLAFF+S DN L
Sbjct: 65 PDTSSGTVIYNTPIRFYDPDSNTTASFSTHFSFSVQNLNPDPTSAGDGLAFFLSHDNDTL 124
Query: 117 GSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176
GS GG LGLVNSSQ KN+FVAIEFDT+LDPHF+DP NH+GLD+DSL SI T+DP
Sbjct: 125 GSPGGYLGLVNSSQPMKNRFVAIEFDTKLDPHFNDPSGNHVGLDVDSLNSIATSDPSNSS 184
Query: 177 -IDLKSGNVITAWIDYKNDLRMLKVFMSYSN-----LKPVTPLLKVNIDLSGYLKGNMYV 230
IDLKSG IT+WIDYKNDLR+L VF+SY++ KP PLL V IDLS +L G MYV
Sbjct: 185 QIDLKSGKSITSWIDYKNDLRLLNVFLSYTDPIAITKKPEKPLLSVKIDLSPFLNGEMYV 244
Query: 231 GFSASTEGSTELHMIQSWSFQTSGFRPVRPKL-HPHNVSDSSVVVETDFPTS--NSTNKH 287
GFS STEGSTE+H+I++WSF+TSGF PVR K H HNVSDSSV D P + + KH
Sbjct: 245 GFSGSTEGSTEIHLIENWSFKTSGFLPVRSKSNHLHNVSDSSV---NDDPVAIPSKKRKH 301
Query: 288 HNKIGLGLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSAT 347
+ + +GLGI+ P FFC+ L VFGY ++KKWK+++ L+ +L+ G REFSY+EL +AT
Sbjct: 302 RHNLAIGLGISCPVFFCLALLVFGYFTLKKWKSVKAEKELKTELITGLREFSYKELYTAT 361
Query: 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNL 406
+GFHS+R++GRGAFGNVY+A F SSG+++AVKRS+H S EGKTEFLAELSIIACLRHKNL
Sbjct: 362 KGFHSSRVIGRGAFGNVYRAMFVSSGTISAVKRSRHNSTEGKTEFLAELSIIACLRHKNL 421
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENG-VLLSWYHRLNIVVGLASALTYLH 465
VQL GWC EKGELLLVYE+MPNGSLD++LYQ+SE G V L W HRLNI +GLASAL+YLH
Sbjct: 422 VQLQGWCNEKGELLLVYEFMPNGSLDKILYQESETGAVALDWSHRLNIAIGLASALSYLH 481
Query: 466 QECEQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQ 512
ECEQQV+HRD+K SNIMLD NFNARL TLTAGTMGYLAPEYLQ
Sbjct: 482 HECEQQVVHRDVKTSNIMLDINFNARLGDFGLARLTEHDKSPVSTLTAGTMGYLAPEYLQ 541
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572
YGTATEKTD FSYGVV+LEVACGRRPI++E E K VNLVDWVW L++EGR++EA D+RL
Sbjct: 542 YGTATEKTDAFSYGVVILEVACGRRPIDKEPESQKTVNLVDWVWRLHSEGRVLEAVDERL 601
Query: 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLTFSSVSL 632
G F+E+ MK+LLLVGL CA+PDS+ RPSMRRV QILNNE EP VPK+KP L+F S L
Sbjct: 602 KGEFDEEMMKKLLLVGLKCAHPDSNERPSMRRVLQILNNEVEPSPVPKMKPTLSF-SCGL 660
Query: 633 TLEDIVSEDEESD 645
+L+DIVSEDEE D
Sbjct: 661 SLDDIVSEDEEGD 673
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553507|ref|XP_003545097.1| PREDICTED: probable L-type lectin-domain containing receptor kinase S.7-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/650 (60%), Positives = 478/650 (73%), Gaps = 54/650 (8%)
Query: 21 LSNNMNFDFTSFNLRNITLLGDSYLRN-GVIGLTRELGVPASSSGSLIYNNPVPFFDQET 79
+++N++FDF SF L NITLLGDS LRN GV+ LT P SS+G+++Y+ PV F
Sbjct: 29 VADNVSFDFPSFTLNNITLLGDSSLRNNGVVRLTN--AAPTSSTGAVVYSQPVSLFH--- 83
Query: 80 NTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAI 139
ASF++ FSFSI+N+NP+S GDGLAFF+SP+ + S G LGL T FVAI
Sbjct: 84 ---ASFSTTFSFSIHNLNPTSSGDGLAFFLSPNTTL--SLSGPLGLP-----TATGFVAI 133
Query: 140 EFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLK 199
EFDTRLD FDDP+ENH+G D+DS++S+ T DPIL GIDLKSGN I AWIDY +L
Sbjct: 134 EFDTRLDARFDDPNENHVGFDVDSMKSLVTGDPILDGIDLKSGNTIAAWIDYNTQYTLLN 193
Query: 200 VFMSYS-NLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTSGFRPV 258
VF+SYS + KP+ PLL V DLS +L+ +YVGFSAST+GS ELH I++W+F + + +
Sbjct: 194 VFLSYSRSSKPLLPLLSVKFDLSHHLRDPVYVGFSASTQGSIELHHIKNWTFHS---KTI 250
Query: 259 RPKLH-PHNVSDSSVVVETDFPTSNSTNKHHNKIGLGLGIAGPAFFCVVLAVF-GYISIK 316
LH PHNVS + S +T K ++ +G+ +AG F V +F GY+ ++
Sbjct: 251 TTTLHHPHNVSVVGI------SRSGATKKRDKRV-VGI-VAGSVSFFVAFTIFLGYVFVR 302
Query: 317 KWK-----NMRTGICLRADLVPGPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFAS 371
+WK ++ V PREF Y+EL+SATR FH +RI+G G+FG VYKA+F S
Sbjct: 303 RWKIGGRKEREKDKFQKSGFVAYPREFHYKELKSATREFHPSRIVGHGSFGTVYKAFFIS 362
Query: 372 SGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431
SG++AAVKRS+HSHEGKTEFLAEL+ IA LRHKNLVQL GWC EKGELLLVY++MPNGSL
Sbjct: 363 SGTIAAVKRSRHSHEGKTEFLAELNTIAGLRHKNLVQLQGWCVEKGELLLVYDFMPNGSL 422
Query: 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491
D+MLY++ E G LLSW HR NI +GLAS L YLHQECEQ+VIHRDIKA NI+LD NFN R
Sbjct: 423 DKMLYKEPERGKLLSWSHRQNIALGLASVLVYLHQECEQRVIHRDIKAGNILLDGNFNPR 482
Query: 492 L-------------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRP 538
L TLTAGTMGYLAPEYLQYG AT+KTDVFSYGVVVLEVACGRRP
Sbjct: 483 LGDFGLAKLMDHDKSPVSTLTAGTMGYLAPEYLQYGKATDKTDVFSYGVVVLEVACGRRP 542
Query: 539 IERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSA 598
IER EG KM+NL+DWVWGL++EG++IEAADKRLNG F E+EM++LL++GLSCANPDS+
Sbjct: 543 IER--EGSKMLNLIDWVWGLHSEGKVIEAADKRLNGEFEEEEMRKLLILGLSCANPDSAE 600
Query: 599 RPSMRRVFQILNNEAEPLVVPKLKPCLTFSS---VSLTLEDIVSE-DEES 644
RPSMRRV QILNNEA PL VPK+KP LTFSS + LT+EDIVSE D+ES
Sbjct: 601 RPSMRRVLQILNNEAAPLAVPKVKPTLTFSSDLPLPLTIEDIVSEADQES 650
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 645 | ||||||
| TAIR|locus:2162212 | 681 | AT5G55830 [Arabidopsis thalian | 0.758 | 0.718 | 0.636 | 1.3e-169 | |
| TAIR|locus:2143528 | 711 | AT5G03140 [Arabidopsis thalian | 0.947 | 0.859 | 0.470 | 1.6e-143 | |
| TAIR|locus:2083986 | 715 | AT3G53380 [Arabidopsis thalian | 0.534 | 0.482 | 0.444 | 2.3e-129 | |
| TAIR|locus:2099941 | 684 | AT3G55550 [Arabidopsis thalian | 0.920 | 0.868 | 0.381 | 3.7e-96 | |
| TAIR|locus:2133229 | 674 | LPK1 "lectin-like protein kina | 0.933 | 0.893 | 0.370 | 2e-95 | |
| TAIR|locus:2040681 | 675 | RLK "receptor lectin kinase" [ | 0.468 | 0.447 | 0.450 | 1.6e-92 | |
| TAIR|locus:2084375 | 677 | AT3G53810 [Arabidopsis thalian | 0.937 | 0.893 | 0.356 | 9.6e-89 | |
| TAIR|locus:2133239 | 669 | AT4G02420 [Arabidopsis thalian | 0.920 | 0.887 | 0.345 | 1.6e-88 | |
| TAIR|locus:2142499 | 651 | AT5G10530 [Arabidopsis thalian | 0.913 | 0.904 | 0.364 | 9.9e-87 | |
| TAIR|locus:2020608 | 666 | AT1G70110 [Arabidopsis thalian | 0.913 | 0.884 | 0.339 | 5.6e-84 |
| TAIR|locus:2162212 AT5G55830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1649 (585.5 bits), Expect = 1.3e-169, P = 1.3e-169
Identities = 321/504 (63%), Positives = 393/504 (77%)
Query: 4 KKLLVFFS-IFLLNFS---FVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVP 59
K L++FF+ I L+ S FV S+NMNF F SF +RN+T LGDS+LRNGV+GLTRELGVP
Sbjct: 6 KLLVIFFTWITALSMSKPIFVSSDNMNFTFKSFTIRNLTFLGDSHLRNGVVGLTRELGVP 65
Query: 60 ASSSGSLIYNNPVPFFDQEXXXXXXXXXXXXXXINNVNP--SSFGDGLAFFISPDNQILG 117
+SSG++IYNNP+ F+D + + N+NP +S GDGLAFF+S DN LG
Sbjct: 66 DTSSGTVIYNNPIRFYDPDSNTTASFSTHFSFTVQNLNPDPTSAGDGLAFFLSHDNDTLG 125
Query: 118 SAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG- 176
S GG LGLVNSSQ KN+FVAIEFDT+LDPHF+DP+ NHIGLD+DSL SI T+DP+L
Sbjct: 126 SPGGYLGLVNSSQPMKNRFVAIEFDTKLDPHFNDPNGNHIGLDVDSLNSISTSDPLLSSQ 185
Query: 177 IDLKSGNVITAWIDYKNDLRMLKVFMSYSN-----LKPVTPLLKVNIDLSGYLKGNMYVG 231
IDLKSG IT+WIDYKNDLR+L VF+SY++ KP PLL VNIDLS +L G MYVG
Sbjct: 186 IDLKSGKSITSWIDYKNDLRLLNVFLSYTDPVTTTKKPEKPLLSVNIDLSPFLNGEMYVG 245
Query: 232 FSASTEGSTELHMIQSWSFQTSGFRPVRPKL-HPHNVSDSSVVVETDFPTSNSTNKHHNK 290
FS STEGSTE+H+I++WSF+TSGF PVR K H HNVSDSSVV + + +H +
Sbjct: 246 FSGSTEGSTEIHLIENWSFKTSGFLPVRSKSNHLHNVSDSSVVNDDPVVIPSKKRRHRHN 305
Query: 291 IGLGLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGF 350
+ +GLGI+ P C+ L VFGY ++KKWK+++ L+ +L+ G REFSY+EL +AT+GF
Sbjct: 306 LAIGLGISCPVLICLALFVFGYFTLKKWKSVKAEKELKTELITGLREFSYKELYTATKGF 365
Query: 351 HSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQL 409
HS+R++GRGAFGNVY+A F SSG+++AVKRS+H S EGKTEFLAELSIIACLRHKNLVQL
Sbjct: 366 HSSRVIGRGAFGNVYRAMFVSSGTISAVKRSRHNSTEGKTEFLAELSIIACLRHKNLVQL 425
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENG-VLLSWYHRLNIVVGLASALTYLHQEC 468
GWC EKGELLLVYE+MPNGSLD++LYQ+S+ G V L W HRLNI +GLASAL+YLH EC
Sbjct: 426 QGWCNEKGELLLVYEFMPNGSLDKILYQESQTGAVALDWSHRLNIAIGLASALSYLHHEC 485
Query: 469 EQQVIHRDIKASNIMLDANFNARL 492
EQQV+HRDIK SNIMLD NFNARL
Sbjct: 486 EQQVVHRDIKTSNIMLDINFNARL 509
|
|
| TAIR|locus:2143528 AT5G03140 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1403 (498.9 bits), Expect = 1.6e-143, P = 1.6e-143
Identities = 308/654 (47%), Positives = 404/654 (61%)
Query: 27 FDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQEXXXXXXXX 86
FD + L ++ LLGD++L NG I LTREL VP S++G +Y PV F E
Sbjct: 37 FDLGTLTLSSLKLLGDAHLNNGTIKLTRELSVPTSTAGKALYGKPVKFRHPETKSPASFT 96
Query: 87 XXXXXXINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLD 146
+ N+NPSS G GLAF ISPD LGS GG LGL + + + FVA+EFDT +D
Sbjct: 97 TYFSFSVTNLNPSSIGGGLAFVISPDEDYLGSTGGFLGLTEETG-SGSGFVAVEFDTLMD 155
Query: 147 PHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSN 206
F D + NH+GLD++++ S AD IDLKSGN + +WI Y R+L V++SYSN
Sbjct: 156 VQFKDVNGNHVGLDLNAVVSAAVADLGNVDIDLKSGNAVNSWITYDGSGRVLTVYVSYSN 215
Query: 207 LKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSF-----QTSGFRPVRPK 261
LKP +P+L V +DL Y+ +M+VGFS ST+GSTE+H + WSF ++S P P
Sbjct: 216 LKPKSPILSVPLDLDRYVSDSMFVGFSGSTQGSTEIHSVDWWSFSSSFEESSESPPPMPN 275
Query: 262 LHPHNVSDSSVVV-------ETDFPTSNSTNKHHNKIGLGLG--IAGPAFFCVVLA-VFG 311
P + SS+ +T P+S+ NK K + + AFF + A V
Sbjct: 276 SPPPSSPSSSITPSLSTVRRKTADPSSSCRNKLCKKSPAAVAGVVTAGAFFLALFAGVII 335
Query: 312 YISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFAS 371
++ KK K R L ++++ PREF+Y+EL+ AT F S+R++G GAFG VYK
Sbjct: 336 WVYSKKIKYTRKSESLASEIMKSPREFTYKELKLATDCFSSSRVIGNGAFGTVYKGILQD 395
Query: 372 SGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431
SG + A+KR H +G TEFL+ELS+I LRH+NL++L G+C EKGE+LL+Y+ MPNGSL
Sbjct: 396 SGEIIAIKRCSHISQGNTEFLSELSLIGTLRHRNLLRLQGYCREKGEILLIYDLMPNGSL 455
Query: 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491
D+ LY E+ L W HR I++G+ASAL YLHQECE Q+IHRD+K SNIMLDANFN +
Sbjct: 456 DKALY---ESPTTLPWPHRRKILLGVASALAYLHQECENQIIHRDVKTSNIMLDANFNPK 512
Query: 492 L-------------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRP 538
L T AGTMGYLAPEYL G ATEKTDVFSYG VVLEV GRRP
Sbjct: 513 LGDFGLARQTEHDKSPDATAAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVCTGRRP 572
Query: 539 IER-ETE-GHK---MVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCAN 593
I R E E G + +LVDWVWGLY EG+++ A D+RL+ FN +EM R+++VGL+C+
Sbjct: 573 ITRPEPEPGLRPGLRSSLVDWVWGLYREGKLLTAVDERLS-EFNPEEMSRVMMVGLACSQ 631
Query: 594 PDSSARPSMRRVFQILNNEAEPLVVPKLKPC--LTFSSVSLTLEDIVSEDEESD 645
PD RP+MR V QIL EA+ VP KP ++FS+ L L +D SD
Sbjct: 632 PDPVTRPTMRSVVQILVGEADVPEVPIAKPSSSMSFSTSELLL---TLQDSVSD 682
|
|
| TAIR|locus:2083986 AT3G53380 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 742 (266.3 bits), Expect = 2.3e-129, Sum P(2) = 2.3e-129
Identities = 163/367 (44%), Positives = 234/367 (63%)
Query: 294 GLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGFHSN 353
G+ AG F + ++ KK+K + ++++ P+EFSY+EL++ T+ F+ +
Sbjct: 320 GVVTAGAFFLALFAGALFWVYSKKFKRVERSDSFASEIIKAPKEFSYKELKAGTKNFNES 379
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGK-TEFLAELSIIACLRHKNLVQLLGW 412
RI+G GAFG VY+ +G + AVKR HS + K EFL+ELSII LRH+NLV+L GW
Sbjct: 380 RIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQDKKNEFLSELSIIGSLRHRNLVRLQGW 439
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTY-------LH 465
C EKGE+LLVY+ MPNGSLD+ L++ S + ++ + V A A + +H
Sbjct: 440 CHEKGEILLVYDLMPNGSLDKALFE-SRFTLPWDHRKKILLGVASALAYLHRECENQVIH 498
Query: 466 QECEQQVIHRDIKASNIML-DANFNARLESS----FTLTAGTMGYLAPEYLQYGTATEKT 520
++ + I D ++ N L D ++E T+ AGTMGYLAPEYL G A+EKT
Sbjct: 499 RDVKSSNIMLD-ESFNAKLGDFGLARQIEHDKSPEATVAAGTMGYLAPEYLLTGRASEKT 557
Query: 521 DVFSYGVVVLEVACGRRPIERE--TEGHKM---VNLVDWVWGLYAEGRIIEAADKRLNGA 575
DVFSYG VVLEV GRRPIE++ + H + NLV+WVWGLY EG++ AAD RL G
Sbjct: 558 DVFSYGAVVLEVVSGRRPIEKDLNVQRHNVGVNPNLVEWVWGLYKEGKVSAAADSRLEGK 617
Query: 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLTFSS--VSLT 633
F+E EM R+L+VGL+C++PD + RP+MR V Q+L EA+ VVPK +P ++FS+ + L+
Sbjct: 618 FDEGEMWRVLVVGLACSHPDPAFRPTMRSVVQMLIGEADVPVVPKSRPTMSFSTSHLLLS 677
Query: 634 LEDIVSE 640
L+D +S+
Sbjct: 678 LQDTLSD 684
|
|
| TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 956 (341.6 bits), Expect = 3.7e-96, P = 3.7e-96
Identities = 245/642 (38%), Positives = 338/642 (52%)
Query: 6 LLVFFSIFLLNFSFVLSNNMNFDFTSFNLR--NITLLGDSYLR-NGVIGLTRELGVPASS 62
+++ IFL + V S +F F F N+TL G + + G I LT E
Sbjct: 7 VILLLLIFLTHL--VSSLIQDFSFIGFKKASPNLTLNGVAEIAPTGAIRLTTET---QRV 61
Query: 63 SGSLIYNNPVPFFDQEXXXXXXXXXXXXXXINNVNPSSFGDGLAFFISPDNQILGSAGG- 121
G Y+ P+ F + + G GLAF I+P + GS
Sbjct: 62 IGHAFYSLPIRFKPIGVNRALSFSTSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQ 121
Query: 122 CLGLVNSSQLT-KNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLES-IKT------ADPI 173
LGL+NSS++ + F A+EFDT D F+D ++NH+G+DI+S+ES I T A+
Sbjct: 122 YLGLLNSSRVNFSSHFFAVEFDTVRDLEFEDINDNHVGIDINSMESSISTPAGYFLANST 181
Query: 174 LQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFS 233
+ + L G VI AWIDY ++ + L V +S + KP LL ++DLS L MYVGFS
Sbjct: 182 KKELFLDGGRVIQAWIDYDSNKKRLDVKLSPFSEKPKLSLLSYDVDLSSVLGDEMYVGFS 241
Query: 234 ASTEGSTELHMIQSWSFQTSGFRPVRPKLHPHNVSDSSVVVETDFPTS-NSTNKHHNKIG 292
AST H I W+F SG ++S S+ P+S K +
Sbjct: 242 ASTGLLASSHYILGWNFNMSG--------EAFSLSLPSL---PRIPSSIKKRKKKRQSLI 290
Query: 293 LGLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGFHS 352
LG+ + VL ++K K+ D GP FSYREL+ AT GF
Sbjct: 291 LGVSLLCSLLIFAVLVAASLFVVRKVKDEDRVEEWELDF--GPHRFSYRELKKATNGFGD 348
Query: 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQLLG 411
+LG G FG VYK S AVKR H S +G EF++E+S I LRH+NLVQLLG
Sbjct: 349 KELLGSGGFGKVYKGKLPGSDEFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLG 408
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
WC + +LLLVY++MPNGSLD L+ ++ V+L+W R I+ G+AS L YLH+ EQ
Sbjct: 409 WCRRRDDLLLVYDFMPNGSLDMYLFDENPE-VILTWKQRFKIIKGVASGLLYLHEGWEQT 467
Query: 472 VIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATE 518
VIHRDIKA+N++LD+ N R+ + T GT GYLAPE + G T
Sbjct: 468 VIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTT 527
Query: 519 KTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNE 578
TDV+++G V+LEVACGRRPIE ++V +VDWVW + G I + D+RLNG F+E
Sbjct: 528 STDVYAFGAVLLEVACGRRPIETSALPEELV-MVDWVWSRWQSGDIRDVVDRRLNGEFDE 586
Query: 579 DEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE-AEPLVVP 619
+E+ ++ +GL C+N RP+MR+V L + P VVP
Sbjct: 587 EEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLEKQFPSPEVVP 628
|
|
| TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 949 (339.1 bits), Expect = 2.0e-95, P = 2.0e-95
Identities = 241/651 (37%), Positives = 351/651 (53%)
Query: 5 KLLVFFSIFLLNFSFVL---SNNMNFDFTSFNL--RNITLLGDSYLR-NGVIGLTRELGV 58
KL F F++ S L S ++NF + SF+ NI++ G + + NG++ LT + +
Sbjct: 4 KLFTIFFFFIILLSKPLNSSSQSLNFTYNSFHRPPTNISIQGIATVTSNGILKLTDKTVI 63
Query: 59 PASSSGSLIYNNPVPFFDQEXXXXXXXXXXXXXXINNVNPSSFGDGLAFFISPDNQILGS 118
S+G Y P+ F D I + P+ G G+AFFI+P N +L S
Sbjct: 64 ---STGHAFYTEPIRFKDSPNDTVSSFSTTFVIGIYSGIPTISGHGMAFFIAP-NPVLSS 119
Query: 119 AGGC--LGLVNSSQLTK--NKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTA---- 170
A LGL +S+ N +A+EFDT ++P FDD ++NH+G++I+SL S+K++
Sbjct: 120 AMASQYLGLFSSTNNGNDTNHILAVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGY 179
Query: 171 -DPILQ--GIDLKSGNVITAWIDYKNDLRMLKVFMS-YSNLKPVTPLLKVNIDLSGYLKG 226
D I Q + L S + W+DY + + V M+ + +KP L+ V DLS
Sbjct: 180 WDEINQFNNLTLISRKRMQVWVDYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQ 239
Query: 227 NMYVGFSASTEGSTELHMIQSWSFQTSGFRPVRPKLHPHNVSDSSVVVETDFPTSNSTNK 286
+MY+GFSA+T H + WSF G P L V V PTS
Sbjct: 240 DMYLGFSAATGYVLSEHFVFGWSFMVKG--KTAPPLTLSKVPKFPRVG----PTSLQ-RF 292
Query: 287 HHNKIGLGLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSA 346
+ N++ L + P F V L +++ + + G +++L A
Sbjct: 293 YKNRMPLFSLLLIPVLFVVSLIFLVRFIVRRRRKFAEEF-EDWETEFGKNRLRFKDLYYA 351
Query: 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKN 405
T+GF +LG G FG VY+ ++ AVKR S S +G EF+AE+ I + H+N
Sbjct: 352 TKGFKDKDLLGSGGFGRVYRGVMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRN 411
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
LV LLG+C + ELLLVY+YMPNGSLD+ LY E V L W R N+++G+AS L YLH
Sbjct: 412 LVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPE--VTLDWKQRFNVIIGVASGLFYLH 469
Query: 466 QECEQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQ 512
+E EQ VIHRDIKASN++LDA +N RL + T GT GYLAP++++
Sbjct: 470 EEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVR 529
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572
G AT TDVF++GV++LEVACGRRPIE E E + V LVD V+G + EG I++A D L
Sbjct: 530 TGRATTATDVFAFGVLLLEVACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNL 589
Query: 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKP 623
+++ E++ +L +GL C++ D RP+MR+V Q L +A +P L P
Sbjct: 590 GSVYDQREVETVLKLGLLCSHSDPQVRPTMRQVLQYLRGDA---TLPDLSP 637
|
|
| TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 1.6e-92, Sum P(2) = 1.6e-92
Identities = 145/322 (45%), Positives = 200/322 (62%)
Query: 334 GPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFL 392
G F +++L AT+GF +LG G FG+VYK + AVKR H S +G EF+
Sbjct: 331 GKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFV 390
Query: 393 AELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN 452
AE+ I + H+NLV LLG+C +GELLLVY+YMPNGSLD+ LY E V L+W R+
Sbjct: 391 AEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPE--VTLNWKQRIK 448
Query: 453 IVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL-------------ESSFTLT 499
+++G+AS L YLH+E EQ VIHRD+KASN++LD N RL + T
Sbjct: 449 VILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHV 508
Query: 500 AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY 559
GT+GYLAPE+ + G AT TDVF++G +LEVACGRRPIE + E + LVDWV+GL+
Sbjct: 509 VGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLW 568
Query: 560 AEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVP 619
+G I+ A D + +E E++ +L +GL C++ D ARPSMR+V L +A+ +P
Sbjct: 569 NKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAK---LP 625
Query: 620 KLKPC-LTFSSVSLTLEDIVSE 640
+L P L+ S + + D SE
Sbjct: 626 ELSPLDLSGSGMMFGVHDGFSE 647
|
|
| TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 886 (316.9 bits), Expect = 9.6e-89, P = 9.6e-89
Identities = 234/657 (35%), Positives = 340/657 (51%)
Query: 4 KKLLVFFSIFLLNFSFVLSNNMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTRELGVPA 60
K L+FF L S N+NF + F+ L +I+L G + + NG++ LT
Sbjct: 4 KLKLIFFFFLLCQIMISSSQNLNFTYNGFHPPLTDISLQGLATVTPNGLLKLTN---TSV 60
Query: 61 SSSGSLIYNNPVPFFDQEXXXXXXXXXXXXXXINNVNPSSFGDGLAFFISPDNQI-LGSA 119
+G + F D + I++ P+ G G+AF ++P +
Sbjct: 61 QKTGHAFCTERIRFKDSQNGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALP 120
Query: 120 GGCLGLVNSSQLTK--NKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIK--TAD---- 171
+GL N S N A+EFDT F DP++NH+G+D++ L S TA
Sbjct: 121 SQYIGLFNISNNGNDTNHIFAVEFDTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGYRDD 180
Query: 172 -PILQGIDLKSGNVITAWIDYKNDLRMLKVFMS-YSNLKPVTPLLKVNIDLSGYLKGNMY 229
Q + L S I WIDY N + V ++ + + KP PL+ DLS L +MY
Sbjct: 181 HDKFQNLSLISRKRIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMY 240
Query: 230 VGFSASTEGSTELHMIQSWSFQTSGFRPVRPKLHPHNVSDSSVVVETDFPTSNSTNKHHN 289
VGFS++T H + WSF+ +G P+ +S S + F + +
Sbjct: 241 VGFSSATGSVLSEHFLVGWSFRLNGEAPM--------LSLSKLPKLPRFEPRRISEFY-- 290
Query: 290 KIGLGLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRG 349
KIG+ L I+ F ++ F YI +K K + G F ++EL AT+G
Sbjct: 291 KIGMPL-ISLSLIFSIIFLAF-YIVRRKKKYEEELDDWETEF--GKNRFRFKELYHATKG 346
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQ 408
F +LG G FG VY+ ++ AVKR H S +G EF+AE+ I + H+NLV
Sbjct: 347 FKEKDLLGSGGFGRVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVP 406
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
LLG+C +GELLLVY+YMPNGSLD+ LY + E L W R I+ G+AS L YLH+E
Sbjct: 407 LLGYCRRRGELLLVYDYMPNGSLDKYLYNNPET--TLDWKQRSTIIKGVASGLFYLHEEW 464
Query: 469 EQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGT 515
EQ VIHRD+KASN++LDA+FN RL + T GT+GYLAPE+ + G
Sbjct: 465 EQVVIHRDVKASNVLLDADFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGR 524
Query: 516 ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575
AT TDV+++G +LEV GRRPIE + LV+WV+ L+ G I+EA D +L +
Sbjct: 525 ATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSS 584
Query: 576 -FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPC-LTFSSV 630
++ +E++ +L +GL C++ D ARPSMR+V Q L + + +P+L P L+ SV
Sbjct: 585 GYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQYLRGD---MALPELTPLDLSAGSV 638
|
|
| TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 884 (316.2 bits), Expect = 1.6e-88, P = 1.6e-88
Identities = 223/646 (34%), Positives = 344/646 (53%)
Query: 10 FSIFLLNFSF--VLSNNMNFDFTSFNLR----NITLLGDSYLR-NGVIGLTRELGVPASS 62
F+IF L+F + + S++ DFT R +I++LG + + NG++ LT S
Sbjct: 7 FTIFFLSFFWQSLKSSSQIIDFTYNGFRPPPTDISILGIATITPNGLLKLTN---TTMQS 63
Query: 63 SGSLIYNNPVPFFDQEXXXXXXXXXXXXXXINNVNPSSFGDGLAFFISPDNQI-LGSAGG 121
+G Y P+ F D I++ P G+AF I+P+ ++ GS
Sbjct: 64 TGHAFYTKPIRFKDSPNGTVSSFSTTFVFAIHSQIP--IAHGMAFVIAPNPRLPFGSPLQ 121
Query: 122 CLGLVN--SSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTA-------DP 172
LGL N ++ +N A+E DT ++ F+D + NH+G+DI+SL S+K++ +
Sbjct: 122 YLGLFNVTNNGNVRNHVFAVELDTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYWDEND 181
Query: 173 ILQGIDLKSGNVITAWIDYKNDLRMLKVFMS-YSNLKPVTPLLKVNIDLSGYLKGNMYVG 231
+ L S + W+D+ ++ V M+ + +KP PL+ + DLS L +M+VG
Sbjct: 182 QFHNLTLISSKRMQVWVDFDGPTHLIDVTMAPFGEVKPRKPLVSIVRDLSSVLLQDMFVG 241
Query: 232 FSASTEGSTELHMIQSWSFQTSGFRPVRPKLHPHNVSDSSVVVETDFPTSNSTNKHHNKI 291
FS++T + WSF +G + P +S + D + + N +
Sbjct: 242 FSSATGNIVSEIFVLGWSFGVNG------EAQPLALSKLPRLPVWDLKPTRVYRFYKNWV 295
Query: 292 GLGLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGFH 351
L + P F +++ + +I ++ K + G +++L AT+GF
Sbjct: 296 PLISLLLIP--FLLIIFLVRFIMKRRRKFAEEVEDWETEF--GKNRLRFKDLYYATKGFK 351
Query: 352 SNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
ILG G FG+VYK + AVKR S S +G EF+AE+ I + H+NLV L+
Sbjct: 352 DKNILGSGGFGSVYKGIMPKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLV 411
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
G+C + ELLLVY+YMPNGSLD+ LY E V L W R ++ G+ASAL YLH+E EQ
Sbjct: 412 GYCRRRDELLLVYDYMPNGSLDKYLYNSPE--VTLDWKQRFKVINGVASALFYLHEEWEQ 469
Query: 471 QVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTAT 517
VIHRD+KASN++LDA N RL + T GT GYLAP++++ G AT
Sbjct: 470 VVIHRDVKASNVLLDAELNGRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRAT 529
Query: 518 EKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577
TDVF++GV++LEVACGRRPIE + + V LVDWV+ + E I++A D L ++
Sbjct: 530 TTTDVFAFGVLLLEVACGRRPIEINNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYD 589
Query: 578 EDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKP 623
+ E++ +L +GL C++ D ARP+MR+V Q L +A ++P L P
Sbjct: 590 QKEVEMVLKLGLLCSHSDPLARPTMRQVLQYLRGDA---MLPDLSP 632
|
|
| TAIR|locus:2142499 AT5G10530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 867 (310.3 bits), Expect = 9.9e-87, P = 9.9e-87
Identities = 238/653 (36%), Positives = 346/653 (52%)
Query: 7 LVFFSIFLLNFSFVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSL 66
++ FS F+L FV S N ++ I GD+ NG + LT + + G
Sbjct: 5 ILLFS-FVLVLPFVCSVQFNISRFGSDVSEIAYQGDARA-NGAVELTN-IDYTCRA-GWA 60
Query: 67 IYNNPVPFFDQEXXXXXXXXXXXXXXIN--NVNPSSFGDGLAFFISPDNQIL--GSAGGC 122
Y VP ++ I+ NV ++G G AFF++P L SAGG
Sbjct: 61 TYGKQVPLWNPGTSKPSDFSTRFSFRIDTRNVGYGNYGHGFAFFLAPARIQLPPNSAGGF 120
Query: 123 LGLVNSSQLTKNKF--VAIEFDTRLDPHFDDPD-ENHIGLDIDSLESIKTADPILQGIDL 179
LGL N + + F V +EFDT +P +D D ++H+G++ +SL S +
Sbjct: 121 LGLFNGTNNQSSAFPLVYVEFDTFTNPEWDPLDVKSHVGINNNSLVSSNYTSWNATSHNQ 180
Query: 180 KSGNVITAWIDYKNDLRMLKVFMSYS-NLKPV-TPLLKVNIDLSGYLKGNMYVGFSASTE 237
G V+ I Y + R L V +Y P+ L IDLS L + +GFSA++
Sbjct: 181 DIGRVL---IFYDSARRNLSVSWTYDLTSDPLENSSLSYIIDLSKVLPSEVTIGFSATSG 237
Query: 238 GSTELHMIQSWSFQTSGFRPVRPKLHPHNVSDSSVVVETDFPTSNSTNKHHNKIGLGL-G 296
G TE + + SW F +S L ++ S +K IG+ + G
Sbjct: 238 GVTEGNRLLSWEFSSS--------LELIDIKKSQ------------NDKKGMIIGISVSG 277
Query: 297 IAGPAFFCVVLAVFGYISIKKWKNMRTG--ICLRADLV--PGPREFSYRELRSATRGFHS 352
FF L VF +K K T + DL GPR+F+Y++L SA F
Sbjct: 278 FVLLTFFITSLIVFLKRKQQKKKAEETENLTSINEDLERGAGPRKFTYKDLASAANNFAD 337
Query: 353 NRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
+R LG G FG VY+ Y S + A+K+ + S +GK EF+ E+ II+ LRH+NLVQL+G
Sbjct: 338 DRKLGEGGFGAVYRGYLNSLDMMVAIKKFAGGSKQGKREFVTEVKIISSLRHRNLVQLIG 397
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
WC EK E L++YE+MPNGSLD L+ + L+W+ R I +GLASAL YLH+E EQ
Sbjct: 398 WCHEKDEFLMIYEFMPNGSLDAHLFGKKPH---LAWHVRCKITLGLASALLYLHEEWEQC 454
Query: 472 VIHRDIKASNIMLDANFNARLESSFTLT--------------AGTMGYLAPEYLQYGTAT 517
V+HRDIKASN+MLD+NFNA+L F L AGT GY+APEY+ G A+
Sbjct: 455 VVHRDIKASNVMLDSNFNAKL-GDFGLARLMDHELGPQTTGLAGTFGYMAPEYISTGRAS 513
Query: 518 EKTDVFSYGVVVLEVACGRRPIERETEGH--KMVNLVDWVWGLYAEGRIIEAADKRLN-G 574
+++DV+S+GVV LE+ GR+ ++R +G + NLV+ +W LY +G +I A D++L G
Sbjct: 514 KESDVYSFGVVTLEIVTGRKSVDRR-QGRVEPVTNLVEKMWDLYGKGEVITAIDEKLRIG 572
Query: 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLTF 627
F+E + + L++VGL CA+PD + RPS+++ Q+LN EA +P P T+
Sbjct: 573 GFDEKQAECLMIVGLWCAHPDVNTRPSIKQAIQVLNLEAPVPHLPTKMPVATY 625
|
|
| TAIR|locus:2020608 AT1G70110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 841 (301.1 bits), Expect = 5.6e-84, P = 5.6e-84
Identities = 216/637 (33%), Positives = 335/637 (52%)
Query: 6 LLVFFSIFLLNFSFVLSNNMNFDFTSFNLR-NITLLGDSYLRN-GVIGLTRELGVPASSS 63
LL+F +F + S V+ N + FN N+ G +Y+ N G+I LT P ++
Sbjct: 3 LLLFLVLFFVPES-VVCQRPNPNGVEFNTSGNMYTSGSAYINNNGLIRLTNS--TP-QTT 58
Query: 64 GSLIYNNPVPFFDQEXXXXXXXXXXXXXXINNVNPSSFGDGLAFFISPDNQILGSAGGC- 122
G + YN+ + F + I N G G+AF I P + +
Sbjct: 59 GQVFYNDQLRFKNSVNGTVSSFSTTFVFSIEFHNGIYGGYGIAFVICPTRDLSPTFPTTY 118
Query: 123 LGLVNSSQL--TKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTA-------DPI 173
LGL N S + KN VA+E DT++D F+D D NH+G+DI++L S A +
Sbjct: 119 LGLFNRSNMGDPKNHIVAVELDTKVDQQFEDKDANHVGIDINTLVSDTVALAGYYMDNGT 178
Query: 174 LQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNL-KPVTPLLKVNIDLSGYLKGNMYVGF 232
+ + L SG + WI+Y + + + V + + KP PLL + DLS YL MYVGF
Sbjct: 179 FRSLLLNSGQPMQIWIEYDSKQKQINVTLHPLYVPKPKIPLLSLEKDLSPYLLELMYVGF 238
Query: 233 SASTEGSTELHMIQSWSFQTSGFRPVRPKLHPHNVSDSSVVVETDFPTSNSTNKHHNKIG 292
+++T T H I W+F+ +G P + P + + + P S N +
Sbjct: 239 TSTTGDLTASHYILGWTFKMNG---TTPDIDPSRLPK---IPRYNQPWIQSPN---GILT 289
Query: 293 LGLGIAGPAFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSATRGFHS 352
+ L ++G ++L++ ++ +K+ K + + ++ GP F++++L AT+GF
Sbjct: 290 ISLTVSG-VIILIILSLSLWLFLKRKKLLE--VLEDWEVQFGPHRFAFKDLHIATKGFKD 346
Query: 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQLLG 411
+LG+G FG VYK S AVK H S +G EF+AE++ I LRH NLV+L G
Sbjct: 347 TEVLGKGGFGKVYKGTLPVSNVEIAVKMVSHDSRQGMREFIAEIATIGRLRHPNLVRLQG 406
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
+C KGEL LVY+ M GSLD+ LY L W R I+ +AS L YLHQ+ Q
Sbjct: 407 YCRHKGELYLVYDCMAKGSLDKFLYHQQTGN--LDWSQRFKIIKDVASGLYYLHQQWVQV 464
Query: 472 VIHRDIKASNIMLDANFNARLESSFTLT--------------AGTMGYLAPEYLQYGTAT 517
+IHRDIK +NI+LDAN NA+L F L AGT+GY++PE + G A+
Sbjct: 465 IIHRDIKPANILLDANMNAKL-GDFGLAKLCDHGTDPQTSHVAGTLGYISPELSRTGKAS 523
Query: 518 EKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577
++DVF++G+V+LE+ACGR+PI +MV L DWV + I++ D ++ +
Sbjct: 524 TRSDVFAFGIVMLEIACGRKPILPRASQREMV-LTDWVLECWENEDIMQVLDHKIGQEYV 582
Query: 578 EDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614
E++ +L +GL C++P ++ RP+M V Q+L++ A+
Sbjct: 583 EEQAALVLKLGLFCSHPVAAIRPNMSSVIQLLDSVAQ 619
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9FHG4 | LRKS7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6557 | 0.9937 | 0.9412 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 645 | |||
| cd06899 | 236 | cd06899, lectin_legume_LecRK_Arcelin_ConA, legume | 5e-85 | |
| pfam00139 | 231 | pfam00139, Lectin_legB, Legume lectin domain | 3e-72 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-30 | |
| cd01951 | 223 | cd01951, lectin_L-type, legume lectins | 2e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-22 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-07 | |
| cd07308 | 218 | cd07308, lectin_leg-like, legume-like lectins: ERG | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.003 |
| >gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Score = 266 bits (681), Expect = 5e-85
Identities = 112/236 (47%), Positives = 148/236 (62%), Gaps = 8/236 (3%)
Query: 26 NFDFTSFN--LRNITLLGDSYLR-NGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTT 82
+F+F F+ N+TL GD+ + NG + LT + PASS G +Y+ PV +D T
Sbjct: 2 SFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTS-PASSVGRALYSKPVRLWDSTTGKV 60
Query: 83 ASFTSRFSFSINNVNPSSFGDGLAFFISP-DNQILGSAGGCLGLVNSS--QLTKNKFVAI 139
ASF++ FSFSI NPS GDGLAFF++P D+ S+GG LGL NSS + N VA+
Sbjct: 61 ASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAV 120
Query: 140 EFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLK 199
EFDT +P F DPD+NH+G+D++SL S+K G LKSG + AWIDY + + L
Sbjct: 121 EFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDDDGGKLKSGKPMQAWIDYDSSSKRLS 180
Query: 200 VFMSYSNL-KPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTSG 254
V ++YS + KP PLL +DLS L +YVGFSAST TELH I SWSF ++G
Sbjct: 181 VTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSFSSNG 236
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236 |
| >gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 3e-72
Identities = 101/231 (43%), Positives = 145/231 (62%), Gaps = 10/231 (4%)
Query: 26 NFDFTSF-NLRNITLLGD-SYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTA 83
+F++ F N+ N+TL GD + L NG++ LT V +S+G +Y+ P+ +D T A
Sbjct: 4 SFNYNGFSNVSNLTLQGDATVLPNGLLQLTN---VTNNSAGRALYSKPIRLWDSSTGKVA 60
Query: 84 SFTSRFSFSINNVNPS-SFGDGLAFFISPDNQILGS-AGGCLGLVNSS--QLTKNKFVAI 139
SF++ F F+I N+ S + GDGLAFF++P G+ +GG LGL NSS + N VA+
Sbjct: 61 SFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFNSSNNGNSSNHIVAV 120
Query: 140 EFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLK 199
EFDT L+P F+D D+NH+G+D++S+ S+ + +DL SG I WIDY + L
Sbjct: 121 EFDTFLNPEFNDIDDNHVGIDVNSIISVASESASFVPLDLNSGKPIQVWIDYDGSSKRLS 180
Query: 200 VFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSF 250
V ++Y N KP PLL ++DLS L +YVGFSAST G+TE H + SWSF
Sbjct: 181 VTLAYPN-KPKRPLLSASVDLSTVLPEWVYVGFSASTGGATESHYVLSWSF 230
|
Length = 231 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 83/276 (30%), Positives = 117/276 (42%), Gaps = 38/276 (13%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEF---LAELSIIACLRHKNL 406
+ R LG G+FG VYKA +G + AVK K E + E+ I+ L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
V+L+ +K L LV EY G L L G LS I + + L YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLH- 115
Query: 467 ECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEYLQYG 514
+IHRD+K NI+LD N ++ SS T GT Y+APE L G
Sbjct: 116 --SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 515 T-ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK--R 571
K DV+S GV++ E+ G+ P E ++ + RI+ +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR----------RILGPPLEFDE 223
Query: 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607
+ +E K L+ C N D S RP+ + Q
Sbjct: 224 PKWSSGSEEAKDLI---KKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 7e-42
Identities = 78/283 (27%), Positives = 113/283 (39%), Gaps = 54/283 (19%)
Query: 353 NRILGRGAFGNVYKA-YFASSGSV---AAVKRSKHSH--EGKTEFLAELSIIACLRHKNL 406
+ LG GAFG VYK AVK K + EFL E I+ L H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
V+LLG C E+ L++V EYMP G L L + + LS L+ + +A + YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRP-KELSLSDLLSFALQIARGMEYLE- 120
Query: 467 ECEQQVIHRDIKASNIMLDANFN--------ARLESSFTLTAGTMG-----YLAPEYLQY 513
+ IHRD+ A N ++ N +R G ++APE L+
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 514 GTATEKTDVFSYGVVVLEVA-CGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572
G T K+DV+S+GV++ E+ G P Y E +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP--------------------YPGMSNAEVLEYLK 218
Query: 573 NGAFNE------DEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609
G E+ +L+ L C D RP+ + +IL
Sbjct: 219 KGYRLPKPPNCPPELYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 9e-42
Identities = 80/283 (28%), Positives = 113/283 (39%), Gaps = 55/283 (19%)
Query: 353 NRILGRGAFGNVYKA-YFASSGSV---AAVKRSKHSHEGKT--EFLAELSIIACLRHKNL 406
+ LG GAFG VYK G AVK K + EFL E I+ L H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
V+LLG C E+ L +V EYM G L L +N LS L+ + +A + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLE- 119
Query: 467 ECEQQVIHRDIKASNIMLDANFN--------ARLESSFTLTAGTMG-----YLAPEYLQY 513
+ IHRD+ A N ++ N +R G ++APE L+
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 514 GTATEKTDVFSYGVVVLEVA-CGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572
G T K+DV+S+GV++ E+ G +P Y E +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP--------------------YPGMSNEEVLEYLK 217
Query: 573 NGAFNE------DEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609
NG E+ L+ L C D RP+ + +IL
Sbjct: 218 NGYRLPQPPNCPPELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 79/278 (28%), Positives = 122/278 (43%), Gaps = 44/278 (15%)
Query: 353 NRILGRGAFGNVYKAYFASSGSVA----AVKRSKH--SHEGKTEFLAELSIIACLRHKNL 406
+ LG GAFG VYK G AVK K S E + EFL E SI+ L H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
V+LLG C + L +V EYMP G L L + +G L+ L + + +A + YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK---HGEKLTLKDLLQMALQIAKGMEYLE- 119
Query: 467 ECEQQVIHRDIKASNIMLDANFNAR---------LESSFTLTAGTMGYL-----APEYLQ 512
+ +HRD+ A N ++ N + + G L APE L+
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 513 YGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571
G T K+DV+S+GV++ E+ G +P + +++ L++ +G + +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLELLE-------DGYRLPRPEN- 228
Query: 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609
DE+ L+ L C D RP+ + + L
Sbjct: 229 -----CPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-41
Identities = 81/284 (28%), Positives = 119/284 (41%), Gaps = 51/284 (17%)
Query: 354 RILGRGAFGNVYKAYF---ASSGSVAAVKRSK--HSHEGKTEFLAELSIIACLRHKNLVQ 408
+ LG GAFG VYK + AVK K S E + +FL E ++ L H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRML-----YQDSENGVLLSWYHRLNIVVGLASALTY 463
LLG C E+ L LV EYM G L L S LS L+ + +A + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNAR---------LESSFTLTAGTMG-----YLAPE 509
L ++ +HRD+ A N ++ + + + T G ++APE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 510 YLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA- 567
L+ G T K+DV+S+GV++ E+ G P GL E ++E
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP----------------GLSNE-EVLEYL 220
Query: 568 -ADKRLNGAFN-EDEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609
RL DE+ L+ LSC D RP+ + + L
Sbjct: 221 RKGYRLPKPEYCPDELYELM---LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE--FLAELSIIACLRHKNLVQLLG 411
LG G+FG VY A +G + A+K K K L E+ I+ L+H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
++ +L LV EY G L +L + LS + + SAL YLH +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLHS---KG 117
Query: 472 VIHRDIKASNIMLDANFNARL-----------ESSFTLTAGTMGYLAPEYLQYGTATEKT 520
++HRD+K NI+LD + + +L T GT Y+APE L +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 521 DVFSYGVVVLEVACGRRPIERETEGHKMVNLV 552
D++S GV++ E+ G+ P + + ++ +
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKI 209
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-40
Identities = 66/192 (34%), Positives = 90/192 (46%), Gaps = 22/192 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG--KTEFLAELSIIACLRHKNLVQLLGWC 413
LG G FG VY A +G A+K K E L E+ I+ L H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
++ L LV EY GSL +L EN LS L I++ + L YLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLH---SNGII 114
Query: 474 HRDIKASNIMLD-------------ANFNARLESSFTLTAGTMGYLAPEYL-QYGTATEK 519
HRD+K NI+LD + +S GT Y+APE L G +EK
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 520 TDVFSYGVVVLE 531
+D++S GV++ E
Sbjct: 175 SDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 35/270 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+ +G+G+FG VY S G + +K S S + + + L E+ I+ L H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
EKG+L +V EY G L + + + + G L+ V L AL YLH +
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SR 122
Query: 471 QVIHRDIKASNIMLDANFNARL---------ESSFTLT---AGTMGYLAPEYLQYGTATE 518
+++HRDIK NI L +N +L S+ L GT YL+PE Q
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNY 182
Query: 519 KTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNE 578
K+D++S G V+ E+ + P EG ++ L +I++ + ++
Sbjct: 183 KSDIWSLGCVLYELCTLKHPF----EGENLLELAL---------KILKGQYPPIPSQYS- 228
Query: 579 DEMKRLLLVGLSCANPDSSARPSMRRVFQI 608
E++ L+ S D RPS+ ++ Q
Sbjct: 229 SELRNLV---SSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 30/206 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEF-LAELSIIACLRHKNLVQLLGWCA 414
+G+G FG VYKA +G A+K K + K E + E+ I+ +H N+V+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN------IVVGLASALTYLHQEC 468
+K EL +V E+ GSL +L S L + L L YLH
Sbjct: 68 KKDELWIVMEFCSGGSLKD---------LLKSTNQTLTESQIAYVCKELLKGLEYLH--- 115
Query: 469 EQQVIHRDIKASNIML---------DANFNARLESSFTL--TAGTMGYLAPEYLQYGTAT 517
+IHRDIKA+NI+L D +A+L + GT ++APE +
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 518 EKTDVFSYGVVVLEVACGRRPIERET 543
K D++S G+ +E+A G+ P
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELP 201
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 38/210 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE---FLAELSIIACLRHKNLVQLL 410
+LGRG+FG+VY A +G + AVK + S + + E E+ I++ L+H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 411 G--WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNI-VVG-----LASALT 462
G EK L + EY+ GSL +L + + +L V+ + L
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKK----------FGKLPEPVIRKYTRQILEGLA 115
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARL--------------ESSFTLTAGTMGYLAP 508
YLH ++HRDIK +NI++D++ +L GT ++AP
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 509 EYLQYGTATEKTDVFSYGVVVLEVACGRRP 538
E ++ D++S G V+E+A G+ P
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173886 cd01951, lectin_L-type, legume lectins | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 68/233 (29%), Positives = 101/233 (43%), Gaps = 23/233 (9%)
Query: 26 NFDFTSFNLR-NITLLGDSYL--RNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTT 82
NF S N + N L G + L +GV+ LT + G + +GS Y P+ +
Sbjct: 4 NFSNFSNNNQSNWQLNGSATLTTDSGVLRLTPDTG---NQAGSAWYKTPIDL-------S 53
Query: 83 ASFTSRFSFSINNVNPSSFGDGLAFFISPDN-QILGSAGGCLGLVNSSQLTKNKFVAIEF 141
FT+ F F + + DG+AF + D LG GG GL VA+EF
Sbjct: 54 KDFTTTFKFYLGTKGTNG-ADGIAFVLQNDPAGALGGGGGGGGLGYGGI---GNSVAVEF 109
Query: 142 DTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVI----TAWIDYKNDLRM 197
DT + +DP+ NHI +D++ + L L +G + T I Y
Sbjct: 110 DTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSASLPNGTGLGNEHTVRITYDPTTNT 169
Query: 198 LKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSF 250
L V++ + + + + +DL Y GF+AST G T LH I +WSF
Sbjct: 170 LTVYLDNGS-TLTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSF 221
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 17/197 (8%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415
+G+G FG+V + G AVK K FLAE S++ LRH NLVQLLG +
Sbjct: 14 IGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHR 475
L +V EYM GSL + Y S +++ +L + + + YL E+ +HR
Sbjct: 72 GNPLYIVTEYMAKGSL--VDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 476 DIKASNIMLD-------ANFNARLESSFTLTAGTM--GYLAPEYLQYGTATEKTDVFSYG 526
D+ A N+++ ++F E+S +G + + APE L+ + K+DV+S+G
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFG 186
Query: 527 VVVLEV-ACGRRPIERE 542
+++ E+ + GR P R
Sbjct: 187 ILLWEIYSFGRVPYPRI 203
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 28/202 (13%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
++GRGAFG VYK +G A+K+ K E + E+ ++ L+H N+V+ +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L ++ EY NGSL +++ + E+ L++ Y ++ GLA YLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPES--LVAVYVY-QVLQGLA----YLH--- 116
Query: 469 EQQVIHRDIKASNIMLDANFNARL------------ESSFTLTAGTMGYLAPEYLQYGTA 516
EQ VIHRDIKA+NI+ + +L GT ++APE ++ A
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 517 TEKTDVFSYGVVVLEVACGRRP 538
+ +D++S G V+E+ G P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
LG G G V K +G + AVK R + + + + L EL I+ +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 414 AEKGELLLVYEYMPNGSLDRML--YQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
G++ + EYM GSLD++L Q +L I V + LTYLH++ +
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEK--HK 121
Query: 472 VIHRDIKASNIMLDA-------NF--NARLESSFTLT-AGTMGYLAPEYLQYGTATEKTD 521
+IHRD+K SNI++++ +F + +L +S T GT Y+APE +Q + K+D
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSD 181
Query: 522 VFSYGVVVLEVACGRRPIERETEGHKMV 549
++S G+ ++E+A GR P E + +
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGI 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA----AVK--RSKHSHEGKTEFLAELSIIACLRHKNLV 407
++LG GAFG VYK + G A+K R + S + E L E ++A + H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+LLG C ++ L+ + MP G L + +N + + LN V +A ++YL
Sbjct: 73 RLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDN---IGSQYLLNWCVQIAKGMSYLE-- 126
Query: 468 CEQQVIHRDIKASNIMLD-------ANFN-ARL----ESSFTLTAGTM--GYLAPEYLQY 513
E++++HRD+ A N+++ +F A+L E + G + ++A E + +
Sbjct: 127 -EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 514 GTATEKTDVFSYGVVVLEVAC-GRRPIE 540
T K+DV+SYGV V E+ G +P E
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 36/270 (13%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415
LG G +G VY+ + AVK K EFL E +++ ++H NLVQLLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHR 475
+ ++ E+M G+L + Y N ++ L + ++SA+ YL + + IHR
Sbjct: 74 EPPFYIITEFMTYGNL--LDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHR 128
Query: 476 DIKASNIMLD-------ANFN-ARL--ESSFTLTAGT---MGYLAPEYLQYGTATEKTDV 522
D+ A N ++ A+F +RL ++T AG + + APE L Y + K+DV
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188
Query: 523 FSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEM 581
+++GV++ E+A G P + ++L V+ L +G +E R G ++
Sbjct: 189 WAFGVLLWEIATYGMSP-------YPGIDLSQ-VYELLEKGYRME----RPEGC--PPKV 234
Query: 582 KRLLLVGLSCANPDSSARPSMRRVFQILNN 611
L+ +C + S RPS + Q
Sbjct: 235 YELM---RACWQWNPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 41/214 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE-------FLAELSIIACLRHKNL 406
+ LG GAF + Y+A +G++ AVK+ + +E E+ ++A L H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRML--YQDSENGVLLSWYHRLNIVVGLASALTYL 464
+++LG E L E+M GS+ +L Y + V++++ + ++ GL+ YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ--LLRGLS----YL 119
Query: 465 HQECEQQVIHRDIKASNIMLD--------ANFNA--RLESSFTLTA-------GTMGYLA 507
H E Q+IHRD+K +N+++D A+F A RL + T GT+ ++A
Sbjct: 120 H---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 508 PEYL---QYGTATEKTDVFSYGVVVLEVACGRRP 538
PE L QYG + DV+S G V++E+A + P
Sbjct: 177 PEVLRGEQYGRS---CDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 30/210 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
+G+G+FG V+K + V A+K+ SK + + E + E ++A L +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQD-----SENGVLLSWYHRLNIVVGLASALTYLHQE 467
+KG+L +V EY NG L ++L E+ V W + I++GLA +LH
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV---WRFFIQILLGLA----HLHS- 119
Query: 468 CEQQVIHRDIKASNIMLDANFN--------ARLESSFTLTA----GTMGYLAPEYLQYGT 515
++++HRDIK+ N+ LDA N A+L S T A GT YL+PE +
Sbjct: 120 --KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 516 ATEKTDVFSYGVVVLEVACGRRPIERETEG 545
EK+DV++ GVV+ E G+ P + +G
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQG 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 39/210 (18%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA---ELSIIACLRHKNLVQLLGW 412
+G G FG VY A +G + AVK + E+ ++ L+H NLV+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG-----LASALTYLHQE 467
+ ++ + EY G+L+ +L E+G +L V+ L L YLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELL----EHGRILD-----EHVIRVYTLQLLEGLAYLH-- 116
Query: 468 CEQQVIHRDIKASNIMLDAN-------FNA--RLESSFTL-------TAGTMGYLAPEYL 511
++HRDIK +NI LD N F +L+++ T AGT Y+APE +
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 512 QYGTATEK---TDVFSYGVVVLEVACGRRP 538
G D++S G VVLE+A G+RP
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 63/195 (32%), Positives = 100/195 (51%), Gaps = 23/195 (11%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
+G+G FG+VYK + VA VK RS + K +FL E I+ H N+V+L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVA-VKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
C +K + +V E +P GSL L + +N L+ L + + A+ + YL +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFL-RKKKNR--LTVKKLLQMSLDAAAGMEYLESKN--- 113
Query: 472 VIHRDIKASNIMLDAN-------FN-ARLESS--FTLTAGT----MGYLAPEYLQYGTAT 517
IHRD+ A N ++ N F +R E +T++ G + + APE L YG T
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 518 EKTDVFSYGVVVLEV 532
++DV+SYG+++ E
Sbjct: 174 SESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 67/203 (33%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQL 409
R LG G FG V+ + + VA VK K FL E I+ LRH LVQL
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVA-VKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
C+E+ + +V EYM GSL + + S G L +++ +A + YL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSL--LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---S 121
Query: 470 QQVIHRDIKASNIMLDANFN--------ARL--ESSFTLTAGT---MGYLAPEYLQYGTA 516
+ IHRD+ A NI++ N ARL + +T G + + APE YG
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF 181
Query: 517 TEKTDVFSYGVVVLE-VACGRRP 538
T K+DV+S+G+++ E V GR P
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
LG GA G+V K ++G + A+K + + + + + L EL I + +V+ G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 412 WCAEK--GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
++ + + EY GSLD + + + G + I + L+YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---S 123
Query: 470 QQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTA 516
+++IHRDIK SNI+L +L +FT GT Y+APE +Q
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKPY 180
Query: 517 TEKTDVFSYGVVVLEVACGRRPIERETE 544
+ +DV+S G+ +LEVA R P E E
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGE 208
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-23
Identities = 79/323 (24%), Positives = 143/323 (44%), Gaps = 26/323 (8%)
Query: 301 AFFCVVLAVFGYISIKKWKNMRTGICLRADLVPGPREFSYRELRSAT-----RGFHSNRI 355
AF + L FG++ I+ N+ D + F + +S T +
Sbjct: 638 AFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENV 697
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415
+ RG G YK +G VK + + +A++ L+H N+V+L+G C
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK---LQHPNIVKLIGLCRS 754
Query: 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHR 475
+ L++EY+ +L +L LSW R I +G+A AL +LH C V+
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 476 DIKASNIMLDANFNARLESSF-------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVV 528
++ I++D L S T + Y+APE + TEK+D++ +G++
Sbjct: 808 NLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLI 867
Query: 529 VLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK--RLNGAFNEDEMKRLLL 586
++E+ G+ P + E H ++V+W Y++ + D R + + N++E+ ++
Sbjct: 868 LIELLTGKSPADAEFGVHG--SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMN 925
Query: 587 VGLSCANPDSSARPSMRRVFQIL 609
+ L C D +ARP V + L
Sbjct: 926 LALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 8e-23
Identities = 57/206 (27%), Positives = 108/206 (52%), Gaps = 27/206 (13%)
Query: 354 RILGRGAFGNVYKAYFASSG---SVAAVKRSK--HSHEGKTEFLAELSIIACLRHKNLVQ 408
+++G G FG V++ G A+K K ++ + + +FL+E SI+ H N+++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L G + +++ EYM NG+LD+ L ++ S Y + ++ G+A+ + YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMKYL---S 124
Query: 469 EQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMG--YLAPEYLQY 513
+ +HRD+ A NI++++N ++ E ++T + G + + APE + Y
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 514 GTATEKTDVFSYGVVVLEV-ACGRRP 538
T +DV+S+G+V+ EV + G RP
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 9e-23
Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 27/204 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT------EFLAELSIIACLRHKNLV 407
+LG G+FG+VY+ G AVK + +G+T + E+++++ L+H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQ-DSENGVLLSWYHRLNIVVGLASALTYLHQ 466
Q LG E+ L + E +P GSL ++L + S ++ Y R I++GL YLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLH- 119
Query: 467 ECEQQVIHRDIKASNIMLDANFNARL----------ESSFTLT-AGTMGYLAPEYL-QYG 514
++ +HRDIK +NI++D N +L E SF + G+ ++APE + Q G
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 515 TATEKTDVFSYGVVVLEVACGRRP 538
D++S G VLE+A G+ P
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 354 RILGRGAFGNVYKAYFAS-----SGSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNL 406
R LG GAFG V+ + AVK K S++ + +F E ++ +H+N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRML-----------YQDSENGVLLSWYHRLNIVV 455
V+ G C E ++V+EYM +G L++ L DS G L+ L I V
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQIAV 129
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT------------AGTM 503
+AS + YL Q +HRD+ N ++ + ++ F ++ TM
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKI-GDFGMSRDVYTTDYYRVGGHTM 185
Query: 504 ---GYLAPEYLQYGTATEKTDVFSYGVVVLEV-ACGRRP 538
++ PE + Y T ++DV+S+GVV+ E+ G++P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 32/203 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKR--SKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
LG+G+ G VYK +G + A+K+ E + + L EL + +V+ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
++GE+ +V EYM GSL +L + E VL I + L YLH ++
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEP-VLAY------IARQILKGLDYLHT--KR 119
Query: 471 QVIHRDIKASNIMLD-------ANF--NARLESSFTLTA---GTMGYLAPEYLQ---YGT 515
+IHRDIK SN++++ A+F + LE++ GT+ Y++PE +Q Y
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179
Query: 516 ATEKTDVFSYGVVVLEVACGRRP 538
A D++S G+ +LE A G+ P
Sbjct: 180 A---ADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 28/207 (13%)
Query: 353 NRILGRGAFGNVYKAYFASSGS---VAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLV 407
+++G G FG V + G A+K ++ S + + +FL E SI+ H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+L G + ++++ EYM NGSLD+ L ++ + + ++ G+AS + YL +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLSEM 125
Query: 468 CEQQVIHRDIKASNIMLDANFNARLESSFTLTAG---------TMG------YLAPEYLQ 512
+HRD+ A NI++++N ++ S F L+ T G + APE +
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKV-SDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 513 YGTATEKTDVFSYGVVVLEV-ACGRRP 538
Y T +DV+S+G+V+ EV + G RP
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 73/223 (32%), Positives = 109/223 (48%), Gaps = 38/223 (17%)
Query: 356 LGRGAFGNVYKAYFASSGSV---AAVKRSKHSHE--GKTEFLAELSIIACLRHKNLVQLL 410
LG G FG+V K + AVK K H GK EFL E S++A L H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 411 GWCAEKGE-LLLVYEYMPNGSLDRMLYQDSENGV--LLSWYHRLNIVVGLASALTYLHQE 467
G C KGE L+LV E P G L + L + E V L H+ +A + YL
Sbjct: 63 GVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLE-- 112
Query: 468 CEQQVIHRDIKASNIMLDANFNARLESSFTL-----------TAGTMG-----YLAPEYL 511
+ +HRD+ A N++L A++ S F + A T G + APE +
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKI-SDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 512 QYGTATEKTDVFSYGVVVLEV-ACGRRPIERETEGHKMVNLVD 553
YG + K+DV+SYGV + E + G +P E +G +++ +++
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPY-GEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 70/207 (33%), Positives = 103/207 (49%), Gaps = 33/207 (15%)
Query: 355 ILGRGAFGNVYKAYFASSG--SVAAVKRSKH--SHEGKTEFLAELSIIACL-RHKNLVQL 409
++G G FG V KA G AA+KR K S + +F EL ++ L H N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 410 LGWCAEKGELLLVYEYMPNGSL------DRMLYQD------SENGVLLSWYHRLNIVVGL 457
LG C +G L L EY P+G+L R+L D + LS L+ +
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 458 ASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAG-------TMG-----Y 505
A + YL Q +Q IHRD+ A NI++ N+ A++ + F L+ G TMG +
Sbjct: 134 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI-ADFGLSRGQEVYVKKTMGRLPVRW 189
Query: 506 LAPEYLQYGTATEKTDVFSYGVVVLEV 532
+A E L Y T +DV+SYGV++ E+
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEI 216
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 77/279 (27%), Positives = 124/279 (44%), Gaps = 35/279 (12%)
Query: 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSK----HSHEGKTEFLAELSIIACLR 402
F + +G+G F VYKA G V A+K+ + + + + L E+ ++ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 403 HKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
H N+++ L E EL +V E G L RM+ + L+ V L SAL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARLE--------SSFTLTA----GTMGYLAPEY 510
++H ++++HRDIK +N+ + A +L SS T A GT Y++PE
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 511 LQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD- 569
+ K+D++S G ++ E+A + P G KM LY+ + IE D
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKM--------NLYSLCKKIEKCDY 225
Query: 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608
L +E++ L+ C NPD RP + V Q+
Sbjct: 226 PPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 97.9 bits (242), Expect = 7e-22
Identities = 71/232 (30%), Positives = 107/232 (46%), Gaps = 28/232 (12%)
Query: 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE-FLAELSIIACLRH-KNL 406
+ R LG G+FG VY A ++ + + S + E FL E+ I+A L H N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
V+L + ++G L LV EY+ GSL+ +L + G L L I+ + SAL YLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSE-SEALFILAQILSALEYLH- 118
Query: 467 ECEQQVIHRDIKASNIMLDANFN---------ARLESSFTLTA----------GTMGYLA 507
+ +IHRDIK NI+LD + A+L T+ GT GY+A
Sbjct: 119 --SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 508 PEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW 556
PE L A+ +D++S G+ + E+ G P E E + +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 40/221 (18%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAV----KRSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
LG+G+FG V +G + A+ K+ + L E +I++ + H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 412 WCA--EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN------IVVGLASALTY 463
A + +L LV EY P G L L + R + + AL Y
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSK----------EGRFSEERARFYAAEIVLALEY 108
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEYL 511
LH +I+RD+K NI+LDA+ + +L E S T T GT YLAPE L
Sbjct: 109 LH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL 165
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLV 552
+ D +S GV++ E+ G+ P E ++ +
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKI 205
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEF----LAELSIIACLRHKNLVQL 409
+G G +G VYKA +G + A+K+ + +E K F + E+ ++ LRH N+V+L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENE-KEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 410 LGWCAEK--GELLLVYEYMP---NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
K G + +V+EYM G LD + +E + + +L L YL
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTE-SQIKCYMKQL------LEGLQYL 116
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLTAG--TMGYLAPEYL 511
H ++HRDIK SNI+++ + +L +S T T+ Y PE L
Sbjct: 117 HS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 512 ----QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKM 548
+YG D++S G ++ E+ G+ + TE ++
Sbjct: 174 LGATRYGPE---VDMWSVGCILAELFLGKPIFQGSTELEQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 64/199 (32%), Positives = 97/199 (48%), Gaps = 20/199 (10%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
R LG G FG V++ + ++ VA VK K +FLAE I+ LRH L+QL C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVA-VKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+ + +V E M GSL + Y G L +++ +AS + YL Q I
Sbjct: 71 TLEEPIYIVTELMKYGSL--LEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYI 125
Query: 474 HRDIKASNIMLD-------ANFN-ARL--ESSFTLTAGT---MGYLAPEYLQYGTATEKT 520
HRD+ A N+++ A+F AR+ E + G + + APE Y + K+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 521 DVFSYGVVVLE-VACGRRP 538
DV+S+G+++ E V GR P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG---KTEFLAELSIIACLRHKNLVQLLGW 412
LG G FG V+ + VA K EG + +F+ E ++ L H NLVQL G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAI----KMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
C ++ + +V EYM NG L L + L L++ + A+ YL
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLE---SNGF 121
Query: 473 IHRDIKASNIMLDANFN--------AR--LESSFTLTAGT---MGYLAPEYLQYGTATEK 519
IHRD+ A N ++ + AR L+ +T + GT + + PE Y + K
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 520 TDVFSYGVVVLEV-ACGRRPIERETEG 545
+DV+S+GV++ EV + G+ P ER +
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNS 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 37/205 (18%)
Query: 354 RILGRGAFGNVYKAYFA----SSGSVAAVKRSKHSHEGK--TEFLAELSIIACLRHKNLV 407
+ LG G FG V + ++G AVK HS E + ++F E+ I+ L H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 408 QLLGWCAEKGE--LLLVYEYMPNGSLDRMLYQDSEN---GVLLSWYHRLNIVVGLASALT 462
+ G C + G L L+ EY+P+GSL L + + LL + + +
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF------SSQICKGMD 123
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT-AGTMG---------------YL 506
YL Q+ IHRD+ A NI++++ ++ S F L +
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKI-SDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 507 APEYLQYGTATEKTDVFSYGVVVLE 531
APE L+ + +DV+S+GV + E
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415
+G G FG V+ Y+ VA +K + + +F+ E ++ L H LVQL G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVA-IKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHR 475
+ + LV+E+M +G L Y ++ G S L + + + + YL VIHR
Sbjct: 71 RSPICLVFEFMEHGCLSD--YLRAQRG-KFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 476 DIKASNIMLDANFNAR----------LESSFTLTAGT---MGYLAPEYLQYGTATEKTDV 522
D+ A N ++ N + L+ +T + GT + + +PE + + K+DV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 523 FSYGVVVLEV-ACGRRPIERETEG 545
+S+GV++ EV + G+ P E +
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNS 208
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 29/207 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGS---VAAVKRSK--HSHEGKTEFLAELSIIACLRHKNLVQ 408
+++G G FG V G A+K K ++ + + +FL+E SI+ H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQ-DSENGVLLSWYHRLNIVVGLASALTYLHQE 467
L G + +++V EYM NGSLD L + D + V+ + ++ G+AS + YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI----QLVGMLRGIASGMKYL--- 122
Query: 468 CEQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMG--YLAPEYLQ 512
+ +HRD+ A NI++++N ++ E+++T G + + APE +
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 513 YGTATEKTDVFSYGVVVLEV-ACGRRP 538
Y T +DV+SYG+V+ EV + G RP
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 19/196 (9%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGK-TEFLAELSIIACLRHKNLVQ 408
F R LG G FG V++ + + VA +K K K +F E+ + LRHK+L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVA-IKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L C+ + ++ E M GSL + + S G +L +++ +A + YL
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--- 121
Query: 469 EQQVIHRDIKASNIMLD-------ANFN-ARL-ESSFTLTAGT---MGYLAPEYLQYGTA 516
EQ IHRD+ A NI++ A+F ARL + L++ + APE +GT
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 517 TEKTDVFSYGVVVLEV 532
+ K+DV+S+G+++ E+
Sbjct: 182 STKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 61/197 (30%), Positives = 105/197 (53%), Gaps = 21/197 (10%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415
LG G FG V+ Y+ VA +K K FLAE +++ L+H LV+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVA-IKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHR 475
+ + ++ EYM NGSL + + + G+ L+ +++ +A + ++ + + IHR
Sbjct: 72 QEPIYIITEYMENGSL--VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHR 126
Query: 476 DIKASNIMLD-------ANFN-ARL--ESSFTLTAGT---MGYLAPEYLQYGTATEKTDV 522
D++A+NI++ A+F ARL ++ +T G + + APE + YGT T K+DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 523 FSYGVVVLE-VACGRRP 538
+S+G+++ E V GR P
Sbjct: 187 WSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 42/213 (19%)
Query: 356 LGRGAFGNVYKA-----YFASSGSVAAVKRSKHSHEGKT--EFLAELSIIACLRHKNLVQ 408
LG GAFG VYK S + A+K K + E K EF E +++ L+H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRML------------YQDSENGVLLSWYHRLNIVVG 456
LLG C ++ +++EY+ +G L L D L L+I +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 457 LASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAGTMGY----------- 505
+A+ + YL +HRD+ A N ++ ++ S F L+ Y
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKI-SDFGLS--RDIYSADYYRVQSKS 186
Query: 506 ------LAPEYLQYGTATEKTDVFSYGVVVLEV 532
+ PE + YG T ++D++S+GVV+ E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 64/212 (30%), Positives = 92/212 (43%), Gaps = 32/212 (15%)
Query: 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTE-FLAELSIIACLRHK 404
F R++G+GAFG V + + A+K + K +G L E I+ L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 405 NLVQLLGWCAEKGE--LLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLAS 459
LV L W + + E + LV + + G L L Q SE V + +
Sbjct: 61 FLVNL--WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVL 111
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLTAGTMGYLAP 508
AL YLH + +IHRDIK NI+LD + + ++ T T+GT GY+AP
Sbjct: 112 ALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAP 168
Query: 509 EYLQYGTATEKTDVFSYGVVVLEVACGRRPIE 540
E L + D +S GV E G+RP
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 69/278 (24%), Positives = 117/278 (42%), Gaps = 43/278 (15%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE---FLAELSIIACLRHKNLVQLLG 411
+G+G+FG V K S G + K + + + E ++E++I+ L+H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 412 WC--AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH--QE 467
L +V EY G L +++ + + + I+ L AL H +
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 468 CEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEYLQYGT 515
V+HRD+K +NI LDAN N +L +SSF T GT Y++PE L + +
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS 186
Query: 516 ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE--GRIIEAADKRLN 573
EK+D++S G ++ E+ P + +I E +R+
Sbjct: 187 YDEKSDIWSLGCLIYELCALSPPFTARN---------------QLQLASKIKEGKFRRIP 231
Query: 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
++ + L V S N D RPS ++L
Sbjct: 232 YRYSSE----LNEVIKSMLNVDPDKRPS---TEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 66/212 (31%), Positives = 110/212 (51%), Gaps = 35/212 (16%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKR---------SKHSHEGKTEFLA-ELSIIACLRHK 404
++G G+FG+VY ASSG + AVK+ SK + LA E++++ L+H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
N+VQ LG + L + EY+P GS+ +L G R N V + L YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN---YGAFEETLVR-NFVRQILKGLNYL 122
Query: 465 HQECEQQVIHRDIKASNIMLD-------ANF--NARLESSFTLTA---------GTMGYL 506
H + +IHRDIK +NI++D ++F + +LE++ T G++ ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 507 APEYLQYGTATEKTDVFSYGVVVLEVACGRRP 538
APE ++ + T K D++S G +V+E+ G+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 33/209 (15%)
Query: 355 ILGRGAFGNVYKAYFASSG---SVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQL 409
++G G FG V + G A+K +S ++ + + +FL+E SI+ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQ-DSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
G + ++++ E+M NG+LD L Q D + V+ + ++ G+A+ + YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI----QLVGMLRGIAAGMKYL---S 123
Query: 469 EQQVIHRDIKASNIMLDANFNARLESSFTLT------------AGTMG------YLAPEY 510
E +HRD+ A NI++++N ++ S F L+ ++G + APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKV-SDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 511 LQYGTATEKTDVFSYGVVVLEV-ACGRRP 538
+ Y T +DV+SYG+V+ EV + G RP
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 28/215 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+ +G+G FG+V + G+ AVK K+ + FLAE S++ LRH NLVQLLG
Sbjct: 12 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLLGVI 68
Query: 414 AE-KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
E KG L +V EYM GSL + Y S +L L + + A+ YL
Sbjct: 69 VEEKGGLYIVTEYMAKGSL--VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNF 123
Query: 473 IHRDIKASNIMLD-------ANFNARLESSFTLTAGTM--GYLAPEYLQYGTATEKTDVF 523
+HRD+ A N+++ ++F E+S T G + + APE L+ + K+DV+
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 524 SYGVVVLEV-ACGRRP---------IERETEGHKM 548
S+G+++ E+ + GR P + R +G+KM
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 218
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 26/199 (13%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415
+G GA G VYKA ++G A+K+ + + K + E+ I+ +H N+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHR 475
EL +V EYM GSL ++ Q N V ++ + + L YLH Q VIHR
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQ---NFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHR 140
Query: 476 DIKASNIMLDANFNARLESSFTLTA-------------GTMGYLAPEYLQ---YGTATEK 519
DIK+ NI+L + + +L + F A GT ++APE ++ YG K
Sbjct: 141 DIKSDNILLSKDGSVKL-ADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP---K 196
Query: 520 TDVFSYGVVVLEVACGRRP 538
D++S G++ +E+A G P
Sbjct: 197 VDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 46/213 (21%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKR--SKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
+LG+G +G VY A S+ A+K + S + E+++ + L+H+N+VQ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQYLGS 73
Query: 413 CAEKGELLLVYEYMPNGSLDRML------YQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
+E G + E +P GSL +L +D+E ++ ++ I+ G L YLH
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTII---FYTKQILEG----LKYLH- 125
Query: 467 ECEQQVIHRDIKASNIML----------DANFNARL------ESSFTLTAGTMGYLAPEY 510
+ Q++HRDIK N+++ D + RL +FT GT+ Y+APE
Sbjct: 126 --DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEV 180
Query: 511 LQ-----YGTATEKTDVFSYGVVVLEVACGRRP 538
+ YG D++S G ++E+A G+ P
Sbjct: 181 IDKGPRGYGAP---ADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 26/202 (12%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE-FLAELSIIACLRHKNLVQLLGWCA 414
LG GAFG VYKA +G AA K + E + E F+ E+ I++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
+ +L ++ E+ G+LD ++ L R + + AL +LH +VIH
Sbjct: 73 YENKLWILIEFCDGGALDSIM--LELERGLTEPQIRY-VCRQMLEALNFLH---SHKVIH 126
Query: 475 RDIKASNIMLDANFNARLESSFTLTA-------------GTMGYLAPEYLQYGTATE--- 518
RD+KA NI+L + + +L + F ++A GT ++APE + T +
Sbjct: 127 RDLKAGNILLTLDGDVKL-ADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPY 185
Query: 519 --KTDVFSYGVVVLEVACGRRP 538
K D++S G+ ++E+A P
Sbjct: 186 DYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 40/218 (18%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVK----------RSKHSHEGKTEFL-AELSIIACLRH 403
++G+G +G VY A ++G + AVK R + + L +E+ + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 404 KNLVQLLGWCAEKGELLLVY-EYMPNGSLDRML--YQDSENGVLLSWYHRLNIVVGLASA 460
N+VQ LG E L ++ EY+P GS+ L Y E ++ + + ++ GLA
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--VLEGLA-- 122
Query: 461 LTYLHQECEQQVIHRDIKASNIMLDA-------NF-------NARLESSFTLTAGTMGYL 506
YLH + ++HRD+KA N+++DA +F + G++ ++
Sbjct: 123 --YLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 507 APE--YLQYGTATEKTDVFSYGVVVLEVACGRRPIERE 542
APE + + K D++S G VVLE+ GRRP E
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-19
Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 33/207 (15%)
Query: 355 ILGRGAFGNVYKAYFASSGS--VAAVKRSKH--SHEGKTEFLAELSIIACL-RHKNLVQL 409
++G G FG V +A G AA+K K S +F EL ++ L H N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 410 LGWCAEKGELLLVYEYMPNGSL------DRMLYQD----SENGV--LLSWYHRLNIVVGL 457
LG C +G L + EY P G+L R+L D E+G L+ L +
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 458 ASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAG-------TMG-----Y 505
A+ + YL E+Q IHRD+ A N+++ N +++ + F L+ G TMG +
Sbjct: 129 ATGMQYL---SEKQFIHRDLAARNVLVGENLASKI-ADFGLSRGEEVYVKKTMGRLPVRW 184
Query: 506 LAPEYLQYGTATEKTDVFSYGVVVLEV 532
+A E L Y T K+DV+S+GV++ E+
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEI 211
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 31/202 (15%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCA 414
LG G++G+VYKA +G V A+K E E + E+SI+ +V+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIK-VVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 415 EKGELLLVYEYMPNGSLDRML------YQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
+ +L +V EY GS+ ++ + E +L + GL YLH
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAIL-----YQTLKGLE----YLHS-- 117
Query: 469 EQQVIHRDIKASNIMLDANFNARLES---SFTLT---------AGTMGYLAPEYLQYGTA 516
+ IHRDIKA NI+L+ A+L S LT GT ++APE +Q
Sbjct: 118 -NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 517 TEKTDVFSYGVVVLEVACGRRP 538
K D++S G+ +E+A G+ P
Sbjct: 177 NNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 26/199 (13%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRS--KHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+G+G+FG VYKA + V A+K + + + + E+ ++ R + + G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 414 AEKGELLLVYEYMPNGS-LDRMLYQ-DSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
+ +L ++ EY GS LD + E + I+ + L YLH E+
Sbjct: 69 LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGLEYLH---EEG 118
Query: 472 VIHRDIKASNIMLDANFNARL-------ESSFTLT-----AGTMGYLAPEYLQYGTATEK 519
IHRDIKA+NI+L + +L + + T++ GT ++APE ++ EK
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK 178
Query: 520 TDVFSYGVVVLEVACGRRP 538
D++S G+ +E+A G P
Sbjct: 179 ADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 71/277 (25%), Positives = 126/277 (45%), Gaps = 37/277 (13%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSK----HSHEGKTEFLAELSIIACLRHKN 405
F + +GRG F VY+A G A+K+ + + + + + E+ ++ L H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+++ E EL +V E G L RM+ + L+ V L SAL ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 466 QECEQQVIHRDIKASNIMLDAN-------------FNARLESSFTLTAGTMGYLAPEYLQ 512
++V+HRDIK +N+ + A F+++ ++ +L GT Y++PE +
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD-KR 571
K+D++S G ++ E+A + P G KM LY+ + IE D
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKM--------NLYSLCKKIEQCDYPP 227
Query: 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608
L +E+++L+ + C NPD RP + V+ +
Sbjct: 228 LPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 42/207 (20%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG---KTEFLAELSIIACLRHKNLVQLLGW 412
+G GA+G V K ++G + A+K+ K S + K L E+ ++ LRH+N+V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGV------LLSWYHRLNIVVGLASALTYLHQ 466
KG L LV+EY+ L+ L + S G+ W L A+ Y H
Sbjct: 69 FRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHS 118
Query: 467 ECEQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYL-- 511
+IHRDIK NI++ + +L S T T Y APE L
Sbjct: 119 ---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175
Query: 512 --QYGTATEKTDVFSYGVVVLEVACGR 536
YG DV++ G ++ E+ G
Sbjct: 176 DTNYGKP---VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNL 406
+ + +G G+FG +Y A S +K +K + K E+ ++A ++H N+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
V E G L +V EY G L M + + GVL S L+ V ++ L ++H
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDL--MKRINRQRGVLFSEDQILSWFVQISLGLKHIH- 118
Query: 467 ECEQQVIHRDIKASNIMLDAN--------------FNARLESSFTLTAGTMGYLAPEYLQ 512
+++++HRDIK+ NI L N N +E ++T GT YL+PE Q
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQ 175
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRPIE 540
KTD++S G V+ E+ + P E
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 74/275 (26%), Positives = 123/275 (44%), Gaps = 44/275 (16%)
Query: 356 LGRGAFGNVYKA-YFASSGSVAAVKR-----------SKHSHEGKTEFLAELSII-ACLR 402
LG GAFG VYK + ++ A+K + + + ++E++II LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 403 HKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
H N+V+ E L +V + + L E + NI V + AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLTAGTMGYLAPEYL 511
YLH+E ++++HRD+ +NIML + + ES T GT+ Y PE +
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV 185
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571
+ EK DV+++G ++ ++ C +P T M++L +I+EA +
Sbjct: 186 KNEPYGEKADVWAFGCILYQM-CTLQPPFYST---NMLSLAT---------KIVEAVYEP 232
Query: 572 LN-GAFNEDEMKRLLLVGLSCANPDSSARPSMRRV 605
L G ++ED + V SC PD+ ARP + +V
Sbjct: 233 LPEGMYSED----VTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 64/272 (23%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSK---HSHEGKTEFLAELSIIACLRHKN 405
F + LG+G++G+VYK S A+K S + + + + E+ I+A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
++ + +L +V EY P G L + + + + L+ I + L L LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 466 QECEQQVIHRDIKASNIMLDANFNAR---------LESSFTLTA-GTMGYLAPEYLQYGT 515
EQ+++HRD+K++NI+L AN + L+ + T GT Y+APE +
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRP 177
Query: 516 ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575
+ K+D++S G ++ E+A P E + M +L ++ +
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARS----MQDL---------RYKVQRGKYPPIPPI 224
Query: 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607
+++D L S RP+ ++
Sbjct: 225 YSQD----LQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 31/201 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE---FLAELSIIACLRHKNLVQLLGW 412
+G G +G VYKA +G + A+K+ K E + L E+ ++ L H N+++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQD-SENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
KG+L LV+E+M D LY+ + L + + L L + H
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HG 118
Query: 472 VIHRDIKASNIMLD-------ANFN-ARLESS----FTLTAGTMGYLAPEYL----QYGT 515
++HRD+K N++++ A+F AR S +T T Y APE L Y
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY-- 176
Query: 516 ATEKTDVFSYGVVVLEVACGR 536
+ D++S G + E+ R
Sbjct: 177 -STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 21/195 (10%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCA 414
I+G G FG V + + +G AVK K + FL E +++ L HKNLV+LLG
Sbjct: 13 IIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQA-FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
G L +V E M G+L L + L+S L + +A + YL ++++H
Sbjct: 70 HNG-LYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVH 123
Query: 475 RDIKASNIMLDANFNARLESSFTL-TAGTMG---------YLAPEYLQYGTATEKTDVFS 524
RD+ A NI++ + A++ S F L G+MG + APE L++ + K+DV+S
Sbjct: 124 RDLAARNILVSEDGVAKV-SDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWS 182
Query: 525 YGVVVLEV-ACGRRP 538
YGV++ EV + GR P
Sbjct: 183 YGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 70/207 (33%), Positives = 103/207 (49%), Gaps = 33/207 (15%)
Query: 355 ILGRGAFGNVYKAYFASSG--SVAAVKRSKH--SHEGKTEFLAELSIIACL-RHKNLVQL 409
++G G FG V KA G AA+KR K S + +F EL ++ L H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 410 LGWCAEKGELLLVYEYMPNGSL------DRMLYQD----SENGV--LLSWYHRLNIVVGL 457
LG C +G L L EY P+G+L R+L D N LS L+ +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 458 ASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAG-------TMG-----Y 505
A + YL ++Q IHRD+ A NI++ N+ A++ + F L+ G TMG +
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKI-ADFGLSRGQEVYVKKTMGRLPVRW 177
Query: 506 LAPEYLQYGTATEKTDVFSYGVVVLEV 532
+A E L Y T +DV+SYGV++ E+
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+ LG G FG V+ Y+ +S VA VK K FL E +++ L+H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVA-VKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
++ + ++ EYM GSL L D VLL ++ +A + Y+ + + I
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIER---KNYI 125
Query: 474 HRDIKASNIMLD-------ANFN-ARL--ESSFTLTAGT---MGYLAPEYLQYGTATEKT 520
HRD++A+N+++ A+F AR+ ++ +T G + + APE + +G+ T K+
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 521 DVFSYGVVVLE-VACGRRPIERETEGHKMVNL 551
DV+S+G+++ E V G+ P + M L
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLA---ELSIIACLRHKNLV 407
++LG+GAFG VY Y +G AVK+ S E K E A E+ ++ L+H+ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 408 QLLGWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
Q G + L + EYMP GS+ D++ + + Y R I+ G+ YLH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QILEGVE----YLH- 121
Query: 467 ECEQQVIHRDIKASNIMLDANFNARL------------------ESSFTLTAGTMGYLAP 508
++HRDIK +NI+ D+ N +L S T GT +++P
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT---GTPYWMSP 176
Query: 509 EYLQYGTATEKTDVFSYGVVVLEVACGRRP 538
E + K DV+S G V+E+ + P
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 60/197 (30%), Positives = 103/197 (52%), Gaps = 26/197 (13%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE-FLAELSIIACLRHKNLVQLLGWCA 414
LG GAFG VYKA +G++AA K + E + E ++ E+ I+A H +V+LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
G+L ++ E+ P G++D ++ + L+ I + AL YLH ++IH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHS---MKIIH 133
Query: 475 RDIKASNIMLDANFNARLESSFTLTA-------------GTMGYLAPEYLQYGTATE--- 518
RD+KA N++L + + +L + F ++A GT ++APE + T +
Sbjct: 134 RDLKAGNVLLTLDGDIKL-ADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192
Query: 519 --KTDVFSYGVVVLEVA 533
K D++S G+ ++E+A
Sbjct: 193 DYKADIWSLGITLIEMA 209
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 35/211 (16%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKR------SKHSHEGKTEFL-AELSIIACLRHKNLV 407
+LG+GA+G VY + G + AVK+ + + E + E L E+ ++ L+H N+V
Sbjct: 7 VLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQ-DSENGVLLSWYHRLNIVVGLASALTYLHQ 466
Q LG C + + + E++P GS+ +L + + Y + I+ G+A YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHN 120
Query: 467 ECEQQVIHRDIKASNIMLDANFNARL----------------ESSFTLTA--GTMGYLAP 508
C V+HRDIK +N+ML N +L S L + GT ++AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 509 EYLQYGTATEKTDVFSYGVVVLEVACGRRPI 539
E + K+D++S G V E+A G+ P+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGS---VAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQ 408
RILG G FG + + A+ R+ S + + FLAE + H N+V+
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L G +++V EYM NG+LD L + L + ++ GLAS + YL
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYL---S 124
Query: 469 EQQVIHRDIKASNIMLDANFNA-----------RLESSFTLTAGTMGYL--APEYLQYGT 515
E +H+ + A ++++++ + E+ +T +G L APE +QY
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184
Query: 516 ATEKTDVFSYGVVVLEV-ACGRRP 538
+ +DV+S+G+V+ EV + G RP
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 31/206 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE--FLAEL-SIIACLRHKNLVQLLGW 412
+GRGAFG V K SG++ AVKR + + + K + L +L ++ +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 413 CAEKGELLLVYEYMPNGSLDR--MLYQDSENGVL----LSWYHRLNIVVGLASALTYLHQ 466
+G+ + E M + SLD+ + V+ L I V AL YL +
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNYLKE 125
Query: 467 ECEQQVIHRDIKASNIMLDANFNAR---------LESSF--TLTAGTMGYLAPEYLQYGT 515
E ++IHRD+K SNI+LD N N + L S T AG Y+APE +
Sbjct: 126 EL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 183
Query: 516 ATE---KTDVFSYGVVVLEVACGRRP 538
++DV+S G+ + EVA G+ P
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 53/236 (22%), Positives = 92/236 (38%), Gaps = 52/236 (22%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEF-LAELSIIACL-RHK 404
F +I+G G+F V A + A+K E K ++ E ++ L H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
+++L ++ L V EY PNG L + S + +Y + AL Y
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY-----AAEILLALEY 117
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARL------------------------------- 492
LH + +IHRD+K NI+LD + + ++
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 493 ----ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
+SF GT Y++PE L A + +D+++ G ++ ++ G+ P E
Sbjct: 175 NRRRFASFV---GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 21/197 (10%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415
LG+G FG V+ + + VA +K K FL E ++ LRH+ LVQL +E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHR 475
+ + +V EYM GSL L E G L +++ +AS + Y+ + +HR
Sbjct: 73 E-PIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126
Query: 476 DIKASNIMLDANFN--------ARL--ESSFTLTAGT---MGYLAPEYLQYGTATEKTDV 522
D++A+NI++ N ARL ++ +T G + + APE YG T K+DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 523 FSYGVVVLEVAC-GRRP 538
+S+G+++ E+ GR P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 34/211 (16%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA----AVK--RSKHSHEGKTEFLAELSIIACLRHKNLV 407
++LG GAFG VYK + G A+K + EF+ E I+A + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSEN---GVLLSWYHRLNIVVGLASALTYL 464
+LLG C + LV + MP+G L +++ +N +LL+W V +A + YL
Sbjct: 73 RLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125
Query: 465 HQECEQQVIHRDIKASNIMLDA-------NFN-ARL----ESSFTLTAGTM--GYLAPEY 510
E++++HRD+ A N+++ + +F ARL E + G M ++A E
Sbjct: 126 E---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 511 LQYGTATEKTDVFSYGVVVLEVAC-GRRPIE 540
+ Y T ++DV+SYGV + E+ G +P +
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 32/205 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRH--KNLVQLLG 411
+G G G VYK F +G V AVK+ + + E L +L ++ H +V+ G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV-LKSHDCPYIVKCYG 81
Query: 412 WCAEKGELLLVYEYMPNGSLDRML---YQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
+ ++ + E M LD++L +L + V + AL YL ++
Sbjct: 82 YFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILG------KMTVAIVKALHYLKEK- 133
Query: 469 EQQVIHRDIKASNIMLDANFNARL----------ES-SFTLTAGTMGYLAPEYLQYGTAT 517
VIHRD+K SNI+LDA+ N +L +S + T +AG Y+APE +
Sbjct: 134 -HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPN 192
Query: 518 EK----TDVFSYGVVVLEVACGRRP 538
K DV+S G+ ++E+A G+ P
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 7e-17
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 21/200 (10%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415
LG G FG V + VA +K K + EF+ E ++ L H+ LVQL G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVA-IKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHR 475
+ + +V EYM NG L L E+G L + + + YL +Q IHR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHR 124
Query: 476 DIKASNIMLDANFNAR----------LESSFTLTAGT---MGYLAPEYLQYGTATEKTDV 522
D+ A N ++D + L+ +T + G+ + + PE L Y + K+DV
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 523 FSYGVVVLEV-ACGRRPIER 541
+++GV++ EV + G+ P ER
Sbjct: 185 WAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 55/192 (28%), Positives = 90/192 (46%), Gaps = 22/192 (11%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGW 412
+LG+G FG V+K VA VK K E K +FL+E I+ H N+V+L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVA-VKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
C ++ + +V E +P G L + + L + + A+ + YL +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLES---KNC 114
Query: 473 IHRDIKASNIMLDANFNARLE-------------SSFTLTAGTMGYLAPEYLQYGTATEK 519
IHRD+ A N ++ N ++ SS L + + APE L YG + +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 520 TDVFSYGVVVLE 531
+DV+SYG+++ E
Sbjct: 175 SDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 58/207 (28%), Positives = 86/207 (41%), Gaps = 33/207 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
+G GA VY A + A+KR K E E+ ++ H N+V+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVKYYTS 67
Query: 413 CAEKGELLLVYEYMPNGS-LDRMLYQDSENG---VLLSWYHRLNIVVGLASALTYLHQEC 468
EL LV Y+ GS LD M G +++ ++ + L YLH
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA-----TVLKEVLKGLEYLHS-- 120
Query: 469 EQQVIHRDIKASNIMLD-------ANF--NARLESSFTLT-------AGTMGYLAPEYLQ 512
IHRDIKA NI+L A+F +A L T GT ++APE ++
Sbjct: 121 -NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 513 YGTA-TEKTDVFSYGVVVLEVACGRRP 538
K D++S+G+ +E+A G P
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHK---NLVQL 409
LGRGA+G V K +G++ AVKR + +S E K L +L I +R V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-RLLMDLDI--SMRSVDCPYTVTF 65
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
G +G++ + E M + SLD+ + + G+ + I V + AL YLH +
Sbjct: 66 YGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL- 123
Query: 470 QQVIHRDIKASNIMLDANFNARL-----------ESSFTLTAGTMGYLAPEYLQYGTATE 518
VIHRD+K SN++++ N +L + T+ AG Y+APE + +
Sbjct: 124 -SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 182
Query: 519 ----KTDVFSYGVVVLEVACGRRPIER 541
K+DV+S G+ ++E+A GR P +
Sbjct: 183 GYDVKSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 37/205 (18%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEF----LAELSIIACLRHKNLVQLL 410
LG G +G VYKA +G + A+K+ + +E + L E+S++ L+H N+V+LL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLL 64
Query: 411 GWCAEKGELLLVYEYMPN---GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+ +L LV+EY LD+ S N + Y L L Y H
Sbjct: 65 DVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLR-------GLAYCHS- 116
Query: 468 CEQQVIHRDIKASNIMLD-------ANFN-ARL----ESSFTLTAGTMGYLAPEYL---- 511
+++HRD+K NI+++ A+F AR ++T T+ Y APE L
Sbjct: 117 --HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK 174
Query: 512 QYGTATEKTDVFSYGVVVLEVACGR 536
Y TA D++S G + E+ G+
Sbjct: 175 HYSTA---VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 29/205 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSV---AAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
LG G+FG V + +++SG AVK +S + +FL E +I+ L H+NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
G L++V E P GSL L +D+ L+S + V +A+ + YL +
Sbjct: 63 GVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLC--DYAVQIANGMRYLES---K 116
Query: 471 QVIHRDIKASNIMLDANFNARLESSFTLTAG--------TM--------GYLAPEYLQYG 514
+ IHRD+ A NI+L ++ ++ F L M + APE L+
Sbjct: 117 RFIHRDLAARNILLASDDKVKI-GDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 515 TATEKTDVFSYGVVVLEV-ACGRRP 538
T + +DV+ +GV + E+ G P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 44/266 (16%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGK--TEFLAELSIIACLRH---KNLVQL 409
++GRGA+G VY+ +G V A+K ++ E+++++ LR N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 410 LGWCAEKG-ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
G KG L ++ EY GS+ R L + G + Y + I+ + AL Y+H+
Sbjct: 68 YG-SYLKGPRLWIIMEYAEGGSV-RTL---MKAGPIAEKYISV-IIREVLVALKYIHKV- 120
Query: 469 EQQVIHRDIKASNIMLDANFNARL-----ESSFTLT-------AGTMGYLAPEYLQYGTA 516
VIHRDIKA+NI++ N +L + GT ++APE + G
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 517 TE-KTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575
+ K D++S G+ + E+A G P + + + L I ++ RL
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDV-DAFRAMML------------IPKSKPPRLEDN 225
Query: 576 FNEDEMKRLLLVGLSCANPDSSARPS 601
++ + +C + + R S
Sbjct: 226 GYSKLLREFV---AACLDEEPKERLS 248
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 21/200 (10%)
Query: 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
+ LG G FG V+ A + VA VK K FLAE +++ L+H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVA-VKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA- 68
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
K + ++ E+M GSL L D + L ++ +A + ++ Q +
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNY 123
Query: 473 IHRDIKASNIMLD-------ANFN-ARL--ESSFTLTAGT---MGYLAPEYLQYGTATEK 519
IHRD++A+NI++ A+F AR+ ++ +T G + + APE + +G+ T K
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 520 TDVFSYGVVVLE-VACGRRP 538
+DV+S+G++++E V GR P
Sbjct: 184 SDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQLLGWCA 414
+G G +G+VYKA ++G + A+K K + E+S++ RH N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
+ +L +V EY GSL +YQ LS + L YLH+ IH
Sbjct: 71 RRDKLWIVMEYCGGGSLQ-DIYQ--VTRGPLSELQIAYVCRETLKGLAYLHE---TGKIH 124
Query: 475 RDIKASNIMLD-------ANF--NARLESSF----TLTAGTMGYLAPEYLQ---YGTATE 518
RDIK +NI+L A+F +A+L ++ + GT ++APE G
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYDG 183
Query: 519 KTDVFSYGVVVLEVACGRRP 538
K D+++ G+ +E+A + P
Sbjct: 184 KCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 30/206 (14%)
Query: 354 RILGRGAFGNVYKAYFA-----SSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNL 406
R LG GAFG VY+ + + AVK S + +++FL E I++ H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLASALTY 463
V+L+G E+ ++ E M G L L ++ E L+ L +A Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 464 LHQECEQQVIHRDIKASNIMLD----------ANFN-AR--LESSFTLTAG-TM---GYL 506
L E IHRDI A N +L A+F AR +S+ G M ++
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 507 APEYLQYGTATEKTDVFSYGVVVLEV 532
PE G T KTDV+S+GV++ E+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 30/216 (13%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415
LG G FG V+ + + VA VK K FL E I+ LRH LVQL +E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVA-VKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHR 475
+ + +V EYM GSL L +D E G L + +++ +A+ + Y+ + IHR
Sbjct: 73 E-PIYIVTEYMSKGSLLDFL-KDGE-GRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 126
Query: 476 DIKASNIMLD-------ANFN-ARL--ESSFTLTAGT---MGYLAPEYLQYGTATEKTDV 522
D++++NI++ A+F ARL ++ +T G + + APE YG T K+DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 523 FSYGVVVLE-VACGRRP---------IERETEGHKM 548
+S+G+++ E V GR P +E+ G++M
Sbjct: 187 WSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT--EFLAELSIIACLRHKNLVQLLGWC 413
LG+G +G+VYK +G A+K + + + + EL I+ +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+G + + EYM GSLD++ + R I + L +L +E +I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKFLKEE--HNII 125
Query: 474 HRDIKASNIMLDAN---------FNARLESSFTLT-AGTMGYLAPEYLQYGTATE----- 518
HRD+K +N++++ N + L +S T G Y+APE ++ G +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYT 185
Query: 519 -KTDVFSYGVVVLEVACGRRPIERET 543
++DV+S G+ +LE+A GR P ET
Sbjct: 186 VQSDVWSLGLSILEMALGRYPYPPET 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 35/212 (16%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR----HKNLVQLL 410
++G G +G VYKA +G + A+K + + E E +I LR H N+
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNI---LRKYSNHPNIATFY 69
Query: 411 GWCAEKG------ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
G +K +L LV E GS+ ++ + G L I+ L YL
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL 129
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARLESSFTLTA-------------GTMGYLAPEYL 511
H E +VIHRDIK NI+L N +L F ++A GT ++APE +
Sbjct: 130 H---ENKVIHRDIKGQNILLTKNAEVKL-VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI 185
Query: 512 ---QYGTAT--EKTDVFSYGVVVLEVACGRRP 538
+ A+ ++DV+S G+ +E+A G+ P
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 76/292 (26%), Positives = 122/292 (41%), Gaps = 57/292 (19%)
Query: 354 RILGRGAFGNVYKAYF-----ASSGSV-AAVK--RSKHSHEGKTEFLAELSIIACLRHKN 405
LG GAFG VY+ SG + AVK R + + K EFL E +++ H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQ---DSENGVLLSWYHRLNIVVGLASALT 462
+V+LLG C ++ E M G L L + LL+ L+I + +A
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAGTMG------------------ 504
YL Q IHRD+ A N ++ ++ + G G
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEK---GYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 505 ----YLAPEYLQYGTATEKTDVFSYGVVVLEV-ACGRRPIERETEGHKMVNLVDWVWGLY 559
++APE L G T ++DV+S+GV++ E+ G++P ++ V
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY----PALNNQEVLQHV---T 227
Query: 560 AEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
A GR+ + + D++ +L+ +C D S RP+ R+ +IL N
Sbjct: 228 AGGRLQKPEN-------CPDKIYQLM---TNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 28/210 (13%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGS----VAAVK--RSKHSHEGKTEFLAELSIIACLRH 403
F ++LG GAFG VYK + G A+K R S + E L E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 404 KNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
++ +LLG C + L+ + MP G L + + +N + + LN V +A + Y
Sbjct: 69 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNY 124
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARL------------ESSFTLTAGT--MGYLAPE 509
L E++++HRD+ A N+++ + ++ E + G + ++A E
Sbjct: 125 LE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 510 YLQYGTATEKTDVFSYGVVVLEVAC-GRRP 538
+ + T ++DV+SYGV V E+ G +P
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 354 RILGRGAFGNVYKAYF-----ASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLV 407
R LG GAFG V+ A + AVK K S + +F E ++ L+H+++V
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL---------LSWYHRLNIVVGLA 458
+ G C E L++V+EYM +G L++ L + VL L+ L+I +A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 459 SALTYLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLTAGTM---G 504
+ + YL Q +HRD+ N ++ N ++ + + TM
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 505 YLAPEYLQYGTATEKTDVFSYGVVVLEV-ACGRRP 538
++ PE + Y T ++DV+S GVV+ E+ G++P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 356 LGRGAFGNVYKAYFA-----SSGSVAAVKRSKHSHE-GKTEFLAELSIIACLRHKNLVQL 409
LG GAFG V+ A + AVK K + E + +F E ++ L+H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL-----------LSWYHRLNIVVGLA 458
G C E LL+V+EYM +G L+R L + + L+ L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 459 SALTYLHQECEQQVIHRDIKASNIML---------DANFNARLESS--FTLTAGTM---G 504
S + YL +HRD+ N ++ D + + S+ + + TM
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 505 YLAPEYLQYGTATEKTDVFSYGVVVLEV-ACGRRP 538
++ PE + Y T ++D++S+GVV+ E+ G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 38/225 (16%)
Query: 358 RGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWC 413
+GAFG+VY A S+G A+K K S T AE +I+ V L +
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 414 AEKGE-LLLVYEYMPNG---SLDRMLYQDSENGVL-LSWYHRLNIVVGLASALTYLHQEC 468
+ + L LV EY+ G SL + L G L W + + + LHQ
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTL------GGLPEDWAK--QYIAEVVLGVEDLHQ-- 115
Query: 469 EQQVIHRDIKASNIMLDANFNARLESSFTLT---------AGTMGYLAPEYLQYGTATEK 519
+ +IHRDIK N+++D + +L + F L+ GT YLAPE + +
Sbjct: 116 -RGIIHRDIKPENLLIDQTGHLKL-TDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKM 173
Query: 520 TDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564
+D +S G V+ E G P ET D V+ RI
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAET--------PDAVFDNILSRRI 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 32/205 (15%)
Query: 355 ILGRGAFGNVYKAYF-----ASSGSVAAVKRSKHSHEGK--TEFLAELSIIACLRHKNLV 407
LGRG FG V+ A ++ VK + + + +EF EL + L HKN+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL------LSWYHRLNIVVGLASAL 461
+LLG C E ++ EY G L + L + +++ LS ++ + +A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFL-RATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 462 TYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAGT--------------MGYLA 507
+L + +HRD+ A N ++ + ++ S +L+ + +LA
Sbjct: 131 DHLSN---ARFVHRDLAARNCLVSSQREVKV-SLLSLSKDVYNSEYYKLRNALIPLRWLA 186
Query: 508 PEYLQYGTATEKTDVFSYGVVVLEV 532
PE +Q + K+DV+S+GV++ EV
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 29/200 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA-ELSIIACLRHKNLVQLLGWCA 414
+G+GA G VY A ++G A+K+ + K E + E+ ++ +H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDS-ENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
EL +V EY+ GSL ++ + + G + + + AL +LH QVI
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS---NQVI 137
Query: 474 HRDIKASNIML---------DANFNARL---ESSFTLTAGTMGYLAPEYL---QYGTATE 518
HRDIK+ NI+L D F A++ +S + GT ++APE + YG
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP--- 194
Query: 519 KTDVFSYGVVVLEVACGRRP 538
K D++S G++ +E+ G P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 53/289 (18%)
Query: 354 RILGRGAFGNV----YKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLV 407
R+LG G FG V Y +G + AVK + + + + + E++I+ L H+N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 408 QLLGWCAEKGE--LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+ G C+E+G L L+ EY+P GSL L + + LA L +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---------------LNLAQLLLFAQ 114
Query: 466 QECE-------QQVIHRDIKASNIMLDANFNARLES--SFTLT----AGTMGY------- 505
Q CE Q IHRD+ A N++LD N RL F L G Y
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 506 -----LAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA 560
A E L+ + +DV+S+GV + E+ +++ K ++ G
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDS--KQSPPKKFEEMIGPKQGQMT 229
Query: 561 EGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609
R+IE ++ + ++ + + ++ +C ++ RP+ R + IL
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
R+LG+GAFG S+ K ++ S + + + L E+ I++ L+H N++
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
+ LL+ EY G+L + + + G L L + + SA++Y+H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAVSYIHKA--- 120
Query: 471 QVIHRDIKASNIML---------DANFNARLESSFTLT---AGTMGYLAPEYLQYGTATE 518
++HRDIK NI L D + L S +++ GT Y++PE Q
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 519 KTDVFSYGVVVLEVACGRRPIE 540
K+D+++ G V+ E+ +R +
Sbjct: 181 KSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 22/192 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+GRG FG V+ + + AVK R + K +FL E I+ H N+V+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+K + +V E + G L + G L + +V A+ + YL + I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 474 HRDIKASNIMLD-------ANFNARLESSFTLTAGTMG-------YLAPEYLQYGTATEK 519
HRD+ A N ++ ++F E + A T G + APE L YG + +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 520 TDVFSYGVVVLE 531
+DV+S+G+++ E
Sbjct: 177 SDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 32/200 (16%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCA 414
LG GAFG VYKA +G +AA K S E +++ E+ I+A H N+V+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 415 EKGELLLVYEYMPNGSLDRMLYQ----DSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
+ L ++ E+ G++D ++ + +E + + L AL YLH E
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE-------ALNYLH---EN 122
Query: 471 QVIHRDIKASNIMLD-------ANFNARLESSFTLT-----AGTMGYLAPEYLQYGTATE 518
++IHRD+KA NI+ A+F +++ T+ GT ++APE + T+ +
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 519 -----KTDVFSYGVVVLEVA 533
K DV+S G+ ++E+A
Sbjct: 183 RPYDYKADVWSLGITLIEMA 202
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 25/198 (12%)
Query: 353 NRILGRGAFGNVYKAYFASSGSVA---AVKRSKHSHEG--KTEFLAELSIIACLRHKNLV 407
R +G G FG+VY+ + S + AVK K+ + +FL E I+ H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+L+G E + +V E P G L L + + L S + L++AL YL
Sbjct: 71 KLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASL---ILYSYQLSTALAYLES- 125
Query: 468 CEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLTAGTM--GYLAPEYLQYG 514
++ +HRDI A N+++ + +L ES + + G + ++APE + +
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 515 TATEKTDVFSYGVVVLEV 532
T +DV+ +GV + E+
Sbjct: 184 RFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 47/211 (22%)
Query: 354 RILGRGAFGNVYKAY---FASSGSVAAV-----KRSKHSHEGKTEFLAELSIIACL-RHK 404
+ LG GAFG V +A + S +V V K + HS E + ++EL I++ L H+
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE-REALMSELKIMSHLGNHE 99
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
N+V LLG C G +L++ EY G L L + E L+ L+ +A + +L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFL 157
Query: 465 HQECEQQVIHRDIKASN-------------------IMLDANF----NARLESSFTLTAG 501
+ IHRD+ A N IM D+N+ NARL
Sbjct: 158 ---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--------- 205
Query: 502 TMGYLAPEYLQYGTATEKTDVFSYGVVVLEV 532
+ ++APE + T ++DV+SYG+++ E+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 48/221 (21%)
Query: 354 RILGRGAFGNVYKAYFASSGSV-------AAVKRSKH--SHEGKTEFLAELSIIACLRHK 404
R +G+GAFG V++A + G + AVK K S + + +F E +++A H
Sbjct: 11 RDIGQGAFGRVFQA--RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDS------------------ENGVLLS 446
N+V+LLG CA + L++EYM G L+ L S N + LS
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 447 WYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT------- 499
+L I +A+ + YL E++ +HRD+ N ++ N ++ + F L+
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKI-ADFGLSRNIYSAD 184
Query: 500 --------AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEV 532
A + ++ PE + Y T ++DV++YGVV+ E+
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 36/218 (16%)
Query: 354 RILGRGAFGNVYKA--YFASSGS---VAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLV 407
R LG GAFG V+ A Y S + AVK K + +F E ++ L+H+++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL------------LSWYHRLNIVV 455
+ G C + L++V+EYM +G L++ L + ++ L L+I
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL----------ESSFTLTAG-TM- 503
+AS + YL Q +HRD+ N ++ AN ++ + + G TM
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 504 --GYLAPEYLQYGTATEKTDVFSYGVVVLEV-ACGRRP 538
++ PE + Y T ++DV+S+GV++ E+ G++P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK-----RSKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
LG+G FG V ++G + A K R K +G+ L E I+ + + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLS--WYHRLNIVVGLASALTYLHQEC 468
K +L LV M G L +Y E G + ++ I+ GL +LHQ
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL----EHLHQR- 114
Query: 469 EQQVIHRDIKASNIMLDANFNARL-----------ESSFTLTAGTMGYLAPEYLQYGTAT 517
++++RD+K N++LD + N R+ AGT GY+APE LQ
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172
Query: 518 EKTDVFSYGVVVLEVACGRRPIERETE 544
D F+ G + E+ GR P + E
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 35/276 (12%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSK----HSHEGKTEFLAELSIIACLRHKN 405
F + +GRG F VY+A A+K+ + + + + + E+ ++ L H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+++ L E EL +V E G L +M+ + L+ V L SA+ ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 466 QECEQQVIHRDIKASNIMLDANFNARLE--------SSFTLTA----GTMGYLAPEYLQY 513
++V+HRDIK +N+ + A +L SS T A GT Y++PE +
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD-KRL 572
K+D++S G ++ E+A + P G KM L++ + IE D L
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPF----YGDKM--------NLFSLCQKIEQCDYPPL 228
Query: 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608
++++ L+ + C PD RP + V QI
Sbjct: 229 PTEHYSEKLRELVSM---CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSK---HSHEGKTEFLA---ELSIIACLRHKNLV 407
++LG+GAFG VY Y +G A K+ + S E E A E+ ++ L+H+ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 408 QLLGWCAEKGE--LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
Q G ++ E L + EYMP GS+ L G L R + ++YLH
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTR-KYTRQILEGMSYLH 123
Query: 466 QECEQQVIHRDIKASNIMLDANFNARL---------------ESSFTLTAGTMGYLAPEY 510
++HRDIK +NI+ D+ N +L + GT +++PE
Sbjct: 124 S---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 511 LQYGTATEKTDVFSYGVVVLEVACGRRP 538
+ K DV+S G V+E+ + P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 41/221 (18%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFL-AELSIIACLRHKNLVQLLGWCA 414
+G G+ G V A S+G AVK+ + + E L E+ I+ +H N+V++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN------IVVGLASALTYLHQEC 468
EL +V E++ G+L ++ R+N + + + AL++LH
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHT-----------RMNEEQIATVCLAVLKALSFLHA-- 133
Query: 469 EQQVIHRDIKASNIMLDANFNARLESSFTLTA-------------GTMGYLAPEY---LQ 512
Q VIHRDIK+ +I+L ++ +L S F A GT ++APE L
Sbjct: 134 -QGVIHRDIKSDSILLTSDGRVKL-SDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVD 553
YGT + D++S G++V+E+ G P E M + D
Sbjct: 192 YGT---EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 28/200 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGW 412
LG G G+V K +G+V A K+ H + + L EL I+ R +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASA----LTYLHQEC 468
+ + + E+M GSLDR+ + G + + I+ +A A LTYL+
Sbjct: 72 FLNENNICMCMEFMDCGSLDRIY---KKGGPI-----PVEILGKIAVAVVEGLTYLYNV- 122
Query: 469 EQQVIHRDIKASNIML---------DANFNARLESSFTLT-AGTMGYLAPEYLQYGTATE 518
+++HRDIK SNI++ D + L +S T GT Y++PE +Q G T
Sbjct: 123 -HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 519 KTDVFSYGVVVLEVACGRRP 538
K+DV+S G+ ++E+A G+ P
Sbjct: 182 KSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 354 RILGRGAFGNVYKAYFA--SSGSV---AAVK---RSKHSHEGKTEFLAELSIIACLRHKN 405
R LG+G+FG VY+ G A+K + E + EFL E S++ +
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE-RIEFLNEASVMKEFNCHH 70
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLD---RMLYQDSENGVLLSWYHR---LNIVVGLAS 459
+V+LLG + L+V E M G L R ++EN L + + +A
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT----------AGTMGYL--- 506
+ YL ++ +HRD+ A N M+ + ++ F +T G G L
Sbjct: 131 GMAYLA---AKKFVHRDLAARNCMVAEDLTVKI-GDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 507 --APEYLQYGTATEKTDVFSYGVVVLEVA 533
APE L+ G T K+DV+S+GVV+ E+A
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 32/209 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLA---ELSIIACLRHKNLV 407
++LGRGAFG VY Y A +G AVK+ S E E A E+ ++ LRH +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 408 QLLGWC---AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
Q G C E+ +L + EYMP GS+ L G L R + ++YL
Sbjct: 68 QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTR-RYTRQILQGVSYL 122
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARL---------------ESSFTLTAGTMGYLAPE 509
H ++HRDIK +NI+ D+ N +L + GT +++PE
Sbjct: 123 HS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 510 YLQYGTATEKTDVFSYGVVVLEVACGRRP 538
+ K DV+S V+E+ + P
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 25/198 (12%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA--EL-SIIACLRHKNLVQLLGW 412
LG G FG+VY A +G + A+K+ K E + E+ S+ H N+V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQ--DSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
E EL V+EYM + LYQ G S +I+ + L ++H+
Sbjct: 67 FRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---H 118
Query: 471 QVIHRDIKASNIMLDANFN--------AR-LESSFTLTA--GTMGYLAPE-YLQYGTATE 518
HRD+K N+++ AR + S T T Y APE L+ + +
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSS 178
Query: 519 KTDVFSYGVVVLEVACGR 536
D+++ G ++ E+ R
Sbjct: 179 PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415
LG+G FG V+ + + VA +K K FL E I+ LRH LV L +E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVA-IKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHR 475
+ + +V E+M GSL L + +G L +++ +A + Y+ + IHR
Sbjct: 73 E-PIYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126
Query: 476 DIKASNIMLDANFN--------ARL--ESSFTLTAGT---MGYLAPEYLQYGTATEKTDV 522
D++A+NI++ N ARL ++ +T G + + APE YG T K+DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 523 FSYGVVVLE-VACGRRP---------IERETEGHKM 548
+S+G+++ E V GR P +E+ G++M
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 31/208 (14%)
Query: 354 RILGRGAFGNVYKAYF----ASSGSVA--AVKRSKHSHEGKTEFLAELSIIACLRHKNLV 407
+ILG G FG+V + S VA +K H++ EFL+E + + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 408 QLLGWCAEKGEL------LLVYEYMPNGSLDRMLYQD--SENGVLLSWYHRLNIVVGLAS 459
+L+G C E L +++ +M +G L L L L +V +A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFN---ARLESSFTLTAGT-----------MGY 505
+ YL + IHRD+ A N ML + A S + +G + +
Sbjct: 125 GMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 506 LAPEYLQYGTATEKTDVFSYGVVVLEVA 533
+A E L T K+DV+++GV + E+A
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 73/285 (25%), Positives = 125/285 (43%), Gaps = 55/285 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA---ELSIIACLRHKNLVQLL 410
R++GRGAFG V+ + + +K+ K E LA E ++ L H N+++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
E L++V EY P G+L + Q N LL L+ V + AL ++H +
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYI-QKRCNS-LLDEDTILHFFVQILLALHHVHT---K 120
Query: 471 QVIHRDIKASNIMLDANFNARLESSFTLT------------AGTMGYLAPEYLQYGTATE 518
++HRD+K NI+LD + F ++ GT Y++PE + +
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 519 KTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN- 577
K+D+++ G V+ E+A ++R E + LV K ++G F
Sbjct: 181 KSDIWALGCVLYELA----SLKRAFEAANLPALV----------------LKIMSGTFAP 220
Query: 578 -----EDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLV 617
++++L+ LS N D S RP + QI+ A+P+
Sbjct: 221 ISDRYSPDLRQLI---LSMLNLDPSKRPQLS---QIM---AQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 31/200 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG---KTEFLAELSIIACLRHKNLVQLLGW 412
+G G++G V+K +G + A+K+ S + K L E+ ++ L+H NLV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
K +L LV+EY + L+ + + + GV + I+ A+ + H+
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNEL--EKNPRGV--PEHLIKKIIWQTLQAVNFCHK---HNC 121
Query: 473 IHRDIKASNIML---------DANFNARL----ESSFTLTAGTMGYLAPEYL----QYGT 515
IHRD+K NI++ D F AR+ +T T Y APE L QYG
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGF-ARILTGPGDDYTDYVATRWYRAPELLVGDTQYGP 180
Query: 516 ATEKTDVFSYGVVVLEVACG 535
DV++ G V E+ G
Sbjct: 181 P---VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-14
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA--AVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
+ LG G FG V+ + + VA A+ S E +F+ E ++ L H LVQL G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYG 66
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
C ++ L +V E+M NG L L Q G LS L++ + + YL +
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQ--RQGK-LSKDMLLSMCQDVCEGMEYLER---NS 120
Query: 472 VIHRDIKASNIMLDA-------NFN-AR--LESSFTLTAGT---MGYLAPEYLQYGTATE 518
IHRD+ A N ++ + +F R L+ +T ++G + + PE + +
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 519 KTDVFSYGVVVLEVAC-GRRPIERET 543
K+DV+S+GV++ EV G+ P E+++
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 45/217 (20%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEF----LAELSIIACLRHKNLVQL- 409
+G G +G VYKA +G + A+K+ + +E K F + E+ I+ L H+N+V L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 410 ---------LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENG-VLLSWYHRLNIVVGLAS 459
L + +KG LV+EYM D L E+G V S H + + L
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLD-------ANFN-ARLESS-----FTLTAGTMGYL 506
L Y H+ + +HRDIK SNI+L+ A+F ARL +S +T T+ Y
Sbjct: 128 GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 507 APEYL----QYGTATEKTDVFSYGVVVLEVACGRRPI 539
PE L +YG A DV+S G ++ E+ ++PI
Sbjct: 185 PPELLLGEERYGPA---IDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 64/203 (31%), Positives = 90/203 (44%), Gaps = 29/203 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR----SKHSHEGKTEFLAELSIIACLRHKNLVQL 409
R +G G+FG VY A + V A+K+ K S+E + + E+ + LRH N ++
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVV---GLASALTYLHQ 466
G + LV EY GS +L V + I G L YLH
Sbjct: 81 KGCYLREHTAWLVMEYCL-GSASDIL------EVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 467 ECEQQVIHRDIKASNIMLD-------ANF-NARLESSFTLTAGTMGYLAPEY---LQYGT 515
IHRDIKA NI+L A+F +A L S GT ++APE + G
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQ 190
Query: 516 ATEKTDVFSYGVVVLEVACGRRP 538
K DV+S G+ +E+A R+P
Sbjct: 191 YDGKVDVWSLGITCIELA-ERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE----FLAELSIIACLRHKN 405
F ++GRG FG V ++G + A+K K S E F E I++
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRML--YQDSENGVLLSWYHRLNIVVGLASALTY 463
+ QL +K L LV EY P G L +L Y+D + + +Y LA +
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--------LAELVLA 114
Query: 464 LHQECEQQVIHRDIKASNIMLD-------ANFN--ARLESSFTLTA----GTMGYLAPEY 510
+H + +HRDIK N+++D A+F ARL ++ + + GT Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 511 LQ----YGTATE--KTDVFSYGVVVLEVACGRRPIERET 543
L G T + D +S GV+ E+ GR P T
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 70/256 (27%), Positives = 104/256 (40%), Gaps = 65/256 (25%)
Query: 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEF----LAELSIIAC 400
S R + LG G FG VYKA +G V A+K+ +E K F L E+ I+
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKK 63
Query: 401 LRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDR------MLYQDSE-NGVL------LSW 447
L+H N+V L+ + E R Y D + +G+L L+
Sbjct: 64 LKHPNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTE 114
Query: 448 YHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD-------ANFN-ARL------- 492
++ L + YLH E ++HRDIKA+NI++D A+F AR
Sbjct: 115 SQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171
Query: 493 --------ESSFTLTAGTMGYLAPEYL----QYGTATEKTDVFSYGVVVLEVACGRRPI- 539
+T T Y PE L +Y TA D++ G V E+ RRPI
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA---VDIWGIGCVFAEMF-TRRPIL 227
Query: 540 ERETE---GHKMVNLV 552
+ +++ H + L
Sbjct: 228 QGKSDIDQLHLIFKLC 243
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 71/288 (24%), Positives = 115/288 (39%), Gaps = 64/288 (22%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSK----------HSHEGKTEFLAELSIIACLRHKN 405
LG+G F N+YK + V + H F S+++ L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
LV+L G C E ++V EY+ G LD L +N V L W +L++ LASAL YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFL-HREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 466 QECEQQVIHRDIKASNIMLDANFNARLESS-------------FTLTAGTMGY------- 505
+++++H ++ NI++ AR + +T +
Sbjct: 119 ---DKKLVHGNVCGKNILV-----ARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPW 170
Query: 506 LAPEYLQYGTA--TEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEG 562
+APE ++ G A T D +S+G +LE+ G P+ + K Y +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER--------FYQDQ 222
Query: 563 RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610
+ D E+ L+ C D + RPS R + + LN
Sbjct: 223 HRLPMPD--------CAELANLI---NQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
+G G+FG G +K SK S + + E E+++++ ++H N+VQ
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
E G L +V +Y G L + + +++ GVL L+ V + AL ++H ++++
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVH---DRKI 122
Query: 473 IHRDIKASNIML---------DANFNARLESSFTLT---AGTMGYLAPEYLQYGTATEKT 520
+HRDIK+ NI L D L S+ L GT YL+PE + K+
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKS 182
Query: 521 DVFSYGVVVLEVACGRRPIERETEGHKMVNLV 552
D+++ G V+ E+ ++ E M NLV
Sbjct: 183 DIWALGCVLYEMCT----LKHAFEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 33/206 (16%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE----FLA--ELSIIACLRHKNLVQL 409
LG G + VYKA +G + A+K+ K + + F A E+ ++ L+H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
L K + LV+E+M L + +D ++L+ + ++ L YLH
Sbjct: 68 LDVFGHKSNINLVFEFME-TDL-EKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH---S 120
Query: 470 QQVIHRDIKASNIMLDAN-------FN-ARLESS----FTLTAGTMGYLAPEYL----QY 513
++HRD+K +N+++ ++ F AR S T T Y APE L Y
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHY 180
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPI 539
G D++S G + E+ R P
Sbjct: 181 GVG---VDMWSVGCIFAEL-LLRVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 356 LGRGAFGNVY--------------KAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIA 399
LG G FG V+ F + AVK R+ + + +FL E+ I++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 400 CLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQ--------DSENGVLLSWYHRL 451
L++ N+++LLG C L ++ EYM NG L++ L Q + N +S + L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 452 NIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES---SFTLTAGT------ 502
+ V +AS + YL +HRD+ N ++ ++ ++ S L +G
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 503 -----MGYLAPEYLQYGTATEKTDVFSYGVVVLEV--ACGRRP 538
+ ++A E + G T +DV+++GV + E+ C +P
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA-ELSIIACLRHKNLVQLLGWCA 414
+G+GA G V+ A ++G A+K+ + K E + E+ ++ L++ N+V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
EL +V EY+ GSL ++ + + ++ R + AL +LH QVIH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHA---NQVIH 138
Query: 475 RDIKASNIML---------DANFNARL---ESSFTLTAGTMGYLAPEYLQYGTATEKTDV 522
RDIK+ N++L D F A++ +S + GT ++APE + K D+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 523 FSYGVVVLEVACGRRPIERE 542
+S G++ +E+ G P E
Sbjct: 199 WSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 40/209 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG--KTEFLAELSIIACLRHKNLVQLLG 411
+G GA G VYK +G + A+K +HE + + E+ I+ + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 412 WCAEKGELLLVYEYMPNGSLD-RMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
GE+ ++ E+M GSL+ + + L+ R I+ G+A YLH+ +
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQF----LADVAR-QILSGIA----YLHR---R 187
Query: 471 QVIHRDIKASNIMLDANFNARLESSFTL-------------TAGTMGYLAPEYLQY---- 513
++HRDIK SN+++++ N ++ + F + + GT+ Y++PE +
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKI-ADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNH 246
Query: 514 ----GTATEKTDVFSYGVVVLEVACGRRP 538
G A D++S GV +LE GR P
Sbjct: 247 GAYDGYA---GDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSV----AAVK--RSKHSHEGKTEFLAELSIIACLRHKNLV 407
++LG G FG V+K + G A+K + + + E + + L H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+LLG C L LV + P GSL + Q ++ L LN V +A + YL
Sbjct: 73 RLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDS---LDPQRLLNWCVQIAKGMYYLE-- 126
Query: 468 CEQQVIHRDIKASNIMLDANFNARL--------------ESSFTLTAGTMGYLAPEYLQY 513
E +++HR++ A NI+L ++ ++ + ++ + ++A E + +
Sbjct: 127 -EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 514 GTATEKTDVFSYGVVVLEV 532
G T ++DV+SYGV V E+
Sbjct: 186 GRYTHQSDVWSYGVTVWEM 204
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 68/284 (23%), Positives = 125/284 (44%), Gaps = 54/284 (19%)
Query: 356 LGRGAFGNVYKAYFASSG----SVAAVKRSK--HSHEGKTEFLAELSIIACLRHKNLVQL 409
LG AFG +YK + G + A+K K ++ + EF E S++A L H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDS----------ENGVLLSWYHR---LNIVVG 456
LG ++ + +++EY+ G L L S E+G + S L+I +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 457 LASALTYLHQECEQQVIHRDIKASNIML---------DANFNARLESS--FTLTAGTM-- 503
+A+ + YL +H+D+ A NI++ D + + S+ + + ++
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 504 -GYLAPEYLQYGTATEKTDVFSYGVVVLEV-ACGRRPIERETEGHKMVNLVDWVWGLYAE 561
++ PE + YG + +D++S+GVV+ E+ + G +P +G ++
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP----------------YYG-FSN 232
Query: 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRV 605
+IE KR +ED R+ + C S RP + +
Sbjct: 233 QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 29/200 (14%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
++G G++G V K +G + A+K+ S+ K + E+ ++ LRH+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
K L LV+E++ + LD + + NG+ S + + + + + H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVRK--YLFQILRGIEFCHS---HN 120
Query: 472 VIHRDIKASNIML---------DANFNARLES---SFTLTAGTMGYLAPEYL----QYGT 515
+IHRDIK NI++ D F L + +T T Y APE L +YG
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 516 ATEKTDVFSYGVVVLEVACG 535
A D+++ G +V E+ G
Sbjct: 181 A---VDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKR----SKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
+G G+FG VY A + + V AVK+ K ++E + + E+ + L+H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
++ LV EY + D + L I G L YLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 472 VIHRDIKASNIMLD-------ANF-NARLESSFTLTAGTMGYLAPEY---LQYGTATEKT 520
+IHRDIKA NI+L A+F +A S GT ++APE + G K
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKV 201
Query: 521 DVFSYGVVVLEVACGRRP 538
DV+S G+ +E+A R+P
Sbjct: 202 DVWSLGITCIELA-ERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 44/207 (21%)
Query: 356 LGRGAFGNV----YKAYFASSGSVAAVKRSKHSHEGKTE-FLAELSIIACLRHKNLVQLL 410
LG+G FG+V Y ++G V AVK+ +HS F E+ I+ L+H N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 411 GWCAEKG--ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
G C G L LV EY+P GSL L + RL+ L Y Q C
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR---------ERLD----HRKLLLYASQIC 118
Query: 469 -------EQQVIHRDIKASNIMLDANFNARLESSFTLTA----------------GTMGY 505
++ +HRD+ NI++++ ++ F LT + +
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKI-GDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 506 LAPEYLQYGTATEKTDVFSYGVVVLEV 532
APE L + +DV+S+GVV+ E+
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 29/199 (14%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
ILG G G VYKAY + + AVK + E + + ++EL I+ ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
+ + + E+M GSLD +Y+ VL I V + LTYL ++
Sbjct: 68 FFVENRISICTEFMDGGSLD--VYRKIPEHVL------GRIAVAVVKGLTYLWS---LKI 116
Query: 473 IHRDIKASNIML---------DANFNARLESSFTLT-AGTMGYLAPEYL---QYGTATEK 519
+HRD+K SN+++ D + +L +S T GT Y+APE + QYG
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGI---H 173
Query: 520 TDVFSYGVVVLEVACGRRP 538
+DV+S G+ +E+A GR P
Sbjct: 174 SDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 30/202 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTE--FLAELSIIACLRHKNLVQLLG 411
LG G FG V S A+K K H E + +E I+ H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
+K + ++ EY G L +L + G L Y + + A YLH +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR---DRG-LFDEYTARFYIACVVLAFEYLH---NRG 113
Query: 472 VIHRDIKASNIMLDAN---------FNARLES---SFTLTAGTMGYLAPEYLQ---YGTA 516
+I+RD+K N++LD+N F +L+S ++T GT Y+APE + Y +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF-CGTPEYVAPEIILNKGYDFS 172
Query: 517 TEKTDVFSYGVVVLEVACGRRP 538
D +S G+++ E+ GR P
Sbjct: 173 ---VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 8e-13
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 41/214 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR----SKHSHEGKTEFLAELSIIACLRHKNLVQL 409
+ +G GA+G V A +G A+K+ + K L E+ ++ LRH+N++ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK-RILREIKLLRHLRHENIIGL 64
Query: 410 L-----GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
L + ++ +V E M L +++ L+ H + + L YL
Sbjct: 65 LDILRPPSPEDFNDVYIVTELMET-DLHKVIKS----PQPLTDDHIQYFLYQILRGLKYL 119
Query: 465 HQECEQQVIHRDIKASNIMLDAN-------FN-ARLESSFTLTAGTMG-------YLAPE 509
H VIHRD+K SNI++++N F AR G + Y APE
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 510 YL----QYGTATEKTDVFSYGVVVLEVACGRRPI 539
L +Y A D++S G + E+ R+P+
Sbjct: 177 LLLSSSRYTKA---IDIWSVGCIFAELL-TRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 20/204 (9%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLG 411
LG+G FG V ++G + A K+ G+ L E I+ + +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
K L LV M G L +Y E G+ + ++ + + +LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME--RVIHYSAQITCGILHLH---SMD 115
Query: 472 VIHRDIKASNIMLDANFNARLE-----------SSFTLTAGTMGYLAPEYLQYGTATEKT 520
+++RD+K N++LD N RL + T AGT GY+APE L+ +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 521 DVFSYGVVVLEVACGRRPIERETE 544
D F+ G + E+ GR P + E
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 44/216 (20%)
Query: 354 RILGRGAFGNVYKAYFASSGS-----VA-AVKRSKHSHEGKTEFLAELSIIACLRHKNLV 407
++LG GAFG VYK + G VA V R S + E L E ++A + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 408 QLLGWCAEKGELLLVYEYMPNGSL--------DRMLYQDSENGVLLSWYHRLNIVVGLAS 459
+LLG C + LV + MP G L DR+ QD LL+W V +A
Sbjct: 73 RLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQD-----LLNW------CVQIAK 120
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDA-------NFN-ARL----ESSFTLTAGT--MGY 505
++YL E +++HRD+ A N+++ + +F ARL E+ + G + +
Sbjct: 121 GMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 506 LAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIE 540
+A E + + T ++DV+SYGV V E+ G +P +
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 36/214 (16%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTE-FLAELSIIACLR-HKNLVQ 408
R+LG+G+FG V A SG + AVK K + E + E I++ R H L Q
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L L V E++ G L + + + ++ I SAL +LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----SALMFLH--- 113
Query: 469 EQQVIHRDIKASNIMLD-------ANF--------NARLESSFTLTAGTMGYLAPEYLQ- 512
++ +I+RD+K N++LD A+F N + S+F GT Y+APE LQ
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF---CGTPDYIAPEILQE 170
Query: 513 --YGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
YG + D ++ GV++ E+ CG P E E E
Sbjct: 171 MLYGPSV---DWWAMGVLLYEMLCGHAPFEAENE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 27/209 (12%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKR-------SKHSHEGKTEFLAELSIIACLRHKNLVQ 408
LG+G FG V ++G + A K+ + +EG + E I+A + + +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGA---MVEKRILAKVHSRFIVS 57
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L K +L LV M G L +Y E + S L +LHQ
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-- 115
Query: 469 EQQVIHRDIKASNIMLDANFNARLESSFTLT-------------AGTMGYLAPEYLQYGT 515
+++I+RD+K N++LD + N R+ S L AGT G++APE LQ
Sbjct: 116 -RRIIYRDLKPENVLLDNDGNVRI-SDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 516 ATEKTDVFSYGVVVLEVACGRRPIERETE 544
D F+ GV + E+ R P E
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 30/196 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKR--SKHSHEG-KTEFLAELSIIACLRHKNLVQLLGW 412
+G GA G V+KA +G A+K+ + G + L E+ + +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
+LV EYMP L +L +D E + + + L + Y+H +
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVKSYMRM--LLKGVAYMHAN---GI 120
Query: 473 IHRDIKASNIMLDAN-------------FNARLESSFTLTAGTMGYLAPEYL----QYGT 515
+HRD+K +N+++ A+ F+ ++ T Y APE L +Y
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 516 ATEKTDVFSYGVVVLE 531
D+++ G + E
Sbjct: 181 G---VDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSK---HSHEGKTEFLA---ELSIIACLRHKNLV 407
++LG+GAFG VY Y A +G AVK+ + S E E A E+ ++ L H+ +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 408 QLLGWCAEKGE--LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
Q G + E L + E+MP GS+ L G L R + ++YLH
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTR-KYTRQILEGVSYLH 123
Query: 466 QECEQQVIHRDIKASNIMLDANFNARL---------------ESSFTLTAGTMGYLAPEY 510
++HRDIK +NI+ D+ N +L + GT +++PE
Sbjct: 124 S---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 511 LQYGTATEKTDVFSYGVVVLEVACGRRP 538
+ K D++S G V+E+ + P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 21/196 (10%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA---ELSIIACLRHKNLVQLL 410
R++G+G++G V + G +K+ + + E A E +++ L+H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 411 -GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
W E G L +V + G L L + + G LL + V +A AL YLH E
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLH---E 120
Query: 470 QQVIHRDIKASNIML---------DANFNARLESSFTLTA---GTMGYLAPEYLQYGTAT 517
+ ++HRD+K N+ L D LE+ + + GT Y++PE
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYN 180
Query: 518 EKTDVFSYGVVVLEVA 533
K+DV++ G V E+A
Sbjct: 181 YKSDVWALGCCVYEMA 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 74/286 (25%), Positives = 121/286 (42%), Gaps = 54/286 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSV---AAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQ 408
R++G+G FG VY S AVK E +FL E I+ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 409 LLGWC-AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGL--ASALTYLH 465
LLG C +G L+V YM +G L + ++ N + I GL A + YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL- 114
Query: 466 QECEQQVIHRDIKASNIMLDANFNARLESSFTL---------------TAGTM--GYLAP 508
++ +HRD+ A N MLD +F ++ + F L T + ++A
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKV-ADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 509 EYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568
E LQ T K+DV+S+GV++ E+ P + + + + +GR
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-------LQGR----- 219
Query: 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPS----MRRVFQILN 610
+ L + D + ++ LSC +P RP+ + R+ QI +
Sbjct: 220 -RLLQPEYCPDPLYEVM---LSCWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 21/200 (10%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA-ELSIIACLRHKNLVQLLGWCA 414
+G+GA G VY A ++G A+K+ + K E + E+ ++ ++ N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
EL +V EY+ GSL ++ + + ++ R + AL +LH QVIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHS---NQVIH 138
Query: 475 RDIKASNIML---------DANFNARL---ESSFTLTAGTMGYLAPEYLQYGTATEKTDV 522
RDIK+ NI+L D F A++ +S + GT ++APE + K D+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 523 FSYGVVVLEVACGRRPIERE 542
+S G++ +E+ G P E
Sbjct: 199 WSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 51/182 (28%), Positives = 79/182 (43%), Gaps = 42/182 (23%)
Query: 391 FLAELSIIACLRHKNLVQLL--GWCAEKGELLLVYEYMPNGSLDRMLYQD-----SENGV 443
F E ++ A L H N+V LL G G L V+EY+P +L +L D E G
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAADGALPAGETGR 83
Query: 444 LLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA----------------- 486
L+ L ++ LA A H Q ++HRD+K NIM+
Sbjct: 84 LM-----LQVLDALACA----H---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTL 131
Query: 487 --NFNARLESSFTLTA---GTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIER 541
++ T T GT Y APE L+ T +D++++G++ LE G+R ++
Sbjct: 132 LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQG 191
Query: 542 ET 543
+
Sbjct: 192 AS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 75/312 (24%), Positives = 122/312 (39%), Gaps = 84/312 (26%)
Query: 356 LGRGAFGNVY--------------KAYFASSGSVA--AVK--RSKHSHEGKTEFLAELSI 397
LG G FG V+ A ++ + AVK R S + +FL E+ I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 398 IACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQ-------DSENGVLLSWYHR 450
++ L N+ +LLG C L ++ EYM NG L++ L + + N LS+
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 451 LNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-----------NA------RLE 493
L + +AS + YL +HRD+ N ++ N+ N R++
Sbjct: 133 LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 494 SSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVA--CGRRPIERETEGHKMVNL 551
L + ++A E + G T K+DV+++GV + E+ C +P E T+
Sbjct: 190 GRAPL---PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD------- 239
Query: 552 VDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLL------------VGLSCANPDSSAR 599
V IE A G F D+ +++ L + L C D R
Sbjct: 240 -QQV---------IENA-----GHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDR 284
Query: 600 PSMRRVFQILNN 611
P+ R + L
Sbjct: 285 PTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 31/222 (13%)
Query: 343 LRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL- 401
LR F ++G G +G VYK +G +AA+K + + + E E++++
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 402 RHKNLVQLLGWCAEKG------ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVV 455
H+N+ G +K +L LV E+ GS+ ++ N + W I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICR 118
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTA-------------GT 502
+ L++LHQ +VIHRDIK N++L N +L F ++A GT
Sbjct: 119 EILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKL-VDFGVSAQLDRTVGRRNTFIGT 174
Query: 503 MGYLAPEYLQY-----GTATEKTDVFSYGVVVLEVACGRRPI 539
++APE + T K+D++S G+ +E+A G P+
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE----FLAELSIIACL-RHKNLVQ 408
++LG+G+FG V A + + AVK K + + + E ++A +H L Q
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L K L V EY+ G L ++ +G + L +LH
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRF-DEPRARFYAAEIVLGLQFLH--- 113
Query: 469 EQQVIHRDIKASNIMLDANFNARLESSFTLT-------------AGTMGYLAPEYLQYGT 515
E+ +I+RD+K N++LD+ + ++ + F + GT Y+APE L Y
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKI-ADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP 172
Query: 516 ATEKTDVFSYGVVVLEVACGRRPIERETE 544
D ++ GV++ E+ G+ P E + E
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG---KTEFLAELSIIACLRHKNLVQLLG 411
++G GA+G V K + + A+K+ K S E K L EL ++ L+ +N+V+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
+G+L LV+EY+ L+ L ++ NGV + + L A+ + H+
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVR--SYIYQLIKAIHWCHK---ND 120
Query: 472 VIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATE 518
++HRDIK N+++ N +L +++T T Y +PE L +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 519 KTDVFSYGVVVLEVACGRRPIERETE 544
D++S G ++ E++ G+ E+E
Sbjct: 181 AVDMWSVGCILGELSDGQPLFPGESE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 35/224 (15%)
Query: 343 LRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL- 401
LR F ++G G +G VYK +G +AA+K + + + E E++++
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS 70
Query: 402 RHKNLVQLLGWCAEKG------ELLLVYEYMPNGSLDRMLYQDSENGVLLSW--YHRLNI 453
H+N+ G +K +L LV E+ GS+ ++ N + W Y I
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130
Query: 454 VVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTA------------- 500
+ GLA +LH +VIHRDIK N++L N +L F ++A
Sbjct: 131 LRGLA----HLHA---HKVIHRDIKGQNVLLTENAEVKL-VDFGVSAQLDRTVGRRNTFI 182
Query: 501 GTMGYLAPEYLQY-----GTATEKTDVFSYGVVVLEVACGRRPI 539
GT ++APE + T ++D++S G+ +E+A G P+
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFL-AELSIIACLRHKNLVQLLGWCA 414
+G G+ G V A SG AVK + + E L E+ I+ +H+N+V++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
EL ++ E++ G+L ++ Q L+ + + AL YLH Q VIH
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHS---QGVIH 140
Query: 475 RDIKASNIMLDANFNARLESSFTLTA-------------GTMGYLAPEYLQYGTATEKTD 521
RDIK+ +I+L + +L S F A GT ++APE + + D
Sbjct: 141 RDIKSDSILLTLDGRVKL-SDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 522 VFSYGVVVLEVACGRRPIERETEGHKMVNLVD 553
++S G++V+E+ G P ++ M L D
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD 231
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 32/210 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLG--W 412
+G+G +G VYK GS+AAVK + E AE +I+ L H N+V+ G +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 413 CAEK---GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN---IVVGLASALTYLHQ 466
A+K G+L LV E GS+ ++ LL RL+ I L AL L
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKG------LLICGQRLDEAMISYILYGALLGLQH 143
Query: 467 ECEQQVIHRDIKASNIML---------DANFNARLESS---FTLTAGTMGYLAPEYL--- 511
++IHRD+K +NI+L D +A+L S+ + GT ++APE +
Sbjct: 144 LHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203
Query: 512 -QYGTATE-KTDVFSYGVVVLEVACGRRPI 539
QY + + + DV+S G+ +E+ G P+
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 23/197 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFL-AELSIIACLRHKNLVQLLGWCA 414
+G G+ G V A SSG + AVK+ + + E L E+ I+ +H+N+V++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
EL +V E++ G+L ++ N ++ + + + AL+ LH Q VIH
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVIH 139
Query: 475 RDIKASNIMLDANFNARLESSFTLTA-------------GTMGYLAPEYLQYGTATEKTD 521
RDIK+ +I+L + +L S F A GT ++APE + + D
Sbjct: 140 RDIKSDSILLTHDGRVKL-SDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 522 VFSYGVVVLEVACGRRP 538
++S G++V+E+ G P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 31/213 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK----RSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
+ +GA+G V+ A S+G + A+K + L E I++ + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
K L LV EY+P G L +L EN L + + AL YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLL----ENVGSLDEDVARIYIAEIVLALEYLHS---NG 113
Query: 472 VIHRDIKASNIMLDANFNARLE----SSFTLT----------------AGTMGYLAPEYL 511
+IHRD+K NI++D+N + +L S L GT Y+APE +
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
++ D +S G ++ E G P ET
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 28/196 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGK---TEFLAELSIIACLRHKNLVQLLGW 412
+G G +G VYKA +G V A+K+ + E + + + E+S++ L H N+V+LL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
+ +L LV+E++ D + D+ + + + L L + H +V
Sbjct: 68 IHTENKLYLVFEFL---HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRV 121
Query: 473 IHRDIKASNIMLDANFNARLES------------SFTLTAGTMGYLAPEYL----QYGTA 516
+HRD+K N++++ +L ++T T+ Y APE L Y TA
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 181
Query: 517 TEKTDVFSYGVVVLEV 532
D++S G + E+
Sbjct: 182 ---VDIWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 4e-12
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 21/200 (10%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA-ELSIIACLRHKNLVQLLGWCA 414
+G+GA G VY A ++G A+++ + K E + E+ ++ ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
EL +V EY+ GSL ++ + + ++ R + AL +LH QVIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHS---NQVIH 139
Query: 475 RDIKASNIML---------DANFNARL---ESSFTLTAGTMGYLAPEYLQYGTATEKTDV 522
RDIK+ NI+L D F A++ +S + GT ++APE + K D+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 523 FSYGVVVLEVACGRRPIERE 542
+S G++ +E+ G P E
Sbjct: 200 WSLGIMAIEMIEGEPPYLNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 77/295 (26%), Positives = 120/295 (40%), Gaps = 40/295 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQL 409
++LG+G FG V ++G A+K K + + L E ++ RH L L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
L V EY G L L ++ + ++ IV SAL YLH E
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV----SALDYLHSE-- 114
Query: 470 QQVIHRDIKASNIMLDANFNARLE------------SSFTLTAGTMGYLAPEYLQYGTAT 517
+ V++RD+K N+MLD + + ++ ++ GT YLAPE L+
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 518 EKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA----ADKRLN 573
D + GVV+ E+ CGR P + + K+ L+ L E R A L+
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELI-----LMEEIRFPRTLSPEAKSLLS 228
Query: 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPLVVPKLKPCLT 626
G +D +RL PD + + F + + E +VP KP +T
Sbjct: 229 GLLKKDPKQRL------GGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVT 277
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 24/214 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSK----HSHEGKTEFLAELSIIACLRHKNLVQLLG 411
+G+G +G V+ A +G + A+KR K L E I+ + + LV+LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
+ L L EY+P G +L + GVL + R + A+ LH+
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFE-AVDALHE---LG 121
Query: 472 VIHRDIKASNIMLDANFNARLESSFTLTAGTMG----------YLAPEYLQYGTATEKT- 520
IHRD+K N ++DA+ + +L + F L+ G + Y+APE L G + T
Sbjct: 122 YIHRDLKPENFLIDASGHIKL-TDFGLSKGIVTYANSVVGSPDYMAPEVL-RGKGYDFTV 179
Query: 521 DVFSYGVVVLEVACGRRPIERETEGHKMVNLVDW 554
D +S G ++ E CG P T NL W
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 32/208 (15%)
Query: 354 RILGRGAFGNVY--------KAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKN 405
R LG+G+FG VY K + +V V S E + EFL E S++ +
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE-RIEFLNEASVMKGFTCHH 70
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLD---RMLYQDSENG---VLLSWYHRLNIVVGLAS 459
+V+LLG ++ L+V E M +G L R L ++EN + + + +A
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFNARL----------ESSFTLTAGT----MGY 505
+ YL+ ++ +HRD+ A N M+ +F ++ E+ + G + +
Sbjct: 131 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 506 LAPEYLQYGTATEKTDVFSYGVVVLEVA 533
+APE L+ G T +D++S+GVV+ E+
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEIT 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 8e-12
Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR----SKHSHEGKTEFLAELSIIACLRHKN 405
F R +G G+FG VY A + V A+K+ K S+E + + E+ + ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
++ G + LV EY + D + L I G L YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLH 142
Query: 466 QECEQQVIHRDIKASNIMLD-------ANF-NARLESSFTLTAGTMGYLAPEY---LQYG 514
+IHRDIKA NI+L A+F +A + S GT ++APE + G
Sbjct: 143 S---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEG 199
Query: 515 TATEKTDVFSYGVVVLEVACGRRPI 539
K DV+S G+ +E+A + P+
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-12
Identities = 62/246 (25%), Positives = 99/246 (40%), Gaps = 63/246 (25%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG----KTEFLAELSIIACLRHKNLVQL 409
R++G+G G VY AY A+K+ + K FL E I A L H +V +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 410 LGWCAEKGELLLVYEYMP----------------NGSLDRMLYQDSENGVLLSWYHRLNI 453
C++ VY MP SL + L + + G LS +H++
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI-- 122
Query: 454 VVGLASALTYLHQECEQQVIHRDIKASNIML---------------------------DA 486
+ + Y+H + V+HRD+K NI+L D
Sbjct: 123 ----CATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 487 NFNARLESSFTL---TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERET 543
+ SS T+ GT Y+APE L A+E TD+++ GV++ ++ P R+
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK- 234
Query: 544 EGHKMV 549
+G K+
Sbjct: 235 KGRKIS 240
|
Length = 932 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 32/203 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGW 412
LG G G V K SG + A K H + + + EL ++ +V G
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARK-LIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDS---ENGVLLSWYHRLNIVVGLASALTYLHQECE 469
GE+ + E+M GSLD++L + EN +L I + + LTYL ++
Sbjct: 68 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEN--ILG-----KISIAVLRGLTYLREK-- 118
Query: 470 QQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTA 516
+++HRD+K SNI++++ +L +SF GT Y++PE LQ
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHY 175
Query: 517 TEKTDVFSYGVVVLEVACGRRPI 539
T ++D++S G+ ++E+A GR PI
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 354 RILGRGAFGNVY---KAYFASSGSVAAVKRSK-----HSHEGKTEFLAELSIIACLRHKN 405
++LG+G +G V+ K A +G + A+K K + + AE +I+ ++H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLL---SWYHRLNIVVGLASALT 462
+V L+ G+L L+ EY+ G L L ++ G+ + + ++ I + AL
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLERE---GIFMEDTACFYLSEISL----ALE 114
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEY 510
+LHQ Q +I+RD+K NI+LDA + +L E + T T GT+ Y+APE
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 511 LQYGTATEKTDVFSYGVVVLEVACGRRPIERE 542
L + D +S G ++ ++ G P E
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 61/219 (27%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEG-KTEFLAELSIIACLRHKNLVQLLGW 412
+G G +G VYKA +G + A+K R + EG + + E+S++ L H N+V+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 413 CAEKGELLLVYEYM-----------PNGSLDRML-----YQDSENGVLLSWYHRLNIVVG 456
+ +L LV+E++ P LD L YQ
Sbjct: 67 VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ------------------- 107
Query: 457 LASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES------------SFTLTAGTMG 504
L + Y H +V+HRD+K N+++D +L ++T T+
Sbjct: 108 LLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW 164
Query: 505 YLAPEYL----QYGTATEKTDVFSYGVVVLEVACGRRPI 539
Y APE L QY T D++S G + E+ RRP+
Sbjct: 165 YRAPEILLGSRQYSTP---VDIWSIGCIFAEM-VNRRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 31/214 (14%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVK----RSKHSHEGKTEFLAE---LSIIACLRHKNLV 407
I+GRG FG VY A +G + A+K + +G+T L E LS+++ +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLS---WYHRLNIVVGLASALTYL 464
+ +L + + M G L Y S++GV ++ I++GL ++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLH---YHLSQHGVFSEKEMRFYATEIILGLE----HM 113
Query: 465 HQECEQQVIHRDIKASNIMLDANFNAR-----LESSFT-----LTAGTMGYLAPEYLQYG 514
H + V++RD+K +NI+LD + + R L F+ + GT GY+APE LQ G
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 515 TATEKT-DVFSYGVVVLEVACGRRPIERETEGHK 547
TA + + D FS G ++ ++ G P + K
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 29/215 (13%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFL-AELSIIACLRHKNLVQLLGWCA 414
+G G+ G V A +G AVK+ + + E L E+ I+ H+N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
EL +V E++ G+L ++ N ++ + + + AL+YLH Q VIH
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN---QGVIH 141
Query: 475 RDIKASNIMLDANFNARLESSFTLTA-------------GTMGYLAPEY---LQYGTATE 518
RDIK+ +I+L ++ +L S F A GT ++APE L YGT
Sbjct: 142 RDIKSDSILLTSDGRIKL-SDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT--- 197
Query: 519 KTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVD 553
+ D++S G++V+E+ G P E M + D
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKN 405
F R+LG+G FG V ++G + A K+ + +G++ L E I+ + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGV--LLSWYHRLNIVVGLASALTY 463
+V L K L LV M G L +Y E G + ++ I GL
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED---- 117
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARLE-----------SSFTLTAGTMGYLAPEYLQ 512
LHQE ++++RD+K NI+LD + + R+ + GT+GY+APE ++
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 174
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRPIER 541
T D ++ G ++ E+ G+ P ++
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 18/196 (9%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
LG G G V K SG + A K + + + + EL ++ +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
GE+ + E+M GSLD++L + + + ++ GLA YL ++ Q++
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA----YLREK--HQIM 126
Query: 474 HRDIKASNIMLDANFNARL----------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVF 523
HRD+K SNI++++ +L +S GT Y++PE LQ + ++D++
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186
Query: 524 SYGVVVLEVACGRRPI 539
S G+ ++E+A GR PI
Sbjct: 187 SMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 66/280 (23%), Positives = 117/280 (41%), Gaps = 70/280 (25%)
Query: 375 VAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLD 432
+ AVK R + + +FL E+ I++ L+ N+++LLG C ++ L ++ EYM NG L+
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 433 -----RMLYQDSENGV----------LLSWYHRLNIVVGLASALTYLHQECEQQVIHRDI 477
L ENG +S+ L++ + +AS + YL +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164
Query: 478 KASNIMLDANFNARLES---SFTLTAGT-----------MGYLAPEYLQYGTATEKTDVF 523
N ++ N ++ S L AG + ++A E + G T +DV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 524 SYGVVVLEV--ACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEM 581
++GV + E+ C +P +G + ++IE A G F D+
Sbjct: 225 AFGVTLWEILMLCKEQP-----------------YGELTDEQVIENA-----GEFFRDQG 262
Query: 582 KRLLL------------VGLSCANPDSSARPSMRRVFQIL 609
+++ L + L C + D RPS + L
Sbjct: 263 RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 39/213 (18%)
Query: 355 ILGRGAFGNVYKAYF-----ASSGSVAAVKRSKHSHEGK--TEFLAELSIIACL-RHKNL 406
LG GAFG V KA + S AVK K K ++ ++E+ ++ + +HKN+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSL-----DR----MLYQDSENGVL---LSWYHRLNIV 454
+ LLG C ++G L +V EY +G+L R + L+ ++
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 455 VGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAG----------TMG 504
+A + +L ++ IHRD+ A N+++ + ++ + F L T G
Sbjct: 139 YQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKI-ADFGLARDIHHIDYYRKTTNG 194
Query: 505 YL-----APEYLQYGTATEKTDVFSYGVVVLEV 532
L APE L T ++DV+S+GV++ E+
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 41/209 (19%)
Query: 356 LGRGAFGNVY--KAYFASSGSVAAVKRSKHSHEGKTE--FLAELSIIACLRHKNLVQLLG 411
+G G FG V +A+ S + VK + S + FL E+ L H N++Q LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 412 WCAEKGELLLVYEYMPNGSLDR-------MLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
C E LLV E+ P G L M+ Q ++ VL +AS L +L
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACE------VASGLLWL 116
Query: 465 HQECEQQVIHRDIKASNIMLDANFN----------ARLESSFTLTAGT----MGYLAPEY 510
HQ IH D+ N L A+ + + + +T + +LAPE
Sbjct: 117 HQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 511 -------LQYGTATEKTDVFSYGVVVLEV 532
L T+K++++S GV + E+
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR----SKHSHEGKTEFLAELSIIACLRHKN 405
F R +G G+FG VY A + V A+K+ K S+E + + E+ + LRH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+Q G + LV EY + D + L + G L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLH 132
Query: 466 QECEQQVIHRDIKASNIMLD-------ANF-NARLESSFTLTAGTMGYLAPEY---LQYG 514
+IHRD+KA NI+L +F +A + + GT ++APE + G
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEG 189
Query: 515 TATEKTDVFSYGVVVLEVACGRRPI 539
K DV+S G+ +E+A + P+
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 36/210 (17%)
Query: 356 LGRGAFGNVYKAYF-----ASSGSVAAVKRSKHSHEG--KTEFLAELSIIACLRHKNLVQ 408
LG FG VYK + A+K K EG + EF E + + L+H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL------------LSWYHRLNIVVG 456
LLG ++ L +++ Y + L L S + + L ++IV
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 457 LASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES-----------SFTLTAGTM-- 503
+A+ + +L V+H+D+ N+++ N ++ + L ++
Sbjct: 133 IAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 504 -GYLAPEYLQYGTATEKTDVFSYGVVVLEV 532
+++PE + YG + +D++SYGVV+ EV
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 75/291 (25%), Positives = 121/291 (41%), Gaps = 33/291 (11%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQL 409
++LG+G FG V +SG A+K K + + L E ++ RH L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
K L V EY+ G L L ++ + ++ IV SAL YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIV----SALDYLHS--- 113
Query: 470 QQVIHRDIKASNIMLDANFNARLE------------SSFTLTAGTMGYLAPEYLQYGTAT 517
++++RD+K N+MLD + + ++ ++ GT YLAPE L+
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 518 EKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577
D + GVV+ E+ CGR P + + K+ L+ + + + A L+G
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELI-LMEDIKFPRTLSADAKSLLSGLLI 231
Query: 578 EDEMKRLLLVGLSCANPDSSARPSMRRVFQILN--NEAEPLVVPKLKPCLT 626
+D KRL PD + F +N + + +VP KP +T
Sbjct: 232 KDPNKRL------GGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVT 276
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HKNLVQLLGWCA 414
+G+G +G V+K +GS AAVK H+ E AE +I+ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 415 EK-----GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
+K +L LV E GS+ ++ + G + I L AL L
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME---EPIIAYILHEALMGLQHLHV 142
Query: 470 QQVIHRDIKASNIML---------DANFNARLESS---FTLTAGTMGYLAPEYLQY---- 513
+ IHRD+K +NI+L D +A+L S+ + GT ++APE +
Sbjct: 143 NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202
Query: 514 -GTATEKTDVFSYGVVVLEVACGRRPI 539
T + DV+S G+ +E+ G P+
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 356 LGRGAFGNVYKAYFA--SSGSVAAVKRSKHSHEG---KTEFLAELSIIACLRHKNLVQLL 410
LG G FG V K + S AVK K+ + K E L E +++ L + +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
G C E +LV E G L++ L ++ ++ + +V ++ + YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKH----VTEKNITELVHQVSMGMKYLE---ET 114
Query: 471 QVIHRDIKASNIMLDANFNARLESSFTLT-----------AGTMG-----YLAPEYLQYG 514
+HRD+ A N++L A++ S F L+ A T G + APE + Y
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKI-SDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 515 TATEKTDVFSYGVVVLEV-ACGRRPIER 541
+ K+DV+S+GV++ E + G++P +
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKG 201
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 18/196 (9%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
LG G G V+K SG + A K + + + + EL ++ +V G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
GE+ + E+M GSLD++L + + +++I V LTYL ++ +++
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAV--IKGLTYLREK--HKIM 126
Query: 474 HRDIKASNIMLDANFNARL----------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVF 523
HRD+K SNI++++ +L +S GT Y++PE LQ + ++D++
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186
Query: 524 SYGVVVLEVACGRRPI 539
S G+ ++E+A GR PI
Sbjct: 187 SMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 64/201 (31%), Positives = 95/201 (47%), Gaps = 34/201 (16%)
Query: 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGK---TEFLAELSIIACLRHKNLVQL 409
NRI G G +G VY+A +SG + A+K+ + +E L E++++ LRH N+V+L
Sbjct: 13 NRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVEL 71
Query: 410 LGWCAEK--GELLLVYEYMPN--GSL-DRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
K + LV EY SL D M SE+ V +++ L L YL
Sbjct: 72 KEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC-------LMLQLLRGLQYL 124
Query: 465 HQECEQQVIHRDIKASNIMLD-------ANFN-ARLES----SFTLTAGTMGYLAPEYLQ 512
H+ +IHRD+K SN++L A+F AR T T+ Y APE L
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELL- 180
Query: 513 YG--TATEKTDVFSYGVVVLE 531
G T T D+++ G ++ E
Sbjct: 181 LGCTTYTTAIDMWAVGCILAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 354 RILGRGAFGNVYKAYFA--------SSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKN 405
R LG+G+FG VY+ + ++ V + E + EFL E S++ +
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE-RIEFLNEASVMKEFNCHH 70
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLD---RMLYQDSENGVLLS---WYHRLNIVVGLAS 459
+V+LLG ++ L++ E M G L R L + EN + + + + +A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFNARL----------ESSFTLTAGT----MGY 505
+ YL+ + +HRD+ A N M+ +F ++ E+ + G + +
Sbjct: 131 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 506 LAPEYLQYGTATEKTDVFSYGVVVLEVA 533
++PE L+ G T +DV+S+GVV+ E+A
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
R++G G+FG +S A+K K S + E ++A ++H N+V
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAFK 64
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
G L +V EY G L + + + G L L V + + ++H E+
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIH---EK 119
Query: 471 QVIHRDIKASNIMLDANFN--------ARLES---SFTLT-AGTMGYLAPEYLQYGTATE 518
+V+HRDIK+ NI L N ARL + ++ T GT Y+ PE +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179
Query: 519 KTDVFSYGVVVLEVACGRRPIE 540
K+D++S G ++ E+ + P +
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 76/301 (25%), Positives = 120/301 (39%), Gaps = 53/301 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK-RSKHSHEGKTEF---LAELSIIACLRHKNLVQL 409
++LG+G FG V ++G A+K K K E + E ++ RH L L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 410 LGWCAEKGELLLVYEYMPNGSL------DRMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
L V EY G L +R+ ++ ++ IV SAL Y
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR------FYGAEIV----SALEY 110
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARL------------ESSFTLTAGTMGYLAPEYL 511
LH + V++RDIK N+MLD + + ++ ++ GT YLAPE L
Sbjct: 111 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 167
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR----IIEA 567
+ D + GVV+ E+ CGR P + + ++ L+ L E R +
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELI-----LMEEIRFPRTLSPE 221
Query: 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN--NEAEPLVVPKLKPCL 625
A L G +D +RL P + R F +N + + ++P KP +
Sbjct: 222 AKSLLAGLLKKDPKQRL------GGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 275
Query: 626 T 626
T
Sbjct: 276 T 276
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 46/215 (21%), Positives = 84/215 (39%), Gaps = 43/215 (20%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+ ++ K + ++ AVK+ S E E+ L+H N++ +
Sbjct: 8 KCFEDLMIVHLAKH--KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 411 GWCAEKGELLLVYEYMPNGSLDRML---YQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
EL +V M GS + +L + + + ++ I+ + +AL Y+H +
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA-----FILKDVLNALDYIHSK 120
Query: 468 CEQQVIHRDIKASNIMLDANFNARL----------ESSFTLT---------AGTMGYLAP 508
IHR +KAS+I+L + L + + +L+P
Sbjct: 121 ---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 509 EYLQ-----YGTATEKTDVFSYGVVVLEVACGRRP 538
E LQ Y EK+D++S G+ E+A G P
Sbjct: 178 EVLQQNLQGY---NEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 42/210 (20%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEG-KTEFLAELSIIACLRHKNLVQLLGW 412
+G G +G VYK +G + A+K R + EG + + E+S++ L+H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDS-------ENGVLLSWYHRLNIVVGLASALTYLH 465
++ L L++E++ S+D Y DS + ++ S+ ++ + + + H
Sbjct: 68 LMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQ------ILQGILFCH 118
Query: 466 QECEQQVIHRDIKASNIMLDANFNARLES------------SFTLTAGTMGYLAPEYL-- 511
++V+HRD+K N+++D +L +T T+ Y APE L
Sbjct: 119 S---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 512 --QYGTATEKTDVFSYGVVVLEVACGRRPI 539
+Y T D++S G + E+A ++P+
Sbjct: 176 SPRYSTP---VDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 1e-10
Identities = 63/213 (29%), Positives = 90/213 (42%), Gaps = 50/213 (23%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKH--------SHEGKTEFLAELSIIACLRHK 404
+ LG G+FG V SG A+K SK H L E I+ +RH
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-----VLNEKRILQSIRHP 61
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGL------A 458
LV L G + L LV EY+P G L L + R V
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK----------SGRFPEPVARFYAAQVV 111
Query: 459 SALTYLHQECEQQVIHRDIKASNIMLDAN---------FNARLES-SFTLTAGTMGYLAP 508
AL YLH +++RD+K N++LD++ F R++ ++TL GT YLAP
Sbjct: 112 LALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL-CGTPEYLAP 167
Query: 509 EYLQ---YGTATEKTDVFSYGVVVLEVACGRRP 538
E + YG A D ++ G+++ E+ G P
Sbjct: 168 EIILSKGYGKA---VDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 35/206 (16%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSK--HSHEGKTEF-LAELSIIACLRHKNLVQLLGW 412
+G G +G V+KA + + A+KR + EG L E+ ++ L+HKN+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENG-----VLLSWYHRLNIVVGLASALTYLHQE 467
+L LV+EY D Y DS NG ++ S+ +L + GLA + H
Sbjct: 68 LHSDKKLTLVFEYCDQ---DLKKYFDSCNGDIDPEIVKSFMFQL--LKGLA----FCHS- 117
Query: 468 CEQQVIHRDIKASNIMLDANFNARLES------------SFTLTAGTMGYLAPEYLQYGT 515
V+HRD+K N++++ N +L ++ T+ Y P+ L +G
Sbjct: 118 --HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL-FGA 174
Query: 516 ATEKT--DVFSYGVVVLEVACGRRPI 539
T D++S G + E+A RP+
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 63/210 (30%), Positives = 85/210 (40%), Gaps = 41/210 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQL 409
++LG+G FG V ++G A+K K + + L E ++ RH L L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRL---NIVVGLASALTYLHQ 466
L V EY G L + S V R IV SAL YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIV----SALGYLH- 112
Query: 467 ECEQQVIHRDIKASNIMLD-------ANF--------NARLESSFTLTAGTMGYLAPEYL 511
V++RD+K N+MLD +F + +F GT YLAPE L
Sbjct: 113 --SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVL 167
Query: 512 Q---YGTATEKTDVFSYGVVVLEVACGRRP 538
+ YG A D + GVV+ E+ CGR P
Sbjct: 168 EDNDYGRAV---DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 24/212 (11%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKN 405
F R+LG+G FG V ++G + A KR + +G++ L E I+ + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL--LSWYHRLNIVVGLASALTY 463
+V L K L LV M G L +Y G + ++ I+ GL
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE----D 117
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARLE-----------SSFTLTAGTMGYLAPEYLQ 512
LH+E ++RD+K NI+LD + R+ S GT+GY+APE L
Sbjct: 118 LHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN 174
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
T D + G ++ E+ G+ P E
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 33/206 (16%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVK-----RSKHSHEGKTEFLAE---LSIIACLRHKNL 406
I+GRG FG VY A +G + A+K R K +G+T L E LS+++ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFI 59
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSW---YHRLNIVVGLASALTY 463
V + +L + + M G L Y S++GV ++ I++GL +
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEAEMRFYAAEIILGLE----H 112
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNAR-----LESSFT-----LTAGTMGYLAPEYLQY 513
+H + V++RD+K +NI+LD + + R L F+ + GT GY+APE LQ
Sbjct: 113 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 514 GTATEKT-DVFSYGVVVLEVACGRRP 538
G A + + D FS G ++ ++ G P
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 22/197 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+G+G+FG VYK + V A+K + + + + E+++++ + + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+ +L ++ EY+ GS +L + G L Y I+ + L YLH E + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL----KPGPLEETY-IATILREILKGLDYLHSE---RKI 123
Query: 474 HRDIKASNIMLDANFNARLES-----SFTLT-------AGTMGYLAPEYLQYGTATEKTD 521
HRDIKA+N++L + +L T T GT ++APE ++ K D
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 522 VFSYGVVVLEVACGRRP 538
++S G+ +E+A G P
Sbjct: 184 IWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 68/284 (23%), Positives = 115/284 (40%), Gaps = 65/284 (22%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSI-----------------I 398
LG+G+FG VY VK K E + + L E+ + +
Sbjct: 8 LGKGSFGTVY-----------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLL 56
Query: 399 ACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLA 458
+ L H +V+ E+ ++ EY LD L + G LS + L
Sbjct: 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 459 SALTYLHQECEQQVIHRDIKASNIMLDANF--------------NARLESSFTLTAGTMG 504
+ Y+HQ ++++HRD+KA NI L N + L ++FT GT
Sbjct: 117 LGVHYMHQ---RRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFT---GTPY 170
Query: 505 YLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564
Y++PE L++ K+D++S G ++ E+ C + EG +++V RI
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEMCC----LAHAFEGQNFLSVVL---------RI 217
Query: 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608
+E L ++ ++L + S N D S RPS + +
Sbjct: 218 VEGPTPSLPETYS----RQLNSIMQSMLNKDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 66/307 (21%), Positives = 126/307 (41%), Gaps = 78/307 (25%)
Query: 356 LGRGAFGNVY-----------KAYFASSGS-----VAAVK--RSKHSHEGKTEFLAELSI 397
LG G FG V+ F+ S + AVK R + + +FL E+ I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 398 IACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQ-------DSENGVLLSWYHR 450
++ L+ N+++LL C L ++ EYM NG L++ L + + + V +S+
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 451 LNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES---SFTLTAGT----- 502
+ + +AS + YL +HRD+ N ++ N+ ++ S L +G
Sbjct: 133 IFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 503 ------MGYLAPEYLQYGTATEKTDVFSYGVVVLEVA--CGRRPIERETEGHKMVNLVDW 554
+ +++ E + G T +DV+++GV + E+ C +P
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP---------------- 233
Query: 555 VWGLYAEGRIIEAADKRLNGAFNEDEMKRLLL------------VGLSCANPDSSARPSM 602
+ ++ ++IE G F D+ +++ L + LSC ++ RPS
Sbjct: 234 -YSQLSDEQVIEN-----TGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF 287
Query: 603 RRVFQIL 609
+ + L
Sbjct: 288 QEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 31/203 (15%)
Query: 354 RILGRGAFGNV----YKAYFASSGSVAAVKRSKHSHEGK--TEFLAELSIIACLRHKNLV 407
R LG G FG V Y ++G AVK K G + E+ I+ L H+N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 408 QLLGWCAEKGE--LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+ G C E G + L+ E++P+GSL L N ++ +L V + + YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 466 QECEQQVIHRDIKASNIMLDANFNARLESSFTLTAGT----------------MGYLAPE 509
+Q +HRD+ A N+++++ ++ F LT + + APE
Sbjct: 127 S---RQYVHRDLAARNVLVESEHQVKI-GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 510 YLQYGTATEKTDVFSYGVVVLEV 532
L +DV+S+GV + E+
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 73/306 (23%), Positives = 127/306 (41%), Gaps = 62/306 (20%)
Query: 353 NRILGRGAFGNVYKAY-FASSG----SVAAVKRSKH--SHEGKTEFLAELSIIACLRHKN 405
+ LG G FG V KA F G + AVK K S + L+E +++ + H +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDS--ENGVLLSWYHRLNIV--------V 455
+++L G C++ G LLL+ EY GSL L + L S +R + +
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 456 GLASALTYLHQEC-------EQQVIHRDIKASNIMLDANFNARLESSFTLTAGT------ 502
+ +++ Q E +++HRD+ A N+++ ++ S F L+
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKI-SDFGLSRDVYEEDSY 183
Query: 503 ---------MGYLAPEYLQYGTATEKTDVFSYGVVVLE-VACGRRPIERETEGHKMVNLV 552
+ ++A E L T ++DV+S+GV++ E V G P G L
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY----PGIAPERL- 238
Query: 553 DWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612
+ L G +E + +EM L+ L+C + RP+ F ++ E
Sbjct: 239 ---FNLLKTGYRMERPEN------CSEEMYNLM---LTCWKQEPDKRPT----FADISKE 282
Query: 613 AEPLVV 618
E ++V
Sbjct: 283 LEKMMV 288
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 27/203 (13%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEF---LAELSIIACLRHKN---LVQ 408
+G+G FG VY+ + + A+K SK K E + E +I+ +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L +L LV +YM G L L ++ + ++ + L AL +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFY----IAELVLALEHLH--- 113
Query: 469 EQQVIHRDIKASNIMLDANFNARL----ESSFTLTA--------GTMGYLAPE-YLQYGT 515
+ +++RD+K NI+LDA + L S LT GT YLAPE L
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 516 ATEKTDVFSYGVVVLEVACGRRP 538
T+ D +S GV+V E+ CG P
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 47/228 (20%)
Query: 341 RELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTE---FLAELS 396
+LR F +++GRGAFG V SS V A+K SK +++ F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 397 IIACLRHKNLVQLLGWCAEKGE--LLLVYEYMPNGSLDRML--YQDSENGVLLSW--YHR 450
I+A + +VQL A + + L +V EYMP G L ++ Y E W ++
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----WARFYT 148
Query: 451 LNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL------------ 498
+V+ AL +H IHRD+K N++LD + + +L T
Sbjct: 149 AEVVL----ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 499 TA-GTMGYLAPEYLQ-------YGTATEKTDVFSYGVVVLEVACGRRP 538
TA GT Y++PE L+ YG + D +S GV + E+ G P
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYG---RECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 48/197 (24%), Positives = 89/197 (45%), Gaps = 22/197 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+G+G+FG V+K + V A+K + + + + E+++++ + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+ +L ++ EY+ GS +L + ++ + L YLH E + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSE---KKI 123
Query: 474 HRDIKASNIMLDANFNARLES-----SFTLT-------AGTMGYLAPEYLQYGTATEKTD 521
HRDIKA+N++L + +L T T GT ++APE +Q K D
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183
Query: 522 VFSYGVVVLEVACGRRP 538
++S G+ +E+A G P
Sbjct: 184 IWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 34/217 (15%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKN 405
F R+LG+G FG V ++G + A K+ + +G+ L E I+ + +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQ------DSENGVLLSWYHRLNIVVGLAS 459
+V L K L LV M G L +Y D + + ++ + GL
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAI----FYAAELCCGLED 117
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTA------------GTMGYLA 507
L +E ++++RD+K NI+LD + R+ S L GT+GY+A
Sbjct: 118 ----LQRE---RIVYRDLKPENILLDDRGHIRI-SDLGLAVQIPEGETVRGRVGTVGYMA 169
Query: 508 PEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
PE + T D + G ++ E+ G+ P + E
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 26/204 (12%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE----FLAELSIIACLRHKNLVQLLG 411
LG G+FG V A +G A+K K K + E SI+ L H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSE--NGVLLSWYHRLNIVVGLASALTYLHQECE 469
++ + + E++ G L L + N V +YH L A YLH
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA-KFYH-----AELVLAFEYLH---S 136
Query: 470 QQVIHRDIKASNIMLDANFNARL----------ESSFTLTAGTMGYLAPEYLQYGTATEK 519
+ +I+RD+K N++LD + ++ + +FTL GT YLAPE +Q +
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-CGTPEYLAPEVIQSKGHGKA 195
Query: 520 TDVFSYGVVVLEVACGRRPIERET 543
D ++ GV++ E G P +T
Sbjct: 196 VDWWTMGVLLYEFIAGYPPFFDDT 219
|
Length = 329 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 61/240 (25%), Positives = 103/240 (42%), Gaps = 51/240 (21%)
Query: 356 LGRGAFGNVYKA-------YFASSGSVAAVKRSKHSHEGK--TEFLAELSIIACL-RHKN 405
LG G FG V +A AVK K + K + ++E+ ++ + +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGV------------LLSWYHRLNI 453
++ LLG C ++G L ++ EY G+L L G LS+ ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 454 VVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAGT----------- 502
+A + YL ++ IHRD+ A N+++ + N + F L G
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSN 195
Query: 503 ----MGYLAPEYLQYGTATEKTDVFSYGVVVLEV-ACGRRP---IERET------EGHKM 548
+ ++APE L T ++DV+S+G+++ E+ G P I E EGH+M
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRM 255
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 36/204 (17%)
Query: 356 LGRGAFGNVY-------KAYFA----SSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHK 404
+G G FG V+ + Y+A + V +K+ +H H E ++ + H
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN-------EKRVLKEVSHP 61
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
+++L ++ L ++ EY+P G L L ++ IV AL YL
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV----CALEYL 117
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARL----------ESSFTLTAGTMGYLAPEYLQYG 514
H +++++RD+K NI+LD + +L + ++TL GT YLAPE +Q
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-CGTPEYLAPEVIQSK 173
Query: 515 TATEKTDVFSYGVVVLEVACGRRP 538
+ D ++ G+++ E+ G P
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 65/287 (22%), Positives = 120/287 (41%), Gaps = 63/287 (21%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSK-------HSHEGKTE-FLAELSIIACLRHKNLV 407
LG+G F ++K G + +++ SH +E F S+++ L HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
G C E ++V EY+ GSLD L + ++N + +SW +L + LA AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISW--KLEVAKQLAWALHFLE-- 117
Query: 468 CEQQVIHRDIKASNIMLDANFNARLES-----------SFTLTAGTM-----GYLAPEYL 511
++ + H ++ A N++L + + + S T+ + ++ PE +
Sbjct: 118 -DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 512 QYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570
+ + D +S+G + E+ G G K ++ +D + K
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG---------GDKPLSALD--------------SQK 213
Query: 571 RLNGAFNEDEMK-------RLLLVGLSCANPDSSARPSMRRVFQILN 610
+L F ED + L + C + + RPS R + + LN
Sbjct: 214 KLQ--FYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+G+G+FG V+K + V A+K + + + + E+++++ + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+ +L ++ EY+ GS +L + ++ I+ + L YLH E + I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE---KKI 123
Query: 474 HRDIKASNIMLDANFNARLES-----SFTLT-------AGTMGYLAPEYLQYGTATEKTD 521
HRDIKA+N++L + +L T T GT ++APE ++ K D
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 522 VFSYGVVVLEVACGRRPIERETEGHKM 548
++S G+ +E+A G P +E H M
Sbjct: 184 IWSLGITAIELAKGEPP---HSELHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 74/268 (27%), Positives = 114/268 (42%), Gaps = 34/268 (12%)
Query: 341 RELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVK-RSKHSHEGKTE---FLAELS 396
R+L+ + +++GRGAFG V SS V A+K SK +++ F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 397 IIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSW--YHRLNIV 454
I+A +VQL + L +V EYMP G L ++ S V W ++ +V
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAEVV 152
Query: 455 VGLASALTYLHQECEQQVIHRDIKASNIMLD-------ANFNARLESSFT------LTAG 501
+ AL +H +IHRD+K N++LD A+F ++ T G
Sbjct: 153 L----ALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 502 TMGYLAPEYLQY----GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG 557
T Y++PE L+ G + D +S GV + E+ G P ++ ++D
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS 265
Query: 558 L-YAEGRIIEAADKRLNGAFNEDEMKRL 584
L + E I K L AF D RL
Sbjct: 266 LNFPEDVEISKHAKNLICAFLTDREVRL 293
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTE-FLAELSIIACLR-HKNLVQ 408
++LG+G+FG V A + V A+K K + + + E I+A H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L K L V EY+ G L + + + S ++ + AL +LH+
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVT----LALMFLHR-- 114
Query: 469 EQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEYLQ---Y 513
VI+RD+K NI+LDA + +L T T GT Y+APE LQ Y
Sbjct: 115 -HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPIERETE 544
G + D ++ GV++ E+ G+ P E + E
Sbjct: 174 GPS---VDWWALGVLMYEMMAGQPPFEADNE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 45/227 (19%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEF----LAELSIIACLRHKNLVQLL 410
+G+G FG V+KA + + A+K+ +E K F L E+ I+ L+H+N+V L+
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLI 77
Query: 411 GWCAE--------KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
C KG LV+E+ + L +L S V + ++ L + L
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL---SNKNVKFTLSEIKKVMKMLLNGLY 133
Query: 463 YLHQECEQQVIHRDIKASNIMLD-------ANFN-ARLESSFTLTAG--------TMGYL 506
Y+H+ +++HRD+KA+NI++ A+F AR S + T+ Y
Sbjct: 134 YIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 507 APEYL----QYGTATEKTDVFSYGVVVLEVACGRRPIER-ETEGHKM 548
PE L YG D++ G ++ E+ R PI + TE H++
Sbjct: 191 PPELLLGERDYGPP---IDMWGAGCIMAEMWT-RSPIMQGNTEQHQL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSV--AAVKRSKHSHEGKTEFLAELSIIACLR---HKNLVQ 408
+ LG G FG+V + S+ AVK K + ++E LS C++ H N+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 409 LLGWCAEKGEL------LLVYEYMPNGSLDR-MLYQD-SENGVLLSWYHRLNIVVGLASA 460
L+G C + E +++ +M +G L +LY + L + + +AS
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 461 LTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAGT---------------MGY 505
+ YL + IHRD+ A N ML+ N N + + F L+ + +
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCV-ADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 506 LAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRP 538
+A E L T K+DV+S+GV + E+A G+ P
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 28/199 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA--ELSIIACLRHKNLVQLLGWC 413
LG G++ VYK +G + A+K + HE F A E S++ L+H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVV---GLASALTYLHQECEQ 470
K L LV+EY+ D Y D G L N+ + L L Y HQ +
Sbjct: 73 HTKKTLTLVFEYLDT---DLKQYMDDCGGGL----SMHNVRLFLFQLLRGLAYCHQ---R 122
Query: 471 QVIHRDIKASNIMLD-------ANFN-ARLESSFTLTAG----TMGYLAPEYLQYGTA-T 517
+V+HRD+K N+++ A+F AR +S + T T+ Y P+ L T +
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 518 EKTDVFSYGVVVLEVACGR 536
D++ G + E+A GR
Sbjct: 183 TSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 24/197 (12%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA--ELSIIACLRHKNLVQLLGWC 413
LG G + V+K + ++ A+K + HE A E+S++ L+H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSEN-GVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
+ L LV+EY LD L Q +N G L+S ++ + L L+Y H ++++
Sbjct: 73 HTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKI 124
Query: 473 IHRDIKASNIMLD-------ANFN-ARLESSFTLTAG----TMGYLAPEYLQYGTA-TEK 519
+HRD+K N++++ A+F AR +S T T T+ Y P+ L T +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP 184
Query: 520 TDVFSYGVVVLEVACGR 536
D++ G ++ E+A GR
Sbjct: 185 IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 40/219 (18%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSK--HSHEGKTEFLAELSIIACLR------HKNL 406
+G GA+G VYKA ++G A+K+ + S EG L+ L IA L+ H N+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLKQLESFEHPNI 63
Query: 407 VQLLGWCA-----EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASAL 461
V+LL C + +L LV+E++ + L L + + G L +++ L +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPG--LPPETIKDLMRQLLRGV 120
Query: 462 TYLHQECEQQVIHRDIKASNIMLD-------ANFN-ARL---ESSFTLTAGTMGYLAPEY 510
+LH ++HRD+K NI++ A+F AR+ E + T T+ Y APE
Sbjct: 121 DFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEV 177
Query: 511 L---QYGTATEKTDVFSYGVVVLEVACGRRPIER-ETEG 545
L Y T D++S G + E+ RRP+ R +E
Sbjct: 178 LLQSSYATP---VDMWSVGCIFAELF-RRRPLFRGTSEA 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 41/214 (19%)
Query: 356 LGRGAFGNVYKAYF-------ASSGSVAAVK--RSKHSHEGKTEFLAELSIIACL-RHKN 405
LG G FG V A + + AVK +S + + ++ ++E+ ++ + +HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRML-----------YQDSENGV-LLSWYHRLNI 453
++ LLG C + G L ++ EY G+L L Y ++ LS+ ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 454 VVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL-------------TA 500
+A + YL ++ IHRD+ A N+++ + N + F L T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTN 201
Query: 501 GTM--GYLAPEYLQYGTATEKTDVFSYGVVVLEV 532
G + ++APE L T ++DV+S+GV++ E+
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 350 FHSNRILGRGAFGNVYKAYFAS---SGSVAAVKRSK---HSHEGKTEFLAELSIIACLRH 403
F R+LG+G FG+V +A S S AVK K S EFL E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 404 KNLVQLLGWCAE---KGEL---LLVYEYMPNGSLDRMLYQD--SENGVLLSWYHRLNIVV 455
N+++L+G KG L +++ +M +G L L E L + ++
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDANFN---ARLESSFTLTAGT---------- 502
+AS + YL + IHRD+ A N ML+ N A S + +G
Sbjct: 121 DIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 503 -MGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRP 538
+ +LA E L T +DV+++GV + E+ G+ P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 51/240 (21%)
Query: 356 LGRGAFGNVYKAYF-------ASSGSVAAVKRSKHSHEGK--TEFLAELSIIACL-RHKN 405
LG G FG V A AVK K K ++ ++E+ ++ + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGV------------LLSWYHRLNI 453
++ LLG C + G L ++ EY G+L L G+ +++ ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 454 VVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL-------------TA 500
+A + YL Q+ IHRD+ A N+++ N N + F L T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTN 198
Query: 501 GTM--GYLAPEYLQYGTATEKTDVFSYGVVVLEV-ACGRRP---IERE------TEGHKM 548
G + ++APE L T ++DV+S+GV++ E+ G P I E EGH+M
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 258
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 25/176 (14%)
Query: 394 ELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNI 453
E+ I+ + H+ ++ L+ K + +V MP D Y D + L + I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLE--QAITI 190
Query: 454 VVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL----------ESSFTLT---- 499
L AL YLH + +IHRD+K NI LD NA L T
Sbjct: 191 QRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW 247
Query: 500 AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRP---IERETEGHKMVNLV 552
+GT+ +PE L KTD++S G+V+ E++ + ++ ++ +++
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII 303
|
Length = 392 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSK-HSHEGKTEFLAELSIIACLR 402
R+ F + +G G +G+VYKA ++G +AA+K K E E+ ++ +
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64
Query: 403 HKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
H N+V G + +L + E+ GSL + + Y + G L
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQG----LY 120
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTA-------------GTMGYLAPE 509
YLH + + +HRDIK +NI+L N + +L + F ++A GT ++APE
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGHVKL-ADFGVSAQITATIAKRKSFIGTPYWMAPE 176
Query: 510 YL---QYGTATEKTDVFSYGVVVLEVA 533
+ G + D+++ G+ +E+A
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELA 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 25/195 (12%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFL-AELSIIACLRHKNLVQLLGWCA 414
+G G +G+VYKA +G +AAVK K + E+ ++ +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
+ +L + EY GSL + + L Y + GLA YLH + + +H
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA----YLHSKGK---MH 129
Query: 475 RDIKASNIMLDANFNARLESSFTLTA-------------GTMGYLAPEYL---QYGTATE 518
RDIK +NI+L N + +L + F + A GT ++APE + G +
Sbjct: 130 RDIKGANILLTDNGDVKL-ADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 519 KTDVFSYGVVVLEVA 533
D+++ G+ +E+A
Sbjct: 189 LCDIWAVGITAIELA 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 30/209 (14%)
Query: 356 LGRGAFGNVYKAY-FASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR------HKNLVQ 408
+G GA+G V+KA + G A+KR + + L+ + +A LR H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 409 LLGWCA-----EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
L C + +L LV+E++ + L L + E GV +++ L L +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDF 125
Query: 464 LHQECEQQVIHRDIKASNIMLD-------ANFN-ARLES---SFTLTAGTMGYLAPEYLQ 512
LH +V+HRD+K NI++ A+F AR+ S + T T+ Y APE L
Sbjct: 126 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRPIER 541
+ D++S G + E+ R+P+ R
Sbjct: 183 QSSYATPVDLWSVGCIFAEMF-RRKPLFR 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 24/197 (12%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA--ELSIIACLRHKNLVQLLGWC 413
LG G + VYK + ++ A+K + HE A E+S++ L+H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSEN-GVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
+ L LV+EY LD+ L Q ++ G ++ ++ + L L Y H+ ++V
Sbjct: 74 HTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKV 125
Query: 473 IHRDIKASNIMLD-------ANFN-ARLESSFTLTAG----TMGYLAPEYLQYGTA-TEK 519
+HRD+K N++++ A+F AR +S T T T+ Y P+ L T + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 520 TDVFSYGVVVLEVACGR 536
D++ G + E++ GR
Sbjct: 186 IDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 30/200 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA--ELSIIACLRHKNLVQLLGWC 413
LG G + V+K + ++ A+K + HE A E+S++ L+H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSEN-GVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
L LV+EY LD+ L Q ++ G ++S ++ + + L Y H+ ++V
Sbjct: 74 HTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125
Query: 473 IHRDIKASNIMLD-------ANFN-ARLESSFTLTAG----TMGYLAPEYL----QYGTA 516
+HRD+K N++++ A+F AR +S T T T+ Y P+ L +Y T
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST- 184
Query: 517 TEKTDVFSYGVVVLEVACGR 536
+ D++ G + E+A GR
Sbjct: 185 --QIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 22/197 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA--ELSIIACLRHKNLVQLLGWC 413
LG G + VYK ++G + A+K E T A E+S++ L+H+N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+ +L+LV+EYM + L + + G L + + L + + H E +V+
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVK-SFTYQLLKGIAFCH---ENRVL 122
Query: 474 HRDIKASNIMLDANFNARLE------------SSFTLTAGTMGYLAPEYLQYGTATEKT- 520
HRD+K N++++ +L ++F+ T+ Y AP+ L G+ T T
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVL-LGSRTYSTS 181
Query: 521 -DVFSYGVVVLEVACGR 536
D++S G ++ E+ GR
Sbjct: 182 IDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 44/206 (21%)
Query: 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEF----LAELSIIACLRHKNLVQ 408
NRI G +G VY+A +G + A+K+ K E K F L E++I+ L+H N+V
Sbjct: 11 NRI-EEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQHPNIVT 68
Query: 409 L----LGWCAEKGELLLVYEYMPN---GSLDRMLYQDSENGVLLSWYHRLNIVVGLASAL 461
+ +G +K + +V EY+ + ++ M ++ V +++ L S +
Sbjct: 69 VKEVVVGSNLDK--IYMVMEYVEHDLKSLMETMKQPFLQSEVK-------CLMLQLLSGV 119
Query: 462 TYLHQECEQQVIHRDIKASNIMLD-------ANFN-ARLESS----FTLTAGTMGYLAPE 509
+LH ++HRD+K SN++L+ +F AR S +T T+ Y APE
Sbjct: 120 AHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPE 176
Query: 510 YL----QYGTATEKTDVFSYGVVVLE 531
L +Y TA D++S G + E
Sbjct: 177 LLLGAKEYSTA---IDMWSVGCIFAE 199
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 39/215 (18%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAE------------LSIIACLR 402
+LGRG FG V A + +G + A+K K K + +A R
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALK-----KGDIIARDEVESLMCEKRIFETANSER 60
Query: 403 HKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
H LV L + + V EY G L ++ D + +Y +V+GL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY-AACVVLGL----Q 115
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAGTMGY-------------LAPE 509
YLH E ++++RD+K N++LD ++ + F L MG+ LAPE
Sbjct: 116 YLH---ENKIVYRDLKLDNLLLDTEGFVKI-ADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 510 YLQYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
L + T D + GV++ E+ G P + E
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLR------HKNLV 407
+G GA+G VYKA SG A+K R + + +G L+ + +A L+ H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP--LSTVREVALLKRLEAFDHPNIV 65
Query: 408 QLLGWCA-----EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
+L+ CA + ++ LV+E++ D Y D L +++ L
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 463 YLHQECEQQVIHRDIKASNIMLD-------ANFN-ARLES---SFTLTAGTMGYLAPEYL 511
+LH C ++HRD+K NI++ A+F AR+ S + T T+ Y APE L
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPI 539
T D++S G + E+ R+P+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMF-RRKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 33/221 (14%)
Query: 341 RELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVK-RSKHSHEGKTE---FLAELS 396
R+LR + +++GRGAFG V S+ V A+K SK +++ F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 397 IIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSW--YHRLNIV 454
I+A +VQL + L +V EYMP G L ++ S V W ++ +V
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVV 152
Query: 455 VGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT-------------LTAG 501
+ AL +H IHRD+K N++LD + + +L T G
Sbjct: 153 L----ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205
Query: 502 TMGYLAPEYLQY----GTATEKTDVFSYGVVVLEVACGRRP 538
T Y++PE L+ G + D +S GV + E+ G P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTE-FLAELSIIACLRHKNLVQLL 410
+LG+G+FG V A + + A+K K + E + E ++A + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 411 GWCAEK-GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
C + L V EY+ G L + Q + + ++ I VGL +LH
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGL----FFLH---R 119
Query: 470 QQVIHRDIKASNIMLD-------ANFNARLESSF----TLT-AGTMGYLAPEYLQYGTAT 517
+ +I+RD+K N+MLD A+F E T T GT Y+APE + Y
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYG 179
Query: 518 EKTDVFSYGVVVLEVACGRRPIERETE 544
+ D ++YGV++ E+ G+ P + E E
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 34/201 (16%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA--ELSIIACLRHKNLVQLLGWC 413
LG G++ VYK +G + A+K + E T F A E S++ L+H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNI---VVGLASALTYLHQECEQ 470
K L LV+EY+ D Y D G L H N+ + L L+Y+HQ +
Sbjct: 73 HTKETLTLVFEYV---HTDLCQYMDKHPGGL----HPENVKLFLFQLLRGLSYIHQ---R 122
Query: 471 QVIHRDIKASNIMLD-------ANFN-ARLES----SFTLTAGTMGYLAPEYL----QYG 514
++HRD+K N+++ A+F AR +S +++ T+ Y P+ L +Y
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 515 TATEKTDVFSYGVVVLEVACG 535
T D++ G + +E+ G
Sbjct: 183 TC---LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 1e-08
Identities = 65/213 (30%), Positives = 96/213 (45%), Gaps = 49/213 (23%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE---------FLAELSIIACLRHKNL 406
LG+GA+G V+KA + V A+K+ + T+ FL EL H N+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNI 69
Query: 407 VQLLG-WCAEKG-ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
V+LL AE ++ LV+EYM + L+ +L H+ I+ L AL Y+
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILED-VHKRYIMYQLLKALKYI 123
Query: 465 HQECEQQVIHRDIKASNIMLD-------ANFN-ARLESSFTLTAG---------TMGYLA 507
H VIHRD+K SNI+L+ A+F AR S T Y A
Sbjct: 124 HS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 508 PEYL----QYGTATEKTDVFSYGVVVLEVACGR 536
PE L +Y T+ D++S G ++ E+ G+
Sbjct: 181 PEILLGSTRY---TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 36/218 (16%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVK-----RSKHSHEGKTEFLAELSIIACLRHK 404
F R+LG+G FG V ++G + A K R K G+ L E I+ + +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-GEAMALNEKQILEKVNSR 60
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQ------DSENGVLLSWYHRLNIVVGLA 458
+V L K L LV M G L +Y D E V ++ I GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAV----FYAAEITCGL- 115
Query: 459 SALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTA------------GTMGYL 506
LH+E ++++RD+K NI+LD + R+ S L GT+GY+
Sbjct: 116 ---EDLHRE---RIVYRDLKPENILLDDYGHIRI-SDLGLAVEIPEGETIRGRVGTVGYM 168
Query: 507 APEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
APE ++ T D + G ++ E+ G+ P + E
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 39/213 (18%)
Query: 356 LGRGAFGNVYKAYF-------ASSGSVAAVKRSKHSHEGK--TEFLAELSIIACL-RHKN 405
LG G FG V A + AVK K K ++ ++E+ ++ + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGV------------LLSWYHRLNI 453
++ LLG C + G L ++ EY G+L L G+ L++ ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 454 VVGLASALTYLHQECEQQVIHRDIKASNIMLD-------ANFN-AR----LESSFTLTAG 501
+A + YL Q+ IHRD+ A N+++ A+F AR ++ T G
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 502 TM--GYLAPEYLQYGTATEKTDVFSYGVVVLEV 532
+ ++APE L T ++DV+S+GV++ E+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRH 403
RS + + I+G G+FG VY+A + A+K+ + K EL I+ L H
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR---ELLIMKNLNH 118
Query: 404 KNLVQLLGW----CAEKGE----LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVV 455
N++ L + C +K E L +V E++P M + N L + +L
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL-YSY 177
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDANFNA----RLESSFTLTAGTMG------- 504
L AL Y+H + + HRD+K N+++D N + S+ L AG
Sbjct: 178 QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 505 -YLAPEYLQYGTA-TEKTDVFSYGVVVLEVACG 535
Y APE + T T D++S G ++ E+ G
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 39/212 (18%)
Query: 356 LGRGAFGNVYKAYFA--SSGSVAAVKRSKHSHEG--KTEFLAELSIIACLRHKNLVQLLG 411
LG G FG V K + A+K K+ +E + E + E I+ L + +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSE-----NGVLLSWYHRLNIVVGLASALTYLHQ 466
C E L+LV E G L++ L + N V L H++++ + YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVEL--MHQVSM------GMKYLE- 112
Query: 467 ECEQQVIHRDIKASNIMLDANFNARLESSFTL-----------TAGTMG-----YLAPEY 510
+ +HRD+ A N++L A++ S F L A + G + APE
Sbjct: 113 --GKNFVHRDLAARNVLLVNQHYAKI-SDFGLSKALGADDSYYKARSAGKWPLKWYAPEC 169
Query: 511 LQYGTATEKTDVFSYGVVVLEV-ACGRRPIER 541
+ + + ++DV+SYG+ + E + G++P ++
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKPYKK 201
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 36/214 (16%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGW- 412
++LG+G+FG V A G AVK K K L + + C + V L W
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALK-----KDVVLID-DDVECTMVEKRVLALAWE 54
Query: 413 --------CA--EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
C K L V E++ G L + + + ++ IV GL
Sbjct: 55 NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGL----Q 110
Query: 463 YLHQECEQQVIHRDIKASNIMLD-------ANF-----NARLESSFTLTAGTMGYLAPEY 510
+LH + +I+RD+K N+MLD A+F N ++ + GT Y+APE
Sbjct: 111 FLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI 167
Query: 511 LQYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
LQ T D +S+GV++ E+ G+ P + E
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 76/299 (25%), Positives = 119/299 (39%), Gaps = 56/299 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGW- 412
++LG+G+FG V A + A+K K + + E + C + V L W
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALK------KDVVLEDDDVECTMVERRVLALAWE 54
Query: 413 --------CA--EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
C K L V EY+ G L + + ++ I+ GL
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGL----Q 110
Query: 463 YLHQECEQQVIHRDIKASNIMLD-------ANF-----NARLESSFTLTAGTMGYLAPEY 510
+LH+ + +I+RD+K N++LD A+F N E + GT Y+APE
Sbjct: 111 FLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEI 167
Query: 511 LQYGTATEKTDVFSYGVVVLEVACGRRPIERETEG---HKMVNLVDW--VWGLYAEGRII 565
L+ E D +S+GV++ E+ G+ P E E ++N W I
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRW-------IS 220
Query: 566 EAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRV-FQILNN-EAEPLVVPKLK 622
+ A L+ F D KRL + G D P R + ++ L E P PK+K
Sbjct: 221 KEAKDCLSKLFERDPTKRLGVDG------DIRQHPFFRGIDWERLEKREIPPPFKPKVK 273
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 354 RILGRGAFGNVY---KAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLV 407
++LG+G+FG V+ K +G + A+K K + + E I+A + H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLASALTYL 464
+L +G+L L+ +++ G L L ++ +E V +Y + LA AL +L
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV--KFY-----LAELALALDHL 114
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARLESSFTLT-------------AGTMGYLAPEYL 511
H +I+RD+K NI+LD + +L + F L+ GT+ Y+APE +
Sbjct: 115 HS---LGIIYRDLKPENILLDEEGHIKL-TDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKM 548
T+ D +S+GV++ E+ G P + + M
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM 207
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 61/256 (23%), Positives = 97/256 (37%), Gaps = 58/256 (22%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKN 405
F S +++GRGAFG V +G V A+K + + E AE I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+V++ +K L L+ E++P G + +L + + ++ V+ + S +H
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS----IH 118
Query: 466 QECEQQVIHRDIKASNIMLDA-------------------------NFNARLESSFTL-- 498
Q IHRDIK N++LD+ N N L S FT
Sbjct: 119 Q---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 499 --------------------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRP 538
T GT Y+APE + D +S GV++ E+ G P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 539 IERETEGHKMVNLVDW 554
ET +++W
Sbjct: 236 FCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 22/196 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA--ELSIIACLRHKNLVQLLGWC 413
LG G++ VYK +G + A+K E F A E S++ L+H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
K L V+EYM D Y G L + RL + L L Y+H Q ++
Sbjct: 73 HTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG---QHIL 125
Query: 474 HRDIKASNIMLD-------ANFN-ARLES----SFTLTAGTMGYLAPEYLQYGTA-TEKT 520
HRD+K N+++ A+F AR +S +++ T+ Y P+ L T +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL 185
Query: 521 DVFSYGVVVLEVACGR 536
D++ G + +E+ G+
Sbjct: 186 DIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 35/217 (16%)
Query: 354 RILGRGAFGNVY---KAYFASSGSVAAVKRSKHS---HEGKT--EFLAELSIIACLRHKN 405
R+LG GA+G V+ K +G + A+K K + + KT E ++ +R
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 406 LVQLLGWCAE-KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG-LASALTY 463
+ L + + +L L+ +Y+ G L LYQ E+ + + + + AL +
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ-REHFTE----SEVRVYIAEIVLALDH 120
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT--------------AGTMGYLAPE 509
LHQ +I+RDIK NI+LD+ + L + F L+ GT+ Y+APE
Sbjct: 121 LHQ---LGIIYRDIKLENILLDSEGHVVL-TDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 510 YLQYGTA--TEKTDVFSYGVVVLEVACGRRPIERETE 544
++ G+ + D +S GV+ E+ G P + E
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 36/208 (17%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE---FLAELSIIACLRHKNLVQLLGW 412
+GRGA+G V A + + A+K+ ++ + + + L E+ ++ L H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 413 CAEKG-----ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
++ +VYE M D L+Q + LS H + L L Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS- 126
Query: 468 CEQQVIHRDIKASNIMLDANFN--------ARLESS----FTLTAGTMGYLAPEYL---- 511
V+HRD+K SN++L+AN + AR S T T Y APE L
Sbjct: 127 --ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCS 184
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPI 539
+Y TA DV+S G + E+ GR+P+
Sbjct: 185 EYTTA---IDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 44/224 (19%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQL 409
F +++GRGAFG V + + A+K K E L AC R + V +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-----KWEMLKRAET-ACFREERNVLV 56
Query: 410 LGWCA----------EKGELLLVYEYMPNGSLDRML--YQDSENGVLLSWYHRLNIVVGL 457
G C ++ L LV +Y G L +L ++D + +Y + +
Sbjct: 57 NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEM 111
Query: 458 ASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES-------------SFTLTAGTMG 504
A+ +HQ +HRDIK N++LD N + RL ++ GT
Sbjct: 112 VLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD 168
Query: 505 YLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERET 543
Y++PE LQ G + D +S GV + E+ G P E+
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 64/238 (26%), Positives = 91/238 (38%), Gaps = 60/238 (25%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE----FLAELSIIACLRHKN 405
F +++GRGAFG V+ +G V A+K + S K AE I+A
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL----LSWYHRLNIVVGLASAL 461
+V+L ++ L LV EYMP G L +L V +Y + L AL
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFY-----IAELVLAL 114
Query: 462 TYLHQECEQQVIHRDIKASNIMLD-------ANF----------------NARLESSFTL 498
+H+ IHRDIK NI++D A+F N F
Sbjct: 115 DSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 499 ------------------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRP 538
T GT Y+APE L+ + D +S GV++ E+ G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 24/202 (11%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK-RSKHSHEGKTE---FLAELSI-IACLRHKNLVQ 408
+++G+G+FG V A + G AVK K + K E +AE ++ + ++H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L +L V +Y+ G L L ++ + ++ I ASAL YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEI----ASALGYLH--- 113
Query: 469 EQQVIHRDIKASNIMLDANFNARL------------ESSFTLTAGTMGYLAPEYLQYGTA 516
+I+RD+K NI+LD+ + L + + GT YLAPE L+
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 517 TEKTDVFSYGVVVLEVACGRRP 538
D + G V+ E+ G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 64/255 (25%), Positives = 108/255 (42%), Gaps = 33/255 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSK----HSHEGKTEFLAELSIIACLRHKNLVQL 409
R++GRG++ V + + A+K K H E E + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 410 LGWCAE-KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L C + L LV EY+ G D M + + L H + AL +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGG--DLMFHMQRQRK--LPEEHARFYAAEICIALNFLH--- 113
Query: 469 EQQVIHRDIKASNIMLDANFNARLES------------SFTLTAGTMGYLAPEYLQYGTA 516
E+ +I+RD+K N++LDA+ + +L + + GT Y+APE L+
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 517 TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI-------IEAAD 569
D ++ GV++ E+ GR P + T+ M N D+++ + E I ++A+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVILEKPIRIPRFLSVKASH 232
Query: 570 KRLNGAFNEDEMKRL 584
L G N+D +RL
Sbjct: 233 V-LKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 349 GFHSNRILGRGAFGNVYKAYF----ASSGSVAAVKRSKH--SHEGKTEFLAELSIIACLR 402
+ +L G FG ++ VK K S T L E ++ L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 403 HKNLVQLLGWCAEKGELLLV-YEYMPNGSLDRMLYQ----DSENGVLLSWYHRLNIVVGL 457
H+N++ +L C E GE V Y YM G+L L Q ++ N LS +++ + +
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 458 ASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS------FTLTAGTMG------- 504
A ++YLH+ + VIH+DI A N ++D ++ + F + +G
Sbjct: 127 ACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 505 -YLAPEYLQYGTATEKTDVFSYGVVVLEVA 533
++A E L + +DV+S+GV++ E+
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS-----HEGKTEFLAELSIIACLRHKNLVQ 408
++LG+G+FG V+ A + A+K K + + + + + H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L K L V EY+ G L + + + + ++ I+ GL +LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGL----QFLHS-- 114
Query: 469 EQQVIHRDIKASNIMLD-------ANF-----NARLESSFTLTAGTMGYLAPEYL---QY 513
+ +++RD+K NI+LD A+F N ++ GT Y+APE L +Y
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPIERETE 544
T+ D +S+GV++ E+ G+ P E
Sbjct: 174 NTS---VDWWSFGVLLYEMLIGQSPFHGHDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 42/210 (20%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEG-KTEFLAELSIIACLRHKNLVQLLGW 412
+G G +G VYKA + A+K R + EG + + E+S++ ++H N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRL------NIVVGLASALTYLHQ 466
+ L LV+EY LD L + ++ + RL I+ G+A Y H
Sbjct: 70 VHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCHS 120
Query: 467 ECEQQVIHRDIKASNIMLDANFNARLESSFTLTAG-------------TMGYLAPEYL-- 511
+V+HRD+K N+++D NA + F L T+ Y APE L
Sbjct: 121 ---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG 177
Query: 512 --QYGTATEKTDVFSYGVVVLEVACGRRPI 539
Y T D++S G + E+ ++P+
Sbjct: 178 SRHYSTP---VDIWSVGCIFAEMV-NQKPL 203
|
Length = 294 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 30/210 (14%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTE-FLAELSIIACL-RHKNLVQL 409
+LG+G+FG V A + + A+K K + E + E ++A + L QL
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL---LSWYHRLNIVVGLASALTYLHQ 466
L V EY+ G L +Y + G + ++ I +GL +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGL----FFLHS 119
Query: 467 ECEQQVIHRDIKASNIMLD-------ANFNARLESSF----TLT-AGTMGYLAPEYLQYG 514
+ +I+RD+K N+MLD A+F E+ F T T GT Y+APE + Y
Sbjct: 120 ---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQ 176
Query: 515 TATEKTDVFSYGVVVLEVACGRRPIERETE 544
+ D +++GV++ E+ G+ P + E E
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 17/162 (10%)
Query: 393 AELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN 452
+EL +A H +V+ +LLL+ EY G L++ + Q + + Y
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 453 IVVGLASALTYLHQECEQQVIHRDIKASNIML---------DANFNARLESSFTLTA--- 500
+ + AL +H ++HRD+K++NI L D F+ + S +L
Sbjct: 174 LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 501 --GTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIE 540
GT YLAPE + ++K D++S GV++ E+ RP +
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 34/136 (25%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 357 GRGAFGNVYKAYF--ASSGSVAAVKRSKHSHEGKTEF----LAELSIIACLRHKNLVQLL 410
GRG +G VYKA G A+K+ K E T E++++ L+H+N+V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 411 GWCAEKGE--LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
E + + L+++Y + + + V + +++ + + + YLH
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--- 125
Query: 469 EQQVIHRDIKASNIML 484
V+HRD+K +NI++
Sbjct: 126 SNWVLHRDLKPANILV 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173892 cd07308, lectin_leg-like, legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47 | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 60/231 (25%), Positives = 81/231 (35%), Gaps = 50/231 (21%)
Query: 32 FNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSF 91
+ N T+ G + + I LT ++ S SGSL P+P F F
Sbjct: 17 GEIGNWTVGGSTVITKNYIRLTPDV---PSQSGSLWSRVPIPA--------KDFEIEVEF 65
Query: 92 SINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKF--VAIEFDT-----R 144
SI+ GDG AF+ + + G G +KF +AI FDT +
Sbjct: 66 SIHG-GSGLGGDGFAFWYTEEPGSDGPLFG----------GPDKFKGLAIFFDTYDNDGK 114
Query: 145 LDPHF-----DDPDENHIGLDIDSLESIKTADPILQGIDLKSGN---VITAWIDYKNDLR 196
P D D + LE L LK N T I Y N+
Sbjct: 115 GFPSISVFLNDGTKSYDYETDGEKLE--------LASCSLKFRNSNAPTTLRISYLNNT- 165
Query: 197 MLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQS 247
LKV ++YS V + L Y GFSA T ++ H I S
Sbjct: 166 -LKVDITYSEGNNWKECFTVEDVI---LPSQGYFGFSAQTGDLSDNHDILS 212
|
The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 218 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 14/151 (9%)
Query: 354 RILGRGAFGNVYKAYFASSG--------SVAAVKRSKHSHEGKTEFLAELSIIACL-RHK 404
+ LG GAFG V +A G +V +K S H+ E + ++EL I++ L +HK
Sbjct: 44 KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE-REALMSELKILSHLGQHK 102
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
N+V LLG C G +L++ EY G L L + +E + + + ++ Y
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFV----MALPEISETSSDYK 158
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARLESS 495
+ E++ I D S+ D R SS
Sbjct: 159 NITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTE-FLAELSIIACLRHKN 405
F+ +LG+G+FG V A + + A+K K + E + E ++A
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 406 LVQLLGWCAEKGE-LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
+ L C + + L V EY+ G L +YQ + G H + +A L +L
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKE-PHAVFYAAEIAIGLFFL 117
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARLESSFTLT-------------AGTMGYLAPEYL 511
H + +I+RD+K N+MLD+ + ++ + F + GT Y+APE +
Sbjct: 118 HS---KGIIYRDLKLDNVMLDSEGHIKI-ADFGMCKENMWDGVTTKTFCGTPDYIAPEII 173
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
Y + D +++GV++ E+ G+ P E E E
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 52/215 (24%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEG-KTEFLAELSIIACLRHKN-LVQLL 410
+G G +G VYKA ++G + A+K R + EG L E+S++ L +V+LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 411 GWCAE-------KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRL------NIVVGL 457
E K L LV+EY+ D + DS L + + L
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL---DSDLKKFMDSNGR---GPGRPLPAKTIKSFMYQL 119
Query: 458 ASALTYLHQECEQQVIHRDIKASNIMLD--------ANFNARLESSFTLTAG-------T 502
+ + H+ V+HRD+K N+++D A+ L +F++ T
Sbjct: 120 LKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG--LGRAFSIPVKSYTHEIVT 174
Query: 503 MGYLAPEYL----QYGTATEKTDVFSYGVVVLEVA 533
+ Y APE L Y T D++S G + E++
Sbjct: 175 LWYRAPEVLLGSTHYSTP---VDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 67/248 (27%), Positives = 106/248 (42%), Gaps = 26/248 (10%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK----RSKHSHEGKTEFLAELSII-ACLRHKNLVQ 408
+++G+G+FG V A S GS AVK ++ + + +AE +++ L+H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L +L V +Y+ G L L ++ L R +ASA+ YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRER---CFLEPRARF-YAAEVASAIGYLHS-- 114
Query: 469 EQQVIHRDIKASNIMLDANFNARL------------ESSFTLTAGTMGYLAPEYLQYGTA 516
+I+RD+K NI+LD+ + L E + + GT YLAPE L+
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 517 TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576
D + G V+ E+ G P N++ L G AA L G
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH--KPLQLPGGKTVAACDLLVGLL 231
Query: 577 NEDEMKRL 584
++D+ +RL
Sbjct: 232 HKDQRRRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFL-AELSIIACLRHKN 405
F S +++GRGAFG V +G + A+K+ + S + + + AE I+A +
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLASALT 462
+V+L ++ L L+ EY+P G + +L + +E +Y + A+
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR--FY-----IAETILAID 115
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAG 501
+H+ IHRDIK N++LDA + +L S F L G
Sbjct: 116 SIHK---LGYIHRDIKPDNLLLDAKGHIKL-SDFGLCTG 150
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 26/248 (10%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTE--FLAELSII-ACLRHKNLVQ 408
+++G+G+FG V A + AVK + K + K E ++E +++ ++H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L +L V +Y+ G L Y L R +ASAL YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARF-YAAEIASALGYLHS-- 114
Query: 469 EQQVIHRDIKASNIMLDA-------NF-----NARLESSFTLTAGTMGYLAPEYLQYGTA 516
+++RD+K NI+LD+ +F N + + GT YLAPE L
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 517 TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576
D + G V+ E+ G P N+++ L + I +A L G
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARHLLEGLL 231
Query: 577 NEDEMKRL 584
+D KRL
Sbjct: 232 QKDRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 31/204 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK----RSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
+G G FG V S + A V R S + + +FL E L+H NL+Q LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRL--NIVVGLASALTYLHQECE 469
C E LLV E+ P G L L + L++ + +A L +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHK--- 118
Query: 470 QQVIHRDIKASNIMLDANFNARL----------ESSFTLTAGT----MGYLAPEYLQ--Y 513
IH D+ N +L A+ ++ + + +T + ++APE + +
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 514 GT-----ATEKTDVFSYGVVVLEV 532
G T++++V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 39/213 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT---EFLAELSIIACLRHKNLVQLL 410
+G GA+G V A SG A+K+ H+ + T L EL I+ +H N++ +
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 411 GWCAEKGELL----LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
G +V + M + L +++ D L+ H + L L Y+H
Sbjct: 71 DILRPPGADFKDVYVVMDLMES-DLHHIIHSDQP----LTEEHIRYFLYQLLRGLKYIHS 125
Query: 467 ECEQQVIHRDIKASNIMLDAN-------FN-ARLESSF--------TLTAGTMGYLAPEY 510
VIHRD+K SN++++ + F AR SS T T Y APE
Sbjct: 126 AN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 511 L----QYGTATEKTDVFSYGVVVLEVACGRRPI 539
L +Y T D++S G + E+ GRR +
Sbjct: 183 LLSLPEY---TTAIDMWSVGCIFAEM-LGRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLG 411
+G+G+FG V + + + A+K + +H T LAE +++A + +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
+L LV ++ G L L ++ + + ++ ++ AL LH +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLC----ALENLH---KFN 113
Query: 472 VIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEYLQYGTATEK 519
VI+RD+K NI+LD + L + T T GT YLAPE L T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 520 TDVFSYGVVVLEVACGRRPIERE 542
D ++ GV++ E+ G P E
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDE 196
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 36/298 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFL----AELSII-ACLRHKNLVQ 408
R++GRG++ V + + A+K K E + E + H LV
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L + L V EY+ G D M + + L H ++ AL YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRK--LPEEHARFYSAEISLALNYLH--- 113
Query: 469 EQQVIHRDIKASNIMLDANFNARLES------------SFTLTAGTMGYLAPEYLQYGTA 516
E+ +I+RD+K N++LD+ + +L + + GT Y+APE L+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 517 TEKTDVFSYGVVVLEVACGRRPIE-RETEGHKMVNLVDWVWGLYAEGRI-------IEAA 568
D ++ GV++ E+ GR P + + + N D+++ + E +I ++AA
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 233
Query: 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLT 626
L N+D +RL + D P R V L + + VVP KP ++
Sbjct: 234 SV-LKSFLNKDPKERLGCHPQT-GFADIQGHPFFRNVDWDLMEQKQ--VVPPFKPNIS 287
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 48/223 (21%)
Query: 354 RILGRGAFGNVY---KAYFASSGSV---------AAVKRSKHSHEGKTEFLAELSIIACL 401
++LG GA+G V+ K +G + A V+++K +TE +++ +
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTE----RNVLEHV 61
Query: 402 RHKNLVQLLGWCAE-KGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVG- 456
R + L + + + +L L+ +Y+ G + LYQ SE+ V G
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV--------RFYSGE 113
Query: 457 LASALTYLHQECEQQVIHRDIKASNIMLDANFNARL--------------ESSFTLTAGT 502
+ AL +LH+ +++RDIK NI+LD+ + L E +++ GT
Sbjct: 114 IILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF-CGT 169
Query: 503 MGYLAPEYLQYGTATEK-TDVFSYGVVVLEVACGRRPIERETE 544
+ Y+APE ++ K D +S G+++ E+ G P E E
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 58/256 (22%), Positives = 97/256 (37%), Gaps = 58/256 (22%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKN 405
F S +++GRGAFG V +G + A+K + + E AE I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+V++ +K L L+ E++P G + +L + + ++ V+ A+ +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL----AIDAIH 118
Query: 466 QECEQQVIHRDIKASNIMLDANFNARLE-------------------------SSFTL-- 498
Q IHRDIK N++LDA + +L S F+
Sbjct: 119 Q---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 499 --------------------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRP 538
T GT Y+APE + D +S GV++ E+ G P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 539 IERETEGHKMVNLVDW 554
ET +++W
Sbjct: 236 FCSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 52/238 (21%)
Query: 342 ELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVK---------RSKHSHEGKTEFL 392
+ + + +R+LG GA G V A S G AVK K+ + + L
Sbjct: 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCL 85
Query: 393 AE---LSIIACLRHKNLVQLLGWCAEKGELL-LVYEYMPNGSLDRML---------YQDS 439
SI+ C H++ + E ++ LV +Y G L + + +++
Sbjct: 86 LNCDFFSIVKC--HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH 143
Query: 440 ENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT 499
E G+L I V LA +H + +IHRDIK++NI+L +N +L F +
Sbjct: 144 EAGLLF-------IQVLLA-----VHHVHSKHMIHRDIKSANILLCSNGLVKL-GDFGFS 190
Query: 500 ---------------AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERE 542
GT Y+APE + ++K D+FS GV++ E+ +RP + E
Sbjct: 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248
|
Length = 496 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 25/149 (16%)
Query: 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEF----------------LAELS 396
LG G +G V KAY +G + A+K+ K E + L EL
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 397 IIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG 456
I+ ++H+N++ L+ E + LV + M L +++ + + L+ I++
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV----DRKIRLTESQVKCILLQ 127
Query: 457 LASALTYLHQECEQQVIHRDIKASNIMLD 485
+ + L LH+ +HRD+ +NI ++
Sbjct: 128 ILNGLNVLHK---WYFMHRDLSPANIFIN 153
|
Length = 335 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 39/153 (25%), Positives = 65/153 (42%), Gaps = 20/153 (13%)
Query: 392 LAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRL 451
L E ++ + H +++++ +V +P+ S D Y + L L
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPL-PIDQAL 160
Query: 452 NIVVGLASALTYLHQECEQQVIHRDIKASNIMLD------------ANFNARLESSFTLT 499
I + L YLH Q++IHRD+K NI ++ A F + +F
Sbjct: 161 IIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV-VAPAFLGL 216
Query: 500 AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEV 532
AGT+ APE L K D++S G+V+ E+
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 33/200 (16%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA-----ELSIIACLRHKNLVQLL 410
+G GAFG V A +G A+K K T LA EL ++ LRH+N++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 411 G-WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL---LSWYHRLNIVVGLASALTYLHQ 466
+ + ++ V E + L R+L + L Y I+ G L Y+H
Sbjct: 76 DIFISPLEDIYFVTELLGT-DLHRLL----TSRPLEKQFIQYFLYQILRG----LKYVHS 126
Query: 467 ECEQQVIHRDIKASNIMLDANFN--------ARL-ESSFTLTAGTMGYLAPE-YLQYGTA 516
V+HRD+K SNI+++ N + AR+ + T T Y APE L +
Sbjct: 127 ---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKY 183
Query: 517 TEKTDVFSYGVVVLEVACGR 536
+ D++S G + E+ G+
Sbjct: 184 DVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 51/234 (21%), Positives = 100/234 (42%), Gaps = 39/234 (16%)
Query: 356 LGRGAFGNVYKAYFASSGSV---AAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
+G G FG V+ + A+ K++ + E++++ L+HKN+V+ +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 413 CAEKG--ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE- 469
K +L ++ E+ G L R + + + + + ++I L AL Y H +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 470 ---QQVIHRDIKASNIMLDA-------------NFNAR---------------LESSFTL 498
++V+HRD+K NI L N N R +ES
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHS 200
Query: 499 TAGTMGYLAPEYLQYGTAT--EKTDVFSYGVVVLEVACGRRPIERETEGHKMVN 550
GT Y +PE L + T + +K+D+++ G ++ E+ G+ P + ++++
Sbjct: 201 CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLIS 254
|
Length = 1021 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 37/211 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR----SKHSHEGKTEFLAELSIIACLRHKNLVQL 409
+G GA+G V A +G A+K+ + +T L E+ I+ +H+N++ +
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT--LREIKILRRFKHENIIGI 68
Query: 410 L-----GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
L ++ +V E M L +++ LS H + + L Y+
Sbjct: 69 LDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH-----LSNDHIQYFLYQILRGLKYI 122
Query: 465 HQECEQQVIHRDIKASNIMLDANFN--------ARL-----ESSFTLT--AGTMGYLAPE 509
H V+HRD+K SN++L+ N + AR+ + + LT T Y APE
Sbjct: 123 HS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
Query: 510 -YLQYGTATEKTDVFSYGVVVLEVACGRRPI 539
L T+ D++S G ++ E+ RP+
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 44/224 (19%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQL 409
F +++GRGAFG V ++ V A+K K E L AC R + V +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-----KWEMLKRAET-ACFREERDVLV 56
Query: 410 LG---WCA-------EKGELLLVYEYMPNGSLDRML--YQDSENGVLLSWYHRLNIVVGL 457
G W ++ L LV +Y G L +L ++D + +Y + +
Sbjct: 57 NGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEM 111
Query: 458 ASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES-------------SFTLTAGTMG 504
A+ +HQ +HRDIK NI++D N + RL ++ GT
Sbjct: 112 VIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 168
Query: 505 YLAPEYLQY-----GTATEKTDVFSYGVVVLEVACGRRPIERET 543
Y++PE LQ G + D +S GV + E+ G P E+
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 53/209 (25%), Positives = 81/209 (38%), Gaps = 55/209 (26%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR----HKNLVQLLG 411
+G G F V KA +G A+K K + + L I LR H N+++L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVN-NLREIQALRRLSPHPNILRLIE 65
Query: 412 WCAEK--GELLLV--------YEYM-------PNGSLDRMLYQDSENGVLLSWYHRLNIV 454
++ G L LV YE + P + +YQ
Sbjct: 66 VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQ----------------- 108
Query: 455 VGLASALTYLHQECEQQVIHRDIKASNIMLD------ANF-NARLESS---FTLTAGTMG 504
L +L ++H+ + HRDIK NI++ A+F + R S +T T
Sbjct: 109 --LLKSLDHMHR---NGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRW 163
Query: 505 YLAPE-YLQYGTATEKTDVFSYGVVVLEV 532
Y APE L G K D+++ G V E+
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEI 192
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 40/144 (27%), Positives = 64/144 (44%), Gaps = 13/144 (9%)
Query: 356 LGRGAFGNVY--KAYFASSGSVAAVKRSKHSHEGK--TEFLAELSIIACLRHKNLVQLLG 411
+G G FG V + Y + + VK K + K EFL + L+H N++Q LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSE---NGVLLSWYHRLNIVVGLASALTYLHQEC 468
C E LLV+EY G L L Q+ N LL + +A+ +T++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHK-- 117
Query: 469 EQQVIHRDIKASNIMLDANFNARL 492
+H D+ N L ++ ++
Sbjct: 118 -HNFLHSDLALRNCFLTSDLTVKV 140
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA-----ELSIIACLRHKNLVQ 408
+G GA+G V A+ +G A+K K S ++ A EL ++ + H+N++
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMDHENVIG 78
Query: 409 LLGWCAEKGELLLVYE--YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
LL L ++ Y+ + L + L S H +V + L Y+H
Sbjct: 79 LLD-VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKL-SDDHIQFLVYQILRGLKYIHS 136
Query: 467 ECEQQVIHRDIKASNIMLDAN-------FN-ARL-ESSFTLTAGTMGYLAPE-YLQYGTA 516
+IHRD+K SNI ++ + F AR + T T Y APE L +
Sbjct: 137 ---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHY 193
Query: 517 TEKTDVFSYGVVVLEVACGR 536
+ D++S G ++ E+ G+
Sbjct: 194 NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 42/153 (27%), Positives = 63/153 (41%), Gaps = 31/153 (20%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVK---------RSKHSHEGKTEFLAELSIIAC 400
F ++LG+G G V+ +G + A+K R+K L E I+A
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKR-----VLTEQEILAT 57
Query: 401 LRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG---- 456
L H L L + L LV +Y P G L R+L + G L+ V
Sbjct: 58 LDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPG------KCLSEEVARFYA 109
Query: 457 --LASALTYLHQECEQQVIHRDIKASNIMLDAN 487
+ AL YLH +++RD+K NI+L +
Sbjct: 110 AEVLLALEYLHL---LGIVYRDLKPENILLHES 139
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 46/176 (26%), Positives = 85/176 (48%), Gaps = 31/176 (17%)
Query: 391 FLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHR 450
F S+++ + H +L + G C E ++V E++ +G LD L ++ V ++W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGR-VPVAW--K 119
Query: 451 LNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------TLTAGT 502
+ + LASAL+YL ++ ++H ++ A NI+L A S F + TA +
Sbjct: 120 ITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 503 -------MGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVAC--------GRRPIERE 542
+ ++APE + G + + D +S+G +LE+ C R P E+E
Sbjct: 177 REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-CFDGEVPLKERTPSEKE 231
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSK----HSHEGKTEFLAELSII-ACLRHKNLVQ 408
R++GRG++ V + + A+K K + E E + H LV
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L + L V E++ G L M + + L H ++ AL +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRK--LPEEHARFYSAEISLALNFLH--- 113
Query: 469 EQQVIHRDIKASNIMLDANFNARL---------------ESSFTLTAGTMGYLAPEYLQ- 512
E+ +I+RD+K N++LDA + +L S+F GT Y+APE L+
Sbjct: 114 ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF---CGTPNYIAPEILRG 170
Query: 513 --YGTATEKTDVFSYGVVVLEVACGRRPIE 540
YG + D ++ GV++ E+ GR P +
Sbjct: 171 EDYGFS---VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA----ELSIIACLRHKN 405
FH+ +++G+GAFG V +G + A+K S K + LA E ++A
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRML--YQD-SENGVLLSWYHRLNIVVGLASALT 462
+V L + L L+ E++P G L ML Y SE+ ++ ++ V+ + +
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED---VTRFYMAECVLAIEA--- 116
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAG 501
+H+ IHRDIK NI++D + +L S F L+ G
Sbjct: 117 -VHK---LGFIHRDIKPDNILIDRGGHIKL-SDFGLSTG 150
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 38/219 (17%)
Query: 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA-----ELSIIACLR- 402
+ + LG+GA+G V A A + V K ++ + LA EL ++ R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 403 HKNLVQLLG----WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLA 458
HKN+ L + EL L E M + L+Q +G L+ H + + +
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELM-----EADLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 459 SALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAG----------------- 501
L Y+H V+HRD+K N++++A+ ++ F L G
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKI-CDFGLARGFSENPGENAGFMTEYVA 171
Query: 502 TMGYLAPE-YLQYGTATEKTDVFSYGVVVLEVACGRRPI 539
T Y APE L + + T+ DV+S G ++ E+ GR+P+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 66/229 (28%), Positives = 97/229 (42%), Gaps = 54/229 (23%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFL--AELSIIACLRHKNLV 407
F +++GRGAFG V ++G V A+K K E L AE AC R + V
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN-----KWEMLKRAE---TACFREERDV 54
Query: 408 QLLG---WCA-------EKGELLLVYEYMPNGSLDRML--YQDSENGVLLSWYHRLNIVV 455
+ G W ++ L LV +Y G L +L ++D + +Y +
Sbjct: 55 LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LA 109
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLE---SSFTLTA----------GT 502
+ A+ +HQ +HRDIK N++LD N + RL S L A GT
Sbjct: 110 EMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGT 166
Query: 503 MGYLAPEYLQ--------YGTATEKTDVFSYGVVVLEVACGRRPIERET 543
Y++PE LQ YG + D +S GV + E+ G P E+
Sbjct: 167 PDYISPEILQAMEDGKGRYGP---ECDWWSLGVCMYEMLYGETPFYAES 212
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 32/203 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT---EFLAELSIIACLRHKNLVQLL 410
+ +G GA G V A+ G AVK+ + +T EL ++ C+ HKN++ LL
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 411 G------WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN-IVVGLASALTY 463
E ++ LV E M + +L ++++ + + + R++ ++ + + +
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELD-------HERMSYLLYQMLCGIKH 138
Query: 464 LHQECEQQVIHRDIKASNI---------MLDANFNARLESSFTLT--AGTMGYLAPEYLQ 512
LH +IHRD+K SNI +LD ++F +T T Y APE +
Sbjct: 139 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195
Query: 513 YGTATEKTDVFSYGVVVLEVACG 535
E D++S G ++ E+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 42/154 (27%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 358 RGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWC 413
RGAFG VY ++ + AVK K + + AE +A + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 414 AEKGELLLVYEYMPNGSLDRML----YQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
+ LV EY+ G + +L Y D E V + +A AL YLH+
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV--------KYISEVALALDYLHR--- 122
Query: 470 QQVIHRDIKASNIMLDANFNARLESSFTLTAGTM 503
+IHRD+K N+++ + +L + F L+ T+
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKL-TDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 32/202 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEF---LAELSIIACLRHKNLVQLLG- 411
+G GA G V AY A A+K+ + +T EL ++ C+ HKN++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 412 WCAEKG-----ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN-IVVGLASALTYLH 465
+ +K ++ +V E M + +L +++ + + + R++ ++ + + +LH
Sbjct: 92 FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 143
Query: 466 QECEQQVIHRDIKASNIMLDANFNAR-LESSFTLTAG----------TMGYLAPEYLQYG 514
+IHRD+K SNI++ ++ + L+ TAG T Y APE +
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 515 TATEKTDVFSYGVVVLEVACGR 536
E D++S G ++ E+ G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 35/211 (16%)
Query: 354 RILGRGAFGNVY---KAYFASSGSVAAVKRSKHS---HEGKT--EFLAELSIIACLRHKN 405
++LG GA+G V+ K SG + A+K K + + KT E ++ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 406 LVQLLGWCAE-KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG-LASALTY 463
+ L + + +L L+ +Y+ G L L Q + I G + AL +
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-----EQEVQIYSGEIVLALEH 120
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT--------------AGTMGYLAPE 509
LH+ +I+RDIK NI+LD+N + L + F L+ GT+ Y+AP+
Sbjct: 121 LHK---LGIIYRDIKLENILLDSNGHVVL-TDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176
Query: 510 YLQYGTA--TEKTDVFSYGVVVLEVACGRRP 538
++ G + D +S GV++ E+ G P
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 354 RILGRGAFGNVYK--AYFASSG------SVAAVKRSKHSHEGKTEFLAELSIIACL-RHK 404
RILG GAFG V + AY S +V +K + S E K ++EL I+ L H
Sbjct: 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSE-KQALMSELKIMTHLGPHL 101
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSEN 441
N+V LLG C + G + ++ EY G L L+++ +N
Sbjct: 102 NIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDN 138
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 37/215 (17%)
Query: 355 ILGRG--AFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQL 409
++GRG V A + +G V+R ++E T EL + H N+V
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRML---YQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
EL +V +M GS ++ + D + + +++ I+ G+ AL Y+H
Sbjct: 65 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY-----ILQGVLKALDYIHH 119
Query: 467 ECEQQVIHRDIKASNIMLDAN---FNARLESSFTL----------------TAGTMGYLA 507
+HR +KAS+I++ + + + L S+ ++ + + +L+
Sbjct: 120 ---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLS 176
Query: 508 PEYLQYGTA--TEKTDVFSYGVVVLEVACGRRPIE 540
PE LQ K+D++S G+ E+A G P +
Sbjct: 177 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 56/225 (24%)
Query: 340 YRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA-----E 394
YR+L+ +G GA+G V A +G+ A+K K ++E A E
Sbjct: 17 YRDLKQ----------VGSGAYGTVCSALDRRTGAKVAIK--KLYRPFQSELFAKRAYRE 64
Query: 395 LSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDR-------MLYQDSENGVLLSW 447
L ++ ++H+N++ LL + P+ SLDR M + ++ G L+
Sbjct: 65 LRLLKHMKHENVIGLLD------------VFTPDLSLDRFHDFYLVMPFMGTDLGKLMK- 111
Query: 448 YHRLN------IVVGLASALTYLHQECEQQVIHRDIKASNI---------MLDANFNARL 492
+ +L+ +V + L Y+H +IHRD+K N+ +LD +
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168
Query: 493 ESSFTLTAGTMGYLAPEY-LQYGTATEKTDVFSYGVVVLEVACGR 536
+S T T Y APE L + T+ D++S G ++ E+ G+
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 33/124 (26%), Positives = 57/124 (45%), Gaps = 24/124 (19%)
Query: 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASN 481
+Y +M + + D ++D L R I+ L A+ Y+H ++++IHRDIK N
Sbjct: 249 LYSFMYDEAFD---WKDRP----LLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLEN 297
Query: 482 IMLDANFNARLESSFTLT-------------AGTMGYLAPEYLQYGTATEKTDVFSYGVV 528
I L+ + L T GT+ +PE L E TD++S G++
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLI 357
Query: 529 VLEV 532
+L++
Sbjct: 358 LLDM 361
|
Length = 501 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 32/198 (16%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT---EFLAELSIIACLRHKNLVQLLG- 411
+G GA G V AY A A+K+ + +T EL ++ C+ HKN++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 412 -----WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN-IVVGLASALTYLH 465
E ++ LV E M + +L +++ + + + R++ ++ + + +LH
Sbjct: 85 FTPQKSLEEFQDVYLVMELM-DANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 466 QECEQQVIHRDIKASNIMLDANFNAR-LESSFTLTAG----------TMGYLAPEYLQYG 514
+IHRD+K SNI++ ++ + L+ TAG T Y APE +
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 515 TATEKTDVFSYGVVVLEV 532
E D++S G ++ E+
Sbjct: 194 GYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 10/87 (11%)
Query: 354 RILGRGAFGNV--------YKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHK 404
+ LG GAFG V +K+ A + +V +K S H E + ++EL +++ L H
Sbjct: 41 KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLSYLGNHI 99
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSL 431
N+V LLG C G L++ EY G L
Sbjct: 100 NIVNLLGACTVGGPTLVITEYCCYGDL 126
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 27/94 (28%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 391 FLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHR 450
F S++ + HK++V L G C E ++V E++ G LD +++ S+ +L+ +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWK 107
Query: 451 LNIVVGLASALTYLHQECEQQVIHRDIKASNIML 484
+ LASAL+YL ++ ++H ++ NI+L
Sbjct: 108 FKVAKQLASALSYLE---DKDLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 27/159 (16%)
Query: 394 ELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNI 453
E I+ + H +++QL G L+ +P D Y ++ + + L I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAIC--DILAI 187
Query: 454 VVGLASALTYLHQECEQQVIHRDIKASNIMLD-------ANFNARL------ESSFTLTA 500
+ A+ YLH E ++IHRDIKA NI ++ +F A + + A
Sbjct: 188 ERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244
Query: 501 GTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVACGR 536
GT+ APE L YG A D++S G+V+ E+A
Sbjct: 245 GTIATNAPELLARDPYGPA---VDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 21/212 (9%)
Query: 341 RELRSATRGFHSNRILGRGAFGNVYKAYFASSG-SVAAVKRSKHSHEGKTE----FLAEL 395
R+ + F+ R LG G+FG V A + + A+KR + S K + +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 396 SIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVV 455
I+ + H V L G ++ L LV E++ G L ++ + ++ IV+
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDAN---------FNARLESSFTLTAGTMGYL 506
YL +++RD+K N++LD + F +++ GT Y+
Sbjct: 143 ----IFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYI 195
Query: 507 APEYLQYGTATEKTDVFSYGVVVLEVACGRRP 538
APE L + D ++ G+ + E+ G P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---GKTEFLAELSIIACLRHKNLVQLLG 411
++G+G++G V A +G A+K+ E T L E+ ++ LRH ++V++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 412 WC-----AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
E ++ +V+E M + L+Q + L+ H + L AL Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121
Query: 467 ECEQQVIHRDIKASNIMLDANFN--------ARLESSFTLTA-------GTMGYLAPEYL 511
V HRD+K NI+ +A+ AR+ + T TA T Y APE
Sbjct: 122 ---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 512 Q--YGTATEKTDVFSYGVVVLEVACGR 536
+ T D++S G + EV G+
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---------RSKHSHEGKTEFLAELSII-ACLRH 403
+++G+G+FG V A G AVK R + H +AE +++ ++H
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKH-----IMAERNVLLKNVKH 55
Query: 404 KNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
LV L +L V +++ G L L ++ + ++ +ASAL Y
Sbjct: 56 PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFY----AAEIASALGY 111
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARL------------ESSFTLTAGTMGYLAPEYL 511
LH +++RD+K NI+LD+ + L + T GT YLAPE +
Sbjct: 112 LHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRP 538
+ D + G V+ E+ G P
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 26/199 (13%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHS-----HEGKTEFLAELSIIACLRHKNLVQLL 410
+G GA+G+V A+ +G AVK+ H +T EL ++ ++H+N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT--YRELRLLKHMKHENVIGLL 82
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL---LSWYHRLNIVVGLASALTYLHQE 467
L E+ + ++ D N V L+ H ++ + L Y+H
Sbjct: 83 DVFTPARSL---EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 138
Query: 468 CEQQVIHRDIKASNI---------MLDANFNARLESSFTLTAGTMGYLAPE-YLQYGTAT 517
+IHRD+K SN+ +LD + T T Y APE L +
Sbjct: 139 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYN 196
Query: 518 EKTDVFSYGVVVLEVACGR 536
+ D++S G ++ E+ GR
Sbjct: 197 QTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 32/202 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHS-----HEGKTEFLAELSIIACLRHKNLVQLL 410
+G GA+G+V AY AVK+ H +T EL ++ ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT--YRELRLLKHMKHENVIGLL 80
Query: 411 ------GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
E+ LV M L+ ++ LS H ++ L L Y+
Sbjct: 81 DVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQK-----LSDEHVQFLIYQLLRGLKYI 134
Query: 465 HQECEQQVIHRDIKASNI---------MLDANFNARLESSFTLTAGTMGYLAPE-YLQYG 514
H +IHRD+K SN+ +LD + + T T Y APE L +
Sbjct: 135 HS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWM 191
Query: 515 TATEKTDVFSYGVVVLEVACGR 536
+ D++S G ++ E+ G+
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 354 RILGRGAFGNVYKA------YFASSGSVAA--VKRSKHSHEGKTEFLAELSIIACL-RHK 404
R LG GAFG V +A + S+ VA +K + S E K ++EL I++ L H
Sbjct: 43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE-KQALMSELKIMSHLGPHL 101
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQD 438
N+V LLG C + G + ++ EY G L L+++
Sbjct: 102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRN 135
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 15/98 (15%)
Query: 350 FHSNRILGRGAFGNVYKAYF-----ASSGSVAAVKRSKHSHEGKT-----EFLAELSIIA 399
++LG GAFG V +A SS + AVK K EG T ++EL I+
Sbjct: 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLK---EGATASEHKALMSELKILI 65
Query: 400 CL-RHKNLVQLLGWCAE-KGELLLVYEYMPNGSLDRML 435
+ H N+V LLG C + G L+++ E+ G+L L
Sbjct: 66 HIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 356 LGRGAFGN---VYKAYFASSGSVAAVKRS---KHSHEGKTEFLAELSIIACLRHKNLVQL 409
+GRG F N VY A +G++ V+ + + E E+ + RH N++
Sbjct: 6 IGRG-FCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRML---YQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
L ++ +M GS + +L + + + L+ NI+ G L YLHQ
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQ 119
Query: 467 ECEQQVIHRDIKASNIMLDANF------------------NARLESSF-TLTAGTMGYLA 507
IHR+IKAS+I++ + A++ F + + +L+
Sbjct: 120 ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176
Query: 508 PEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIE 540
PE L+ YG K+D++S G+ E+A GR P +
Sbjct: 177 PELLRQDLYGYNV-KSDIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 29/91 (31%), Positives = 42/91 (46%), Gaps = 17/91 (18%)
Query: 457 LASALTYLHQECEQQVIHRDIKASNIMLD-------ANFNA-------RLESSFTLTAGT 502
L SA+ Y+H E +IHRDIK N++++ +F A AGT
Sbjct: 269 LLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGT 325
Query: 503 MGYLAPEYLQYGTATEKTDVFSYGVVVLEVA 533
+ APE L T D++S G+V+ E A
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 22/174 (12%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVK---------RSKHSHEGKTEFLAELSIIAC 400
F + LG GAFG V A + ++ A+K R++ +H AE I+A
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAH-----VKAERDILAE 57
Query: 401 LRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASA 460
++ +V+L +K L V +Y+P G + +L + G+ R I L A
Sbjct: 58 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR---MGIFPEDLARFYIA-ELTCA 113
Query: 461 LTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAGTMGYLAPEYLQYG 514
+ +H+ IHRDIK NI++D + + +L + F L G +Y Q G
Sbjct: 114 VESVHK---MGFIHRDIKPDNILIDRDGHIKL-TDFGLCTGFRWTHDSKYYQSG 163
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 33/202 (16%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA-----ELSIIACLRHKNLVQLL 410
+G GA+G+V A +G A+K K S ++E A EL+++ ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 411 GWCA------EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
E + LV YM M + SE+ V Y L L Y+
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML-------CGLKYI 133
Query: 465 HQECEQQVIHRDIKASNI---------MLDANFNARLESSFTLTAGTMGYLAPEY-LQYG 514
H +IHRD+K N+ +LD ++ T T Y APE L +
Sbjct: 134 HS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWM 190
Query: 515 TATEKTDVFSYGVVVLEVACGR 536
+ D++S G ++ E+ G+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 57/213 (26%), Positives = 86/213 (40%), Gaps = 50/213 (23%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT---EFLAELSIIACLRHKNLVQLL 410
+ +G GA G V AY +G A+K+ + T EL ++ + HKN++ LL
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 411 GW------CAEKGELLLVYEYMPNGSL----------DRMLYQDSENGVLLSWYHRLNIV 454
E ++ LV E M + +L +RM Y LL Y L
Sbjct: 82 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSY-------LL--YQML--- 128
Query: 455 VGLASALTYLHQECEQQVIHRDIKASNI---------MLDANFNARLESSFTLT--AGTM 503
+ +LH +IHRD+K SNI +LD +SF +T T
Sbjct: 129 ----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 181
Query: 504 GYLAPEYLQYGTATEKTDVFSYGVVVLEVACGR 536
Y APE + E D++S G ++ E+ G
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 34/94 (36%), Positives = 47/94 (50%), Gaps = 15/94 (15%)
Query: 354 RILGRGAFGNVYKAYF-----ASSGSVAAVKRSKHSHEGKTE-----FLAELSIIACL-R 402
+ LGRGAFG V +A ++S AVK K EG T + EL I+ +
Sbjct: 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLK---EGATASEYKALMTELKILIHIGH 69
Query: 403 HKNLVQLLGWCAEK-GELLLVYEYMPNGSLDRML 435
H N+V LLG C + G L+++ EY G+L L
Sbjct: 70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 12/166 (7%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK--RSKH--SHEGKTEFLAELSIIACLRHKNLVQL 409
+ LG GAFG V A + ++ A+K R K + AE I+A ++ +V+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
+K L V +Y+P G + +L + +L+ ++ + L A+ +H+
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY----IAELTLAIESVHK--- 119
Query: 470 QQVIHRDIKASNIMLDANFNARLESSFTLTAGTMGYLAPEYLQYGT 515
IHRDIK NI++D + + +L + F L G +Y Q G+
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKL-TDFGLCTGFRWTHNSKYYQKGS 164
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 9e-04
Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 22/157 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---------RSKHSHEGKTEFLAELSIIACLRHK 404
+ +G GAFG V + ++ A+K R++ +H AE I+A ++
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAH-----VKAERDILAEADNE 61
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
+V+L +K L V +Y+P G + +L + G+ R I L A+ +
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR---LGIFEEDLARFYIA-ELTCAIESV 117
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAG 501
H+ IHRDIK NI++D + + +L + F L G
Sbjct: 118 HK---MGFIHRDIKPDNILIDRDGHIKL-TDFGLCTG 150
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 62/263 (23%), Positives = 94/263 (35%), Gaps = 89/263 (33%)
Query: 356 LGRGAFGNVYKAYF-----ASSGSVAAVKRSKH--SHEGKTEFLAELSIIACL-RHKNLV 407
LGRGAFG V +A ++ AVK K +H ++EL I+ + H N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 408 QLLGWCAEKGELLLVY------------------EYMPNGSLDRMLYQDSENGVLLS--W 447
LLG C + G L+V E++P + D Q +S
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 448 YHRLNIVVGLASA----------------------------LTYLHQEC----------- 468
RL+ + S+ LT C
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 469 --EQQVIHRDIKASNIMLDANFNARLESSFTLTAGTMGYLAPEYLQYGTA---------- 516
++ IHRD+ A NI+L N N F L Y P+Y++ G A
Sbjct: 195 LASRKCIHRDLAARNILLSEN-NVVKICDFGLARDI--YKDPDYVRKGDARLPLKWMAPE 251
Query: 517 -------TEKTDVFSYGVVVLEV 532
T ++DV+S+GV++ E+
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 41/148 (27%), Positives = 61/148 (41%), Gaps = 26/148 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR--SKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
R LG G+ G V+ A + AVK+ K L E+ II L H N+V++
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK-HALREIKIIRRLDHDNIVKVYE 69
Query: 412 WCAEKGE--------------LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGL 457
G + +V EYM L +L E G L + RL + L
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL----EQGPLSEEHARL-FMYQL 123
Query: 458 ASALTYLHQECEQQVIHRDIKASNIMLD 485
L Y+H V+HRD+K +N+ ++
Sbjct: 124 LRGLKYIHS---ANVLHRDLKPANVFIN 148
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 645 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06899 | 236 | lectin_legume_LecRK_Arcelin_ConA legume lectins, l | 100.0 | |
| PF00139 | 236 | Lectin_legB: Legume lectin domain; InterPro: IPR00 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd01951 | 223 | lectin_L-type legume lectins. The L-type (legume-t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| cd07308 | 218 | lectin_leg-like legume-like lectins: ERGIC-53, ERG | 99.89 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| cd06901 | 248 | lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.74 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.69 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.69 | |
| cd06902 | 225 | lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran | 99.68 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.65 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.58 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.57 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.57 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.55 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.53 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.52 | |
| PF03388 | 229 | Lectin_leg-like: Legume-like lectin family; InterP | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.49 | |
| cd06903 | 215 | lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem | 99.41 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.39 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.37 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.25 | |
| KOG3839 | 351 | consensus Lectin VIP36, involved in the transport | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.05 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.05 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.02 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.97 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.91 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.9 | |
| KOG3838 | 497 | consensus Mannose lectin ERGIC-53, involved in gly | 98.8 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.74 | |
| cd06900 | 255 | lectin_VcfQ VcfQ bacterial pilus biogenesis protei | 98.68 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.67 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.47 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.46 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.35 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.19 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.17 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.02 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.0 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.79 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.69 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.65 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.52 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.47 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.46 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.43 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.43 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.34 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.12 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.0 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.91 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.88 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.75 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.72 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.71 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.37 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.35 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.3 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.28 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.25 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.65 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.58 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.31 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.03 | |
| PLN02236 | 344 | choline kinase | 94.82 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.17 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 94.13 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.92 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 93.79 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.04 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 92.76 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.48 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-55 Score=463.57 Aligned_cols=278 Identities=45% Similarity=0.790 Sum_probs=249.8
Q ss_pred CCcccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcch-hHhHHHHHHHHhhcCCCCeeeeeee
Q 041096 334 GPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG-KTEFLAELSIIACLRHKNLVQLLGW 412 (645)
Q Consensus 334 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~ 412 (645)
..+.|+|+||+.||++|...++||+|+||.||+|.+.+ +..||||++...... .++|.+|++++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 56789999999999999999999999999999999986 489999988775544 6779999999999999999999999
Q ss_pred eeeCC-eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCee
Q 041096 413 CAEKG-ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491 (645)
Q Consensus 413 ~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~k 491 (645)
|.+.+ +.+||||||++|+|.++|+..... +++|.+|++|+.++|+||+|||+.+.++|+||||||+|||||+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99998 599999999999999999876543 699999999999999999999999988999999999999999999999
Q ss_pred eeccc----ccc---------ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh
Q 041096 492 LESSF----TLT---------AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 492 l~d~~----~~~---------~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
++|.. ... .||.+|+|||+...+..++|+|||||||+|+||++|+.|.+... ......+.+|++..
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHH
Confidence 98821 111 79999999999999999999999999999999999999887543 23344589999999
Q ss_pred hccCchhHHhhhhcc-CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 559 YAEGRIIEAADKRLN-GAFNE-DEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
+.++++.+++|+++. +.++. +++..+..+++.|++.+|.+||+|.||+++|+.....
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999999997 66665 7899999999999999999999999999999655443
|
|
| >cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-54 Score=431.76 Aligned_cols=228 Identities=48% Similarity=0.789 Sum_probs=207.6
Q ss_pred eeEEeCCCCC--CCeEEecceEee-CCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCC
Q 041096 25 MNFDFTSFNL--RNITLLGDSYLR-NGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSF 101 (645)
Q Consensus 25 ~~f~~~~f~~--~~~~l~G~a~~~-~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 101 (645)
++|+|++|+. .+|+|+|+|.+. ++.|+||++.. ..+++|||+|++||+||++.+++++||+|+|+|+|.+.+...+
T Consensus 1 ~~f~f~~f~~~~~~l~l~G~A~~~~~~~i~LT~~~~-~~~~~G~v~y~~pi~l~~~~~~~~~sFst~F~F~i~~~~~~~~ 79 (236)
T cd06899 1 LSFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTS-PASSVGRALYSKPVRLWDSTTGKVASFSTSFSFSITPPNPSLG 79 (236)
T ss_pred CceecCCCCCCCCCEEEecceEcCCCCeEEecCCCC-CCcceEEEEeCCCEEeecCCCCCceeEEEEEEEEEEcCCCCCC
Confidence 4799999985 799999999998 89999999732 2678999999999999999999999999999999998776788
Q ss_pred CCceEEEEecCCCCC-CCCCCccccccCCCC--CCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccccc
Q 041096 102 GDGLAFFISPDNQIL-GSAGGCLGLVNSSQL--TKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGID 178 (645)
Q Consensus 102 g~G~aF~l~p~~~~~-~~~g~~lGl~~~~~~--~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~~ 178 (645)
||||||+|+|....+ +..|++|||++..++ +.+++|||||||++|.+++||++||||||+|++.|..+..+....++
T Consensus 80 gdGlAF~i~~~~~~~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHigIdvn~~~S~~~~~~~~~~~~ 159 (236)
T cd06899 80 GDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDDDGGK 159 (236)
T ss_pred CCeEEEEEecCCCCCCCCCcceeeeecCCCCCCcccceEEEEeecccCcccCCCCCCeEEEEcCCcccceeecccccccc
Confidence 999999999987744 588999999987665 45899999999999999999999999999999999888777665666
Q ss_pred cCCCCeEEEEEEecCCCceEEEEEEeCC-CCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeeeeeec
Q 041096 179 LKSGNVITAWIDYKNDLRMLKVFMSYSN-LKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTS 253 (645)
Q Consensus 179 ~~~g~~~~~~I~Y~~~~~~l~v~~~~~~-~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~~~ 253 (645)
+.+|+.++|||+||+.+++|+|+|++.. .+|..|+++.++||+.+|+++|||||||+||...|.|+|++|+|+++
T Consensus 160 l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~~~~~h~i~sWsF~s~ 235 (236)
T cd06899 160 LKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSFSSN 235 (236)
T ss_pred ccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcCCCcceEEEEEEEEEcC
Confidence 8899999999999999999999999765 37889999999999999999999999999999999999999999975
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin |
| >PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=419.21 Aligned_cols=226 Identities=46% Similarity=0.755 Sum_probs=200.6
Q ss_pred ceeEEeCCC-CCCCeEEecceEe-eCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC--CCC
Q 041096 24 NMNFDFTSF-NLRNITLLGDSYL-RNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV--NPS 99 (645)
Q Consensus 24 ~~~f~~~~f-~~~~~~l~G~a~~-~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~--~~~ 99 (645)
+++|+|++| +..+++|+|+|.+ .++.|+||+... .+++|||+|++||+|||+.+++++||+|+|+|+|... ...
T Consensus 1 ~~~F~~~~F~~~~~~~l~G~A~~~~~~~l~LT~~~~--~~~~G~~~y~~pi~l~d~~~~~~~sF~t~F~f~i~~~~~~~~ 78 (236)
T PF00139_consen 1 SVSFSFPSFSNSSNLTLNGDASISSNGSLQLTPDST--NNQAGRAWYNNPIQLWDSTTGNVASFSTSFSFSITNGPGSSN 78 (236)
T ss_dssp EEEEEESSBTTGTTEEEEETEEEETTSEEESSTBET--SSEEEEEEESSEEESBETTTTEBEEEEEEEEEEEEESSSSSS
T ss_pred CceEEcCCCCCCCceEEEeeEEeccCCeEEcCCCCC--CCcEEEEEECCcEEEeCCCCcceeeeeeEEEEEEeccCCCCc
Confidence 368999999 5899999999998 789999999732 3799999999999999999999999999999999653 567
Q ss_pred CCCCceEEEEecCCCCC-CCCCCccccccCCCCC--CCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCC---
Q 041096 100 SFGDGLAFFISPDNQIL-GSAGGCLGLVNSSQLT--KNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPI--- 173 (645)
Q Consensus 100 ~~g~G~aF~l~p~~~~~-~~~g~~lGl~~~~~~~--~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~--- 173 (645)
.+||||||||+|....+ ++.|++||+++..+.+ .++.|||||||++|++++||++|||||++|++.|..+.++.
T Consensus 79 ~~~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d~~~nHIgI~~n~~~s~~~~~~~~~~ 158 (236)
T PF00139_consen 79 NGGDGLAFVIQPDPNLPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYNDPDDNHIGIDVNSVVSNKTASAGYYS 158 (236)
T ss_dssp S-BEEEEEEEEETTSSTTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTTTSSSEEEEEESSSSESEEEE----E
T ss_pred cCCCceEEEEecCcccccCCCCCccCccccccCCCccCcEEEEEEeeeecccccccCCCEEEEECCCCcccccccccccc
Confidence 88999999999998643 5699999999876654 58999999999999999999999999999999998876543
Q ss_pred ccccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeeeee
Q 041096 174 LQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQ 251 (645)
Q Consensus 174 ~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~ 251 (645)
....++.+|+.++|||+||+.+++|+|+|+....+|..|+++..+||+.+|+++||||||||||...|.|.|++|+|+
T Consensus 159 ~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~~~~~h~I~sW~F~ 236 (236)
T PF00139_consen 159 SPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNSSKPSSPVLSVNVDLSAVLPEQVYVGFSASTGGSYQTHDILSWSFS 236 (236)
T ss_dssp EEEHHHGTTSEEEEEEEEETTTTEEEEEEEETTTTSEEEEEEEE--HHHHSCSEEEEEEEEEESSSSEEEEEEEEEEE
T ss_pred cccccccCCcEEEEEEEEcCCccEEEEEEecccCCCcceeEEEEEchHHhcCCCcEEEEEeecCCCcceEEEEEEEeC
Confidence 345678999999999999999999999999776789999999999999999999999999999999999999999995
|
Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B .... |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=383.07 Aligned_cols=238 Identities=33% Similarity=0.505 Sum_probs=203.4
Q ss_pred CceeccCCceEEEEEEECCCCeE-EEEEeccCCcc---hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC-eEEEEEecCC
Q 041096 353 NRILGRGAFGNVYKAYFASSGSV-AAVKRSKHSHE---GKTEFLAELSIIACLRHKNLVQLLGWCAEKG-ELLLVYEYMP 427 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~-vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~ 427 (645)
.+.||+|+||+||+|.+. |.. ||||++..... ..++|.+|+.+|.+++|||||+++|.|.+.. .++||||||+
T Consensus 46 ~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 455999999999999998 455 99999887332 2568999999999999999999999999987 7999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC-eeeCCCCCCcEEEcCCC-Ceeeecc----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ-VIHRDIKASNIMLDANF-NARLESS---------- 495 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDlkp~NIlld~~~-~~kl~d~---------- 495 (645)
+|+|.++|+.. ....++|..+++++.|||+||.|||+ .+ ||||||||+||||+.++ .+||+|.
T Consensus 124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 99999999874 22349999999999999999999999 66 99999999999999997 9999882
Q ss_pred --ccccccCCcccCccccc--CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 496 --FTLTAGTMGYLAPEYLQ--YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 496 --~~~~~gt~~y~APE~~~--~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
.+...||+.|||||++. ...|+.|+|||||||+||||+||+.||...... .. ...++...
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~----~~------------~~~v~~~~ 262 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV----QV------------ASAVVVGG 262 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH----HH------------HHHHHhcC
Confidence 12257999999999999 569999999999999999999999999875431 11 12233344
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
.+...+..+...+..++..||+.||.+||++.+++..|+...
T Consensus 263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 555666778899999999999999999999999999998553
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=383.77 Aligned_cols=250 Identities=30% Similarity=0.473 Sum_probs=217.1
Q ss_pred cccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeee
Q 041096 336 REFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415 (645)
Q Consensus 336 ~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 415 (645)
..+..++++. .+.||+|.||.||.|.+.. ...||+|.++......+.|.+|+++|++|+|+|||+++|+|..
T Consensus 201 wei~r~~l~l-------~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 201 WEIPREELKL-------IRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred eeecHHHHHH-------HHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 3455555544 5779999999999999974 4589999998877777899999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 416 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
++.+|||||||++|+|.+||+... +..+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|.
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDF 347 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDF 347 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEccc
Confidence 989999999999999999998732 3348999999999999999999999 99999999999999999999999883
Q ss_pred cccc-------------ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhcc
Q 041096 496 FTLT-------------AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAE 561 (645)
Q Consensus 496 ~~~~-------------~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~ 561 (645)
.-.. .-...|.|||.+..++++.|||||||||+||||+| |+.||......
T Consensus 348 GLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---------------- 411 (468)
T KOG0197|consen 348 GLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---------------- 411 (468)
T ss_pred ccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------------
Confidence 2111 12457999999999999999999999999999999 99999875432
Q ss_pred CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 562 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
++.+.++...+-..|..|+..+.+||..||+.+|++|||++.+...|+.....
T Consensus 412 -ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 412 -EVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred -HHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 35566677777788899999999999999999999999999999999876543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=389.55 Aligned_cols=249 Identities=29% Similarity=0.446 Sum_probs=211.4
Q ss_pred cCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
.+....+.||+|+||+||+|.... ....||||.++.. .+.+++|.+|++++..++|||||+|+|.|.+++.+|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 445556789999999999998743 3468999999883 336789999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCC----------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 421 LVYEYMPNGSLDRMLYQDSEN----------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
+|+|||..|+|.++|...... ..+|+..+.+.||.|||.||+||-+ +.+|||||.++|+||.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEE
Confidence 999999999999999754321 2238899999999999999999998 999999999999999999999
Q ss_pred eeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHH
Q 041096 491 RLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWV 555 (645)
Q Consensus 491 kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~ 555 (645)
||+|..- ...-..+||+||.+..++||++||||||||+|||+++ |+.||.+....
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---------- 712 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---------- 712 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH----------
Confidence 9988211 1223578999999999999999999999999999999 99999876542
Q ss_pred HhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 556 WGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 556 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
++.+.+..+-.-..+++++..++.||+.||+.+|++||+++||-..|+...+..
T Consensus 713 -------EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 713 -------EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred -------HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 223333333334678899999999999999999999999999999998665543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=384.10 Aligned_cols=257 Identities=28% Similarity=0.489 Sum_probs=225.1
Q ss_pred ccCHHHHHHHhcCC---------CcCceeccCCceEEEEEEECCCC---eEEEEEeccC--CcchhHhHHHHHHHHhhcC
Q 041096 337 EFSYRELRSATRGF---------HSNRILGRGAFGNVYKAYFASSG---SVAAVKRSKH--SHEGKTEFLAELSIIACLR 402 (645)
Q Consensus 337 ~~~~~~l~~~~~~f---------~~~~~lG~G~fg~Vy~g~~~~~~---~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~ 402 (645)
.++|+|.-.|...| .+.++||.|.||.||+|.++..+ ..||||.++. .+..+.+|+.|+.+|.+..
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 46787776666554 34588999999999999997655 5799999987 4566789999999999999
Q ss_pred CCCeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 041096 403 HKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNI 482 (645)
Q Consensus 403 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NI 482 (645)
||||++|.|+....+..|||+|||+||+|+.+|+.+..+ +.|.|+..++.+||.||.||-+ .++|||||.++||
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNI 762 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNI 762 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhhe
Confidence 999999999999999999999999999999999987654 9999999999999999999998 9999999999999
Q ss_pred EEcCCCCeeeeccccc---------c----cc--CCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccccc
Q 041096 483 MLDANFNARLESSFTL---------T----AG--TMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGH 546 (645)
Q Consensus 483 lld~~~~~kl~d~~~~---------~----~g--t~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~ 546 (645)
||+.+..+|++|..-. . .| ..+|.|||.+..+++|.+||||||||||||+++ |.+||.....
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-- 840 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-- 840 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--
Confidence 9999999999872211 1 11 368999999999999999999999999999888 9999987643
Q ss_pred chhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 547 KMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 547 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
.+++..+.+..+..-+.+|+..|.+||++||++|-.+||++.+++..|+++.-.|
T Consensus 841 ---------------QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 841 ---------------QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ---------------HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 2456677777777888999999999999999999999999999999999775555
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=348.35 Aligned_cols=245 Identities=27% Similarity=0.396 Sum_probs=205.6
Q ss_pred ccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeee
Q 041096 337 EFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCA 414 (645)
Q Consensus 337 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 414 (645)
.++..||+. .+.||+|..|+|||+.++.++..+|+|.+.. ....++++.+|++++++.+||+||.++|.|.
T Consensus 75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 355666654 5789999999999999999999999999854 4555788999999999999999999999999
Q ss_pred eCC-eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeee
Q 041096 415 EKG-ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLE 493 (645)
Q Consensus 415 ~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~ 493 (645)
... +..|+||||.+|||+.++..... +++...-+|+.+|++||.|||++ ++||||||||+||||+..+.+||.
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g~----i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVGR----IPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEec
Confidence 988 59999999999999999986533 89999999999999999999963 899999999999999999999998
Q ss_pred cc----------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc-ccchhhHHHHHHhhhccC
Q 041096 494 SS----------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETE-GHKMVNLVDWVWGLYAEG 562 (645)
Q Consensus 494 d~----------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~-~~~~~~l~~~~~~~~~~~ 562 (645)
|. ....+||..|||||.+.+..|+.++||||||+.++|+++|+.||..... ......++.+
T Consensus 222 DFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~-------- 293 (364)
T KOG0581|consen 222 DFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA-------- 293 (364)
T ss_pred cccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH--------
Confidence 82 2445899999999999999999999999999999999999999976521 1122223222
Q ss_pred chhHHhhhhccCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 563 RIIEAADKRLNGAFNED-EMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 563 ~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+++. -....+.+ +...+..++..|+++||.+||+++|+++
T Consensus 294 ----Iv~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 294 ----IVDE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ----HhcC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 11223343 6677888999999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=333.42 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=205.0
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeee-eeeCCe-EEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGW-CAEKGE-LLLVY 423 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~-~~~~~~-~~lV~ 423 (645)
+|.+.++||+|.||.|||+....+|..+|.|.+.. ....++....|+.+|++|+|||||+++++ +.++.+ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46677899999999999999999999999998875 34556789999999999999999999995 444555 89999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCcEEEcCCCCeeeecc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ-QVIHRDIKASNIMLDANFNARLESS------- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NIlld~~~~~kl~d~------- 495 (645)
|||..|+|...++..+++++.++....++++.|+++||.++|..+.+ -|+||||||.||+|+.++.+|++|.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999998887788899999999999999999999985533 3889999999999999999999982
Q ss_pred -----ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 496 -----FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 496 -----~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....+||+.||+||.+.+..|+.||||||+||++|||+.-+.||.+.+ ...+. +.+..
T Consensus 180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n----~~~L~-------------~KI~q 242 (375)
T KOG0591|consen 180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN----LLSLC-------------KKIEQ 242 (375)
T ss_pred chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc----HHHHH-------------HHHHc
Confidence 233589999999999999999999999999999999999999998742 22222 11111
Q ss_pred hccCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 571 RLNGAFN-EDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 571 ~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.-....+ ....+.+.+|+..|+..||+.||+.-.+++.+...
T Consensus 243 gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 243 GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 1111223 45678899999999999999999965555555543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=339.21 Aligned_cols=190 Identities=29% Similarity=0.462 Sum_probs=171.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
..+|...+.||+|+||+||+|+++.++..||||.+.+. ....+....|+.+|+.++|||||+|+++++.++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35677888899999999999999999999999998764 345667889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC------CCeeeeccc-
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN------FNARLESSF- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~------~~~kl~d~~- 496 (645)
|||.+|+|..|++.+.. ++......++.|+|.||++||+ ++||||||||+||||+.. -..||.|..
T Consensus 89 EyC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999998764 8999999999999999999999 999999999999999875 345777621
Q ss_pred ----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccc
Q 041096 497 ----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERET 543 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~ 543 (645)
...+|++-|||||++..++|+.|+|+||.|++|||+++|+.||...+
T Consensus 162 AR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 162 ARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 23589999999999999999999999999999999999999998644
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=353.86 Aligned_cols=238 Identities=26% Similarity=0.428 Sum_probs=203.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
..|...+.||+|||+.+|+++...+|+.||+|++.+ .....+...+||++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 568889999999999999999988999999999876 4555677899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-------- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-------- 495 (645)
|+|++++|.++++++. ++++.+...++.||+.||.|||+ ++|+|||||..|+||++++++||+|.
T Consensus 98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999998543 39999999999999999999999 99999999999999999999999982
Q ss_pred ----ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 496 ----FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 496 ----~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....|||+.|+|||++.....+-.+||||+||+||-|+.|++||+..+-.+....+ +..+-
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I--------------k~~~Y- 235 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI--------------KLNEY- 235 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH--------------HhcCc-
Confidence 23458999999999999999999999999999999999999999864321111100 00011
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHc
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILN 610 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~ 610 (645)
.+|........+|+..+|+++|.+|||+++|+. ++.
T Consensus 236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 223344556677888999999999999999986 553
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=394.71 Aligned_cols=257 Identities=26% Similarity=0.482 Sum_probs=215.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
...|...++||+|+||.||+|....++..||||++...... ..+|++++++++|||||+++|+|.+.+..++||||+
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 35677889999999999999999888999999988753322 235688999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-------cccc
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-------FTLT 499 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-------~~~~ 499 (645)
++|+|.++++. ++|.++.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++... ....
T Consensus 766 ~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~ 838 (968)
T PLN00113 766 EGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKC 838 (968)
T ss_pred CCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEEeccccccccCCCc
Confidence 99999999952 899999999999999999999766689999999999999999988776421 1223
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC--CCC
Q 041096 500 AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG--AFN 577 (645)
Q Consensus 500 ~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~ 577 (645)
.||..|+|||++.+..++.|+|||||||++|||++|+.||+.... ....+.+|++...........+|+.+.. ..+
T Consensus 839 ~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred cccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 578999999999999999999999999999999999999964322 2345667776666555666667777644 345
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 578 EDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 578 ~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
.++...+.+++.+||+.+|++||||+||++.|++....
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 56778899999999999999999999999999977553
|
|
| >cd01951 lectin_L-type legume lectins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=321.22 Aligned_cols=198 Identities=31% Similarity=0.474 Sum_probs=170.3
Q ss_pred CCCeEEecceEee--CCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCCCceEEEEec
Q 041096 34 LRNITLLGDSYLR--NGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISP 111 (645)
Q Consensus 34 ~~~~~l~G~a~~~--~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~p 111 (645)
..++.++|||.+. ++.|+||++ ..+++||++|++||++| ++|+|+|+|.|.+.. ..+||||||+|+|
T Consensus 13 ~~~~~~~G~A~~~~~~~~l~Lt~~---~~~~~G~~~~~~~i~~~-------~~F~~~F~f~i~~~~-~~~gdG~aF~l~~ 81 (223)
T cd01951 13 QSNWQLNGSATLTTDSGVLRLTPD---TGNQAGSAWYKTPIDLS-------KDFTTTFKFYLGTKG-TNGADGIAFVLQN 81 (223)
T ss_pred hhhcEEcccEEecCCCCEEEECCC---CCCcEEEEEECCcEecc-------CCEEEEEEEEEeCCC-CCCCCcEEEEEec
Confidence 5789999999998 899999997 46799999999999998 689999999999765 5689999999999
Q ss_pred CCCCC-CCCC--CccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccc-------cccCCCccccccCC
Q 041096 112 DNQIL-GSAG--GCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESI-------KTADPILQGIDLKS 181 (645)
Q Consensus 112 ~~~~~-~~~g--~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~-------~~~~~~~~~~~~~~ 181 (645)
..... +..| ++||+ .+.++.+||||||++|.+++||+.+||||++|+..+. ....+ .....+
T Consensus 82 ~~~~~~~~~g~~~~lG~-----~~~~~~~aVefDT~~N~~~~dp~~~higi~~n~~~~~~~~~~~~~~~~~---~~~~~~ 153 (223)
T cd01951 82 DPAGALGGGGGGGGLGY-----GGIGNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSASL---PNGTGL 153 (223)
T ss_pred CCCCccccCCCCCccCc-----cccCCeEEEEEeccccCCCCCCCCCEEEEEcCCCCCCcccccccceeeC---CCccCC
Confidence 87643 3444 78887 5668899999999999988899999999999999754 22221 112223
Q ss_pred CCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeeeee
Q 041096 182 GNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQ 251 (645)
Q Consensus 182 g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~ 251 (645)
|+.++|||+|++.+++|+|+|..... |..++++.++||+.+++++||||||||||...+.|.|++|+|.
T Consensus 154 g~~~~v~I~Y~~~~~~L~v~l~~~~~-~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V~~wsf~ 222 (223)
T cd01951 154 GNEHTVRITYDPTTNTLTVYLDNGST-LTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFT 222 (223)
T ss_pred CCEEEEEEEEeCCCCEEEEEECCCCc-cccccEEEeeeecccCCCcEEEEEEcccCCCcceeEEEEEEec
Confidence 89999999999999999999986543 6778999999999999999999999999999999999999996
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=371.30 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=208.4
Q ss_pred CCCcCceeccCCceEEEEEEECCCC-----eEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSG-----SVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~-----~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
+....+.||+|.||.||+|...+.. ..||||.+++ +.+...+|.+|..+|++++|||||+++|.|.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 4455678999999999999986533 3489999887 46678899999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCC---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc
Q 041096 422 VYEYMPNGSLDRMLYQDSE---NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL 498 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~ 498 (645)
++|||++|+|..||++.+. +...|+..+.+.++.|||+|+.||++ +.+|||||.++|+||++...+||+|..-.
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchh
Confidence 9999999999999987632 23459999999999999999999999 99999999999999999999999882211
Q ss_pred --------------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCc
Q 041096 499 --------------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGR 563 (645)
Q Consensus 499 --------------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 563 (645)
..-..+|||||.+..+.+|.|+|||||||+|||++| |..||...+..+....
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~------------- 916 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD------------- 916 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH-------------
Confidence 122468999999999999999999999999999999 9999987654221110
Q ss_pred hhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 564 IIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 564 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
.+... +-..+..|++.++++|+.||+.+|++||++..+++.+..+....
T Consensus 917 ---~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 917 ---VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ---HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 11111 34667889999999999999999999999999999887664433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=345.53 Aligned_cols=252 Identities=21% Similarity=0.376 Sum_probs=204.8
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC
Q 041096 340 YRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEK 416 (645)
Q Consensus 340 ~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 416 (645)
.+++....+.+.....||+|.||+||+|.+-. .||||.++. ..+..+.|++|+..+++-+|.||+-+.|||...
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34555555666778899999999999999963 589998876 345678899999999999999999999999988
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF 496 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~ 496 (645)
.. .||+.+|++.+|+.+|+.... .++..+.++|+.|||+||.|||. ++|||||||+.||+|++++.+||+|..
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred ce-eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEeccc
Confidence 77 999999999999999987654 39999999999999999999999 999999999999999999999999832
Q ss_pred --------------cccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh
Q 041096 497 --------------TLTAGTMGYLAPEYLQY---GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY 559 (645)
Q Consensus 497 --------------~~~~gt~~y~APE~~~~---~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~ 559 (645)
....|...|||||++.. .+|+.++||||||+|+|||++|..||......... +
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi----------f 603 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII----------F 603 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE----------E
Confidence 22346788999999974 46899999999999999999999999832221111 1
Q ss_pred ccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 560 AEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 560 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
..++-.-. +.+ .....++++.+.+|+..||..++++||.+.+|+..|+.+..
T Consensus 604 mVGrG~l~--pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 604 MVGRGYLM--PDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred EecccccC--ccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11110000 111 12234677788889999999999999999999998887655
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=339.79 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=197.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-----CCCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeC-C
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFA-----SSGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEK-G 417 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~-----~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 417 (645)
.++|+..++||+|+||.||+|.+. ..+..||||++... ....+.+.+|+.++.++ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 467888999999999999999752 33568999998753 23346789999999999 899999999998764 4
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCC--------------------------------------------------------
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSEN-------------------------------------------------------- 441 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~-------------------------------------------------------- 441 (645)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999999753210
Q ss_pred --CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc--------------ccccCCcc
Q 041096 442 --GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--------------LTAGTMGY 505 (645)
Q Consensus 442 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--------------~~~gt~~y 505 (645)
...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+|++|... ...++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1348889999999999999999999 9999999999999999999999987321 12345789
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHH
Q 041096 506 LAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRL 584 (645)
Q Consensus 506 ~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 584 (645)
+|||++.+..++.++|||||||+||||++ |+.||........ +.. ....+. ....+......+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~---~~~----~~~~~~---------~~~~~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---FCQ----RLKDGT---------RMRAPENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH---HHH----HHhcCC---------CCCCCCCCCHHH
Confidence 99999999999999999999999999997 9999976432111 111 011110 111223345678
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 585 LLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 585 ~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
.+++..||+.||++|||+.++++.|+....
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.54 Aligned_cols=239 Identities=25% Similarity=0.330 Sum_probs=193.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc--------hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE--------GKTEFLAELSIIACLRHKNLVQLLGWCAEKGE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 418 (645)
.+.|...+.||+|+||.|-+|..+.+++.||||++.+... ......+|+++|++|+|||||++.+++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3456778999999999999999999999999999876211 12235799999999999999999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC---CCeeeec-
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN---FNARLES- 494 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~---~~~kl~d- 494 (645)
.||||||+.+|.|.+.+-.+.. +......-+++|++.|+.|||+ +||+||||||+||||..+ ...||.|
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999976554 6666778899999999999999 999999999999999766 5567766
Q ss_pred ----------cccccccCCcccCcccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc
Q 041096 495 ----------SFTLTAGTMGYLAPEYLQYGT---ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE 561 (645)
Q Consensus 495 ----------~~~~~~gt~~y~APE~~~~~~---~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~ 561 (645)
.....|||+.|.|||++.+.. +..+.|+||+||+||-+++|.+||............+
T Consensus 324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI--------- 394 (475)
T KOG0615|consen 324 GLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI--------- 394 (475)
T ss_pred chhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH---------
Confidence 334568999999999998654 3458899999999999999999998765433221111
Q ss_pred CchhHHhhhhcc--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 562 GRIIEAADKRLN--GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 562 ~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...++. ...-....++...++.+++..||++|||+.|+++
T Consensus 395 ------~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 ------LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ------hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111110 1122344677889999999999999999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.82 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=204.8
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.....++||+|.||.|.++.... +..||||+++.. ...+.+|.+|+++|.+|+|||||+|+|.|..++.+++|+|||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 34556889999999999999864 689999999873 345689999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---ccc-----
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS---FTL----- 498 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~---~~~----- 498 (645)
++|+|.++|..+.... +.-....+|+.|||+||+||.+ .++|||||.++|+|+|.++++||.|. ...
T Consensus 618 EnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred hcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999998764321 4556778899999999999999 99999999999999999999999884 211
Q ss_pred ------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 499 ------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC--GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 499 ------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t--G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
.+-..+|||||.+.-+++|.+||||+||+.|||+++ ..+||....+.+ .++....+++.+....
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~----vven~~~~~~~~~~~~---- 764 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ----VVENAGEFFRDQGRQV---- 764 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH----HHHhhhhhcCCCCcce----
Confidence 123578999999999999999999999999999865 788998755432 2232222332222111
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
....+.-++..++++++.||+.|.++||+++++...|++.+
T Consensus 765 --~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 765 --VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred --eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 12345567889999999999999999999999999998654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.43 Aligned_cols=245 Identities=29% Similarity=0.407 Sum_probs=205.7
Q ss_pred CcCceeccCCceEEEEEEECCCCe---E-EEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 351 HSNRILGRGAFGNVYKAYFASSGS---V-AAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 351 ~~~~~lG~G~fg~Vy~g~~~~~~~---~-vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
...++||+|+||.||+|.+...+. . ||||..+. ......+|++|.++|++++|||||+++|++.....+|||
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 345889999999999999865322 3 89998774 355678999999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccccccc-
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAG- 501 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~~~g- 501 (645)
||+|.||+|.+||.+... .++..+++.++.+.|.||+|||+ .+++||||.++|+|++.+..+||+|..-...|
T Consensus 240 mEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 999999999999988764 39999999999999999999999 99999999999999999999999884333322
Q ss_pred -----------CCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 502 -----------TMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 502 -----------t~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
..+|+|||.+..+.|+.++|||||||++||+++ |..||.+.... .+..+ ++.
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~k------------I~~ 377 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAK------------IVK 377 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHH------------HHh
Confidence 368999999999999999999999999999999 88899875432 11111 112
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCC
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLV 617 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~ 617 (645)
...+...+...+..+..++..||..+|++||+|.++.+.|+.......
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 233344555677888888899999999999999999999987655544
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=323.84 Aligned_cols=242 Identities=24% Similarity=0.434 Sum_probs=198.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC---CCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFA---SSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~---~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
++|+..+.||+|+||.||+|.+. ..+..+|+|.++.. ......|.+|+.++.+++||||++++|++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999875 34578999988763 23346799999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-----
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT----- 497 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~----- 497 (645)
|||+++|+|.+++..... .+++.+++.++.|++.||+|||+ ++++||||||+|||++.++..++.|...
T Consensus 85 ~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999976432 38999999999999999999998 9999999999999999999999976321
Q ss_pred --------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 498 --------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 498 --------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
...++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .+.. .+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----~~~~-------------~~ 221 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIK-------------AV 221 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHH-------------HH
Confidence 1123568999999999999999999999999999775 99999764321 1111 11
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
........+..++..+.+++..||+.+|.+||+++++.+.|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11111223445667788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=327.84 Aligned_cols=261 Identities=25% Similarity=0.340 Sum_probs=201.9
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHh--hcCCCCeeeeeeeeeeCC----eEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIA--CLRHKNLVQLLGWCAEKG----ELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~--~l~H~niv~l~g~~~~~~----~~~l 421 (645)
......++||+|+||.||||.+. ++.||||++.. +..+.|.+|-++.+ .++|+||+++++.-..+. +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34455678999999999999997 58999999865 55667888777765 458999999999987766 8999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC------CCCeeeCCCCCCcEEEcCCCCeeeec-
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC------EQQVIHRDIKASNIMLDANFNARLES- 494 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDlkp~NIlld~~~~~kl~d- 494 (645)
|+||.++|+|.+||..+. ++|....+|+..+++||+|||++. +++|+|||||++||||.+|+++.|.|
T Consensus 286 Vt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999998764 899999999999999999999865 66899999999999999999999987
Q ss_pred -------------cccccccCCcccCcccccCCC------CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH
Q 041096 495 -------------SFTLTAGTMGYLAPEYLQYGT------ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV 555 (645)
Q Consensus 495 -------------~~~~~~gt~~y~APE~~~~~~------~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~ 555 (645)
+....+||.+|||||++.+.. .-.+.||||+|.|||||++...-+......+....+-..+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 222358999999999997642 2347999999999999999776553222222222233333
Q ss_pred HhhhccCchhHHh-hhhccCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCC
Q 041096 556 WGLYAEGRIIEAA-DKRLNGAFNE-----DEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLV 617 (645)
Q Consensus 556 ~~~~~~~~~~~~~-d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~ 617 (645)
.....-+++.+.+ .++.+..++. .-+..+++.+..||+.||+.|.|+.=|.+++.++.....
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 3333333333322 3333344433 246789999999999999999999999988877655544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=321.58 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=204.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.+.|+..+.||.|..++||+|.....++.||||++...+ .+...+.+|+..|+.++||||++++..|..+.++|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 356888899999999999999999899999999988743 345789999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS--------- 495 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~--------- 495 (645)
||.+||+.++++..-..+ ++...+..|.+++++||.|||. +|.||||||+.||||+++|.+||+|.
T Consensus 105 fMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999998765444 8999999999999999999999 99999999999999999999999872
Q ss_pred -------ccccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 496 -------FTLTAGTMGYLAPEYLQY--GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 496 -------~~~~~gt~~y~APE~~~~--~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
+...+||++|||||++.. ..|+.|+||||||+..+||++|+.||..... +..++....+....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP---mkvLl~tLqn~pp~----- 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP---MKVLLLTLQNDPPT----- 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh---HHHHHHHhcCCCCC-----
Confidence 244589999999999653 4699999999999999999999999987532 22222211111100
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
.....+..+........+.+++-.|+..||.+|||++++++ +++..
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 00001111111223347888889999999999999999986 45443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=321.91 Aligned_cols=230 Identities=24% Similarity=0.316 Sum_probs=193.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.++|+..++||+|+||+||.++.+++++.+|+|.+++. ....+...+|..+|.+++||.||++.-.+++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45789999999999999999999999999999998873 33466788999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec--------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES-------- 494 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d-------- 494 (645)
+||+.||.|..+|.+... ++.....-.+..|+.||.|||+ .+|+||||||+|||||.+|.+++.|
T Consensus 104 ld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999987654 8888888899999999999999 9999999999999999999999976
Q ss_pred ----cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 495 ----SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 495 ----~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
.....+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+....... +...
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~----------------I~~~ 240 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK----------------ILKG 240 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH----------------HhcC
Confidence 23345899999999999999999999999999999999999999987543221111 1111
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARP 600 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 600 (645)
++ ...+.-......+++...+..||++|.
T Consensus 241 k~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 241 KL-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cC-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11 112222344556666788999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=313.65 Aligned_cols=249 Identities=23% Similarity=0.305 Sum_probs=197.7
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcch---hHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG---KTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.|+...++|+|+||.|||++.+++|+.||||++..++++ .+-.++||++|++|+|+|+|.|+.+|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 466678899999999999999999999999999875543 45688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec-----------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES----------- 494 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d----------- 494 (645)
|+.. +.+-|...... ++.....+++.|++.|+.|+|+ ++++||||||+||||+.++..|++|
T Consensus 83 ~dhT-vL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 83 CDHT-VLHELERYPNG---VPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred cchH-HHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 9764 44445544432 8889999999999999999999 9999999999999999999999987
Q ss_pred -cccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh---
Q 041096 495 -SFTLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD--- 569 (645)
Q Consensus 495 -~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d--- 569 (645)
..+..+.|.+|+|||.+.+ -+|...+||||.||++.||++|...|.+..+-+....+......+... -++++.
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr--hq~iF~~N~ 233 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR--HQSIFSSNP 233 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH--HHHHhccCC
Confidence 3345578999999999987 689999999999999999999999888765544333333322222111 111110
Q ss_pred -------hh------ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 570 -------KR------LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 570 -------~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
|. +...+ ++....+++++..|++.||.+|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 00 00011 123347889999999999999999998865
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=323.41 Aligned_cols=250 Identities=18% Similarity=0.291 Sum_probs=199.6
Q ss_pred CCcccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcch----hHhHHHHHHHHhhcCCCCeeee
Q 041096 334 GPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG----KTEFLAELSIIACLRHKNLVQL 409 (645)
Q Consensus 334 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~----~~~~~~Ei~~l~~l~H~niv~l 409 (645)
..+.++++++. ......||+|++|.||+|.+. +..||||++...... .+.|.+|+.+|.+++||||+++
T Consensus 11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred cceecCHHHcC-----CCCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 34455666662 233467999999999999984 789999998764332 3667899999999999999999
Q ss_pred eeeeee----CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 041096 410 LGWCAE----KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485 (645)
Q Consensus 410 ~g~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld 485 (645)
+|++.+ ....++||||+++|+|.+++.... .++|...+.++.|++.||.|||+. .+++||||||+|||++
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~ 157 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVT 157 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEEC
Confidence 999877 347899999999999999997643 389999999999999999999971 4788999999999999
Q ss_pred CCCCeeeeccc---------cccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHH
Q 041096 486 ANFNARLESSF---------TLTAGTMGYLAPEYLQY--GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDW 554 (645)
Q Consensus 486 ~~~~~kl~d~~---------~~~~gt~~y~APE~~~~--~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~ 554 (645)
.++.+|+.|.. ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+...
T Consensus 158 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----~~~~~ 233 (283)
T PHA02988 158 ENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----EIYDL 233 (283)
T ss_pred CCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----HHHHH
Confidence 99999997732 22457889999999976 68999999999999999999999999764321 11111
Q ss_pred HHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 555 VWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 555 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+ .........+......+.+++..||+.||++|||++++++.|+..
T Consensus 234 i------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 234 I------------INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred H------------HhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1 011111123334566788999999999999999999999999754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.63 Aligned_cols=240 Identities=25% Similarity=0.447 Sum_probs=204.5
Q ss_pred cccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeee
Q 041096 336 REFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415 (645)
Q Consensus 336 ~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 415 (645)
.++.++++.. .+-||+|+.|.||+|++. ++.||||+.+.- -..+|+-|++|+|+||+.+.|+|..
T Consensus 119 WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~--netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 119 WEIPFEEISE-------LEWLGSGAQGAVFLGRLH--NETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred ccCCHHHhhh-------hhhhccCcccceeeeecc--CceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecC
Confidence 3455666543 456999999999999998 789999987542 2367888999999999999999999
Q ss_pred CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 416 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
..-+|||||||+.|-|.+.|+..+. +.......+.++||.||.|||. +.|||||||.-||||..+..+||+|.
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~~~----itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDF 256 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAGRP----ITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDF 256 (904)
T ss_pred CceeEEeeeccccccHHHHHhccCc----cCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccc
Confidence 9999999999999999999987654 7888889999999999999999 99999999999999999999999884
Q ss_pred cc-----------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 496 FT-----------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 496 ~~-----------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
.+ ..+||..|||||++...+.++|+||||||||||||+||..||...+.... +|+.
T Consensus 257 GTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------IwGV------ 323 (904)
T KOG4721|consen 257 GTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------IWGV------ 323 (904)
T ss_pred cchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------EEec------
Confidence 32 24799999999999999999999999999999999999999987643211 1111
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
-...|....+..+++.+..|+++||+..|..||++++++..|+-..
T Consensus 324 ---GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 324 ---GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred ---cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 1233444677889999999999999999999999999999998443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=335.58 Aligned_cols=244 Identities=27% Similarity=0.423 Sum_probs=214.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
..+....++||-|.||.||.|.++.-...||||.++...-..++|++|..+|+.++|||+|+|+|+|..+..+|||+|||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 34556678999999999999999988899999999998888999999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc----------c
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS----------F 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~----------~ 496 (645)
.+|+|.+||++.... .++-...+.++.||++||.||.. +.+|||||.++|+|+.++..+|+.|. .
T Consensus 346 ~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 999999999876543 37778889999999999999998 99999999999999999999999772 2
Q ss_pred ccccc---CCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 TLTAG---TMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ~~~~g---t~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
+...| ...|.|||.+....++.|+|||+|||+||||.| |..||.+.+-. .+.+.+.+..
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----------------qVY~LLEkgy 483 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYGLLEKGY 483 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----------------HHHHHHhccc
Confidence 22333 457999999999999999999999999999999 99999875321 2334455556
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+.+.++.|+..+++||+.||+.+|.+||+++|+-+.++..
T Consensus 484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 6677888999999999999999999999999998877744
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=323.07 Aligned_cols=236 Identities=36% Similarity=0.566 Sum_probs=188.7
Q ss_pred cCceeccCCceEEEEEEEC----CCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 352 SNRILGRGAFGNVYKAYFA----SSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 352 ~~~~lG~G~fg~Vy~g~~~----~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
..+.||.|.||.||+|.+. ..+..|+||.++.. ....+.|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999998 34678999999653 33468899999999999999999999999988889999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++|+|.++|.... ...+++.+++.|+.||++||+|||+ .+++|+||+++||+|+.++.+|+++..
T Consensus 83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999998862 2238999999999999999999999 899999999999999999999998731
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....+...|+|||.+....++.++||||||+++|||++ |+.||...... .+ .+.+..
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~----~~-------------~~~~~~ 220 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE----EI-------------IEKLKQ 220 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH----HH-------------HHHHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc----cc-------------cccccc
Confidence 11235678999999999999999999999999999999 77888654221 11 112222
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L 609 (645)
..+...+..++..+.+++..||+.+|++||+|+++++.|
T Consensus 221 ~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 222334445677788999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.18 Aligned_cols=251 Identities=23% Similarity=0.391 Sum_probs=196.8
Q ss_pred cCCCcCceeccCCceEEEEEEECC----------------CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeee
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS----------------SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQL 409 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~----------------~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l 409 (645)
++|...++||+|+||.||+|.+.. .+..||+|.+... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 567888999999999999998643 3447999988763 3345679999999999999999999
Q ss_pred eeeeeeCCeEEEEEecCCCCCHhHHhhhcCC---------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 041096 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSE---------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474 (645)
Q Consensus 410 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 474 (645)
++++.+.+..++||||+++|+|.+++..... ....++|.+.++++.|++.||+|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 9999999999999999999999999865321 11347899999999999999999999 99999
Q ss_pred CCCCCCcEEEcCCCCeeeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCC
Q 041096 475 RDIKASNIMLDANFNARLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC--GRRP 538 (645)
Q Consensus 475 rDlkp~NIlld~~~~~kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t--G~~P 538 (645)
|||||+|||++.++.+|++|... ...++..|+|||++..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999988321 1234678999999998899999999999999999987 5567
Q ss_pred CCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 539 IERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 539 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
|...... .....+........ .......+..++..+.+++..||+.+|++||||++|.+.|++
T Consensus 242 ~~~~~~~----~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE----QVIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH----HHHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7654321 12222211111100 000011223455678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.24 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=197.1
Q ss_pred hcCCCcCceeccCCceEEEEEEE-----CCCCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYF-----ASSGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~-----~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 418 (645)
.++|+..+.||+|+||.||+|+. .+++..||||+++.. ....+.+.+|+.++..+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688889999999999999974 345678999998753 23446788999999999 89999999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCC----------------------------------------------------------
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSE---------------------------------------------------------- 440 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 440 (645)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999975321
Q ss_pred -------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----------
Q 041096 441 -------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------- 497 (645)
Q Consensus 441 -------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------- 497 (645)
....++|..+++++.||++||+|||+ ++++||||||+|||++.+..+|+.|...
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 01247899999999999999999999 9999999999999999999999987321
Q ss_pred ----ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 498 ----LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 498 ----~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
...++..|+|||.+.+..++.++|||||||++|||++ |..||....... .+... +....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~~-------------~~~~~ 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYKM-------------IKEGY 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHHH-------------HHhCc
Confidence 1123457999999999999999999999999999998 888986543211 11111 11111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
....+...+..+.+++..||+.||++||+|.+|++.|++.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1112222345688999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.49 Aligned_cols=256 Identities=23% Similarity=0.391 Sum_probs=196.0
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHh--hcCCCCeeeeeeeeeeCC----
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIA--CLRHKNLVQLLGWCAEKG---- 417 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~--~l~H~niv~l~g~~~~~~---- 417 (645)
+...++....+.||+|.||.||+|.++ |+.||||++...++ +.+.+|.++.+ .|+|+||+.+++.-..+.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 445567888899999999999999998 89999999976543 34556555554 569999999998765443
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeeCCCCCCcEEEcCCCCeee
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC-----EQQVIHRDIKASNIMLDANFNARL 492 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlkp~NIlld~~~~~kl 492 (645)
++|||++|.++|||.+||.... ++....++++..+|.||+|||.+. ++.|.|||||+.||||..++.+.|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~t-----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNT-----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHhhcc-----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 7899999999999999997643 899999999999999999999753 788999999999999999999999
Q ss_pred ec----------------cccccccCCcccCcccccCCC------CCcchhHHHHHHHHHHHHcC----------CCCCC
Q 041096 493 ES----------------SFTLTAGTMGYLAPEYLQYGT------ATEKTDVFSYGVVVLEVACG----------RRPIE 540 (645)
Q Consensus 493 ~d----------------~~~~~~gt~~y~APE~~~~~~------~t~ksDV~SfGvvl~El~tG----------~~P~~ 540 (645)
.| ..+..+||.+|||||++...- .-..+||||||+|+||++.. +.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 77 334568999999999997532 13469999999999999863 34665
Q ss_pred ccccccchhhHHHHHHhhhccCchhHHhhhhccCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 541 RETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF-NEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 541 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
.....+....-+..+ --.+.+.|.+...+ +.+.+..+.++|..||..+|..|-|+-.+.+.|.++.+.
T Consensus 438 d~Vp~DPs~eeMrkV-------VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKV-------VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred cCCCCCCCHHHHhcc-------eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 433222111111000 01112223332222 235788999999999999999999999999998877653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.29 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=202.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
.+|...+.||+|+||.||+|.....+..+|+|.+........++.+|++++++++|+||++++++|..++..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 35777889999999999999998889999999988766667789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc---------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL--------- 498 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~--------- 498 (645)
+++|.+++..... ..+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+|+.|....
T Consensus 86 ~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999975432 348999999999999999999998 99999999999999999999999873211
Q ss_pred ----cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 499 ----TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 499 ----~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
..++..|+|||.+.+..++.++|||||||++|||++ |..||...... .. .+.+.....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~-------------~~~~~~~~~ 223 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QV-------------YELLEKGYR 223 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HH-------------HHHHHCCCC
Confidence 123457999999999999999999999999999998 89998653221 11 111111222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
...+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 233344567788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.30 Aligned_cols=244 Identities=26% Similarity=0.457 Sum_probs=200.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCC-----eEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSG-----SVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~-----~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
++|+..+.||+|+||.||+|.....+ ..+++|.+... ......|.+|++++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 35777899999999999999876544 67999988653 233567899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCC------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 041096 421 LVYEYMPNGSLDRMLYQDSEN------------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF 488 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~ 488 (645)
++|||+++++|.+++...... ...+++...+.++.|++.||+|||+ .+++||||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 999999999999999764221 1348899999999999999999999 9999999999999999999
Q ss_pred Ceeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHH
Q 041096 489 NARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVD 553 (645)
Q Consensus 489 ~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~ 553 (645)
.+++.|.. ....++..|+|||.+....++.++|||||||++|||++ |..||...... .+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----~~~- 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----EVI- 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHH-
Confidence 99997722 12245678999999998899999999999999999998 99999764321 111
Q ss_pred HHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 554 WVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 554 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
+.+........+...+..+.+++..||+.+|.+||++++|++.|++
T Consensus 237 ------------~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 ------------EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1222222223345567889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.87 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=206.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHh--HHHHHHHHhhcC-CCCeeeeeeeeeeCC-eEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE--FLAELSIIACLR-HKNLVQLLGWCAEKG-ELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~--~~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~lV 422 (645)
.++|...++||.|.||.||+|+-..++..||||+++..-..-++ =++|+..|++|. ||||++|...+.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 35677788999999999999999999999999999874433333 468999999998 999999999999888 99999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec--------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES-------- 494 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d-------- 494 (645)
|||| ..+|++.++.+. ..++..++..|+.||++||+|+|+ +|+.|||+||+|||+......||+|
T Consensus 89 fE~M-d~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhh-hhhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 9999 569999998764 359999999999999999999999 9999999999999999999999988
Q ss_pred ---cccccccCCcccCccccc-CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc------h
Q 041096 495 ---SFTLTAGTMGYLAPEYLQ-YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR------I 564 (645)
Q Consensus 495 ---~~~~~~gt~~y~APE~~~-~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~------~ 564 (645)
..+..+.|.+|+|||++. .+.|+.+.||||+|||++|+.+-+..|.+.++.+....+++ +.+...... +
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~-VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE-VLGTPDKDSWPEGYNL 240 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH-HhCCCccccchhHHHH
Confidence 345567899999999875 57899999999999999999999999988766554444433 222222111 1
Q ss_pred hHHhhhhccC-------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 565 IEAADKRLNG-------AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 565 ~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
...+.=++.. ..-..+.....+++..|+..||.+|||+.|++++
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1122111110 1112366788899999999999999999999984
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=318.93 Aligned_cols=240 Identities=23% Similarity=0.318 Sum_probs=195.6
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.|+..+.||+|+||.||+|....++..||+|.+... ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999999888999999987652 2234468899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++|+|..++..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++..++.|..
T Consensus 81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999988865332 248999999999999999999999 999999999999999999999998721
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....||..|+|||++.+..++.++|||||||++|||++|+.||...........+.. .+ ....
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~-------------~~-~~~~ 221 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR-------------RV-KEDQ 221 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH-------------Hh-hccc
Confidence 224589999999999999999999999999999999999999986433211111100 00 0011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPS-----MRRVFQ 607 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~~vl~ 607 (645)
..++......+.+++..||+.||.+||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1233344567788999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=329.32 Aligned_cols=236 Identities=27% Similarity=0.377 Sum_probs=201.4
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchh-HhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGK-TEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~-~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
.|....+||+|..|.||.+....++..||||++....+.. +-..+|+.+|+..+|+|||+++..+..++++|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 4666788999999999999999999999999999866654 457899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec------------c
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES------------S 495 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d------------~ 495 (645)
+|+|.+.+.... +++.++..|+.++++||+|||. ++|+|||||.+||||+.++..||.| .
T Consensus 354 ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 354 GGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 999999997654 8999999999999999999999 9999999999999999999999987 2
Q ss_pred ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 496 FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 496 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
....+||++|||||++....|..|.||||||++++||+-|..||-..+.-..+ .++ ...-.+.+ .
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl-yLI------------a~ng~P~l--k 490 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLI------------ATNGTPKL--K 490 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH-HHH------------hhcCCCCc--C
Confidence 34458999999999999999999999999999999999999999764321111 110 11111222 2
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.++.....+.++..+|++.|+.+||++.|+++
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 34445667788889999999999999999997
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=311.90 Aligned_cols=239 Identities=24% Similarity=0.374 Sum_probs=195.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|+..+.||+|+||.||++.+.. +..+|+|.+.........+.+|++++++++||||++++++|...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 357778899999999999998865 5678999887655556789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------- 497 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------- 497 (645)
+|+|.+++..... .++|..+..++.|++.||+|||+ ++++||||||+||+++.++.+++.|...
T Consensus 83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999999975432 38999999999999999999999 9999999999999999999999977221
Q ss_pred ---ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 498 ---LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 498 ---~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
...++..|+|||.+....++.++||||||+++|||++ |+.||...... .....+.. +. .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~----~~~~~i~~----~~---------~ 219 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY----EVVEMISR----GF---------R 219 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHC----CC---------C
Confidence 1123457999999998889999999999999999999 89998754321 11111111 00 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
...+......+.+++.+||+.+|++||+|.++++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0112223456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=333.20 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=196.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 418 (645)
.++|+..+.||+|+||.||+|.... ++..||+|++... ......+.+|+++++++ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 3578889999999999999998533 3457999998753 22345688999999999 89999999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCC----------------------------------------------------------
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSE---------------------------------------------------------- 440 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 440 (645)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864321
Q ss_pred --------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc--------------c
Q 041096 441 --------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--------------L 498 (645)
Q Consensus 441 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--------------~ 498 (645)
....+++.++++++.|+++||+|||+ ++++||||||+|||++.++.++++|... .
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 01247889999999999999999999 9999999999999999999999987321 1
Q ss_pred cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC
Q 041096 499 TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577 (645)
Q Consensus 499 ~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 577 (645)
..++..|+|||++....++.++|||||||++|||++ |+.||......... ...+........+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~----------------~~~~~~~~~~~~~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF----------------YKMVKRGYQMSRP 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH----------------HHHHHcccCccCC
Confidence 123457999999998999999999999999999997 99999764322111 1111111111122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 578 EDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 578 ~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
...+..+.+++..||+.+|++||++.+|++.|+++
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22346788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=323.14 Aligned_cols=245 Identities=23% Similarity=0.396 Sum_probs=196.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCe----EEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGS----VAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~----~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
.+|+..+.||+|+||.||+|++..++. .||+|.+... ....+++.+|+.+++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468889999999999999999765554 3899988653 33456899999999999999999999999875 5789
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc---
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL--- 498 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~--- 498 (645)
++||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+++||||||+|||++.++.+|+.|....
T Consensus 86 v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999986543 38899999999999999999999 99999999999999999999999872111
Q ss_pred -----------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 499 -----------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 499 -----------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
..++..|+|||++....++.++|||||||++|||++ |+.||...... .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~----~~~~------------- 222 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISS------------- 222 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHH-------------
Confidence 123567999999999999999999999999999998 99998753211 1111
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
.+........+..+...+.+++..||..+|.+||++.++++.|......+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 223 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 11111111122234456788999999999999999999999988665433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.39 Aligned_cols=240 Identities=26% Similarity=0.399 Sum_probs=195.3
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC--eEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQLLGWCAEKG--ELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~Ey 425 (645)
++...+.||+|.||.||++...++|...|||...... ...+.+.+|+.+|.+++|||||+++|.....+ .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 4556788999999999999999889999999876642 12456899999999999999999999855544 69999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCeeeeccc--------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA-NFNARLESSF-------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~-~~~~kl~d~~-------- 496 (645)
+++|+|.+++.+... .++.........||++||+|||+ ++|+||||||+||||+. ++.+||.|..
T Consensus 98 ~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred cCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999987653 39999999999999999999998 99999999999999999 7999998722
Q ss_pred -------cccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 -------TLTAGTMGYLAPEYLQYGT-ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~-~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....||+.|||||++..+. ...++||||+||++.||+||+.||.... ....+. ..+.
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~~~~~---------~~ig 236 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF------EEAEAL---------LLIG 236 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc------chHHHH---------HHHh
Confidence 1246999999999999643 3459999999999999999999997631 011111 1111
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L 609 (645)
.......++........+++..|+..+|++|||++++++..
T Consensus 237 ~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 237 REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11122245556667788888999999999999999999854
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.07 Aligned_cols=238 Identities=24% Similarity=0.316 Sum_probs=203.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 420 (645)
..++|...+.||+|+|++|++|+...++..+|||++.+. +.-.+....|-++|.+| .||.|++|+-.|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346788899999999999999999999999999998762 23345677888999999 8999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS----- 495 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~----- 495 (645)
+|+||++||+|.++|++.+. ++.......+.+|+.||+|||+ .|||||||||+|||||.|+..+|.|.
T Consensus 151 FvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999998764 8888889999999999999999 99999999999999999999999761
Q ss_pred --------------------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH
Q 041096 496 --------------------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV 555 (645)
Q Consensus 496 --------------------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~ 555 (645)
....+||..|.+||++..+..+..+|+|+|||+||+|+.|.+||...++--....++
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--- 300 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--- 300 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH---
Confidence 123589999999999999999999999999999999999999998755321111111
Q ss_pred HhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 556 WGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 556 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.++ -.+++..++.+.+|+...+..||.+|+|.+++.+.
T Consensus 301 -----------~l~----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 301 -----------ALD----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----------Hhc----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111 24455556777888889999999999999999773
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=317.58 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=194.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..+.||+|+||.||+|+...++..+|+|++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4688899999999999999999988999999988753 2335678899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|++++.|..+.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+|++|..
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987776554322 238999999999999999999998 999999999999999999999998721
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH-------h-hhccCc
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW-------G-LYAEGR 563 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~-------~-~~~~~~ 563 (645)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...........+..... . ......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 123578999999999988999999999999999999999999976432221111111000 0 000000
Q ss_pred hhHHhhhhccC------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 564 IIEAADKRLNG------AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 564 ~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
......+.... .........+.+++..|++.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.37 Aligned_cols=236 Identities=21% Similarity=0.236 Sum_probs=196.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||+|....+++.+|+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999999889999999886522 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|.+++..... +++.....++.|++.||+|||+ ++++||||||+|||++.++..|+.|..
T Consensus 81 e~~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999976543 8899999999999999999999 999999999999999999999998732
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +... +.... .
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----~~~~------------i~~~~--~ 215 (291)
T cd05612 154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----IYEK------------ILAGK--L 215 (291)
T ss_pred CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH------------HHhCC--c
Confidence 12358999999999999889999999999999999999999997643211 1110 00111 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPS-----MRRVFQI 608 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~~vl~~ 608 (645)
.++......+.+++..|++.||.+||+ ++++++.
T Consensus 216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 223333456788999999999999995 8888763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.91 Aligned_cols=247 Identities=25% Similarity=0.369 Sum_probs=202.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||+|+...++..+|||.+.. .......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 578889999999999999999988899999997654 2233457899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++++|.+++.........++......++.|+++||+|||+ .+++|+||||+||+++.++..++.|..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999986544334458899999999999999999998 999999999999999999999997732
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+.. .+...
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~-------------~~~~~ 223 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQ-------------KIEQC 223 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--HHHHHH-------------HHhcC
Confidence 1235788999999999888999999999999999999999998653211 111111 11111
Q ss_pred -ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 572 -LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 572 -l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
............+.+++.+||+.+|++||++.+|++.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11112234456789999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.34 Aligned_cols=252 Identities=24% Similarity=0.302 Sum_probs=198.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.++|+..+.||+|+||.||++....++..+|+|.+... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 36788899999999999999999989999999988753 2335679999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++++|.+++..... +++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+++.|..
T Consensus 84 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999976443 8899999999999999999997 2369999999999999999999998732
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc--------------
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA-------------- 560 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~-------------- 560 (645)
....|+..|+|||++.+..++.++|||||||++|||++|+.||....... +.........
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhcccccccccCCccccCccc
Confidence 22358999999999999999999999999999999999999996533211 1110000000
Q ss_pred ----------------cCchhHHhhhhcc---CCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 561 ----------------EGRIIEAADKRLN---GAF-NEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 561 ----------------~~~~~~~~d~~l~---~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.....+..+.... ... .......+.+++.+||+.||++|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000111111110 011 11234568899999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.39 Aligned_cols=242 Identities=26% Similarity=0.441 Sum_probs=198.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCC---CeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASS---GSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~---~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
++|+..+.||+|+||.||+|.+... ...+|+|.+... .....+|.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5688899999999999999998643 457899988653 33456799999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-----
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT----- 497 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~----- 497 (645)
|||+++++|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++..++.|...
T Consensus 84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999976443 48999999999999999999999 9999999999999999999999977211
Q ss_pred ---------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHH
Q 041096 498 ---------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 498 ---------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
...++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~------------ 221 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIKAV------------ 221 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----HHHHHH------------
Confidence 1123567999999999999999999999999999998 99998653321 111111
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
........+...+..+.+++..||+.+|++||++++|++.|++.
T Consensus 222 -~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 -EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111122334566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.17 Aligned_cols=241 Identities=23% Similarity=0.426 Sum_probs=197.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|+..++||+|+||.||+|.... +..+|+|.+.......+.+.+|+.++++++|+||+++++.+...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 467888999999999999999764 5678999887655567789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------- 497 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------- 497 (645)
+++|.+++.... ...+++.+++.++.|+++||+|||+ .+++||||||+||+++.++..++.|...
T Consensus 85 ~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 85 KGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999997543 2348899999999999999999998 9999999999999999999999977211
Q ss_pred ---ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 498 ---LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 498 ---~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
...++..|+|||++....++.++|||||||++|||++ |+.||...... ....... ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~~-------------~~~~ 222 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMSALQ-------------RGYR 222 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHHHHH-------------cCCC
Confidence 1124567999999998889999999999999999998 99998653321 1111111 0111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
.......+..+.+++.+||+.+|++||+++++.+.|++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11122344668889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.13 Aligned_cols=242 Identities=28% Similarity=0.435 Sum_probs=200.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.++|+..+.||+|++|.||+|.... +..+|+|.++......+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 4568888999999999999999764 577999998776556778999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--------- 497 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--------- 497 (645)
++++|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++..++.|...
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999997644 2348999999999999999999998 9999999999999999999999987321
Q ss_pred -cccc---CCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 498 -LTAG---TMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 498 -~~~g---t~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
...| +..|+|||++.+..++.++||||||+++|||++ |+.||...... .+.. .++...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~-------------~~~~~~ 221 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQ-------------QVDQGY 221 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHH-------------HHHcCC
Confidence 1112 347999999999999999999999999999999 99998654321 1111 111111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
....+......+.+++.+|++.+|.+||++.++++.|++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 112233456778999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.29 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=199.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCC--cchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHS--HEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 418 (645)
.++|...++||+|+||.||+|+... .+..||||++... ....+.+.+|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678888999999999999998643 2346999998753 233567999999999996 9999999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCC----------------------------------------------------------
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSE---------------------------------------------------------- 440 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 440 (645)
.||||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999999875321
Q ss_pred ----------------------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC
Q 041096 441 ----------------------------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA 486 (645)
Q Consensus 441 ----------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~ 486 (645)
....+++.+++.++.|+++||+|||+ .+++||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 01247889999999999999999999 99999999999999999
Q ss_pred CCCeeeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhH
Q 041096 487 NFNARLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNL 551 (645)
Q Consensus 487 ~~~~kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l 551 (645)
++.+|+.|... ...++..|+|||.+.+..++.++|||||||++|||++ |..||........ +
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---~ 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---F 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH---H
Confidence 99999977221 1235678999999999999999999999999999997 9999875422111 1
Q ss_pred HHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 552 VDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 552 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
. ..+........+...+..+.+++..||+.+|++||++.+|.++|+...
T Consensus 350 ~-------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 Y-------------NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H-------------HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0 111111112233445677889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.04 Aligned_cols=234 Identities=26% Similarity=0.413 Sum_probs=193.1
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
+.||+|+||.||+|+...++..+|+|..... ......+.+|++++++++|+||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999999888999999987652 33456799999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccccc------------
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT------------ 499 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~~------------ 499 (645)
.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++..++.|.....
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99996543 238999999999999999999998 999999999999999999999998732111
Q ss_pred --ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 500 --AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 500 --~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
.++..|+|||.+.++.++.++||||||+++|||++ |..||....... ....+........
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----------------~~~~~~~~~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----------------TREAIEQGVRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----------------HHHHHHcCCCCCC
Confidence 12346999999999999999999999999999998 888886532211 1111112222233
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
+...+..+.+++..|++.+|++|||+.++++.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 4445667889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=324.36 Aligned_cols=244 Identities=25% Similarity=0.326 Sum_probs=198.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||+|....++..||+|++... ......+.+|++++..++||||+++++++.+.+..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4688899999999999999999988999999998752 233457889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|.+++.... .+++.+...++.|++.||.|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999997543 38899999999999999999999 999999999999999999999998832
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..|. . .+......
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------~---~~~~~~~~ 223 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-------E---TLQRPVYD 223 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-------c---cccCCCCC
Confidence 23468999999999999999999999999999999999999997643222111111110 0 00000000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.........+.+++..|+..+|.+||+++++++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0011234567788899999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=310.85 Aligned_cols=243 Identities=24% Similarity=0.395 Sum_probs=202.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc-hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE-GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
+..+|...++||+|+||.||+|.... +..+++|.+..... ....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34568888999999999999999987 88899999877443 46679999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------- 497 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------- 497 (645)
|+++++|.+++..... ..+++.+++.++.|++.||+|||+ ++++||||||+||+++.++..++.|...
T Consensus 83 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999976432 348999999999999999999998 9999999999999999999999977211
Q ss_pred -----ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 498 -----LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 498 -----~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
...++..|+|||.+....++.++||||||++++||++ |+.||...... .... .+...
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----~~~~-------------~~~~~ 220 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----EVYD-------------QITAG 220 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----HHHH-------------HHHhC
Confidence 1134567999999998899999999999999999998 89999654321 1111 11122
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
.....+..++..+.+++.+||+.+|.+|||++++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 2222334456778899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=321.74 Aligned_cols=229 Identities=26% Similarity=0.332 Sum_probs=191.1
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 429 (645)
++||+|+||.||++....++..+|+|++... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999989999999988752 233456889999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------c
Q 041096 430 SLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------T 497 (645)
Q Consensus 430 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------~ 497 (645)
+|.+++.... .+++.+...++.||+.||+|||+ .+|+||||||+|||++.++.+|+.|.. .
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 9999997644 38999999999999999999999 999999999999999999999998732 1
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC
Q 041096 498 LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 577 (645)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.... .... ..++
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~~------------~~~~--~~~p 215 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELI------------LMEE--IRFP 215 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH----HHHHHH------------HcCC--CCCC
Confidence 235899999999999999999999999999999999999999753321 111111 0000 1223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 578 EDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 578 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
......+.+++..||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 33455678889999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=311.21 Aligned_cols=244 Identities=24% Similarity=0.418 Sum_probs=199.2
Q ss_pred cCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCCcc--hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHSHE--GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
++|...+.||+|+||.||+|.... .+..+|+|.+..... ..+.+.+|++++.+++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998743 357899999876432 4578999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCC----------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 421 LVYEYMPNGSLDRMLYQDSE----------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
+||||+++++|.+++..... ....+++.++..++.|++.||+|||+ .+++||||||+||+++.++..
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 99999999999999976432 22348899999999999999999998 999999999999999999999
Q ss_pred eeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHH
Q 041096 491 RLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWV 555 (645)
Q Consensus 491 kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~ 555 (645)
+++|... ...++..|+|||++.+..++.++|||||||++|||++ |..||...... ...+..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----~~~~~~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----EVIECI 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHH
Confidence 9977321 1234567999999999999999999999999999998 99998754321 111111
Q ss_pred HhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 556 WGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 556 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
........+...+..+.+++..||+.+|++||+++||++.|++
T Consensus 238 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 -------------TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -------------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111112233455678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=324.09 Aligned_cols=235 Identities=24% Similarity=0.283 Sum_probs=195.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|...+.||+|+||.||+|....++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5688889999999999999999988999999988652 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|.+++..... +++.....++.|++.||+|||+ .+|+||||||+||||+.++.+|+.|..
T Consensus 98 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGR----FPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999976543 7888999999999999999999 999999999999999999999998732
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +....+
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~------------i~~~~~-- 232 (329)
T PTZ00263 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIYEK------------ILAGRL-- 232 (329)
T ss_pred CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHHHH------------HhcCCc--
Confidence 2246899999999999999999999999999999999999999753221 11110 011111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPS-----MRRVFQ 607 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~~vl~ 607 (645)
.++......+.+++..||+.||.+||+ +++++.
T Consensus 233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 122223455778999999999999997 677764
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.61 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=197.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCe
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGE 418 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 418 (645)
++++|+..+.||+|+||.||+|.+.. .+..+|+|.+.... ....++.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46779999999999999999998642 35679999876532 345578999999999999999999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCCC------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeee
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSEN------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL 492 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl 492 (645)
.++||||+++++|.+++...... ...+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999754321 2246889999999999999999999 89999999999999999999999
Q ss_pred ecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHh
Q 041096 493 ESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWG 557 (645)
Q Consensus 493 ~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~ 557 (645)
.|... ...++..|+|||.+.++.++.++|||||||++|||++ |..||...... .....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~----~~~~~~-- 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----QVLRFV-- 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH--
Confidence 77321 1234667999999998899999999999999999999 78888654321 111110
Q ss_pred hhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 558 LYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 558 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
..+ . ....+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 235 --~~~--------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 --MEG--------G-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --HcC--------C-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 000 0 011233345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=305.04 Aligned_cols=247 Identities=27% Similarity=0.396 Sum_probs=204.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||+|....++..+|+|.++. .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 578889999999999999999988899999998753 2233567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++++|.+++.........+++.+++.++.|+++||+|||+ .+++||||||+||+++.++..++.|..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999997654444558999999999999999999998 999999999999999999999997721
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+. .+.....
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~----------~~~~~~~ 223 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSL----------CKKIEKC 223 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHHH----------HhhhhcC
Confidence 123578889999999988899999999999999999999999865321 11111 1111111
Q ss_pred ccCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 572 LNGAFNE-DEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 572 l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.....+. .....+.+++..||+.+|++||++.+|+++|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1112222 4556788999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=306.95 Aligned_cols=238 Identities=26% Similarity=0.403 Sum_probs=194.9
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
+|...+.||+|+||.||+|.... +..+|+|.+........+|.+|+.++.+++||||++++++|.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 46777899999999999998764 45699998876555567899999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-----------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT----------- 497 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~----------- 497 (645)
|+|.+++..... .+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+|+.|...
T Consensus 84 ~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 84 GCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999976433 38999999999999999999998 9999999999999999999999987321
Q ss_pred --ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 498 --LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 498 --~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
...++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ..... ......
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----~~~~~-------------~~~~~~ 220 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE----TVEKV-------------SQGLRL 220 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHHH-------------hcCCCC
Confidence 1123467999999998889999999999999999998 999986543211 11111 111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
..+......+.+++..||+.+|.+||++.++++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112223567889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=307.51 Aligned_cols=242 Identities=26% Similarity=0.477 Sum_probs=197.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCC---eEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSG---SVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~---~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
++|+..+.||+|+||.||+|....++ ..+++|.+... ....+.+..|++++.+++|+|++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46788899999999999999986544 37899988653 33456799999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc----
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL---- 498 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~---- 498 (645)
|||+++++|.+++..... .+++.++..++.|++.||+|||+ .+++||||||+||+++.++..++.|....
T Consensus 85 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999975432 38999999999999999999998 99999999999999999999999772211
Q ss_pred -----------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 499 -----------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 499 -----------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
...+..|+|||++..+.++.++|||||||++|||++ |+.||...... .+..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~----~~~~------------- 221 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH----EVMK------------- 221 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHHH-------------
Confidence 112346999999998899999999999999999997 99999654321 1111
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.+..........+.+..+.+++.+||+.+|++||+|.+|++.|+++
T Consensus 222 ~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 222 AINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111111122334566789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=319.62 Aligned_cols=234 Identities=26% Similarity=0.377 Sum_probs=199.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc---hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|...+.||+|.||.||||+.+.+.+.||+|.+.+... ..+...+|++++++|+|||||.++.||+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 467777889999999999999999999999998877433 34568899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS--------- 495 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~--------- 495 (645)
|+.+ +|..+|..... ++..+...|+.++.+||.|||+ .+|+|||+||+||||+.++..|++|.
T Consensus 82 ~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9966 99999987654 9999999999999999999999 99999999999999999999999882
Q ss_pred ---ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 496 ---FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 496 ---~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
.+...||+.|||||+..++.|+..+|.||+||+|||+++|++||.... ...+++. ... |+
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s----i~~Lv~~---I~~--------d~-- 216 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS----ITQLVKS---ILK--------DP-- 216 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH----HHHHHHH---Hhc--------CC--
Confidence 223469999999999999999999999999999999999999997532 1122211 111 11
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
-.++......+..+....+.+||.+|.|-.++++
T Consensus 217 -v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 -VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1234466677888888999999999999999876
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.86 Aligned_cols=238 Identities=27% Similarity=0.377 Sum_probs=198.0
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----c--chhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCC
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----H--EGKTEFLAELSIIACLR-HKNLVQLLGWCAEKG 417 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 417 (645)
...++|...+.||+|.||+|++|....++..||+|.+... . ...+...+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457888999999999999999999999999999976553 1 23445668999999999 999999999999999
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeeeecc-
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN-FNARLESS- 495 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~-~~~kl~d~- 495 (645)
..++||||+.+|+|.+++.+... +.......++.|+++|++|||+ ++|+||||||+|||||.+ ++.|+.|.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~----l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGR----LKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCC----CChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999987433 8889999999999999999999 999999999999999999 99999872
Q ss_pred -----------ccccccCCcccCcccccCCC-CC-cchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC
Q 041096 496 -----------FTLTAGTMGYLAPEYLQYGT-AT-EKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG 562 (645)
Q Consensus 496 -----------~~~~~gt~~y~APE~~~~~~-~t-~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~ 562 (645)
....+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+.. .+...
T Consensus 167 ~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----~l~~k-------- 234 (370)
T KOG0583|consen 167 LSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----NLYRK-------- 234 (370)
T ss_pred cccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH----HHHHH--------
Confidence 23358999999999999977 85 7899999999999999999999873221 11100
Q ss_pred chhHHhhhhccCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 563 RIIEAADKRLNGAFNEDE-MKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 563 ~~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+..... .++... ...+..++..|+..+|.+|+|+.++++
T Consensus 235 ----i~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 235 ----IRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ----HhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 011111 223333 667788889999999999999999984
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.80 Aligned_cols=247 Identities=26% Similarity=0.458 Sum_probs=198.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-----CCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFA-----SSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~-----~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|...+.||+|+||+||++... .++..+|+|.+... ....+.+.+|++++.+++|+||++++++|...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999852 34567899988763 3446679999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCC---------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeee
Q 041096 422 VYEYMPNGSLDRMLYQDSE---------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL 492 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl 492 (645)
||||+++++|.+++..... ....+++.+++.++.|++.||+|||+ .+++||||||+|||++.++..++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 9999999999999975431 12348999999999999999999998 99999999999999999999999
Q ss_pred ecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHh
Q 041096 493 ESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWG 557 (645)
Q Consensus 493 ~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~ 557 (645)
.|... ...++..|+|||.+.+..++.++|||||||+++||++ |..||....... ....+
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~----~~~~i-- 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----VIECI-- 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH--
Confidence 77321 1223668999999999999999999999999999998 899986543211 11111
Q ss_pred hhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 558 LYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 558 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
..+. ....+......+.+++..||+++|.+|||++++++.|++...
T Consensus 236 --~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 236 --TQGR---------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred --HcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1111 011122234568999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.26 Aligned_cols=245 Identities=25% Similarity=0.382 Sum_probs=193.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCe----EEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGS----VAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~----~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|+..+.||+|+||.||+|.+..++. .+++|.+... .....++..|+..+++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 356778899999999999999866555 4777877542 2234678888889999999999999998864 46789
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
++||+++|+|.+++..... .++|..++.++.|++.||+|||+ ++++||||||+|||++.++.+|+.|..
T Consensus 86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999976443 38999999999999999999998 999999999999999999999998731
Q ss_pred ---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 ---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....++..|+|||.+.++.++.++|||||||++|||++ |+.||...... .+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~------------ 223 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDL------------ 223 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH------------
Confidence 11235678999999998999999999999999999998 99998754321 11111
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
+........+..+...+.+++..||..+|++|||+.++++.|......+
T Consensus 224 -~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 224 -LEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -HHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 1111111111223456778889999999999999999999998765433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.81 Aligned_cols=238 Identities=25% Similarity=0.402 Sum_probs=195.8
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
+|+..+.||+|+||.||+|.... +..+|+|.+.........+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 46678899999999999998864 66789998876555566789999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc----------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL---------- 498 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~---------- 498 (645)
++|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++..|+.|....
T Consensus 84 ~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 84 GCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999976433 38999999999999999999999 99999999999999999999999873211
Q ss_pred ---cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 499 ---TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 499 ---~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ... .+......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~-------------~~~~~~~~ 220 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE----VVE-------------SVSAGYRL 220 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH----HHH-------------HHHcCCcC
Confidence 112347999999999999999999999999999999 888987543211 111 11111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
..+...+..+.+++..||+.+|++||||.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 223335667899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=312.08 Aligned_cols=247 Identities=25% Similarity=0.441 Sum_probs=199.7
Q ss_pred cCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCCc-chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|...+.||+|+||.||+|.... ++..+++|.+.... ...+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 457778899999999999998532 34568899887643 335679999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 041096 422 VYEYMPNGSLDRMLYQDSE------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN 489 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~ 489 (645)
||||+++++|.+++..... ....++|..++.++.|++.||+|||+ ++++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999975431 12348999999999999999999998 99999999999999999999
Q ss_pred eeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHH
Q 041096 490 ARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDW 554 (645)
Q Consensus 490 ~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~ 554 (645)
+++.|.. ....++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ..+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~~~~ 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----VIEC 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH
Confidence 9997722 11234678999999999999999999999999999998 999986543211 1111
Q ss_pred HHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 555 VWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 555 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
+........+...+..+.+++.+||+.+|++||++++|+++|+.+..
T Consensus 238 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 -------------ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -------------HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111111223345678899999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=317.89 Aligned_cols=229 Identities=25% Similarity=0.335 Sum_probs=190.1
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 429 (645)
+.||+|+||.||++....++..||+|.+... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999999888999999988652 234456788999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------c
Q 041096 430 SLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------T 497 (645)
Q Consensus 430 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------~ 497 (645)
+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|+.|.. .
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 9999887543 38999999999999999999999 999999999999999999999998722 1
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC
Q 041096 498 LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 577 (645)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ..... .... ..++
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~~~------------~~~~--~~~p 215 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELI------------LMEE--IRFP 215 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHH------------hcCC--CCCC
Confidence 2358999999999999999999999999999999999999997543211 11100 0000 0122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 578 EDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 578 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
......+.+++..||+.||.+|| +++++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 33445677888999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=311.72 Aligned_cols=253 Identities=19% Similarity=0.258 Sum_probs=193.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|...++||+|+||.||+|....++..||+|.+... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4688889999999999999999988999999988653 22345678999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
++ ++|.+++..... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++..|++|..
T Consensus 85 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 599998865432 37899999999999999999999 999999999999999999999998732
Q ss_pred ---cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH-------Hhhhc-cCch
Q 041096 497 ---TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV-------WGLYA-EGRI 564 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~-------~~~~~-~~~~ 564 (645)
....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.... |.... ....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 12357889999998865 568999999999999999999999997643322111111100 00000 0000
Q ss_pred hHHhhhhccCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 IEAADKRLNGAF----NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 ~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.....+...... .........+++..|++.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000101100000 0112345678899999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.31 Aligned_cols=240 Identities=27% Similarity=0.335 Sum_probs=204.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
..++|+..++||+|+||.||+++-+++|.++|+|+++++ ....+..+.|-.+|....++.||+|+-.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 456899999999999999999999999999999999884 3456678899999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec-------
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES------- 494 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d------- 494 (645)
||||+|||++..+|..... |+.......+.+++.|+.-||+ .|+|||||||+|+|||..|..|+.|
T Consensus 219 iMEylPGGD~mTLL~~~~~----L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT----LTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHHhcCc----CchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999987654 8888888899999999999999 9999999999999999999999976
Q ss_pred -------------------------ccc---------------------------ccccCCcccCcccccCCCCCcchhH
Q 041096 495 -------------------------SFT---------------------------LTAGTMGYLAPEYLQYGTATEKTDV 522 (645)
Q Consensus 495 -------------------------~~~---------------------------~~~gt~~y~APE~~~~~~~t~ksDV 522 (645)
.+. ..+|||-|||||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 000 0369999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCC-
Q 041096 523 FSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPS- 601 (645)
Q Consensus 523 ~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt- 601 (645)
||+|||+|||+.|.+||...+..+....++.|...+... -.........+++..|+. ||++|.-
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP--------------~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP--------------EEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC--------------CcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 999999999999999999988777777888876332211 111122556677777777 9999976
Q ss_pred --HHHHHH
Q 041096 602 --MRRVFQ 607 (645)
Q Consensus 602 --~~~vl~ 607 (645)
++||.+
T Consensus 437 ~G~~EIK~ 444 (550)
T KOG0605|consen 437 KGAEEIKK 444 (550)
T ss_pred ccHHHHhc
Confidence 555544
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.22 Aligned_cols=227 Identities=24% Similarity=0.270 Sum_probs=187.3
Q ss_pred eccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 356 lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
||+|+||.||+|....++..+|+|++... ......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999988999999988652 33456788999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------ccc
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------TLT 499 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------~~~ 499 (645)
.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+++.|.. ...
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 99997643 28999999999999999999999 999999999999999999999998732 123
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHH
Q 041096 500 AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED 579 (645)
Q Consensus 500 ~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 579 (645)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ... . ..... ..++..
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----~~~---~---------~~~~~--~~~~~~ 215 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----MYR---K---------ILQEP--LRFPDG 215 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----HHH---H---------HHcCC--CCCCCc
Confidence 58999999999999999999999999999999999999997532211 111 0 11111 122333
Q ss_pred HHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 041096 580 EMKRLLLVGLSCANPDSSARPS---MRRVFQ 607 (645)
Q Consensus 580 ~~~~l~~l~~~Cl~~dP~~RPt---~~~vl~ 607 (645)
....+.+++..||+.||.+||+ +.+++.
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 4456788889999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=302.58 Aligned_cols=238 Identities=26% Similarity=0.395 Sum_probs=198.4
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|...+.||+|++|.||+|....++..+++|.+.. .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 46778899999999999999998899999998764 234567899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++.... ...+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+++.|..
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998653 2348999999999999999999998 999999999999999999999997721
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....|+..|+|||+..+..++.++||||||+++|||++|+.||...... ..... ......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-------------~~~~~~ 218 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG----ALILK-------------IIRGVF 218 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-------------HHcCCC
Confidence 1235788999999999999999999999999999999999999754321 11111 011111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 22233455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=308.33 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=197.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCe
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGE 418 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 418 (645)
.+++|...+.||+|++|.||+|.+.. .+..+++|..... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999999976 6788999988653 3345679999999999999999999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCC---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---Ceee
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSE---NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF---NARL 492 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~---~~kl 492 (645)
.++||||+++++|.+++..... ....++|.+++.++.||+.||+|||+ .+++||||||+||+++.++ ..|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976532 12348999999999999999999999 8999999999999998754 4777
Q ss_pred eccccc--------------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHh
Q 041096 493 ESSFTL--------------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWG 557 (645)
Q Consensus 493 ~d~~~~--------------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~ 557 (645)
+|.... ...+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----~~~~---- 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----EVME---- 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH----
Confidence 763211 112457999999999999999999999999999997 99999754321 1111
Q ss_pred hhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 558 LYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 558 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
.+........+...+..+.+++..|++.+|++||++.+|++.|+
T Consensus 233 ---------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 ---------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111112233344567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=316.69 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=194.4
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeEEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GELLLVY 423 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 423 (645)
.|+..++||+|.||.||+|+...+|..||+|++.... .......+||.+|++|.||||++|.+...+. ..+|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 3555678999999999999999999999999987633 3345678999999999999999999988776 6899999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec---------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES--------- 494 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d--------- 494 (645)
|||++ +|..++....- .++..++..+++|++.||+|||+ ++|+|||||.+|||||.++..||.|
T Consensus 198 eYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred ecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99965 88888876443 38999999999999999999999 9999999999999999999999988
Q ss_pred ----cccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh----hhccCchh
Q 041096 495 ----SFTLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG----LYAEGRII 565 (645)
Q Consensus 495 ----~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~----~~~~~~~~ 565 (645)
..+..+-|.+|+|||.+.+ ..|+.+.|+||.||||.||+.|+..|.+.++-+....+...... .|...++.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 2345578999999999987 47999999999999999999999999876543222222211000 01100110
Q ss_pred --HHh------hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 566 --EAA------DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 566 --~~~------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..+ ...+.+. ........++|+..+|..||.+|.|+.++++
T Consensus 351 ~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000 0111111 1122445677778888999999999999986
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=305.93 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=201.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||++....++..++||.+... .....++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677788999999999999999888999999977542 233467899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++++|.+++.........+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+++.|..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999987544334458999999999999999999998 999999999999999999999997721
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....|+..|+|||.+.+..++.++||||||+++|||++|..||...... ....... +. ...
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~---------~~---~~~ 224 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKK---------IE---QCD 224 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhh---------hh---cCC
Confidence 1235788999999999889999999999999999999999998653221 0111110 00 000
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
............+.+++..||+.+|++||||.+|++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 01111223456788899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=332.82 Aligned_cols=239 Identities=21% Similarity=0.263 Sum_probs=195.1
Q ss_pred CCCcCceeccCCceEEEEEEECCC-CeEEEEEeccCCc-chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASS-GSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~-~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.|...+.||+|+||.||+|....+ +..||+|.+.... .....+.+|+.+++.++||||++++++|...+..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 378889999999999999988766 6788888765533 33456788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++|+|.++|........++++..+..++.|++.||+|||+ ++|+||||||+||||+.++.+|+.|..
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999999987654334458999999999999999999999 999999999999999999999998721
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
...+||++|+|||++.+..++.++|||||||++|||++|+.||...... .+.... ....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----~~~~~~------------~~~~- 287 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR----EIMQQV------------LYGK- 287 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH------------HhCC-
Confidence 1235899999999999999999999999999999999999999753321 111110 0000
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
....+......+.+++..||+.+|++||+++++++
T Consensus 288 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01122234456888999999999999999998864
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=309.27 Aligned_cols=244 Identities=25% Similarity=0.417 Sum_probs=196.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC----CCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFA----SSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~----~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
.+|+..+.||+|+||.||+|... ..+..+++|.+... .+....+.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 35777889999999999999852 34578999988752 2334678999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 041096 422 VYEYMPNGSLDRMLYQDSE-------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF 488 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~ 488 (645)
||||+++++|.+++..... ....+++.+.+.++.|++.||+|||+ ++++||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 9999999999999864321 12348899999999999999999999 9999999999999999999
Q ss_pred Ceeeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHH
Q 041096 489 NARLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVD 553 (645)
Q Consensus 489 ~~kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~ 553 (645)
.+|+.|... ...++..|+|||++.+..++.++||||||+++|||++ |..||..... ..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----~~~~- 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----QEVI- 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHH-
Confidence 999987221 1234567999999998889999999999999999998 9889865321 1111
Q ss_pred HHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 554 WVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 554 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
+.++.......+......+.+++..||+.+|++||++.++.+.|..
T Consensus 237 ------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 ------------EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111112333445678889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=312.74 Aligned_cols=247 Identities=24% Similarity=0.386 Sum_probs=200.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCC-----CeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCC
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASS-----GSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKG 417 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~-----~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 417 (645)
..++|+..+.||+|+||.||++..... ...+|+|.+... .....++.+|++++.++ +|+||++++++|..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 345688889999999999999987533 378999988753 23345788999999999 7999999999999999
Q ss_pred eEEEEEecCCCCCHhHHhhhcC------------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDS------------ENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld 485 (645)
..+++|||+++|+|..++.... .....+++..++.++.|++.||+|||+ .+++||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 9999999999999999997532 223458999999999999999999998 9999999999999999
Q ss_pred CCCCeeeeccccc--------------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhh
Q 041096 486 ANFNARLESSFTL--------------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVN 550 (645)
Q Consensus 486 ~~~~~kl~d~~~~--------------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~ 550 (645)
.++..+++|.... ..++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence 9999999883211 123567999999999999999999999999999998 999986532211
Q ss_pred HHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 551 LVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 551 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+. +.+........+......+.+++..||+.+|++|||++++++.|+.+
T Consensus 243 ~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 LF-------------KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HH-------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11 11111111223334566788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=316.05 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=196.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.++|+..++||+|+||.||++....++..+|+|.+... ......+.+|++++++++|+||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 36788999999999999999999988999999987653 2334678999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++++|.+++.... .+++.....++.|++.||.|||+ ..+++||||||+|||++.++.+|+.|..
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999997643 38899999999999999999997 2479999999999999999999998732
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC------------
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG------------ 562 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~------------ 562 (645)
....|+..|+|||++.+..++.++|||||||++|||++|+.||....... + .........+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE----L-ELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH----H-HHHhcCcccCCccccccCcccC
Confidence 22358899999999998899999999999999999999999997543211 0 0000000000
Q ss_pred -----------------chhHHhhhhccC---CCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 563 -----------------RIIEAADKRLNG---AFNE-DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 563 -----------------~~~~~~d~~l~~---~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
......+..... ..+. .....+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000111111110 0110 12345788999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=316.38 Aligned_cols=256 Identities=22% Similarity=0.311 Sum_probs=193.7
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-----CeEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK-----GELL 420 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~ 420 (645)
+|+..++||+|+||.||+|....++..||||++... ......+.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999999988999999988642 23345688999999999999999999987543 2589
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---- 496 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---- 496 (645)
+||||+. ++|.+++.... .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|..
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 78999887543 38999999999999999999999 999999999999999999999998722
Q ss_pred -----------cccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh----
Q 041096 497 -----------TLTAGTMGYLAPEYLQY--GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY---- 559 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~--~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~---- 559 (645)
....||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~----~~~~~~~~~~~~~ 228 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH----QLDLITDLLGTPS 228 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH----HHHHHHHHhCCCC
Confidence 12358899999999875 678999999999999999999999997643211 111111100
Q ss_pred -------ccCchhHHh---hhhccCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCC
Q 041096 560 -------AEGRIIEAA---DKRLNGAFN---EDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPL 616 (645)
Q Consensus 560 -------~~~~~~~~~---d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~ 616 (645)
......+.+ .+....... ......+.+++..||+.+|++|||++++++ .+++.....
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~ 300 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence 000001111 110000000 012345778999999999999999999987 355544433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=320.97 Aligned_cols=234 Identities=23% Similarity=0.358 Sum_probs=186.6
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
|+..++||+|+||.||+|+...++..||||.+... ......+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 44567899999999999999888999999998653 2335678999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----------- 496 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----------- 496 (645)
+|+|.... ...+..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 156 ~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 156 GGSLEGTH--------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred CCcccccc--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 99986532 25677788999999999999999 999999999999999999999998732
Q ss_pred -cccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 -TLTAGTMGYLAPEYLQY-----GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 -~~~~gt~~y~APE~~~~-----~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....||..|+|||.+.. ...+.++|||||||++|||++|+.||....... ...+... ...
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~-------------~~~ 290 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCA-------------ICM 290 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHH-------------Hhc
Confidence 23468999999998753 234568999999999999999999997432211 1111110 000
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.............+.+++..||+.||++||++.|+++.
T Consensus 291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112233445678889999999999999999999984
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=309.24 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=198.2
Q ss_pred CCcCceeccCCceEEEEEEE----CCCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeEEE
Q 041096 350 FHSNRILGRGAFGNVYKAYF----ASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GELLL 421 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~----~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 421 (645)
|...+.||+|+||+||++.. ...+..+|+|...... .....+.+|++++++++||||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988653 3457789999887632 3456789999999999999999999998764 36899
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---- 497 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---- 497 (645)
||||+++++|.+++.... +++.++..++.|++.||+|||+ .+++||||||+|||++.++.+++.|...
T Consensus 86 v~e~~~~~~l~~~~~~~~-----l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999999996532 8999999999999999999999 9999999999999999999999977211
Q ss_pred -----------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 498 -----------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 498 -----------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
...++..|+|||.+....++.++||||||+++|||++|+.|+...... ................+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhh
Confidence 113455699999999888999999999999999999999998653221 1111111111111122333
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.++.......+...+..+.+++..||+++|++|||++++++.|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 3333333333445567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=291.69 Aligned_cols=251 Identities=25% Similarity=0.313 Sum_probs=205.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC-----eEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG-----ELL 420 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 420 (645)
.++|++.++||+|||+.||+++.-.++..+|+|++... .++.+..++|++..++++|||++++++++..+. +.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 46788999999999999999998888999999998774 467888999999999999999999999986543 589
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc--
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL-- 498 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~-- 498 (645)
|+++|...|+|.+.+......+..++..+.+.|+.+|++||++||+. .+++.||||||.|||+.+.+.+.+.|..+.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999998777777899999999999999999999982 345999999999999999999988773222
Q ss_pred -------------------cccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH
Q 041096 499 -------------------TAGTMGYLAPEYLQY---GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW 556 (645)
Q Consensus 499 -------------------~~gt~~y~APE~~~~---~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~ 556 (645)
..-|..|+|||.+.- ...++++|||||||+||+|+.|..||+...+......+.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA---- 254 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA---- 254 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe----
Confidence 235788999998864 456999999999999999999999998754322111110
Q ss_pred hhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 557 GLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 557 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+....+.-.......+.+.+++.+|++.||.+||+..+++..++.+
T Consensus 255 ----------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 255 ----------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0111111111122567899999999999999999999999988754
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=318.55 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=196.0
Q ss_pred cCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeC-Ce
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEK-GE 418 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~ 418 (645)
++|+..+.||+|+||.||+|.... ++..||+|++... ....+.+..|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 468889999999999999997533 3478999988753 22345688899999999 799999999988654 57
Q ss_pred EEEEEecCCCCCHhHHhhhcCCC---------------------------------------------------------
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSEN--------------------------------------------------------- 441 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~--------------------------------------------------------- 441 (645)
+++++||+++++|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 89999999999999998643210
Q ss_pred CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc--------------ccccCCcccC
Q 041096 442 GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--------------LTAGTMGYLA 507 (645)
Q Consensus 442 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--------------~~~gt~~y~A 507 (645)
...++|..+..++.||+.||+|||+ .+|+||||||+|||++.++.+++.|... ...++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1258999999999999999999998 9999999999999999999999987321 1234568999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHH
Q 041096 508 PEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLL 586 (645)
Q Consensus 508 PE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 586 (645)
||++.+..++.++|||||||++|||++ |+.||......+. +. +.+........+......+.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~~-------------~~~~~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FC-------------RRLKEGTRMRAPEYATPEIYS 307 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---HH-------------HHHhccCCCCCCccCCHHHHH
Confidence 999999999999999999999999998 9999975322111 10 111111111222334567889
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 587 VGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 587 l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
++++||+.+|++||++.++++.|+...+
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=309.26 Aligned_cols=240 Identities=23% Similarity=0.318 Sum_probs=195.7
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
+|+..++||+|+||+||++....++..||+|.+.... .....+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777899999999999999998889999999886522 223557889999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+++.|..
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999998865322 348999999999999999999999 999999999999999999999997721
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...........+ ...+.. ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~-------------~~~~~~-~~ 221 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV-------------ERRVKE-DQ 221 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH-------------HHHhhh-cc
Confidence 1236789999999999889999999999999999999999999764321111011 111111 11
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
..++......+.+++..||+.||++|| +++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 223344566788999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=309.56 Aligned_cols=246 Identities=22% Similarity=0.361 Sum_probs=197.5
Q ss_pred CCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
+|+..+.||+|+||.||+|.... ....+++|.+.... .....+.+|+.+++.++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 36778899999999999998742 23578888876532 334678999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCC--------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 041096 422 VYEYMPNGSLDRMLYQDSE--------------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASN 481 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N 481 (645)
++||+++++|.+++..... ....+++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 9999999999999865321 12348899999999999999999998 999999999999
Q ss_pred EEEcCCCCeeeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccccc
Q 041096 482 IMLDANFNARLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGH 546 (645)
Q Consensus 482 Illd~~~~~kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~ 546 (645)
||+++++.+++.|... ...++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999977321 1234668999999988899999999999999999998 9999865321
Q ss_pred chhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 547 KMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 547 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
..+.+ .+........+......+.+++..||+.+|++||++.++++.|++...
T Consensus 236 --~~~~~-------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 --ERLFN-------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred --HHHHH-------------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111 111111222233445678899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=308.21 Aligned_cols=235 Identities=25% Similarity=0.300 Sum_probs=190.6
Q ss_pred eccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 356 lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
||+|+||+||++....+++.+|+|.+.... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999999889999999886522 2335678899999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc------------cc
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------------LT 499 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------------~~ 499 (645)
..++.........+++..+..++.|++.||+|||+ .+|+||||||+||+++.++..++.|... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 98886544334458999999999999999999999 9999999999999999999999977321 23
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHH
Q 041096 500 AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED 579 (645)
Q Consensus 500 ~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 579 (645)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.. ...... ..++..
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~------------~~~~~~--~~~~~~ 223 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------RILNDS--VTYPDK 223 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH------------hhcccC--CCCccc
Confidence 578999999999999999999999999999999999999975432111111110 000110 122334
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 580 EMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 580 ~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
....+.+++..||+.+|++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 556788899999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.35 Aligned_cols=254 Identities=19% Similarity=0.224 Sum_probs=192.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.++|+..+.||+|+||.||+|....++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999998889999999987532 234467899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|++ ++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++..|++|..
T Consensus 84 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 788888865432 38889999999999999999999 999999999999999999999998732
Q ss_pred ----cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch---hH--
Q 041096 497 ----TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI---IE-- 566 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~---~~-- 566 (645)
....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||............+............ ..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 12357889999998865 458999999999999999999999997643211111111111100000000 00
Q ss_pred Hhhh-hccCCCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 567 AADK-RLNGAFNE---------DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 567 ~~d~-~l~~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..++ ......+. .....+.+++..|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 00000000 01245678889999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.16 Aligned_cols=230 Identities=27% Similarity=0.342 Sum_probs=190.7
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 429 (645)
++||+|+||.||++....++..+|+|++... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999988999999988752 234567889999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------c
Q 041096 430 SLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------T 497 (645)
Q Consensus 430 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------~ 497 (645)
+|..++.... .+++.++..++.||+.||+|||+ .+|+||||||+||||+.++.+|+.|.. .
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 9999887543 38999999999999999999999 999999999999999999999998732 1
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC
Q 041096 498 LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 577 (645)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.... .. . + ..++
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----~~~~~~---~~-~------~----~~~p 215 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELI---LM-E------D----IKFP 215 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH----HHHHHh---cc-C------C----ccCC
Confidence 235899999999999999999999999999999999999999754321 111110 00 0 0 1122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 041096 578 EDEMKRLLLVGLSCANPDSSARP-----SMRRVFQI 608 (645)
Q Consensus 578 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~~ 608 (645)
......+.+++..|++.||++|| ++.++++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 23345677888999999999997 88988763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=318.00 Aligned_cols=237 Identities=21% Similarity=0.251 Sum_probs=194.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCC-eEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSG-SVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~-~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
.++|...+.||+|+||.||+|.+...+ ..+|+|++... ....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 356888999999999999999876544 68999987642 2335578899999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||||+++|+|.+++..... +++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+++.|..
T Consensus 109 v~Ey~~~g~L~~~i~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKR----FPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999976543 8999999999999999999999 999999999999999999999998732
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... +....
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~~------------i~~~~- 244 (340)
T PTZ00426 182 DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----IYQK------------ILEGI- 244 (340)
T ss_pred CCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----HHHH------------HhcCC-
Confidence 22368999999999999889999999999999999999999997643211 1110 00000
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQI 608 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~~ 608 (645)
..++......+.+++..|++.+|++|+ +++++++.
T Consensus 245 -~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 -IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 012223344567888999999999995 89988763
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=310.58 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=199.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCe--EEEEEeccC--CcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGS--VAAVKRSKH--SHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~--~vavK~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 422 (645)
++|+..++||+|+||.||+|....++. .+++|.++. .....+.+.+|++++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999999876654 468887764 233456789999999999 799999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 423 YEYMPNGSLDRMLYQDSE------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
+||+++++|.+++..... ....+++.++..++.|++.||+|||+ .+++||||||+|||++.++..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 999999999999975431 11248899999999999999999998 999999999999999999999
Q ss_pred eeeccccc-----------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhh
Q 041096 491 RLESSFTL-----------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 491 kl~d~~~~-----------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
|+.|.... ...+..|+|||++....++.++|||||||++|||++ |+.||...... .+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~----~~~------ 228 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA----ELY------ 228 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHH------
Confidence 99873211 122456999999998899999999999999999997 99999754321 111
Q ss_pred hccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 559 YAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
+..........+......+.+++..||+.+|.+||+++++++.|+......
T Consensus 229 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 -------EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111111222223344567889999999999999999999999988766544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=332.86 Aligned_cols=247 Identities=23% Similarity=0.286 Sum_probs=201.0
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC-
Q 041096 342 ELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG- 417 (645)
Q Consensus 342 ~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~- 417 (645)
+.+...++|...++||+|+||+||+|....++..||||++... ......+.+|+.++..++|+|++++...+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3445567999999999999999999999888999999988653 334567889999999999999999988765432
Q ss_pred -------eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 418 -------ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 418 -------~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
..++||||+++|+|.+++.........+++..+..++.|++.||+|||+ ++|+||||||+||||+.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCE
Confidence 3689999999999999998655445568999999999999999999999 999999999999999999999
Q ss_pred eeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH
Q 041096 491 RLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW 556 (645)
Q Consensus 491 kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~ 556 (645)
||+|.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~----~~~~~-- 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME----EVMHK-- 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHH--
Confidence 998732 1235899999999999999999999999999999999999999753211 11110
Q ss_pred hhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 557 GLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 557 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.. .......+......+.+++..||+.+|.+||++.++++.
T Consensus 257 ----------~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 ----------TL-AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----------Hh-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00 001112333455678899999999999999999999763
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.36 Aligned_cols=243 Identities=26% Similarity=0.406 Sum_probs=194.5
Q ss_pred CCcCceeccCCceEEEEEEECCC---CeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCe-----
Q 041096 350 FHSNRILGRGAFGNVYKAYFASS---GSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGE----- 418 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~---~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 418 (645)
|...+.||+|+||.||+|....+ +..+|+|+++.. ......+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 45678899999999999998653 378999988753 2334678999999999999999999999876554
Q ss_pred -EEEEEecCCCCCHhHHhhhcCC--CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 419 -LLLVYEYMPNGSLDRMLYQDSE--NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 419 -~~lV~Ey~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
.++++||+++|+|..++..... ....+++.....++.|++.||+|||+ .+++||||||+||++++++.+|+.|.
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 7999999999999999865432 22358999999999999999999998 99999999999999999999999872
Q ss_pred cc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhc
Q 041096 496 FT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYA 560 (645)
Q Consensus 496 ~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~ 560 (645)
.. ...++..|+|||.+....++.++|||||||++|||++ |..||...... .+.++..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~----~~~~~~~---- 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH----EIYDYLR---- 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH----
Confidence 21 1124568999999988889999999999999999999 88888653321 1112111
Q ss_pred cCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 561 EGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 561 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.......+......+.+++..||+.||++||++.++++.|+++
T Consensus 230 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 ---------HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111123334566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=306.01 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=198.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECCC-----CeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASS-----GSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~-----~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 419 (645)
.++|...+.||+|+||.||+|..... +..+|+|...... .....+.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 35678889999999999999988643 3789999986532 3356789999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCC------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeee
Q 041096 420 LLVYEYMPNGSLDRMLYQDSEN------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLE 493 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~ 493 (645)
++||||+++|+|.+++...... ...++|..++.++.|++.||.|||+ .+++||||||+|||++.++..++.
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 9999999999999999754321 2247899999999999999999998 999999999999999999999997
Q ss_pred ccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhh
Q 041096 494 SSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 494 d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
|.. ....++..|+|||.+..+.++.++|||||||++||+++ |+.||...... .+.+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~~~--- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE----EVLKFV--- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH----HHHHHH---
Confidence 732 11235678999999988889999999999999999998 89998653321 111111
Q ss_pred hccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 559 YAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
........+......+.+++..||+.+|++|||+.++++.|+.
T Consensus 235 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 ----------IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111112233346788899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=323.66 Aligned_cols=239 Identities=23% Similarity=0.327 Sum_probs=190.3
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.|...+.||+|+||+||+|....++..+|+|++... ....+.+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999999999999999998652 2335678999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------- 497 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------- 497 (645)
|+++|+|.+++.+.. .+++.....++.|++.||+|||+ .+|+||||||+||||+.++.+++.|...
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999997644 38888999999999999999999 9999999999999999999999987321
Q ss_pred ----------------------------------------------------ccccCCcccCcccccCCCCCcchhHHHH
Q 041096 498 ----------------------------------------------------LTAGTMGYLAPEYLQYGTATEKTDVFSY 525 (645)
Q Consensus 498 ----------------------------------------------------~~~gt~~y~APE~~~~~~~t~ksDV~Sf 525 (645)
..+||..|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 1368999999999999899999999999
Q ss_pred HHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHH--HccCCCCCCCCCHH
Q 041096 526 GVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGL--SCANPDSSARPSMR 603 (645)
Q Consensus 526 Gvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~--~Cl~~dP~~RPt~~ 603 (645)
||++|||++|+.||...........+..|.. . ... + ....++.+ +.+++. .|+..++..||+++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~------~-~~~--~-~~~~~s~~----~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWEN------T-LHI--P-PQVKLSPE----AVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcccc------c-cCC--C-CCCCCCHH----HHHHHHHHccCcccccCCCCHH
Confidence 9999999999999976432221111111100 0 000 0 00112333 333443 37777888899999
Q ss_pred HHHHH
Q 041096 604 RVFQI 608 (645)
Q Consensus 604 ~vl~~ 608 (645)
++++.
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.54 Aligned_cols=240 Identities=26% Similarity=0.431 Sum_probs=195.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|+..+.||+|+||.||+|.... +..+|+|.+.......+.+.+|+.++++++|+|++++++++.+ +..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 467788999999999999998764 5678999887755566789999999999999999999998854 56899999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------- 497 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------- 497 (645)
+++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++.++..++.|...
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999997543 2248999999999999999999999 9999999999999999999999877211
Q ss_pred ---ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 498 ---LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 498 ---~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
...++..|+|||.+....++.++||||||+++|||++ |+.||...... ...+ .+.....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~-------------~~~~~~~ 221 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----EVLE-------------QVERGYR 221 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH----HHHH-------------HHHcCCC
Confidence 1123457999999988899999999999999999999 88898653221 1111 1111112
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
...+......+.+++.+|++++|++|||++++.+.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 22334456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=301.22 Aligned_cols=233 Identities=21% Similarity=0.370 Sum_probs=189.4
Q ss_pred eccCCceEEEEEEEC--CCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 356 LGRGAFGNVYKAYFA--SSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 356 lG~G~fg~Vy~g~~~--~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
||+|+||.||+|.+. +.+..+|+|.+.... ...+.+.+|+.++++++|+||++++++|.. +..++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999875 445679999887632 335679999999999999999999998864 578999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc-------------
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL------------- 498 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~------------- 498 (645)
.+++..... .+++.++++++.|++.||+|||+ .+++||||||+||+++.++.+|+.|....
T Consensus 82 ~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSGKKD---EITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999975432 38999999999999999999998 89999999999999999999999772111
Q ss_pred --cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 499 --TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 499 --~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
..++..|+|||.+..+.++.++|||||||++||+++ |+.||....... . ...+.......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~-------------~~~~~~~~~~~ 218 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----V-------------MSFIEQGKRLD 218 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH----H-------------HHHHHCCCCCC
Confidence 112467999999998889999999999999999996 999997643211 1 11112222223
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.+..+...+.+++..||..+|++||++.+|.+.|+..
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 4445567888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=309.39 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=189.0
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCeEEEEEeccCCc---chhHhHHHHHHHHhhc---CCCCeeeeeeeeee-----
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFA-SSGSVAAVKRSKHSH---EGKTEFLAELSIIACL---RHKNLVQLLGWCAE----- 415 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~----- 415 (645)
++|+..+.||+|+||.||+|... .++..+|+|++.... .....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999984 456889999876522 2234567788777766 69999999999852
Q ss_pred CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 416 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
....++||||++ ++|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+|+.|.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 346899999995 699999875432 238999999999999999999999 99999999999999999999999873
Q ss_pred c-----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 496 F-----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 496 ~-----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
. ....||..|+|||.+....++.++|||||||++|||++|+.||......+....+.+... .......
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~-~~~~~~~ 233 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-LPGEEDW 233 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC-CCChhhc
Confidence 2 223578999999999988999999999999999999999999986543322222222110 0000000
Q ss_pred hHH---hhhhcc--C-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 IEA---ADKRLN--G-----AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 ~~~---~d~~l~--~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+. ....+. . ....+....+.+++.+|++.+|++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 000000 0 001123355678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.91 Aligned_cols=240 Identities=30% Similarity=0.451 Sum_probs=192.5
Q ss_pred ceeccCCceEEEEEEECCCCe--EEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGS--VAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~--~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||.||+|.+..++. .+++|..... ....+.+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999977664 4688887652 34456789999999999 799999999999999999999999999
Q ss_pred CCHhHHhhhcCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc
Q 041096 429 GSLDRMLYQDSE------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF 496 (645)
Q Consensus 429 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~ 496 (645)
|+|.+++..... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.+|++|..
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 999999975431 12348899999999999999999998 999999999999999999999998732
Q ss_pred cc-----------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 TL-----------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 ~~-----------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
.. ...+..|+|||++....++.++|||||||++|||++ |+.||...... ....
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~----------- 222 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYE----------- 222 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH----HHHH-----------
Confidence 11 123457999999998899999999999999999997 99999653221 1111
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
.+........+......+.+++..||+.+|.+|||+.++++.|+.+.
T Consensus 223 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 223 --KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --HHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111111222234456889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.23 Aligned_cols=240 Identities=28% Similarity=0.445 Sum_probs=199.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|+..+.||+|+||.||+|... +..+|+|.+.......+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46778899999999999999876 7889999988765567789999999999999999999999999899999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------cc
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------TL 498 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------~~ 498 (645)
+++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++..++.|.. ..
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~ 158 (256)
T cd05039 84 KGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS 158 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccccc
Confidence 9999999976542 248999999999999999999999 999999999999999999999998732 11
Q ss_pred cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC
Q 041096 499 TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577 (645)
Q Consensus 499 ~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 577 (645)
..++..|+|||.+..+.++.++||||||+++||+++ |+.||...... .+... +........+
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~-------------~~~~~~~~~~ 221 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPH-------------VEKGYRMEAP 221 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH-------------HhcCCCCCCc
Confidence 234567999999998899999999999999999997 99998654221 11111 1111111223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 578 EDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 578 ~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
...+..+.+++.+||..+|++||++++++++|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 3345778899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.02 Aligned_cols=240 Identities=25% Similarity=0.425 Sum_probs=195.9
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|...++||+|+||.||+|.+..+ ..+|+|++.......+.+.+|++++++++|+||+++++.+.+ +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 4688889999999999999988754 469999988755556789999999999999999999998754 56899999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------- 497 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------- 497 (645)
+|+|.+++.... ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+++.|...
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999997542 2347999999999999999999999 9999999999999999999999977321
Q ss_pred ---ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 498 ---LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 498 ---~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
...++..|+|||+..+..++.++||||||+++|||++ |+.||...... .... .......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~-------------~~~~~~~ 221 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD-------------QVERGYR 221 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHH-------------HHhcCCC
Confidence 1234567999999998899999999999999999999 88888654321 1111 0111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
...+.+.+..+.+++..|++.+|++||++.++++.|+.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 12234556778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=323.30 Aligned_cols=188 Identities=28% Similarity=0.375 Sum_probs=168.4
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.|+..++||+|+||.||+|....++..+|+|++... ......+.+|++++++++|+||+++++.+.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999999989999999988653 2334578899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------- 497 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------- 497 (645)
|+++|+|.+++.+.. .++......++.||+.||+|||+ .+|+||||||+||||+.++.+|+.|..-
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999997643 37888889999999999999999 9999999999999999999999987321
Q ss_pred ----------------------------------------------------ccccCCcccCcccccCCCCCcchhHHHH
Q 041096 498 ----------------------------------------------------LTAGTMGYLAPEYLQYGTATEKTDVFSY 525 (645)
Q Consensus 498 ----------------------------------------------------~~~gt~~y~APE~~~~~~~t~ksDV~Sf 525 (645)
..+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 1258999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCccc
Q 041096 526 GVVVLEVACGRRPIERET 543 (645)
Q Consensus 526 Gvvl~El~tG~~P~~~~~ 543 (645)
||++|||++|+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.46 Aligned_cols=239 Identities=27% Similarity=0.346 Sum_probs=196.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|...+.||+|+||.||+|....++..||+|++... ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4688899999999999999999988999999998752 244567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||||+.++.+++.|..
T Consensus 81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999997653 38999999999999999999999 999999999999999999999997721
Q ss_pred ----------------------------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 041096 497 ----------------------------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERE 542 (645)
Q Consensus 497 ----------------------------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~ 542 (645)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 1235899999999999999999999999999999999999999764
Q ss_pred ccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 041096 543 TEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPS-MRRVFQI 608 (645)
Q Consensus 543 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~~vl~~ 608 (645)
........+..|. ..+...........+.+++..|++ +|.+||+ ++++++.
T Consensus 234 ~~~~~~~~i~~~~--------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWK--------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccC--------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4211111111100 111111111135567788889997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.45 Aligned_cols=232 Identities=24% Similarity=0.366 Sum_probs=188.5
Q ss_pred eeccCCceEEEEEEE--CCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCC
Q 041096 355 ILGRGAFGNVYKAYF--ASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 355 ~lG~G~fg~Vy~g~~--~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 429 (645)
.||+|+||.||+|.+ ..++..+|+|+++... ...+++.+|+.++++++|+||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999975 3457889999886532 235678999999999999999999999864 5679999999999
Q ss_pred CHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc------------
Q 041096 430 SLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------------ 497 (645)
Q Consensus 430 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------------ 497 (645)
+|.+++.... .+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++++|...
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999997543 38999999999999999999998 9999999999999999999999987211
Q ss_pred ---ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 498 ---LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 498 ---~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
...++..|+|||.+....++.++|||||||++|||++ |+.||...... .+. +.+.....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~-------------~~i~~~~~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN----EVT-------------QMIESGER 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHH-------------HHHHCCCC
Confidence 1123468999999988889999999999999999998 99999754321 111 11122222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
...+......+.+++..||+.+|++||++.+|.+.|++
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 23334455678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=314.62 Aligned_cols=239 Identities=26% Similarity=0.408 Sum_probs=202.1
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.|...++||+|.||.||||.+..+++.||+|++.. .....++..+|+.++.+++|+||.+++|.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 45666889999999999999999999999999876 4455678999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec------------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES------------ 494 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d------------ 494 (645)
.+|++.+.|+.... +......-|+.++..||.|||+ ++.+|||||+.||||..++.+|+.|
T Consensus 94 ~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999976543 5777777899999999999999 9999999999999999999999987
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 495 SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 495 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
.....+||+.|||||++....|+.|+||||+|++++||++|.+|+........... +.+..-|.|.+
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------Ipk~~PP~L~~ 233 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------IPKSAPPRLDG 233 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------ccCCCCCcccc
Confidence 22446899999999999988999999999999999999999999987654222111 11112233333
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcC
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNN 611 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~ 611 (645)
+....+.+++..|++.+|+.||++.++++ +|+.
T Consensus 234 ----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 234 ----DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ----ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 45567888889999999999999999986 4554
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.79 Aligned_cols=249 Identities=29% Similarity=0.441 Sum_probs=198.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCe--EEEEEeccC--CcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGS--VAAVKRSKH--SHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~--~vavK~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 422 (645)
++|+..+.||+|+||.||+|.+..++. .+++|.+.. .......+.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 567888999999999999999876664 457777654 233456788999999999 899999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 423 YEYMPNGSLDRMLYQDSE------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
|||+++++|.+++..... ....+++.+++.++.|++.||+|||+ .+++||||||+|||++.++..
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 999999999999975431 12358999999999999999999998 999999999999999999999
Q ss_pred eeeccccc-----------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhh
Q 041096 491 RLESSFTL-----------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 491 kl~d~~~~-----------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
++.|.... ..++..|+|||++....++.++|||||||++|||++ |..||......+ ..+
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~----- 234 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYE----- 234 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH----HHH-----
Confidence 99873211 123567999999988889999999999999999998 999986543211 111
Q ss_pred hccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 559 YAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
.+........+......+.+++.+||+.+|++||+++++++.|+...+..
T Consensus 235 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 235 --------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred --------HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111111122233456788999999999999999999999988654444
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.95 Aligned_cols=235 Identities=28% Similarity=0.434 Sum_probs=191.2
Q ss_pred ceeccCCceEEEEEEECCCC---eEEEEEeccCCcc--hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSG---SVAAVKRSKHSHE--GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~---~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||.||+|.....+ ..+|+|.+..... ..+++.+|+++++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999875544 7899999876443 5668999999999999999999999876 4568999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc----------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL---------- 498 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~---------- 498 (645)
++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+|||++.++..++.|....
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997654 38999999999999999999998 89999999999999999999999772110
Q ss_pred -----cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 499 -----TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 499 -----~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
..++..|+|||.+....++.++||||||+++|||++ |+.||...... .+..+.... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~----~~~~~~~~~-------------~ 215 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA----EVIAMLESG-------------E 215 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHHcC-------------C
Confidence 112357999999998999999999999999999998 99998754321 122221111 0
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
....+...+..+.+++.+||+.+|.+||++.++++.|++..
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11223334567889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=300.97 Aligned_cols=241 Identities=24% Similarity=0.446 Sum_probs=197.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.++|+..++||+|+||.||+|...+ +..+|+|.+.........+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 3567888999999999999998764 678999998876666778999999999999999999999874 45789999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--------- 497 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--------- 497 (645)
++++|.+++.... +..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++..++.|...
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 83 ENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999986543 2348999999999999999999998 9999999999999999999999977211
Q ss_pred ----ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 498 ----LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 498 ----~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
...++..|+|||++....++.++||||||++++||++ |+.||....... +.. .+....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~-------------~~~~~~ 220 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE----VIQ-------------NLERGY 220 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH----HHH-------------HHHcCC
Confidence 1234567999999998889999999999999999999 999997543211 111 111111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
....+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 112233345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.42 Aligned_cols=189 Identities=29% Similarity=0.396 Sum_probs=169.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||+||++....++..+|+|++... ......+.+|+.++.+++|+||+++++.+.+....||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688899999999999999999988999999998652 223456788999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------ 497 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------ 497 (645)
||+++|+|.+++.+.. .+++.+...++.|++.||+|||+ .+|+||||||+|||++.++.+||.|...
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997643 38999999999999999999999 9999999999999999999999987321
Q ss_pred -----------------------------------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCC
Q 041096 498 -----------------------------------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGR 536 (645)
Q Consensus 498 -----------------------------------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~ 536 (645)
..+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 236899999999999999999999999999999999999
Q ss_pred CCCCccc
Q 041096 537 RPIERET 543 (645)
Q Consensus 537 ~P~~~~~ 543 (645)
.||....
T Consensus 234 ~Pf~~~~ 240 (363)
T cd05628 234 PPFCSET 240 (363)
T ss_pred CCCCCCC
Confidence 9997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.71 Aligned_cols=242 Identities=25% Similarity=0.351 Sum_probs=194.9
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeC------C
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEK------G 417 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~------~ 417 (645)
.+++.|+..+.||+|+||.||+|....++..+|+|++.........+..|+.++.++ +|+||+++++++... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 466788889999999999999999998899999999877666667889999999998 699999999998753 4
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT 497 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~ 497 (645)
..++||||+++++|.+++..... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++..++.|...
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 68999999999999999976432 348999999999999999999999 9999999999999999999999987321
Q ss_pred ------------ccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc
Q 041096 498 ------------LTAGTMGYLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA 560 (645)
Q Consensus 498 ------------~~~gt~~y~APE~~~-----~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~ 560 (645)
...|+..|+|||++. ...++.++|||||||++|||++|+.||......... .. ...
T Consensus 158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~----~~---~~~ 230 (272)
T cd06637 158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----FL---IPR 230 (272)
T ss_pred ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH----HH---Hhc
Confidence 235788999999986 345788999999999999999999999653221100 00 000
Q ss_pred cCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 561 EGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 561 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..............+.+++.+||+.+|.+|||+.++++
T Consensus 231 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 ---------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00011111223456788999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=286.17 Aligned_cols=252 Identities=20% Similarity=0.292 Sum_probs=200.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc---hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.+|...++||+|.||.||+|++..+|+.||||+++..+. -.....+||+.|+.++|+||+.+++++...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 356677889999999999999999999999999887432 25678999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS--------- 495 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~--------- 495 (645)
||+ .+|...++.... .+...+...++.++++|++|||+ +.|+||||||.|+|+++++..|+.|.
T Consensus 82 fm~-tdLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 995 589999976544 48999999999999999999999 99999999999999999999999882
Q ss_pred ---ccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC---------
Q 041096 496 ---FTLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG--------- 562 (645)
Q Consensus 496 ---~~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~--------- 562 (645)
.+..+-|.+|+|||.+.+ +.|+...||||.||++.||+-|.+-|.+.++-+. +..+.+.+...
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ----L~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ----LSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH----HHHHHHHcCCCCcccCcccc
Confidence 122367889999999876 5699999999999999999998877766543222 22222221111
Q ss_pred chhH------HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcC
Q 041096 563 RIIE------AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNN 611 (645)
Q Consensus 563 ~~~~------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~ 611 (645)
.+.+ .-.+.+.. .-..+....++++..++..||.+|+|+.|+++ .+..
T Consensus 231 ~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred ccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 0111 11111221 23344556699999999999999999999987 4554
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.53 Aligned_cols=244 Identities=25% Similarity=0.401 Sum_probs=197.2
Q ss_pred cCCCcCceeccCCceEEEEEEE-----CCCCeEEEEEeccCCc--chhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYF-----ASSGSVAAVKRSKHSH--EGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~-----~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 419 (645)
++|...+.||+|+||.||++.. ...+..+|+|+++... ...+.+.+|+++++++ +|+||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 5688899999999999999975 2345689999887632 3345789999999999 799999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc--
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT-- 497 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~-- 497 (645)
++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+ ++++|+||||+|||++.+..++++|...
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999975432 238999999999999999999999 9999999999999999999999877211
Q ss_pred ------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 498 ------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 498 ------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
...++..|+|||.+....++.++|||||||++|||++ |..||........ +.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---~~------------ 254 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---FY------------ 254 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---HH------------
Confidence 1234567999999999999999999999999999998 9999875432111 11
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+.++.......+......+.+++..|++++|++||++.++++.|++.
T Consensus 255 -~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 255 -KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111111112223346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.98 Aligned_cols=252 Identities=24% Similarity=0.411 Sum_probs=198.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCC----------------eEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeee
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSG----------------SVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQ 408 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~----------------~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~ 408 (645)
.++|+..+.||+|+||.||++.....+ ..+|+|.+... ....+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357888999999999999999876433 56899988763 334678999999999999999999
Q ss_pred eeeeeeeCCeEEEEEecCCCCCHhHHhhhcCC-------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 041096 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSE-------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASN 481 (645)
Q Consensus 409 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N 481 (645)
++++|..++..++++||+++++|.+++..... ....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 99999999999999999999999999976541 11248999999999999999999998 999999999999
Q ss_pred EEEcCCCCeeeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCccccc
Q 041096 482 IMLDANFNARLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC--GRRPIERETEG 545 (645)
Q Consensus 482 Illd~~~~~kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t--G~~P~~~~~~~ 545 (645)
|+++.++.+++.|... ...++..|+|||.+....++.++|||||||++|||++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999977321 1234668999999998899999999999999999998 67787653321
Q ss_pred cchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 546 HKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 546 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
.........+.... .......+...+..+.+++..||+.+|++|||+.+|++.|+.
T Consensus 241 ----~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 ----QVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ----HHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 12222211111111 011111222344678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=322.24 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=198.2
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-----CCCeEEEEEeccCC--cchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCC
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFA-----SSGSVAAVKRSKHS--HEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKG 417 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~-----~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 417 (645)
..++|...++||+|+||.||+|++. ..+..||+|++... ....+.+.+|++++.++. ||||++++|+|...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456777899999999999999864 24568999998763 223457899999999997 999999999999999
Q ss_pred eEEEEEecCCCCCHhHHhhhcCC---------------------------------------------------------
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSE--------------------------------------------------------- 440 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 440 (645)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999975421
Q ss_pred -------------------------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 041096 441 -------------------------------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIM 483 (645)
Q Consensus 441 -------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIl 483 (645)
....++|.+.+.++.|++.||+|||+ .+++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEE
Confidence 11247888999999999999999998 99999999999999
Q ss_pred EcCCCCeeeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccch
Q 041096 484 LDANFNARLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKM 548 (645)
Q Consensus 484 ld~~~~~kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~ 548 (645)
++.++.+++.|... ...++..|+|||.+....++.++|||||||++|||++ |+.||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999977221 1235678999999998889999999999999999998 8889865332111
Q ss_pred hhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 549 VNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 549 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+ .+.+....+...+......+.+++..||+.+|.+||++++|++.|+..
T Consensus 351 --~-------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 --F-------------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred --H-------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 111111111222333456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.35 Aligned_cols=251 Identities=22% Similarity=0.386 Sum_probs=194.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCC--------------CeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeee
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASS--------------GSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLG 411 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~--------------~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g 411 (645)
++|+..+.||+|+||.||++..... ...||+|.+... ......|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5788889999999999999987532 235899988653 333557999999999999999999999
Q ss_pred eeeeCCeEEEEEecCCCCCHhHHhhhcCC--------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 041096 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSE--------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIM 483 (645)
Q Consensus 412 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIl 483 (645)
++...+..++||||+++++|.+++..... ....++|..++.++.|++.||+|||+ .+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 99999999999999999999999965321 11237899999999999999999999 99999999999999
Q ss_pred EcCCCCeeeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCccccccc
Q 041096 484 LDANFNARLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC--GRRPIERETEGHK 547 (645)
Q Consensus 484 ld~~~~~kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t--G~~P~~~~~~~~~ 547 (645)
++.++.+|+.|... ...++..|+|||++..+.++.++|||||||+++||++ |..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999977211 1123568999999998899999999999999999998 566776543211
Q ss_pred hhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 548 MVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 548 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
........+... ........+...+..+.+++.+||+.+|++||+|.+|++.|+.
T Consensus 241 ---~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 ---VIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111100 0011111122345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.32 Aligned_cols=242 Identities=24% Similarity=0.385 Sum_probs=195.2
Q ss_pred CCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCCcc--hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 350 FHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHSHE--GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
|+..+.||+|+||.||+|.... .+..+|+|++..... ..+.+.+|+.++.+++||||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 5556789999999999998753 257899999876332 346688999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcC------------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 423 YEYMPNGSLDRMLYQDS------------ENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
+||+++++|.+++.... .....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCce
Confidence 99999999999985321 112348899999999999999999998 999999999999999999999
Q ss_pred eeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHH
Q 041096 491 RLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWV 555 (645)
Q Consensus 491 kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~ 555 (645)
|+.|... ...+++.|+|||.+..+.++.++|||||||++|||++ |..||...... .+.+
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~-- 237 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----DVIE-- 237 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH--
Confidence 9987321 1234678999999998889999999999999999998 88888653221 1111
Q ss_pred HhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 556 WGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 556 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
.+...-....+.+.+..+.+++..||+.+|.+||++++|++.|+.
T Consensus 238 -----------~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 -----------MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----------HHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111122344566778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.44 Aligned_cols=244 Identities=24% Similarity=0.414 Sum_probs=196.4
Q ss_pred cCCCcCceeccCCceEEEEEEEC-----CCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFA-----SSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~-----~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|+..++||+|+||.||++... ..+..+++|.+... ......+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999999753 24568899987763 3445689999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCC-----------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 422 VYEYMPNGSLDRMLYQDSEN-----------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
+|||+++++|.+++...... ...+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 99999999999999764321 1348999999999999999999998 999999999999999999999
Q ss_pred eeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHH
Q 041096 491 RLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWV 555 (645)
Q Consensus 491 kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~ 555 (645)
++.|... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~-- 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----AIE-- 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH----HHH--
Confidence 9977321 1223578999999999999999999999999999998 899986543211 111
Q ss_pred HhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 556 WGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 556 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
..........+...+..+.+++..||+.+|.+||++++|++.|+.
T Consensus 236 -----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 -----------CITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -----------HHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111111112223345668899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=301.06 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=196.3
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 343 LRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 343 l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++.+++++.....||+|+||.||+|....++..+++|.+... ....+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 445677787888999999999999999888899999987663 3456689999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCeeeeccc----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA-NFNARLESSF---- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~-~~~~kl~d~~---- 496 (645)
|+||+++++|.+++...... ...++..+..++.|++.||+|||+ .+|+||||||+||+++. ++..++.|..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999999999999764321 012788899999999999999998 99999999999999986 5678887621
Q ss_pred --------cccccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 --------TLTAGTMGYLAPEYLQYGT--ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~~~--~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....|+..|+|||++.... ++.++||||||+++|||++|+.||........ ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~----~~~~----------- 223 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA----AMFK----------- 223 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh----hHhh-----------
Confidence 1234788999999987643 78999999999999999999999865322110 0000
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..........+......+.+++.+||+.+|.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 224 VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00001112234445567888999999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=322.32 Aligned_cols=238 Identities=24% Similarity=0.332 Sum_probs=192.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..++||+|+||.||+|....++..||||++... ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688899999999999999999988999999998652 233456788999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------ 497 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------ 497 (645)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+++.|...
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999997643 38999999999999999999999 9999999999999999999999977321
Q ss_pred --------------------------------------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHH
Q 041096 498 --------------------------------------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVA 533 (645)
Q Consensus 498 --------------------------------------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~ 533 (645)
..+||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 125899999999999999999999999999999999
Q ss_pred cCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 041096 534 CGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPS---MRRVFQ 607 (645)
Q Consensus 534 tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~~vl~ 607 (645)
+|+.||...........+..| ...+...........+.+++..|+. +|.+|++ ++++++
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~--------------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINW--------------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcC--------------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999764322111111111 0001000001123445666777886 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.97 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=194.3
Q ss_pred cCCCcCceeccCCceEEEEEEE----CCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeee--CCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYF----ASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAE--KGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~----~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 420 (645)
++|+..+.||+|+||.||++.. ..++..||+|.+... ....+.+.+|++++++++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677789999999999999985 345789999998764 3345678999999999999999999998754 34689
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccccc-
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT- 499 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~~- 499 (645)
+||||+++++|.+++..... .++|..+..++.|++.||+|||+ .+++||||||+||+++.++.+++.|.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 99999999999999975432 38999999999999999999998 999999999999999999999998722111
Q ss_pred --------------ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc----c
Q 041096 500 --------------AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA----E 561 (645)
Q Consensus 500 --------------~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~----~ 561 (645)
.++..|+|||.+.+..++.++|||||||++|||++|..|+...... .......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 232 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-----FMRMMGNDKQGQMIV 232 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-----hhhhcccccccccch
Confidence 1233599999999888999999999999999999988775432110 0000000000 0
Q ss_pred CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 562 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
..+.+.+........+...+..+.+++.+||..+|++||||++|++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 011112222111122334456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.16 Aligned_cols=242 Identities=26% Similarity=0.440 Sum_probs=195.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCC---CeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASS---GSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~---~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.+|+..+.||+|+||.||+|....+ +..+|+|.+... ....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 4677889999999999999987533 347899988653 23456899999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc----
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL---- 498 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~---- 498 (645)
|||+++++|.+++..... .+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+++.|....
T Consensus 84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999976432 38999999999999999999998 99999999999999999999999773110
Q ss_pred -----------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 499 -----------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 499 -----------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
..++..|+|||++.++.++.++||||||+++||+++ |+.||......+ ......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~----~~~~~~---------- 223 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----VIKAIE---------- 223 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH----HHHHHh----------
Confidence 112457999999998899999999999999999886 999987543211 111110
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.......+...+..+.+++..|++.+|.+||+|.++++.|+..
T Consensus 224 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 224 ---EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111112223456778999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.60 Aligned_cols=241 Identities=26% Similarity=0.461 Sum_probs=196.0
Q ss_pred CCCcCceeccCCceEEEEEEECCCCe---EEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGS---VAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~---~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
.|+..+.||+|+||.||+|....++. .||+|.+... .....+|..|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999999876553 6999998763 334568999999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc-----
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL----- 498 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~----- 498 (645)
||+++++|.+++..... .+++.+++.++.|++.||.|||+ .+++||||||+||+++.++..++.|....
T Consensus 85 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999976433 38999999999999999999998 99999999999999999999998772110
Q ss_pred ---------cc---cCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchh
Q 041096 499 ---------TA---GTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRII 565 (645)
Q Consensus 499 ---------~~---gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 565 (645)
.. .+..|+|||.+....++.++|||||||++||+++ |..||...... ....++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----~~~~~i~--------- 225 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVINAIE--------- 225 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----HHHHHHH---------
Confidence 01 1346999999999999999999999999999886 99999754321 1222111
Q ss_pred HHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 566 EAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 566 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.......+.+.+..+.+++..||+.+|.+||+++++++.|+..
T Consensus 226 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 ----QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111122234456788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=296.91 Aligned_cols=233 Identities=26% Similarity=0.439 Sum_probs=191.0
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
++||+|+||.||+|... ++..+|+|.+.... .....+.+|++++++++|+||++++++|...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36999999999999876 47889999877632 3345789999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-------------c
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT-------------L 498 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~-------------~ 498 (645)
.+++..... .+++..++.++.|++.+|.|||+ ++++||||||+||+++.++.+++.|... .
T Consensus 80 ~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 80 LSFLRKKKD---ELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 999865432 38999999999999999999998 9999999999999999999999987321 1
Q ss_pred cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC
Q 041096 499 TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577 (645)
Q Consensus 499 ~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 577 (645)
..++..|+|||++.++.++.++||||||+++||+++ |..||....... ... .+........+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~----~~~-------------~~~~~~~~~~~ 216 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ----ARE-------------QVEKGYRMSCP 216 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH----HHH-------------HHHcCCCCCCC
Confidence 123567999999999999999999999999999998 999997543211 111 11111111223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 578 EDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 578 ~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
...+..+.+++..|++.+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 345678899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=304.45 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=199.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECC----CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeee-CCeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFAS----SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAE-KGEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~----~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 419 (645)
.++|...++||+|+||.||+|.... .+..|++|++... ......+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999875 3578899987653 3345678999999999999999999999876 4678
Q ss_pred EEEEecCCCCCHhHHhhhcCCC----CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 420 LLVYEYMPNGSLDRMLYQDSEN----GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
++++||+++++|.+++...... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++.++..|+.|.
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999999764322 1458999999999999999999998 99999999999999999999999762
Q ss_pred cc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhc
Q 041096 496 FT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYA 560 (645)
Q Consensus 496 ~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~ 560 (645)
.. ...++..|+|||++....++.++||||||+++||+++ |+.||...... .+..+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~---- 233 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF----EMAAYLK---- 233 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH----HHHHHHH----
Confidence 21 1234667999999998889999999999999999999 99999754321 1111111
Q ss_pred cCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 561 EGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 561 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
...........+..+.+++.+||+.+|++|||+.++++.|+...
T Consensus 234 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 ---------DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ---------cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111122234567889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.40 Aligned_cols=245 Identities=27% Similarity=0.443 Sum_probs=197.5
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 419 (645)
.++|+..+.||+|+||.||++.... ++..+|+|.+... .....++.+|+.++++++||||++++++|.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4678889999999999999998742 5678999988763 23456799999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCC------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 041096 420 LLVYEYMPNGSLDRMLYQDSE------------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASN 481 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N 481 (645)
++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 999999999999999975321 11247899999999999999999998 999999999999
Q ss_pred EEEcCCCCeeeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccccc
Q 041096 482 IMLDANFNARLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGH 546 (645)
Q Consensus 482 Illd~~~~~kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~ 546 (645)
|+++.++..++.|... ....+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999977321 1123456999999998899999999999999999998 88888653321
Q ss_pred chhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 547 KMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 547 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
..... ...+. . ...+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 ---~~~~~----~~~~~--------~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ---EVIYY----VRDGN--------V-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHHHH----HhcCC--------C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 11111 1 11233445678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=286.71 Aligned_cols=238 Identities=26% Similarity=0.365 Sum_probs=203.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.++|+..+.||+|.||.||.|..+.++..||+|++.++ .+-.+++.+|+++-+.|+||||+++++|+.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35788999999999999999999999999999998763 23456789999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS------- 495 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~------- 495 (645)
+||.++|.|...|..... ..++......++.|+|.||.|+|. ++++||||||+|+|++.++..|+.|.
T Consensus 101 lEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999985432 237777888899999999999998 99999999999999999999999873
Q ss_pred ---ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 496 ---FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 496 ---~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....+||.-|++||-..+..++...|+|++|++.+|++.|..||+.....+....+. .+
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--------------k~---- 237 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--------------KV---- 237 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--------------Hc----
Confidence 234589999999999999999999999999999999999999998765332222111 11
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.-.++........+++..|+..+|.+|.+..|+++
T Consensus 238 ~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 DLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred cccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 12334555667788889999999999999999986
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=300.95 Aligned_cols=242 Identities=26% Similarity=0.397 Sum_probs=191.4
Q ss_pred CcCceeccCCceEEEEEEECCCCe--EEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC------CeE
Q 041096 351 HSNRILGRGAFGNVYKAYFASSGS--VAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK------GEL 419 (645)
Q Consensus 351 ~~~~~lG~G~fg~Vy~g~~~~~~~--~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~ 419 (645)
...++||+|+||.||+|.....+. .+|+|.++.. ....+.+.+|+++++.++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999999876654 6899987653 33456789999999999999999999987532 246
Q ss_pred EEEEecCCCCCHhHHhhhcC--CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc
Q 041096 420 LLVYEYMPNGSLDRMLYQDS--ENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT 497 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~ 497 (645)
++++||+++|+|.+++.... .....+++.....++.|++.||+|||+ ++|+||||||+|||++.++..++.|...
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999885432 123458999999999999999999999 9999999999999999999999988321
Q ss_pred --------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccC
Q 041096 498 --------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEG 562 (645)
Q Consensus 498 --------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~ 562 (645)
...++..|+|||++....++.++||||||+++|||++ |+.||...... .+.+. ...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~----~~~~ 230 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS----EIYDY----LRQG 230 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH----HHcC
Confidence 1134567999999999999999999999999999999 78888653221 11111 1111
Q ss_pred chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 563 RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 563 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
. ....+......+.+++..||+.+|++|||+.++++.|+..
T Consensus 231 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 N---------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 0112233456688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=298.25 Aligned_cols=240 Identities=25% Similarity=0.421 Sum_probs=195.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|...+.||+|++|.||+|....+ ..+|+|.+.......+.+.+|++++++++|+|++++++++.. +..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4577788999999999999988654 468999887655556779999999999999999999998854 56899999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc---------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL--------- 498 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~--------- 498 (645)
+++|.+++.... ...++|..+..++.|++.||+|||+ .+++||||||+||++++++..++.|....
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999997643 2348999999999999999999998 89999999999999999999999772211
Q ss_pred ----cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 499 ----TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 499 ----~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
..++..|+|||...+..++.++||||||+++|||++ |+.||....... ...+. .....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~-------------~~~~~ 221 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE----VLEQV-------------ERGYR 221 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH-------------HcCCC
Confidence 124567999999998999999999999999999999 899987543211 11111 11111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
...+...+..+.+++.+||+.+|.+||++++|++.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 12233456778899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=298.96 Aligned_cols=238 Identities=24% Similarity=0.352 Sum_probs=196.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc------chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH------EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|...+.||+|++|.||+|....++..+++|.+.... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999998889999999876421 123568899999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
|+||+++++|.+++.... .+++.....++.|++.||+|||+ .+++||||||+||++++++.+++.|..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999997643 38889999999999999999999 999999999999999999999997722
Q ss_pred ----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 ----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~-------------~ 218 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AIF-------------K 218 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HHH-------------H
Confidence 12346778999999999889999999999999999999999986532110 110 1
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
..........+......+.+++..||+.+|.+|||++++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 219 IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111111123334455678889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.38 Aligned_cols=249 Identities=23% Similarity=0.383 Sum_probs=198.6
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCe
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGE 418 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 418 (645)
..++|+..++||+|+||.||+|...+ .+..||+|.+.... .....+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678889999999999999997642 34579999876533 234568899999999999999999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCCC------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeee
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSEN------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL 492 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl 492 (645)
.++||||+++|+|.+++...... ...+.+..+..++.|++.||+|||+ ++++||||||+||+++.++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999753321 2346788899999999999999998 99999999999999999999999
Q ss_pred ecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHh
Q 041096 493 ESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWG 557 (645)
Q Consensus 493 ~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~ 557 (645)
.|... ...++..|+|||.+.++.++.++|||||||++|||++ |..||......+ ..+..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~----~~~~~-- 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ----VLKFV-- 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH--
Confidence 88321 1134567999999999899999999999999999998 788886533211 11110
Q ss_pred hhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 558 LYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 558 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
.+.. ....+......+.+++..|++.+|++|||+.++++.|++...
T Consensus 235 ----------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 235 ----------MDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred ----------HcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 0110 112233345789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.25 Aligned_cols=232 Identities=24% Similarity=0.356 Sum_probs=187.8
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHH---hhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSII---ACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
|+..+.||+|+||.||+|....++..||||++... ....+.+.+|++++ ++++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56678999999999999999988999999998752 22334566666554 567899999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++++|..++... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++..|+.|..
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999888642 38999999999999999999999 999999999999999999999998732
Q ss_pred ------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 ------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||....... .... +...
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~----~~~~------------i~~~ 216 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE----VFDS------------IVND 216 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH----HHHH------------HHhC
Confidence 12358999999999999999999999999999999999999997543211 1110 0000
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
. ..++......+.+++..||+.||.+|| ++.++++
T Consensus 217 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 E--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred C--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 112233455678899999999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=303.60 Aligned_cols=231 Identities=24% Similarity=0.387 Sum_probs=180.4
Q ss_pred eeccCCceEEEEEEECCC------------------------CeEEEEEeccCCc-chhHhHHHHHHHHhhcCCCCeeee
Q 041096 355 ILGRGAFGNVYKAYFASS------------------------GSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQL 409 (645)
Q Consensus 355 ~lG~G~fg~Vy~g~~~~~------------------------~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l 409 (645)
.||+|+||.||+|.+... ...|++|.+.... ....+|.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999986321 2458888886532 234678899999999999999999
Q ss_pred eeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 041096 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN 489 (645)
Q Consensus 410 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~ 489 (645)
+++|.+....++||||+++|+|..++..... .+++..++.++.|+++||+|||+ ++++||||||+|||++.++.
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999875432 38899999999999999999998 99999999999999986542
Q ss_pred -------eeeeccc--------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHH-cCCCCCCccccccchhhHH
Q 041096 490 -------ARLESSF--------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVA-CGRRPIERETEGHKMVNLV 552 (645)
Q Consensus 490 -------~kl~d~~--------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~-tG~~P~~~~~~~~~~~~l~ 552 (645)
.++.|.. ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||........ .
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~ 231 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK----E 231 (274)
T ss_pred ccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH----H
Confidence 4565521 22346788999998875 56899999999999999995 68999875432110 0
Q ss_pred HHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 553 DWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 553 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
. ...... ..+......+.+++..||+.+|++||+|+++++.|+
T Consensus 232 ~-------------~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 R-------------FYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H-------------HHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 001111 111112345788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=320.60 Aligned_cols=239 Identities=24% Similarity=0.289 Sum_probs=193.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
..++|+..++||+|+||.||++....++..+|+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 346788899999999999999999989999999998642 2334557899999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||||+++|+|.+++.... ++......++.|++.||+|||+ .+|+||||||+|||++.++.+||+|..
T Consensus 121 v~Ey~~gg~L~~~l~~~~-----l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999986532 7788888899999999999999 999999999999999999999998721
Q ss_pred --------cccccCCcccCcccccCC----CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 --------TLTAGTMGYLAPEYLQYG----TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~~----~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....||+.|+|||.+... .++.++|||||||++|||++|+.||......... .
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~----~----------- 257 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY----S----------- 257 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH----H-----------
Confidence 124589999999998653 4789999999999999999999999764321111 1
Q ss_pred hHHhhhhccCCCCH--HHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 041096 565 IEAADKRLNGAFNE--DEMKRLLLVGLSCANPDSSA--RPSMRRVFQI 608 (645)
Q Consensus 565 ~~~~d~~l~~~~~~--~~~~~l~~l~~~Cl~~dP~~--RPt~~~vl~~ 608 (645)
+++...-...++. .....+.+++..|++.+|.+ ||++.++++.
T Consensus 258 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 258 -KIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -HHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111100011111 23456778889999999988 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.74 Aligned_cols=234 Identities=24% Similarity=0.353 Sum_probs=191.5
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCC-CCeeeeeeeeeeCCeEEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRH-KNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 423 (645)
+|+..+.||+|+||.||+|....++..||+|++... ....+.+..|++++..++| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 477889999999999999999988999999988752 2345678889999999976 56888999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|.+++..... +++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+++.|..
T Consensus 81 E~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK----FKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999976443 8899999999999999999999 999999999999999999999998732
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....||..|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ ...
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i------------~~~- 216 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELFQSI------------MEH- 216 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHH------------HcC-
Confidence 1235899999999999999999999999999999999999999764321 111111 000
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSM-----RRVFQ 607 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~~vl~ 607 (645)
...++......+.+++..|++.+|.+||+. +++.+
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 217 -NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112223344567788899999999999986 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=290.21 Aligned_cols=190 Identities=28% Similarity=0.411 Sum_probs=173.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||.|+||.|.+++.+.++..+|+|++.+. -...+...+|..+|+.+.||.++++++.|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 3567789999999999999999999999999998873 234566789999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec---------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES--------- 494 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d--------- 494 (645)
||+++|-|..+|++.+. ++.....-++.||+.||+|||+ ..|++|||||+|||||.+|-.|+.|
T Consensus 124 eyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999987654 8999999999999999999999 9999999999999999999998877
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 041096 495 SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544 (645)
Q Consensus 495 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~ 544 (645)
.....|||+.|+|||++....+..++|.|||||++|||+.|..||.....
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 34456899999999999999999999999999999999999999987543
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=302.62 Aligned_cols=245 Identities=24% Similarity=0.389 Sum_probs=196.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCe----EEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGS----VAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~----~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|+..++||+|+||+||+|++..++. .||+|.+... .....++.+|+.++..++|+||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 567888999999999999999765555 4799988652 33456789999999999999999999999754 5789
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc---
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL--- 498 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~--- 498 (645)
++||+++|+|.+++..... .+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+|+.|....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 9999999999999976432 38999999999999999999999 99999999999999999999999873211
Q ss_pred -----------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 499 -----------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 499 -----------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
..++..|+|||...+..++.++|||||||++|||++ |..||...... .+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~------------ 223 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR----EIPDL------------ 223 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH------------
Confidence 123567999999999999999999999999999998 88998653221 11111
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
+........+......+.+++..||+.||++||++.++++.|+.....+
T Consensus 224 -~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 224 -LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1111111122334567888999999999999999999999998765544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.36 Aligned_cols=242 Identities=25% Similarity=0.423 Sum_probs=204.1
Q ss_pred CCCcCceeccCCceEEEEEEECCC----CeEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASS----GSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~----~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.....++||.|.||.||+|++.+. .-.||||..+. .....+.|+.|..+|++++||||++|+|.|.+. ..|||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 344567899999999999997432 34689998776 345578899999999999999999999999874 78999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc----
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL---- 498 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~---- 498 (645)
||.++-|-|++||+.+... |+.......+.||+.+|+|||+ .+.|||||..+|||+.+...+|++|..-.
T Consensus 469 mEL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 9999999999999877654 8999999999999999999999 99999999999999999999999883211
Q ss_pred ---------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 499 ---------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 499 ---------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
..-...|||||.+..+++|.+||||.|||.+||++. |..||.+....+.. -.+
T Consensus 543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-----------------~~i 605 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-----------------GHI 605 (974)
T ss_pred ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----------------EEe
Confidence 122457999999999999999999999999999988 99999886554332 222
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
...-+...+++|+..++.++.+||..+|.+||++.++...|.++.+
T Consensus 606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 3333456788999999999999999999999999999887765433
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=314.42 Aligned_cols=251 Identities=21% Similarity=0.224 Sum_probs=193.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|+..+.||+|+||.||++....+++.||+|... ...+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~- 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY- 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-
Confidence 57999999999999999999999999999999653 235789999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------- 497 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------- 497 (645)
.++|..++.... .+++.+++.++.|++.||+|||+ .+|+||||||+||||+.++.+||.|...
T Consensus 166 ~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 KTDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 478998886543 28999999999999999999999 8999999999999999999999987321
Q ss_pred ---ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccc---hhhHHHHHHhhhc----c------
Q 041096 498 ---LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHK---MVNLVDWVWGLYA----E------ 561 (645)
Q Consensus 498 ---~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~---~~~l~~~~~~~~~----~------ 561 (645)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+..+..... +
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 13589999999999999999999999999999999999988754321110 0011111111000 0
Q ss_pred CchhHHh---hhh-cc--CCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcC
Q 041096 562 GRIIEAA---DKR-LN--GAF-----NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNN 611 (645)
Q Consensus 562 ~~~~~~~---d~~-l~--~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~ 611 (645)
..+.+.. ... .. ... ..+.+..+.+++..|++.||++|||++|+++ .+..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 0001000 000 00 000 0123456888999999999999999999985 4544
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.22 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=198.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-------CCCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFA-------SSGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEK 416 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~-------~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 416 (645)
..+|...+.||+|+||.||+|... ..+..+|+|..... ....+.+.+|+.++..+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356778899999999999999752 23457999988753 33456789999999999 899999999999999
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSE------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML 484 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll 484 (645)
+..++||||+++|+|.+++..... ....++|.+++.++.|+++||+|||+ .+++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 999999999999999999976432 12348899999999999999999999 999999999999999
Q ss_pred cCCCCeeeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchh
Q 041096 485 DANFNARLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMV 549 (645)
Q Consensus 485 d~~~~~kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~ 549 (645)
+.++..++.|... ...++..|+|||++.+..++.++||||||+++|||++ |..||..... .
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~ 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----E 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----H
Confidence 9999999977311 1234567999999998899999999999999999998 7888865321 1
Q ss_pred hHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 550 NLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 550 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
.+.+ .+........+......+.+++..||+.+|.+||+|.++++.|+++..
T Consensus 247 ~~~~-------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 ELFK-------------LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHH-------------HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1111 111111112233456678889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=297.50 Aligned_cols=242 Identities=28% Similarity=0.452 Sum_probs=200.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.++|...++||+|+||.||+|...+ +..+|||.+.......+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4678889999999999999999864 577999998876666778999999999999999999999999988999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--------- 497 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--------- 497 (645)
++++|.+++.... ...+++.++..++.|++.||+|||+ .+++|+||||+||+++.++..++.|...
T Consensus 84 ~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 84 SKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999997643 2348999999999999999999998 8999999999999999999999987321
Q ss_pred ----ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 498 ----LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 498 ----~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
...++..|+|||.+.+..++.++||||||++++|+++ |+.||...... ...+. +....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~-------------~~~~~ 221 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR----EVLEQ-------------VERGY 221 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH-------------HHcCC
Confidence 1123457999999998899999999999999999998 99998653221 11111 11111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
....+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 112223335678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.21 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=206.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
+-|+..+.||+|+-|.|-+|++..+|+.+|||++.+. ......+.+||-+|+-|.|||++++++.+++..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3456678899999999999999999999999998763 333456889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|-|.++|-.++. ++..+..+++.||..|+.|+|. .+|+||||||+|+|||.+++.||.|..
T Consensus 92 Eyv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999987654 8999999999999999999999 999999999999999999999998832
Q ss_pred ----cccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
...||++-|.|||++.+.+| ..++||||.|||||.|++|+.||++.+ ...+... +...
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----ir~LLlK-------------V~~G 227 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----IRVLLLK-------------VQRG 227 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----HHHHHHH-------------HHcC
Confidence 34589999999999999998 579999999999999999999998532 2222221 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCCC
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPLV 617 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~~ 617 (645)
. -+.+.+.......|+..|+..||++|.|++||++ .|.+-...+.
T Consensus 228 ~-f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 228 V-FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred c-ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence 1 1234555667788889999999999999999998 4565555443
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=321.47 Aligned_cols=239 Identities=23% Similarity=0.285 Sum_probs=190.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|...+.||+|+||.||++....++..||||.+... ....+.+.+|++++++++||||+++++++.+.+..||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688889999999999999999999999999987652 223456888999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------ 497 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------ 497 (645)
||+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+++.|...
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999997543 38888999999999999999999 9999999999999999999999987321
Q ss_pred -----------------------------------------------------ccccCCcccCcccccCCCCCcchhHHH
Q 041096 498 -----------------------------------------------------LTAGTMGYLAPEYLQYGTATEKTDVFS 524 (645)
Q Consensus 498 -----------------------------------------------------~~~gt~~y~APE~~~~~~~t~ksDV~S 524 (645)
..+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 135899999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCC---CCC
Q 041096 525 YGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSA---RPS 601 (645)
Q Consensus 525 fGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~---RPt 601 (645)
|||++|||++|+.||...........+..|. ..+.-.-.......+.+++..|+. +|.+ ||+
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWR--------------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccC--------------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 9999999999999997643221111111110 001000001123446667778887 5665 469
Q ss_pred HHHHHHH
Q 041096 602 MRRVFQI 608 (645)
Q Consensus 602 ~~~vl~~ 608 (645)
+.++++.
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.17 Aligned_cols=253 Identities=25% Similarity=0.325 Sum_probs=200.4
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeee--
Q 041096 338 FSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCA-- 414 (645)
Q Consensus 338 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~-- 414 (645)
+.++.+..+.++|+..+.||+|+||.||++....++..+|+|..........++.+|+.++.++ +|+||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3455666788999999999999999999999988899999998876544556788999999999 6999999999884
Q ss_pred ---eCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCee
Q 041096 415 ---EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491 (645)
Q Consensus 415 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~k 491 (645)
.++..++||||+++++|.+++.........+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEE
Confidence 3457899999999999999886543333458999999999999999999999 9999999999999999999999
Q ss_pred eeccc------------cccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHH
Q 041096 492 LESSF------------TLTAGTMGYLAPEYLQY-----GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDW 554 (645)
Q Consensus 492 l~d~~------------~~~~gt~~y~APE~~~~-----~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~ 554 (645)
+.|.. ....|+..|+|||++.. ..++.++|||||||++|||++|+.||....... .+...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---~~~~~ 241 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---ALFKI 241 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---HHhhc
Confidence 97721 12358889999998853 457889999999999999999999987543211 11100
Q ss_pred HHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 555 VWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 555 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
... ..+.+ ..+......+..++..||+.+|++|||++++++.
T Consensus 242 -----~~~-----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 242 -----PRN-----PPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -----ccc-----CCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 00000 0111223468889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=300.58 Aligned_cols=242 Identities=23% Similarity=0.308 Sum_probs=194.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
++|+..+.||+|+||.||+|+...++..+|+|+.... ......+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688889999999999999999888999999988653 334556889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++++|.+++.... .+++.++..++.|++.||+|||+ .+++||||||+||+++.++..++.|..
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999986543 38999999999999999999998 999999999999999999999997721
Q ss_pred --cccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 --TLTAGTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~---~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....|+..|+|||.+. ...++.++|||||||++|||++|+.||............ .... ...+.
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------~~~~---~~~~~ 230 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------SKSN---FQPPK 230 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------ecCC---CCCCC
Confidence 1235778999999884 345788999999999999999999998653321111000 0000 00011
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L 609 (645)
.. ........+.+++..||+.+|++||+++++++.|
T Consensus 231 ~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 10 0112346788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.41 Aligned_cols=229 Identities=21% Similarity=0.321 Sum_probs=186.5
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
+.||+|+||.||+|....++..||+|.++.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999988999999988753 23345567788888764 899999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|.+++.... .+++.++..++.|++.||+|||+ .+++||||||+|||++.++..++.|..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 99999997643 28899999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
....||..|+|||++.+..++.++|||||||++|||++|+.||...... .+...+. ...+ .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~i~----------~~~~----~~ 215 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQSIR----------MDNP----CY 215 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHH----------hCCC----CC
Confidence 1235889999999999999999999999999999999999999754321 1111110 0001 12
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSMR-RVFQ 607 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-~vl~ 607 (645)
+......+.+++..||+.+|++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 222345577888999999999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=300.57 Aligned_cols=238 Identities=28% Similarity=0.415 Sum_probs=191.8
Q ss_pred ceeccCCceEEEEEEECCCC------eEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 354 RILGRGAFGNVYKAYFASSG------SVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~------~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+.||+|+||.||+|+..+.. ..+++|.+.... .....+.+|+.+++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36999999999999986433 678999876532 4567899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCC---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-----Ceeeecccc
Q 041096 426 MPNGSLDRMLYQDSE---NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-----NARLESSFT 497 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~-----~~kl~d~~~ 497 (645)
+++++|.+++..... ....++|.+++.++.|++.||+|||+ .+++|+||||+||+++.+. ..++.|...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975432 22348899999999999999999998 8999999999999999877 788876221
Q ss_pred --------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccC
Q 041096 498 --------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEG 562 (645)
Q Consensus 498 --------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~ 562 (645)
...++..|+|||++.++.++.++|||||||++|||++ |+.||...... .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~----~~~~~~------- 226 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ----EVLQHV------- 226 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH----HHHHHH-------
Confidence 1234578999999999999999999999999999998 99998653321 111111
Q ss_pred chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 563 RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 563 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
........+...+..+.+++.+||..+|.+||+++++++.|++
T Consensus 227 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 ------TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111112233456778899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=305.02 Aligned_cols=251 Identities=22% Similarity=0.393 Sum_probs=195.7
Q ss_pred cCCCcCceeccCCceEEEEEEECC----------------CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeee
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS----------------SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQL 409 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~----------------~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l 409 (645)
++|+..+.||+|+||.||++.... ++..+|+|.+... .....++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 568889999999999999985432 3457899988753 3345689999999999999999999
Q ss_pred eeeeeeCCeEEEEEecCCCCCHhHHhhhcCCC-------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 041096 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSEN-------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNI 482 (645)
Q Consensus 410 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NI 482 (645)
++++...+..++||||+++++|.+++...... ...+++.+++.++.|++.||+|||+ .+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 99999999999999999999999999764321 1347889999999999999999999 8999999999999
Q ss_pred EEcCCCCeeeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCcccccc
Q 041096 483 MLDANFNARLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC--GRRPIERETEGH 546 (645)
Q Consensus 483 lld~~~~~kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t--G~~P~~~~~~~~ 546 (645)
|++.++.+++.|... ...++..|+|||....+.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999977321 1123567999999888899999999999999999998 778886543211
Q ss_pred chhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 547 KMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 547 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
........+... ........+..++..+.+++.+||+.+|.+||+|.+|++.|++
T Consensus 242 ----~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 ----VIENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ----HHHHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111000 0000011122345788899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.14 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=202.4
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeC
Q 041096 338 FSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEK 416 (645)
Q Consensus 338 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 416 (645)
+.++++..++++|...+.||+|+||.||++....++..+|+|.+.........+.+|+.++.++ +|+|++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 4556667788999999999999999999999988899999999876555566788999999999 799999999998754
Q ss_pred -----CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCee
Q 041096 417 -----GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491 (645)
Q Consensus 417 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~k 491 (645)
+..++|+||+++++|.+++.........+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEE
Confidence 36899999999999999987543334458999999999999999999998 9999999999999999999999
Q ss_pred eeccc------------cccccCCcccCcccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHH
Q 041096 492 LESSF------------TLTAGTMGYLAPEYLQYG-----TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDW 554 (645)
Q Consensus 492 l~d~~------------~~~~gt~~y~APE~~~~~-----~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~ 554 (645)
+.|.. ....|+..|+|||.+... .++.++|||||||++|||++|+.||....... .+..+
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~---~~~~~ 245 (291)
T cd06639 169 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK---TLFKI 245 (291)
T ss_pred EeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH---HHHHH
Confidence 98721 123577889999998643 36899999999999999999999997543211 11111
Q ss_pred HHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 555 VWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 555 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
. . .. .+.+ ..+.+....+.+++..||+.+|++||++.++++.
T Consensus 246 ~----~-~~-----~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 P----R-NP-----PPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred h----c-CC-----CCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 0 00 0011 1122334568899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.24 Aligned_cols=229 Identities=24% Similarity=0.328 Sum_probs=184.9
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||.||+|....++..||+|.++.. ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999988999999988752 22344556677777654 899999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|..++.... .++..+...++.|++.||+|||+ .+|+||||||+|||++.++.+|+.|..
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 99999987643 28899999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
....||..|+|||.+.+..++.++|||||||++|||++|+.||...+... +...+ .. ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~----~~~~i-------------~~-~~~~~ 215 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE----LFDSI-------------LN-DRPHF 215 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH----HHHHH-------------Hc-CCCCC
Confidence 12358999999999999999999999999999999999999997643211 11100 00 01122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSMR-RVFQ 607 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-~vl~ 607 (645)
+......+.+++..||+.+|++||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 333445667888999999999999975 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=302.23 Aligned_cols=235 Identities=24% Similarity=0.302 Sum_probs=187.2
Q ss_pred eccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 356 lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
||+|+||.||++....++..+|+|++... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999988999999988642 22334566799999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------cccc
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-----------TLTA 500 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-----------~~~~ 500 (645)
..++..... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++..++.|.. ....
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA 155 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence 988865432 238999999999999999999999 999999999999999999999998722 1245
Q ss_pred cCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHH
Q 041096 501 GTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDE 580 (645)
Q Consensus 501 gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 580 (645)
|+..|+|||++.+..++.++|||||||++|||++|+.||............ .... ....... .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~---~~~~---------~~~~~~~-~~~~~ 222 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KRRT---------LEDEVKF-EHQNF 222 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH---HHHh---------hcccccc-ccccC
Confidence 889999999999888999999999999999999999999753321111111 0000 0001100 01123
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 581 MKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 581 ~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
...+.+++..||+.||++||+++|+++.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 4567889999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.07 Aligned_cols=232 Identities=24% Similarity=0.392 Sum_probs=182.9
Q ss_pred ceeccCCceEEEEEEECCCCe-------EEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 354 RILGRGAFGNVYKAYFASSGS-------VAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~-------~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+.||+|+||.||+|.....+. .+++|..... ....+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998865433 4788877653 23456788999999999999999999999998999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe--------eeeccc-
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA--------RLESSF- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~--------kl~d~~- 496 (645)
+++|+|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.. ++.|..
T Consensus 81 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999976543 38999999999999999999999 999999999999999887764 555421
Q ss_pred -------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCC-CCCCccccccchhhHHHHHHhhhccCchhHH
Q 041096 497 -------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGR-RPIERETEGHKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~-~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
....++..|+|||++.+ +.++.++||||||+++|||++|. .|+..... .. ... .
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~---~~~-------------~ 217 (258)
T cd05078 155 SITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QK---KLQ-------------F 217 (258)
T ss_pred ccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HH---HHH-------------H
Confidence 22457889999999986 45799999999999999999985 55543221 10 000 0
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
... ....+......+.+++..||+.+|++|||++++++.|+
T Consensus 218 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 218 YED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 001 11222223356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=317.53 Aligned_cols=239 Identities=27% Similarity=0.329 Sum_probs=193.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|...+.||+|+||.||++....++..+|+|++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999999989999999998763 224567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|.+++..... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999976532 38999999999999999999999 999999999999999999999998732
Q ss_pred ------cccccCCcccCccccc------CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 ------TLTAGTMGYLAPEYLQ------YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~------~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...........+. ....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~-------~~~~- 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------NFQR- 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH-------cCCC-
Confidence 1235899999999986 4567899999999999999999999997643211111110 0000
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+...........+.+++..|++ +|.+||+++++++
T Consensus 227 ------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 ------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 01001111234557778888997 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.50 Aligned_cols=229 Identities=26% Similarity=0.337 Sum_probs=188.1
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||.||+|+...++..+|+|++... ....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999988999999988752 23345678899998876 799999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|..++..... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|.|..
T Consensus 81 ~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 81 GDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 999999876543 8999999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
....||..|+|||++.+..++.++|||||||++|||++|+.||....... +...+ .... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~----~~~~i------------~~~~--~~~ 215 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD----LFESI------------LHDD--VLY 215 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH----HHHHH------------HcCC--CCC
Confidence 12358999999999999999999999999999999999999997643211 11111 0000 011
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARP-------SMRRVFQ 607 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RP-------t~~~vl~ 607 (645)
+......+.+++..|++.+|++|| +++++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 222345677888999999999999 7888865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.02 Aligned_cols=237 Identities=24% Similarity=0.319 Sum_probs=189.3
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||.||++....++..+|+|.+... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999998999999988752 23345677898888877 799999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 99999886543 38999999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccc-hhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHK-MVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
....||..|+|||++.+..++.++|||||||++|||++|+.||........ ......+...... ... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~--------~~~--~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--------EKQ--IR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh--------cCC--CC
Confidence 123589999999999999999999999999999999999999964221111 1111111111111 111 12
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHH
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPS------MRRVFQ 607 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~~vl~ 607 (645)
++......+.+++..||+.||++||+ +.++++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 33344566788999999999999998 466644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=322.02 Aligned_cols=239 Identities=23% Similarity=0.311 Sum_probs=190.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||++....++..+|+|.+... ......+.+|++++++++|+||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688899999999999999999988999999988652 223456889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------ 497 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------ 497 (645)
||+++|+|.+++.+.. .++......++.||+.||+|||+ .+|+||||||+|||++.++..+|.|...
T Consensus 81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999997643 37888889999999999999999 9999999999999999999999987421
Q ss_pred -------------------------------------------------ccccCCcccCcccccCCCCCcchhHHHHHHH
Q 041096 498 -------------------------------------------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVV 528 (645)
Q Consensus 498 -------------------------------------------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvv 528 (645)
..+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 1368999999999999999999999999999
Q ss_pred HHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHHH
Q 041096 529 VLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARP---SMRRV 605 (645)
Q Consensus 529 l~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~~v 605 (645)
+|||++|+.||...........+..|. ..+...........+.+++..|+ .+|.+|+ ++.++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~--------------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWE--------------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccC--------------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999999997643221111111110 00000001112233444445554 4999999 88888
Q ss_pred HHH
Q 041096 606 FQI 608 (645)
Q Consensus 606 l~~ 608 (645)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=307.49 Aligned_cols=246 Identities=23% Similarity=0.373 Sum_probs=197.7
Q ss_pred cCCCcCceeccCCceEEEEEEECC-------CCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS-------SGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKG 417 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~-------~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 417 (645)
++|...+.||+|+||.||++.... ....+|+|.+... .....++.+|++++.++ +|+||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 568889999999999999998642 2356999988753 33456788999999999 7999999999999999
Q ss_pred eEEEEEecCCCCCHhHHhhhcCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSE------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld 485 (645)
..++||||+++|+|.+++..... ....++|.+++.++.|++.||+|||+ .+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 99999999999999999976432 12348999999999999999999998 9999999999999999
Q ss_pred CCCCeeeeccccc--------------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhh
Q 041096 486 ANFNARLESSFTL--------------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVN 550 (645)
Q Consensus 486 ~~~~~kl~d~~~~--------------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~ 550 (645)
.++.+++.|.... ..++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~----~ 250 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----E 250 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----H
Confidence 9999999773211 113457999999998899999999999999999998 88888643211 1
Q ss_pred HHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 551 LVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 551 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
+. +.+........+......+.+++..||+.+|++||+|.+|++.|+.+.
T Consensus 251 ~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 251 LF-------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HH-------------HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11 111111112233445567888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.95 Aligned_cols=229 Identities=24% Similarity=0.343 Sum_probs=189.7
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||+||+|....++..+|+|++... ......+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999988999999988752 23345677899999888 699999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|..++.... .+++.++..++.|++.||+|||+ .+++||||||+|||++.++..++.|..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 99999987653 38999999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
...+|+..|+|||++.+..++.++|||||||++|||++|+.||...... .+.... .... ..+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~----~~~~~i------------~~~~--~~~ 215 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED----ELFQSI------------LEDE--VRY 215 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----HHHHHH------------HcCC--CCC
Confidence 1235889999999999999999999999999999999999999754321 111110 0000 112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSM-----RRVFQ 607 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~~vl~ 607 (645)
+......+.+++..||+.||.+||++ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 23345667889999999999999999 88865
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=311.57 Aligned_cols=237 Identities=24% Similarity=0.327 Sum_probs=189.9
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||.||++....++..||+|+++.. ......+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999989999999998752 23345688899999998 699999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|..++.... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||.|..
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 99999886543 38999999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccc-hhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHK-MVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
....||..|+|||++.+..++.++|||||||++|||++|+.||........ .....++...... .... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~--~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL--------EKQI--R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH--------cCCC--C
Confidence 123589999999999999999999999999999999999999964321110 0111111111111 1111 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHH
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPS------MRRVFQ 607 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~~vl~ 607 (645)
.+......+.+++..|++.||.+||+ ++++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 22333456788889999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.82 Aligned_cols=230 Identities=27% Similarity=0.340 Sum_probs=189.3
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 429 (645)
+.||+|+||.||++....++..+|+|.+... ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999888999999988752 233456788999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------c
Q 041096 430 SLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------T 497 (645)
Q Consensus 430 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------~ 497 (645)
+|..++.... .+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||.|.. .
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 9999887543 38999999999999999999996 2699999999999999999999998732 1
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC
Q 041096 498 LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 577 (645)
...||..|+|||++.+..++.++|||||||++|||++|+.||...... .+..... ... ..++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~----~~~~~i~------------~~~--~~~p 216 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELIL------------MEE--IRFP 216 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH----HHHHHHh------------cCC--CCCC
Confidence 235899999999999999999999999999999999999999754321 1111110 000 0122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 578 EDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 578 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
......+.+++..|++.||++|+ +++++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 23345677888999999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=296.35 Aligned_cols=239 Identities=24% Similarity=0.414 Sum_probs=195.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
.+|+..+.||+|+||.||+|.+.. +..+|+|.+.........|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 356778899999999999998864 6689999887765556789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------- 497 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------- 497 (645)
+++|.+++..... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++..++.|...
T Consensus 83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 9999999975432 38899999999999999999998 8999999999999999999999877321
Q ss_pred ---ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 498 ---LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 498 ---~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
...++.+|+|||.+.++.++.++||||||+++|||++ |+.||...... .+.+. +.....
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~~-------------~~~~~~ 219 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS----EVVET-------------INAGFR 219 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHH-------------HhCCCC
Confidence 1123468999999998899999999999999999998 99998753321 11111 000011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
...+......+.+++.+||+.+|++||++.++++.|.
T Consensus 220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1111123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=303.02 Aligned_cols=256 Identities=24% Similarity=0.367 Sum_probs=198.9
Q ss_pred CCCcCceeccCCceEEEEEEECC----CCeEEEEEeccCCcc--hhHhHHHHHHHHhhcCCCCeeeeeeeeee--CCeEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFAS----SGSVAAVKRSKHSHE--GKTEFLAELSIIACLRHKNLVQLLGWCAE--KGELL 420 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~----~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 420 (645)
.|...+.||+|+||.||+|.+.. ++..+|+|.+..... ..+.|.+|++++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 46667889999999999998753 378999999887554 36789999999999999999999999987 55789
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--- 497 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--- 497 (645)
++|||+++++|.+++..... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++..+++|...
T Consensus 85 lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999976543 38999999999999999999998 9999999999999999999999987211
Q ss_pred ------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchh
Q 041096 498 ------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRII 565 (645)
Q Consensus 498 ------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 565 (645)
...++..|+|||.+....++.++||||||+++|||++|+.|+......... .............+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 236 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIVTRLL 236 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccHHHHH
Confidence 112345699999999889999999999999999999999998653211100 000000000000111
Q ss_pred HHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 566 EAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 566 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+.+........+..++..+.+++.+||+.+|++||||.+|+++|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 22222222222334457789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.74 Aligned_cols=248 Identities=24% Similarity=0.333 Sum_probs=188.3
Q ss_pred cCceeccC--CceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 352 SNRILGRG--AFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 352 ~~~~lG~G--~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
..++||+| +|++||++....++..||+|++... ....+.+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35679999 7899999999999999999998753 223456778999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++|+|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+|||++.++..++.+..
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999975432 238999999999999999999998 999999999999999999888876521
Q ss_pred ---------cccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc----c
Q 041096 497 ---------TLTAGTMGYLAPEYLQY--GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA----E 561 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~--~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~----~ 561 (645)
....++..|+|||++.. ..++.++|||||||++|||++|+.||........ .......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 233 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDT 233 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCccccccc
Confidence 11245677999999976 4689999999999999999999999975432111 1000000000 0
Q ss_pred Cch-hHH---------hhhh-----------------ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 562 GRI-IEA---------ADKR-----------------LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 562 ~~~-~~~---------~d~~-----------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
... .+. .+.. ............+.+++..||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 000 0000 000111223457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=296.47 Aligned_cols=240 Identities=30% Similarity=0.429 Sum_probs=194.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeee-eCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCA-EKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~Ey~ 426 (645)
++|...+.||+|+||.||++... +..+++|...... ..+.+.+|+.++++++|+|++++++++. +.+..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 36778899999999999999876 6788999886533 3567899999999999999999999764 456789999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--------- 497 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--------- 497 (645)
++++|.+++..... ..+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+|++|...
T Consensus 83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 83 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence 99999999976432 348999999999999999999998 9999999999999999999999987321
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 498 LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
...++..|+|||++....++.++|||||||++|||++ |+.||..... ..+...+ ........
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~-------------~~~~~~~~ 220 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRV-------------EKGYKMDA 220 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH-------------hcCCCCCC
Confidence 1234567999999998899999999999999999997 9999865321 1111111 11111222
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
....+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 334566788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=300.31 Aligned_cols=240 Identities=23% Similarity=0.321 Sum_probs=192.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|+..++||+|+||.||+|....++..+|+|..... ....+.+.+|++++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577788999999999999999888999999987653 33456799999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|..+. .+++.....++.|++.||+|||+ .+++|+||||+|||++.++..++.|..
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999997652 26788899999999999999999 999999999999999999999998732
Q ss_pred -cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 497 -TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 497 -~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
....|+..|+|||++.+..++.++||||||+++|||++|+.||................ +.+.......
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~~~~~ 219 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL----------QCIVDEDPPV 219 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH----------HHHhccCCCC
Confidence 22468889999999999899999999999999999999999997543221111111110 0000000001
Q ss_pred C-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 576 F-NEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 576 ~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
. .......+.+++..|++.+|++||+++++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1 11233467888999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.95 Aligned_cols=224 Identities=26% Similarity=0.363 Sum_probs=185.3
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||.||+|....++..||+|++... ....+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999988999999988652 23455678888888877 699999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|..++..... +++..+..++.|++.||+|||+ .+++||||||+|||++.++.+++.|..
T Consensus 81 g~L~~~i~~~~~----l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 81 GDLMFHIQKSRR----FDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred chHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 999999876543 8999999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+...+ ..+. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i----~~~~----------~~~ 215 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----DLFEAI----LNDE----------VVY 215 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHH----hcCC----------CCC
Confidence 1235899999999999999999999999999999999999999764321 111111 0000 012
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSM 602 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~ 602 (645)
+......+.+++..|++.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 22334567888899999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=323.60 Aligned_cols=259 Identities=20% Similarity=0.301 Sum_probs=192.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--------C
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEK--------G 417 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~ 417 (645)
..++|...++||+|+||.||+|....++..||||++.... ....+|+.++++++|+||+++++++... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 3467999999999999999999998889999999876532 2345799999999999999998876432 2
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-Ceeeeccc
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-NARLESSF 496 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~-~~kl~d~~ 496 (645)
.+++||||++ ++|.+++.........+++.....++.|++.||+|||+ .+|+||||||+||||+.++ .+||+|..
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 4679999997 57877776543334458999999999999999999999 9999999999999999765 68998722
Q ss_pred -----------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 -----------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........++... .......
T Consensus 217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~p~~~~- 294 (440)
T PTZ00036 217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL-GTPTEDQ- 294 (440)
T ss_pred cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCHHH-
Confidence 12357899999999875 468999999999999999999999997654322222211110 0000000
Q ss_pred hHHhh-------------hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCC
Q 041096 565 IEAAD-------------KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEA 613 (645)
Q Consensus 565 ~~~~d-------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~ 613 (645)
...+. ..+...++......+.+++..||+.||.+|||+.|+++ .++...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00000 01111122233457889999999999999999999985 455443
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=302.84 Aligned_cols=237 Identities=24% Similarity=0.318 Sum_probs=195.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.+|+..+.||+|+||.||+|....++..+++|.+... ......+.+|+.+++.++|+|++++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4688889999999999999999888999999988763 334567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++++|.+++... .+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998643 27899999999999999999999 999999999999999999999998732
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||....... .+..+ .. ......
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~---~~~~~----~~--------~~~~~~ 236 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLI----AT--------NGTPEL 236 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH---hHHHH----hc--------CCCCCC
Confidence 12367889999999998889999999999999999999999997543211 11100 00 000001
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..+......+.+++.+||..+|++||++.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 122334566888999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=297.27 Aligned_cols=232 Identities=24% Similarity=0.401 Sum_probs=180.8
Q ss_pred ceeccCCceEEEEEEECCC------------CeEEEEEeccCCc-chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 354 RILGRGAFGNVYKAYFASS------------GSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~------------~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
+.||+|+||.||+|+.... ...+++|.+.... .....|.+|+.+++.++||||++++++|......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986422 2358888876533 33457889999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC-------eeee
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN-------ARLE 493 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~-------~kl~ 493 (645)
+||||+++|+|..++..... .+++..++.++.||++||+|||+ ++++||||||+|||++.++. .++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999999875432 38999999999999999999998 99999999999999987654 5665
Q ss_pred ccc--------cccccCCcccCccccc-CCCCCcchhHHHHHHHHHHHH-cCCCCCCccccccchhhHHHHHHhhhccCc
Q 041096 494 SSF--------TLTAGTMGYLAPEYLQ-YGTATEKTDVFSYGVVVLEVA-CGRRPIERETEGHKMVNLVDWVWGLYAEGR 563 (645)
Q Consensus 494 d~~--------~~~~gt~~y~APE~~~-~~~~t~ksDV~SfGvvl~El~-tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 563 (645)
|.. ....++..|+|||++. ...++.++|||||||++|||+ .|+.|+......+ . .. ..
T Consensus 155 d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~-~~---~~---- 222 (262)
T cd05077 155 DPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----K-ER---FY---- 222 (262)
T ss_pred CCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----H-HH---HH----
Confidence 521 2235788899999887 467899999999999999997 5888876432110 0 00 00
Q ss_pred hhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 564 IIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 564 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
.... .........+.+++..||+.||.+||++.++++.|+
T Consensus 223 -----~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 -----EGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -----hcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000 011112356788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.56 Aligned_cols=241 Identities=24% Similarity=0.300 Sum_probs=191.8
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeE
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 419 (645)
....++|+..+.||+|+||.||++....++..+|+|.+.. .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 3445789999999999999999999999999999998864 223345688999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
|+||||+++|+|.+++.... ++..+...++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~-----~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 99999999999999996432 7888999999999999999999 999999999999999999999998721
Q ss_pred ----------cccccCCcccCcccccCC----CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC
Q 041096 497 ----------TLTAGTMGYLAPEYLQYG----TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG 562 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~~----~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~ 562 (645)
....||+.|+|||++... .++.++||||+||++|||++|+.||.........
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~-------------- 256 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY-------------- 256 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH--------------
Confidence 234589999999998754 3788999999999999999999999764321111
Q ss_pred chhHHhhhhccCCCCH--HHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 041096 563 RIIEAADKRLNGAFNE--DEMKRLLLVGLSCANPDSSA--RPSMRRVFQI 608 (645)
Q Consensus 563 ~~~~~~d~~l~~~~~~--~~~~~l~~l~~~Cl~~dP~~--RPt~~~vl~~ 608 (645)
..+++......++. .....+.+++..|+..++.+ ||++.++++.
T Consensus 257 --~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 257 --SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111111111111 22445666777788755543 8999999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.79 Aligned_cols=229 Identities=24% Similarity=0.335 Sum_probs=187.6
Q ss_pred ceeccCCceEEEEEEEC---CCCeEEEEEeccCC-----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 354 RILGRGAFGNVYKAYFA---SSGSVAAVKRSKHS-----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~---~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++||+|+||.||++... ..+..+|+|.+... ......+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999863 45789999988652 22345678899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++..... +.+..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREGI----FMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999976442 7888889999999999999999 999999999999999999999998732
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .+....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----~~~------------~~~~~~-- 216 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----TID------------KILKGK-- 216 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----HHH------------HHHcCC--
Confidence 12358999999999998889999999999999999999999997643211 111 111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
...+......+.+++..||+.+|++|| +++++++
T Consensus 217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 122333445678899999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=305.05 Aligned_cols=254 Identities=24% Similarity=0.301 Sum_probs=196.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|+..+.||+|+||.||++....++..+|+|.+... ......+.+|++++.+++||||++++++|.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999999999988999999987653 23345688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++.... .+++..+..++.|+++||.|||+ ..+++||||||+|||++.++..++.|..
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999997653 38899999999999999999997 2589999999999999999999997732
Q ss_pred -cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc--------------
Q 041096 497 -TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE-------------- 561 (645)
Q Consensus 497 -~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~-------------- 561 (645)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||...+... ..............
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccCCCCCc
Confidence 22357889999999988889999999999999999999999986533111 00000000000000
Q ss_pred ---CchhHHhhhhcc---CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 562 ---GRIIEAADKRLN---GAFNE-DEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 562 ---~~~~~~~d~~l~---~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
....+..+.... ...+. .....+.+++.+||+.+|++||++++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111111110 01111 133458899999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=309.80 Aligned_cols=234 Identities=24% Similarity=0.355 Sum_probs=191.2
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 423 (645)
+|...+.||+|+||.||+|....++..+|+|.+... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477889999999999999999988999999988752 22334567788888877 5899999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|..++..... +++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+|+.|..
T Consensus 81 E~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR----FKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999876443 8899999999999999999999 999999999999999999999998732
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ ....
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i------------~~~~ 217 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSI------------MEHN 217 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----HHHHHH------------HhCC
Confidence 1235899999999999999999999999999999999999999764321 111111 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSM-----RRVFQ 607 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~~vl~ 607 (645)
..++......+.+++..|++.+|.+|++. +++.+
T Consensus 218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 12233445667889999999999999984 56543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=295.85 Aligned_cols=238 Identities=27% Similarity=0.360 Sum_probs=197.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|+..+.||+|+||.||+|....++..+++|.+..... .+++.+|++++++++|+||+++++++...+..++++||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 578888999999999999999988889999999876443 6789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----------- 496 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----------- 496 (645)
+++|.+++..... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++..++.|..
T Consensus 82 ~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 82 AGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred CCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999999965432 48999999999999999999998 899999999999999999999997721
Q ss_pred -cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 497 -TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 497 -~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||............ .. ...+. ..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--------~~-----~~~~~--~~ 220 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--------PN-----KPPPT--LS 220 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--------cc-----CCCCC--CC
Confidence 1234778999999999989999999999999999999999999754321110000 00 00000 11
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+......+.+++..||+.+|++|||+.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 12234456888999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.50 Aligned_cols=228 Identities=24% Similarity=0.333 Sum_probs=185.8
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||.||+|....++..||+|.++.. ......+..|..++..+ +|+||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999989999999988752 23345567788887764 899999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|..++.... .+++.+...++.|+++||+|||+ .+|+||||||+|||++.++.+++.|..
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 99999987643 28899999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
....||..|+|||++.+..++.++|||||||++|||++|+.||...... .+.+... ... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----~~~~~~~----------~~~----~~~ 215 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----ELFESIR----------VDT----PHY 215 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHH----------hCC----CCC
Confidence 1235899999999999999999999999999999999999999754321 1111110 000 112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSMR-RVF 606 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-~vl 606 (645)
+......+.+++..||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 222344567888999999999999984 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.13 Aligned_cols=237 Identities=30% Similarity=0.469 Sum_probs=196.5
Q ss_pred ceeccCCceEEEEEEECCC---CeEEEEEeccCCcch--hHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASS---GSVAAVKRSKHSHEG--KTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~---~~~vavK~~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
+.||+|+||.||+|..... +..+++|.+...... .+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999865 889999998874433 67899999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCC-----CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--------
Q 041096 429 GSLDRMLYQDSEN-----GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-------- 495 (645)
Q Consensus 429 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-------- 495 (645)
++|.+++...... ...+++.++..++.|+++||+|||+ .+++||||||+||+++.++..++.|.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875221 2458999999999999999999999 99999999999999999999999872
Q ss_pred ------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 496 ------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 496 ------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
.....++..|+|||.+....++.++||||+|++++||++ |+.||...... .+.+. +
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~-------------~ 220 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE----EVLEY-------------L 220 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH-------------H
Confidence 112346788999999998899999999999999999999 69998764221 11111 1
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
........+......+.+++..||+.+|.+||++.++++.|+
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111112233444678889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=305.98 Aligned_cols=247 Identities=22% Similarity=0.386 Sum_probs=196.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-------CCCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFA-------SSGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKG 417 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~-------~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 417 (645)
.+|...+.||+|+||.||++... .....+|+|++... .....++.+|+.++.++ +|+||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999753 23457899988753 23356788999999999 6999999999999999
Q ss_pred eEEEEEecCCCCCHhHHhhhcCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSE------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld 485 (645)
..+++|||+++|+|.+++..... ....++|.++..++.|++.||.|||+ .+++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 99999999999999999976432 12358999999999999999999998 9999999999999999
Q ss_pred CCCCeeeeccccc--------------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhh
Q 041096 486 ANFNARLESSFTL--------------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVN 550 (645)
Q Consensus 486 ~~~~~kl~d~~~~--------------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~ 550 (645)
.++..|+.|.... ..++..|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~ 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE----E 244 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH----H
Confidence 9999999872211 112356999999998899999999999999999999 88888653211 1
Q ss_pred HHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 551 LVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 551 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
+... +........+......+.+++.+||+.+|++||++.++++.|++...
T Consensus 245 ~~~~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 LFKL-------------LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHH-------------HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111 11111112233445677889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=309.84 Aligned_cols=238 Identities=22% Similarity=0.279 Sum_probs=189.9
Q ss_pred CCCcCceeccCCceEEEEEEEC---CCCeEEEEEeccCC-----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFA---SSGSVAAVKRSKHS-----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~---~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 419 (645)
+|+..+.||+|+||.||++... .++..+|+|++... ....+.+..|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998863 46789999988652 22345678899999999 499999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
++||||+++|+|.+++..... +++.+...++.||+.||+|||+ .+|+||||||+|||++.++.++|.|..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN----FSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999976443 8999999999999999999999 999999999999999999999998732
Q ss_pred ----------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchh
Q 041096 497 ----------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRII 565 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 565 (645)
....||..|+|||++.+. .++.++|||||||++|||++|+.||...........+.... .
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---~------ 224 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI---L------ 224 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH---h------
Confidence 123589999999999865 47899999999999999999999997543222111111100 0
Q ss_pred HHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 566 EAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 566 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
..++ .++......+.+++..||+.||++|| +++++++
T Consensus 225 -~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 225 -KCDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -cCCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0111 22233445677888999999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=301.29 Aligned_cols=239 Identities=24% Similarity=0.346 Sum_probs=193.6
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
|+..++||+|+||.||++....++..+|+|.+.... .....+.+|+.++++++|+|++.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999999999999999876521 2234578899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++..... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++..++.|..
T Consensus 82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999865432 238999999999999999999998 999999999999999999999997722
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....|+..|+|||++.+..++.++||||||+++|||++|+.||.............. .. .....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~-------------~~-~~~~~ 222 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-------------LV-KEVQE 222 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh-------------hh-hhhhh
Confidence 123688999999999999999999999999999999999999976432111100000 00 00111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPS-----MRRVFQ 607 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~~vl~ 607 (645)
.++......+.+++..||+.||++||| ++++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 122233456788899999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=310.53 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=193.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-----CCCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeC-C
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFA-----SSGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEK-G 417 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~-----~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 417 (645)
.++|+..+.||+|+||.||+|... .++..||||+++.. ......+.+|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 357888999999999999999842 35678999998753 23345788999999999 689999999988654 4
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCC--------------------------------------------------------
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSEN-------------------------------------------------------- 441 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~-------------------------------------------------------- 441 (645)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 689999999999999998753210
Q ss_pred -------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc--------------cc
Q 041096 442 -------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL--------------TA 500 (645)
Q Consensus 442 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~--------------~~ 500 (645)
...++|.++..++.|+++||+|||+ .+|+||||||+|||++.++.++++|.... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1237889999999999999999998 99999999999999999999999873211 12
Q ss_pred cCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHH
Q 041096 501 GTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED 579 (645)
Q Consensus 501 gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 579 (645)
++..|+|||.+.+..++.++||||||+++|||++ |..||....... .+.. .+........+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~-------------~~~~~~~~~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCR-------------RLKEGTRMRAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH---HHHH-------------HHhccCCCCCCCC
Confidence 3567999999998899999999999999999997 899986532211 1111 0111111111112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 580 EMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 580 ~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
....+.+++..||+.+|++||++.++++.|+...+
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23467889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=296.97 Aligned_cols=240 Identities=31% Similarity=0.449 Sum_probs=193.1
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhH---hHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT---EFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~---~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
|+..+.||+|+||+||++....++..+|+|++........ ...+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999999999999999987544333 3456999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++++|.+++.... .+++..+..++.|+++||+|||+ .+++|+||||+||+++.++..++.|..
T Consensus 81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred ccccccccccccc----ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999998433 28999999999999999999999 999999999999999999999997722
Q ss_pred --cccccCCcccCccccc-CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 --TLTAGTMGYLAPEYLQ-YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~-~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....++..|+|||++. ...++.++||||+|+++|||++|+.||...........+.... ........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL---------KRPLPSSS- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH---------HTHHHHHT-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc---------cccccccc-
Confidence 1235788999999998 8889999999999999999999999998652111111111000 00000000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.........+.+++..||+.+|++||++.++++
T Consensus 224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011278889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.53 Aligned_cols=236 Identities=26% Similarity=0.398 Sum_probs=185.6
Q ss_pred ceeccCCceEEEEEEECC---CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeee-CCeEEEEEecCC
Q 041096 354 RILGRGAFGNVYKAYFAS---SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAE-KGELLLVYEYMP 427 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~---~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~~ 427 (645)
+.||+|+||.||+|...+ ....+|+|++... ....+.+.+|+.+++.++||||++++++|.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 3467999987642 3345678899999999999999999998764 456899999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------- 497 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------- 497 (645)
+|+|.+++..... .+.+..++.++.|+++||+|||+ .+++||||||+|||++.++.+|++|...
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999976433 26888889999999999999998 9999999999999999999999977321
Q ss_pred ------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcC-CCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 498 ------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACG-RRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 498 ------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG-~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
...++..|+|||.+....++.++|||||||++|||++| ..||..... ..+...+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~------------- 217 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----FDITVYLLQ------------- 217 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHhc-------------
Confidence 12345679999999988999999999999999999995 555543221 111111110
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
......+...+..+.+++..||+.+|++||++.++++.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 218 GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001111223356788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.58 Aligned_cols=253 Identities=18% Similarity=0.278 Sum_probs=192.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|...+.||+|+||.||+|+...++..+|+|.+... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5688889999999999999999888999999988653 22345678999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
++ ++|.+++..... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+|+.|..
T Consensus 86 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 96 488888865432 37899999999999999999999 999999999999999999999998722
Q ss_pred ---cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHH-------HHhhhccCchh
Q 041096 497 ---TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDW-------VWGLYAEGRII 565 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~-------~~~~~~~~~~~ 565 (645)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+... .|.........
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 12357889999998865 56899999999999999999999999765432211111110 00000000000
Q ss_pred HHhh-hhccC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 566 EAAD-KRLNG----AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 566 ~~~d-~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+ +.... .........+.+++..|++.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000 00000 000112345678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.86 Aligned_cols=241 Identities=24% Similarity=0.438 Sum_probs=196.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.++|+..+.||+|+||.||++.... +..+++|.+.......+.+.+|++++++++|+||+++.+.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3578888999999999999998754 5678999887655556789999999999999999999999887 7789999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--------- 497 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--------- 497 (645)
++++|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++..++.|...
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 83 AKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999997643 2348899999999999999999998 8999999999999999999999987211
Q ss_pred ----ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 498 ----LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 498 ----~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
...++..|+|||++....++.++|||||||+++|+++ |+.||...... .+..+. ....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~-------------~~~~ 220 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRAL-------------ERGY 220 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHHHH-------------hCCC
Confidence 1123467999999998889999999999999999999 89998754321 111111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
........+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111223345678889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=301.55 Aligned_cols=254 Identities=21% Similarity=0.326 Sum_probs=194.5
Q ss_pred cCCCcCceeccCCceEEEEEEE----CCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYF----ASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GEL 419 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~----~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 419 (645)
+.|...+.||+|+||.||++.. ..++..+|+|.+... ......+.+|++++++++|+||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467788999999999999985 345788999998653 33356799999999999999999999998875 568
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
++||||+++++|.+++.+... .++|.+++.++.|++.||+|||+ ++++||||||+||+++.++..++.|..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 999999999999999965432 38999999999999999999999 999999999999999999999997721
Q ss_pred ------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC--
Q 041096 497 ------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG-- 562 (645)
Q Consensus 497 ------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~-- 562 (645)
....++..|+|||++.+..++.++||||||+++|||++++.|...... .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~~~ 232 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQMTV 232 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccccH
Confidence 112356679999999988899999999999999999998876533110 0000000000000
Q ss_pred -chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 563 -RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 563 -~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
...+.+...............+.+++.+||+.+|++||++.++++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00111111111122233567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=299.93 Aligned_cols=234 Identities=24% Similarity=0.336 Sum_probs=193.4
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
|+..+.||+|+||.||+|.+..++..+|+|.+... ....+.+.+|++++++++|+||+++++++..+...++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 45567799999999999999888999999987653 3345678999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------- 497 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------- 497 (645)
+++|.+++... .+++..+..++.|+++||.|||+ ++++|+||+|+||+++.++..++.|...
T Consensus 86 ~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 86 GGSALDLLKPG-----PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 99999998642 38899999999999999999998 9999999999999999999999977321
Q ss_pred --ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 498 --LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 498 --~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
...|+..|+|||++.+..++.++|||||||++|||++|+.|+........ .. .+.......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~-------------~~~~~~~~~ 220 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV----LF-------------LIPKNSPPT 220 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH----Hh-------------hhhcCCCCC
Confidence 12477889999999998999999999999999999999999865322110 00 011111112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
........+.+++..||+.+|.+||+|.++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 233445678889999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=312.76 Aligned_cols=247 Identities=21% Similarity=0.266 Sum_probs=191.2
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC-----eEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG-----ELL 420 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 420 (645)
+|+..+.||+|+||.||++....++..||+|++... ....+.+.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999999888999999988653 223467889999999999999999999998776 789
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---- 496 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---- 496 (645)
+|+||+. ++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||.|..
T Consensus 81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 68888875433 38999999999999999999999 999999999999999999999998732
Q ss_pred ---------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch--
Q 041096 497 ---------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI-- 564 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~-- 564 (645)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+. ........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~----~~~g~~~~~~ 228 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT----DLLGTPSLEA 228 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH----HHcCCCCHHH
Confidence 123568899999998874 47999999999999999999999997654321111111 11110000
Q ss_pred --------hHHhhhhc-cC-------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 --------IEAADKRL-NG-------AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 --------~~~~d~~l-~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+.... .. .........+.+++..|++.||++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000000 00 111122456788999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=307.56 Aligned_cols=231 Identities=25% Similarity=0.325 Sum_probs=186.6
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||.||+|....++..+|+|++... ....+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999998999999998763 23345688999999888 699999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|..++.... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++..|+.|..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 99999887543 38999999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...++...... ... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~--------~~~--~~~ 222 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVIL--------EKP--IRI 222 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-ccHHHHHHHHH--------hCC--CCC
Confidence 1235899999999999999999999999999999999999999753322111 11111111111 111 122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSM 602 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~ 602 (645)
+......+.+++..|++.||.+||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 33334567788899999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.32 Aligned_cols=238 Identities=23% Similarity=0.320 Sum_probs=195.2
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
+|+..+.||+|+||.||++....++..+|+|.+.. .....+.+.+|+.+++.++|+||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 46778999999999999999998899999998754 2334567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++++|.+++.... ...++....+.++.|++.||.|||+ .+++|+||||+||+++.++..++.|..
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999986533 2347899999999999999999998 999999999999999999999987721
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....|+..|+|||++.+..++.++||||||+++|||++|+.||...... .... ... . ....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~---~~~-~---------~~~~ 218 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK----NLIL---KVC-Q---------GSYK 218 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH----HHHH---HHh-c---------CCCC
Confidence 1235788899999999888999999999999999999999999753211 1110 000 0 0011
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
..+......+.+++.+||+.+|++||++.+++..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1223344567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.93 Aligned_cols=226 Identities=23% Similarity=0.319 Sum_probs=184.8
Q ss_pred ceeccCCceEEEEEEE---CCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 354 RILGRGAFGNVYKAYF---ASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~---~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
+.||+|+||.||++.. ..++..+|+|++.... .....+..|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 3468899999887522 234567789999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----------- 496 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----------- 496 (645)
+|+|.+++.+.. .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++..++.|..
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 999999996543 38999999999999999999999 999999999999999999999998732
Q ss_pred -cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 497 -TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 497 -~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
....||..|+|||.+.+..++.++|||||||++|||++|+.||...... ...... .... ..
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~~i------------~~~~--~~ 216 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----ETMTMI------------LKAK--LG 216 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH----HHHHHH------------HcCC--CC
Confidence 1235789999999999888999999999999999999999999754321 111110 0011 12
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPSMRR 604 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~ 604 (645)
.+......+.+++..||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 23334456778889999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.57 Aligned_cols=243 Identities=25% Similarity=0.410 Sum_probs=195.9
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCe----EEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGS----VAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~----~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
.+|+..+.||+|+||.||+|....++. .+|+|...... ....++.+|+.++++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 456778899999999999999866554 58999877643 345678999999999999999999999987 78999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc---
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL--- 498 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~--- 498 (645)
|+||+++|+|.+++..... .+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+++.|....
T Consensus 86 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999976543 38999999999999999999999 99999999999999999999999773211
Q ss_pred -----------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 499 -----------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 499 -----------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
..++..|+|||.+....++.++||||||+++||+++ |+.||...... .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~------------- 222 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV----EIPD------------- 222 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH----HHHH-------------
Confidence 112457999999988899999999999999999998 99998764321 1111
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
.+........+..+...+.+++..||..+|.+||++.++++.|+....
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 223 LLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111111111222234567888999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=299.40 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=200.6
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeee-
Q 041096 338 FSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAE- 415 (645)
Q Consensus 338 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~- 415 (645)
.++.++..+.+.|+..+.||+|+||.||+|....++..+|+|..........++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4566777788899999999999999999999988899999999877655567788999999998 69999999999853
Q ss_pred -----CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 416 -----KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 416 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
.+..+++|||+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++..
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCE
Confidence 4578999999999999999976432 247888899999999999999999 999999999999999999999
Q ss_pred eeeccc------------cccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHH
Q 041096 491 RLESSF------------TLTAGTMGYLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVD 553 (645)
Q Consensus 491 kl~d~~------------~~~~gt~~y~APE~~~-----~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~ 553 (645)
++.|.. ....|+..|+|||.+. ...++.++|||||||++|||++|+.||..........
T Consensus 161 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---- 236 (282)
T cd06636 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---- 236 (282)
T ss_pred EEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----
Confidence 998731 1235788999999886 3467889999999999999999999996532211100
Q ss_pred HHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 554 WVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 554 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..................+.+++..||+.+|.+||++.++++
T Consensus 237 ------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 ------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000011111234567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.36 Aligned_cols=243 Identities=26% Similarity=0.366 Sum_probs=198.4
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeee--CCeEEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAE--KGELLLVY 423 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 423 (645)
+|+..+.||+|+||.||++....++..+|+|.+... ....+.+..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 467788999999999999999888999999987642 3345678899999999999999999998754 45689999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeeCCCCCCcEEEcCCCCeeeecc------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC--EQQVIHRDIKASNIMLDANFNARLESS------ 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlkp~NIlld~~~~~kl~d~------ 495 (645)
||+++++|.+++.........+++..++.++.|++.||+|||..+ ..+++|+||||+||+++.++..++.|.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765444456999999999999999999999321 289999999999999999999999772
Q ss_pred ------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 496 ------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 496 ------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
.....|+..|+|||.+....++.++||||||+++|||++|+.||..... ..+.. .+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~-------------~~~ 223 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----LQLAS-------------KIK 223 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----HHHHH-------------HHh
Confidence 2234678899999999988899999999999999999999999976431 11111 111
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.......+......+.+++..|++.+|++||++++|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111223444556788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=322.05 Aligned_cols=261 Identities=19% Similarity=0.245 Sum_probs=193.5
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCC------CeeeeeeeeeeC
Q 041096 343 LRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHK------NLVQLLGWCAEK 416 (645)
Q Consensus 343 l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~------niv~l~g~~~~~ 416 (645)
+...+++|+..++||+|+||+||+|.+...+..||||+++.......++..|+.++..++|. +++++++++...
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 33456889999999999999999999988899999999876444455667788888777654 588899988764
Q ss_pred -CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC------
Q 041096 417 -GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN------ 489 (645)
Q Consensus 417 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~------ 489 (645)
...|+|||++ +++|.+++.+.. .+++..+..|+.||+.||+|||+ ..+|+||||||+||||+.++.
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccc
Confidence 5789999998 788999887643 38999999999999999999997 149999999999999987653
Q ss_pred ----------eeeeccc---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhh
Q 041096 490 ----------ARLESSF---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVN 550 (645)
Q Consensus 490 ----------~kl~d~~---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~ 550 (645)
.||.|.. ...+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-~ 355 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL-H 355 (467)
T ss_pred ccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-H
Confidence 7787632 2347899999999999999999999999999999999999999764432111 1
Q ss_pred HHHHHHhhh--------ccCchhHHhhhh--ccCCCC---------------HHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 041096 551 LVDWVWGLY--------AEGRIIEAADKR--LNGAFN---------------EDEMKRLLLVGLSCANPDSSARPSMRRV 605 (645)
Q Consensus 551 l~~~~~~~~--------~~~~~~~~~d~~--l~~~~~---------------~~~~~~l~~l~~~Cl~~dP~~RPt~~~v 605 (645)
++....+.. ......+..+.. +..... ......+++++..||+.||++|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 111110000 000000000000 000000 0113457799999999999999999999
Q ss_pred HH--HHcC
Q 041096 606 FQ--ILNN 611 (645)
Q Consensus 606 l~--~L~~ 611 (645)
++ +|.+
T Consensus 436 L~Hp~~~~ 443 (467)
T PTZ00284 436 TTHPYVLK 443 (467)
T ss_pred hcCccccc
Confidence 97 4554
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=295.67 Aligned_cols=235 Identities=23% Similarity=0.349 Sum_probs=196.2
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.|+..+.||+|+||.||+|....++..+|+|.+... ......+.+|+.++++++|+||+++++.+.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 456678899999999999999888999999987653 344567899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++++|.+++... .+++.+...++.|++.||+|||+ .+++|+||+|+||+++.++..++.|..
T Consensus 85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998642 28889999999999999999998 999999999999999999999997721
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....++..|+|||++.+..++.++|||||||++|||++|..||....... .. .........
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~-------------~~~~~~~~~ 219 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VL-------------FLIPKNNPP 219 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hh-------------hhhhcCCCC
Confidence 12346788999999998889999999999999999999999987543211 00 011111122
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
......+..+.+++..||+.+|++||+++++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3445567788899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.57 Aligned_cols=235 Identities=26% Similarity=0.346 Sum_probs=195.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|+..+.||.|++|.||+|....++..+|+|.+... ......+.+|++++++++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3577788999999999999999988999999988653 33456788999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++... .+++.....++.|++.||.|||+ .+++||||+|+||+++.++..++.|..
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999999754 38999999999999999999998 999999999999999999999997721
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....++..|+|||++.+..++.++||||||+++|||++|+.||....... ... .+.....
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~----~~~-------------~~~~~~~ 215 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR----VLF-------------LIPKNNP 215 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH----HHH-------------HhhhcCC
Confidence 22357788999999998889999999999999999999999997543211 000 0001111
Q ss_pred CCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 574 GAFNED-EMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 574 ~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...... ....+.+++..||+.+|++|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111111 4456788899999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=314.16 Aligned_cols=247 Identities=23% Similarity=0.287 Sum_probs=194.6
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeeeee
Q 041096 340 YRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415 (645)
Q Consensus 340 ~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 415 (645)
++++....++|+..+.||+|+||.||++....++..+|+|.+.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 45566667899999999999999999999999999999998764 22334567899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 416 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
++..++||||+++|+|.+++.... ++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999999986532 7888889999999999999999 99999999999999999999999873
Q ss_pred c-------------cccccCCcccCcccccCC----CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh
Q 041096 496 F-------------TLTAGTMGYLAPEYLQYG----TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 496 ~-------------~~~~gt~~y~APE~~~~~----~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
. ....||+.|+|||++... .++.++|||||||++|||++|+.||...+.... ... .
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----~~~---i 259 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT----YSK---I 259 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH----HHH---H
Confidence 1 134589999999998754 378999999999999999999999976432111 110 0
Q ss_pred hccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 041096 559 YAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSA--RPSMRRVFQI 608 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~~vl~~ 608 (645)
.... ..+.-....+....+.+++..|+..++.+ ||+++++++.
T Consensus 260 ~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 260 MNHK-------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HcCC-------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0000 00100111123455677778898744443 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=301.37 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=193.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..++||+|+||.||+|....++..+|+|++.... ...+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999998889999999876532 234578899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++++|.++..... .++|.+++.++.|+++||+|||+ .+++|+||+|+||++++++.+++.|..
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999988765432 28999999999999999999999 899999999999999999999997721
Q ss_pred ----cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc-h---hHH
Q 041096 497 ----TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR-I---IEA 567 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~-~---~~~ 567 (645)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||...........+..+......... . ...
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 12347788999999875 45788999999999999999999998754322111111111111100000 0 000
Q ss_pred hhhhccCC---------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 568 ADKRLNGA---------FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 568 ~d~~l~~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+...... ........+.+++..||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 01123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=323.03 Aligned_cols=242 Identities=26% Similarity=0.409 Sum_probs=204.5
Q ss_pred CcCceeccCCceEEEEEEECCCC----eEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 351 HSNRILGRGAFGNVYKAYFASSG----SVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 351 ~~~~~lG~G~fg~Vy~g~~~~~~----~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
+..++||+|+||+||+|.+-..+ .+||+|.+.. ..+...++++|+.+|.+|+||||++|+|+|..+. +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34678999999999999985433 4788998776 3445789999999999999999999999998876 899999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------- 497 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------- 497 (645)
|||.|+|.+|++.++.. +.-+..+.+..|||+||.|||+ ++++||||.++||||.+-..+|+.|...
T Consensus 778 ~mP~G~LlDyvr~hr~~---igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDN---IGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHhhcc---ccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999987654 8889999999999999999998 9999999999999999888888866221
Q ss_pred -----ccc--cCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 498 -----LTA--GTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 498 -----~~~--gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
... -.+.|||-|.+..+.|+.++|||||||.+||++| |..|+++.... ++.+.+.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----------------eI~dlle 914 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----------------EIPDLLE 914 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------------HhhHHHh
Confidence 111 2457999999999999999999999999999999 99999875421 2333444
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
...+...++.+...++.++..||..|+..||+++++...+.+.+..|
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 44445677888899999999999999999999999999988776555
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.90 Aligned_cols=245 Identities=25% Similarity=0.403 Sum_probs=196.5
Q ss_pred cCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCCcc--hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHSHE--GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
++|+..+.||+|+||.||+|+.+. ....+++|.+..... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 467888999999999999999753 346789998766333 3568999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCC-----ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 421 LVYEYMPNGSLDRMLYQDSENG-----VLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
+||||+++|+|.+++....... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++..++++.
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997654221 248999999999999999999998 89999999999999999999988762
Q ss_pred c-------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhcc
Q 041096 496 F-------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAE 561 (645)
Q Consensus 496 ~-------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~ 561 (645)
. ....++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+.... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~----~~~~~~----~~ 233 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE----EVLNRL----QA 233 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH----HHHHHH----Hc
Confidence 1 12245667999999988889999999999999999999 78888643221 111111 00
Q ss_pred CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 562 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
..+....+...+..+.+++.+||+.+|.+||++.++++.|.+
T Consensus 234 --------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 234 --------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred --------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 111111222345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.01 Aligned_cols=239 Identities=24% Similarity=0.310 Sum_probs=192.6
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
|+..+.||+|+||+||+|....++..+|+|.+.... .....+.+|++++++++|+|++.+.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999999889999999886532 2344578899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+++.|..
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999998865432 248999999999999999999998 999999999999999999999998722
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...........+ .. .+... ..
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~----~~---------~~~~~-~~ 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV----DR---------RVLET-EE 222 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HH---------hhhcc-cc
Confidence 1235789999999999899999999999999999999999999754321111000 00 00000 01
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPS-----MRRVFQ 607 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~~vl~ 607 (645)
.+.......+.+++..|++.+|++||+ ++++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 122334456788889999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.58 Aligned_cols=182 Identities=24% Similarity=0.299 Sum_probs=160.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
...+|...+.||+|+||.||+|....++..||+|..... ....|+.++++++|+||+++++++...+..++|+||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 346799999999999999999999988899999975432 245799999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc--------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT-------- 497 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~-------- 497 (645)
+ .++|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+++.|...
T Consensus 139 ~-~~~l~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 139 Y-SSDLYTYLTKRSR---PLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred c-CCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 9 5789998865433 48999999999999999999999 9999999999999999999999987321
Q ss_pred ---ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 041096 498 ---LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPI 539 (645)
Q Consensus 498 ---~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~ 539 (645)
...||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 235889999999999999999999999999999999866554
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=297.69 Aligned_cols=237 Identities=26% Similarity=0.336 Sum_probs=191.3
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
|+..+.||+|+||.||+|....++..+++|.+... ....+.+.+|+++++.++|+|++++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 34567899999999999999988999999988763 34466789999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
++|..++.+... .+++..+..++.|+++||+|||+ .+++||||||+||+++.++..++.|..
T Consensus 87 ~~l~~~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 87 GAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred CcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 999998865332 48999999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 TLTAGTMGYLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~-----~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....++..|+|||++. ...++.++|||||||++|||++|+.||....... ........ ..+.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~~----------~~~~ 227 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---VLLKIAKS----------EPPT 227 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---HHHHHhhc----------CCCC
Confidence 2235788999999984 3457889999999999999999999987543211 11110000 0000
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+ ..+......+.+++..||+.+|.+||++.++++
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 228 L--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 112233456788999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=293.33 Aligned_cols=231 Identities=28% Similarity=0.471 Sum_probs=185.7
Q ss_pred ceeccCCceEEEEEEECCCC----------eEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 354 RILGRGAFGNVYKAYFASSG----------SVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~----------~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
+.||+|+||.||+|.+...+ ..+++|...........|.+|+.++++++|+||++++++|.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999997665 357888776644447789999999999999999999999988 7789999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-------Ceeeeccc
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-------NARLESSF 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~-------~~kl~d~~ 496 (645)
||+++|+|.+++..... .+++..++.++.|++.||+|||+ ++++||||||+|||++.++ ..+++|..
T Consensus 80 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986543 38999999999999999999998 9999999999999999887 67887732
Q ss_pred c--------ccccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchh
Q 041096 497 T--------LTAGTMGYLAPEYLQYG--TATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRII 565 (645)
Q Consensus 497 ~--------~~~gt~~y~APE~~~~~--~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 565 (645)
. ...++..|+|||++... .++.++||||||+++|||++ |..|+........ ..+ +.
T Consensus 154 ~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~----~~~----~~----- 220 (259)
T cd05037 154 IPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK----ERF----YQ----- 220 (259)
T ss_pred cccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH----HHH----Hh-----
Confidence 1 23467889999999876 78999999999999999999 5777755431110 000 00
Q ss_pred HHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 566 EAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 566 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
.. ...+......+.+++..||..+|.+|||+.++++.|+
T Consensus 221 ---~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 ---DQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---cC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0011111267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.00 Aligned_cols=225 Identities=25% Similarity=0.328 Sum_probs=182.5
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHH-HHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELS-IIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||+||+|....++..||+|++... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999999989999999998652 222344555555 46789999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|..++.... .+++.....++.||+.||+|||+ .+|+||||||+|||++.++..|+.|..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 99999997643 38899999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.+. .....+ ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~------------i~~~~~--~~ 215 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----MYDN------------ILNKPL--RL 215 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----HHHH------------HHcCCC--CC
Confidence 12358999999999999999999999999999999999999997543211 1110 011111 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSMR 603 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 603 (645)
+......+.+++..|++.+|.+||+++
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 223355678888999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.12 Aligned_cols=241 Identities=25% Similarity=0.344 Sum_probs=184.3
Q ss_pred ceeccCCceEEEEEEECC--CCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCC
Q 041096 354 RILGRGAFGNVYKAYFAS--SGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~--~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 429 (645)
+.||+|+||.||+|.... ++..+|+|.+.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998653 34678999876532 33457899999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 430 SLDRMLYQDSE-NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 430 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
+|.+++..... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999976432 22346788888999999999999999 999999999999999999999998732
Q ss_pred --cccccCCcccCcccccCC-------CCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 --TLTAGTMGYLAPEYLQYG-------TATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~-------~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....++..|+|||++... .++.++||||||+++|||++ |+.||......+. ..... .+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~----~~~~~----~~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV----LTYTV----REQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH----HHHHh----hcccCC
Confidence 112456789999988642 35789999999999999996 9999975432211 11100 001111
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
..++.+ .......+.+++..|| .+|++|||+++|++.|+
T Consensus 230 ~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 1122345677888999 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.79 Aligned_cols=244 Identities=25% Similarity=0.432 Sum_probs=193.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCe----EEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGS----VAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~----~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|+..+.||+|+||.||+|....++. .+|+|.+.... ....++.+|+.++++++|+||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 467778899999999999999866554 46888876532 2244788999999999999999999999754 5689
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---- 497 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---- 497 (645)
++||+++|+|.+++..... .+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+|++|...
T Consensus 86 v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccc
Confidence 9999999999999876432 38999999999999999999998 9999999999999999999999987211
Q ss_pred ----------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 498 ----------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 498 ----------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
...++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~~~~~----------- 224 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REIPDLL----------- 224 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH-----------
Confidence 1224568999999998999999999999999999997 8999865321 1111111
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
........+..+...+.+++..||..+|++||+++++++.|+.....
T Consensus 225 --~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 225 --EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111111222345678899999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.10 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=197.6
Q ss_pred cCCCcCceeccCCceEEEEEEECC-------CCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS-------SGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKG 417 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~-------~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 417 (645)
.+|...+.||+|+||.||++.... .+..+|+|..... ....+++.+|++++.++ +|+||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 457888999999999999997532 2346899987753 33456899999999999 7999999999999999
Q ss_pred eEEEEEecCCCCCHhHHhhhcCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSE------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld 485 (645)
..++++||+++|+|.+++..... ....++|.+++.++.|++.||+|||+ .+++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 99999999999999999976431 12348999999999999999999998 9999999999999999
Q ss_pred CCCCeeeeccccc--------------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhh
Q 041096 486 ANFNARLESSFTL--------------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVN 550 (645)
Q Consensus 486 ~~~~~kl~d~~~~--------------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~ 550 (645)
.++..|+.|.... ..++..|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~ 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----E 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH----H
Confidence 9999999873211 123457999999999999999999999999999998 88888653211 1
Q ss_pred HHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 551 LVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 551 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
+.. .+........+......+.+++..||+.+|.+||+|.++++.|+....
T Consensus 245 ~~~-------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 245 LFK-------------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHH-------------HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 111 111111112233445678899999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=322.42 Aligned_cols=245 Identities=24% Similarity=0.300 Sum_probs=201.4
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccC-CcchhHhHHHHHHHHhhcC-CCCeeeeeee-eee------CCeE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLR-HKNLVQLLGW-CAE------KGEL 419 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~-~~~------~~~~ 419 (645)
+.++.++|.+|||+.||.+.+...+..+|+|++-. .....+...+||++|++|+ |+|||.+++. ... .-+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 44567889999999999999988779999998655 5666788999999999997 9999999993 221 1378
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc-
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL- 498 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~- 498 (645)
+|+||||++|+|-+++..+...+ |+..++++|+.|+|+|+++||. +.++|||||||-+||||+.++.-||+|....
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 99999999999999998765543 9999999999999999999997 4678999999999999999999999883322
Q ss_pred --------------------cccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH
Q 041096 499 --------------------TAGTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV 555 (645)
Q Consensus 499 --------------------~~gt~~y~APE~~~---~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~ 555 (645)
..-|+.|+|||.+. +...++|+|||++||+||-||....||+.....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 13589999999764 567899999999999999999999999864221
Q ss_pred HhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 556 WGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 556 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
.++.....-.-.......+..||..||+++|.+||++.+|++.+..++..+
T Consensus 265 ----------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ----------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ----------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 111222211222467888999999999999999999999999887665444
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=294.27 Aligned_cols=245 Identities=25% Similarity=0.365 Sum_probs=194.4
Q ss_pred CCCcCceeccCCceEEEEEEECC-CCeEEEEEeccCC-----------cchhHhHHHHHHHHhh-cCCCCeeeeeeeeee
Q 041096 349 GFHSNRILGRGAFGNVYKAYFAS-SGSVAAVKRSKHS-----------HEGKTEFLAELSIIAC-LRHKNLVQLLGWCAE 415 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~-~~~~vavK~~~~~-----------~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~ 415 (645)
+|+..+.||+|+||.||+|.... .+..+|+|.+... .....++..|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999977 6788999976531 1223457788888875 799999999999999
Q ss_pred CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 416 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
++..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ ..+++|+||||+||+++.++.+++.|.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999986533333458999999999999999999995 267999999999999999999999872
Q ss_pred c-----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 496 F-----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 496 ~-----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
. ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .....
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~----~~~~~---------- 224 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML----SLATK---------- 224 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----HHHHH----------
Confidence 2 2345788999999999888999999999999999999999998643211 11110
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
..+..............+.+++.+||+.||++||++.|+.++|++
T Consensus 225 --~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 225 --IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred --HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 001111111111234568889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=295.72 Aligned_cols=240 Identities=26% Similarity=0.362 Sum_probs=182.9
Q ss_pred eeccCCceEEEEEEECC--CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCC
Q 041096 355 ILGRGAFGNVYKAYFAS--SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGS 430 (645)
Q Consensus 355 ~lG~G~fg~Vy~g~~~~--~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 430 (645)
.||+|+||.||+|.... ....+++|.+... ......+.+|+++++.++|+||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997643 3457888877643 3345678999999999999999999999999999999999999999
Q ss_pred HhHHhhhcCCC-CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc------------
Q 041096 431 LDRMLYQDSEN-GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------------ 497 (645)
Q Consensus 431 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------------ 497 (645)
|.+++...... ....++...+.++.|++.||+|||+ ++|+||||||+|||++.++..|+.|...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999765432 2235788889999999999999999 9999999999999999999999987321
Q ss_pred --ccccCCcccCcccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHH
Q 041096 498 --LTAGTMGYLAPEYLQY-------GTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 498 --~~~gt~~y~APE~~~~-------~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
...++..|+|||++.. ..++.++|||||||++|||++ |+.||....... ..... ... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~~~---~~~-~~~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ----VLKQV---VRE-QDIKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH----HHHHH---hhc-cCccC
Confidence 1134567999998743 356889999999999999999 788886543211 11110 000 00111
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
.++ ..+......+.+++..|| .||++|||+++|++.|.
T Consensus 231 ~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 122334456667778898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.92 Aligned_cols=245 Identities=27% Similarity=0.370 Sum_probs=197.7
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCC------
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKG------ 417 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~------ 417 (645)
.++++|+..+.||+|++|.||+|....++..+++|.+.......+.+.+|+++++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 356889999999999999999999988889999999887666667899999999999 6999999999997644
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF- 496 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~- 496 (645)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++..++.|..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987644333458999999999999999999998 999999999999999999999997732
Q ss_pred -----------cccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc
Q 041096 497 -----------TLTAGTMGYLAPEYLQY-----GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA 560 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~-----~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~ 560 (645)
....|+..|+|||.+.. ..++.++|||||||+++||++|+.||....... .+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----- 231 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---ALFKIP----- 231 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---HHHHhh-----
Confidence 22357888999998753 346889999999999999999999996532211 111100
Q ss_pred cCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 561 EGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 561 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.. ..+.+ ..+......+.+++.+||..||++|||+.++++
T Consensus 232 ~~-----~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RN-----PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cc-----CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 00011 112234567889999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.99 Aligned_cols=233 Identities=23% Similarity=0.336 Sum_probs=199.6
Q ss_pred cCceeccCCceEEEEEEECCC---CeEEEEEeccCCcc--hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 352 SNRILGRGAFGNVYKAYFASS---GSVAAVKRSKHSHE--GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 352 ~~~~lG~G~fg~Vy~g~~~~~---~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
..++||+|.||.|++|.+... ...||||+++.... ...+|++|+.+|.+|+|+|+++|||...+ ...+||+|++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 357899999999999999653 24689999987433 56789999999999999999999999988 7899999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccccc-------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT------- 499 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~~------- 499 (645)
+.|||.+.|++.. ...|.......++.|||.||+||.+ +++|||||.++|+||-..-.+||+|..-+.
T Consensus 193 plGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999998732 3347888899999999999999999 999999999999999999999998832221
Q ss_pred --------ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 500 --------AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 500 --------~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
.-...|+|||.+..++++.+||||+|||.+|||++ |..||-+.... .+.+.+|.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----------------qIL~~iD~ 330 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----------------QILKNIDA 330 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----------------HHHHhccc
Confidence 12456999999999999999999999999999999 88898775431 23455666
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+-+...++.|.+.++++++.||..+|++|||+..+.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 5566778899999999999999999999999999974
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.18 Aligned_cols=245 Identities=26% Similarity=0.354 Sum_probs=197.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|+..+.||+|+||+||++....++..+|+|..... ....+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4567778999999999999999888999999987653 33457899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++.... .+++.....++.+++.||.|||+ ..+++||||||+||+++.++.+++.|..
T Consensus 85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999986543 38999999999999999999996 2589999999999999999999997732
Q ss_pred -cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccccc----chhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGH----KMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~----~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....+.++... .....
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~ 229 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ---------IVQEP 229 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH---------Hhhcc
Confidence 12368899999999988899999999999999999999999997643211 11111111111 11111
Q ss_pred ccCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 572 LNGAFN-EDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 572 l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
. ...+ .+.+..+.+++..||+.+|.+|||+.|++++
T Consensus 230 ~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 230 P-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred C-CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1 1111 1245678889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=292.07 Aligned_cols=235 Identities=26% Similarity=0.365 Sum_probs=191.6
Q ss_pred ceeccCCceEEEEEEECC-CC--eEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFAS-SG--SVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~-~~--~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|++|.||+|.+.. ++ ..+|+|.+.... ...+.+.+|+.++++++|+||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999854 23 368999987743 356789999999999999999999999988 889999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
++|.+++.+... ..++|.....++.|++.||+|||+ .+++||||||+||+++.++..|+.|..
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976542 348999999999999999999999 999999999999999999999998721
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ ....... ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~~------------~~~ 218 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----ILKKIDK------------EGE 218 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHh------------cCC
Confidence 11245678999999999999999999999999999998 999986543211 1111100 000
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
....+...+..+.+++..||+.+|++||++.++++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11122334567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.35 Aligned_cols=254 Identities=19% Similarity=0.272 Sum_probs=191.8
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|+..+.||+|++|.||+|+...++..||+|.+... ......+.+|+.++.+++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 467788999999999999999888999999987653 22346788999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
++ ++|.+++..... ...+++.++..++.|+++||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 96 689888865432 2358999999999999999999998 999999999999999999999998732
Q ss_pred ---cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh----hhccCchhHHh
Q 041096 497 ---TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG----LYAEGRIIEAA 568 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~----~~~~~~~~~~~ 568 (645)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.................. .+.........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 12346789999998865 45789999999999999999999999764322111111110000 00000000000
Q ss_pred hhhccC-------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 569 DKRLNG-------AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 569 d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+.... .........+.+++..||+.||++|||+++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 001112356678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=291.99 Aligned_cols=237 Identities=23% Similarity=0.334 Sum_probs=195.8
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|+..+.||+|+||.+|++....++..+++|++... ....+++.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999999888999999987642 33456789999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++..... ..+++.+.+.++.|++.||+|||+ .+++|+||+|+|||++.++.+++.|..
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999875432 237899999999999999999998 999999999999999999999998732
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....|+..|+|||++.++.++.++|||||||+++||++|+.||...... .. +.. .... ..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----~~---~~~---------~~~~-~~ 218 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----NL---VLK---------IIRG-SY 218 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH----HH---HHH---------HhcC-CC
Confidence 1234788899999999999999999999999999999999998653211 11 100 0000 01
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+......+.+++.+||+.+|.+||+|++|++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1223344567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=290.91 Aligned_cols=238 Identities=24% Similarity=0.330 Sum_probs=197.0
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|+..+.||+|+||.||.+....++..+++|.+... ....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999999888999999987642 34456789999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++.... ...+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+|+.|..
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997653 2348999999999999999999998 899999999999999999999997721
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ... . ......
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~~---~---------~~~~~~- 218 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----LVV---K---------IVQGNY- 218 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----HHH---H---------HHcCCC-
Confidence 22457899999999998889999999999999999999999996532211 111 0 000011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
...+......+.+++..||+.+|.+||+++++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11123345668889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.56 Aligned_cols=231 Identities=25% Similarity=0.364 Sum_probs=196.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 420 (645)
..++|...++||+|.||+|+++.++.+++.+|||.+++. +.+.+..+.|-+++... +||.|++|+.++...+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 456899999999999999999999999999999999883 44566678888887777 5999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec------
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES------ 494 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d------ 494 (645)
.||||+.||++..+.+.. .++...+.-++..|+.||+|||+ ++||+||||.+|||||.+|-+||.|
T Consensus 446 fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 999999999954444322 28999999999999999999999 9999999999999999999999977
Q ss_pred ------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 495 ------SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 495 ------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
..+..+||+.|||||++.++.|+..+|+|||||+||||+.|..||.+.++++....++.
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~--------------- 582 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN--------------- 582 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------------
Confidence 34556899999999999999999999999999999999999999997655332222110
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSM 602 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 602 (645)
|. ..++.....+...|+...+..+|++|.-+
T Consensus 583 d~---~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DE---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CC---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 13555667778888899999999999876
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.61 Aligned_cols=229 Identities=24% Similarity=0.345 Sum_probs=188.0
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 423 (645)
+|+..+.||+|+||.||+|....++..||+|++... ....+.+..|..++..+. |++|+++.+++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467789999999999999999988999999988752 233456788999998886 577888999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|..++..... +++.++..++.|++.||+|||+ .+++||||||+|||++.++.+++.|..
T Consensus 81 Ey~~~g~L~~~i~~~~~----l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK----FKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999876433 8999999999999999999999 999999999999999999999998732
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ ....
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i------------~~~~ 217 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----ELFQSI------------MEHN 217 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHH------------HhCC
Confidence 1234899999999999989999999999999999999999999764321 111111 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSM 602 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 602 (645)
..++......+.+++..|++.+|.+|++.
T Consensus 218 --~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 --VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 12233344567888899999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=290.06 Aligned_cols=238 Identities=22% Similarity=0.340 Sum_probs=194.1
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeee-CCeEEEEEe
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAE-KGELLLVYE 424 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 424 (645)
+|+..+.||+|++|.||++....++..+|+|.+... ....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 477889999999999999999888899999988652 2345678899999999999999999998764 446899999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++++|.+++.... ...+++.++..++.|++.|++|||+ .+++||||||+||+++.++..++.|..
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997643 2348999999999999999999999 999999999999999999999997721
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....+++.|+|||.+.+..++.++||||||++++||++|+.||...+.. ....... ...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~~~~----------~~~ 218 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-------SLVYRII----------EGK 218 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHH----------hcC
Confidence 1235788999999999999999999999999999999999998753211 1110100 011
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
....+......+.+++..|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112333455678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.05 Aligned_cols=252 Identities=23% Similarity=0.273 Sum_probs=188.4
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhc---CCCCeeeeeeeeee-----CC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACL---RHKNLVQLLGWCAE-----KG 417 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~-----~~ 417 (645)
+|+..+.||+|+||.||+|....++..+|+|.+.... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999999999999999876522 2234566777777665 69999999998764 24
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF- 496 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~- 496 (645)
..++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++..|+.|..
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 5899999997 589988875432 238999999999999999999999 999999999999999999999998731
Q ss_pred ----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 ----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....||..|+|||++.+..++.++|||||||++|||++|+.||...........+..... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (288)
T cd07863 155 ARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPPEDDWPR 233 (288)
T ss_pred cccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC-CCChhhCcc
Confidence 223578899999999988999999999999999999999999976433222222221110 000000000
Q ss_pred -------Hhhhhcc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 567 -------AADKRLN---GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 567 -------~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+... .....+..+.+.+++..|++.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 0011123456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.92 Aligned_cols=249 Identities=22% Similarity=0.258 Sum_probs=189.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
.+|...+.||+|+||.||++.+...+..||||... ...+.+|++++++++|+|||++++++..++..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~- 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY- 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-
Confidence 36888999999999999999999889999999643 234678999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------- 497 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------- 497 (645)
.++|.+++..... .++|.+++.++.|+++||+|||+ .+|+||||||+||||+.++.++|.|...
T Consensus 243 ~~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 243 RSDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 5799998865432 48999999999999999999999 9999999999999999999999987321
Q ss_pred ----ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccccc----chhhHHHHHHhhh---c------
Q 041096 498 ----LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGH----KMVNLVDWVWGLY---A------ 560 (645)
Q Consensus 498 ----~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~----~~~~l~~~~~~~~---~------ 560 (645)
...||..|+|||++.+..++.++|||||||+||||++|..|+....... ....+...+.... .
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1358999999999999999999999999999999999887654322111 1111111111100 0
Q ss_pred cCchhHHhhhh----ccCCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 561 EGRIIEAADKR----LNGAFNE-------DEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 561 ~~~~~~~~d~~----l~~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
..++....... ....... .....+.+++..||+.||.+|||+.|+++.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00011110000 0000000 112357788899999999999999999874
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=297.34 Aligned_cols=239 Identities=26% Similarity=0.352 Sum_probs=193.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
+.|+..++||+|+||.||+|....++..+++|.+... ....+.+.+|+.++++++|+|++++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 5677889999999999999999988999999998763 344677899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++++|..++.+... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++..++.|..
T Consensus 92 ~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99999988865432 38999999999999999999998 999999999999999999999998732
Q ss_pred --cccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 --TLTAGTMGYLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~-----~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
....++..|+|||++. ...++.++|||||||++|||++|+.||....... .+... .. .. .
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~----~~-~~-----~ 232 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKI----AK-SE-----P 232 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH---HHHHH----hc-CC-----C
Confidence 1224678899999985 3446889999999999999999999986533211 11110 00 00 0
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+.+ ..+......+.+++..||+.+|++||+++++++
T Consensus 233 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 112233456788899999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=295.13 Aligned_cols=243 Identities=24% Similarity=0.387 Sum_probs=194.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCC---CeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASS---GSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~---~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
++|...++||+|+||.||+|...+. ...+++|..... ....+.+.+|+.++++++|+||++++++|.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577788999999999999987543 356899987653 3345689999999999999999999999875 467899
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-----
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT----- 497 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~----- 497 (645)
|||+++++|.+++..... .+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+++.|...
T Consensus 85 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 999999999999976432 38999999999999999999998 9999999999999999999999977311
Q ss_pred --------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 498 --------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 498 --------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
...++..|+|||.+....++.++||||||+++||+++ |+.||....... ...+. ..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----~~~~~----~~~------ 224 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND----VIGRI----ENG------ 224 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHH----HcC------
Confidence 1123457999999988889999999999999999986 999997643211 11111 000
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
.....+...+..+.+++.+|+..+|.+|||+.++++.|++...
T Consensus 225 ---~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 225 ---ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111223445678889999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=297.02 Aligned_cols=253 Identities=22% Similarity=0.266 Sum_probs=193.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..+.||+|+||.||+|....++..+|+|++.... ...+.+.+|++++++++|+|++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46788899999999999999999889999999876532 234568899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++++|..++.... .+++.++..++.|++.||+|||+ ++++||||||+||+++.++..++.|..
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999998888775433 38999999999999999999999 999999999999999999999998721
Q ss_pred ----cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh-------hccCch
Q 041096 497 ----TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL-------YAEGRI 564 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~-------~~~~~~ 564 (645)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....... +.....
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 12346788999999876 567899999999999999999999997644322111111110000 000000
Q ss_pred h-HHhhhhccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 I-EAADKRLNGAFN-----EDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 ~-~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
. ....+......+ ......+.+++..||+++|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 000000000000 122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.11 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=194.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..+.||+|+||.||+|....++..|++|.+... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3688889999999999999999988999999988652 2335678999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|++++.|..+..... .+++.++..++.|++.||+|||+ .+++||||+|+||+++.++.+++.|..
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASPG----GLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877766554322 28999999999999999999999 999999999999999999999998721
Q ss_pred -----cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc--------cC
Q 041096 497 -----TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA--------EG 562 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~--------~~ 562 (645)
....++..|+|||++.+. .++.++||||||+++|||++|+.||......+....+......... ..
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 123567889999999887 8899999999999999999999999754322111111110000000 00
Q ss_pred ch-----hHHhhh-hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 563 RI-----IEAADK-RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 563 ~~-----~~~~d~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.. .+..++ .+...++......+.+++..||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 000000 0000112223677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.25 Aligned_cols=237 Identities=25% Similarity=0.353 Sum_probs=195.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.+|+..+.||.|++|.||+|....++..+++|.+... ....+.+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999999888999999988653 334567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++++|.+++... .+++.++..++.|++.||+|||+ .+++||||||+||+++.++..++.|..
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999998643 28999999999999999999999 999999999999999999999998732
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||........ .. ... .. . .+.+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~---~~-~~~---~~-~-----~~~~-- 235 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LY-LIA---TN-G-----TPEL-- 235 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH-HHH---hc-C-----Cccc--
Confidence 123577899999999988899999999999999999999999976432111 00 000 00 0 0001
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..+......+.+++..||..+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 122233456778899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=310.26 Aligned_cols=228 Identities=25% Similarity=0.309 Sum_probs=183.6
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHH-HHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELS-IIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||.||+|....++..+|+|++... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999999988999999988652 223445566655 46778999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|..++.... .+++.+...++.||+.||+|||+ .+|+||||||+|||++.++..|+.|..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 99999887543 38999999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
....||..|+|||++.+..++.++|||||||++|||++|+.||...+... +.+. .....+ ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~~~~------------~~~~~~--~~ 215 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----MYDN------------ILHKPL--VL 215 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----HHHH------------HHcCCc--cC
Confidence 12358999999999999999999999999999999999999997543211 1110 000111 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSMRRVF 606 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl 606 (645)
.......+.+++..|++.+|.+||++++.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 122345577888999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=292.50 Aligned_cols=234 Identities=26% Similarity=0.408 Sum_probs=193.1
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc----------hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeE
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE----------GKTEFLAELSIIACLRHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~----------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 419 (645)
|.....||+|++|.||+|....++..+|+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 5667889999999999999988889999998764211 124688999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc--
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT-- 497 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~-- 497 (645)
++|+||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++..++.|...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999997643 38899999999999999999998 8999999999999999999999977210
Q ss_pred ----------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc
Q 041096 498 ----------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE 561 (645)
Q Consensus 498 ----------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~ 561 (645)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||....... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~--------- 222 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIF--------- 222 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHH---------
Confidence 1246788999999998889999999999999999999999997543211 110
Q ss_pred CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 562 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
... .......+......+.+++..||+++|.+||++.++++
T Consensus 223 ----~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 ----KIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----HHh-ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 11122333445677888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=298.16 Aligned_cols=244 Identities=24% Similarity=0.315 Sum_probs=198.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
++|...+.||+|+||.||+|....++..+|+|.+... ....+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788899999999999999999888999999988763 334566889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++++|.+++.+. .+++.++..++.|++.||.|||+ .+++||||||+|||++.++..++.|..
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998643 27899999999999999999999 999999999999999999999998732
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....++..|+|||.+.+..++.++|||||||++|||++|+.||............ .. ......
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-------~~--------~~~~~~ 235 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------AT--------NGTPEL 235 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-------cc--------CCCCCC
Confidence 1235788999999999988999999999999999999999999654321110000 00 000000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCC
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAE 614 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~ 614 (645)
..+......+.+++..||+.+|++||+++++++ .++...+
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 122234456778889999999999999999987 4443333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=292.23 Aligned_cols=236 Identities=25% Similarity=0.386 Sum_probs=188.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc------chhHhHHHHHHHHhhcCCCCeeeeeeeeee--CCeE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH------EGKTEFLAELSIIACLRHKNLVQLLGWCAE--KGEL 419 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 419 (645)
.+|...+.||+|+||.||+|....++..+++|++.... .....+.+|+.++++++|+||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999998889999999875421 234568899999999999999999998875 3578
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc--
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT-- 497 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~-- 497 (645)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+ .+++||||||+||+++.++..++.|...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 99999999999999997543 28899999999999999999998 9999999999999999999999977321
Q ss_pred -------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 498 -------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 498 -------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
...++..|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---~~------------- 218 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---AI------------- 218 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---HH-------------
Confidence 1247788999999998889999999999999999999999997532111 00
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
............+......+..++ .||..+|++||+|++|++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 219 FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 001101111222333334444454 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=329.33 Aligned_cols=247 Identities=23% Similarity=0.293 Sum_probs=196.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..++||+|+||.||+|....++..||+|++... ....+.|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5788899999999999999999988999999988652 223467999999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCC-------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc
Q 041096 424 EYMPNGSLDRMLYQDSE-------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~ 496 (645)
||+++|+|.+++..... ....+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+++.|..
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999874321 12336788899999999999999999 999999999999999999999987621
Q ss_pred c------------------------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccccc
Q 041096 497 T------------------------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGH 546 (645)
Q Consensus 497 ~------------------------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~ 546 (645)
. ..+||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 0 1358999999999999999999999999999999999999997632211
Q ss_pred chhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHcCC
Q 041096 547 KMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARP-SMRRVFQILNNE 612 (645)
Q Consensus 547 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~~vl~~L~~~ 612 (645)
.... . . ..++.-. ....+.+..+.+++.+|++.||++|| +++++++.|+..
T Consensus 239 ----i~~~--~-----~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ----ISYR--D-----V---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ----hhhh--h-----h---ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0000 0 0 0000000 00113345678889999999999996 566677666543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=306.37 Aligned_cols=225 Identities=26% Similarity=0.317 Sum_probs=182.3
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHH-HHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELS-IIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||.||+|+...++..+|+|++... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999988999999988652 222344555554 57889999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
++|..++.... .++..+...++.||++||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 99998886543 27888889999999999999998 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.. .+.+.+ .... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i------------~~~~--~~~ 215 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----QMYDNI------------LHKP--LQL 215 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH----HHHHHH------------hcCC--CCC
Confidence 1235889999999999989999999999999999999999999764311 111111 1111 122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSMR 603 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 603 (645)
+......+.+++..|++.+|.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 333455688899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=288.99 Aligned_cols=234 Identities=27% Similarity=0.445 Sum_probs=192.2
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCCcc--hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE--GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
++||+|+||.||++.... +..+++|....... ....+.+|++++++++|+||+++++++.+.+..++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999987 89999998876333 456799999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc-------------
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL------------- 498 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~------------- 498 (645)
.+++..... .+++..++.++.+++.||+|||+ ++++||||||+||+++.++..++.|....
T Consensus 80 ~~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999975432 37899999999999999999998 99999999999999999999999873211
Q ss_pred -cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 499 -TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 499 -~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
..++..|+|||.+.++.++.++||||||+++|||++ |..||....... .. +.+........
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~----~~-------------~~~~~~~~~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ----TR-------------ERIESGYRMPA 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH----HH-------------HHHhcCCCCCC
Confidence 122456999999998899999999999999999999 888886543211 11 11111111122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
+...+..+.+++..|++.+|.+|||+.++++.|+.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 33445678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=295.33 Aligned_cols=234 Identities=23% Similarity=0.374 Sum_probs=200.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
.+|++.+.||+|.||+|-++.....|+.||||.+++ +.++.-.+.+||++|+.|+||||+.++.+|++.+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 457777889999999999999988899999998876 3445567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec---------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES--------- 494 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d--------- 494 (645)
||..+|.|++|+..++. |+......++.||.+|+.|+|. ++++|||||.+|||||.++++||.|
T Consensus 133 EYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999988765 9999999999999999999999 9999999999999999999999987
Q ss_pred --cccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 495 --SFTLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 495 --~~~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
.....||++-|.+||++.+..| .+..|-||+||+||-|+.|..||++.+.. .++ .+-
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk----~lv----------------rQI 265 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK----RLV----------------RQI 265 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----HHH----------------HHh
Confidence 2345689999999999999888 57899999999999999999999875431 111 111
Q ss_pred ccCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 572 LNGAFN-EDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 572 l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
-++.+. ++.+....-|+.||+..+|++|.|+.+|...
T Consensus 266 s~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 266 SRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred hcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 122222 2334556678899999999999999999763
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=308.02 Aligned_cols=229 Identities=24% Similarity=0.319 Sum_probs=183.5
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHH-HHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELS-IIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
+.||+|+||.||+|....++..+|+|++... ......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999999988999999988652 122334455544 56788999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|.+++..... +.......++.||++||+|||+ .+|+||||||+|||++.++..++.|..
T Consensus 81 ~~L~~~~~~~~~----~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 81 GELFYHLQRERC----FLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred CcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 999999976432 7788888899999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ....+ ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i------------~~~~~--~~ 215 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNI------------LNKPL--QL 215 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----HHHHH------------HhCCc--CC
Confidence 12358999999999999999999999999999999999999997543211 11111 00111 12
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..+....+.+++..|++.+|.+||++.+.+.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 2234456778889999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=312.87 Aligned_cols=189 Identities=30% Similarity=0.407 Sum_probs=169.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||++....++..+|+|++... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688889999999999999999989999999988652 233456888999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------ 497 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------ 497 (645)
||+++|+|.+++.+... +++.....++.|++.||+|||+ .+|+||||||+||||+.++.+++.|...
T Consensus 81 E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT----LSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999976433 8999999999999999999999 9999999999999999999999977321
Q ss_pred -----------------------------------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCC
Q 041096 498 -----------------------------------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGR 536 (645)
Q Consensus 498 -----------------------------------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~ 536 (645)
..+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 236899999999999999999999999999999999999
Q ss_pred CCCCccc
Q 041096 537 RPIERET 543 (645)
Q Consensus 537 ~P~~~~~ 543 (645)
.||....
T Consensus 234 ~Pf~~~~ 240 (360)
T cd05627 234 PPFCSET 240 (360)
T ss_pred CCCCCCC
Confidence 9997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=297.20 Aligned_cols=241 Identities=26% Similarity=0.342 Sum_probs=194.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.++|+..+.||+|+||.||+|....++..+|+|..... ....+.+.+|++++++++|+||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 45688889999999999999999888999999988653 33456799999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++..++.|..
T Consensus 84 ~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999999876432 38999999999999999999999 999999999999999999999997732
Q ss_pred ---cccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 ---TLTAGTMGYLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~-----~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....|+..|+|||.+. ...++.++||||||+++|||++|+.||....... .+.... ...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~~~~~-----~~~----- 224 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VLLKIL-----KSE----- 224 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HHHHHh-----cCC-----
Confidence 1235788999999875 3456789999999999999999999997543211 111110 000
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.+.+ ..+......+.+++..||+.+|.+||+++++++.
T Consensus 225 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011 1122334567888999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=307.85 Aligned_cols=248 Identities=20% Similarity=0.257 Sum_probs=190.7
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC-----
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG----- 417 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 417 (645)
..++|+..+.||+|+||.||++....++..+|+|.+... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999999888999999998652 334567889999999999999999999886543
Q ss_pred -eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc
Q 041096 418 -ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF 496 (645)
Q Consensus 418 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~ 496 (645)
..|+||||++ ++|...+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|+.|..
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCC
Confidence 5799999996 467666632 27888899999999999999999 999999999999999999999998832
Q ss_pred -----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC---
Q 041096 497 -----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG--- 562 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~--- 562 (645)
....||..|+|||.+.+..++.++|||||||++|||++|+.||...+.......+. ......
T Consensus 169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~----~~~~~~~~~ 244 (359)
T cd07876 169 LARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI----EQLGTPSAE 244 (359)
T ss_pred CccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----HhcCCCcHH
Confidence 22367889999999999999999999999999999999999997653211111110 000000
Q ss_pred -------chhHHhhh--hccC----------------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 563 -------RIIEAADK--RLNG----------------AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 563 -------~~~~~~d~--~l~~----------------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+...... ...+ .........+.+++..|++.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0000 001112356788999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=306.47 Aligned_cols=239 Identities=25% Similarity=0.381 Sum_probs=204.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCe-EEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGE-LLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 423 (645)
++|...+++|+|+||.++...++..+..+++|.+... ...++....|+.++++++|||||.+.+.+.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4677889999999999999999988999999988763 3344578999999999999999999999998887 99999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-------- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-------- 495 (645)
+||+||+|.+.+.+.+ +..++..++.+++.|++.|+.|||+ ..|+|||||+.||+++.+..++++|.
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998765 3458999999999999999999998 99999999999999999999999882
Q ss_pred ----ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 496 ----FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 496 ----~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....+||+.||.||.+.+.+|..|+||||+||++|||++-+++|...+- ..++. .+-+.
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m----~~Li~-------------ki~~~ 221 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM----SELIL-------------KINRG 221 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch----HHHHH-------------HHhhc
Confidence 2336899999999999999999999999999999999999999976432 22222 12222
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
+....+......+..++..|++.+|..||++.+++..
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2334566667788889999999999999999999864
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=289.52 Aligned_cols=241 Identities=24% Similarity=0.329 Sum_probs=196.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
++|+..+.||+|+||.||+|....++..+++|.+... ....+.+.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5788889999999999999999888889999988763 334678999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++++|.+++..... .++..++..++.|++.||+|||+ .+++|+||||+||+++.++..++.|..
T Consensus 83 ~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVTRG---PLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 99999999876522 38999999999999999999998 999999999999999999999998731
Q ss_pred --cccccCCcccCcccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 --TLTAGTMGYLAPEYLQYG---TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~---~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....++..|+|||.+... .++.++||||||+++|||++|+.||......... .... .... ..+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~---~~~~-----~~~~---~~~~ 225 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL---FLIS-----KSNF---PPPK 225 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH-----hccC---CCcc
Confidence 223567889999999776 7899999999999999999999999754321111 0000 0000 0000
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+ .........+.+++.+||+.+|.+|||+.+++.
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 112334567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=290.81 Aligned_cols=238 Identities=28% Similarity=0.439 Sum_probs=192.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|...+.||+|+||.||+|.. .+..+|+|...... ....+.+|+.++++++|+|++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577889999999999999975 47789999886533 346789999999999999999999998764 5799999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---------c
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------L 498 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------~ 498 (645)
+++|.+++..... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+++.|... .
T Consensus 82 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~ 156 (254)
T cd05083 82 KGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN 156 (254)
T ss_pred CCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccCCC
Confidence 9999999976432 248899999999999999999998 9999999999999999999999988321 1
Q ss_pred cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC
Q 041096 499 TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577 (645)
Q Consensus 499 ~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 577 (645)
...+..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .+........+
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~-------------~~~~~~~~~~~ 219 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK----EVKE-------------CVEKGYRMEPP 219 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH----HHHH-------------HHhCCCCCCCC
Confidence 223567999999998899999999999999999998 99998654321 1111 11111111223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 578 EDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 578 ~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
...+..+.+++..||+.+|++||+++++++.|++
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 3445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=289.22 Aligned_cols=237 Identities=25% Similarity=0.363 Sum_probs=193.7
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|+..+.||+|+||.||++....++..+|+|.+... ......+.+|++++++++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999999888999999987653 33456789999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-Ceeeeccc--------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-NARLESSF-------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~-~~kl~d~~-------- 496 (645)
+++++|.+++.... ...+++..+..++.|++.||+|||+ ++++|+||||+||+++.+. ..++.|..
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997643 2348999999999999999999999 9999999999999998654 46776621
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....|+..|+|||.+....++.++||||||+++|||++|+.||...+.. ...... . ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~~------------~-~~~~ 218 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVLKI------------M-SGTF 218 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH----HHHHHH------------H-hcCC
Confidence 1235788999999999888999999999999999999999998654321 111110 0 0111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+......+.+++..||+.+|.+|||++++++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1222234566889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=298.30 Aligned_cols=239 Identities=24% Similarity=0.291 Sum_probs=195.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|++|.||+|....++..+|+|.+.... ...+.+.+|++++.+++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999998889999999887632 23457889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------ 497 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------ 497 (645)
||+.+++|.+++.... +..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+++.|...
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987543 2348999999999999999999998 9999999999999999999999976211
Q ss_pred -----------------------------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 041096 498 -----------------------------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERE 542 (645)
Q Consensus 498 -----------------------------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~ 542 (645)
...|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 125788899999999888999999999999999999999999754
Q ss_pred ccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 041096 543 TEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPS----MRRVFQ 607 (645)
Q Consensus 543 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~~vl~ 607 (645)
...... .+..+....-.........+.+++.+||+.+|++||+ ++++++
T Consensus 236 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDETF----------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHHHH----------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 322111 1111111111111124678899999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=294.99 Aligned_cols=242 Identities=24% Similarity=0.370 Sum_probs=194.8
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
+|+..+.||+|+||.||++....++..+|+|.+... ......+.+|++++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 567788999999999999999888999999987652 333567899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++++|..++..... ...+++..+..++.|++.||.|||+ ..+++||||||+||+++.++..+++|..
T Consensus 82 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 82 DAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred CCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 99999999876421 2348999999999999999999996 2589999999999999999999998732
Q ss_pred cccccCCcccCcccccCCC------CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 TLTAGTMGYLAPEYLQYGT------ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~------~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....++..|+|||.+.+.. ++.++|||||||++|||++|+.||....... .... +....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~---------~~~~~~- 224 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQ---------LSAIVD- 224 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----HHHH---------HHHHhh-
Confidence 1234778999999986543 4889999999999999999999996532211 1100 001111
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
......+.+....+.+++.+||+.+|++||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 225 GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1112334446677888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=289.70 Aligned_cols=236 Identities=24% Similarity=0.344 Sum_probs=190.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC------cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS------HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GEL 419 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 419 (645)
.+|+..++||+|+||.||+|....++..||+|.+... ....+.+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999999988999999987532 12245788899999999999999999988763 468
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
+++|||+++++|.+++..... +++...++++.|++.||+|||+ .+++|+||||+||+++.++..++.|..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA----LTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999875432 7888899999999999999998 999999999999999999999997732
Q ss_pred ------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 ------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 ------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||....... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~------------ 219 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---AIF------------ 219 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---HHH------------
Confidence 12347888999999988889999999999999999999999996532111 110
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+..........+......+..++..|+. +|++||+++++++
T Consensus 220 -~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 220 -KIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -HHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1111111223344555667778888885 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=298.28 Aligned_cols=252 Identities=19% Similarity=0.248 Sum_probs=192.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|...+.||+|+||.||+|....++..||+|.+... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4688889999999999999999888999999987653 23345678999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
++ ++|.+++..... .+++.....++.|+++||+|||+ .+++||||||+||+++.++..+++|..
T Consensus 86 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 699998875433 38899999999999999999999 999999999999999999999998732
Q ss_pred ---cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh---
Q 041096 497 ---TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD--- 569 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d--- 569 (645)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+... ............+.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI-LGTPTEETWPGILSNEE 237 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-cCCCChhhchhhhcccc
Confidence 12346788999998865 45789999999999999999999999764322111111100 00000000000000
Q ss_pred ------hhccCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 570 ------KRLNGA----FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 570 ------~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+..... ........+.+++.+|++.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 01122345778999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.12 Aligned_cols=242 Identities=23% Similarity=0.297 Sum_probs=195.3
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc---------------hhHhHHHHHHHHhhcCCCCeeee
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---------------GKTEFLAELSIIACLRHKNLVQL 409 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---------------~~~~~~~Ei~~l~~l~H~niv~l 409 (645)
...++|+..+.||+|.||.|-+|....++..||||++.+... ..+...+||.+|++++|+|||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 445789999999999999999999999999999998865211 12467899999999999999999
Q ss_pred eeeeeeC--CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC
Q 041096 410 LGWCAEK--GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN 487 (645)
Q Consensus 410 ~g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~ 487 (645)
+.+..+. +.+|||+|||..|.+...= .....+...+.++++.++..||+|||. ++|+||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence 9998764 5899999999888775432 112228999999999999999999999 999999999999999999
Q ss_pred CCeeeecc-----------------ccccccCCcccCcccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCcccccc
Q 041096 488 FNARLESS-----------------FTLTAGTMGYLAPEYLQYGT----ATEKTDVFSYGVVVLEVACGRRPIERETEGH 546 (645)
Q Consensus 488 ~~~kl~d~-----------------~~~~~gt~~y~APE~~~~~~----~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~ 546 (645)
+.+||+|. ....+||+.|+|||...++. ...+.||||+||.||-|+.|+.||.....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 99999872 12357999999999987743 25688999999999999999999976432
Q ss_pred chhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 041096 547 KMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609 (645)
Q Consensus 547 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L 609 (645)
..+. .+++...|.-...++.-+.+.+|++.+|.+||++|.+..+|....
T Consensus 325 --~~l~------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 --LELF------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred --HHHH------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1111 123333342222335677888999999999999999999987754
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=329.98 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=196.8
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeee--CCe
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAE--KGE 418 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~ 418 (645)
....++|.+.+.||+|+||+||++....++..+|+|.+... ......+..|+.++.+|+|||||++++++.. .+.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34557899999999999999999999999999999987652 3345678999999999999999999998754 357
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC----CCCeeeCCCCCCcEEEcCC-------
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC----EQQVIHRDIKASNIMLDAN------- 487 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivHrDlkp~NIlld~~------- 487 (645)
+||||||+++|+|.++|.........+++..++.|+.||+.||+|||+.. ..+|+||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999764433345999999999999999999999732 1459999999999999653
Q ss_pred ----------CCeeeeccc-----------cccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 041096 488 ----------FNARLESSF-----------TLTAGTMGYLAPEYLQY--GTATEKTDVFSYGVVVLEVACGRRPIERETE 544 (645)
Q Consensus 488 ----------~~~kl~d~~-----------~~~~gt~~y~APE~~~~--~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~ 544 (645)
..+||.|.. ....||+.|+|||++.. ..++.++|||||||+||||++|+.||.....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 236777632 22468999999999864 4589999999999999999999999975322
Q ss_pred ccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCC
Q 041096 545 GHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAE 614 (645)
Q Consensus 545 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~ 614 (645)
. ..++.. .... +.+. .......+.+++..||+.+|.+||++.++++ .|....+
T Consensus 249 ~---~qli~~----lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 249 F---SQLISE----LKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred H---HHHHHH----HhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 1 111111 0000 0110 0122456788999999999999999999984 5654443
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=288.91 Aligned_cols=236 Identities=26% Similarity=0.389 Sum_probs=193.5
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc------chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH------EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
+|+..+.||+|++|.||+|....++..+++|.+.... +..+.+.+|+.++++++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999998788999999875522 2456789999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
+||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++..|+.|..
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999997543 38899999999999999999999 999999999999999999999998731
Q ss_pred -----cccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGT-ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~-~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....|+..|+|||.+.... ++.++|+||||+++|||++|+.||...... ..... . ...
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~---~~~~~----~---------~~~ 217 (258)
T cd06632 154 EFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV---AAVFK----I---------GRS 217 (258)
T ss_pred ccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH---HHHHH----H---------Hhc
Confidence 2345788899999988766 899999999999999999999999754311 11111 0 000
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.-....+......+.+++.+||+.+|.+||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0011223334566788899999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=291.94 Aligned_cols=240 Identities=23% Similarity=0.309 Sum_probs=191.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
++|...+.||+|+||.||+|....++..+|+|.++... .....+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777788999999999999998889999999887532 33456888999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++++|.+++.... .+++.+.+.++.|++.||.|||+ .+++|+||||+||+++.++..++.|..
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 9999999987544 38999999999999999999999 899999999999999999999987621
Q ss_pred --cccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 --TLTAGTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~---~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||........ +......... .+.
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~--------~~~ 230 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLMTKSNFQ--------PPK 230 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HHhhhccCCC--------CCc
Confidence 2236889999999874 45688999999999999999999999865332111 1000000000 000
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
... .......+.+++..|++.+|++||+++++++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000 0112345778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=295.90 Aligned_cols=262 Identities=20% Similarity=0.280 Sum_probs=196.4
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc------hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE------GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
+|+..+.||+|++|.||+|....++..|++|.+..... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 46778899999999999999988899999999876322 244577899999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+ +++|.+++.... ..+++..+..++.||++||+|||+ .+++|+||||+||+++.++.++++|..
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999997543 248999999999999999999999 999999999999999999999997721
Q ss_pred ------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh----h-ccCch
Q 041096 497 ------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL----Y-AEGRI 564 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~----~-~~~~~ 564 (645)
....++..|+|||.+.+ ..++.++|||||||++|||++|..||................... + .....
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 11235678999998865 467899999999999999999987776543221111111100000 0 00000
Q ss_pred hHHhhhhccCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HcCCCCCCC
Q 041096 565 IEAADKRLNGA-----FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI--LNNEAEPLV 617 (645)
Q Consensus 565 ~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~--L~~~~~~~~ 617 (645)
........... ........+.+++..||+.+|++|||+.++++. +++...+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 00000000001 112235678899999999999999999999984 655444443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=291.31 Aligned_cols=240 Identities=22% Similarity=0.320 Sum_probs=182.6
Q ss_pred eeccCCceEEEEEEECCC--CeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCC
Q 041096 355 ILGRGAFGNVYKAYFASS--GSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGS 430 (645)
Q Consensus 355 ~lG~G~fg~Vy~g~~~~~--~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 430 (645)
.||+|+||.||+|..... ...+++|.+... ....+.|.+|+.+++.++||||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999976432 235667766543 2345789999999999999999999999999999999999999999
Q ss_pred HhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-------------
Q 041096 431 LDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------------- 497 (645)
Q Consensus 431 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------------- 497 (645)
|.+++.+.......+++.....++.||++||+|||+ .+++||||||+|||++.++..++.|...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999998654333446778888999999999999998 9999999999999999999999987321
Q ss_pred -ccccCCcccCcccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 498 -LTAGTMGYLAPEYLQY-------GTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 498 -~~~gt~~y~APE~~~~-------~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
...++..|+|||++.. ..++.++|||||||++|||++ |..||...... .....+ .. +......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~~~~---~~-~~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR----EVLNHV---IK-DQQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH---Hh-hcccccC
Confidence 1246788999998753 245789999999999999997 56687643321 111111 11 1111222
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
++.+... ....+.+++..|| .+|.+||++++|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2333222 3345677888899 67999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.95 Aligned_cols=234 Identities=24% Similarity=0.355 Sum_probs=193.7
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
|+..+.||+|+||.||+|....++..+|+|..... ....+.+.+|+.++.+++|+||+++++++.+++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 56678899999999999999888999999987653 2344678899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----------- 496 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----------- 496 (645)
+++|.+++... .+++.....++.|++.||.|||+ .+++|+||||+||+++.++..++.|..
T Consensus 86 ~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 86 GGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 99999998643 38999999999999999999998 999999999999999999999998731
Q ss_pred -cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 497 -TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 497 -~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
....++..|+|||.+.+..++.++|||||||++|||++|..||...... .... .+.......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~-------------~~~~~~~~~ 220 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM----KVLF-------------LIPKNNPPT 220 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH----HHHH-------------HHhcCCCCC
Confidence 1125788899999999888999999999999999999999998653211 1110 011111112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.+......+.+++..||+.+|.+||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 233445667889999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=306.35 Aligned_cols=254 Identities=20% Similarity=0.240 Sum_probs=192.2
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-----
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK----- 416 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 416 (645)
...++|+..+.||+|+||.||++.....+..+|+|++... ......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3457899999999999999999999888999999988753 23346788999999999999999999987643
Q ss_pred -CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 417 -GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 417 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
...++||||++ ++|.+.+.. .+++..+..++.|+++||+|||+ ++|+||||||+||||+.++.+|++|.
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeC
Confidence 35799999995 467776642 27889999999999999999999 99999999999999999999999872
Q ss_pred c-----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh----hhc
Q 041096 496 F-----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG----LYA 560 (645)
Q Consensus 496 ~-----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~----~~~ 560 (645)
. ....||..|+|||++.+..++.++|||||||++|||++|+.||............+..... ...
T Consensus 164 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 164 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 2 2246889999999999999999999999999999999999999764321111111110000 000
Q ss_pred --cCchhHHhhh---------------hcc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 561 --EGRIIEAADK---------------RLN---GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 561 --~~~~~~~~d~---------------~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.......++. .+. ..........+.+++..|++.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 000 00111124567899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=293.19 Aligned_cols=240 Identities=27% Similarity=0.405 Sum_probs=189.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc--chhHhHHHHHHH-HhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTEFLAELSI-IACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..+.||+|+||.||++....++..||+|++.... .....+..|+.. ++.++|+||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999999889999999887632 334456667665 566789999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ-QVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
|++ |+|.+++.........+++..++.++.|++.||+|||+ + +++||||||+||+++.++..|+.|..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 78988887644334568999999999999999999998 6 89999999999999999999998732
Q ss_pred ----cccccCCcccCcccccC----CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 ----TLTAGTMGYLAPEYLQY----GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~----~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... ...+. ...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~-------------~~~ 221 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLK-------------QVV 221 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHH-------------HHH
Confidence 12357888999998865 45688999999999999999999999643211 11111 111
Q ss_pred hhhccCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 569 DKRLNGAFN-EDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 569 d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.. .....+ ......+.+++..||..+|.+||+++++++
T Consensus 222 ~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 222 EE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred hc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 001111 123456888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.81 Aligned_cols=250 Identities=26% Similarity=0.318 Sum_probs=197.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 423 (645)
++|+..+.||.|++|.||++....++..+|+|.+.... .....+.+|++++++++|+||++++++|.+. +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999998889999999887532 3456799999999999999999999998653 4789999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++++|.+++.........+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.+++.|..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999886543334458899999999999999999999 999999999999999999999998732
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccc-cchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEG-HKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..+.... .... +....
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~ 232 (287)
T cd06621 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPE-LKDEP 232 (287)
T ss_pred cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchh-hccCC
Confidence 1234678899999999999999999999999999999999999764321 1111222221110 0000 00000
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.........+.+++.+||+.+|.+|||+.|+++
T Consensus 233 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 --GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred --CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 001123567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=289.27 Aligned_cols=236 Identities=26% Similarity=0.407 Sum_probs=190.7
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-------chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-------EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
+|...+.||+|+||.||+|... ++..+|+|.+.... .....+.+|++++++++|+||++++++|.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 3667889999999999999874 57889999876421 123568899999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
++||+++++|.+++.+.. .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++..++.|..
T Consensus 80 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999997543 27899999999999999999998 899999999999999999999997721
Q ss_pred -------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc
Q 041096 497 -------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR 563 (645)
Q Consensus 497 -------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 563 (645)
....|+..|+|||++.+..++.++||||||+++|||++|+.||........ ..... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~----~--- 222 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---MFYIG----A--- 222 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---HHHhh----h---
Confidence 123478889999999988899999999999999999999999975432111 00000 0
Q ss_pred hhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 564 IIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 564 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
........+......+..++..||+.+|.+||++.++++
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 -----HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000111223334566788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.05 Aligned_cols=252 Identities=20% Similarity=0.236 Sum_probs=191.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC------
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK------ 416 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 416 (645)
..++|...+.||+|+||.||++.....+..+|||++... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999999888999999998753 23456788999999999999999999987543
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF 496 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~ 496 (645)
...|+||||++ ++|.+++.. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+|+.|..
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999996 577777742 27889999999999999999999 999999999999999999999998732
Q ss_pred -----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH-------Hhh
Q 041096 497 -----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV-------WGL 558 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~-------~~~ 558 (645)
....||..|+|||++.+..++.++|||||||++|||++|+.||...+.......++... +..
T Consensus 172 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 172 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred CccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 22468899999999999999999999999999999999999997654321111111000 000
Q ss_pred hccCchhHHhh--------------hhcc----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 559 YAEGRIIEAAD--------------KRLN----GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 559 ~~~~~~~~~~d--------------~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.. ..+...+. +... ..........+.+++..|++.||.+|||+.++++.
T Consensus 252 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hh-HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000000 0000 00011123467889999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.72 Aligned_cols=257 Identities=21% Similarity=0.248 Sum_probs=192.9
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-----
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEK----- 416 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 416 (645)
...++|...+.||+|+||.||+|....++..||||++.... ...+.+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999998889999999887532 2345678999999999999999999987543
Q ss_pred -CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 417 -GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 417 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
...++++|++ +++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|+.|.
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCC
Confidence 3579999998 88998887532 28999999999999999999999 99999999999999999999999873
Q ss_pred c---------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh-------h
Q 041096 496 F---------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG-------L 558 (645)
Q Consensus 496 ~---------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~-------~ 558 (645)
. ....||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+...... .
T Consensus 163 g~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 163 GLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 2 23468999999999876 56899999999999999999999999754321111111110000 0
Q ss_pred hccCchhHHhhhhccCCCCH--------HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 559 YAEGRIIEAADKRLNGAFNE--------DEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
......... ...+. ..+. .....+.+++..|++.||.+|||+.++++ .+...
T Consensus 243 ~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 243 ISSEHARKY-IQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred cchhhHHHH-hhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 000000000 00000 0010 11234678999999999999999999996 35443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=293.68 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=190.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|+..+.||+|++|.||+|....++..||+|.+.... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999998889999999886532 2234577899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc--------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT-------- 497 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~-------- 497 (645)
++ ++|.+++..... .+++.....++.|+++||.|||+ .+++||||||+||+++.++.+++.|...
T Consensus 85 ~~-~~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 97 599998875433 38999999999999999999998 9999999999999999999999987321
Q ss_pred ----ccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc---CchhHHh-
Q 041096 498 ----LTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE---GRIIEAA- 568 (645)
Q Consensus 498 ----~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~- 568 (645)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......+..... .......
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE---DQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHHHHHhcCCCChhhhhhhhh
Confidence 1235778999998875 458999999999999999999999997543211 111111111100 0000000
Q ss_pred -------------hhhccCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 569 -------------DKRLNGAF-NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 569 -------------d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+.... .......+.+++..|++.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 0011256678899999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=293.51 Aligned_cols=253 Identities=20% Similarity=0.263 Sum_probs=190.6
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|+..+.||+|++|.||+|....++..+|||.+.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999998889999999886532 2335788999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+. ++|.+++..... ..+++.++..++.|++.||+|||+ .+++||||+|+||+++.++..++.|..
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 689998865432 348999999999999999999998 999999999999999999999997732
Q ss_pred ---cccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh----cc-CchhHH
Q 041096 497 ---TLTAGTMGYLAPEYLQYGT-ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY----AE-GRIIEA 567 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~-~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~----~~-~~~~~~ 567 (645)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...........+..+..... .. ....+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 1124577899999887644 68899999999999999999999976432221111111100000 00 000000
Q ss_pred hh--hhccC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 568 AD--KRLNG----AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 568 ~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.. +.... .........+.+++.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 00000 000112345678899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=294.71 Aligned_cols=258 Identities=23% Similarity=0.299 Sum_probs=195.5
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC-----eEEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG-----ELLLVY 423 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV~ 423 (645)
.|...+++|+|+||.||+|.+..+++.||||+.-.... .--+|+++|+++.|||||+|.-++.... ...|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 35567899999999999999999999999998755332 3347999999999999999998876432 346899
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeeeeccccc----
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN-FNARLESSFTL---- 498 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~-~~~kl~d~~~~---- 498 (645)
||||. +|.++++.....+..++.....-+..|+.+||+|||+ .+|+||||||+|+|+|.+ +..||+|..+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99975 8999998654444558888888899999999999999 999999999999999987 77899884433
Q ss_pred -------cccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh--
Q 041096 499 -------TAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA-- 568 (645)
Q Consensus 499 -------~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-- 568 (645)
..-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|+..|.+.+..+....++ .+.+...++++..+-
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIi-k~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEII-KVLGTPTREDIKSMNPN 256 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHH-HHhCCCCHHHHhhcCcc
Confidence 235778999999987 469999999999999999999999998855433322222 222332222221111
Q ss_pred -----hhhccC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCC
Q 041096 569 -----DKRLNG-----AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAE 614 (645)
Q Consensus 569 -----d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~ 614 (645)
.+.+.. -+........++++.+|+..+|.+|.++.|++. +++.+.+
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 111111 123345667888999999999999999999986 4554433
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=293.65 Aligned_cols=249 Identities=20% Similarity=0.264 Sum_probs=189.6
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|+..+.||+|+||.||+|....+|..+|+|++... ......+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 467788999999999999999988999999988652 22245678899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+. ++|.+++..... .+++.....++.||++||.|||+ .+++||||||+||+++.++.+++.|..
T Consensus 81 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCNG---DIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 588888765432 38999999999999999999999 999999999999999999999997721
Q ss_pred ---cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc------hhH
Q 041096 497 ---TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR------IIE 566 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~------~~~ 566 (645)
....++..|+|||.+.+. .++.++|||||||++|||++|+.|+........ ............. ..+
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH---HHHHHHHHhCCCChHHhHHhhh
Confidence 123467889999998764 479999999999999999999998754322111 1111111000000 000
Q ss_pred HhhhhccC---------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 567 AADKRLNG---------AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 567 ~~d~~l~~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..+..... .........+.+++..||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000 011123456778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=285.89 Aligned_cols=238 Identities=30% Similarity=0.485 Sum_probs=194.6
Q ss_pred CCcCceeccCCceEEEEEEECCCC----eEEEEEeccCCcc--hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSG----SVAAVKRSKHSHE--GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~----~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
|...+.||+|+||.||++.....+ ..+|+|.+..... ..+.+..|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 345688999999999999998765 8899999876443 5678999999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------ 497 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------ 497 (645)
||+++++|.+++...... .+++.++..++.|++.||+|||+ .+++||||||+||+++.++..++.|...
T Consensus 81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999999764321 18999999999999999999999 8999999999999999999999977211
Q ss_pred -------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 498 -------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 498 -------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
...++..|+|||.+....++.++||||+|++++||++ |+.||..... ..+...+ .
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~-------------~ 218 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----EEVLEYL-------------K 218 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH-------------h
Confidence 1225688999999988889999999999999999998 7888865321 1111111 1
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L 609 (645)
.......+......+.+++.+|++.+|++|||+.++++.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 219 KGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111122233566788899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.81 Aligned_cols=238 Identities=28% Similarity=0.343 Sum_probs=191.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
+.|+..+.||+|+||.||+|....++..||+|.+... ....+++.+|++++++++||||+++.++|.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4578889999999999999999888999999987642 223457889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||++ |+|.+++..... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++..++.|..
T Consensus 95 e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 678777754332 38999999999999999999998 999999999999999999999998732
Q ss_pred -cccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 -TLTAGTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 -~~~~gt~~y~APE~~~---~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....++..|+|||++. .+.++.++||||||+++|||++|+.||........ +. .... ...
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~~----~~~~---------~~~ 231 (307)
T cd06607 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LY----HIAQ---------NDS 231 (307)
T ss_pred CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---HH----HHhc---------CCC
Confidence 2235788999999874 45688999999999999999999999875432110 00 0000 000
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
...........+.+++..||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 001122345678899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.76 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=200.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC-CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
++|...+.||+|+||.||+|....++..+++|.+.. .....+.+.+|+.++++++|||++++++.|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 578888999999999999999887888999998865 3334567899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++++|.+++.+.. +++.++..++.|++.||.|||+ .+++||||||+||+++.++..++.|..
T Consensus 99 ~~~~L~~~~~~~~-----l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999996532 7899999999999999999998 999999999999999999999997732
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....|+..|+|||.+....++.++||||||+++||+++|+.||...........+ .. ......
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~~--------~~~~~~ 235 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------AT--------NGTPEL 235 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------hc--------CCCCCC
Confidence 1235778899999998888999999999999999999999999754321111000 00 000001
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HcCCCCCCCCC
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI--LNNEAEPLVVP 619 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~--L~~~~~~~~~p 619 (645)
.........+.+++..||..+|++||++++++.. +....+...+|
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~ 282 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLT 282 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccccc
Confidence 1122334567889999999999999999999874 55555444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=287.49 Aligned_cols=239 Identities=27% Similarity=0.429 Sum_probs=194.1
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-------chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-------EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
+|+..+.||+|++|.||+|....++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4777899999999999999998889999999886522 124678999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-Ceeeeccc----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-NARLESSF---- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~-~~kl~d~~---- 496 (645)
|+||+++++|.+++.+.. .+++.....++.|++.||+|||+ .+++|+||||+||+++.++ ..++.|..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999997543 38899999999999999999999 9999999999999998775 47776621
Q ss_pred ------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 ------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 ------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....|+..|+|||.+.+..++.++||||+|++++||++|+.||........ ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~--------- 220 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALI--------- 220 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHH---------
Confidence 123567899999999888899999999999999999999999964322111 1110
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+..........+......+.+++..|++.+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111111122344455677888999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.86 Aligned_cols=241 Identities=26% Similarity=0.387 Sum_probs=190.5
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----c-------hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----E-------GKTEFLAELSIIACLRHKNLVQLLGWCAEKG 417 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 417 (645)
+|...+.||+|+||.||+|....++..+|+|.+.... . ..+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3566789999999999999998889999999875311 0 1245788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF- 496 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~- 496 (645)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++..++.|..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999997653 38999999999999999999998 899999999999999999999997722
Q ss_pred -------------cccccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc
Q 041096 497 -------------TLTAGTMGYLAPEYLQYGT--ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE 561 (645)
Q Consensus 497 -------------~~~~gt~~y~APE~~~~~~--~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~ 561 (645)
....|+..|+|||.+.... ++.++||||||+++||+++|..||....... .+. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~----~~~~~ 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA---AMF----KLGNK 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH---HHH----Hhhcc
Confidence 1124778899999987654 7999999999999999999999986432111 111 00000
Q ss_pred CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 562 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.. ...+...........+.+++..||+++|.+||++++|++.
T Consensus 228 -~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 -RS----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -cc----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00 0011111122335678888999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=295.83 Aligned_cols=241 Identities=19% Similarity=0.260 Sum_probs=196.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||++.....+..|++|.+.... .....+.+|+++++.++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999999889999999876532 23457889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc-----
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL----- 498 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~----- 498 (645)
||+++++|.+++.... .+++.....++.|++.||+|||+ .+++||||||+||+++.++.+++.|....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999997643 38999999999999999999999 99999999999999999999999773211
Q ss_pred ----------------------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH
Q 041096 499 ----------------------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW 556 (645)
Q Consensus 499 ----------------------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~ 556 (645)
..|+..|+|||.+....++.++||||||+++|||++|+.||.+.... .+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~~~~~-- 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELFGQ-- 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH--
Confidence 24677899999999888999999999999999999999999753221 11110
Q ss_pred hhhccCchhHHhhhhcc-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 557 GLYAEGRIIEAADKRLN-GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 557 ~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
....... ..........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 228 ----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 ----------VISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ----------HHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0000000 00111235567899999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=301.73 Aligned_cols=189 Identities=28% Similarity=0.374 Sum_probs=166.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..++||+|+||.||++....++..+|+|++.+. ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4688889999999999999999988999999988642 223445888999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|.+++.+... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|+.|..
T Consensus 81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999976432 38999999999999999999999 999999999999999999999998732
Q ss_pred ------cccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 041096 497 ------TLTAGTMGYLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERE 542 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~-----~~~~t~ksDV~SfGvvl~El~tG~~P~~~~ 542 (645)
....||+.|+|||++. .+.++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 1246899999999986 346889999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=300.00 Aligned_cols=189 Identities=28% Similarity=0.387 Sum_probs=166.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||++....++..+|+|.+.. .....+.+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999999998899999999864 2223456889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|.+++.+... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++..|+.|..
T Consensus 81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999975332 38899999999999999999999 999999999999999999999998722
Q ss_pred ------cccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 041096 497 ------TLTAGTMGYLAPEYLQY-----GTATEKTDVFSYGVVVLEVACGRRPIERE 542 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~-----~~~t~ksDV~SfGvvl~El~tG~~P~~~~ 542 (645)
....||+.|+|||++.. +.++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 11358999999999863 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=286.35 Aligned_cols=243 Identities=24% Similarity=0.307 Sum_probs=197.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|+..+.||+|+||+||+|....++..+++|++... ....+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688899999999999999999888899999998653 23557899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++..... ...+++.....++.|++.||+|||+ .+++||||||+||++++++..++.|..
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976432 1248999999999999999999998 999999999999999999999997621
Q ss_pred -------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 -------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....|+..|+|||.+... .++.++|||||||++|||++|+.||....... .+.+.... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~~----------~ 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTLQN----------D 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHhcC----------C
Confidence 122578899999998877 78999999999999999999999997543211 11111100 0
Q ss_pred hhhccCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 569 DKRLNGAF-NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 569 d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+.+.... .......+.+++..||+.+|++||+++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111111 1234567789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=287.19 Aligned_cols=238 Identities=21% Similarity=0.245 Sum_probs=196.0
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.|+..+.||+|.-|+||++.+..++...|+|++.+. .........|-+||+.+.||.+..|++.++.++..||+||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 345568899999999999999999999999999873 2334557789999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec----------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES---------- 494 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d---------- 494 (645)
||+||+|...++++.. ..++...+.-.+..|+-||+|||- .|||.|||||+||||.++|.+-+.|
T Consensus 158 yCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred cCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999876543 458999999999999999999999 9999999999999997776655543
Q ss_pred ----------------------------------------------------------cccccccCCcccCcccccCCCC
Q 041096 495 ----------------------------------------------------------SFTLTAGTMGYLAPEYLQYGTA 516 (645)
Q Consensus 495 ----------------------------------------------------------~~~~~~gt~~y~APE~~~~~~~ 516 (645)
.....+||..|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0011368999999999999999
Q ss_pred CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCC
Q 041096 517 TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDS 596 (645)
Q Consensus 517 t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP 596 (645)
+.++|+|+|||+||||+.|..||.+.+..+... .++.+.+.-.-..+....+.+|+...+.+||
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~----------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR----------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH----------------HHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 999999999999999999999998865543322 2333333222222456778889999999999
Q ss_pred CCCCC----HHHHHH
Q 041096 597 SARPS----MRRVFQ 607 (645)
Q Consensus 597 ~~RPt----~~~vl~ 607 (645)
++|.. +.||.+
T Consensus 377 ~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhccccchHHhhc
Confidence 99998 777765
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=285.44 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=199.1
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc---hhHhHHHHHHHHhhcCCCC-eeeeeeeeeeCC------e
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---GKTEFLAELSIIACLRHKN-LVQLLGWCAEKG------E 418 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~------~ 418 (645)
.|...++||+|.||+||+|....+|..||+|++....+ ......+|+.++++|+|+| ||+|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 45556779999999999999999999999999876433 3456789999999999999 999999998877 7
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec----
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES---- 494 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d---- 494 (645)
+++|+||+ .-+|..++.........++...+..++.|+++||+|||+ ++|+||||||+||||++++..|+.|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999 669999998765322347778899999999999999999 9999999999999999999999988
Q ss_pred --------cccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC---
Q 041096 495 --------SFTLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG--- 562 (645)
Q Consensus 495 --------~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~--- 562 (645)
..+..++|..|+|||++.+. .|+...||||+||++.||++++..|.+..+.+ ....+.......
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~----ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID----QLFRIFRLLGTPNEK 243 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH----HHHHHHHHcCCCCcc
Confidence 24456789999999999886 68999999999999999999998888765422 222222221111
Q ss_pred ---chhHHhhhhc--c-----CCCCHHHH---HHHHHHHHHccCCCCCCCCCHHHHHHH--HcCC
Q 041096 563 ---RIIEAADKRL--N-----GAFNEDEM---KRLLLVGLSCANPDSSARPSMRRVFQI--LNNE 612 (645)
Q Consensus 563 ---~~~~~~d~~l--~-----~~~~~~~~---~~l~~l~~~Cl~~dP~~RPt~~~vl~~--L~~~ 612 (645)
.+....+-.. . ..+..... ....+++.+|++.+|.+|.|++.++++ +...
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 0111111110 0 00111111 367888899999999999999999985 5544
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=287.13 Aligned_cols=237 Identities=26% Similarity=0.379 Sum_probs=193.1
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|...+.||+|+||.||+|....++..+|+|.+... ....+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 477789999999999999999988999999987653 23456788999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC-eeeeccc--------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN-ARLESSF-------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~-~kl~d~~-------- 496 (645)
+++++|.+++..... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++. .++++..
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999975432 347999999999999999999998 99999999999999998754 5776621
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....|+..|+|||+.....++.++||||||+++|||++|+.||...... ++.... ....+
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~---------~~~~~ 219 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-------QLVLKI---------CQGYF 219 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHH---------hcccC
Confidence 1235788899999998888999999999999999999999998653211 111111 11111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..........+.+++.+||+.+|++|||+.++++
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112233456888899999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=294.98 Aligned_cols=233 Identities=24% Similarity=0.305 Sum_probs=189.9
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
...||+|+||.||++....++..+|||.+... ....+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 45699999999999999888999999988653 33456788999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------ccc
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------TLT 499 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------~~~ 499 (645)
.+++... .+++.+...++.|++.||+|||+ .+++||||||+||+++.++..++.|.. ...
T Consensus 107 ~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 107 TDIVTHT-----RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence 9988542 28899999999999999999999 899999999999999999999998732 123
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHH
Q 041096 500 AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED 579 (645)
Q Consensus 500 ~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 579 (645)
.|+..|+|||.+....++.++||||||+++|||++|+.||....... .... +.....+.+.. ...
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~~---------~~~~~~~~~~~--~~~ 243 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ----AMRR---------IRDNLPPRVKD--SHK 243 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH---------HHhcCCCcccc--ccc
Confidence 57889999999988889999999999999999999999997532211 1110 00111111111 112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 580 EMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 580 ~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
....+..++..||..+|++|||++++++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 33457778899999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=285.88 Aligned_cols=236 Identities=28% Similarity=0.421 Sum_probs=193.0
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc---hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|...+.||+|+||.||+|....++..+++|.+..... ..+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 46778899999999999999988899999999876433 567899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++.... .+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.+++.|..
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999997643 37899999999999999999999 999999999999999999999997721
Q ss_pred -------cccccCCcccCcccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 -------TLTAGTMGYLAPEYLQYGT---ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~---~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....++..|+|||++.... .+.++||||||+++||+++|+.||....... ...... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~~~~---~------- 220 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIMFHV---G------- 220 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHHHHH---h-------
Confidence 1234678999999998766 8999999999999999999999997542111 010000 0
Q ss_pred HhhhhccCCCCHH--HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 567 AADKRLNGAFNED--EMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 567 ~~d~~l~~~~~~~--~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.......+.. ....+.+++..||+.+|.+||++++++.
T Consensus 221 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 221 ---AGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---cCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0001111221 2556778899999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=290.12 Aligned_cols=241 Identities=28% Similarity=0.369 Sum_probs=199.6
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
..+++|+..+.||+|++|.||+|.....+..+++|.+.......+.+.+|++++++++|+|++++++.+...+..++|+|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 34567888889999999999999998788999999987754456788999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++..++.|..
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999998754 249999999999999999999999 999999999999999999999997732
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ... ......
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~---~~~-------------~~~~~~ 233 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA---LFL-------------ITTKGI 233 (286)
T ss_pred hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-------------HHhcCC
Confidence 122467889999999988899999999999999999999999865322110 000 000001
Q ss_pred c-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 N-GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
. ..........+.+++.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 234 PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 0111224567888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.27 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=193.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 422 (645)
++|+..+.||+|+||.||+|....++..+++|.++... .....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999999889999999886532 2234577899999999999999999998877 789999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||++ ++|.+++..... .+++.....++.|++.||+|||+ .+++|+||||+||+++.++.+++.|..
T Consensus 85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99996 599998876433 48999999999999999999999 899999999999999999999998721
Q ss_pred ------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH-------Hhhhcc-
Q 041096 497 ------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV-------WGLYAE- 561 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~-------~~~~~~- 561 (645)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.... |..+..
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 223467889999998764 46899999999999999999999997643322111111110 000000
Q ss_pred -----CchhHHhhhhccCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 562 -----GRIIEAADKRLNGAFNED-EMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 562 -----~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..........+...++.. ....+.+++..||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000111111222222 3566788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=282.44 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=194.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcch---hHhHHHHHHHHhhcCCCCeeeeeeeeee--CCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG---KTEFLAELSIIACLRHKNLVQLLGWCAE--KGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 422 (645)
++|+..+.|++|.||.||+|+++.+++.||+|+++...+. .-.-++||.+|.+++|||||.+-.+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 3567788999999999999999999999999999874422 2356899999999999999999877654 3579999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec--------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES-------- 494 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d-------- 494 (645)
||||+ -+|...+....+ ++...+...++.|+++|++|||. +-|+|||||++|+|+...+..|+.|
T Consensus 156 Me~~E-hDLksl~d~m~q---~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMKQ---PFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHH-hhHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 99995 489999987653 48888999999999999999999 9999999999999999999999988
Q ss_pred ----cccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHH-------HHhhhccC
Q 041096 495 ----SFTLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDW-------VWGLYAEG 562 (645)
Q Consensus 495 ----~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~-------~~~~~~~~ 562 (645)
..+..+.|.+|+|||.+.+. .|++..|+||+|||+.|++++++.|.+..+.+....+... .|.-+..-
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 24445779999999999875 5899999999999999999999999876543322222211 11111111
Q ss_pred chhHHh------hhhccCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 563 RIIEAA------DKRLNGAFNED-EMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 563 ~~~~~~------d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.....+ -..++..+... ..+.-+++....+..||.+|-|++|.++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 111000 01111122111 2355667778889999999999999986
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=301.16 Aligned_cols=241 Identities=22% Similarity=0.262 Sum_probs=187.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|...+.||+|+||.||++....++..+|+|.+... ......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999999988999999988652 223445888999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|.+++..... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+|+.|..
T Consensus 81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999976432 38899999999999999999999 999999999999999999999998732
Q ss_pred ------cccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchh
Q 041096 497 ------TLTAGTMGYLAPEYLQY-----GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRII 565 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~-----~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 565 (645)
....||+.|+|||++.+ +.++.++|||||||+||||++|+.||........ .. .........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----~~---~i~~~~~~~ 227 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET----YG---KIMNHEERF 227 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH----HH---HHHcCCCcc
Confidence 12358999999999875 5678999999999999999999999975432111 10 000000000
Q ss_pred HHhhhhccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 041096 566 EAADKRLNGAFNEDEMKRLLLVGLSCANPDSSA--RPSMRRVFQ 607 (645)
Q Consensus 566 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~~vl~ 607 (645)
.+ .....+..+.+.+++..|+..++.+ |++++++++
T Consensus 228 -----~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 228 -----QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -----cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00 0111122455666777777755544 568888865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=288.20 Aligned_cols=252 Identities=19% Similarity=0.246 Sum_probs=191.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++++|...+.||+|+||.||+|....++..+++|++.... .....+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999998889999999986532 23346789999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+. ++|.+++..... .+.+.++..++.|+++||+|||+ .+++||||||+||+++.++..+++|..
T Consensus 83 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHPG---GLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 788777754332 37888899999999999999999 899999999999999999999998732
Q ss_pred -----cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC--------
Q 041096 497 -----TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG-------- 562 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~-------- 562 (645)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||...... .......+......
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV---FEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH---HHHHHHHHHHcCCCChhhhhhh
Confidence 123468889999998764 5789999999999999999999999754321 11111111111000
Q ss_pred ----chhHHhhhhc-cCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 563 ----RIIEAADKRL-NGAF-----NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 563 ----~~~~~~d~~l-~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+...... .... .......+.+++..|+..||++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 0000 0011356778889999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=286.26 Aligned_cols=243 Identities=26% Similarity=0.367 Sum_probs=197.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|+..+.||+|++|.||++....++..+++|++... ....+++.+|++++++++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 3567788999999999999999988999999988763 34456789999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc--------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT-------- 497 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~-------- 497 (645)
+++++|.+++.... ..++......++.|++.||+|||+ ..+++|+||||+||+++.++..++.|...
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999997653 248899999999999999999997 37999999999999999999999987321
Q ss_pred --ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 498 --LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 498 --~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
...++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...+.... ..... ...
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~---------~~~~~-~~~ 223 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD--GIFELLQY---------IVNEP-PPR 223 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc--cHHHHHHH---------HhcCC-CCC
Confidence 14578899999999999999999999999999999999999976432111 11111100 01110 111
Q ss_pred CCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 576 FNED-EMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 576 ~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+.. ....+.+++..||..+|++|||+.+++.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 2222 4566889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=288.32 Aligned_cols=253 Identities=20% Similarity=0.293 Sum_probs=193.7
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
+|+..+.||+|++|.||+|+...++..+|+|.+.... .....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5778899999999999999999889999999887632 23456788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
+ ++|.+++..... ...+++.++..++.|+++||+|||+ .+++||||||+||++++++..++.|..
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 D-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred C-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 7 489888865442 2348999999999999999999998 899999999999999999999997721
Q ss_pred --cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh-hhc
Q 041096 497 --TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD-KRL 572 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-~~l 572 (645)
....++..|++||.+.+ ..++.++|||||||++|||++|+.||...+..+....+.+.. ............+ +.+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM-GTPTESTWPGISQLPEY 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCChhhHHHHhcCchh
Confidence 22356888999998865 457899999999999999999999997654322211111110 0000000000000 000
Q ss_pred c-----------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 N-----------GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~-----------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
. ....+.....+.+++..|++.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0111223456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=284.22 Aligned_cols=241 Identities=25% Similarity=0.385 Sum_probs=200.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|+..+.||+|++|.||++....++..+++|++.... .....+.+|++.+.+++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999999889999999887643 3467899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++.... .+++..++.++.|+++||+|||+. .+++||||+|+||+++.++..++.|..
T Consensus 81 ~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999997653 389999999999999999999962 799999999999999999999997721
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....++..|+|||.+....++.++||||||+++|||++|+.||...... .......+.. ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~-------------~~~~ 220 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAIC-------------DGPP 220 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHh-------------cCCC
Confidence 1235778999999999989999999999999999999999999765321 1111221111 1111
Q ss_pred CCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 574 GAFNED-EMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 574 ~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
...+.. ....+.+++..||+++|++||++.++++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 123333 56788999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=302.97 Aligned_cols=228 Identities=26% Similarity=0.305 Sum_probs=179.7
Q ss_pred eccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhc---CCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACL---RHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 356 lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
||+|+||+||+|....++..+|+|++.... .....+..|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999889999999986521 2233455677777665 699999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|..++.... .+++..+..++.||++||+|||+ ++|+||||||+|||++.++..++.|..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 99999987543 38999999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 497 TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
....||..|+|||.+.+. .++.++|||||||++|||++|+.||....... +... ...+. ..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----~~~~----i~~~~------~~~~-- 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----MYRN----IAFGK------VRFP-- 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----HHHH----HHcCC------CCCC--
Confidence 123589999999998765 47999999999999999999999997643211 1110 00000 0111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHH
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARP----SMRRVFQ 607 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RP----t~~~vl~ 607 (645)
.......+.+++..||+.+|.+|| ++.++++
T Consensus 218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 011244567888999999999998 4666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=287.52 Aligned_cols=243 Identities=25% Similarity=0.395 Sum_probs=190.8
Q ss_pred CCcCceeccCCceEEEEEEECC---CCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC------
Q 041096 350 FHSNRILGRGAFGNVYKAYFAS---SGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG------ 417 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~---~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 417 (645)
|...++||+|+||.||+|.+.. ++..+|||++... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 4567889999999999998643 4688999988653 234567889999999999999999999886532
Q ss_pred eEEEEEecCCCCCHhHHhhhcCC--CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSE--NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
..++++||+++|+|..++..... ....+++...++++.|++.||+|||+ .+++||||||+||+++.++.+++.|.
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 24789999999999988754321 12247899999999999999999998 89999999999999999999999773
Q ss_pred cc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhc
Q 041096 496 FT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYA 560 (645)
Q Consensus 496 ~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~ 560 (645)
.. ...++..|++||.+....++.++||||||+++|||++ |+.||...... .+..+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~----~~~~~~~~--- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS----EIYNYLIK--- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH----HHHHHHHc---
Confidence 21 1123467999999998889999999999999999999 88888654321 11111110
Q ss_pred cCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 561 EGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 561 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.. ....+......+.+++.+||+.+|.+||++.++++.|+++
T Consensus 231 -~~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 -GN---------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -CC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0011223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=288.63 Aligned_cols=235 Identities=23% Similarity=0.311 Sum_probs=191.9
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
|...+.||+|++|.||++....++..+++|++.... ...+.+.+|+.+++.++|+||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444578999999999999998888999999876532 3355688999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
++|.+++... .+++..+..++.|++.||+|||+ .+++||||+|+||+++.++..++.|..
T Consensus 101 ~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 101 GALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred CCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence 9999998762 28999999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ....... ....+.+ ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~----~~~~~~~---------~~~~~~~--~~ 237 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL----QAMKRIR---------DNLPPKL--KN 237 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH----HHHHHHH---------hcCCCCC--cc
Confidence 1135788999999999888999999999999999999999998653221 1111000 0000111 01
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1124467899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=292.15 Aligned_cols=245 Identities=26% Similarity=0.328 Sum_probs=194.5
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
|...+.||+|+||.||+|....++..+|+|.+... ......+.+|++++++++|+|+++++++|.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 56678899999999999999888999999987642 22345688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------c
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------T 497 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------~ 497 (645)
++ |+|.+++..... .++|.++..++.|++.||.|||+ .+++||||+|+||+++.++..++.|.. .
T Consensus 107 ~~-g~l~~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (317)
T cd06635 107 CL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN 179 (317)
T ss_pred CC-CCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCcc
Confidence 96 588877764332 38999999999999999999999 999999999999999999999998732 2
Q ss_pred ccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 498 LTAGTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 498 ~~~gt~~y~APE~~~---~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
...|+..|+|||++. .+.++.++|||||||++|||++|+.||........ +.. ........
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~-------------~~~~~~~~ 243 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYH-------------IAQNESPT 243 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHH-------------HHhccCCC
Confidence 335788999999974 45689999999999999999999999865321111 111 11111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCC
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLV 617 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~ 617 (645)
.........+.+++.+||+.+|.+||++.++++.+--....+.
T Consensus 244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 1122345568889999999999999999999986554444443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=287.34 Aligned_cols=235 Identities=26% Similarity=0.392 Sum_probs=190.7
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcC---CCCeeeeeeeeeeCCeEEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLR---HKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 423 (645)
.|+..+.||+|+||.||+|....++..+++|.+... .....++.+|+.++++++ |+|++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778899999999999999888999999987653 334567889999999997 999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++++|.+++... .+++...+.++.|++.||.|||+ .+++|+||+|+||+++.++..++.|..
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998643 38999999999999999999998 999999999999999999999997721
Q ss_pred -----cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....|+..|+|||.+.++ .++.++||||||+++|||++|+.||....... ... ..... ..+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~~-~~~~~-----~~~ 220 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AMM-LIPKS-----KPP 220 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hhh-ccccC-----CCC
Confidence 123578889999988754 46899999999999999999999997542211 000 00000 001
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+.. ......+.+++..||+.+|++||++.++++
T Consensus 221 ~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 114456888999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=303.11 Aligned_cols=248 Identities=21% Similarity=0.220 Sum_probs=189.8
Q ss_pred cCCCcCceeccCCceEEEEEEECC--CCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS--SGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~--~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.+|...+.||+|+||.||++...+ .+..||+|.+... ....+|++++++++|+||+++++++......++||||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 468889999999999999997643 4578899987653 2456899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+. ++|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+||||+.++.+++.|..
T Consensus 168 ~~-~~l~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 168 YK-CDLFTYVDRSG----PLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred cC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 94 78988884332 38999999999999999999999 999999999999999999999998732
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc-------C--
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE-------G-- 562 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~-------~-- 562 (645)
....||..|+|||++....++.++|||||||++|||++|+.||...........+.... ..... .
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~-~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII-RCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH-HHhccCccccCCccc
Confidence 12358999999999999999999999999999999999999997654322111111111 10000 0
Q ss_pred -chhHHhh---hhccCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 563 -RIIEAAD---KRLNGAFN-------EDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 563 -~~~~~~d---~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.+.+.+. ...+..+. ......+.+++..|++.+|++|||+.+++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0001110 00111111 0123456778899999999999999999874
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.75 Aligned_cols=232 Identities=23% Similarity=0.293 Sum_probs=189.6
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccC-CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
...||+|+||.||++....++..+|+|.+.. .....+.+.+|+.++..++||||+++++.+..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 3469999999999999988899999999865 333456788999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------ccc
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------TLT 499 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------~~~ 499 (645)
..++... .+++.+++.++.|++.||+|||+ .+++||||||+||+++.++..++.|.. ...
T Consensus 106 ~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 106 TDIVSQT-----RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred HHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 9987542 28999999999999999999998 999999999999999999999998721 224
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHH
Q 041096 500 AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED 579 (645)
Q Consensus 500 ~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 579 (645)
.|+..|+|||++.+..++.++|||||||++|||++|+.||....... ........ . .+.. .....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~----~-----~~~~--~~~~~ 242 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----AMKRLRDS----P-----PPKL--KNAHK 242 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcc----C-----CCCc--cccCC
Confidence 57889999999998889999999999999999999999997533211 11111000 0 0000 11112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 580 EMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 580 ~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
....+.+++..||+.+|++||+++++++
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 3445778899999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=287.69 Aligned_cols=236 Identities=26% Similarity=0.315 Sum_probs=196.2
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
+|+..+.||+|+||.||+|....++..+|+|.+.... ...+.+.+|++++++++||||+++++.+.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5778899999999999999998889999999886532 345789999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++++|.+++.... .+++..+..++.|+++||.|||+ ++++|+||||+||++++++..++.|..
T Consensus 81 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999997652 38999999999999999999998 999999999999999999999997721
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....|+..|+|||.+....++.++||||||+++|||++|+.||...... ...+... .... ..
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~---------~~~~-~~ 218 (258)
T cd05578 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRA---------KQET-AD 218 (258)
T ss_pred ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHH---------Hhcc-cc
Confidence 2345788899999999888999999999999999999999999765431 1111111 1110 11
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSM--RRVF 606 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~~vl 606 (645)
...+...+..+.+++..||+.+|.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 23344455788899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=290.54 Aligned_cols=249 Identities=20% Similarity=0.245 Sum_probs=193.4
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|+..+.||+|+||.||+|....++..+++|++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 467788999999999999999888999999988753 23356799999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc----------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS---------- 495 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~---------- 495 (645)
+ +++|.+++.... ..+++.++..++.|+++||+|||+ .+++|+||||+||+++.++..++.|.
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987544 248999999999999999999999 99999999999999999999998762
Q ss_pred ---ccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch-------
Q 041096 496 ---FTLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI------- 564 (645)
Q Consensus 496 ---~~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~------- 564 (645)
.....|+..|+|||.+.+. .++.++||||+|++++||++|+.||....... ...++.........
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE----QLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH----HHHHHHHHcCCCChHHHhhcc
Confidence 1234578899999998654 46899999999999999999988776543211 11111111110000
Q ss_pred --hHH---hhhhcc----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 565 --IEA---ADKRLN----GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 565 --~~~---~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.+. ..+.-. .....+....+.+++.+|++.+|++||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 000000 00111234778899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=290.00 Aligned_cols=185 Identities=22% Similarity=0.306 Sum_probs=152.6
Q ss_pred CceeccCCceEEEEEEECC--CCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeee--CCeEEEEEecCCC
Q 041096 353 NRILGRGAFGNVYKAYFAS--SGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE--KGELLLVYEYMPN 428 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~--~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~ 428 (645)
.++||+|+||.||+|.... ++..+|+|.+.... ....+.+|++++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 4679999999999999753 56789999886533 23457899999999999999999998854 457899999995
Q ss_pred CCHhHHhhhcCC-----CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE----cCCCCeeeeccc---
Q 041096 429 GSLDRMLYQDSE-----NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML----DANFNARLESSF--- 496 (645)
Q Consensus 429 gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll----d~~~~~kl~d~~--- 496 (645)
++|.+++..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+|++|..
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 588888753321 12348899999999999999999999 999999999999999 455778887721
Q ss_pred ------------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 041096 497 ------------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERE 542 (645)
Q Consensus 497 ------------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~ 542 (645)
....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 12467889999999876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=283.21 Aligned_cols=240 Identities=24% Similarity=0.347 Sum_probs=199.9
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|+..+.||+|++|.||++....++..+++|.+... .....++.+|++++++++|+||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477788999999999999999888999999988652 33456788999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++.+.......+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++..++.|..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999997754434558999999999999999999998 999999999999999999999997721
Q ss_pred -cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 497 -TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 497 -~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
....++..|++||.+.+..++.++|+||||+++|||++|+.||...+.. .+.. .........
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~-------------~~~~~~~~~ 220 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----DLRY-------------KVQRGKYPP 220 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH-------------HHhcCCCCC
Confidence 1235788999999999989999999999999999999999999754321 1111 111111223
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.+......+.+++..|++.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 334556778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.55 Aligned_cols=252 Identities=22% Similarity=0.274 Sum_probs=191.0
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
|+..+.||+|++|.||+|....++..+|+|++.... .....+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999998889999999886532 23457889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
+++|.+++..... ..+++..++.++.|+++||+|||+ ++++||||+|+||+++.++..++.|..
T Consensus 81 -~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 -DLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred -CcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 4799999876542 248999999999999999999999 999999999999999999999998721
Q ss_pred --cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH-------Hhhhc-cCchh
Q 041096 497 --TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV-------WGLYA-EGRII 565 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~-------~~~~~-~~~~~ 565 (645)
....++..|+|||++.+. .++.++||||||+++|||++|+.||...........+.++. |.... .....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 122457889999988664 57899999999999999999999997643221111111110 00000 00000
Q ss_pred HHhhhh---ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 566 EAADKR---LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 566 ~~~d~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...... ............+.+++.+|++++|++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 000011122356788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=295.07 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=187.7
Q ss_pred ceeccC--CceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRG--AFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G--~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
..||+| +||+||++.+..++..||+|+..... ...+.+.+|+.+++.++||||++++++|..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 89999999998889999999986532 2346788999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-----------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT----------- 497 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~----------- 497 (645)
++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++..++.+...
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999876532 238899999999999999999998 9999999999999999998888865210
Q ss_pred --------ccccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh--------
Q 041096 498 --------LTAGTMGYLAPEYLQYG--TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY-------- 559 (645)
Q Consensus 498 --------~~~gt~~y~APE~~~~~--~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~-------- 559 (645)
...++..|+|||++.+. .++.++|||||||++|||++|+.||......... ........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML---LQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH---HHHhcCCCCCCccccc
Confidence 11235569999999764 4789999999999999999999999764321111 11000000
Q ss_pred ---------------cc---------CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 560 ---------------AE---------GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 560 ---------------~~---------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.. .......+..+...........+.+++..||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 0000011111222223345677899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=302.84 Aligned_cols=238 Identities=26% Similarity=0.437 Sum_probs=198.5
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccC-CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCHh
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLD 432 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 432 (645)
-+||+|.||+||-|++..+...+|||-+.. ..+..+-..+||.+.++|+|+|||+++|.|.+++.+-|.||-+|||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999999999999999998876 4455677899999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCccC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCeeeeccc------------c
Q 041096 433 RMLYQDSENGVLL--SWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA-NFNARLESSF------------T 497 (645)
Q Consensus 433 ~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~-~~~~kl~d~~------------~ 497 (645)
..|...-+. + .....-...+||++||.|||+ +.|||||||-+||||+. .|..||+|.. .
T Consensus 661 sLLrskWGP---lKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 661 SLLRSKWGP---LKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred HHHHhccCC---CccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 999876542 4 567777889999999999999 99999999999999964 5677887733 2
Q ss_pred ccccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 498 LTAGTMGYLAPEYLQYG--TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~~--~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
...||..|||||++..+ .|..++|||||||.+.||+||++||......... +.++-.-+....
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---------------MFkVGmyKvHP~ 799 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---------------MFKVGMYKVHPP 799 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---------------hhhhcceecCCC
Confidence 34699999999999865 4899999999999999999999999765432211 111112233456
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
.+++.......+++.|+.++|.+||+++++++ +|+..
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 77888888999999999999999999999987 55533
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=287.96 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=191.7
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeEEEEEe
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GELLLVYE 424 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 424 (645)
|+..+.||+|++|.||+|....++..+|+|++... ......+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 55678899999999999999988999999998764 23345788999999999999999999999988 78999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS--------- 495 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~--------- 495 (645)
|++ ++|.+++.... ..+++.+++.++.|+++||+|||+ .+++|+||||+||++++++.+++.|.
T Consensus 81 ~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 48998886543 248999999999999999999999 89999999999999999999999772
Q ss_pred ----ccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh-------hcc--
Q 041096 496 ----FTLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL-------YAE-- 561 (645)
Q Consensus 496 ----~~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~-------~~~-- 561 (645)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....... ...
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 122356778999998765 457999999999999999999999997654322111111110000 000
Q ss_pred ----CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 562 ----GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 562 ----~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..........+...+...+...+.+++..||+.+|.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000001111111113567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=288.29 Aligned_cols=235 Identities=23% Similarity=0.300 Sum_probs=194.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|...+.||+|+||.||++....++..+|+|.+... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4678889999999999999999888999999988652 233466889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++..++.|..
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999997653 38999999999999999999999 999999999999999999999997721
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....|++.|+|||.+.+...+.++||||||+++|||++|+.||...... .... ...... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~------------~~~~~~--~ 215 (290)
T cd05580 154 RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYE------------KILEGK--V 215 (290)
T ss_pred CCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHH------------HHhcCC--c
Confidence 2235788999999998888999999999999999999999999754311 1110 001111 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
..+......+.+++..||..+|.+|| +++++++
T Consensus 216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 22333456778899999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=280.71 Aligned_cols=239 Identities=29% Similarity=0.397 Sum_probs=199.0
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|+..+.||+|+||.||++....++..+++|++.... ...+.+.+|++++++++|+|++++.+.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999998889999999987632 4566789999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++.........+++..+..++.++++||.|||+ .+++|+||+|+||+++.++..++.|..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998764334559999999999999999999999 899999999999999999999997721
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....|++.|+|||......++.++||||+|++++||++|+.||...... .+... ......
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~-------------~~~~~~ 220 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL----ELALK-------------ILKGQY 220 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH----HHHHH-------------HhcCCC
Confidence 1235788899999999888999999999999999999999998654311 11110 001111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+......+.+++.+||..+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2223344567888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=289.77 Aligned_cols=255 Identities=20% Similarity=0.271 Sum_probs=190.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCe-----
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGE----- 418 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~----- 418 (645)
++|+..+.||+|+||.||+|....++..||+|...... .....+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999999889999999876532 23457889999999995 6999999999887665
Q ss_pred EEEEEecCCCCCHhHHhhhcCCC-CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCeeeeccc
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSEN-GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA-NFNARLESSF 496 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~-~~~~kl~d~~ 496 (645)
.|+||||+++ +|.+++...... ...+++..++.++.||+.||+|||+ .+++||||||+||+++. ++.+++.|..
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 898888654332 3458999999999999999999999 99999999999999998 8888997732
Q ss_pred c------------ccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC-
Q 041096 497 T------------LTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG- 562 (645)
Q Consensus 497 ~------------~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~- 562 (645)
. ...+++.|+|||++.+ ..++.++||||||+++|||++|..||...........+..... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG-TPTEQV 235 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC-CCChhh
Confidence 1 1245778999998865 4579999999999999999999999976433221111111100 00000
Q ss_pred --chhHHhh----hhcc----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 563 --RIIEAAD----KRLN----GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 563 --~~~~~~d----~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+..+ +... ....+.....+.+++..||+++|.+||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 0000 0001123456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=286.60 Aligned_cols=246 Identities=22% Similarity=0.248 Sum_probs=187.3
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeC--CeEEEEEe
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLR-HKNLVQLLGWCAEK--GELLLVYE 424 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 424 (645)
|+..+.||+|+||.||+|....++..+|+|+++.. ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 45678899999999999999888999999988763 223344567899999985 99999999999987 88999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|++ ++|.+++..... .++|.++..++.|++.||+|||+ .+++||||||+||+++. +..++.|..
T Consensus 81 ~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRKR---PLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 688888865432 48999999999999999999999 89999999999999999 899997721
Q ss_pred ---cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC--chhHHhhh
Q 041096 497 ---TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG--RIIEAADK 570 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~d~ 570 (645)
....++..|+|||.+.. +.++.++|||||||++|||++|..||...+..+. ..+........ ...+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ----IAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH----HHHHHHHcCCCCHHHHHhhcc
Confidence 22347888999997654 5578999999999999999999999976443221 11111111000 00000000
Q ss_pred hccC--C-----------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 571 RLNG--A-----------FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 571 ~l~~--~-----------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.-.. . ........+.+++..||+++|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000 0 01234578899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=287.70 Aligned_cols=185 Identities=21% Similarity=0.309 Sum_probs=151.9
Q ss_pred CceeccCCceEEEEEEECC--CCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeee--CCeEEEEEecCCC
Q 041096 353 NRILGRGAFGNVYKAYFAS--SGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE--KGELLLVYEYMPN 428 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~--~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~ 428 (645)
.++||+|+||.||+|...+ .+..+|+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 3579999999999999754 45789999886533 23467899999999999999999998854 457899999986
Q ss_pred CCHhHHhhhcC-----CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE----cCCCCeeeeccc---
Q 041096 429 GSLDRMLYQDS-----ENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML----DANFNARLESSF--- 496 (645)
Q Consensus 429 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll----d~~~~~kl~d~~--- 496 (645)
++|.+++.... .....+++..+..++.|++.||.|||+ .+++||||||+|||+ +.++..||+|..
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 57877775321 112348899999999999999999999 999999999999999 556778887721
Q ss_pred ------------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 041096 497 ------------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERE 542 (645)
Q Consensus 497 ------------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~ 542 (645)
....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 12357889999999876 45799999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=317.40 Aligned_cols=246 Identities=27% Similarity=0.424 Sum_probs=204.1
Q ss_pred cCCCcCceeccCCceEEEEEEECC-------CCeEEEEEeccC--CcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS-------SGSVAAVKRSKH--SHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKG 417 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~-------~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 417 (645)
++....+.||+|.||.|++|.... ....||||.++. .....+.+..|+++|+.+ +|+||+.++|+|..++
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 344556689999999999998642 146799999887 334577899999999999 5999999999999999
Q ss_pred eEEEEEecCCCCCHhHHhhhcC---C---C----C--ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDS---E---N----G--VLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~---~---~----~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld 485 (645)
..++|.||+..|+|.++|+..+ . . . ..++..+.+.++.|||.||+||++ .+++||||.++||||.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEec
Confidence 9999999999999999998876 0 0 1 238999999999999999999999 9999999999999999
Q ss_pred CCCCeeeeccccc-------------ccc--CCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchh
Q 041096 486 ANFNARLESSFTL-------------TAG--TMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMV 549 (645)
Q Consensus 486 ~~~~~kl~d~~~~-------------~~g--t~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~ 549 (645)
.+..+||.|..-. ..| ...|||||.+....|+.|||||||||+||||++ |..||.+.... .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~---~ 529 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT---E 529 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH---H
Confidence 9999999882211 111 345999999999999999999999999999999 89999763211 1
Q ss_pred hHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 550 NLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 550 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
++.+.+.+.-+...+..+...++++|+.||+.+|++||++.++++.|+..
T Consensus 530 -------------~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 -------------ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 12223344445566778889999999999999999999999999999874
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=282.90 Aligned_cols=231 Identities=23% Similarity=0.285 Sum_probs=190.7
Q ss_pred eccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 356 lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
||.|++|.||+++...++..+++|.+.... ...+.+.+|+.++++++|+||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999998889999999886522 3456799999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------cccc
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-----------TLTA 500 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-----------~~~~ 500 (645)
.+++.+... +++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+++.|.. ....
T Consensus 81 ~~~l~~~~~----l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~ 153 (262)
T cd05572 81 WTILRDRGL----FDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC 153 (262)
T ss_pred HHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccccc
Confidence 999976432 8999999999999999999999 999999999999999999999997721 1235
Q ss_pred cCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHH
Q 041096 501 GTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDE 580 (645)
Q Consensus 501 gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 580 (645)
|+..|++||.+....++.++|+||||+++|||++|..||....... .... ....+......++...
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~------------~~~~~~~~~~~~~~~~ 219 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIY------------NDILKGNGKLEFPNYI 219 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHH------------HHHhccCCCCCCCccc
Confidence 7889999999988889999999999999999999999997643211 1111 1111111122334444
Q ss_pred HHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 041096 581 MKRLLLVGLSCANPDSSARPS-----MRRVFQ 607 (645)
Q Consensus 581 ~~~l~~l~~~Cl~~dP~~RPt-----~~~vl~ 607 (645)
...+.+++..||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 678899999999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=278.60 Aligned_cols=237 Identities=26% Similarity=0.385 Sum_probs=198.9
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeEEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GELLLVY 423 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 423 (645)
+|+..+.||+|++|.||+|....++..+++|.+.... ...+.+.+|++++++++|+||+++++++... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999999889999999887644 4567899999999999999999999999988 8899999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-------- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-------- 495 (645)
||+++++|.+++.... .+++.++..++.|+++||+|||+ .+++|+||+|+||+++.++..++.|.
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999997654 38999999999999999999999 99999999999999999999999772
Q ss_pred ------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 496 ------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 496 ------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
.....++..|+|||.+.....+.++||||||++++||++|+.||..... .....+. ...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~---------~~~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALYK---------IGS 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHh---------ccc
Confidence 2234578899999999988899999999999999999999999976431 1111111 111
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.......+......+.+++.+|+..+|.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122334445678899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=276.44 Aligned_cols=235 Identities=26% Similarity=0.395 Sum_probs=195.5
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc-hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE-GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
|+..+.||+|++|.||++....++..+++|+...... ..+.+.+|++++++++|+|++++++++...+..++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 6677899999999999999988899999999877443 567899999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-----------cc
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-----------FT 497 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-----------~~ 497 (645)
++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++..++.|. ..
T Consensus 82 ~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 155 (253)
T cd05122 82 GSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155 (253)
T ss_pred CcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence 99999987653 238999999999999999999998 99999999999999999999999772 13
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC
Q 041096 498 LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 577 (645)
...++..|+|||.+....++.++||||||++++||++|+.||...+.... .... .........
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~-------------~~~~~~~~~ 218 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA----LFKI-------------ATNGPPGLR 218 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH----HHHH-------------HhcCCCCcC
Confidence 34578889999999988899999999999999999999999875432110 0000 001111111
Q ss_pred HH--HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 578 ED--EMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 578 ~~--~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.. ....+.+++..||+.+|++|||+.++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 2567888999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.93 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=200.5
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-C-----CCeeeeeeeeeeCCeEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-H-----KNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~lV 422 (645)
+|.+.+.||+|.||.|-+|.+..+++.||||+++....-..+-..|+.+|..|+ | -|+|++++++..++++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 788899999999999999999999999999999987777778889999999997 5 4999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC--CCeeeecccc---
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN--FNARLESSFT--- 497 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~--~~~kl~d~~~--- 497 (645)
+|.+ ..+|+++|+.+...+ ++......|+.||+.||.+||+ .+|||+||||+||||.+- ..+|+.|...
T Consensus 267 fELL-~~NLYellK~n~f~G--lsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKFRG--LSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhh-hhhHHHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999 679999999877554 8999999999999999999998 999999999999999654 3567777332
Q ss_pred ------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh------------
Q 041096 498 ------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY------------ 559 (645)
Q Consensus 498 ------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~------------ 559 (645)
..+.+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.++.+....+++ +.+..
T Consensus 341 ~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e-~lG~Pp~~mL~~~~~~~ 419 (586)
T KOG0667|consen 341 ESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE-VLGLPPPKMLDTAKKAH 419 (586)
T ss_pred cCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH-HhCCCCHHHHHhccccc
Confidence 23467789999999999999999999999999999999888877654333322222 11111
Q ss_pred ---cc-Cc------hhH--------H--------hhhhccC--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 041096 560 ---AE-GR------IIE--------A--------ADKRLNG--------AFNEDEMKRLLLVGLSCANPDSSARPSMRRV 605 (645)
Q Consensus 560 ---~~-~~------~~~--------~--------~d~~l~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~v 605 (645)
.. .. ..+ . .+..... ......-..+.++++.|+..||.+|+|..+.
T Consensus 420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qa 499 (586)
T KOG0667|consen 420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQA 499 (586)
T ss_pred eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHH
Confidence 00 00 000 0 0110000 0111334567899999999999999999999
Q ss_pred HH
Q 041096 606 FQ 607 (645)
Q Consensus 606 l~ 607 (645)
++
T Consensus 500 l~ 501 (586)
T KOG0667|consen 500 LN 501 (586)
T ss_pred hc
Confidence 87
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=300.02 Aligned_cols=235 Identities=27% Similarity=0.355 Sum_probs=195.8
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc----hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE----GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
|...+.||.|+||.||-+.+..+.++||||++.-+.. .-+++++|+..|++++|||++.+-||+......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 5556779999999999999999999999999876432 235689999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------c
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------T 497 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------~ 497 (645)
| -||-.++|.-..+ ++....+..|..|.+.||+|||+ .+.||||||+.||||.+.+.+|++|.. .
T Consensus 108 C-lGSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred H-hccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 9 5677777765544 48889999999999999999999 999999999999999999999998844 3
Q ss_pred ccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 498 LTAGTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 498 ~~~gt~~y~APE~~~---~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
..+||+.|||||++. .+.|+-|+||||+||...||+..++|+...+.-.....+ .+.--|.|
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-------------AQNesPtL-- 245 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------AQNESPTL-- 245 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-------------HhcCCCCC--
Confidence 358999999999885 578999999999999999999999998775421111111 01111222
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+....+..++..|++.-|.+|||.++++.
T Consensus 246 -qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 -QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 24567888999999999999999999988876
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=283.77 Aligned_cols=237 Identities=27% Similarity=0.351 Sum_probs=201.5
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 429 (645)
|++..+||+|+||.||++.++.+|.++|||...- +.+.+++.+|+.+|++.+.|++|+++|.+.....+|+|||||--|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 5667889999999999999999999999998764 446788999999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec------------ccc
Q 041096 430 SLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES------------SFT 497 (645)
Q Consensus 430 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d------------~~~ 497 (645)
+..+.++.+++ +|....+..++...++||+|||. ..-+|||||+.||||+.++.+|+.| ...
T Consensus 114 SiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 114 SISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred cHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 99999987654 49999999999999999999998 8889999999999999999999977 234
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC
Q 041096 498 LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 577 (645)
...||+-|||||++..-.|+.++||||+|+...||..|++||.....-.....+. . ..-+.. .-+
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-------T------~PPPTF--~KP 252 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-------T------KPPPTF--KKP 252 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-------C------CCCCCC--CCh
Confidence 4679999999999999999999999999999999999999997643211110000 0 000111 234
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 578 EDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 578 ~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
+.....+.+++..|+-..|++|-|+.++++.
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 5667788999999999999999999998873
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=287.46 Aligned_cols=255 Identities=18% Similarity=0.245 Sum_probs=189.9
Q ss_pred CCCcCceeccCCceEEEEEEECC--CCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFAS--SGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GELL 420 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~--~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 420 (645)
+|+..+.||+|+||.||+|.... .+..+|+|.+.... ...+.+.+|+.++.+++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47778899999999999999987 78999999887632 2345678899999999999999999999988 7899
Q ss_pred EEEecCCCCCHhHHhhhcCCCC-ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC----CCCeeeecc
Q 041096 421 LVYEYMPNGSLDRMLYQDSENG-VLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA----NFNARLESS 495 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~----~~~~kl~d~ 495 (645)
+||||+++ +|.+++....... ..++......++.|++.||+|||+ .+++||||||+||+++. ++..|+.|.
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 7777765433222 258899999999999999999999 99999999999999999 888999772
Q ss_pred c---------------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccch-----hhHHHH
Q 041096 496 F---------------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKM-----VNLVDW 554 (645)
Q Consensus 496 ~---------------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~-----~~l~~~ 554 (645)
. ....++..|+|||.+.+. .++.++|||||||+++||++|+.||......... ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 2 112467889999988764 5799999999999999999999999765432200 000000
Q ss_pred HHhhhcc------------CchhHHhhhhccCCCC----H-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 555 VWGLYAE------------GRIIEAADKRLNGAFN----E-------DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 555 ~~~~~~~------------~~~~~~~d~~l~~~~~----~-------~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+...... .......+......++ . .....+.+++..|++.+|++|||+.++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1010000 0000100011111111 0 22346888999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=295.25 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=193.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-----CeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEK-----GEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 419 (645)
+++|...++||+|+||.||+|....++..||+|.+.. .......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4689999999999999999999988899999998864 223455688999999999999999999987654 358
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
++|+||+. ++|..++... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++..++.|..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECccccee
Confidence 99999996 5888877543 38999999999999999999999 999999999999999999999997721
Q ss_pred ------------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC-
Q 041096 497 ------------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG- 562 (645)
Q Consensus 497 ------------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~- 562 (645)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~----~~~~~~~~~~~~~ 230 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH----QLNLILGVLGTPS 230 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHcCCCC
Confidence 11357888999998754 568999999999999999999999996543211 111111111110
Q ss_pred --chhHHhhhh-------cc--CCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HcCCCCC
Q 041096 563 --RIIEAADKR-------LN--GAF-----NEDEMKRLLLVGLSCANPDSSARPSMRRVFQI--LNNEAEP 615 (645)
Q Consensus 563 --~~~~~~d~~-------l~--~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~--L~~~~~~ 615 (645)
......+.. +. ... .......+.+++..||+.+|++|||+.++++. ++.....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 011000000 00 000 01124568899999999999999999999985 6655433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=284.00 Aligned_cols=232 Identities=25% Similarity=0.307 Sum_probs=182.7
Q ss_pred eeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHh---hcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIA---CLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 355 ~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~---~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
+||+|+||.||++....++..+|+|.+.... .....+.+|..++. ..+|+|++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999998889999999876522 22233455554443 3479999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------- 497 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------- 497 (645)
+++|.+++.... .+++.+...++.|++.||+|||+ .+++||||||+|||++.++..++.|...
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 153 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCcc
Confidence 999999987543 38999999999999999999999 9999999999999999999999977321
Q ss_pred ccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 498 LTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
...|+..|+|||.+.. ..++.++|||||||+++||++|+.||........ ..+.. .........
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~--------------~~~~~~~~~ 218 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR--------------MTLTVNVEL 218 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHH--------------HhhcCCcCC
Confidence 2358999999999864 5689999999999999999999999975432111 11100 001111223
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQI 608 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~~ 608 (645)
+......+.+++..|++.+|++|| +++++++.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 344556788888999999999999 59999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.24 Aligned_cols=254 Identities=19% Similarity=0.246 Sum_probs=189.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..+.||+|++|.||+|....++..+|+|.+.... .....+.+|++++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999998889999999886532 234578899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCeeeeccc-------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA-NFNARLESSF------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~-~~~~kl~d~~------- 496 (645)
|++ ++|.+++..... ..+++.....++.||+.||+|||+ ++++||||||+||+++. +...|+.|..
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 688888754332 236788888999999999999998 99999999999999985 4557886621
Q ss_pred -----cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh----hcc-Cchh
Q 041096 497 -----TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL----YAE-GRII 565 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~----~~~-~~~~ 565 (645)
....++..|+|||++.+. .++.++|||||||++|||++|+.||......+............ +.. ..+.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 123467889999988764 57899999999999999999999997643322111111110000 000 0000
Q ss_pred HHh--hhhccCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 566 EAA--DKRLNGA----FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 566 ~~~--d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+.. .+..... ........+.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0000000 01122355788999999999999999999986
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=277.88 Aligned_cols=268 Identities=24% Similarity=0.320 Sum_probs=203.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeeeee-----CCe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWCAE-----KGE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~ 418 (645)
...|...+.||+|+||.|+.+....+|+.||||++.. .....+.-.+|+++|+.++|+||+.+.+.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3445556789999999999999999999999999874 34456778899999999999999999998765 247
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS--- 495 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~--- 495 (645)
.|+|+|+| ..+|...++.+.. |+..+...++.|+++||.|+|+ .+++||||||+|+|++.+...||.|.
T Consensus 101 vYiV~elM-etDL~~iik~~~~----L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQD----LTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCcc----ccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccce
Confidence 89999999 7799999976543 8899999999999999999999 99999999999999999999998772
Q ss_pred -----------ccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc
Q 041096 496 -----------FTLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR 563 (645)
Q Consensus 496 -----------~~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 563 (645)
.+..+.|.+|+|||++.. ..||.+.||||.||++.||++|+..|.+.+.-+.. .++..+.+...+..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql-~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL-QLILELLGTPSEED 251 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH-HHHHHhcCCCCHHH
Confidence 244567899999998864 67999999999999999999999999876532222 22222222221111
Q ss_pred --------hhHHhhhhc---cCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCCCCCCCCC
Q 041096 564 --------IIEAADKRL---NGAF---NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPLVVPKLKP 623 (645)
Q Consensus 564 --------~~~~~d~~l---~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~~~p~~~~ 623 (645)
....+...- +..+ -++.-...+++...++..||.+|+|++|.++ +|....++..-|...+
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~ 327 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQP 327 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCC
Confidence 111111000 0000 0123345678888999999999999999987 5666555554443333
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=292.05 Aligned_cols=252 Identities=21% Similarity=0.234 Sum_probs=191.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC------
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK------ 416 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 416 (645)
..++|+..+.||+|+||.||+|....++..+|+|++... ......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999999988999999988652 23345678899999999999999999987643
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF 496 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~ 496 (645)
...++||||+. ++|.+.+... ++..++..++.|++.||+|||+ .+++||||||+||+++.++..++.|..
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 5888887532 7888999999999999999999 999999999999999999999997721
Q ss_pred -----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH---------
Q 041096 497 -----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW--------- 556 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~--------- 556 (645)
....++..|+|||.+.+..++.++|||||||++|||++|+.||...+.......+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 164 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred cceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 123478889999999999999999999999999999999999975432111111110000
Q ss_pred -----h-hhcc------CchhHHhhhhcc----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 557 -----G-LYAE------GRIIEAADKRLN----GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 557 -----~-~~~~------~~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
. .... ....+.....+. ..........+.+++..|++.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0000 000001000000 0001123556789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=278.47 Aligned_cols=236 Identities=25% Similarity=0.357 Sum_probs=191.9
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC------cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS------HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GEL 419 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 419 (645)
.+|+..++||+|+||.||+|....++..+++|.+... ......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999999888999999986431 22345788999999999999999999998764 468
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
++++||+++++|.+++.... .+++.....++.|++.||.|||+ .+++|+||||+||+++.++..++.|..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 99999999999999987543 27899999999999999999998 999999999999999999999987721
Q ss_pred ------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 ------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 ------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....|+..|+|||.+.+..++.++|||||||+++||++|+.||...... .. +
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~-------------~ 218 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AA-------------I 218 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HH-------------H
Confidence 1234788999999999888999999999999999999999999753211 11 1
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+..........+....+.+.+++..||+ +|.+||+..+++.
T Consensus 219 ~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 219 FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111112233455556778888999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=281.29 Aligned_cols=233 Identities=25% Similarity=0.329 Sum_probs=187.6
Q ss_pred eccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 356 lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
||+|+||+||++....++..+|+|.+... ....+.+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999888999999987642 22345678899999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------cccc
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-----------TLTA 500 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-----------~~~~ 500 (645)
.+++..... ..+++.++..++.|++.||.|||+ .+++||||+|+||+++.++..+++|.. ....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA 155 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence 999976542 248999999999999999999999 999999999999999999999997732 1235
Q ss_pred cCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHH
Q 041096 501 GTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDE 580 (645)
Q Consensus 501 gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 580 (645)
++..|+|||.+.++.++.++||||||++++||++|+.||...........+.. ... ......+...
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------~~~-~~~~~~~~~~ 221 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR-------------RTL-EMAVEYPDKF 221 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh-------------ccc-cccccCCccC
Confidence 67889999999888899999999999999999999999976432111111100 000 0011223334
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 581 MKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 581 ~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
...+.+++..||+.+|.+|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 56778899999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=281.79 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=190.9
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc--hhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEEEecC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE--GKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
|...+.||+|++|.||+|....++..++||++..... ......+|+..+.+++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 4567889999999999999988899999998876432 3334567999999999 999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
+|+|.+++.... +..+++.++..++.|++++|.|||+ .+++|+||+|+||+++.++..++.|..
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999987654 2348999999999999999999999 999999999999999999999998721
Q ss_pred -cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH---------HhhhccCchh
Q 041096 497 -TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV---------WGLYAEGRII 565 (645)
Q Consensus 497 -~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~---------~~~~~~~~~~ 565 (645)
....++..|+|||.+.. ..++.++||||||+++|||++|+.||................ ..........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 22357888999998754 557999999999999999999999997643322211111110 0000000000
Q ss_pred HHhhhhcc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 566 EAADKRLN---GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 566 ~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..+..... ..........+.+++..||+.+|++|||++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 0001112466889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=275.51 Aligned_cols=235 Identities=27% Similarity=0.429 Sum_probs=195.8
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|+..+.||+|++|.||++.....+..+++|.+.... .....+.+|++++++++|+|++++++++.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999998888999999987743 3566899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++..++.|..
T Consensus 81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999997653 38999999999999999999998 999999999999999999999998721
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....++..|+|||......++.++||||+|+++|||++|+.||...... .... ... ....
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~~~~----~~~----------~~~~ 216 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---AALF----RIV----------QDDH 216 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---HHHH----HHh----------ccCC
Confidence 1235788899999998888899999999999999999999998754311 0110 000 0111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+......+..++.+|++.+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1233344567888999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.80 Aligned_cols=254 Identities=24% Similarity=0.264 Sum_probs=190.9
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC----
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG---- 417 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 417 (645)
.+.++|+..+.||+|+||.||+|....++..||+|.++.. ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3557889999999999999999999988999999988653 223456788999999999999999999987654
Q ss_pred ------eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCee
Q 041096 418 ------ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491 (645)
Q Consensus 418 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~k 491 (645)
..++|+||+++ +|...+.... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence 78999999975 7777776542 238999999999999999999999 9999999999999999999999
Q ss_pred eecccc-------------ccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh
Q 041096 492 LESSFT-------------LTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG 557 (645)
Q Consensus 492 l~d~~~-------------~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~ 557 (645)
+.|... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 977221 1234678999998865 45789999999999999999999999754322211111111100
Q ss_pred hhccCchhHH--------hhh------hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 558 LYAEGRIIEA--------ADK------RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 558 ~~~~~~~~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
. ......+. .++ ..... ....+..+.+++..||+.+|.+||+++++++
T Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 P-CPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred C-Chhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00000000 000 00000 0112467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=291.18 Aligned_cols=240 Identities=26% Similarity=0.329 Sum_probs=200.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 421 (645)
...|...+.||+|.||.||+++.+.+|..+|+|.+.+.. .......+|+.+|+++. |||||.+.+.+++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 356777889999999999999999999999999987632 24568999999999998 9999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC----CCeeeec---
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN----FNARLES--- 494 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~----~~~kl~d--- 494 (645)
|||++.+|.|.+.+... .++..+...++.|++.+++|||+ .+++||||||+|+|+... +..++.|
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999876 18999999999999999999999 999999999999999654 3567766
Q ss_pred --------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 495 --------SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 495 --------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
.....+||+.|+|||++....|+.++||||.||++|.|++|..||...........+.. ++
T Consensus 186 a~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~--------~~--- 254 (382)
T KOG0032|consen 186 AKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR--------GD--- 254 (382)
T ss_pred ceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc--------CC---
Confidence 23446899999999999999999999999999999999999999987654322221111 00
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.......-......+.+++..|+..||.+|+|+.++++.
T Consensus 255 ---~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 ---FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 011122223346677788899999999999999999984
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=285.22 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=187.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC------
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKG------ 417 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 417 (645)
.++|+..+.||+|+||.||+|....++..+|||.+.... .....+.+|++++++++||||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357888999999999999999999889999999876422 22345678999999999999999999987643
Q ss_pred --eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 418 --ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 418 --~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
..++||||+. ++|.+++..... .+++.+.+.++.|++.||+|||+ .+++|+||||+||+++.++.+++.|.
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNV---KFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcC
Confidence 4599999995 588888865432 38999999999999999999999 89999999999999999999999772
Q ss_pred c----------------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh
Q 041096 496 F----------------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 496 ~----------------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
. ....++..|+|||.+.+. .++.++||||||+++|||++|+.||...... .....+......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~~~~~~ 242 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLISQLCGS 242 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence 1 112457789999988664 4788999999999999999999998764321 111122221111
Q ss_pred hcc-----CchhH-------------HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 559 YAE-----GRIIE-------------AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 559 ~~~-----~~~~~-------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
... ....+ .....+... .....+.+++..||+.+|++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 00000 011111100 01245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=285.10 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=189.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 421 (645)
.++|+..+.||+|+||.||+|....++..||+|.+.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999999889999999886432 1233567899999999999999999998754 56899
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||||+. ++|.+++.... ..+++.++..++.|+++||+|||+ .+++||||||+||+++.++..++.|..
T Consensus 86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 58988887543 248999999999999999999999 999999999999999999999997721
Q ss_pred -------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH-------Hhhhcc
Q 041096 497 -------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV-------WGLYAE 561 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~-------~~~~~~ 561 (645)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+.+.. |.....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 11234677999999875 457999999999999999999999997644322211111110 000000
Q ss_pred CchhHHhh---hhccCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 562 GRIIEAAD---KRLNGAF---NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 562 ~~~~~~~d---~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
........ ... ... .......+.+++..|++.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 239 LPLVGKFTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccccCCCC-CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 000 000 0012445678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=280.06 Aligned_cols=230 Identities=27% Similarity=0.380 Sum_probs=189.9
Q ss_pred eccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 356 lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
||+|+||.||+++...++..+++|.+.... ...+.+.+|++++++++|+||+++++.+..++..|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999999889999999886532 3456789999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------------
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------------- 496 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------------- 496 (645)
.+++.+.. .+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++..++.|..
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997644 38999999999999999999998 999999999999999999999997721
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....++..|+|||.......+.++||||||+++|||++|+.||....... .... .....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~------------~~~~~ 217 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----IFQN------------ILNGK 217 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHH------------HhcCC
Confidence 12246778999999988889999999999999999999999997543211 1110 00001
Q ss_pred ccCCCCHHH--HHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 572 LNGAFNEDE--MKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 572 l~~~~~~~~--~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
. ..+... ...+.+++..||+.+|.+|||+..+.+.|+
T Consensus 218 ~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 218 I--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred c--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1 112222 567889999999999999999977776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=284.31 Aligned_cols=244 Identities=27% Similarity=0.372 Sum_probs=187.5
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEEEec
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+|...+.||+|+||.||++....++..+|+|.+... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 344567899999999999999988999999988653 234567899999999996 99999999999999999999999
Q ss_pred CCCCCHhHHhhhc-CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 426 MPNGSLDRMLYQD-SENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
+. ++|.++.... ......+++.....++.|++.||+|||+ ..+++||||||+||+++.++..++.|..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 4555433211 1112348999999999999999999997 2589999999999999999999997731
Q ss_pred ---cccccCCcccCcccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 ---TLTAGTMGYLAPEYLQYG---TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~---~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....|+..|+|||.+... .++.++|||||||++|||++|+.||..... .......... ...+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~------~~~~ 229 (288)
T cd06616 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS------VFDQLTQVVK------GDPP 229 (288)
T ss_pred CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch------HHHHHhhhcC------CCCC
Confidence 123578899999998876 689999999999999999999999965321 1111100000 0011
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+...........+.+++..||+.+|++|||+++|++
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1212222234567889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=273.66 Aligned_cols=240 Identities=21% Similarity=0.280 Sum_probs=191.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
+++|+..+.||+|.|+.||++....+|+.+|+|++.. +..+.++..+|+++.+.|+|||||+|.....+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4567778899999999999999999999999997754 4446778999999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC---CCeeeec------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN---FNARLES------ 494 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~---~~~kl~d------ 494 (645)
|+|.+++|..-+-.+ ...+....-..+.||+++|.|+|. ++|+|||+||.|++|.+. -..|+++
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999997766554 237788888999999999999999 999999999999999543 2345544
Q ss_pred -----cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 495 -----SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 495 -----~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
.....+||++|||||++...+|+..+|||+.||+||-|+.|+.||.+.+.......+... +
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g--------------~ 228 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG--------------A 228 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------c
Confidence 123357999999999999999999999999999999999999999875432222111110 0
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
-...+..-....+...+|+..|+..||++|.|+.|.+.
T Consensus 229 yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 229 YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 00111111123455667788999999999999887753
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=289.90 Aligned_cols=264 Identities=21% Similarity=0.264 Sum_probs=197.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-----Ce
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK-----GE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 418 (645)
.++|...+.||+|+||.||+|....++..||||.+... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788899999999999999999888999999987652 33345678899999999999999999988654 35
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-- 496 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-- 496 (645)
.++|+||+. ++|.+++.... .+++.....++.|++.||.|||+ .+++||||||+||+++.++..|+.|..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 899999995 78998886543 38999999999999999999999 999999999999999999999997722
Q ss_pred ----------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH-------Hhh
Q 041096 497 ----------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV-------WGL 558 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~-------~~~ 558 (645)
....++..|+|||.+.. ..++.++|||||||++|||++|+.||...+.......+.+.. +..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 12357788999998865 468999999999999999999999997543211111111100 000
Q ss_pred hccCchhHHhhhhccC------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HcCCCCCCCC
Q 041096 559 YAEGRIIEAADKRLNG------AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI--LNNEAEPLVV 618 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~--L~~~~~~~~~ 618 (645)
.......+.++..... ....+....+.+++.+||+.+|++|||++++++. ++........
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 0111111111100000 0111235667899999999999999999999985 6655444433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=278.43 Aligned_cols=236 Identities=25% Similarity=0.257 Sum_probs=185.2
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHH-hhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSII-ACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
+.||+|+||.||+|....++..+|+|.+.... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999998889999999886532 1223344555444 445899999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------cccc
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------TLTA 500 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------~~~~ 500 (645)
++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+++.|.. ....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 154 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV 154 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccccccCC
Confidence 99999997543 38899999999999999999999 999999999999999999999997732 2335
Q ss_pred cCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHH
Q 041096 501 GTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDE 580 (645)
Q Consensus 501 gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 580 (645)
|+..|+|||.+.+..++.++||||||+++|||++|..||....... ... ....+. ...........
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~----~~~~~~------~~~~~~~~~~~ 220 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA----VFD----NILSRR------INWPEEVKEFC 220 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHH----HHHhcc------cCCCCcccccC
Confidence 7889999999988889999999999999999999999997543211 110 000000 00011112234
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 581 MKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 581 ~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
...+.+++..||+.+|++||++.++.+.|.
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 567889999999999999998877766554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=287.18 Aligned_cols=263 Identities=18% Similarity=0.242 Sum_probs=193.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC------C
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK------G 417 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 417 (645)
.++|...+.||+|+||.||+|....++..+|+|++... ......+.+|+.++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37899999999999999999999888999999988652 22345688999999999999999999998654 3
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF- 496 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~- 496 (645)
..++|+||+. .+|..++. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 5699999995 47776652 128899999999999999999999 899999999999999999999998732
Q ss_pred --------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH-------Hhhhc
Q 041096 497 --------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV-------WGLYA 560 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~-------~~~~~ 560 (645)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.... .....
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 164 ARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 12356788999999876 468999999999999999999999997643211111111000 00000
Q ss_pred cCchhHHhhh--hc-cCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCCCCC
Q 041096 561 EGRIIEAADK--RL-NGAF---NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPLVVP 619 (645)
Q Consensus 561 ~~~~~~~~d~--~l-~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~~~p 619 (645)
........+. .. .... .......+.+++..||+.||++||+++++++ .+++..+....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~ 310 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence 0000000000 00 0000 0112345778999999999999999999995 477665544333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=283.57 Aligned_cols=236 Identities=26% Similarity=0.334 Sum_probs=187.9
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
|...+.||+|+||.||+|+...++..+++|.+... ....+.+.+|+++++.++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 45567899999999999999888999999987642 22335688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------c
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------T 497 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------~ 497 (645)
+. |+|.+++..... .+++.++..++.|++.||+|||+ .+++||||||+||+++.++..++.|.. .
T Consensus 103 ~~-~~l~~~l~~~~~---~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~ 175 (313)
T cd06633 103 CL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN 175 (313)
T ss_pred CC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCCC
Confidence 95 678887765432 38999999999999999999998 999999999999999999999998731 2
Q ss_pred ccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 498 LTAGTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 498 ~~~gt~~y~APE~~~---~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
...|+..|+|||++. .+.++.++|||||||++|||++|..||......... .. ... .....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~----~~---~~~---------~~~~~ 239 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YH---IAQ---------NDSPT 239 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH----HH---HHh---------cCCCC
Confidence 345788999999984 456889999999999999999999998764321111 00 000 00001
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.........+.+++..||+.+|.+||++.+++..
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112233457888999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=288.47 Aligned_cols=261 Identities=22% Similarity=0.287 Sum_probs=195.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeee----CCeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAE----KGEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 419 (645)
.++|+..+.||+|+||.||+|....++..||+|++... ......+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36788899999999999999999988999999988753 2334567889999999999999999998763 3468
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
++|+||+. ++|.+++.... .+++.....++.|+++||+|||+ .+++||||||+||+++.++..|+.|..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 68999886543 28999999999999999999999 999999999999999999999997721
Q ss_pred -------------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHH-------H
Q 041096 497 -------------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDW-------V 555 (645)
Q Consensus 497 -------------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~-------~ 555 (645)
....|+..|+|||.+.. ..++.++|||||||++|||++|+.||...+.......+... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 12357889999998865 56899999999999999999999999764321111110000 0
Q ss_pred HhhhccCchhHHhhhh-ccCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCC
Q 041096 556 WGLYAEGRIIEAADKR-LNGAF-----NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEP 615 (645)
Q Consensus 556 ~~~~~~~~~~~~~d~~-l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~ 615 (645)
+.....+.+.+..+.. ..... .......+.+++..||+.+|.+||++.++++ .+++...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 0000011111111100 00011 1223567899999999999999999999987 34444333
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=282.98 Aligned_cols=231 Identities=23% Similarity=0.311 Sum_probs=188.3
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCHh
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLD 432 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 432 (645)
.+||+|+||.||++....++..+|+|.+... ......+.+|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5699999999999999888999999987653 334567899999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------cccc
Q 041096 433 RMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------TLTA 500 (645)
Q Consensus 433 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------~~~~ 500 (645)
+++... .+++.....++.|++.||+|||+ .+++||||||+||+++.++..++.|.. ....
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 106 DIVTHT-----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence 987543 27899999999999999999999 899999999999999999999997721 1235
Q ss_pred cCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHH
Q 041096 501 GTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDE 580 (645)
Q Consensus 501 gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 580 (645)
|+..|+|||.+....++.++||||||+++|||++|..||...... ....... +...+.+. .....
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~----~~~~~~~---------~~~~~~~~--~~~~~ 242 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIR---------DNLPPKLK--NLHKV 242 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH---------hhCCcccC--CcccC
Confidence 788999999998888999999999999999999999998753221 1111000 00111110 11123
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 581 MKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 581 ~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 445778889999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=279.78 Aligned_cols=250 Identities=21% Similarity=0.290 Sum_probs=192.2
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
|+..+.||+|++|.||+|....++..+++|.+.... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999998889999999886632 23567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++ +|.+++..... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++..++.|..
T Consensus 81 ~~-~l~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQR---GLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhhcc---cCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 64 89888876432 38999999999999999999999 999999999999999999999997721
Q ss_pred --cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc---CchhH---H
Q 041096 497 --TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE---GRIIE---A 567 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~---~~~~~---~ 567 (645)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||...+..+......... ..... ....+ .
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTL-GTPDPEVWPKFTSLARN 232 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc-CCCchHhcccchhhhhh
Confidence 123467789999998876 78999999999999999999999997644321111111100 00000 00000 0
Q ss_pred hhhhcc-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 568 ADKRLN-------GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 568 ~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...... .....+....+.+++..||+++|.+||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 0111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=276.29 Aligned_cols=242 Identities=21% Similarity=0.262 Sum_probs=188.3
Q ss_pred HHHHHHhcCCCcCcee--ccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCC
Q 041096 341 RELRSATRGFHSNRIL--GRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKG 417 (645)
Q Consensus 341 ~~l~~~~~~f~~~~~l--G~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 417 (645)
.+.....++|+..+.+ |+|+||.||++....++..+|+|......... .|+.....+ +|+||+++++++...+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 4445555677777766 99999999999999889999999876532211 122222222 6999999999999999
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-Ceeeeccc
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-NARLESSF 496 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~-~~kl~d~~ 496 (645)
..++||||+++++|.+++.... .+++.++..++.|+++||.|||+ .+++||||||+||+++.++ ..+++|..
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 9999999999999999997653 38999999999999999999999 8999999999999999988 88887732
Q ss_pred --------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 --------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....|+..|+|||++.+..++.++||||||+++|||++|+.||....... .....+... .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~----------~ 223 (267)
T PHA03390 156 LCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKR----------Q 223 (267)
T ss_pred cceecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHh----------h
Confidence 22357889999999999899999999999999999999999997543221 111111111 1
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPS-MRRVFQ 607 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~~vl~ 607 (645)
.... .........+.+++..||+.+|.+||+ ++++++
T Consensus 224 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1111 122244567888889999999999996 688874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=284.43 Aligned_cols=240 Identities=23% Similarity=0.295 Sum_probs=179.4
Q ss_pred CceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCHhHHhh
Q 041096 360 AFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLY 436 (645)
Q Consensus 360 ~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~ 436 (645)
++|.||.++...++..+|+|++... ....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 3444555555557899999998653 3445679999999999999999999999999999999999999999999997
Q ss_pred hcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------------------c
Q 041096 437 QDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------------------T 497 (645)
Q Consensus 437 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------------------~ 497 (645)
.... ..+++.....++.|+++||+|||+ .+|+||||||+||+++.++.+++.+.. .
T Consensus 92 ~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 THFP--EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 6432 238889999999999999999999 999999999999999999999987621 1
Q ss_pred ccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh----ccCc-------h
Q 041096 498 LTAGTMGYLAPEYLQY--GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY----AEGR-------I 564 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~--~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~----~~~~-------~ 564 (645)
...++..|+|||.+.. ..++.++|||||||++|||++|+.||....... .+.+...... .... .
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccCccccccCchhhhcCCc
Confidence 1235678999999876 358899999999999999999999997643211 1111111000 0000 0
Q ss_pred hH----Hhhh----hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 IE----AADK----RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 ~~----~~d~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+ ..++ .............+.+++..||+.+|++|||++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00 0000 0001112233456888999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=277.84 Aligned_cols=238 Identities=25% Similarity=0.344 Sum_probs=188.8
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccC------CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH------SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~------~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
+|...+.||+|+||.||++.....+..+++|..+. .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999999876666565665443 122334577899999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++++|..++.........+++.+++.++.|+++||.|||+ .+++|+||||+||+++.+ ..++.|..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~~-~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeecC-CEeecccCceeecC
Confidence 99999999999987644444569999999999999999999998 999999999999999864 47776621
Q ss_pred ------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 ------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....|+..|+|||......++.++||||||+++|||++|+.||..... ...... .. .
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----~~~~~~------------~~-~ 219 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF----LSVVLR------------IV-E 219 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHHH------------HH-c
Confidence 123478899999999888899999999999999999999999864221 111110 00 1
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
......+......+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1112234455667889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=284.76 Aligned_cols=238 Identities=27% Similarity=0.331 Sum_probs=189.4
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.|+..+.||+|+||.||+|....++..+++|.+.. .....+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 35666789999999999999988899999998754 22234568899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+. |+|.+++..... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++..++.|..
T Consensus 96 ~~~-~~l~~~~~~~~~---~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 688887754332 38899999999999999999998 999999999999999999999997732
Q ss_pred cccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 TLTAGTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~---~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....|+..|+|||.+. .+.++.++|||||||++|||++|+.||........ +..+ ......
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~-------------~~~~~~ 232 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHI-------------AQNESP 232 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH---HHHH-------------hhcCCC
Confidence 2235788999999874 35678899999999999999999999865322110 0000 000000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L 609 (645)
..........+.+++.+||+.+|.+||++.++++.-
T Consensus 233 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 111223456678899999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=285.69 Aligned_cols=258 Identities=20% Similarity=0.221 Sum_probs=195.2
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeee-CC
Q 041096 342 ELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAE-KG 417 (645)
Q Consensus 342 ~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~ 417 (645)
++...+++|+..+.||+|+||.||++....++..+|+|++... ....+.+.+|++++.+++||||+++++++.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 3455788999999999999999999999988999999987542 2345678899999999999999999998865 56
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF- 496 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~- 496 (645)
..++++||+ +++|.+++... .+++.....++.|+++||+|||+ .+++||||||+||+++.++..++.|..
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccc
Confidence 789999998 67898888643 27888888999999999999999 999999999999999999999997732
Q ss_pred --------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH-------Hhhhc
Q 041096 497 --------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV-------WGLYA 560 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~-------~~~~~ 560 (645)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.+.. .....
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 155 ARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 22356788999998866 568999999999999999999999997543211111111110 00000
Q ss_pred cCchhHHhhh-hccCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 561 EGRIIEAADK-RLNGAFNE-----DEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 561 ~~~~~~~~d~-~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.+...+.... ......+. .....+.+++..|++.+|++||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0111111111 00111111 124678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=289.56 Aligned_cols=254 Identities=24% Similarity=0.301 Sum_probs=190.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeC--CeE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEK--GEL 419 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~ 419 (645)
..++|...+.||+|+||.||+|....++..+|+|++.. .......+.+|+.+++++ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 35678888999999999999999988899999998754 223345677899999999 999999999998653 468
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
++||||++ ++|..++... .++|..+..++.|++.||+|||+ .+++||||||+||+++.++..|+.|..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999996 5999988654 38899999999999999999998 999999999999999999999998721
Q ss_pred --------------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH-----
Q 041096 497 --------------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW----- 556 (645)
Q Consensus 497 --------------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~----- 556 (645)
....|+..|+|||.+.. ..++.++||||||+++|||++|+.||...........+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 11247888999998765 4578999999999999999999999975432211111111100
Q ss_pred --hhhccCchhHHhhhhccC------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 557 --GLYAEGRIIEAADKRLNG------AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 557 --~~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.........+.++..... ....+....+.+++..||+.+|++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000111100000 0011135678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=281.12 Aligned_cols=245 Identities=19% Similarity=0.238 Sum_probs=180.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCC---CeEEEEEeccCCcch------------hHhHHHHHHHHhhcCCCCeeeeeee
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASS---GSVAAVKRSKHSHEG------------KTEFLAELSIIACLRHKNLVQLLGW 412 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~---~~~vavK~~~~~~~~------------~~~~~~Ei~~l~~l~H~niv~l~g~ 412 (645)
++|...++||+|+||.||+|....+ +..+|+|........ ......+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5788999999999999999998776 566777754332211 0112233445566789999999997
Q ss_pred eeeCC----eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 041096 413 CAEKG----ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF 488 (645)
Q Consensus 413 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~ 488 (645)
+.... ..++++|++. .++.+.+..... .++..+..++.|+++||+|||+ .+++||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKC----KNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhcc----CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCC
Confidence 76543 4578888873 466666654321 5788889999999999999999 8999999999999999999
Q ss_pred Ceeeecccc-------------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchh
Q 041096 489 NARLESSFT-------------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMV 549 (645)
Q Consensus 489 ~~kl~d~~~-------------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~ 549 (645)
.+++.|... ...||+.|+|||+..+..++.++|||||||++|||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999987221 1358999999999999999999999999999999999999998653322111
Q ss_pred hHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 550 NLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 550 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
..... .. +.......+ .....+..+.+++..|++.+|++||++.++++.|+
T Consensus 244 ~~~~~--~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKC--DF-----IKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHH--HH-----HHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11100 00 001111111 11233577889999999999999999999998874
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=295.02 Aligned_cols=237 Identities=22% Similarity=0.375 Sum_probs=188.8
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEE---ecc--CCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC--eEEEEEec
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVK---RSK--HSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG--ELLLVYEY 425 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK---~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~Ey 425 (645)
..+||+|.|-+||||.+..+|..||-- .-. ......+.|..|+.+|+.|+|+||++++.++.+.. ..-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 456999999999999999889888743 222 23444578999999999999999999999887654 47899999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeeeec----------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN-FNARLES---------- 494 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~-~~~kl~d---------- 494 (645)
|..|+|+.|+++.+. +..+...+++.||++||.|||+. .++|+|||||.+||+|+.+ |.+||||
T Consensus 125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999998776 78889999999999999999984 5899999999999999865 7799998
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 495 SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 495 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
......|||.|||||... ..|++..||||||+.++||+|+..||....... .+... ...|.....+.
T Consensus 200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A---QIYKK----V~SGiKP~sl~----- 266 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA---QIYKK----VTSGIKPAALS----- 266 (632)
T ss_pred ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH---HHHHH----HHcCCCHHHhh-----
Confidence 223358999999999887 789999999999999999999999997654321 11111 11111111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcC
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNN 611 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~ 611 (645)
.. .-..+.+++..|+.. ..+|||+.|+++ +|..
T Consensus 267 kV---~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 267 KV---KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred cc---CCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 01 123567788999999 999999999997 5554
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=288.99 Aligned_cols=262 Identities=19% Similarity=0.246 Sum_probs=196.5
Q ss_pred ccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeee
Q 041096 337 EFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWC 413 (645)
Q Consensus 337 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 413 (645)
.....++...+++|...+.||+|+||.||+|....++..||+|++.... ...+.+.+|+.++.+++|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 3445677788899999999999999999999998889999999887532 2345688899999999999999999988
Q ss_pred eeC------CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC
Q 041096 414 AEK------GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN 487 (645)
Q Consensus 414 ~~~------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~ 487 (645)
... ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+ .+++||||||+||+++.+
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 156 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCC
Confidence 643 3478888887 88998887543 28999999999999999999999 999999999999999999
Q ss_pred CCeeeeccc---------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH--
Q 041096 488 FNARLESSF---------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV-- 555 (645)
Q Consensus 488 ~~~kl~d~~---------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~-- 555 (645)
+.+++.|.. ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 157 CELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred CCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998732 22357889999998876 568899999999999999999999996543221111111110
Q ss_pred -----HhhhccCchhH---HhhhhccCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 556 -----WGLYAEGRIIE---AADKRLNGAFN---EDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 556 -----~~~~~~~~~~~---~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
........... .+.......+. ......+.+++..|++.+|.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 00000000000 00000000000 012345788999999999999999999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=278.71 Aligned_cols=252 Identities=22% Similarity=0.270 Sum_probs=188.8
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhc---CCCCeeeeeeeeeeCCe-----
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACL---RHKNLVQLLGWCAEKGE----- 418 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~----- 418 (645)
|+..+.||+|+||.||+|..+.++..+|+|++.... .....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999998889999999987522 2234566788777666 59999999999988776
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-- 496 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-- 496 (645)
.+++|||+. ++|.+++..... ..+++.++..++.|+++||+|||+ .+++|+||+|+||+++.++.+++.|..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 999999996 589998876432 248999999999999999999999 899999999999999999999998721
Q ss_pred ---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh----hccCc
Q 041096 497 ---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL----YAEGR 563 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~----~~~~~ 563 (645)
....++..|+|||++.+..++.++|||||||++|||++|+.||...........+.+..... +....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 12346788999999999899999999999999999999999987644322111111110000 00000
Q ss_pred --hhHHhhhhcc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 564 --IIEAADKRLN---GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 564 --~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.......... .....+....+.+++..||+.||.+||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 0111233466788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=281.68 Aligned_cols=240 Identities=27% Similarity=0.386 Sum_probs=187.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc--chhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..+.||+|+||.||+|....++..+|||.+.... ....++..|+.++.+.. |+||++++++|.++...+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 56778899999999999999999889999999987532 33456777888777775 9999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+. ++|..++..... .+++..+..++.|+++||+|||+ .++++||||+|+||+++.++..+|.|..
T Consensus 95 ~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 984 577777655332 48999999999999999999996 2589999999999999999999998732
Q ss_pred ---cccccCCcccCcccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 ---TLTAGTMGYLAPEYLQYGT----ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~----~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... . ..... .++
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~-~~~~~------------~~~ 233 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--F-EVLTK------------ILQ 233 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--H-HHHHH------------Hhc
Confidence 1224677899999987654 789999999999999999999999653211 0 11111 111
Q ss_pred hhcc-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 570 KRLN-GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 570 ~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.... ..........+.+++.+||+.+|.+||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 234 EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1100 00111235568889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=279.71 Aligned_cols=235 Identities=23% Similarity=0.314 Sum_probs=195.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 422 (645)
++|...+.||+|+||.||+|....++..+++|++... ....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688889999999999999999888999999988652 233567889999999998 99999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-----
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT----- 497 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~----- 497 (645)
|||+++++|.+++.+.. .+++..++.++.|++.||.|||+ .+++|+||||+||+++.++..++.|...
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997654 39999999999999999999998 9999999999999999999999877211
Q ss_pred ---------------------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhh
Q 041096 498 ---------------------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVN 550 (645)
Q Consensus 498 ---------------------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~ 550 (645)
...++..|+|||......++.++||||||++++|+++|+.||.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---- 229 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---- 229 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----
Confidence 1235788999999998889999999999999999999999997643211
Q ss_pred HHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 041096 551 LVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSM----RRVFQ 607 (645)
Q Consensus 551 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~~vl~ 607 (645)
... ... ......+......+.+++..||+.+|.+||++ +++++
T Consensus 230 ~~~------------~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 TFQ------------KIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHH------------HHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111 011 11112333446678899999999999999999 76654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=276.78 Aligned_cols=251 Identities=23% Similarity=0.290 Sum_probs=203.6
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEECCC-----CeEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeee
Q 041096 341 RELRSATRGFHSNRILGRGAFGNVYKAYFASS-----GSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWC 413 (645)
Q Consensus 341 ~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~-----~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 413 (645)
++|.....+++...++-+|.||.||+|.+.+. .+.|.+|..+. +.-....++.|.-++..+.|||+..+.|.|
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 45555556788889999999999999977643 23456676655 333456788999999999999999999998
Q ss_pred eeC-CeEEEEEecCCCCCHhHHhhhcCC----CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 041096 414 AEK-GELLLVYEYMPNGSLDRMLYQDSE----NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF 488 (645)
Q Consensus 414 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~ 488 (645)
.+. +..+.+|.++.-|+|..+|...+. ..+.++-.+...++.|++.||+|||. ++++|.||.++|+++|+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhe
Confidence 765 567999999999999999984332 23457888999999999999999999 9999999999999999999
Q ss_pred Ceeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHH
Q 041096 489 NARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVD 553 (645)
Q Consensus 489 ~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~ 553 (645)
.+|+.|.. ........||+||.+....|+.++|||||||+||||+| |+.||...+..+..
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~----- 508 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME----- 508 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-----
Confidence 99997721 11224568999999999999999999999999999999 99999876543322
Q ss_pred HHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 554 WVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 554 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
..+.+..+-..+-+|+++++.+|.-||...|++||+++|++.-|.+
T Consensus 509 ------------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 ------------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ------------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 2223333445677899999999999999999999999999987753
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=269.07 Aligned_cols=240 Identities=24% Similarity=0.352 Sum_probs=193.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-----cc----hhHhHHHHHHHHhhc-CCCCeeeeeeeeeeC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-----HE----GKTEFLAELSIIACL-RHKNLVQLLGWCAEK 416 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-----~~----~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 416 (645)
-+.|...+.||.|..+.|-++..+.++...|+|++... .+ -.+.-.+|+.+|+++ .||+|+.+.++++..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 35678889999999999999999999999999987541 11 123456799999998 599999999999999
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS- 495 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~- 495 (645)
..+++|+|.|+.|-|.++|...- .++.....+|+.|+.+|++|||. ..|+||||||+|||+|++.+.+|+|.
T Consensus 96 sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccc
Confidence 99999999999999999997654 38999999999999999999999 99999999999999999999999882
Q ss_pred ----------ccccccCCcccCcccccC------CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh
Q 041096 496 ----------FTLTAGTMGYLAPEYLQY------GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY 559 (645)
Q Consensus 496 ----------~~~~~gt~~y~APE~~~~------~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~ 559 (645)
....|||++|+|||.+.. ..|+...|+||+||++|-|+.|..||....+--... +.
T Consensus 169 Fa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR--------~I 240 (411)
T KOG0599|consen 169 FACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLR--------MI 240 (411)
T ss_pred eeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHH--------HH
Confidence 234589999999998864 357889999999999999999999997532211000 00
Q ss_pred ccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 560 AEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 560 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+|+. .....-=.+....+.+++.+|++.||.+|.|++|+++
T Consensus 241 meGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 241 MEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred Hhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11100 0001111233456788899999999999999999976
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=276.37 Aligned_cols=231 Identities=25% Similarity=0.326 Sum_probs=181.7
Q ss_pred eeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHH---HhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSI---IACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 355 ~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~---l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
+||+|+||.||++....+++.||+|.+.... .....+..|..+ ++...|+||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999998889999999876522 122234444443 444579999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------c
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----------T 497 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----------~ 497 (645)
+++|..++.... .+++..+..++.|+++||+|||+ .+++||||||+||+++.++..++.|.. .
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 153 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc
Confidence 999999886543 38999999999999999999999 999999999999999999999997732 1
Q ss_pred ccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 498 LTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
...|+..|+|||.+.++ .++.++||||+|+++|||++|+.||......... . ... .........
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-~-~~~-------------~~~~~~~~~ 218 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-E-IDR-------------MTLTMAVEL 218 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-H-HHH-------------HhhccCCCC
Confidence 23589999999998754 6899999999999999999999999764221110 0 000 000111122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
+......+.+++..|+..+|.+|| ++.++++
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 333456788888999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-33 Score=294.43 Aligned_cols=234 Identities=26% Similarity=0.344 Sum_probs=195.3
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccC-CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
...||.|+||+||++..++++...|-|.+.. +.+..++|+-||++|....||+||+|++.|.-.+.++|+.|||.||..
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 4568999999999999998888888887765 566678999999999999999999999999989999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc------------cccc
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS------------FTLT 499 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~------------~~~~ 499 (645)
+..+-.-.. .|+..++..+++|++.||.|||+ +.|||||||+.|||++-+|.+++.|. ....
T Consensus 117 DaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 117 DAIMLELGR---VLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred hHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 998865443 49999999999999999999999 99999999999999999999999872 2345
Q ss_pred ccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 500 AGTMGYLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 500 ~gt~~y~APE~~~-----~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
.||++|||||+.. .++|+.++||||||+.|.||+.+.+|....+. +..++..... --|.|
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---MRVllKiaKS----------ePPTL-- 255 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKS----------EPPTL-- 255 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---HHHHHHHhhc----------CCCcc--
Confidence 7999999999875 46799999999999999999999999765432 1111111100 01111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..+......+.++...|+..||..||++.++++
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 235567778889999999999999999999986
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-33 Score=282.90 Aligned_cols=233 Identities=25% Similarity=0.362 Sum_probs=195.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
+.|+.-++||+||||.||-+..+.+|..+|+|++.+ .+......++|-.+|.+++.+.||.+--.++..+.+|||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 568888999999999999999999999999998765 3445667889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec---------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES--------- 494 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d--------- 494 (645)
..|.||+|.-+|.+... ..++.....-.+.+|+.||++||. .+||.|||||+|||||+.+.++|+|
T Consensus 265 tlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999987664 338999999999999999999999 9999999999999999999999988
Q ss_pred --cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 495 --SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 495 --~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
.....+||.+|||||++..+.|+...|.||+||+||||+.|+.||....+.. -.+.+|.+.
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-----------------k~eEvdrr~ 402 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-----------------KREEVDRRT 402 (591)
T ss_pred CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-----------------hHHHHHHHH
Confidence 2334589999999999999999999999999999999999999996532211 112233332
Q ss_pred c---CCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 041096 573 N---GAFNEDEMKRLLLVGLSCANPDSSARPSM 602 (645)
Q Consensus 573 ~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 602 (645)
. .+++....+....+....++.||++|.-.
T Consensus 403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 2 23444445556666677789999998653
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=278.82 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=191.8
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
|+..+.||+|++|.||+|+...++..+++|.+... ....+.+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 45567899999999999999988999999988763 333467889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
+ ++|.+++.... ..+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.+++.|..
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 59999998653 238999999999999999999999 999999999999999999999998721
Q ss_pred --cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH-------HhhhccCchhH
Q 041096 497 --TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV-------WGLYAEGRIIE 566 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~-------~~~~~~~~~~~ 566 (645)
....++..|+|||.+... .++.++|||||||++|||++|+.||...........+.... |.....-...+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 122346779999998776 78999999999999999999999997644221111111100 00000000000
Q ss_pred HhhhhccC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 567 AADKRLNG----AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 567 ~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..-+.... .........+.+++..||..+|++||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000 000112457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=283.15 Aligned_cols=267 Identities=18% Similarity=0.247 Sum_probs=197.7
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC---
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG--- 417 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--- 417 (645)
....++|+..+.||+|+||.||++....++..||||++... ......+.+|++++++++|+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999999888999999988642 223456889999999999999999999887543
Q ss_pred ---eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec
Q 041096 418 ---ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES 494 (645)
Q Consensus 418 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d 494 (645)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+||+++.++..++.|
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEee
Confidence 469999999 78999888642 38999999999999999999999 9999999999999999999999977
Q ss_pred cc---------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH-------Hh
Q 041096 495 SF---------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV-------WG 557 (645)
Q Consensus 495 ~~---------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~-------~~ 557 (645)
.. ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ..
T Consensus 162 fg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 162 FGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 22 12356889999999876 458899999999999999999999997643221111111100 00
Q ss_pred hhccCchhHHhhh--hcc----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCCCCC
Q 041096 558 LYAEGRIIEAADK--RLN----GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPLVVP 619 (645)
Q Consensus 558 ~~~~~~~~~~~d~--~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~~~p 619 (645)
............. ... .....+....+.+++..|++.+|++|||+.++++ .++...+....+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~ 311 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET 311 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccccc
Confidence 0000000000000 000 0011123345788999999999999999999984 566554444433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=301.01 Aligned_cols=258 Identities=20% Similarity=0.221 Sum_probs=181.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeE-EE------------------EEeccCCcchhHhHHHHHHHHhhcCCCCe
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSV-AA------------------VKRSKHSHEGKTEFLAELSIIACLRHKNL 406 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~-va------------------vK~~~~~~~~~~~~~~Ei~~l~~l~H~ni 406 (645)
..++|+..+.||+|+||+||++..+..... .+ .|...........+.+|+.++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 356899999999999999999876432211 11 12222223345568899999999999999
Q ss_pred eeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCC-CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 041096 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSEN-GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485 (645)
Q Consensus 407 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld 485 (645)
+++++++...+..|+|+|++ .++|.+++...... .......+...++.|++.||+|||+ .+|+||||||+||||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 99999999999999999999 56788877643311 1123456677899999999999999 9999999999999999
Q ss_pred CCCCeeeecccc-------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHH
Q 041096 486 ANFNARLESSFT-------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLV 552 (645)
Q Consensus 486 ~~~~~kl~d~~~-------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~ 552 (645)
.++.+||.|... ...||..|+|||++.+..++.++|||||||++|||++|..++...........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999987311 2368999999999999999999999999999999999876443222211111222
Q ss_pred HHHHhhh--cc------CchhHHhhhhccCCCC---H------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 553 DWVWGLY--AE------GRIIEAADKRLNGAFN---E------DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 553 ~~~~~~~--~~------~~~~~~~d~~l~~~~~---~------~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+...... .. .++.+.++........ . .....+.+++.+|++.||++|||+.|+++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 2111100 00 0011111100000000 0 11234566788999999999999999987
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=282.70 Aligned_cols=253 Identities=25% Similarity=0.295 Sum_probs=186.5
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-------
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK------- 416 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------- 416 (645)
.++|+..++||+|+||.||+|....++..+|+|++... ......+.+|++++++++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999999888999999987542 22234678999999999999999999987543
Q ss_pred -CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 417 -GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 417 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
..+++|+||+. ++|...+.... ..+++.++..++.|+++||+|||+ .+++||||||+||+++.++..++.|.
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcC
Confidence 35799999995 47777776433 238999999999999999999999 99999999999999999999999772
Q ss_pred c-----------------------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhH
Q 041096 496 F-----------------------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNL 551 (645)
Q Consensus 496 ~-----------------------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l 551 (645)
. ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1 11235677999998765 45799999999999999999999999764432111111
Q ss_pred HHHHHhhhccC------chhHHhhhhccCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 552 VDWVWGLYAEG------RIIEAADKRLNGAFN-------EDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 552 ~~~~~~~~~~~------~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
... ....... .+....+.......+ ......+.+++..|++.+|++|||+.+++.
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKL-CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHH-hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 110 0000000 000000000000000 112256788999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=277.40 Aligned_cols=243 Identities=25% Similarity=0.303 Sum_probs=191.9
Q ss_pred CCCcCceeccCCceEEEEEEEC---CCCeEEEEEeccCC-----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFA---SSGSVAAVKRSKHS-----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~---~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 419 (645)
+|+..+.||+|++|.||++... .++..+|||.+... ....+.+.+|+.++.++ +|+||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677889999999999999863 35678999988652 22345688999999999 599999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
++||||+++++|.+++.... .+++.....++.|+++||.|||+ .+++||||||+||+++.++..++.|..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999987543 38899999999999999999998 999999999999999999999987731
Q ss_pred ----------cccccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 ----------TLTAGTMGYLAPEYLQYGT--ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~~~--~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....|+..|+|||.+.+.. .+.++||||||+++|||++|..||...........+.. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---~------- 223 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR---R------- 223 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH---H-------
Confidence 1124788999999987665 78899999999999999999999864321111111111 0
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.... ....+......+.+++.+||+.+|++|||++++.+.|+..
T Consensus 224 --~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 224 --ILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --HHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0000 1122223345677889999999999999999998887753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=285.21 Aligned_cols=260 Identities=21% Similarity=0.260 Sum_probs=198.6
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC-----eEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG-----ELL 420 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 420 (645)
+|...+.||+|++|.||+|....++..+++|++... ....+.+.+|+.+++.++|+||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 477889999999999999999888999999988763 334567999999999999999999999998775 789
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS----- 495 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~----- 495 (645)
++|||++ ++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+++.|.
T Consensus 81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 58988886543 48999999999999999999999 99999999999999999999999761
Q ss_pred ----------ccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH-------h
Q 041096 496 ----------FTLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW-------G 557 (645)
Q Consensus 496 ----------~~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~-------~ 557 (645)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+..... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 1123467889999999887 789999999999999999999999976543221111111100 0
Q ss_pred hhccCchhHHhhhhc-cC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCC
Q 041096 558 LYAEGRIIEAADKRL-NG-----AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPL 616 (645)
Q Consensus 558 ~~~~~~~~~~~d~~l-~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~ 616 (645)
........+.+...- .. .........+.+++..||+.+|.+||+++++++ .+++...++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence 000001111111000 00 001123466889999999999999999999998 466554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=285.09 Aligned_cols=250 Identities=22% Similarity=0.275 Sum_probs=188.5
Q ss_pred cCCCc-CceeccCCceEEEEEEECCCCeEEEEEeccCCcchh---------------HhHHHHHHHHhhcCCCCeeeeee
Q 041096 348 RGFHS-NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGK---------------TEFLAELSIIACLRHKNLVQLLG 411 (645)
Q Consensus 348 ~~f~~-~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~---------------~~~~~Ei~~l~~l~H~niv~l~g 411 (645)
++|.. .+.||+|+||.||+|.....+..||+|.+....... ..+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 44543 467999999999999998889999999876532211 24789999999999999999999
Q ss_pred eeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCee
Q 041096 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491 (645)
Q Consensus 412 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~k 491 (645)
++...+..++||||+. |+|.+++.... .+++.....++.|++.||+|||+ .+++||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEE
Confidence 9999999999999996 69999986543 38899999999999999999998 9999999999999999999999
Q ss_pred eecccc--------------------------ccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 041096 492 LESSFT--------------------------LTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETE 544 (645)
Q Consensus 492 l~d~~~--------------------------~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~ 544 (645)
+.|... ...++..|+|||.+.+. .++.++|||||||++|||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 977221 12357789999998764 468999999999999999999999976543
Q ss_pred ccchhhHHHHHHhhhccCchhHHh--------h----hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 545 GHKMVNLVDWVWGLYAEGRIIEAA--------D----KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 545 ~~~~~~l~~~~~~~~~~~~~~~~~--------d----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+....+...... .......+.. . +.+. .........+.+++..|++.+|++||++++++.
T Consensus 240 ~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQLGRIFELLGT-PNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHhCC-CchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 2221111111100 0000000000 0 0000 001122456788999999999999999999986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=278.13 Aligned_cols=246 Identities=23% Similarity=0.344 Sum_probs=207.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
.+-|+..+.||+|.|..|-++++--+|+.||||++.+.+ .....+..|++.|+-++|||||+||.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 345777788999999999999998899999999998743 34567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE-cCCCCeeeec--------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML-DANFNARLES-------- 494 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll-d~~~~~kl~d-------- 494 (645)
|+-.+|+|.+|+-+.... +......+.+.||..|+.|+|+ ..+|||||||+||.. ..-+-+|+.|
T Consensus 97 ELGD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999877654 8899999999999999999999 999999999999865 4556677765
Q ss_pred ---cccccccCCcccCcccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 495 ---SFTLTAGTMGYLAPEYLQYGTAT-EKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 495 ---~~~~~~gt~~y~APE~~~~~~~t-~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
..+..+|+..|-|||++.+..|+ ++.||||+|||||-|++|+.||+..++.+.... ++|-
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm----------------ImDC 234 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM----------------IMDC 234 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh----------------hhcc
Confidence 34556899999999999999885 689999999999999999999998766543333 3333
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCC
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPL 616 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~ 616 (645)
+. ..+......+.+|+..|+..||++|.+.++++. .|+...+.+
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 33 456677888999999999999999999999875 466554444
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=275.01 Aligned_cols=238 Identities=23% Similarity=0.273 Sum_probs=188.1
Q ss_pred CCCcCceeccCCceEEEEEEEC---CCCeEEEEEeccCCc-----chhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFA---SSGSVAAVKRSKHSH-----EGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~---~~~~~vavK~~~~~~-----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 419 (645)
+|+..+.||+|+||.||++... .++..+|+|++.... ...+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677889999999999999874 367899999886522 2346688899999999 599999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
++||||+++++|.+++.... .+++.....++.|+++||.|||+ .+++||||||+|||++.++..++.|..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999997643 38899999999999999999998 999999999999999999999998721
Q ss_pred ----------cccccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 ----------TLTAGTMGYLAPEYLQYG--TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~~--~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....|+..|+|||.+... .++.++||||||+++|||++|+.||...........+.. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~------- 223 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---R------- 223 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH---H-------
Confidence 123478899999998753 468899999999999999999999964322111111111 0
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
+... ...++......+.+++..||+.+|++|| ++++++.
T Consensus 224 ---~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 224 ---ILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---hhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0000 1123333456778899999999999997 6677655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=282.79 Aligned_cols=254 Identities=19% Similarity=0.256 Sum_probs=192.5
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCe---
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGE--- 418 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--- 418 (645)
...++|...+.||+|++|.||+|....++..+|+|++... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3467899999999999999999999988999999987652 2234567789999999999999999998876554
Q ss_pred ---EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 419 ---LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 419 ---~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+ .+++||||||+||+++.++..++.|.
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccc
Confidence 89999999 67999988642 38999999999999999999999 99999999999999999999999872
Q ss_pred c---------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH-------Hhh
Q 041096 496 F---------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV-------WGL 558 (645)
Q Consensus 496 ~---------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~-------~~~ 558 (645)
. ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.+.. +..
T Consensus 163 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 163 GLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred cccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 2 22357888999999865 367899999999999999999999997543221111111110 000
Q ss_pred hccCchhHHhhhhcc---CCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 559 YAEGRIIEAADKRLN---GAFN---EDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~---~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.........+..... ..+. ......+.+++..|++++|++|||+.+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000001111110000 0000 112457889999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=279.90 Aligned_cols=250 Identities=21% Similarity=0.250 Sum_probs=185.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC----------
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK---------- 416 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~---------- 416 (645)
.+|...+.||+|+||.||+|....++..||+|.+... ....+.+.+|++++++++|+||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 6788899999999999999999988999999987653 34456788999999999999999999776543
Q ss_pred ----CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCee
Q 041096 417 ----GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA-NFNAR 491 (645)
Q Consensus 417 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~-~~~~k 491 (645)
...++||||++ ++|.+++... .+++.....++.|+++||.|||+ .+++||||||+||+++. +...+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEE
Confidence 35799999996 5898888543 28899999999999999999998 99999999999999985 44567
Q ss_pred eeccc---------------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH
Q 041096 492 LESSF---------------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV 555 (645)
Q Consensus 492 l~d~~---------------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~ 555 (645)
+.|.. ....++..|+|||.+.. ..++.++|||||||++|||++|+.||.............+..
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 76521 11246778999998754 567899999999999999999999997643322111111100
Q ss_pred Hhhhcc---CchhHHhhhhc-----cCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 556 WGLYAE---GRIIEAADKRL-----NGAF-----NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 556 ~~~~~~---~~~~~~~d~~l-----~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..... ..........+ .... .......+.+++..|++.+|.+|||+.++++
T Consensus 236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 -PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred -CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 00000000000 0000 0112356778999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=276.50 Aligned_cols=251 Identities=20% Similarity=0.234 Sum_probs=185.2
Q ss_pred CCCcCceeccCCceEEEEEEECCC--CeEEEEEeccCC---cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeC----Ce
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASS--GSVAAVKRSKHS---HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEK----GE 418 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~--~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~ 418 (645)
+|+..+.||+|+||.||++..... +..+|+|++... ....+.+.+|+++++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 477788999999999999999877 889999987652 22345788999999999 599999999875432 45
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-- 496 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-- 496 (645)
.++++||+. ++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.++|.|..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999985 68999886543 38999999999999999999999 999999999999999999999997722
Q ss_pred --------------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH-----
Q 041096 497 --------------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW----- 556 (645)
Q Consensus 497 --------------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~----- 556 (645)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 11357889999998765 4689999999999999999999999875432111111111000
Q ss_pred --hhhccCchhHHhhh---hccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 557 --GLYAEGRIIEAADK---RLNG---AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 557 --~~~~~~~~~~~~d~---~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.............. .-.. .........+.+++..|++.+|++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000 0000 000112356888999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=266.34 Aligned_cols=224 Identities=27% Similarity=0.313 Sum_probs=186.5
Q ss_pred eccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 356 lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
||+|+||.||++.....+..+++|.+.... .....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999998889999999876632 2455789999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------ccc
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------TLT 499 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------~~~ 499 (645)
.+++.... .+++.....++.|++.||.|||+ .+++|+||+|+||+++.++..+++|.. ...
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 99997654 38999999999999999999999 999999999999999999999997721 223
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHH
Q 041096 500 AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED 579 (645)
Q Consensus 500 ~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 579 (645)
.++..|++||...+...+.++|+||||+++|||++|+.||..... ......+ ... ....+..
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~------------~~~--~~~~~~~ 215 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKI------------LKD--PLRFPEF 215 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHH------------hcC--CCCCCCC
Confidence 578899999999988899999999999999999999999965432 1111110 011 1123333
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHH
Q 041096 580 EMKRLLLVGLSCANPDSSARPSMRR 604 (645)
Q Consensus 580 ~~~~l~~l~~~Cl~~dP~~RPt~~~ 604 (645)
....+.+++..||..+|++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 3567788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-33 Score=312.56 Aligned_cols=238 Identities=26% Similarity=0.363 Sum_probs=195.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
-++.....||.|.||.||-|...++|+..|+|-++- .....+...+|+.++..|+|||+|+++|+-.++++.+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 355667889999999999999999999999997654 23335678899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------- 497 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------- 497 (645)
||.+|+|.+.+...+. .+.......-.|++.|++|||+ ++||||||||.||+||.++..|.+|...
T Consensus 1315 yC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999987654 5666667788999999999999 9999999999999999999999988322
Q ss_pred ---------ccccCCcccCcccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchh
Q 041096 498 ---------LTAGTMGYLAPEYLQYGT---ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRII 565 (645)
Q Consensus 498 ---------~~~gt~~y~APE~~~~~~---~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 565 (645)
...||+-|||||++.+.+ ...+.||||+|||++||+||++||...+.. |.. +
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--------~aI--------M 1451 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--------WAI--------M 1451 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--------hHH--------H
Confidence 246999999999998654 456899999999999999999999765431 211 1
Q ss_pred HHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 566 EAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 566 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
-.+...-...+++.....-.+++..|+..||++|.++.|+++.
T Consensus 1452 y~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1452 YHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111122234555556666778889999999999999888764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=260.72 Aligned_cols=258 Identities=20% Similarity=0.338 Sum_probs=199.9
Q ss_pred CHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC-CcchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeC
Q 041096 339 SYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLR-HKNLVQLLGWCAEK 416 (645)
Q Consensus 339 ~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 416 (645)
+++|+.+.|. ++||+|+++.|-.++...++..+|||++.+ ....+....+|++++.+.+ |+||++|+.|++++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4677777764 679999999999999988999999999987 5556778899999999885 99999999999999
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---Ceeee
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF---NARLE 493 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~---~~kl~ 493 (645)
..+|||||-|.+|+|..+++++.. ++..+..++.++|+.||.|||. ++|.||||||+|||-..-. -+||.
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKH----FNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeee
Confidence 999999999999999999987664 8899999999999999999999 9999999999999974332 34554
Q ss_pred c-------------------cccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchh
Q 041096 494 S-------------------SFTLTAGTMGYLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMV 549 (645)
Q Consensus 494 d-------------------~~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~ 549 (645)
| .....+|+..|||||+.. ...|+.++|.||+|||||-|++|..||.+.-..+.
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC-- 299 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC-- 299 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--
Confidence 4 223357889999999764 34689999999999999999999999987644321
Q ss_pred hHHHHHHhhhccCchhHHhhh----hccC---CCCHHH----HHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCC
Q 041096 550 NLVDWVWGLYAEGRIIEAADK----RLNG---AFNEDE----MKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPL 616 (645)
Q Consensus 550 ~l~~~~~~~~~~~~~~~~~d~----~l~~---~~~~~~----~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~ 616 (645)
-|..|+.-+.... .++. +++.++ .....+++...+-.++.+|.++.+++. .+....+..
T Consensus 300 --------GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek 371 (463)
T KOG0607|consen 300 --------GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK 371 (463)
T ss_pred --------CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence 1233332222222 2211 344432 234455666677799999999999887 344444443
Q ss_pred CC
Q 041096 617 VV 618 (645)
Q Consensus 617 ~~ 618 (645)
.+
T Consensus 372 al 373 (463)
T KOG0607|consen 372 AL 373 (463)
T ss_pred cC
Confidence 33
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=283.71 Aligned_cols=236 Identities=22% Similarity=0.314 Sum_probs=196.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
...|.+.+.||+|.|++|.+|++..++..||||.+.++. ...+.+.+|+++|..|+|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467888999999999999999999999999999988743 23455889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-------- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-------- 495 (645)
||+.+|.+.+||.+... +.......++.|+.++++|||+ +.|+|||||++||||+.+++.||+|.
T Consensus 135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999988765 4557888899999999999999 99999999999999999999999882
Q ss_pred ---ccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 496 ---FTLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 496 ---~~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....+|++.|.|||++.+..| .+++|+||+|++||-|++|..||++..-.. +- ...+..+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~----Lr------------~rvl~gk 271 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE----LR------------PRVLRGK 271 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc----cc------------chheeee
Confidence 234589999999999998877 689999999999999999999998743211 10 0111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
++ .+.-....+-+++...+-++|.+|++++++.+
T Consensus 272 ~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 272 YR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ec--ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11 11122334556667888999999999999976
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=257.30 Aligned_cols=235 Identities=26% Similarity=0.408 Sum_probs=185.8
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEEEecCCCC
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~g 429 (645)
...||.|.+|.|+++..+.+|...|||.+... .+..+.++..++++.+-. +|.||+.+|||..+...++.||.| ..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 45699999999999999999999999998873 445567788888876664 899999999999999999999998 33
Q ss_pred CHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-----------ccc
Q 041096 430 SLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-----------FTL 498 (645)
Q Consensus 430 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-----------~~~ 498 (645)
-++.+|..-.. ++++..+-++...+.+||.||.+ +++|+|||+||+|||+|+.++.|+.|. .+.
T Consensus 176 C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtr 250 (391)
T KOG0983|consen 176 CAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTR 250 (391)
T ss_pred HHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccccc
Confidence 45555554332 38888888999999999999998 599999999999999999999999872 334
Q ss_pred cccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 499 TAGTMGYLAPEYLQY---GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 499 ~~gt~~y~APE~~~~---~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
..|-+.|||||.+.. .+|+.++||||||+.|+||+||+.||.....+- ..+..+. +..-|.|.+.
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF---e~ltkvl---------n~ePP~L~~~ 318 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF---EVLTKVL---------NEEPPLLPGH 318 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH---HHHHHHH---------hcCCCCCCcc
Confidence 578899999999864 478999999999999999999999998753221 1111111 1111233221
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
. .....+.++...|++.|+.+||...++++
T Consensus 319 ~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 319 M--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred c--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1 13556788889999999999999999886
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=262.19 Aligned_cols=211 Identities=19% Similarity=0.165 Sum_probs=172.1
Q ss_pred CCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhc
Q 041096 359 GAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQD 438 (645)
Q Consensus 359 G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~ 438 (645)
|.+|.||++....++..+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 789999999999999999999987643 2344555566667999999999999999999999999999999999764
Q ss_pred CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---------ccccCCcccCcc
Q 041096 439 SENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------LTAGTMGYLAPE 509 (645)
Q Consensus 439 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------~~~gt~~y~APE 509 (645)
.. +++.....++.|+++||+|||+ ++++||||||+||+++.++..++.|... ...++..|+|||
T Consensus 80 ~~----l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE 152 (237)
T cd05576 80 LN----IPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE 152 (237)
T ss_pred cC----CCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCc
Confidence 32 8999999999999999999998 9999999999999999999999877321 234567799999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHH
Q 041096 510 YLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGL 589 (645)
Q Consensus 510 ~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 589 (645)
......++.++||||+|+++|||++|+.|+........ .......+......+.+++.
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~li~ 210 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------------THTTLNIPEWVSEEARSLLQ 210 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------------cccccCCcccCCHHHHHHHH
Confidence 99888899999999999999999999988753211000 00000122233456788899
Q ss_pred HccCCCCCCCCCH
Q 041096 590 SCANPDSSARPSM 602 (645)
Q Consensus 590 ~Cl~~dP~~RPt~ 602 (645)
+|++.||++||++
T Consensus 211 ~~l~~dp~~R~~~ 223 (237)
T cd05576 211 QLLQFNPTERLGA 223 (237)
T ss_pred HHccCCHHHhcCC
Confidence 9999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=276.54 Aligned_cols=236 Identities=22% Similarity=0.351 Sum_probs=183.9
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 423 (645)
+.|+..++||+||.+.||++...+ ...+|+|+... ..+...-|.+|+..|.+|+ |.+||+|++|-..++.+||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 457788999999999999998765 45667766544 3445677999999999995 999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-------- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-------- 495 (645)
||= ..+|..+|.++... ...| .+..+..|++.++.++|+ .+|||.||||.|+|+-. |..||.|.
T Consensus 440 E~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred ecc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 986 67999999876543 2345 777899999999999999 99999999999998754 44555551
Q ss_pred ------ccccccCCcccCcccccCCC-----------CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh
Q 041096 496 ------FTLTAGTMGYLAPEYLQYGT-----------ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 496 ------~~~~~gt~~y~APE~~~~~~-----------~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
....+||+.||+||.+.... ...+|||||+||+||+|+.|+.||.... +...
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------n~~a----- 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------NQIA----- 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------HHHH-----
Confidence 12357999999999885432 4679999999999999999999996421 1111
Q ss_pred hccCchhHHhhhhccCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 559 YAEGRIIEAADKRLNGAFNEDE-MKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
++..+.++.-.-+++.-. ...+.++|..||..||.+|||..++++
T Consensus 581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 234445553333333221 222899999999999999999999986
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=295.04 Aligned_cols=242 Identities=25% Similarity=0.371 Sum_probs=184.8
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeee------
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAE------ 415 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------ 415 (645)
.+-..+|++..+||+||||.||+++.+-+|+.||||++... ........+|+.++++|+|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34567899999999999999999999999999999998774 4445678899999999999999999631100
Q ss_pred -----------------------------------------------------------C--------------------
Q 041096 416 -----------------------------------------------------------K-------------------- 416 (645)
Q Consensus 416 -----------------------------------------------------------~-------------------- 416 (645)
+
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHH
Q 041096 417 ----------------------------------GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462 (645)
Q Consensus 417 ----------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~ 462 (645)
..+||=||||+..+|+.++..+.-. -.....++++.+|++||+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHH
Confidence 1257789999888888888765421 135667899999999999
Q ss_pred HHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec------------------------------cccccccCCcccCccccc
Q 041096 463 YLHQECEQQVIHRDIKASNIMLDANFNARLES------------------------------SFTLTAGTMGYLAPEYLQ 512 (645)
Q Consensus 463 yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d------------------------------~~~~~~gt~~y~APE~~~ 512 (645)
|+|+ ++||||||||.||+||++..+||+| ..+..+||.-|+|||++.
T Consensus 712 YIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 9999 9999999999999999999999987 223457999999999997
Q ss_pred CC---CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHH
Q 041096 513 YG---TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGL 589 (645)
Q Consensus 513 ~~---~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 589 (645)
+. +|+.|+|+||+|||++||+. ||... .+....+ ..++.+.+..- ..+..+....=..++.
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---MERa~iL----~~LR~g~iP~~------~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS---MERASIL----TNLRKGSIPEP------ADFFDPEHPEEASLIR 852 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCch---HHHHHHH----HhcccCCCCCC------cccccccchHHHHHHH
Confidence 64 49999999999999999986 55421 1111111 11112211111 1233444555667889
Q ss_pred HccCCCCCCCCCHHHHHH
Q 041096 590 SCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 590 ~Cl~~dP~~RPt~~~vl~ 607 (645)
++++.||.+|||+.|++.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999874
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=284.21 Aligned_cols=191 Identities=32% Similarity=0.465 Sum_probs=162.6
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC------eEEE
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG------ELLL 421 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 421 (645)
+...+.||+|+||.||+|+.+.+|+.||||.++. .....+...+|+++|++|+|+|||++++.-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3445779999999999999999999999999887 3445667889999999999999999999866543 5789
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC----Ceeeec---
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF----NARLES--- 494 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~----~~kl~d--- 494 (645)
|||||.+|||+..|.+... ..-|+..+.+.+..+++.||.|||+ ++|+||||||.||++-... .-|+.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999976433 3459999999999999999999998 9999999999999984322 234444
Q ss_pred --------cccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 041096 495 --------SFTLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETE 544 (645)
Q Consensus 495 --------~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~ 544 (645)
.+...+||..|++||.... +.|+..+|.|||||++||.+||..||.....
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 3455689999999999985 7889999999999999999999999976543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=293.75 Aligned_cols=134 Identities=26% Similarity=0.361 Sum_probs=120.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|...++||+|+||.||+|.+...+..||||++.... .....+..|+.++..++|+||+++++++...+..||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999999889999999987532 23467889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF 488 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~ 488 (645)
||+++++|.+++.... .+++...+.++.||+.||+|||+ .+|+||||||+||||+.++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g 141 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEG 141 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCC
Confidence 9999999999997543 27889999999999999999999 8999999999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=251.51 Aligned_cols=225 Identities=29% Similarity=0.369 Sum_probs=185.5
Q ss_pred CceEEEEEEECCCCeEEEEEeccCCcc-h-hHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhh
Q 041096 360 AFGNVYKAYFASSGSVAAVKRSKHSHE-G-KTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQ 437 (645)
Q Consensus 360 ~fg~Vy~g~~~~~~~~vavK~~~~~~~-~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 437 (645)
+||.||+|....++..+++|++..... . .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999988889999999876332 2 57899999999999999999999999999999999999999999999976
Q ss_pred cCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-----------ccccccCCccc
Q 041096 438 DSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-----------FTLTAGTMGYL 506 (645)
Q Consensus 438 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-----------~~~~~gt~~y~ 506 (645)
... +++..++.++.++++++.|||+ .+++|+||+|+||+++.++..++.|. .....++..|+
T Consensus 81 ~~~----~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR----LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred ccC----CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 443 8899999999999999999999 89999999999999999999998772 23345788999
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHH--HHHHH
Q 041096 507 APEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED--EMKRL 584 (645)
Q Consensus 507 APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~--~~~~l 584 (645)
+||.+....++.++||||||++++||++|..||...... ..+.+. +........... ....+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---~~~~~~-------------~~~~~~~~~~~~~~~~~~~ 217 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---LELFKK-------------IGKPKPPFPPPEWKISPEA 217 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHH-------------HhccCCCCccccccCCHHH
Confidence 999999888999999999999999999999998653211 111111 111111110111 45678
Q ss_pred HHHHHHccCCCCCCCCCHHHHHH
Q 041096 585 LLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 585 ~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 88999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=279.12 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=210.0
Q ss_pred ccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeee
Q 041096 337 EFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAE 415 (645)
Q Consensus 337 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 415 (645)
...++.+...+.-|++.+.||.|.+|.||+++...+++.+|+|++.......++...|.++++.+ .|||++.++|++..
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 34455556667788999999999999999999999999999999988777788899999999998 59999999999864
Q ss_pred -----CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 416 -----KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 416 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
++++|||||||.+||..+.++... +..+.|..+..|+..++.||++||. +.++|||||-.||||+.++.+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcE
Confidence 468999999999999999998765 4569999999999999999999998 999999999999999999999
Q ss_pred eeec------------cccccccCCcccCcccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHH
Q 041096 491 RLES------------SFTLTAGTMGYLAPEYLQYG-----TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVD 553 (645)
Q Consensus 491 kl~d------------~~~~~~gt~~y~APE~~~~~-----~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~ 553 (645)
|+.| ......||+.|||||++... .|+.++|+||+|++..||.-|.+|+....... .+.
T Consensus 163 KLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---aLF- 238 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---ALF- 238 (953)
T ss_pred EEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---hhc-
Confidence 9977 23345799999999999643 46889999999999999999999987653211 110
Q ss_pred HHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 554 WVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 554 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+.. .|......+....+.+.+++..|+..|-++||++.++++
T Consensus 239 ---------~IpR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 ---------LIPR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---------cCCC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0111 122222446778889999999999999999999988876
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=254.65 Aligned_cols=230 Identities=26% Similarity=0.341 Sum_probs=189.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.++|+..++||+|.||+|-+++-+.++..+|+|++++. +.....-+.|-++|+..+||.+..|--.+...+++|.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 36788899999999999999999999999999999873 34455667899999999999999998889999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec--------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES-------- 494 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d-------- 494 (645)
|||..+|.|.-+|.+.+. ++.......-..|..||.|||+ ++||.||||.+|.|||.++..||.|
T Consensus 247 MeyanGGeLf~HLsrer~----FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERV----FSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehhhhhc----ccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999999976543 7777777788899999999999 9999999999999999999999976
Q ss_pred ----cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 495 ----SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 495 ----~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
.....+||+.|+|||++....|..+.|.|.+|||+|||++|+.||...+.+... .+ +-+-|-
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF-eL-------------Il~ed~ 385 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF-EL-------------ILMEDL 385 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHH-HH-------------HHhhhc
Confidence 344568999999999999999999999999999999999999999875432211 11 111111
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPS 601 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 601 (645)
.++.........|....+..||.+|.-
T Consensus 386 ----kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 386 ----KFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred ----cCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 223333333444456678899999954
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=258.17 Aligned_cols=229 Identities=23% Similarity=0.351 Sum_probs=189.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 421 (645)
..+|....+||+|+||+|-++..+.+.+.+|||++++. ..+.+--+.|-++|... +-|.++++..++..-+.+|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 35688899999999999999999999999999998873 22233345666666665 46899999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec-------
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES------- 494 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d------- 494 (645)
||||+.+|+|--++++-.+ +....+.-.+..||-||-|||+ ++|+.||||.+|||||.++.+||.|
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999987665 6777888899999999999999 9999999999999999999999977
Q ss_pred -----cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 495 -----SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 495 -----~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
.....+||+.|+|||++..++|...+|+|||||+||||+.|+.||++.++.+....+. +
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~----------------e 564 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM----------------E 564 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----------------H
Confidence 2234589999999999999999999999999999999999999999876543322222 2
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARP 600 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 600 (645)
.. -.++.....+...+....+...|.+|.
T Consensus 565 hn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 HN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 21 245666666677777788888898884
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=246.18 Aligned_cols=258 Identities=19% Similarity=0.266 Sum_probs=190.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCe----EEEEEeccCCcc---hhHhHHHHHHHHhhcCCCCeeeeeeeeee-CCe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGS----VAAVKRSKHSHE---GKTEFLAELSIIACLRHKNLVQLLGWCAE-KGE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~----~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~ 418 (645)
...|+....||+|.||.||++.-.+++. .+|+|+++..+. -.....+|+.+++.|+|+|++.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3468888999999999999997655433 689998876422 24567899999999999999999999887 778
Q ss_pred EEEEEecCCCCCHhHHhhhcCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC----CCeeee
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSE-NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN----FNARLE 493 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~----~~~kl~ 493 (645)
.+|++||.+. +|...++..+. ....++......|+.||+.|+.|||+ +=|+||||||.||||..+ +.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEee
Confidence 9999999955 88888875443 23458889999999999999999999 889999999999999888 899998
Q ss_pred c---------------cccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccc-----cchhhHH
Q 041096 494 S---------------SFTLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEG-----HKMVNLV 552 (645)
Q Consensus 494 d---------------~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~-----~~~~~l~ 552 (645)
| .....+.|..|+|||.+.+. -||.+.||||.||+..||++-.+.|...... ......+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 8 23345679999999999875 5899999999999999999988887654321 1111222
Q ss_pred HHHHhhhc---cC------------chhHHhhhhccCCCCH-H-------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 553 DWVWGLYA---EG------------RIIEAADKRLNGAFNE-D-------EMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 553 ~~~~~~~~---~~------------~~~~~~d~~l~~~~~~-~-------~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
+.+...+. +. ....-+.........- . -....+.|...++..||.+|.|+++.++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 22222211 11 0000000000001000 0 01125677789999999999999999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=257.22 Aligned_cols=254 Identities=19% Similarity=0.294 Sum_probs=198.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCC--C----CeeeeeeeeeeCCeEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRH--K----NLVQLLGWCAEKGELL 420 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H--~----niv~l~g~~~~~~~~~ 420 (645)
+++|....++|+|.||.|-.+.+...+..||||+++.-....+..+-|++++++|.+ | -+|.+.+|+.-.++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 678999999999999999999999889999999999877777788899999999943 2 4888899999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-------------
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN------------- 487 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~------------- 487 (645)
||+|.+ +-|+.++|..+.. .+++..++..|+.|++++++|||+ .+++|-||||+|||+-+.
T Consensus 168 ivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 999998 7799999987654 358889999999999999999999 999999999999997322
Q ss_pred -------CCeeeecc---------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhH
Q 041096 488 -------FNARLESS---------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNL 551 (645)
Q Consensus 488 -------~~~kl~d~---------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l 551 (645)
..+|+.|. ....+.|..|+|||++.+-.++.++||||+||||.|+++|...|+..+..+.. .+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL-aM 320 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL-AM 320 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH-HH
Confidence 22334332 23346799999999999999999999999999999999999999876533321 23
Q ss_pred HHHHHhhhc--------------cCch-----------hHHhhhh--c--cCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 041096 552 VDWVWGLYA--------------EGRI-----------IEAADKR--L--NGAFNEDEMKRLLLVGLSCANPDSSARPSM 602 (645)
Q Consensus 552 ~~~~~~~~~--------------~~~~-----------~~~~d~~--l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 602 (645)
++.+.+-.. .+++ ....++. + .......+...+++|+..++..||.+|+|+
T Consensus 321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl 400 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL 400 (415)
T ss_pred HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence 332222110 0000 0000000 0 011234567789999999999999999999
Q ss_pred HHHHH
Q 041096 603 RRVFQ 607 (645)
Q Consensus 603 ~~vl~ 607 (645)
+|+++
T Consensus 401 ~EAL~ 405 (415)
T KOG0671|consen 401 REALS 405 (415)
T ss_pred HHHhc
Confidence 99986
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-31 Score=252.88 Aligned_cols=248 Identities=27% Similarity=0.383 Sum_probs=191.2
Q ss_pred cccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeee
Q 041096 336 REFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGW 412 (645)
Q Consensus 336 ~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~ 412 (645)
..|+-++|+. ...||.|.||+|+|-.++.+|...|||+++.. ...+++++.|.+...+- +.||||+++|.
T Consensus 59 ~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 59 HTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 3455555544 45699999999999999999999999998873 34567888999876555 69999999999
Q ss_pred eeeCCeEEEEEecCCCCCHhHHhhhc-CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCee
Q 041096 413 CAEKGELLLVYEYMPNGSLDRMLYQD-SENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491 (645)
Q Consensus 413 ~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~k 491 (645)
+..++..|+.||.| ..||+.+...- ..+...+++.-.-+|......||.||-+ +..|+|||+||+|||||..+.+|
T Consensus 132 ~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEe
Confidence 99999999999999 56776654321 1122348888888899999999999998 48999999999999999999999
Q ss_pred eecc-----------ccccccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh
Q 041096 492 LESS-----------FTLTAGTMGYLAPEYLQYG--TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 492 l~d~-----------~~~~~gt~~y~APE~~~~~--~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
+.|. .+..+|-..|||||-+... .|+.+|||||+|+.|+|++||+.||.+.+. +.+.+...
T Consensus 209 LCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeql~~V 282 (361)
T KOG1006|consen 209 LCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQLCQV 282 (361)
T ss_pred eecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHHHHHH
Confidence 9882 2334688899999998643 489999999999999999999999987542 11111111
Q ss_pred hccCchhHHhhhhccCCCCH---HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 559 YAEGRIIEAADKRLNGAFNE---DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~---~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
... |+... ..+. +....+...+-.|+..|-..||+..++.+
T Consensus 283 v~g-------dpp~l-~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 283 VIG-------DPPIL-LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HcC-------CCCee-cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 110 11110 1222 24556788888999999999999999876
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=268.25 Aligned_cols=231 Identities=26% Similarity=0.306 Sum_probs=187.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+..|.....+|.|+|+.|-++....++...++|++.+. ..+-.+|+.++... +|+||+++.+.|.+..+.|+|||+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 45666777799999999999999999999999998875 22344677665555 699999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE-cCCCCeeeecccc-------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML-DANFNARLESSFT------- 497 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll-d~~~~~kl~d~~~------- 497 (645)
+.++-|.+.+..... .. ..+..|+.+|+.++.|||+ ++++||||||+|||+ ++.+..++.+...
T Consensus 398 l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999888777765442 23 6777899999999999999 999999999999999 5888899977321
Q ss_pred --ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 498 --LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 498 --~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
..+-|..|.|||++....|++++|+||||++||||++|+.||.....+ ..+ ......+.
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei----------------~~~i~~~~ 530 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEI----------------HTRIQMPK 530 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHH----------------HHhhcCCc
Confidence 235678899999999999999999999999999999999999865432 111 11111233
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+.........+|+.+|++.||.+||+|.++..
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 33445566777889999999999999999976
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=274.08 Aligned_cols=249 Identities=18% Similarity=0.198 Sum_probs=162.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCC----CeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeee------eee
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASS----GSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGW------CAE 415 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~----~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~~ 415 (645)
..++|+..++||+|+||.||+|++..+ +..||+|++...... +.+..| .+....+.++..++.. +..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 567899999999999999999999888 889999987653221 111111 1222222333222211 345
Q ss_pred CCeEEEEEecCCCCCHhHHhhhcCCC----------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 041096 416 KGELLLVYEYMPNGSLDRMLYQDSEN----------------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKA 479 (645)
Q Consensus 416 ~~~~~lV~Ey~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp 479 (645)
+.+.+|||||+++++|.+++...... ........+..++.|++.||+|||+ ++|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCH
Confidence 67899999999999999998754210 0011233456799999999999999 9999999999
Q ss_pred CcEEEcC-CCCeeeecccc-------------ccccCCcccCcccccCC----------------------CCCcchhHH
Q 041096 480 SNIMLDA-NFNARLESSFT-------------LTAGTMGYLAPEYLQYG----------------------TATEKTDVF 523 (645)
Q Consensus 480 ~NIlld~-~~~~kl~d~~~-------------~~~gt~~y~APE~~~~~----------------------~~t~ksDV~ 523 (645)
+||||+. ++.+|+.|... ...+++.|+|||.+... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 57899987321 23578899999965321 234567999
Q ss_pred HHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC-chh---HHhhhhccCC------CCHHHHHHHHHHHHHccC
Q 041096 524 SYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG-RII---EAADKRLNGA------FNEDEMKRLLLVGLSCAN 593 (645)
Q Consensus 524 SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~-~~~---~~~d~~l~~~------~~~~~~~~l~~l~~~Cl~ 593 (645)
||||+||||+++..|+.... ..+.. .....+ ... ....+....+ ..........+++..|++
T Consensus 364 SlGviL~el~~~~~~~~~~~-----~~~~~---~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSNL-----IQFNR---QLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHhCcCCCchHH-----HHHHH---HHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999776643210 01100 000000 000 0011110000 000112235579999999
Q ss_pred CCCCCCCCHHHHHHH
Q 041096 594 PDSSARPSMRRVFQI 608 (645)
Q Consensus 594 ~dP~~RPt~~~vl~~ 608 (645)
.||++|||++++++.
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999973
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=282.88 Aligned_cols=198 Identities=30% Similarity=0.387 Sum_probs=177.4
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeee
Q 041096 338 FSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWC 413 (645)
Q Consensus 338 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 413 (645)
-...+++....+|.+.++||+|+||.|..++++.++.+||+|++.+ ......-|.+|-.+|..-..+=|++|+-.|
T Consensus 65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 3456777778899999999999999999999999999999999887 234456789999999999999999999999
Q ss_pred eeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeee
Q 041096 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLE 493 (645)
Q Consensus 414 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~ 493 (645)
.+.+++|+|||||+||+|-.++.+.. .++.......+..|..||.-||+ .|+|||||||+|||||..|..|+.
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeec
Confidence 99999999999999999999998765 28888888889999999999999 999999999999999999999998
Q ss_pred cc-------------ccccccCCcccCccccc----C-CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 041096 494 SS-------------FTLTAGTMGYLAPEYLQ----Y-GTATEKTDVFSYGVVVLEVACGRRPIERE 542 (645)
Q Consensus 494 d~-------------~~~~~gt~~y~APE~~~----~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~ 542 (645)
|. ....+|||-|++||++. + +.|...+|+||+||++|||+.|..||...
T Consensus 218 DFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 218 DFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred cchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 72 24468999999999985 2 57899999999999999999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=225.69 Aligned_cols=250 Identities=20% Similarity=0.306 Sum_probs=187.9
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc---hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
|+..++||+|.||+||+|+..++.+.||+|+.+..+. -....++|+-+++.++|+|||++++....++.+-||+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 4455789999999999999999999999998876332 2467899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec------------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES------------ 494 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d------------ 494 (645)
..+|..|...-... ++......++.|+++||.|+|+ +.+.||||||+|.|++.++..|+.|
T Consensus 84 -dqdlkkyfdslng~---~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 84 -DQDLKKYFDSLNGD---LDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred -hHHHHHHHHhcCCc---CCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 56888888765443 8899999999999999999999 9999999999999999999999987
Q ss_pred cccccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccC---chhHHhh
Q 041096 495 SFTLTAGTMGYLAPEYLQYGT-ATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEG---RIIEAAD 569 (645)
Q Consensus 495 ~~~~~~gt~~y~APE~~~~~~-~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d 569 (645)
.++..+.|..|++|.++.+.+ |++..|+||-||++.|+.. |++.|.+.+..+.... +-|+.+...++ .+.+..|
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkr-if~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHH-HHHHhCCCccccCCccccCCC
Confidence 234456789999999998765 7999999999999999998 5555655433222111 11222222222 1222223
Q ss_pred hhccCCCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 570 KRLNGAFNE---------DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
-.....++. ..-..=.++....+.-+|.+|.++++.++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 222222221 11111234444555668999999998876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=264.49 Aligned_cols=251 Identities=16% Similarity=0.251 Sum_probs=171.9
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC----------------CCCeEEEEEeccCCcch-h--------------HhHHHH
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFA----------------SSGSVAAVKRSKHSHEG-K--------------TEFLAE 394 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~----------------~~~~~vavK~~~~~~~~-~--------------~~~~~E 394 (645)
..++|+..++||+|+||.||+|.+. ..+..||||++....+. . +.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3678999999999999999999752 23467999998653221 2 234457
Q ss_pred HHHHhhcCCCCe-----eeeeeeeee--------CCeEEEEEecCCCCCHhHHhhhcCC--------------------C
Q 041096 395 LSIIACLRHKNL-----VQLLGWCAE--------KGELLLVYEYMPNGSLDRMLYQDSE--------------------N 441 (645)
Q Consensus 395 i~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------~ 441 (645)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877654 678888754 3568999999999999999874321 0
Q ss_pred CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-------------ccccCCcccCc
Q 041096 442 GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT-------------LTAGTMGYLAP 508 (645)
Q Consensus 442 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~-------------~~~gt~~y~AP 508 (645)
...++|..+..++.|+++||.|||+ .+|+||||||+|||++.++..|+.|... ...+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1235788899999999999999998 8999999999999999999999987321 11247899999
Q ss_pred ccccCCCC----------------------CcchhHHHHHHHHHHHHcCCC-CCCccccccchhhHHH---HHHhhhccC
Q 041096 509 EYLQYGTA----------------------TEKTDVFSYGVVVLEVACGRR-PIERETEGHKMVNLVD---WVWGLYAEG 562 (645)
Q Consensus 509 E~~~~~~~----------------------t~ksDV~SfGvvl~El~tG~~-P~~~~~~~~~~~~l~~---~~~~~~~~~ 562 (645)
|.+..... ..+.||||+||+++||++|.. |+.............+ ..|......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98754321 234799999999999999875 6653211100000000 011111111
Q ss_pred chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHH
Q 041096 563 RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDS---SARPSMRRVFQ 607 (645)
Q Consensus 563 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~~vl~ 607 (645)
. ..-...........+++..++..+| .+|+|++|+++
T Consensus 460 ~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 K--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 0000111223456666777777655 78999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=241.27 Aligned_cols=238 Identities=24% Similarity=0.334 Sum_probs=191.5
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 421 (645)
.++|+..++||+|+|.+|-.+.+..+.+.+|+|++++ .+++......|-.+..+. +||.+|.|..++..+..++.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4679999999999999999999999999999998876 344455566677666665 69999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec-------
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES------- 494 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d------- 494 (645)
|.||+++|+|--++++.++ |+...+......|+.||.|||+ ++|+.||||.+|||||.++..|+.|
T Consensus 329 vieyv~ggdlmfhmqrqrk----lpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhhhhc----CcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999988877665 8999998899999999999999 9999999999999999999999855
Q ss_pred -----cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 495 -----SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 495 -----~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
..+..+||+.|+|||++.+..|.-..|+|++||+++||..|+.||+-........+--++..... +.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--------le 473 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--------LE 473 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--------hh
Confidence 45567999999999999999999999999999999999999999976432222222222222211 11
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPS 601 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 601 (645)
+.+ ..+.........+.+.-++.||.+|..
T Consensus 474 kqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 474 KQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 222 123333344555667788999998843
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=239.02 Aligned_cols=236 Identities=21% Similarity=0.283 Sum_probs=187.1
Q ss_pred HhcCCCcC-ceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeee----CCeE
Q 041096 346 ATRGFHSN-RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAE----KGEL 419 (645)
Q Consensus 346 ~~~~f~~~-~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~ 419 (645)
.|++|.+. ++||-|-.|+|-.+..+.+++.+|+|++..+. ...+|+++.-.. .|+|||.+++++.+ ...+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 34555544 57999999999999999999999999987643 455788775444 69999999998865 3568
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCeeeec--
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA---NFNARLES-- 494 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~---~~~~kl~d-- 494 (645)
++|||.|+||.|...+.++.. ..++..+.-.|+.||+.|+.|||+ .+|.||||||+|+|-.. |-..|+.|
T Consensus 135 LiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence 899999999999999987664 358999999999999999999999 99999999999999853 33446655
Q ss_pred ---------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchh
Q 041096 495 ---------SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRII 565 (645)
Q Consensus 495 ---------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 565 (645)
.....+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.........
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais----------------- 272 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------------- 272 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-----------------
Confidence 223456799999999999999999999999999999999999999875432111
Q ss_pred HHhhhhcc---CCCCHH----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 566 EAADKRLN---GAFNED----EMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 566 ~~~d~~l~---~~~~~~----~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.-+..+++ -+++.+ ..+...++++..++.+|.+|.|+.+++.
T Consensus 273 pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 273 PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11111111 133433 3456677888999999999999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=269.11 Aligned_cols=232 Identities=25% Similarity=0.384 Sum_probs=176.5
Q ss_pred CCcCceeccCCceE-EEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 350 FHSNRILGRGAFGN-VYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 350 f~~~~~lG~G~fg~-Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
|...+++|.|+.|+ ||+|... ++.||||++.... ..-..+|+..|+.- +|||||++++.-.+++..||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 55667899999986 7999997 7899999886533 23456899998887 5999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---C--CCeeeec--------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA---N--FNARLES-------- 494 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~---~--~~~kl~d-------- 494 (645)
..+|.+++...........-...+.+..|+++||++||+ .+||||||||+||||+. + ..++|+|
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 679999998742111111114456788999999999999 99999999999999976 2 4677766
Q ss_pred -------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 495 -------SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 495 -------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
......||-||+|||.+...+-+.++||||+|||+|..++ |..||......+ .+++.... .+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~------~L~- 733 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNY------TLV- 733 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCcc------cee-
Confidence 2233569999999999999999999999999999999999 589998643211 11111000 000
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVF 606 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl 606 (645)
.| ....++ ...+|+..|++++|..||++.+|+
T Consensus 734 ----~L--~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 734 ----HL--EPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ----ee--ccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 00 111122 667888999999999999999995
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=254.00 Aligned_cols=212 Identities=26% Similarity=0.383 Sum_probs=181.5
Q ss_pred cCHHHHHHHhc---CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeee
Q 041096 338 FSYRELRSATR---GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLL 410 (645)
Q Consensus 338 ~~~~~l~~~~~---~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~ 410 (645)
-.|-.|+.+.- -|...+.||-|+||.|.++.-.++...+|+|.+.+. +......++|-+||.....+=||+|+
T Consensus 616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 34444555442 366778899999999999999888899999998873 33455678899999999999999999
Q ss_pred eeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 411 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
-.|.+++.+|+||||++||++-.+|-+... +.+..+...+..+..|+++.|. .|+|||||||+|||||.++..
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCce
Confidence 999999999999999999999999987654 7777777788899999999999 999999999999999999999
Q ss_pred eeecc------------------------------------------------------ccccccCCcccCcccccCCCC
Q 041096 491 RLESS------------------------------------------------------FTLTAGTMGYLAPEYLQYGTA 516 (645)
Q Consensus 491 kl~d~------------------------------------------------------~~~~~gt~~y~APE~~~~~~~ 516 (645)
|+.|. -...+||..|+|||++....+
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~ 848 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY 848 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence 99660 011369999999999999999
Q ss_pred CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH
Q 041096 517 TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW 556 (645)
Q Consensus 517 t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~ 556 (645)
+.-+|+||.|||||||+.|+.||-.....+....+++|..
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh
Confidence 9999999999999999999999988777766667777753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-27 Score=240.57 Aligned_cols=145 Identities=26% Similarity=0.398 Sum_probs=124.1
Q ss_pred CCcccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-----C---CC
Q 041096 334 GPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-----H---KN 405 (645)
Q Consensus 334 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-----H---~n 405 (645)
|.+.....|... .++|...++||-|.|++||++.+..+.+.||+|+.+......+..+.||++|++++ | ..
T Consensus 65 GYHpV~IGD~F~-~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~ 143 (590)
T KOG1290|consen 65 GYHPVRIGDVFN-GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKC 143 (590)
T ss_pred CCceeecccccc-CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence 344444444432 36788999999999999999999999999999999988888888999999999984 2 47
Q ss_pred eeeeeeeeee----CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 041096 406 LVQLLGWCAE----KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASN 481 (645)
Q Consensus 406 iv~l~g~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N 481 (645)
||+|+++|.. +.++|||+|++ |-+|..++......+ ++.....+|++||+.||.|||.+ .+|||.||||+|
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPEN 218 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPEN 218 (590)
T ss_pred eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcce
Confidence 9999999875 45899999999 889999998765444 88999999999999999999995 699999999999
Q ss_pred EEE
Q 041096 482 IML 484 (645)
Q Consensus 482 Ill 484 (645)
|||
T Consensus 219 vLl 221 (590)
T KOG1290|consen 219 VLL 221 (590)
T ss_pred eee
Confidence 998
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=225.39 Aligned_cols=187 Identities=32% Similarity=0.436 Sum_probs=162.5
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccC--CcchhHhHHHHHHHHhh-cCCCCeeeeeeeeeeCCeEEEEEecCCCC
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKH--SHEGKTEFLAELSIIAC-LRHKNLVQLLGWCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 429 (645)
...||+|++|.|-+-++..+|...|+|++.. ..+.++..+.|+.+..+ ..+|.+|.++|...+....++.||.| ..
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence 4569999999999999999999999999876 45566778889988555 47999999999999999999999999 56
Q ss_pred CHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------cc
Q 041096 430 SLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-----------TL 498 (645)
Q Consensus 430 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-----------~~ 498 (645)
||+.+..+--..+..+++.-+-+|+..|.+||.|||+ ...++|||+||+|||+|.++.+|+.|.. +.
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~ 207 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTM 207 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHH
Confidence 8888876655556678999999999999999999999 4889999999999999999999998832 33
Q ss_pred cccCCcccCcccccC----CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 041096 499 TAGTMGYLAPEYLQY----GTATEKTDVFSYGVVVLEVACGRRPIERE 542 (645)
Q Consensus 499 ~~gt~~y~APE~~~~----~~~t~ksDV~SfGvvl~El~tG~~P~~~~ 542 (645)
..|-..|||||.+.. ..|+-||||||+|+.+.||++++.||+..
T Consensus 208 daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 208 DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 467889999998864 36899999999999999999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-29 Score=236.38 Aligned_cols=250 Identities=23% Similarity=0.377 Sum_probs=187.8
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccC--Ccc-hhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--------Ce
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH--SHE-GKTEFLAELSIIACLRHKNLVQLLGWCAEK--------GE 418 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~--~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~~ 418 (645)
|....+||+|.||.||++..++++..||+|+.-. .++ -....++|+++|..|+|+|++.++..|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 3344679999999999999999999999886543 222 245678999999999999999999998653 35
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS--- 495 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~--- 495 (645)
+|||+++|+. +|...|..... .++..++.+++.++..||.|+|. ..|+|||+||.|+||+.++..|+.|.
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 8999999954 88888876533 38899999999999999999999 99999999999999999999999872
Q ss_pred -------------ccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHH-------
Q 041096 496 -------------FTLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDW------- 554 (645)
Q Consensus 496 -------------~~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~------- 554 (645)
.+..+.|..|++||.+.+ +.|+++.|||.-||++.||+++.+-+.+..+... ..++..
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq-l~~Is~LcGs~tk 250 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ-LHLISQLCGSITK 250 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH-HHHHHHHhccCCc
Confidence 233455899999999876 5689999999999999999999988887654322 222222
Q ss_pred -HHhhhccCchhHHh--hhhccCCCC--HHHHH------HHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 555 -VWGLYAEGRIIEAA--DKRLNGAFN--EDEMK------RLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 555 -~~~~~~~~~~~~~~--d~~l~~~~~--~~~~~------~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+|....+-.+.+.+ .|.-.+.+. ++..+ ..++++..++..||.+|+.+.+++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 22222222222222 111111110 11111 4567778889999999999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=248.59 Aligned_cols=238 Identities=25% Similarity=0.367 Sum_probs=181.5
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcch--------hHhHHHHHHHHhhcCCCCeeeeeeeeee-CCeE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG--------KTEFLAELSIIACLRHKNLVQLLGWCAE-KGEL 419 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~--------~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 419 (645)
+|-..++||+|||+.||++.+-...+.||||+-...+.+ .+...+|.++.+.|.||.||++++|+.- .+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 466678899999999999999888899999986543322 2346789999999999999999999875 4678
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC---CCeeeec--
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN---FNARLES-- 494 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~---~~~kl~d-- 494 (645)
|-|+|||++.+|+-||+.+.. ++...+..|++||..||.||.+ ..++|||-||||.||||-.. +..||.|
T Consensus 544 CTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred eeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 999999999999999987654 8999999999999999999986 56899999999999999543 4456644
Q ss_pred -----------------cccccccCCcccCcccccC----CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHH
Q 041096 495 -----------------SFTLTAGTMGYLAPEYLQY----GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVD 553 (645)
Q Consensus 495 -----------------~~~~~~gt~~y~APE~~~~----~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~ 553 (645)
......||.+|++||++.- .+.+.|+||||.||++|..+.|+.||...-.. ..++.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---QdILq 695 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---QDILQ 695 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---HHHHh
Confidence 1233579999999998853 45799999999999999999999999764221 12221
Q ss_pred HHHhhhccCchhHHhhhhccCCCC--HHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 041096 554 WVWGLYAEGRIIEAADKRLNGAFN--EDEMKRLLLVGLSCANPDSSARPSMRRV 605 (645)
Q Consensus 554 ~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPt~~~v 605 (645)
...+..+-.- .++ +........++..|+...-++|....++
T Consensus 696 -------eNTIlkAtEV----qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 696 -------ENTILKATEV----QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred -------hhchhcceec----cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 1111111111 111 1123345567789999988888765544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=252.85 Aligned_cols=236 Identities=21% Similarity=0.253 Sum_probs=194.2
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
+++....||-||||.|=++..+......|+|++++ .....+....|-.+|...+.|.||+|+-.+.+.+..|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 44455679999999999999876555688898876 23445678899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec----------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES---------- 494 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d---------- 494 (645)
-|-+|.|...|.++.. ++......++.++.+|++|||+ ++||.|||||+|.|||.++-+|+-|
T Consensus 501 aClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999987654 7778888899999999999999 9999999999999999999999976
Q ss_pred -cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 495 -SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 495 -~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
.....+||+.|.|||++.....+.++|.||+|++++||++|++||...++-..+..++.. +|.
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-------------id~--- 637 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-------------IDK--- 637 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-------------hhh---
Confidence 345579999999999999999999999999999999999999999886542222111111 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPS-----MRRVFQ 607 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~~vl~ 607 (645)
-.++....+...++++..++.+|.+|.- ..++-+
T Consensus 638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 1345555666777888888999999977 556544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-26 Score=221.92 Aligned_cols=198 Identities=35% Similarity=0.517 Sum_probs=176.3
Q ss_pred eccCCceEEEEEEECCCCeEEEEEeccCCcc--hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCHhH
Q 041096 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHE--GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDR 433 (645)
Q Consensus 356 lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 433 (645)
||+|.+|.||++....++..+++|++..... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999988889999999887544 35789999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCeeeecc------------ccccc
Q 041096 434 MLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA-NFNARLESS------------FTLTA 500 (645)
Q Consensus 434 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~-~~~~kl~d~------------~~~~~ 500 (645)
++.... ..+++..+..++.++++++++||+ .+++|+||+|.||+++. +...++.|. .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 997653 238999999999999999999999 89999999999999999 888888772 22244
Q ss_pred cCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHH
Q 041096 501 GTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED 579 (645)
Q Consensus 501 gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 579 (645)
+...|++||..... ..+.++|+|++|++++||
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 77889999999877 889999999999999999
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 580 EMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 580 ~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
..+.+++..|++.+|.+||+++++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 457788899999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=246.43 Aligned_cols=184 Identities=26% Similarity=0.415 Sum_probs=159.6
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCC
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 429 (645)
.++||+|.||+||-|+++.+|+.||||.+.+ .........+|+.+|+++.||.||.|...|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 4789999999999999999999999998876 4455678999999999999999999999999999999999999 56
Q ss_pred CHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---Ceeeec-----------c
Q 041096 430 SLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF---NARLES-----------S 495 (645)
Q Consensus 430 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~---~~kl~d-----------~ 495 (645)
+..+.+....+ ..|+......++.||+.||.|||. ++|+|+||||+||||.+.. .+|+.| .
T Consensus 648 DMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILSSEK--GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 66555543332 238888888999999999999999 9999999999999996542 345555 2
Q ss_pred ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 041096 496 FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERE 542 (645)
Q Consensus 496 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~ 542 (645)
....+||+.|+|||++....|+..-|+||.||++|--++|.-||...
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 34568999999999999999999999999999999999999999764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=243.17 Aligned_cols=186 Identities=23% Similarity=0.341 Sum_probs=164.2
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhH---------hHHHHHHHHhhcC---CCCeeeeeeeeeeC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT---------EFLAELSIIACLR---HKNLVQLLGWCAEK 416 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~---------~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 416 (645)
.|...+.+|+|+||.|+.|.++.+...|+||.+.+.+--.. ..-.||.+|..|+ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 57788899999999999999999999999998876432221 2456999999997 99999999999999
Q ss_pred CeEEEEEecC-CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec-
Q 041096 417 GELLLVYEYM-PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES- 494 (645)
Q Consensus 417 ~~~~lV~Ey~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d- 494 (645)
+.+||+||-. ++.+|.+++..+.. ++.....-|++||+.|+++||+ ++|+|||||-+||.||.++.+|+.|
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeec
Confidence 9999999986 56689999976554 8999999999999999999999 9999999999999999999999987
Q ss_pred ---------cccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCc
Q 041096 495 ---------SFTLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIER 541 (645)
Q Consensus 495 ---------~~~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~ 541 (645)
.+...+||..|.|||++.+.+| ...-|||++|++||-++....||..
T Consensus 715 gsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 3455689999999999999988 5668999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-25 Score=216.74 Aligned_cols=186 Identities=34% Similarity=0.485 Sum_probs=164.4
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc--hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE--GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
|+..+.||+|++|.||++....++..+++|....... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999988789999999876433 46789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----------- 496 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----------- 496 (645)
+++|.+++...... +++.....++.+++.++.|||+ .+++|+||+|+||+++.++..++.|..
T Consensus 81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999999765432 7899999999999999999999 899999999999999999999887621
Q ss_pred --cccccCCcccCcccc-cCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 041096 497 --TLTAGTMGYLAPEYL-QYGTATEKTDVFSYGVVVLEVACGRRPIER 541 (645)
Q Consensus 497 --~~~~gt~~y~APE~~-~~~~~t~ksDV~SfGvvl~El~tG~~P~~~ 541 (645)
....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 223567789999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=210.98 Aligned_cols=249 Identities=19% Similarity=0.306 Sum_probs=185.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeC--CeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HKNLVQLLGWCAEK--GELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 423 (645)
.++|+..+++|+|.++.||.|....+++.++||+++..+ .+.+.+|+.+|..|+ ||||++|++...+. ....||+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 357888899999999999999988888999999987633 457889999999997 99999999998765 4678999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC-eeeec--------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN-ARLES-------- 494 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~-~kl~d-------- 494 (645)
||+.+.+....... |+-.++...+.++++||.|+|+ .||.|||+||.|+|+|.... .++.|
T Consensus 115 E~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 115 EYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99998887766532 7778888999999999999999 99999999999999996543 45544
Q ss_pred ---cccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh-----------
Q 041096 495 ---SFTLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY----------- 559 (645)
Q Consensus 495 ---~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~----------- 559 (645)
.....+.+..|.-||.+.. +.|+..-|+|||||+|.+|+..+.||....+......-+..+.+.-
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 3445567888999998865 6789999999999999999999999975443322111111111110
Q ss_pred -ccCchhHHhhhhccCCC-----CH--H-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 560 -AEGRIIEAADKRLNGAF-----NE--D-EMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 560 -~~~~~~~~~d~~l~~~~-----~~--~-~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
-+.+..+++....+..+ +. . .....++++...+..|-++|||++|.+.
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01111122211111111 00 1 1245677778889999999999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-26 Score=220.76 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=184.4
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-----CeEEEE
Q 041096 351 HSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK-----GELLLV 422 (645)
Q Consensus 351 ~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV 422 (645)
+..+-||.|+||.||..++..+|+.||+|++..- -...+.+.+|+++|...+|.|++..++...-. +++|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457799999999999999999999999988763 23457788999999999999999998876543 257889
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS------- 495 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~------- 495 (645)
+|.| ..+|..++-... .|+-....-+..||++||.|||+ .+|.||||||.|.|++++...||.|.
T Consensus 136 TELm-QSDLHKIIVSPQ----~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSPQ----ALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHH-HhhhhheeccCC----CCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccc
Confidence 9988 557877775433 38888888899999999999999 99999999999999999999999872
Q ss_pred ------ccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc--------
Q 041096 496 ------FTLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA-------- 560 (645)
Q Consensus 496 ------~~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~-------- 560 (645)
.+..+.|.+|+|||.+.+ +.|+.+.||||.||++.||+..+..|.....-+.. .++....+...
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL-~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL-QMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH-HHHHHHhCCCcHHHHHHHh
Confidence 334567889999999987 56899999999999999999888888654322111 11111111111
Q ss_pred cCchhHHhhhhccCC--------CC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 561 EGRIIEAADKRLNGA--------FN-EDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 561 ~~~~~~~~d~~l~~~--------~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
+|....++....+.. .+ .+.-.....+...++..||.+|.+..+.+..+..
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 111111111111100 01 1111223345567899999999999998887643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=214.91 Aligned_cols=252 Identities=21% Similarity=0.245 Sum_probs=186.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC------Ce
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK------GE 418 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 418 (645)
.+|...+.+|.|.- .|.-+.+.-.+++||+|+.... ....+...+|..++..++|+|+++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45556677888887 7777877777899999987653 33445678999999999999999999988644 36
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec----
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES---- 494 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d---- 494 (645)
.|+||||| ..+|...+... ++-.....|..|++.|++|||+ .+|+||||||+||++..+...|+.|
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhh
Confidence 89999999 67999888732 6677888999999999999999 9999999999999999999999976
Q ss_pred -------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchh---------------hHH
Q 041096 495 -------SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMV---------------NLV 552 (645)
Q Consensus 495 -------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~---------------~l~ 552 (645)
..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+..|.+.+.-+... .+.
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 2234567889999999999889999999999999999999999887543211111 111
Q ss_pred HHHHhhhccCc------hhHHhhhh-ccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHc
Q 041096 553 DWVWGLYAEGR------IIEAADKR-LNG--AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILN 610 (645)
Q Consensus 553 ~~~~~~~~~~~------~~~~~d~~-l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~ 610 (645)
..+........ ..+.+... ... +.+.-.......++..|+-.+|++|-+.+++++ +++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 11111111000 00000000 000 011122345667778999999999999999998 454
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-25 Score=228.38 Aligned_cols=273 Identities=20% Similarity=0.200 Sum_probs=210.5
Q ss_pred cccCCCCCcccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-----
Q 041096 328 RADLVPGPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR----- 402 (645)
Q Consensus 328 ~~~~~~~~~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~----- 402 (645)
.|+...|.....+.|+. -.+|.+....|+|-|++|.+|.+...+..||||++.....-.+.=+.|+++|.+|+
T Consensus 414 NWdDaEGYYrv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~E 491 (752)
T KOG0670|consen 414 NWDDAEGYYRVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPE 491 (752)
T ss_pred CcccccceEEEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCch
Confidence 34455566666666653 46788888899999999999999888899999999987776777789999999996
Q ss_pred -CCCeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 041096 403 -HKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASN 481 (645)
Q Consensus 403 -H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N 481 (645)
.-|+++|+-.|...+++|||+|-+ ..+|.+.|++... ..-|........+.|+.-||..|-. .+|+|.||||.|
T Consensus 492 dk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDN 566 (752)
T KOG0670|consen 492 DKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDN 566 (752)
T ss_pred hhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccc
Confidence 358999999999999999999988 6799999987654 3347888889999999999999998 899999999999
Q ss_pred EEEcCCCC-eeeeccccc----------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhh
Q 041096 482 IMLDANFN-ARLESSFTL----------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVN 550 (645)
Q Consensus 482 Illd~~~~-~kl~d~~~~----------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~ 550 (645)
|||++.-+ .||+|.... ...+.-|.|||++.+-.|+...|+||.||.||||.||+..|.+....++...
T Consensus 567 iLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 567 ILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred eEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 99997654 577774332 2234569999999999999999999999999999999999998776555443
Q ss_pred HHHHHHhh----hccCc---------------------------hhHHhhh------hccC--CCCHH---HHHHHHHHH
Q 041096 551 LVDWVWGL----YAEGR---------------------------IIEAADK------RLNG--AFNED---EMKRLLLVG 588 (645)
Q Consensus 551 l~~~~~~~----~~~~~---------------------------~~~~~d~------~l~~--~~~~~---~~~~l~~l~ 588 (645)
.++..... +..+. ++..+.| .|.+ .++.+ ....+..|.
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 33321111 11110 0111111 1111 13333 455677888
Q ss_pred HHccCCCCCCCCCHHHHHH
Q 041096 589 LSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 589 ~~Cl~~dP~~RPt~~~vl~ 607 (645)
-.|+..||++|.|..+.++
T Consensus 727 dkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 727 DKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHhccChhhcCCHHHHhc
Confidence 9999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=238.95 Aligned_cols=241 Identities=24% Similarity=0.317 Sum_probs=194.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC-CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
..+|....++|.|.+|.|||+++..+++..|+|.++. ...+.+-...|+-+++..+|+|||.++|.+...+.+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4578888999999999999999999999999999887 455566778899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
|.+|+|.+..+... +++..++...++...+||+|||+ .+-+|||||-.|||+++.+.+|+.|+.
T Consensus 94 cgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999887544 38999999999999999999999 999999999999999999999997722
Q ss_pred ---cccccCCcccCcccc---cCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 ---TLTAGTMGYLAPEYL---QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~---~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....||++|||||+. ..+.|.+++|||+.|+...|+..-+.|...... +..+.--....+. -+
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---mr~l~LmTkS~~q--------pp 235 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---MRALFLMTKSGFQ--------PP 235 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---HHHHHHhhccCCC--------CC
Confidence 234699999999976 356799999999999999999888877544221 1111000000000 01
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.++ -.....+.+-++++.|+..+|++||+++.+++
T Consensus 236 ~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 12234567788899999999999999877654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-25 Score=256.71 Aligned_cols=182 Identities=17% Similarity=0.240 Sum_probs=133.3
Q ss_pred hcCC-CCeeeeeeee-------eeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 041096 400 CLRH-KNLVQLLGWC-------AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471 (645)
Q Consensus 400 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 471 (645)
.++| +||++++++| .+.+.+++++||+ .++|.++|.... ..+++.+++.++.||++||+|||+ ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 4556 6888899887 2334678889988 669999997532 238999999999999999999998 99
Q ss_pred eeeCCCCCCcEEEcCCC-------------------Ceeeeccc----------------------------cccccCCc
Q 041096 472 VIHRDIKASNIMLDANF-------------------NARLESSF----------------------------TLTAGTMG 504 (645)
Q Consensus 472 ivHrDlkp~NIlld~~~-------------------~~kl~d~~----------------------------~~~~gt~~ 504 (645)
|+||||||+||||+..+ ..|+.|.. ....||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996433 34443311 01247888
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHH
Q 041096 505 YLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRL 584 (645)
Q Consensus 505 y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 584 (645)
|||||++.+..++.++|||||||+||||++|..|+..... .+..... ....+.. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~---------~~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRH---------RVLPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHH---------hhcChhh-----hhcCHHH
Confidence 9999999999999999999999999999998887643110 0000000 0001100 1112334
Q ss_pred HHHHHHccCCCCCCCCCHHHHHH
Q 041096 585 LLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 585 ~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..++.+||+++|.+||+|.|+++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 57778999999999999999986
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-25 Score=211.26 Aligned_cols=238 Identities=19% Similarity=0.346 Sum_probs=190.8
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGS 430 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 430 (645)
.+|.+...|..|+|+++. ..+++|++.- .....++|.+|.-.|+-..||||+.++|.|.....+.++..||+.||
T Consensus 196 tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 458888999999999974 4455666543 33345689999999999999999999999999999999999999999
Q ss_pred HhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---cc----ccccCC
Q 041096 431 LDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS---FT----LTAGTM 503 (645)
Q Consensus 431 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~---~~----~~~gt~ 503 (645)
|+..|+... +...+-.+..+++.++|+||+|||+. ++-|.---|.+..+++|++.+++|+-. ++ ...-.+
T Consensus 274 lynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y~p 350 (448)
T KOG0195|consen 274 LYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAYSP 350 (448)
T ss_pred HHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeeccccccCc
Confidence 999998754 34577789999999999999999984 233334468999999999999999641 11 123367
Q ss_pred cccCcccccCCCC---CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHH
Q 041096 504 GYLAPEYLQYGTA---TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDE 580 (645)
Q Consensus 504 ~y~APE~~~~~~~---t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 580 (645)
.||+||.++..+. -.++|+|||+++||||.|...||.....-+. -.++.-+.|+...++..
T Consensus 351 awmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec----------------gmkialeglrv~ippgi 414 (448)
T KOG0195|consen 351 AWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC----------------GMKIALEGLRVHIPPGI 414 (448)
T ss_pred ccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh----------------hhhhhhccccccCCCCc
Confidence 8999999987554 3579999999999999999999976543211 12334456666778888
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 581 MKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 581 ~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
...+.+++.-|.+.||.+||.+..++-+|++.
T Consensus 415 s~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 88999999999999999999999999988864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=218.34 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=186.7
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEECC---CCeEEEEEeccCCcchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCe
Q 041096 343 LRSATRGFHSNRILGRGAFGNVYKAYFAS---SGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGE 418 (645)
Q Consensus 343 l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~---~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 418 (645)
+....+.|...++||+|.|++||++++.. ....||+|.+.... ......+|+++|..+. +.||+++.+++...+.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 44455678899999999999999999877 67899999886632 2345889999999995 9999999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCee-e-----
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR-L----- 492 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~k-l----- 492 (645)
..+|+||++.....+++.. ++..++...+..+..||+++|+ ++|+||||||+|+|-+.....- +
T Consensus 110 v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechh
Confidence 9999999999999998864 7788899999999999999999 9999999999999853211100 0
Q ss_pred -------------------------ec--------------------------cccccccCCcccCcccccC-CCCCcch
Q 041096 493 -------------------------ES--------------------------SFTLTAGTMGYLAPEYLQY-GTATEKT 520 (645)
Q Consensus 493 -------------------------~d--------------------------~~~~~~gt~~y~APE~~~~-~~~t~ks 520 (645)
+. ..-...||+||.|||++.. +..++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 00 0112469999999999875 5679999
Q ss_pred hHHHHHHHHHHHHcCCCCCCccccccc-hhhHHHHH-----Hh-hhccCc-----------hhHHh------h-hhccC-
Q 041096 521 DVFSYGVVVLEVACGRRPIERETEGHK-MVNLVDWV-----WG-LYAEGR-----------IIEAA------D-KRLNG- 574 (645)
Q Consensus 521 DV~SfGvvl~El~tG~~P~~~~~~~~~-~~~l~~~~-----~~-~~~~~~-----------~~~~~------d-~~l~~- 574 (645)
||||-|||++-+++++.||......-. ...++... .. ....+. +.+.. + ..+..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 999999999999999999976543211 11111100 00 000011 00000 0 00000
Q ss_pred --------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 575 --------AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 575 --------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
......+..++++..+|+..||.+|-|+++.++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 011112347889999999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=195.64 Aligned_cols=161 Identities=23% Similarity=0.184 Sum_probs=118.1
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec-----cccccccCC
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES-----SFTLTAGTM 503 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d-----~~~~~~gt~ 503 (645)
|+|.+++..... .++|.+++.++.|+++||+|||+ .+ ||+|||++.++..++-. ......||+
T Consensus 1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~fG~~~~~~~~~~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKLDGSVAFKTPEQSRVDP 68 (176)
T ss_pred CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceeeccceEeeccccCCCcc
Confidence 789999976432 39999999999999999999998 44 99999999998888711 112236899
Q ss_pred cccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHH-
Q 041096 504 GYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMK- 582 (645)
Q Consensus 504 ~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~- 582 (645)
.|||||++.+..++.++|||||||++|||++|+.||........ .+.......... ++.- .........
T Consensus 69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~-------~~~~-~~~~~~~~~~ 138 (176)
T smart00750 69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMPAD-------DPRD-RSNLESVSAA 138 (176)
T ss_pred cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhccC-------Cccc-cccHHHHHhh
Confidence 99999999999999999999999999999999999965322111 111111110000 0000 011122222
Q ss_pred -HHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 583 -RLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 583 -~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
.+.+++..||+.+|.+||++.++++.+..
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 58999999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-22 Score=195.17 Aligned_cols=190 Identities=28% Similarity=0.290 Sum_probs=136.6
Q ss_pred CCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCCCceEEEEecCC
Q 041096 34 LRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDN 113 (645)
Q Consensus 34 ~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~p~~ 113 (645)
..++.+.|+|.+.++.|+||++ ..++.|++||+.|+++ ++|+|+|+|+|.+.. ..+||||||+++|..
T Consensus 19 ~~~w~~~G~a~~~~~~i~LT~~---~~~~~G~~~~~~pi~~--------~~F~~~f~F~i~~~~-~~~gdG~af~~~~~~ 86 (218)
T cd07308 19 IGNWTVGGSTVITKNYIRLTPD---VPSQSGSLWSRVPIPA--------KDFEIEVEFSIHGGS-GLGGDGFAFWYTEEP 86 (218)
T ss_pred cCCeEEcCCeEEeCCEEEeCCC---CCCCEeEEEeCCCccC--------CCEEEEEEEEEeCCC-CCCCCEEEEEEECCC
Confidence 4689999999999999999997 4678999999999998 489999999998764 568999999999965
Q ss_pred CCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcc-ccc------ccCCCccccccC-CCCeE
Q 041096 114 QILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLE-SIK------TADPILQGIDLK-SGNVI 185 (645)
Q Consensus 114 ~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~-s~~------~~~~~~~~~~~~-~g~~~ 185 (645)
.. .|..+|. ....+.+||||||+.|. +-...+|.+-+|.-. +.. ......-.+... .+.++
T Consensus 87 ~~---~g~~~G~-----~~~~~Glai~fdt~~n~---~~~~p~i~~~~Ndg~~~~~~~~d~~~~~~~~c~~~~~~~~~~~ 155 (218)
T cd07308 87 GS---DGPLFGG-----PDKFKGLAIFFDTYDND---GKGFPSISVFLNDGTKSYDYETDGEKLELASCSLKFRNSNAPT 155 (218)
T ss_pred CC---CCccccc-----CCCCCEEEEEEEcCCCC---CCCCCeEEEEEeCCCceecccCCCccccccceeEecccCCCCe
Confidence 43 4555565 23467799999999985 223345555443322 110 111111111222 26789
Q ss_pred EEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeeeee
Q 041096 186 TAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQ 251 (645)
Q Consensus 186 ~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~ 251 (645)
+++|.|+ .+.|.|.+.+........++.. +.. .+|+..|+||||+||...+.|.|++|.+.
T Consensus 156 ~~~I~y~--~~~l~v~i~~~~~~~~~~c~~~--~~~-~l~~~~y~G~sA~tg~~~d~~dIls~~~~ 216 (218)
T cd07308 156 TLRISYL--NNTLKVDITYSEGNNWKECFTV--EDV-ILPSQGYFGFSAQTGDLSDNHDILSVHTY 216 (218)
T ss_pred EEEEEEE--CCEEEEEEeCCCCCCccEEEEc--CCc-ccCCCCEEEEEeccCCCcCcEEEEEEEee
Confidence 9999999 6899999975433333333322 211 46788999999999999999999999874
|
The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-23 Score=200.65 Aligned_cols=245 Identities=20% Similarity=0.342 Sum_probs=182.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeee-eeeCCeEEEEEe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGW-CAEKGELLLVYE 424 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E 424 (645)
.+.|.+.+.||+|.||.+-++.++.++..+++|.+.......++|.+|...--.| .|.||+.-+.. ++..+.+..++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 3567888999999999999999999999999999988888889999998775556 48999988764 677788899999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE-cCC-CCeeeeccc-ccccc
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML-DAN-FNARLESSF-TLTAG 501 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll-d~~-~~~kl~d~~-~~~~g 501 (645)
|+|.|+|.+-+...+ +......+++.|+++|+.|+|+ ..+||||||.+|||| +.| ..+|+.|.. +...|
T Consensus 103 ~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999999886533 7778888999999999999999 999999999999998 333 367777732 22233
Q ss_pred --------CCcccCcccccC---C--CCCcchhHHHHHHHHHHHHcCCCCCCccccc-cchhhHHHHHHhhhccCchhHH
Q 041096 502 --------TMGYLAPEYLQY---G--TATEKTDVFSYGVVVLEVACGRRPIERETEG-HKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 502 --------t~~y~APE~~~~---~--~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
+..|.+||.... + ...+.+|||.||++++.++||+.||+..... ..+.....| ..+...
T Consensus 175 ~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w-----~~rk~~-- 247 (378)
T KOG1345|consen 175 TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW-----LKRKNP-- 247 (378)
T ss_pred ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH-----hcccCc--
Confidence 456899997653 2 2477899999999999999999999854321 122222333 222211
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
.-|+.-..+. +.++.+-..-+.++|++|=...++.++..
T Consensus 248 ~~P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 248 ALPKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cCchhhcccC----HHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 1112212232 34445556778899999966555555443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-20 Score=193.10 Aligned_cols=153 Identities=22% Similarity=0.235 Sum_probs=120.7
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECC-CCeEEEEEeccCC------cchhHhHHHHHHHHhhcCCCCeee-eeeeeee
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFAS-SGSVAAVKRSKHS------HEGKTEFLAELSIIACLRHKNLVQ-LLGWCAE 415 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~-~~~~vavK~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~ 415 (645)
....++|...+.||+|+||+||+|.+.. ++..+|||+.... ....+.|.+|+++|++++|+|++. ++.+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456789999999999999999998865 6788899986532 123556999999999999999985 4432
Q ss_pred CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC-CCCcEEEcCCCCeeeec
Q 041096 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDI-KASNIMLDANFNARLES 494 (645)
Q Consensus 416 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-kp~NIlld~~~~~kl~d 494 (645)
+..+|||||+++++|... . . .. ...++.|++++|.|||+ ++|+|||| ||+|||++.++.++|.|
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~--~-----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-R--P-----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-C--c-----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 457999999999999632 1 1 11 14578899999999999 99999999 99999999999999987
Q ss_pred cc--------------------cccccCCcccCcccccCC
Q 041096 495 SF--------------------TLTAGTMGYLAPEYLQYG 514 (645)
Q Consensus 495 ~~--------------------~~~~gt~~y~APE~~~~~ 514 (645)
.. ....++..|+|||.+...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 22 123467789999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-18 Score=177.78 Aligned_cols=247 Identities=31% Similarity=0.407 Sum_probs=185.7
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc----hhHhHHHHHHHHhhcCCC-CeeeeeeeeeeCCeEEEEEe
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE----GKTEFLAELSIIACLRHK-NLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~----~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~E 424 (645)
|...+.||.|+||.||++... ..+++|.+..... ....+.+|+.++..+.|+ +++++.+.+......++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 556778999999999999987 6788888776322 367899999999999988 79999999977777899999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-Ceeeecc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-NARLESS-------- 495 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~-~~kl~d~-------- 495 (645)
|+.+++|.+++...... ..+.......++.|++.++.|+|+ .+++|||+||+||+++... ..++.|.
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999777654321 238889999999999999999999 8999999999999999888 5777651
Q ss_pred ----------ccccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC
Q 041096 496 ----------FTLTAGTMGYLAPEYLQY---GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG 562 (645)
Q Consensus 496 ----------~~~~~gt~~y~APE~~~~---~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~ 562 (645)
.....|+..|+|||.+.. ..+....|+||+|++++++++|..||.............+........
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP- 233 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-
Confidence 134578999999999987 578999999999999999999999976543210011111111111100
Q ss_pred chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 563 RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 563 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223567788889999999999999887764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-18 Score=182.32 Aligned_cols=249 Identities=20% Similarity=0.213 Sum_probs=184.8
Q ss_pred CCCcCceeccCCceEEEEEEECCCC-eEEEEEeccCCc-chhHhHHHHHHHHhhcCC----CCeeeeeeee-eeCCeEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSG-SVAAVKRSKHSH-EGKTEFLAELSIIACLRH----KNLVQLLGWC-AEKGELLL 421 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~-~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l 421 (645)
+|...++||+|+||.||++.....+ ..+|+|...... .....+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7889999999999999999987654 578888766532 222268889999999873 5888888888 47778899
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-----Ceeeec--
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-----NARLES-- 494 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~-----~~kl~d-- 494 (645)
||+.+ +.+|.++..... ...++..+.+.|+.|++.+|++||+ .+++||||||.|+++.... ...+.|
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99998 899999876554 3348999999999999999999999 9999999999999997553 222222
Q ss_pred ---------c-----------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHH
Q 041096 495 ---------S-----------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDW 554 (645)
Q Consensus 495 ---------~-----------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~ 554 (645)
. .....||..|.++....+...+.+.|+||++.++.|+..|..||...........+..
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~- 251 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK- 251 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH-
Confidence 0 1123499999999999999999999999999999999999999966443222111111
Q ss_pred HHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 555 VWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 555 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
..............+..+.++...+-..+...+|....+...|++.....
T Consensus 252 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 252 ------------DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ------------HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111111011223344555555566689999999999998887665544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-19 Score=200.72 Aligned_cols=237 Identities=24% Similarity=0.215 Sum_probs=170.0
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHH--HhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSI--IACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++...+.||++.|=+|.+|++.+ |. |+||++-+. .-..+.|.++++- ...++|||.+.+.-+-...+..|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 56667889999999999999875 44 788887652 2334445444433 455689999999988777777889999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec----------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES---------- 494 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d---------- 494 (645)
|+ .-+|++.|..+. .|...+...|+.|++.||.-+|. .+|+|||||.+||||++-+=+-+.|
T Consensus 102 yv-khnLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HH-hhhhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 98 448888886543 47888899999999999999999 9999999999999998644444433
Q ss_pred ---------cccccccCCcccCcccccCC-----------CCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHH
Q 041096 495 ---------SFTLTAGTMGYLAPEYLQYG-----------TATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVD 553 (645)
Q Consensus 495 ---------~~~~~~gt~~y~APE~~~~~-----------~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~ 553 (645)
.+.....-.+|+|||-+... ..+++-||||.||++.||++ |++||.- ..+..
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~a 246 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLA 246 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHh
Confidence 22222334579999976431 15778999999999999988 6777753 23333
Q ss_pred HHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 554 WVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 554 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+.... ....+.+-..+.. ..+.++++.|++.||++|.++++.++.-.+.
T Consensus 247 Yr~~~---~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 YRSGN---ADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HhccC---ccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 22111 1111111122211 2577888999999999999999998874433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.5e-19 Score=187.92 Aligned_cols=204 Identities=22% Similarity=0.352 Sum_probs=155.8
Q ss_pred HhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe-eeCC
Q 041096 398 IACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV-IHRD 476 (645)
Q Consensus 398 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vHrD 476 (645)
|+.+.|.|+.+++|.|.++...++|.+||..|+|.+.+.....+ ++|.....++++++.||+|||. .+| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~---~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIK---LDYFFILSFIRDISKGLAYLHN---SPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccC---ccHHHHHHHHHHHHHHHHHHhc---Ccceeeee
Confidence 45789999999999999999999999999999999999875443 9999999999999999999998 454 9999
Q ss_pred CCCCcEEEcCCCCeeeeccccccc--------------cCCcccCcccccCCC-------CCcchhHHHHHHHHHHHHcC
Q 041096 477 IKASNIMLDANFNARLESSFTLTA--------------GTMGYLAPEYLQYGT-------ATEKTDVFSYGVVVLEVACG 535 (645)
Q Consensus 477 lkp~NIlld~~~~~kl~d~~~~~~--------------gt~~y~APE~~~~~~-------~t~ksDV~SfGvvl~El~tG 535 (645)
++++|+++|.....|+.+..-... -..-|.|||.+.... .+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999977221111 123489999987631 47789999999999999999
Q ss_pred CCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 536 RRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 536 ~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
+.||...........++..+.. .-.....|.+... .+....+..++..||..+|.+||++++|-..++....
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999875433322233333222 0001111111110 1334478999999999999999999999988875543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.8e-19 Score=199.53 Aligned_cols=239 Identities=22% Similarity=0.281 Sum_probs=176.0
Q ss_pred cCceeccCCceEEEEEEECCCCeEEEEEecc----CCcc---hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 352 SNRILGRGAFGNVYKAYFASSGSVAAVKRSK----HSHE---GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 352 ~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~----~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
..+++|.|.+|.|+...........+.|... .... ....+..|+.+-..++|+|++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999988877765545544544332 2111 11225667788888999999998888877766666699
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
||++ +|...+..... +.-.++..+++|+..|+.|||+ .++.|||+|++|++++.++..|+.|..
T Consensus 402 ~~~~-Dlf~~~~~~~~----~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGK----LTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhcccc----cchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 99999976522 7888899999999999999999 999999999999999999999997722
Q ss_pred --------cccccCCcccCcccccCCCCCc-chhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHH
Q 041096 497 --------TLTAGTMGYLAPEYLQYGTATE-KTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~~~~t~-ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
...+|+..|+|||.+....|.+ ..||||.|+++..|++|+.||......+....... ...+...
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-----~~~~~~~-- 546 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-----YSDQRNI-- 546 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc-----ccccccc--
Confidence 2346899999999999998865 68999999999999999999976543322110000 0000000
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.... ...-...+.....++..+++++|.+|-|+++|++
T Consensus 547 -~~~~-~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 -FEGP-NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -ccCh-HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000 0112234566777888999999999999999986
|
|
| >cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-16 Score=159.02 Aligned_cols=196 Identities=19% Similarity=0.220 Sum_probs=131.1
Q ss_pred CCCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCCCceEEEEecC
Q 041096 33 NLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPD 112 (645)
Q Consensus 33 ~~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~p~ 112 (645)
...++.+.|+|.+.++.|+||++ .+++.|++||+.|+++ .+|+|+|+|+|.+.+...+||||||+++..
T Consensus 18 ~i~~w~~~G~a~v~~~~IrLTp~---~~~~~G~~w~~~p~~~--------~~F~~~f~F~I~~~~~~~~GdGlAfw~t~~ 86 (248)
T cd06901 18 SMPLWDFLGSTMVTSQYIRLTPD---HQSKQGSIWNRVPCYL--------RDWEMHVHFKVHGSGKNLFGDGFAIWYTKE 86 (248)
T ss_pred CCCCEEEcceEEEcCCeEEECCC---CCCCEEEEeccCCccC--------CCEEEEEEEEEeCCCCCCCCCEEEEEEEcC
Confidence 36799999999999999999997 3457999999999998 579999999999876667899999999986
Q ss_pred CCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCC-CCCCCeeeeecCCc-ccccc------cCCC--ccccccCCC
Q 041096 113 NQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFD-DPDENHIGLDIDSL-ESIKT------ADPI--LQGIDLKSG 182 (645)
Q Consensus 113 ~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~-d~~~~Hvgi~vns~-~s~~~------~~~~--~~~~~~~~g 182 (645)
.. ..|..+|-. ....-+||-|||+.|..-. .....-|.+-+|.- ..-.. .... ...+ -+.+
T Consensus 87 ~~---~~G~~fG~~-----~~f~Gl~I~~Dt~~n~~~~~~~~~P~i~~~~NDGt~~yd~~~Dg~~~~~~~C~~~~-rn~~ 157 (248)
T cd06901 87 RM---QPGPVFGSK-----DNFHGLAIFFDTYSNQNGEHEHVHPYISAMVNNGSLSYDHDRDGTHTELAGCSAPF-RNKD 157 (248)
T ss_pred CC---ccCcccccC-----CCCceEEEEEECCCCCCCcccCCCceEEEEEcCCCeeecccCCCchhhcCceeeec-cCCC
Confidence 54 234444442 2244589999999885310 01112233322221 11000 0001 1111 1334
Q ss_pred CeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeeeeeec
Q 041096 183 NVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTS 253 (645)
Q Consensus 183 ~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~~~ 253 (645)
.+.+++|.|.. ..+.|.++..+...-..|+.. -.-.||...|+||||+||...+.|.|++-.+...
T Consensus 158 ~~t~~rI~Y~~--~~l~v~vd~~~~~~w~~Cf~~---~~v~LP~~~yfGiSA~Tg~~sd~hdIlsv~~~~l 223 (248)
T cd06901 158 HDTFVAIRYSK--GRLTVMTDIDGKNEWKECFDV---TGVRLPTGYYFGASAATGDLSDNHDIISMKLYEL 223 (248)
T ss_pred CCeEEEEEEEC--CeEEEEEecCCCCceeeeEEe---CCeecCCCCEEEEEecCCCCCCcEEEEEEEEecC
Confidence 55789999996 457777764332222334332 1223577799999999999999999999887653
|
The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=168.10 Aligned_cols=224 Identities=19% Similarity=0.250 Sum_probs=147.3
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCC----------CCeeeeeeee--
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRH----------KNLVQLLGWC-- 413 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H----------~niv~l~g~~-- 413 (645)
+...+.||.|+++.||.+++.++++.+|+|.+... ....+++++|.-....+.+ -.++.-++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 34467899999999999999999999999976542 2334567777655555432 1222222211
Q ss_pred -------eeCC--------eEEEEEecCCCCCHhHHhh---hcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 041096 414 -------AEKG--------ELLLVYEYMPNGSLDRMLY---QDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHR 475 (645)
Q Consensus 414 -------~~~~--------~~~lV~Ey~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 475 (645)
.... ..+++|+-+ .++|...+. ........+....++.+..|+.+.+++||+ .+++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 1111 236778877 678877753 333223345667788888999999999999 999999
Q ss_pred CCCCCcEEEcCCCCeeeeccccc---------cccCCcccCcccccCC--------CCCcchhHHHHHHHHHHHHcCCCC
Q 041096 476 DIKASNIMLDANFNARLESSFTL---------TAGTMGYLAPEYLQYG--------TATEKTDVFSYGVVVLEVACGRRP 538 (645)
Q Consensus 476 Dlkp~NIlld~~~~~kl~d~~~~---------~~gt~~y~APE~~~~~--------~~t~ksDV~SfGvvl~El~tG~~P 538 (645)
||||+|++++.+|...+++.... ...+..|.+||..... .++.+.|.|++|+++|.|+||+.|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 99999999999999999883221 2345678999976432 478899999999999999999999
Q ss_pred CCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCC
Q 041096 539 IERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSAR 599 (645)
Q Consensus 539 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 599 (645)
|........... . -..+. +.++.+..|+...++++|.+|
T Consensus 250 f~~~~~~~~~~~--------------------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADPEW--------------------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGSTSGG--------------------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccccccc--------------------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 986543221100 1 12344 778889999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.2e-18 Score=168.44 Aligned_cols=169 Identities=12% Similarity=0.058 Sum_probs=126.7
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhH----------hHHHHHHHHhhcCCCCeeeeeeeeee
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT----------EFLAELSIIACLRHKNLVQLLGWCAE 415 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~----------~~~~Ei~~l~~l~H~niv~l~g~~~~ 415 (645)
..++|+..++||.|+||.||+... ++..+|+|.+.......+ .+.+|+..+.+++|++|..+..++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 457899999999999999999655 366799999875322211 26899999999999999999888553
Q ss_pred C--------CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC
Q 041096 416 K--------GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN 487 (645)
Q Consensus 416 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~ 487 (645)
. ...+|||||++|.+|.++.. ++. ....+++.+|..||+ .+++|||+||+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCC
Confidence 2 35899999999999988732 222 245699999999999 999999999999999988
Q ss_pred CCeeeeccccccccCCcccCcccccCCCCCcchhHHHHHHHHHHH
Q 041096 488 FNARLESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEV 532 (645)
Q Consensus 488 ~~~kl~d~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El 532 (645)
+ .++.|............-..+...+.+..++|+||||+.+.-.
T Consensus 172 g-i~liDfg~~~~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred C-EEEEECCCcccccchhhHHHHHHHhHhcccccccceeEeehHH
Confidence 8 8888832221111111111234455677899999999987654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=159.26 Aligned_cols=242 Identities=19% Similarity=0.265 Sum_probs=177.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCC-CCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRH-KNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.+.|...++||+|+||.+|.|....+|+.||||.-.. .....+...|..+...|+| ..|..+.-+..++..-.||||.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 3678899999999999999999999999999997654 2233457789999999975 5677777778888889999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC------------CCeeee
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN------------FNARLE 493 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~------------~~~kl~ 493 (645)
+ +.||.+.+.-.... ++..+.+-++-|+..-++|+|. ++++||||||+|+|..-+ ...|--
T Consensus 93 L-GPsLEdLfnfC~R~---ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSRR---FTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred c-CccHHHHHHHHhhh---hhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 8 88999988655433 8889999999999999999999 999999999999986432 222221
Q ss_pred c----------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc
Q 041096 494 S----------SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR 563 (645)
Q Consensus 494 d----------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 563 (645)
| ......||.+|.+--...+-..+.+.|+-|+|.+|...--|..||++.......+.+-
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE----------- 234 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE----------- 234 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH-----------
Confidence 2 1123468999988877777777889999999999999999999998865433222111
Q ss_pred hhHHhhhhcc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 041096 564 IIEAADKRLN---GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609 (645)
Q Consensus 564 ~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L 609 (645)
.+...++. .......+.++...+.-|-..--++-|...-+.+.+
T Consensus 235 --kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 235 --KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred --HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 11111110 111222344555556678788888888865554443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.5e-17 Score=158.61 Aligned_cols=132 Identities=18% Similarity=0.170 Sum_probs=100.3
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcc---h-------hHh-----------------HHHHHHHHhhcCCCC
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---G-------KTE-----------------FLAELSIIACLRHKN 405 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~-------~~~-----------------~~~Ei~~l~~l~H~n 405 (645)
...||+|+||.||+|... +|+.||||+++.... . ... ...|++.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999987 789999998865321 1 112 234999999998877
Q ss_pred eeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeeCCCCCCcEEE
Q 041096 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL-HQECEQQVIHRDIKASNIML 484 (645)
Q Consensus 406 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlkp~NIll 484 (645)
+.....+.. ...+|||||+++++|........ .++..+...++.|++.+|.|| |+ .+|+||||||+|||+
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~----~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA----PLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 643332221 22389999999887765533222 388999999999999999999 56 899999999999999
Q ss_pred cCCCCeeeecc
Q 041096 485 DANFNARLESS 495 (645)
Q Consensus 485 d~~~~~kl~d~ 495 (645)
+ ++..++.|.
T Consensus 152 ~-~~~v~LiDF 161 (190)
T cd05147 152 H-DGKLYIIDV 161 (190)
T ss_pred E-CCcEEEEEc
Confidence 8 467888774
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=155.73 Aligned_cols=134 Identities=17% Similarity=0.219 Sum_probs=104.6
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhc-----CCCCeeeeeeeeeeCC---e-EE
Q 041096 351 HSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACL-----RHKNLVQLLGWCAEKG---E-LL 420 (645)
Q Consensus 351 ~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~~ 420 (645)
...++||+|+||.||. ++.++.. +||+.... ....+.+.+|+.+++.+ .||||++++|++.++. . +.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3467899999999996 5555555 68877653 33456799999999999 5799999999998863 4 34
Q ss_pred EEEec--CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHH-HHHhhcCCCCeeeCCCCCCcEEEcCC----CCeeee
Q 041096 421 LVYEY--MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASAL-TYLHQECEQQVIHRDIKASNIMLDAN----FNARLE 493 (645)
Q Consensus 421 lV~Ey--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDlkp~NIlld~~----~~~kl~ 493 (645)
+|+|| +++++|.+++.+.. ++.. ..++.+++.++ +|||+ ++|+||||||+|||++.. ...+|.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 66899999996532 4444 35677888787 99999 999999999999999743 367887
Q ss_pred cccc
Q 041096 494 SSFT 497 (645)
Q Consensus 494 d~~~ 497 (645)
|.+.
T Consensus 152 Dg~G 155 (210)
T PRK10345 152 DNIG 155 (210)
T ss_pred ECCC
Confidence 7443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-16 Score=156.88 Aligned_cols=187 Identities=17% Similarity=0.233 Sum_probs=155.9
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
+|++.++||+|.||..+.|+.--++++||||.-.. +....++..|.+..+.|. .+.|...+-+..++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 57788999999999999999888899999996433 333456778888888884 689999998888888899999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC-----eeeec--------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN-----ARLES-------- 494 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~-----~kl~d-------- 494 (645)
+-||.+++.-... .++..+...+|.|+..-++|+|+ +.+|.|||||+|+||..-++ ..+.|
T Consensus 107 GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8899988764433 38999999999999999999999 99999999999999964332 22223
Q ss_pred -----------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccc
Q 041096 495 -----------SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERET 543 (645)
Q Consensus 495 -----------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~ 543 (645)
......||.+||+--...+...+.+-|+=|+|-+++..+-|..||.+..
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 2233469999999988888899999999999999999999999998754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.4e-16 Score=150.94 Aligned_cols=175 Identities=17% Similarity=0.083 Sum_probs=131.1
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhH-----hHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEEEe
Q 041096 351 HSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT-----EFLAELSIIACLR-HKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 351 ~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~-----~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 424 (645)
.....|++|+||+||.+.. .+..++.+.+.......+ .+.+|+++|++|+ |+++.+++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3467899999999997755 467777777766443222 5889999999995 5889999887 34699999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC-CCCcEEEcCCCCeeeecccccc----
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDI-KASNIMLDANFNARLESSFTLT---- 499 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-kp~NIlld~~~~~kl~d~~~~~---- 499 (645)
|+.+.+|...+.. ....++.|++++|.++|+ .+|+|||| ||+|||++.++.+++.|.....
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999998754321 113477899999999999 99999999 7999999999999998732211
Q ss_pred ---------------------ccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccc
Q 041096 500 ---------------------AGTMGYLAPEYLQY--GTATEKTDVFSYGVVVLEVACGRRPIERETEG 545 (645)
Q Consensus 500 ---------------------~gt~~y~APE~~~~--~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~ 545 (645)
..++.|++|+-..- ..--...+.++-|.-+|.++|++.+.....++
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 13555666653321 22225679999999999999999998765443
|
|
| >cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.4e-15 Score=144.76 Aligned_cols=191 Identities=21% Similarity=0.198 Sum_probs=132.0
Q ss_pred CCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCCCceEEEEecCC
Q 041096 34 LRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDN 113 (645)
Q Consensus 34 ~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~p~~ 113 (645)
..++.+.|+|.+.++.|+||++ .+++.|.+|.+.|++. -+|+.+|+|+|.... ..+||||||.++...
T Consensus 21 i~~W~~~G~t~~~~~~IrLTp~---~~~~~G~iw~~~~~~~--------~~w~ie~~Fri~g~~-~~~gdG~a~W~t~~~ 88 (225)
T cd06902 21 VPFWSHGGDAIASLEQVRLTPS---LRSKKGSVWTKNPFSF--------ENWEVEVTFRVTGRG-RIGADGLAIWYTKER 88 (225)
T ss_pred CCceEecccEEecCCEEEECCC---CCCCEEEEeeCCCcCC--------CCEEEEEEEEEecCC-CCCCCEEEEEEECCC
Confidence 4689999999999999999997 5778999999999983 369999999999764 356899999999764
Q ss_pred CCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCc-cccccc-CC-----Ccccccc-CCCCeE
Q 041096 114 QILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSL-ESIKTA-DP-----ILQGIDL-KSGNVI 185 (645)
Q Consensus 114 ~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~-~s~~~~-~~-----~~~~~~~-~~g~~~ 185 (645)
. ..|+.+|.. ....-+||.|||+.|.. ..+...|.+-+|.- ..-... .. ..-.... +...+.
T Consensus 89 ~---~~G~~~G~~-----~~f~Gl~I~~Dt~~n~~--~~~~p~i~~~~NDGt~~yd~~~D~~~~~~~~C~~~~rn~~~p~ 158 (225)
T cd06902 89 G---EEGPVFGSS-----DKWNGVGIFFDSFDNDG--KKNNPAILVVGNDGTKSYDHQNDGLTQALGSCLRDFRNKPYPV 158 (225)
T ss_pred C---CCCCccCCC-----CcccEEEEEEECCCCCC--CCCCcEEEEEECCCCeeccccCCCcccccceEEEeccCCCCCe
Confidence 3 245556552 23456899999998753 23334565544332 111110 00 0000112 235678
Q ss_pred EEEEEecCCCceEEEEEEeCCC---CCCcceEEEeecCCc-cCCCccEEeEEeccCCccceeeeeeeeeee
Q 041096 186 TAWIDYKNDLRMLKVFMSYSNL---KPVTPLLKVNIDLSG-YLKGNMYVGFSASTEGSTELHMIQSWSFQT 252 (645)
Q Consensus 186 ~~~I~Y~~~~~~l~v~~~~~~~---~~~~~~l~~~vdl~~-~l~~~~~vGfsastg~~~~~~~i~sw~f~~ 252 (645)
+++|.|.. ..|+|.++.... ....-|+. +.. .||...|+||||+||...+.|+|++|+|.+
T Consensus 159 ~~rI~Y~~--~~l~V~~d~~~~~~~~~~~~Cf~----~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~~~s 223 (225)
T cd06902 159 RAKITYYQ--NVLTVSINNGFTPNKDDYELCTR----VENMVLPPNGYFGVSAATGGLADDHDVLSFLTFS 223 (225)
T ss_pred EEEEEEEC--CeEEEEEeCCcCCCCCcccEEEe----cCCeeCCCCCEEEEEecCCCCCCcEeEEEEEEec
Confidence 99999997 568888864321 11222332 222 457789999999999999999999999864
|
ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.7e-16 Score=151.71 Aligned_cols=132 Identities=20% Similarity=0.138 Sum_probs=102.2
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcch---------------------------hHhHHHHHHHHhhcCCCC
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG---------------------------KTEFLAELSIIACLRHKN 405 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~Ei~~l~~l~H~n 405 (645)
...||+|++|.||+|... +|..||||++...... ...+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 7999999987753210 112357889999999998
Q ss_pred eeeeeeeeeeCCeEEEEEecCCCCCHhHH-hhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 041096 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRM-LYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML 484 (645)
Q Consensus 406 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll 484 (645)
+.....+... ..+|||||++++++... +.. . .++..+...++.|++.++.+||+ ..+|+||||||+|||+
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~----~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll 151 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-V----PLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILY 151 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhh-c----cCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEE
Confidence 7544433322 24899999988865443 322 1 26788899999999999999997 3799999999999999
Q ss_pred cCCCCeeeecc
Q 041096 485 DANFNARLESS 495 (645)
Q Consensus 485 d~~~~~kl~d~ 495 (645)
+ ++.+++.|.
T Consensus 152 ~-~~~~~liDF 161 (190)
T cd05145 152 H-DGKPYIIDV 161 (190)
T ss_pred E-CCCEEEEEc
Confidence 9 788888773
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.5e-17 Score=174.99 Aligned_cols=178 Identities=27% Similarity=0.380 Sum_probs=147.9
Q ss_pred eeccCCceEEEEEEE---CCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 355 ILGRGAFGNVYKAYF---ASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 355 ~lG~G~fg~Vy~g~~---~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|+|.||.|+++.- .+.+..+|+|..++. .........|..++...+ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999987542 345677888877652 112225667888888887 9999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec--------ccccc
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES--------SFTLT 499 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d--------~~~~~ 499 (645)
+|.|...+.+... .+..........++-+++++|+ .+++|||+|++||+++.+|..++.| .....
T Consensus 81 gg~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM----FDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccCCc----hHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999998876543 5666666677788999999999 9999999999999999999888866 22334
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 041096 500 AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIER 541 (645)
Q Consensus 500 ~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~ 541 (645)
+||..|||||++. .....+|.||||++++||++|..||..
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999998 567889999999999999999999976
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=153.47 Aligned_cols=183 Identities=23% Similarity=0.283 Sum_probs=131.2
Q ss_pred CCCCeeeeeeeeee---------------------------CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHH
Q 041096 402 RHKNLVQLLGWCAE---------------------------KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIV 454 (645)
Q Consensus 402 ~H~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 454 (645)
+|||||++.+.|.+ ...+|+||.-. ..+|++||..+. .+...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-----CchHHHHHHH
Confidence 68888888876643 23589999877 459999997654 5566677789
Q ss_pred HHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc--C---------CCCeeeeccc-----------cccccCCcccCccccc
Q 041096 455 VGLASALTYLHQECEQQVIHRDIKASNIMLD--A---------NFNARLESSF-----------TLTAGTMGYLAPEYLQ 512 (645)
Q Consensus 455 ~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld--~---------~~~~kl~d~~-----------~~~~gt~~y~APE~~~ 512 (645)
.|+++|+.|||. ++|.|||+|++||||. + |+.+++.|+. -...|...-||||+..
T Consensus 348 aQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 999999999999 9999999999999983 3 3444444421 1124677899999886
Q ss_pred CCC------CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHH
Q 041096 513 YGT------ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLL 586 (645)
Q Consensus 513 ~~~------~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 586 (645)
..+ --.|+|.|+.|-+.||++....||.+..+ ....... ..+ .-....+..++..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~r~----------Yqe----~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDTRT----------YQE----SQLPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heechhh----------hhh----hhCCCCcccCChHHHH
Confidence 432 14689999999999999999999987321 1111111 111 1112345566777888
Q ss_pred HHHHccCCCCCCCCCHHHHHHHH
Q 041096 587 VGLSCANPDSSARPSMRRVFQIL 609 (645)
Q Consensus 587 l~~~Cl~~dP~~RPt~~~vl~~L 609 (645)
++...+++||++||+..-....|
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 88899999999999976554444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.3e-15 Score=146.60 Aligned_cols=135 Identities=18% Similarity=0.198 Sum_probs=103.8
Q ss_pred CCCcCceeccCCceEEEEEE-ECCCCeEEEEEeccCCcc-------------------------hhHhHHHHHHHHhhcC
Q 041096 349 GFHSNRILGRGAFGNVYKAY-FASSGSVAAVKRSKHSHE-------------------------GKTEFLAELSIIACLR 402 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~-~~~~~~~vavK~~~~~~~-------------------------~~~~~~~Ei~~l~~l~ 402 (645)
.|...+.||+|+||.||+|. ...+|..||+|++..... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47778899999999999998 556789999998764321 0123568999999997
Q ss_pred CC--CeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC-eeeCCCCC
Q 041096 403 HK--NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ-VIHRDIKA 479 (645)
Q Consensus 403 H~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDlkp 479 (645)
+. .+.+++++ ...++||||+++.+|...+.... .+...+...++.|++.++++||+ .+ ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCCh
Confidence 53 33444443 23489999999988876653222 25556678899999999999999 88 99999999
Q ss_pred CcEEEcCCCCeeeecc
Q 041096 480 SNIMLDANFNARLESS 495 (645)
Q Consensus 480 ~NIlld~~~~~kl~d~ 495 (645)
+||+++ ++..++.|.
T Consensus 178 ~NIli~-~~~i~LiDF 192 (237)
T smart00090 178 YNILVH-DGKVVIIDV 192 (237)
T ss_pred hhEEEE-CCCEEEEEC
Confidence 999999 777888763
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.7e-15 Score=164.26 Aligned_cols=136 Identities=18% Similarity=0.243 Sum_probs=107.5
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-------chhHhHHHHHHHHhhcCCCCeeeeeeeeeeC
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-------EGKTEFLAELSIIACLRHKNLVQLLGWCAEK 416 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 416 (645)
......|...++||+|+||.||+|.+......+.++..+... ...+.+.+|++++.+++|++++....++...
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 334455677899999999999999886543322222221111 1235688999999999999999888888877
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
...++||||+++++|.+++. ....++.+++++|.|||+ .+++||||||+|||+ .++..++.|.
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeC
Confidence 78899999999999998885 346789999999999999 999999999999999 5678888773
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-14 Score=166.78 Aligned_cols=184 Identities=22% Similarity=0.299 Sum_probs=145.0
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC---CCCeeeeeeeeeeCCeEE
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR---HKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~ 420 (645)
..-...|.+.+.||+|+||+||+|...+ +..+|+|.-+.... .+|.--.+++.+|+ -+-|..+...+.-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--eeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3344568888999999999999999987 99999998776443 34444455566665 223334444444456779
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-------CCeeee
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN-------FNARLE 493 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~-------~~~kl~ 493 (645)
||+||.+.|+|.+++... +.++|...+.++.|+++-+.+||. .+|||+||||+|+||... ...+|.
T Consensus 771 lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEE
Confidence 999999999999999733 349999999999999999999999 999999999999999432 234554
Q ss_pred c--------------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCC
Q 041096 494 S--------------SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRR 537 (645)
Q Consensus 494 d--------------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~ 537 (645)
| .+....+|-.+--+|...++.++.+.|-|.++-+++-|+.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 4 3344567888888999999999999999999999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.1e-14 Score=141.53 Aligned_cols=128 Identities=20% Similarity=0.309 Sum_probs=106.3
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCCcc---------hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---------GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
+.||+|++|.||+|... +..+++|....... ....+.+|++++..++|+++.....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeC--CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 57999999999999873 66788887543211 12457889999999999998888877777778899999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
|+++++|.+++... .+ .+..++.+++.+|.+||+ .+++|||++|.|||++ ++.+++.|.
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf 138 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDF 138 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEEC
Confidence 99999999998542 22 788999999999999999 9999999999999999 677777773
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.7e-14 Score=139.46 Aligned_cols=124 Identities=18% Similarity=0.287 Sum_probs=99.8
Q ss_pred eeccCCceEEEEEEECCCCeEEEEEeccCCc----c-----hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----E-----GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 355 ~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.||+|+||.||+|.+. +..+++|...... . ....+.+|++++..++|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 4899999999999864 6778888754311 1 125577899999999988766655566666678999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
+++++|.+++.... . .++.+++.+|.+||+ .+++|||++|.||+++ ++.+++.|.
T Consensus 79 ~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDf 133 (199)
T TIGR03724 79 IEGKPLKDVIEEGN-----D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDF 133 (199)
T ss_pred ECCccHHHHHhhcH-----H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEEC
Confidence 99999998875421 1 789999999999999 9999999999999999 778888774
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.8e-15 Score=158.42 Aligned_cols=110 Identities=27% Similarity=0.435 Sum_probs=97.0
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec---
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES--- 494 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d--- 494 (645)
.+|+.|++|...+|.++|.++.. ....+|...+.++.|++.|+.| ++.+|||+||.||+...+...||+|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 58999999999999999975543 3447899999999999999999 5789999999999998888888876
Q ss_pred ---------------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc
Q 041096 495 ---------------SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC 534 (645)
Q Consensus 495 ---------------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t 534 (645)
..+..+||..||+||.+.++.|+.|+||||+|++|+|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 2334579999999999999999999999999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.4e-14 Score=137.45 Aligned_cols=136 Identities=17% Similarity=0.210 Sum_probs=104.4
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc-----------------------hhHhHHHHHHHH
Q 041096 342 ELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE-----------------------GKTEFLAELSII 398 (645)
Q Consensus 342 ~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~Ei~~l 398 (645)
++...-..|...+.||+|+||.||++... ++..+|||++..... ....+..|+.++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 34343334777889999999999999885 589999998654221 112367788999
Q ss_pred hhcCCC--CeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCC
Q 041096 399 ACLRHK--NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRD 476 (645)
Q Consensus 399 ~~l~H~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 476 (645)
.++.|+ .+...++. ...++||||+++++|...... .....++.+++.++.++|+ .+++|||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~---~gi~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK---HGIIHGD 150 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH---CCCCcCC
Confidence 999887 44444443 345899999999999765421 2345688999999999999 9999999
Q ss_pred CCCCcEEEcCCCCeeeecc
Q 041096 477 IKASNIMLDANFNARLESS 495 (645)
Q Consensus 477 lkp~NIlld~~~~~kl~d~ 495 (645)
|||+||+++.++.+++.|.
T Consensus 151 l~p~Nill~~~~~~~liDf 169 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDW 169 (198)
T ss_pred CCcccEEEcCCCcEEEEEC
Confidence 9999999999999999873
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.2e-14 Score=163.55 Aligned_cols=196 Identities=20% Similarity=0.271 Sum_probs=132.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
.+|+..++|..|++|.||...++.+.+..|+|+-+... ..+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn--ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN--ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc--cccccCCccee--------------------
Confidence 57888999999999999999999888888885332211 1110 22222233332
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec-------------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES------------- 494 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d------------- 494 (645)
|+-...++.-.. ++. +++.+++|||+ .+|+|||+||+|.+|+.-+..|+.|
T Consensus 136 -gDc~tllk~~g~----lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 -GDCATLLKNIGP----LPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred -chhhhhcccCCC----Ccc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 333333332221 322 22779999999 9999999999999999988888866
Q ss_pred --------------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc
Q 041096 495 --------------SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA 560 (645)
Q Consensus 495 --------------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~ 560 (645)
.....+||+.|+|||++..+.|...+|+|++|+++||.+.|+.||.+...++....++......
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w-- 277 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW-- 277 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc--
Confidence 1123589999999999999999999999999999999999999999865443332222211000
Q ss_pred cCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 041096 561 EGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPS 601 (645)
Q Consensus 561 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 601 (645)
.+-++..+.+..+++...++.+|..|--
T Consensus 278 -------------pE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 278 -------------PEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred -------------cccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 1112223344555556677788888744
|
|
| >PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-12 Score=129.15 Aligned_cols=191 Identities=24% Similarity=0.271 Sum_probs=124.4
Q ss_pred CCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCCCceEEEEecCCC
Q 041096 35 RNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQ 114 (645)
Q Consensus 35 ~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~p~~~ 114 (645)
.++.+.|+|.+.++.|+||++ .+++.|.+|.+.|++. .+|+.+|+|+|........||||||.++....
T Consensus 22 ~~W~~~G~t~i~~~~IrLTp~---~~~~~G~iws~~~~~~--------~~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~~ 90 (229)
T PF03388_consen 22 PNWDIGGSTVITDNFIRLTPD---RQSQSGSIWSRKPIPF--------DNWEIEFTFRISGQEKGLGGDGMAFWYTKDPG 90 (229)
T ss_dssp TTEEEEET-EEESSEEEEE-S---STTEEEEEEESS-BEE--------SEEEEEEEEEEESS-SSS-S-EEEEEEESSSS
T ss_pred CCEEECCeEEecCCEEEECCC---cccCEEEEEEcCCCCc--------cCEEEEEEEEEeccccCcCCCeEEEEEEcCcc
Confidence 489999999999999999998 5778999999999987 37999999999987556689999999997554
Q ss_pred CCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCC-CCCCCeeeeecCCcc-cccccCC----Ccc--cccc-CCCCeE
Q 041096 115 ILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFD-DPDENHIGLDIDSLE-SIKTADP----ILQ--GIDL-KSGNVI 185 (645)
Q Consensus 115 ~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~-d~~~~Hvgi~vns~~-s~~~~~~----~~~--~~~~-~~g~~~ 185 (645)
. .|..+|. .....-+||=|||+.|.+-. ......|.+-+|.-. +-..... ... ..+. +.+.+.
T Consensus 91 ~---~G~~fG~-----~~~f~Gl~i~idt~~N~~~~~~~~~p~i~~~~NDGt~~~~~~~dg~~~~~~~C~~~~rn~~~p~ 162 (229)
T PF03388_consen 91 S---DGPVFGG-----PDKFDGLGIFIDTYDNDEGGHKRGFPYISAMLNDGTKSYDHDNDGKDQSLGSCSADYRNSDVPT 162 (229)
T ss_dssp S---SCSBTTB------SS-EEEEEEEEES-TTCTTCTSTSSEEEEEEEESSS---GGGTTTTT-SEEEE---BTESSEE
T ss_pred c---cccccCC-----CcccceEEEEEEcccCCCcccccccceEEEEecCCCccccccccCcccccccceeccCcCCCCE
Confidence 3 5565664 22345589999999886421 112344555443321 1111100 000 1122 235678
Q ss_pred EEEEEecCCCceEEEEEEe---CCCCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeee
Q 041096 186 TAWIDYKNDLRMLKVFMSY---SNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWS 249 (645)
Q Consensus 186 ~~~I~Y~~~~~~l~v~~~~---~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~ 249 (645)
+++|.|.. +.+.|.+.. .....-..|+... .-.||...|+||||+||...+.|+|++-.
T Consensus 163 ~~ri~Y~~--~~l~v~id~~~~~~~~~~~~Cf~~~---~v~LP~~~yfGvSA~Tg~~~d~hdi~s~~ 224 (229)
T PF03388_consen 163 RIRISYSK--NTLTVSIDSNYLKNQDDWELCFTTD---GVDLPEGYYFGVSAATGELSDNHDILSVK 224 (229)
T ss_dssp EEEEEEET--TEEEEEEETSCCSECCTTEEEEEES---TEEGGSSBEEEEEEEESSSGGEEEEEEEE
T ss_pred EEEEEEEC--CeEEEEEecccccCCcCCcEEEEcC---CeecCCCCEEEEEecCCCCCCcEEEEEEE
Confidence 99999986 467777762 2233445566642 12357788999999999999999999854
|
This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B .... |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.6e-14 Score=140.47 Aligned_cols=190 Identities=24% Similarity=0.370 Sum_probs=141.4
Q ss_pred HHhhcCCCCeeeeeeeeeeCC-----eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 041096 397 IIACLRHKNLVQLLGWCAEKG-----ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471 (645)
Q Consensus 397 ~l~~l~H~niv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 471 (645)
-|-.+-|.|||+++.|+.+.+ +..+++|||..|+|..+|++.......+......+++-||..||.|||+ |.++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 355567999999999876543 5789999999999999999887776778888888999999999999998 6799
Q ss_pred eeeCCCCCCcEEEcCCCCeeeecc----------------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcC
Q 041096 472 VIHRDIKASNIMLDANFNARLESS----------------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACG 535 (645)
Q Consensus 472 ivHrDlkp~NIlld~~~~~kl~d~----------------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG 535 (645)
|+|+++..+-|++..++-.|++.. .....+-++|.|||+-.....+.++|||+||+..+||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999999998651 1122467899999998888889999999999999999887
Q ss_pred CCC-CCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 536 RRP-IERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 536 ~~P-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
..- -...........+.. ...-+...+. ...+..|++.+|..||+|++++..
T Consensus 279 Eiq~tnseS~~~~ee~ia~----------~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIAN----------VIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcceeehhhhhhh----------heeeccCccc-----------cCcCcccccCCCCCCcchhhhhcC
Confidence 642 221111000001100 0000011111 123468999999999999988653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.49 E-value=3e-13 Score=124.74 Aligned_cols=129 Identities=21% Similarity=0.200 Sum_probs=108.6
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCC--CCeeeeeeeeeeCCeEEEEEecCCCCC
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRH--KNLVQLLGWCAEKGELLLVYEYMPNGS 430 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gs 430 (645)
.+.||+|.++.||++.... ..+++|....... ...+.+|+..+..++| .++.++++++...+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999863 6789998866443 5678999999999987 599999999888888999999998877
Q ss_pred HhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 431 LDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 431 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
+..+ +......++.+++++|++||.....+++|+|++|+||+++..+..++.|.
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df 133 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDW 133 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEec
Confidence 7643 45666788999999999999854457999999999999998888888774
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.6e-11 Score=118.56 Aligned_cols=182 Identities=20% Similarity=0.241 Sum_probs=122.8
Q ss_pred CCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCCCceEEEEecCC
Q 041096 34 LRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDN 113 (645)
Q Consensus 34 ~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~p~~ 113 (645)
..++.+.|+|.+.++.|+||++ +++.|.+|-+.|+++-+ +|+.+|+|+|..+. ..+||||||.++...
T Consensus 20 i~~W~~~G~t~v~~~~IrLTp~----~s~~G~iWs~~pl~~~~-------~w~ie~~Fri~G~~-~~~gdGla~W~t~~~ 87 (215)
T cd06903 20 IPNWQTSGNPKLESGRIILTPP----GNQRGSLWLKKPLSLKD-------EWTIEWTFRSTGPE-GRSGGGLNFWLVKDG 87 (215)
T ss_pred CCCeEEcCcEEeeCCeEEECCC----CCceEeEeeCCcCCCCC-------CEEEEEEEEecccC-CcCCCEEEEEEECCC
Confidence 4689999999999999999997 45789999999998742 69999999998764 367999999999764
Q ss_pred CCCCCCC-CccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCC-cccccccC-----CC--ccccccCCCCe
Q 041096 114 QILGSAG-GCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDS-LESIKTAD-----PI--LQGIDLKSGNV 184 (645)
Q Consensus 114 ~~~~~~g-~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns-~~s~~~~~-----~~--~~~~~~~~g~~ 184 (645)
... .| ..+|- .....-+||.|||+.|.. ..|.+-+|. -..-.... .+ .... .+.+.+
T Consensus 88 ~~~--~g~~~fG~-----~~~f~Gl~I~~Dt~~n~~------p~i~~~~NDGt~~yd~~~d~~~~~g~C~~~~-rn~~~p 153 (215)
T cd06903 88 NAD--VGTSSIYG-----PSKFDGLQLLIDNNGGSG------GSLRGFLNDGSKDYKNEDVDSLAFGSCLFAY-QDSGVP 153 (215)
T ss_pred ccc--CCccccCC-----CCCCcEEEEEEECCCCCC------ceEEEEECCCCeeccccCCcccccceeeEec-cCCCCC
Confidence 421 11 22232 122344799999997631 233333322 11111111 11 1111 244667
Q ss_pred EEEEEEecCCCceEEEEEEeCCCCCCcceEEE-eecCCccCC-CccEEeEEeccCCccceeeeeeeeee
Q 041096 185 ITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKV-NIDLSGYLK-GNMYVGFSASTEGSTELHMIQSWSFQ 251 (645)
Q Consensus 185 ~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~-~vdl~~~l~-~~~~vGfsastg~~~~~~~i~sw~f~ 251 (645)
.+++|.|......|+|.++. +.|+.. .+. || ...|+||||+||...+.|.|++-.+-
T Consensus 154 ~~iri~Y~~~~~~l~v~vd~------~~Cf~~~~v~----lP~~~y~fGiSAaTg~~~d~hdIl~~~~~ 212 (215)
T cd06903 154 STIRLSYDALNSLFKVQVDN------RLCFQTDKVQ----LPQGGYRFGITAANADNPESFEILKLKVW 212 (215)
T ss_pred EEEEEEEECCCCEEEEEECC------CEEEecCCee----cCCCCCEEEEEEcCCCCCCcEEEEEEEEe
Confidence 89999998877888888742 133332 233 34 45689999999999999999987653
|
EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.5e-13 Score=127.52 Aligned_cols=130 Identities=18% Similarity=0.246 Sum_probs=90.0
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcch---hHhH----------------------HHHHHHHhhcCCCC--
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG---KTEF----------------------LAELSIIACLRHKN-- 405 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~---~~~~----------------------~~Ei~~l~~l~H~n-- 405 (645)
.+.||+|+||.||+|... ++..||||++...... ...+ ..|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 6889999987653211 1111 34555555554332
Q ss_pred eeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 041096 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485 (645)
Q Consensus 406 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld 485 (645)
+.+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. .++++||||||+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE
Confidence 3334432 245899999998654322111110 11 5567899999999999997 37899999999999999
Q ss_pred CCCCeeeecc
Q 041096 486 ANFNARLESS 495 (645)
Q Consensus 486 ~~~~~kl~d~ 495 (645)
++..++.|.
T Consensus 150 -~~~~~liDf 158 (187)
T cd05119 150 -DGKVYIIDV 158 (187)
T ss_pred -CCcEEEEEC
Confidence 888888774
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.5e-12 Score=126.76 Aligned_cols=131 Identities=19% Similarity=0.204 Sum_probs=100.6
Q ss_pred Cceec-cCCceEEEEEEECCCCeEEEEEeccCC--------------cchhHhHHHHHHHHhhcCCCCe--eeeeeeeee
Q 041096 353 NRILG-RGAFGNVYKAYFASSGSVAAVKRSKHS--------------HEGKTEFLAELSIIACLRHKNL--VQLLGWCAE 415 (645)
Q Consensus 353 ~~~lG-~G~fg~Vy~g~~~~~~~~vavK~~~~~--------------~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~ 415 (645)
...|| .||.|+||+.... +..++||++... ......+.+|++++.+|+|+++ +..++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45788 8999999999885 677888877431 1223467889999999998875 677776543
Q ss_pred CC----eEEEEEecCCC-CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 416 KG----ELLLVYEYMPN-GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 416 ~~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
.. ..++|+||+++ .+|.+++.... ++.. .+.+++.+|.+||+ .+|+||||||.|||++.++.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~-----l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAP-----LSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCC-----CCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCE
Confidence 32 23599999997 69998885421 4433 35789999999999 999999999999999988888
Q ss_pred eeecccc
Q 041096 491 RLESSFT 497 (645)
Q Consensus 491 kl~d~~~ 497 (645)
++.|...
T Consensus 182 ~LIDfg~ 188 (239)
T PRK01723 182 WLIDFDR 188 (239)
T ss_pred EEEECCC
Confidence 8887543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.1e-12 Score=147.77 Aligned_cols=241 Identities=24% Similarity=0.258 Sum_probs=172.9
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CCeEEEEEeccCCc---chhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS-SGSVAAVKRSKHSH---EGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~-~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 422 (645)
..|...+.||+|.|+.|-...... ....+|+|.+.... ........|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456666779999999998876633 34556777665533 22333445777777776 99999999999999999999
Q ss_pred EecCCCCCHhHHh-hhcCCCCccCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeeCCCCCCcEEEcCCC-Ceeeecc----
Q 041096 423 YEYMPNGSLDRML-YQDSENGVLLSWYHRLNIVVGLASALTYLH-QECEQQVIHRDIKASNIMLDANF-NARLESS---- 495 (645)
Q Consensus 423 ~Ey~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDlkp~NIlld~~~-~~kl~d~---- 495 (645)
.||..++++.+-+ ..... ..+....-....|+..++.|+| . .++.|||+||+|.+++..+ +.++.|.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~---~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST---GTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCCcc---CCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999998888 33221 2455566678999999999999 6 9999999999999999988 7777651
Q ss_pred -----------cccccc-CCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC
Q 041096 496 -----------FTLTAG-TMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG 562 (645)
Q Consensus 496 -----------~~~~~g-t~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~ 562 (645)
....+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++....... ....|...
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--~~~~~~~~----- 246 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--RYSSWKSN----- 246 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--cceeeccc-----
Confidence 122467 9999999999885 457889999999999999999999876543221 11111100
Q ss_pred chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 563 RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 563 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
. .......-.........+...|+..+|..|.+.+++..
T Consensus 247 ~------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 247 K------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 00000111122334556667788899999999877754
|
|
| >KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.9e-09 Score=106.29 Aligned_cols=193 Identities=20% Similarity=0.219 Sum_probs=130.7
Q ss_pred CCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCCCceEEEEecCC
Q 041096 34 LRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDN 113 (645)
Q Consensus 34 ~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~p~~ 113 (645)
..++.+.|++.+...-|+||.+ .+++.|.++=..||... +|...+.|.|..+.....|||||+.++-..
T Consensus 71 ~~~W~~~Gstvv~~~~irLT~d---~qsk~GAv~n~~Pv~s~--------~wev~v~fkv~~~s~~lfgdG~Aiw~t~Er 139 (351)
T KOG3839|consen 71 QPNWNLSGSTVVTSNYIRLTPD---EQSKSGAVWNRQPVFSR--------DWEVLVHFKVHGQSKNLFGDGMAIWYTKER 139 (351)
T ss_pred ccCccccccEEEEeeeeecccc---ccccccccccCCCcccc--------ceeEEEEEEEecCCCcccccceEEEeeccc
Confidence 4589999999999999999998 57899999999999743 699999999999988899999999998765
Q ss_pred CCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCC--CeeeeecCCcc-cc------cccCCCccccccCCCC-
Q 041096 114 QILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDE--NHIGLDIDSLE-SI------KTADPILQGIDLKSGN- 183 (645)
Q Consensus 114 ~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~--~Hvgi~vns~~-s~------~~~~~~~~~~~~~~g~- 183 (645)
.. +|.-+|-+ .+.+.+||=.||+-|.. +.+.. .-|.+.+|... |- ..+.++.-..++++..
T Consensus 140 ~q---~GPvFG~~-----dkF~GL~vfidtY~n~~-g~~~~v~P~isvmv~~gs~sYD~~~Dg~~tel~gc~a~~rn~~~ 210 (351)
T KOG3839|consen 140 AQ---PGPVFGSK-----DKFTGLAVFIDTYGNHN-GPHEHVFPYISVMVNIGSLSYDHSKDGTHTELAGCTANFRNLPH 210 (351)
T ss_pred cc---CCCCCCCc-----ccceeEEEEEeccCCcC-CCcccceeeEEEEeccCCcccccCCCCCccccccceeeeccCCC
Confidence 43 56667763 23456899999998753 12221 12333332211 10 0111110011222222
Q ss_pred eEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCcc-CCCccEEeEEeccCCccceeeeeeeeeee
Q 041096 184 VITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGY-LKGNMYVGFSASTEGSTELHMIQSWSFQT 252 (645)
Q Consensus 184 ~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~-l~~~~~vGfsastg~~~~~~~i~sw~f~~ 252 (645)
.-.+-|.|+. ++|++..++.+. .. ..--.++.++ ||.--|+|+||+||..++.|.|.|-.+..
T Consensus 211 dt~~~iry~~--~~l~~~~dl~~~--~~--~~~c~~~n~v~lp~g~~fg~SasTGdlSd~HdivS~kl~~ 274 (351)
T KOG3839|consen 211 DTLVVIRYEK--KTLSISIDLEGP--NE--WIDCFSLNNVELPLGYFFGVSASTGDLSDSHDIVSLKLFE 274 (351)
T ss_pred cceeEEEecC--CceEEEEecCCC--ce--eeeeeeecceecccceEEeeeeccCccchhhHHHHhhhhh
Confidence 1357788987 777777765442 22 2333455554 46667899999999999999999876543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.6e-11 Score=126.62 Aligned_cols=234 Identities=25% Similarity=0.268 Sum_probs=167.7
Q ss_pred CCCcCceecc--CCceEEEEEEE--CCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEE
Q 041096 349 GFHSNRILGR--GAFGNVYKAYF--ASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 349 ~f~~~~~lG~--G~fg~Vy~g~~--~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 420 (645)
.|.....+|. |.+|.||.+.. ..++..+|+|+-+.. ......=.+|+....+++ |+|.++....+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556778999 99999999998 778889999975442 233344567777777774 999999888889999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHH----HHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeeeecc
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLAS----ALTYLHQECEQQVIHRDIKASNIMLDAN-FNARLESS 495 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDlkp~NIlld~~-~~~kl~d~ 495 (645)
+-+|++ +.+|..+.+.... .++....+....+..+ ||.++|+ ..++|-|+||.||++..+ ...++++.
T Consensus 195 iqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCc
Confidence 999999 5788888765433 2556666677777777 9999999 999999999999999988 66665441
Q ss_pred c-----------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh
Q 041096 496 F-----------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 496 ~-----------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
. ....|...|++||... +.++..+|+|++|.+.+|..++..+....... .| ..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W--~~ 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS-------SW--SQ 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-------Cc--cc
Confidence 1 1114677899999776 56888999999999999999987655332100 01 11
Q ss_pred hccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 559 YAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+... +..++...-...+.....++++.+|-.|++.+.+..
T Consensus 338 ~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 LRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11100 111222222233444677899999999999877754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.05 E-value=8.3e-10 Score=104.61 Aligned_cols=125 Identities=17% Similarity=0.098 Sum_probs=90.7
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCee-eeeeeeeeCCeEEEEEecCCCCCHh
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLV-QLLGWCAEKGELLLVYEYMPNGSLD 432 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL~ 432 (645)
+.|+.|.++.||++... +..+++|...........+..|+..+..+.+.+++ +++.+.. +..++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 56889999999999875 67899998765433344678899999998765544 4444432 3458999999998876
Q ss_pred HHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 433 RMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC--EQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 433 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
..- . ....++.+++++|+.||+.. ...++|+|++|.||+++ ++..++.|.
T Consensus 80 ~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf 131 (170)
T cd05151 80 TED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDW 131 (170)
T ss_pred ccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEec
Confidence 430 1 11235678999999999822 12369999999999999 556777663
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3e-09 Score=116.17 Aligned_cols=157 Identities=18% Similarity=0.231 Sum_probs=118.4
Q ss_pred EEEECCCCeEEEEEeccCCcc-hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCcc
Q 041096 366 KAYFASSGSVAAVKRSKHSHE-GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL 444 (645)
Q Consensus 366 ~g~~~~~~~~vavK~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~ 444 (645)
.|..+..+.+|.|+..+.+.. ......+-++.|+.|+||||++++.....++..|||+|-+. .|..++.+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------ 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------ 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------
Confidence 466666778888887766433 33446778889999999999999999999999999999873 677777653
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc--cccCC----------cccCccccc
Q 041096 445 LSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL--TAGTM----------GYLAPEYLQ 512 (645)
Q Consensus 445 l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~--~~gt~----------~y~APE~~~ 512 (645)
.-....-.+.||+.||.|||+ +.+++|++|..+.|+|++.+..||++.... ..|+. .|..|+.+.
T Consensus 102 -~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 102 -GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID 178 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence 234455678899999999997 378999999999999999999999873222 11222 244444333
Q ss_pred CCCCCcchhHHHHHHHHHHHHcC
Q 041096 513 YGTATEKTDVFSYGVVVLEVACG 535 (645)
Q Consensus 513 ~~~~t~ksDV~SfGvvl~El~tG 535 (645)
... -..|.|-|||+++|++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 221 245999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.7e-09 Score=118.13 Aligned_cols=133 Identities=19% Similarity=0.172 Sum_probs=92.0
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcch-----------------------------------------hHhH
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG-----------------------------------------KTEF 391 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~-----------------------------------------~~~~ 391 (645)
.+.||.|++|.||+|++.+ |+.||||+....... +-+|
T Consensus 122 ~~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 3679999999999999974 789999987542100 0124
Q ss_pred HHHHHHHhhcC----CCCeeeeeeeee-eCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHH-HHHHHh
Q 041096 392 LAELSIIACLR----HKNLVQLLGWCA-EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLAS-ALTYLH 465 (645)
Q Consensus 392 ~~Ei~~l~~l~----H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH 465 (645)
.+|...+.+++ |.+-+.+-..+. .....+|||||+++++|.++....... . .+..++..++. .+..+|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHH
Confidence 45555555542 333333333332 234579999999999998876532211 2 23456666666 467888
Q ss_pred hcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 466 QECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 466 ~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
. .+++|+|+||.||+++.++..++.|.
T Consensus 275 ~---~g~~H~D~hPgNilv~~~g~i~liDf 301 (437)
T TIGR01982 275 R---DGFFHADLHPGNIFVLKDGKIIALDF 301 (437)
T ss_pred h---CCceeCCCCcccEEECCCCcEEEEeC
Confidence 7 99999999999999999998888773
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.4e-10 Score=121.79 Aligned_cols=136 Identities=15% Similarity=0.131 Sum_probs=84.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc-----------------------------------hhH---
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE-----------------------------------GKT--- 389 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-----------------------------------~~~--- 389 (645)
..|+. +.||+|++|.||+|+++++|+.||||+...... -.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35766 789999999999999988799999998864310 011
Q ss_pred ---hHHHHHHHHhhcC----CCCeeeeeeeeee-CCeEEEEEecCCCCCHhHH--hhhcCCCCccCCHHHHHHHHHHHHH
Q 041096 390 ---EFLAELSIIACLR----HKNLVQLLGWCAE-KGELLLVYEYMPNGSLDRM--LYQDSENGVLLSWYHRLNIVVGLAS 459 (645)
Q Consensus 390 ---~~~~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~ia~ 459 (645)
+|.+|+.-+.+++ +.+.+.+-..+.+ ..+.+|||||+.|+.|.++ +.........+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 2334444444442 3333333333322 3456899999999999874 3222111111222222222233
Q ss_pred HHHHHhhcCCCCeeeCCCCCCcEEEcCCC----Ceeeec
Q 041096 460 ALTYLHQECEQQVIHRDIKASNIMLDANF----NARLES 494 (645)
Q Consensus 460 gL~yLH~~~~~~ivHrDlkp~NIlld~~~----~~kl~d 494 (645)
+.. .+++|+|+||.||+++.++ ..++.|
T Consensus 276 ----if~---~GffHaDpHPGNIlv~~~g~~~~~i~llD 307 (537)
T PRK04750 276 ----VFR---DGFFHADMHPGNIFVSYDPPENPRYIALD 307 (537)
T ss_pred ----HHh---CCeeeCCCChHHeEEecCCCCCCeEEEEe
Confidence 333 8999999999999999887 666655
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-08 Score=100.95 Aligned_cols=136 Identities=18% Similarity=0.216 Sum_probs=104.1
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCCcc--hhHhHHHHHHHHhhcCC--CCeeeeeeeeeeCC---eEEEEEecC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE--GKTEFLAELSIIACLRH--KNLVQLLGWCAEKG---ELLLVYEYM 426 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~---~~~lV~Ey~ 426 (645)
+.|+.|..+.||++...+ |..+++|....... ....+..|.+++..+++ .++.+++.++.... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998864 57889998765433 45678999999999976 34577788776643 568999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC-------------------------------------- 468 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 468 (645)
++.++...+.. ..++..++..++.++++.|..||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99988776532 12677788888889999999998521
Q ss_pred ---------------CCCeeeCCCCCCcEEEcC--CCCeeeecc
Q 041096 469 ---------------EQQVIHRDIKASNIMLDA--NFNARLESS 495 (645)
Q Consensus 469 ---------------~~~ivHrDlkp~NIlld~--~~~~kl~d~ 495 (645)
...++|+|+++.||+++. +....+.|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~ 201 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDW 201 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEec
Confidence 245799999999999998 444566563
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.3e-09 Score=117.96 Aligned_cols=238 Identities=21% Similarity=0.204 Sum_probs=164.3
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEEC-CCCeEEEEEeccCCcc---hhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCe
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFA-SSGSVAAVKRSKHSHE---GKTEFLAELSIIACL-RHKNLVQLLGWCAEKGE 418 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~-~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 418 (645)
...+.+|.....||.|.|+.|++...+ .++..+++|.+...-. +...-..|+.+...+ .|.++++....+...+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344567888999999999999998766 6788999997765322 222234566666665 48888887766666667
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeeeecccc
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN-FNARLESSFT 497 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~-~~~kl~d~~~ 497 (645)
.|+=-|||.++++.....-. ..++...++++..|++.++.++|+ ..++|+|+||+||++..+ +..++++...
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccc
Confidence 77999999999887666222 226777889999999999999998 999999999999999886 6666665322
Q ss_pred c---------cccCCccc--CcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 498 L---------TAGTMGYL--APEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 498 ~---------~~gt~~y~--APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
+ ..+..++. +++......+..+.|+||||.-+.|.+++..--....+- ..+ ..+
T Consensus 414 ~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i--------~~~---- 478 (524)
T KOG0601|consen 414 WTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTI--------RSG---- 478 (524)
T ss_pred ccccceecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eee--------ecc----
Confidence 2 12233444 555556667889999999999999999887543321110 000 000
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L 609 (645)
.-+. .+ .....+..+...+..+++..||.+.++....
T Consensus 479 -~~p~----~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 479 -DTPN----LP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred -cccC----CC-chHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 0011 11 1124455566677889999999988776543
|
|
| >KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.8e-07 Score=91.32 Aligned_cols=185 Identities=19% Similarity=0.254 Sum_probs=121.7
Q ss_pred eEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCCCceEEEEecCCCCC
Q 041096 37 ITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQIL 116 (645)
Q Consensus 37 ~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~p~~~~~ 116 (645)
+...|||-.+...|+|+++ ..++.|.+|-+.-+++ -.|..+.+|+|++.+ .-++|||||--+...
T Consensus 56 W~~~GdAIas~eqvRlaPS---mrsrkGavWtka~~~f--------e~weVev~~rVtGrG-RiGAdGlaiWYt~~~--- 120 (497)
T KOG3838|consen 56 WSHHGDAIASSEQVRLAPS---MRSRKGAVWTKASVPF--------ENWEVEVQFRVTGRG-RIGADGLAIWYTRGR--- 120 (497)
T ss_pred eeecCcccccccceeeccc---cccccCceeecccCCc--------ccceEEEEEEecccc-cccCCceEEEEecCC---
Confidence 7788999888899999997 5678899977766655 358999999999875 567999999977532
Q ss_pred CCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcc-cccccCCC------ccccccCC-CCeEEEE
Q 041096 117 GSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLE-SIKTADPI------LQGIDLKS-GNVITAW 188 (645)
Q Consensus 117 ~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~-s~~~~~~~------~~~~~~~~-g~~~~~~ 188 (645)
|-.|.-+|-.+ .=.-+++=||.|-|.. .-|+.-|.+-.|.-. +-.....+ .=.-++.| =-+++|+
T Consensus 121 G~~GpVfGg~d-----~WnGigiffDSfdnD~--qknnP~Is~~lndGt~~ydh~~DGasQ~LssCqrDFRNkPyPvRar 193 (497)
T KOG3838|consen 121 GHVGPVFGGLD-----SWNGIGIFFDSFDNDG--QKNNPAISVLLNDGTIPYDHPGDGASQGLSSCQRDFRNKPYPVRAR 193 (497)
T ss_pred Ccccccccccc-----cccceEEEeecccccC--CcCCccEEEEecCCcccccCCCccHHHHHHHhhHHhccCCCCceEE
Confidence 22333333211 1123688899998742 335555666554322 21111111 00122332 2358999
Q ss_pred EEecCCCceEEEEEEeCCC--CCCcceEEEeecCCc-cCCCccEEeEEeccCCccceeeeeeee
Q 041096 189 IDYKNDLRMLKVFMSYSNL--KPVTPLLKVNIDLSG-YLKGNMYVGFSASTEGSTELHMIQSWS 249 (645)
Q Consensus 189 I~Y~~~~~~l~v~~~~~~~--~~~~~~l~~~vdl~~-~l~~~~~vGfsastg~~~~~~~i~sw~ 249 (645)
|+|-. .+|.|.+..+.. .++.-|+ +... +||..-|+|.||+||....-|+|+++.
T Consensus 194 ItY~~--nvLtv~innGmtp~d~yE~C~----rve~~~lp~nGyFGvSAATGgLADDHDVl~Fl 251 (497)
T KOG3838|consen 194 ITYYG--NVLTVMINNGMTPSDDYEFCV----RVENLLLPPNGYFGVSAATGGLADDHDVLSFL 251 (497)
T ss_pred EEEec--cEEEEEEcCCCCCCCCcceeE----eccceeccCCCeeeeeecccccccccceeeeE
Confidence 99974 889998875442 2233233 3333 458889999999999999999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.8e-07 Score=99.49 Aligned_cols=170 Identities=17% Similarity=0.242 Sum_probs=125.5
Q ss_pred ceEEEEEEECCCCeEEEEEeccCCc-chhHhHHHHHHHHhhcCCCCeeeeeeeeee----CCeEEEEEecCCC-CCHhHH
Q 041096 361 FGNVYKAYFASSGSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQLLGWCAE----KGELLLVYEYMPN-GSLDRM 434 (645)
Q Consensus 361 fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~ 434 (645)
-.+.||++..-+|..|++|++...+ +.......-+++++++.|.|+|++...+.. +..+++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4678999999999999999994322 222234566788999999999999988763 3478999999886 688877
Q ss_pred hhhcCC-----------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccccccCC
Q 041096 435 LYQDSE-----------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAGTM 503 (645)
Q Consensus 435 l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~~~gt~ 503 (645)
...... ++...+...+|.++.|+..||.++|+ .|+.-+-|.+++|+++.+...+|+....+.+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dv--- 442 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDV--- 442 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceee---
Confidence 654322 12347788999999999999999999 8999999999999999998888854221111
Q ss_pred cccCcccccCCCCCcchhHHHHHHHHHHHHcCCCC
Q 041096 504 GYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRP 538 (645)
Q Consensus 504 ~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P 538 (645)
+-++-...-.--.+-|.=.||.+++.|.||..-
T Consensus 443 --l~~d~~~~le~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 443 --LQEDPTEPLESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred --ecCCCCcchhHHhhhhHHHHHHHHHHHhhcccc
Confidence 111100000123467999999999999999654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.74 E-value=1e-07 Score=92.04 Aligned_cols=130 Identities=14% Similarity=0.102 Sum_probs=90.0
Q ss_pred ceeccCCceEEEEEEECC------CCeEEEEEeccCCc-----------------------chhHhH----HHHHHHHhh
Q 041096 354 RILGRGAFGNVYKAYFAS------SGSVAAVKRSKHSH-----------------------EGKTEF----LAELSIIAC 400 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~------~~~~vavK~~~~~~-----------------------~~~~~~----~~Ei~~l~~ 400 (645)
..||.|.-+.||.|...+ .+..+|||..+.+. ...+.+ .+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 24789999654210 011122 379999998
Q ss_pred cCC--CCeeeeeeeeeeCCeEEEEEecCCCCCHhH-HhhhcCCCCccCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeeCC
Q 041096 401 LRH--KNLVQLLGWCAEKGELLLVYEYMPNGSLDR-MLYQDSENGVLLSWYHRLNIVVGLASALTYL-HQECEQQVIHRD 476 (645)
Q Consensus 401 l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrD 476 (645)
+.. -++...+++ ..-+|||||+.+..+.. .|... .++..+...+..+++.+|..| |+ .+++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKE---CNLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 853 455555654 35689999997654422 22211 144456677889999999999 77 8999999
Q ss_pred CCCCcEEEcCCCCeeeeccc
Q 041096 477 IKASNIMLDANFNARLESSF 496 (645)
Q Consensus 477 lkp~NIlld~~~~~kl~d~~ 496 (645)
|++.|||++. +...+.|..
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~ 169 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVS 169 (197)
T ss_pred CCHHHEEEEC-CcEEEEECC
Confidence 9999999974 556776643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.7e-06 Score=82.34 Aligned_cols=195 Identities=19% Similarity=0.228 Sum_probs=114.4
Q ss_pred eeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCCCceEEEEec--CCCCCCCCCCc
Q 041096 45 LRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISP--DNQILGSAGGC 122 (645)
Q Consensus 45 ~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~p--~~~~~~~~g~~ 122 (645)
+.+|.||||+. ..+++|-+.|.+++|--+. -...+|.+-.-.. ...++||+||||+- ..+.++..||.
T Consensus 29 i~~g~LRLT~~---~~nqata~~~~~~FPs~~n------~v~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~fGGs 98 (255)
T cd06900 29 VVNNRLRLTDA---SGNQATAVTLQRLFPSAGN------YVEVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGAFGGS 98 (255)
T ss_pred cccCeEEeccC---ccCcceeEEEeeeeccCCC------eEEEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCCcCcc
Confidence 46899999998 4678999999998885321 2677777766654 46789999999983 33356889999
Q ss_pred cccccCC--CCCC-CcEEEEEeeCCCCCCC-CCCC-------CCeeeeecCCcc-c----ccccCCCcccccc------C
Q 041096 123 LGLVNSS--QLTK-NKFVAIEFDTRLDPHF-DDPD-------ENHIGLDIDSLE-S----IKTADPILQGIDL------K 180 (645)
Q Consensus 123 lGl~~~~--~~~~-~~~vAVEFDt~~n~~~-~d~~-------~~Hvgi~vns~~-s----~~~~~~~~~~~~~------~ 180 (645)
||+--.. ..+. --.+.|-||-|-|..- .+.. -+-|+|-=..-. + .+.+......++. .
T Consensus 99 LGYa~~~~~~~GfaGGwLGiGlDEyGNFsn~~eg~~~~~g~r~~sV~vRGsg~g~~gY~yl~gt~~~~~~id~~~~~~~~ 178 (255)
T cd06900 99 LGYAQRNDGVPGFAGGWLGIGLDEYGNFSNPNEGRNGFSGRRPQSVTVRGSGSGYTGYKYITGTGVLPPGIDNNSTSTPA 178 (255)
T ss_pred cccccccCCCCccccceEEEEEeccccccCCCCCccCCcccccceEEEECCCCCCcCceEecccCCCCcccccCCCCCCC
Confidence 9996543 2222 4678898887766321 0111 133333211000 0 0000000111111 1
Q ss_pred CCCeEEEEEEecCC-CceEEEEEEeCCCCCCcceEEE--eecCC--ccCCCccEEeEEeccCCccceeeeeeee
Q 041096 181 SGNVITAWIDYKND-LRMLKVFMSYSNLKPVTPLLKV--NIDLS--GYLKGNMYVGFSASTEGSTELHMIQSWS 249 (645)
Q Consensus 181 ~g~~~~~~I~Y~~~-~~~l~v~~~~~~~~~~~~~l~~--~vdl~--~~l~~~~~vGfsastg~~~~~~~i~sw~ 249 (645)
.+-++++.|+=... ...|+|.-+..+.....+++.. .++.. .-+|+..+++|++|||...-.|.|-..+
T Consensus 179 ~~hrY~i~Ids~~~~~~~vsV~R~~~~gg~~~~~I~~~d~~~~~~q~avP~~f~lS~TgSTGgstN~HEIdnf~ 252 (255)
T cd06900 179 PGHRYRITIDSTNGDNAWLSVERDIGNGGAYFVVILTFDALAEQNQDAIPENFYLSFTGSTGGSTNTHEIDNFQ 252 (255)
T ss_pred CceEEEEEEecCCCCceEEEEEEEccCCceeEEeecceeeccccCCCCCCccEEEEEEecCCCcccceeecceE
Confidence 23456666666533 3345555553322212222211 12333 6679999999999999999999987654
|
This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.8e-07 Score=87.28 Aligned_cols=133 Identities=17% Similarity=0.201 Sum_probs=96.9
Q ss_pred cCceeccCCceEEEEEEECCCCeEEEEEe-ccCC--------cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 352 SNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHS--------HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 352 ~~~~lG~G~fg~Vy~g~~~~~~~~vavK~-~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
...+|-+|+-+.|+++.+. |+.++||. +.+. .-..+..++|++.+.+++--.|.--.-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 4678899999999999886 77777773 3321 11245678899999988644444333445555566899
Q ss_pred EecCCC-CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCee
Q 041096 423 YEYMPN-GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491 (645)
Q Consensus 423 ~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~k 491 (645)
|||+++ .++.+++...-... ..-.....++..|-+.+.-||. ..|+|+||.++||+|..+++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~ 153 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQI 153 (229)
T ss_pred EEeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcC
Confidence 999976 47888887544321 2223336788999999999999 9999999999999998877655
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=6.8e-09 Score=118.03 Aligned_cols=194 Identities=24% Similarity=0.271 Sum_probs=136.4
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
.....|...+-+-+|.++.++...-...+...+.|..... ....+....+-.++-..+||-++...--+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 3445677777788899999988876666644444443331 122233333333333345566666555555567899
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec------
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES------ 494 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d------ 494 (645)
|+++|..+++|...|+.... .+..-....+..+...++|||. ..+.|||++|.|++...++..++.+
T Consensus 881 L~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccc
Confidence 99999999999999876542 2222223345567788999998 6699999999999986665544432
Q ss_pred -------------------------------------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCC
Q 041096 495 -------------------------------------SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRR 537 (645)
Q Consensus 495 -------------------------------------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~ 537 (645)
......||+.|++||.+.+......+|+|+.|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 0122358999999999999999999999999999999999999
Q ss_pred CCCccccc
Q 041096 538 PIERETEG 545 (645)
Q Consensus 538 P~~~~~~~ 545 (645)
||......
T Consensus 1034 p~na~tpq 1041 (1205)
T KOG0606|consen 1034 PFNAETPQ 1041 (1205)
T ss_pred CCCCcchh
Confidence 99875543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.8e-06 Score=86.65 Aligned_cols=126 Identities=12% Similarity=0.052 Sum_probs=88.6
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCCc------------chhHhHHHHHHHHhhcCCCC--eeeeeeeeee----
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSH------------EGKTEFLAELSIIACLRHKN--LVQLLGWCAE---- 415 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~------------~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~---- 415 (645)
+.+-......|.+..+. |..+.||+..... .....+.+|...+.+|...+ ....+++...
T Consensus 28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 44444444557777764 6789999764422 11124789999988885332 3334445433
Q ss_pred -CCeEEEEEecCCCC-CHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC
Q 041096 416 -KGELLLVYEYMPNG-SLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA 486 (645)
Q Consensus 416 -~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~ 486 (645)
....+||+|++++. +|.+++..... ...+...+..++.+++..+.-||. .+|+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~ 173 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHL 173 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEec
Confidence 23578999999876 89998854221 124556777899999999999999 99999999999999985
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=4e-06 Score=87.27 Aligned_cols=266 Identities=16% Similarity=0.199 Sum_probs=159.6
Q ss_pred cCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeee------eeeCC-eEEEEE
Q 041096 352 SNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGW------CAEKG-ELLLVY 423 (645)
Q Consensus 352 ~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~------~~~~~-~~~lV~ 423 (645)
..+-||+|+.+.+|----- +. .+-|+........+ ...+..|.+. .||-+-.=+.| .-+++ ..-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh--hc-hhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3567999999999954211 12 23455554322211 1222333333 46544332222 12222 366777
Q ss_pred ecCCCC-CHhHHhhh--cCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-----
Q 041096 424 EYMPNG-SLDRMLYQ--DSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS----- 495 (645)
Q Consensus 424 Ey~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~----- 495 (645)
..+++. ....++.. +++......|.-.++.+..+|.+.+-||+ .|.+-+|+.++|+|+.++..+.+.|.
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence 777553 23333321 12223457899999999999999999999 99999999999999999988888652
Q ss_pred ------ccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcC-CCCCCccccccchhhHHHHHHhhhccCc
Q 041096 496 ------FTLTAGTMGYLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACG-RRPIERETEGHKMVNLVDWVWGLYAEGR 563 (645)
Q Consensus 496 ------~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SfGvvl~El~tG-~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 563 (645)
+...+|...|.+||.-. +-..+...|-|.+||++++++.| +.||.+.........-.+. ....+.
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~Ia~g~ 243 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DIAHGR 243 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hhhcce
Confidence 22346888999999644 33457889999999999999885 9999875322111110000 000111
Q ss_pred hhHHhh--hhcc---CCCCHH-HHHHHHHHHHHccCCC--CCCCCCHHHHHHHHcCCCCCCCCCCCCCccccc
Q 041096 564 IIEAAD--KRLN---GAFNED-EMKRLLLVGLSCANPD--SSARPSMRRVFQILNNEAEPLVVPKLKPCLTFS 628 (645)
Q Consensus 564 ~~~~~d--~~l~---~~~~~~-~~~~l~~l~~~Cl~~d--P~~RPt~~~vl~~L~~~~~~~~~p~~~~~~~~~ 628 (645)
....-| ..++ ...+-. .+..+-.+-.+|+... +.-|||++.-+..|....+.+..+..+..+.|+
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~y~ 316 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHVYP 316 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhccccccc
Confidence 111111 1111 112222 2234444456676543 568999999999888887777766666655554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.2e-06 Score=78.64 Aligned_cols=124 Identities=22% Similarity=0.285 Sum_probs=92.0
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEe-ccCCc----c----hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSH----E----GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~-~~~~~----~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
..+++|+-+.+|.+.+. |..+++|. +.+.- - ....-.+|..++.+++--.|.--+-+..+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999775 44566663 33311 1 12346789999999875554444445566677889999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES 494 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d 494 (645)
|+++..|.+.+... +..++..+-.-+.-||. .+|+|+||.++||+|..+. ..+.|
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~ID 134 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFID 134 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEE
Confidence 99999999888654 24677888888999999 9999999999999998876 44434
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.3e-07 Score=100.03 Aligned_cols=139 Identities=25% Similarity=0.340 Sum_probs=95.5
Q ss_pred HHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---------------------ccccCCcccCccccc
Q 041096 454 VVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---------------------LTAGTMGYLAPEYLQ 512 (645)
Q Consensus 454 ~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---------------------~~~gt~~y~APE~~~ 512 (645)
+.+++.||.|+|. ..++||++|.|++|.++.++..|+..... ...-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3456699999998 58999999999999999999999854110 012245699999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHcc
Q 041096 513 YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCA 592 (645)
Q Consensus 513 ~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl 592 (645)
....+.++|+||+||+++-+..|..+.-............ ...+..-...+..+.+..+.+-+...+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHh
Confidence 9888999999999999999996555433222211111110 001111111233555667777777889
Q ss_pred CCCCCCCCCHHHHHH
Q 041096 593 NPDSSARPSMRRVFQ 607 (645)
Q Consensus 593 ~~dP~~RPt~~~vl~ 607 (645)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998777643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.9e-05 Score=73.91 Aligned_cols=132 Identities=20% Similarity=0.147 Sum_probs=98.3
Q ss_pred eeccCCceEEEEEEECCCCeEEEEEeccC----C---cchhHhHHHHHHHHhhcCC--CCeeeeeeeeeeC-----CeEE
Q 041096 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKH----S---HEGKTEFLAELSIIACLRH--KNLVQLLGWCAEK-----GELL 420 (645)
Q Consensus 355 ~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~---~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~-----~~~~ 420 (645)
--|+||-+-|++-.+. |..+-+|+-.. + ......|.+|+..|.+|.. -.+.+.+ ++... ...+
T Consensus 25 N~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 25 NYRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred CcCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 3577899999998776 44688897652 1 3357789999999999963 2344444 33321 2478
Q ss_pred EEEecCCC-CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC--eeeec
Q 041096 421 LVYEYMPN-GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN--ARLES 494 (645)
Q Consensus 421 lV~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~--~kl~d 494 (645)
||+|-+.+ -+|.+++.+... ...+...+..+..+++..++-||+ .++.|+|+.+.||+++.++. +++.|
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEE
Confidence 99997753 689988865432 135777888999999999999999 99999999999999986665 55555
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.1e-05 Score=73.54 Aligned_cols=100 Identities=22% Similarity=0.278 Sum_probs=76.4
Q ss_pred hHhHHHHHHHHhhcCC--CCeeeeeeeeeeC----CeEEEEEecCCCC-CHhHHhhhcCCCCccCCHHHHHHHHHHHHHH
Q 041096 388 KTEFLAELSIIACLRH--KNLVQLLGWCAEK----GELLLVYEYMPNG-SLDRMLYQDSENGVLLSWYHRLNIVVGLASA 460 (645)
Q Consensus 388 ~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~----~~~~lV~Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g 460 (645)
.....+|...+..|.. -...+.+++.... ...+||+|++++. +|.+++..... ++......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence 4467888888888753 3345556665543 2468999999874 89999876332 4556778899999999
Q ss_pred HHHHhhcCCCCeeeCCCCCCcEEEcCCC---Ceeeec
Q 041096 461 LTYLHQECEQQVIHRDIKASNIMLDANF---NARLES 494 (645)
Q Consensus 461 L~yLH~~~~~~ivHrDlkp~NIlld~~~---~~kl~d 494 (645)
++-||+ .+|+|+|+++.|||++.+. ...+.|
T Consensus 131 i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lID 164 (206)
T PF06293_consen 131 IAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLID 164 (206)
T ss_pred HHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEc
Confidence 999999 9999999999999999886 444555
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.02 E-value=4e-05 Score=73.81 Aligned_cols=118 Identities=19% Similarity=0.242 Sum_probs=73.4
Q ss_pred EEEEEEECCCCeEEEEEeccCCc--------------c-------------hhHhHHHHHHHHhhcCCC--Ceeeeeeee
Q 041096 363 NVYKAYFASSGSVAAVKRSKHSH--------------E-------------GKTEFLAELSIIACLRHK--NLVQLLGWC 413 (645)
Q Consensus 363 ~Vy~g~~~~~~~~vavK~~~~~~--------------~-------------~~~~~~~Ei~~l~~l~H~--niv~l~g~~ 413 (645)
.||.|...+ +..+|+|..+... . ......+|.+.|.++... ++.+.+.+.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 489998754 7899999654310 0 123467799999999765 456665443
Q ss_pred eeCCeEEEEEecCC--CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 414 AEKGELLLVYEYMP--NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL-HQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 414 ~~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
.-.|||||++ +..+..+.... +.......++.+++..+..+ |. .+++|+||.+.||+++.+ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eE
Confidence 2379999998 54554433221 11233456777787766664 66 899999999999999988 67
Q ss_pred eeecc
Q 041096 491 RLESS 495 (645)
Q Consensus 491 kl~d~ 495 (645)
.+.|.
T Consensus 146 ~iIDf 150 (188)
T PF01163_consen 146 YIIDF 150 (188)
T ss_dssp EE--G
T ss_pred EEEec
Confidence 77674
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=3.7e-05 Score=76.61 Aligned_cols=128 Identities=17% Similarity=0.201 Sum_probs=87.9
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEeccCC-----------------------cchhHhHHHHHHHHhhcCCC--C
Q 041096 351 HSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-----------------------HEGKTEFLAELSIIACLRHK--N 405 (645)
Q Consensus 351 ~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-----------------------~~~~~~~~~Ei~~l~~l~H~--n 405 (645)
...+.||-|.-+.||.|..+. |..+|||.-+.. ...+....+|.+.|.+|.-. .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345789999999999999874 788999942210 01123467899999998644 6
Q ss_pred eeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 041096 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485 (645)
Q Consensus 406 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld 485 (645)
+.+-++|- .-.+||||+.+--|...-- +....-.|+..|+.-+.-+-. .+++|+|+.+-||+++
T Consensus 173 VP~P~~~n----RHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAWN----RHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVT 236 (304)
T ss_pred CCCccccc----cceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEe
Confidence 66666554 3479999998866554321 112222334444444444444 8999999999999999
Q ss_pred CCCCeeeecc
Q 041096 486 ANFNARLESS 495 (645)
Q Consensus 486 ~~~~~kl~d~ 495 (645)
+|+...+.|-
T Consensus 237 ~dg~~~vIDw 246 (304)
T COG0478 237 EDGDIVVIDW 246 (304)
T ss_pred cCCCEEEEeC
Confidence 9999998774
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00031 Score=70.01 Aligned_cols=72 Identities=17% Similarity=0.165 Sum_probs=53.0
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCC--eeeeeeeeeeCCeEEEEEecCCCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKN--LVQLLGWCAEKGELLLVYEYMPNGS 430 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gs 430 (645)
..||+|..+.||+.. +..+++|...... ......+|.+++..+..-. +.+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 468999999999841 3456788776522 3445688999999886433 4667777777778889999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00015 Score=70.05 Aligned_cols=96 Identities=24% Similarity=0.276 Sum_probs=77.8
Q ss_pred HHHHHHHhhcCC-CCeeeeeeeeeeCCeEEEEEecCCCCCHhHH---hhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhc
Q 041096 392 LAELSIIACLRH-KNLVQLLGWCAEKGELLLVYEYMPNGSLDRM---LYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467 (645)
Q Consensus 392 ~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~---l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 467 (645)
..|.-+++.+++ +++.+++|+|-+ ++|.||...+++... +.+.. ..+|..|.+|+.++++.+.+|++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~----~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFL----QSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccccc----ccCHHHHHHHHHHHHHHHHHHhcC
Confidence 357888888976 699999999954 679999987766432 11111 268999999999999999999986
Q ss_pred CCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 468 CEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 468 ~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
....+.-.|++++|+-+++++..|+.|.
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDl 106 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDGRLKLIDL 106 (188)
T ss_pred CCCcEEEeecchHHeEEeCCCcEEEEec
Confidence 5556888999999999999999999873
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.65 E-value=5.8e-06 Score=90.27 Aligned_cols=176 Identities=19% Similarity=0.135 Sum_probs=121.6
Q ss_pred CCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCC-eeeeeeeeeeCCeEEEEEecCCC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKN-LVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
+..-+-+++|+.+++||.+.......+ .+.+... ....-++++|.+++||| .+..++-+..++..+++++++..
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 333455789999999998765433332 4433322 44567889999999999 77777777777889999999977
Q ss_pred C-CHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec-----------cc
Q 041096 429 G-SLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES-----------SF 496 (645)
Q Consensus 429 g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d-----------~~ 496 (645)
+ +-..-.... ...+...+...+...-.+++++||+ ..-+||| ||+..++. .+..+ ..
T Consensus 319 ~rs~~~~~~~s---e~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~~~-~~~~~~~v~~~L~~~~~~ 387 (829)
T KOG0576|consen 319 GRSSALEMTVS---EIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSEEE-VKLLDFAVPPQLTRTMKP 387 (829)
T ss_pred CccccccCChh---hHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccccc-cccccccCCcccCccccc
Confidence 6 211111100 1114444555667777889999998 4568998 77776532 22212 13
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIER 541 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~ 541 (645)
....+++.|+|||+.....+..+.|+|+.|+-..++.-|-.|-..
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 345689999999999999999999999999988888888776543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0011 Score=64.90 Aligned_cols=132 Identities=13% Similarity=0.178 Sum_probs=86.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc-hhH---------hHHHHHHHHhhcCC---CCeeeeeee
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE-GKT---------EFLAELSIIACLRH---KNLVQLLGW 412 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~---------~~~~Ei~~l~~l~H---~niv~l~g~ 412 (645)
..++|...+++-......|.+-... +..+++|..+.... ..+ +..+++..+.+++. -....++..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3467888888888777777776654 78889997765221 111 12344444444432 223332322
Q ss_pred ee-----eCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC
Q 041096 413 CA-----EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN 487 (645)
Q Consensus 413 ~~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~ 487 (645)
.. -....+|+|||++|..|.++.. ++. .++..+.+++.-||+ .|++|+|..|.|++++.+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC
Confidence 22 2235679999999988876542 221 245667788999999 999999999999999966
Q ss_pred CCeeeecc
Q 041096 488 FNARLESS 495 (645)
Q Consensus 488 ~~~kl~d~ 495 (645)
+ .++.|.
T Consensus 172 ~-i~iID~ 178 (229)
T PF06176_consen 172 G-IRIIDT 178 (229)
T ss_pred c-EEEEEC
Confidence 5 556563
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00087 Score=66.36 Aligned_cols=77 Identities=21% Similarity=0.320 Sum_probs=56.7
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCC--Ceeeeeeeeee---CCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHK--NLVQLLGWCAE---KGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~---~~~~~lV~Ey~~~ 428 (645)
+.|+.|..+.||+....+ ..+++|..... .......+|..++..+... .+.+++.++.. ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999875 47888987654 4566788899998888533 34566664432 3357999999999
Q ss_pred CCHhH
Q 041096 429 GSLDR 433 (645)
Q Consensus 429 gsL~~ 433 (645)
..+..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 88877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0015 Score=77.59 Aligned_cols=79 Identities=13% Similarity=0.321 Sum_probs=57.7
Q ss_pred CceeccCCceEEEEEEECCCC--eEEEEEeccCCc--chhHhHHHHHHHHhhcC-CCCe--eeeeeeeeeC---CeEEEE
Q 041096 353 NRILGRGAFGNVYKAYFASSG--SVAAVKRSKHSH--EGKTEFLAELSIIACLR-HKNL--VQLLGWCAEK---GELLLV 422 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~--~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 422 (645)
.+.++.|.+..+|+.....++ ..+++|+..... .....+.+|.++++.+. |.++ .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 456889999999998776432 356777654422 23456889999999995 6665 7888888764 467899
Q ss_pred EecCCCCCH
Q 041096 423 YEYMPNGSL 431 (645)
Q Consensus 423 ~Ey~~~gsL 431 (645)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0023 Score=66.65 Aligned_cols=77 Identities=12% Similarity=0.143 Sum_probs=56.3
Q ss_pred cCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCC---CCeeeeeeeeeeC---CeEEEEEec
Q 041096 352 SNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRH---KNLVQLLGWCAEK---GELLLVYEY 425 (645)
Q Consensus 352 ~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~---~~~~lV~Ey 425 (645)
..+.||.|..+.||+-...+ + .+.+|..+. ......+..|.+.|+.|.- -.+.+++++|... +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ-G-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCC-C-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 34569999999999987643 3 456666432 2234578999999998853 3678888887643 568999999
Q ss_pred CCCCCH
Q 041096 426 MPNGSL 431 (645)
Q Consensus 426 ~~~gsL 431 (645)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0015 Score=65.72 Aligned_cols=75 Identities=13% Similarity=0.163 Sum_probs=53.6
Q ss_pred eccCCc-eEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEEEecCCCCCHhH
Q 041096 356 LGRGAF-GNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLVYEYMPNGSLDR 433 (645)
Q Consensus 356 lG~G~f-g~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 433 (645)
|-.|.. ..||+.... +..+.+|+..... .....+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 789998764 4677888775532 345778999988884 4445577777776667899999999988764
Q ss_pred H
Q 041096 434 M 434 (645)
Q Consensus 434 ~ 434 (645)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 4
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.002 Score=62.66 Aligned_cols=122 Identities=17% Similarity=0.231 Sum_probs=86.0
Q ss_pred cCceeccCCceEEEEEEECCCCeEEEEEeccCCc-----------------chhHhHHHHHHHHhhcC------CCCeee
Q 041096 352 SNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-----------------EGKTEFLAELSIIACLR------HKNLVQ 408 (645)
Q Consensus 352 ~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-----------------~~~~~~~~Ei~~l~~l~------H~niv~ 408 (645)
....||+|+.-.||.--. .....||+..... ...++..+|+.....+. +.+|.+
T Consensus 5 ~~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 356799999999996433 3345667665533 23466777877766666 889999
Q ss_pred eeeeeeeCCeEEEEEecCCC------CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 041096 409 LLGWCAEKGELLLVYEYMPN------GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNI 482 (645)
Q Consensus 409 l~g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NI 482 (645)
++|+.+++.-.-+|+|.+.+ -+|.+++.+.. ++. ... ..+-+-..||-+ ..|+.+|++|.||
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~---~~L~~f~~~l~~---~~Iv~~dl~~~NI 149 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELR---QALDEFKRYLLD---HHIVIRDLNPHNI 149 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHH---HHHHHHHHHHHH---cCCeecCCCcccE
Confidence 99999999888999998643 36888885433 444 333 333344566666 8999999999999
Q ss_pred EEcCCC
Q 041096 483 MLDANF 488 (645)
Q Consensus 483 lld~~~ 488 (645)
++....
T Consensus 150 v~~~~~ 155 (199)
T PF10707_consen 150 VVQRRD 155 (199)
T ss_pred EEEecC
Confidence 996543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00065 Score=75.31 Aligned_cols=131 Identities=18% Similarity=0.174 Sum_probs=80.1
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCCcch-----------------------------------------hHhHH
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG-----------------------------------------KTEFL 392 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~-----------------------------------------~~~~~ 392 (645)
+-|+.++-|.||+|++++ |+.||||+....-.. +-++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 568999999999999986 899999976542100 00133
Q ss_pred HHHHHHhhcC----CCCeeeeeeeeee-CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHH-HHHHhh
Q 041096 393 AELSIIACLR----HKNLVQLLGWCAE-KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASA-LTYLHQ 466 (645)
Q Consensus 393 ~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~ 466 (645)
.|..-+.+++ ...-+.+=..|++ .....|+|||++|-.+.+...-.... .+-. .++..++++ +..+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d~k---~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---IDRK---ELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CCHH---HHHHHHHHHHHHHHHh
Confidence 3444444432 2222222223332 45678999999999998884332221 3422 233333322 222222
Q ss_pred cCCCCeeeCCCCCCcEEEcCCCCeeeec
Q 041096 467 ECEQQVIHRDIKASNIMLDANFNARLES 494 (645)
Q Consensus 467 ~~~~~ivHrDlkp~NIlld~~~~~kl~d 494 (645)
.++.|.|..|.||+++.++..-+-|
T Consensus 284 ---dgffHaDpHpGNi~v~~~g~i~~lD 308 (517)
T COG0661 284 ---DGFFHADPHPGNILVRSDGRIVLLD 308 (517)
T ss_pred ---cCccccCCCccceEEecCCcEEEEc
Confidence 6899999999999999997766655
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0055 Score=61.22 Aligned_cols=75 Identities=19% Similarity=0.210 Sum_probs=48.0
Q ss_pred ceeccCCceEEEEEEECC-CCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCC-eeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 354 RILGRGAFGNVYKAYFAS-SGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKN-LVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~-~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
+.|..|-...+|+....+ .+..+++|+.........+..+|+.++..+.... ..++++.+. + .+||||+++.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCcC
Confidence 457778888999987653 2467788876543322233457888888885333 344444332 1 479999988776
Q ss_pred h
Q 041096 432 D 432 (645)
Q Consensus 432 ~ 432 (645)
.
T Consensus 80 ~ 80 (235)
T cd05157 80 E 80 (235)
T ss_pred C
Confidence 3
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0052 Score=61.56 Aligned_cols=73 Identities=12% Similarity=0.111 Sum_probs=46.0
Q ss_pred ceeccCCce-EEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCC---CeeeeeeeeeeC---CeEEEEEecC
Q 041096 354 RILGRGAFG-NVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHK---NLVQLLGWCAEK---GELLLVYEYM 426 (645)
Q Consensus 354 ~~lG~G~fg-~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~---~~~~lV~Ey~ 426 (645)
+.|+.|+.. .||+. +..+++|.... ......+.+|.+.+..+... .+.+.++.+... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777766 48875 23466776554 33455788999999888532 334444444332 2358899999
Q ss_pred CCCCHh
Q 041096 427 PNGSLD 432 (645)
Q Consensus 427 ~~gsL~ 432 (645)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.012 Score=58.46 Aligned_cols=146 Identities=18% Similarity=0.159 Sum_probs=87.3
Q ss_pred cCHHHHHHHhcCCCcCce---eccCCceEEEEEEECCCCeEEEEEeccCCcchh-------------------------H
Q 041096 338 FSYRELRSATRGFHSNRI---LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGK-------------------------T 389 (645)
Q Consensus 338 ~~~~~l~~~~~~f~~~~~---lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~-------------------------~ 389 (645)
.+++.|....++..+..+ |.+|.-+.||+|... ++..+|+|++....... .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 455666666666655555 456777889999764 47889999876522111 0
Q ss_pred hHHHHHHHHhhcC--CCCeeeeeeeeeeCCeEEEEEecCCCCCH-hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhh
Q 041096 390 EFLAELSIIACLR--HKNLVQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466 (645)
Q Consensus 390 ~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 466 (645)
...+|..-|.++. +-.+.+-+++. +-.|||||+....+ .-.|.. ..+...+...+..++.+.|.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHH
Confidence 1233444444442 22222222222 34799999854311 111111 112333566677788888887775
Q ss_pred cCCCCeeeCCCCCCcEEEcCCCCeeeeccc
Q 041096 467 ECEQQVIHRDIKASNIMLDANFNARLESSF 496 (645)
Q Consensus 467 ~~~~~ivHrDlkp~NIlld~~~~~kl~d~~ 496 (645)
..++||+||..-|||+. ++.+-+.|..
T Consensus 185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~ 211 (268)
T COG1718 185 --EAGLVHGDLSEYNILVH-DGEPYIIDVS 211 (268)
T ss_pred --hcCcccccchhhheEEE-CCeEEEEECc
Confidence 37899999999999999 6777776743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.011 Score=57.28 Aligned_cols=122 Identities=21% Similarity=0.326 Sum_probs=86.8
Q ss_pred CcccCHHHHHHHhcCCCcCceeccCCc-eEEEEEEECCCCeEEEEEeccC-----C--------c---------chhHhH
Q 041096 335 PREFSYRELRSATRGFHSNRILGRGAF-GNVYKAYFASSGSVAAVKRSKH-----S--------H---------EGKTEF 391 (645)
Q Consensus 335 ~~~~~~~~l~~~~~~f~~~~~lG~G~f-g~Vy~g~~~~~~~~vavK~~~~-----~--------~---------~~~~~~ 391 (645)
...|+.. +..++..+.||.|.. |.||++... |..+|+|.+.. . . .....|
T Consensus 29 L~~F~~h-----~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF 101 (207)
T PF13095_consen 29 LEPFTHH-----GDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF 101 (207)
T ss_pred cCCcCCC-----CCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence 3456652 277888999999999 999999987 78999998322 0 0 112358
Q ss_pred HHHHHHHhhcC---CCCe--eeeeeeeeeC------------------CeEEEEEecCCCCCHhHHhhhcCCCCccCCHH
Q 041096 392 LAELSIIACLR---HKNL--VQLLGWCAEK------------------GELLLVYEYMPNGSLDRMLYQDSENGVLLSWY 448 (645)
Q Consensus 392 ~~Ei~~l~~l~---H~ni--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~ 448 (645)
..|.+...+|+ +.++ |+++||..-. ...-||.||++... .+.
T Consensus 102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~-- 166 (207)
T PF13095_consen 102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ-- 166 (207)
T ss_pred HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc--
Confidence 88999888885 4566 9999997322 02467888775433 022
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 041096 449 HRLNIVVGLASALTYLHQECEQQVIHRDIKASNIM 483 (645)
Q Consensus 449 ~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIl 483 (645)
.+-+.++.+-|..+|. .+|+-+|+|+.|..
T Consensus 167 --~~~~~~~~~dl~~~~k---~gI~~~Dv~~~ny~ 196 (207)
T PF13095_consen 167 --IRDIPQMLRDLKILHK---LGIVPRDVKPRNYR 196 (207)
T ss_pred --hhHHHHHHHHHHHHHH---CCeeeccCcccccc
Confidence 2335677788889998 99999999999964
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.021 Score=61.61 Aligned_cols=75 Identities=13% Similarity=0.108 Sum_probs=52.6
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCC--------cchhHhHHHHHHHHhhcC---CCCeeeeeeeeeeCCeEEEE
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS--------HEGKTEFLAELSIIACLR---HKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--------~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 422 (645)
+.||.|.+..||+....+++..++||..... ......+..|.+.|..+. -.++.+++.+.. +..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 4689999999999998764468899974320 123445677888887763 245677776643 457899
Q ss_pred EecCCCCC
Q 041096 423 YEYMPNGS 430 (645)
Q Consensus 423 ~Ey~~~gs 430 (645)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0099 Score=60.35 Aligned_cols=71 Identities=13% Similarity=0.122 Sum_probs=45.7
Q ss_pred eccCCceEEEEEEECCCCeEEEEEeccCCcchh-HhHHHHHHHHhhcCCCCe-eeeeeeeeeCCeEEEEEecCCCCCHh
Q 041096 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGK-TEFLAELSIIACLRHKNL-VQLLGWCAEKGELLLVYEYMPNGSLD 432 (645)
Q Consensus 356 lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~-~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~ 432 (645)
+..|-...+|+... ++..+++|......... -...+|.++++.+....+ .++++.+. -++||||++|..+.
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 45677788998874 36678888765432221 246788889888864333 33444332 36899999987654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0053 Score=72.17 Aligned_cols=185 Identities=20% Similarity=0.135 Sum_probs=118.7
Q ss_pred HHHHHHHHhhcCCCCeeeeeeeeeeCCeE----EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhh
Q 041096 391 FLAELSIIACLRHKNLVQLLGWCAEKGEL----LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466 (645)
Q Consensus 391 ~~~Ei~~l~~l~H~niv~l~g~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 466 (645)
-.-|++.+.+++|+|++.+++|..++... .+..|++..-++...+..-.. .+....+.+..+..+||+|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~----i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS----IPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc----cCHHHHHHHHHHHhhhHHHHHH
Confidence 44567778889999999999997765432 345578888888887765443 7788888899999999999998
Q ss_pred cCCCCeeeCCCCCC---cEEEcCCCCeeee--cc-----------ccccccCCcccCcccccCCCCCc--chhHHHHHHH
Q 041096 467 ECEQQVIHRDIKAS---NIMLDANFNARLE--SS-----------FTLTAGTMGYLAPEYLQYGTATE--KTDVFSYGVV 528 (645)
Q Consensus 467 ~~~~~ivHrDlkp~---NIlld~~~~~kl~--d~-----------~~~~~gt~~y~APE~~~~~~~t~--ksDV~SfGvv 528 (645)
....|.-|..+ +--.+.++...++ +. .....-+..|.|||......+.. ..|+|.+|..
T Consensus 305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred ---hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 54444444333 2223333333332 10 00112244577777776655544 4799999999
Q ss_pred HHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 529 VLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 529 l~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
+..+..|..+-..... +..-+..... ..+......|+..++++|++..+++..
T Consensus 382 ~~~~~~~~~i~~~~~~-----------------------~~~~l~~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV-----------------------PVSLLDVLST----SELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HhhhhhcCcccccccc-----------------------hhhhhccccc----hhhhhhhhhhcchhhhhccchhhhhhc
Confidence 9999987765322110 0000100111 134455578999999999999999875
Q ss_pred H
Q 041096 609 L 609 (645)
Q Consensus 609 L 609 (645)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 3
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.018 Score=59.77 Aligned_cols=139 Identities=17% Similarity=0.151 Sum_probs=80.3
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCC--eeeeeeee------eeCCeEEEEEe
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKN--LVQLLGWC------AEKGELLLVYE 424 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~E 424 (645)
.+.|..|....+|+.... +..+++|+... ........|++++..|.+.. +.+.+... ...+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 345777777889998664 34678888764 33456777888888885432 44444321 22345689999
Q ss_pred cCCCCCHhH----H----------hhhcCC-------CCccCCHHHHHH----------HHHHHHHHHHHHhh----cCC
Q 041096 425 YMPNGSLDR----M----------LYQDSE-------NGVLLSWYHRLN----------IVVGLASALTYLHQ----ECE 469 (645)
Q Consensus 425 y~~~gsL~~----~----------l~~~~~-------~~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~ 469 (645)
|++|..+.. . ++.... ......|..... ....+...+.++.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998876532 1 111100 001123332211 11123344445443 124
Q ss_pred CCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 470 QQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 470 ~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
.+++|+|+.|.||+++.+....+.|.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDf 200 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDF 200 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeeh
Confidence 57999999999999998765556563
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.029 Score=62.30 Aligned_cols=125 Identities=18% Similarity=0.199 Sum_probs=74.0
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCCcch--------------------------------------hHhHHHHH
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG--------------------------------------KTEFLAEL 395 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~--------------------------------------~~~~~~Ei 395 (645)
+-||.-+.|.||+|++++ |+.||||+-+..-+. +-+|..|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 568999999999999987 999999965542110 01233343
Q ss_pred HHHhh----cCCCC---eeeeeeeeee-CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhc
Q 041096 396 SIIAC----LRHKN---LVQLLGWCAE-KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467 (645)
Q Consensus 396 ~~l~~----l~H~n---iv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 467 (645)
+=..+ ++|-+ =|.+=..+++ .....|+||||+|..+.+.-.-.... ++......-+.++..-+-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~~qIf---- 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYLEQIF---- 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHHHHHH----
Confidence 32222 23444 1112222222 24679999999998776653322221 4444443333333222222
Q ss_pred CCCCeeeCCCCCCcEEEcCC
Q 041096 468 CEQQVIHRDIKASNIMLDAN 487 (645)
Q Consensus 468 ~~~~ivHrDlkp~NIlld~~ 487 (645)
..|++|+|-.|.||+++.+
T Consensus 319 -~~GffHaDPHPGNilv~~~ 337 (538)
T KOG1235|consen 319 -KTGFFHADPHPGNILVRPN 337 (538)
T ss_pred -hcCCccCCCCCCcEEEecC
Confidence 2689999999999999953
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.026 Score=58.69 Aligned_cols=76 Identities=22% Similarity=0.265 Sum_probs=49.3
Q ss_pred ceeccCCceEEEEEEECC------CCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCe-eeeeeeeeeCCeEEEEEecC
Q 041096 354 RILGRGAFGNVYKAYFAS------SGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNL-VQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~------~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~ 426 (645)
+.|..|-.-.+|+..... .+..+++|+.........+..+|.+++..+....+ .++++++.. .+|+||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 345556667899887653 24778899876644444566788888888853333 345555532 3589999
Q ss_pred CCCCHhH
Q 041096 427 PNGSLDR 433 (645)
Q Consensus 427 ~~gsL~~ 433 (645)
+|..+..
T Consensus 80 ~G~~l~~ 86 (302)
T cd05156 80 PSRTLTT 86 (302)
T ss_pred CCCcCCH
Confidence 8877643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.026 Score=53.19 Aligned_cols=122 Identities=14% Similarity=0.249 Sum_probs=78.4
Q ss_pred cCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeee-eeeeeeeCCeEEEEEecCCCCC
Q 041096 352 SNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQ-LLGWCAEKGELLLVYEYMPNGS 430 (645)
Q Consensus 352 ~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~~~~~lV~Ey~~~gs 430 (645)
..+.|++|.+|.||+|.+. +..+|+|.-.. +..+..+..|+++|..++-.++.. ++.|.. -.+.|||+.|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc--CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 3467999999999999987 56888886544 445678999999999987655543 333332 245599998878
Q ss_pred HhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC--CcEEEcCCCCeeeecc
Q 041096 431 LDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKA--SNIMLDANFNARLESS 495 (645)
Q Consensus 431 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp--~NIlld~~~~~kl~d~ 495 (645)
|.+.-... +-.+ ...+++.---|-. .+|-|+.|.- .||++..+ .+-|.|.
T Consensus 99 L~~~~~~~-------~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~-~~~iIDF 150 (201)
T COG2112 99 LGKLEIGG-------DRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDR-DVYIIDF 150 (201)
T ss_pred hhhhhhcc-------cHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEecCC-cEEEEEc
Confidence 87655321 1222 3344444333333 7888888753 45555443 5666563
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.0077 Score=65.18 Aligned_cols=162 Identities=23% Similarity=0.323 Sum_probs=92.2
Q ss_pred HhHHHHHHHHhhcCCCCeeeeeeeeeeC-CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhc
Q 041096 389 TEFLAELSIIACLRHKNLVQLLGWCAEK-GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467 (645)
Q Consensus 389 ~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 467 (645)
....-...+++.++|+|+...+.+.... ....+|+|++ +.||++++..+.. . .....+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l-----~------~~s~~~--------- 85 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL-----K------DESLLA--------- 85 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc-----c------hhhhcc---------
Confidence 4566677888999999999998877654 3578899998 7899998865431 1 111111
Q ss_pred CCCCeeeCCCCCCcEEEcCCCCeeeeccccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccc
Q 041096 468 CEQQVIHRDIKASNIMLDANFNARLESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHK 547 (645)
Q Consensus 468 ~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~ 547 (645)
+++.|- ||+...+ ...+. | |- ...+|+||||+|.++.|++-|..-+......
T Consensus 86 --~~~~~~-----~~~~~td---~~~t~---------~--~~-----~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s-- 137 (725)
T KOG1093|consen 86 --HGVLHL-----NIIYITD---HFLTK---------Y--PS-----PIGPKSDVWSLGFIILELYLGISLEAELTES-- 137 (725)
T ss_pred --ccccee-----hhhhccc---ccccc---------C--CC-----CCCcchhhhhHHHHHHHHHHhhHHHHHHHHH--
Confidence 222221 2222111 00000 1 11 1114999999999999999988665443221
Q ss_pred hhhHHHHHHhhhc-cCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 041096 548 MVNLVDWVWGLYA-EGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRR 604 (645)
Q Consensus 548 ~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~ 604 (645)
........... ++......... .+..++.+..+++...|.-..|..||...+
T Consensus 138 --~~l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 138 --EYLEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred --HHHHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhH
Confidence 11111111111 11111111111 223455667888889999999999986433
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.12 Score=54.09 Aligned_cols=90 Identities=9% Similarity=0.033 Sum_probs=50.9
Q ss_pred cCHHHHHHHhcCCCc-----CceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCC--eeeee
Q 041096 338 FSYRELRSATRGFHS-----NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKN--LVQLL 410 (645)
Q Consensus 338 ~~~~~l~~~~~~f~~-----~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~ 410 (645)
.+.+++......|.. .+.|+.|....+|+....+ + .+++|+... ........|+.++..|.... +.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQ-G-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCC-C-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 344555554455543 2446667777899987653 3 678887752 22334445566666653222 22333
Q ss_pred ee------eeeCCeEEEEEecCCCCCH
Q 041096 411 GW------CAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 411 g~------~~~~~~~~lV~Ey~~~gsL 431 (645)
.. ....+..++++||++|..+
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~ 109 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWP 109 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCC
Confidence 21 1224567999999988753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.21 Score=52.19 Aligned_cols=152 Identities=16% Similarity=0.178 Sum_probs=82.5
Q ss_pred HHHHHHHhcCCCc-----CceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCC--Ceeeeeee
Q 041096 340 YRELRSATRGFHS-----NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHK--NLVQLLGW 412 (645)
Q Consensus 340 ~~~l~~~~~~f~~-----~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~ 412 (645)
.++|....+.|.. .+.++.|....+|+.... +..+++|+..... ...+...|++++..|... .+.+.+..
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeC--CCcEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 3455444444533 345666766789988654 3357788765422 233455677777777432 23444432
Q ss_pred e------eeCCeEEEEEecCCCCCHhH-----------H---hhhcCCC----C----ccCCHHHHHH------------
Q 041096 413 C------AEKGELLLVYEYMPNGSLDR-----------M---LYQDSEN----G----VLLSWYHRLN------------ 452 (645)
Q Consensus 413 ~------~~~~~~~lV~Ey~~~gsL~~-----------~---l~~~~~~----~----~~l~~~~~~~------------ 452 (645)
. ...+..++++||++|..+.. . ++..... . ..-.|.....
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 2 12356789999998855321 1 1111100 0 0112221110
Q ss_pred HHHHHHHHHHHHhh----cCCCCeeeCCCCCCcEEEcCCCCeeeec
Q 041096 453 IVVGLASALTYLHQ----ECEQQVIHRDIKASNIMLDANFNARLES 494 (645)
Q Consensus 453 i~~~ia~gL~yLH~----~~~~~ivHrDlkp~NIlld~~~~~kl~d 494 (645)
....+.+.++++.. ....+++|+|+.+.||+++.+....+.|
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vID 211 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVID 211 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEee
Confidence 11223344555542 2357899999999999999876555656
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.11 Score=53.67 Aligned_cols=73 Identities=18% Similarity=0.348 Sum_probs=48.4
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC---CCCeeeeeeeeeeCCeEEEEEecCCCC
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR---HKNLVQLLGWCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~g 429 (645)
.+.++.|....+|+.. .++..+.||.-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999987 457788999776 344567889999988884 345778888887777779999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.0042 Score=74.58 Aligned_cols=152 Identities=13% Similarity=0.012 Sum_probs=109.6
Q ss_pred HhHHHHHHHHhhcCCCCeeeeeeeeee--CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhh
Q 041096 389 TEFLAELSIIACLRHKNLVQLLGWCAE--KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466 (645)
Q Consensus 389 ~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 466 (645)
+....|...++...|+++.....-... ..+.+..++|+..|.+...+-+..+....+...-......+...+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 334455556667789988776554332 346789999999999999998776655445444333333333444444444
Q ss_pred c--CCCCeeeCCCCCCcEEEcCCCCeeeec------------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHH
Q 041096 467 E--CEQQVIHRDIKASNIMLDANFNARLES------------SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEV 532 (645)
Q Consensus 467 ~--~~~~ivHrDlkp~NIlld~~~~~kl~d------------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El 532 (645)
. ...-.+|++||+-|.+|..+.++++++ ..+...+++.|+.|+....-+++.++|+|..|+.+++.
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 2 234478999999999999998777755 33445678899999999988999999999999999999
Q ss_pred HcCCCCCC
Q 041096 533 ACGRRPIE 540 (645)
Q Consensus 533 ~tG~~P~~ 540 (645)
.-|..+|-
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 88877653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.45 Score=51.40 Aligned_cols=79 Identities=14% Similarity=0.126 Sum_probs=51.3
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccC-----Cc---chhHhHHHHHHHHhhcC---CCCeeeeeeeeeeCCeEEE
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKH-----SH---EGKTEFLAELSIIACLR---HKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-----~~---~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~l 421 (645)
.+.||.|..-.||+.... +..++||.-.. .. .....-..|.+.|+.+. -.++.+++.+|.+ ..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence 456899999999998764 44688887552 11 12223334456665553 3578888988884 4678
Q ss_pred EEecCCC--CCHhHHh
Q 041096 422 VYEYMPN--GSLDRML 435 (645)
Q Consensus 422 V~Ey~~~--gsL~~~l 435 (645)
+|||+++ ..+++.|
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 9999976 3455544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.22 Score=52.96 Aligned_cols=74 Identities=18% Similarity=0.205 Sum_probs=46.3
Q ss_pred eeccCCceEEEEEEECC----CCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCee-eeeeeeeeCCeEEEEEecCCCC
Q 041096 355 ILGRGAFGNVYKAYFAS----SGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLV-QLLGWCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 355 ~lG~G~fg~Vy~g~~~~----~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~g 429 (645)
.|-.|-.-.+|+..... .+..+++|+........-+..+|..++..+...++. ++++.+..+ .|+||+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 34446667888887542 236788888766433333346788888888644333 445555332 589999877
Q ss_pred CHh
Q 041096 430 SLD 432 (645)
Q Consensus 430 sL~ 432 (645)
+|.
T Consensus 119 ~l~ 121 (344)
T PLN02236 119 TLS 121 (344)
T ss_pred CCC
Confidence 764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.42 Score=46.80 Aligned_cols=151 Identities=17% Similarity=0.188 Sum_probs=93.9
Q ss_pred CceEEEEEEECCCCeEEEEEeccC-Ccc-hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhh
Q 041096 360 AFGNVYKAYFASSGSVAAVKRSKH-SHE-GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQ 437 (645)
Q Consensus 360 ~fg~Vy~g~~~~~~~~vavK~~~~-~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 437 (645)
+..+.-.|..+- | +..+|++.. .-+ ...-|..+.++++++. .|++|.. .+.-..-++.|+|-..
T Consensus 74 gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~-------- 139 (308)
T PF07387_consen 74 GNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKI-------- 139 (308)
T ss_pred CceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCc--------
Confidence 344444444332 2 334555554 333 3556788888888774 4555552 1334567899988321
Q ss_pred cCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccccccCCcccCcccccCCCCC
Q 041096 438 DSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAGTMGYLAPEYLQYGTAT 517 (645)
Q Consensus 438 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~~~gt~~y~APE~~~~~~~t 517 (645)
.....-.|..+ .+.|.-.|++ ..+.+|+|-.|+|||=|..+..|+-|.......+..|.--|+ ...|
T Consensus 140 --------~i~~~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~~V~~vN~~Y---~~lT 206 (308)
T PF07387_consen 140 --------KINFSNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLENQVNMVNIEY---ESLT 206 (308)
T ss_pred --------ccchhHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhhheeeEEeeec---cccC
Confidence 11111112222 4678888964 378999999999999999999999885544444445554332 3357
Q ss_pred cchhHHHHHHHHHHHHcCCC
Q 041096 518 EKTDVFSYGVVVLEVACGRR 537 (645)
Q Consensus 518 ~ksDV~SfGvvl~El~tG~~ 537 (645)
.++.+-+|=.-++++....+
T Consensus 207 ~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 207 QEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred hHHHHHHHHHHHHHHHHHHh
Confidence 88889899888888877443
|
The function of this family is unknown. |
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.061 Score=37.19 Aligned_cols=23 Identities=13% Similarity=0.414 Sum_probs=11.6
Q ss_pred CccceeeeeecchhHHHHHHHHH
Q 041096 286 KHHNKIGLGLGIAGPAFFCVVLA 308 (645)
Q Consensus 286 ~~~~~~~i~~~i~~~~~~~~~~~ 308 (645)
++++...|+++++.++.++++++
T Consensus 6 ~~~~~vaIa~~VvVPV~vI~~vl 28 (40)
T PF08693_consen 6 SNSNTVAIAVGVVVPVGVIIIVL 28 (40)
T ss_pred CCCceEEEEEEEEechHHHHHHH
Confidence 34455556666555554444433
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.92 E-value=0.75 Score=48.84 Aligned_cols=80 Identities=16% Similarity=0.104 Sum_probs=48.1
Q ss_pred eeccCCceEEEEEEECCCCeEEEEEeccC-------C-cchhHhHHHHHHHHhhcC--CC-CeeeeeeeeeeCCeEEEEE
Q 041096 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKH-------S-HEGKTEFLAELSIIACLR--HK-NLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 355 ~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-------~-~~~~~~~~~Ei~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 423 (645)
.||.|....||++....++..++||.... + .-......-|.+.|.... -| .+.+++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 37999999999999865446789985332 1 112333445666666553 34 3444443 3344567999
Q ss_pred ecCCCC-CHhHHhh
Q 041096 424 EYMPNG-SLDRMLY 436 (645)
Q Consensus 424 Ey~~~g-sL~~~l~ 436 (645)
|+++.. .|+..|.
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 998543 3445443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.49 Score=48.63 Aligned_cols=69 Identities=17% Similarity=0.121 Sum_probs=37.2
Q ss_pred ccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-C-C-CeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 357 GRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-H-K-NLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 357 G~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H-~-niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
++|-...|+..... .|..+++|.-.. ........+|.++|..+. | + -+.+++..+ .-+++|++++|..+
T Consensus 20 ~~g~~~~v~~i~~~-~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~~----~~~~~y~~i~G~p~ 91 (276)
T cd05152 20 ESGLDFQVVFAKDT-DGVPWVLRIPRR-PDVSERAAAEKRVLALVRKHLPVQVPDWRVHT----PELIAYPKLPGVPA 91 (276)
T ss_pred CCcceeEEEEEEcC-CCCeEEEEecCC-HHHHHHHHHHHHHHHHHHhcCCCCCCceeeec----CceEEEeccCCCcc
Confidence 44444556655332 366777776643 233456789999999885 2 1 112222222 12566777666544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.04 E-value=1.1 Score=46.92 Aligned_cols=59 Identities=19% Similarity=0.295 Sum_probs=37.1
Q ss_pred CeEEEEEecc--CCcchhHhHHHHHHHHhhcC--CCCeeeeeeeeeeCC--eEEEEEecCCCCCH
Q 041096 373 GSVAAVKRSK--HSHEGKTEFLAELSIIACLR--HKNLVQLLGWCAEKG--ELLLVYEYMPNGSL 431 (645)
Q Consensus 373 ~~~vavK~~~--~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~--~~~lV~Ey~~~gsL 431 (645)
++.+++.+-. ..........+|..+|+.+. ---....++.|.++. ..+.||+|+++..+
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~ 112 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVV 112 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceec
Confidence 5667777221 12233445567777777764 234455677887776 67999999988433
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=92.76 E-value=0.16 Score=52.52 Aligned_cols=142 Identities=14% Similarity=0.156 Sum_probs=90.1
Q ss_pred cCHHHHHHHhcC---CCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-----------------cc------hhHhH
Q 041096 338 FSYRELRSATRG---FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-----------------HE------GKTEF 391 (645)
Q Consensus 338 ~~~~~l~~~~~~---f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-----------------~~------~~~~~ 391 (645)
+.|--|+..+++ +...+.||-|.-+.+|.+-..+ |.+.++|.-+.. .. ++-..
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 445555554443 5667899999999999998865 677787732210 00 11234
Q ss_pred HHHHHHHhhcC-CC-CeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCC
Q 041096 392 LAELSIIACLR-HK-NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469 (645)
Q Consensus 392 ~~Ei~~l~~l~-H~-niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 469 (645)
.+|...|+.|. |. -+.+.++++ .-++|||++.+-.|...-+- .+..+++.-+.+ -+.-|-.
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~---~Iv~la~--- 220 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMG---LIVRLAN--- 220 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeeec-------CChHHHHHHHHH---HHHHHHH---
Confidence 56788888874 32 233344433 45899999988877654322 222333332222 2333444
Q ss_pred CCeeeCCCCCCcEEEcCCCCeeeecccc
Q 041096 470 QQVIHRDIKASNIMLDANFNARLESSFT 497 (645)
Q Consensus 470 ~~ivHrDlkp~NIlld~~~~~kl~d~~~ 497 (645)
+|+||+|..-=||+++++..+.+.|...
T Consensus 221 ~GlIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 221 HGLIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred cCceecccchheeEEecCCCEEEeechH
Confidence 8999999999999999988888877443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.48 E-value=0.99 Score=47.67 Aligned_cols=73 Identities=15% Similarity=0.173 Sum_probs=45.7
Q ss_pred eeccCCceEEEEEEECCC---CeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCe-eeeeeeeeeCCeEEEEEecCCCCC
Q 041096 355 ILGRGAFGNVYKAYFASS---GSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNL-VQLLGWCAEKGELLLVYEYMPNGS 430 (645)
Q Consensus 355 ~lG~G~fg~Vy~g~~~~~---~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gs 430 (645)
.|..|-.-.+|+....+. +..+++|.........-+..+|..+++.+...++ .++++++..+ +|.+|+++..
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~~ 96 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINART 96 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCCC
Confidence 344466677888876432 2378888776543333345678888888865444 3455555322 5899997766
Q ss_pred H
Q 041096 431 L 431 (645)
Q Consensus 431 L 431 (645)
|
T Consensus 97 l 97 (330)
T PLN02421 97 L 97 (330)
T ss_pred C
Confidence 5
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 645 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-50 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-22 | ||
| 1gsl_A | 243 | Lectin (Fourth Isolated From (Griffonia Simplicifol | 1e-20 | ||
| 1hql_A | 257 | The Xenograft Antigen In Complex With The B4 Isolec | 8e-20 | ||
| 1gnz_A | 257 | Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)m | 8e-20 | ||
| 3usu_B | 242 | Crystal Structure Of Butea Monosperma Seed Lectin L | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 3ipv_B | 239 | Crystal Structure Of Spatholobus Parviflorus Seed L | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 3usu_A | 256 | Crystal Structure Of Butea Monosperma Seed Lectin L | 1e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-19 | ||
| 3ujo_A | 281 | Galactose-Specific Seed Lectin From Dolichos Lablab | 3e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-19 | ||
| 3ipv_A | 251 | Crystal Structure Of Spatholobus Parviflorus Seed L | 3e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-19 | ||
| 1bjq_A | 253 | The Dolichos Biflorus Seed Lectin In Complex With A | 6e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-18 | ||
| 1qnw_A | 242 | Lectin Ii From Ulex Europaeus Length = 242 | 3e-18 | ||
| 1wbl_A | 241 | Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga | 4e-18 | ||
| 1wbf_A | 242 | Winged Bean Lectin, Saccharide Free Form Length = 2 | 4e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-18 | ||
| 2e7q_A | 237 | Crystal Structure Of Basic Winged Bean Lectin In Co | 4e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-17 | ||
| 2pel_A | 236 | Peanut Lectin Length = 236 | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 1bzw_A | 232 | Peanut Lectin Complexed With C-Lactose Length = 232 | 2e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-17 | ||
| 2eig_A | 234 | Lotus Tetragonolobus Seed Lectin (Isoform) Length = | 3e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-17 | ||
| 1gz9_A | 239 | High-Resolution Crystal Structure Of Erythrina Cris | 1e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-16 | ||
| 3zvx_A | 261 | Structure Of The Lectin From Platypodium Elegans In | 2e-16 | ||
| 2bqp_A | 234 | The Structure Of The Pea Lectin-D-Glucopyranose Com | 2e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-16 | ||
| 1fny_A | 237 | Legume Lectin Of The Bark Of Robinia Pseudoacacia. | 3e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-16 | ||
| 3n35_A | 242 | Erythrina Corallodendron Lectin Mutant (Y106g) With | 4e-16 | ||
| 2fmd_A | 240 | Structural Basis Of Carbohydrate Recognition By Bow | 4e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 1lul_A | 253 | Db58, A Legume Lectin From Dolichos Biflorus Length | 4e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-16 | ||
| 1lte_A | 239 | Structure Of A Legume Lectin With An Ordered N-Link | 5e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-15 | ||
| 1ax0_A | 239 | Erythrina Corallodendron Lectin In Complex With N-A | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-15 | ||
| 1fyu_A | 255 | Crystal Structure Of Erythrina Corallodendron Lecti | 2e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 1sfy_A | 239 | Crystal Structure Of Recombinant Erythrina Corallod | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-15 | ||
| 1uzy_A | 242 | Erythrina Crystagalli Lectin Length = 242 | 4e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-14 | ||
| 1dbn_A | 239 | Maackia Amurensis Leukoagglutinin (Lectin) With Sia | 1e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 1fat_A | 252 | Phytohemagglutinin-L Length = 252 | 2e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 1g8w_A | 233 | Improved Structure Of Phytohemagglutinin-L From The | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-14 | ||
| 1fay_A | 238 | Winged Bean Acidic Lectin Complexed With Methyl-Alp | 3e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-14 | ||
| 2sba_A | 253 | Soybean Agglutinin Complexed With 2,6-Pentasacchari | 4e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-14 | ||
| 1qmo_E | 133 | Structure Of Fril, A Legume Lectin That Delays Hema | 1e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 2lal_A | 181 | Crystal Structure Determination And Refinement At 2 | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 1q8o_A | 252 | Pterocartpus Angolensis Lectin Pal In Complex With | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 1n3o_A | 252 | Pterocarcpus Angolensis Lectin In Complex With Alph | 2e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-13 | ||
| 2ltn_A | 181 | Design, Expression, And Crystallization Of Recombin | 4e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-13 | ||
| 1ofs_A | 187 | Pea Lectin-sucrose Complex Length = 187 | 6e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 1loa_A | 181 | Three-Dimensional Structures Of Complexes Of Lathyr | 1e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 1lof_C | 181 | X-Ray Structure Of A Biantennary Octasaccharide-Lec | 2e-12 | ||
| 1rin_A | 180 | X-Ray Crystal Structure Of A Pea Lectin-Trimannosid | 2e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 1lgb_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 4e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-12 | ||
| 1lgc_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 5e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 1n47_A | 233 | Isolectin B4 From Vicia Villosa In Complex With The | 6e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 1fx5_A | 242 | Crystal Structure Analysis Of Ulex Europaeus Lectin | 3e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 2ovu_A | 237 | Crystal Strucure Of A Lectin From Canavalia Gladiat | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 1avb_A | 226 | Arcelin-1 From Phaseolus Vulgaris L Length = 226 | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 2b7y_A | 182 | Fava Bean Lectin-Glucose Complex Length = 182 | 3e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 2yz4_A | 237 | The Neutron Structure Of Concanavalin A At 2.2 Angs | 4e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-09 | ||
| 2ctv_A | 237 | High Resolution Crystallographic Studies Of Native | 5e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-09 | ||
| 1wuv_A | 237 | Crystal Structure Of Native Canavalia Gladiata Lect | 6e-09 | ||
| 1azd_A | 237 | Concanavalin From Canavalia Brasiliensis Length = 2 | 6e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-09 | ||
| 2cwm_A | 237 | Native Crystal Structure Of No Releasing Inductive | 9e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-09 | ||
| 2ow4_A | 237 | Crystal Structure Of A Lectin From Canavalia Mariti | 9e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 1cn1_A | 237 | Crystal Structure Of Demetallized Concanavalin A. T | 2e-08 | ||
| 2cna_A | 237 | The Covalent And Three-Dimensional Structure Of Con | 2e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-08 | ||
| 2je7_A | 239 | Crystal Structure Of Recombinant Dioclea Guianensis | 2e-08 | ||
| 2jdz_A | 239 | Crystal Structure Of Recombinant Dioclea Guianensis | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3a0k_A | 237 | Crystal Structure Of An Antiflamatory Legume Lectin | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-08 | ||
| 1h9w_A | 237 | Native Dioclea Guianensis Seed Lectin Length = 237 | 5e-08 | ||
| 2jec_A | 239 | Crystal Structure Of Recombinant Dioclea Grandiflor | 6e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-08 | ||
| 1h9p_A | 237 | Crystal Structure Of Dioclea Guianensis Seed Lectin | 6e-08 | ||
| 2gdf_A | 237 | Crystal Structure Of Dioclea Violacea Seed Lectin L | 6e-08 | ||
| 3rrd_A | 237 | Native Structure Of Dioclea Virgata Lectin Length = | 6e-08 | ||
| 2je9_A | 239 | Crystal Structure Of Recombinant Dioclea Grandiflor | 6e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-08 | ||
| 3sh3_A | 237 | Crystal Structure Of A Pro-Inflammatory Lectin From | 7e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-08 | ||
| 1mvq_A | 236 | Cratylia Mollis Lectin (Isoform 1) In Complex With | 9e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-07 | ||
| 2zbj_A | 237 | Crystal Structure Of Dioclea Rostrata Lectin Length | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 3u4x_A | 236 | Crystal Structure Of A Lectin From Camptosema Pedic | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 1dgl_A | 237 | Lectin From Dioclea Grandiflora Complexed To Triman | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-07 | ||
| 2d3p_A | 236 | Cratylia Floribunda Seed Lectin Crystallized At Bas | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1GSL|A Chain A, Lectin (Fourth Isolated From (Griffonia Simplicifolia)) Complex With Y Human Blood Group Determinant Length = 243 | Back alignment and structure |
|
| >pdb|1HQL|A Chain A, The Xenograft Antigen In Complex With The B4 Isolectin Of Griffonia Simplicifolia Lectin-1 Length = 257 | Back alignment and structure |
|
| >pdb|1GNZ|A Chain A, Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)metal Free Form Length = 257 | Back alignment and structure |
|
| >pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242 | Back alignment and structure |
|
| >pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241 | Back alignment and structure |
|
| >pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PEL|A Chain A, Peanut Lectin Length = 236 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1BZW|A Chain A, Peanut Lectin Complexed With C-Lactose Length = 232 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2EIG|A Chain A, Lotus Tetragonolobus Seed Lectin (Isoform) Length = 234 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261 | Back alignment and structure |
|
| >pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242 | Back alignment and structure |
|
| >pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FAY|A Chain A, Winged Bean Acidic Lectin Complexed With Methyl-Alpha-D-Galactose (Monoclinic Form) Length = 238 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1QMO|E Chain E, Structure Of Fril, A Legume Lectin That Delays Hematopoietic Progenitor Maturation Length = 133 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2LAL|A Chain A, Crystal Structure Determination And Refinement At 2.3 Angstroms Resolution Of The Lentil Lectin Length = 181 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Q8O|A Chain A, Pterocartpus Angolensis Lectin Pal In Complex With The Dimmanoside Man(Alpha1-2)man Length = 252 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1N3O|A Chain A, Pterocarcpus Angolensis Lectin In Complex With Alpha-Methyl Glucose Length = 252 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2LTN|A Chain A, Design, Expression, And Crystallization Of Recombinant Lectin From The Garden Pea (Pisum Sativum) Length = 181 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1OFS|A Chain A, Pea Lectin-sucrose Complex Length = 187 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1LOA|A Chain A, Three-Dimensional Structures Of Complexes Of Lathyrus Ochrus Isolectin I With Glucose And Mannose: Fine Specificity Of The Monosaccharide-Binding Site Length = 181 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1LOF|C Chain C, X-Ray Structure Of A Biantennary Octasaccharide-Lectin Complex At 2.3 Angstroms Resolution Length = 181 | Back alignment and structure |
|
| >pdb|1RIN|A Chain A, X-Ray Crystal Structure Of A Pea Lectin-Trimannoside Complex At 2.6 Angstroms Resolution Length = 180 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1LGB|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1LGC|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1FX5|A Chain A, Crystal Structure Analysis Of Ulex Europaeus Lectin I Length = 242 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2OVU|A Chain A, Crystal Strucure Of A Lectin From Canavalia Gladiata (Cgl) In Complex With Man1-2man-Ome Length = 237 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1AVB|A Chain A, Arcelin-1 From Phaseolus Vulgaris L Length = 226 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2B7Y|A Chain A, Fava Bean Lectin-Glucose Complex Length = 182 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2YZ4|A Chain A, The Neutron Structure Of Concanavalin A At 2.2 Angstroms Length = 237 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2CTV|A Chain A, High Resolution Crystallographic Studies Of Native Concanavalin A Using Rapid Laue Data Collection Methods And The Introduction Of A Monochromatic Large-Angle Oscillation Technique (Lot) Length = 237 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1WUV|A Chain A, Crystal Structure Of Native Canavalia Gladiata Lectin (Cgl): A Tetrameric Cona-Like Lectin Length = 237 | Back alignment and structure |
|
| >pdb|1AZD|A Chain A, Concanavalin From Canavalia Brasiliensis Length = 237 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2CWM|A Chain A, Native Crystal Structure Of No Releasing Inductive Lectin From Seeds Of The Canavalia Maritima (Conm) Length = 237 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2OW4|A Chain A, Crystal Structure Of A Lectin From Canavalia Maritima Seeds (Conm) In Complex With Man1-2man-Ome Length = 237 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1CN1|A Chain A, Crystal Structure Of Demetallized Concanavalin A. The Metal- Binding Region Length = 237 | Back alignment and structure |
|
| >pdb|2CNA|A Chain A, The Covalent And Three-Dimensional Structure Of Concanavalin A, Iv.Atomic Coordinates,Hydrogen Bonding,And Quaternary Structure Length = 237 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2JE7|A Chain A, Crystal Structure Of Recombinant Dioclea Guianensis Lectin S131h Complexed With 5-Bromo-4-Chloro-3-Indolyl-A-D-Mannose Length = 239 | Back alignment and structure |
|
| >pdb|2JDZ|A Chain A, Crystal Structure Of Recombinant Dioclea Guianensis Lectin Complexed With 5-Bromo-4-Chloro-3-Indolyl-A-D-Mannose Length = 239 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3A0K|A Chain A, Crystal Structure Of An Antiflamatory Legume Lectin From Cymbosema Roseum Seeds Length = 237 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1H9W|A Chain A, Native Dioclea Guianensis Seed Lectin Length = 237 | Back alignment and structure |
|
| >pdb|2JEC|A Chain A, Crystal Structure Of Recombinant Dioclea Grandiflora Lectin Mutant E123a-H131n-K132q Complexed With 5-Bromo-4-Chloro-3- Indolyl-A-D-Mannose Length = 239 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1H9P|A Chain A, Crystal Structure Of Dioclea Guianensis Seed Lectin Length = 237 | Back alignment and structure |
|
| >pdb|2GDF|A Chain A, Crystal Structure Of Dioclea Violacea Seed Lectin Length = 237 | Back alignment and structure |
|
| >pdb|3RRD|A Chain A, Native Structure Of Dioclea Virgata Lectin Length = 237 | Back alignment and structure |
|
| >pdb|2JE9|A Chain A, Crystal Structure Of Recombinant Dioclea Grandiflora Lectin Complexed With 5-Bromo-4-Chloro-3-Indolyl-A-D-Mannose Length = 239 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SH3|A Chain A, Crystal Structure Of A Pro-Inflammatory Lectin From The Seeds Of Dioclea Wilsonii Standl Length = 237 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1MVQ|A Chain A, Cratylia Mollis Lectin (Isoform 1) In Complex With Methyl-Alpha-D- Mannose Length = 236 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZBJ|A Chain A, Crystal Structure Of Dioclea Rostrata Lectin Length = 237 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3U4X|A Chain A, Crystal Structure Of A Lectin From Camptosema Pedicellatum Seeds In Complex With 5-Bromo-4-Chloro-3-Indolyl-Alpha-D-Mannose Length = 236 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1DGL|A Chain A, Lectin From Dioclea Grandiflora Complexed To Trimannoside Length = 237 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2D3P|A Chain A, Cratylia Floribunda Seed Lectin Crystallized At Basic Ph Length = 236 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 645 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-121 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-108 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-105 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-64 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 6e-55 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 1e-54 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 5e-54 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 7e-54 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 2e-53 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 2e-53 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 4e-53 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 1e-52 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 3e-52 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 3e-51 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 1e-50 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 2e-50 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-50 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-50 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 4e-50 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 5e-50 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 2e-49 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 3e-49 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 5e-49 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 2e-48 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-48 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 2e-48 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 5e-47 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 7e-47 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-46 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-46 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-45 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 3e-45 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 4e-45 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 7e-44 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-42 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 7e-42 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-40 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-39 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-38 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-38 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-37 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-37 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-37 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-37 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 6e-37 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 8e-37 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-35 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-35 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-35 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 7e-35 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-34 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-34 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-34 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-34 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-34 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 5e-34 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-34 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-33 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-33 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 6e-33 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-32 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-32 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-32 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-32 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-32 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-32 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-32 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-32 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-32 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-32 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-32 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 4e-32 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 6e-32 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 8e-32 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 8e-32 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-31 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-31 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-31 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-31 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-31 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-31 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-31 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 4e-31 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-31 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-31 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 5e-31 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 6e-31 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 7e-31 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 7e-31 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 7e-31 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 7e-31 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-30 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-30 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-30 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-30 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-30 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 6e-30 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 8e-30 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 9e-30 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-29 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-29 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-29 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 4e-29 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 5e-29 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 6e-29 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 6e-29 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 6e-29 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 6e-29 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-29 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-28 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-28 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-28 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-28 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 5e-28 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 7e-14 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 8e-28 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-27 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-27 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-27 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-27 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-27 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-27 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-26 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-26 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-26 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 9e-26 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-25 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-25 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-25 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-25 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-25 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-25 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 7e-25 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-24 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-24 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-24 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-24 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-24 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-24 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-24 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-24 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-24 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-24 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 5e-24 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 5e-24 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 9e-24 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-23 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-23 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-23 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-23 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-23 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 4e-23 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-23 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-23 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-23 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 9e-23 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-22 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-22 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 7e-22 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 7e-22 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-21 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-21 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-21 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-21 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-21 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-21 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 6e-21 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-20 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-20 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 6e-20 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-19 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 6e-19 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 7e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 7e-19 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 1e-18 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-18 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-18 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-18 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 5e-18 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-18 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 5e-18 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 6e-18 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-17 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-17 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-17 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-17 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-17 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-17 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-17 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-17 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-17 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 5e-17 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 6e-17 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 7e-17 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 7e-17 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 8e-17 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-16 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-16 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-16 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-16 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-16 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-16 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 7e-16 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 7e-16 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-15 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-15 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-15 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-15 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-15 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-15 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-15 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 4e-15 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-15 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-15 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 9e-15 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-14 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-14 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-14 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-14 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-14 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-14 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-14 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-14 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-14 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 7e-14 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-13 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-13 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 4e-13 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 4e-13 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-13 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 8e-13 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-12 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-12 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-12 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-12 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-12 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-11 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-11 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-11 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 3e-11 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 5e-11 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 5e-11 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 8e-11 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 9e-11 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-10 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-10 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-10 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-09 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 6e-09 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-08 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 2e-08 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-08 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-08 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 8e-07 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 9e-07 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-06 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 8e-06 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-05 | |
| 2a6v_A | 226 | EMP46P; beta sandwich, carbohydrate binding protei | 3e-05 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-05 | |
| 2a6y_A | 256 | EMP47P (FORM1); beta sandwich, carbohydrate bindin | 9e-05 | |
| 2a6z_A | 222 | EMP47P (FORM2); beta sandwich, carbohydrate bindin | 2e-04 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-04 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 7e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-121
Identities = 112/296 (37%), Positives = 164/296 (55%), Gaps = 19/296 (6%)
Query: 335 PREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEG-KTEFL 392
+ FS REL+ A+ F + ILGRG FG VYK + G++ AVKR + +G + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQ 75
Query: 393 AELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN 452
E+ +I+ H+NL++L G+C E LLVY YM NGS+ L + E+ L W R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 453 IVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------------TL 498
I +G A L YLH C+ ++IHRD+KA+NI+LD F A + F T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV-GDFGLAKLMDYKDTHVTTA 194
Query: 499 TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIE-RETEGHKMVNLVDWVWG 557
GT+G++APEYL G ++EKTDVF YGV++LE+ G+R + V L+DWV G
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 558 LYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613
L E ++ D L G + ++E+++L+ V L C RP M V ++L +
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 329 bits (845), Expect = e-108
Identities = 101/290 (34%), Positives = 149/290 (51%), Gaps = 22/290 (7%)
Query: 336 REFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAE 394
+L AT F ++G G FG VYK G+ A+KR S +G EF E
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETE 85
Query: 395 LSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIV 454
+ ++ RH +LV L+G+C E+ E++L+Y+YM NG+L R LY + +SW RL I
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 455 VGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------------TLT 499
+G A L YLH +IHRD+K+ NI+LD NF ++ + F T+
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI-TDFGISKKGTELDQTHLSTVV 201
Query: 500 AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY 559
GT+GY+ PEY G TEK+DV+S+GVV+ EV C R I + + +MVNL +W +
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ-SLPREMVNLAEWAVESH 260
Query: 560 AEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609
G++ + D L + +++ + C S RPSM V L
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-105
Identities = 99/308 (32%), Positives = 154/308 (50%), Gaps = 39/308 (12%)
Query: 333 PGPREFSYRELRSATRGFHS------NRILGRGAFGNVYKAYFASSGSVAAVKR-----S 381
FS+ EL++ T F +G G FG VYK Y + + AVK+
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVD 67
Query: 382 KHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSEN 441
+ E K +F E+ ++A +H+NLV+LLG+ ++ +L LVY YMPNGSL L +
Sbjct: 68 ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS-CLDG 126
Query: 442 GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT-- 499
LSW+ R I G A+ + +LH+ IHRDIK++NI+LD F A++ S F L
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKI-SDFGLARA 182
Query: 500 -------------AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGH 546
GT Y+APE L+ G T K+D++S+GVV+LE+ G ++ E
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241
Query: 547 KMVNLVDWVWGLYAEGRIIEA-ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRV 605
L+D + E + IE DK++N + ++ + V C + + RP +++V
Sbjct: 242 ---LLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 606 FQILNNEA 613
Q+L
Sbjct: 298 QQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-64
Identities = 62/312 (19%), Positives = 114/312 (36%), Gaps = 44/312 (14%)
Query: 336 REFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAEL 395
+ L + + RG FG V+KA AVK + + E+
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEV 69
Query: 396 SIIACLRHKNLVQLLGWCAE----KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRL 451
+ ++H+N++Q +G +L L+ + GSL L + +SW
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELC 124
Query: 452 NIVVGLASALTYLHQE-------CEQQVIHRDIKASNIMLDANFN--------ARLESSF 496
+I +A L YLH++ + + HRDIK+ N++L N A +
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 497 TLT------AGTMGYLAPEYLQYG-----TATEKTDVFSYGVVVLEVACGRRPIERETEG 545
GT Y+APE L+ A + D+++ G+V+ E+A + +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 546 HKMVNLVDWVWGLYAEGRIIEAADKRL------NGAFNEDEMKRLLLVGLSCANPDSSAR 599
+ M+ + + + + E + + M L C + D+ AR
Sbjct: 245 Y-MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 600 PSMRRVFQILNN 611
S V + +
Sbjct: 304 LSAGCVGERITQ 315
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 6e-55
Identities = 81/243 (33%), Positives = 118/243 (48%), Gaps = 16/243 (6%)
Query: 22 SNNMNFDFTSFNL--RNITLLGD-SYLRNGVIGLTRE---LGVPASSSGSLIYNNPVPFF 75
+ +F F+ F N+ L GD GV+ LT SS G Y+ P+ +
Sbjct: 1 AEETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIW 60
Query: 76 DQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKN 134
D T ASF + F F+I N ++ DGLAFF++P S GG LGL +S+ +
Sbjct: 61 DSATGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDSGGGFLGLFDSAVSGSTY 120
Query: 135 KFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKND 194
+ VA+EFDT + F DP HIG D++S+ SIKT L +G I Y +
Sbjct: 121 QTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVK-----WSLANGEAAKVLITYNSA 175
Query: 195 LRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQ 251
+++L + Y + + +L +DLS L + VGFSA+T G E H + SWSF
Sbjct: 176 VKLLVASLVYPS-SKTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSFA 234
Query: 252 TSG 254
+
Sbjct: 235 SKL 237
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253 | Back alignment and structure |
|---|
Score = 186 bits (472), Expect = 1e-54
Identities = 74/254 (29%), Positives = 127/254 (50%), Gaps = 16/254 (6%)
Query: 22 SNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELG---VPASSSGSLIYNNPVPFFDQE 78
++ +F F +FN + L GD+ + + + LT+ G SS G Y++P+ +D+
Sbjct: 1 ADIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKS 60
Query: 79 TNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFV 137
T AS+ + F+ +I N SS DG+AF + P S G LG+ +S + V
Sbjct: 61 TGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDNSAQTV 120
Query: 138 AIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRM 197
A+EFDT + + DP HIG+D++S++SI+TA L +G I Y +
Sbjct: 121 AVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTAS-----WGLANGQNAEILITYNAATSL 174
Query: 198 LKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQTSG 254
L + + + + + ++ +D++ L + +GFSA+T EG TE H + SWSF +
Sbjct: 175 LVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASKL 233
Query: 255 FRPVRPKLHPHNVS 268
P P +++
Sbjct: 234 --PDDSTTEPLDIA 245
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 5e-54
Identities = 77/246 (31%), Positives = 127/246 (51%), Gaps = 15/246 (6%)
Query: 22 SNNMNFDFTSFN---LRNITLLGDSYLRNGVIGLTRELGVP---ASSSGSLIYNNPVPFF 75
S++++F F +F +I GD+ G + L + S+G +Y++PV +
Sbjct: 2 SDSVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLW 61
Query: 76 DQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQL---T 132
D +T + ASF + F+F + + DGLAFF++P + + AG LGL N S +
Sbjct: 62 DNKTESVASFYTEFTFFLKI-TGNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPS 120
Query: 133 KNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYK 192
KN+ VA+EFDT +P+F +P HIG++++S+ S+ T + D+ SG + TA I Y
Sbjct: 121 KNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKR--WEDSDIFSGKIATARISYD 178
Query: 193 NDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTEL-HMIQSWSFQ 251
+L V +SY +L ++D+ L ++ VG SAST + L I SW F
Sbjct: 179 GSAEILTVVLSYP--DGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFS 236
Query: 252 TSGFRP 257
++
Sbjct: 237 SNLQST 242
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 7e-54
Identities = 78/239 (32%), Positives = 118/239 (49%), Gaps = 15/239 (6%)
Query: 22 SNNMNFDFTSFNLRNITLLGD-SYLRNGVIGLTRE---LGVPASSSGSLIYNNPVPFFDQ 77
SN++ F+F FN N+ L D S +G + LT S G Y+ P+ +D
Sbjct: 1 SNDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDN 60
Query: 78 ETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFV 137
T T ASF + F+F+I N + DGLAF + P GG LGL + S + V
Sbjct: 61 TTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKDKGGFLGLFDGSN-SNFHTV 119
Query: 138 AIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRM 197
A+EFDT + + DP E HIG+D++S+ SIKT D +G I Y + +
Sbjct: 120 AVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRW-----DFVNGENAEVLITYDSSTNL 173
Query: 198 LKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQTS 253
L + Y + + + ++ +DL L + VGFSA+T +G+ E + + SWSF +
Sbjct: 174 LVASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASK 231
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234 | Back alignment and structure |
|---|
Score = 182 bits (462), Expect = 2e-53
Identities = 68/240 (28%), Positives = 120/240 (50%), Gaps = 16/240 (6%)
Query: 22 SNNMNFDFTSF--NLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQET 79
+ +F T F + +N+ GD Y + LT+ + ++ G +Y++P+ +D+ET
Sbjct: 1 TETTSFLITKFSPDQQNLIFQGDGYTTKEKLTLTKAVK---NTVGRALYSSPIHIWDRET 57
Query: 80 NTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTK-NKFVA 138
A+F + F+F IN N + DG FFI+P + + GG LG+ NS++ K + VA
Sbjct: 58 GNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDKTTQTVA 117
Query: 139 IEFDTRLDPHFDDPDE-NHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRM 197
+EFDT + +D + HIG+D++S++S+ T L++G I + +
Sbjct: 118 VEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKS-----WKLQNGEEANVVIAFNAATNV 172
Query: 198 LKVFMSYSN----LKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTS 253
L V ++Y N + + L + L + + +GFSA+T H + SWSF +
Sbjct: 173 LTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSE 232
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-53
Identities = 69/237 (29%), Positives = 118/237 (49%), Gaps = 14/237 (5%)
Query: 22 SNNMNFDFTSFNL--RNITLLGD-SYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQE 78
+ ++F+F SF+ I GD + L NG I LT +S G ++Y PV +
Sbjct: 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTN--LNKVNSVGRVLYAMPVRIWSSA 58
Query: 79 TNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQL-TKNKFV 137
T ASF + FSF + ++ DG+ FFI+P++ + + G + S FV
Sbjct: 59 TGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKGAGHFV 118
Query: 138 AIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRM 197
+EFDT + ++DP +H+G+D++S++S+KT + SG V+ + Y + +
Sbjct: 119 GVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW-----NSVSGAVVKVTVIYDSSTKT 173
Query: 198 LKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST-EGSTELHMIQSWSFQTS 253
L V ++ + +DL L + GFSAS G ++H+I+SWSF ++
Sbjct: 174 LSVAVTND--NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTST 228
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-53
Identities = 79/243 (32%), Positives = 122/243 (50%), Gaps = 19/243 (7%)
Query: 23 NNMNFDFTSF------NLRNITLLGDSYLRNGVIGLTRELGVP---ASSSGSLIYNNPVP 73
N +NF + F N IT LGD+ G + LT+ SS+G Y+ PV
Sbjct: 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVF 61
Query: 74 FFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQL-- 131
+D T ASF + F+F + N + DGLAFF++P + + GG LGL
Sbjct: 62 LWDS-TGKAASFYTSFTFLLKNYGAPT-ADGLAFFLAPVDSSVKDYGGFLGLFRHETAAD 119
Query: 132 -TKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWID 190
+KN+ VA+EFDT ++ ++DP HIG+D++S+ S+ T + D ++ TA I
Sbjct: 120 PSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTR--WENDDAYGSSIATAHIT 177
Query: 191 YKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSF 250
Y ++L V +SY + +L +DL+ L + +GFSA G E+ I SW F
Sbjct: 178 YDARSKILTVLLSYEH--GRDYILSHVVDLAKVLPQKVRIGFSAGV-GYDEVTYILSWHF 234
Query: 251 QTS 253
++
Sbjct: 235 FST 237
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-52
Identities = 72/242 (29%), Positives = 122/242 (50%), Gaps = 16/242 (6%)
Query: 22 SNNMNFDFTSF--NLRNITLLGDSYLR-NGVIGLTRELGVPAS--SSGSLIYNNPVPFFD 76
+ +++F F F N + GD+ + GV+ LT + S S G +Y P +D
Sbjct: 1 TGSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWD 60
Query: 77 QETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTK-NK 135
T ASF + F+F I NP++ DGLAFF++P + GG LG+ K N+
Sbjct: 61 STTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNKSNQ 120
Query: 136 FVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDL 195
VA+EFDT + +D P H+G++++S+ESIKT + +G V +I Y+
Sbjct: 121 IVAVEFDTFSNGDWD-PKGRHLGINVNSIESIKTVP-----WNWTNGEVANVFISYEAST 174
Query: 196 RMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQT 252
+ L + Y + + ++ +D+ L + GFSA+T +G + + + SWSF++
Sbjct: 175 KSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFES 233
Query: 253 SG 254
+
Sbjct: 234 NL 235
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-52
Identities = 70/240 (29%), Positives = 118/240 (49%), Gaps = 12/240 (5%)
Query: 22 SNNMNFDFTSF--NLRNITLLGD-SYLRNGVIGLTR-ELGVPASSSGSLIYNNPVPFFDQ 77
S++++F F +F N ++++ G+ S + GV+ L + +P + G Y P+ ++
Sbjct: 1 SDDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNC 60
Query: 78 ETNTTASFTSRFSFSIN-NVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLT-KNK 135
T ASF + FSF + + NP + DGL FF++P + L AGG GL N ++ +
Sbjct: 61 NTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTKCDSSYQ 120
Query: 136 FVAIEFDTRLD-PHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKND 194
VA+EFDT +F DP HIG+D++ ++SI NV I Y+
Sbjct: 121 TVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW---NKRYGLNNVANVEIIYEAS 177
Query: 195 LRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST-EGSTELHMIQSWSFQTS 253
+ L ++Y + + + +DL L + VGFS ST G H + +W F ++
Sbjct: 178 SKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFTST 236
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-51
Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 22 SNNMNFDFTSFNLRNITLLGD-SYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETN 80
SN+ +F+ +FN N+ L GD + G + LT G S G Y+ P+ D+ +
Sbjct: 1 SNDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTID 60
Query: 81 TTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAI 139
ASF++ F+F IN N + GLAF + P G LGL N++ VA+
Sbjct: 61 NLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKLKGRYLGLFNTTNYDRDAHTVAV 120
Query: 140 EFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLK 199
FDT N I +D++S+ I T +G I Y + L+
Sbjct: 121 VFDT---------VSNRIEIDVNSIRPIATESC---NFGHNNGEKAEVRITYDSPKNDLR 168
Query: 200 VFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQTS 253
V + Y + + + L ++ + VGFSA++ + +TE H + SWSF ++
Sbjct: 169 VSLLYPS-SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSN 224
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-50
Identities = 75/238 (31%), Positives = 124/238 (52%), Gaps = 15/238 (6%)
Query: 26 NFDFTSF-NLRNITLLGD-SYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTA 83
+F++T F + ++ GD +G + + + V ++ +Y PVP +D T A
Sbjct: 2 SFNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDPLVN-RTTSHALYATPVPIWDSATGNVA 60
Query: 84 SFTSRFSFSINNVNPSSFGDGLAFFISPDNQIL--GSAGGCLGLVNSSQLTKNKFVAIEF 141
SF + FSF ++NV DG+ FF++P + S GG LG+ +SS ++N+FVA+EF
Sbjct: 61 SFITSFSFIVSNVQRYPPTDGVVFFLAPWGTEIPPNSQGGYLGITDSSN-SQNQFVAVEF 119
Query: 142 DTRLDP-HFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLKV 200
D+ + +HIG+D++S+ S+K + + SG++ A I Y +D ++L V
Sbjct: 120 DSHPNVWDPKSLRSSHIGIDVNSIMSLKAVN-----WNRVSGSLEKATIIYDSDTKILTV 174
Query: 201 FMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEG-STELHMIQSWSFQTSGFRP 257
M++ N + IDL L + VGFSA+T E H I SWSF ++ P
Sbjct: 175 VMTHQN--GQITTISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWSFTSTLKEP 230
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261 | Back alignment and structure |
|---|
Score = 175 bits (444), Expect = 2e-50
Identities = 71/268 (26%), Positives = 125/268 (46%), Gaps = 20/268 (7%)
Query: 14 LLNFSFVLSNNMNFDFTSFNL--RNITLLGD-SYLRNGVIGLTRE---LGVPASSSGSLI 67
+L +++++F F +F+ RN+ GD RN ++ LTR S+ G ++
Sbjct: 1 MLLNRANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRIL 60
Query: 68 YNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQIL-GSAGGCLGLV 126
++ V +++ TN A+ ++FSF +++ + F PD I GSAGG LGL
Sbjct: 61 HSAQVRLWEKSTNRVANLQTQFSFFLSSPLSNPADGIAFFIAPPDTTIPSGSAGGLLGLF 120
Query: 127 NSSQL---TKNKFVAIEFDTRLDPH--FDDPDENHIGLDIDSLESIKTADPILQGIDLKS 181
N + N+ +A+EFDT + DP+ HIG+D++S+ S K + +
Sbjct: 121 NPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVVR-----WERRE 175
Query: 182 GNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTE 241
G + + Y R + V +Y + L +DL+ L + VGFSA++ +
Sbjct: 176 GKTLNVLVTYNPSTRTIDVVATYPD--GQRYQLSHVVDLTTILPEWVRVGFSAASGEQFQ 233
Query: 242 LHMIQSWSFQTSGFRPVRPKLHPHNVSD 269
H ++SWSF ++ K + D
Sbjct: 234 THNLESWSFTST-LLYTAQKEDEYLARD 260
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-50
Identities = 73/270 (27%), Positives = 126/270 (46%), Gaps = 35/270 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
++GRGAFG V KA + A+K+ + E K F+ EL ++ + H N+V+L G C
Sbjct: 14 EVVGRGAFGVVCKAKW--RAKDVAIKQIESESERK-AFIVELRQLSRVNHPNIVKLYGAC 70
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+ LV EY GSL +L +E + H ++ + + + YLH + +I
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 474 HRDIKASNIMLDANFN---------AR-LESSFTLTAGTMGYLAPEYLQYGTATEKTDVF 523
HRD+K N++L A A +++ T G+ ++APE + +EK DVF
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVF 187
Query: 524 SYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR--IIEAADKRLNGAFNEDEM 581
S+G+++ EV R+P + +W ++ R +I+ K +
Sbjct: 188 SWGIILWEVITRRKPFD-----EIGGPAFRIMWAVHNGTRPPLIKNLPK---------PI 233
Query: 582 KRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+ L+ C + D S RPSM + +I+ +
Sbjct: 234 ESLM---TRCWSKDPSQRPSMEEIVKIMTH 260
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-50
Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 41/276 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+G G+FG V++A + GS AVK E EFL E++I+ LRH N+V +
Sbjct: 43 EKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
G + L +V EY+ GSL R+L S L RL++ +A + YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 471 QVIHRDIKASNIMLDANFN--------ARLESSFTLT----AGTMGYLAPEYLQYGTATE 518
++HR++K+ N+++D + +RL++S L+ AGT ++APE L+ + E
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 519 KTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR---IIEAADKRLNGA 575
K+DV+S+GV++ E+A ++P +N V + + + I +
Sbjct: 219 KSDVYSFGVILWELATLQQP-------WGNLNPAQVVAAVGFKCKRLEIPRNLNP----- 266
Query: 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
++ ++ C + RPS + +L
Sbjct: 267 ----QVAAII---EGCWTNEPWKRPSFATIMDLLRP 295
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 4e-50
Identities = 77/240 (32%), Positives = 111/240 (46%), Gaps = 18/240 (7%)
Query: 26 NFDFTSFNL--RNITLLGD-SYLRNGVIGLTRE---LGVPASSSGSLIYNNPVPFFDQET 79
+F F+ F N+TL G ++GV+ LT+ S+G +Y PV +D T
Sbjct: 5 SFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTT 64
Query: 80 NTTASFTSRFSFSINNVNPSSFGD-GLAFFISPDNQILGSAGGCLGLVN-SSQLTKNKFV 137
T ASF +RFSFSI GL FF+ P G LG+ N S Q + +
Sbjct: 65 GTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDNSYQTL 124
Query: 138 AIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRM 197
A+EFDT + +D P HIG+D++S+ SIKT L +G V I Y ++
Sbjct: 125 AVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQP-----FQLDNGQVANVVIKYDAPSKI 178
Query: 198 LKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQTSG 254
L V + Y + + +D+ L + VG S +T + E H + SWSFQ S
Sbjct: 179 LHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQASL 237
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-50
Identities = 71/244 (29%), Positives = 120/244 (49%), Gaps = 17/244 (6%)
Query: 22 SNNMNFDFTSF--NLRNITLLGD-SYLRNGVIGLTRE---LGVPASSSGSLIYNNPVPFF 75
+ ++F + F N+ L GD +G + L + SS G +Y+ P+ +
Sbjct: 1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW 60
Query: 76 DQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNK 135
D+ET + ASF + F+F+ + DGLAFF++P + + G LGL N ++ + ++
Sbjct: 61 DKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQTHAGYLGLFNENE-SGDQ 119
Query: 136 FVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDL 195
VA+EFDT + DP HIG++++S+ SIKT DL + V I Y
Sbjct: 120 VVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTS-----WDLANNKVAKVLITYDAST 172
Query: 196 RMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST--EGSTELHMIQSWSFQTS 253
+L + Y + + + +L +DL L + +GFSA+T + E H + SWSF ++
Sbjct: 173 SLLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASN 231
Query: 254 GFRP 257
Sbjct: 232 LPHA 235
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239 | Back alignment and structure |
|---|
Score = 171 bits (433), Expect = 2e-49
Identities = 79/244 (32%), Positives = 121/244 (49%), Gaps = 18/244 (7%)
Query: 22 SNNMNFDFTSF--NLRNITLLGD-SYLRNGVIGLTREL--GVPASSSGSLIYNNPVPFFD 76
S+ ++F +F N ++ G+ S GV+ LT+ S G +Y PV +
Sbjct: 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWG 60
Query: 77 QETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQIL--GSAGGCLGLVNSSQLT-K 133
T + ASF++ F+F + NP DGLAF+++P + + GS LGL N+S
Sbjct: 61 NTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSS 120
Query: 134 NKFVAIEFDTRLDPHFD--DPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDY 191
N+ VA+EFDT +D DP+ HIG+D++ +ESIKT D +G V A I Y
Sbjct: 121 NQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQW-----DWINGGVAFATITY 175
Query: 192 KNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST--EGSTELHMIQSWS 249
+ L + Y + T + ++DL L + VGFSA+T E H + SWS
Sbjct: 176 LAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWS 234
Query: 250 FQTS 253
F ++
Sbjct: 235 FTST 238
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242 | Back alignment and structure |
|---|
Score = 171 bits (433), Expect = 3e-49
Identities = 81/242 (33%), Positives = 114/242 (47%), Gaps = 23/242 (9%)
Query: 26 NFDFTSF--NLRNITLLGD-SYLRNGVIGLTREL--GVPASSSGSLIYNNPVPFFDQETN 80
+F+F F N + L D N V+ LT+ + +S+G +Y PV +D T
Sbjct: 5 SFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTG 64
Query: 81 TTASFTSRFSFSINNVNPSSF-GDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAI 139
ASF +RFSFSI P DGL FFI+P N G GG G+ N + FVA+
Sbjct: 65 NVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPL--SPYPFVAV 122
Query: 140 EFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLK 199
EFDT + DP HIG+D++S+ S KT L +G + I Y ++L
Sbjct: 123 EFDTFRNT--WDPQIPHIGIDVNSVISTKTVP-----FTLDNGGIANVVIKYDASTKILH 175
Query: 200 VFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST-------EGSTELHMIQSWSFQT 252
V + + + + +DL L ++ VGFSA+T +TE H I SWSF
Sbjct: 176 VVLVFPS-LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSFSA 234
Query: 253 SG 254
S
Sbjct: 235 SL 236
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 5e-49
Identities = 75/242 (30%), Positives = 110/242 (45%), Gaps = 19/242 (7%)
Query: 22 SNNMNFDFTSFNL--RNITLLGD-SYLRNGVIGLTRE--LGVPASSSGSLIYNNPVPFFD 76
+ + +F FT+FN N+ L D G + LT S G +Y P+ D
Sbjct: 1 TESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHD 60
Query: 77 QETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGL-VNSSQLTKNK 135
T ASFT+ FSF + ++ DGLAFF++P + + GG LGL + + +
Sbjct: 61 NTTL--ASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHDASYQ 118
Query: 136 FVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDL 195
VA+EFDT + DP+ HIG+D + +ES KT D+ G I Y+
Sbjct: 119 TVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTP-----FDMVYGEKANIVITYQAST 171
Query: 196 RMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQT 252
+ L + + + + +DL L + VGFSA+T G E H I SWSF
Sbjct: 172 KALAASLVFPV-SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAV 230
Query: 253 SG 254
S
Sbjct: 231 SL 232
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240 | Back alignment and structure |
|---|
Score = 169 bits (428), Expect = 2e-48
Identities = 73/242 (30%), Positives = 119/242 (49%), Gaps = 17/242 (7%)
Query: 22 SNNMNFDFTSF--NLRNITLLGD-SYLRNGVIGLTRELGVP---ASSSGSLIYNNPVPFF 75
+N++ F FT F +++ GD S N + LT+ S G +Y P+ +
Sbjct: 1 ANSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLW 60
Query: 76 DQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILG-SAGGCLGLVNSSQL--T 132
++ ASF + F+FSI+ + + F SPD +I S G LGL SS +
Sbjct: 61 QS-SSLVASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGS 119
Query: 133 KNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYK 192
N V++EFDT + DP+ HIG+D++S+ S + D ++G TA I Y
Sbjct: 120 DNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASK-----WDWQNGKTATAHISYN 174
Query: 193 NDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQT 252
+ + L V SY N P ++ +++L+ + VGFSA+T T+ + I +WSF++
Sbjct: 175 SASKRLSVVSSYPNSSP--VVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSFRS 232
Query: 253 SG 254
S
Sbjct: 233 SL 234
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 72/284 (25%), Positives = 119/284 (41%), Gaps = 52/284 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-----EGKTEFLAELSIIACLRHKNLVQ 408
I+G G FG VY+A++ G AVK ++H + E + A L+H N++
Sbjct: 13 EIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L G C ++ L LV E+ G L+R+L + +N V +A + YLH E
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEA 125
Query: 469 EQQVIHRDIKASNIMLDANFN----------------ARLESSFTLT--AGTMGYLAPEY 510
+IHRD+K+SNI++ AR T AG ++APE
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEV 185
Query: 511 LQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR---IIEA 567
++ ++ +DV+SYGV++ E+ G P + ++ + +G+ I
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVP-------FRGIDGLAVAYGVAMNKLALPIPST 238
Query: 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+ +L+ C NPD +RPS + L
Sbjct: 239 CPE---------PFAKLM---EDCWNPDPHSRPSFTNILDQLTT 270
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-48
Identities = 80/244 (32%), Positives = 130/244 (53%), Gaps = 17/244 (6%)
Query: 21 LSNNMNFDFTSF--NLRNITLLGDSYLR-NGVIGLTRELGVPASSSGSLIYNNPVPFFDQ 77
LS++++F+F F N +NI GD+ + GV+ +T+ +S G +Y P+ +D
Sbjct: 2 LSDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDS 61
Query: 78 ETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQIL--GSAGGCLGLVNSSQ-LTKN 134
T ASF + FSF + + S DGLAFF++P N + GS+ G GL +SS + N
Sbjct: 62 ITGKVASFATSFSFVVKA-DKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSN 120
Query: 135 KFVAIEFDTRLDPHFD--DPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYK 192
+ +A+EFDT ++ DPD HIG+D++S++SIKT D ++G V I Y+
Sbjct: 121 QIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKW-----DWRNGEVADVVITYR 175
Query: 193 NDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGST--ELHMIQSWSF 250
+ L V +SY + + ++ ++DL L + VGFS + E H + SW F
Sbjct: 176 APTKSLTVCLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYF 234
Query: 251 QTSG 254
++
Sbjct: 235 TSNL 238
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 5e-47
Identities = 63/333 (18%), Positives = 121/333 (36%), Gaps = 59/333 (17%)
Query: 337 EFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELS 396
E + E ++GRG +G VYK AVK ++ F+ E +
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKN 57
Query: 397 I--IACLRHKNLVQLLGWCAE-----KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYH 449
I + + H N+ + + + E LLV EY PNGSL + L + W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVS 112
Query: 450 RLNIVVGLASALTYLHQECEQ------QVIHRDIKASNIMLDANFN--------ARLESS 495
+ + L YLH E + + HRD+ + N+++ + + +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 496 FTLT------------AGTMGYLAPEYLQ-------YGTATEKTDVFSYGVVVLEVACGR 536
L GT+ Y+APE L+ +A ++ D+++ G++ E+ R
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-R 231
Query: 537 RPIERETEGHKMVNLV--DWVWGL--YAEGRIIEAADKR---LNGAFNEDEMKRLLLVGL 589
E + V + + +++ + +K+ A+ E+ + L
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 590 --SCANPDSSARPSMRRVFQILNNEAEPLVVPK 620
C + D+ AR + + + + K
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 7e-47
Identities = 75/241 (31%), Positives = 112/241 (46%), Gaps = 22/241 (9%)
Query: 26 NFDFTSF--NLRNITLLGD-SYLRNGVIGLTR---ELGVPASSSGSLIYNNPVPFFDQET 79
+F+F F N + + L S NGV+ LT+ S+G +Y P+ +D T
Sbjct: 4 SFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTT 63
Query: 80 NTTASFTSRFSFSINNVNPSSF-GDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVA 138
ASF +RFSF+I DGL FF+ P N G GG LG+ + A
Sbjct: 64 GNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGEDGGNLGVFKPP--EGDNAFA 121
Query: 139 IEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRML 198
+EFDT + DP HIG+D++S+ S KT L++G V I Y + ++L
Sbjct: 122 VEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLH-----FQLENGGVANVVIKYDSPTKIL 174
Query: 199 KVFMSYSNLKPVTPLLKVNIDLSGYLKGN--MYVGFSAST---EGSTELHMIQSWSFQTS 253
V +++ + L +DL + + VG SA+T + + E H I SWSF +S
Sbjct: 175 NVVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFTSS 233
Query: 254 G 254
Sbjct: 234 L 234
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-46
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 33/212 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQLLGW 412
+LG+G FG K +G V +K E + FL E+ ++ CL H N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
+ L + EY+ G+L ++ W R++ +AS + YLH +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 473 IHRDIKASNIMLDANFN--------ARLES------------------SFTLTAGTMGYL 506
IHRD+ + N ++ N N ARL G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 507 APEYLQYGTATEKTDVFSYGVVVLEVACGRRP 538
APE + + EK DVFS+G+V+ E+
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 59/285 (20%), Positives = 113/285 (39%), Gaps = 50/285 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--------EGKTEFLAELSIIACLRHKN 405
+ +G+G FG V+K SV A+K E EF E+ I++ L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+V+L G +V E++P G L L + W +L +++ +A + Y+
Sbjct: 85 IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 466 QECEQQVIHRDIKASNIMLDANFN-------------ARLES-SFTLTAGTMGYLAPEYL 511
++HRD+++ NI L + ++ S + G ++APE +
Sbjct: 140 N-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETI 198
Query: 512 QY--GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR---IIE 566
+ TEK D +S+ +++ + G P + + G + ++ + EG I E
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGLRPTIPE 253
Query: 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
++ ++ C + D RP + + L+
Sbjct: 254 DCPP---------RLRNVI---ELCWSGDPKKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 51/276 (18%), Positives = 96/276 (34%), Gaps = 42/276 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
L G ++K + G+ VK S +F E + H N++ +L
Sbjct: 16 TKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 411 GWCAE--KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
G C L+ +MP GSL +L+ ++ + + +A + +LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLHT-L 130
Query: 469 EQQVIHRDIKASNIMLDANFNAR-------LESSFTLTAGTMGYLAPEYLQ---YGTATE 518
E + + + ++M+D + AR ++APE LQ T
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRR 190
Query: 519 KTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR---IIEAADKRLNGA 575
D++S+ V++ E+ P ++ ++ + EG I
Sbjct: 191 SADMWSFAVLLWELVTREVP-------FADLSNMEIGMKVALEGLRPTIPPGISP----- 238
Query: 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+ +L+ C N D + RP + IL
Sbjct: 239 ----HVSKLM---KICMNEDPAKRPKFDMIVPILEK 267
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 3e-45
Identities = 53/250 (21%), Positives = 94/250 (37%), Gaps = 37/250 (14%)
Query: 22 SNNMNFDFTSFNLRNITLLGD-SYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETN 80
+ +F +FN N+ L GD + NG + L+ S Y+ P+ D T
Sbjct: 1 ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYN---SYDSMSRAFYSAPIQIRDSTTG 57
Query: 81 TTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIE 140
ASF + F+ +I ++ GL F + P +K V +E
Sbjct: 58 NVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPE----------------SKGDTVTVE 101
Query: 141 FDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLKV 200
FDT L + I +D+++ + + G I Y + ++ V
Sbjct: 102 FDTFL---------SRISIDVNNNDIKSVP----WDVHDYDGQNAEVRITYNSSTKVFSV 148
Query: 201 FMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQTSGFRP 257
+S + + + ++L + + VGFSA++ + S E H + SWSF +
Sbjct: 149 SLSNPS-TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSKFINL 207
Query: 258 VRPKLHPHNV 267
K N+
Sbjct: 208 KDQKSERSNI 217
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-45
Identities = 56/189 (29%), Positives = 99/189 (52%), Gaps = 12/189 (6%)
Query: 22 SNNMNFDFTSF--NLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQET 79
+ +F T F + +N+ GD Y + LT+ + ++ G +Y++P+ +D+ET
Sbjct: 1 TETTSFLITKFSPDQQNLIFQGDGYTTKEKLTLTKAVK---NTVGRALYSSPIHIWDRET 57
Query: 80 NTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTK-NKFVA 138
A+F + F+F IN N + DG FFI+P + + GG LG+ NS++ K + VA
Sbjct: 58 GNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDKTTQTVA 117
Query: 139 IEFDTRLDPHFDDPDE-NHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRM 197
+EFDT + +D + HIG+D++S++S+ T L++G I + +
Sbjct: 118 VEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKS-----WKLQNGEEANVVIAFNAATNV 172
Query: 198 LKVFMSYSN 206
L V ++Y N
Sbjct: 173 LTVSLTYPN 181
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 7e-44
Identities = 59/242 (24%), Positives = 101/242 (41%), Gaps = 24/242 (9%)
Query: 22 SNNMNFDFTSFNLR-NITLLGD-SYLRNGVIGLTRELG---VPASSSGSLIYNNPVPFFD 76
+ +F+F +F+ + L G+ + G + LT S G Y++P+ D
Sbjct: 1 ATETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD 60
Query: 77 QETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKN-K 135
+N ASF + F+F I N S GLAF + P N LG+ N++ N +
Sbjct: 61 --SNNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQKKQEFLGIFNTNNPEPNAR 118
Query: 136 FVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDL 195
VA+ F+T +N I D + ++ + +G I Y +
Sbjct: 119 TVAVVFNTF---------KNRIDFDKNFIKPYVNENC---DFHKYNGEKTDVQITYDSSN 166
Query: 196 RMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQT 252
L+VF+ ++ V + + L + + VGFS ++ E +TE H + SWSF +
Sbjct: 167 NDLRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSS 225
Query: 253 SG 254
Sbjct: 226 KF 227
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 61/278 (21%), Positives = 117/278 (42%), Gaps = 42/278 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+ +G G+FG VYK + G VA VK + + + F E+ ++ RH N++ +
Sbjct: 30 QRIGSGSFGTVYKGKW--HGDVA-VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
G+ +L +V ++ SL L+ + ++I A + YLH +
Sbjct: 87 GYS-TAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA---K 139
Query: 471 QVIHRDIKASNIMLDANFN--------ARLE------SSFTLTAGTMGYLAPEYLQYGTA 516
+IHRD+K++NI L + A + F +G++ ++APE ++ +
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 517 ---TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573
+ ++DV+++G+V+ E+ G+ P + N + + + + R N
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIEMVGRGSLSPDLSKVRSN 253
Query: 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
MKRL+ C RPS R+ +
Sbjct: 254 ---CPKRMKRLM---AECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 51/288 (17%), Positives = 105/288 (36%), Gaps = 57/288 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
++G+G FG VY + G VA ++ + + + F E+ RH+N+V +
Sbjct: 39 ELIGKGRFGQVYHGRW--HGEVA-IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
G C L ++ +L ++ + ++L I + + YLH +
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 471 QVIHRDIKASNIMLD----------------ANFNARLESSFTLTAGTMGYLAPEYLQYG 514
++H+D+K+ N+ D R E + G + +LAPE ++
Sbjct: 150 GILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 515 TA---------TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR-- 563
+ ++ +DVF+ G + E+ P K +W + +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP-------FKTQPAEAIIWQMGTGMKPN 262
Query: 564 IIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+ + E+ +L L C + RP+ ++ +L
Sbjct: 263 LSQIG--------MGKEISDIL---LFCWAFEQEERPTFTKLMDMLEK 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 64/295 (21%), Positives = 110/295 (37%), Gaps = 46/295 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+G+G +G V++ + G AVK E EL LRH+N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 414 ----AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
+L L+ Y GSL L + L L IV+ +AS L +LH E
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 470 QQ-----VIHRDIKASNIMLDANFN--------ARLESS--------FTLTAGTMGYLAP 508
+ HRD+K+ NI++ N A + S GT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 509 E------YLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG 562
E + + ++ D++++G+V+ EVA + D V +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED--YKPPFYDVVPNDPSFE 244
Query: 563 RIIEA-ADKRL-----NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+ + + N F++ + L + C + SAR + R+ + L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 62/294 (21%), Positives = 119/294 (40%), Gaps = 46/294 (15%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCA 414
+G+G FG V++ + G AVK E AE+ LRH+N++ +
Sbjct: 49 SIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 415 EKG----ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
+ +L LV +Y +GSL L + + ++ + + + AS L +LH E
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 471 Q-----VIHRDIKASNIMLDANFN--------ARLESSFTLT--------AGTMGYLAPE 509
+ HRD+K+ NI++ N A S T T GT Y+APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 510 YL------QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR 563
L ++ + ++ D+++ G+V E+A + D V +
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP--YYDLVPSDPSVEE 279
Query: 564 IIEA-ADKRL-----NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+ + +++L N + + ++ + + C + +AR + R+ + L+
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 32/221 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
+GRG FG V+ + ++ AVK R + K +FL E I+ H N+V+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
C +K + +V E + G L G L L +V A+ + YL +
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLE---SKC 233
Query: 472 VIHRDIKASNIMLDANFN--------ARL--ESSFTLTAGTMGY----LAPEYLQYGTAT 517
IHRD+ A N ++ +R + + + G APE L YG +
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 518 EKTDVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
++DV+S+G+++ E G P E +G ++
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL 334
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 63/271 (23%), Positives = 118/271 (43%), Gaps = 33/271 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR----SKHSHEGKTEFLAELSIIACLRHKNLVQL 409
+ +GRG F VY+A G A+K+ + + + + E+ ++ L H N+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
E EL +V E G L RM+ + L+ V L SAL ++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154
Query: 470 QQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEYLQYGTAT 517
++V+HRDIK +N+ + A +L +++ + GT Y++PE +
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 518 EKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577
K+D++S G ++ E+A + P + + +L +I + L
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCK---------KIEQCDYPPLPSDHY 263
Query: 578 EDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608
+E+++L+ C NPD RP + V+ +
Sbjct: 264 SEELRQLV---NMCINPDPEKRPDVTYVYDV 291
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 62/295 (21%), Positives = 114/295 (38%), Gaps = 46/295 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+ +G+G +G V+ + G AVK + E E+ +RH+N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 414 ----AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
+L L+ +Y NGSL L + L L + S L +LH E
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 470 QQ-----VIHRDIKASNIMLDANFN--------ARLESSFTLT--------AGTMGYLAP 508
+ HRD+K+ NI++ N A S T GT Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 509 E------YLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG 562
E + + D++S+G+++ EVA R E +++ D V +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLP-YHDLVPSDPSYE 273
Query: 563 RIIEA-ADKRL-----NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+ E K+L N +++ ++++ + C + ++R + RV + L
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-37
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
LG G +G VY+ + AVK K EFL E +++ ++H NLVQLLG C
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+ ++ E+M G+L L N +S L + ++SA+ YL ++ I
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 340
Query: 474 HRDIKASNIMLD-------ANFN-ARLESSFTLTAGTMGYL-----APEYLQYGTATEKT 520
HR++ A N ++ A+F +RL + T TA APE L Y + K+
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 521 DVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
DV+++GV++ E+A G P E + ++M
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 438
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 65/288 (22%), Positives = 121/288 (42%), Gaps = 43/288 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+ +G G+FG G +K S+ S + + E E++++A ++H N+VQ
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
E G L +V +Y G L + + + GVL L+ V + AL ++H ++
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVH---DR 144
Query: 471 QVIHRDIKASNIMLDANFNARL-----------ESSFTLTA-GTMGYLAPEYLQYGTATE 518
+++HRDIK+ NI L + +L GT YL+PE +
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204
Query: 519 KTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNE 578
K+D+++ G V+ E+ + E M NLV +II + ++ ++
Sbjct: 205 KSDIWALGCVLYELCTLKHAF----EAGSMKNLVL---------KIISGSFPPVSLHYSY 251
Query: 579 DEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLT 626
+++ L+ + RPS V IL + +++ L+
Sbjct: 252 -DLRSLV---SQLFKRNPRDRPS---VNSILEK---GFIAKRIEKFLS 289
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-37
Identities = 65/288 (22%), Positives = 120/288 (41%), Gaps = 42/288 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+G G++G K S G + K + K ++E++++ L+H N+V+
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 411 GWCAEK--GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ-- 466
++ L +V EY G L ++ + ++ L L ++ L AL H+
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 467 ECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEYLQYG 514
+ V+HRD+K +N+ LD N +L ++SF T GT Y++PE +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM 191
Query: 515 TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574
+ EK+D++S G ++ E+ P L +I E +R+
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPF----TAFSQKELAG---------KIREGKFRRIPY 238
Query: 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLK 622
+++ E+ ++ N RPS V +IL N PL++
Sbjct: 239 RYSD-ELNEII---TRMLNLKDYHRPS---VEEILEN---PLILEHHH 276
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+ +G G FG V+ Y+ + VA +K + + +F+ E ++ L H LVQL G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
E+ + LV E+M +G L L L + L + + + + YL E VI
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 474 HRDIKASNIMLDANFN--------ARLESSFTLTAGTMGYL-----APEYLQYGTATEKT 520
HRD+ A N ++ N R T+ T +PE + + K+
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 521 DVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
DV+S+GV++ EV G+ P +E + G ++
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
LG G +G VY+ + AVK K EFL E +++ ++H NLVQLLG C
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+ ++ E+M G+L L N +S L + ++SA+ YL ++ I
Sbjct: 79 TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 474 HRDIKASNIMLDANFN--------ARLESSFTLTAGTMGYL-----APEYLQYGTATEKT 520
HRD+ A N ++ N +RL + T TA APE L Y + K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 521 DVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
DV+++GV++ E+A G P E + ++M
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+ LG G FG V + VA VK K + EF E + L H LV+ G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVA-VKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+++ + +V EY+ NG L L +G L L + + + +L Q I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFI 126
Query: 474 HRDIKASNIMLDANFN--------ARL--ESSFTLTAGTM---GYLAPEYLQYGTATEKT 520
HRD+ A N ++D + R + + + GT + APE Y + K+
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 521 DVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
DV+++G+++ EV G+ P + + ++GH++
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL 224
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+ LG G FG V + VA +K K + EF+ E ++ L H+ LVQL G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVA-IKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
++ + ++ EYM NG L L E L + + A+ YL +Q +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 142
Query: 474 HRDIKASNIMLDANFN--------ARL--ESSFTLTAGTM---GYLAPEYLQYGTATEKT 520
HRD+ A N +++ +R + +T + G+ + PE L Y + K+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 521 DVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
D++++GV++ E+ G+ P E +G ++
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 240
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 30/218 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
LG G FG V+ Y+ VA VK K FLAE +++ L+H+ LV+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVA-VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
++ + ++ EYM NGSL L + +G+ L+ L++ +A + ++ E+ I
Sbjct: 78 TQEP-IYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 474 HRDIKASNIMLDANFN--------ARLESSFTLTAGTMGYL-----APEYLQYGTATEKT 520
HRD++A+NI++ + ARL TA APE + YGT T K+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 521 DVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
DV+S+G+++ E+ GR P I+ G++M
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM 229
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 53/228 (23%), Positives = 87/228 (38%), Gaps = 32/228 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
+ LG G F V G A+KR H + + E E + H N+++L+ +
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 413 CAE----KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
C K E L+ + G+L + + + G L+ L +++G+ L +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-- 152
Query: 469 EQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTA--------GTMGYLA 507
+ HRD+K +NI+L L E S T+ Y A
Sbjct: 153 -KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 508 PEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLV 552
PE + E+TDV+S G V+ + G P + + V L
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 67/280 (23%), Positives = 97/280 (34%), Gaps = 51/280 (18%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE---FLAELSIIACL-RHKN 405
F LG G++G V+K G + AVKRS G + LAE+ + +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
V+L E G L L E SL + G L + AL +LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 466 QECEQQVIHRDIKASNIMLDANFNARL----------ESSFTLTA-GTMGYLAPEYLQYG 514
Q ++H D+K +NI L +L + G Y+APE LQ G
Sbjct: 175 ---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-G 230
Query: 515 TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574
+ DVFS G+ +LEVAC ++ L
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ-------------------GYLPP 271
Query: 575 AFNE---DEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
F E++ +L + PD R + +L
Sbjct: 272 EFTAGLSSELRSVL---VMMLEPDPKLRATAE---ALLAL 305
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-34
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 30/218 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
LG+G FG V+ + + VA +K K FL E ++ LRH+ LVQL
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+E+ + +V EYM GSL L E G L +++ +AS + Y+ +
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 474 HRDIKASNIMLDANFN--------ARLESSFTLTAGTMGYL-----APEYLQYGTATEKT 520
HRD++A+NI++ N ARL TA APE YG T K+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 521 DVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
DV+S+G+++ E+ GR P +++ G++M
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 400
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA----AVK--RSKHSHEGKTEFLAELSIIACLRHKNLV 407
++LG GAFG VYK + G A+K R S + E L E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+LLG C + L+ + MP G L + + +N + + LN V +A + YL
Sbjct: 81 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLE-- 134
Query: 468 CEQQVIHRDIKASNIMLDANFN--------ARL---ESSFTLTAGTM---GYLAPEYLQY 513
+++++HRD+ A N+++ + A+L E G ++A E + +
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 514 GTATEKTDVFSYGVVVLEVA-CGRRP 538
T ++DV+SYGV V E+ G +P
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-34
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 30/218 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
LG+G FG V+ + + VA +K K FL E ++ LRH+ LVQL
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+E+ + +V EYM GSL L E G L +++ +AS + Y+ +
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 474 HRDIKASNIMLDANFN--------ARLESSFTLTAGTMGYL-----APEYLQYGTATEKT 520
HRD++A+NI++ N ARL TA APE YG T K+
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 521 DVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
DV+S+G+++ E+ GR P +++ G++M
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 483
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 63/305 (20%), Positives = 108/305 (35%), Gaps = 61/305 (20%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE---FLAELSIIACL-RHKN 405
FH +G G FG+V+K G + A+KRSK G + L E+ A L +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+V+ AE +L+ EY GSL + ++ ++++ + L Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 466 QECEQQVIHRDIKASNIMLDANFNARLESSFTLTA------------------------- 500
++H DIK SNI + S
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 501 --GTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG 557
G +LA E LQ K D+F+ + V+ A + H++
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ------- 242
Query: 558 LYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLV 617
GR+ R+ ++ E LL +PD RPS ++ + ++
Sbjct: 243 ----GRL-----PRIPQVLSQ-EFTELL---KVMIHPDPERRPS---AMALVKH---SVL 283
Query: 618 VPKLK 622
+ +
Sbjct: 284 LSASR 288
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-33
Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+ LG G FG V+ A + VA VK K FLAE +++ L+H LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVA-VKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
++ + ++ E+M GSL + S+ G ++ +A + ++ ++ I
Sbjct: 253 TKEP-IYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306
Query: 474 HRDIKASNIMLDANFN--------ARLESSFTLTAGTMGYL-----APEYLQYGTATEKT 520
HRD++A+NI++ A+ AR+ TA APE + +G+ T K+
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 521 DVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
DV+S+G++++E+ GR P I G++M
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM 404
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 43/234 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSV--AAVKRSK--HSHEGKTEFLAELSIIACL-RHKNLVQ 408
++G G FG V KA G AA+KR K S + +F EL ++ L H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRML------------YQDSENGVLLSWYHRLNIVVG 456
LLG C +G L L EY P+G+L L + LS L+
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 457 LASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT-------AGTMGYL--- 506
+A + YL ++Q IHRD+ A NI++ N+ A++ + F L+ TMG L
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKI-ADFGLSRGQEVYVKKTMGRLPVR 206
Query: 507 --APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
A E L Y T +DV+SYGV++ E+ G P E+ +G+++
Sbjct: 207 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 260
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 6e-33
Identities = 71/216 (32%), Positives = 107/216 (49%), Gaps = 30/216 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+ +G+G FG+V + G+ AVK K+ + FLAE S++ LRH NLVQLLG
Sbjct: 27 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ-AFLAEASVMTQLRHSNLVQLLGVI 83
Query: 414 -AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
EKG L +V EYM GSL L S +L L + + A+ YL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 473 IHRDIKASNIMLDANFNARLESSFTL-----TAGTMGYL-----APEYLQYGTATEKTDV 522
+HRD+ A N+++ + A++ S F L + G L APE L+ + K+DV
Sbjct: 139 VHRDLAARNVLVSEDNVAKV-SDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 523 FSYGVVVLEVA-CGRRP---------IERETEGHKM 548
+S+G+++ E+ GR P + R +G+KM
Sbjct: 198 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 233
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 55/238 (23%), Positives = 91/238 (38%), Gaps = 46/238 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA-----AVK--RSKHSHEGKTEFLAELSIIACLRHKNL 406
LG FG VYK + A+K + K + EF E + A L+H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRML------------YQDSENGVLLSWYHRLNIV 454
V LLG + L +++ Y +G L L D L +++V
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 455 VGLASALTYLHQECEQQVIHRDIKASNIMLDANFN--------AR-LESSFTLTAGTMGY 505
+A+ + YL V+H+D+ N+++ N R + ++
Sbjct: 135 AQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 506 L-----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
L APE + YG + +D++SYGVV+ EV G +P +E +
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL 249
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA---AVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQ 408
+I+G G G V G A+K ++ ++ + +FL+E SI+ H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L G ++V EYM NGSLD L + + ++ G+ + + YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLS--- 168
Query: 469 EQQVIHRDIKASNIMLDANFN--------ARL--ESSFTLTAGTMGYL-----APEYLQY 513
+ +HRD+ A N+++D+N +R+ + T G + APE + +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 514 GTATEKTDVFSYGVVVLEVA-CGRRP 538
T + +DV+S+GVV+ EV G RP
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA---AVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQ 408
R +G G FG+V++ + S + A A+K ++ S + +FL E + H ++V+
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L+G E + ++ E G L L L + L++AL YL
Sbjct: 81 LIGVITEN-PVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLE--- 133
Query: 469 EQQVIHRDIKASNIMLDANFN--------ARL--ESSFTLTAGTM---GYLAPEYLQYGT 515
++ +HRDI A N+++ +N +R +S++ + ++APE + +
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 516 ATEKTDVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
T +DV+ +GV + E+ G +P I R G ++
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 236
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 28/207 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA----AVK--RSKHSHEGKTEFLAELSIIACLRHKNLV 407
+++G G FG VYK +S A+K ++ ++ + + +FL E I+ H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+L G ++ ++++ EYM NG+LD+ L E S + ++ G+A+ + YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLA-- 164
Query: 468 CEQQVIHRDIKASNIMLDANFN--------AR-LESSFTLTAGTMG------YLAPEYLQ 512
+HRD+ A NI++++N +R LE T T G + APE +
Sbjct: 165 -NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 513 YGTATEKTDVFSYGVVVLEVA-CGRRP 538
Y T +DV+S+G+V+ EV G RP
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 58/267 (21%), Positives = 97/267 (36%), Gaps = 39/267 (14%)
Query: 353 NRILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQL 409
+ +GRG+F VYK + A K + + F E ++ L+H N+V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 410 LG----WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
K ++LV E M +G+L L V + + + L +LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKV-MKIKVLRSWCRQILKGLQFLH 146
Query: 466 QECEQQVIHRDIKASNIMLDAN----------FNARLESSFTLT-AGTMGYLAPEYLQYG 514
+IHRD+K NI + +SF GT ++APE +
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK 205
Query: 515 TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574
E DV+++G+ +LE+A P ++ V G + DK
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-------TSGVKPASFDKVAI- 256
Query: 575 AFNEDEMKRLLLVGLSCANPDSSARPS 601
E+K ++ C + R S
Sbjct: 257 ----PEVKEII---EGCIRQNKDERYS 276
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 71/216 (32%), Positives = 106/216 (49%), Gaps = 30/216 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+ +G+G FG+V + G+ AVK K+ FLAE S++ LRH NLVQLLG
Sbjct: 199 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 414 -AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
EKG L +V EYM GSL Y S +L L + + A+ YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 310
Query: 473 IHRDIKASNIMLDANFNARLESSFTL-----TAGTMGYL-----APEYLQYGTATEKTDV 522
+HRD+ A N+++ + A++ S F L + G L APE L+ + K+DV
Sbjct: 311 VHRDLAARNVLVSEDNVAKV-SDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 523 FSYGVVVLEVA-CGRRP---------IERETEGHKM 548
+S+G+++ E+ GR P + R +G+KM
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 405
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 26/204 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA---AVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQ 408
RILG G FG VY+ + + AVK + + + K +F++E I+ L H ++V+
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L+G E+ ++ E P G L L N L + + + A+ YL
Sbjct: 78 LIGII-EEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLE--- 130
Query: 469 EQQVIHRDIKASNIMLDANFN--------ARL--ESSFTLTAGTM---GYLAPEYLQYGT 515
+HRDI NI++ + +R + + + T +++PE + +
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 190
Query: 516 ATEKTDVFSYGVVVLEVA-CGRRP 538
T +DV+ + V + E+ G++P
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQP 214
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 28/206 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA----AVK--RSKHSHEGKTEFLAELSIIACLRHKNLV 407
++LG G FG V+K + G +K K + + I L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+LLG C L LV +Y+P GSL + Q L LN V +A + YL
Sbjct: 79 RLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLE-- 132
Query: 468 CEQQVIHRDIKASNIMLDANFN--------ARL---ESSFTLTAGTM---GYLAPEYLQY 513
E ++HR++ A N++L + A L + L + ++A E + +
Sbjct: 133 -EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 514 GTATEKTDVFSYGVVVLEVA-CGRRP 538
G T ++DV+SYGV V E+ G P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA----AVK--RSKHSHEGKTEFLAELSIIACLRHKNLV 407
++LG GAFG VYK + G A+K R S + E L E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+LLG C + L+ + MP G L + + +N + + LN V +A + YL
Sbjct: 81 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLE-- 134
Query: 468 CEQQVIHRDIKASNIMLDANFN--------ARL---ESSFTLTAGTM---GYLAPEYLQY 513
+++++HRD+ A N+++ + A+L E G ++A E + +
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 514 GTATEKTDVFSYGVVVLEVA-CGRRP 538
T ++DV+SYGV V E+ G +P
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 42/234 (17%)
Query: 353 NRILGRGAFGNVYKAYFASSGSVA-----AVK--RSKHSHEGKTEFLAELSIIACLRHKN 405
+R LG+G+FG VY+ A+K S + EFL E S++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLD------RMLYQDSENGVLLSWYHRLNIVVGLAS 459
+V+LLG ++ L++ E M G L R ++ S + + +A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT----------AGTMGYL--- 506
+ YL+ + +HRD+ A N M+ +F ++ F +T G G L
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKI-GDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 507 --APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
+PE L+ G T +DV+S+GVV+ E+A +P + EG +
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA---AVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQ 408
++GRG FG VY + AVK ++FL E I+ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 409 LLGWCAE-KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
LLG C +G L+V YM +G L + ++ N + + + +A + YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLA-- 145
Query: 468 CEQQVIHRDIKASNIMLDANFN--------ARL---ESSFTLTAGTMGYL-----APEYL 511
++ +HRD+ A N MLD F AR + +++ T L A E L
Sbjct: 146 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 512 QYGTATEKTDVFSYGVVVLEVAC-GRRP 538
Q T K+DV+S+GV++ E+ G P
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 62/232 (26%), Positives = 90/232 (38%), Gaps = 40/232 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA-----AVK--RSKHSHEGKTEFLAELSIIACLRHKNL 406
R LG GAFG VY+ + + AVK S + + +FL E II+ H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLD---RMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
V+ +G + ++ E M G L R L+ L++ +A Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 464 LHQECEQQVIHRDIKASNIMLDANFN-----------AR-LESSFTLTAGTMGYL----- 506
L E IHRDI A N +L AR + + G L
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 507 APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
PE G T KTD +S+GV++ E+ G P +E T G +M
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 351 HSNRILGRGAFGNVYKAYFASSGSVA---AVK--RSKHSHEGKTEFLAELSIIACLRHKN 405
HS+R++G+G FG VY + A+K + FL E ++ L H N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 406 LVQLLGWC-AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
++ L+G +G ++ YM +G L + + N + ++ + +A + YL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGMEYL 140
Query: 465 HQECEQQVIHRDIKASNIMLDANFN--------ARL---ESSFTLTAGTMGYL-----AP 508
EQ+ +HRD+ A N MLD +F AR +++ L A
Sbjct: 141 A---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 509 EYLQYGTATEKTDVFSYGVVVLEVA-CGRRP 538
E LQ T K+DV+S+GV++ E+ G P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA---AVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQ 408
+++G G FG V A+K + ++ + + +FL E SI+ H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L G + +++V EYM NGSLD L ++ + + ++ G+AS + YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLS--- 164
Query: 469 EQQVIHRDIKASNIMLDANFN--------ARL--ESSFTLTAGTMGYL-----APEYLQY 513
+ +HRD+ A NI++++N R+ + G + +PE + Y
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 514 GTATEKTDVFSYGVVVLEVA-CGRRP 538
T +DV+SYG+V+ EV G RP
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 8e-32
Identities = 48/140 (34%), Positives = 73/140 (52%), Gaps = 7/140 (5%)
Query: 134 NKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKN 193
+ VA+EFDT L+P + DP+ HIG+D++S+ S TA D ++G + TA I Y +
Sbjct: 1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW-----DWQNGKIATAHISYNS 55
Query: 194 DLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTS 253
+ L V Y+ KP L +I+L L + VG SAST E + + SWSF +S
Sbjct: 56 VSKRLSVTSYYAGSKP--ATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSS 113
Query: 254 GFRPVRPKLHPHNVSDSSVV 273
+ V K + + V+
Sbjct: 114 LWTNVAKKENENKYITRGVL 133
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 31/214 (14%)
Query: 353 NRILGRGAFGNVYKAYFASSGSVA---AVKRSK---HSHEGKTEFLAELSIIACLRHKNL 406
+ILG G FG+V + + AVK K S EFL+E + + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 407 VQLLGWCAEKG-----ELLLVYEYMPNGSLDRML--YQDSENGVLLSWYHRLNIVVGLAS 459
++LLG C E + +++ +M G L L + + L +V +A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFN--------AR-LESSFTLTAGTMGYL---- 506
+ YL + +HRD+ A N ML + ++ + S G + +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 507 -APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP 538
A E L T K+DV+++GV + E+A G P
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 37/232 (15%)
Query: 329 ADLVPGPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEG 387
D E+ Y + R +LG+G +G VY S+ A+K +
Sbjct: 8 GDCESDLLEYDYEYDENGDR-----VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY 62
Query: 388 KTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRML------YQDSEN 441
E+++ L+HKN+VQ LG +E G + + E +P GSL +L +D+E
Sbjct: 63 SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ 122
Query: 442 GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD--------ANFNA--R 491
+ +Y + I+ GL YLH + Q++HRDIK N++++ ++F R
Sbjct: 123 --TIGFYTK-QILEGLK----YLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
Query: 492 LESSFTLT---AGTMGYLAPEYLQYGT--ATEKTDVFSYGVVVLEVACGRRP 538
L T GT+ Y+APE + G + D++S G ++E+A G+ P
Sbjct: 173 LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 29/208 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA---AVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQ 408
++GRG FG VY + AVK ++FL E I+ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 409 LLGWCAEKGE-LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
LLG C L+V YM +G L + ++ N + + + +A + +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLA-- 209
Query: 468 CEQQVIHRDIKASNIMLDANFN--------ARL---ESSFTLTAGTMGYL-----APEYL 511
++ +HRD+ A N MLD F AR + ++ T L A E L
Sbjct: 210 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 512 QYGTATEKTDVFSYGVVVLEVAC-GRRP 538
Q T K+DV+S+GV++ E+ G P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 55/239 (23%), Positives = 92/239 (38%), Gaps = 37/239 (15%)
Query: 335 PREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVA----AVK--RSKHSHEGK 388
P F R L+ R LG G FG V + G AVK + +
Sbjct: 15 PTHFEKRFLKR-------IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI 67
Query: 389 TEFLAELSIIACLRHKNLVQLLGWCAEKGE--LLLVYEYMPNGSLDRMLYQDSENGVLLS 446
+ E+ I+ L H+N+V+ G C E G + L+ E++P+GSL L ++ ++
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---IN 124
Query: 447 WYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN--------ARL--ESSF 496
+L V + + YL +Q +HRD+ A N+++++ +
Sbjct: 125 LKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 497 TLTAGTMGYL-----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRPIERETEGHKMV 549
T APE L +DV+S+GV + E+ KM+
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 47/203 (23%), Positives = 85/203 (41%), Gaps = 27/203 (13%)
Query: 356 LGRGAFGNVYKAYFASSGSVA--AVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
LG G FG+V + + A+K + E + E I+ L + +V+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
C + L+LV E G L + L + + ++ ++ + YL E+
Sbjct: 78 VCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 472 VIHRDIKASNIMLDANFN--------ARL--ESSFTLTAGTMGYL-----APEYLQYGTA 516
+HRD+ A N++L ++ TA + G APE + +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 517 TEKTDVFSYGVVVLEVA-CGRRP 538
+ ++DV+SYGV + E G++P
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 59/239 (24%), Positives = 96/239 (40%), Gaps = 39/239 (16%)
Query: 335 PREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVA----AVK--RSKHSHEGK 388
P F R L+ R LG G FG V + + AVK ++ + +
Sbjct: 25 PTVFHKRYLKK-------IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR 77
Query: 389 TEFLAELSIIACLRHKNLVQLLGWCAEKGE--LLLVYEYMPNGSLDRMLYQDSENGVLLS 446
+ + E+ I+ L H+++++ G C + G L LV EY+P GSL L + S +
Sbjct: 78 SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IG 132
Query: 447 WYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN--------ARL--ESSF 496
L + + YLH Q IHRD+ A N++LD + A+ E
Sbjct: 133 LAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189
Query: 497 TLTAGTMGYL-----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRPIERETEGHKMV 549
G APE L+ +DV+S+GV + E+ T+ +++
Sbjct: 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 62/232 (26%), Positives = 90/232 (38%), Gaps = 40/232 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA-----AVK--RSKHSHEGKTEFLAELSIIACLRHKNL 406
R LG GAFG VY+ + + AVK S + + +FL E II+ H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLD---RMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
V+ +G + ++ E M G L R L+ L++ +A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 464 LHQECEQQVIHRDIKASNIMLDANFN-----------AR-LESSFTLTAGTMGYL----- 506
L E IHRDI A N +L AR + + G L
Sbjct: 197 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 507 APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
PE G T KTD +S+GV++ E+ G P +E T G +M
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 34/216 (15%)
Query: 353 NRILGRGAFGNVYKAYFASSGS----VA--AVKRSKHSHEGKTEFLAELSIIACLRHKNL 406
R+LG+G FG+V +A VA +K + EFL E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 407 VQLLGWCAEKG------ELLLVYEYMPNGSLDRML--YQDSENGVLLSWYHRLNIVVGLA 458
+L+G +++ +M +G L L + EN L + +V +A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 459 SALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT----------AGTMGYL-- 506
+ YL + IHRD+ A N ML + + + F L+ G L
Sbjct: 148 CGMEYLS---SRNFIHRDLAARNCMLAEDMTVCV-ADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 507 ---APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP 538
A E L T +DV+++GV + E+ G+ P
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 353 NRILGRGAFGNVYKAYFASSGSVA--AVKRSKH---SHEGKTEFLAELSIIACLRHKNLV 407
++ LG G FG V K Y+ V AVK K+ K E LAE +++ L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+++G C + +LV E G L++ L Q+ + + + +V ++ + YL E
Sbjct: 82 RMIGICEAES-WMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL--E 134
Query: 468 CEQQVIHRDIKASNIMLDANFNARLESSFTL-----------TAGTMGYL-----APEYL 511
E +HRD+ A N++L A++ S F L A T G APE +
Sbjct: 135 -ESNFVHRDLAARNVLLVTQHYAKI-SDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 512 QYGTATEKTDVFSYGVVVLEVA-CGRRP 538
Y + K+DV+S+GV++ E G++P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 49/230 (21%), Positives = 91/230 (39%), Gaps = 41/230 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA-------AVKRSKHSH-EGKTEFLAELSIIACLRHKN 405
LG+G F ++K G +K +H F S+++ L HK+
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
LV G C E +LV E++ GSLD L +N ++ +L + LA+A+ +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 466 QECEQQVIHRDIKASNIMLDANFNARLESS-------FTLT---AGTMGY------LAPE 509
E +IH ++ A NI+L + + + ++ + PE
Sbjct: 131 ---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPE 187
Query: 510 YLQYGTA-TEKTDVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
++ TD +S+G + E+ G +P ++ + H++
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL 237
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 36/227 (15%)
Query: 335 PREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVA----AVKRSKHSH-EGKT 389
P F R L+ LG+G FG+V + G AVK+ +HS + +
Sbjct: 17 PTIFEERHLKYI-------SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR 69
Query: 390 EFLAELSIIACLRHKNLVQLLGWCAEKGE--LLLVYEYMPNGSLDRMLYQDSENGVLLSW 447
+F E+ I+ L +V+ G G L LV EY+P+G L L + L
Sbjct: 70 DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDA 126
Query: 448 YHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN--------ARL--ESSFT 497
L + + YL ++ +HRD+ A NI++++ + A+L
Sbjct: 127 SRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183
Query: 498 LTAGTMGYL-----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP 538
G APE L + ++DV+S+GVV+ E+ +
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 45/237 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA-----AVKRSK-HSHEGKTEFLAELSIIACLRHKNLV 407
R LG GAFG V+ A + AVK K + + +F E ++ L+H+++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRML------------YQDSENGVLLSWYHRLNIVV 455
+ G C + L++V+EYM +G L++ L Q + L L+I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDANFN--------AR-LESSFTLTAGTMGYL 506
+AS + YL Q +HRD+ N ++ AN +R + S+ G L
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 507 -----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
PE + Y T ++DV+S+GV++ E+ G++P IE T+G +
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL 254
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 62/255 (24%), Positives = 108/255 (42%), Gaps = 18/255 (7%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
LG G G V+K SG V A K + + + + EL ++ +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
GE+ + E+M GSLD++L + G + + + + LTYL ++ +++
Sbjct: 101 YSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGK-VSIAVIKGLTYLREK--HKIM 154
Query: 474 HRDIKASNIMLDAN---------FNARLESSFTLT-AGTMGYLAPEYLQYGTATEKTDVF 523
HRD+K SNI++++ + +L S + GT Y++PE LQ + ++D++
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 214
Query: 524 SYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKR 583
S G+ ++E+A GR PI + V G AE R F D
Sbjct: 215 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP 274
Query: 584 LLLVGLSCANPDSSA 598
+ + L +
Sbjct: 275 MAIFELLDYIVNEPP 289
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-31
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 35/223 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA---AVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQ 408
R +G G FG+V++ + S + A A+K ++ S + +FL E + H ++V+
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L+G E + ++ E G L L L + L++AL YL
Sbjct: 456 LIGVITEN-PVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLE--- 508
Query: 469 EQQVIHRDIKASNIMLDANFN--------ARLESSFTLTAGTMGYL-----APEYLQYGT 515
++ +HRDI A N+++ +N +R T + G L APE + +
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 516 ATEKTDVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
T +DV+ +GV + E+ G +P I R G ++
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 611
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 57/300 (19%), Positives = 112/300 (37%), Gaps = 63/300 (21%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQL 409
F ++G G FG V+KA G +KR K+++E + E+ +A L H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAKLDHVNIVHY 69
Query: 410 LG----------------WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNI 453
G ++ L + E+ G+L++ + + G L L +
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK--RRGEKLDKVLALEL 127
Query: 454 VVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLTAGT 502
+ + Y+H +++I+RD+K SNI L ++ + T + GT
Sbjct: 128 FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184
Query: 503 MGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG 562
+ Y++PE + ++ D+++ G+++ E+ +
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT------AFETSKF----------- 227
Query: 563 RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLK 622
+ D ++ F+ + K LL + RP+ +IL V K
Sbjct: 228 -FTDLRDGIISDIFD-KKEKTLL---QKLLSKKPEDRPNTS---EILRT---LTVWKKSP 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 335 PREFSYRELRSATRGFHSNRILGRGAFGNVYKAYF----ASSGSVAAVKRSKHSHEGKT- 389
P +F R L+ + LG+G FG+V + ++G V AVK+ +HS E
Sbjct: 4 PTQFEERHLKFL-------QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 56
Query: 390 EFLAELSIIACLRHKNLVQLLGWCAEKGE--LLLVYEYMPNGSLDRMLYQDSENGVLLSW 447
+F E+ I+ L+H N+V+ G C G L L+ EY+P GSL L + E +
Sbjct: 57 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDH 113
Query: 448 YHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN--------ARL--ESSFT 497
L + + YL ++ IHRD+ NI+++ ++ +
Sbjct: 114 IKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF 170
Query: 498 LTAGTMGYL-----APEYLQYGTATEKTDVFSYGVVVLEV 532
G APE L + +DV+S+GVV+ E+
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 335 PREFSYRELRSATRGFHSNRILGRGAFGNVYKAYF----ASSGSVAAVKRSKHSHEG-KT 389
P +F R L+ + LG+G FG+V + ++G V AVK+ +HS E
Sbjct: 35 PTQFEERHLKFL-------QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 87
Query: 390 EFLAELSIIACLRHKNLVQLLGWCAEKGE--LLLVYEYMPNGSLDRMLYQDSENGVLLSW 447
+F E+ I+ L+H N+V+ G C G L L+ EY+P GSL L + E +
Sbjct: 88 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDH 144
Query: 448 YHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN--------ARL--ESSFT 497
L + + YL ++ IHRD+ NI+++ ++ +
Sbjct: 145 IKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201
Query: 498 LTAGTMGYL-----APEYLQYGTATEKTDVFSYGVVVLEV 532
G APE L + +DV+S+GVV+ E+
Sbjct: 202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 50/218 (22%), Positives = 86/218 (39%), Gaps = 35/218 (16%)
Query: 342 ELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL 401
E R +GRG+FG V++ +G AVK+ + EL A L
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV----EELVACAGL 107
Query: 402 RHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLA 458
+V L G E + + E + GSL +++ Q E+ +Y + GL
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED--RALYYLG-QALEGLE 164
Query: 459 SALTYLHQECEQQVIHRDIKASNIMLDAN----------FNARLESSFTLTA-------- 500
YLH ++++H D+KA N++L ++ L+ +
Sbjct: 165 ----YLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 501 GTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRP 538
GT ++APE + K D++S ++L + G P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 44/236 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA-----AVKRSK-HSHEGKTEFLAELSIIACLRHKNLV 407
LG GAFG V+ A + AVK K S + +F E ++ L+H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRML-----------YQDSENGVLLSWYHRLNIVVG 456
+ G C E LL+V+EYM +G L+R L + L L +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 457 LASALTYLHQECEQQVIHRDIKASNIMLDANFN--------AR-LESSFTLTAGTMGYL- 506
+A+ + YL +HRD+ N ++ +R + S+ G L
Sbjct: 167 VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 507 ----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP---------IERETEGHKM 548
PE + Y T ++DV+S+GVV+ E+ G++P I+ T+G ++
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 279
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 56/247 (22%)
Query: 354 RILGRGAFGNVYKAYFA-----SSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNL 406
+ LG G FG V KA + + AVK + S + L+E +++ + H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSL--------------------DRMLYQDSENGVLLS 446
++L G C++ G LLL+ EY GSL D + L+
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 447 WYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT------- 499
++ ++ + YL E +++HRD+ A NI++ ++ S F L+
Sbjct: 149 MGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKI-SDFGLSRDVYEED 204
Query: 500 ---AGTMGYL-----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP---------IER 541
+ G + A E L T ++DV+S+GV++ E+ G P
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL 264
Query: 542 ETEGHKM 548
GH+M
Sbjct: 265 LKTGHRM 271
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 59/239 (24%), Positives = 97/239 (40%), Gaps = 48/239 (20%)
Query: 354 RILGRGAFGNVYKAYFA-----SSGSVAAVK--RSKHSHEGKTEFLAELSIIACL-RHKN 405
+ LG GAFG V +A + AVK +S + K ++EL I++ L +H+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSL----------DRMLYQDSENGVLLSWYHRLNIVV 455
+V LLG C G +L++ EY G L + S L+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT----------AGTMGY 505
+A + +L + IHRD+ A N++L A++ F L
Sbjct: 172 QVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKI-GDFGLARDIMNDSNYIVKGNAR 227
Query: 506 L-----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP----------IERETEGHKM 548
L APE + T ++DV+SYG+++ E+ G P + +G++M
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 52/228 (22%), Positives = 92/228 (40%), Gaps = 40/228 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA---AVKRSK----HSHEGKTEFLAELSIIACLRHKNL 406
LG G+FG V + + + AVK K E +F+ E++ + L H+NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
++L G + +V E P GSL L + + V +A + YL
Sbjct: 84 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLE- 138
Query: 467 ECEQQVIHRDIKASNIMLDAN-------FN-ARL----ESSFTLTAGTM---GYLAPEYL 511
++ IHRD+ A N++L F R + + + + APE L
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 512 QYGTATEKTDVFSYGVVVLEVA-CGRRP---------IER-ETEGHKM 548
+ T + +D + +GV + E+ G+ P + + + EG ++
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSII-ACLRHKNLVQLLGW 412
+GRGA+G+V K SG + AVK RS + + + L +L ++ +VQ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN------IVVGLASALTYLHQ 466
+G+ + E M + S D+ V + I + AL +L +
Sbjct: 90 LFREGDCWICMELM-STSFDKFYKY-----VYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 467 ECEQQVIHRDIKASNIMLDAN-------F--NARLESSF--TLTAGTMGYLAPEYLQYGT 515
++IHRDIK SNI+LD + F + +L S T AG Y+APE +
Sbjct: 144 --NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 201
Query: 516 A----TEKTDVFSYGVVVLEVACGRRP 538
+ ++DV+S G+ + E+A GR P
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 60/247 (24%), Positives = 105/247 (42%), Gaps = 56/247 (22%)
Query: 354 RILGRGAFGNVYKAYF-----ASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNL 406
R +G GAFG V++A ++ AVK + + S + + +F E +++A + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSL--------------------DRMLYQDSENGVLLS 446
V+LLG CA + L++EYM G L S LS
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 447 WYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT------- 499
+L I +A+ + YL E++ +HRD+ N ++ N ++ + F L+
Sbjct: 173 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI-ADFGLSRNIYSAD 228
Query: 500 ---AGTMGYL-----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP---------IER 541
A + PE + Y T ++DV++YGVV+ E+ G +P I
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 288
Query: 542 ETEGHKM 548
+G+ +
Sbjct: 289 VRDGNIL 295
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 51/242 (21%)
Query: 354 RILGRGAFGNVYKAY-------FASSGSVAAVK--RSKHSHEGKTEFLAELSIIACL-RH 403
+ LG G FG V A AVK + + + ++ ++E+ ++ + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 404 KNLVQLLGWCAEKGELLLVYEYMPNGSL------------DRMLYQDSENGVLLSWYHRL 451
KN++ LLG C + G L ++ EY G+L + + +++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 452 NIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT----------AG 501
+ LA + YL Q+ IHRD+ A N+++ N ++ + F L
Sbjct: 207 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKI-ADFGLARDINNIDYYKKT 262
Query: 502 TMGYL-----APEYLQYGTATEKTDVFSYGVVVLEVAC-GRRP---------IERETEGH 546
T G L APE L T ++DV+S+GV++ E+ G P + EGH
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 322
Query: 547 KM 548
+M
Sbjct: 323 RM 324
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSII-ACLRHKNLVQLLGW 412
LGRGA+G V K SG + AVK R+ + + + L +L I + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
+G++ + E M + SLD+ Q + G + I V + AL +LH + V
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSV 131
Query: 473 IHRDIKASNIMLDAN-------F--NARLESSFTLT--AGTMGYLAPE----YLQYGTAT 517
IHRD+K SN++++A F + L AG Y+APE L +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYS 191
Query: 518 EKTDVFSYGVVVLEVACGRRPIE 540
K+D++S G+ ++E+A R P +
Sbjct: 192 VKSDIWSLGITMIELAILRFPYD 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 51/242 (21%)
Query: 354 RILGRGAFGNVYKAY-------FASSGSVAAVK--RSKHSHEGKTEFLAELSIIACL-RH 403
+ LG GAFG V A AVK + + + ++ ++E+ ++ + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 404 KNLVQLLGWCAEKGELLLVYEYMPNGSL------------DRMLYQDSENGVLLSWYHRL 451
KN++ LLG C + G L ++ EY G+L + + +++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 452 NIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT----------AG 501
+ LA + YL Q+ IHRD+ A N+++ N ++ + F L
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKI-ADFGLARDINNIDYYKKT 216
Query: 502 TMGYL-----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP---------IERETEGH 546
T G L APE L T ++DV+S+GV++ E+ G P + EGH
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 276
Query: 547 KM 548
+M
Sbjct: 277 RM 278
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 59/242 (24%), Positives = 98/242 (40%), Gaps = 51/242 (21%)
Query: 354 RILGRGAFGNVYKAYF-----ASSGSVAAVK--RSKHSHEGKTEFLAELSIIACL-RHKN 405
+ LGRGAFG V +A ++ AVK + +H ++EL I+ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 406 LVQLLGWCAEKGE-LLLVYEYMPNGSL------------DRMLYQDSENGVLLSWYHRLN 452
+V LLG C + G L+++ E+ G+L + + L+ H +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 453 IVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT----------AGT 502
+A + +L ++ IHRD+ A NI+L ++ F L
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKI-CDFGLARDIYKDPDYVRKG 208
Query: 503 MGYL-----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP----------IERETEGH 546
L APE + T ++DV+S+GV++ E+ G P R EG
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 547 KM 548
+M
Sbjct: 269 RM 270
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 33/210 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTE-FLAELSIIACLRHKNLVQL 409
R LG+G FGNVY A S + A+K +++ G E+ I + LRH N+++L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN------IVVGLASALTY 463
G+ + + L+ EY P G++ R L + + + + LA+AL+Y
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKL----------SKFDEQRTATYITELANALSY 124
Query: 464 LHQECEQQVIHRDIKASNIMLDANFN---------ARLESSFTLTA-GTMGYLAPEYLQY 513
H ++VIHRDIK N++L + SS GT+ YL PE ++
Sbjct: 125 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPIERET 543
EK D++S GV+ E G+ P E T
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 58/242 (23%), Positives = 94/242 (38%), Gaps = 50/242 (20%)
Query: 354 RILGRGAFGNVYKAY-----FASSGSVAAVK--RSKHSHEGKTEFLAELSIIACL-RHKN 405
+ LG GAFG V +A + + AVK + + ++EL +++ L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRML--------------YQDSENGVLLSWYHRL 451
+V LLG C G L++ EY G L L ++ + L L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 452 NIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN--------AR-LESSFTLTAGT 502
+ +A + +L + IHRD+ A NI+L AR +++
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 503 MGYL-----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP----------IERETEGH 546
L APE + T ++DV+SYG+ + E+ G P + EG
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265
Query: 547 KM 548
+M
Sbjct: 266 RM 267
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-29
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 29/204 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSVA--AVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
LG G FG+V + + A+K + E + E I+ L + +V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
C + L+LV E G L + L + + ++ ++ + YL E+
Sbjct: 404 VCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 472 VIHRDIKASNIMLDANFNARLESSFTL-----------TAGTMGYL-----APEYLQYGT 515
+HR++ A N++L A++ S F L TA + G APE + +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKI-SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 516 ATEKTDVFSYGVVVLEVA-CGRRP 538
+ ++DV+SYGV + E G++P
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 51/243 (20%)
Query: 353 NRILGRGAFGNVYKAY-------FASSGSVAAVK--RSKHSHEGKTEFLAELSIIACL-R 402
+ LG GAFG V A + + AVK +S + + ++ ++E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 403 HKNLVQLLGWCAEKGELLLVYEYMPNGSL------------DRMLYQDSENGVLLSWYHR 450
HKN++ LLG C + G L ++ EY G+L + LS
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 451 LNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT----------A 500
++ +A + YL ++ IHRD+ A N+++ + ++ + F L
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKI-ADFGLARDIHHIDYYKK 249
Query: 501 GTMGYL-----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP---------IERETEG 545
T G L APE L T ++DV+S+GV++ E+ G P + EG
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 309
Query: 546 HKM 548
H+M
Sbjct: 310 HRM 312
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 33/210 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLA-ELSIIACLRHKNLVQL 409
R LG+G FGNVY A + + A+K +S+ EG L E+ I + LRH N++++
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN------IVVGLASALTY 463
+ ++ + L+ E+ P G L + L + R + + LA AL Y
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQKH----------GRFDEQRSATFMEELADALHY 129
Query: 464 LHQECEQQVIHRDIKASNIMLDAN---------FNARLESSFTLTA-GTMGYLAPEYLQY 513
H+ ++VIHRDIK N+++ ++ S T GT+ YL PE ++
Sbjct: 130 CHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEG 186
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPIERET 543
T EK D++ GV+ E G P + +
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 59/248 (23%), Positives = 98/248 (39%), Gaps = 57/248 (22%)
Query: 354 RILGRGAFGNVYKAYF-----ASSGSVAAVK--RSKHSHEGKTEFLAELSIIACL-RHKN 405
++LG GAFG V A AVK + K + ++EL ++ L H+N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSL-------------------DRMLYQDSENGVLLS 446
+V LLG C G + L++EY G L ++ ++ E+ +L+
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 447 WYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT------- 499
+ L +A + +L + +HRD+ A N+++ ++ F L
Sbjct: 171 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKI-CDFGLARDIMSDS 226
Query: 500 ---AGTMGYL-----APEYLQYGTATEKTDVFSYGVVVLEVA-CGRRP----------IE 540
L APE L G T K+DV+SYG+++ E+ G P +
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 286
Query: 541 RETEGHKM 548
G KM
Sbjct: 287 LIQNGFKM 294
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 49/229 (21%), Positives = 88/229 (38%), Gaps = 31/229 (13%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLA-ELSIIACLRHKNLV 407
+ + ILG+GA NV++ +G + A+K + S + E ++ L HKN+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 408 QLLG--WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+L +L+ E+ P GSL +L ++ N L L ++ + + +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 466 QECEQQVIHRDIKASNIMLDANFNARL--------------ESSFTLTA-GTMGYLAPEY 510
E ++HR+IK NIM + + + ++ GT YL P+
Sbjct: 130 ---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 511 LQYGTA--------TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNL 551
+ D++S GV A G P + +
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 60/209 (28%), Positives = 86/209 (41%), Gaps = 26/209 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLL- 410
LG G FG V + +G A+K R + S + + + E+ I+ L H N+V
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 411 -----GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
A LL EY G L + L EN L ++ ++SAL YLH
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 466 QECEQQVIHRDIKASNIMLDANFN-----------ARL--ESSFTLTA-GTMGYLAPEYL 511
E ++IHRD+K NI+L A+ + GT+ YLAPE L
Sbjct: 139 ---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPIE 540
+ T D +S+G + E G RP
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 54/301 (17%), Positives = 103/301 (34%), Gaps = 64/301 (21%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT--EFLAELSIIACLRHKNLV 407
F + LGRG FG V++A A+KR + + + + E+ +A L H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 408 QLLGWCAEK------------GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVV 455
+ EK L + + +L + L+I +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-NGRCTIEERERSVCLHIFL 125
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL----------------------- 492
+A A+ +LH + ++HRD+K SNI + ++
Sbjct: 126 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 493 -ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNL 551
+ T GT Y++PE + + + K D+FS G+++ E+ P + E + +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239
Query: 552 VDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
V + ++ ++ +P RP I+ N
Sbjct: 240 VR-------NLKFPPLFTQKY------PCEYVMV---QDMLSPSPMERPE---AINIIEN 280
Query: 612 E 612
Sbjct: 281 A 281
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 41/133 (30%), Positives = 63/133 (47%), Gaps = 7/133 (5%)
Query: 134 NKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKN 193
+ VA+E DT + DP HIG+DI S+ S KT ++++G V TA I Y +
Sbjct: 2 DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKT-----AKWNMQNGKVGTAHIIYNS 56
Query: 194 DLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTS 253
+ L +SY N + + ++DL L + VG SAST E + I SWSF +
Sbjct: 57 VDKRLSAVVSYPN--ADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSK 114
Query: 254 GFRPVRPKLHPHN 266
+ + +
Sbjct: 115 LKSNSTHETNALH 127
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 70.7 bits (172), Expect = 7e-14
Identities = 31/112 (27%), Positives = 49/112 (43%), Gaps = 7/112 (6%)
Query: 23 NNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRE---LGVPASSSGSLIYNNPVPFFDQET 79
+ M F+ I + +G + LTR SS G ++ PV ++ +
Sbjct: 127 HFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-S 185
Query: 80 NTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQIL--GSAGGCLGLVNSS 129
ASF + F+F I + + DG+AFFIS + + GS G LGL +
Sbjct: 186 AVVASFEATFTFLIKSPDSHP-ADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 34/265 (12%), Positives = 64/265 (24%), Gaps = 47/265 (17%)
Query: 327 LRADLVPGPREFSYR-ELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVK----RS 381
+ A + P E + L R L G V+ A+K +
Sbjct: 40 VTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGA 99
Query: 382 KHSHEGKTEFLAELSIIACLRHKNLVQLLGWC--------------------------AE 415
++S A L ++ +
Sbjct: 100 ENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYA 159
Query: 416 KGELLLVYEYMP--NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
LL+ L L + L L + ++
Sbjct: 160 VANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216
Query: 474 HRDIKASNIMLDAN---------FNARLESSFTLTAGTMGYLAPEYLQYGTA--TEKTDV 522
H N+ + + ++ + ++ + Y E+L TA T +
Sbjct: 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNA 276
Query: 523 FSYGVVVLEVACGRRPIERETEGHK 547
+ G+ + V C P T G K
Sbjct: 277 WQLGLSIYRVWCLFLPFGLVTPGIK 301
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 25/202 (12%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSII-ACLRHKNLVQLLGW 412
+G G G V+K F +G V AVK R + E L +L ++ +VQ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
++ + E M +++ + G + + V + AL YL ++ V
Sbjct: 93 FITNTDVFIAMELM-GTCAEKLKKR--MQGPIPERILG-KMTVAIVKALYYLKEK--HGV 146
Query: 473 IHRDIKASNIMLDAN---------FNARLESSF--TLTAGTMGYLAPEYLQYGTATE--- 518
IHRD+K SNI+LD + RL +AG Y+APE + T+
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 519 --KTDVFSYGVVVLEVACGRRP 538
+ DV+S G+ ++E+A G+ P
Sbjct: 207 DIRADVWSLGISLVELATGQFP 228
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 23/206 (11%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSK-HSHEGKTEFLAELSIIACLRHKNLVQL 409
R LG+G F ++ A + V A K +S + + E+SI L H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
G+ + + +V E SL + L R + + YLH+
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEAR-YYLRQIVLGCQYLHR--- 133
Query: 470 QQVIHRDIKASNIMLDANFN---------ARLE--SSFTLTA-GTMGYLAPEYLQYGTAT 517
+VIHRD+K N+ L+ + ++E GT Y+APE L +
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 518 EKTDVFSYGVVVLEVACGRRPIERET 543
+ DV+S G ++ + G+ P E
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSC 219
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 23/206 (11%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTE-FLAELSIIACLRHKNLVQL 409
R LG+G F ++ A + V A K +S + E E+SI L H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
G+ + + +V E SL + L R + + YLH+
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEAR-YYLRQIVLGCQYLHR--- 159
Query: 470 QQVIHRDIKASNIMLDANFN---------ARLE--SSFTLTA-GTMGYLAPEYLQYGTAT 517
+VIHRD+K N+ L+ + ++E GT Y+APE L +
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 518 EKTDVFSYGVVVLEVACGRRPIERET 543
+ DV+S G ++ + G+ P E
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSC 245
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 68/310 (21%), Positives = 120/310 (38%), Gaps = 79/310 (25%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQL 409
F +LG+GAFG V KA A A+K+ +H+ E + L+E+ ++A L H+ +V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 410 LG-------------WCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVV 455
+K L + EY NG+L D + + +
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYWRLFR 123
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL----------------------- 492
+ AL+Y+H Q +IHRD+K NI +D + N ++
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 493 ---ESSFTLTAGTMGYLAPEYLQ----YGTATEKTDVFSYGVVVLEVACGRRPIERETEG 545
+ T GT Y+A E L Y EK D++S G++ E+ G
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYN---EKIDMYSLGIIFFEMIYPFST------G 231
Query: 546 HKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED---EMKRLLLVGLSCANPDSSARPSM 602
+ VN++ + + + F+++ K+++ + D + RP
Sbjct: 232 MERVNIL----------KKLRSVSIEFPPDFDDNKMKVEKKII---RLLIDHDPNKRPGA 278
Query: 603 RRVFQILNNE 612
R +LN+
Sbjct: 279 R---TLLNSG 285
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSK-HSHEGKTEFLAELSIIACLRHKNLVQL 409
+LG+G+F VY+A +G A+K + + E+ I L+H ++++L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
+ + + LV E NG ++R L R + + + + + YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEAR-HFMHQIITGMLYLHS--- 130
Query: 470 QQVIHRDIKASNIMLDANFN---------ARLE--SSFTLTA-GTMGYLAPEYLQ---YG 514
++HRD+ SN++L N N +L+ T GT Y++PE +G
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHG 190
Query: 515 TATEKTDVFSYGVVVLEVACGRRPIERET 543
++DV+S G + + GR P + +T
Sbjct: 191 ---LESDVWSLGCMFYTLLIGRPPFDTDT 216
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 48/230 (20%), Positives = 87/230 (37%), Gaps = 33/230 (14%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLA-ELSIIACLRHKNLV 407
+ + ILG+GA NV++ +G + A+K + S + E ++ L HKN+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 408 QLLGW--CAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
+L +L+ E+ P GSL + ++ N L L ++ + + +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARL--------------ESSFTLTA-GTMGYLAPE 509
E ++HR+IK NIM + + + ++ GT YL P+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 510 YLQYGTA--------TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNL 551
+ D++S GV A G P + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-26
Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 31/248 (12%)
Query: 317 KWKNMRTGICLRADLVPGPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVA 376
+ R + + DL P F + + + + LG GA+G V +
Sbjct: 6 HHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVER 65
Query: 377 AVK---RSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL-D 432
A+K ++ S ++ L E++++ L H N+++L + +K LV E G L D
Sbjct: 66 AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 433 RMLYQD--SENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-N 489
++++ +E I+ + S +TYLH+ ++HRD+K N++L++ +
Sbjct: 126 EIIHRMKFNEVDA-------AVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKD 175
Query: 490 ARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGR 536
A + + GT Y+APE L+ EK DV+S GV++ + G
Sbjct: 176 ALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY 234
Query: 537 RPIERETE 544
P +T+
Sbjct: 235 PPFGGQTD 242
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 28/209 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLA----ELSIIACLRHKNLV 407
R++GRG G+VY+A + A+K S + F E L+ ++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD--PVFRTRMQREARTAGRLQEPHVV 97
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+ + G+L + + L ML G L + + IV + SAL H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPL-APPRAVAIVRQIGSALDAAHA- 152
Query: 468 CEQQVIHRDIKASNIMLDAN-------FN-ARLESSFTLTA-----GTMGYLAPEYLQYG 514
HRD+K NI++ A+ F A + LT GT+ Y+APE
Sbjct: 153 --AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 515 TATEKTDVFSYGVVVLEVACGRRPIERET 543
AT + D+++ V+ E G P + +
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
R LG GAFG+V+ SSG +K S + AE+ ++ L H N++++
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 412 WCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
+ + +V E G L +R++ + LS + ++ + +AL Y H Q
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKA-LSEGYVAELMKQMMNALAYFHS---Q 143
Query: 471 QVIHRDIKASNIML-DANFNARL-------------ESSFTLTAGTMGYLAPEYLQ--YG 514
V+H+D+K NI+ D + ++ + + T AGT Y+APE +
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVT 203
Query: 515 TATEKTDVFSYGVVVLEVACGRRPIERETE 544
K D++S GVV+ + G P +
Sbjct: 204 ---FKCDIWSAGVVMYFLLTGCLPFTGTSL 230
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 9e-26
Identities = 32/113 (28%), Positives = 60/113 (53%), Gaps = 6/113 (5%)
Query: 22 SNNMNFDFTSF--NLRNITLLGDSYLRNGVIGLTRELGVP---ASSSGSLIYNNPVPFFD 76
+ +++F FT F N ++ G + N V+ +T+ +SS+G ++Y+ P+ ++
Sbjct: 1 AQSLSFSFTKFDPNQEDLIFQGHATSTNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWE 60
Query: 77 QETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSS 129
+ SF + +F I+ S DGLAFFI+P + ++ GG LGL ++
Sbjct: 61 D-SAVLTSFDTIINFEISTPYTSRIADGLAFFIAPPDSVISYHGGFLGLFPNA 112
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 59/314 (18%), Positives = 108/314 (34%), Gaps = 77/314 (24%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLR-HKNLVQLLG 411
R+L G F VY+A SG A+KR + E + E+ + L H N+VQ
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 412 WCA--------EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
+ + E LL+ E ++ + + E+ LS L I A+ +
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 464 LHQECEQQVIHRDIKASNIMLDANFN-----------ARLESSFTLTA------------ 500
+H+ + +IHRD+K N++L ++ +A
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 501 -GTMGYLAPE---YLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW 556
T Y PE EK D+++ G ++ + + P E +G K+
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE---DGAKL-------- 259
Query: 557 GLYAEGRIIEAADKRLNGAFNE-------DEMKRLLLVGLSCANPDSSARPSMRRVFQIL 609
RI +NG ++ L+ + + R S + +++
Sbjct: 260 ------RI-------VNGKYSIPPHDTQYTVFHSLI---RAMLQVNPEERLS---IAEVV 300
Query: 610 NNEAEPLVVPKLKP 623
+ E + P
Sbjct: 301 HQLQEIAAARNVNP 314
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 63/240 (26%), Positives = 100/240 (41%), Gaps = 32/240 (13%)
Query: 326 CLRADLVPGPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVK----RS 381
+ L P F + + R+LG+G+FG V +G AVK R
Sbjct: 4 SMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 63
Query: 382 KHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQD-- 438
K L E+ ++ L H N+++L + +KG LV E G L D ++ +
Sbjct: 64 VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF 123
Query: 439 SENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML-DANFNARL----- 492
SE I+ + S +TY+H+ +++HRD+K N++L + +A +
Sbjct: 124 SEVDA-------ARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 493 --------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
GT Y+APE L GT EK DV+S GV++ + G P E
Sbjct: 174 GLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANE 232
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 56/207 (27%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA----ELSIIACLRHKNLVQL 409
LG G VY A A+K K E L E+ + L H+N+V +
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
+ E LV EY+ +L + +G L S +N + + + H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPL-SVDTAINFTNQILDGIKHAHD--- 129
Query: 470 QQVIHRDIKASNIMLDANFN--------ARLESSFTLTA-----GTMGYLAPEYLQYGTA 516
+++HRDIK NI++D+N A+ S +LT GT+ Y +PE +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 517 TEKTDVFSYGVVVLEVACGRRPIERET 543
E TD++S G+V+ E+ G P ET
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGET 216
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 59/242 (24%), Positives = 102/242 (42%), Gaps = 34/242 (14%)
Query: 327 LRADLVPGPREFSYRELRSATRGFHSN------RILGRGAFGNVYKAYFASSGSVAAVKR 380
L D+ P F +R + + +S ILG G FG V+K ++G A K
Sbjct: 62 LAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKI 121
Query: 381 -SKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQD 438
+ K E E+S++ L H NL+QL K +++LV EY+ G L DR++
Sbjct: 122 IKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII--- 178
Query: 439 SENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL------ 492
+ L+ + + + + ++HQ ++H D+K NI+ ++
Sbjct: 179 -DESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFG 234
Query: 493 -------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGV---VVLEVACGRRPIERE 542
+ GT +LAPE + Y + TD++S GV ++L G P +
Sbjct: 235 LARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL---SGLSPFLGD 291
Query: 543 TE 544
+
Sbjct: 292 ND 293
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 35/271 (12%), Positives = 81/271 (29%), Gaps = 56/271 (20%)
Query: 327 LRADLVPGPREFSYRELRSA-TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVK------ 379
+ L + F R +LG+ +A +G V
Sbjct: 51 VSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE 110
Query: 380 -----------------------RSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEK 416
+++ + F+ ++ + K ++++ +
Sbjct: 111 RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDM 170
Query: 417 GELLLVYEYM----PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
L + Y + +L S L + RL + + + L LH +
Sbjct: 171 WVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227
Query: 473 IHRDIKASNIMLDANFNARL--------ESSFTLTAGTMGYLAPEYLQY----------- 513
+H ++ +I+LD L + + +++ + G+ PE
Sbjct: 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRR 287
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPIERETE 544
T D ++ G+V+ + C PI ++
Sbjct: 288 TLMTFSFDAWALGLVIYWIWCADLPITKDAA 318
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+LG+G+FG V K + AVK ++ ++ + L E+ ++ L H N+++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 411 GWCAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVGLASALTYLHQE 467
+ +V E G L D ++ + SE+ I+ + S +TY+H+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------ARIIKQVFSGITYMHK- 139
Query: 468 CEQQVIHRDIKASNIML-DANFNARL-------------ESSFTLTAGTMGYLAPEYLQ- 512
++HRD+K NI+L + + + GT Y+APE L+
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG 197
Query: 513 -YGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
Y EK DV+S GV++ + G P + E
Sbjct: 198 TYD---EKCDVWSAGVILYILLSGTPPFYGKNE 227
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 49/228 (21%), Positives = 91/228 (39%), Gaps = 26/228 (11%)
Query: 336 REFSYRELRSATRGFHSN----RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTE 390
+++ + + + LG GAFG V++ ++G V K + K
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT 94
Query: 391 FLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYH 449
E+SI+ L H L+ L +K E++L+ E++ G L DR+ +S
Sbjct: 95 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA----AEDYKMSEAE 150
Query: 450 RLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL-------------ESSF 496
+N + L ++H+ ++H DIK NIM + + + +
Sbjct: 151 VINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207
Query: 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
+T T + APE + TD+++ GV+ + G P E +
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 33/270 (12%), Positives = 73/270 (27%), Gaps = 55/270 (20%)
Query: 327 LRADLVPGPREFSYRELRSA-TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVK------ 379
+ L + F R +LG+ +A +G V
Sbjct: 56 VSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE 115
Query: 380 ---------------RSKHSHEGKTEFLAE-----LSIIACLRHKNLVQL--LGWCAEKG 417
R + K + A+ + ++ ++ +
Sbjct: 116 RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDM 175
Query: 418 ELLLVYEYMP-----NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
+L + P + +L S L + RL + + + L LH +
Sbjct: 176 WVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232
Query: 473 IHRDIKASNIMLDANFN--------ARLESSFTLTAGTMGYLAPEYL----------QYG 514
+H ++ +I+LD + + ++ G+ PE
Sbjct: 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPT 292
Query: 515 TATEKTDVFSYGVVVLEVACGRRPIERETE 544
T D ++ G+ + + C P +
Sbjct: 293 LMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 50/197 (25%), Positives = 92/197 (46%), Gaps = 22/197 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKR--SKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+G+G+FG V+K + V A+K + + + + E+++++ + + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+ +L ++ EY+ GS +L E G L I+ + L YLH ++ I
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLL----EPGP-LDETQIATILREILKGLDYLH---SEKKI 141
Query: 474 HRDIKASNIMLDANFNARLE---SSFTLTA---------GTMGYLAPEYLQYGTATEKTD 521
HRDIKA+N++L + +L + LT GT ++APE ++ K D
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 201
Query: 522 VFSYGVVVLEVACGRRP 538
++S G+ +E+A G P
Sbjct: 202 IWSLGITAIELARGEPP 218
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 42/225 (18%), Positives = 82/225 (36%), Gaps = 40/225 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK-----------RSKHSHEGKTEFLA-------EL 395
R L +G F + A+K S+ K + EL
Sbjct: 37 RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 396 SIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL-----DRMLYQDSENGVLLSWYHR 450
II ++++ + G E+ ++YEYM N S+ + + + +
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 451 LNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN---------ARLESSFTLTA- 500
I+ + ++ +Y+H E+ + HRD+K SNI++D N + +
Sbjct: 155 -CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR 211
Query: 501 GTMGYLAPEYLQ--YGTATEKTDVFSYGVVVLEVACGRRPIERET 543
GT ++ PE+ K D++S G+ + + P +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 43/214 (20%), Positives = 71/214 (33%), Gaps = 36/214 (16%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSI-IACLRHKNLV 407
F +LG GA G + + VA VKR E+ + H N++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVA-VKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+ ++ + E +L + + + ++ S L +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLH-- 135
Query: 468 CEQQVIHRDIKASNIML-----DANFNARL------------ESSFTLT---AGTMGYLA 507
++HRD+K NI++ A + SF+ GT G++A
Sbjct: 136 -SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 508 PEYLQ---YGTATEKTDVFSYGVVVLEVACGRRP 538
PE L T D+FS G V V
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 51/232 (21%), Positives = 93/232 (40%), Gaps = 32/232 (13%)
Query: 335 PREFSYRELRSATRGFHS----NRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKT 389
+++ + + + LG GAFG V++ ++G+ A K K
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 390 EFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQD---SENGVLL 445
E+ ++ LRH LV L + E++++YE+M G L +++ + SE+
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA-- 257
Query: 446 SWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL------------- 492
+ + + L ++H E +H D+K NIM + L
Sbjct: 258 -----VEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
Query: 493 ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
+ S +T GT + APE + TD++S GV+ + G P E +
Sbjct: 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 27/208 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
LGRG FG V++ SS K K + E+SI+ RH+N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 414 AEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
EL++++E++ + +R+ + L+ ++ V + AL +LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERIN----TSAFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 473 IHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEK 519
H DI+ NI+ ++ + +F L Y APE Q+ +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 520 TDVFSYGV---VVLEVACGRRPIERETE 544
TD++S G V+L G P ET
Sbjct: 184 TDMWSLGTLVYVLL---SGINPFLAETN 208
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQ 408
+ LG GAFG VYKA +G++AA K S E +++ E+ I+A H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
LLG G+L ++ E+ P G++D + + + G L+ + + AL +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVD-AIMLELDRG--LTEPQIQVVCRQMLEALNFLHS-- 135
Query: 469 EQQVIHRDIKASNIMLDANFNARLE---SSFTLTA---------GTMGYLAPEYLQYGTA 516
+++IHRD+KA N+++ + RL S GT ++APE + T
Sbjct: 136 -KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 517 TE-----KTDVFSYGVVVLEVACGRRP 538
+ K D++S G+ ++E+A P
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
+GRG++G V A + A K+ K+ E F E+ I+ L H N+++L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 413 CAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVGLASALTYLHQECE 469
+ ++ LV E G L +R++++ E+ I+ + SA+ Y H+
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDA-------ARIMKDVLSAVAYCHK--- 124
Query: 470 QQVIHRDIKASNIMLDANF-NARL-------------ESSFTLTAGTMGYLAPEYLQ--Y 513
V HRD+K N + + ++ L GT Y++P+ L+ Y
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLY 184
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPIERETE 544
G + D +S GV++ + CG P T+
Sbjct: 185 G---PECDEWSAGVMMYVLLCGYPPFSAPTD 212
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 22/204 (10%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVK----RSKHSHEGKTEFLAELSIIACLRHKN 405
F R +G G+FG VY A + V A+K K S+E + + E+ + LRH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+Q G + LV EY + D + L + G L YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH 171
Query: 466 QECEQQVIHRDIKASNIMLDANFNARLE---SSFTLT-----AGTMGYLAPE---YLQYG 514
+IHRD+KA NI+L +L S+ + GT ++APE + G
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEG 228
Query: 515 TATEKTDVFSYGVVVLEVACGRRP 538
K DV+S G+ +E+A + P
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPP 252
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 35/213 (16%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+LG+G+FG V K + AVK ++ ++ + L E+ ++ L H N+++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 411 GWCAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVGLASALTYLHQE 467
+ +V E G L D ++ + SE+ I+ + S +TY+H+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------ARIIKQVFSGITYMHK- 139
Query: 468 CEQQVIHRDIKASNIMLDANF-NARL-------------ESSFTLTAGTMGYLAPEYLQ- 512
++HRD+K NI+L++ + + + GT Y+APE L+
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG 197
Query: 513 -YGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
Y EK DV+S GV++ + G P + E
Sbjct: 198 TYD---EKCDVWSAGVILYILLSGTPPFYGKNE 227
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 23/197 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCA 414
+G G+ G V A SG AVK + + E+ I+ +H N+V++
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
EL ++ E++ G+L D + V L+ + + AL YLH Q VIH
Sbjct: 113 VGEELWVLMEFLQGGAL-----TDIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIH 164
Query: 475 RDIKASNIMLDAN---------FNARLESSF----TLTAGTMGYLAPEYLQYGTATEKTD 521
RDIK+ +I+L + F A++ +L GT ++APE + + D
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPYWMAPEVISRSLYATEVD 223
Query: 522 VFSYGVVVLEVACGRRP 538
++S G++V+E+ G P
Sbjct: 224 IWSLGIMVIEMVDGEPP 240
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 36/216 (16%), Positives = 80/216 (37%), Gaps = 42/216 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAA--VKRSKHSHEGKTEFLAELSIIACLRHKNL--VQL 409
+ +G G V++ A V + ++ + E++ + L+ + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLASALTYLHQ 466
+ + +V E N L+ L + W + + A+ +HQ
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKN-------MLEAVHTIHQ 145
Query: 467 ECEQQVIHRDIKASNIMLD-----------ANFNARLESSFTLT--AGTMGYLAPEYLQY 513
++H D+K +N ++ AN +S GT+ Y+ PE ++
Sbjct: 146 ---HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 514 GTA-----------TEKTDVFSYGVVVLEVACGRRP 538
++ + K+DV+S G ++ + G+ P
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 23/197 (11%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCA 414
+G+GA G VY A ++G A+++ + K + E+ ++ ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474
EL +V EY+ GSL ++ + + + AL +LH QVIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 475 RDIKASNIMLDAN---------FNARLESSF----TLTAGTMGYLAPEYLQYGTATEKTD 521
RDIK+ NI+L + F A++ T+ GT ++APE + K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVD 198
Query: 522 VFSYGVVVLEVACGRRP 538
++S G++ +E+ G P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 37/222 (16%), Positives = 82/222 (36%), Gaps = 42/222 (18%)
Query: 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAA--VKRSKHSHEGKTEFLAELSIIACLRHKN 405
R + + +G G V++ A V + ++ + E++ + L+ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 406 L--VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLASA 460
++L + + +V E N L+ L + W + + A
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN-------MLEA 120
Query: 461 LTYLHQECEQQVIHRDIKASNIMLD-----------ANFNARLESSFTLT--AGTMGYLA 507
+ +HQ ++H D+K +N ++ AN +S GT+ Y+
Sbjct: 121 VHTIHQ---HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 508 PEYLQYGTA-----------TEKTDVFSYGVVVLEVACGRRP 538
PE ++ ++ + K+DV+S G ++ + G+ P
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 31/209 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSK--HSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+G GA V AY A A+KR E L E+ ++ H N+V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLN------IVVGLASALTYLHQE 467
K EL LV + + GS+ ++ G S L+ I+ + L YLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS--GVLDESTIATILREVLEGLEYLH-- 138
Query: 468 CEQQVIHRDIKASNIMLDAN---------FNARLESSFTLT--------AGTMGYLAPEY 510
+ IHRD+KA NI+L + +A L + +T GT ++APE
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 511 LQYGTA-TEKTDVFSYGVVVLEVACGRRP 538
++ K D++S+G+ +E+A G P
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 36/223 (16%), Positives = 81/223 (36%), Gaps = 44/223 (19%)
Query: 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLAELSIIACLRHK 404
R + + +G G V++ + A+K + ++ + E++ + L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 405 NL--VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLAS 459
+ ++L + + +V E N L+ L + W + +
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN-------MLE 166
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLD-----------ANFNARLESSFTLT--AGTMGYL 506
A+ +HQ ++H D+K +N ++ AN +S G + Y+
Sbjct: 167 AVHTIHQ---HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 507 APEYLQ-----------YGTATEKTDVFSYGVVVLEVACGRRP 538
PE ++ + K+DV+S G ++ + G+ P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 42/222 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK--------------RSKHSHEGKTEFLAELSIIA 399
R LG GA+G V + S A+K +K+ + E E+S++
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 400 CLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVG 456
L H N+++L +K LV E+ G L ++++ + E NI+
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA-------ANIMKQ 154
Query: 457 LASALTYLHQECEQQVIHRDIKASNIML-DANFNARL-------------ESSFTLTAGT 502
+ S + YLH+ ++HRDIK NI+L + N + + GT
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 503 MGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
Y+APE L+ EK DV+S GV++ + CG P + +
Sbjct: 212 AYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND 252
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 48/209 (22%), Positives = 81/209 (38%), Gaps = 31/209 (14%)
Query: 356 LGRGA--FGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+G+G V A + +G V+R S+E T EL + H N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
EL +V +M GS ++ +G ++ I+ G+ AL Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDG--MNELAIAYILQGVLKALDYIHH---M 147
Query: 471 QVIHRDIKASNIMLDANFNARL-------------------ESSFTLTAGTMGYLAPEYL 511
+HR +KAS+I++ + L + + +L+PE L
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207
Query: 512 QYGTA--TEKTDVFSYGVVVLEVACGRRP 538
Q K+D++S G+ E+A G P
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 36/240 (15%), Positives = 75/240 (31%), Gaps = 35/240 (14%)
Query: 341 RELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVA-----AVKRSKHSHEGKTEFL-AE 394
E + ++ + + +LG GAF VY+A +K K ++ +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 395 LSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNI 453
+ + ++ + +LV E G+L + + + ++ ++
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 454 VVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS------------------ 495
+ + + +H + ++IH DIK N +L F + +
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 496 -------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKM 548
FT T G+ E L + D F V + G + G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
+LG GAF V+ +G + A+K K + E++++ ++H+N+V L
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 413 CAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVGLASALTYLHQECE 469
LV + + G L DR+L + +E ++ + SA+ YLH E
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS-------LVIQQVLSAVKYLH---E 124
Query: 470 QQVIHRDIKASNIMLDANF-NARL------------ESSFTLTAGTMGYLAPEYLQYGTA 516
++HRD+K N++ N+++ + GT GY+APE L
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 517 TEKTDVFSYGVVVLEVACGRRPIERETE 544
++ D +S GV+ + CG P ETE
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETE 212
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIA-CLRHKNLVQLLG--- 411
+G G +G VYK +G +AA+K + + + E E++++ H+N+ G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 412 ---WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
+L LV E+ GS+ L ++++ L I + L++LH
Sbjct: 92 KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNT-LKEEWIAYICREILRGLSHLH--- 146
Query: 469 EQQVIHRDIKASNIMLDANFNARLE---SSFTLTA---------GTMGYLAPEYLQYGTA 516
+ +VIHRDIK N++L N +L S L GT ++APE +
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 206
Query: 517 TE-----KTDVFSYGVVVLEVACGRRP 538
+ K+D++S G+ +E+A G P
Sbjct: 207 PDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQL 409
F LG G++G+VYKA +G + A+K+ + + E + E+SI+ ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-EIIKEISIMQQCDSPHVVKY 89
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
G + +L +V EY GS+ ++ L+ I+ L YLH
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHF--- 143
Query: 470 QQVIHRDIKASNIMLDANFNARLE---SSFTLTA---------GTMGYLAPEYLQYGTAT 517
+ IHRDIKA NI+L+ +A+L + LT GT ++APE +Q
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203
Query: 518 EKTDVFSYGVVVLEVACGRRP 538
D++S G+ +E+A G+ P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-23
Identities = 44/208 (21%), Positives = 75/208 (36%), Gaps = 25/208 (12%)
Query: 354 RILGRGAFGNVYKAY-FASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+ G G +Y A +G +K E + +AE +A + H ++VQ+
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 411 -----GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+V EY+ SL R Q L + ++ + AL+YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLH 199
Query: 466 QECEQQVIHRDIKASNIMLDAN------FN-ARLESSFTLTAGTMGYLAPEYLQYGTATE 518
+++ D+K NIML +SF GT G+ APE ++ T
Sbjct: 200 ---SIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYLYGTPGFQAPEIVR-TGPTV 255
Query: 519 KTDVFSYGVVVLEVACGRRPIERETEGH 546
TD+++ G + +
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRNGRYVDG 283
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 30/213 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA----ELSIIACLRHKNLVQL 409
ILG G V+ A AVK + F E A L H +V +
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 410 LGWCAEKGELL----LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+ +V EY+ +L ++ G + + + ++ AL + H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPM-TPKRAIEVIADACQALNFSH 133
Query: 466 QECEQQVIHRDIKASNIMLDAN-------F---NARLESSFTLTA-----GTMGYLAPEY 510
+ +IHRD+K +NIM+ A F A +S ++T GT YL+PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 511 LQYGTATEKTDVFSYGVVVLEVACGRRPIERET 543
+ + ++DV+S G V+ EV G P ++
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 49/253 (19%), Positives = 86/253 (33%), Gaps = 65/253 (25%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK------RSKHSHEGKTEFLAELSIIACLRHKNLV 407
+G+G++G V A + ++ A+K + + + E+ ++ L H N+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 408 QLLGWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRL--------------- 451
+L ++ + LV E G L D++ ++ +
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 452 --------------------NIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491
NI+ + SAL YLH Q + HRDIK N + N +
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFE 208
Query: 492 L------------------ESSFTLTAGTMGYLAPEYLQYGTA--TEKTDVFSYGVVVLE 531
+ T AGT ++APE L K D +S GV++
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 532 VACGRRPIERETE 544
+ G P +
Sbjct: 269 LLMGAVPFPGVND 281
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 7e-22
Identities = 70/312 (22%), Positives = 112/312 (35%), Gaps = 84/312 (26%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSI-IACLRHKNLV 407
S +ILG G+ G V + G AVKR + L E+ + H N++
Sbjct: 17 VVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVI 72
Query: 408 QLLGWCAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVGLASALTYL 464
+ L + E N +L D + ++ EN L Y+ ++++ +AS + +L
Sbjct: 73 RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 465 HQECEQQVIHRDIKASNIMLD-----------ANFNARL--------------ESSFTLT 499
H ++IHRD+K NI++ N R+ +SSF
Sbjct: 132 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 500 ----AGTMGYLAPEYLQYGTA-------TEKTDVFSYGVVVLEVAC-GRRPIERETEGHK 547
+GT G+ APE L+ T D+FS G V + G+ P +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS--- 245
Query: 548 MVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLS---------CANPDSSA 598
E I + G F+ DEMK L L + D
Sbjct: 246 ------------RESNI-------IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK 286
Query: 599 RPSMRRVFQILN 610
RP+ ++L
Sbjct: 287 RPTAM---KVLR 295
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 48/200 (24%), Positives = 80/200 (40%), Gaps = 35/200 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK-------RSKHSHEGKTEFLAELSIIACLRHKNL 406
LG G F V K S+G A K R+ + E E+SI+ + H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVGLASALTY 463
+ L + +++L+ E + G L D + ++ SE + + + + Y
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-------TSFIKQILDGVNY 130
Query: 464 LHQECEQQVIHRDIKASNIML-DANFNARL--------------ESSFTLTAGTMGYLAP 508
LH +++ H D+K NIML D N F GT ++AP
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 509 EYLQYGTATEKTDVFSYGVV 528
E + Y + D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 37/215 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
LG+GAF V + +G A K S + E I L+H N+V+L
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 411 GWCAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVGLASALTYLHQE 467
+E+G L+++ + G L + ++ ++ SE + + + A+ + H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA-------SHCIQQILEAVLHCH-- 127
Query: 468 CEQQVIHRDIKASNIML-DANFNARL--------------ESSFTLTAGTMGYLAPEYLQ 512
+ V+HR++K N++L A + + ++ AGT GYL+PE L+
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 513 YGTATEKTDVFSYGVVV---LEVACGRRPIERETE 544
+ D+++ GV++ L G P E +
Sbjct: 187 KDPYGKPVDLWACGVILYILL---VGYPPFWDEDQ 218
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 46/200 (23%), Positives = 79/200 (39%), Gaps = 35/200 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK-------RSKHSHEGKTEFLAELSIIACLRHKNL 406
LG G F V K S+G A K R+ + E E+SI+ + H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVGLASALTY 463
+ L + +++L+ E + G L D + ++ SE + + + + Y
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-------TSFIKQILDGVNY 130
Query: 464 LHQECEQQVIHRDIKASNIMLD--ANFNARL-------------ESSFTLTAGTMGYLAP 508
LH +++ H D+K NIML + F GT ++AP
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 509 EYLQYGTATEKTDVFSYGVV 528
E + Y + D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVI 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 41/219 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK-------RSKHSHEGKTEFLAELSIIACLRHKNL 406
LG G F V K +G A K S + E E++I+ +RH N+
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVGLASALTY 463
+ L K +++L+ E + G L D + ++ +E+ + + + Y
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQILDGVHY 123
Query: 464 LHQECEQQVIHRDIKASNIMLD--ANFNARL-------------ESSFTLTAGTMGYLAP 508
LH +++ H D+K NIML N R+ + F GT ++AP
Sbjct: 124 LHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 509 EYLQYGTATEKTDVFSYGV---VVLEVACGRRPIERETE 544
E + Y + D++S GV ++L G P ET+
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILL---SGASPFLGETK 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 34/213 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
LG+GAF V + ++G A K K S + E I L+H N+V+L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 411 GWCAEKGELLLVYEYMPNGSL-DRML----YQDSENGVLLSWYHRLNIVVGLASALTYLH 465
E+ LV++ + G L + ++ Y +++ + + + ++ Y H
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---------HCIQQILESIAYCH 122
Query: 466 QECEQQVIHRDIKASNIML-DANFNARL-------------ESSFTLTAGTMGYLAPEYL 511
++HR++K N++L A + ++ AGT GYL+PE L
Sbjct: 123 ---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
+ ++ D+++ GV++ + G P E +
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 212
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 48/216 (22%), Positives = 90/216 (41%), Gaps = 40/216 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
LG+GAF V + ++G A K K S + E I L+H N+V+L
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 411 GWCAEKGELLLVYEYMPNGSL-DRML----YQDSENGVLLSWYHRLNIVVGLASALTYLH 465
E+ LV++ + G L + ++ Y +++ + + + ++ Y H
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---------HCIQQILESIAYCH 145
Query: 466 QECEQQVIHRDIKASNIML-DANFNARL-------------ESSFTLTAGTMGYLAPEYL 511
++HR++K N++L A + ++ AGT GYL+PE L
Sbjct: 146 ---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 202
Query: 512 QYGTATEKTDVFSYGVVV---LEVACGRRPIERETE 544
+ ++ D+++ GV++ L G P E +
Sbjct: 203 KKDPYSKPVDIWACGVILYILL---VGYPPFWDEDQ 235
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 47/213 (22%), Positives = 87/213 (40%), Gaps = 31/213 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLAELSIIACLRH-KNLVQL 409
+ LGRG F V + S+G A K + + + + E L E++++ + ++ L
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 410 LGWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
E++L+ EY G + L + +E +S + ++ + + YLH
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEM---VSENDVIRLIKQILEGVYYLH--- 148
Query: 469 EQQVIHRDIKASNIMLDANF-NARL-------------ESSFTLTAGTMGYLAPEYLQYG 514
+ ++H D+K NI+L + + + GT YLAPE L Y
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 515 TATEKTDVFSYGV---VVLEVACGRRPIERETE 544
T TD+++ G+ ++L P E
Sbjct: 209 PITTATDMWNIGIIAYMLL---THTSPFVGEDN 238
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 41/219 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK-------RSKHSHEGKTEFLAELSIIACLRHKNL 406
LG G F V K S+G A K +S + + E+SI+ ++H N+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVGLASALTY 463
+ L K +++L+ E + G L D + ++ +E + + + I+ + + Y
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA--TEFLK-QIL----NGVYY 129
Query: 464 LHQECEQQVIHRDIKASNIML--DANFNARL-------------ESSFTLTAGTMGYLAP 508
LH Q+ H D+K NIML R+ + F GT ++AP
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 509 EYLQYGTATEKTDVFSYGV---VVLEVACGRRPIERETE 544
E + Y + D++S GV ++L G P +T+
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILL---SGASPFLGDTK 222
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 47/210 (22%), Positives = 83/210 (39%), Gaps = 32/210 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK------RSKHSHEGKTEFLAELSIIACLRHKNLV 407
++G+G F V + +G AVK + + E SI L+H ++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 408 QLLGWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
+LL + G L +V+E+M L ++ + V S + + + AL Y H
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV-YSEAVASHYMRQILEALRYCH- 147
Query: 467 ECEQQVIHRDIKASNIML-DANFNARL--------------ESSFTLTAGTMGYLAPEYL 511
+ +IHRD+K ++L +A + GT ++APE +
Sbjct: 148 --DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 512 QYGTATEKTDVFSYGVVV---LEVACGRRP 538
+ + DV+ GV++ L G P
Sbjct: 206 KREPYGKPVDVWGCGVILFILL---SGCLP 232
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 30/213 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
LGRGA VY+ + A+K K + E+ ++ L H N+++L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLKEI 116
Query: 413 CAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVGLASALTYLHQECE 469
E+ LV E + G L DR++ + SE + V + A+ YLH E
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAA-------DAVKQILEAVAYLH---E 166
Query: 470 QQVIHRDIKASNIML-DANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGT 515
++HRD+K N++ +A L + GT GY APE L+
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 516 ATEKTDVFSYGVVVLEVACGRRPIERETEGHKM 548
+ D++S G++ + CG P E M
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 58/254 (22%), Positives = 92/254 (36%), Gaps = 58/254 (22%)
Query: 328 RADLVPGPREFSYRELRSATRGFHSN----RILGRGAFGNVYKAYFASSGSVAAVK---- 379
R +PG +T GF+ N ILGRG V + + AVK
Sbjct: 2 RDAALPGSH---------STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDV 52
Query: 380 ------RSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYMPNGSL- 431
++ E + L E+ I+ + H N++QL LV++ M G L
Sbjct: 53 TGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF 112
Query: 432 DRML----YQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN 487
D + + E I+ L + LH + ++HRD+K NI+LD +
Sbjct: 113 DYLTEKVTLSEKETR---------KIMRALLEVICALH---KLNIVHRDLKPENILLDDD 160
Query: 488 FNARL-----------ESSFTLTAGTMGYLAPEYLQYGTATEKT------DVFSYGVVVL 530
N +L GT YLAPE ++ D++S GV++
Sbjct: 161 MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 220
Query: 531 EVACGRRPIERETE 544
+ G P +
Sbjct: 221 TLLAGSPPFWHRKQ 234
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-20
Identities = 25/192 (13%), Positives = 58/192 (30%), Gaps = 28/192 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVK----RSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
G ++A + A+ + + E L+ ++ + + ++L
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
+ L+V E++ GSL + + S + + LA+A H+
Sbjct: 99 VVHTRAGGLVVAEWIRGGSLQEVA----DTS--PSPVGAIRAMQSLAAAADAAHR---AG 149
Query: 472 VIHRDIKASNIMLDANFNARLESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLE 531
V S + + + + L + A + D+ G +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVL--------AYPATMPD-------ANPQDDIRGIGASLYA 194
Query: 532 VACGRRPIERET 543
+ R P+
Sbjct: 195 LLVNRWPLPEAG 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 61/289 (21%), Positives = 98/289 (33%), Gaps = 95/289 (32%)
Query: 354 RILGRGAFGNVYKAY-----FASSGSVAAVKRSK--HSHEGKTEFLAELSIIACL-RHKN 405
+ LGRGAFG V +A ++ AVK K +H ++EL I+ + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 406 LVQLLGWC-AEKGELLLVYEYMPNGSL-------------------DRMLYQDSENGVLL 445
+V LLG C G L+++ E+ G+L +D + +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 446 SWYHRLNIVVGLASALTYLHQEC------------------------------------- 468
RL+ + S+ + E
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 469 ---EQQVIHRDIKASNIMLDANFNARLESSFTLT----------AGTMGYL-----APEY 510
++ IHRD+ A NI+L ++ F L L APE
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKI-CDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 511 LQYGTATEKTDVFSYGVVVLEVAC-GRRP----------IERETEGHKM 548
+ T ++DV+S+GV++ E+ G P R EG +M
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 315
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 50/223 (22%), Positives = 85/223 (38%), Gaps = 44/223 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---------RSKHSHEGKTEFLAELSIIACLR-H 403
++GRG V + ++G AVK + E + E I+ + H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 404 KNLVQLLGWCAEKGELLLVYEYMPNGSL-DRML----YQDSENGVLLSWYHRLNIVVGLA 458
+++ L+ + LV++ M G L D + + E +I+ L
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR---------SIMRSLL 210
Query: 459 SALTYLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLTAGTMGYLA 507
A+++LH ++HRD+K NI+LD N RL GT GYLA
Sbjct: 211 EAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267
Query: 508 PEYLQYGTATEKT------DVFSYGVVVLEVACGRRPIERETE 544
PE L+ D+++ GV++ + G P +
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 43/220 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLA----ELSIIACLRHK-- 404
+LG G FG+VY S A+K + + S G+ E+ ++ +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 405 NLVQLLGWCAEKGELLLVYEY-MPNGSL-DRMLYQDSENGVLLSWYHRLN------IVVG 456
+++LL W +L+ E P L D + +E G L
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI----TERG-------ALQEELARSFFWQ 157
Query: 457 LASALTYLHQECEQQVIHRDIKASNIMLDAN-FNARL----------ESSFTLTAGTMGY 505
+ A+ + H V+HRDIK NI++D N +L ++ +T GT Y
Sbjct: 158 VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 214
Query: 506 LAPEYLQYGT-ATEKTDVFSYGVVVLEVACGRRPIERETE 544
PE+++Y V+S G+++ ++ CG P E + E
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 62/215 (28%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEF---LAELSIIACLRHKN 405
F R +G+G+FG V + + A+K +K + E EL I+ L H
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 406 LVQLLGWCA--EKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLASA 460
LV L W + ++ ++ +V + + G L L Q+ E V L + + L A
Sbjct: 77 LVNL--WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL--F-----ICELVMA 127
Query: 461 LTYLHQECEQQVIHRDIKASNIMLDANFNARL----------ESSFTLT-AGTMGYLAPE 509
L YL Q++IHRD+K NI+LD + + + + T AGT Y+APE
Sbjct: 128 LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPE 184
Query: 510 YLQ------YGTATEKTDVFSYGVVVLEVACGRRP 538
Y A D +S GV E+ GRRP
Sbjct: 185 MFSSRKGAGYSFA---VDWWSLGVTAYELLRGRRP 216
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260 | Back alignment and structure |
|---|
Score = 85.3 bits (210), Expect = 1e-18
Identities = 38/244 (15%), Positives = 71/244 (29%), Gaps = 31/244 (12%)
Query: 13 FLLNFSFVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPV 72
F +SF + + D T G++ I + L S GS+
Sbjct: 30 FEYKYSFKGPHLVQSDGTV---PFWAHAGNAIPSADQIRIAPSL---KSQRGSVWTKTKA 83
Query: 73 PFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLT 132
F ++ +F + DGLA + + + + G G + N
Sbjct: 84 AF--------ENWEVEVTFRVTGRG-RIGADGLAIWYTENQGLDGPVFGSADMWNG---- 130
Query: 133 KNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGID------LKSGNVIT 186
V I FD+ + + + + + D Q + +
Sbjct: 131 ----VGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVR 186
Query: 187 AWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQ 246
A I Y L V ++ + + + G SA+T G + H +
Sbjct: 187 AKITYYQK--TLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVL 244
Query: 247 SWSF 250
S+
Sbjct: 245 SFLT 248
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 51/212 (24%), Positives = 82/212 (38%), Gaps = 36/212 (16%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---------RSKHSHEGKTEFLAELSIIACLRHK 404
+ LG GA G V A+ + A++ S + E+ I+ L H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
++++ + + + +V E M G L D+++ N L + + A+ Y
Sbjct: 201 CIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNKRLKEATCK-LYFYQMLLAVQY 254
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTA-GTMGYLAPE 509
LH E +IHRD+K N++L + L E+S T GT YLAPE
Sbjct: 255 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311
Query: 510 YLQYGTA---TEKTDVFSYGVVVLEVACGRRP 538
L D +S GV++ G P
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 48/199 (24%), Positives = 81/199 (40%), Gaps = 41/199 (20%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIA-CLRHKNLVQLLG 411
+G G++ + ++ AVK K + E+ I+ +H N++ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKD 83
Query: 412 WCAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVGLASALTYLHQEC 468
+ + +V E M G L D++L Q SE ++ + + YLH
Sbjct: 84 VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA-------SAVLFTITKTVEYLH--- 133
Query: 469 EQQVIHRDIKASNIML-DANFNA--------------RLESSFTLTA-GTMGYLAPEYLQ 512
Q V+HRD+K SNI+ D + N R E+ +T T ++APE L+
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE 193
Query: 513 ---YGTATEKTDVFSYGVV 528
Y D++S GV+
Sbjct: 194 RQGYD---AACDIWSLGVL 209
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 45/222 (20%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLA----ELSIIACLR---- 402
+LG+G FG V+ + + A+K R++ E++++ +
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 403 HKNLVQLLGWCAEKGELLLVYEYMPNGS--LDRMLYQDSENGVLLSWYHRL------NIV 454
H +++LL W + +LV E D + +E G L
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI----TEKG-------PLGEGPSRCFF 145
Query: 455 VGLASALTYLHQECEQQVIHRDIKASNIMLDANFN----------ARLESS-FTLTAGTM 503
+ +A+ + H + V+HRDIK NI++D A L +T GT
Sbjct: 146 GQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTR 202
Query: 504 GYLAPEYLQYGT-ATEKTDVFSYGVVVLEVACGRRPIERETE 544
Y PE++ V+S G+++ ++ CG P ER+ E
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 59/233 (25%), Positives = 89/233 (38%), Gaps = 46/233 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK-RSKHSHEGKTEFLA-ELSIIACLRHKNLVQLLG 411
+ LG GA+G V A + AVK E + E+ I L H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 412 WCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVG------LASALTYL 464
E L EY G L DR+ + + L + + YL
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI----EPDI-------GMPEPDAQRFFHQLMAGVVYL 121
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARLESSFTLTA---------------GTMGYLAPE 509
H + HRDIK N++LD N ++ S F L GT+ Y+APE
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKI-SDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 510 YLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY 559
L+ + E DV+S G+V+ + G P ++ ++ DW
Sbjct: 178 LLKRREF--HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKT 226
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 5e-18
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKN 405
F R+LGRG FG V+ ++G + A K+ +G + E I+A + +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 406 LVQLLGWCAE-KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
+V L + E K +L LV M G + +Y E+ + + S L +L
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEYLQ 512
H ++ +I+RD+K N++LD + N R+ + T AGT G++APE L
Sbjct: 306 H---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
D F+ GV + E+ R P E
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 5e-18
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 43/216 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLA-ELSIIACLRHKNLVQL 409
LG G FG V +G AVK R K + E+ + RH ++++L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 410 LGWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVG------LASALT 462
+ + +V EY+ G L D + ++G R+ + + SA+
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYI----CKHG-------RVEEMEARRLFQQILSAVD 125
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTA------------GTMGYLAPEY 510
Y H+ V+HRD+K N++LDA+ NA++ + F L+ G+ Y APE
Sbjct: 126 YCHR---HMVVHRDLKPENVLLDAHMNAKI-ADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181
Query: 511 LQ---YGTATEKTDVFSYGVVVLEVACGRRPIERET 543
+ Y + D++S GV++ + CG P + E
Sbjct: 182 ISGRLYAGP--EVDIWSCGVILYALLCGTLPFDDEH 215
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 6e-18
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKN 405
F R+LG+G FG V ++G + A K+ + +G+ L E I+ + +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSW---YHRLNIVVGLASALT 462
+V L K L LV M G L +Y + G + Y + L
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY-----AAEICCGLE 300
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARL----------ESSFTLT-AGTMGYLAPEYL 511
LH +++++RD+K NI+LD + + R+ E GT+GY+APE +
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNL 551
+ T D ++ G ++ E+ G+ P ++ + K +
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 59/229 (25%), Positives = 89/229 (38%), Gaps = 46/229 (20%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK-RSKHSHEGKTEFLA-ELSIIACLRHKNLVQLLG 411
+ LG GA+G V A + AVK E + E+ I L H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 412 WCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVG------LASALTYL 464
E L EY G L DR+ + + L + + YL
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI----EPDI-------GMPEPDAQRFFHQLMAGVVYL 121
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARLESSFTLTA---------------GTMGYLAPE 509
H + HRDIK N++LD N ++ S F L GT+ Y+APE
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKI-SDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 510 YLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV 555
L+ + E DV+S G+V+ + G P ++ ++ DW
Sbjct: 178 LLKRREF--HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWK 222
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 60/245 (24%), Positives = 95/245 (38%), Gaps = 56/245 (22%)
Query: 332 VPGPREFSYRELRSATRGFHSN-----RILGRGAFGNVYKAYFASSGSVAAVK---RSKH 383
+ P + E +A G +S LG GAFG V+ A VK + K
Sbjct: 3 LEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKV 62
Query: 384 SHEGKTEFLA------ELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQ 437
+ E E++I++ + H N++++L +G LV E +G
Sbjct: 63 LEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-------- 114
Query: 438 DSENGVL---LSWYHRLN------IVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF 488
L + + RL+ I L SA+ YL + +IHRDIK NI++ +F
Sbjct: 115 ----LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDF 167
Query: 489 NARLESSFTLTA------------GTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVA 533
+L F A GT+ Y APE L Y + +++S GV + +
Sbjct: 168 TIKL-IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGP--ELEMWSLGVTLYTLV 224
Query: 534 CGRRP 538
P
Sbjct: 225 FEENP 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 33/202 (16%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG----KTEFLAELSIIACLRHKNLVQLLG 411
+G G++G V+K +G + A+K+ S + K L E+ ++ L+H NLV LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA-LREIRMLKQLKHPNLVNLLE 69
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSEN-GVLLSWYHRLNIVVGLASALTYLHQECEQ 470
K L LV+EY D + + + + + +I A+ + H+
Sbjct: 70 VFRRKRRLHLVFEYC-----DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK---H 121
Query: 471 QVIHRDIKASNIMLDANFN--------ARLESS----FTLTAGTMGYLAPEYL----QYG 514
IHRD+K NI++ + ARL + + T Y +PE L QYG
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 515 TATEKTDVFSYGVVVLEVACGR 536
DV++ G V E+ G
Sbjct: 182 PP---VDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 31/201 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGK-TEFLA--ELSIIACLRHKNLVQLLGW 412
+G G++G V K +G + A+K+ S + K + +A E+ ++ LRH+NLV LL
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSEN-GVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
C +K LV+E++ D + D E L + + + + + + H
Sbjct: 93 CKKKKRWYLVFEFV-----DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS---HN 144
Query: 472 VIHRDIKASNIMLDANFN--------ARLESS----FTLTAGTMGYLAPEYL----QYGT 515
+IHRDIK NI++ + AR ++ + T Y APE L +YG
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGK 204
Query: 516 ATEKTDVFSYGVVVLEVACGR 536
A DV++ G +V E+ G
Sbjct: 205 A---VDVWAIGCLVTEMFMGE 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 42/215 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+ +G+G F V A +G A+K +++ + + E+ I+ L H N+V+L
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 411 GWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVG------LASALTY 463
+ L L+ EY G + D + +G R+ + SA+ Y
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYL----VAHG-------RMKEKEARSKFRQIVSAVQY 129
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTA------------GTMGYLAPEYL 511
HQ ++++HRD+KA N++LDA+ N ++ + F + G Y APE
Sbjct: 130 CHQ---KRIVHRDLKAENLLLDADMNIKI-ADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185
Query: 512 Q---YGTATEKTDVFSYGVVVLEVACGRRPIERET 543
Q Y + DV+S GV++ + G P + +
Sbjct: 186 QGKKY--DGPEVDVWSLGVILYTLVSGSLPFDGQN 218
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLL--- 410
+++G G+FG VY+A SG + A+K+ + K EL I+ L H N+V+L
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 411 ---GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
G ++ L LV +Y+P ++ R+ S L + + L +L Y+H
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS- 174
Query: 468 CEQQVIHRDIKASNIMLDANFN---------AR-LESSFTLTA--GTMGYLAPEYL---- 511
+ HRDIK N++LD + A+ L + + Y APE +
Sbjct: 175 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 232
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPI 539
Y ++ DV+S G V+ E+ +PI
Sbjct: 233 DYTSS---IDVWSAGCVLAEL-LLGQPI 256
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAE---LSIIACLR 402
F +RI+GRG FG VY A +G + A+K +G+T L E LS+++
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 403 HKNLVQLLGWCA--EKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGL 457
+V + A +L + + M G L L Q SE + Y +
Sbjct: 251 CPFIVCM--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF--Y-----AAEI 301
Query: 458 ASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLT-----------AGTMGYL 506
L ++H + V++RD+K +NI+LD + + R+ S L GT GY+
Sbjct: 302 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRI-SDLGLACDFSKKKPHASVGTHGYM 357
Query: 507 APEYLQYGTATEKT-DVFSYGVVVLEVACGRRP 538
APE LQ G A + + D FS G ++ ++ G P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 47/233 (20%), Positives = 86/233 (36%), Gaps = 32/233 (13%)
Query: 335 PREFSYRELRSATRGFH-----SNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT 389
E ++ S ++LG G G V + + +G A+K S + +
Sbjct: 11 GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ 70
Query: 390 EFLAELSIIACLRHKNLVQLLGWC----AEKGELLLVYEYMPNGSL-DRMLYQDSENGVL 444
E ++V +L K LL++ E M G L R+ + +
Sbjct: 71 EVDHHWQ---ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA--- 124
Query: 445 LSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML-DANFNARL----------- 492
+ I+ + +A+ +LH + HRD+K N++ +A L
Sbjct: 125 FTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181
Query: 493 -ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
+++ T Y+APE L + D++S GV++ + CG P T
Sbjct: 182 TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 5e-17
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 35/206 (16%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSK--HSHEGKTEF----LAELSIIACLRHKNLVQL 409
+G G +G V+KA + + A+KR + EG L E+ ++ L+HKN+V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIVRL 66
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
+L LV+E+ D Y DS NG L + + L L + H
Sbjct: 67 HDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGFCHS--- 119
Query: 470 QQVIHRDIKASNIMLD-------ANFN-ARLESS----FTLTAGTMGYLAPEYL----QY 513
+ V+HRD+K N++++ ANF AR ++ T+ Y P+ L Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPI 539
T+ D++S G + E+A RP+
Sbjct: 180 STS---IDMWSAGCIFAELANAGRPL 202
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 52/214 (24%), Positives = 86/214 (40%), Gaps = 31/214 (14%)
Query: 352 SNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSII-ACLRHKNLVQLL 410
++ LG G+F K S AVK E T+ E++ + C H N+V+L
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLH 72
Query: 411 GWCAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHRLNIVVGLASALTYLHQE 467
++ LV E + G L +R+ + SE I+ L SA++++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEA-------SYIMRKLVSAVSHMH-- 123
Query: 468 CEQQVIHRDIKASNIML-DANFNARL--------------ESSFTLTAGTMGYLAPEYLQ 512
+ V+HRD+K N++ D N N + T+ Y APE L
Sbjct: 124 -DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN 182
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRPIERETEGH 546
E D++S GV++ + G+ P +
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL 216
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 46/306 (15%), Positives = 99/306 (32%), Gaps = 55/306 (17%)
Query: 336 REFSYRELRSATRGFHSNRILGRGAFGN-----VYKAYFASSGSVAAVKRSKHSHEGKTE 390
RE RE+++ + H + A+ + + S
Sbjct: 48 REKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDA 107
Query: 391 FLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHR 450
++ + KN V L + K L + + +L + +
Sbjct: 108 PSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR-EHGVC 166
Query: 451 LNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL------------------ 492
L+I + +A A+ +LH + ++HRD+K SNI + ++
Sbjct: 167 LHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 493 ------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGH 546
++ T GT Y++PE + + K D+FS G+++ E+ + E
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERV 280
Query: 547 KMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVF 606
+++ V + ++ + ++ +P + RP
Sbjct: 281 RIITDVR-------NLKFPLLFTQKY------PQEHMMV---QDMLSPSPTERPE---AT 321
Query: 607 QILNNE 612
I+ N
Sbjct: 322 DIIENA 327
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 37/213 (17%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEF-LAELSIIACLRHKN 405
F +ILG G+F V A ++ A+K + H E K + E +++ L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG------LAS 459
V+L + +L Y NG L L + + + S
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGEL---LKY-------IRKIGSFDETCTRFYTAEIVS 141
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFNARL-------------ESSFTLT-AGTMGY 505
AL YLH + +IHRD+K NI+L+ + + ++ + + + GT Y
Sbjct: 142 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 506 LAPEYLQYGTATEKTDVFSYGVVVLEVACGRRP 538
++PE L +A + +D+++ G ++ ++ G P
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 49/202 (24%), Positives = 80/202 (39%), Gaps = 36/202 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---------RSKHSHEGKTEFLAELSIIACLRHK 404
+ LG GA G V A+ + A+K S + E+ I+ L H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
++++ + + + +V E M G L D+++ N L + + A+ Y
Sbjct: 76 CIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNKRLKEATCK-LYFYQMLLAVQY 129
Query: 464 LHQECEQQVIHRDIKASNIMLDANF-NARL------------ESSFTLTA-GTMGYLAPE 509
LH E +IHRD+K N++L + + + E+S T GT YLAPE
Sbjct: 130 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 510 YLQYGTA---TEKTDVFSYGVV 528
L D +S GV+
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVI 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 47/217 (21%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEF--LAELSIIACLRHKNLVQ 408
+LG G++G V + + + AVK + K E E+ ++ LRHKN++Q
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 409 LLG--WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG------LASA 460
L+ + EK ++ +V EY G + + R + L
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQAHGYFCQLIDG 121
Query: 461 LTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTA---------------GTMGY 505
L YLH Q ++H+DIK N++L ++ S+ + G+ +
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKI-SALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 506 LAPEYLQ----YGTATEKTDVFSYGVVVLEVACGRRP 538
PE + K D++S GV + + G P
Sbjct: 178 QPPEIANGLDTFSGF--KVDIWSAGVTLYNITTGLYP 212
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 28/199 (14%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA--ELSIIACLRHKNLVQLLGWC 413
LG G + VYK + ++ A+K + HE A E+S++ L+H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+ L LV+EY+ D Y D G +++ ++ + L L Y H+ Q+V+
Sbjct: 70 HTEKSLTLVFEYL---DKDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHR---QKVL 122
Query: 474 HRDIKASNIMLD-------ANFN-ARLESS----FTLTAGTMGYLAPEYL----QYGTAT 517
HRD+K N++++ A+F AR +S + T+ Y P+ L Y T
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQ- 181
Query: 518 EKTDVFSYGVVVLEVACGR 536
D++ G + E+A GR
Sbjct: 182 --IDMWGVGCIFYEMATGR 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 43/216 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLA-ELSIIACLRHKNLVQL 409
LG G FG V +G AVK R K + E+ + RH ++++L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 410 LGWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVG------LASALT 462
+ ++ +V EY+ G L D + +NG RL+ + S +
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYI----CKNG-------RLDEKESRRLFQQILSGVD 130
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTA------------GTMGYLAPEY 510
Y H+ V+HRD+K N++LDA+ NA++ + F L+ G+ Y APE
Sbjct: 131 YCHR---HMVVHRDLKPENVLLDAHMNAKI-ADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186
Query: 511 LQ---YGTATEKTDVFSYGVVVLEVACGRRPIERET 543
+ Y + D++S GV++ + CG P + +
Sbjct: 187 ISGRLYAGP--EVDIWSSGVILYALLCGTLPFDDDH 220
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 46/218 (21%), Positives = 85/218 (38%), Gaps = 46/218 (21%)
Query: 355 ILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSII-ACLRHKNLVQLLGW 412
+LG GA V + AVK K ++ E+ ++ C H+N+++L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 413 CAEKGELLLVYEYMPNGSL-DRMLYQD--SENGVLLSWYHR--LNIVVGLASALTYLHQE 467
E+ LV+E M GS+ + + +E +V +ASAL +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNE---------LEASVVVQDVASALDFLH-- 128
Query: 468 CEQQVIHRDIKASNIML----------------------DANFNARLESSFTLTAGTMGY 505
+ + HRD+K NI+ + + + G+ Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 506 LAPEYLQYGTATEKT-----DVFSYGVVVLEVACGRRP 538
+APE ++ + D++S GV++ + G P
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 45/206 (21%), Positives = 82/206 (39%), Gaps = 32/206 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSII-ACLRHKNLVQLLG 411
++LG G G V + + + A+K + E+ + + ++V+++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVD 122
Query: 412 WC----AEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
A + LL+V E + G L R+ + + + I+ + A+ YLH
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLH- 178
Query: 467 ECEQQVIHRDIKASNIML-DANFNARL-------------ESSFTLTAGTMGYLAPEYLQ 512
+ HRD+K N++ NA L +S T T Y+APE L
Sbjct: 179 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRP 538
+ D++S GV++ + CG P
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 44/227 (19%)
Query: 335 PREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAE 394
RE +Y + ++G G+FG V++A S V A+K+ K E
Sbjct: 37 QREIAYTNCK----------VIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFK---NRE 82
Query: 395 LSIIACLRHKNLVQLL------GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWY 448
L I+ ++H N+V L G ++ L LV EY+P ++ R ++ +
Sbjct: 83 LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPML 141
Query: 449 HRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN---------AR-LESSFTL 498
+ L +L Y+H + HRDIK N++LD A+ L +
Sbjct: 142 LIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 499 TA--GTMGYLAPEYL----QYGTATEKTDVFSYGVVVLEVACGRRPI 539
+ + Y APE + Y T D++S G V+ E+ +P+
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTN---IDIWSTGCVMAEL-MQGQPL 241
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 41/208 (19%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSK--HSHEGKTEF----LAELSIIACLRHKNLVQL 409
LG G +G VYKA + A+KR + H EG + E+S++ L+H+N+++L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG---VPGTAIREVSLLKELQHRNIIEL 98
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
L L++EY D Y D +S + + L + + + H
Sbjct: 99 KSVIHHNHRLHLIFEYA---ENDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHS--- 150
Query: 470 QQVIHRDIKASNIMLDANFN-------------ARLESS----FTLTAGTMGYLAPEYL- 511
++ +HRD+K N++L + AR FT T+ Y PE L
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILL 210
Query: 512 ---QYGTATEKTDVFSYGVVVLEVACGR 536
Y T+ D++S + E+
Sbjct: 211 GSRHYSTS---VDIWSIACIWAEMLMKT 235
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 38/212 (17%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSK--HSHEGKTEF----LAELSI---IACLRHKNL 406
+G GA+G VYKA SG A+K + + G + E+++ + H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 407 VQLL-----GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASAL 461
V+L+ + ++ LV+E++ D Y D L +++ L
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 462 TYLHQECEQQVIHRDIKASNIMLD-------ANFN-AR---LESSFTLTAGTMGYLAPEY 510
+LH ++HRD+K NI++ A+F AR + + T T+ Y APE
Sbjct: 134 DFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEV 190
Query: 511 L---QYGTATEKTDVFSYGVVVLEVACGRRPI 539
L Y T D++S G + E+ R+P+
Sbjct: 191 LLQSTYATP---VDMWSVGCIFAEMFR-RKPL 218
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 44/219 (20%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTE---FLAELSIIACLRHKN 405
F +++GRGAFG V ++ V A+K +K + E F E ++ K
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 406 LVQLLGWCA--EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG------L 457
+ L A + L LV +Y G L +L + RL + +
Sbjct: 136 ITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFE---------DRLPEEMARFYLAEM 184
Query: 458 ASALTYLHQECEQQVIHRDIKASNIMLDANFNARL------------ESSFTLTA-GTMG 504
A+ +HQ +HRDIK NI++D N + RL + + A GT
Sbjct: 185 VIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 505 YLAPEYLQYGTATEKT-----DVFSYGVVVLEVACGRRP 538
Y++PE LQ + D +S GV + E+ G P
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 52/247 (21%), Positives = 90/247 (36%), Gaps = 78/247 (31%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLA----------------- 393
+G+G++G V AY + + A+K + K +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 394 -------ELSIIACLRHKNLVQLLG--WCAEKGELLLVYEYMPNGSL-D----------- 432
E++I+ L H N+V+L+ + L +V+E + G + +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 433 -RMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN-- 489
R +QD L + YLH Q++IHRDIK SN+++ + +
Sbjct: 139 ARFYFQD------------------LIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIK 177
Query: 490 -------ARLESSFTL---TAGTMGYLAPEYLQYGTAT---EKTDVFSYGVVVLEVACGR 536
+ S L T GT ++APE L + DV++ GV + G+
Sbjct: 178 IADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
Query: 537 RPIERET 543
P E
Sbjct: 238 CPFMDER 244
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 49/214 (22%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEF------LAELSIIACLRHKNLVQL 409
LG G F VYKA ++ + A+K+ K H + + L E+ ++ L H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLL-----SWYHRLNIVVGLASALTYL 464
L K + LV+++M D + + VL ++ L YL
Sbjct: 78 LDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLM------TLQGLEYL 128
Query: 465 HQECEQQVIHRDIKASNIMLDANFN--------ARLESSF-----TLTAG--TMGYLAPE 509
HQ ++HRD+K +N++LD N A+ SF T T Y APE
Sbjct: 129 HQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK---SFGSPNRAYTHQVVTRWYRAPE 182
Query: 510 YL----QYGTATEKTDVFSYGVVVLEVACGRRPI 539
L YG D+++ G ++ E+ R P
Sbjct: 183 LLFGARMYGVG---VDMWAVGCILAEL-LLRVPF 212
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 44/216 (20%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLA-ELSIIACLRHKNLVQL 409
LG G+FG V A + A+K R + E+S + LRH ++++L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 410 LGWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVG------LASALT 462
++++V EY G L D + E R+ G + A+
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYI----VEKK-------RMTEDEGRRFFQQIICAIE 122
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTA------------GTMGYLAPEY 510
Y H+ +++HRD+K N++LD N N ++ + F L+ G+ Y APE
Sbjct: 123 YCHR---HKIVHRDLKPENLLLDDNLNVKI-ADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178
Query: 511 LQ---YGTATEKTDVFSYGVVVLEVACGRRPIERET 543
+ Y + DV+S G+V+ + GR P + E
Sbjct: 179 INGKLYAGP--EVDVWSCGIVLYVMLVGRLPFDDEF 212
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTE---FLAELSIIACLRHKN 405
+ +++GRGAFG V S+ V A+K SK +++ F E I+A
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 406 LVQLLGWCA--EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG------L 457
+VQL + A + L +V EYMP G L ++ + + +
Sbjct: 131 VVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEV 177
Query: 458 ASALTYLHQECEQQVIHRDIKASNIMLDANFNARL------------ESSFTLTA-GTMG 504
AL +H IHRD+K N++LD + + +L TA GT
Sbjct: 178 VLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 505 YLAPEYLQ-------YGTATEKTDVFSYGVVVLEVACGRRP 538
Y++PE L+ YG D +S GV + E+ G P
Sbjct: 235 YISPEVLKSQGGDGYYGRE---CDWWSVGVFLYEMLVGDTP 272
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 54/216 (25%), Positives = 79/216 (36%), Gaps = 45/216 (20%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+ +G G FG + + AVK R E + E+ LRH N+V+
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQ--REIINHRSLRHPNIVRFK 82
Query: 411 GWCAEKGELLLVYEYMPNGSL-DRMLYQDSENGVLLSWYHRLNIVVG------LASALTY 463
L ++ EY G L +R+ G R + L S ++Y
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERI----CNAG-------RFSEDEARFFFQQLLSGVSY 131
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARLE-SSFTLTA------------GTMGYLAPEY 510
H Q+ HRD+K N +LD + RL+ F + GT Y+APE
Sbjct: 132 CHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188
Query: 511 LQ---YGTATEKTDVFSYGVVVLEVACGRRPIERET 543
L Y DV+S GV + + G P E
Sbjct: 189 LLRQEYDGK--IADVWSCGVTLYVMLVGAYPFEDPE 222
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253 | Back alignment and structure |
|---|
Score = 74.9 bits (183), Expect = 4e-15
Identities = 37/232 (15%), Positives = 69/232 (29%), Gaps = 33/232 (14%)
Query: 28 DFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTS 87
S ++ G + L + + LT + S GS+ + P +
Sbjct: 18 GVGSSSMPLWDFQGSTILTSQYVRLTPD---ERSKEGSIWNHQPCFL--------KDWEM 66
Query: 88 RFSFSINNVNPSS-FGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLD 146
F ++ + GDG+A + + D + G G + +AI DT +
Sbjct: 67 HVHFKVHGTGKKNLHGDGIALWYTRDRLVPGPVFGSKDNFHG--------LAIFLDTYPN 118
Query: 147 PHFDDPDENHIGLDI--DSLESIKTADPILQGID------LKSGNVITAWIDYKNDLRML 198
+ +I + + SL + D + + + Y L
Sbjct: 119 DETTERVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADFRNRDHDTFLAVRYSRG--RL 176
Query: 199 KVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSF 250
V + + + L Y G SA T ++ H I S
Sbjct: 177 TVMTDLEDKNEWKNCIDIT---GVRLPTGYYFGASAGTGDLSDNHDIISMKL 225
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 62/232 (26%), Positives = 95/232 (40%), Gaps = 50/232 (21%)
Query: 341 RELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTE---FLAELS 396
+E+R F +++GRGAF V +G V A+K +K + E F E
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 397 IIACLRHKNLVQLLGWCA--EKGELLLVYEYMPNGSLDRMLYQDSENGVLLS-----WYH 449
++ + + QL A ++ L LV EY G L L S+ G + +Y
Sbjct: 114 VLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDL---LTLLSKFGERIPAEMARFY- 167
Query: 450 RLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL------------ESSFT 497
+ + A+ +H+ +HRDIK NI+LD + RL + +
Sbjct: 168 ----LAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220
Query: 498 LTA-GTMGYLAPEYLQ----------YGTATEKTDVFSYGVVVLEVACGRRP 538
L A GT YL+PE LQ YG D ++ GV E+ G+ P
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPE---CDWWALGVFAYEMFYGQTP 269
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 31/203 (15%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA--ELSIIACLRHKNLVQLLGWC 413
LG G + VYK ++G A+K K E T A E+S++ L+H+N+V+L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG----LASALTYLHQECE 469
+ +L LV+E+M D Y DS LN+V L L + H+
Sbjct: 73 HTENKLTLVFEFM---DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--- 126
Query: 470 QQVIHRDIKASNIMLD-------ANFN-ARLESS----FTLTAGTMGYLAPEYL----QY 513
+++HRD+K N++++ +F AR F+ T+ Y AP+ L Y
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 514 GTATEKTDVFSYGVVVLEVACGR 536
T+ D++S G ++ E+ G+
Sbjct: 187 STS---IDIWSCGCILAEMITGK 206
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 55/219 (25%), Positives = 85/219 (38%), Gaps = 29/219 (13%)
Query: 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRH 403
R F R+ G+G FG V S+G A+K+ + L + +A L H
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHH 78
Query: 404 KNLVQLL-----GWCAEKGE--LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG 456
N+VQL ++ + L +V EY+P+ +L R V +
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 457 LASALTYLHQECEQQVIHRDIKASNIMLDANFN---------AR-LESSFTLTA--GTMG 504
L ++ LH V HRDIK N++++ A+ L S A +
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 505 YLAPEYL----QYGTATEKTDVFSYGVVVLEVACGRRPI 539
Y APE + Y TA D++S G + E+ PI
Sbjct: 197 YRAPELIFGNQHYTTA---VDIWSVGCIFAEM-MLGEPI 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 51/212 (24%), Positives = 82/212 (38%), Gaps = 40/212 (18%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE----FLAELSIIACLRHKN 405
F + LG G+FG V SG+ A+K K + L E I+ +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG------LAS 459
LV+L + L +V EY+ G + L + R + +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----------GRFSEPHARFYAAQIVL 152
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFNARL----------ESSFTLTAGTMGYLAPE 509
YLH +I+RD+K N+++D ++ ++TL GT LAPE
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-CGTPEALAPE 208
Query: 510 YLQ---YGTATEKTDVFSYGVVVLEVACGRRP 538
+ Y A D ++ GV++ E+A G P
Sbjct: 209 IILSKGYNKA---VDWWALGVLIYEMAAGYPP 237
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 36/203 (17%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSK--HSHEGKTEF----LAELSIIACLRHKNLVQL 409
+G G +G VYKA + G A+K+ + EG + E+SI+ L+H N+V+L
Sbjct: 10 IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEG---IPSTTIREISILKELKHSNIVKL 65
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
K L+LV+E++ D D G L S + ++ L + + Y H
Sbjct: 66 YDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLES-VTAKSFLLQLLNGIAYCHD--- 118
Query: 470 QQVIHRDIKASNIMLD-------ANFN-ARLESS----FTLTAGTMGYLAPEYL----QY 513
++V+HRD+K N++++ A+F AR +T T+ Y AP+ L +Y
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 514 GTATEKTDVFSYGVVVLEVACGR 536
T D++S G + E+ G
Sbjct: 179 STT---IDIWSVGCIFAEMVNGT 198
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 61/211 (28%), Positives = 87/211 (41%), Gaps = 22/211 (10%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEF---LAELSIIACLRHKN 405
F ++LG+G FG V ++G A+K K K E L E ++ RH
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
L L L V EY G L + S V R + SAL YLH
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYG-AEIVSALDYLH 265
Query: 466 QECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEYLQY 513
E+ V++RD+K N+MLD + + ++ + + T GT YLAPE L+
Sbjct: 266 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPIERETE 544
D + GVV+ E+ CGR P +
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 48/218 (22%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSK--HSHEGKTEF----LAELSIIACLRHKNLVQL 409
+G+G FG V+KA +G A+K+ + EG F L E+ I+ L+H+N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNL 81
Query: 410 LGWCAEK--------GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASAL 461
+ C K G + LV+++ D + V + ++ L + L
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGL 137
Query: 462 TYLHQECEQQVIHRDIKASNIMLD-------ANFN-ARL------ESSFTLTAG--TMGY 505
Y+H+ +++HRD+KA+N+++ A+F AR T T+ Y
Sbjct: 138 YYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 506 LAPEYL----QYGTATEKTDVFSYGVVVLEVACGRRPI 539
PE L YG D++ G ++ E+ R PI
Sbjct: 195 RPPELLLGERDYGPP---IDLWGAGCIMAEM-WTRSPI 228
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 35/215 (16%)
Query: 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKR-----SKHSHEGKTEFLAELSIIACL 401
+ + + + +G GA G V AY A A+K+ +H + EL ++ C+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCV 118
Query: 402 RHKNLVQLL------GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVV 455
HKN++ LL E ++ LV E M +L +++ + L ++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME------LDHERMSYLLY 171
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDAN-------FN-AR-LESSFTLT--AGTMG 504
+ + +LH +IHRD+K SNI++ ++ F AR +SF +T T
Sbjct: 172 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 505 YLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPI 539
Y APE + E D++S G ++ E+ + +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKIL 262
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 40/212 (18%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE----FLAELSIIACLRHKN 405
F R LG G+FG V+ +G A+K K + + E +++ + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG------LAS 459
++++ G + ++ ++ +Y+ G L L R V +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGEL--FSL--------LRKSQRFPNPVAKFYAAEVCL 117
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFNARL----------ESSFTLTAGTMGYLAPE 509
AL YLH + +I+RD+K NI+LD N + ++ + ++TL GT Y+APE
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-CGTPDYIAPE 173
Query: 510 YLQ---YGTATEKTDVFSYGVVVLEVACGRRP 538
+ Y + D +S+G+++ E+ G P
Sbjct: 174 VVSTKPYNKS---IDWWSFGILIYEMLAGYTP 202
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 40/198 (20%), Positives = 76/198 (38%), Gaps = 37/198 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSI-IACLRHKNLVQLLG 411
++LG G G V + + + A+K + E+ + + ++V+++
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVD 78
Query: 412 WC----AEKGELLLVYEYMPNGSL-DRMLYQD----SENGVLLSWYHRLNIVVGLASALT 462
A + LL+V E + G L R+ + +E I+ + A+
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA-------SEIMKSIGEAIQ 131
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAGTMGYLAPEYLQ--YGTATEKT 520
YLH + HRD+K N++ + + L G A E Y +
Sbjct: 132 YLH---SINIAHRDVKPENLLYTSK-----RPNAILKLTDFG-FAKETTGEKYD---KSC 179
Query: 521 DVFSYGVVVLEVACGRRP 538
D++S GV++ + CG P
Sbjct: 180 DMWSLGVIMYILLCGYPP 197
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 46/215 (21%), Positives = 86/215 (40%), Gaps = 36/215 (16%)
Query: 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKR-----SKHSHEGKTEFLAELSIIACL 401
+ + S +G GA+G+V A SG A+K+ + EL ++ +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA--YRELLLLKHM 80
Query: 402 RHKNLVQLL------GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVV 455
+H+N++ LL + LV +M L +++ S +V
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK------FSEEKIQYLVY 133
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDAN-------FN-ARLESSFTLTA--GTMGY 505
+ L Y+H V+HRD+K N+ ++ + F AR + +T T Y
Sbjct: 134 QMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVVTRWY 189
Query: 506 LAPE-YLQYGTATEKTDVFSYGVVVLEVACGRRPI 539
APE L + + D++S G ++ E+ + +
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEML-TGKTL 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 36/203 (17%)
Query: 356 LGRGAFGNVYKAYFASSGSVAAVKRSK--HSHEGKTEF----LAELSIIACLRHKNLVQL 409
+G G +G VYKA S G + A+KR + EG + E+S++ L H N+V L
Sbjct: 29 VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEG---IPSTAIREISLLKELHHPNIVSL 84
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
+ + L LV+E+M D D L + L + + HQ
Sbjct: 85 IDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQD-SQIKIYLYQLLRGVAHCHQ--- 137
Query: 470 QQVIHRDIKASNIMLD-------ANFN-ARLESS----FTLTAGTMGYLAPEYL----QY 513
+++HRD+K N++++ A+F AR +T T+ Y AP+ L +Y
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 514 GTATEKTDVFSYGVVVLEVACGR 536
T+ D++S G + E+ G+
Sbjct: 198 STS---VDIWSIGCIFAEMITGK 217
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 45/215 (20%), Positives = 83/215 (38%), Gaps = 39/215 (18%)
Query: 356 LGRGAFGNVYKAYFAS--SGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+GRG +G+VYKA A+K+ + + + E++++ L+H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQKVF 87
Query: 414 AEKGE--LLLVYEYMPN---GSLDRMLYQDSEN-GVLLSWYHRLNIVVGLASALTYLHQE 467
+ + L+++Y + + + V L +++ + + YLH
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA- 146
Query: 468 CEQQVIHRDIKASNIMLDANFNAR---------LESSF-----TLTAG-----TMGYLAP 508
V+HRD+K +NI++ R F L T Y AP
Sbjct: 147 --NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 509 EYL----QYGTATEKTDVFSYGVVVLEVACGRRPI 539
E L Y A D+++ G + E+ PI
Sbjct: 205 ELLLGARHYTKA---IDIWAIGCIFAEL-LTSEPI 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 35/215 (16%)
Query: 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKR-----SKHSHEGKTEFLAELSIIACL 401
+ + + + +G GA G V AY A A+K+ +H + EL ++ C+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCV 81
Query: 402 RHKNLVQLL------GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVV 455
HKN++ LL E ++ +V E M +L +++ + L ++
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME------LDHERMSYLLY 134
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDANFN--------AR-LESSFTLT--AGTMG 504
+ + +LH +IHRD+K SNI++ ++ AR +SF +T T
Sbjct: 135 QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 505 YLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPI 539
Y APE + E D++S G ++ E+ +
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVL 225
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 63/217 (29%), Positives = 91/217 (41%), Gaps = 35/217 (16%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEF---LAELSIIACLRHKN 405
F ++LG+G FG V ++G A+K K K E + E ++ RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLASALT 462
L L L V EY G L L ++ +E Y + SAL
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF--Y-----GAEIVSALE 119
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEY 510
YLH + V++RDIK N+MLD + + ++ + + T GT YLAPE
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 511 LQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
L+ YG A D + GVV+ E+ CGR P +
Sbjct: 177 LEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQDH 210
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA-----ELSIIACL 401
+ + +G GA+G+V A+ +G AVK K S ++ A EL ++ +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 402 RHKNLVQLL------GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVV 455
+H+N++ LL E ++ LV M L+ ++ L+ H ++
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK-----LTDDHVQFLIY 139
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDAN-------FN-ARLESSF-TLTAGTMGYL 506
+ L Y+H +IHRD+K SN+ ++ + F AR + T T Y
Sbjct: 140 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYR 196
Query: 507 APE-YLQYGTATEKTDVFSYGVVVLEVACGRRPI 539
APE L + + D++S G ++ E+ R +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTL 229
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 41/215 (19%)
Query: 350 FHSNRILGRGAFGNVY---KAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRH 403
F ++LG+G+FG V+ K + + + A+K K + + E I+ + H
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 404 KNLVQLLGWCA--EKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLA 458
+V+L A +G+L L+ +++ G L L ++ +E V Y + LA
Sbjct: 86 PFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF--Y-----LAELA 136
Query: 459 SALTYLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYL 506
AL +LH +I+RD+K NI+LD + +L + GT+ Y+
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 193
Query: 507 APEYLQ---YGTATEKTDVFSYGVVVLEVACGRRP 538
APE + + + D +S+GV++ E+ G P
Sbjct: 194 APEVVNRRGHTQS---ADWWSFGVLMFEMLTGTLP 225
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 42/213 (19%)
Query: 356 LGRGAFGNVYKAY-FASSGSVAAVKRSK--HSHEGKTEF----LAELSIIACLR---HKN 405
+G GA+G V+KA + G A+KR + EG + E++++ L H N
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPN 75
Query: 406 LVQLL-----GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASA 460
+V+L + +L LV+E++ D Y D + +++ L
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 461 LTYLHQECEQQVIHRDIKASNIMLD-------ANFN-AR---LESSFTLTAGTMGYLAPE 509
L +LH +V+HRD+K NI++ A+F AR + + T T+ Y APE
Sbjct: 133 LDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 189
Query: 510 YL---QYGTATEKTDVFSYGVVVLEVACGRRPI 539
L Y T D++S G + E+ R+P+
Sbjct: 190 VLLQSSYATP---VDLWSVGCIFAEMFR-RKPL 218
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 33/214 (15%)
Query: 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA-----ELSIIACL 401
+ + +G GA+G V A +G+ A+K K ++E A EL ++ +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHM 81
Query: 402 RHKNLVQLL------GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVV 455
RH+N++ LL + + LV +M L +++ + L +V
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK-----LGEDRIQFLVY 135
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDAN-------FN-ARLESSF-TLTAGTMGYL 506
+ L Y+H +IHRD+K N+ ++ + F AR S T T Y
Sbjct: 136 QMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYR 192
Query: 507 APEY-LQYGTATEKTDVFSYGVVVLEVACGRRPI 539
APE L + T+ D++S G ++ E+ + +
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTL 225
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 8e-13
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 24/212 (11%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSK----HSHEGKTEFLAELSIIAC-LRHK 404
F+ +LG+G+FG V + + + AVK K + + E ++A +
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
L QL L V EY+ G L +Y + G + +A L +L
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVF-YAAEIAIGLFFL 458
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEYLQ 512
+ +I+RD+K N+MLD+ + ++ + T T GT Y+APE +
Sbjct: 459 Q---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 515
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
Y + D +++GV++ E+ G+ P E E E
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 46/205 (22%), Positives = 79/205 (38%), Gaps = 34/205 (16%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HKNLVQLLG- 411
R LGRG + V++A ++ VK K + K E+ I+ LR N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI--KREIKILENLRGGPNIITLADI 99
Query: 412 -WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
LV+E++ N + LYQ L+ Y + + AL Y H
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQ-LYQT------LTDYDIRFYMYEILKALDYCHS---M 149
Query: 471 QVIHRDIKASNIMLDANFN---------ARL---ESSFTLTAGTMGYLAPE----YLQYG 514
++HRD+K N+M+D A + + + + PE Y Y
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 209
Query: 515 TATEKTDVFSYGVVVLEVACGRRPI 539
+ D++S G ++ + + P
Sbjct: 210 YS---LDMWSLGCMLASMIFRKEPF 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 49/214 (22%), Positives = 82/214 (38%), Gaps = 36/214 (16%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAA--VKRSKHSHEGKTEF---------LAELSIIACLR 402
R + G++G V + VA V + L E+ ++
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 403 HKNLVQLL-----GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGL 457
H N++ L +L LV E M L ++++ +++S H + +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD---QRIVISPQHIQYFMYHI 143
Query: 458 ASALTYLHQECEQQVIHRDIKASNIMLDAN-------FN-AR-LESSFTLTA--GTMGYL 506
L LH E V+HRD+ NI+L N FN AR + T Y
Sbjct: 144 LLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR 200
Query: 507 APEY-LQYGTATEKTDVFSYGVVVLEVACGRRPI 539
APE +Q+ T+ D++S G V+ E+ R+ +
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMF-NRKAL 233
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 32/144 (22%), Positives = 63/144 (43%), Gaps = 20/144 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA-----ELSIIACLRHKNLVQ 408
++G G++G+V +AY V A+K K + E++I+ L H ++V+
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLNHDHVVK 116
Query: 409 LL-----GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
+L + EL +V E D + V L+ H ++ L + Y
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171
Query: 464 LHQECEQQVIHRDIKASNIMLDAN 487
+H ++HRD+K +N +++ +
Sbjct: 172 VH---SAGILHRDLKPANCLVNQD 192
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 50/240 (20%), Positives = 94/240 (39%), Gaps = 65/240 (27%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLL--- 410
+ LG G+FG V + + SG A+K K + + + EL I+ L H N+++L+
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALK--KVLQDPRYK-NRELDIMKVLDHVNIIKLVDYF 69
Query: 411 -----------------------------------GWCAEKGELLLVYEYMPNGSLDRML 435
++ L ++ EY+P+ +L ++L
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVL 128
Query: 436 YQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN------ 489
+G + + L A+ ++H + HRDIK N+++++ N
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 490 ---AR-LESSFTLTA--GTMGYLAPEYL----QYGTATEKTDVFSYGVVVLEVACGRRPI 539
A+ L S A + Y APE + +Y + D++S G V E+ +P+
Sbjct: 186 FGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPS---IDLWSIGCVFGEL-ILGKPL 241
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 43/213 (20%)
Query: 354 RILGRGAFGNVY---KAYFASSGSVAAVK--RSKHSHEGKTEF---LAELSIIACLRHKN 405
R+LG+G +G V+ K A++G + A+K + + AE +I+ ++H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 406 LVQLLGWCA--EKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLASA 460
+V L+ A G+L L+ EY+ G L L ++ E+ Y + ++ A
Sbjct: 83 IVDLI--YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF--Y-----LAEISMA 133
Query: 461 LTYLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAP 508
L +LH ++ +I+RD+K NIML+ + +L + + T T GT+ Y+AP
Sbjct: 134 LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 509 EYLQ---YGTATEKTDVFSYGVVVLEVACGRRP 538
E L + A D +S G ++ ++ G P
Sbjct: 191 EILMRSGHNRA---VDWWSLGALMYDMLTGAPP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGK--TEFLAELSIIA-CLRHK 404
F R+LG+G+FG V A +G + AVK + + + E I++ H
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
L QL L V E++ G L ++ ++ R + SAL +L
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARF-YAAEIISALMFL 140
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEYLQ 512
H ++ +I+RD+K N++LD + +L T T GT Y+APE LQ
Sbjct: 141 H---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197
Query: 513 ---YGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
YG A D ++ GV++ E+ CG P E E E
Sbjct: 198 EMLYGPA---VDWWAMGVLLYEMLCGHAPFEAENE 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 49/223 (21%), Positives = 79/223 (35%), Gaps = 52/223 (23%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+ LG G G V+ A A+K+ + L E+ II L H N+V++
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA--LREIKIIRRLDHDNIVKVF 74
Query: 411 --------------GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVG 456
G E + +V EYM L +L Q L H +
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP-----LLEEHARLFMYQ 128
Query: 457 LASALTYLHQECEQQVIHRDIKASNIMLDAN--------FN-ARLESSFTLTAGTMG--- 504
L L Y+H V+HRD+K +N+ ++ F AR+ G +
Sbjct: 129 LLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 505 ----YLAPEYL----QYGTATEKTDVFSYGVVVLEVACGRRPI 539
Y +P L Y A D+++ G + E+ + +
Sbjct: 186 VTKWYRSPRLLLSPNNYTKA---IDMWAAGCIFAEML-TGKTL 224
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 37/218 (16%)
Query: 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKR----SKHSHEGKTEFLAELSIIACLR 402
+ + +G GA+G V AY + A+K+ ++ +T L E+ I+ R
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFR 83
Query: 403 HKNLVQLL-----GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGL 457
H+N++ + + ++ +V + M L ++L LS H + +
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH-----LSNDHICYFLYQI 137
Query: 458 ASALTYLHQECEQQVIHRDIKASNIMLDAN-------FN-ARLESSFTLTAGTMG----- 504
L Y+H V+HRD+K SN++L+ F AR+ G +
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 505 --YLAPEY-LQYGTATEKTDVFSYGVVVLEVACGRRPI 539
Y APE L T+ D++S G ++ E+ RPI
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPI 231
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE----FLAELSIIAC-LRHK 404
F+ +LG+G+FG V + + + AVK K + + + E ++A +
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
L QL L V EY+ G L +Y + G + +A L +L
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVF-YAAEIAIGLFFL 137
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEYLQ 512
+ +I+RD+K N+MLD+ + ++ + T T GT Y+APE +
Sbjct: 138 Q---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
Y + D +++GV++ E+ G+ P E E E
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 28/214 (13%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEF---LAELSIIA-CLRHK 404
F +++LG+G+FG V+ A F + A+K K + + E +++ H
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 405 NLVQLLGWCA--EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
L + +C K L V EY+ G L +Y + L
Sbjct: 79 FLTHM--FCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATF-YAAEIILGLQ 132
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEY 510
+LH + +++RD+K NI+LD + + ++ + T T GT Y+APE
Sbjct: 133 FLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 511 LQYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
L D +S+GV++ E+ G+ P + E
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 34/144 (23%), Positives = 65/144 (45%), Gaps = 20/144 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLA-----ELSIIACLRHKNLVQ 408
++GRG++G VY AY ++ A+K K + + E++I+ L+ +++
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKSDYIIR 89
Query: 409 LL-----GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
L + EL +V E D L + + + L+ H I+ L +
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 464 LHQECEQQVIHRDIKASNIMLDAN 487
+H E +IHRD+K +N +L+ +
Sbjct: 145 IH---ESGIIHRDLKPANCLLNQD 165
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 8e-11
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 24/206 (11%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGK--TEFLAELSIIA-CLRHK 404
F R++GRG++ V + + A+K + + ++ + E + H
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
LV L + L V EY+ G L ++ L + R ++ AL YL
Sbjct: 71 FLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNYL 126
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPEYLQ 512
H E+ +I+RD+K N++LD+ + +L T T GT Y+APE L+
Sbjct: 127 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 183
Query: 513 YGTATEKTDVFSYGVVVLEVACGRRP 538
D ++ GV++ E+ GR P
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 47/224 (20%)
Query: 354 RILGRGAFGNVY---KAYFASSGSVAAVKR-SKHSHEGKTEF----LAELSIIACLRHKN 405
++LG GA+G V+ K +G + A+K K + K + E ++ +R
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 406 -LVQLLGWCA--EKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLAS 459
LV L A + +L L+ +Y+ G L L Q +E+ V Y V +
Sbjct: 120 FLVTL--HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV--QIY-----VGEIVL 170
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFNARL------------ESSFTLT-AGTMGYL 506
AL +LH + +I+RDIK NI+LD+N + L E+ GT+ Y+
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 507 APEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERETEG 545
AP+ ++ + A D +S GV++ E+ G P + E
Sbjct: 228 APDIVRGGDSGHDKA---VDWWSLGVLMYELLTGASPFTVDGEK 268
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 30/209 (14%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGK--TEFLAELSIIA-CLRHK 404
F R++GRG++ V + + A++ + + ++ + E + H
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLASAL 461
LV L + L V EY+ G L + + E Y ++ AL
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF--Y-----SAEISLAL 166
Query: 462 TYLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLAPE 509
YLH E+ +I+RD+K N++LD+ + +L T T GT Y+APE
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 510 YLQYGTATEKTDVFSYGVVVLEVACGRRP 538
L+ D ++ GV++ E+ GR P
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 56/225 (24%), Positives = 91/225 (40%), Gaps = 58/225 (25%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR----SKHSHEGKTEFLAELSIIACLRHKNLVQL 409
+LG GA+G V A +G + A+K+ K +T L E+ I+ +H+N++ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT--LREIKILKHFKHENIITI 74
Query: 410 L-----GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL----LSWYHRLNIVVGLASA 460
E+ ++ E M L++ V+ LS H + A
Sbjct: 75 FNIQRPDSFENFNEVYIIQELM-----QTDLHR-----VISTQMLSDDHIQYFIYQTLRA 124
Query: 461 LTYLHQECEQQVIHRDIKASNIMLDAN-------FN-ARLESSFTLTAG----------- 501
+ LH VIHRD+K SN+++++N F AR+
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 502 ---TMGYLAPEYL----QYGTATEKTDVFSYGVVVLEVACGRRPI 539
T Y APE + +Y A DV+S G ++ E+ RRPI
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRA---MDVWSCGCILAELF-LRRPI 222
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 40/214 (18%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEF---LAELSIIA-CLRHK 404
FH +++G+G+FG V A + AVK K + K E ++E +++ ++H
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 405 NLVQLLGWCA--EKGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLAS 459
LV L + +L V +Y+ G L L ++ E Y +AS
Sbjct: 100 FLVGLH--FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF--Y-----AAEIAS 150
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLT-AGTMGYLA 507
AL YLH +++RD+K NI+LD+ + L +S T T GT YLA
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLA 207
Query: 508 PEYLQ---YGTATEKTDVFSYGVVVLEVACGRRP 538
PE L Y D + G V+ E+ G P
Sbjct: 208 PEVLHKQPYDRT---VDWWCLGAVLYEMLYGLPP 238
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 41/216 (18%), Positives = 83/216 (38%), Gaps = 41/216 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR----------- 402
R LG G F V+ A + + A+K + E+ ++ +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 403 HKNLVQLLGWCAEKGE----LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLA 458
++++LL KG +++V+E + +L ++ + G+ L + + I L
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQLL 141
Query: 459 SALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS---------------FTLTAGTM 503
L Y+H+ C +IH DIK N++++ + +T + T
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 504 GYLAPE---YLQYGTATEKTDVFSYGVVVLEVACGR 536
Y +PE +G D++S ++ E+ G
Sbjct: 200 EYRSPEVLLGAPWGCG---ADIWSTACLIFELITGD 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 6e-09
Identities = 41/238 (17%), Positives = 74/238 (31%), Gaps = 54/238 (22%)
Query: 334 GPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVK-------------R 380
GP FS+ T +G G FG V++ + + A+K
Sbjct: 9 GPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSH 63
Query: 381 SKHSHEGKTEF-----LAELSIIACLRHKNLVQLLGWCAEKG----ELLLVYEYMP--NG 429
K E E L+ LS C R + + L +G LL +++ G
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 430 SLDRMLYQDSENGV-------------------LLSWYHRLNIVVGLASALTYLHQECEQ 470
S + ++ + L S +I+ L ++L
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181
Query: 471 QVIHRDIKASNIMLDANFNARLESSF---TLTAGTMGYLAPEYLQYGTATEKTDVFSY 525
+ HRD+ N++L +L + + T + G + Y + + D
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVS-IIDYTLSRLERDGIVV 238
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 43/203 (21%), Positives = 86/203 (42%), Gaps = 29/203 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHK------NLV 407
+++G+G+FG V KAY A+K ++ + E+ I+ LR + N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+L + + + +E + + +L ++ ++ G L + + L LH+
Sbjct: 163 HMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDALHK- 218
Query: 468 CEQQVIHRDIKASNIMLDANFNARLE-----SSFTLTAGTMGYL------APE---YLQY 513
++IH D+K NI+L + ++ SS Y+ APE +Y
Sbjct: 219 --NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARY 276
Query: 514 GTATEKTDVFSYGVVVLEVACGR 536
G D++S G ++ E+ G
Sbjct: 277 GMP---IDMWSLGCILAELLTGY 296
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-08
Identities = 12/43 (27%), Positives = 20/43 (46%)
Query: 211 TPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTS 253
+ L + L + + +GFSA+T H + SWSF +
Sbjct: 3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSE 45
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 46/211 (21%), Positives = 89/211 (42%), Gaps = 35/211 (16%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVK----RSKHSHEGKTEFLAELSIIACLRH-- 403
+ + ++G+G+FG V KAY A+K + ++ + E+ ++ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI----EVRLLELMNKHD 111
Query: 404 ----KNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLAS 459
+V L + L LV+E + + +L +L + GV L+ + + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRK--FAQQMCT 168
Query: 460 ALTYLHQECEQQVIHRDIKASNIMLDANFNARLE-----SSFTLTAGTMGYL------AP 508
AL +L E +IH D+K NI+L + ++ SS L Y+ +P
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSP 227
Query: 509 E---YLQYGTATEKTDVFSYGVVVLEVACGR 536
E + Y A D++S G +++E+ G
Sbjct: 228 EVLLGMPYDLA---IDMWSLGCILVEMHTGE 255
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-----SKHSHEGKTEFLAELSIIACLR-HKNLV 407
+ LG+GA+G V+K+ +G V AVK+ + +T E+ I+ L H+N+V
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT--FREIMILTELSGHENIV 72
Query: 408 QLLGWCAEKG--ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
LL ++ LV++YM L ++ + L H+ +V L + YLH
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMET-DLHAVIRANI-----LEPVHKQYVVYQLIKVIKYLH 126
Query: 466 QECEQQVIHRDIKASNIMLDAN 487
++HRD+K SNI+L+A
Sbjct: 127 ---SGGLLHRDMKPSNILLNAE 145
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 39/153 (25%), Positives = 63/153 (41%), Gaps = 31/153 (20%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR--------HKN 405
R LG G F V+ ++ A+K K + L E+ ++ +R +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 406 LVQLLGWCAEKGE----LLLVYEYMPNG-SLDRMLYQDSENGVLLSWYHRL------NIV 454
+VQLL G + +V+E + G L + + + S Y L I+
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIK--------SNYQGLPLPCVKKII 152
Query: 455 VGLASALTYLHQECEQQVIHRDIKASNIMLDAN 487
+ L YLH +C ++IH DIK NI+L N
Sbjct: 153 QQVLQGLDYLHTKC--RIIHTDIKPENILLSVN 183
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 32/140 (22%), Positives = 58/140 (41%), Gaps = 19/140 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK----RSKHSHEGKTEFLAELSIIACLRH-----K 404
R +G G FG V + AVK K++ K E I+ +++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDINNN 96
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
N+V+ G + L++E + SL ++ +++ NG + + + AL YL
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE--DIKLYCIEILKALNYL 153
Query: 465 HQECEQQVIHRDIKASNIML 484
+ + H D+K NI+L
Sbjct: 154 R---KMSLTHTDLKPENILL 170
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 36/154 (23%), Positives = 57/154 (37%), Gaps = 30/154 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA-----AVKRSKHSH-----EGKT-EFLAELSIIACLR 402
+G+G FG +Y A SS SV VK + E K + A+ I
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 403 HKNLVQLLG-----WCAEKGELLLVYEYM------PNGSLDRMLYQDSENGVLLSWYHRL 451
++ LG + Y +M L ++ N S L
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQKIY---EANAKRFSRKTVL 155
Query: 452 NIVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485
+ + + L Y+H E + +H DIKASN++L+
Sbjct: 156 QLSLRILDILEYIH---EHEYVHGDIKASNLLLN 186
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 32/152 (21%), Positives = 56/152 (36%), Gaps = 29/152 (19%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAA-----VKRSKHS---HEGKTE-FLAELSIIACLRHK 404
+ +G G FG +Y A+ + A V+ ++ E K +A+ I +
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 405 NLVQLLG-----WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNI--VVGL 457
+ LG Y +M ++R L D + + V+ L
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFM---VMER-LGIDLQK--ISGQNGTFKKSTVLQL 156
Query: 458 A----SALTYLHQECEQQVIHRDIKASNIMLD 485
L Y+H E + +H DIKA+N++L
Sbjct: 157 GIRMLDVLEYIH---ENEYVHGDIKAANLLLG 185
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 31/145 (21%), Positives = 56/145 (38%), Gaps = 21/145 (14%)
Query: 354 RILGRGAFGNVYKAY-FASSGSVAAVK--RSKHS--HEGKTEFLAELSIIACLRHK---- 404
LG G FG V + A S A+K R+ + E++++ ++ K
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL----EINVLKKIKEKDKEN 80
Query: 405 --NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
V + W G + + +E + + L +++ L + L AL
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRH--MAYQLCHALR 137
Query: 463 YLHQECEQQVIHRDIKASNIMLDAN 487
+LH E Q+ H D+K NI+ +
Sbjct: 138 FLH---ENQLTHTDLKPENILFVNS 159
|
| >2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A Length = 226 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 44/241 (18%), Positives = 71/241 (29%), Gaps = 41/241 (17%)
Query: 15 LNFSFVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPF 74
N + L N + L TL L G LT ++ GSL
Sbjct: 7 WNKGYSLPNLLEVTDQQKELSQWTLGDKVKLEEGRFVLTP----GKNTKGSLWLKPEYSI 62
Query: 75 FDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKN 134
D + T ++F S+ GLAF++ N+ + +
Sbjct: 63 KD-------AMTIEWTFRSFGFRGST-KGGLAFWLKQGNEGDSTE--------LFGGSSK 106
Query: 135 KF--VAIEFDTRLDPHFDDPDENHIGLDID--SLESIKTADPILQGIDLK---SGNVITA 187
KF + I DD + ++ + + + P + S T
Sbjct: 107 KFNGLMILLRL------DDKLGESVTAYLNDGTKDLDIESSPYFASCLFQYQDSMVPSTL 160
Query: 188 WIDY-KNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQ 246
+ Y D +LK+ M + KV S +G SA + S E I
Sbjct: 161 RLTYNPLDNHLLKLQMDN---RVCFQTRKVKFMGSSPF----RIGTSAINDASKESFEIL 213
Query: 247 S 247
Sbjct: 214 K 214
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 30/142 (21%), Positives = 56/142 (39%), Gaps = 21/142 (14%)
Query: 354 RILGRGAFGNVYKAY-FASSGSVAAVK----RSKHSHEGKTEFLAELSIIACLRHK---- 404
LG GAFG V + + G AVK ++ ++ E+ ++ L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS----EIQVLEHLNTTDPNS 75
Query: 405 --NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
VQ+L W G + +V+E + S + ++ L H + + ++
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVN 132
Query: 463 YLHQECEQQVIHRDIKASNIML 484
+LH ++ H D+K NI+
Sbjct: 133 FLH---SNKLTHTDLKPENILF 151
|
| >2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13 Length = 256 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 40/240 (16%), Positives = 65/240 (27%), Gaps = 49/240 (20%)
Query: 15 LNFSFVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPF 74
L+ + L + +N N + L G I LT +S GSL
Sbjct: 14 LSSDYSLPDLINTRKVP---NNWQTGEQASLEEGRIVLTS----NQNSKGSLWLKQGFDL 66
Query: 75 FDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAG---------GCLGL 125
D SFT ++F G++F+ D+ I G L
Sbjct: 67 KD-------SFTMEWTFRSVG-YSGQTDGGISFWFVQDSNIPRDKQLYNGPVNYDGLQLL 118
Query: 126 VNSSQLTKNKFVAIEFD-TRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNV 184
V+++ D + D++ + +S
Sbjct: 119 VDNNGPLGPTLRGQLNDGQKPVDKTKIYDQSFASCLMGYQDS---------------SVP 163
Query: 185 ITAWIDY-KNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELH 243
T + Y D +LKV + K KV Y +G +A
Sbjct: 164 STIRVTYDLEDDNLLKVQVDN---KVCFQTRKVRFPSGSY-----RIGVTAQNGAVNNNA 215
|
| >2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A Length = 222 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 39/239 (16%), Positives = 66/239 (27%), Gaps = 47/239 (19%)
Query: 15 LNFSFVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPF 74
L+ + L + +N N + L G I LT +S GSL
Sbjct: 7 LSSDYSLPDLINTRKVP---NNWQTGEQASLEEGRIVLTS----NQNSKGSLWLKQGFDL 59
Query: 75 FDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKN 134
D SFT ++F G++F+ D+ I
Sbjct: 60 KD-------SFTMEWTFRSVG-YSGQTDGGISFWFVQDSNIPRDK--------QLYNGPV 103
Query: 135 KF--VAIEFDTRLDPHFDDPDENHIGLDID----SLESIKTADPILQGIDLK---SGNVI 185
+ + + D + P + ++ ++ K D + S
Sbjct: 104 NYDGLQLLVDN------NGPLGPTLRGQLNDGQKPVDKTKIYDQSFASCLMGYQDSSVPS 157
Query: 186 TAWIDY-KNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELH 243
T + Y D +LKV + K KV Y +G +A
Sbjct: 158 TIRVTYDLEDDNLLKVQVDN---KVCFQTRKVRFPSGSY-----RIGVTAQNGAVNNNA 208
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 24/138 (17%), Positives = 49/138 (35%), Gaps = 21/138 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
R +G G+FG +++ + A+K + E L + + +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-LRDEYRTYKLLAGCTGIPNVYYF 74
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHR---LNIVVGLA----SALTYLHQ 466
++G + + L L LL R + V A + + +H
Sbjct: 75 GQEGL----HNVLVIDLLGPSLED------LLDLCGRKFSVKTVAMAAKQMLARVQSIH- 123
Query: 467 ECEQQVIHRDIKASNIML 484
E+ +++RDIK N ++
Sbjct: 124 --EKSLVYRDIKPDNFLI 139
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 31/153 (20%), Positives = 50/153 (32%), Gaps = 28/153 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA--------AVKRSKHSHEGKTEF-----LAELSIIAC 400
R G +Y+A S+ + ++K E A+ +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 401 LRHKNLVQLLG-----WCAEKGEL--LLVYEYMPNG-SLDRMLYQDSENGVLLSWYHRLN 452
+ LL + LV + G SL L D +LS L
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL--DVSPKHVLSERSVLQ 163
Query: 453 IVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485
+ L AL +LH E + +H ++ A NI +D
Sbjct: 164 VACRLLDALEFLH---ENEYVHGNVTAENIFVD 193
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 645 | |||
| 3ujo_A | 281 | Legume lectin; carbohydrate-binding, galactose, ad | 100.0 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 100.0 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 100.0 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 100.0 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 100.0 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 100.0 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 100.0 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 100.0 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 100.0 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 100.0 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 100.0 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 100.0 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 100.0 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 100.0 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 100.0 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 100.0 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 100.0 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 100.0 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 100.0 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 100.0 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 100.0 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 100.0 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 99.95 | |
| 2a6y_A | 256 | EMP47P (FORM1); beta sandwich, carbohydrate bindin | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.89 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 2a6z_A | 222 | EMP47P (FORM2); beta sandwich, carbohydrate bindin | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.5 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 99.44 | |
| 2a6v_A | 226 | EMP46P; beta sandwich, carbohydrate binding protei | 99.4 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.89 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.74 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.57 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.25 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.09 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.99 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.94 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.79 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.6 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.47 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.22 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.79 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.42 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.33 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.32 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.03 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.01 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.99 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.96 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.55 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.37 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.49 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.11 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 89.72 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.29 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 86.2 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.51 |
| >3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-63 Score=498.05 Aligned_cols=237 Identities=32% Similarity=0.517 Sum_probs=205.7
Q ss_pred HHHHHHhh-cccCCceeEEeCCCCCCCeEEecceEeeCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEE
Q 041096 11 SIFLLNFS-FVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFT 86 (645)
Q Consensus 11 ~~~~~~~~-~~~~~~~~f~~~~f~~~~~~l~G~a~~~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~ 86 (645)
++||+++. ...+..++|+|++|+..||+|+|||.+.+|.|+||+.+.. ..+++|||+|++||+|||+++|+++||+
T Consensus 12 ~~fl~l~~~~~sa~~~sF~f~~F~~~nL~l~GdA~i~~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~d~~tg~vaSFs 91 (281)
T 3ujo_A 12 VLFLILLTKAASANLISFTFKKFNETNLILQRDATVSSGKLRITKAAENGVPTAGSLGRAFYSTPIQIWDNTTGTVASWA 91 (281)
T ss_dssp ------------CEEEEEEESSCCSTTEEECSSCCCBTTBEECSCCCSSCCCCSSCEEEEEESSCEECBCSSSCCBEEEE
T ss_pred HHHHHHHcccCcCCcceEEcCCCCccCEEEecceEEeCCEEEeCCCCCCCcccCCceEEEEECCCEEcccCCCCCceeEE
Confidence 34444443 3446789999999999999999999999999999997432 1358999999999999999999999999
Q ss_pred EEEEEEEeeCCCCCCCCceEEEEecCCCCCCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcc
Q 041096 87 SRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLE 165 (645)
Q Consensus 87 t~F~f~i~~~~~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~ 165 (645)
|+|+|.|.+++...+||||||||+|.+..+++.||||||+|.++ ++.+|+|||||||++|++| ||++|||||||||+.
T Consensus 92 TsFsF~I~~~~~~~~gdGlAF~laP~~~~p~~~gg~LGL~n~~~~~~~n~~vAVEFDT~~N~e~-Dp~~nHVGIDvNSi~ 170 (281)
T 3ujo_A 92 TSFTFNLQAPNAASPADGLAFALVPVGSQPKDKGGFLGLFDSKNYASSNQTVAVEFDTFYNGGW-DPTERHIGIDVNSIK 170 (281)
T ss_dssp EEEEEECCCSSTTSCCEEEEEEEEETTCCCCCCGGGTTTCSCSSCCTTSCCEEEEECCSCCCSS-CCSSSEEEEEESSSC
T ss_pred EEEEEEEecCCCCCCCCceEEEEecCCCCCCCCcceeeeccccCCCccCcEEEEEEeccccccC-CCCCCeEEEEcCCCC
Confidence 99999999887788999999999999876678899999998764 4558999999999999988 999999999999999
Q ss_pred cccccCCCccccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCC---ccce
Q 041096 166 SIKTADPILQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEG---STEL 242 (645)
Q Consensus 166 s~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~---~~~~ 242 (645)
|.++.+| ++.+|+.++|||+||+.+++|+|+|++.+. +..|+|+..|||+++|||+||||||||||. ..|.
T Consensus 171 S~~t~~~-----~l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~-~~~~~lS~~vDL~~~L~e~v~VGFSAsTG~~~~~~e~ 244 (281)
T 3ujo_A 171 SIKTTSW-----DFANGENAEVLITYDSSTNLLVASLVHPSQ-KTSFIVSERVDLTSVLPEWVSVGFSATTGLSKGYVET 244 (281)
T ss_dssp CSCEEEC-----CCCSSCCEEEEEEECTTTCEEEEEEECTTT-CCCEEEEEECCSTTTSCSEEEEEEEEEECSSTTSCCC
T ss_pred ccccccc-----cccCCCEEEEEEEEeCCCCEEEEEEecCCC-CCCceEEEEechHHhccCcEEEEEEeecCCCCcccce
Confidence 9998876 467899999999999999999999997663 558899999999999999999999999996 5899
Q ss_pred eeeeeeeeeecC
Q 041096 243 HMIQSWSFQTSG 254 (645)
Q Consensus 243 ~~i~sw~f~~~~ 254 (645)
|+|++|+|++..
T Consensus 245 H~IlsWSFss~l 256 (281)
T 3ujo_A 245 NEVLSWSFASKL 256 (281)
T ss_dssp CEEEEEEEEEEE
T ss_pred eEEEEEEEEEEc
Confidence 999999999863
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-62 Score=482.44 Aligned_cols=226 Identities=36% Similarity=0.547 Sum_probs=205.4
Q ss_pred CceeEEeCCCC--CCCeEEecceEe-eCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYL-RNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV 96 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~-~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 96 (645)
..++|+|++|. ..||+|+|||.+ .+|.|+||+.+.. ..+++|||+|++||+|||+++|+++||+|+|+|.|.++
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~ 81 (251)
T 3ipv_A 2 EETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATGLVASFATSFRFTIYAP 81 (251)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred cceEEEeCCCCCCCCCeEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEeecCCCCceeeEEEEEEEEEeCC
Confidence 46899999998 789999999999 6899999997432 13489999999999999999999999999999999988
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCcc
Q 041096 97 NPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQ 175 (645)
Q Consensus 97 ~~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~ 175 (645)
+...+||||||||+|....++..||||||+|.++ +..+|+|||||||++|.+|+||++|||||||||+.|.++.+|
T Consensus 82 ~~~~~gdGlAF~lap~~~~~~~~gg~LGL~n~~~~~~~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNsi~S~~t~~~--- 158 (251)
T 3ipv_A 82 NIATIADGLAFFLAPVASAPDSGGGFLGLFDSAVSGSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVKW--- 158 (251)
T ss_dssp STTSCCEEEEEEEEETTCCCCCCGGGTTTCSSSSCCTTSCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC---
T ss_pred CCCCCCCceEEEEecCCCCCCCCCceeeeccccCCCccCcEEEEEEecccccccCCCCCCeEEEEcCCCccccccee---
Confidence 7788999999999999876667899999998764 345899999999999999999999999999999999998875
Q ss_pred ccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc---cceeeeeeeeeee
Q 041096 176 GIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS---TELHMIQSWSFQT 252 (645)
Q Consensus 176 ~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~sw~f~~ 252 (645)
++.+|+.++|||+||+.+++|+|+|++.+. +..|+|+..|||+.+|+|+|||||||+||.. .|.|+|++|+|++
T Consensus 159 --~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~e~h~IlsWsF~s 235 (251)
T 3ipv_A 159 --SLANGEAAKVLITYNSAVKLLVASLVYPSS-KTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSFAS 235 (251)
T ss_dssp --CCCTTCEEEEEEEEETTTTEEEEEEECTTT-CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEE
T ss_pred --EecCCCEEEEEEEEeCCCCEEEEEEecCCC-CccceEEEEechHHhCCCcEEEEEEEecCCCccccceeEEEEEEEEE
Confidence 478999999999999999999999997664 5688999999999999999999999999998 9999999999998
Q ss_pred cC
Q 041096 253 SG 254 (645)
Q Consensus 253 ~~ 254 (645)
..
T Consensus 236 ~l 237 (251)
T 3ipv_A 236 KL 237 (251)
T ss_dssp EE
T ss_pred EC
Confidence 63
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-61 Score=478.51 Aligned_cols=228 Identities=32% Similarity=0.539 Sum_probs=203.6
Q ss_pred hcccCCceeEEeCCCC--CCCeEEecceEe-eCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEE
Q 041096 18 SFVLSNNMNFDFTSFN--LRNITLLGDSYL-RNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSF 91 (645)
Q Consensus 18 ~~~~~~~~~f~~~~f~--~~~~~l~G~a~~-~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f 91 (645)
....+..++|+|++|. ..||+|+|||.+ .+|.|+||+.+.+ ..+++|||+|++||+|||+.+|+++||+|+|+|
T Consensus 5 ~~~sa~~~sF~f~~F~~~~~~l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~d~~tg~vaSFsT~F~F 84 (261)
T 3zyr_A 5 RANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWEKSTNRVANLQTQFSF 84 (261)
T ss_dssp ---CCEEEEEEESSCCSCCTTEEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECBCTTTCCBEEEEEEEEE
T ss_pred ccCcCcccEEEcCCCCCCCCCeEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEeecCCCCCceeEEEEEEE
Confidence 4455678999999998 789999999999 6899999997421 137899999999999999999999999999999
Q ss_pred EEeeCCCCCCCCceEEEEecCCCC--CCCCCCccccccCCCCC---CCcEEEEEeeCC---CCCCCCCCCCCeeeeecCC
Q 041096 92 SINNVNPSSFGDGLAFFISPDNQI--LGSAGGCLGLVNSSQLT---KNKFVAIEFDTR---LDPHFDDPDENHIGLDIDS 163 (645)
Q Consensus 92 ~i~~~~~~~~g~G~aF~l~p~~~~--~~~~g~~lGl~~~~~~~---~~~~vAVEFDt~---~n~~~~d~~~~Hvgi~vns 163 (645)
.|.+. ...+||||||||+|.+.. .+++||||||+|.++++ .+|+|||||||+ +|.+| ||++|||||||||
T Consensus 85 ~I~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n~~~-Dp~~nHVGIdvNs 162 (261)
T 3zyr_A 85 FLSSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTW-DPNYQHIGIDVNS 162 (261)
T ss_dssp EEECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTTCTT-SCSSCEEEEEESS
T ss_pred EEecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccCcCC-CCCCCeEEEEcCC
Confidence 99987 677899999999998763 47889999999987653 379999999999 99888 9999999999999
Q ss_pred cccccccCCCccccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCcccee
Q 041096 164 LESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELH 243 (645)
Q Consensus 164 ~~s~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~ 243 (645)
+.|.++.+| .+.+|+.++|||+||+.+++|+|+|++.+.+ .|+|+..|||+.+|||+|||||||+||...|.|
T Consensus 163 i~S~~s~~~-----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~--~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~e~h 235 (261)
T 3zyr_A 163 IRSSKVVRW-----ERREGKTLNVLVTYNPSTRTIDVVATYPDGQ--RYQLSHVVDLTTILPEWVRVGFSAASGEQFQTH 235 (261)
T ss_dssp SSCSEEEEC-----CCCTTCCEEEEEEEETTTTEEEEEEECTTCC--EEEEEEECCGGGTSCSEEEEEEEEEESSSCCEE
T ss_pred CCccccccc-----cccCCceEEEEEEEcCCCCEEEEEEEcCCCC--CeEEEEEechHHhCcCcEEEEEEecCCCccceE
Confidence 999998876 4678999999999999999999999976633 889999999999999999999999999999999
Q ss_pred eeeeeeeeecC
Q 041096 244 MIQSWSFQTSG 254 (645)
Q Consensus 244 ~i~sw~f~~~~ 254 (645)
+|++|+|++..
T Consensus 236 ~IlsWsF~s~l 246 (261)
T 3zyr_A 236 NLESWSFTSTL 246 (261)
T ss_dssp EEEEEEEEEEE
T ss_pred EEEEEEEEEEc
Confidence 99999999863
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-60 Score=466.22 Aligned_cols=224 Identities=31% Similarity=0.558 Sum_probs=200.9
Q ss_pred CceeEEeCCCC--CCCeEEecceEee-CCcEEccCCC-CC-CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTREL-GV-PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVN 97 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~~-~~~~~Lt~~~-~~-~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 97 (645)
.+++|+|++|. ..||+|+|||.+. +|.|+||++. +. ..+++|||+|++||+|||+.+|+++||+|+|+|+|.+++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~~ 81 (237)
T 1fny_A 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPN 81 (237)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCC
Confidence 35789999998 6899999999994 7999999864 11 157899999999999999999999999999999999887
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccc
Q 041096 98 PSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176 (645)
Q Consensus 98 ~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~ 176 (645)
...+||||||||+|....+++.||||||+|.++ ++.+++|||||||++|.+| ||++|||||||||+.|.++.+|
T Consensus 82 ~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~n~~~-Dp~~nHVGIdvNsi~S~~~~~~---- 156 (237)
T 1fny_A 82 PATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPW---- 156 (237)
T ss_dssp TTSCCEEEEEEEEETTCCCCCCGGGTTTCC---CCTTSCCEEEEEECSCCTTT-CCSSSEEEEEESSSSCSEEEEC----
T ss_pred CCCCCCCEEEEeccCCCCCCCCCCcccccccCCCCccccEEEEEeecccCccc-CCCCCceEEecCCccccccccc----
Confidence 778899999999998776778899999998653 4458999999999999985 9999999999999999998876
Q ss_pred cccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc---cceeeeeeeeeeec
Q 041096 177 IDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS---TELHMIQSWSFQTS 253 (645)
Q Consensus 177 ~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~sw~f~~~ 253 (645)
++.+|+.++|||+||+.+++|+|+|++.+ .|..|+|+..|||+.+||++|||||||+||.. .|.|+|++|+|++.
T Consensus 157 -~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~IlsWsF~s~ 234 (237)
T 1fny_A 157 -NWTNGEVANVFISYEASTKSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFESN 234 (237)
T ss_dssp -CCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred -cccCCCEEEEEEEEeCCCcEEEEEEecCC-CCCcceEEEEechHHhCCCcEEEEEEEeeCCCCcccceeEEEEEEEEEe
Confidence 48899999999999999999999999765 36679999999999999999999999999998 99999999999875
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-59 Score=462.89 Aligned_cols=224 Identities=35% Similarity=0.565 Sum_probs=201.6
Q ss_pred CceeEEeCCCC--CCCeEEecceEee-CCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV 96 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~~-~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 96 (645)
.+++|+|++|. ..||+|+|||.+. +|.|+||++..+ ..+++|||+|++||+||++.+|+++||+|+|+|+|.++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~ 81 (239)
T 1gzc_A 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQP 81 (239)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCC
T ss_pred eeEEEEeCCCCCCCCCeEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCC
Confidence 35789999998 6899999999995 799999997422 14789999999999999999999999999999999987
Q ss_pred C-CCCCCCceEEEEecCCCCCCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCc
Q 041096 97 N-PSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPIL 174 (645)
Q Consensus 97 ~-~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~ 174 (645)
+ ...+||||||||+|....+++.||||||+|.++ ++.+++|||||||++|. |+||++|||||||||+.|.++.+|
T Consensus 82 ~~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~n~-~dDp~~nHVGIdvns~~S~~~~~~-- 158 (239)
T 1gzc_A 82 YTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQPF-- 158 (239)
T ss_dssp CSSSCCCEEEEEEEECSSCCCCCCGGGTTTCSSSSCCGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSEEEEC--
T ss_pred CCCCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCccccEEEEEEeccccc-CCCCCCCeEEEecCCccccccccc--
Confidence 6 677899999999998776778999999998653 33489999999999998 888999999999999999998875
Q ss_pred cccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCC---ccceeeeeeeeee
Q 041096 175 QGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEG---STELHMIQSWSFQ 251 (645)
Q Consensus 175 ~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~---~~~~~~i~sw~f~ 251 (645)
++.+|+.++|||+||+.+++|+|+|++.+ .|..|+|+..+||+.+||++|||||||+||. ..|.|+|++|+|+
T Consensus 159 ---~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~IlsWsF~ 234 (239)
T 1gzc_A 159 ---QLDNGQVANVVIKYDAPSKILHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQ 234 (239)
T ss_dssp ---CCCTTCEEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEE
T ss_pred ---cccCCCEEEEEEEEeCCCcEEEEEEecCC-CCccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEEeE
Confidence 48899999999999999999999999765 3567999999999999999999999999997 4899999999998
Q ss_pred ec
Q 041096 252 TS 253 (645)
Q Consensus 252 ~~ 253 (645)
+.
T Consensus 235 s~ 236 (239)
T 1gzc_A 235 AS 236 (239)
T ss_dssp EE
T ss_pred Ee
Confidence 75
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-59 Score=460.82 Aligned_cols=225 Identities=29% Similarity=0.492 Sum_probs=202.5
Q ss_pred CceeEEeCCCC--CCCeEEecceEee-CCcEEccCCCCCCCCceEE-EEeCCCcccccCCCCceeeEEEEEEEEEeeC-C
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTRELGVPASSSGS-LIYNNPVPFFDQETNTTASFTSRFSFSINNV-N 97 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~~-~~~~~Lt~~~~~~~~~~Gr-~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~-~ 97 (645)
.+++|+|++|. ..||+|+|||.+. +|.|+||++.....+++|| |+|++||+||++.+|+++||+|+|+|+|.++ +
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gr~a~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~ 81 (242)
T 1fx5_A 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSAN 81 (242)
T ss_dssp CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESSC
T ss_pred cceEEEcCCCCCCCCCeEEcccEEeccCCcEEecCCCCcccCCccCEEEeCCCEEeecCCCCCccceEEEEEEEEecCCC
Confidence 46799999998 6899999999995 7999999974222578999 9999999999999999999999999999987 5
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCC-CCCCCCeeeeecCCcccccccCCCcc
Q 041096 98 PSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHF-DDPDENHIGLDIDSLESIKTADPILQ 175 (645)
Q Consensus 98 ~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~-~d~~~~Hvgi~vns~~s~~~~~~~~~ 175 (645)
...+||||||||+|....+++.||||||+|.++ ++.+++|||||||++|.++ +||++|||||||||+.|.++.++
T Consensus 82 ~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~~S~~~~~~--- 158 (242)
T 1fx5_A 82 PKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTKCDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW--- 158 (242)
T ss_dssp GGGCCCEEEEEEECTTCCCCBCGGGTTTBSSSCCCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEEC---
T ss_pred CCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCccCcEEEEEeccccCcccccCCCCCeEEEecCCccccceecc---
Confidence 667899999999998776778899999998654 3348999999999999986 69999999999999999998875
Q ss_pred ccccCCC--CeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEecc--CCccceeeeeeeeee
Q 041096 176 GIDLKSG--NVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST--EGSTELHMIQSWSFQ 251 (645)
Q Consensus 176 ~~~~~~g--~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsast--g~~~~~~~i~sw~f~ 251 (645)
++.+| +.++|||+||+.+++|+|+|++... |..|+|+..+||+.+||++|||||||+| |.. |.|+|++|+|+
T Consensus 159 --~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~IlsWsF~ 234 (242)
T 1fx5_A 159 --NKRYGLNNVANVEIIYEASSKTLTASLTYPSD-QTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQ-ATHEVLNWYFT 234 (242)
T ss_dssp --CCCCSGGGCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCGGGTSCSEEEEEEEEEEETTSC-EEEEEEEEEEE
T ss_pred --cccCCCceeEEEEEEEeCCCCEEEEEEecCCC-CccceeeEEechHHhCCccEEEEEEecccCCCc-ceeEEEEEEeE
Confidence 47899 9999999999999999999998653 5679999999999999999999999999 999 99999999999
Q ss_pred ecC
Q 041096 252 TSG 254 (645)
Q Consensus 252 ~~~ 254 (645)
+..
T Consensus 235 s~l 237 (242)
T 1fx5_A 235 STF 237 (242)
T ss_dssp EES
T ss_pred eec
Confidence 863
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-59 Score=462.77 Aligned_cols=224 Identities=34% Similarity=0.560 Sum_probs=201.2
Q ss_pred CceeEEeCCCC--CCCeEEecceEee-CCcEEccCCC-CC-CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTREL-GV-PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVN 97 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~~-~~~~~Lt~~~-~~-~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 97 (645)
.+++|+|++|. ..||+|+|||.+. +|.|+||++. +. ..+++|||+|++||+|||+.+|+++||+|+|+|+|.+++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~ 81 (239)
T 1dbn_A 2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAPN 81 (239)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCC
Confidence 46799999998 6899999999994 7999999864 11 157899999999999999999999999999999999887
Q ss_pred CCCCCCceEEEEecCCCC--CCCCCCccccccCCC-CCCCcEEEEEeeCCCC---CCCCCCCCCeeeeecCCcccccccC
Q 041096 98 PSSFGDGLAFFISPDNQI--LGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLD---PHFDDPDENHIGLDIDSLESIKTAD 171 (645)
Q Consensus 98 ~~~~g~G~aF~l~p~~~~--~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n---~~~~d~~~~Hvgi~vns~~s~~~~~ 171 (645)
...+||||||||+|.... .++.||||||+|.++ ++.+++|||||||++| .+| ||++|||||||||+.|.++.+
T Consensus 82 ~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~n~~~~~~-Dp~~nHVGIdvNs~~S~~~~~ 160 (239)
T 1dbn_A 82 PDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSSNQIVAVEFDTYFAHSYDPW-DPNYRHIGIDVNGIESIKTVQ 160 (239)
T ss_dssp TTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSCCCTTSCCEEEEEECCCCTTTCTT-SCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCCCCccccEEEEEEeccccCccccc-CCCCCcEEEecCCccccceEc
Confidence 778899999999998763 468899999998653 3458999999999999 774 999999999999999999887
Q ss_pred CCccccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc--cceeeeeeee
Q 041096 172 PILQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS--TELHMIQSWS 249 (645)
Q Consensus 172 ~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~--~~~~~i~sw~ 249 (645)
+ ++.+|+.++|||+||+.+++|+|+|++.. .+..|+|+..|||+.+|+++|||||||+||.. .|.|+|++|+
T Consensus 161 ~-----~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~h~IlsWs 234 (239)
T 1dbn_A 161 W-----DWINGGVAFATITYLAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWS 234 (239)
T ss_dssp C-----CCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEEEEE
T ss_pred c-----cccCCCEEEEEEEEeCCCcEEEEEEccCC-CCCcceEEEEechHHhCCccEEEEEEeccCCCccceeeEEEEEE
Confidence 6 48899999999999999999999999865 35679999999999999999999999999999 9999999999
Q ss_pred eeec
Q 041096 250 FQTS 253 (645)
Q Consensus 250 f~~~ 253 (645)
|+++
T Consensus 235 F~s~ 238 (239)
T 1dbn_A 235 FTST 238 (239)
T ss_dssp EEEE
T ss_pred eEec
Confidence 9874
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=460.28 Aligned_cols=223 Identities=32% Similarity=0.528 Sum_probs=202.9
Q ss_pred CceeEEeCCCC--CCCeEEecceEe-eCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYL-RNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV 96 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~-~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 96 (645)
.+++|+|++|. ..||+|+|||.+ .+|.|+||++..+ ..+++|||+|++||+|||+.+|+++||+|+|+|+|.++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~ 81 (253)
T 1sbf_A 2 ETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYAP 81 (253)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEecccCCCCcccceEEEEEEEEeCC
Confidence 45799999998 689999999999 5899999997422 14789999999999999999999999999999999988
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccc
Q 041096 97 NPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176 (645)
Q Consensus 97 ~~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~ 176 (645)
+...+||||||||+|....+++.||||||+|.+ ++.+++|||||||++|. +||++|||||||||+.|.++.++
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~~~~g~~LGL~n~~-~~~n~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~t~~~---- 154 (253)
T 1sbf_A 82 DTKRLADGLAFFLAPIDTKPQTHAGYLGLFNEN-ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTSW---- 154 (253)
T ss_dssp STTSCCEEEEEEEEETTCCCCCCGGGTTTCCTT-SCCCSCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEEC----
T ss_pred CCCCCCCcEEEEEecCCCCCCCCCCccccccCC-CcccceEEEEeccccCC--CCCCCCcEEEEcCCccccceecc----
Confidence 777889999999999877677889999999876 67799999999999998 49999999999999999998875
Q ss_pred cccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc--cceeeeeeeeeeecC
Q 041096 177 IDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS--TELHMIQSWSFQTSG 254 (645)
Q Consensus 177 ~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~--~~~~~i~sw~f~~~~ 254 (645)
++.+|+.++|||+||+.+++|+|+|++... |..|+|+..+||+.+||++|||||||+||.. .|.|+|++|+|++..
T Consensus 155 -~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~H~IlsWsF~s~l 232 (253)
T 1sbf_A 155 -DLANNKVAKVLITYDASTSLLVASLVYPSQ-RTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASNL 232 (253)
T ss_dssp -CCCTTCCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSSSCCCEEEEEEEEEEEEE
T ss_pred -cccCCCeeEEEEEEeCCCcEEEEEEecCCC-CCcceEEEEechHHhCCCceEEEEEeccCCCccceeeEEEEEEeEeec
Confidence 478999999999999999999999998653 5679999999999999999999999999999 999999999999863
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=456.34 Aligned_cols=219 Identities=32% Similarity=0.596 Sum_probs=200.1
Q ss_pred CceeEEeCCCC--CCCeEEecceEe-eCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYL-RNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPS 99 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~-~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~ 99 (645)
.+++|+|++|+ ..||+|+|||.+ .+|.|+||++. ..+++|||+|++||+|||+.+|+++||+|+|+|+|.+++..
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~--~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~~~ 79 (232)
T 1v6i_A 2 ETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLN--KVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDY 79 (232)
T ss_dssp EEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTT--STTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSSS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEEccCCcEEeCCCC--CCCceEEEEeCCCEEeecCCCCCccceEEEEEEEEecCCCC
Confidence 35799999998 689999999999 57999999861 35789999999999999999999999999999999988777
Q ss_pred CCCCceEEEEecCCC--CCCC-CCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccc
Q 041096 100 SFGDGLAFFISPDNQ--ILGS-AGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176 (645)
Q Consensus 100 ~~g~G~aF~l~p~~~--~~~~-~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~ 176 (645)
.+||||||||+|... +.++ .||||||+|. ++.+++|||||||++|.+++||++|||||||||+.|.++.++
T Consensus 80 ~~gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~--~~~~~~vAVEFDT~~n~~~~Dp~~nHVGIdvns~~S~~~~~~---- 153 (232)
T 1v6i_A 80 DPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT--KGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW---- 153 (232)
T ss_dssp BCCCEEEEEEEETTCCCCTTCCCGGGTTTSCT--TSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEEC----
T ss_pred CCCCCEEEEEecCCCCCCCCcCCCcccccccC--CCcccEEEEEeecccccccCCCCCCeEEEEcCCccccccccc----
Confidence 889999999999875 3456 8999999986 566899999999999998789999999999999999998876
Q ss_pred cccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCC--ccceeeeeeeeeeec
Q 041096 177 IDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEG--STELHMIQSWSFQTS 253 (645)
Q Consensus 177 ~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~--~~~~~~i~sw~f~~~ 253 (645)
++.+|+.++|||+||+.+++|+|+|++ + .|..|+|+..|||+.+||++|||||| +||. ..|.|+|++|+|++.
T Consensus 154 -~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~-~~~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~~~~h~IlsWsF~s~ 228 (232)
T 1v6i_A 154 -NSVSGAVVKVTVIYDSSTKTLSVAVTN-D-NGDITTIAQVVDLKAKLPERVKFGFS-ASGSLGGRQIHLIRSWSFTST 228 (232)
T ss_dssp -CCCTTCEEEEEEEEETTTTEEEEEEEC-T-TSCEEEEEEECCHHHHSCSEEEEEEE-EECCSSBCCEEEEEEEEEEEE
T ss_pred -cccCCCEEEEEEEEeCCCcEEEEEEec-C-CCCcceEEEEechHHhCCccEEEEEE-ecCCCccccEEEEEEEEEEee
Confidence 488999999999999999999999998 4 57789999999999999999999999 9998 699999999999886
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=461.13 Aligned_cols=225 Identities=32% Similarity=0.492 Sum_probs=203.9
Q ss_pred CceeEEeCCCCCCCeEEecceEeeCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCC
Q 041096 23 NNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPS 99 (645)
Q Consensus 23 ~~~~f~~~~f~~~~~~l~G~a~~~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~ 99 (645)
.+++|+|++|...||+|+|||.+.+|.|+||++..+ ..+++|||+|++||+|||+.+|+++||+|+|+|+|.+++..
T Consensus 2 ~~~~F~f~~F~~~~l~l~GdA~v~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~~ 81 (253)
T 1g7y_A 2 DIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAPNKS 81 (253)
T ss_dssp EEEEEEESSCCSSCEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSSGG
T ss_pred cceEEEcCCCCcCCEEEecceEEeCCEEEeCCCCCCCccccCCeEEEEECCCEEeecCCCCCccceEEEEEEEEecCCCC
Confidence 457999999999999999999999999999997422 15789999999999999999999999999999999987667
Q ss_pred CCCCceEEEEecCCCCCCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccccc
Q 041096 100 SFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGID 178 (645)
Q Consensus 100 ~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~~ 178 (645)
.+||||||||+|....+++.|+||||+|.++ ++.+++|||||||++|.+| ||++|||||||||+.|.++.++ +
T Consensus 82 ~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~n~~vAVEFDT~~N~~~-Dp~~nHVGIdvns~~S~~t~~~-----~ 155 (253)
T 1g7y_A 82 SSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDNSAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASW-----G 155 (253)
T ss_dssp GCCCEEEEEEEETTCCCCCCGGGTTTCSCSSCCGGGCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEEEC-----C
T ss_pred CCCCcEEEEEecCCCCCCCCCCcccccccCCCCccCceEEEEecceeccCc-CCCCCcEeeccCCccccceecc-----c
Confidence 7899999999998776778899999998753 3348999999999999984 9999999999999999998875 4
Q ss_pred cCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc---cceeeeeeeeeeecC
Q 041096 179 LKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS---TELHMIQSWSFQTSG 254 (645)
Q Consensus 179 ~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~sw~f~~~~ 254 (645)
+.+|+.++|||+||+.+++|+|+|++.. .|..|+|+..+||+.+||++|||||||+||.. .|.|+|++|+|++..
T Consensus 156 l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~l 233 (253)
T 1g7y_A 156 LANGQNAEILITYNAATSLLVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASKL 233 (253)
T ss_dssp CCTTSEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCEEEEEEEEEEE
T ss_pred cCCCCeEEEEEEEeCCCCEEEEEEecCC-CCCcceEEEEechHHhCCCceEEEEEeCcCCCCcccceeEEEEEEEEeeC
Confidence 7899999999999999999999999865 35679999999999999999999999999999 999999999999863
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=460.39 Aligned_cols=228 Identities=33% Similarity=0.528 Sum_probs=203.4
Q ss_pred CceeEEeCCCC---CCCeEEecceEeeCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC
Q 041096 23 NNMNFDFTSFN---LRNITLLGDSYLRNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV 96 (645)
Q Consensus 23 ~~~~f~~~~f~---~~~~~l~G~a~~~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 96 (645)
..++|+|++|. ..||+|+|||.+.+|.|+||++..+ ..++.|||+|++||+|||+.+|+++||+|+|+|+|.++
T Consensus 3 ~~~~F~f~~F~~~~~~~l~l~GdA~v~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vasFsT~F~F~I~~~ 82 (257)
T 1hql_A 3 DSVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKIT 82 (257)
T ss_dssp -CCEEEESCSCSCGGGTEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEEC
T ss_pred cceEEEcCCCCCCCCCCEEEccceEecCCcEEecCCccCCcccCCCeEEEEECCCEecccCCCCCeeceEEEEEEEEecC
Confidence 46799999998 6799999999999999999997422 15789999999999999999999999999999999987
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccccCCC---CCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCC
Q 041096 97 NPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ---LTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPI 173 (645)
Q Consensus 97 ~~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~---~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~ 173 (645)
...+||||||||+|....+++.|+||||+|.++ ++.+++|||||||++|.+|+||++|||||||||+.|.++.++.
T Consensus 83 -~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHVGIdvNs~~S~~s~~~~ 161 (257)
T 1hql_A 83 -GNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWE 161 (257)
T ss_dssp -SSCCCCEEEEEEECTTCCCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEECC
T ss_pred -CCCCCCcEEEEEecCCCCCCCCCccccccccccccCCccCceEEEEecccccccccCCCCCceeeeeCCccccceeccC
Confidence 677899999999998776778899999998764 2348999999999999999999999999999999999988873
Q ss_pred ccccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccC-Cccceeeeeeeeeee
Q 041096 174 LQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTE-GSTELHMIQSWSFQT 252 (645)
Q Consensus 174 ~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg-~~~~~~~i~sw~f~~ 252 (645)
. .+|.+|+.++|||+||+.+++|+|+|++... ..|+|+..+||+.+||++|||||||+|| ...|.|+|++|+|++
T Consensus 162 ~--~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~e~~~vGFSAsTG~~~~~~H~IlsWsF~s 237 (257)
T 1hql_A 162 D--SDIFSGKIATARISYDGSAEILTVVLSYPDG--SDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFSS 237 (257)
T ss_dssp H--HHHTSCSCEEEEEEEETTTTEEEEEEEETTT--EEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEEEEEEEEE
T ss_pred c--ccccCCceEEEEEEEeCCCCEEEEEEecCCC--CceeeEEeechHHhcCCceEEEEEeccCCCccceeEEEEEEeEe
Confidence 2 1255699999999999999999999998654 5689999999999999999999999999 899999999999998
Q ss_pred cCC
Q 041096 253 SGF 255 (645)
Q Consensus 253 ~~~ 255 (645)
...
T Consensus 238 ~~~ 240 (257)
T 1hql_A 238 NLQ 240 (257)
T ss_dssp EC-
T ss_pred cCC
Confidence 753
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=460.99 Aligned_cols=224 Identities=34% Similarity=0.532 Sum_probs=204.1
Q ss_pred CceeEEeCCCCCCCeEEecceEe-eCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCC
Q 041096 23 NNMNFDFTSFNLRNITLLGDSYL-RNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNP 98 (645)
Q Consensus 23 ~~~~f~~~~f~~~~~~l~G~a~~-~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 98 (645)
.+++|+|++|...||+|+|||.+ .+|.|+||++..+ ..++.|||+|++||+|||+.+|+++||+|+|+|+|.+++.
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~ 81 (252)
T 1fat_A 2 NDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVPNN 81 (252)
T ss_dssp CCEEEEESSCCGGGEEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECEETTTTEEEEEEEEEEEECCCCSS
T ss_pred cceEEEcCCCCcCCEEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEecccCCCCcccceEEEEEEEEeCCCC
Confidence 46899999999899999999999 5799999997421 1578999999999999999999999999999999998876
Q ss_pred CCCCCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccccc
Q 041096 99 SSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGID 178 (645)
Q Consensus 99 ~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~~ 178 (645)
..+||||||||+|....+++.|+||||+|.+ ++.+++|||||||++|.+| ||++|||||||||+.|.++.++ +
T Consensus 82 ~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~-~~~~~~vAVEFDT~~N~~~-Dp~~nHVGIdvNs~~S~~~~~~-----~ 154 (252)
T 1fat_A 82 AGPADGLAFALVPVGSQPKDKGGFLGLFDGS-NSNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRW-----D 154 (252)
T ss_dssp CBCCEEEEEEEEETTCCCCCSGGGTTTCCSS-CCCCCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEEEC-----C
T ss_pred CCCCCcEEEEEccCCCCCCCCCccccccccC-CccCcEEEEEeecccCCCC-CCCCCeEEEecCCccccceecc-----c
Confidence 7789999999999877677889999999876 6779999999999999984 9999999999999999998875 4
Q ss_pred cCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc---cceeeeeeeeeeecC
Q 041096 179 LKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS---TELHMIQSWSFQTSG 254 (645)
Q Consensus 179 ~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~sw~f~~~~ 254 (645)
+.+|+.++|||+||+.+++|+|+|++... |..|+|+..+||+.+||++|||||||+||.. .|.|+|++|+|++..
T Consensus 155 l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~l 232 (252)
T 1fat_A 155 FVNGENAEVLITYDSSTNLLVASLVYPSQ-KTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASKL 232 (252)
T ss_dssp CCTTCEEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCEEEEEEEEEEE
T ss_pred ccCCCEEEEEEEEeCCCCEEEEEEecCCC-CCcceEEEEechHHhCCCceEEEEEeccCCCCcccceEEEEEEEEEeeC
Confidence 78899999999999999999999998653 5679999999999999999999999999999 999999999999863
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-58 Score=450.33 Aligned_cols=218 Identities=34% Similarity=0.589 Sum_probs=198.6
Q ss_pred eeEEeCCCC-CCCeEEecceEee-CCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCC
Q 041096 25 MNFDFTSFN-LRNITLLGDSYLR-NGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFG 102 (645)
Q Consensus 25 ~~f~~~~f~-~~~~~l~G~a~~~-~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g 102 (645)
++|+|++|. ..||+|+|||.+. +|.|+||++. ...+++|||+|++||+||++.+|+++||+|+|+|+|.+++...+|
T Consensus 1 ~sF~f~~F~~~~~l~l~G~A~v~~~g~l~LT~~~-~~~~~~Gra~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~~~~g 79 (234)
T 2eig_A 1 VSFNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDP-LVNRTTSHALYATPVPIWDSATGNVASFITSFSFIVSNVQRYPPT 79 (234)
T ss_dssp CEEEESSCCSSSSEEEEETCEEEGGGEEESSSCG-GGSSEEEEEEESSCEECBCTTTCCBCEEEEEEEEEEEECTTSCCC
T ss_pred CeEEcCCCCCCCCeEEcccEEEcCCCCeeeCCCC-CccCceEEEEeCCCEEeecCCCCCccceEEEEEEEEeCCCCCCCC
Confidence 479999998 8899999999995 7999999861 124689999999999999999999999999999999988777899
Q ss_pred CceEEEEecCCC--CCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCC---CeeeeecCCcccccccCCCcccc
Q 041096 103 DGLAFFISPDNQ--ILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDE---NHIGLDIDSLESIKTADPILQGI 177 (645)
Q Consensus 103 ~G~aF~l~p~~~--~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~---~Hvgi~vns~~s~~~~~~~~~~~ 177 (645)
|||||||+|... +.++.|+||||+|.+ ++.+++|||||||++|. | ||++ |||||||||+.|.++.++
T Consensus 80 dGlAF~l~p~~~~~p~~~~g~~LGl~n~~-~~~~~~vAVEFDT~~N~-~-Dp~~~~~nHVGIdvNsi~S~~~~~~----- 151 (234)
T 2eig_A 80 DGVVFFLAPWGTEIPPNSQGGYLGITDSS-NSQNQFVAVEFDSHPNV-W-DPKSLRSSHIGIDVNSIMSLKAVNW----- 151 (234)
T ss_dssp CEEEEEEEETTCCCCTTCCGGGTTTCCTT-CSCCCCEEEEEECSCCT-T-SCTTTCSSEEEEEESSSSCSEEEEC-----
T ss_pred CcEEEEEecCCCCCCcCCCCCccccccCC-CccccEEEEEeccccCc-c-CCCCCCCCceEEecCCccccceecc-----
Confidence 999999999875 446889999999876 67799999999999998 4 9999 999999999999988875
Q ss_pred ccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEecc--CCccceeeeeeeeeeecC
Q 041096 178 DLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST--EGSTELHMIQSWSFQTSG 254 (645)
Q Consensus 178 ~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsast--g~~~~~~~i~sw~f~~~~ 254 (645)
++.+|+.++|||+||+.+++|+|+|++ + .|..|+|+..+||+.+||++|||||||+| |.. |.|+|++|+|++..
T Consensus 152 ~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~IlsWsF~s~l 227 (234)
T 2eig_A 152 NRVSGSLEKATIIYDSDTKILTVVMTH-Q-NGQITTISQEIDLKTVLPEKVSVGFSATTWNPER-ERHDIYSWSFTSTL 227 (234)
T ss_dssp CCCTTCCEEEEEEEETTTTEEEEEEEE-T-TSCEEEEEEECCHHHHSCSEEEEEEEEEECSSCC-EEEEEEEEEEEEEC
T ss_pred cccCCCEEEEEEEEeCCCcEEEEEEec-C-CCCcceEeEeechHHhcCCceEEEEEeeecCCCc-ceeEEEEEEEEecC
Confidence 478999999999999999999999999 4 57789999999999999999999999999 998 99999999999863
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-58 Score=454.09 Aligned_cols=222 Identities=34% Similarity=0.561 Sum_probs=200.4
Q ss_pred CceeEEeCCC----C--CCCeEEecceEeeCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEE
Q 041096 23 NNMNFDFTSF----N--LRNITLLGDSYLRNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSI 93 (645)
Q Consensus 23 ~~~~f~~~~f----~--~~~~~l~G~a~~~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i 93 (645)
.+++|+|++| . ..||+|+|||.+.+|.|+||++... ..++.|||+|++||+||+ .+|+++||+|+|+|+|
T Consensus 2 ~~~~F~f~~F~~~~~~~~~~l~l~GdA~i~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~-~tg~vasFsT~F~F~I 80 (243)
T 1gsl_A 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVFLWD-STGKAASFYTSFTFLL 80 (243)
T ss_dssp CCCEEEESCCCCTTCCTTSSEEEEETCEEETTEEECSCBCTTSCBCSSEEEEEEESSCEECBC-TTSCBCEEEEEEEEEE
T ss_pred cceEEEcCCCccccCCCCCCEEEccceEecCCcEEecCCccCCcccCCCeEEEEECCCEEccC-CCCCcCceEEEEEEEE
Confidence 4579999999 6 5799999999999999999997421 157899999999999999 9999999999999999
Q ss_pred eeCCCCCCCCceEEEEecCCCCCCCCCCccccccCCCC---CCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCccccccc
Q 041096 94 NNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQL---TKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTA 170 (645)
Q Consensus 94 ~~~~~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~---~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~ 170 (645)
.++ ...+||||||||+|....+++.|+||||+|.+++ +.+++|||||||++|.+|+||++||||||+||+.|.++.
T Consensus 81 ~~~-~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHvGIdvns~~S~~~~ 159 (243)
T 1gsl_A 81 KNY-GAPTADGLAFFLAPVDSSVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATT 159 (243)
T ss_dssp EES-SSSCBCEEEEEEEETTCCCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEE
T ss_pred ecC-CCCCCCCEEEEEecCCCCCCCCCCcccccccccccCCccCcEEEEEeccccccccCCCCCCceeeccCCcccccee
Confidence 987 6778999999999987767788999999987642 348999999999999999999999999999999999888
Q ss_pred CCCccccccCC---CCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeee
Q 041096 171 DPILQGIDLKS---GNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQS 247 (645)
Q Consensus 171 ~~~~~~~~~~~---g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~s 247 (645)
++ ++.+ |+.++|||+||+.+++|+|+|++... ..|+|+..+||+.+||++|||||||+|| ..|.|+|++
T Consensus 160 ~~-----~l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~~~~~vGFSAsTG-~~~~h~Ils 231 (243)
T 1gsl_A 160 RW-----ENDDAYGSSIATAHITYDARSKILTVLLSYEHG--RDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTYILS 231 (243)
T ss_dssp EC-----CHHHHTSCCEEEEEEEEETTTTEEEEEEEETTS--CEEEEEEECCHHHHSCSEEEEEEEEEEC-BSEEEEEEE
T ss_pred ee-----EEeccCCCcEEEEEEEEeCCCCEEEEEEecCCC--CceeEEEEechHHhCCCceEEEEEeccC-CcceeEEEE
Confidence 76 3666 99999999999999999999998654 5789999999999999999999999999 999999999
Q ss_pred eeeeecC
Q 041096 248 WSFQTSG 254 (645)
Q Consensus 248 w~f~~~~ 254 (645)
|+|++..
T Consensus 232 WsF~s~l 238 (243)
T 1gsl_A 232 WHFFSTL 238 (243)
T ss_dssp EEEEEEC
T ss_pred EEEEeec
Confidence 9999863
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=451.92 Aligned_cols=224 Identities=35% Similarity=0.604 Sum_probs=200.6
Q ss_pred CCceeEEeCCCC--CCCeEEecceEee-CCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCC
Q 041096 22 SNNMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNP 98 (645)
Q Consensus 22 ~~~~~f~~~~f~--~~~~~l~G~a~~~-~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 98 (645)
+..++|+|++|. ..||+|+|||.+. +|.|+||++.....+++|||+|++||+||++.+|+++||+|+|+|+|.++ .
T Consensus 3 ~~~~~F~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~tg~vasFsT~F~F~I~~~-~ 81 (242)
T 1qnw_A 3 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKAD-K 81 (242)
T ss_dssp CCSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBS-S
T ss_pred ccceEEEcCCCCCCCCCeEEccceEEccCCcEEecCCCCcccCCeEEEEeCCCEeeecCCCCCcccEEEEEEEEEecC-C
Confidence 457899999998 6899999999995 79999999742125789999999999999999999999999999999987 6
Q ss_pred CCCCCceEEEEecCCC--CCCCCCCccccccCCC-CCCCcEEEEEeeCC----CCCCCCCCCCCeeeeecCCcccccccC
Q 041096 99 SSFGDGLAFFISPDNQ--ILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTR----LDPHFDDPDENHIGLDIDSLESIKTAD 171 (645)
Q Consensus 99 ~~~g~G~aF~l~p~~~--~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~----~n~~~~d~~~~Hvgi~vns~~s~~~~~ 171 (645)
..+||||||||+|... +.++.||||||+|.++ ++.+++|||||||+ +|. +||++|||||||||+.|.++.+
T Consensus 82 ~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~~~~~N~--~Dp~~nHVGIdvNs~~S~~~~~ 159 (242)
T 1qnw_A 82 SDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQIIAVEFDTYFGKAYNP--WDPDFKHIGIDVNSIKSIKTVK 159 (242)
T ss_dssp SCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSSCCTTSCCEEEEEECCCCTTTCT--TSCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCCEEEEEecCCCCCCcCCCCCcccccccCCCCccccEEEEEeecccccccCC--CCCCCCcEEEecCCccccceec
Confidence 7789999999999875 4468899999998654 34589999999999 997 4999999999999999999887
Q ss_pred CCccccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc--cceeeeeeee
Q 041096 172 PILQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS--TELHMIQSWS 249 (645)
Q Consensus 172 ~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~--~~~~~i~sw~ 249 (645)
| ++.+|+.++|||+||+.+++|+|+|++.. .|..|+|+..+||+.+||++|||||||+||.. .|.|+|++|+
T Consensus 160 ~-----~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~h~IlsWs 233 (242)
T 1qnw_A 160 W-----DWRNGEVADVVITYRAPTKSLTVCLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWY 233 (242)
T ss_dssp C-----CCCTTCCEEEEEEEEGGGTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCEEEEEE
T ss_pred c-----cccCCCEEEEEEEEeCCCcEEEEEEecCC-CCcceeEEEeechHHhcCCceEEEEEeccCCCccceEEEEEEEE
Confidence 5 47899999999999999999999999765 36679999999999999999999999999999 9999999999
Q ss_pred eeecC
Q 041096 250 FQTSG 254 (645)
Q Consensus 250 f~~~~ 254 (645)
|++..
T Consensus 234 F~s~l 238 (242)
T 1qnw_A 234 FTSNL 238 (242)
T ss_dssp EEEEC
T ss_pred eEeec
Confidence 99863
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=450.54 Aligned_cols=221 Identities=33% Similarity=0.525 Sum_probs=200.7
Q ss_pred ceeEEeCCCC--CCCeEEecceEee-CCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC-
Q 041096 24 NMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV- 96 (645)
Q Consensus 24 ~~~f~~~~f~--~~~~~l~G~a~~~-~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~- 96 (645)
+++|+|++|. ..||+|+|||.+. +|.|+||++..+ ..++.|||+|++||+|||+.+|+++||+|+|+|+|.++
T Consensus 2 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~~g~vasFsT~F~F~I~~~~ 81 (238)
T 1f9k_A 2 TQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQPY 81 (238)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCC
T ss_pred CeEEEcCCCCCCCCCeEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEeecCCCCCeeeEEEEEEEEEecCC
Confidence 5789999998 6899999999994 799999997421 14789999999999999999999999999999999987
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccc
Q 041096 97 NPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176 (645)
Q Consensus 97 ~~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~ 176 (645)
+...+||||||||+|....+++.|+||||+|.+ ++ +++|||||||++|. +||++||||||||++.|.++.++
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~-~~-~~~vAVEFDT~~N~--~Dp~~nHVgIdvns~~S~~s~~~---- 153 (238)
T 1f9k_A 82 AYPEPADGLTFFMVPPNSPQGEDGGNLGVFKPP-EG-DNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLHF---- 153 (238)
T ss_dssp SSSCCCEEEEEEEECTTCCCCCSGGGTTTCCSS-CC-SCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEEC----
T ss_pred CCCCCCCcEEEEEccCCCCCCCCCCcccccccC-CC-CcEEEEEEecccCC--CCCCCCeEEEecCCccccceEee----
Confidence 667789999999999877677889999999876 66 99999999999998 49999999999999999988775
Q ss_pred cccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCC--ccEEeEEeccCCc---cceeeeeeeeee
Q 041096 177 IDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKG--NMYVGFSASTEGS---TELHMIQSWSFQ 251 (645)
Q Consensus 177 ~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~--~~~vGfsastg~~---~~~~~i~sw~f~ 251 (645)
++.+|+.++|||+||+.+++|+|+|++.. .|..|+|+..|||+.+||+ +||||||||||.. .|.|+|++|+|+
T Consensus 154 -~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~~~~~~~~h~IlsWsF~ 231 (238)
T 1f9k_A 154 -QLENGGVANVVIKYDSPTKILNVVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFT 231 (238)
T ss_dssp -CCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCEEEEEEEEEE
T ss_pred -cccCCCEEEEEEEEeCCCCEEEEEEecCC-CCCceeEEEEechHHhCCCCceEEEEEEeCcCCCCcccceEEEEEeEeE
Confidence 58899999999999999999999999865 3567899999999999999 9999999999999 999999999999
Q ss_pred ecC
Q 041096 252 TSG 254 (645)
Q Consensus 252 ~~~ 254 (645)
+..
T Consensus 232 s~~ 234 (238)
T 1f9k_A 232 SSL 234 (238)
T ss_dssp EEC
T ss_pred eec
Confidence 863
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=452.01 Aligned_cols=222 Identities=37% Similarity=0.594 Sum_probs=200.4
Q ss_pred CceeEEeCCCC--CCCeEEecceEe-eCCcEEccCCC-CC-CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC-
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYL-RNGVIGLTREL-GV-PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV- 96 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~-~~~~~~Lt~~~-~~-~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~- 96 (645)
.+++|+|++|. ..||+|+|||.+ .+|.|+||+.. +. ..+++|||+|++||+|||+.+|+++||+|+|+|+|.++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~ 81 (242)
T 1wbf_A 2 KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPF 81 (242)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSC
T ss_pred cceEEEcCCCCCCCCCeEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEecccCCCCCeeeEEEEEEEEEeCCC
Confidence 45799999998 689999999999 57999999863 11 15789999999999999999999999999999999987
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccc
Q 041096 97 NPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176 (645)
Q Consensus 97 ~~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~ 176 (645)
+...+||||||||+|....+++.|+||||+|.+ +.+++|||||||++|. +||++|||||||||+.|.++.++
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~~~~g~~LGl~n~~--~~~~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~~~~~---- 153 (242)
T 1wbf_A 82 PRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPL--SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVPF---- 153 (242)
T ss_dssp CSSCCCEEEEEEEECSSCCCCCCGGGTTTCCTT--SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEEC----
T ss_pred CCCCCCCcEEEEEecCCCCCCCCCCccccccCC--CcCcEEEEEeccccCC--CCCCCCeEEEECCCccccceeee----
Confidence 567789999999999877677889999999865 6799999999999998 49999999999999999988775
Q ss_pred cccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEecc----CCc---cceeeeeeee
Q 041096 177 IDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST----EGS---TELHMIQSWS 249 (645)
Q Consensus 177 ~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsast----g~~---~~~~~i~sw~ 249 (645)
++.+|+.++|||+||+.+++|+|+|++... |..|+|+..|||+.+||++|||||||+| |.. .|.|+|++|+
T Consensus 154 -~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~G~~~~~~~~h~IlsWs 231 (242)
T 1wbf_A 154 -TLDNGGIANVVIKYDASTKILHVVLVFPSL-GTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWS 231 (242)
T ss_dssp -CCCTTSCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCCCCEEEEEE
T ss_pred -EecCCCEEEEEEEEeCCCCEEEEEEccCCC-CCcceEEEEechHHhcCCceEEEEEEeecCcCCccccccceEEEEEEE
Confidence 588999999999999999999999998653 5678999999999999999999999999 888 8999999999
Q ss_pred eeecC
Q 041096 250 FQTSG 254 (645)
Q Consensus 250 f~~~~ 254 (645)
|++..
T Consensus 232 F~s~l 236 (242)
T 1wbf_A 232 FSASL 236 (242)
T ss_dssp EEEEC
T ss_pred eEecC
Confidence 99863
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-57 Score=448.13 Aligned_cols=222 Identities=31% Similarity=0.559 Sum_probs=201.0
Q ss_pred CceeEEeCCCC--CCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSS 100 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~ 100 (645)
.+++|+|++|+ ..||+|+|||...+|.|+||++ ..++.|||+|++||+|||+.+|+++||+|+|+|+|.+++...
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~~~~g~l~LT~~---~~~~~G~a~y~~Pv~l~~~~~~~~~sFst~F~F~I~~~~~~~ 78 (234)
T 2bqp_A 2 ETTSFLITKFSPDQQNLIFQGDGYTTKEKLTLTKA---VKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYN 78 (234)
T ss_dssp EEEEEEESSBCTTCTTEEEEETCEEETBEEEEECS---CTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTS
T ss_pred cceEEEcCCCCCCCCCEEEeeceecCCCEEEeCCC---CCCCEEEEEECCCEEcccCCCCceeeEEEEEEEEEeCCCCCC
Confidence 45799999998 6899999999977899999997 457999999999999999999999999999999999887778
Q ss_pred CCCceEEEEecCCCCCCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCCCCC--CCeeeeecCCcccccccCCCcccc
Q 041096 101 FGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFDDPD--ENHIGLDIDSLESIKTADPILQGI 177 (645)
Q Consensus 101 ~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~d~~--~~Hvgi~vns~~s~~~~~~~~~~~ 177 (645)
+||||||+|+|....+++.|++|||+|.++ ++.+++|||||||++|.+| ||+ +||||||||++.|.++.++
T Consensus 79 ~gdGlAF~l~p~~~~p~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~N~~~-Dp~~~~nHVgIdvns~~S~~s~~~----- 152 (234)
T 2bqp_A 79 VADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDKTTQTVAVEFDTFYNAAW-DPSNRDRHIGIDVNSIKSVNTKSW----- 152 (234)
T ss_dssp CCCEEEEEEEETTCCCCCCGGGTTTCSCSSCCGGGCCEEEEEECSCCTTT-SCTTCCCEEEEEESSSSCSEEEEC-----
T ss_pred CCCcEEEEEecCCCCCCCCCCccccccccCCCCCCcEEEEEEecccCccc-CCCCCCCceeEeeCCccccceEee-----
Confidence 999999999998775668899999998753 3348999999999999885 999 9999999999999988775
Q ss_pred ccCCCCeEEEEEEecCCCceEEEEEEeCCC----CCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeeeeeec
Q 041096 178 DLKSGNVITAWIDYKNDLRMLKVFMSYSNL----KPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTS 253 (645)
Q Consensus 178 ~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~----~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~~~ 253 (645)
++.+|+.++|||+||+.+++|+|+|++... +|..|+|+..+||+.+||++|||||||+||...|.|+|++|+|+++
T Consensus 153 ~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF~s~ 232 (234)
T 2bqp_A 153 KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSE 232 (234)
T ss_dssp CCCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEE
T ss_pred EEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCCCcccEEEEEEEEEee
Confidence 477899999999999999999999997643 4678999999999999999999999999999999999999999875
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-57 Score=446.46 Aligned_cols=221 Identities=33% Similarity=0.529 Sum_probs=197.5
Q ss_pred CceeEEeCCCC--CCCeEEecceEe-eCCcEEccCCCC-C-CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYL-RNGVIGLTRELG-V-PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVN 97 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~-~~~~~~Lt~~~~-~-~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 97 (645)
.+++|+|++|. ..||+|+|||.+ .+|.|+||++.. . ..++.|||+|++||+|||+.+ ++||+|+|+|+|.+++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~~--~~sFsT~F~F~I~~~~ 79 (233)
T 1n47_A 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNTT--LASFTTSFSFVMAAPA 79 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSSC--BCEEEEEEEEECCCSS
T ss_pred cceEEEcCCCCCCCCCeEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEeccCCCC--cCCEEEEEEEEEeCCC
Confidence 45799999998 689999999999 579999999742 1 147899999999999999877 9999999999999887
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccc
Q 041096 98 PSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176 (645)
Q Consensus 98 ~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~ 176 (645)
...+||||||||+|....+++.|+||||+|.++ ++.+++|||||||++|. | ||++||||||+||+.|.++.++
T Consensus 80 ~~~~gdGlAF~l~p~~~~p~~~g~~LGl~n~~~~~~~n~~vAVEFDT~~N~-~-Dp~~nHvGIdvns~~S~~~~~~---- 153 (233)
T 1n47_A 80 AAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHDASYQTVAVEFDTYSNA-W-DPNYTHIGIDTNGIESKKTTPF---- 153 (233)
T ss_dssp TTSCCEEEEEEEECTTCCCCCCGGGTTTCSSSSCCGGGCCEEEEEECSCCT-T-SCSSCEEEEEESSSSCSEEEEC----
T ss_pred CCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCccCceEEEEeccccCC-C-CCCCCcEEEccCCccccccccc----
Confidence 778899999999998765668899999998753 33489999999999998 4 9999999999999999988775
Q ss_pred cccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc---cceeeeeeeeeeec
Q 041096 177 IDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS---TELHMIQSWSFQTS 253 (645)
Q Consensus 177 ~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~sw~f~~~ 253 (645)
++.+|+.++|||+||+.+++|+|+|++... +..|+|+..+||+.+||++|||||||+||.. .|.|+|++|+|+++
T Consensus 154 -~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~~~~~vGFSAsTG~~~~~~~~h~IlsWsF~s~ 231 (233)
T 1n47_A 154 -DMVYGEKANIVITYQASTKALAASLVFPVS-QTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVS 231 (233)
T ss_dssp -CCCTTSCEEEEEEEETTTTEEEEEEEETTT-TEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred -cccCCCEEEEEEEEeCCCCEEEEEEecCCC-CCcceEEEEechHHhCCCceEEEEEeccCCCccccceeEEEEEEEEee
Confidence 577999999999999999999999998653 3578999999999999999999999999998 99999999999875
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-57 Score=446.64 Aligned_cols=222 Identities=32% Similarity=0.536 Sum_probs=198.9
Q ss_pred CceeEEeCCCC--CCCeEEecceEee-CCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV 96 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~~-~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 96 (645)
.+++|+|++|. ..||+|+|||.+. +|.|+||++..+ ..++.|||+|++||+|||+ +|+++||+|+|+|+|.++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~~~-~g~~~sFst~F~F~I~~~ 80 (240)
T 2fmd_A 2 NSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQS-SSLVASFETTFTFSISQG 80 (240)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TCSEEEEEEEEEEECCBS
T ss_pred cceEEEcCCCCCCCCCeEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEeeCC-CCCcCcEEEEEEEEEecC
Confidence 46799999998 6899999999994 799999997421 1378999999999999999 999999999999999987
Q ss_pred CCCCCCCceEEEEecCCCCCC--CCCCccccccCCC--CCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCC
Q 041096 97 NPSSFGDGLAFFISPDNQILG--SAGGCLGLVNSSQ--LTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADP 172 (645)
Q Consensus 97 ~~~~~g~G~aF~l~p~~~~~~--~~g~~lGl~~~~~--~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~ 172 (645)
...+||||||+|+|....++ +.|++|||+|.++ ++.+++|||||||++|.+++||++||||||+|++.|.++.++
T Consensus 81 -~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~Dp~~nHvgIdvns~~S~~s~~~ 159 (240)
T 2fmd_A 81 -SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKW 159 (240)
T ss_dssp -SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC
T ss_pred -CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEeccccccccCCCCCCceeeccccccccceeEE
Confidence 67789999999999877543 7899999998764 345899999999999998679999999999999999988775
Q ss_pred CccccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeeeeee
Q 041096 173 ILQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQT 252 (645)
Q Consensus 173 ~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~~ 252 (645)
++.+|+.++|||+||+.+++|+|+|++... ..|+|+..+||+.+||++|||||||+||...|.|+|++|+|++
T Consensus 160 -----~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF~s 232 (240)
T 2fmd_A 160 -----DWQNGKTATAHISYNSASKRLSVVSSYPNS--SPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSFRS 232 (240)
T ss_dssp -----CCCSSCEEEEEEEEETTTTEEEEEEECTTS--CCEEEEEECCGGGTSCSEEEEEEEEECCSSCBCCEEEEEEEEE
T ss_pred -----EeeCCCEEEEEEEEeCCCCEEEEEEecCCC--CceEEEEEechHHhCCCceEEEEEeccCCccccEEEEEEEeEe
Confidence 477899999999999999999999997654 5789999999999999999999999999999999999999988
Q ss_pred c
Q 041096 253 S 253 (645)
Q Consensus 253 ~ 253 (645)
.
T Consensus 233 ~ 233 (240)
T 2fmd_A 233 S 233 (240)
T ss_dssp E
T ss_pred c
Confidence 6
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-57 Score=442.85 Aligned_cols=218 Identities=30% Similarity=0.459 Sum_probs=195.6
Q ss_pred CceeEEeCCCCCCCeEEecceEee-CCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCC
Q 041096 23 NNMNFDFTSFNLRNITLLGDSYLR-NGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSF 101 (645)
Q Consensus 23 ~~~~f~~~~f~~~~~~l~G~a~~~-~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 101 (645)
..++|+|++|...||+|+|||.+. +|.|+||++.....+++|||+|++||+|||+.+|+++||+|+|+|+|.+++...+
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~~g~vaSFsT~F~F~I~~~~~~~~ 81 (226)
T 1avb_A 2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIENS 81 (226)
T ss_dssp EEEEEEESSCCGGGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTTSC
T ss_pred cceEEEcCCCCccCEEEeccEEECCCCEEEeCCCCCCccCCeEEEEeCCCEEeecCCCCCcccEEEEEEEEEeCCCCCCC
Confidence 357899999999999999999995 8999999874223578999999999999999999999999999999999877789
Q ss_pred CCceEEEEecCCCCCCCCCCccccccCCCC-CCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccccccC
Q 041096 102 GDGLAFFISPDNQILGSAGGCLGLVNSSQL-TKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLK 180 (645)
Q Consensus 102 g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~-~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~~~~ 180 (645)
||||||||+|....+++.|+||||+|.+++ ..+++|||||||+ +|||||||||+.|.++.++ +..+.
T Consensus 82 gdGlAF~l~p~~~~p~~~g~~LGl~n~~~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~---~~~l~ 149 (226)
T 1avb_A 82 AYGLAFALVPVGSRPKLKGRYLGLFNTTNYDRDAHTVAVVFDTV---------SNRIEIDVNSIRPIATESC---NFGHN 149 (226)
T ss_dssp CEEEEEEEEETTCCCCCCGGGTTTCSCSSCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEEC---CSGGG
T ss_pred CCcEEEEEecCCCCCCCCCCcccccccCCCCCcccEEEEEecCc---------CCccceeecCcccCccccC---Ccccc
Confidence 999999999987756688999999987533 3489999999998 5999999999999998887 35677
Q ss_pred CCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc---cceeeeeeeeeeec
Q 041096 181 SGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS---TELHMIQSWSFQTS 253 (645)
Q Consensus 181 ~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~sw~f~~~ 253 (645)
+|+.++|||+||+.+++|+|+|++.+. +..|+|+..+||+.+||++|||||||+||.. .|.|+|++|+|+++
T Consensus 150 ~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~h~IlsWsF~s~ 224 (226)
T 1avb_A 150 NGEKAEVRITYDSPKNDLRVSLLYPSS-EEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSN 224 (226)
T ss_dssp TTCEEEEEEEEEGGGTEEEEEEEETTT-TEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEEEEEEEE
T ss_pred CCCeEEEEEEEeCCCcEEEEEEeecCC-CccceEEEEechHHhCCCceEEEEEeccCCCCcccceeEEEEEEEEee
Confidence 999999999999999999999997653 3479999999999999999999999999999 99999999999874
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=435.71 Aligned_cols=217 Identities=26% Similarity=0.401 Sum_probs=193.2
Q ss_pred CceeEEeCCCCCCC-eEEecceEee-CCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCC
Q 041096 23 NNMNFDFTSFNLRN-ITLLGDSYLR-NGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVN 97 (645)
Q Consensus 23 ~~~~f~~~~f~~~~-~~l~G~a~~~-~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 97 (645)
.+++|+|++|...| |+|+|||.+. +|.|+||++..+ ..++.|||+|++||+|||+. +++||+|+|+|+|.+++
T Consensus 2 ~~~~F~f~~F~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~d~~--~vaSFsT~F~F~I~~~~ 79 (240)
T 1ioa_A 2 TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDSN--NVASFNTNFTFIIRAKN 79 (240)
T ss_dssp CCCEEEESSCCTTSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCSS--CBEEEEEEEEEECCBSC
T ss_pred cceEEEcCCCCCCCcEEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEccCCC--ccccEEEEEEEEEeCCC
Confidence 46799999999999 9999999995 899999987431 12689999999999999986 89999999999999887
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccc
Q 041096 98 PSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176 (645)
Q Consensus 98 ~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~ 176 (645)
...+||||||||+|....+++.|+||||+|.++ +..+++|||||||+ +|||||||||+.|.++.+| +
T Consensus 80 ~~~~gdGlAF~l~p~~~~p~~~g~~LGL~n~~~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~---~ 147 (240)
T 1ioa_A 80 QSISAYGLAFALVPVNSPPQKKQEFLGIFNTNNPEPNARTVAVVFNTF---------KNRIDFDKNFIKPYVNENC---D 147 (240)
T ss_dssp TTSCCEEEEEEEEETTCCCCCCGGGTTTCCCSSCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEEC---C
T ss_pred CCCCCCcEEEEEecCCCCCCCCCCcccccccCCCCCcCcEEEEEecCc---------CCceeeeeCCccccccccC---C
Confidence 778999999999998775668899999998753 23489999999998 5999999999999998886 3
Q ss_pred cccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc---cceeeeeeeeeeec
Q 041096 177 IDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS---TELHMIQSWSFQTS 253 (645)
Q Consensus 177 ~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~sw~f~~~ 253 (645)
..+.+|+.++|||+||+.+++|+|+|++.+. +..|+|+..+||+.+||++|||||||+||.. .|.|+|++|+|++.
T Consensus 148 ~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~H~IlsWsF~s~ 226 (240)
T 1ioa_A 148 FHKYNGEKTDVQITYDSSNNDLRVFLHFTVS-QVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSSK 226 (240)
T ss_dssp HHHHCSSCEEEEEEEETTTTEEEEEEEETTT-CCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCCEEEEEEEEEE
T ss_pred ccccCCCEEEEEEEEeCCCcEEEEEEecCCC-CccceeEEEechHHhCCCceEEEEEeccCCCCcccceeEEEEEEEEee
Confidence 5677899999999999999999999997653 4489999999999999999999999999999 99999999999986
Q ss_pred C
Q 041096 254 G 254 (645)
Q Consensus 254 ~ 254 (645)
.
T Consensus 227 ~ 227 (240)
T 1ioa_A 227 F 227 (240)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=405.98 Aligned_cols=199 Identities=25% Similarity=0.383 Sum_probs=175.1
Q ss_pred CceeEEeCCCCCCCeEEecceEee-CCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCC
Q 041096 23 NNMNFDFTSFNLRNITLLGDSYLR-NGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSF 101 (645)
Q Consensus 23 ~~~~f~~~~f~~~~~~l~G~a~~~-~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 101 (645)
..++|+|++|...||+|+|||.+. +|.|+||+. ..++.|||+|++||+|||+.+|+++||+|+|+|+|.+++...+
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~---~~~~~Gra~y~~Pi~l~~~~~g~vaSFsT~F~F~I~~~~~~~~ 78 (223)
T 1dhk_B 2 TETSFIIDAFNKTNLILQGDATVSSNGNLQLSYN---SYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANS 78 (223)
T ss_dssp CCCEEEESSCCGGGEEEESSEEECTTSCEEESSS---CSSEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---C
T ss_pred cceEEEcCCCCcCCEEEeccEEECCCCEEEcCCC---CCCCEEEEEECCCEEeecCCCCCccceEEEEEEEEeCCCCCCC
Confidence 457999999999999999999995 899999986 4679999999999999999999999999999999998877788
Q ss_pred CCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccccccCC
Q 041096 102 GDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKS 181 (645)
Q Consensus 102 g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~~~~~ 181 (645)
||||||||+|....++ +++|||||||+ +||||||+||+ |.++.+| +..+.+
T Consensus 79 gdGlAF~l~p~~~~p~----------------~~~vAVEFDT~---------~nHVGIdvNsi-S~~~~~~---~~~l~~ 129 (223)
T 1dhk_B 79 AVGLDFVLVPVQPESK----------------GDTVTVEFDTF---------LSRISIDVNNN-DIKSVPW---DVHDYD 129 (223)
T ss_dssp CSEEEEEEEEC----------------------CCEEEEEETT---------TTEEEEEETTE-EEEEEEC---CGGGTT
T ss_pred CCceEEEEecCCCCCC----------------ccEEEEEecCC---------CCcccccCCcc-ccccccC---CccccC
Confidence 9999999999765321 34899999998 59999999999 9988876 456779
Q ss_pred CCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc---cceeeeeeeeeeecC
Q 041096 182 GNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS---TELHMIQSWSFQTSG 254 (645)
Q Consensus 182 g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~sw~f~~~~ 254 (645)
|+.++|||+||+.+++|+|+|++.+. +..|+++..+||+.+||++|||||||+||.. .|.|+|++|+|++..
T Consensus 130 g~~~~v~I~Yd~~~~~L~V~l~~~~~-~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~~ 204 (223)
T 1dhk_B 130 GQNAEVRITYNSSTKVFSVSLSNPST-GKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSKF 204 (223)
T ss_dssp TSCEEEEEEEETTTTEEEEEEECTTT-CCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEEEEEEC
T ss_pred CCEEEEEEEEeCCCCEEEEEEecCCC-CccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEEEEecc
Confidence 99999999999999999999997653 3489999999999999999999999999999 999999999999863
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=435.56 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=209.1
Q ss_pred cCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|...++||+|+||+||+|++.. ++..||||+++.. ....++|.+|+++|++++|||||+++|+|.+.+.+||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 356677899999999999998753 5789999999764 4456789999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCC-----------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 422 VYEYMPNGSLDRMLYQDSEN-----------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
|||||++|+|.++|+..... ..+++|.+++.|+.|||+||+|||+ ++|+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 99999999999999865321 2359999999999999999999999 999999999999999999999
Q ss_pred eeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHH
Q 041096 491 RLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWV 555 (645)
Q Consensus 491 kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~ 555 (645)
||+|.. ....||+.|||||++.+..++.++|||||||+||||+| |+.||...... .++.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~-- 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT----EAID-- 271 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH----HHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH----HHHH--
Confidence 998822 22468999999999999999999999999999999999 89999764321 1111
Q ss_pred HhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 556 WGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 556 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
.+....+...+..++..+.+|+..||+.||++||||+||++.|+.+.+.|
T Consensus 272 -----------~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 272 -----------CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp -----------HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred -----------HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 11122223445566778899999999999999999999999999776543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=432.69 Aligned_cols=246 Identities=25% Similarity=0.435 Sum_probs=205.7
Q ss_pred cCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|...+.||+|+||+||+|++.. ++..||||+++.. ....++|.+|+++|++++|||||+++|+|.+++..||
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 467778999999999999998753 5788999999763 4456789999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcC---------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeee
Q 041096 422 VYEYMPNGSLDRMLYQDS---------ENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL 492 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl 492 (645)
|||||++|+|.++|+... .....++|.+++.|+.|||+||+|||+ ++|+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997643 223459999999999999999999999 99999999999999999999999
Q ss_pred eccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHh
Q 041096 493 ESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWG 557 (645)
Q Consensus 493 ~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~ 557 (645)
+|.. ....||++|||||++.++.|+.++|||||||+||||+| |+.||...... .+..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~---- 241 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIE---- 241 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHH----
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH----
Confidence 8821 12358999999999999999999999999999999999 89999765321 1111
Q ss_pred hhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 558 LYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 558 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
.+........+..++..+.+++..||+.||++||||++|++.|+++.
T Consensus 242 ---------~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 242 ---------CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp ---------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11122223445566778899999999999999999999999998654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=429.80 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=204.4
Q ss_pred CCCcCceeccCCceEEEEEEEC-----CCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFA-----SSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~-----~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
+++..+.||+|+||+||+|.+. .++..||||+++.. ....++|.+|+.++++++|||||+++|+|.+.+.++|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455788999999999999974 35689999998763 3346789999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCC------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 041096 422 VYEYMPNGSLDRMLYQDSEN------------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN 489 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~ 489 (645)
|||||++|+|.++|...... ...++|.++++|+.|||+||+|||+ ++|+||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence 99999999999999754321 2359999999999999999999999 99999999999999999999
Q ss_pred eeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHH
Q 041096 490 ARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDW 554 (645)
Q Consensus 490 ~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~ 554 (645)
+||+|.. +...||++|||||++.++.++.++|||||||+||||+| |+.||...... .+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~----~~~-- 257 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----DVV-- 257 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH----HHH--
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH----HHH--
Confidence 9998821 22468999999999999999999999999999999998 89999765321 122
Q ss_pred HHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 555 VWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 555 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+.+........+.+++..+.+++..||+.||++||||+||++.|+..
T Consensus 258 -----------~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 -----------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -----------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -----------HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 12222222345566778899999999999999999999999999854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=416.30 Aligned_cols=244 Identities=23% Similarity=0.403 Sum_probs=197.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
+++...++||+|+||+||+|++.. .||||+++. ..+..+.|.+|++++++++|||||+++|+|.+ +.++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 467778999999999999998753 589998865 33446789999999999999999999999865 56899999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
||++|+|.++|+.... .++|.+++.|+.|||+||+|||+ ++|+||||||+||||++++.+||+|..
T Consensus 112 y~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999976543 39999999999999999999999 999999999999999999999998822
Q ss_pred ------cccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHH
Q 041096 497 ------TLTAGTMGYLAPEYLQY---GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~---~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
...+||+.|||||++.+ +.|+.++|||||||+||||+||+.||....... .+...+.....
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~---~~~~~~~~~~~------- 255 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD---QIIFMVGRGYA------- 255 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHTTCC-------
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH---HHHHHHhcCCC-------
Confidence 22479999999999864 468999999999999999999999997643211 11111111110
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
.+.+ ...+.+++..+.+++..||+.||++||||.||++.|+.+.
T Consensus 256 -~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 256 -SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp -CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred -CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1111 1234456678889999999999999999999999887553
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=364.79 Aligned_cols=174 Identities=32% Similarity=0.607 Sum_probs=157.8
Q ss_pred CceeEEeCCCC--CCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSS 100 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~ 100 (645)
.+++|+|++|. ..||+|+|||...+|.|+||+. ...++|||+|++||+||++.+|+++||+|+|+|.|.+.+...
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~~~~g~l~LT~~---~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~~~ 78 (181)
T 2ltn_A 2 ETTSFLITKFSPDQQNLIFQGDGYTTKEKLTLTKA---VKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYN 78 (181)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEECSSSEEEECS---CSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTS
T ss_pred cceEEEcCCCCCCCCCEEEeccccCCCCCeEcCCC---CCCCEEEEEECCCEEeecCCCCCccceEEEEEEEEecCCCCC
Confidence 45799999998 6899999999966899999997 357899999999999999999999999999999999887778
Q ss_pred CCCceEEEEecCCCCCCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCCCCC--CCeeeeecCCcccccccCCCcccc
Q 041096 101 FGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFDDPD--ENHIGLDIDSLESIKTADPILQGI 177 (645)
Q Consensus 101 ~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~d~~--~~Hvgi~vns~~s~~~~~~~~~~~ 177 (645)
+||||||||+|....+++.||||||+|.++ ++.+++|||||||++|.+| ||+ +|||||||||+.|.++.+|
T Consensus 79 ~gdGlAF~l~p~~~~p~~~g~~LGL~n~~~~~~~n~~vAVEFDT~~n~~~-Dp~~~~nHVGIdvNs~~S~~t~~~----- 152 (181)
T 2ltn_A 79 VADGFTFFIAPVDTKPQTGGGYLGVFNSAEYDKTTQTVAVEFDTFYNAAW-DPSNRDRHIGIDVNSIKSVNTKSW----- 152 (181)
T ss_dssp CCCEEEEEEEETTCCCCCCGGGTTTCSCSSCCTTSCCEEEEEECSCCTTT-SCTTCCCEEEEEESSSSCSEEEEC-----
T ss_pred CCCceEEEEecCCCCCCCCCccccccccCCCCccccEEEEEecccccccc-CCCCCCCEEEEEcCCccccceecc-----
Confidence 899999999998775568899999998753 3458999999999999984 999 9999999999999998886
Q ss_pred ccCCCCeEEEEEEecCCCceEEEEEEeC
Q 041096 178 DLKSGNVITAWIDYKNDLRMLKVFMSYS 205 (645)
Q Consensus 178 ~~~~g~~~~~~I~Y~~~~~~l~v~~~~~ 205 (645)
++.+|+.++|||+||+.+++|+|+|+|+
T Consensus 153 ~l~~G~~~~v~I~Yd~~~~~L~V~l~~~ 180 (181)
T 2ltn_A 153 KLQNGEEANVVIAFNAATNVLTVSLTYP 180 (181)
T ss_dssp CCCTTCCEEEEEEEETTTTEEEEEEEEC
T ss_pred ccCCCCEEEEEEEEECCCCEEEEEEecC
Confidence 4779999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=417.52 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=208.1
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEECCC-----CeEEEEEeccCC--cchhHhHHHHHHHHhhcCC-CCeeeeeee
Q 041096 341 RELRSATRGFHSNRILGRGAFGNVYKAYFASS-----GSVAAVKRSKHS--HEGKTEFLAELSIIACLRH-KNLVQLLGW 412 (645)
Q Consensus 341 ~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~-----~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H-~niv~l~g~ 412 (645)
.+++...++|+..+.||+|+||+||+|.+... ++.||||++... ....++|.+|+++|.+++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 34444557889999999999999999997643 368999998763 3345679999999999975 899999999
Q ss_pred eeeC-CeEEEEEecCCCCCHhHHhhhcCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 041096 413 CAEK-GELLLVYEYMPNGSLDRMLYQDSE------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKA 479 (645)
Q Consensus 413 ~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp 479 (645)
|.+. +.++||||||++|+|.++|+.... ....++|.+++.++.|||+||+|||+ ++|+||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCc
Confidence 9764 578999999999999999976432 12458999999999999999999999 9999999999
Q ss_pred CcEEEcCCCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccc
Q 041096 480 SNIMLDANFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETE 544 (645)
Q Consensus 480 ~NIlld~~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~ 544 (645)
+||||++++.+||+|.. +..+||+.|||||++.++.|+.++|||||||+||||+| |+.||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999998822 12368999999999999999999999999999999998 9999976432
Q ss_pred ccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 545 GHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 545 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
... + ...+....+...+..+...+.+++..||+.||++||||.||++.|+.+
T Consensus 294 ~~~---~-------------~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 294 DEE---F-------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp SHH---H-------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH---H-------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 211 1 122222233344555667888999999999999999999999998765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=410.63 Aligned_cols=238 Identities=24% Similarity=0.333 Sum_probs=195.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..+.||+|+||+||+|+...+++.||||++... ....+.+.+|+++|++|+|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999999999999999998653 3345679999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
||++|+|.++|..... ..+++.+.+.++.||+.||+|||+ ++|+||||||+||||+.++.+||.|..
T Consensus 104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999975432 347899999999999999999999 999999999999999999999998832
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
...+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.. .+...+ +....
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i------------~~~~~ 242 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK----NLVLKI------------ISGSF 242 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHH------------HHTCC
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHH------------HcCCC
Confidence 2246999999999999999999999999999999999999999764321 111111 11111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+......+.+++..||+.||++|||++|+++
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122334556788999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=405.63 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=195.9
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC----eEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG----ELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 423 (645)
+++...++||+|+||+||+|++. |+.||||++.........+..|+..+.+++|||||+++|+|.+.+ ++||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 45677889999999999999985 899999998764443344456677778899999999999998764 689999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeeCCCCCCcEEEcCCCCeeeeccc--
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC-----EQQVIHRDIKASNIMLDANFNARLESSF-- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlkp~NIlld~~~~~kl~d~~-- 496 (645)
|||++|+|.++|+... ++|.++++++.|+|+||+|||+.+ .++|+||||||+|||||.++.+||+|..
T Consensus 81 Ey~~~gsL~~~l~~~~-----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999997643 899999999999999999999731 2499999999999999999999998832
Q ss_pred --------------cccccCCcccCcccccCC------CCCcchhHHHHHHHHHHHHcCCCCCCccccccchh-h-----
Q 041096 497 --------------TLTAGTMGYLAPEYLQYG------TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMV-N----- 550 (645)
Q Consensus 497 --------------~~~~gt~~y~APE~~~~~------~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~-~----- 550 (645)
...+||+.|||||++.+. .++.++|||||||+||||+||+.|+.......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 123699999999999764 36789999999999999999988775433211100 0
Q ss_pred -HHHHHHhhhccCchhHHhhhhccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 551 -LVDWVWGLYAEGRIIEAADKRLNGAFN-----EDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 551 -l~~~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
...... ....+..++...+ .+++..+.+++..||+.||++||||.||++.|+.+.+.
T Consensus 236 ~~~~~~~--------~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 236 PSVEEMR--------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHH--------HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chHHHHH--------HHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 000000 0111222222222 35677899999999999999999999999999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=406.00 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=202.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
+.|+..+.||+|+||+||+|+...+|+.||||++... ....+.+.+|+++|++++|||||++++++.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4588889999999999999999999999999998653 334567899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS----------- 495 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~----------- 495 (645)
++|+|.+++.+.. +++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||.|.
T Consensus 154 ~gg~L~~~l~~~~-----l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 9999999997532 8999999999999999999999 99999999999999999999999882
Q ss_pred -ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 496 -FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 496 -~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. .+...+.. ...+.+
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~---------~~~~~~-- 290 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRD---------NLPPRL-- 290 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHH---------SSCCCC--
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHHc---------CCCCCC--
Confidence 23357999999999999999999999999999999999999999764321 11111111 000111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCC
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEA 613 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~ 613 (645)
.........+.+++..||+.||++|||++|+++ +|.+..
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 112233456788899999999999999999987 455443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=402.99 Aligned_cols=239 Identities=22% Similarity=0.229 Sum_probs=201.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
+.|...++||+|+||+||+|++..+++.||||+++... ...+|+.++++++|||||++++++.+++.+|||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 46778889999999999999999999999999987532 23579999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-Ceeeeccc----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-NARLESSF---------- 496 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~-~~kl~d~~---------- 496 (645)
+|+|.++|.+... +++.++..++.||+.||+|||+ ++|+||||||+||||+.++ .+||.|..
T Consensus 134 gg~L~~~l~~~~~----l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 134 GGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999986543 9999999999999999999999 9999999999999999987 59998832
Q ss_pred -------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 -------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
...+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+.. ..
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-------~~------- 272 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-------EP------- 272 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH-------SC-------
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc-------CC-------
Confidence 113699999999999999999999999999999999999999986544332221111 00
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+. ....+.+....+.+++..||+.||++|||+.|+++.|...
T Consensus 273 ~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 273 PP-IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp CG-GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 00 0123344556788889999999999999999999887643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=395.98 Aligned_cols=234 Identities=22% Similarity=0.356 Sum_probs=189.7
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeeeee----CCeEEEEE
Q 041096 351 HSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWCAE----KGELLLVY 423 (645)
Q Consensus 351 ~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 423 (645)
+..+.||+|+||+||+|.+..++..||+|++.. .....+.|.+|++++++|+|||||+++++|.+ ++.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 456779999999999999999999999998865 33445679999999999999999999999865 34689999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEEcC-CCCeeeecc-----
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ--VIHRDIKASNIMLDA-NFNARLESS----- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NIlld~-~~~~kl~d~----- 495 (645)
|||++|+|.++|.+... +++..+..++.||++||+|||+ ++ |+||||||+||||+. ++.+||+|.
T Consensus 109 Ey~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 99999999999986543 8999999999999999999998 66 999999999999985 789999882
Q ss_pred -----ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 496 -----FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 496 -----~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....+||+.|||||++.+ +|+.++|||||||+||||+||+.||...... ..+...+ ..+... .
T Consensus 182 ~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~---~~~~~~i----~~~~~~----~ 249 (290)
T 3fpq_A 182 KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIYRRV----TSGVKP----A 249 (290)
T ss_dssp CCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHHHHH----TTTCCC----G
T ss_pred CCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH---HHHHHHH----HcCCCC----C
Confidence 223479999999998864 6999999999999999999999999754321 1111111 111000 0
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.++......+.+++..||+.||++|||++|+++
T Consensus 250 ----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111112345778889999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=407.27 Aligned_cols=242 Identities=23% Similarity=0.302 Sum_probs=203.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
+.|+..+.||+|+||.||+|....+|+.||||++... ....+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5688899999999999999999999999999998763 344567899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS----------- 495 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~----------- 495 (645)
++|+|.+++.... +++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||.|.
T Consensus 231 ~gG~L~~~i~~~~-----l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999997542 8999999999999999999999 99999999999999999999999882
Q ss_pred -ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 496 -FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 496 -~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .+...+.. ...+.+
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~---------~~~~~~-- 367 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRD---------NLPPRL-- 367 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHH---------SCCCCC--
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHHc---------CCCCCC--
Confidence 22357999999999999999999999999999999999999999764321 11111111 001111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
.........+.+++..||+.||++|||++|+++ +|.+.
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 111223456778889999999999999999987 46544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=395.94 Aligned_cols=234 Identities=22% Similarity=0.299 Sum_probs=199.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..++||+|+||+||+|+...+++.||||++.+. ....+.+.+|+++|++++|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688999999999999999999999999999998652 234567999999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
|||++|+|.+++.+... +++.+...++.||+.||+|||+ ++|+||||||+||||+.++.+||.|..
T Consensus 112 Ey~~gG~L~~~i~~~~~----l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999986543 9999999999999999999999 999999999999999999999998821
Q ss_pred -------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 -------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
...+||+.|||||++.+..|+.++||||+||+||||++|+.||...+.. .+...+ ..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i------------~~ 248 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG----LIFAKI------------IK 248 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH------------HH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH------------Hc
Confidence 2347999999999999999999999999999999999999999764321 111111 11
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVF 606 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl 606 (645)
.. -.++......+.+++..|++.||++|||++|++
T Consensus 249 ~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 249 LE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp TC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11 122333345678889999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=385.19 Aligned_cols=238 Identities=23% Similarity=0.355 Sum_probs=191.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||+||+|....+++.||||++.+. ....+.+.+|++++++++|||||++++++.+.+..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999999999999999998653 233567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+ +|+|.+++.++.. +++.+...++.||+.||+|||+ ++|+||||||+||||+.++.+||+|..
T Consensus 93 Ey~-~g~L~~~l~~~~~----l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSCS----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 7899999976543 9999999999999999999999 999999999999999999999998822
Q ss_pred ----cccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
...+||+.|||||++.+..+ +.++||||+||++|||++|+.||...+.. .+...+ ....
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~----~~~~~i------------~~~~ 228 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP----VLFKNI------------SNGV 228 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH------------HHTC
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHH------------HcCC
Confidence 23579999999999998876 57999999999999999999999764321 111111 0111
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcC
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNN 611 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~ 611 (645)
..++......+.+++..||+.||++|||++|+++ .++.
T Consensus 229 --~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 --YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1222333456778899999999999999999987 4543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=390.85 Aligned_cols=235 Identities=22% Similarity=0.292 Sum_probs=192.0
Q ss_pred cCCCcCceeccCCceEEEEEEEC---CCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFA---SSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~---~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|+..+.||+|+||+||+|+.. .+++.||||++... ......+.+|+++|++++|||||++++++.+.+.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999873 45789999998763 2334568899999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc------
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS------ 495 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~------ 495 (645)
|||||++|+|.++|.+... +++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||.|.
T Consensus 104 vmEy~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM----FTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999987543 9999999999999999999999 99999999999999999999999882
Q ss_pred ------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 496 ------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 496 ------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
....+||+.|||||++.+..|+.++||||+||+||||++|+.||...+..+ +...+ ..
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~i------------~~ 240 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----TMTMI------------LK 240 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH------------HH
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH----HHHHH------------Hc
Confidence 223579999999999999999999999999999999999999997643221 11111 11
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPS-----MRRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~~vl~ 607 (645)
.. ..++......+.+++..||+.||++||| ++|+++
T Consensus 241 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 241 AK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11 1233334556788999999999999998 467764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=381.10 Aligned_cols=238 Identities=23% Similarity=0.340 Sum_probs=189.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC--------
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG-------- 417 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-------- 417 (645)
++|+..+.||+|+||+||+|+...+++.||||++... ....+.+.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4588899999999999999999999999999988653 334567999999999999999999999987644
Q ss_pred ----eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeee
Q 041096 418 ----ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLE 493 (645)
Q Consensus 418 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~ 493 (645)
.+|||||||++|+|.+++..... ....++..++.++.||++||+|||+ ++|+||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999976543 2336778889999999999999999 999999999999999999999998
Q ss_pred ccc------------------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchh
Q 041096 494 SSF------------------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMV 549 (645)
Q Consensus 494 d~~------------------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~ 549 (645)
|.. +..+||+.|||||++.+..|+.++|||||||++|||++ ||....+ ..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---~~ 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---RV 234 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---HH
Confidence 832 11369999999999999999999999999999999996 7754211 00
Q ss_pred hHHHHHHhhhccCchhHHhhhhccCCCCH---HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcC
Q 041096 550 NLVDWVWGLYAEGRIIEAADKRLNGAFNE---DEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNN 611 (645)
Q Consensus 550 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~---~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~ 611 (645)
..+.. . ....++. +....+.+++..||+.||++|||+.|+++ .+++
T Consensus 235 ~~~~~------------~----~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 235 RTLTD------------V----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHH------------H----HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHH------------H----hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 11100 0 0112222 22344667899999999999999999987 4543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=371.76 Aligned_cols=282 Identities=40% Similarity=0.707 Sum_probs=244.0
Q ss_pred CCcccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeee
Q 041096 334 GPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLG 411 (645)
Q Consensus 334 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g 411 (645)
....++++++..++++|+..+.||+|+||.||+|... ++..||||++.... .....+.+|++++++++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 4567899999999999999999999999999999865 48899999987632 23447899999999999999999999
Q ss_pred eeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCee
Q 041096 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491 (645)
Q Consensus 412 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~k 491 (645)
+|...+..++||||+++|+|.+++.........++|..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999987766566799999999999999999999993333999999999999999999999
Q ss_pred eecccc-------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccc-cccchhhHHHHHHh
Q 041096 492 LESSFT-------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERET-EGHKMVNLVDWVWG 557 (645)
Q Consensus 492 l~d~~~-------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~-~~~~~~~l~~~~~~ 557 (645)
|.|... ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .......+.+|+..
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 987321 2348999999999998899999999999999999999999996432 12233456778877
Q ss_pred hhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 558 LYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 558 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
...........+..+...+..++...+.+++..||+.||.+|||+++|+++|++.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 77777788888888888899999999999999999999999999999999999754443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=378.41 Aligned_cols=267 Identities=22% Similarity=0.272 Sum_probs=203.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeee------CCe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAE------KGE 418 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 418 (645)
++|+..+.||+|+||+||+|.+..+|+.||||++.... ...+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57899999999999999999999999999999987632 335678899999999999999999998754 367
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-- 496 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-- 496 (645)
+|||||||. |+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++..|+.|..
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeeccee
Confidence 999999995 78999997643 39999999999999999999999 999999999999999999999998722
Q ss_pred --------------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh--
Q 041096 497 --------------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY-- 559 (645)
Q Consensus 497 --------------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~-- 559 (645)
...+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 234799999999998875 569999999999999999999999987543322222221110000
Q ss_pred -----ccCchhHHhhhhccC--CCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCCCCCCCCC
Q 041096 560 -----AEGRIIEAADKRLNG--AFN-----EDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPLVVPKLKP 623 (645)
Q Consensus 560 -----~~~~~~~~~d~~l~~--~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~~~p~~~~ 623 (645)
........+ ..+.. ..+ ......+.+++..||+.||++|||++|+++ +|++..++...|...+
T Consensus 286 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~ 362 (398)
T 4b99_A 286 VIQAVGAERVRAYI-QSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP 362 (398)
T ss_dssp GTC-----CHHHHH-HSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS
T ss_pred Hhhhhhhhhhhhhh-hcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC
Confidence 000000000 00000 000 011345678899999999999999999987 5766554444444333
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=367.62 Aligned_cols=272 Identities=36% Similarity=0.675 Sum_probs=233.5
Q ss_pred ccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeee
Q 041096 337 EFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415 (645)
Q Consensus 337 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 415 (645)
.+.+.++..++++|+..+.||+|+||.||+|.+. ++..||||++... ....+.+.+|++++++++||||++++++|.+
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 3445556667899999999999999999999975 5889999987763 4456789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 416 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
.+..++||||+++|+|.+++.........++|.+++.++.|+++||+|||+ .+++||||||+|||++.++.+|+.|.
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999997665444569999999999999999999999 99999999999999999999999873
Q ss_pred c--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc
Q 041096 496 F--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE 561 (645)
Q Consensus 496 ~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~ 561 (645)
. ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .......|.......
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNN 262 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS-SCCCHHHHTHHHHTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH-HHHHHHHHhhhcccc
Confidence 2 1234899999999999899999999999999999999999999765432 334556666555566
Q ss_pred CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 562 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
+.+.+.+++.+......+....+.+++..||+.||++|||++++++.|+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 6666777777777788899999999999999999999999999999998653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=365.29 Aligned_cols=188 Identities=25% Similarity=0.351 Sum_probs=164.8
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEC---CCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEE
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFA---SSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~---~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 420 (645)
...+.|+..++||+|+||+||+|+.+ .+++.||+|.+.... ....+.+|+++|..+ +|||||++++++.+.+++|
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 34578999999999999999999874 357889999887643 345688999999998 6999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeeeecccc--
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN-FNARLESSFT-- 497 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~-~~~kl~d~~~-- 497 (645)
||||||++|+|.+++.. +++.+...++.|++.||+|||+ ++|+||||||+||||+.+ +..||.|...
T Consensus 97 lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999842 8999999999999999999999 999999999999999877 6788877321
Q ss_pred --------------------------------------ccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCC
Q 041096 498 --------------------------------------LTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRP 538 (645)
Q Consensus 498 --------------------------------------~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P 538 (645)
..+||+.|||||++.+. .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 13699999999999875 589999999999999999999999
Q ss_pred CCccc
Q 041096 539 IERET 543 (645)
Q Consensus 539 ~~~~~ 543 (645)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 97543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=385.45 Aligned_cols=241 Identities=22% Similarity=0.289 Sum_probs=199.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.++|+..+.||+|+||.||+|..+.+|..||+|.+.... ...+.+.+|+++|++++|||||++++++.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999999999999999987643 3456789999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC--CCeeeeccc-------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN--FNARLESSF------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~--~~~kl~d~~------- 496 (645)
|++|+|.++|..... .+++.++..++.||+.||+|||+ ++|+||||||+||||+.+ +..||.|..
T Consensus 236 ~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999965432 38999999999999999999999 999999999999999865 788998722
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
...+||+.|||||++.+..|+.++||||+||++|||++|+.||....... ....+... +..+
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~----~~~~i~~~----------~~~~ 375 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLRNVKSC----------DWNM 375 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTT----------CCCC
T ss_pred CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHhC----------CCCC
Confidence 23479999999999999999999999999999999999999997654321 11111100 0000
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...........+.+++..||+.||.+|||+.|+++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111122345678889999999999999999988
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=349.63 Aligned_cols=246 Identities=23% Similarity=0.402 Sum_probs=206.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC-CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
++|...++||+|+||+||+|.+..++..+|+|++.. .....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 567888999999999999999999999999998765 4455678999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--------- 497 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--------- 497 (645)
++|+|.+++..... .+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+|+.|...
T Consensus 90 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999987433 38999999999999999999999 9999999999999999999999987321
Q ss_pred -----------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc
Q 041096 498 -----------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA 560 (645)
Q Consensus 498 -----------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~ 560 (645)
...||+.|+|||.+.+..++.++||||||+++|||++|..|+...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---------- 233 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---------- 233 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----------
Confidence 34689999999999999999999999999999999999999875432211100
Q ss_pred cCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 561 EGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 561 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
.......+.. .+...+..+.+++..||+.||++|||++++++.|+.+..
T Consensus 234 -~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 234 -LNVRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp -BCHHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hhhhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111122222 223344568889999999999999999999999986643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=352.27 Aligned_cols=255 Identities=28% Similarity=0.434 Sum_probs=203.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
..++|+..+.||+|+||+||+|... +..||||++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3467888999999999999999874 7889999987633 3346789999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEEcCCCCeeeeccc----
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ--VIHRDIKASNIMLDANFNARLESSF---- 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NIlld~~~~~kl~d~~---- 496 (645)
|||+++|+|.+++..... ...+++..++.++.|+++||+|||+ .+ |+||||||+|||++.++.+||.|..
T Consensus 113 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999975432 2348999999999999999999998 78 9999999999999999999998732
Q ss_pred --------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 --------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+ .
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~----~~~~~------------~ 252 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----VVAAV------------G 252 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH----HHHHH------------H
T ss_pred ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH------------H
Confidence 23468999999999999999999999999999999999999997643211 11111 0
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCCCCCCC
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLK 622 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~~p~~~ 622 (645)
........+......+.+++..||+.+|.+|||++++++.|+.......+|..+
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~ 306 (309)
T 3p86_A 253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306 (309)
T ss_dssp HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence 011112334445567889999999999999999999999999887666555443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=377.84 Aligned_cols=238 Identities=24% Similarity=0.308 Sum_probs=194.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHH---HHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLA---ELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
++|+..++||+|+||+||+|+...+|..||||++.+. ........+ ++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5799999999999999999999999999999998652 122223333 466677889999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS----- 495 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~----- 495 (645)
||||||+||+|..+|.+... +++..+..++.||+.||+|||+ ++|+||||||+|||||.++.+||.|.
T Consensus 269 lVmEy~~GGdL~~~l~~~~~----l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999987543 8999999999999999999999 99999999999999999999999882
Q ss_pred -----ccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 496 -----FTLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 496 -----~~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
....+||+.|||||++.. ..|+.++||||+||+||||++|+.||........ ..+.... ..
T Consensus 342 ~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~~i------------~~ 408 (689)
T 3v5w_A 342 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMT------------LT 408 (689)
T ss_dssp CSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHHHH------------HH
T ss_pred cCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhh------------cC
Confidence 234589999999999975 5799999999999999999999999976433221 1111111 11
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPS-----MRRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~~vl~ 607 (645)
. ...++......+.+++..||+.||.+|++ ++||++
T Consensus 409 ~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 409 M--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred C--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1 11233344556788899999999999998 688765
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=341.28 Aligned_cols=269 Identities=34% Similarity=0.569 Sum_probs=223.2
Q ss_pred CcccCHHHHHHHhcCCCcC------ceeccCCceEEEEEEECCCCeEEEEEeccCC-----cchhHhHHHHHHHHhhcCC
Q 041096 335 PREFSYRELRSATRGFHSN------RILGRGAFGNVYKAYFASSGSVAAVKRSKHS-----HEGKTEFLAELSIIACLRH 403 (645)
Q Consensus 335 ~~~~~~~~l~~~~~~f~~~------~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l~H 403 (645)
...|++.++..++++|... +.||+|+||.||+|... +..+|+|++... ....+.+.+|+.++++++|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4679999999999999988 89999999999999874 788999987652 2345679999999999999
Q ss_pred CCeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 041096 404 KNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIM 483 (645)
Q Consensus 404 ~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIl 483 (645)
|||+++++++.+.+..++||||+++++|.+++..... ...++|..++.++.|++.||+|||+ .+++||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 9999999999999999999999999999999975432 2358999999999999999999999 99999999999999
Q ss_pred EcCCCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchh
Q 041096 484 LDANFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMV 549 (645)
Q Consensus 484 ld~~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~ 549 (645)
++.++.+++.|.. ....||+.|+|||.+.+ .++.++||||||+++|||++|+.||..........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 9999999998732 12368999999998864 58999999999999999999999998755443333
Q ss_pred hHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 550 NLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 550 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
.+..... .....+.+.+++.+ ...+......+.+++..||+.+|.+|||+++|++.|+++.
T Consensus 245 ~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DIKEEIE--DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHH--TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHhh--hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 3222111 11223344444444 3457788899999999999999999999999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=361.16 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=204.9
Q ss_pred cCCCcCceeccCCceEEEEEEEC-----CCCeEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFA-----SSGSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~-----~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
++|...+.||+|+||.||+|.+. .++..||||++.. .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56888899999999999999953 4577899999875 3445567999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCC---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---Ceeeec
Q 041096 421 LVYEYMPNGSLDRMLYQDSE---NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF---NARLES 494 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~---~~kl~d 494 (645)
+||||+++|+|.+++..... ....+++.+++.++.||++||+|||+ .+|+||||||+||||+.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999987542 22358999999999999999999999 9999999999999999554 489987
Q ss_pred cc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhh
Q 041096 495 SF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLY 559 (645)
Q Consensus 495 ~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~ 559 (645)
.. ....||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~----~~~------- 296 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVL------- 296 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHH-------
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHH-------
Confidence 21 22457889999999999999999999999999999998 99999764321 111
Q ss_pred ccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCC
Q 041096 560 AEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLV 617 (645)
Q Consensus 560 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~ 617 (645)
+.+........+......+.+++..||+.+|++|||+.+|++.|+.....+.
T Consensus 297 ------~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 297 ------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp ------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ------HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 1111212223344455678899999999999999999999999987765543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=352.57 Aligned_cols=256 Identities=24% Similarity=0.315 Sum_probs=201.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC----eEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG----ELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV 422 (645)
.++|+..++||+|+||+||+|++. +..||||++.........+..|+.++.+++||||+++++++.+.. .+++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467888999999999999999886 789999999776656667778999999999999999999998754 47999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCC----------CeeeCCCCCCcEEEcCCCCeee
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ----------QVIHRDIKASNIMLDANFNARL 492 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~ivHrDlkp~NIlld~~~~~kl 492 (645)
|||+++|+|.+++.... ++|..++.++.|+++||+|||+ . +|+||||||+|||++.++.+||
T Consensus 101 ~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EecCCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 99999999999997643 8999999999999999999998 7 9999999999999999999999
Q ss_pred eccc--------------cccccCCcccCcccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHH
Q 041096 493 ESSF--------------TLTAGTMGYLAPEYLQYG-----TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVD 553 (645)
Q Consensus 493 ~d~~--------------~~~~gt~~y~APE~~~~~-----~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~ 553 (645)
+|.. ....||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ....
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~ 251 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML-PFEE 251 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC-TTHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc-chhh
Confidence 8732 124689999999999863 4567899999999999999999999765432211 1111
Q ss_pred HHHhhhccCchhHHh-hhhccCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 554 WVWGLYAEGRIIEAA-DKRLNGAF-----NEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 554 ~~~~~~~~~~~~~~~-d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
..........+.+.+ ........ .......+.+++..||+.||++|||+++|++.|+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 100000000111111 11111111 2245677999999999999999999999999998653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.33 Aligned_cols=238 Identities=24% Similarity=0.315 Sum_probs=199.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.++|+..+.||+|+||+||+|....++..||||++... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35799999999999999999999888999999988653 33456789999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++|+|.+++.... +++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 99 ~~~~~L~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999997642 8999999999999999999999 999999999999999999999998732
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ... .. .....
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~----~~--------~~~~~ 235 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL---YLI----AT--------NGTPE 235 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHH----HH--------HCSCC
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH----Hh--------CCCCC
Confidence 2346899999999999999999999999999999999999999764321111 000 00 00001
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+......+.+++..||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1223334566888999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=352.56 Aligned_cols=245 Identities=25% Similarity=0.417 Sum_probs=203.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCC---CeEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASS---GSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~---~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
++|+..+.||+|+||.||+|.+..+ +..||||++.. .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 4677789999999999999999744 45699999876 334467899999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-----
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT----- 497 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~----- 497 (645)
|||+++|+|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+||||+.++.+||.|...
T Consensus 129 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999975433 39999999999999999999999 9999999999999999999999987321
Q ss_pred ----------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 498 ----------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 498 ----------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
...+|..|+|||++.+..++.++|||||||++|||++ |+.||...... .+. +
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~-------------~ 265 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----DVI-------------S 265 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHH-------------H
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH----HHH-------------H
Confidence 1234668999999999999999999999999999999 99999764321 111 1
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
.+........+......+.+++..||+.||.+|||+++|++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 266 SVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1222222234445567788999999999999999999999999876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=360.47 Aligned_cols=243 Identities=25% Similarity=0.398 Sum_probs=204.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.++|...+.||+|+||.||+|.+..++..||||.+... ....+.|.+|++++++++||||++++++|.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 35678889999999999999999888999999998763 2345679999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------- 497 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------- 497 (645)
|+++|+|.+++..... .+++.+++.++.|+++||+|||+ .+++||||||+||||+.++.+||.|...
T Consensus 193 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999976432 38999999999999999999999 9999999999999999999999988321
Q ss_pred -------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 498 -------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 498 -------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
...++..|+|||.+..+.++.++|||||||++|||++ |+.||...... .. .+.+.
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----~~-------------~~~~~ 329 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----QT-------------REFVE 329 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----HH-------------HHHHH
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HH-------------HHHHH
Confidence 1124667999999999999999999999999999998 99999764321 11 11222
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
...+...+..++..+.+++..||+.||++|||++++++.|+.+
T Consensus 330 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 2222233445567788999999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=359.61 Aligned_cols=245 Identities=27% Similarity=0.458 Sum_probs=201.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC---CCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFA---SSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~---~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
++|+..+.||+|+||.||+|++. ..+..||||++... ....+.|.+|+.++++++||||++++++|.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57888999999999999999886 45678999998763 33456899999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccc----
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL---- 498 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~---- 498 (645)
|||+++|+|.+++..... .+++.+++.++.|+++||+|||+ .+|+||||||+||||+.++.+|+.|....
T Consensus 125 ~e~~~~~sL~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999976432 38999999999999999999999 99999999999999999999999873211
Q ss_pred -----------cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 499 -----------TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 499 -----------~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
..++..|+|||++.+..++.++|||||||++|||++ |+.||...... . +.+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~----~-------------~~~ 261 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----D-------------VIK 261 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH----H-------------HHH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----H-------------HHH
Confidence 124668999999999999999999999999999998 99999764321 1 112
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
.+........+..++..+.+++..||+.+|++||+|++|++.|+.....
T Consensus 262 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 2223333334445667889999999999999999999999999876443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=353.46 Aligned_cols=247 Identities=24% Similarity=0.383 Sum_probs=204.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-------CCCeEEEEEeccCCc--chhHhHHHHHHHHhhc-CCCCeeeeeeeeeeC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFA-------SSGSVAAVKRSKHSH--EGKTEFLAELSIIACL-RHKNLVQLLGWCAEK 416 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~-------~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 416 (645)
.++|...+.||+|+||.||+|.+. ..+..||||++.... ...+.+.+|+++++++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367888999999999999999864 245689999987642 3456799999999999 899999999999999
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCCC------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSEN------------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML 484 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll 484 (645)
+..|+||||+++|+|.+++...... ...+++.+++.++.||++||+|||+ .+|+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 9999999999999999999865421 2348999999999999999999999 999999999999999
Q ss_pred cCCCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchh
Q 041096 485 DANFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMV 549 (645)
Q Consensus 485 d~~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~ 549 (645)
+.++.+||.|.. ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---- 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 999999998732 11245678999999999999999999999999999999 99999764321
Q ss_pred hHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 550 NLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 550 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
.+. ..+........+..+...+.+++..||+.+|.+||++.|+++.|+.+.
T Consensus 313 ~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 313 ELF-------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp GHH-------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH-------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 112222222344455677889999999999999999999999998653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=345.12 Aligned_cols=250 Identities=23% Similarity=0.288 Sum_probs=206.4
Q ss_pred CcccCHHHHHHHhcC----------CCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCC
Q 041096 335 PREFSYRELRSATRG----------FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRH 403 (645)
Q Consensus 335 ~~~~~~~~l~~~~~~----------f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H 403 (645)
+..+++++++.+++. |+..+.||+|+||.||+|....++..||||++... ....+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 456889999988875 66678999999999999999888999999998763 3445678999999999999
Q ss_pred CCeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 041096 404 KNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIM 483 (645)
Q Consensus 404 ~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIl 483 (645)
|||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEE
Confidence 99999999999999999999999999999998643 28999999999999999999999 99999999999999
Q ss_pred EcCCCCeeeeccc------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhH
Q 041096 484 LDANFNARLESSF------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNL 551 (645)
Q Consensus 484 ld~~~~~kl~d~~------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l 551 (645)
++.++.+|+.|.. ....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----~~ 249 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----QA 249 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HH
T ss_pred ECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HH
Confidence 9999999998732 2246899999999999999999999999999999999999999764321 11
Q ss_pred HHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 552 VDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 552 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...... ...+.+ .........+.+++..||+.||++|||++++++
T Consensus 250 ~~~~~~---------~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 250 MKRLRD---------SPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHH---------SSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhc---------CCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111110 000111 111223456788899999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=351.39 Aligned_cols=243 Identities=24% Similarity=0.400 Sum_probs=196.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeE----EEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSV----AAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~----vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|+..++||+|+||+||+|.+..++.. ||+|.+.. .....+.+.+|+.++++++||||++++++|.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 5688899999999999999998766654 58887755 2345678999999999999999999999998764 789
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
|+||+++|+|.+++..... .+++..++.++.|+++||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 94 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999987543 38999999999999999999999 899999999999999999999998832
Q ss_pred ---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 ---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....||..|+|||++.+..++.++|||||||++|||++ |+.||....... +.+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----------------~~~ 230 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------ISS 230 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------HHH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----------------HHH
Confidence 12245778999999999999999999999999999999 999997643221 112
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
.+........+..+...+.+++..||+.+|.+||+++++++.|+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 222222223344556678899999999999999999999999976544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=369.51 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=211.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
..+|...+.||+|+||.||+|.+..++..||||.+.......++|.+|+.+|++++||||++++++|.+.+..+|||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 45678889999999999999999988999999999876667788999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--------- 497 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--------- 497 (645)
++|+|.+++..... ..+++..++.++.||++||+|||+ ++|+||||||+||||+.++.+||.|...
T Consensus 299 ~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 299 TYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp TTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999976432 348999999999999999999999 9999999999999999999999987321
Q ss_pred ----ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 498 ----LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 498 ----~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
...++..|+|||++....++.++|||||||+||||++ |+.||...... . +.+.+....
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----~-------------~~~~~~~~~ 436 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----Q-------------VYELLEKDY 436 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----G-------------HHHHHHTTC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----H-------------HHHHHHcCC
Confidence 1234678999999999999999999999999999999 99999764321 1 112222333
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
+...+..++..+.+++..||+.||++||||++|++.|+...+.
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 3344555667889999999999999999999999999977543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.65 Aligned_cols=242 Identities=25% Similarity=0.413 Sum_probs=204.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|+..+.||+|+||.||+|.... +..||+|++.......+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 467888999999999999999874 7789999998877677889999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----------- 496 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----------- 496 (645)
+++|.+++..... .+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 89 ~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 89 HGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 9999999976443 38999999999999999999999 999999999999999999999998732
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .+.....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~----~~~~-------------~~~~~~~ 225 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVE-------------DISTGFR 225 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHH-------------HHHTTCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH----HHHH-------------HHhcCcc
Confidence 12345678999999999999999999999999999999 99999764321 1111 1111112
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
...+......+.+++..||+.+|++|||++++++.|+++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 2223334566888999999999999999999999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=334.42 Aligned_cols=245 Identities=23% Similarity=0.342 Sum_probs=204.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.++|+..+.||+|+||.||+|.... +..||+|++.......+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 4578889999999999999998874 678999999887667788999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--------- 497 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--------- 497 (645)
++++|.+++..... .+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+++.|...
T Consensus 86 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999999976533 38999999999999999999999 9999999999999999999999987321
Q ss_pred ----ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 498 ----LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 498 ----~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
...+|..|+|||.+.+..++.++||||||+++|||++ |+.||....... ... .+....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~-------------~~~~~~ 222 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE----VVL-------------KVSQGH 222 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHH-------------HHHTTC
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH----HHH-------------HHHcCC
Confidence 1235667999999998889999999999999999999 999997643211 111 111111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
....+......+.+++..||+.+|++|||++++++.|+.+.+.
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1122223345688899999999999999999999999977653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=344.35 Aligned_cols=236 Identities=22% Similarity=0.323 Sum_probs=199.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
.++|+..+.||+|+||.||+|.+..++..||||++... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999999889999999998653 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|.+++..... +++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+|+.|..
T Consensus 94 e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGR----MKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999976543 8999999999999999999999 999999999999999999999998732
Q ss_pred ----cccccCCcccCcccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTAT-EKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t-~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
...+||+.|+|||++.+..+. .++|||||||++|||++|+.||...... .+...+ ....
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i------------~~~~ 230 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK----ELRERV------------LRGK 230 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH------------HHCC
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH----HHHHHH------------HhCC
Confidence 234689999999999988775 7999999999999999999999764321 111111 0111
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+......+.+++..||+.||.+|||++|+++
T Consensus 231 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 231 --YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1122334456778899999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=351.44 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=208.4
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEE-----ECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeee
Q 041096 338 FSYRELRSATRGFHSNRILGRGAFGNVYKAY-----FASSGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQL 409 (645)
Q Consensus 338 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~-----~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l 409 (645)
+...++....++|...+.||+|+||.||+|. ...++..||||++... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4455666677899999999999999999998 4456689999998763 23456799999999999 79999999
Q ss_pred eeeeeeCC-eEEEEEecCCCCCHhHHhhhcCCC-----------------------------------------------
Q 041096 410 LGWCAEKG-ELLLVYEYMPNGSLDRMLYQDSEN----------------------------------------------- 441 (645)
Q Consensus 410 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~----------------------------------------------- 441 (645)
+++|.+.+ ..++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998765 489999999999999999865421
Q ss_pred ---------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 442 ---------------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 442 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
...+++..++.++.|+++||+|||+ .+|+||||||+||||+.++.+||+|..
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1228999999999999999999999 999999999999999999999998732
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....||+.|+|||++.+..++.++|||||||++|||++ |+.||........ + ...+...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~-------------~~~~~~~ 312 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F-------------CRRLKEG 312 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---H-------------HHHHHHT
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH---H-------------HHHHHcC
Confidence 12357888999999999999999999999999999998 9999976433211 1 1111122
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
.....+......+.+++..||+.||.+|||++++++.|+.+.
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 222333344567888999999999999999999999998653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=360.84 Aligned_cols=247 Identities=24% Similarity=0.415 Sum_probs=207.0
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
...++|...+.||+|+||.||+|.+.. +..||||+++......+.|.+|++++++++||||+++++++. .+..++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 345678889999999999999999864 678999999886667889999999999999999999999987 567899999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------- 497 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------- 497 (645)
|+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||.|...
T Consensus 263 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred ecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999975431 238899999999999999999999 9999999999999999999999988321
Q ss_pred ------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 498 ------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 498 ------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
...++..|+|||++..+.++.++|||||||+||||++ |+.||...... .+. +.+..
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~----~~~-------------~~i~~ 400 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVI-------------RALER 400 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHH-------------HHHHH
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH----HHH-------------HHHHc
Confidence 1235678999999999999999999999999999999 99999764321 111 11222
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
..+...+..++..+.+++..||+.||++||||++|++.|+.....
T Consensus 401 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 401 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 222233445667889999999999999999999999999987543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=335.96 Aligned_cols=244 Identities=19% Similarity=0.324 Sum_probs=201.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 422 (645)
++|...+.||+|+||.||+|++. +..+|||++... ....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 56888899999999999999986 788999998763 33456799999999999999999999999877 788999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEEcCCCCeeeec------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ--VIHRDIKASNIMLDANFNARLES------ 494 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NIlld~~~~~kl~d------ 494 (645)
|||+++|+|.+++..... ..+++.+++.++.|+++||+|||+ .+ ++||||||+|||++.++.+++.+
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999976442 348999999999999999999998 77 99999999999999999999865
Q ss_pred -cccccccCCcccCcccccCCCCCc---chhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 495 -SFTLTAGTMGYLAPEYLQYGTATE---KTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 495 -~~~~~~gt~~y~APE~~~~~~~t~---ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
......||+.|+|||.+.+..++. ++||||||+++|||++|+.||........ . ......
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~------------~~~~~~ 226 (271)
T 3kmu_A 163 FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI----G------------MKVALE 226 (271)
T ss_dssp TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH----H------------HHHHHS
T ss_pred ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH----H------------HHHHhc
Confidence 223356899999999998765544 89999999999999999999976432111 0 111112
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
......+......+.+++..||+.||++|||++++++.|+.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 22223344456678899999999999999999999999986543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=346.40 Aligned_cols=251 Identities=26% Similarity=0.393 Sum_probs=206.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCe
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGE 418 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 418 (645)
..++|...+.||+|+||.||+|.... ++..||||.+... ....+.+.+|+.++++++||||++++++|.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 45788899999999999999999863 4589999998763 3345679999999999999999999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCCC--------------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSEN--------------------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIK 478 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk 478 (645)
.++||||+++|+|.+++...... ...+++.+++.++.||++||+|||+ .+|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 99999999999999999864321 1458999999999999999999999 999999999
Q ss_pred CCcEEEcCCCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccc
Q 041096 479 ASNIMLDANFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERET 543 (645)
Q Consensus 479 p~NIlld~~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~ 543 (645)
|+|||++.++.+|+.|.. ....||+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999998732 12357888999999999999999999999999999999 999997643
Q ss_pred cccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 544 EGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 544 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
.. .+... +........+...+..+.+++..||+.||++||++.++++.|+++.+..
T Consensus 282 ~~----~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 282 HE----EVIYY-------------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HH----HHHHH-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred hH----HHHHH-------------HhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 21 11111 1111111233445567889999999999999999999999999876643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=339.22 Aligned_cols=251 Identities=23% Similarity=0.285 Sum_probs=204.5
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.++|+..+.||+|+||.||+|....++..||+|.+... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35788999999999999999999988999999987542 23356789999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++++|.+++..... +++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+|+.|..
T Consensus 90 ~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999976543 8999999999999999999999 999999999999999999999998732
Q ss_pred -------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 -------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........ ..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------~~~~~~~~-~~---- 230 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-------AIKHIQDS-VP---- 230 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-------HHHHHSSC-CC----
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhhcc-CC----
Confidence 123589999999999999999999999999999999999999976432111 00111100 00
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHcCCCCCCC
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARP-SMRRVFQILNNEAEPLV 617 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~~vl~~L~~~~~~~~ 617 (645)
........+.+..+.+++..|++.||++|| +++++.+.|+.......
T Consensus 231 -~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 231 -NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp -CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred -CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 000112223456788899999999999998 89999999997765543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.43 Aligned_cols=243 Identities=23% Similarity=0.379 Sum_probs=202.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.++|+..+.||+|+||.||+|.+. ++..||+|++.......+++.+|++++.+++|+||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 457888899999999999999887 4778999999887667788999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--------- 497 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--------- 497 (645)
++++|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+++.|...
T Consensus 102 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 102 ANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp TTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999976433 38999999999999999999999 9999999999999999999999988321
Q ss_pred ----ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 498 ----LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 498 ----~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .. +.+....
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~----~~-------------~~~~~~~ 238 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TA-------------EHIAQGL 238 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HH-------------HHHHTTC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH----HH-------------HHHhccc
Confidence 2245678999999999999999999999999999998 999997643211 11 1111222
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
....+......+.+++..||+.+|.+|||++++++.|+++.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 22223334567888999999999999999999999997653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=355.98 Aligned_cols=241 Identities=28% Similarity=0.411 Sum_probs=203.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC-eEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG-ELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 425 (645)
.++|+..+.||+|+||.||+|.+. +..||||+++... ..+.|.+|++++++++||||++++++|.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 356788899999999999999986 7899999987643 5678999999999999999999999987765 79999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++|+|.+++..... ..+++..++.++.||++||+|||+ .+++||||||+||||+.++.+||.|..
T Consensus 269 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999999999986542 237999999999999999999999 999999999999999999999998832
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ + .+.+....+..
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~-------------~~~i~~~~~~~ 406 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----V-------------VPRVEKGYKMD 406 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----H-------------HHHHHTTCCCC
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----H-------------HHHHHcCCCCC
Confidence 12356789999999999999999999999999999998 999997654321 1 11222222234
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.+..++..+.+++..||+.||++|||++++++.|+.+
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 4555677889999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=337.40 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=204.4
Q ss_pred cCCCcCceeccCCceEEEEEE----ECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAY----FASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~----~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 420 (645)
++|+..+.||+|+||.||+|. ...++..||||++... ....+.+.+|++++++++||||++++++|... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 578889999999999999998 4557899999998764 34457899999999999999999999998653 5689
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--- 497 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--- 497 (645)
+||||+++|+|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+|+.|...
T Consensus 90 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999976543 38999999999999999999999 9999999999999999999999987321
Q ss_pred ------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh----cc
Q 041096 498 ------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY----AE 561 (645)
Q Consensus 498 ------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~----~~ 561 (645)
...++..|+|||.+.+..++.++||||||+++|||++|..|+...... ......... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQMIV 238 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccchhH
Confidence 123566799999999999999999999999999999999998653210 111000000 00
Q ss_pred CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 562 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
..+.+.+........+..++..+.+++..||+.||++|||++++++.|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0122223333333445566778999999999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.81 Aligned_cols=242 Identities=21% Similarity=0.277 Sum_probs=203.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.++|...+.||+|+||.||+|....++..+|+|.+.........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 46788999999999999999999999999999998876666778999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC--CCCeeeeccc--------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA--NFNARLESSF-------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~--~~~~kl~d~~-------- 496 (645)
++|+|.+++..... .+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+|+.|..
T Consensus 84 ~g~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 84 SGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999999975432 38999999999999999999999 99999999999999997 7888998732
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+. ....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~------------~~~~- 220 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----IIENIM------------NAEY- 220 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHH------------HTCC-
T ss_pred CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH----HHHHHH------------cCCC-
Confidence 22458999999999998889999999999999999999999997643211 111110 0000
Q ss_pred CCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 574 GAFNE----DEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 574 ~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
.++. +....+.+++..||+.||.+|||+.|+++ .+.+.
T Consensus 221 -~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 221 -TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 1111 12456788999999999999999999998 45544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=337.88 Aligned_cols=265 Identities=21% Similarity=0.238 Sum_probs=209.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC--eEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG--ELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 423 (645)
++|...++||+|+||+||+|....++..||||++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 5688899999999999999999999999999998753 234567889999999999999999999988755 789999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE----cCCCCeeeeccc---
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML----DANFNARLESSF--- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll----d~~~~~kl~d~~--- 496 (645)
||+++++|.+++..... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||| +.++.+||.|..
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999986543 2238999999999999999999999 999999999999999 777788887722
Q ss_pred --------cccccCCcccCccccc--------CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc
Q 041096 497 --------TLTAGTMGYLAPEYLQ--------YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA 560 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~--------~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~ 560 (645)
....||..|+|||++. +..++.++|||||||++|||++|+.||............+..+.....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 2346899999999886 577899999999999999999999999764433333333322221111
Q ss_pred cCchhHH---------hhh--hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 561 EGRIIEA---------ADK--RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 561 ~~~~~~~---------~d~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
....... ..+ .............+.+++..||+.||++|||++|+++..++.+.+-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~ 311 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG 311 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence 0000000 000 1112456778889999999999999999999999999988765543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=360.55 Aligned_cols=248 Identities=24% Similarity=0.389 Sum_probs=206.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
..++|...+.||+|+||.||+|.+.. +..||||++.......++|.+|++++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 44678889999999999999999975 5679999998766667789999999999999999999999976 678999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc--------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT-------- 497 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~-------- 497 (645)
+++|+|.+++..... ..+++.+++.++.|++.||+|||+ ++|+||||||+||||+.++.+||.|...
T Consensus 260 ~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999975421 238999999999999999999999 9999999999999999999999988321
Q ss_pred -----ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 498 -----LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 498 -----~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
...++..|+|||.+..+.++.++|||||||++|||++ |+.||...... .+. +.+...
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~~-------------~~i~~~ 397 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVL-------------DQVERG 397 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHH-------------HHHHTT
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH----HHH-------------HHHHcC
Confidence 1235678999999999999999999999999999999 99999764321 111 112222
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCC
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLV 617 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~ 617 (645)
.+...+..++..+.+++..||+.+|++|||++++++.|+.......
T Consensus 398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 2233445567788999999999999999999999999998765443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=333.11 Aligned_cols=244 Identities=25% Similarity=0.431 Sum_probs=199.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcch--------hHhHHHHHHHHhhcCCCCeeeeeeeeeeCCe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG--------KTEFLAELSIIACLRHKNLVQLLGWCAEKGE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~--------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 418 (645)
.++|+..+.||+|+||.||+|.+..++..||+|++...... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36788899999999999999999988999999988652211 167899999999999999999999997765
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEEcCCCC-----ee
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ--VIHRDIKASNIMLDANFN-----AR 491 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NIlld~~~~-----~k 491 (645)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+ ++||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhcccC---CccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 699999999999999876443 49999999999999999999998 78 999999999999988776 88
Q ss_pred eeccc---------cccccCCcccCccccc--CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc
Q 041096 492 LESSF---------TLTAGTMGYLAPEYLQ--YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA 560 (645)
Q Consensus 492 l~d~~---------~~~~gt~~y~APE~~~--~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~ 560 (645)
+.|.. ....||+.|+|||.+. ...++.++|||||||++|||++|+.||........ ....
T Consensus 170 l~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~------- 240 (287)
T 4f0f_A 170 VADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--KFIN------- 240 (287)
T ss_dssp ECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--HHHH-------
T ss_pred eCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH--HHHH-------
Confidence 98732 2356899999999984 45678999999999999999999999976433211 1111
Q ss_pred cCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 561 EGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 561 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
...........+......+.+++..||+.||++|||++++++.|+++
T Consensus 241 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 -----MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -----HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -----HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11122223334455567889999999999999999999999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=343.63 Aligned_cols=233 Identities=27% Similarity=0.342 Sum_probs=189.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..++||+|+||+||+|.+..++..||||++.... .....+..|+..+.++ +|+||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999999889999999876532 2344566666666665 8999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+ +++|.+++..... .++|..++.++.|++.||+|||+ .+|+||||||+||||+.++.+||+|..
T Consensus 137 e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 7899999876543 39999999999999999999999 899999999999999999999998832
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....||++|+|||++.+ .++.++|||||||++|||++|..|+..... +.....+.....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~~~~~~~~----- 272 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQGYLPPE----- 272 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHHTTTCCCHH-----
T ss_pred CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHhccCCCcc-----
Confidence 22458999999998875 799999999999999999999877654211 011111111111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
++......+.+++..||+.||++|||++++++
T Consensus 273 ---~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 ---FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11123456888999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=338.03 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=210.2
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
..++|+..+.||+|+||.||+|.+..++..||+|.+.......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 45778889999999999999999998899999999988777778899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc--------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT-------- 497 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~-------- 497 (645)
+++++|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+++.|...
T Consensus 91 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999976432 348999999999999999999999 8999999999999999999999987321
Q ss_pred -----ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 498 -----LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 498 -----~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... + .+.+...
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----~-------------~~~~~~~ 228 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----V-------------YELLEKD 228 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----H-------------HHHHHTT
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----H-------------HHHHhcc
Confidence 1245778999999999999999999999999999999 999997643221 1 1222222
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
.....+...+..+.+++..|++.||.+|||++++++.|+...
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 223334455677889999999999999999999999997543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=337.78 Aligned_cols=249 Identities=23% Similarity=0.383 Sum_probs=197.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCC-------eEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSG-------SVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~-------~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 419 (645)
++|...+.||+|+||.||+|....++ ..||+|.+... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 56888899999999999999987655 57999998663 34567799999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC--------ee
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN--------AR 491 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~--------~k 491 (645)
++||||+++|+|.+++..... .+++..++.++.|+++||+|||+ .+|+||||||+|||++.++. +|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999986543 38999999999999999999999 99999999999999999887 78
Q ss_pred eecccc--------ccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC
Q 041096 492 LESSFT--------LTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG 562 (645)
Q Consensus 492 l~d~~~--------~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~ 562 (645)
+.|... ...||..|+|||.+.+ ..++.++||||||+++|||++|..|+....... .....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~-------- 230 (289)
T 4fvq_A 162 LSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ---RKLQF-------- 230 (289)
T ss_dssp ECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHH--------
T ss_pred eccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH---HHHHH--------
Confidence 877322 2357899999999987 678999999999999999999655544322111 11110
Q ss_pred chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCCCCC
Q 041096 563 RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPK 620 (645)
Q Consensus 563 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~~p~ 620 (645)
... ....+......+.+++..||+.||++|||++++++.|+.+..+...+.
T Consensus 231 -----~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 231 -----YED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp -----HHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred -----hhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 000 011122224457889999999999999999999999998877655443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=338.45 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=203.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC-CcchhHhHHHHHHHHhhcCCCCeeeeeeeeee----CCeEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQLLGWCAE----KGELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 421 (645)
.++|+..+.||+|+||.||++....++..||||++.. .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 3578889999999999999999988899999998765 34456789999999999999999999999873 347899
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---- 497 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---- 497 (645)
||||+++|+|.+++.........+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+++.|...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999998754444569999999999999999999999 8999999999999999999999987431
Q ss_pred -----------------ccccCCcccCcccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh
Q 041096 498 -----------------LTAGTMGYLAPEYLQYGT---ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG 557 (645)
Q Consensus 498 -----------------~~~gt~~y~APE~~~~~~---~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~ 557 (645)
...||+.|+|||.+.... ++.++||||||+++|||++|+.||........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------- 254 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---------- 254 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS----------
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc----------
Confidence 124689999999987654 68999999999999999999999964221111
Q ss_pred hhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCCCC
Q 041096 558 LYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVP 619 (645)
Q Consensus 558 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~~p 619 (645)
.....................+.+++..||+.||.+|||++++++.|+.+.+++..+
T Consensus 255 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 255 -----SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp -----CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred -----hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 011111111111222334567889999999999999999999999999876555433
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.17 Aligned_cols=247 Identities=22% Similarity=0.363 Sum_probs=204.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-----CCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFA-----SSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~-----~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 419 (645)
.++|...+.||+|+||.||+|... .++..||||++... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 467888999999999999999873 44589999998763 33457789999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCC--------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 041096 420 LLVYEYMPNGSLDRMLYQDSE--------------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKA 479 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp 479 (645)
++||||+++++|.+++..... ....+++.+++.++.|+++||+|||+ .+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999986543 12348999999999999999999999 9999999999
Q ss_pred CcEEEcCCCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccc
Q 041096 480 SNIMLDANFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETE 544 (645)
Q Consensus 480 ~NIlld~~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~ 544 (645)
+|||++.++.+|+.|.. ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999998732 12246778999999999899999999999999999999 9999976433
Q ss_pred ccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 545 GHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 545 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
.. +. +.+........+......+.+++..||+.||++||++.++++.|+.+.
T Consensus 259 ~~----~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 ER----LF-------------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GG----HH-------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HH-------------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 21 11 111122222334445667889999999999999999999999998653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=342.89 Aligned_cols=243 Identities=25% Similarity=0.384 Sum_probs=197.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeE----EEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSV----AAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~----vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|+..++||+|+||.||+|.+..++.. ||+|.+... ....+.+.+|+.++++++||||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 4688889999999999999998776654 778876542 334567889999999999999999999986 457899
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 92 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSSGG---GSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHccc---cCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 9999999999999976432 48999999999999999999999 999999999999999999999998732
Q ss_pred ---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 ---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....||..|+|||.+.++.++.++|||||||++|||++ |+.||....... +. +
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~-------------~ 228 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----VP-------------D 228 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH----HH-------------H
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH----HH-------------H
Confidence 22346779999999999999999999999999999999 999997643221 11 1
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
.+........+......+.+++..||+.||.+||+++++++.|+....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 229 LLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp HHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111111222233344567889999999999999999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=339.95 Aligned_cols=240 Identities=24% Similarity=0.300 Sum_probs=196.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.++|+..+.||+|+||.||+|....+++.||||++... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 36789999999999999999999989999999998653 2334678999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999997543 38999999999999999999999 999999999999999999999998732
Q ss_pred ------cccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 ------TLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
....||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....+...
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~------------ 224 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEK------------ 224 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHHTT------------
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHhcc------------
Confidence 23468999999999987765 7899999999999999999999976443211 11111100
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.............+.+++..||+.||++|||++|+++.
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 -KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00001112234566788999999999999999999873
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=340.36 Aligned_cols=235 Identities=25% Similarity=0.325 Sum_probs=199.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||+||+|....++..||+|++... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5788899999999999999999999999999998652 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|..++..... +++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 85 E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999976543 8999999999999999999999 999999999999999999999998732
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+...+ ....
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i------------~~~~ 221 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELI------------LMEE 221 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH------------HHCC
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH----HHHHHH------------HcCC
Confidence 2346899999999999999999999999999999999999999764321 111110 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
..++......+.+++..||+.||++|| +++++++
T Consensus 222 --~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 123333456678889999999999999 8999976
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=343.39 Aligned_cols=242 Identities=21% Similarity=0.233 Sum_probs=195.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.++|+..+.||+|+||.||++....++..||||++.......+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 46789999999999999999999989999999999876666678999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC--eeeeccc--------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN--ARLESSF-------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~--~kl~d~~-------- 496 (645)
++|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+||||+.++. +||.|..
T Consensus 99 ~~~~L~~~l~~~~~----~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 99 SGGELYERICNAGR----FSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999976543 8999999999999999999999 99999999999999988776 8887732
Q ss_pred ---cccccCCcccCcccccCCCCCcc-hhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEK-TDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~k-sDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....||+.|+|||++.+..++.+ +|||||||++|||++|+.||................ .....
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~------------~~~~~ 239 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI------------LSVKY 239 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH------------HTTCC
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH------------hcCCC
Confidence 23468999999999988887665 899999999999999999998654433222222111 11111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...........+.+++..||+.||++|||++|+++
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 11111123456788999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=330.03 Aligned_cols=239 Identities=28% Similarity=0.467 Sum_probs=193.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
++|+..+.||+|+||.||+|.+. +..+|||++.... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 57888999999999999999985 7899999886532 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC---eeeCCCCCCcEEEcC--------CCCee
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ---VIHRDIKASNIMLDA--------NFNAR 491 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~---ivHrDlkp~NIlld~--------~~~~k 491 (645)
|||+++++|.+++... .+++..++.++.|+++||+|||+ .+ ++||||||+|||++. ++.++
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceE
Confidence 9999999999999533 38999999999999999999999 66 999999999999986 66788
Q ss_pred eeccc----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc
Q 041096 492 LESSF----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE 561 (645)
Q Consensus 492 l~d~~----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~ 561 (645)
+.|.. ....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~--------- 223 (271)
T 3dtc_A 157 ITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA----VA--------- 223 (271)
T ss_dssp ECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH----HH---------
T ss_pred EccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HH---------
Confidence 87732 22468999999999999999999999999999999999999997643211 00
Q ss_pred CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 562 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
............+......+.+++..||+.+|.+|||++++++.|+.+
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 224 ---YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 011111222233444567788999999999999999999999999753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=342.24 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=203.6
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-----CCCCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCC
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYF-----ASSGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKG 417 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~-----~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 417 (645)
..++|...+.||+|+||.||+|.+ ...+..||+|++... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 456888999999999999999997 235678999998753 33457899999999999 8999999999999999
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCC-------------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSEN-------------------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIK 478 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk 478 (645)
..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+ .+|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 999999999999999999765321 1248999999999999999999999 999999999
Q ss_pred CCcEEEcCCCCeeeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccc
Q 041096 479 ASNIMLDANFNARLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERET 543 (645)
Q Consensus 479 p~NIlld~~~~~kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~ 543 (645)
|+||||+.++.++|+|... ...||+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999987321 2346778999999999999999999999999999998 999997654
Q ss_pred cccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 544 EGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 544 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
.... + ...+........+......+.+++..||+.||.+|||+.++++.|+.....
T Consensus 280 ~~~~---~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 VDAN---F-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CSHH---H-------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cHHH---H-------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 3211 1 111222222233444567788999999999999999999999999876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=341.97 Aligned_cols=238 Identities=22% Similarity=0.313 Sum_probs=197.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC------cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS------HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
+.|+..+.||+|+||.||+|....++..||||++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5688899999999999999999999999999987531 2245679999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC---eeeecc---
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN---ARLESS--- 495 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~---~kl~d~--- 495 (645)
||||+++++|.+++......+..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +|+.|.
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998887654434458999999999999999999999 99999999999999987655 888772
Q ss_pred ---------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 496 ---------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 496 ---------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...+
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~i----------- 244 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGI----------- 244 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----HHHHHH-----------
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----HHHHHH-----------
Confidence 1234689999999999999999999999999999999999999976321 111111
Q ss_pred HhhhhccCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 567 AADKRLNGAFNE----DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 567 ~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..... ..+. .....+.+++..||+.||++|||+.++++
T Consensus 245 -~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 245 -IKGKY--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -HHTCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HcCCC--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 0111 12456788999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=333.60 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=192.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhh--cCCCCeeeeeeeeeeC----CeEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIAC--LRHKNLVQLLGWCAEK----GELL 420 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----~~~~ 420 (645)
.++|+..+.||+|+||+||+|... +..||||++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET--TEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC--CEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 467899999999999999999884 899999998653 34556667777666 7999999999987653 4689
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeeCCCCCCcEEEcCCCCeee
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH--------QECEQQVIHRDIKASNIMLDANFNARL 492 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlkp~NIlld~~~~~kl 492 (645)
+||||+++|+|.+++... .+++..++.++.|+++||+||| + ++|+||||||+||||+.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEE
Confidence 999999999999999543 3899999999999999999999 6 89999999999999999999999
Q ss_pred ecccc----------------ccccCCcccCcccccCC------CCCcchhHHHHHHHHHHHHcC----------CCCCC
Q 041096 493 ESSFT----------------LTAGTMGYLAPEYLQYG------TATEKTDVFSYGVVVLEVACG----------RRPIE 540 (645)
Q Consensus 493 ~d~~~----------------~~~gt~~y~APE~~~~~------~~t~ksDV~SfGvvl~El~tG----------~~P~~ 540 (645)
.|... ...||+.|+|||.+.+. .++.++|||||||++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 87321 12789999999999876 455799999999999999999 78886
Q ss_pred ccccccchhhHHHHHHhhhccCchhHHhhhhcc-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 541 RETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN-GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 541 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
............... ...... .+.+. ...+......+.+++..||+.||++|||+.+|++.|++
T Consensus 235 ~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKV--VCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTSCSSCCHHHHHHH--HTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCcchhhhhHH--HhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 543322211111110 000000 01110 01233567889999999999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=339.66 Aligned_cols=236 Identities=23% Similarity=0.287 Sum_probs=196.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-------chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-------EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 419 (645)
.++|...+.||+|+||.||+|....++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999999999999999876532 1356799999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC----Ceeeecc
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF----NARLESS 495 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~----~~kl~d~ 495 (645)
++||||+++++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+|+.|.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999997543 38999999999999999999999 9999999999999999887 7888772
Q ss_pred c-----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 496 F-----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 496 ~-----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~~~~~------ 232 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANVSAV------ 232 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHHT------
T ss_pred CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHHHhc------
Confidence 2 23468999999999999999999999999999999999999997643211 11111000
Q ss_pred hHHhhhhccCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 IEAADKRLNGAFNE----DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 ~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...++. .....+.+++..||+.||++|||++++++
T Consensus 233 --------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 233 --------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp --------CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --------CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 001111 12356778899999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=334.95 Aligned_cols=246 Identities=27% Similarity=0.451 Sum_probs=197.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|+..+.||+|+||.||+|... +..||+|.+... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46788899999999999999986 788999998653 346789999999999999999999999874 4799999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC-eeeeccc---------c
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN-ARLESSF---------T 497 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~-~kl~d~~---------~ 497 (645)
+|+|.+++..... ...+++..++.++.|+++||+|||+...++|+||||||+|||++.++. +|+.|.. .
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~ 161 (307)
T 2eva_A 83 GGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT 161 (307)
T ss_dssp TCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccc
Confidence 9999999976432 234789999999999999999999854468999999999999998886 6897732 2
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC
Q 041096 498 LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 577 (645)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..+. + .. .........
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~-~--~~----------~~~~~~~~~ 226 (307)
T 2eva_A 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIM-W--AV----------HNGTRPPLI 226 (307)
T ss_dssp ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHHH-H--HH----------HTTCCCCCB
T ss_pred cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHHH-H--HH----------hcCCCCCcc
Confidence 3468999999999999999999999999999999999999997543211 1111 1 10 111111222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 578 EDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 578 ~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
...+..+.+++..||+.||++|||++++++.|+.+.+
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 3345668889999999999999999999999986643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=361.76 Aligned_cols=255 Identities=22% Similarity=0.256 Sum_probs=205.2
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeee
Q 041096 338 FSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWC 413 (645)
Q Consensus 338 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 413 (645)
+.+++++..+++|+..++||+|+||+||+|+...++..||+|++... ......+.+|+.++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34566666778999999999999999999999999999999998652 22334589999999999999999999999
Q ss_pred eeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeee
Q 041096 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLE 493 (645)
Q Consensus 414 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~ 493 (645)
.+.+..|||||||++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||||+.++.+||.
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~---~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFED---RLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 999999999999999999999976432 38999999999999999999999 999999999999999999999998
Q ss_pred ccc-------------cccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH
Q 041096 494 SSF-------------TLTAGTMGYLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV 555 (645)
Q Consensus 494 d~~-------------~~~~gt~~y~APE~~~-----~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~ 555 (645)
|.. ...+||+.|+|||++. .+.++.++|||||||++|||++|+.||...+..+....+..+.
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence 832 1247999999999987 5678999999999999999999999998654322211111110
Q ss_pred HhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH--HHcC
Q 041096 556 WGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSA--RPSMRRVFQ--ILNN 611 (645)
Q Consensus 556 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~~vl~--~L~~ 611 (645)
.. ..+ ..........+.+++..|+..+|++ ||+++|+++ .+++
T Consensus 298 ~~------------~~~-p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 298 ER------------FQF-PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp HH------------CCC-CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred cc------------ccC-CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 00 000 0111123455677888888888888 999999987 3543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=327.46 Aligned_cols=242 Identities=25% Similarity=0.396 Sum_probs=203.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|+..+.||+|+||.||+|... ++..||+|++.......+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 56788899999999999999987 47889999998876667889999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----------- 496 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----------- 496 (645)
+++|.+++..... .+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 87 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 9999999976543 38999999999999999999999 999999999999999999999998732
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... +.....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~-------------i~~~~~ 223 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVED-------------ISTGFR 223 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHH-------------HHTTCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH----HHHHH-------------HhcCCc
Confidence 12345678999999998999999999999999999999 89999764321 11111 111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
...+......+.+++..||+.+|++||+++++++.|+++.
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1223334567888999999999999999999999998654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=345.81 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=205.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-------CCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFAS-------SGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEK 416 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~-------~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 416 (645)
.++|...+.||+|+||.||+|.... .+..||||++... ....+.+.+|+++++++ +||||++++++|.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4678889999999999999999642 3468999998763 33457799999999999 899999999999999
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCCC------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSEN------------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML 484 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll 484 (645)
+..++||||+++|+|.+++...... ...+++.+++.++.|+++||+|||+ .+|+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 9999999999999999999875421 2348999999999999999999999 999999999999999
Q ss_pred cCCCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchh
Q 041096 485 DANFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMV 549 (645)
Q Consensus 485 d~~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~ 549 (645)
+.++.+||+|.. ....+|..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---- 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 999999998732 12246778999999999999999999999999999999 99999764321
Q ss_pred hHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 550 NLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 550 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
.+. +.+........+......+.+++..||+.+|++|||+++|++.|+.+....
T Consensus 301 ~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 301 ELF-------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHH-------------HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHH-------------HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 111 112222222333445567889999999999999999999999998775443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=332.39 Aligned_cols=252 Identities=14% Similarity=0.138 Sum_probs=204.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.++|+..+.||+|+||.||+|....++..||||++... ...+.+.+|+.++.++ +|+|++++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 35788999999999999999999888999999988653 2345688999999999 799999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC-----eeeeccc----
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN-----ARLESSF---- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~-----~kl~d~~---- 496 (645)
+ +++|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++. +|+.|..
T Consensus 88 ~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 88 L-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9 9999999986533 38999999999999999999998 99999999999999988776 8987721
Q ss_pred ---------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc
Q 041096 497 ---------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE 561 (645)
Q Consensus 497 ---------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~ 561 (645)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ....+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~ 239 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGEKKQS 239 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH-HHHHHHhhccC
Confidence 22358999999999999999999999999999999999999998754322211 11111000000
Q ss_pred CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 562 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
... +.+ ....+..+.+++..||+.+|++||++++|++.|++.....
T Consensus 240 ~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 240 TPL-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp SCH-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccH-----HHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 000 011 1123467888999999999999999999999998775543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=336.24 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=205.0
Q ss_pred hcCCCcCceeccCCceEEEEEEE-----CCCCeEEEEEeccCCc--chhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYF-----ASSGSVAAVKRSKHSH--EGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~-----~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 418 (645)
.++|...+.||+|+||.||+|++ ..++..||+|++.... ...+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46788899999999999999985 3467899999987643 3457799999999999 89999999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCCC--------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSEN--------------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML 484 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll 484 (645)
.++||||+++|+|.+++...... ...+++.+++.++.|+++||+|||+ .+++||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 99999999999999999865421 2248999999999999999999999 999999999999999
Q ss_pred cCCCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchh
Q 041096 485 DANFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMV 549 (645)
Q Consensus 485 d~~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~ 549 (645)
+.++.+|+.|.. ....||+.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF- 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-
Confidence 999999998732 12345678999999999999999999999999999999 99999765432111
Q ss_pred hHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 550 NLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 550 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
.+.+........+......+.+++..||+.||.+|||++++++.|++..
T Consensus 258 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 ---------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ---------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------------HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1112222222233345567889999999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=343.54 Aligned_cols=236 Identities=23% Similarity=0.299 Sum_probs=197.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc-------hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE-------GKTEFLAELSIIACLRHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 419 (645)
.+.|...+.||+|+||.||+|....++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4678899999999999999999999999999998865321 346789999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC----Ceeeecc
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF----NARLESS 495 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~----~~kl~d~ 495 (645)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+|+.|.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999997543 38999999999999999999999 9999999999999998877 6888772
Q ss_pred -----------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 496 -----------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 496 -----------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+..
T Consensus 164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~----~~~~i~~------- 232 (361)
T 2yab_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANITA------- 232 (361)
T ss_dssp SSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHT-------
T ss_pred CCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHh-------
Confidence 233469999999999999999999999999999999999999997643211 1111100
Q ss_pred hHHhhhhccCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 IEAADKRLNGAFNE----DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 ~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
. ...++. .....+.+++..||..||.+|||+.|+++
T Consensus 233 -----~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 233 -----V--SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -----T--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----c--CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 001121 12356788899999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=338.40 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=196.9
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCe---EEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCe
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGS---VAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGE 418 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~---~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 418 (645)
...++|+..+.||+|+||.||+|.+..++. .||||++... ....+.+.+|++++++++||||+++++++...+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999999876554 7999998763 3456789999999999999999999999987765
Q ss_pred E------EEEEecCCCCCHhHHhhhcCC--CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 419 L------LLVYEYMPNGSLDRMLYQDSE--NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 419 ~------~lV~Ey~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
. ++||||+++|+|.+++..... ....+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCE
Confidence 4 999999999999999975432 22248999999999999999999999 999999999999999999999
Q ss_pred eeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHH
Q 041096 491 RLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWV 555 (645)
Q Consensus 491 kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~ 555 (645)
|+.|... ...+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... +...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~- 251 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----IYNY- 251 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHH-
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----HHHH-
Confidence 9987321 1235678999999999999999999999999999999 999997644321 1111
Q ss_pred HhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCCCCCC
Q 041096 556 WGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKL 621 (645)
Q Consensus 556 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~~p~~ 621 (645)
+........+......+.+++..||+.||++|||+.++++.|+++...+.....
T Consensus 252 ------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 252 ------------LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp ------------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred ------------HhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 111111223344556788999999999999999999999999988776655443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=330.27 Aligned_cols=243 Identities=22% Similarity=0.350 Sum_probs=197.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECC---CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFAS---SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~---~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
.++|+..+.||+|+||.||+|.+.. .+..||+|..... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678889999999999999999854 3567999988763 334567999999999999999999999985 457899
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||||+++++|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+|+.|..
T Consensus 93 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999976542 38999999999999999999999 999999999999999999999998732
Q ss_pred --------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHH
Q 041096 497 --------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
....+|+.|+|||.+....++.++||||||+++|||++ |+.||....... ....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~----~~~~------------- 229 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGR------------- 229 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHH-------------
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH----HHHH-------------
Confidence 12245678999999999999999999999999999997 999997644321 1111
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
+........+...+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 230 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 230 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111112233445677889999999999999999999999998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.02 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=202.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeE----EEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSV----AAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~----vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|+..++||+|+||.||+|.+..++.. +++|.+.. .....+.+.+|+.++++++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 5788899999999999999998766654 57777654 3345678999999999999999999999998764 889
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---- 497 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---- 497 (645)
|+||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||.|...
T Consensus 94 v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999987543 38999999999999999999999 9999999999999999999999987321
Q ss_pred ----------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 498 ----------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 498 ----------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
...+|..|+|||.+.+..++.++|||||||++|||++ |+.||....... + .+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~-------------~~ 230 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----I-------------SS 230 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----H-------------HH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----H-------------HH
Confidence 1235778999999999999999999999999999999 999997643321 1 12
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
.+........+......+.+++..||+.||.+||+++++++.|+.....+
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 231 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 22222222334445567889999999999999999999999999876654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=344.61 Aligned_cols=261 Identities=20% Similarity=0.284 Sum_probs=200.6
Q ss_pred hcCCCcCceeccC--CceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 347 TRGFHSNRILGRG--AFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G--~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
.++|+..++||+| +||.||+|....++..||||++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678899999999 9999999999989999999998753 3345678889999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||||+++|+|.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+|+.|..
T Consensus 104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999976532 238999999999999999999999 999999999999999999999998731
Q ss_pred --------------cccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc
Q 041096 497 --------------TLTAGTMGYLAPEYLQY--GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA 560 (645)
Q Consensus 497 --------------~~~~gt~~y~APE~~~~--~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~ 560 (645)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....................
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 11368889999999987 67899999999999999999999999765432221111110000000
Q ss_pred ------cC-------------chhHHhh---h------hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hc
Q 041096 561 ------EG-------------RIIEAAD---K------RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI--LN 610 (645)
Q Consensus 561 ------~~-------------~~~~~~d---~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~--L~ 610 (645)
.. ...+.+. + .............+.+++..||+.||++|||++|+++. ++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 00 0000000 0 00001222334568889999999999999999999863 55
Q ss_pred CC
Q 041096 611 NE 612 (645)
Q Consensus 611 ~~ 612 (645)
+.
T Consensus 339 ~~ 340 (389)
T 3gni_B 339 QI 340 (389)
T ss_dssp GC
T ss_pred HH
Confidence 44
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=340.64 Aligned_cols=204 Identities=22% Similarity=0.258 Sum_probs=181.4
Q ss_pred CCcccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-----CCCeee
Q 041096 334 GPREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-----HKNLVQ 408 (645)
Q Consensus 334 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-----H~niv~ 408 (645)
....+++++-....++|...++||+|+||.||+|....++..||||++.......+.+..|++++.+++ ||||++
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 344566666666778999999999999999999999888999999999876666778889999999997 999999
Q ss_pred eeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC--
Q 041096 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA-- 486 (645)
Q Consensus 409 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~-- 486 (645)
+++++...+..++||||+ +++|.+++..... ..+++.++..++.||+.||+|||+ .+|+||||||+||||+.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPY 174 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTT
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccc
Confidence 999999999999999999 9999999986543 238999999999999999999999 99999999999999975
Q ss_pred -----------------------CCCeeeeccc---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc
Q 041096 487 -----------------------NFNARLESSF---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC 534 (645)
Q Consensus 487 -----------------------~~~~kl~d~~---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t 534 (645)
++.+||+|.. ....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 7788887732 33468999999999999999999999999999999999
Q ss_pred CCCCCCccc
Q 041096 535 GRRPIERET 543 (645)
Q Consensus 535 G~~P~~~~~ 543 (645)
|+.||....
T Consensus 255 g~~pf~~~~ 263 (360)
T 3llt_A 255 GSLLFRTHE 263 (360)
T ss_dssp SSCSCCCSS
T ss_pred CCCCCCCCc
Confidence 999997654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=330.07 Aligned_cols=250 Identities=20% Similarity=0.260 Sum_probs=194.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..+.||+|+||+||+|....++..||+|++... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5788899999999999999999999999999998753 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++ +|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|+.|..
T Consensus 82 ~~~~-~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9965 66666654332 39999999999999999999999 999999999999999999999998732
Q ss_pred ----cccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc---Cch---h
Q 041096 497 ----TLTAGTMGYLAPEYLQYGT-ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE---GRI---I 565 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~-~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~---~~~---~ 565 (645)
....||+.|+|||++.+.. ++.++|||||||++|||++|+.|+....... .....+...... ... .
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHHHHHHHHHCCCCTTTCTTGG
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCChhhhhhhc
Confidence 2346799999999998765 7999999999999999999988865432211 111211111110 000 0
Q ss_pred HHhhh---------hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 566 EAADK---------RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 566 ~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+..+. .............+.+++..|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 0000111234456788999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.91 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=204.6
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEECCCC-----eEEEEEeccCCc--chhHhHHHHHHHHhhc-CCCCeeeeeeeee
Q 041096 343 LRSATRGFHSNRILGRGAFGNVYKAYFASSG-----SVAAVKRSKHSH--EGKTEFLAELSIIACL-RHKNLVQLLGWCA 414 (645)
Q Consensus 343 l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~-----~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 414 (645)
+....++|...+.||+|+||.||+|.....+ ..||+|.+.... ...+.+.+|+.+++++ +||||++++++|.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3344578999999999999999999986544 379999987633 3456799999999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCCHhHHhhhcCC----------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 041096 415 EKGELLLVYEYMPNGSLDRMLYQDSE----------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML 484 (645)
Q Consensus 415 ~~~~~~lV~Ey~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll 484 (645)
+.+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+ .+|+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEE
Confidence 99999999999999999999975421 12348999999999999999999999 999999999999999
Q ss_pred cCCCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchh
Q 041096 485 DANFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMV 549 (645)
Q Consensus 485 d~~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~ 549 (645)
+.++.+||.|.. ....||+.|+|||.+.+..++.++|||||||++|||++ |..||.........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~- 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF- 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-
Confidence 999999998732 12345778999999999999999999999999999998 99999764332211
Q ss_pred hHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 550 NLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 550 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.+.+........+...+..+.+++..||+.||.+|||+.++++.|+..
T Consensus 277 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 ---------------YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ---------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111122222222333456788899999999999999999999999754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=338.58 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=210.2
Q ss_pred ccCHHHHHHHhcCCCcCceeccCCceEEEEEEEC-----CCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeee
Q 041096 337 EFSYRELRSATRGFHSNRILGRGAFGNVYKAYFA-----SSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQL 409 (645)
Q Consensus 337 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~-----~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l 409 (645)
.+..+++....++|...+.||+|+||.||+|... .++..||+|.+.... .....+.+|++++++++||||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3444555666788999999999999999999876 346789999987633 345578999999999999999999
Q ss_pred eeeeeeCCeEEEEEecCCCCCHhHHhhhcCC------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 041096 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSE------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIM 483 (645)
Q Consensus 410 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIl 483 (645)
++++.+.+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+ .+|+||||||+|||
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEE
Confidence 9999999999999999999999999975321 11347999999999999999999999 99999999999999
Q ss_pred EcCCCCeeeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccch
Q 041096 484 LDANFNARLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKM 548 (645)
Q Consensus 484 ld~~~~~kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~ 548 (645)
++.++.+|+.|... ...||+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 247 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--- 247 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---
Confidence 99999999987321 1245788999999999999999999999999999999 88998764321
Q ss_pred hhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 549 VNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 549 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
.+...+ ........+......+.+++..||+.+|.+|||+.++++.|++...+
T Consensus 248 -~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 248 -QVLRFV-------------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp -HHHHHH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -HHHHHH-------------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 111111 11111122334556788899999999999999999999999987663
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=337.19 Aligned_cols=247 Identities=15% Similarity=0.144 Sum_probs=200.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.++|+..+.||+|+||.||+|....++..||||++.... ..+.+.+|+++++++ +|+||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 367889999999999999999998889999999886532 345689999999999 999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC-----eeeeccc----
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN-----ARLESSF---- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~-----~kl~d~~---- 496 (645)
+ +++|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||||+.++. +||.|..
T Consensus 87 ~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 9999999986432 39999999999999999999999 99999999999999998887 8998721
Q ss_pred ---------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc
Q 041096 497 ---------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE 561 (645)
Q Consensus 497 ---------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~ 561 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~-~~~~~i~~~~~~ 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK-ERYQKIGDTKRA 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH-HHHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH-HHHHHHHhhhcc
Confidence 2346899999999999999999999999999999999999999875432211 111111000000
Q ss_pred CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 562 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
...+.+. ...+ .+.+++..||+.+|.+||++++|.+.|++.
T Consensus 239 -----~~~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 -----TPIEVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp -----SCHHHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred -----CCHHHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0000010 1123 788899999999999999999999988754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=331.46 Aligned_cols=247 Identities=21% Similarity=0.296 Sum_probs=202.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeee--eCCeEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCA--EKGELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~l 421 (645)
.++|+..+.||+|+||.||++....++..||+|.+... ....+.+.+|++++++++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46788899999999999999999988999999998653 334567999999999999999999999875 4678999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eeeCCCCCCcEEEcCCCCeeeeccc
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ-----VIHRDIKASNIMLDANFNARLESSF 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDlkp~NIlld~~~~~kl~d~~ 496 (645)
||||+++++|.+++.........+++..++.++.|++.||+|||+ .+ ++||||||+|||++.++.+|+.|..
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999998755444559999999999999999999999 67 9999999999999999999998732
Q ss_pred ------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 ------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 ------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....||..|+|||.+.+..++.++||||||+++|||++|+.||...... .+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~----------- 226 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAG----------- 226 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH-----------
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH----HHHH-----------
Confidence 1235899999999999999999999999999999999999999764321 1111
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
.+........+......+.+++..||+.||++||+++++++.+....
T Consensus 227 --~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 227 --KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp --HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred --HHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 11111111233344567888999999999999999999998775443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.82 Aligned_cols=253 Identities=19% Similarity=0.291 Sum_probs=186.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.++|+..+.||+|+||.||+|....++..||+|++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46788899999999999999999988999999988653 2345678999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCC--CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 425 YMPNGSLDRMLYQDSE--NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|++ |+|.+++..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 699999876432 12348999999999999999999999 999999999999999999999998732
Q ss_pred ------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh----hc-----
Q 041096 497 ------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL----YA----- 560 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~----~~----- 560 (645)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.+..... +.
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 23468999999999976 468999999999999999999999998654322221121111000 00
Q ss_pred -----------cCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 561 -----------EGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 561 -----------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+.+.+.+..... ....+.+++..||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 001111122211112 2346888999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.79 Aligned_cols=235 Identities=22% Similarity=0.242 Sum_probs=199.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||++....++..||+|++... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 5788899999999999999999989999999998652 233567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|.+++..... +++.++..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 121 e~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999986543 8999999999999999999999 999999999999999999999998732
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +... +.... .
T Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~------------i~~~~--~ 255 (350)
T 1rdq_E 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEK------------IVSGK--V 255 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH------------HHHCC--C
T ss_pred CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH----HHHH------------HHcCC--C
Confidence 23479999999999999999999999999999999999999997643211 1110 11111 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPS-----MRRVFQ 607 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~~vl~ 607 (645)
.++......+.+++..||+.||.+||+ ++++++
T Consensus 256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 233344566888999999999999998 888875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=339.87 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=201.2
Q ss_pred hcCCCcCceeccCCceEEEEEEE-----CCCCeEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYF-----ASSGSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~-----~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 419 (645)
.++|...+.||+|+||.||+|.+ ..++..||||.+.. .......+.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788899999999999999984 45677899999865 334566799999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCC---CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCeeee
Q 041096 420 LLVYEYMPNGSLDRMLYQDSEN---GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA---NFNARLE 493 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~---~~~~kl~ 493 (645)
++||||+++++|.+++...... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++. +..++++
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999875421 2348999999999999999999999 99999999999999994 4458887
Q ss_pred ccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhh
Q 041096 494 SSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 494 d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
|.. ....||+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~---- 257 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEF---- 257 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHH----
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH----HHHHH----
Confidence 721 22356889999999999999999999999999999998 99999754321 11111
Q ss_pred hccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCC
Q 041096 559 YAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLV 617 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~ 617 (645)
+........+......+.+++..||+.||.+||++.++++.|+.....+.
T Consensus 258 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 258 ---------VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp ---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ---------HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 11111122333445678899999999999999999999999987655543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=349.23 Aligned_cols=246 Identities=24% Similarity=0.296 Sum_probs=201.5
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeee
Q 041096 340 YRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415 (645)
Q Consensus 340 ~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 415 (645)
+++++...++|+..++||+|+||+||+|....++..||+|++... ....+.+.+|+.+++.++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 345556678999999999999999999999999999999998652 2334568899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 416 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
.+..||||||+++|+|.+++.... +++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|.
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~~-----~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecc
Confidence 999999999999999999997542 8999999999999999999999 99999999999999999999999873
Q ss_pred c-------------cccccCCcccCcccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh
Q 041096 496 F-------------TLTAGTMGYLAPEYLQYGT----ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 496 ~-------------~~~~gt~~y~APE~~~~~~----~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
. ...+||+.|+|||++.... ++.++|||||||++|||++|+.||...+.......+..+.
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--- 289 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--- 289 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH---
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc---
Confidence 1 2356999999999998765 7899999999999999999999997643322111111110
Q ss_pred hccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 041096 559 YAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSA--RPSMRRVFQ 607 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~~vl~ 607 (645)
..+.-.........+.+++..|++.+|.+ ||+++||++
T Consensus 290 -----------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 290 -----------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp -----------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred -----------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 00111111123456778889999999988 999999987
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=331.46 Aligned_cols=237 Identities=22% Similarity=0.283 Sum_probs=189.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc---------------------------hhHhHHHHHHHHh
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---------------------------GKTEFLAELSIIA 399 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---------------------------~~~~~~~Ei~~l~ 399 (645)
.++|...+.||+|+||.||+|....++..||||++..... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3678899999999999999999999999999998865321 2356899999999
Q ss_pred hcCCCCeeeeeeeeee--CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 041096 400 CLRHKNLVQLLGWCAE--KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDI 477 (645)
Q Consensus 400 ~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl 477 (645)
+++||||+++++++.+ .+..++||||+++++|.+++.. ..+++.++..++.|+++||+|||+ .+|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence 9999999999999986 5689999999999999886543 238999999999999999999999 99999999
Q ss_pred CCCcEEEcCCCCeeeeccc------------cccccCCcccCcccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCcc
Q 041096 478 KASNIMLDANFNARLESSF------------TLTAGTMGYLAPEYLQYGT---ATEKTDVFSYGVVVLEVACGRRPIERE 542 (645)
Q Consensus 478 kp~NIlld~~~~~kl~d~~------------~~~~gt~~y~APE~~~~~~---~t~ksDV~SfGvvl~El~tG~~P~~~~ 542 (645)
||+|||++.++.+||.|.. ....||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999998732 2346899999999998765 378999999999999999999999753
Q ss_pred ccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 543 TEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 543 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
... .+...+ ....+...........+.+++..||+.||++|||+.|+++
T Consensus 244 ~~~----~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RIM----CLHSKI------------KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SHH----HHHHHH------------HHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHH----HHHHHH------------hcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 211 111110 0011111111223456888999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=336.74 Aligned_cols=245 Identities=25% Similarity=0.457 Sum_probs=200.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCC----CeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASS----GSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~----~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
++|...+.||+|+||.||+|....+ +..||||.+... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 4566778999999999999988654 346999998763 3345679999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT---- 497 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~---- 497 (645)
||||+++|+|.+++..... .+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+|+.|...
T Consensus 124 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999976533 38999999999999999999999 9999999999999999999999987321
Q ss_pred -----------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchh
Q 041096 498 -----------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRII 565 (645)
Q Consensus 498 -----------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 565 (645)
...+|..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~~------------- 260 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----EVM------------- 260 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHH-------------
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH----HHH-------------
Confidence 1234678999999999999999999999999999999 99999754321 111
Q ss_pred HHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 566 EAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 566 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
+.+........+......+.+++..||+.+|++||++.++++.|+.....
T Consensus 261 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 261 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111112223344566788999999999999999999999999866443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.34 Aligned_cols=235 Identities=22% Similarity=0.296 Sum_probs=198.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||++....++..||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5788899999999999999999989999999998652 233566889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|.+++..... +++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 86 e~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999986543 8999999999999999999998 999999999999999999999998732
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .++...+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~------------~i~~~~~-- 220 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TYE------------KILNAEL-- 220 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH------------HHHHCCC--
T ss_pred ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----HHH------------HHHhCCC--
Confidence 23579999999999999999999999999999999999999997643211 111 1111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
.++......+.+++..|++.||++|| +++++++
T Consensus 221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 22333445678888999999999999 8999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.38 Aligned_cols=251 Identities=21% Similarity=0.312 Sum_probs=193.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc---hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..+.||+|+||.||+|.. .++..+|+|++..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 4688899999999999999998 4688999998865332 24678899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++ +|.+++..... .+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+|+.|..
T Consensus 81 ~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCSE-EHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecCC-CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 9974 99999876433 38999999999999999999999 999999999999999999999998732
Q ss_pred ----cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc---hh--H
Q 041096 497 ----TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR---II--E 566 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~---~~--~ 566 (645)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+...... ..... .. .
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT-PNSKNWPNVTELP 232 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTTGGGST
T ss_pred ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCC-CChhhchhhhccc
Confidence 22368999999999976 45899999999999999999999999765432221111111000 00000 00 0
Q ss_pred Hhhhhcc-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 567 AADKRLN-------GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 567 ~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..++... ..........+.+++..||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0011100 0111223456788999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=360.49 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=206.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
..++|+..++||+|+||.||+|.+.. +..||||+++......++|.+|+++|++++|+||++++++|.+ +..+|||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 44678888999999999999999975 5779999998766667789999999999999999999999976 678999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc--------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT-------- 497 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~-------- 497 (645)
+++|+|.++|..... ..+++.+++.|+.||++||+|||+ ++|+||||||+||||+.++.+||.|...
T Consensus 343 ~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999975421 238999999999999999999999 9999999999999999999999988321
Q ss_pred -----ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 498 -----LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 498 -----~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
...++..|+|||++....++.++|||||||+||||++ |+.||...... .+. +.+...
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~----~~~-------------~~i~~~ 480 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVL-------------DQVERG 480 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH----HHH-------------HHHHTT
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHH-------------HHHHcC
Confidence 2235678999999999999999999999999999999 99999764321 111 112222
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
.+...+..+...+.+++..||+.||++|||+++|++.|+......
T Consensus 481 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 481 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 222334456678889999999999999999999999999876543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=332.54 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=198.0
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhh--cCCCCeeeeeeeeeeC---
Q 041096 342 ELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIAC--LRHKNLVQLLGWCAEK--- 416 (645)
Q Consensus 342 ~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~--- 416 (645)
.-....++|+..+.||+|+||.||+|... +..||||++..... ..+..|.+++.. ++||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33445578999999999999999999986 89999999865433 344455555544 4899999999999887
Q ss_pred -CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeeCCCCCCcEEEcCCCCe
Q 041096 417 -GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC-----EQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 417 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlkp~NIlld~~~~~ 490 (645)
...++||||+++|+|.+++.... +++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCceEEEEeccCCCcHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 78999999999999999996542 899999999999999999999810 1299999999999999999999
Q ss_pred eeecccc----------------ccccCCcccCcccccCCCCCcc------hhHHHHHHHHHHHHcC----------CCC
Q 041096 491 RLESSFT----------------LTAGTMGYLAPEYLQYGTATEK------TDVFSYGVVVLEVACG----------RRP 538 (645)
Q Consensus 491 kl~d~~~----------------~~~gt~~y~APE~~~~~~~t~k------sDV~SfGvvl~El~tG----------~~P 538 (645)
||.|... ...||+.|+|||.+.+...+.+ +|||||||++|||++| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 9988321 2368999999999988776655 9999999999999999 566
Q ss_pred CCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 539 IERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN-----EDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 539 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
|................ .....+....+ .++...+.+++..||+.||++|||+.+|++.|+.+.
T Consensus 262 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREI-----------VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TTTTSCSSCCHHHHHHH-----------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhhcCCCCchhhhHHH-----------HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 65432222111111100 00111122222 267788999999999999999999999999998776
Q ss_pred CCCC
Q 041096 614 EPLV 617 (645)
Q Consensus 614 ~~~~ 617 (645)
+...
T Consensus 331 ~~~~ 334 (337)
T 3mdy_A 331 ESQD 334 (337)
T ss_dssp HTTT
T ss_pred hhcc
Confidence 5543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=340.11 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=206.3
Q ss_pred cCCCcCceeccCCceEEEEEEE----CCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeee--eCCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYF----ASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCA--EKGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~----~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~ 420 (645)
++|+..+.||+|+||.||+|.+ ..++..||||++... ....+.+.+|++++++++|+||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788889999999999999994 567899999998764 344567999999999999999999999886 456799
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---- 496 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---- 496 (645)
+||||+++++|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+|+.|..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999976433 38999999999999999999999 999999999999999999999998722
Q ss_pred -----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchh
Q 041096 497 -----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRII 565 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 565 (645)
....||..|+|||.+.+..++.++||||||+++|||++|+.||........ ....+.........+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL--RMMGCERDVPALSRLL 254 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHCC----CCHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh--hhcccccccccHHHHH
Confidence 123467779999999998999999999999999999999999875322100 0000000000011223
Q ss_pred HHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 566 EAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 566 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
+.+........+......+.+++..||+.||++|||++++++.|+......
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 333444444455566778899999999999999999999999999775544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=339.18 Aligned_cols=241 Identities=22% Similarity=0.285 Sum_probs=190.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
..++|+..+.||+|+||.||+|....++..||||++.... ..+.+.+|++++.+++||||++++++|.+.+..++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 3567899999999999999999999889999999987643 346788999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCeeeeccc------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA---NFNARLESSF------ 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~---~~~~kl~d~~------ 496 (645)
+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||.|..
T Consensus 130 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 130 VTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999997643 38999999999999999999999 99999999999999975 8889998732
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+...+. ... ..
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~i~----~~~------~~ 269 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ---FMFRRIL----NCE------YY 269 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH---HHHHHHH----TTC------CC
T ss_pred cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH---HHHHHHH----hCC------Cc
Confidence 23468999999999999999999999999999999999999997543211 1111110 000 00
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.......+....+.+++..||+.||++|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111234556788999999999999999999987
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=334.77 Aligned_cols=235 Identities=20% Similarity=0.303 Sum_probs=191.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC-------
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG------- 417 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------- 417 (645)
.++|+..+.||+|+||.||+|+...++..||||++.. .....+.+.+|++++++++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4578889999999999999999998899999999875 3345678999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEecCCCCCHhHHhhhcCCCCccCCH
Q 041096 418 --------------------------------------------------ELLLVYEYMPNGSLDRMLYQDSENGVLLSW 447 (645)
Q Consensus 418 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~ 447 (645)
..++||||+++++|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 38999999999999999986543 334678
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc------------------------ccccCC
Q 041096 448 YHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------------------------LTAGTM 503 (645)
Q Consensus 448 ~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------------------------~~~gt~ 503 (645)
..++.++.|++.||+|||+ .+|+||||||+||||+.++.+||+|... ...||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 8899999999999999999 9999999999999999999999987321 135899
Q ss_pred cccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC---HHH
Q 041096 504 GYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN---EDE 580 (645)
Q Consensus 504 ~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~---~~~ 580 (645)
.|+|||.+.+..++.++|||||||++|||++|..|+.... ..... ......+ ...
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~------~~~~~----------------~~~~~~~~~~~~~ 298 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV------RIITD----------------VRNLKFPLLFTQK 298 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH------HHHHH----------------HHTTCCCHHHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH------HHHHH----------------hhccCCCcccccC
Confidence 9999999999999999999999999999999877643210 11100 0011111 233
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 581 MKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 581 ~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+.+++..||+.||++|||++|+++
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 456688999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=341.62 Aligned_cols=258 Identities=18% Similarity=0.218 Sum_probs=201.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCC-----CeEEEEEeccCCcch------------hHhHHHHHHHHhhcCCCCeee
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASS-----GSVAAVKRSKHSHEG------------KTEFLAELSIIACLRHKNLVQ 408 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~-----~~~vavK~~~~~~~~------------~~~~~~Ei~~l~~l~H~niv~ 408 (645)
..++|...+.||+|+||.||+|.+..+ +..||||++...... ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356899999999999999999998764 478999987654311 123445666777888999999
Q ss_pred eeeeeeeC----CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 041096 409 LLGWCAEK----GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML 484 (645)
Q Consensus 409 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll 484 (645)
+++++... ...+|||||+ +++|.+++..... .+++.+++.++.||+.||+|||+ .+|+||||||+||||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence 99998765 4589999999 9999999986533 39999999999999999999999 999999999999999
Q ss_pred c--CCCCeeeecccc-------------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccc
Q 041096 485 D--ANFNARLESSFT-------------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERET 543 (645)
Q Consensus 485 d--~~~~~kl~d~~~-------------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~ 543 (645)
+ .++.+||.|... ...||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 889999987321 1239999999999999999999999999999999999999998643
Q ss_pred cccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCC
Q 041096 544 EGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLV 617 (645)
Q Consensus 544 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~ 617 (645)
.... ......... ...+.+.+++.+.. ...+..+.+++..||+.+|.+||++++|++.|++......
T Consensus 266 ~~~~---~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 266 KDPK---YVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp TCHH---HHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCHH---HHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 3221 111111111 11344445544421 2234667888899999999999999999999987655443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=341.28 Aligned_cols=241 Identities=20% Similarity=0.273 Sum_probs=197.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
..++|...+.||+|+||.||+|....++..||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 346799999999999999999999999999999998653 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---Ceeeeccc---
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF---NARLESSF--- 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~---~~kl~d~~--- 496 (645)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++ .+||.|..
T Consensus 107 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999997543 38999999999999999999999 9999999999999998654 48887722
Q ss_pred --------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 --------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+.. +..
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~~i~~----~~~---- 247 (362)
T 2bdw_A 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQIKA----GAY---- 247 (362)
T ss_dssp CCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH----TCC----
T ss_pred EecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHh----CCC----
Confidence 2347899999999999999999999999999999999999999764321 11111100 000
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.............+.+++..||+.||++|||+.++++
T Consensus 248 --~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 248 --DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp --CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000123456788999999999999999999976
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=335.30 Aligned_cols=254 Identities=21% Similarity=0.312 Sum_probs=201.3
Q ss_pred cCCCcCceeccCCceEEEEEE----ECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeE
Q 041096 348 RGFHSNRILGRGAFGNVYKAY----FASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GEL 419 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~----~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 419 (645)
+.|+..+.||+|+||.||+|. ...++..||+|++... ....+.+.+|++++++++||||+++++++.+. +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 457888999999999999999 4567899999998753 33457899999999999999999999999876 678
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
++||||+++++|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+++.|..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence 999999999999999966543 38999999999999999999999 999999999999999999999998722
Q ss_pred ------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh---cc
Q 041096 497 ------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY---AE 561 (645)
Q Consensus 497 ------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~---~~ 561 (645)
....||..|+|||.+.+..++.++||||||+++|||++|+.|+..... .......... ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA-----LFLKMIGPTHGQMTV 249 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH-----HHHHHHCSCCGGGHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh-----HHhhccCCcccccCH
Confidence 123467789999999999999999999999999999999998653210 0000000000 00
Q ss_pred CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 562 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
..+...+........+......+.+++..||+.||.+|||++++++.|+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 112222233333344555667889999999999999999999999999754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.06 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=197.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 421 (645)
.++|+..++||+|+||+||+|+...++..+|+|++++. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 35788999999999999999999999999999998752 23345688999999887 89999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||||+++|+|..++..... +++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 131 V~E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999986543 8999999999999999999999 999999999999999999999998732
Q ss_pred -------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccch-hhHHHHHHhhhccCchhHHh
Q 041096 497 -------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKM-VNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~ 568 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....+.... .+.
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~--------~i~ 275 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------VIL 275 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH--------HHH
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH--------HHh
Confidence 2346899999999999999999999999999999999999999753221110 000011100 011
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSM------RRVFQ 607 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~~vl~ 607 (645)
... ..++......+.+++..||+.||++||++ +|+++
T Consensus 276 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 276 EKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 111 12344455677889999999999999995 56655
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=333.68 Aligned_cols=253 Identities=20% Similarity=0.259 Sum_probs=195.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
.++|+..+.||+|+||+||+|.... +..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4678899999999999999999864 8899999987532 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||++ ++|.+++..... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 99 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFME-KDLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCS-EEHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCC-CCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9997 588888876443 38999999999999999999999 999999999999999999999998732
Q ss_pred -----cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc-----Cchh
Q 041096 497 -----TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE-----GRII 565 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~-----~~~~ 565 (645)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.......... ..+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 22367999999999876 568999999999999999999999998765443332222211100000 0000
Q ss_pred HHhhhhcc--CCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 566 EAADKRLN--GAF-----NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 566 ~~~d~~l~--~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+.... ... .......+.+++..||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000 000 0112346788999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=342.63 Aligned_cols=236 Identities=25% Similarity=0.343 Sum_probs=197.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 421 (645)
.++|+..++||+|+||+||+|+...++..||||++... ....+.+.+|..++..+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 47899999999999999999999999999999998752 23445688999999988 69999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||||+++|+|..++..... +++.++..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 102 v~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRR----FDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999987543 8999999999999999999999 999999999999999999999998832
Q ss_pred -------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 -------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +... +..
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~------------i~~ 238 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----LFEA------------ILN 238 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH------------HHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH----HHHH------------HHc
Confidence 22468999999999998899999999999999999999999997643221 1111 111
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSM------RRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~~vl~ 607 (645)
.. ..++......+.+++..|++.||++||++ +++++
T Consensus 239 ~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 239 DE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11 12333345567888999999999999998 77765
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.94 Aligned_cols=241 Identities=29% Similarity=0.421 Sum_probs=201.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.++|+..+.||+|+||.||+|....++..+|+|++... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 46788899999999999999999999999999988652 22345788999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++++|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+++.|..
T Consensus 88 ~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999976543 8999999999999999999998 999999999999999999999998832
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..... ...
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~--------------~~~ 222 (279)
T 3fdn_A 161 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRI--------------SRV 222 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHH--------------HHT
T ss_pred cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH----HHHHH--------------HhC
Confidence 23468999999999999999999999999999999999999997543211 11100 001
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
....+......+.+++..||+.||.+|||++|+++ .+...
T Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 223 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 11233334566788999999999999999999997 44443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=338.32 Aligned_cols=240 Identities=20% Similarity=0.301 Sum_probs=199.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.++|...+.||+|+||.||+|.+..++..||+|++... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36788999999999999999999889999999988642 22345789999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+ +|+|.+++..... +++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+|+.|..
T Consensus 88 ~E~~-~g~l~~~l~~~~~----l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKR----MTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 7899999876543 8999999999999999999999 899999999999999999999998732
Q ss_pred -----cccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
...+||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........... +..
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-----------------i~~ 222 (336)
T 3h4j_B 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-----------------VNS 222 (336)
T ss_dssp TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----------------CCS
T ss_pred CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----------------HHc
Confidence 23468999999999988776 7899999999999999999999976432211110 000
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
. ....+......+.+++..||+.||.+|||++|+++ .+...
T Consensus 223 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 223 C-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp S-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred C-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 0 01123334456788999999999999999999987 45543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=333.17 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=201.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||+|....++..||+|++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 568889999999999999999988899999998875 2334567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++++|.+++.........+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999997644334458999999999999999999999 999999999999999999999998732
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+...+. ...
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~------------~~~ 254 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIE------------QCD 254 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHH------------TTC
T ss_pred CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhh------------ccc
Confidence 1235889999999999999999999999999999999999999753221 111111110 000
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCC
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLV 617 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~ 617 (645)
............+.+++..||+.||.+|||+++|++.|+.+.....
T Consensus 255 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 1111112345578889999999999999999999999987654443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.44 Aligned_cols=248 Identities=24% Similarity=0.384 Sum_probs=202.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-------CCCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFA-------SSGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEK 416 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~-------~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 416 (645)
.++|...+.||+|+||.||+|... .++..||+|++... ....+.+.+|+++++++ +||||++++++|.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467888999999999999999975 34678999998763 33456799999999999 899999999999999
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCCC------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSEN------------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML 484 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll 484 (645)
+..++||||+++|+|.+++...... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 9999999999999999999865421 1248999999999999999999999 999999999999999
Q ss_pred cCCCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchh
Q 041096 485 DANFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMV 549 (645)
Q Consensus 485 d~~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~ 549 (645)
+.++.+|+.|.. ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 266 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 266 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----
Confidence 999999998732 12245678999999998889999999999999999999 99999764321
Q ss_pred hHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 550 NLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 550 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
.+.. .+........+......+.+++..||+.+|.+|||++++++.|+.+..
T Consensus 267 ~~~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 ELFK-------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHH-------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH-------------HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111 111111222334455678899999999999999999999999986643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.56 Aligned_cols=241 Identities=21% Similarity=0.251 Sum_probs=196.7
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
..++|+..+.||+|+||.||+|....++..+|+|++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3567899999999999999999999999999999987633 3356789999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCeeeeccc---
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA---NFNARLESSF--- 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~---~~~~kl~d~~--- 496 (645)
|||+++|+|.+++..... +++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||.|..
T Consensus 89 ~E~~~gg~L~~~i~~~~~----~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCSC----CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999986543 8999999999999999999999 99999999999999984 5678887722
Q ss_pred ---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHH
Q 041096 497 ---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
....||+.|+|||++.+..++.++||||+||++|||++|+.||....... +...+.. +.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~----~~---- 229 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR----LYQQIKA----GA---- 229 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHH----TC----
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH----HHHHHHh----CC----
Confidence 22468999999999999999999999999999999999999997643211 1111100 00
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..............+.+++..||+.||++|||+.|+++
T Consensus 230 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 230 --YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp --CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000011123456788899999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.69 Aligned_cols=250 Identities=30% Similarity=0.450 Sum_probs=202.9
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEE--EEEeccC--CcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVA--AVKRSKH--SHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~v--avK~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 422 (645)
++|...+.||+|+||.||+|....++..+ |+|.+.. .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999998777755 8998765 334456799999999999 899999999999999999999
Q ss_pred EecCCCCCHhHHhhhcC------------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 423 YEYMPNGSLDRMLYQDS------------ENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
|||+++++|.+++.... .....+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997653 223358999999999999999999999 999999999999999999999
Q ss_pred eeeccc-----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhh
Q 041096 491 RLESSF-----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 491 kl~d~~-----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
|+.|.. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.
T Consensus 182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~~------ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELY------ 251 (327)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHH------
T ss_pred EEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH----HHH------
Confidence 998732 22346788999999998889999999999999999998 99999764321 111
Q ss_pred hccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCC
Q 041096 559 YAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLV 617 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~ 617 (645)
+.+........+......+.+++..||+.+|.+|||++++++.|+...+...
T Consensus 252 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 252 -------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp -------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -------HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111112222333455678899999999999999999999999987655443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.93 Aligned_cols=242 Identities=21% Similarity=0.236 Sum_probs=199.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.++|+..+.||+|+||.||+|....++..+|+|.+... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999999999999999998764 33456789999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC--CCCeeeeccc-------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA--NFNARLESSF------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~--~~~~kl~d~~------- 496 (645)
+++|+|.+++..... .+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||.|..
T Consensus 130 ~~gg~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTTC---CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999975432 38999999999999999999999 99999999999999984 4668888732
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... ....
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~i~~~----------~~~~ 269 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRC----------DWEF 269 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHHC----------CCCC
T ss_pred CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH----HHHHHHHhC----------CCCC
Confidence 2346899999999999999999999999999999999999999764321 111111000 0001
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
...........+.+++..||+.||++|||+.++++.
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111112334567889999999999999999999973
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=329.03 Aligned_cols=247 Identities=21% Similarity=0.339 Sum_probs=201.0
Q ss_pred cCCCcCc-eeccCCceEEEEEEEC--CCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNR-ILGRGAFGNVYKAYFA--SSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~-~lG~G~fg~Vy~g~~~--~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
++|...+ .||+|+||.||+|.+. .++..||+|++... ....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999864 45788999998773 34567899999999999999999999999 55679999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++++|.+++..... .+++.+++.++.|+++||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 88 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhCCc---cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999975433 38999999999999999999999 999999999999999999999998732
Q ss_pred ---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 ---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....||+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~------------- 224 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMA------------- 224 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHH-------------
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----HHHH-------------
Confidence 11235788999999998889999999999999999998 99999764321 1111
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVV 618 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~~ 618 (645)
.+........+...+..+.+++..||+.+|++||++.++++.|+........
T Consensus 225 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 225 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 1111122234445567888999999999999999999999999876544433
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=327.77 Aligned_cols=243 Identities=25% Similarity=0.433 Sum_probs=201.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.++|+..+.||+|+||.||+|... ++..||+|.+.......+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 467888999999999999999986 46789999998766667889999999999999999999999874 4689999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++++|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+++.|..
T Consensus 90 ~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp TTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999975421 238999999999999999999999 999999999999999999999998732
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. .+....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~-------------~~~~~~ 227 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVIQ-------------NLERGY 227 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHH-------------HHHTTC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH----HHHH-------------HHhccc
Confidence 12245678999999998889999999999999999999 89999764321 1111 111111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
....+......+.+++..||+.+|++|||++++++.|++..
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 22233344567889999999999999999999999998653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=326.36 Aligned_cols=239 Identities=23% Similarity=0.315 Sum_probs=194.9
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 421 (645)
..++|+..+.||+|+||.||+|....++..||+|++... ......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 346788999999999999999999988999999988752 34567789999999999 99999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC--------------
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN-------------- 487 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~-------------- 487 (645)
||||+++++|.+++.........+++.+++.++.|++.||+|||+ ++|+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999998654323448999999999999999999999 999999999999999844
Q ss_pred -----CCeeeeccc--------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHH
Q 041096 488 -----FNARLESSF--------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVD 553 (645)
Q Consensus 488 -----~~~kl~d~~--------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~ 553 (645)
...+++|.. ....||..|+|||.+.+. .++.++|||||||++|||++|..|+..... ..
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-------~~ 238 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-------WH 238 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-------HH
T ss_pred ccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-------HH
Confidence 467887622 234689999999999876 567899999999999999999887643210 00
Q ss_pred HHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 554 WVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 554 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+........+......+.+++..||+.||++|||+.++++
T Consensus 239 -------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 239 -------------EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -------------HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------------HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 00111111223334567888999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=330.06 Aligned_cols=260 Identities=21% Similarity=0.266 Sum_probs=197.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc---hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..+.||+|+||.||+|....++..||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 578899999999999999999998899999998866332 35678899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++++|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+++.|..
T Consensus 83 ~~~~~~l~~~~~~~~~----~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQRG----VPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSSC----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhcC----CCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998865433 8999999999999999999999 999999999999999999999998732
Q ss_pred ----cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh-------hccCch
Q 041096 497 ----TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL-------YAEGRI 564 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~-------~~~~~~ 564 (645)
....||..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....... +.....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 23468899999999976 668999999999999999999999997654322221111110000 000000
Q ss_pred hHHhh-hhccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCC
Q 041096 565 IEAAD-KRLNGAFN-----EDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAE 614 (645)
Q Consensus 565 ~~~~d-~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~ 614 (645)
..... +......+ .+....+.+++..||+.||++|||++|+++ .+++..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 00000 00000000 123455788999999999999999999986 3454433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=339.53 Aligned_cols=238 Identities=22% Similarity=0.321 Sum_probs=198.0
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCe
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGE 418 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 418 (645)
....++|...++||+|+||.||+|+.+.+++.||+|++... ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34567899999999999999999999999999999998753 23455678899999887 89999999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-- 496 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-- 496 (645)
.|+||||+++|+|.+++..... +++.++..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999986543 8999999999999999999999 999999999999999999999998732
Q ss_pred ----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 ----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +...+
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i----------- 230 (345)
T 1xjd_A 166 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSI----------- 230 (345)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH-----------
T ss_pred hhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH----HHHHH-----------
Confidence 23468999999999999999999999999999999999999997643211 11111
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMR-RVF 606 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-~vl 606 (645)
... ...++......+.+++..||+.||++||++. +++
T Consensus 231 -~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 231 -RMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -HHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -HhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 000 0122333446678889999999999999997 665
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=360.40 Aligned_cols=234 Identities=22% Similarity=0.353 Sum_probs=195.4
Q ss_pred eeccCCceEEEEEEEC--CCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCC
Q 041096 355 ILGRGAFGNVYKAYFA--SSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGS 430 (645)
Q Consensus 355 ~lG~G~fg~Vy~g~~~--~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 430 (645)
.||+|+||.||+|.+. .++..||||+++.. ....++|.+|+++|++++|||||+++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 34677999998763 3456789999999999999999999999976 56999999999999
Q ss_pred HhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-------------
Q 041096 431 LDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT------------- 497 (645)
Q Consensus 431 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~------------- 497 (645)
|.+++..... .+++.+++.++.||++||+|||+ .+|+||||||+||||+.++.+||.|...
T Consensus 422 L~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 9999975433 48999999999999999999999 9999999999999999999999988321
Q ss_pred --ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 498 --LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 498 --~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
...++..|+|||++....++.++|||||||++|||++ |+.||......+ +. +.+....+.
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~-------------~~i~~~~~~ 558 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VM-------------AFIEQGKRM 558 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----HH-------------HHHHTTCCC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HH-------------HHHHcCCCC
Confidence 1124578999999999999999999999999999998 999998654321 11 122222233
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
..+..++..+.+++..||+.+|++||++++|++.|+..
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 44556678899999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=336.08 Aligned_cols=238 Identities=25% Similarity=0.339 Sum_probs=198.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|...+.||+|+||.||++....++..||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5688899999999999999999999999999988652 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-------- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-------- 495 (645)
||+++|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|.
T Consensus 95 e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999997643 38999999999999999999999 99999999999999999999999872
Q ss_pred ---ccccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 496 ---FTLTAGTMGYLAPEYLQY---GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 496 ---~~~~~gt~~y~APE~~~~---~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
....+||+.|+|||++.. ..++.++|||||||++|||++|+.||........ ..+... +.
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~-------------~~ 233 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHT-------------FE 233 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-HHHHHH-------------HH
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-HHHHHH-------------Hh
Confidence 233579999999999974 4589999999999999999999999975433211 111111 11
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPS-MRRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~~vl~ 607 (645)
. ....++......+.+++..||+.||.+||+ ++++.+
T Consensus 234 ~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 T-TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp H-CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred h-cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1 112334445567888999999999999999 777764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=330.32 Aligned_cols=241 Identities=25% Similarity=0.369 Sum_probs=197.0
Q ss_pred hcCCCcCc-eeccCCceEEEEEEE--CCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 347 TRGFHSNR-ILGRGAFGNVYKAYF--ASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 347 ~~~f~~~~-~lG~G~fg~Vy~g~~--~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
.++|...+ .||+|+||.||+|.+ ...+..||||++.... ...+.+.+|++++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 899999999999954 5567899999987632 2356799999999999999999999999 567789
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--- 497 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--- 497 (645)
+||||+++++|.+++..... +++..++.++.|++.||+|||+ .+++||||||+|||++.++.+++.|...
T Consensus 94 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhCcC----CCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999986543 8999999999999999999999 9999999999999999999999987321
Q ss_pred ------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 498 ------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 498 ------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~------------ 230 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVT------------ 230 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHH------------
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHH------------
Confidence 1235678999999998889999999999999999999 99999764321 111
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+.+........+......+.+++..||+.||.+||++.++++.|+..
T Consensus 231 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 231 -AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111112233445567788999999999999999999999999854
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.91 Aligned_cols=245 Identities=24% Similarity=0.337 Sum_probs=196.7
Q ss_pred CCCcCceeccCCceEEEEEEECCCC---eEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeE-EEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSG---SVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGEL-LLV 422 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~---~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV 422 (645)
.|...++||+|+||.||+|.+..++ ..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3555688999999999999975443 379999987633 3457799999999999999999999999876655 999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-----
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT----- 497 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~----- 497 (645)
|||+.+|+|.+++..... .+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+|+.|...
T Consensus 102 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999976433 38999999999999999999999 9999999999999999999999987321
Q ss_pred -----------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 498 -----------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 498 -----------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
...++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~~------------- 239 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLTH------------- 239 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHHH-------------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHHH-------------
Confidence 2346788999999999999999999999999999999666654332211 1111
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
.+........+......+.+++..||+.+|.+|||++++++.|+++...
T Consensus 240 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 240 FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111112223334456788999999999999999999999999876443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=323.94 Aligned_cols=245 Identities=20% Similarity=0.268 Sum_probs=200.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
.++|+..+.||+|+||.||+|....++..||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46899999999999999999999999999999988653 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC---eeeeccc----
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN---ARLESSF---- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~---~kl~d~~---- 496 (645)
||+++++|.+++..... +++..+..++.|++.||+|||+ .+++||||||+||+++.++. +|+.|..
T Consensus 85 e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999999876543 8999999999999999999999 99999999999999987665 8887722
Q ss_pred -------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 -------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....... +.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~----~~------ 223 (284)
T 3kk8_A 158 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQIKA----GA------ 223 (284)
T ss_dssp CCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHH----TC------
T ss_pred cccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH----HHHHHHh----cc------
Confidence 22468999999999999999999999999999999999999997643211 1111000 00
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
..............+.+++..||+.||++|||++|+++ .|.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 224 YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 00000111123456788999999999999999999987 45544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.72 Aligned_cols=237 Identities=27% Similarity=0.339 Sum_probs=194.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
+.|...+.||+|+||.||+|....++..||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888899999999999999998889999999986532 23457899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+. |+|.+++..... .+++.++..++.|+++||+|||+ .+|+||||||+||||+.++.+||+|..
T Consensus 134 e~~~-g~l~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9996 788888865433 38999999999999999999999 899999999999999999999998832
Q ss_pred -cccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 -TLTAGTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 -~~~~gt~~y~APE~~~---~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....||+.|+|||++. .+.++.++|||||||++|||++|+.||........ + ..... ...
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---~----~~~~~---------~~~ 270 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L----YHIAQ---------NES 270 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H----HHHHH---------SCC
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---H----HHHHh---------cCC
Confidence 2346899999999984 56789999999999999999999999976432111 1 11110 001
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...........+.+++..||+.||++|||++++++
T Consensus 271 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 271 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11112233456788899999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.14 Aligned_cols=244 Identities=26% Similarity=0.381 Sum_probs=194.9
Q ss_pred CCCcCceeccCCceEEEEEEECCC---CeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeee-CCeEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASS---GSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAE-KGELLLV 422 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~---~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV 422 (645)
.|...++||+|+||.||+|++... +..+|+|.+... ....+.|.+|+.++++++||||++++++|.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 355678999999999999987532 246899988652 3456789999999999999999999998765 4578999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++|+|.+++..... .+++.+++.++.|+++||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 170 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999975433 38899999999999999999999 999999999999999999999998732
Q ss_pred ----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchh
Q 041096 497 ----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRII 565 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 565 (645)
....+|..|+|||.+.+..++.++|||||||++|||++ |..||......+ +....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~----~~~~~---------- 309 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYL---------- 309 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC----HHHHH----------
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH----HHHHH----------
Confidence 12245678999999999999999999999999999999 677776543221 11111
Q ss_pred HHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 566 EAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 566 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
........+...+..+.+++..||+.+|++|||++++++.|+.+...
T Consensus 310 ---~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 310 ---LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp ---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111122334456788999999999999999999999999876443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.73 Aligned_cols=246 Identities=23% Similarity=0.414 Sum_probs=195.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
.++|+..++||+|+||.||+|.... .+|+|++... ....+.+.+|++++++++|+||+++++++. .+..++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence 4678999999999999999998753 4899988653 334567999999999999999999999764 45689999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++++|.+++..... .+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+++.|..
T Consensus 99 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999965433 38999999999999999999999 999999999999999999999998732
Q ss_pred -------cccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 -------TLTAGTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~---~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....||+.|+|||.+. ...++.++||||||+++|||++|+.||....... .+...+.. +..
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~----~~~-- 243 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGR----GSL-- 243 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH---HHHHHHHH----TSC--
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH---HHHHHhcc----ccc--
Confidence 1235899999999987 5678999999999999999999999997643321 11111111 000
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
.+.+ .......+..+.+++..||+.+|.+|||++++++.|+++..
T Consensus 244 --~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 --SPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --CCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --Ccch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0000 11223455778899999999999999999999999997754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=324.39 Aligned_cols=242 Identities=24% Similarity=0.382 Sum_probs=198.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECC---CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFAS---SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~---~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
.++|...+.||+|+||.||+|.+.. .+..||+|.+... ....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4678889999999999999998753 3456999998763 33467899999999999999999999998754 5689
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||||+++++|.+++..... .+++..++.++.|+++||+|||+ .+++||||||+|||++.++.+|+.|..
T Consensus 90 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999976543 38999999999999999999999 999999999999999999999998732
Q ss_pred --------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHH
Q 041096 497 --------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ... .
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----~~~-------------~ 226 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIG-------------V 226 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----HHH-------------H
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH----HHH-------------H
Confidence 12346778999999998999999999999999999998 999997543321 111 1
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+........+......+.+++..||+.+|++||++.++++.|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 227 LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 111111122333456788899999999999999999999999854
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=342.15 Aligned_cols=239 Identities=25% Similarity=0.327 Sum_probs=190.6
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCc-chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
.+.||+|+||.||+|....++..||+|++.... ...+.+.+|++++++++||||++++++|.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999999889999999987643 4567899999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE--cCCCCeeeeccc-----------cc
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML--DANFNARLESSF-----------TL 498 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll--d~~~~~kl~d~~-----------~~ 498 (645)
.+++..... .+++..++.++.||++||+|||+ .+|+||||||+|||+ +.++.+||.|.. ..
T Consensus 174 ~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 174 FDRIIDESY---NLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp HHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred HHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 999875432 38999999999999999999999 999999999999999 567788998722 23
Q ss_pred cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCH
Q 041096 499 TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNE 578 (645)
Q Consensus 499 ~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 578 (645)
..||+.|+|||++....++.++|||||||++|||++|+.||...........+.. ..+. +......
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~---~~~~-----------~~~~~~~ 313 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA---CRWD-----------LEDEEFQ 313 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---TCCC-----------SCSGGGT
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---ccCC-----------CChhhhc
Confidence 4589999999999999999999999999999999999999976543211111110 0000 0000011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcC
Q 041096 579 DEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNN 611 (645)
Q Consensus 579 ~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~ 611 (645)
.....+.+++..||+.||.+|||++|+++ .|.+
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 23456788999999999999999999987 5543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=333.85 Aligned_cols=243 Identities=24% Similarity=0.315 Sum_probs=197.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 422 (645)
++|+..+.||+|+||.||+|+...++..||+|++... ....+.+.+|..++.++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5688899999999999999999999999999998753 23345688999999988 899999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++|+|.+++..... +++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 89 ~e~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999976543 8999999999999999999999 999999999999999999999998732
Q ss_pred ------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccch-hhHHHHHHhhhccCchhHHhh
Q 041096 497 ------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKM-VNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d 569 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......... .+..
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~i~~ 233 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------VILE 233 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH--------HHHH
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH--------HHHc
Confidence 2246899999999999999999999999999999999999999753221100 000000000 0111
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSM------RRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~~vl~ 607 (645)
.. ..++......+.+++..||+.||++||++ +++++
T Consensus 234 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 234 KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred CC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 11 12334445678889999999999999995 66654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=332.88 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=206.8
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEEE-----CCCCeEEEEEeccCCc--chhHhHHHHHHHHhhc-CCCCeeee
Q 041096 338 FSYRELRSATRGFHSNRILGRGAFGNVYKAYF-----ASSGSVAAVKRSKHSH--EGKTEFLAELSIIACL-RHKNLVQL 409 (645)
Q Consensus 338 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~-----~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l 409 (645)
+...++....++|...+.||+|+||.||+|.. ..++..||||++.... ...+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44455555668899999999999999999985 3457899999987633 3456799999999999 79999999
Q ss_pred eeeeeeCC-eEEEEEecCCCCCHhHHhhhcCCC------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCC
Q 041096 410 LGWCAEKG-ELLLVYEYMPNGSLDRMLYQDSEN------------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRD 476 (645)
Q Consensus 410 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 476 (645)
+++|...+ ..++||||+++|+|.+++...... ...+++..++.++.|+++||+|||+ .+|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence 99988754 589999999999999999865432 1237899999999999999999999 9999999
Q ss_pred CCCCcEEEcCCCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 041096 477 IKASNIMLDANFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIER 541 (645)
Q Consensus 477 lkp~NIlld~~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~ 541 (645)
|||+|||++.++.+|+.|.. ....||+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999998732 12346788999999999999999999999999999998 9999976
Q ss_pred cccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 542 ETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 542 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
...... +. ..+........+......+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 254 ~~~~~~---~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 254 VKIDEE---FC-------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCCSHH---HH-------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhHH---HH-------------HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 432211 11 111111112223334567888999999999999999999999998653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.42 Aligned_cols=247 Identities=21% Similarity=0.271 Sum_probs=181.1
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
.+.||+|+||.||+|....++..||||++.. .....+.+|+.++.+++ ||||+++++++.+.+..++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG--GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh--hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 4789999999999999999999999999864 34567889999999997 99999999999999999999999999999
Q ss_pred hHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---Ceeeeccc------------
Q 041096 432 DRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF---NARLESSF------------ 496 (645)
Q Consensus 432 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~---~~kl~d~~------------ 496 (645)
.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||.|..
T Consensus 94 ~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 94 FERIKKKK----HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp HHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 99998754 38999999999999999999999 9999999999999997765 68887732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC-
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA- 575 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~- 575 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.............+ .+.....+.
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-------------~~~~i~~~~~ 233 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-------------IMKKIKKGDF 233 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-------------HHHHHTTTCC
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-------------HHHHHHcCCC
Confidence 234579999999999999999999999999999999999999976543211111111 111111111
Q ss_pred -CC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCCCCCCC
Q 041096 576 -FN----EDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPLVVPKL 621 (645)
Q Consensus 576 -~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~~~p~~ 621 (645)
++ ......+.+++..||+.||++|||++++++ .+++..+.+..|..
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~~ 286 (325)
T 3kn6_A 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLM 286 (325)
T ss_dssp CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCCS
T ss_pred CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCCC
Confidence 11 123467888999999999999999999985 46655544444433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=324.44 Aligned_cols=257 Identities=18% Similarity=0.192 Sum_probs=203.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeee-eeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC-AEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~Ey 425 (645)
.++|+..+.||+|+||.||+|....++..||||++.... ..+.+.+|+.++..++|++++..++++ .+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 468999999999999999999998889999999876533 335689999999999998877766665 556788999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeeeeccc------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML---DANFNARLESSF------ 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll---d~~~~~kl~d~~------ 496 (645)
+ +++|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+|++|..
T Consensus 87 ~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred c-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9 9999999975433 38999999999999999999999 999999999999999 588889998721
Q ss_pred -------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc
Q 041096 497 -------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR 563 (645)
Q Consensus 497 -------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 563 (645)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 236 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--- 236 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH---
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC---
Confidence 2346899999999999999999999999999999999999999865432222111111100000
Q ss_pred hhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCCCCCC
Q 041096 564 IIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKL 621 (645)
Q Consensus 564 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~~p~~ 621 (645)
...+.+. ...+..+.+++..||+.||.+|||++++++.|+........+..
T Consensus 237 ---~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 237 ---TPIEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp ---SCHHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred ---CchHHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 0001111 12345688899999999999999999999999977655554433
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=335.05 Aligned_cols=252 Identities=23% Similarity=0.256 Sum_probs=199.2
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC------CcchhHhHHHHHHHHhhcCCCCeeeeeeeeee
Q 041096 342 ELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH------SHEGKTEFLAELSIIACLRHKNLVQLLGWCAE 415 (645)
Q Consensus 342 ~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~------~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 415 (645)
++....++|+..+.||+|+||.||+|....++..+|+|++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 445667889999999999999999999999999999998754 23445789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHhHHhhhcCCC------------------------------------CccCCHHHHHHHHHHHHH
Q 041096 416 KGELLLVYEYMPNGSLDRMLYQDSEN------------------------------------GVLLSWYHRLNIVVGLAS 459 (645)
Q Consensus 416 ~~~~~lV~Ey~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~ 459 (645)
.+..++||||+++|+|.+++...... ...+++..+..++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998531110 112467778899999999
Q ss_pred HHHHHhhcCCCCeeeCCCCCCcEEEcCCC--Ceeeeccc----------------cccccCCcccCcccccC--CCCCcc
Q 041096 460 ALTYLHQECEQQVIHRDIKASNIMLDANF--NARLESSF----------------TLTAGTMGYLAPEYLQY--GTATEK 519 (645)
Q Consensus 460 gL~yLH~~~~~~ivHrDlkp~NIlld~~~--~~kl~d~~----------------~~~~gt~~y~APE~~~~--~~~t~k 519 (645)
||+|||+ .+|+||||||+||||+.++ .+||+|.. ....||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999999 8999999999999998776 78987732 23468999999999975 678999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC--CCCHHHHHHHHHHHHHccCCCCC
Q 041096 520 TDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG--AFNEDEMKRLLLVGLSCANPDSS 597 (645)
Q Consensus 520 sDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~ 597 (645)
+|||||||++|||++|+.||........... ........ .........+.+++..||+.+|.
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQ----------------VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----------------HHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHH----------------HHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence 9999999999999999999976543211111 11111100 00112345678899999999999
Q ss_pred CCCCHHHHHH--HHcCC
Q 041096 598 ARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 598 ~RPt~~~vl~--~L~~~ 612 (645)
+||++.++++ .+++.
T Consensus 321 ~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 321 ERFDAMRALQHPWISQF 337 (345)
T ss_dssp TSCCHHHHHHSHHHHTT
T ss_pred HCCCHHHHhcChhhccC
Confidence 9999999987 45544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=325.45 Aligned_cols=256 Identities=18% Similarity=0.199 Sum_probs=199.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeee-eeCCeEEEEEe
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC-AEKGELLLVYE 424 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 424 (645)
..++|+..+.||+|+||.||+|....++..||||+..... ....+.+|++++..++|++++..++++ .+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 4578999999999999999999998889999999865532 334688999999999988877777766 56678899999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeeeeccc-----
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML---DANFNARLESSF----- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll---d~~~~~kl~d~~----- 496 (645)
|+ +++|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|..
T Consensus 86 ~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 9999999975433 38999999999999999999999 999999999999999 788899998722
Q ss_pred --------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC
Q 041096 497 --------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG 562 (645)
Q Consensus 497 --------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~ 562 (645)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST- 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-
Confidence 13368999999999999999999999999999999999999998754333222221111100000
Q ss_pred chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCCCC
Q 041096 563 RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVP 619 (645)
Q Consensus 563 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~~p 619 (645)
. .+.+. ...+..+.+++..||+.+|++|||++++++.|++..+....+
T Consensus 238 ~-----~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 238 P-----IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp C-----HHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred h-----hhhhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 0 00111 112457888999999999999999999999998776544433
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=334.01 Aligned_cols=252 Identities=17% Similarity=0.219 Sum_probs=193.1
Q ss_pred cCCCcCceeccCCceEEEEEEECC---CCeEEEEEeccCCcc------------hhHhHHHHHHHHhhcCCCCeeeeeee
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS---SGSVAAVKRSKHSHE------------GKTEFLAELSIIACLRHKNLVQLLGW 412 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~---~~~~vavK~~~~~~~------------~~~~~~~Ei~~l~~l~H~niv~l~g~ 412 (645)
++|...+.||+|+||.||+|.... .+..+|+|+...... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 578889999999999999999976 678999998876432 12346788899999999999999999
Q ss_pred eee----CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 041096 413 CAE----KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF 488 (645)
Q Consensus 413 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~ 488 (645)
+.. ....++||||+ +++|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+||||+.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCC
Confidence 987 67899999999 999999997654 39999999999999999999999 9999999999999999887
Q ss_pred --Ceeeeccc-------------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccc
Q 041096 489 --NARLESSF-------------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHK 547 (645)
Q Consensus 489 --~~kl~d~~-------------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~ 547 (645)
.+||.|.. ....||..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 89998722 223689999999999999999999999999999999999999965322111
Q ss_pred hhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 548 MVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 548 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
. ... ....... .+.+.+..... ....+..+.+++..||+.||++||++++|++.|+....
T Consensus 269 ~--~~~-~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 A--VQT-AKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp H--HHH-HHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred H--HHH-HHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1 111 1110000 11111111110 11234578889999999999999999999999997543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=345.59 Aligned_cols=249 Identities=23% Similarity=0.277 Sum_probs=202.1
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeee
Q 041096 338 FSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWC 413 (645)
Q Consensus 338 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 413 (645)
+.+++++...++|+..++||+|+||+||++..+.+++.||||++.+. ....+.+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34556666678999999999999999999999989999999998652 22345688999999999999999999999
Q ss_pred eeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeee
Q 041096 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLE 493 (645)
Q Consensus 414 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~ 493 (645)
.+.+..||||||+++|+|.+++.+... .+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 999999999999999999999986532 38999999999999999999999 999999999999999999999998
Q ss_pred ccc-------------cccccCCcccCccccc-------CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHH
Q 041096 494 SSF-------------TLTAGTMGYLAPEYLQ-------YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVD 553 (645)
Q Consensus 494 d~~-------------~~~~gt~~y~APE~~~-------~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~ 553 (645)
|.. ...+||+.|+|||++. ...++.++|||||||++|||++|+.||...........+..
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 721 1247999999999987 45689999999999999999999999976543221111111
Q ss_pred HHHhhhccCchhHHhhhhcc-CCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 041096 554 WVWGLYAEGRIIEAADKRLN-GAFNEDEMKRLLLVGLSCANPDSSAR---PSMRRVFQ 607 (645)
Q Consensus 554 ~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~~vl~ 607 (645)
+. ..+. ...+......+.+++..||. +|.+| |+++|+++
T Consensus 285 ~~--------------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 285 YK--------------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HH--------------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cc--------------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 10 0010 11112345667888899999 99998 68999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=323.64 Aligned_cols=242 Identities=20% Similarity=0.310 Sum_probs=198.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeee----------
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE---------- 415 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~---------- 415 (645)
..++|+..+.||+|+||.||+|....++..||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 3457889999999999999999998889999999987643 467899999999999999999998854
Q ss_pred ------CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 041096 416 ------KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN 489 (645)
Q Consensus 416 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~ 489 (645)
....++||||+++++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCC
Confidence 4458999999999999999976532 248999999999999999999999 99999999999999999999
Q ss_pred eeeeccc-----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh
Q 041096 490 ARLESSF-----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 490 ~kl~d~~-----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
+++.|.. ....||+.|+|||.+.+..++.++||||||+++|||++|..|+.... ... .
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~~~----~- 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------KFF----T- 229 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH------HHH----H-
T ss_pred EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH------HHH----H-
Confidence 9998732 23468999999999999999999999999999999999998864311 010 0
Q ss_pred hccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCC
Q 041096 559 YAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLV 617 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~ 617 (645)
...+..+ +......+.+++..||+.||.+|||+.++++.|......+.
T Consensus 230 -------~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 230 -------DLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp -------HHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred -------Hhhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 0111111 22233457788899999999999999999999987665544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.63 Aligned_cols=241 Identities=24% Similarity=0.292 Sum_probs=194.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|...+.||+|+||.||++....++..+|+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5688899999999999999999988999999988663 33457899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeeeeccc------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML---DANFNARLESSF------ 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll---d~~~~~kl~d~~------ 496 (645)
+++|+|.+++.........+++..++.++.|+++||+|||+ .+|+||||||+|||+ +.++.+||.|..
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999997653333459999999999999999999999 999999999999999 455778887732
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....||+.|+|||.+. +.++.++||||||+++|||++|+.||....... ....... . .+.
T Consensus 179 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~----~~~~~~~--~--------~~~ 243 (285)
T 3is5_A 179 SDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE----VQQKATY--K--------EPN 243 (285)
T ss_dssp --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHH--C--------CCC
T ss_pred CcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH----HHhhhcc--C--------Ccc
Confidence 2346899999999886 568999999999999999999999997643211 1111000 0 000
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
... ........+.+++..||+.||++|||++|+++
T Consensus 244 ~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 YAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00112456778899999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=320.74 Aligned_cols=235 Identities=21% Similarity=0.282 Sum_probs=196.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.++|+..+.||+|+||.||+|....++..+|+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 45788999999999999999999998999999988663 34467899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeeeeccc------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML---DANFNARLESSF------ 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll---d~~~~~kl~d~~------ 496 (645)
+++++|.+++..... +++.++..++.|++.||+|||+ .+++||||||+|||+ +.++.+++.|..
T Consensus 88 ~~~~~L~~~~~~~~~----~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHKRV----FRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999976543 8999999999999999999999 999999999999999 788889998732
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....||+.|+|||.+.+. ++.++||||||+++|||++|+.||....... ..... ...
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~-------------~~~ 222 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VMLKI-------------REG 222 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH-------------HHC
T ss_pred CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH----HHHHH-------------HhC
Confidence 234689999999998754 8999999999999999999999997643211 11100 000
Q ss_pred ccCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 572 LNGAFNE----DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 572 l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
. ...+. .....+.+++..|++.||++|||+.++++
T Consensus 223 ~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 223 T-FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp C-CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred C-CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01122 12457888999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=330.75 Aligned_cols=236 Identities=22% Similarity=0.290 Sum_probs=197.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc-------hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE-------GKTEFLAELSIIACLRHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 419 (645)
.++|+..+.||+|+||.||+|....++..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4568889999999999999999998899999998765321 356799999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC----Ceeeecc
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF----NARLESS 495 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~----~~kl~d~ 495 (645)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+++.|.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999997643 38999999999999999999999 9999999999999999888 6888772
Q ss_pred c-----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 496 F-----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 496 ~-----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
. ....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ........
T Consensus 164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~------ 233 (321)
T 2a2a_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANITSV------ 233 (321)
T ss_dssp TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTT------
T ss_pred ccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhc------
Confidence 2 23468999999999999999999999999999999999999997643211 11111000
Q ss_pred hHHhhhhccCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 IEAADKRLNGAFNE----DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 ~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
....+. .....+.+++..||+.||++|||++++++
T Consensus 234 --------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 --------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --------CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --------ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001111 12356788999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=359.79 Aligned_cols=233 Identities=26% Similarity=0.393 Sum_probs=193.9
Q ss_pred ceeccCCceEEEEEEE--CCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYF--ASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~--~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
+.||+|+||.||+|.+ ...+..||||+++.. ....+++.+|++++++++|||||+++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999965 445688999998763 2335789999999999999999999999964 568999999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|.+++..... +++.+++.|+.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 454 g~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCCC----CCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999976443 8999999999999999999999 999999999999999999999998832
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....+|..|+|||++....++.++|||||||++|||++ |+.||....... +.+.+....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~~~~i~~~~ 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTAMLEKGE 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHHHTTC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCC
Confidence 11235678999999999999999999999999999998 999997643211 112222222
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
....+..++..+.+++..||+.||++||++++|++.|++
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 334455567788999999999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=326.73 Aligned_cols=255 Identities=24% Similarity=0.299 Sum_probs=194.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC------cchhHhHHHHHHHHhhcC---CCCeeeeeeeeeeC
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS------HEGKTEFLAELSIIACLR---HKNLVQLLGWCAEK 416 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~------~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 416 (645)
.+++|+..+.||+|+||+||+|....++..||||++... ......+.+|+.++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999999888999999987642 122346778888877765 99999999999876
Q ss_pred C-----eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCee
Q 041096 417 G-----ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491 (645)
Q Consensus 417 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~k 491 (645)
. ..++||||+. ++|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence 5 5899999996 699999976543 238999999999999999999999 9999999999999999999999
Q ss_pred eeccc-----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc
Q 041096 492 LESSF-----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA 560 (645)
Q Consensus 492 l~d~~-----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~ 560 (645)
|.|.. ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.+.. ....
T Consensus 161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~ 239 (308)
T 3g33_A 161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI-GLPP 239 (308)
T ss_dssp ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH-CCCC
T ss_pred EeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCC
Confidence 98832 23468999999999999999999999999999999999999997654332222221111 0000
Q ss_pred cCchhH---Hhhhhcc--CC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 561 EGRIIE---AADKRLN--GA-----FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 561 ~~~~~~---~~d~~l~--~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...... ....... .. ...+....+.+++..||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000000 0000000 00 01123456788999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=321.58 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=201.9
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|...+.||+|+||.||+|....++..||+|.+... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5788899999999999999999988999999988652 223467899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++++|.+++..... +++..+..++.|+++||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 94 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGR----FDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999986543 8999999999999999999998 999999999999999999999998732
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ... .+... .
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~------------~~~~~--~ 228 (284)
T 2vgo_A 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE----THR------------RIVNV--D 228 (284)
T ss_dssp SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH------------HHHTT--C
T ss_pred cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH----HHH------------HHhcc--c
Confidence 23468999999999999999999999999999999999999997643211 111 01111 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCC
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAE 614 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~ 614 (645)
..++......+.+++..|++.||.+||+++++++ .+.....
T Consensus 229 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 229 LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 1223334556788999999999999999999987 5554433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=335.44 Aligned_cols=237 Identities=24% Similarity=0.331 Sum_probs=198.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 420 (645)
..++|+..++||+|+||.||+|....++..||+|++... ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 346899999999999999999999988999999998752 23456688999999988 7999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---- 496 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---- 496 (645)
+||||+++|+|.+++..... +++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 98 lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999986543 8999999999999999999999 999999999999999999999998732
Q ss_pred --------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 --------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +... +.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~------------i~ 234 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQS------------IM 234 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH------------HH
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH----HHHH------------HH
Confidence 23468999999999999999999999999999999999999997643211 1111 11
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPS-----MRRVFQ 607 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~~vl~ 607 (645)
... ..++......+.+++..||+.||.+||+ ++++++
T Consensus 235 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 235 EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred hCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111 1233344567888999999999999995 577765
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=323.73 Aligned_cols=235 Identities=23% Similarity=0.302 Sum_probs=195.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-------chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-------EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
++|+..+.||+|+||.||+|....++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999999889999999876522 13567999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC----Ceeeeccc
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF----NARLESSF 496 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~----~~kl~d~~ 496 (645)
+||||+++++|.+++..... +++.+++.++.|++.||+|||+ .+++||||||+||+++.++ .+++.|..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKES----LTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999976443 8999999999999999999999 9999999999999998877 78887732
Q ss_pred -----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchh
Q 041096 497 -----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRII 565 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 565 (645)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~----~--- 226 (283)
T 3bhy_A 158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE----TLTNISA----V--- 226 (283)
T ss_dssp TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHT----T---
T ss_pred cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH----HHHHhHh----c---
Confidence 22358999999999999999999999999999999999999997643211 1110000 0
Q ss_pred HHhhhhccCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 566 EAADKRLNGAFNE----DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 566 ~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
....+. .....+.+++..||+.||++|||+.++++
T Consensus 227 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 -------NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -------CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 001111 12456788999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=324.83 Aligned_cols=236 Identities=23% Similarity=0.350 Sum_probs=198.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.+.|...+.||+|+||.||+|....++..||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35688899999999999999999888999999998653 3446789999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++++|.+++... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 101 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999999642 38999999999999999999999 999999999999999999999998732
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....||..|+|||.+.+..++.++||||||+++|||++|+.||...... ..... +....
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-------------~~~~~ 235 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM----KVLFL-------------IPKNN 235 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH-------------HHHSC
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH----HHHHH-------------hhcCC
Confidence 2245889999999999999999999999999999999999999754321 11111 11111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
....+......+.+++..||+.+|.+|||+.++++
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11222233456888999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.45 Aligned_cols=264 Identities=22% Similarity=0.254 Sum_probs=208.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC--eEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG--ELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 423 (645)
++|...++||+|+||.||+|.+..++..||||++... ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 5688899999999999999999999999999998753 234567889999999999999999999988755 789999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE----cCCCCeeeeccc---
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML----DANFNARLESSF--- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll----d~~~~~kl~d~~--- 496 (645)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+|+||||||+|||| +.++.+||+|..
T Consensus 89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999976543 2238999999999999999999999 999999999999999 777778887722
Q ss_pred --------cccccCCcccCcccccC--------CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc
Q 041096 497 --------TLTAGTMGYLAPEYLQY--------GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA 560 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~--------~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~ 560 (645)
....||..|+|||++.. ..++.++|||||||++|||++|+.||............+..+.....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 23468999999999865 46788999999999999999999999764433322222222211110
Q ss_pred cCchh---HH------h--hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 561 EGRII---EA------A--DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 561 ~~~~~---~~------~--d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
..... .. . +..............+..++..||+.||++||+++++++.++.+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 00000 00 0 00111234577888999999999999999999999999998876554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=329.91 Aligned_cols=235 Identities=23% Similarity=0.309 Sum_probs=191.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC---CCCeEEEEEeccCCc-----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFA---SSGSVAAVKRSKHSH-----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~---~~~~~vavK~~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 419 (645)
++|+..+.||+|+||.||++... .++..+|+|++.... .....+.+|++++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 57888999999999999999984 578999999987632 2345688999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
++||||+++++|.+++..... +++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGI----FMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEeCCCCCcHHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999976543 8899999999999999999999 999999999999999999999998732
Q ss_pred ---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHH
Q 041096 497 ---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .... +
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~------------i 233 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----TIDK------------I 233 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH------------H
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH----HHHH------------H
Confidence 22468999999999999999999999999999999999999997643211 1111 1
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
.... ..++......+.+++..||+.||++|| +++++++
T Consensus 234 ~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 234 LKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1111 122333456778899999999999999 7888876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=327.99 Aligned_cols=249 Identities=20% Similarity=0.225 Sum_probs=199.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.++|...+.||+|+||.||+|....++..||+|++.... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999999889999999987532 2246789999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++++|.+++..... +++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+++.|..
T Consensus 113 ~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999986543 8999999999999999999999 999999999999999999999998732
Q ss_pred -------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 -------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .+.... ....
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~----~~~~------ 251 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGAHI----NQAI------ 251 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHH----HSCC------
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHh----ccCC------
Confidence 1236889999999999999999999999999999999999999764321 111100 0000
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHcCCCCCCC
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARP-SMRRVFQILNNEAEPLV 617 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~~vl~~L~~~~~~~~ 617 (645)
+ .........+..+.+++..||+.||++|| +++++++.|+.......
T Consensus 252 ~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 252 P-RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp C-CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred C-CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0 00112233445688899999999999999 99999999987765554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.56 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=202.8
Q ss_pred CCcCceeccCCceEEEEEEE----CCCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeC--CeEEE
Q 041096 350 FHSNRILGRGAFGNVYKAYF----ASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEK--GELLL 421 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~----~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 421 (645)
|+..+.||+|+||+||++.+ ..++..||||++.... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 47889999999999988865 3468899999987643 3456799999999999999999999999874 67899
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||||+++|+|.+++.... +++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.++|.|..
T Consensus 113 v~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999997543 8999999999999999999999 999999999999999999999998732
Q ss_pred ----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 ----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....||..|+|||.+.+..++.++||||||+++|||++|+.||...... ......+.........+.+
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK--FLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh--hhhhhcccccchhHHHHHH
Confidence 1234677899999999989999999999999999999999998753211 0000000000111112333
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
.+........+......+.+++..||+.||++|||++++++.|+.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 44444444555666778999999999999999999999999998653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=319.44 Aligned_cols=239 Identities=24% Similarity=0.308 Sum_probs=197.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.++|+..+.||+|+||.||+|....++..||+|.+.. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 4578889999999999999999998899999998864 23445789999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999996543 38999999999999999999999 999999999999999999999998722
Q ss_pred ------cccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 ------TLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
....||..|+|||.+.+..+ +.++||||||+++|||++|+.||........ .+..+...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~------------ 224 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEK------------ 224 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHTT------------
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhhc------------
Confidence 22358899999999987665 7899999999999999999999976443211 11111110
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.............+.+++..||+.||++|||++++++
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 225 -KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0000011123456778999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=326.70 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=197.3
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECC---CCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFAS---SGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG 417 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~---~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 417 (645)
....++|...+.||+|+||.||+|.... ++..||+|++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 3345678888999999999999998764 4568999998753 233567899999999999999999999998755
Q ss_pred -----eEEEEEecCCCCCHhHHhhhcC--CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 418 -----ELLLVYEYMPNGSLDRMLYQDS--ENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 418 -----~~~lV~Ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
..++||||+++++|.+++.... .....+++..++.++.|+++||.|||+ .+|+||||||+|||++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcE
Confidence 3599999999999999986432 223459999999999999999999999 999999999999999999999
Q ss_pred eeecccc--------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHH
Q 041096 491 RLESSFT--------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWV 555 (645)
Q Consensus 491 kl~d~~~--------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~ 555 (645)
|+.|... ...+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... +...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~- 261 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----MYDY- 261 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHHH-
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HHHH-
Confidence 9987321 2245778999999999999999999999999999999 888987643321 1111
Q ss_pred HhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 556 WGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 556 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
+........+......+.+++..||+.+|.+|||+.++++.|+.+.
T Consensus 262 ------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 262 ------------LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp ------------HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------------HHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111112233345567889999999999999999999999998654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=322.49 Aligned_cols=237 Identities=22% Similarity=0.336 Sum_probs=178.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.++|...+.||+|+||.||+|....++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 357888999999999999999998889999999986522 2246789999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++++|.+++..... .+++.+++.++.|+++||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 90 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTCSS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999976533 38999999999999999999999 999999999999999999999998732
Q ss_pred ------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 ------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... . .....
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~------------~~~~~ 227 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----N------------KVVLA 227 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSS
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----H------------HHhhc
Confidence 1245889999999999989999999999999999999999999764322110 0 00000
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
. ...+......+.+++..||+.||++|||++++++
T Consensus 228 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 D--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0 0122233456788999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=332.42 Aligned_cols=231 Identities=24% Similarity=0.303 Sum_probs=195.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc---------hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---------GKTEFLAELSIIACLRHKNLVQLLGWCAEKG 417 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 417 (645)
.++|+..+.||+|+||.||+|....++..||||++..... ....+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4679999999999999999999999999999998876321 3446888999999999999999999999999
Q ss_pred eEEEEEecCCCC-CHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc
Q 041096 418 ELLLVYEYMPNG-SLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF 496 (645)
Q Consensus 418 ~~~lV~Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~ 496 (645)
..++||||+.+| +|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~----l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCC----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 99999976543 8999999999999999999999 999999999999999999999998732
Q ss_pred -----------cccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 -----------TLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......
T Consensus 176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------------ 237 (335)
T 3dls_A 176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------------ 237 (335)
T ss_dssp TCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------------
T ss_pred cceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------------
Confidence 22458999999999988776 889999999999999999999997532110
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.... ..+......+.+++..||+.||++|||++++++.
T Consensus 238 ----~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ----EAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----hhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 1111134567888999999999999999999984
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=334.51 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=200.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|+..+.||+|+||.||+|....++..||+|++... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 5788899999999999999999989999999998763 33456799999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ-QVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
+++++|.+++..... +++..+..++.|++.||+|||+ . +|+||||||+|||++.++.++|.|..
T Consensus 113 ~~~~~L~~~l~~~~~----~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999986543 8999999999999999999998 5 89999999999999999999998832
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHH----------------------
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLV---------------------- 552 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~---------------------- 552 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 23478999999999999999999999999999999999999997643211100000
Q ss_pred HHHHhhhccCchhHHhhhhccC---CC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 553 DWVWGLYAEGRIIEAADKRLNG---AF-NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 553 ~~~~~~~~~~~~~~~~d~~l~~---~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+...........+.++..... .. .......+.+++..||+.||++|||++++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000001111222211111 11 1123456888999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=324.16 Aligned_cols=244 Identities=26% Similarity=0.367 Sum_probs=193.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCC---CeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeee-CCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASS---GSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAE-KGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~---~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~l 421 (645)
.+|+..++||+|+||.||+|.+..+ ...+|+|.+... ....+.+.+|+.++++++||||++++++|.+ ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4577789999999999999997543 346899988763 3345679999999999999999999998654 567899
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||||+++|+|.+++..... .+++.+++.++.|+++||+|||+ .+++||||||+|||++.++.+|+.|..
T Consensus 105 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999975433 38999999999999999999999 999999999999999999999998732
Q ss_pred -----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcC-CCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 -----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACG-RRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG-~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....||+.|+|||.+.+..++.++||||||+++|||++| ..||....... ....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~----~~~~---------- 244 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVY---------- 244 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT----HHHH----------
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH----HHHH----------
Confidence 123466789999999999999999999999999999995 55554432211 1111
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
+........+...+..+.+++..||+.+|++|||++++++.|+.+..
T Consensus 245 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 245 ---LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111112233345678889999999999999999999999986543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=330.82 Aligned_cols=255 Identities=19% Similarity=0.286 Sum_probs=190.4
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
....++|+..++||+|+||+||+|....++..||||++.... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 344578999999999999999999999999999999987532 23456889999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-----CCCCeeeecc
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD-----ANFNARLESS 495 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld-----~~~~~kl~d~ 495 (645)
+||||++ |+|.+++..... +++..+..++.||+.||+|||+ .+|+||||||+||||+ .++.+||.|.
T Consensus 110 lv~e~~~-~~L~~~~~~~~~----~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPD----VSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEecCC-CCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 9999997 599999976543 8999999999999999999999 9999999999999994 4455898873
Q ss_pred c------------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC
Q 041096 496 F------------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG 562 (645)
Q Consensus 496 ~------------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~ 562 (645)
. ....||..|+|||++.+. .++.++|||||||++|||++|+.||...........+.... ......
T Consensus 182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~ 260 (329)
T 3gbz_A 182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL-GLPDDT 260 (329)
T ss_dssp THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-CCCCTT
T ss_pred CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh-CCCchh
Confidence 2 234679999999999874 48999999999999999999999997654322221111110 000000
Q ss_pred chhHH-----hh---hhccCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 563 RIIEA-----AD---KRLNGA-----FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 563 ~~~~~-----~d---~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..... .. +..... ........+.+++..||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 00 000000 00112356788999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=323.30 Aligned_cols=241 Identities=29% Similarity=0.425 Sum_probs=197.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-CeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEK-GELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey 425 (645)
.++|+..+.||+|+||.||+|... +..||||++.... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467888999999999999999885 7899999987643 556799999999999999999999997654 478999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 97 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 999999999976432 237899999999999999999999 999999999999999999999998732
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCC
Q 041096 497 TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575 (645)
Q Consensus 497 ~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 575 (645)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. .+.......
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~-------------~~~~~~~~~ 234 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVP-------------RVEKGYKMD 234 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHH-------------HHTTTCCCC
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH-------------HHhcCCCCC
Confidence 22357889999999999999999999999999999998 99999764321 1111 111112223
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 576 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.+......+.+++..||+.||++||++.++++.|+.+
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 3444567788999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=326.07 Aligned_cols=256 Identities=20% Similarity=0.262 Sum_probs=195.3
Q ss_pred cCCCcC-ceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSN-RILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~-~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 424 (645)
+.|... ++||+|+||.||+|....++..||||++... ....+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456663 7899999999999999888999999998763 34467799999999985 79999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC---eeeecccc----
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN---ARLESSFT---- 497 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~---~kl~d~~~---- 497 (645)
|+++|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +|+.|...
T Consensus 92 ~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999987543 8999999999999999999999 99999999999999998776 88877311
Q ss_pred ---------------ccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh
Q 041096 498 ---------------LTAGTMGYLAPEYLQY-----GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG 557 (645)
Q Consensus 498 ---------------~~~gt~~y~APE~~~~-----~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~ 557 (645)
...||+.|+|||++.. ..++.++|||||||++|||++|+.||............... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~ 243 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA-CP 243 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C-CH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc-ch
Confidence 2248999999999875 55789999999999999999999999765432211000000 00
Q ss_pred hhccCchhHHhhhhccCCCCHH----HHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCC
Q 041096 558 LYAEGRIIEAADKRLNGAFNED----EMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEA 613 (645)
Q Consensus 558 ~~~~~~~~~~~d~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~ 613 (645)
. ....+.+.+.... ..++.. ....+.+++..||+.||++|||++|+++ .+++..
T Consensus 244 ~-~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 244 A-CQNMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp H-HHHHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred h-HHHHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 0 0000111111110 112221 2456889999999999999999999998 455443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=336.98 Aligned_cols=259 Identities=23% Similarity=0.322 Sum_probs=191.5
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCC--e
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKG--E 418 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~ 418 (645)
...++|+..+.||+|+||.||+|.+..++..||||++... ....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999999999999999988652 334567889999999997 999999999997543 7
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT- 497 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~- 497 (645)
.|+|||||+ ++|..++... .+++..+..++.|++.||+|||+ .+|+||||||+||||+.++.+||.|...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999996 6999999763 28999999999999999999999 9999999999999999999999987321
Q ss_pred --------------------------------ccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 041096 498 --------------------------------LTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETE 544 (645)
Q Consensus 498 --------------------------------~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~ 544 (645)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1368999999999986 6789999999999999999999999986543
Q ss_pred ccchhhHHHHHHhhhcc--------CchhHHhh---hh-------ccC------------CCCHHHHHHHHHHHHHccCC
Q 041096 545 GHKMVNLVDWVWGLYAE--------GRIIEAAD---KR-------LNG------------AFNEDEMKRLLLVGLSCANP 594 (645)
Q Consensus 545 ~~~~~~l~~~~~~~~~~--------~~~~~~~d---~~-------l~~------------~~~~~~~~~l~~l~~~Cl~~ 594 (645)
......+... ...... ......+. .. ... .........+.+++..||+.
T Consensus 237 ~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 MNQLERIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 2222111110 000000 00000000 00 000 00012245678899999999
Q ss_pred CCCCCCCHHHHHHH--HcCCC
Q 041096 595 DSSARPSMRRVFQI--LNNEA 613 (645)
Q Consensus 595 dP~~RPt~~~vl~~--L~~~~ 613 (645)
||++|||++|+++. |....
T Consensus 316 dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 316 NPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp SGGGSCCHHHHTTSTTTTTTC
T ss_pred CcccCCCHHHHhCCHHHHHhc
Confidence 99999999999875 55443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=344.66 Aligned_cols=242 Identities=21% Similarity=0.347 Sum_probs=201.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|...+.||+|+||.||+|....++..||||++.... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999999899999999986522 23457899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 96 E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999997543 38999999999999999999999 999999999999999999999998721
Q ss_pred ----cccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
...+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .+...+ .+..
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i------------~~~~ 232 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP----TLFKKI------------CDGI 232 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----HHHHHH------------HTTC
T ss_pred cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH----HHHHHH------------hcCC
Confidence 23468999999999998765 78999999999999999999999764321 111111 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCC
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAE 614 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~ 614 (645)
. ..+......+.+++..||+.||.+|||++++++ .+....+
T Consensus 233 ~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 275 (476)
T 2y94_A 233 F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP 275 (476)
T ss_dssp C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence 1 122223456788899999999999999999997 5665443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=345.93 Aligned_cols=243 Identities=25% Similarity=0.320 Sum_probs=201.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|...++||+|+||.||+|+...+++.||+|++... ....+.+.+|++++++++||||+++++++.+.+.+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 5688889999999999999999989999999998652 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|..++.........+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999998765444569999999999999999999999 999999999999999999999998721
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+ ....
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i------------~~~~ 409 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV------------LEQA 409 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH------------HHCC
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH------------hhcc
Confidence 22379999999999999999999999999999999999999997653322211121111 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSM-----RRVFQ 607 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~~vl~ 607 (645)
..++......+.+++..||+.||++||++ +++++
T Consensus 410 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 --VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 12334445677888999999999999975 66654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=322.85 Aligned_cols=242 Identities=21% Similarity=0.321 Sum_probs=201.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.++|...+.||+|+||.||++....++..+|+|.+... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 35788899999999999999999999999999987652 23456789999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++++|.+++..... +++.+++.++.|+++||+|||+ .+++||||||+|||++.++.+++.|..
T Consensus 94 ~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999876543 8999999999999999999999 999999999999999999999998722
Q ss_pred ------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 ------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ... .....
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~------------~~~~~ 230 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYL------------RIKKN 230 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH------------HHHTT
T ss_pred cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH------------HHhhc
Confidence 22358899999999999899999999999999999999999997643211 100 00000
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCC
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEA 613 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~ 613 (645)
. ...+......+.+++..||+.||++|||++++++ .+.+..
T Consensus 231 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 231 E--YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred c--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 0 1122233456788899999999999999999997 455443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=343.68 Aligned_cols=237 Identities=26% Similarity=0.324 Sum_probs=191.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.++|+..++||+|+||.||+|....++..||||++.. .......+.+|+.++++++||||++++++|.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 3578889999999999999999999999999998864 233456788999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++|+|..++..... +++..+..++.|++.||+|||+. .+|+||||||+||||+.++.+||.|..
T Consensus 227 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERV----FSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999976543 89999999999999999999952 789999999999999999999998832
Q ss_pred ------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 ------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ ...
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i------------~~~ 364 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELI------------LME 364 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH------------HHC
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHH------------HhC
Confidence 2346899999999999999999999999999999999999999764321 111111 011
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
. ..++......+.+++..||+.||.+|| +++|+++
T Consensus 365 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 E--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1 122333456678899999999999999 9999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=329.83 Aligned_cols=243 Identities=23% Similarity=0.268 Sum_probs=192.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC----e
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKG----E 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~ 418 (645)
.++|+..+.||+|+||.||+|....++..||||++.... .....+.+|+.++.+++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 467899999999999999999998899999999987632 23457889999999999999999999987654 3
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc-
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT- 497 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~- 497 (645)
.++||||+++++|.+++..... +++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||.|...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 5999999999999999976543 8999999999999999999999 9999999999999999999999987321
Q ss_pred --------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc
Q 041096 498 --------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR 563 (645)
Q Consensus 498 --------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 563 (645)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------~~~~~~~~~ 236 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-------AYQHVREDP 236 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhcCCC
Confidence 13589999999999999999999999999999999999999976432111 111111110
Q ss_pred hhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH-HHc
Q 041096 564 IIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ-ILN 610 (645)
Q Consensus 564 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~-~L~ 610 (645)
... ... .......+.+++..||+.||++||++.++++ .|.
T Consensus 237 ~~~---~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 237 IPP---SAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp CCH---HHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCc---ccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 000 000 1113456788899999999999997665543 443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.23 Aligned_cols=241 Identities=22% Similarity=0.320 Sum_probs=200.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|...+.||+|+||.||++....++..+|+|.+... ....+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 5678889999999999999999999999999987652 234567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++++|.+++..... +++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 121 e~~~~~~L~~~~~~~~~----l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CCCTTCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999876543 8999999999999999999999 999999999999999999999998732
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....||..|+|||.+.+..++.++||||||+++|||++|+.||....... .... .....
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~------------~~~~~ 257 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLR------------IKKNE 257 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHH------------HHHTC
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----HHHH------------HhcCC
Confidence 22458999999999999999999999999999999999999997643211 1100 00000
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCC
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEA 613 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~ 613 (645)
...+......+.+++..||+.||++|||++++++ .+....
T Consensus 258 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 258 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 1122233456778899999999999999999997 565543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.10 Aligned_cols=236 Identities=22% Similarity=0.349 Sum_probs=191.0
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeeeee----CCeEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWCAE----KGELLL 421 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 421 (645)
.|...+.||+|+||.||+|....++..||+|.+.. .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 36677889999999999999999999999998765 33445679999999999999999999998865 356899
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEEc-CCCCeeeeccc--
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ--VIHRDIKASNIMLD-ANFNARLESSF-- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NIlld-~~~~~kl~d~~-- 496 (645)
||||+++++|.+++..... +++..++.++.|++.||+|||+ .+ ++||||||+|||++ .++.+++.|..
T Consensus 107 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHccC----CCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 9999999999999976543 8999999999999999999998 77 99999999999998 78899998732
Q ss_pred --------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 --------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....||+.|+|||.+. +.++.++||||||+++|||++|+.||....... ...... ..+..
T Consensus 180 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~----~~~~~---- 247 (290)
T 1t4h_A 180 TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIYRRV----TSGVK---- 247 (290)
T ss_dssp GGCCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHHHH----TTTCC----
T ss_pred ccccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH---HHHHHH----hccCC----
Confidence 2346899999999887 459999999999999999999999997643211 111111 11000
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
....+......+.+++..||+.||.+|||++++++
T Consensus 248 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 ----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00111122346888999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.88 Aligned_cols=240 Identities=24% Similarity=0.365 Sum_probs=194.5
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
+|....+||+|+||.||+|....++..||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345566899999999999999888999999988763 3446779999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCeeeeccc----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA-NFNARLESSF---------- 496 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~-~~~~kl~d~~---------- 496 (645)
+++|.+++..... ...+++..+..++.|++.||+|||+ .+++||||||+||+++. ++.+++.|..
T Consensus 103 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999976532 2346789999999999999999999 99999999999999987 8899998732
Q ss_pred --cccccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 --TLTAGTMGYLAPEYLQYGT--ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~--~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....||..|+|||++.... ++.++||||||+++|||++|+.||........ ... .......
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~-------------~~~~~~~ 243 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMF-------------KVGMFKV 243 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHH-------------HHHHHCC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHH-------------hhccccc
Confidence 2236889999999997643 89999999999999999999999975432111 000 0001111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
....+......+.+++..||+.||++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22334445567888999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=332.50 Aligned_cols=260 Identities=20% Similarity=0.281 Sum_probs=191.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeee-----CCeEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE-----KGELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~~~l 421 (645)
.++|+..+.||+|+||.||+|... +..||||++............|+..+..++|+||+++++++.. ....++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEEC--CeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 367888999999999999999874 7999999987543332223344444556899999999985432 336799
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCC---------CeeeCCCCCCcEEEcCCCCeee
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ---------QVIHRDIKASNIMLDANFNARL 492 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~---------~ivHrDlkp~NIlld~~~~~kl 492 (645)
||||+++|+|.+++.... .++..++.++.|+++||+|||+ . +|+||||||+||||+.++.+||
T Consensus 90 v~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEE
Confidence 999999999999997543 6899999999999999999998 6 9999999999999999999999
Q ss_pred ecccc--------------------ccccCCcccCcccccC-------CCCCcchhHHHHHHHHHHHHcCCCCCCccccc
Q 041096 493 ESSFT--------------------LTAGTMGYLAPEYLQY-------GTATEKTDVFSYGVVVLEVACGRRPIERETEG 545 (645)
Q Consensus 493 ~d~~~--------------------~~~gt~~y~APE~~~~-------~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~ 545 (645)
+|... ...||+.|+|||++.+ ..++.++|||||||++|||++|+.|+......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 87321 2258999999999986 35677999999999999999998876543322
Q ss_pred cchhhHHH-HHHhhhccCchhHHh-hhhccCCC------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 546 HKMVNLVD-WVWGLYAEGRIIEAA-DKRLNGAF------NEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 546 ~~~~~l~~-~~~~~~~~~~~~~~~-d~~l~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
........ ..............+ ....+..+ .......+.+++..||+.||++|||++|+++.|+.+...-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 21111110 000000000000001 11111111 2246678999999999999999999999999998765443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=329.71 Aligned_cols=260 Identities=20% Similarity=0.259 Sum_probs=196.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc--chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|...+.||+|+||.||+|....++..||+|++.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999999889999999887532 2233567899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
++ |+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 82 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 96 699999876543 38999999999999999999999 999999999999999999999998732
Q ss_pred ---cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh---
Q 041096 497 ---TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD--- 569 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d--- 569 (645)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.... .............
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL-GTPTEETWPGILSNEE 233 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCTTTSTTGGGCHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCChHhchhhhcchh
Confidence 22367999999999876 568999999999999999999999998654322211111110 0000000000000
Q ss_pred ------hhccCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCC
Q 041096 570 ------KRLNGA----FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEP 615 (645)
Q Consensus 570 ------~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~ 615 (645)
+..... ........+.+++..||+.||++|||++|+++ .+.+..+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 000000 00112356778999999999999999999988 56655443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=330.52 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=202.3
Q ss_pred cccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeee
Q 041096 336 REFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCA 414 (645)
Q Consensus 336 ~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 414 (645)
..+++.++....++|+..+.||+|+||.||+|....++..||||++.......+.+.+|+.++.++ +||||+++++++.
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 344555666678899999999999999999999988899999999887666678899999999999 7999999999997
Q ss_pred e------CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 041096 415 E------KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF 488 (645)
Q Consensus 415 ~------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~ 488 (645)
. .+..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCC
Confidence 7 468999999999999999998653 2348999999999999999999999 9999999999999999999
Q ss_pred Ceeeeccc------------cccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhH
Q 041096 489 NARLESSF------------TLTAGTMGYLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNL 551 (645)
Q Consensus 489 ~~kl~d~~------------~~~~gt~~y~APE~~~-----~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l 551 (645)
.+++.|.. ....||+.|+|||.+. ...++.++|||||||++|||++|+.||....... .
T Consensus 167 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~ 242 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----A 242 (326)
T ss_dssp CEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH----H
T ss_pred CEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----H
Confidence 99998732 1235899999999987 5678999999999999999999999997543211 1
Q ss_pred HHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcC
Q 041096 552 VDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNN 611 (645)
Q Consensus 552 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~ 611 (645)
... . ................+.+++..||+.||.+||+++++++ .+.+
T Consensus 243 ~~~---~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 243 LFL---I---------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp HHH---H---------HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred HHH---h---------hcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 100 0 0000001111223456788899999999999999999987 4543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=337.73 Aligned_cols=232 Identities=24% Similarity=0.318 Sum_probs=186.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHH-HhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSI-IACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
++|+..++||+|+||.||+|+...++..||+|++.... .....+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888999999999999999999999999999986532 234456677776 5778999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++|+|.+++..... +++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 118 ~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERC----FLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999986543 8899999999999999999999 999999999999999999999998722
Q ss_pred ------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 ------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.. .++..
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~------------~i~~~ 254 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYD------------NILNK 254 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH----HHH------------HHHHS
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----HHH------------HHHhc
Confidence 23468999999999999999999999999999999999999997643211 111 11111
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRR 604 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~ 604 (645)
.+ .++......+.+++..||+.||.+||++.+
T Consensus 255 ~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 255 PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred cc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 11 122334456788889999999999999853
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=325.82 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=201.6
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhh--cCCCCeeeeeeeeeeCC
Q 041096 340 YRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIAC--LRHKNLVQLLGWCAEKG 417 (645)
Q Consensus 340 ~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~ 417 (645)
...-....++|...+.||+|+||.||+|... +..||||++.. .....+.+|++++.. ++||||+++++++...+
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~--~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECG--GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCc--hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3333455678999999999999999999984 89999999864 334567889988887 78999999999998876
Q ss_pred ----eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeeCCCCCCcEEEc
Q 041096 418 ----ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH--------QECEQQVIHRDIKASNIMLD 485 (645)
Q Consensus 418 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlkp~NIlld 485 (645)
..++||||+++|+|.+++.+.. +++.+++.++.|++.||+||| + .+|+||||||+||||+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVK 181 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhccC-----ccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEEC
Confidence 7999999999999999997542 899999999999999999999 6 8999999999999999
Q ss_pred CCCCeeeeccc----------------cccccCCcccCcccccCCC------CCcchhHHHHHHHHHHHHcC--------
Q 041096 486 ANFNARLESSF----------------TLTAGTMGYLAPEYLQYGT------ATEKTDVFSYGVVVLEVACG-------- 535 (645)
Q Consensus 486 ~~~~~kl~d~~----------------~~~~gt~~y~APE~~~~~~------~t~ksDV~SfGvvl~El~tG-------- 535 (645)
.++.+||.|.. ....||+.|+|||.+.+.. ++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 99999998722 2236899999999998753 34789999999999999999
Q ss_pred --CCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 536 --RRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF-----NEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 536 --~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
+.||........... .+. .. .....+.... ..+....+.+++..||+.||++|||+++|++.
T Consensus 262 ~~~~p~~~~~~~~~~~~--~~~-~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVE--EMR-KV--------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCCCTTTTTSCSSCCHH--HHH-HH--------HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccCccccCcCcccHH--HHH-HH--------HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 678765432221111 111 00 1111112222 23677889999999999999999999999999
Q ss_pred HcCCCCC
Q 041096 609 LNNEAEP 615 (645)
Q Consensus 609 L~~~~~~ 615 (645)
|+.+.+.
T Consensus 331 L~~i~~~ 337 (342)
T 1b6c_B 331 LSQLSQQ 337 (342)
T ss_dssp HHHHHHT
T ss_pred HHHHHHH
Confidence 9876543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=331.54 Aligned_cols=237 Identities=19% Similarity=0.302 Sum_probs=192.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCC--CCeeeeeeeeeeCCeEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRH--KNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~l 421 (645)
.++|+..+.||+|+||.||++... ++..||||++... ....+.+.+|+.++.+++| +||+++++++.+.+..++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 356888999999999999999885 4889999988653 2334678999999999987 999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||| +.+++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||||+ ++.+||.|..
T Consensus 87 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEe-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999 45889999998754 38999999999999999999999 9999999999999997 5678988732
Q ss_pred ---------cccccCCcccCcccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH
Q 041096 497 ---------TLTAGTMGYLAPEYLQY-----------GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW 556 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~-----------~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~ 556 (645)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~--- 228 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------IS--- 228 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HH---
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------HH---
Confidence 13468999999999864 67899999999999999999999999753221 00
Q ss_pred hhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 557 GLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 557 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.+...+++.....++......+.+++..||+.||.+|||+.++++.
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 229 ------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1122333333334444445678889999999999999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=328.44 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=201.1
Q ss_pred cCCCcCceeccCCceEEEEEEE----CCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC--eEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYF----ASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG--ELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~----~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~ 420 (645)
++|+..+.||+|+||.||+|.+ ..++..||||++... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4678889999999999999984 457899999998764 344578999999999999999999999987654 689
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---- 496 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---- 496 (645)
+||||+++++|.+++..... .+++.+++.++.|+++||+|||+ .+++||||||+|||++.++.+|+.|..
T Consensus 121 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999986543 38999999999999999999999 999999999999999999999998722
Q ss_pred -----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh----cc
Q 041096 497 -----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY----AE 561 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~----~~ 561 (645)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...+...... ..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQMIV 269 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTCCTHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhccccchhhhH
Confidence 112456679999999988899999999999999999999999764311 0000000000 00
Q ss_pred CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 562 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
..+.+.+........+...+..+.+++..||+.||++|||++++++.|+.+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 012222222222233445667889999999999999999999999999865
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=332.37 Aligned_cols=253 Identities=20% Similarity=0.255 Sum_probs=200.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC--------CCCeeeeeeeee----
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR--------HKNLVQLLGWCA---- 414 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~---- 414 (645)
.++|+..++||+|+||+||+|....++..||||++.......+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 36799999999999999999999999999999999877666788999999999996 788999999987
Q ss_pred eCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCcEEEcCCC-----
Q 041096 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ-QVIHRDIKASNIMLDANF----- 488 (645)
Q Consensus 415 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NIlld~~~----- 488 (645)
+....++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+ + +|+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence 456899999999 6677777665432 248999999999999999999999 7 999999999999999775
Q ss_pred --------------------------------------------Ceeeeccc---------cccccCCcccCcccccCCC
Q 041096 489 --------------------------------------------NARLESSF---------TLTAGTMGYLAPEYLQYGT 515 (645)
Q Consensus 489 --------------------------------------------~~kl~d~~---------~~~~gt~~y~APE~~~~~~ 515 (645)
.+|+.|.. ....||+.|+|||++.+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSC
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCC
Confidence 68887732 3346899999999999999
Q ss_pred CCcchhHHHHHHHHHHHHcCCCCCCccccccchh--hHHHHHHhhhccC------------------------------c
Q 041096 516 ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMV--NLVDWVWGLYAEG------------------------------R 563 (645)
Q Consensus 516 ~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~--~l~~~~~~~~~~~------------------------------~ 563 (645)
++.++|||||||++|||++|+.||.......... ............. .
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence 9999999999999999999999997654322111 1111111111000 0
Q ss_pred hhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 564 IIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 564 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..+.+... ...+.+....+.+++..||+.||++|||++|+++
T Consensus 350 ~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 350 LFEVLVEK--YEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHHT--SCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhHhhhhh--cccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01111111 1346777889999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=332.10 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=188.5
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC-CcchhHhHHHHHHHHhhcC-CCCeeeeeeeee--------eC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLR-HKNLVQLLGWCA--------EK 416 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~--------~~ 416 (645)
..+|+..++||+|+||.||+|....++..||||++.. .....+.+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 3578889999999999999999988899999998755 3344667899999999996 999999999984 34
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEEcCCCCeeeec
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ--VIHRDIKASNIMLDANFNARLES 494 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NIlld~~~~~kl~d 494 (645)
...++||||+. |+|.+++..... ...+++.+++.++.|++.||+|||+ .+ |+||||||+||||+.++.+||.|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEec
Confidence 46899999995 899999875332 2349999999999999999999998 77 99999999999999999999988
Q ss_pred ccc------------------------ccccCCcccCcccc---cCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccc
Q 041096 495 SFT------------------------LTAGTMGYLAPEYL---QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHK 547 (645)
Q Consensus 495 ~~~------------------------~~~gt~~y~APE~~---~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~ 547 (645)
... ...||+.|+|||.+ .+..++.++|||||||++|||++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 321 23489999999998 56678999999999999999999999996532211
Q ss_pred hhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCCCCCCCCcc
Q 041096 548 MVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCL 625 (645)
Q Consensus 548 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~~p~~~~~~ 625 (645)
+ +...............+.+++..||+.||.+|||++++++.|+........+...+..
T Consensus 261 ---~----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~~ 319 (337)
T 3ll6_A 261 ---I----------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319 (337)
T ss_dssp ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCCH
T ss_pred ---h----------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccHH
Confidence 1 1111111111122344778899999999999999999999999876655555555443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.43 Aligned_cols=240 Identities=25% Similarity=0.347 Sum_probs=194.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.++|+..+.||+|+||.||+|....++..+|+|.+... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 46788999999999999999999988999999988763 34567899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++..... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+++.|..
T Consensus 98 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred CCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999876433 38999999999999999999999 999999999999999999999998732
Q ss_pred ---cccccCCcccCcccc-----cCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 ---TLTAGTMGYLAPEYL-----QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~-----~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....||..|+|||++ ....++.++||||||+++|||++|+.||........ +.... ....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~----~~~~----- 239 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKIA----KSDP----- 239 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHH----HSCC-----
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHHHh----ccCC-----
Confidence 234689999999998 467789999999999999999999999976432111 11100 0000
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+ ....+......+.+++..||+.||.+|||+.++++
T Consensus 240 -~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 -P--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -C--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -c--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 00112233456888999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.38 Aligned_cols=247 Identities=17% Similarity=0.244 Sum_probs=189.8
Q ss_pred cCCCcC-ceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhh-cCCCCeeeeeeeeee----CCeEEE
Q 041096 348 RGFHSN-RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIAC-LRHKNLVQLLGWCAE----KGELLL 421 (645)
Q Consensus 348 ~~f~~~-~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~~l 421 (645)
++|... ++||+|+||+||+|....++..||||++.. ...+.+|++++.+ .+||||+++++++.. .+.+||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 456555 689999999999999999999999999864 2457788888754 589999999999875 567899
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCeeeeccc--
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA---NFNARLESSF-- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~---~~~~kl~d~~-- 496 (645)
||||+++|+|.+++..... ..+++.++..++.||+.||+|||+ .+|+||||||+||||+. ++.+||+|..
T Consensus 137 v~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999976432 348999999999999999999999 99999999999999998 7889998732
Q ss_pred ---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHH
Q 041096 497 ---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...............+.. +.
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----~~---- 283 (400)
T 1nxk_A 212 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQ---- 283 (400)
T ss_dssp EECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----TC----
T ss_pred cccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----Cc----
Confidence 2346899999999999999999999999999999999999999765432211111111100 00
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCC
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEA 613 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~ 613 (645)
..+...........+.+++..||+.||++|||+.++++ .+.+..
T Consensus 284 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 284 --YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp --CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred --ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 00000001223456788999999999999999999998 355443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=331.48 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=197.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..+.||+|+||.||+|....++..||+|++.... ...+.+.+|++++++++||||++++++|.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57888899999999999999999999999999876532 234568899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
|+++++|..++..... +++..+..++.|++.||+|||+ .+++||||||+|||++.++.++|.|..
T Consensus 105 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELFPNG----LDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHSTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999888764432 8999999999999999999999 999999999999999999999998732
Q ss_pred ----cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh-------hhccCch
Q 041096 497 ----TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG-------LYAEGRI 564 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~-------~~~~~~~ 564 (645)
....||..|+|||.+.+. .++.++|||||||++|||++|+.||...........+...... .+.....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 224689999999999875 7899999999999999999999999775433222222111100 0000000
Q ss_pred -hHHhhhhccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 565 -IEAADKRLNGAFN-----EDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 565 -~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.....+.+....+ ......+.+++..||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000111111 123567889999999999999999999876
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=323.29 Aligned_cols=242 Identities=25% Similarity=0.324 Sum_probs=189.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc--h-hHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE--G-KTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
.++|+..+.||+|+||.||+|....++..||+|++..... . .+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 4678889999999999999999988899999999876322 2 233445555688889999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ-QVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
||++ |+|.+++.........+++..++.++.|++.||+|||+ . +++||||||+|||++.++.+|+.|..
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9996 69988887543334459999999999999999999998 7 99999999999999999999998732
Q ss_pred -----cccccCCcccCcccc----cCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHH
Q 041096 497 -----TLTAGTMGYLAPEYL----QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~----~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
....||+.|+|||.+ ....++.++||||||+++|||++|+.||....... ..+. +.
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~-------------~~ 226 (290)
T 3fme_A 162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQLK-------------QV 226 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--HHHH-------------HH
T ss_pred ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--HHHH-------------HH
Confidence 223689999999996 55678999999999999999999999997532211 1111 11
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
................+.+++..||+.||++|||++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111111112234556888999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.52 Aligned_cols=245 Identities=23% Similarity=0.353 Sum_probs=199.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.++|...+.||+|+||.||++....++..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 357888999999999999999999889999999987643 3446788999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeeeeccc------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML---DANFNARLESSF------ 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll---d~~~~~kl~d~~------ 496 (645)
+++++|.+++..... +++..+..++.|++.||+|||+ .+++||||||+||++ +.++.+++.|..
T Consensus 88 ~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILERGV----YTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999976543 8999999999999999999999 999999999999999 788889998732
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .+...... +. ...
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~i~~----~~------~~~ 226 (304)
T 2jam_A 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES----KLFEKIKE----GY------YEF 226 (304)
T ss_dssp CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHH----CC------CCC
T ss_pred CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHc----CC------CCC
Confidence 1235899999999999999999999999999999999999999764321 11111100 00 000
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
...........+.+++..||+.||++|||++++++ .+++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 11112234567888999999999999999999987 56544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=331.26 Aligned_cols=240 Identities=20% Similarity=0.297 Sum_probs=193.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.++|+..+.||+|+||.||+|....++..||||++..... ...+|++++.++ +||||+++++++.+.+..|+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 4678899999999999999999999999999999876432 356788898888 799999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-C---Ceeeeccc-----
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN-F---NARLESSF----- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~-~---~~kl~d~~----- 496 (645)
+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+..+ + ..|+.|..
T Consensus 98 ~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999997644 38999999999999999999999 999999999999998543 2 37887721
Q ss_pred -------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 -------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+...+ ..+.
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~i----~~~~------ 239 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-PEEILARI----GSGK------ 239 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-HHHHHHHH----HHCC------
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-HHHHHHHH----ccCC------
Confidence 23468999999999988889999999999999999999999997532211 11111111 0000
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..+...........+.+++..||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111112234566788899999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.69 Aligned_cols=235 Identities=18% Similarity=0.304 Sum_probs=191.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcC--CCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLR--HKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV 422 (645)
++|+..+.||+|+||.||+|.... +..||||++... ....+.+.+|+.++.+++ |+||+++++++...+..+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 358889999999999999999875 889999988653 334577999999999997 59999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|| +.+++|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+||||+ ++.+||.|..
T Consensus 135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 56899999998654 38999999999999999999999 9999999999999996 5788998731
Q ss_pred --------cccccCCcccCcccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh
Q 041096 497 --------TLTAGTMGYLAPEYLQY-----------GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG 557 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~-----------~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~ 557 (645)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~---- 275 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------IS---- 275 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HH----
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------HH----
Confidence 23469999999999865 46899999999999999999999999753221 01
Q ss_pred hhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 558 LYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 558 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+...+++.....++......+.+++..||+.||.+|||+.|+++
T Consensus 276 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 276 -----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp -----HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 112223333222333333556788999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=336.03 Aligned_cols=192 Identities=20% Similarity=0.278 Sum_probs=171.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc------CCCCeeeeeeeeeeCCeEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL------RHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~~~ 420 (645)
..+|+..++||+|+||.||+|....++..||||++.......+.+.+|++++..+ +|+||+++++++...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 4578999999999999999999999999999999987766677888999998887 4679999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC--eeeeccc--
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN--ARLESSF-- 496 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~--~kl~d~~-- 496 (645)
+||||+. ++|.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++. +||.|..
T Consensus 176 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999995 799999986543 238999999999999999999999 89999999999999999887 8998732
Q ss_pred -------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 041096 497 -------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~ 544 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 250 CYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp EETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 234689999999999999999999999999999999999999987543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=336.38 Aligned_cols=238 Identities=21% Similarity=0.279 Sum_probs=187.8
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---------chhHhHHHHHHHHhhcCCCCeeeeeeeeee
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---------EGKTEFLAELSIIACLRHKNLVQLLGWCAE 415 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 415 (645)
...++|...+.||+|+||.||+|....++..||||++.... .....+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999999999999999876421 12345889999999999999999999975
Q ss_pred CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---Ceee
Q 041096 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF---NARL 492 (645)
Q Consensus 416 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~---~~kl 492 (645)
.+..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||||+.++ .+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEE
Confidence 456899999999999999987543 38999999999999999999999 9999999999999997544 4888
Q ss_pred eccc-----------cccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh
Q 041096 493 ESSF-----------TLTAGTMGYLAPEYLQY---GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 493 ~d~~-----------~~~~gt~~y~APE~~~~---~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
.|.. ....||+.|+|||++.. ..++.++|||||||++|||++|+.||......... ....
T Consensus 284 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~---~~~i--- 357 (419)
T 3i6u_A 284 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQI--- 357 (419)
T ss_dssp CCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH---HHHH---
T ss_pred eecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH---HHHH---
Confidence 8732 23468999999999863 67889999999999999999999999764332211 1111
Q ss_pred hccCchhHHhhhhccCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 559 YAEGRIIEAADKRLNGAFNE----DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..... .... .....+.+++..||+.||++|||++|+++
T Consensus 358 ----------~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 ----------TSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ----------HTTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----------hcCCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11000 1111 12456888999999999999999999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.40 Aligned_cols=242 Identities=24% Similarity=0.339 Sum_probs=201.5
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.++|+..++||+|+||.||+|....++..||+|++... ......+.+|++++.+++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 35688899999999999999999999999999998652 23356688999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++|+|.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 263 mEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999976442 238999999999999999999999 999999999999999999999998721
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+. .
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--------------~ 403 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--------------E 403 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--------------H
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--------------c
Confidence 235789999999999999999999999999999999999999986543221111111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
....++......+.+++..||+.||.+|| +++|+++
T Consensus 404 ~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11223334456788899999999999999 7888875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.34 Aligned_cols=251 Identities=20% Similarity=0.309 Sum_probs=201.7
Q ss_pred cCHHHHHHHhcCCCcC-ceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcC-CCCeeeeeee
Q 041096 338 FSYRELRSATRGFHSN-RILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLR-HKNLVQLLGW 412 (645)
Q Consensus 338 ~~~~~l~~~~~~f~~~-~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~ 412 (645)
..++......+.|... +.||+|+||.||+|....++..||+|++... ......+.+|+.++.+++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344445556677776 8899999999999999999999999988762 334678999999999995 6999999999
Q ss_pred eeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCC
Q 041096 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA---NFN 489 (645)
Q Consensus 413 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~---~~~ 489 (645)
+.+.+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCc
Confidence 999999999999999999999986532 2348999999999999999999999 99999999999999998 788
Q ss_pred eeeeccc-----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh
Q 041096 490 ARLESSF-----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 490 ~kl~d~~-----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
+||.|.. ....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+. .
T Consensus 173 ~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~----~- 247 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS----Q- 247 (327)
T ss_dssp EEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----H-
T ss_pred EEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH----h-
Confidence 9998732 22468999999999999999999999999999999999999997643221111000 0
Q ss_pred hccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 559 YAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
................+.+++..||+.||++|||++++++
T Consensus 248 ---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 248 ---------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ---------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0011111122234566888999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.31 Aligned_cols=242 Identities=21% Similarity=0.344 Sum_probs=193.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.++|...+.||+|+||.||+|....++..||||.+... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 35788899999999999999999888999999988652 22345788999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++++|.+++..... +++..+..++.|++.||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 90 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGR----VEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999976543 8999999999999999999999 899999999999999999999998732
Q ss_pred -----cccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... .+.+.+ ..
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~-------------~~ 225 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP----TLFKKI-------------RG 225 (276)
T ss_dssp C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH-------------HH
T ss_pred CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHh-------------hc
Confidence 22357899999999987765 68999999999999999999999753221 111111 11
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCC
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEA 613 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~ 613 (645)
.. ...+......+.+++..||+.||.+|||++++++ .+++..
T Consensus 226 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 226 GV-FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred Cc-ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 10 1122233456788999999999999999999998 355443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=329.80 Aligned_cols=241 Identities=22% Similarity=0.266 Sum_probs=196.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEC---CCCeEEEEEeccCC-----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFA---SSGSVAAVKRSKHS-----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKG 417 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~---~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 417 (645)
.++|+..+.||+|+||.||++... .++..||||++... ....+.+.+|++++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 357889999999999999999984 47899999998752 23356688999999999 6999999999999999
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF- 496 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~- 496 (645)
..+|||||+++|+|.+++..... +++..+..++.|+++||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999986543 8999999999999999999999 999999999999999999999998732
Q ss_pred ------------cccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC
Q 041096 497 ------------TLTAGTMGYLAPEYLQY--GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG 562 (645)
Q Consensus 497 ------------~~~~gt~~y~APE~~~~--~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~ 562 (645)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~------ 279 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL------ 279 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH------
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh------
Confidence 12368999999999986 3478999999999999999999999976443322222211110
Q ss_pred chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 041096 563 RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQI 608 (645)
Q Consensus 563 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~~ 608 (645)
. ....++.+....+.+++..||+.||.+|| +++++++.
T Consensus 280 ------~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 280 ------K--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ------H--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ------c--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 0 01223344456788899999999999999 99999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=317.18 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=195.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-----cchhHhHHHHHHHHhhcCCCCeeeeeeeee--eCCeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-----HEGKTEFLAELSIIACLRHKNLVQLLGWCA--EKGEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~ 419 (645)
.++|...+.||+|+||.||++....++..+|+|++... ....+.+.+|++++++++|+||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999999988999999998653 234577999999999999999999999984 45688
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
++||||++++ |.+++..... ..+++..+..++.|+++||+|||+ .+++||||||+|||++.++..++.|..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 7777765432 348999999999999999999999 999999999999999999999998722
Q ss_pred -----------cccccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc
Q 041096 497 -----------TLTAGTMGYLAPEYLQYGT--ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR 563 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~~~--~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 563 (645)
....||..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~--------- 224 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY----KLFEN--------- 224 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHH---------
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH----HHHHH---------
Confidence 1235899999999998654 378999999999999999999999764321 11111
Q ss_pred hhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCC
Q 041096 564 IIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEP 615 (645)
Q Consensus 564 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~ 615 (645)
+... ....+.+....+.+++..||+.||.+|||++++++ .+.+....
T Consensus 225 ----i~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 225 ----IGKG-SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp ----HHHC-CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred ----HhcC-CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 0000 01223334567788999999999999999999997 56655443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=325.26 Aligned_cols=241 Identities=24% Similarity=0.359 Sum_probs=197.3
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc---------hhHhHHHHHHHHhhc-CCCCeeeeee
Q 041096 342 ELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---------GKTEFLAELSIIACL-RHKNLVQLLG 411 (645)
Q Consensus 342 ~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---------~~~~~~~Ei~~l~~l-~H~niv~l~g 411 (645)
......++|...+.||+|+||.||+|.+..+|..||||++..... ..+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 334556789999999999999999999988899999998765321 145678999999999 7999999999
Q ss_pred eeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCee
Q 041096 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491 (645)
Q Consensus 412 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~k 491 (645)
++...+..++||||+++++|.+++..... +++..+..++.||+.||.|||+ .+++||||||+|||++.++.++
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKVA----LSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999976543 8999999999999999999999 9999999999999999999999
Q ss_pred eeccc-----------cccccCCcccCcccccC------CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHH
Q 041096 492 LESSF-----------TLTAGTMGYLAPEYLQY------GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDW 554 (645)
Q Consensus 492 l~d~~-----------~~~~gt~~y~APE~~~~------~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~ 554 (645)
+.|.. ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 241 l~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~ 316 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI----LMLRM 316 (365)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH
T ss_pred EEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH----HHHHH
Confidence 98732 23468999999999863 35789999999999999999999999754321 11111
Q ss_pred HHhhhccCchhHHhhhhccCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 555 VWGLYAEGRIIEAADKRLNGAFNE----DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 555 ~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+.. ... ..+. .....+.+++..||+.||++|||++++++
T Consensus 317 i~~------------~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 IME------------GQY--QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHH------------TCC--CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHh------------CCC--CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 100 000 0111 12345788999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=336.93 Aligned_cols=251 Identities=21% Similarity=0.215 Sum_probs=193.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC------C
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK------G 417 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 417 (645)
.++|+..+.||+|+||+||+|....++..||||++... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999999999999999998753 33456788999999999999999999998654 4
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF- 496 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~- 496 (645)
..||||||+++ +|.+.+.. .+++.++..++.|++.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 68999999965 57666642 28999999999999999999999 999999999999999999999998832
Q ss_pred ----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh----hc--
Q 041096 497 ----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL----YA-- 560 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~----~~-- 560 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+++....- +.
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 33578999999999999999999999999999999999999998654322221111110000 00
Q ss_pred ---------------cCchhHHhhhhccCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 561 ---------------EGRIIEAADKRLNGAF---NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 561 ---------------~~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...........+.... .......+.+++..||+.||++|||++|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000 0112567889999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=336.00 Aligned_cols=253 Identities=20% Similarity=0.255 Sum_probs=192.4
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeee--------
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE-------- 415 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-------- 415 (645)
....++|...+.||+|+||.||+|....++..||||++.... ....+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 455678999999999999999999999999999999886532 233479999999999999999999844
Q ss_pred ------------------------------CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHh
Q 041096 416 ------------------------------KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465 (645)
Q Consensus 416 ------------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH 465 (645)
....++||||++ |+|.+.+......+..+++..+..++.|+++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334899999997 6888888754333445999999999999999999999
Q ss_pred hcCCCCeeeCCCCCCcEEEc-CCCCeeeeccc-----------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHH
Q 041096 466 QECEQQVIHRDIKASNIMLD-ANFNARLESSF-----------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEV 532 (645)
Q Consensus 466 ~~~~~~ivHrDlkp~NIlld-~~~~~kl~d~~-----------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El 532 (645)
+ .+|+||||||+|||++ .++.+||.|.. ....||+.|+|||.+.+. .++.++||||+||++|||
T Consensus 159 ~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 159 S---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp T---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred H---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 8 9999999999999998 57889998732 224678999999998865 489999999999999999
Q ss_pred HcCCCCCCccccccchhhHHHHHHhhhccCchhHH--hhhh-------------ccCCCCHHHHHHHHHHHHHccCCCCC
Q 041096 533 ACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA--ADKR-------------LNGAFNEDEMKRLLLVGLSCANPDSS 597 (645)
Q Consensus 533 ~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~d~~-------------l~~~~~~~~~~~l~~l~~~Cl~~dP~ 597 (645)
++|+.||......+....++.. .......++ +++. ....++......+.+++..||+.||+
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~----~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQI----MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHH----HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HhCCCCCCCCChHHHHHHHHHH----hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 9999999875432222222111 111000000 0000 00012223455688999999999999
Q ss_pred CCCCHHHHHH
Q 041096 598 ARPSMRRVFQ 607 (645)
Q Consensus 598 ~RPt~~~vl~ 607 (645)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=320.33 Aligned_cols=240 Identities=25% Similarity=0.338 Sum_probs=193.6
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
..++|+..+.||+|+||.||+|....++..||+|.+.... ..+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 3467999999999999999999999889999999987633 456789999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
+++++|.+++..... .+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+++.|..
T Consensus 106 ~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 106 CGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CTTEEHHHHHHHHTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred CCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999974332 38999999999999999999999 999999999999999999999998732
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....||..|+|||.+.+..++.++||||||+++|||++|+.||........ . ...... ..+.+
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~---~~~~~~------~~~~~- 245 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA----I---FMIPTN------PPPTF- 245 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH----H---HHHHHS------CCCCC-
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH----H---HHHhcC------CCccc-
Confidence 224688999999999999999999999999999999999999975432110 0 000000 00000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..+......+.+++..||+.||.+|||+.++++
T Consensus 246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112223456888999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=332.78 Aligned_cols=256 Identities=16% Similarity=0.143 Sum_probs=199.0
Q ss_pred cCCCcCceeccCCceEEEEEEECC--------CCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeee-----------
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS--------SGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQ----------- 408 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~--------~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~----------- 408 (645)
++|...+.||+|+||.||+|.... .+..||+|++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 678889999999999999999976 3789999998754 46889999999999999998
Q ss_pred ----eeeeeee-CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 041096 409 ----LLGWCAE-KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIM 483 (645)
Q Consensus 409 ----l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIl 483 (645)
+++++.. .+..++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+ .+|+||||||+|||
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 5667765 67899999999 999999998652 2349999999999999999999999 99999999999999
Q ss_pred EcCCC--Ceeeeccc-------------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 041096 484 LDANF--NARLESSF-------------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERE 542 (645)
Q Consensus 484 ld~~~--~~kl~d~~-------------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~ 542 (645)
++.++ .+||.|.. ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99988 88887722 1236899999999999999999999999999999999999999865
Q ss_pred ccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCCCCC
Q 041096 543 TEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPK 620 (645)
Q Consensus 543 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~~p~ 620 (645)
.... ..+........... ....+... ........+.+++..||+.||++||+++++++.|+++........
T Consensus 272 ~~~~--~~~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 272 LPNT--EDIMKQKQKFVDKP--GPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp TTCH--HHHHHHHHHHHHSC--CCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred CcCH--HHHHHHHHhccCCh--hhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 3211 11111111110000 00000000 001224668888999999999999999999999987765554443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=326.59 Aligned_cols=261 Identities=18% Similarity=0.245 Sum_probs=194.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC------C
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK------G 417 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 417 (645)
.++|+..+.||+|+||.||+|....++..||||++... ....+.+.+|++++++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788899999999999999999989999999998653 23356788999999999999999999998765 3
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-- 495 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-- 495 (645)
..|+||||+ +++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||.|.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 569999999 88999999763 28999999999999999999999 99999999999999999999999873
Q ss_pred -------ccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH-------hhhc
Q 041096 496 -------FTLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW-------GLYA 560 (645)
Q Consensus 496 -------~~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~-------~~~~ 560 (645)
....+||+.|+|||++.+ ..++.++||||+||+++||++|+.||...+.......+..... ....
T Consensus 175 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 175 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp CEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 233578999999999887 6799999999999999999999999986543222111111100 0000
Q ss_pred cCchhHHhhh--hc-c---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCC
Q 041096 561 EGRIIEAADK--RL-N---GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPL 616 (645)
Q Consensus 561 ~~~~~~~~d~--~l-~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~ 616 (645)
.......+.. .. . ..........+.+++..|++.||++|||++++++ .+++..+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 318 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence 0000000000 00 0 0111233456788999999999999999999998 566654443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=317.31 Aligned_cols=241 Identities=23% Similarity=0.306 Sum_probs=196.9
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----------chhHhHHHHHHHHhhcC-CCCeeeeeeeee
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----------EGKTEFLAELSIIACLR-HKNLVQLLGWCA 414 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----------~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~ 414 (645)
..++|+..+.||+|+||.||+|....++..||||++.... ...+.+.+|++++.+++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999999899999999986532 22456889999999996 999999999999
Q ss_pred eCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec
Q 041096 415 EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES 494 (645)
Q Consensus 415 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d 494 (645)
..+..++||||+++++|.+++..... +++..+..++.|++.||+|||+ .+++||||||+||+++.++.+++.|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999986533 8999999999999999999999 9999999999999999999999987
Q ss_pred cc-----------cccccCCcccCccccc------CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh
Q 041096 495 SF-----------TLTAGTMGYLAPEYLQ------YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG 557 (645)
Q Consensus 495 ~~-----------~~~~gt~~y~APE~~~------~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~ 557 (645)
.. ....|++.|+|||.+. ...++.++||||||+++|||++|+.||....... .......
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~ 243 (298)
T 1phk_A 168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----MLRMIMS 243 (298)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHH
T ss_pred ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH----HHHHHhc
Confidence 32 2246899999999885 4568999999999999999999999997543211 1110000
Q ss_pred hhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 558 LYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 558 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+. ..............+.+++..||+.||++|||+.++++
T Consensus 244 ----~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 ----GN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ----TC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ----CC------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00 00000111234567889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=340.07 Aligned_cols=240 Identities=26% Similarity=0.390 Sum_probs=195.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc--------------chhHhHHHHHHHHhhcCCCCeeeeeee
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--------------EGKTEFLAELSIIACLRHKNLVQLLGW 412 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--------------~~~~~~~~Ei~~l~~l~H~niv~l~g~ 412 (645)
.++|...++||+|+||+||+|....++..+|+|++.... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467888999999999999999999999999999886532 335678999999999999999999999
Q ss_pred eeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---C
Q 041096 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF---N 489 (645)
Q Consensus 413 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~---~ 489 (645)
|.+.+..++||||+++|+|.+++..... +++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999976543 8999999999999999999999 9999999999999998776 5
Q ss_pred eeeecc-----------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh
Q 041096 490 ARLESS-----------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 490 ~kl~d~-----------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
+||.|. .....||+.|+|||++. +.++.++||||+||++|||++|+.||....... +...+.
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~-- 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD----IIKKVE-- 260 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHH--
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHH--
Confidence 788772 23346999999999987 569999999999999999999999997643211 111110
Q ss_pred hccCchhHHhhhhccCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 559 YAEGRIIEAADKRLNGAFNE----DEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
.+ .. .++. .....+.+++..||+.||.+|||++|+++ .+++.
T Consensus 261 --~~--------~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 261 --KG--------KY--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp --HC--------CC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred --cC--------CC--CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 00 00 1111 12356788999999999999999999986 45543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=339.84 Aligned_cols=234 Identities=14% Similarity=0.140 Sum_probs=183.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC----CcchhHhHHHHH---HHHhhcCCCCeeeee-------ee
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH----SHEGKTEFLAEL---SIIACLRHKNLVQLL-------GW 412 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~ 412 (645)
.++|...+.||+|+||.||+|+...++..||||++.. .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4668888999999999999999988899999999863 233457789999 555566899999998 55
Q ss_pred eeeCC-----------------eEEEEEecCCCCCHhHHhhhcCC---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 041096 413 CAEKG-----------------ELLLVYEYMPNGSLDRMLYQDSE---NGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472 (645)
Q Consensus 413 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 472 (645)
+.+.+ ..+|||||+ +|+|.+++..... ....+++..++.|+.||++||+|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 44442 289999999 7899999986432 12235578999999999999999999 999
Q ss_pred eeCCCCCCcEEEcCCCCeeeeccc---------cccccCCcccCcccccCC-----------CCCcchhHHHHHHHHHHH
Q 041096 473 IHRDIKASNIMLDANFNARLESSF---------TLTAGTMGYLAPEYLQYG-----------TATEKTDVFSYGVVVLEV 532 (645)
Q Consensus 473 vHrDlkp~NIlld~~~~~kl~d~~---------~~~~gt~~y~APE~~~~~-----------~~t~ksDV~SfGvvl~El 532 (645)
+||||||+||||+.++.+||+|.. ....| +.|+|||++.+. .++.++|||||||++|||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 999999999999999999998832 23457 999999999887 899999999999999999
Q ss_pred HcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 533 ACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 533 ~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
++|+.||.......... .+.+. .......+.+++..||+.||++|||+.++++
T Consensus 307 ltg~~Pf~~~~~~~~~~-----------------~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 307 WCADLPITKDAALGGSE-----------------WIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHSSCCC------CCSG-----------------GGGSS-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHCCCCCcccccccchh-----------------hhhhh-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999997643221111 00000 0122456788889999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.05 Aligned_cols=263 Identities=19% Similarity=0.249 Sum_probs=203.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-----------CCCeeeeeeeeee
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-----------HKNLVQLLGWCAE 415 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~ 415 (645)
.++|...+.||+|+||.||+|....++..||||++.......+.+.+|++++.+++ |+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 35788999999999999999999888999999999876666778999999999886 8999999999886
Q ss_pred CC----eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCcEEEcC----
Q 041096 416 KG----ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ-QVIHRDIKASNIMLDA---- 486 (645)
Q Consensus 416 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NIlld~---- 486 (645)
.+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+ + +|+||||||+||||+.
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 54 789999999 9999999986442 238999999999999999999999 7 9999999999999953
Q ss_pred --CCCeeeecc---------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccch--hhHHH
Q 041096 487 --NFNARLESS---------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKM--VNLVD 553 (645)
Q Consensus 487 --~~~~kl~d~---------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~--~~l~~ 553 (645)
.+.+||.|. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred cCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 346788773 23357899999999999999999999999999999999999999864321110 00111
Q ss_pred HHHhhhcc--------C----------------------chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 041096 554 WVWGLYAE--------G----------------------RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMR 603 (645)
Q Consensus 554 ~~~~~~~~--------~----------------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 603 (645)
........ + .+.+..... ..++......+.+++..||+.||++|||++
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK--YKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHT--TCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhc--ccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 11110000 0 001111111 245677888999999999999999999999
Q ss_pred HHHH--HHcCCCCCCC
Q 041096 604 RVFQ--ILNNEAEPLV 617 (645)
Q Consensus 604 ~vl~--~L~~~~~~~~ 617 (645)
|+++ .+.+......
T Consensus 330 ell~hp~f~~~~~~~~ 345 (373)
T 1q8y_A 330 GLVNHPWLKDTLGMEE 345 (373)
T ss_dssp HHHTCGGGTTCTTCTT
T ss_pred HHhhChhhhcccCccc
Confidence 9998 5666544443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.76 Aligned_cols=245 Identities=21% Similarity=0.277 Sum_probs=193.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-CCCeeeeeeeeee--CCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HKNLVQLLGWCAE--KGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~E 424 (645)
++|+..+.||+|+||.||+|....++..||||++... ..+.+.+|++++++++ ||||+++++++.+ ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 5688899999999999999999888999999998753 3567899999999997 9999999999987 667999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-Ceeeeccc-------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-NARLESSF------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~-~~kl~d~~------- 496 (645)
|+++++|.+++.. +++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||.|..
T Consensus 114 ~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 114 HVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999842 8899999999999999999999 9999999999999999776 78887732
Q ss_pred ----cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh-
Q 041096 497 ----TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK- 570 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~- 570 (645)
....||..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+.. ...........+.++.
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~-~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVR-IAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHH-HHHHHCHHHHHHHHHHT
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHH-HHHhcCCchhhhHHHHh
Confidence 23468899999999987 6789999999999999999999999965332111 1111 1111111111111110
Q ss_pred ----------------------hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 571 ----------------------RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 571 ----------------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.............+.+++..||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111111123567888999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=327.90 Aligned_cols=268 Identities=20% Similarity=0.230 Sum_probs=194.1
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCe--
Q 041096 341 RELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGE-- 418 (645)
Q Consensus 341 ~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-- 418 (645)
.+.....++|...+.||+|+||.||+|....++..||||++.........+.+|++.+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 456677899999999999999999999999889999999987765556678889999999999999999999876433
Q ss_pred -----EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHh--hcCCCCeeeCCCCCCcEEEcC-CCCe
Q 041096 419 -----LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH--QECEQQVIHRDIKASNIMLDA-NFNA 490 (645)
Q Consensus 419 -----~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDlkp~NIlld~-~~~~ 490 (645)
.++||||+++ +|...+.........+++..+..++.|++.||.||| + .+|+||||||+||||+. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcE
Confidence 8999999975 666555443333345899999999999999999999 7 99999999999999997 8899
Q ss_pred eeeccc-----------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh
Q 041096 491 RLESSF-----------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 491 kl~d~~-----------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
||.|.. ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+......
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~- 250 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC- 250 (360)
T ss_dssp EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC-
T ss_pred EEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC-
Confidence 998732 234689999999998765 4899999999999999999999999875433222222111000
Q ss_pred hccCchhHHhhhh----------------ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCC
Q 041096 559 YAEGRIIEAADKR----------------LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAE 614 (645)
Q Consensus 559 ~~~~~~~~~~d~~----------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~ 614 (645)
. .......+++. +...........+.+++..||+.||.+|||+.|+++ .+++..+
T Consensus 251 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 251 P-SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp C-CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred C-CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 0 00011111110 011122224567889999999999999999999997 4665543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=341.62 Aligned_cols=239 Identities=23% Similarity=0.349 Sum_probs=191.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
.++|+..+.||+|+||+||+|....++..+|+|++... ......+.+|+.+++.++||||++++++|.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 35688899999999999999999989999999998763 334677899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC---CCeeeeccc----
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN---FNARLESSF---- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~---~~~kl~d~~---- 496 (645)
||+++|+|.+++..... +++.++..++.||++||+|||+ .+|+||||||+|||++.+ +.+||.|..
T Consensus 116 e~~~~g~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMK----FNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999876543 8999999999999999999999 999999999999999764 448887722
Q ss_pred -------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 -------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
....||+.|+|||++. +.++.++||||+||++|||++|+.||...... .+...+.. +..
T Consensus 189 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~----~~~----- 254 (494)
T 3lij_A 189 FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ----EILRKVEK----GKY----- 254 (494)
T ss_dssp CBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH----TCC-----
T ss_pred CCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHh----CCC-----
Confidence 2346899999999886 56999999999999999999999999764321 11111100 000
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.............+.+++..||+.+|.+|||+.++++
T Consensus 255 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 -TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0000000123456778899999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.51 Aligned_cols=254 Identities=20% Similarity=0.281 Sum_probs=200.1
Q ss_pred hcCCCcCceeccCCceEEEEEEE-CCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCC------eeeeeeeeeeCCeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYF-ASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKN------LVQLLGWCAEKGEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~-~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~~ 419 (645)
.++|+..+.||+|+||.||+|.. ..++..||||++.......+.+.+|++++..++|+| ++++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 35788999999999999999998 557899999999876666778999999999997664 99999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-------------
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA------------- 486 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~------------- 486 (645)
++||||+ +++|.+++..... ..+++.++..++.|+++||+|||+ .+|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 8999999976542 248899999999999999999999 99999999999999987
Q ss_pred ------CCCeeeeccc---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhH
Q 041096 487 ------NFNARLESSF---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNL 551 (645)
Q Consensus 487 ------~~~~kl~d~~---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l 551 (645)
++.+|+.|.. ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~- 245 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM- 245 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH-
T ss_pred ccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH-
Confidence 5678887732 234689999999999999999999999999999999999999976543221111
Q ss_pred HHHHHhhhcc--------C--------------c----hhHHhhhhc-cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 041096 552 VDWVWGLYAE--------G--------------R----IIEAADKRL-NGAFNEDEMKRLLLVGLSCANPDSSARPSMRR 604 (645)
Q Consensus 552 ~~~~~~~~~~--------~--------------~----~~~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~ 604 (645)
+......... . . ..+...+.. ...........+.+++..||+.||.+|||++|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 1111000000 0 0 000000000 01223456778999999999999999999999
Q ss_pred HHH
Q 041096 605 VFQ 607 (645)
Q Consensus 605 vl~ 607 (645)
+++
T Consensus 326 ll~ 328 (339)
T 1z57_A 326 ALK 328 (339)
T ss_dssp HTT
T ss_pred Hhc
Confidence 985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=321.12 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=190.5
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CC--eEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS-SG--SVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~-~~--~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
++|+..+.||+|+||.||+|.+.. ++ ..||+|++... ....+.+.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 578889999999999999998643 22 36899988752 234578999999999999999999999998765 89
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---- 496 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---- 496 (645)
+|+||+++++|.+++..... .+++.++..++.|+++||+|||+ .+++||||||+|||++.++.+++.|..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 99999999999999986532 38999999999999999999999 999999999999999999999998732
Q ss_pred -----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 -----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~--------- 237 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKI--------- 237 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHH---------
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH----HHHHHH---------
Confidence 12346778999999998889999999999999999999 99999764321 111111
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
.........+......+.+++..||+.+|++|||+.++++.|++..+
T Consensus 238 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 238 ---DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ---HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ---HccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 11111112233455678899999999999999999999999986644
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.58 Aligned_cols=239 Identities=28% Similarity=0.433 Sum_probs=191.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeee-----------
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE----------- 415 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----------- 415 (645)
.++|+..+.||+|+||.||+|....++..||||++.......+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 467889999999999999999998889999999997666667789999999999999999999998865
Q ss_pred --CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeee
Q 041096 416 --KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLE 493 (645)
Q Consensus 416 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~ 493 (645)
.+..++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+ .+++||||||+|||++.++..++.
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 357899999999999999998643 237889999999999999999999 999999999999999999999998
Q ss_pred ccc--------------------------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccccc
Q 041096 494 SSF--------------------------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGH 546 (645)
Q Consensus 494 d~~--------------------------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~ 546 (645)
|.. ....||..|+|||.+.+. .++.++|||||||++|||++ ||.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-- 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-- 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence 732 123578899999999864 78999999999999999998 5543211
Q ss_pred chhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 547 KMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 547 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
......... .....+...++......+.+++..||+.||.+|||++++++
T Consensus 234 -~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 -RVNILKKLR----------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHHHHH----------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHHHhcc----------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111110 01111223344455667889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.66 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=181.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
..++|...+.||+|+||.||+|....++..||||++... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 357899999999999999999999888999999988653 334567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcC----CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---
Q 041096 424 EYMPNGSLDRMLYQDS----ENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--- 496 (645)
||+++++|.+++.... .....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+++.|..
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 9999999999987421 112348999999999999999999999 999999999999999999999998731
Q ss_pred --------------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc
Q 041096 497 --------------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE 561 (645)
Q Consensus 497 --------------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~ 561 (645)
....||+.|+|||.+.. ..++.++||||||+++|||++|+.||........ + .........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~-~~~~~~~~~ 245 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---L-MLTLQNDPP 245 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H-HHHHTSSCC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---H-HHHhccCCC
Confidence 12358999999999876 5689999999999999999999999976433211 1 111000000
Q ss_pred CchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 562 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.......++.. .......+.+++..||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000111111 1223456788899999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.08 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=191.7
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc------hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE------GKTEFLAELSIIACLRHKNLVQLLGWCAEKG 417 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 417 (645)
....++|...+.||+|+||.||+|....++..||||++..... ..+.+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 3456789999999999999999999998899999999875221 2356889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF- 496 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~- 496 (645)
..++||||+++ +|..++..... .+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|..
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred ceEEEEEcCCC-CHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 99999999975 89988876432 38889999999999999999999 999999999999999999999998732
Q ss_pred -----------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc-
Q 041096 497 -----------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR- 563 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~- 563 (645)
....||+.|+|||.+.+. .++.++|||||||++|||++|..||...........+..... ......
T Consensus 159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~-~~~~~~~ 237 (346)
T 1ua2_A 159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG-TPTEEQW 237 (346)
T ss_dssp GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCTTTS
T ss_pred ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcC-CCChhhh
Confidence 224689999999999764 589999999999999999999999876543222111111100 000000
Q ss_pred --hhHHhhh---hccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 041096 564 --IIEAADK---RLNGAFN-----EDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608 (645)
Q Consensus 564 --~~~~~d~---~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~ 608 (645)
.....+. ......+ ......+.+++..||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000 0000011 1234678899999999999999999999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=340.17 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=198.2
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
..++|+..++||+|+||+||+|....++..||||++.. .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 34679999999999999999999998899999999864 233467799999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc---CCCCeeeeccc---
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD---ANFNARLESSF--- 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld---~~~~~kl~d~~--- 496 (645)
|||+++|+|.+++..... +++.++..++.|++.||+|||+ .+|+||||||+|||++ .++.+||.|..
T Consensus 100 ~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999999876543 8999999999999999999999 9999999999999995 45568887732
Q ss_pred --------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 --------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....||+.|+|||++.+ .++.++||||+||++|||++|+.||....... +...+.. +..
T Consensus 173 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~----~~~---- 239 (486)
T 3mwu_A 173 CFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVET----GKY---- 239 (486)
T ss_dssp TBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHH----TCC----
T ss_pred ECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHh----CCC----
Confidence 23468999999999875 59999999999999999999999997643211 1111100 000
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
.............+.+++..||+.+|.+|||+.++++ .+++.
T Consensus 240 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 240 --AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp --CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred --CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 0000001123456788999999999999999999998 35544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.34 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=199.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-----CeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK-----GEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 419 (645)
.++|...+.||+|+||.||+|....++..||||++... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46889999999999999999999988999999998753 23356788999999999999999999988764 678
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc--
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT-- 497 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~-- 497 (645)
++||||+. ++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|+.|...
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999996 6999998763 28999999999999999999999 9999999999999999999999987321
Q ss_pred --------------------ccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH
Q 041096 498 --------------------LTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW 556 (645)
Q Consensus 498 --------------------~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~ 556 (645)
...||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~- 239 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII- 239 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-
Confidence 1257899999998764 778999999999999999999999998654321111111100
Q ss_pred hhhc-cC--------chhHHhhhhcc-CCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCC
Q 041096 557 GLYA-EG--------RIIEAADKRLN-GAF-----NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPL 616 (645)
Q Consensus 557 ~~~~-~~--------~~~~~~d~~l~-~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~ 616 (645)
.... .. ...+....... ... .......+.+++..||+.||++|||++++++ .++....+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 0000 00 00111100000 000 0123456788999999999999999999998 566554433
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.30 Aligned_cols=241 Identities=21% Similarity=0.267 Sum_probs=190.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---------chhHhHHHHHHHHhhcCCCCeeeeeeeeeeC
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---------EGKTEFLAELSIIACLRHKNLVQLLGWCAEK 416 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 416 (645)
..++|...+.||+|+||.||+|....++..||||.+.... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467899999999999999999999999999999886522 2234688999999999999999999998765
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC---eeee
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN---ARLE 493 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~---~kl~ 493 (645)
+ .++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +|+.
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 4 899999999999999997543 38999999999999999999999 99999999999999987665 8887
Q ss_pred cccc-----------ccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh
Q 041096 494 SSFT-----------LTAGTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY 559 (645)
Q Consensus 494 d~~~-----------~~~gt~~y~APE~~~---~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~ 559 (645)
|... ...||+.|+|||++. ...++.++|||||||++|||++|+.||......... ...+....
T Consensus 160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~ 236 (322)
T 2ycf_A 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITSGK 236 (322)
T ss_dssp CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH---HHHHHHTC
T ss_pred cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH---HHHHHhCc
Confidence 7321 235899999999974 567899999999999999999999999764432211 11110000
Q ss_pred ccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 560 AEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 560 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.... +... ......+.+++..||+.||++||++.++++
T Consensus 237 --~~~~----~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 237 --YNFI----PEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --CCCC----HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cccC----chhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0000 0000 112456788999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=323.65 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=192.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeee--------C
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAE--------K 416 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~ 416 (645)
++|+..+.||+|+||.||+|....++..||+|++... ......+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788999999999999999999988999999987653 2234578899999999999999999999887 3
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF 496 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~ 496 (645)
+..++||||++ ++|.+.+..... .+++.++..++.|++.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccC-CCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 46899999996 588888765433 38999999999999999999999 999999999999999999999998732
Q ss_pred ----------------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh
Q 041096 497 ----------------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY 559 (645)
Q Consensus 497 ----------------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~ 559 (645)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.... ...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~ 248 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC-GSI 248 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCC
Confidence 22357899999999876 458999999999999999999999998754322221111111 100
Q ss_pred ccCchhHHhh----hhc----cCCCC-HHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 560 AEGRIIEAAD----KRL----NGAFN-EDE------MKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 560 ~~~~~~~~~d----~~l----~~~~~-~~~------~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
........-. ..+ ..... .+. ...+.+++..||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000000000 000 00000 011 235788999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.00 Aligned_cols=248 Identities=19% Similarity=0.331 Sum_probs=194.4
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 344 RSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 344 ~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
....++|+..+.||+|+||.||+|.... .+|+|.+... ....+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 3345788899999999999999999864 3889987652 334467889999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---- 496 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---- 496 (645)
+||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++ ++.+++.|..
T Consensus 106 iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999997643 238999999999999999999999 9999999999999998 6788887732
Q ss_pred -------------cccccCCcccCcccccC---------CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHH
Q 041096 497 -------------TLTAGTMGYLAPEYLQY---------GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDW 554 (645)
Q Consensus 497 -------------~~~~gt~~y~APE~~~~---------~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~ 554 (645)
....||+.|+|||.+.. ..++.++||||||+++|||++|+.||....... ....
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~ 254 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----IIWQ 254 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH----HHHH
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH
Confidence 12348899999999874 457899999999999999999999997643211 1110
Q ss_pred HHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCCC
Q 041096 555 VWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLV 617 (645)
Q Consensus 555 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~~ 617 (645)
. ..+ ..+.+ ........+.+++..||+.+|++|||++++++.|+.+.....
T Consensus 255 ~----~~~-----~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 255 M----GTG-----MKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp H----HTT-----CCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred h----ccC-----CCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 000 00111 111234567889999999999999999999999998876543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.25 Aligned_cols=244 Identities=14% Similarity=0.043 Sum_probs=177.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhc--CCCCeeeee-------eeee
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACL--RHKNLVQLL-------GWCA 414 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l--~H~niv~l~-------g~~~ 414 (645)
.+|...+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.++..| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45788899999999999999999889999999988743 3345677886555555 699988755 3333
Q ss_pred eC-----------------CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHH------HHHHHHHHHHHHHHhhcCCCC
Q 041096 415 EK-----------------GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHR------LNIVVGLASALTYLHQECEQQ 471 (645)
Q Consensus 415 ~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ 471 (645)
.. ...+|||||++ |+|.+++..... .+.+..+ +.++.||++||+|||+ ++
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS---KG 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH---CC
Confidence 22 34899999998 899999986532 2455666 7888999999999999 99
Q ss_pred eeeCCCCCCcEEEcCCCCeeeecccc---------ccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCC
Q 041096 472 VIHRDIKASNIMLDANFNARLESSFT---------LTAGTMGYLAPEYLQY--GTATEKTDVFSYGVVVLEVACGRRPIE 540 (645)
Q Consensus 472 ivHrDlkp~NIlld~~~~~kl~d~~~---------~~~gt~~y~APE~~~~--~~~t~ksDV~SfGvvl~El~tG~~P~~ 540 (645)
|+||||||+||||+.++.+||+|... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999988321 3467799999999987 679999999999999999999999998
Q ss_pred ccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 541 RETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 541 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
........ .+............+...........+.+++..||+.||++|||+.++++
T Consensus 295 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 295 LVTPGIKG---------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTCTT---------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcCccccc---------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 75322110 00000000000111111111234567888999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=341.46 Aligned_cols=239 Identities=26% Similarity=0.361 Sum_probs=196.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
.++|+..++||+|+||.||+|....++..||||++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35688899999999999999999989999999998652 33467799999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeeeeccc---
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML---DANFNARLESSF--- 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll---d~~~~~kl~d~~--- 496 (645)
|||+.+|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||.|..
T Consensus 105 ~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTCSC----CBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999976543 8999999999999999999999 999999999999999 467889998732
Q ss_pred --------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 --------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....||+.|+|||++.+ .++.++||||+||++|||++|+.||...... .+...+.. +..
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~----~~~---- 244 (484)
T 3nyv_A 178 HFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY----DILKKVEK----GKY---- 244 (484)
T ss_dssp HBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH----CCC----
T ss_pred EcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHc----CCC----
Confidence 23468999999999876 6999999999999999999999999764321 11111110 000
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.............+.+++..||+.+|.+|||++++++
T Consensus 245 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 245 --TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp --CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0000001123456788999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.52 Aligned_cols=270 Identities=20% Similarity=0.226 Sum_probs=202.6
Q ss_pred CHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc------------hhHhHHHHHHHHhhcCCCCe
Q 041096 339 SYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE------------GKTEFLAELSIIACLRHKNL 406 (645)
Q Consensus 339 ~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~------------~~~~~~~Ei~~l~~l~H~ni 406 (645)
...++....++|...+.||+|+||.||+|.... +..||||++..... ..+.+.+|++++++++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 457888899999999999999999999999865 88999998754211 12678999999999999999
Q ss_pred eeeeeeeee-----CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 041096 407 VQLLGWCAE-----KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASN 481 (645)
Q Consensus 407 v~l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N 481 (645)
+++++++.. ....++||||+. |+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI---VISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHH
Confidence 999999844 346899999997 789888875432 48999999999999999999999 999999999999
Q ss_pred EEEcCCCCeeeeccc-----------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchh
Q 041096 482 IMLDANFNARLESSF-----------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMV 549 (645)
Q Consensus 482 Illd~~~~~kl~d~~-----------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~ 549 (645)
||++.++.+||.|.. ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..........
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp EEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999998732 22468899999999887 678999999999999999999999998654322222
Q ss_pred hHHHHHHhh-------hccCchhHHhhhhccCC-------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCC
Q 041096 550 NLVDWVWGL-------YAEGRIIEAADKRLNGA-------FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEA 613 (645)
Q Consensus 550 ~l~~~~~~~-------~~~~~~~~~~d~~l~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~ 613 (645)
.+....... .......+.....+... ........+.+++..||+.||++|||++++++ .+++..
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 221111000 00000111111111100 01122456888999999999999999999997 456554
Q ss_pred CCC
Q 041096 614 EPL 616 (645)
Q Consensus 614 ~~~ 616 (645)
++.
T Consensus 325 ~~~ 327 (362)
T 3pg1_A 325 DPL 327 (362)
T ss_dssp CGG
T ss_pred Ccc
Confidence 433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=319.51 Aligned_cols=260 Identities=18% Similarity=0.221 Sum_probs=199.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-----Ce
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK-----GE 418 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 418 (645)
..++|+..+.||+|+||.||+|....++..||||++... ....+.+.+|++++.+++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 356899999999999999999999989999999998753 33347789999999999999999999998754 46
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-- 496 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-- 496 (645)
.++||||+. |+|.+++.... +++.++..++.|++.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~~-----~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQH-----LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999996 69999997532 8999999999999999999999 999999999999999999999998722
Q ss_pred -------------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh----
Q 041096 497 -------------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL---- 558 (645)
Q Consensus 497 -------------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~---- 558 (645)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.......
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 22378999999998754 458999999999999999999999997754433222222110000
Q ss_pred ---hccCchhHHhhhhc-cCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCC
Q 041096 559 ---YAEGRIIEAADKRL-NGAFN-----EDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAE 614 (645)
Q Consensus 559 ---~~~~~~~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~ 614 (645)
.............. ....+ ......+.+++..||+.||++|||++|+++ .+++...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 00000000000000 00011 122356788999999999999999999997 4555433
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=326.68 Aligned_cols=242 Identities=18% Similarity=0.161 Sum_probs=195.1
Q ss_pred HHhcCCCcCceeccCCceEEEEEE-----ECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC---CCCeeeeeeeeeeC
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAY-----FASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR---HKNLVQLLGWCAEK 416 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~-----~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 416 (645)
...++|...++||+|+||.||+|. ...++..||||++... ...++..|++++..++ |+||+++++++...
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 345778999999999999999994 4566889999998763 3557888888888887 99999999999999
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---------
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSE-NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA--------- 486 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~--------- 486 (645)
+..+|||||+++|+|.+++..... ....+++..++.++.||++||+|||+ .+|+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999975432 23459999999999999999999999 99999999999999998
Q ss_pred --CCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhh
Q 041096 487 --NFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVN 550 (645)
Q Consensus 487 --~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~ 550 (645)
++.+||+|.. ...+||++|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-- 294 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-- 294 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence 8999998832 2235899999999999999999999999999999999999999654322110
Q ss_pred HHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHcCCC
Q 041096 551 LVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSAR-PSMRRVFQILNNEA 613 (645)
Q Consensus 551 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~~vl~~L~~~~ 613 (645)
+...+.... ..+.+.+++..|++.+|.+| |+++++.+.|++..
T Consensus 295 -----------------~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 295 -----------------PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp -----------------ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred -----------------echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 001111111 13455667788999999998 67888888777543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.51 Aligned_cols=255 Identities=21% Similarity=0.224 Sum_probs=194.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC------
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG------ 417 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 417 (645)
.++|...+.||+|+||.||+|....++..||||++... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46788999999999999999999989999999998653 234567889999999999999999999987654
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF- 496 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~- 496 (645)
..++||||++ ++|.+++.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999996 578888852 28899999999999999999999 999999999999999999999998832
Q ss_pred ----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHH-------HH---
Q 041096 497 ----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDW-------VW--- 556 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~-------~~--- 556 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+... .+
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 2346899999999999999999999999999999999999999765432111111100 00
Q ss_pred -----hhhc------cCchhHHhhhhccCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcC
Q 041096 557 -----GLYA------EGRIIEAADKRLNGAF---NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNN 611 (645)
Q Consensus 557 -----~~~~------~~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~ 611 (645)
.... .....+.....+.... .......+.+++..||+.||++|||++|+++ .++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0000 0000000000000000 1223567899999999999999999999988 4554
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=334.64 Aligned_cols=248 Identities=18% Similarity=0.192 Sum_probs=198.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCC-CCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRH-KNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.++|+..++||+|+||.||+|.+..++..||||++.... ...++..|++++..++| +++..+..++.+.+..+|||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 467999999999999999999998889999999876533 23468899999999987 5666666677778899999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeeeeccc------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML---DANFNARLESSF------ 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll---d~~~~~kl~d~~------ 496 (645)
+ +++|.+++..... .+++.+++.|+.||+.||+|||+ .+|+||||||+|||| +.++.+||.|..
T Consensus 85 ~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred C-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9 9999999975433 39999999999999999999999 999999999999999 688899998721
Q ss_pred -------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc
Q 041096 497 -------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR 563 (645)
Q Consensus 497 -------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 563 (645)
....||..|+|||.+.+..++.++|||||||+||||++|+.||...........+........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-ATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-HSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-ccc
Confidence 134689999999999999999999999999999999999999987544322221111111000 000
Q ss_pred hhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 564 IIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 564 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+. .+.. ..+..+.+++..||+.+|++||++.+|++.|+.+
T Consensus 237 ~~-----~l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 237 IE-----ALCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HH-----HHHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HH-----HHhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 00 1111 2245788999999999999999999999988765
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=333.25 Aligned_cols=181 Identities=24% Similarity=0.379 Sum_probs=148.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-----Ce
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK-----GE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 418 (645)
.++|+..++||+|+||+||+|....++..||||++... ....+.+.+|++++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36789999999999999999999989999999988653 23456789999999999999999999998443 57
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-- 496 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-- 496 (645)
.|+||||+ +++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccc
Confidence 99999998 679999997543 38999999999999999999999 999999999999999999999998732
Q ss_pred -------------------------------------cccccCCcccCcccc-cCCCCCcchhHHHHHHHHHHHHcC
Q 041096 497 -------------------------------------TLTAGTMGYLAPEYL-QYGTATEKTDVFSYGVVVLEVACG 535 (645)
Q Consensus 497 -------------------------------------~~~~gt~~y~APE~~-~~~~~t~ksDV~SfGvvl~El~tG 535 (645)
...+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 123579999999986 456799999999999999999993
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=321.17 Aligned_cols=259 Identities=20% Similarity=0.217 Sum_probs=200.6
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-CC-----CeeeeeeeeeeCCe
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HK-----NLVQLLGWCAEKGE 418 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~~~~~~ 418 (645)
...++|+..+.||+|+||+||+|....++..||||++........++..|+.++..++ |+ +|+++++++...+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3467899999999999999999999989999999999876666677888999998885 54 49999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc--CCCCeeeeccc
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD--ANFNARLESSF 496 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld--~~~~~kl~d~~ 496 (645)
.+|||||+. ++|.+++..... ..+++..+..++.|++.||+|||+. ..+|+||||||+||||+ .++.+||.|..
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999995 699999986542 2389999999999999999999941 27899999999999994 47778998732
Q ss_pred ---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh----hhcc-C
Q 041096 497 ---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG----LYAE-G 562 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~----~~~~-~ 562 (645)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...... .... .
T Consensus 207 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (382)
T 2vx3_A 207 SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP 286 (382)
T ss_dssp TCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred CceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence 3357899999999999999999999999999999999999999865432222222111000 0000 0
Q ss_pred chhHHhhhh----------------------------c-------------cCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 041096 563 RIIEAADKR----------------------------L-------------NGAFNEDEMKRLLLVGLSCANPDSSARPS 601 (645)
Q Consensus 563 ~~~~~~d~~----------------------------l-------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 601 (645)
...+.++.. + .......+...+.+++..||+.||++|||
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt 366 (382)
T 2vx3_A 287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ 366 (382)
T ss_dssp THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence 000000000 0 00122344567899999999999999999
Q ss_pred HHHHHH
Q 041096 602 MRRVFQ 607 (645)
Q Consensus 602 ~~~vl~ 607 (645)
++|+++
T Consensus 367 a~e~L~ 372 (382)
T 2vx3_A 367 PYYALQ 372 (382)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.75 Aligned_cols=259 Identities=20% Similarity=0.261 Sum_probs=189.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC------C
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK------G 417 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 417 (645)
.++|...+.||+|+||.||+|....++..||||++... ....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36788899999999999999999999999999998653 23456788999999999999999999998654 5
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF- 496 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~- 496 (645)
..++|+||+ +++|.+++... .+++..+..++.||++||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 689999999 78999988652 38999999999999999999999 999999999999999999999998732
Q ss_pred --------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh-------hhc
Q 041096 497 --------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG-------LYA 560 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~-------~~~ 560 (645)
....||..|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+...... ...
T Consensus 179 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 179 ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred cccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 33478999999999887 67899999999999999999999999765432221111111000 000
Q ss_pred cCchhHHhhhhcc--CCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCC
Q 041096 561 EGRIIEAADKRLN--GAFN-----EDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEP 615 (645)
Q Consensus 561 ~~~~~~~~d~~l~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~ 615 (645)
.......+. .+. .... ......+.+++..||+.||++|||++++++ .+++...+
T Consensus 259 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 259 SESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp CHHHHHHHH-TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred hHHHHHHHh-ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence 000001110 010 0001 112356788999999999999999999987 45554443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=328.05 Aligned_cols=186 Identities=23% Similarity=0.353 Sum_probs=162.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-----Ce
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEK-----GE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 418 (645)
.++|...+.||+|+||.||+|....++..||||++... ....+.+.+|++++++++|+||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999999999999999998763 23456789999999999999999999999776 57
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-- 496 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-- 496 (645)
.|+||||+. ++|.+++.... .+++..+..++.||++||+|||+ .+|+||||||+||||+.++.+||+|..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 999999995 69999997543 38999999999999999999999 999999999999999999999998721
Q ss_pred --------------------------------cccccCCcccCcccc-cCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 041096 497 --------------------------------TLTAGTMGYLAPEYL-QYGTATEKTDVFSYGVVVLEVACGRRPIE 540 (645)
Q Consensus 497 --------------------------------~~~~gt~~y~APE~~-~~~~~t~ksDV~SfGvvl~El~tG~~P~~ 540 (645)
...+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 345689999999986 55679999999999999999998655554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=314.70 Aligned_cols=232 Identities=14% Similarity=0.123 Sum_probs=186.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||+|....+++.||||++.... ...+.+.+|+.++.+++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57888999999999999999999889999999987642 23477999999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccccccCC
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAGTM 503 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~~~gt~ 503 (645)
||+++++|.+++... ....+..+++.|++.||+|||+ ++|+||||||+||||+.++.+|++ +.
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~--------~~ 173 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLA--------YP 173 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEEC--------SC
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEE--------ec
Confidence 999999999999532 3455788999999999999999 999999999999999999999985 45
Q ss_pred cccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHH
Q 041096 504 GYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKR 583 (645)
Q Consensus 504 ~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 583 (645)
+|++| ++.++|||||||++|||++|+.||.............. .. .+.... ...+ ..+.+..
T Consensus 174 ~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~----~~-~~~~~~--~~~~----~~~~~~~ 235 (286)
T 3uqc_A 174 ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER----DT-AGQPIE--PADI----DRDIPFQ 235 (286)
T ss_dssp CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB----CT-TSCBCC--HHHH----CTTSCHH
T ss_pred cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH----Hh-ccCCCC--hhhc----ccCCCHH
Confidence 66664 78999999999999999999999987543221100000 00 000000 0001 1123456
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 584 LLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 584 l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
+.+++..||+.||++| |+.++++.|+.....
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred HHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 8889999999999999 999999999875443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=335.11 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=190.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC------CeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEK------GELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 421 (645)
.+|...++||+|+||.||+|++..++..||||++.... ..+.+|++++++++|+||++++++|... ..+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 35778899999999999999999889999999886532 2345799999999999999999988542 24679
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeeeeccc----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN-FNARLESSF---- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~-~~~kl~d~~---- 496 (645)
||||+++ +|.+.+.........+++..+..++.||++||+|||+ .+|+||||||+||||+.+ +..||.|..
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999975 6777665433333459999999999999999999998 999999999999999966 456898732
Q ss_pred -------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch--hH
Q 041096 497 -------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI--IE 566 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~--~~ 566 (645)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....++. ....... ..
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~----~lg~p~~~~~~ 282 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIR 282 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----HHCSCCHHHHH
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----HhCCCCHHHHH
Confidence 234689999999999764 789999999999999999999999987543222222211 1110000 00
Q ss_pred Hhhhhcc--------C-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 567 AADKRLN--------G-----AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 567 ~~d~~l~--------~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
.+.+... . .++......+.+++..||+.||.+|||+.|+++ ++++.
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0111100 0 011223467889999999999999999999986 45543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=348.75 Aligned_cols=237 Identities=24% Similarity=0.333 Sum_probs=200.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 420 (645)
..++|+..++||+|+||.||+|....+++.||||++... ....+.+..|..++..+ +|+||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 356899999999999999999999999999999998752 23456788899999988 7999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---- 496 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---- 496 (645)
|||||+++|+|..++..... +++.++..++.||+.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 419 lV~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999987543 8999999999999999999999 999999999999999999999998732
Q ss_pred --------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 --------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
...+||+.|+|||++.+..++.++|||||||+||||++|+.||...+... +... ++
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~----~~~~------------i~ 555 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQS------------IM 555 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH------------HH
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH----HHHH------------HH
Confidence 23468999999999999999999999999999999999999998643211 1111 11
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSM-----RRVFQ 607 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~~vl~ 607 (645)
... ..++......+.+++..||+.||++||++ +||++
T Consensus 556 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 556 EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred hCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111 12344455678889999999999999997 77764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.28 Aligned_cols=256 Identities=19% Similarity=0.218 Sum_probs=189.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeee-----------
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCA----------- 414 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----------- 414 (645)
.++|...+.||+|+||.||+|....++..||+|++... ....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 35788899999999999999999988999999988764 344678999999999999999999998873
Q ss_pred ---eCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-CCCCe
Q 041096 415 ---EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD-ANFNA 490 (645)
Q Consensus 415 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld-~~~~~ 490 (645)
+.+..++||||++ |+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence 4468899999997 6999999642 38999999999999999999999 9999999999999997 56688
Q ss_pred eeeccc---------------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHH
Q 041096 491 RLESSF---------------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDW 554 (645)
Q Consensus 491 kl~d~~---------------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~ 554 (645)
|+.|.. ....+|..|+|||.+.. ..++.++|||||||++|||++|+.||...........+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 987732 12346888999998865 67899999999999999999999999865432211111110
Q ss_pred HHhhhccCchh-------HHhhhhcc-CCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 555 VWGLYAEGRII-------EAADKRLN-GAF-----NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 555 ~~~~~~~~~~~-------~~~d~~l~-~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
. ......... ..+..... ... .......+.+++..||+.||++|||++++++ .++..
T Consensus 241 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 241 I-PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp S-CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred c-CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 0 000000000 00011110 000 1123467889999999999999999999987 56543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=315.98 Aligned_cols=254 Identities=19% Similarity=0.238 Sum_probs=198.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCC-eEEEEEeccCCcchhHhHHHHHHHHhhcCCCC------eeeeeeeeeeCCeE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSG-SVAAVKRSKHSHEGKTEFLAELSIIACLRHKN------LVQLLGWCAEKGEL 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~-~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~~ 419 (645)
.++|+..+.||+|+||.||+|....++ ..||+|++.......+.+.+|+.++++++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 468999999999999999999987665 79999999876666778999999999998766 99999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---------------
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML--------------- 484 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll--------------- 484 (645)
++||||+ +++|.+++..... ..+++.++..++.||+.||+|||+ .+|+||||||+||||
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence 9999999 7778787765432 248999999999999999999998 999999999999999
Q ss_pred ----cCCCCeeeeccc---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhH
Q 041096 485 ----DANFNARLESSF---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNL 551 (645)
Q Consensus 485 ----d~~~~~kl~d~~---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l 551 (645)
+.++.+||.|.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 567888887732 3347899999999999999999999999999999999999999865432211111
Q ss_pred HHHHHhhhcc--------C--------------chhHHhhhhc-----cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 041096 552 VDWVWGLYAE--------G--------------RIIEAADKRL-----NGAFNEDEMKRLLLVGLSCANPDSSARPSMRR 604 (645)
Q Consensus 552 ~~~~~~~~~~--------~--------------~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~ 604 (645)
.. ....... . .......... .......+...+.+++..||+.||++|||++|
T Consensus 252 ~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 330 (355)
T 2eu9_A 252 EK-ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330 (355)
T ss_dssp HH-HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HH-HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence 11 1000000 0 0000000000 01122345668899999999999999999999
Q ss_pred HHH
Q 041096 605 VFQ 607 (645)
Q Consensus 605 vl~ 607 (645)
+++
T Consensus 331 ~l~ 333 (355)
T 2eu9_A 331 ALL 333 (355)
T ss_dssp HTT
T ss_pred Hhc
Confidence 985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.26 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=197.9
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEC-CCCeEEEEEeccCC---cchhHhHHHHHHHHhhc---CCCCeeeeeeeee---
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFA-SSGSVAAVKRSKHS---HEGKTEFLAELSIIACL---RHKNLVQLLGWCA--- 414 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~-~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~--- 414 (645)
.+.++|+..+.||+|+||.||+|... .++..||+|++... ......+.+|+.+++.+ +||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 35678999999999999999999984 67899999987642 22234677888887776 8999999999987
Q ss_pred --eCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeee
Q 041096 415 --EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL 492 (645)
Q Consensus 415 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl 492 (645)
.....++||||+. |+|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+|+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence 4567899999997 699999976543 238999999999999999999999 99999999999999999999999
Q ss_pred eccc-----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhcc
Q 041096 493 ESSF-----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE 561 (645)
Q Consensus 493 ~d~~-----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~ 561 (645)
.|.. ....||..|+|||.+.+..++.++|||||||++|||++|+.||...........+.+.. .....
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~ 240 (326)
T 1blx_A 162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI-GLPGE 240 (326)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCG
T ss_pred ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc-CCCCc
Confidence 8732 23467999999999999999999999999999999999999998654322211111110 00000
Q ss_pred Cchh-------HHhhh---hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 562 GRII-------EAADK---RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 562 ~~~~-------~~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
.... ..... .....+.......+.+++..||+.||++|||+.++++ .+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0000 00000 0000112234566788999999999999999999995 35443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=347.32 Aligned_cols=244 Identities=22% Similarity=0.348 Sum_probs=199.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC---CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFAS---SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~---~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
..++|+..+.||+|+||.||+|.+.. .+..||+|.+... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 34678888999999999999999854 3567999988763 3345779999999999999999999999854 5689
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecccc---
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFT--- 497 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~--- 497 (645)
+||||+++|+|.+++..... .+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||.|...
T Consensus 467 lv~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTT---TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 99999999999999976532 38999999999999999999999 9999999999999999999999988321
Q ss_pred ----------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 498 ----------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 498 ----------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
...+|+.|+|||.+.+..++.++|||||||++|||++ |..||....... ...
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~~~------------- 603 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIG------------- 603 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHH-------------
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH----HHH-------------
Confidence 1245678999999999999999999999999999997 999997643211 111
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
.+........+...+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 604 ~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 604 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111122334455677889999999999999999999999998653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=309.35 Aligned_cols=241 Identities=23% Similarity=0.321 Sum_probs=195.0
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
...++|+..+.||+|+||.||+|....++..||+|++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 3456899999999999999999999888999999997652 3346779999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---Ceeeeccc--
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF---NARLESSF-- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~---~~kl~d~~-- 496 (645)
|+||+++++|.+++..... +++.+++.++.|++.||+|||+ .+++||||||+||+++.++ .+|+.|..
T Consensus 99 v~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999876543 8999999999999999999999 9999999999999997643 58887732
Q ss_pred ---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHH
Q 041096 497 ---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... .+...+ ..+...
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~----~~~~~~-- 240 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILKRV----ETGKYA-- 240 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----HHCCCC--
T ss_pred eeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH----HHHHHH----HcCCCC--
Confidence 12347889999998875 4899999999999999999999999764321 111111 000000
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
............+.+++..||+.||++|||+.++++
T Consensus 241 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 ----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ----CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000000123456788999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=319.82 Aligned_cols=255 Identities=18% Similarity=0.230 Sum_probs=197.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeE----
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGEL---- 419 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~---- 419 (645)
.++|...+.||+|+||.||+|....++..||||++... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46788899999999999999999999999999998763 22356788999999999999999999999877654
Q ss_pred --EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-
Q 041096 420 --LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF- 496 (645)
Q Consensus 420 --~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~- 496 (645)
++||||+. ++|.+++.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||.|..
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 688888732 28999999999999999999999 999999999999999999999998832
Q ss_pred --------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH-------hhhc
Q 041096 497 --------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW-------GLYA 560 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~-------~~~~ 560 (645)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+..... ....
T Consensus 191 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 191 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp C--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred ccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 33468999999999987 6789999999999999999999999986543222211111100 0000
Q ss_pred cCchhHHhhhhccCC-------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 561 EGRIIEAADKRLNGA-------FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 561 ~~~~~~~~d~~l~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
........ ..+... ........+.+++..||+.||++|||++|+++ .++..
T Consensus 271 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 271 DKAAKSYI-QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CHHHHHHH-HHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhh-hccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 00000000 001000 01122467889999999999999999999987 35543
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=299.01 Aligned_cols=192 Identities=18% Similarity=0.215 Sum_probs=151.7
Q ss_pred CCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCC-CCCCCceEEEEecC
Q 041096 34 LRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNP-SSFGDGLAFFISPD 112 (645)
Q Consensus 34 ~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~-~~~g~G~aF~l~p~ 112 (645)
..++.++|+|.+.+|.|+||++ ..++.||+||+.|+++ +||+|+|+|+|.+++. ..+||||||+|+|.
T Consensus 24 i~~~~l~G~a~i~~g~l~LT~~---~~~~~G~~w~~~pi~~--------~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~ 92 (253)
T 2dur_A 24 MPLWDFQGSTILTSQYVRLTPD---ERSKEGSIWNHQPCFL--------KDWEMHVHFKVHGTGKKNLHGDGIALWYTRD 92 (253)
T ss_dssp CCSEEEEETCEECSSCEEEECS---SSSEEEEEEESSCBCC--------SSEEEEEEEEEECCCCTTCCCCEEEEEEESC
T ss_pred cCCEEEccceEEECCEEEECCC---CCCCEEEEEeCCCCcc--------CcEEEEEEEEEecCCCCCcCCCcEEEEEECC
Confidence 3699999999999999999997 4578999999999997 5899999999998765 57899999999997
Q ss_pred CCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCc-----------ccccc-C
Q 041096 113 NQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPIL-----------QGIDL-K 180 (645)
Q Consensus 113 ~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~-----------~~~~~-~ 180 (645)
... .|++||+.+ .++.|||||||+.|.++.| |++++|+++.+..+..+.. ...++ +
T Consensus 93 ~~~---~G~~lG~~~-----~~~gvAVefDT~~n~~~~~----~~~~~I~~~~n~gs~~~d~~~dg~~~~~~~c~~~~~n 160 (253)
T 2dur_A 93 RLV---PGPVFGSKD-----NFHGLAIFLDTYPNDETTE----RVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADFRN 160 (253)
T ss_dssp CSC---EETBTEECS-----SCEEEEEEEECSCCCTTCC----SCSSEEEEEEEESCCCCCGGGTTGGGCCEEEECCCBT
T ss_pred CCC---CCcccCcCC-----CCCEEEEEEECCCCCCCCC----CCCcEEEEEecCCceeeeccCCCcccccccccHhhcc
Confidence 653 579999733 3688999999999976533 5555555555544333310 01133 3
Q ss_pred CCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeeeeeec
Q 041096 181 SGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTS 253 (645)
Q Consensus 181 ~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~~~ 253 (645)
.|..++|||+|++. +|+|.+++.+..+..++++ ++ ...||+++||||||+||...+.|+|++|+|.+-
T Consensus 161 ~g~~~~v~I~Y~~~--~L~V~l~~~~~~~~~~~~~--~~-~v~Lp~~~yvGfSAaTG~~~~~h~Ilswsf~sl 228 (253)
T 2dur_A 161 RDHDTFLAVRYSRG--RLTVMTDLEDKNEWKNCID--IT-GVRLPTGYYFGASAGTGDLSDNHDIISMKLFQL 228 (253)
T ss_dssp CSSCEEEEEEEETT--EEEEEEECSSSSCCEEEEE--EC-CEECCSSBEEEEEEEESSSCCEEEEEEEEEEEC
T ss_pred CCCCeEEEEEEECC--EEEEEEeCCCCCCceEEEE--eC-CcccCCCcEEEEEeccCCCcceEEEEEEEEEec
Confidence 48899999999975 8999999765445555654 34 446899999999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.41 Aligned_cols=254 Identities=19% Similarity=0.240 Sum_probs=174.8
Q ss_pred HhcCCCcC-ceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeee----CCeEE
Q 041096 346 ATRGFHSN-RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE----KGELL 420 (645)
Q Consensus 346 ~~~~f~~~-~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 420 (645)
..++|... ++||+|+||.||+|....+++.||||++.......+ +....+..++||||+++++++.. ....+
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 35678884 469999999999999998999999999876432222 22334566799999999999876 44689
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC---CCeeeeccc-
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN---FNARLESSF- 496 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~---~~~kl~d~~- 496 (645)
+||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.+ +.+||.|..
T Consensus 103 lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999986542 348999999999999999999999 999999999999999864 448887732
Q ss_pred ---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHH
Q 041096 497 ---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEA 567 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 567 (645)
....||+.|+|||++....++.++||||||+++|||++|+.||............... ...
T Consensus 178 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~ 247 (336)
T 3fhr_A 178 AKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR----------IRL 247 (336)
T ss_dssp CEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred ceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh----------hhc
Confidence 2346799999999998888999999999999999999999999764332111100000 000
Q ss_pred hhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCCC
Q 041096 568 ADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPLV 617 (645)
Q Consensus 568 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~~ 617 (645)
....+...........+.+++..||+.||.+|||++++++ .+.+....+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 299 (336)
T 3fhr_A 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCC
T ss_pred cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCC
Confidence 0001111111234556788999999999999999999998 6665544433
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.16 Aligned_cols=239 Identities=23% Similarity=0.374 Sum_probs=188.3
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-------chhHhHHHHHHHHhhc----CCCCeeeeeeee
Q 041096 345 SATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-------EGKTEFLAELSIIACL----RHKNLVQLLGWC 413 (645)
Q Consensus 345 ~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-------~~~~~~~~Ei~~l~~l----~H~niv~l~g~~ 413 (645)
...++|+..+.||+|+||.||+|....++..||||++.... .....+.+|+.++.++ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 44578999999999999999999998889999999986532 2334577899999999 899999999999
Q ss_pred eeCCeEEEEEec-CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-CCCCee
Q 041096 414 AEKGELLLVYEY-MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD-ANFNAR 491 (645)
Q Consensus 414 ~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld-~~~~~k 491 (645)
...+..++|+|| +.+++|.+++..... +++..++.++.|+++||+|||+ .+|+||||||+||+++ .++.++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGP----LGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEE
Confidence 999999999999 789999999986543 8999999999999999999999 8999999999999999 788899
Q ss_pred eeccc----------cccccCCcccCcccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhc
Q 041096 492 LESSF----------TLTAGTMGYLAPEYLQYGTAT-EKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA 560 (645)
Q Consensus 492 l~d~~----------~~~~gt~~y~APE~~~~~~~t-~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~ 560 (645)
+.|.. ....||..|+|||++.+..+. .++||||||+++|||++|+.||..... .
T Consensus 181 l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~--------- 245 (312)
T 2iwi_A 181 LIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------I--------- 245 (312)
T ss_dssp ECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H---------
T ss_pred EEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------H---------
Confidence 98732 234689999999999877664 599999999999999999999965311 0
Q ss_pred cCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCC
Q 041096 561 EGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAE 614 (645)
Q Consensus 561 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~ 614 (645)
.... ..++......+.+++..||+.+|++|||++++++ .++...+
T Consensus 246 -------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 246 -------LEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp -------HHTC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred -------hhhc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 0011 1122334556788999999999999999999998 4544433
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=317.65 Aligned_cols=247 Identities=18% Similarity=0.293 Sum_probs=194.9
Q ss_pred cccCHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcC--CCCeeeee
Q 041096 336 REFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLR--HKNLVQLL 410 (645)
Q Consensus 336 ~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~--H~niv~l~ 410 (645)
+.+.++.+....++|+..+.||+|+||.||++.... +..||||.+... ....+.+.+|++++.+++ |+||++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 344444455556789999999999999999999865 888999988653 334567899999999997 59999999
Q ss_pred eeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 411 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
+++.+.+..++||| +.+++|.+++.... .+++.+++.++.|+++||+|||+ .+++||||||+|||++. +.+
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~ 165 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GML 165 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEE
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeE
Confidence 99999999999999 56899999998654 38999999999999999999999 99999999999999964 788
Q ss_pred eeeccc--------------cccccCCcccCcccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCccccc
Q 041096 491 RLESSF--------------TLTAGTMGYLAPEYLQY-----------GTATEKTDVFSYGVVVLEVACGRRPIERETEG 545 (645)
Q Consensus 491 kl~d~~--------------~~~~gt~~y~APE~~~~-----------~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~ 545 (645)
|+.|.. ....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (313)
T 3cek_A 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245 (313)
T ss_dssp EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence 987732 12358999999999875 46889999999999999999999999754221
Q ss_pred cchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 546 HKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 546 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
. . .+...+++.....++......+.+++..||+.||.+||+++++++
T Consensus 246 ~------~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 246 I------S---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp H------H---------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H------H---------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 0 0 011222222222333333567888999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.03 Aligned_cols=245 Identities=26% Similarity=0.364 Sum_probs=175.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHH-HHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELS-IIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
.++|...+.||+|+||.||+|....++..||||++... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 36788889999999999999999988999999998763 233445666666 677789999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 424 EYMPNGSLDRMLYQDS-ENGVLLSWYHRLNIVVGLASALTYLHQECEQ-QVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||++ ++|.+++.... .....+++..+..++.|++.||.|||+ . +++||||||+|||++.++.+||+|..
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9997 48888776321 112348999999999999999999999 7 99999999999999999999998732
Q ss_pred ------cccccCCcccCcccc----cCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 ------TLTAGTMGYLAPEYL----QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~----~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....||+.|+|||.+ .+..++.++||||||+++|||++|+.||....... +..... ..
T Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~------~~ 244 (327)
T 3aln_A 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF------DQLTQV------VK 244 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCC------CC
T ss_pred ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH------HHHHHH------hc
Confidence 123689999999998 45678999999999999999999999997532210 000000 00
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...+.+...........+.+++..||+.||++|||++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00011111111234567888999999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=318.30 Aligned_cols=252 Identities=19% Similarity=0.278 Sum_probs=194.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcch------------------hHhHHHHHHHHhhcCCCCeee
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEG------------------KTEFLAELSIIACLRHKNLVQ 408 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~------------------~~~~~~Ei~~l~~l~H~niv~ 408 (645)
.++|...+.||+|+||.||+|.. ++..||+|++...... .+.+.+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46889999999999999999998 6899999987652111 178999999999999999999
Q ss_pred eeeeeeeCCeEEEEEecCCCCCHhHH------hhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 041096 409 LLGWCAEKGELLLVYEYMPNGSLDRM------LYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNI 482 (645)
Q Consensus 409 l~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NI 482 (645)
+++++.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||+|||+ ..+++||||||+||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhE
Confidence 99999999999999999999999999 54321 3459999999999999999999996 37999999999999
Q ss_pred EEcCCCCeeeeccc----------cccccCCcccCcccccCC-CCCc-chhHHHHHHHHHHHHcCCCCCCccccccchhh
Q 041096 483 MLDANFNARLESSF----------TLTAGTMGYLAPEYLQYG-TATE-KTDVFSYGVVVLEVACGRRPIERETEGHKMVN 550 (645)
Q Consensus 483 lld~~~~~kl~d~~----------~~~~gt~~y~APE~~~~~-~~t~-ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~ 550 (645)
|++.++.++++|.. ....||..|+|||.+.+. .++. ++||||||+++|||++|+.||....... .
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~ 260 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV---E 260 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH---H
T ss_pred EEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH---H
Confidence 99999999998732 234689999999999887 6666 9999999999999999999997654311 1
Q ss_pred HHHHHHhhhcc-C----chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 551 LVDWVWGLYAE-G----RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 551 l~~~~~~~~~~-~----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+...+...... . .......+.............+.+++..||+.||.+|||++++++
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111110000 0 000000000000011234567888999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.11 Aligned_cols=231 Identities=22% Similarity=0.365 Sum_probs=193.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-------chhHhHHHHHHHHhhcC--CCCeeeeeeeeeeC
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-------EGKTEFLAELSIIACLR--HKNLVQLLGWCAEK 416 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~ 416 (645)
..++|+..+.||+|+||.||+|....++..||||++.... ...+.+.+|+.++++++ |+||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4567999999999999999999998899999999886532 12356788999999996 59999999999999
Q ss_pred CeEEEEEecCCC-CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-CCCCeeeec
Q 041096 417 GELLLVYEYMPN-GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD-ANFNARLES 494 (645)
Q Consensus 417 ~~~~lV~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld-~~~~~kl~d 494 (645)
+..++|+||+.+ ++|.+++..... +++..++.++.|+++||+|||+ .+|+||||||+|||++ .++.+||.|
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECC
T ss_pred CcEEEEEEcCCCCccHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 999999999976 899999986543 8999999999999999999999 9999999999999999 778899987
Q ss_pred cc----------cccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc
Q 041096 495 SF----------TLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR 563 (645)
Q Consensus 495 ~~----------~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 563 (645)
.. ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ..
T Consensus 194 fg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~----------- 256 (320)
T 3a99_A 194 FGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II----------- 256 (320)
T ss_dssp CTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH-----------
T ss_pred CccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hh-----------
Confidence 32 23468999999999987665 7889999999999999999999965311 00
Q ss_pred hhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 564 IIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 564 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.... .++......+.+++..||+.||++|||++++++
T Consensus 257 -----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 257 -----RGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -----HCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----cccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 112223456788999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.00 Aligned_cols=256 Identities=22% Similarity=0.279 Sum_probs=187.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC------eEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG------ELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 421 (645)
.+|...++||+|+||.||+|....++. +|+|++..... ...+|+++++.++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 457888999999999999999987555 77777654322 2347999999999999999999986543 3889
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-CCCCeeeeccc----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD-ANFNARLESSF---- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld-~~~~~kl~d~~---- 496 (645)
||||++++ +...+.........+++..+..++.|+++||+|||+ .+|+||||||+||||+ .++.+||.|..
T Consensus 116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999764 444443322223358999999999999999999999 9999999999999999 78889998732
Q ss_pred -------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 -------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.... ..... .....+
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~-g~p~~-~~~~~~ 269 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL-GTPSR-EQIKTM 269 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-CCCCH-HHHHHH
T ss_pred ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCCH-HHHHhh
Confidence 234678999999998765 58999999999999999999999998754322222222110 00000 000011
Q ss_pred hhhcc-------------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCC
Q 041096 569 DKRLN-------------GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEA 613 (645)
Q Consensus 569 d~~l~-------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~ 613 (645)
.+... ..+.......+.+++..||+.||.+|||+.|+++ .+++..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 11100 0011223457889999999999999999999997 366543
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=266.69 Aligned_cols=114 Identities=39% Similarity=0.568 Sum_probs=106.0
Q ss_pred CcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcce
Q 041096 134 NKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPL 213 (645)
Q Consensus 134 ~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~ 213 (645)
||+|||||||++|.+++||++|||||||||+.|.++.++ ++.+|+.++|||+||+.+++|+|+|++.+.+ .|+
T Consensus 1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~~-----~l~sG~~~~v~I~Yd~~~~~L~V~l~~~~~~--~p~ 73 (133)
T 1qmo_E 1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW-----DWQNGKIATAHISYNSVSKRLSVTSYYAGSK--PAT 73 (133)
T ss_dssp CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-----CCCTTSCEEEEEEEETTTTEEEEEEECSSSC--CEE
T ss_pred CCEEEEEEeCCcCccccCCCCCeeEEecccccccceeee-----EEcCCCEEEEEEEEeCCCcEEEEEEccCCCc--cce
Confidence 578999999999998779999999999999999998875 4789999999999999999999999976543 799
Q ss_pred EEEeecCCccCCCccEEeEEeccCCccceeeeeeeeeeecC
Q 041096 214 LKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTSG 254 (645)
Q Consensus 214 l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~~~~ 254 (645)
|+.++||+++|+++||||||||||...|.|+|++|+|++..
T Consensus 74 ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~l 114 (133)
T 1qmo_E 74 LSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSL 114 (133)
T ss_dssp EEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEE
T ss_pred EEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEeeC
Confidence 99999999999999999999999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.97 Aligned_cols=257 Identities=18% Similarity=0.231 Sum_probs=180.4
Q ss_pred CCc-CceeccCCceEEEEEEEC--CCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeee--CCeEEEEEe
Q 041096 350 FHS-NRILGRGAFGNVYKAYFA--SSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE--KGELLLVYE 424 (645)
Q Consensus 350 f~~-~~~lG~G~fg~Vy~g~~~--~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~E 424 (645)
|.. .++||+|+||.||+|... .++..||||++.... ....+.+|+.++++++||||+++++++.. ....++|||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 444 457999999999999976 457899999987643 34568899999999999999999999954 678999999
Q ss_pred cCCCCCHhHHhhhcC-----CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE----cCCCCeeeecc
Q 041096 425 YMPNGSLDRMLYQDS-----ENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML----DANFNARLESS 495 (645)
Q Consensus 425 y~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll----d~~~~~kl~d~ 495 (645)
|+. ++|.+++.... .....+++..++.++.||+.||+|||+ .+|+||||||+|||| +.++.+||+|.
T Consensus 101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 995 68888876332 112248999999999999999999999 999999999999999 77789999873
Q ss_pred c---------------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccccc-----chhhHHHH
Q 041096 496 F---------------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGH-----KMVNLVDW 554 (645)
Q Consensus 496 ~---------------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~-----~~~~l~~~ 554 (645)
. ...+||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .....+..
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 2 224689999999999874 58999999999999999999999997543210 00111111
Q ss_pred HHhhhc---cCc---------hhHHhhhhcc---CCCC---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--H
Q 041096 555 VWGLYA---EGR---------IIEAADKRLN---GAFN---------EDEMKRLLLVGLSCANPDSSARPSMRRVFQ--I 608 (645)
Q Consensus 555 ~~~~~~---~~~---------~~~~~d~~l~---~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~ 608 (645)
+..... ... .......... .... ......+.+++..||+.||.+|||++|+++ .
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 111110 000 0000000000 0000 011345778999999999999999999998 4
Q ss_pred HcC
Q 041096 609 LNN 611 (645)
Q Consensus 609 L~~ 611 (645)
+.+
T Consensus 337 f~~ 339 (405)
T 3rgf_A 337 FLE 339 (405)
T ss_dssp GTS
T ss_pred hcc
Confidence 543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.09 Aligned_cols=256 Identities=18% Similarity=0.218 Sum_probs=195.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCe-----
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGE----- 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 418 (645)
.++|...+.||+|+||.||+|....++..||||++.... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888999999999999999999999999999987632 235678899999999999999999999987653
Q ss_pred -EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-
Q 041096 419 -LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF- 496 (645)
Q Consensus 419 -~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~- 496 (645)
.++||||+. ++|.+++.. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+|+.|..
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 599999996 688887742 28999999999999999999999 999999999999999999999998732
Q ss_pred --------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHH-------hhhc
Q 041096 497 --------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVW-------GLYA 560 (645)
Q Consensus 497 --------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~-------~~~~ 560 (645)
....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..... ....
T Consensus 173 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 173 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp TTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred ccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 22468999999999887 6789999999999999999999999986543221111111000 0000
Q ss_pred cCchhHHhhh---hcc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 561 EGRIIEAADK---RLN---GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 561 ~~~~~~~~d~---~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
.......+.. ... ..........+.+++..|++.||++|||++++++ .++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0000000000 000 0112234567888999999999999999999986 45543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.53 Aligned_cols=240 Identities=23% Similarity=0.327 Sum_probs=176.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc--h-hHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE--G-KTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
.++|+..+.||+|+||.||+|....++..||||++..... . .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 3568888999999999999999998899999999876432 2 233445556688889999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ-QVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
||+ ++.+..+...... .+++..+..++.|+++||+|||+ . +++||||||+|||++.++.+||.|..
T Consensus 104 e~~-~~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQG---PIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5555555543222 38999999999999999999998 5 99999999999999999999998732
Q ss_pred -----cccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 -----TLTAGTMGYLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~-----~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....||+.|+|||.+. ...++.++||||||+++|||++|+.||....... ...... ....
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~---~~~~---- 246 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF---EVLTKV---LQEE---- 246 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHH---HHSC----
T ss_pred CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH---HHHHHH---hccC----
Confidence 1236899999999994 4568999999999999999999999997532211 111110 0000
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+.+. ........+.+++..||+.||.+||+++++++
T Consensus 247 --~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 --PPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00010 01123456788899999999999999999976
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=291.67 Aligned_cols=203 Identities=17% Similarity=0.183 Sum_probs=156.9
Q ss_pred eeEEeCCCC-----CCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCC
Q 041096 25 MNFDFTSFN-----LRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPS 99 (645)
Q Consensus 25 ~~f~~~~f~-----~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~ 99 (645)
.||..+.+. ..++.++|||.+.++.|+||++ ..++.||+||+.|+++ +||+|+|+|+|.+++ .
T Consensus 34 ~Sf~~P~~~~~~~~i~~w~~~G~a~i~~~~IrLT~~---~~~~~G~~w~~~p~~~--------~sF~t~F~F~I~~~~-~ 101 (260)
T 1gv9_A 34 YSFKGPHLVQSDGTVPFWAHAGNAIPSADQIRIAPS---LKSQRGSVWTKTKAAF--------ENWEVEVTFRVTGRG-R 101 (260)
T ss_dssp GCEECSSCSCTTSCBTTEEEEETCEECSSCEEEECS---STTCEEEEEESSCBCC--------SSEEEEEEEEEECSS-S
T ss_pred eeEcCccccCCCCccCCeEEcccEEeeCCEEEeCCC---CCCCEEEEEECCCccc--------cCEEEEEEEEEecCC-C
Confidence 456555443 3689999999999999999997 4578999999999964 799999999999765 4
Q ss_pred CCCCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCC-CC------CCCeeeeecCC-cccccccC
Q 041096 100 SFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFD-DP------DENHIGLDIDS-LESIKTAD 171 (645)
Q Consensus 100 ~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~-d~------~~~Hvgi~vns-~~s~~~~~ 171 (645)
.+||||||+|+|.... .|+++|+. ..++.|||||||+.|.++. +| +++|+|||+|+ +.|.....
T Consensus 102 ~~gdGlAF~l~~~~~~---~g~~~G~~-----~~~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~~~d~~s~~~~~ 173 (260)
T 1gv9_A 102 IGADGLAIWYTENQGL---DGPVFGSA-----DMWNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQALAS 173 (260)
T ss_dssp CCCCEEEEEEESSCCC---EEEETTEC-----SCCEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHHHCSEE
T ss_pred CCCCeEEEEEecCCCC---CCCccCCC-----CCCCEEEEEEECCCCCCCCCCCceEEEeCCCceEeecCCCcccceeec
Confidence 6799999999997543 68889983 3467899999999997642 23 46788888875 55544333
Q ss_pred CCcccccc-CCCCeEEEEEEecCCCceEEEEEEeCCC-CCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeee
Q 041096 172 PILQGIDL-KSGNVITAWIDYKNDLRMLKVFMSYSNL-KPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWS 249 (645)
Q Consensus 172 ~~~~~~~~-~~g~~~~~~I~Y~~~~~~l~v~~~~~~~-~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~ 249 (645)
+. ..+ ++|..++|||+|++. +|+|.+.+... ......+...+| ...||+++||||||+||...+.|+|++|+
T Consensus 174 c~---~~~~n~g~~~~~~I~Y~~~--~L~V~l~~~~~~~~~~~~~~~~vd-~~~LP~~~~vGfSAaTG~~~e~hdIlsw~ 247 (260)
T 1gv9_A 174 CQ---RDFRNKPYPVRAKITYYQK--TLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDVLSFL 247 (260)
T ss_dssp EC---CCCBSCSSCEEEEEEEETT--EEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSCCEEEEEEEE
T ss_pred cC---hhhccCCCcEEEEEEEECC--EEEEEEeeccCCCCCcceEEEEEc-ccccCCCcEEEEEEeCCCCcceEEEEEEE
Confidence 21 123 358999999999986 89999986421 111235777888 67899999999999999999999999999
Q ss_pred eeec
Q 041096 250 FQTS 253 (645)
Q Consensus 250 f~~~ 253 (645)
|..-
T Consensus 248 ~~~l 251 (260)
T 1gv9_A 248 TFQL 251 (260)
T ss_dssp EEEE
T ss_pred EEEe
Confidence 9764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.46 Aligned_cols=239 Identities=21% Similarity=0.285 Sum_probs=178.8
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
.|...++||+|+||+||.+.. .++..||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..+|||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 345568899999999976544 35899999988652 245678999999987 89999999999999999999999995
Q ss_pred CCCHhHHhhhcCCCCcc---CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-------------CCee
Q 041096 428 NGSLDRMLYQDSENGVL---LSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN-------------FNAR 491 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~-------------~~~k 491 (645)
|+|.+++......... ..+..++.++.||+.||+|||+ .+|+||||||+||||+.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 7999999865432211 2334567899999999999999 999999999999999754 4688
Q ss_pred eeccc----------------cccccCCcccCcccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCccccccc
Q 041096 492 LESSF----------------TLTAGTMGYLAPEYLQY-------GTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHK 547 (645)
Q Consensus 492 l~d~~----------------~~~~gt~~y~APE~~~~-------~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~ 547 (645)
|+|.. ....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 87721 12368999999999975 678999999999999999999 999996532211
Q ss_pred hhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 548 MVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 548 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.......... +.+...........+.+++..||+.||.+|||+.+|++
T Consensus 248 ----~~i~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ----SNIIRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HHHHHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHhcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111111110 01111224556778999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=330.90 Aligned_cols=248 Identities=24% Similarity=0.287 Sum_probs=190.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeee------CCe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAE------KGE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 418 (645)
.++|+..+.||+|+||.||+|....++..||||++... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999999888999999998763 3445679999999999999999999999765 667
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC---eeeecc
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN---ARLESS 495 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~---~kl~d~ 495 (645)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +++.|.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999986442 2348899999999999999999999 99999999999999997665 778762
Q ss_pred c-----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 496 F-----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 496 ~-----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
. ....||..|+|||.+.+..++.++|||||||++|||++|+.||...... ..|..........
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~------~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP------VQWHGKVREKSNE 242 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH------HHSSTTCC-----
T ss_pred ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch------hhhhhhhhcccch
Confidence 1 2346899999999999999999999999999999999999999753211 1110000000000
Q ss_pred hHHhh----------hh--ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 041096 565 IEAAD----------KR--LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRR 604 (645)
Q Consensus 565 ~~~~d----------~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~ 604 (645)
..... .. ............+.+++..||+.||++|||+++
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00000 00 011234456788999999999999999999866
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=311.73 Aligned_cols=235 Identities=21% Similarity=0.245 Sum_probs=177.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.+|...++||+|+||+||.... .++..||||++.... ...+.+|+++++++ +||||+++++++.+.+..||||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 4588889999999999553333 347899999986532 23467899999999 7999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-----CCCeeeeccc-----
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA-----NFNARLESSF----- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~-----~~~~kl~d~~----- 496 (645)
. |+|.+++...... +.+..++.++.||++||+|||+ .+|+||||||+||||+. ...+||+|..
T Consensus 101 ~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 101 A-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp S-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred C-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 5 6999999765432 4445567899999999999999 99999999999999953 2346677621
Q ss_pred ----------cccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccC
Q 041096 497 ----------TLTAGTMGYLAPEYLQ---YGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEG 562 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~---~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~ 562 (645)
....||+.|+|||++. ...++.++|||||||++|||++ |+.||...... ..... ....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-----~~~~~---~~~~ 245 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-----QANIL---LGAC 245 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-----HHHHH---TTCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-----HHHHH---hccC
Confidence 1245899999999997 4567889999999999999999 89998643211 11100 0000
Q ss_pred chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 563 RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 563 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
. . .. ..........+.+++..||+.||.+|||+++|++
T Consensus 246 ~-~----~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 S-L----DC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-C----TT--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-c----cc--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 0 00 0112234456788999999999999999999984
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=295.38 Aligned_cols=239 Identities=15% Similarity=0.218 Sum_probs=183.2
Q ss_pred hcCCCcC-ceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHH-hhcCCCCeeeeeeeeee----CCeEE
Q 041096 347 TRGFHSN-RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSII-ACLRHKNLVQLLGWCAE----KGELL 420 (645)
Q Consensus 347 ~~~f~~~-~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~ 420 (645)
.++|... ++||+|+||.||+|....++..||+|++.. ...+.+|++++ +.++||||+++++++.. ....+
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 3556666 779999999999999998899999999864 34577888887 55689999999999887 66899
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCeeeecccc
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA---NFNARLESSFT 497 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~---~~~~kl~d~~~ 497 (645)
+||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+++.|...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999987542 348999999999999999999999 99999999999999998 78899987432
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCC
Q 041096 498 LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 577 (645)
. +...+..++.++|||||||++|||++|+.||........... ....+... ....+
T Consensus 167 a----------~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-------------~~~~~~~~-~~~~~ 222 (299)
T 3m2w_A 167 A----------KETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------------MKTRIRMG-QYEFP 222 (299)
T ss_dssp C----------EECTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-------------SCCSSCTT-CCSSC
T ss_pred c----------cccccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-------------HHHHHhhc-cccCC
Confidence 1 223346788999999999999999999999976432111000 00000000 00111
Q ss_pred ----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCCCC
Q 041096 578 ----EDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPLVV 618 (645)
Q Consensus 578 ----~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~~~ 618 (645)
......+.+++..||+.||.+|||++|+++ .+.+....+..
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~ 269 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 269 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCC
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCC
Confidence 123456888999999999999999999998 56655444443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=328.02 Aligned_cols=229 Identities=22% Similarity=0.279 Sum_probs=184.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCe-----
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFAS-SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGE----- 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~-~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 418 (645)
.++|+..+.||+|+||.||+|.+.. ++..||||++... ......+.+|++++.+++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3689999999999999999999875 6899999988653 3345678999999999999999999999987665
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-- 496 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-- 496 (645)
.||||||+++++|.+++.. .++|.+++.++.||++||.|||+ .+|+||||||+||||+.+ .+||.|..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987753 38999999999999999999999 999999999999999986 78887732
Q ss_pred ------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 ------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....||++|+|||++.++. +.++|||||||++|||++|..||......... .
T Consensus 229 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------~--------- 286 (681)
T 2pzi_A 229 SRINSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------E--------- 286 (681)
T ss_dssp EETTCCSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------T---------
T ss_pred hhcccCCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc------------c---------
Confidence 3456999999999987654 89999999999999999999887653211100 0
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHc
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPS-MRRVFQILN 610 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~~vl~~L~ 610 (645)
..........+.+++..||+.||.+||+ ++++.+.|.
T Consensus 287 ---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 287 ---DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ---TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0000122356788999999999999995 566655554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.12 Aligned_cols=233 Identities=16% Similarity=0.102 Sum_probs=175.5
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCC-CCeeeeeee---------
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRH-KNLVQLLGW--------- 412 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H-~niv~l~g~--------- 412 (645)
+++|...++||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++| +|......+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577788999999999999999989999999988742 2235679999999999987 322111111
Q ss_pred ------------eee-----CCeEEEEEecCCCCCHhHHhhhc---CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 041096 413 ------------CAE-----KGELLLVYEYMPNGSLDRMLYQD---SENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472 (645)
Q Consensus 413 ------------~~~-----~~~~~lV~Ey~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 472 (645)
+.. ....+++|+++ +++|.+++... ......+++..++.++.|+++||+|||+ ++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 111 12467777766 78999888521 2223458899999999999999999999 999
Q ss_pred eeCCCCCCcEEEcCCCCeeeeccc---------cccccCCcccCcccc----------cCCCCCcchhHHHHHHHHHHHH
Q 041096 473 IHRDIKASNIMLDANFNARLESSF---------TLTAGTMGYLAPEYL----------QYGTATEKTDVFSYGVVVLEVA 533 (645)
Q Consensus 473 vHrDlkp~NIlld~~~~~kl~d~~---------~~~~gt~~y~APE~~----------~~~~~t~ksDV~SfGvvl~El~ 533 (645)
+||||||+||||+.++.+||.|.. ...+| +.|+|||++ ....++.++|||||||++|||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999998832 23467 999999999 5556889999999999999999
Q ss_pred cCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 041096 534 CGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVF 606 (645)
Q Consensus 534 tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl 606 (645)
+|+.||.......... ..+.. ... .+..+.+++..||+.||++||++.+++
T Consensus 312 tg~~Pf~~~~~~~~~~----------------~~~~~--~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 312 CADLPNTDDAALGGSE----------------WIFRS--CKN----IPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HSSCCCCTTGGGSCSG----------------GGGSS--CCC----CCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HCCCCCCCcchhhhHH----------------HHHhh--ccc----CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999997643221110 00100 012 235688899999999999999976663
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=269.73 Aligned_cols=114 Identities=37% Similarity=0.482 Sum_probs=107.0
Q ss_pred CcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcce
Q 041096 134 NKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPL 213 (645)
Q Consensus 134 ~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~ 213 (645)
+|+|||||||++|.+|+||++|||||||||+.|.++.+| ++.+|+.++|||+||+.+++|+|+|++.+. ..|+
T Consensus 2 n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~~-----~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~ 74 (237)
T 1nls_A 2 DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW-----NMQNGKVGTAHIIYNSVDKRLSAVVSYPNA--DSAT 74 (237)
T ss_dssp CCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-----CCCTTCEEEEEEEEETTTTEEEEEEECTTS--CCEE
T ss_pred CCEEEEEEeCCCCcccCCCCCCeeeEecCCccccccccc-----cccCCCEEEEEEEEeCCCCEEEEEEecCCC--Ccce
Confidence 689999999999999999999999999999999998876 478999999999999999999999997653 6799
Q ss_pred EEEeecCCccCCCccEEeEEeccCCccceeeeeeeeeeecC
Q 041096 214 LKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTSG 254 (645)
Q Consensus 214 l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~~~~ 254 (645)
|++.|||+++|+|+|||||||+||...|.|+|++|+|++..
T Consensus 75 ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~ 115 (237)
T 1nls_A 75 VSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL 115 (237)
T ss_dssp EEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred EEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEecc
Confidence 99999999999999999999999999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=290.03 Aligned_cols=234 Identities=15% Similarity=0.125 Sum_probs=174.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---------chhHhHHHHHHHHhhcC---------CCCeee
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---------EGKTEFLAELSIIACLR---------HKNLVQ 408 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---------~~~~~~~~Ei~~l~~l~---------H~niv~ 408 (645)
.++|+..+.||+|+||+||+|+. ++..||||++.... ...+.+.+|+.++++++ |+||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35688899999999999999998 47999999987532 12367899999999886 555555
Q ss_pred eee-----------------eeee-------------CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHH
Q 041096 409 LLG-----------------WCAE-------------KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLA 458 (645)
Q Consensus 409 l~g-----------------~~~~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia 458 (645)
+.+ ++.+ .+..||||||+++|++.+.+.+ ..+++.++..++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 554 4443 6789999999999987777743 2389999999999999
Q ss_pred HHHHHHh-hcCCCCeeeCCCCCCcEEEcCCC--------------------Ceeeeccc-------cccccCCcccCccc
Q 041096 459 SALTYLH-QECEQQVIHRDIKASNIMLDANF--------------------NARLESSF-------TLTAGTMGYLAPEY 510 (645)
Q Consensus 459 ~gL~yLH-~~~~~~ivHrDlkp~NIlld~~~--------------------~~kl~d~~-------~~~~gt~~y~APE~ 510 (645)
.||+||| + .+|+||||||+||||+.++ .+||.|.. ...+||+.|+|||+
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGG
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhh
Confidence 9999999 8 8999999999999999887 88998832 23479999999999
Q ss_pred ccCCCCCcchhHHHHHHH-HHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHH
Q 041096 511 LQYGTATEKTDVFSYGVV-VLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGL 589 (645)
Q Consensus 511 ~~~~~~t~ksDV~SfGvv-l~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 589 (645)
+.+.. +.++||||++++ .+++++|..||..... ...+.+....... ................+.+++.
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW---LHYLTDKMLKQMT-------FKTKCNTPAMKQIKRKIQEFHR 317 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH---HHHHHHHHHHTCC-------CSSCCCSHHHHHHHHHHHHHHH
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcchhh---hhHHHHhhhhhhc-------cCcccchhhhhhcCHHHHHHHH
Confidence 98766 899999998777 7778889999843100 0001110000000 0000001112346778999999
Q ss_pred HccCCCCCCCCCHHHHH
Q 041096 590 SCANPDSSARPSMRRVF 606 (645)
Q Consensus 590 ~Cl~~dP~~RPt~~~vl 606 (645)
.||+.| |++|++
T Consensus 318 ~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 318 TMLNFS-----SATDLL 329 (336)
T ss_dssp HGGGSS-----SHHHHH
T ss_pred HHhccC-----CHHHHH
Confidence 999866 999988
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=211.49 Aligned_cols=106 Identities=29% Similarity=0.606 Sum_probs=93.8
Q ss_pred CceeEEeCCCC--CCCeEEecceEeeCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYLRNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVN 97 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 97 (645)
.+++|+|++|. ..||+|+|||.+.+|.|+||+.+.+ ..+++|||+|++||+|||+ +++++||+|+|+|.|.+.+
T Consensus 2 ~~~~F~f~~F~~~~~nl~l~G~A~v~~g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~d~-tg~vaSFsT~F~F~I~~~~ 80 (113)
T 1qmo_A 2 QSLSFSFTKFDPNQEDLIFQGHATSTNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWED-SAVLTSFDTIINFEISTPY 80 (113)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEEEECSS
T ss_pred cceEEEcCCCCCCCCCeEEecceEcCCCceEeCCCCCCCcccCCcEEEEEeCCCEEeeCC-CCCEEeeEEEEEEEEecCC
Confidence 45799999998 6899999999998899999997431 1368999999999999999 9999999999999999887
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccccCC
Q 041096 98 PSSFGDGLAFFISPDNQILGSAGGCLGLVNSS 129 (645)
Q Consensus 98 ~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~ 129 (645)
...+||||||||+|....+++.||||||+|.+
T Consensus 81 ~~~~gdGlAF~lap~~~~p~s~g~~LGL~n~~ 112 (113)
T 1qmo_A 81 TSRIADGLAFFIAPPDSVISYHGGFLGLFPNA 112 (113)
T ss_dssp SSCCCCEEEEEEECTTCCCCCCGGGTTTCSSC
T ss_pred CCCCCCeEEEEecCCCCCCCCCccccccccCC
Confidence 77889999999999877555889999999864
|
| >2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13 | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-25 Score=221.41 Aligned_cols=187 Identities=19% Similarity=0.202 Sum_probs=143.4
Q ss_pred CCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCCCceEEEEecCC
Q 041096 34 LRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDN 113 (645)
Q Consensus 34 ~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~p~~ 113 (645)
..++.++|+|.+.++.|+||++ .++.|++|.+.|+++ .++|+|+|+|+|.++. ..+||||||++++..
T Consensus 30 i~~w~~~G~a~v~~~~IrLTp~----~~s~G~iW~~~p~~~-------~~~f~~~f~FrI~g~~-~~~gdGlAfwlt~~~ 97 (256)
T 2a6y_A 30 PNNWQTGEQASLEEGRIVLTSN----QNSKGSLWLKQGFDL-------KDSFTMEWTFRSVGYS-GQTDGGISFWFVQDS 97 (256)
T ss_dssp CTTEEEEETCEEETBEEECCCS----TTCEEEEEESSCEEE-------SSCEEEEEEEEEESCC-SCCSCEEEEEEEECS
T ss_pred cCCeEEccceEEeCCEEEECCC----CCceEEEeeCCCCcc-------cCCEEEEEEEEEecCC-CCCCCeEEEEEeCCC
Confidence 4689999999999999999997 256899877777764 3689999999999764 337999999999976
Q ss_pred CCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCC------CCeeeeecCCcccccccCCCccccccCCCCeEEE
Q 041096 114 QILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPD------ENHIGLDIDSLESIKTADPILQGIDLKSGNVITA 187 (645)
Q Consensus 114 ~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~------~~Hvgi~vns~~s~~~~~~~~~~~~~~~g~~~~~ 187 (645)
..+ ..|+.+|..+ ..+.+||||||+.|. .|. +.|+++|.+++.+.....+.. .+ .++|.+.++
T Consensus 98 ~~~-~~g~~~G~~~-----~f~GlaV~fDT~~n~---~p~i~~~~Ndg~~~~d~~~~~~~~~~~c~~-~~-rn~~~~~~v 166 (256)
T 2a6y_A 98 NIP-RDKQLYNGPV-----NYDGLQLLVDNNGPL---GPTLRGQLNDGQKPVDKTKIYDQSFASCLM-GY-QDSSVPSTI 166 (256)
T ss_dssp SSC-CCCTBTTBCT-----TCEEEEEEEESCSTT---CSEEEEEEEESSSCCCGGGHHHHCSEEEEC-CC-TTCSSCEEE
T ss_pred Ccc-cCCcccCcCC-----CCCEEEEEEECCCCC---CceEEEEECCCceecccCCCcccceeccee-ec-ccCCCcEEE
Confidence 532 5678888853 356699999999873 343 678888888744443333211 11 147889999
Q ss_pred EEEec-CCCceEEEEEEeCCCCCCcceEEEeecCCcc-CCCcc-EEeEEeccC---Cccceeeeeeeeeeec
Q 041096 188 WIDYK-NDLRMLKVFMSYSNLKPVTPLLKVNIDLSGY-LKGNM-YVGFSASTE---GSTELHMIQSWSFQTS 253 (645)
Q Consensus 188 ~I~Y~-~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~-l~~~~-~vGfsastg---~~~~~~~i~sw~f~~~ 253 (645)
||.|+ +..+.|+|.+.+ ..++ ++..+ ||+++ ||||||+|| ...+.|.|++|+|...
T Consensus 167 ~I~Y~~~~~~~L~V~i~~------~~c~----~~~~v~LP~~~~~~GfSAaTG~~~~~~d~hdIls~~~~~~ 228 (256)
T 2a6y_A 167 RVTYDLEDDNLLKVQVDN------KVCF----QTRKVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQFFNG 228 (256)
T ss_dssp EEEEEGGGTSEEEEEETT------EEEE----EESCEECCSEEEEEEEEEECCSGGGCCCEEEEEEEEEEES
T ss_pred EEEEecCCCcEEEEEEcC------EEEE----EECcEEeCCCCeEEEEEEeCCCCCCCcceEEEEEEEEEec
Confidence 99999 878899999954 2233 34444 78887 699999999 7899999999999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-26 Score=256.49 Aligned_cols=172 Identities=20% Similarity=0.076 Sum_probs=121.6
Q ss_pred eccCCceEEEEEEECCCCeEEEEEeccCC-----------cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEEE
Q 041096 356 LGRGAFGNVYKAYFASSGSVAAVKRSKHS-----------HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 356 lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-----------~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 423 (645)
.+.|++|.+..+...-.|+.+++|.+... ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 45555655555444444788999987652 12346799999999999 6999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||++|++|.++|..... ++.. +|+.||+.||+|||+ ++|+||||||+||||+.++.+||.|..
T Consensus 322 Eyv~G~~L~d~i~~~~~----l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE----IDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTTCC----CCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhCCC----CCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999976543 5553 589999999999999 999999999999999999999998832
Q ss_pred -----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCC
Q 041096 497 -----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRP 538 (645)
Q Consensus 497 -----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P 538 (645)
...+||++|||||.+.+ .+..++|+||+|++++++.++..+
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 22468999999999875 467789999999998887665444
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=204.79 Aligned_cols=105 Identities=34% Similarity=0.575 Sum_probs=90.7
Q ss_pred CceeEEeCCCC--CCCeEEecceEe-eCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYL-RNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV 96 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~-~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 96 (645)
..++|.|+.|. ..||+|+|||.+ .+|.|+||+.+.+ ..+++|||+|++||+|||+ +++++||+|+|+|.|.+.
T Consensus 124 ~~~~F~~~~F~~~~~nl~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lwd~-~~~vaSFsT~F~F~I~~~ 202 (237)
T 1nls_A 124 NALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFLIKSP 202 (237)
T ss_dssp EEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEECCCS
T ss_pred ccchhhhccccccCCCeEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEeecC-CCCEeeeEEEEEEEEecC
Confidence 45799999998 469999999999 5899999997521 2468999999999999997 889999999999999986
Q ss_pred CCCCCCCceEEEEecCCC--CCCCCCCccccccCC
Q 041096 97 NPSSFGDGLAFFISPDNQ--ILGSAGGCLGLVNSS 129 (645)
Q Consensus 97 ~~~~~g~G~aF~l~p~~~--~~~~~g~~lGl~~~~ 129 (645)
. ..+||||||||+|... +.+++||||||+|.+
T Consensus 203 ~-~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~ 236 (237)
T 1nls_A 203 D-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236 (237)
T ss_dssp S-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred C-CCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence 4 4689999999999874 457899999999865
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.9e-24 Score=237.06 Aligned_cols=171 Identities=13% Similarity=0.143 Sum_probs=136.3
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---------chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 351 HSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---------EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 351 ~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
...++||+|+||.||+|... +..+++|+..... ...+.+.+|++++++++||||+++..++...++.+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44678999999999999554 6778888654311 113458999999999999999977777777778899
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||||+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. .+||.|..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999965 35799999999999999 99999999999999998 89998721
Q ss_pred --------------cccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCC
Q 041096 497 --------------TLTAGTMGYLAPEYLQY--GTATEKTDVFSYGVVVLEVACGRRPIE 540 (645)
Q Consensus 497 --------------~~~~gt~~y~APE~~~~--~~~t~ksDV~SfGvvl~El~tG~~P~~ 540 (645)
....||+.|||||++.. ..|+.++|+||..+-.++-+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 23468999999999986 668889999999999999888877663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=193.47 Aligned_cols=151 Identities=14% Similarity=0.124 Sum_probs=121.6
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-------------------chhHhHHHHHHHHhhc
Q 041096 341 RELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-------------------EGKTEFLAELSIIACL 401 (645)
Q Consensus 341 ~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-------------------~~~~~~~~Ei~~l~~l 401 (645)
..+......|...+.||+|+||.||+|.. .++..||+|.+.... .....+.+|+++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34444455677779999999999999999 679999999986422 1345689999999999
Q ss_pred CCCCeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 041096 402 RHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASN 481 (645)
Q Consensus 402 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N 481 (645)
+ | +++.+++.. +..++||||+++++|.+ +.. .....++.|+++||+|||+ .+|+||||||+|
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHH
Confidence 9 5 677775544 45699999999999998 521 1234699999999999999 999999999999
Q ss_pred EEEcCCCCeeeeccccccccCCcccCccccc
Q 041096 482 IMLDANFNARLESSFTLTAGTMGYLAPEYLQ 512 (645)
Q Consensus 482 Illd~~~~~kl~d~~~~~~gt~~y~APE~~~ 512 (645)
|||+ ++.++|.| ++....+..++|||++.
T Consensus 224 ILl~-~~~vkl~D-FG~a~~~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIID-FPQSVEVGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECC-CTTCEETTSTTHHHHHH
T ss_pred EEEE-CCcEEEEE-CCCCeECCCCCHHHHHH
Confidence 9999 99999977 45566778899999875
|
| >2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.4e-17 Score=161.34 Aligned_cols=185 Identities=17% Similarity=0.180 Sum_probs=129.2
Q ss_pred CCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCCCceEEEEecCC
Q 041096 34 LRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDN 113 (645)
Q Consensus 34 ~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~p~~ 113 (645)
..++.+.|+|.+.++.|+||++ . ++.|.+|.+.|+++.+ +|+++|+|+|..+. ..+||||||.+++..
T Consensus 23 ~~~W~~~G~a~i~~~~IrLTp~---~-~~~G~iWs~~p~~~~~-------~weie~~Fri~g~~-~~~gdGlA~W~t~~~ 90 (222)
T 2a6z_A 23 PNNWQTGEQASLEEGRIVLTSN---Q-NSKGSLWLKQGFDLKD-------SFTMEWTFRSVGYS-GQTDGGISFWFVQDS 90 (222)
T ss_dssp CTTEEEEETCEEETTEEESCCS---T-TCEEEEEESSCEECCS-------CEEEEEEEEEESCC-SCCSCEEEEEEEECS
T ss_pred cCCcEEcccEEEcCCEEEECCC---C-CCeEEEEeCCCCCCCC-------CEEEEEEEEEeCCC-CCCCCEEEEEEECCC
Confidence 4689999999999999999997 2 4589999999998643 69999999999764 347999999999875
Q ss_pred CCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcc-cccc-----cCCCcccccc-CCCCeEE
Q 041096 114 QILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLE-SIKT-----ADPILQGIDL-KSGNVIT 186 (645)
Q Consensus 114 ~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~-s~~~-----~~~~~~~~~~-~~g~~~~ 186 (645)
.. ...|..+|.. ....-+||+|||+.|. ..+|.+.+|.-. +-.. .....-.... +.+.+.+
T Consensus 91 ~~-~~~g~~~G~~-----~~f~GL~I~~Dt~~n~------~p~i~~~~ndG~~~yd~~~~~~~~~~~C~~~~rn~~~~~~ 158 (222)
T 2a6z_A 91 NI-PRDKQLYNGP-----VNYDGLQLLVDNNGPL------GPTLRGQLNDGQKPVDKTKIYDQSFASCLMGYQDSSVPST 158 (222)
T ss_dssp SS-CCCCTBTTBC-----TTCEEEEEEEESCSTT------SSEEEEEEEESSSCCCGGGHHHHCSEEEECCCTTEEEEEE
T ss_pred cc-cCCCcccCCC-----CCCCEEEEEEECCCCC------CceEEEEECCCCeeeccCCCccccccccceeccCCCCcEE
Confidence 42 1245555552 2344579999998773 245655543321 1000 1111000112 3567899
Q ss_pred EEEEec-CCCceEEEEEEeCCCCCCcceEEEe-ecCCccCCCc-cEEeEEeccC---Cccceeeeeeeeeee
Q 041096 187 AWIDYK-NDLRMLKVFMSYSNLKPVTPLLKVN-IDLSGYLKGN-MYVGFSASTE---GSTELHMIQSWSFQT 252 (645)
Q Consensus 187 ~~I~Y~-~~~~~l~v~~~~~~~~~~~~~l~~~-vdl~~~l~~~-~~vGfsastg---~~~~~~~i~sw~f~~ 252 (645)
++|.|+ ...+.|+|.++. ..|+... |+ ||.. .|+||||+|| ...+.|.|++|++..
T Consensus 159 ~rI~Y~~~~~~~l~v~id~------~~C~~~~~v~----LP~~~~y~G~SA~TG~l~~~~d~hdil~~~~~~ 220 (222)
T 2a6z_A 159 IRVTYDLEDDNLLKVQVDN------KVCFQTRKVR----FPSGSYRIGVTAQNGAVNNNAESFEIFKMQFFN 220 (222)
T ss_dssp EEEEEEGGGTSEEEEEETT------EEEEEESCCC----CCSSEEEEEEEEECCSGGGCCCEEEEEEEEEEE
T ss_pred EEEEEEcCCCcEEEEEEcC------eEEEEeCCee----cCCCCcEEEEEEcCCCCCCCCccEEEEEEEEEc
Confidence 999998 667788888842 3343332 33 4555 4799999999 788999999999854
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.1e-16 Score=159.70 Aligned_cols=130 Identities=16% Similarity=0.128 Sum_probs=99.6
Q ss_pred CCcCceeccCCceEEEEEEECCCCeE--EEEEeccCCcch-------------------------hHhHHHHHHHHhhcC
Q 041096 350 FHSNRILGRGAFGNVYKAYFASSGSV--AAVKRSKHSHEG-------------------------KTEFLAELSIIACLR 402 (645)
Q Consensus 350 f~~~~~lG~G~fg~Vy~g~~~~~~~~--vavK~~~~~~~~-------------------------~~~~~~Ei~~l~~l~ 402 (645)
|...+.||+|+||.||+|....+|.. ||||+++..... ...+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678999999999999998556888 999986542111 136889999999998
Q ss_pred CCCe--eeeeeeeeeCCeEEEEEecCCC-C----CHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHh-hcCCCCeee
Q 041096 403 HKNL--VQLLGWCAEKGELLLVYEYMPN-G----SLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH-QECEQQVIH 474 (645)
Q Consensus 403 H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH 474 (645)
|+++ ...+++ +..+|||||+.+ | +|.++... .++.....++.|++.||.||| + .+|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~---~givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE---AELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT---SCEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH---CCEEe
Confidence 8764 333332 246899999942 4 67666432 223456789999999999999 7 99999
Q ss_pred CCCCCCcEEEcCCCCeeeecc
Q 041096 475 RDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 475 rDlkp~NIlld~~~~~kl~d~ 495 (645)
|||||+|||++. .+++.|.
T Consensus 195 rDlkp~NILl~~--~~~liDF 213 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDM 213 (258)
T ss_dssp SSCSTTSEEESS--SEEECCC
T ss_pred CCCCHHHEEEcC--cEEEEEC
Confidence 999999999998 8888774
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.8e-14 Score=152.35 Aligned_cols=127 Identities=11% Similarity=0.094 Sum_probs=87.4
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc---------------hhHhHHHHHHHHhhcCCCCeeeeeeee
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE---------------GKTEFLAELSIIACLRHKNLVQLLGWC 413 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---------------~~~~~~~Ei~~l~~l~H~niv~l~g~~ 413 (645)
-|++.+.||+|++|.||+|... +|..||||+++.... .......++++.....|+|+++++...
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3888999999999999999986 488999998653211 011222333333333344444443221
Q ss_pred eeC------CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC
Q 041096 414 AEK------GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN 487 (645)
Q Consensus 414 ~~~------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~ 487 (645)
... ...+|||||+++++|..+... .....++.|++.+|.|||+ .+||||||||.||||+.+
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEE
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCC
Confidence 111 123799999999888765421 1234678999999999999 899999999999999887
Q ss_pred CC
Q 041096 488 FN 489 (645)
Q Consensus 488 ~~ 489 (645)
+.
T Consensus 242 gd 243 (397)
T 4gyi_A 242 KD 243 (397)
T ss_dssp EC
T ss_pred CC
Confidence 63
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B | Back alignment and structure |
|---|
Probab=99.44 E-value=4.1e-14 Score=103.49 Aligned_cols=44 Identities=27% Similarity=0.388 Sum_probs=41.5
Q ss_pred cceEEEeecCCccCCCccEEeEEeccCCccceeeeeeeeeeecC
Q 041096 211 TPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTSG 254 (645)
Q Consensus 211 ~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~~~~ 254 (645)
.|+|+.++||+++|+|+|||||||+||...|.|+|++|+|++..
T Consensus 3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~ 46 (52)
T 2ltn_B 3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSEL 46 (52)
T ss_dssp EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEE
T ss_pred eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeec
Confidence 47899999999999999999999999999999999999999864
|
| >2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A | Back alignment and structure |
|---|
Probab=99.40 E-value=1.7e-11 Score=119.27 Aligned_cols=184 Identities=19% Similarity=0.197 Sum_probs=122.9
Q ss_pred CCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCCCceEEEEecCCC
Q 041096 35 RNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQ 114 (645)
Q Consensus 35 ~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~p~~~ 114 (645)
.++.+.|+|.+.++.|+||++ +++.|.+|-+.|+.+- .+|+.+|+|+|+.... .+||||||.++....
T Consensus 27 ~~W~~~G~t~v~~~~IrLTp~----~s~~G~lWs~~p~~~~-------~~weiev~Fri~G~~~-~~gdGlA~Wyt~~~~ 94 (226)
T 2a6v_A 27 SQWTLGDKVKLEEGRFVLTPG----KNTKGSLWLKPEYSIK-------DAMTIEWTFRSFGFRG-STKGGLAFWLKQGNE 94 (226)
T ss_dssp TTEEEEETCEEETTEEESCCS----TTCEEEEEESSCBCCS-------SCEEEEEEEEEESCCS-CCSCEEEEEEECSCC
T ss_pred CCcEEcCCeEEeCCEEEECCC----CCceEEEeeCCCCCCC-------CCeEEEEEEEEecCCC-CCCCEEEEEEECCCC
Confidence 689999999999999999997 4689999999999861 2599999999997653 379999999997543
Q ss_pred CCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCc-cccccc-CCCccc--cc-cCCCCeEEEEE
Q 041096 115 ILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSL-ESIKTA-DPILQG--ID-LKSGNVITAWI 189 (645)
Q Consensus 115 ~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~-~s~~~~-~~~~~~--~~-~~~g~~~~~~I 189 (645)
. ..|..+|-. .....-+||.|||+.|. ...|.+-+|.- .+-... .....+ .. .+.+.+.+++|
T Consensus 95 ~--~~g~vfGg~----~d~f~GlgI~~Dt~~n~------~p~i~~~~NDGt~~yd~~~~~~~g~C~~~~rn~~~~t~~ri 162 (226)
T 2a6v_A 95 G--DSTELFGGS----SKKFNGLMILLRLDDKL------GESVTAYLNDGTKDLDIESSPYFASCLFQYQDSMVPSTLRL 162 (226)
T ss_dssp C--CCCTBTTTB----CSSCEEEEEEEEEETTT------EEEEEEEEEESSSCCCTTTSCCSEEEECCCSSCSSCEEEEE
T ss_pred C--CCccccccc----CCCccEEEEEEECCCCC------CceEEEEECCCCcccCCCCCcccceEeEeccCCCCCEEEEE
Confidence 2 233333210 11234589999998762 12233333221 111111 111111 11 24567889999
Q ss_pred Eec-CCCceEEEEEEeCCCCCCcceEEE-eecCCccCCCc--cEEeEEeccCCccceeeeeeeeeee
Q 041096 190 DYK-NDLRMLKVFMSYSNLKPVTPLLKV-NIDLSGYLKGN--MYVGFSASTEGSTELHMIQSWSFQT 252 (645)
Q Consensus 190 ~Y~-~~~~~l~v~~~~~~~~~~~~~l~~-~vdl~~~l~~~--~~vGfsastg~~~~~~~i~sw~f~~ 252 (645)
.|. ...+.|+|.++. ..|+.. .|+ ||.. +|+||||+||...+.|.|++..+-.
T Consensus 163 ~Y~~~~~~~l~v~id~------~~Cf~~~~v~----LP~g~~~yfGiSAaTg~~~D~hdils~~~~~ 219 (226)
T 2a6v_A 163 TYNPLDNHLLKLQMDN------RVCFQTRKVK----FMGSSPFRIGTSAINDASKESFEILKMKLYD 219 (226)
T ss_dssp EEEGGGTSEEEEEETT------EEEEEESCCC----GGGTSCBEEEEEEECCTTCCEEEEEEEEEES
T ss_pred EEEccCCCEEEEEEcC------CeeEEECCee----cCCCCccEEEEEEcCCCCcccEEEEEEEEEe
Confidence 996 446789998842 234442 133 3444 4999999999999999999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=2e-10 Score=115.59 Aligned_cols=143 Identities=14% Similarity=0.053 Sum_probs=110.1
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-chhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeE
Q 041096 342 ELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-EGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 342 ~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 419 (645)
.+.....+|.....++.|+.+.||+.... +..+++|+..... .....+.+|+++++.+. |.++.++++++.+.+..
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 34555678888888898999999999754 5789999876421 23446899999999995 67788999999988899
Q ss_pred EEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhc--------------------------------
Q 041096 420 LLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE-------------------------------- 467 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------- 467 (645)
|+||||++|.+|.+.+.. ..+...++.+++++|+.||+.
T Consensus 86 ~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 999999999999876421 112346889999999999981
Q ss_pred ------------------------CCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 468 ------------------------CEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 468 ------------------------~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
....++|+|+++.|||++.+....+.|.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDw 208 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL 208 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCC
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEc
Confidence 0145899999999999987544456563
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.89 E-value=2.5e-09 Score=106.83 Aligned_cols=134 Identities=19% Similarity=0.149 Sum_probs=94.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCC--eeeeeeeeeeCCeEEEEEe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKN--LVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E 424 (645)
..++....+.+.|..+.||+.... +|..+++|..... ....+.+|+.+++.+++.+ +.++++++..++..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 344544333345566999999764 4667899987653 3356889999999996544 4568888888788999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC------------------------------------ 468 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 468 (645)
|+++.+|. ... .. ...++.++++.|+.||+..
T Consensus 96 ~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 96 EVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp CCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred ecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 99998884 211 11 1256778888888888621
Q ss_pred -------------------CCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 469 -------------------EQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 469 -------------------~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
...++|+|++|.|||++.+....+.|.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~ 209 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDC 209 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCC
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcc
Confidence 122999999999999987654556563
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.74 E-value=3.3e-08 Score=104.14 Aligned_cols=134 Identities=13% Similarity=0.205 Sum_probs=100.2
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEecc--CCc--chhHhHHHHHHHHhhcC--CCCeeeeeeeeeeC---CeEEEEE
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSK--HSH--EGKTEFLAELSIIACLR--HKNLVQLLGWCAEK---GELLLVY 423 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~--~~~--~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 423 (645)
.+.|+.|.++.||+.... +..+++|+.. ... .....+.+|+.+++.|. +..+.++++++.+. +..++||
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 467899999999999875 4577888776 322 23457889999999997 45688899988776 4589999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC----------------------------------- 468 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------- 468 (645)
||+++..+.+... ..++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999988754211 12678888999999999999999721
Q ss_pred --------------------CCCeeeCCCCCCcEEEcCCCC--eeeec
Q 041096 469 --------------------EQQVIHRDIKASNIMLDANFN--ARLES 494 (645)
Q Consensus 469 --------------------~~~ivHrDlkp~NIlld~~~~--~kl~d 494 (645)
...++|+|+++.|||++.+.. ..+.|
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viD 242 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLD 242 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECC
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEEC
Confidence 257999999999999997754 35656
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.57 E-value=8.6e-08 Score=98.52 Aligned_cols=176 Identities=16% Similarity=0.137 Sum_probs=116.6
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-CCC--eeeeeeeeeeCC---eEEEEEecC
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HKN--LVQLLGWCAEKG---ELLLVYEYM 426 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~Ey~ 426 (645)
.+.++.|....||+.. ..+++|+... ......+.+|.++++.+. +.. +.+.+.++...+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS-HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC-cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999863 3577887543 234567889999999884 322 344555544333 348899999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhc---------------------------------------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE--------------------------------------- 467 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------- 467 (645)
+|.+|...... .++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99888754331 167777888888888888888861
Q ss_pred ----------------CCCCeeeCCCCCCcEEEcCC--CCeeeeccccccccCC--------cc---cCcccccC-----
Q 041096 468 ----------------CEQQVIHRDIKASNIMLDAN--FNARLESSFTLTAGTM--------GY---LAPEYLQY----- 513 (645)
Q Consensus 468 ----------------~~~~ivHrDlkp~NIlld~~--~~~kl~d~~~~~~gt~--------~y---~APE~~~~----- 513 (645)
....++|+|+++.||+++.+ ....+.|......|.+ .+ ..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 02458999999999999984 4455656333333322 11 23332210
Q ss_pred CCCC---------cchhHHHHHHHHHHHHcCCCCCC
Q 041096 514 GTAT---------EKTDVFSYGVVVLEVACGRRPIE 540 (645)
Q Consensus 514 ~~~t---------~ksDV~SfGvvl~El~tG~~P~~ 540 (645)
+..+ ...+.|+++.++|++.+|..+|.
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1111 12689999999999999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.4e-05 Score=80.04 Aligned_cols=130 Identities=20% Similarity=0.187 Sum_probs=91.6
Q ss_pred eeccCCce-EEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEEEecCCCCCHh
Q 041096 355 ILGRGAFG-NVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLVYEYMPNGSLD 432 (645)
Q Consensus 355 ~lG~G~fg-~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 432 (645)
.+..|..| .||+.....++..+++|+.... ...++.+|...|+.|. +--+.++++++.+.+..++|||++++.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34455555 6999887777778899976542 3456888999999885 434677889999999999999999998887
Q ss_pred HHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 041096 433 RMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC-------------------------------------------- 468 (645)
Q Consensus 433 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 468 (645)
+...... .....+..+++..|+-||...
T Consensus 109 ~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7653221 122345566666666666420
Q ss_pred -----------CCCeeeCCCCCCcEEEcCCCCeeeec
Q 041096 469 -----------EQQVIHRDIKASNIMLDANFNARLES 494 (645)
Q Consensus 469 -----------~~~ivHrDlkp~NIlld~~~~~kl~d 494 (645)
...++|+|+.+.|||++.+...-+.|
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viD 217 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCID 217 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECC
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEE
Confidence 12379999999999998765444555
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=3.8e-05 Score=78.84 Aligned_cols=102 Identities=18% Similarity=0.126 Sum_probs=65.9
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCC---Ceeeeeeeee-eCCeEEEEEecCCC
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHK---NLVQLLGWCA-EKGELLLVYEYMPN 428 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~ 428 (645)
.+.++.|....||+. +..+++|+.. .......+.+|.++|..|.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888899987 3557778743 233456789999999999753 3556666664 34567899999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhh
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 466 (645)
.+|....... ++..++..++.++++.|+.||+
T Consensus 98 ~~l~~~~~~~------l~~~~~~~~~~~lg~~La~LH~ 129 (306)
T 3tdw_A 98 QILGEDGMAV------LPDDAKDRLALQLAEFMNELSA 129 (306)
T ss_dssp EECHHHHHTT------SCHHHHHHHHHHHHHHHHHHHH
T ss_pred eECchhhhhh------CCHHHHHHHHHHHHHHHHHHhc
Confidence 8887632110 3344444445555555555543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00017 Score=76.64 Aligned_cols=75 Identities=12% Similarity=0.055 Sum_probs=48.9
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCc--------chhHhHHHHHHHHhhcCC--CC-eeeeeeeeeeCCeEEE
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH--------EGKTEFLAELSIIACLRH--KN-LVQLLGWCAEKGELLL 421 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~--------~~~~~~~~Ei~~l~~l~H--~n-iv~l~g~~~~~~~~~l 421 (645)
.+.||.|..+.||++....++..++||...... .....+..|.+++..+.. +. +.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 457899999999999776556789999754311 123456789888888742 33 34555443 344689
Q ss_pred EEecCCCC
Q 041096 422 VYEYMPNG 429 (645)
Q Consensus 422 V~Ey~~~g 429 (645)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00014 Score=75.99 Aligned_cols=80 Identities=5% Similarity=-0.025 Sum_probs=56.1
Q ss_pred cee-ccCCceEEEEEEEC---C---CCeEEEEEeccCCc---c-hhHhHHHHHHHHhhcC-C--CCeeeeeeeeeeC---
Q 041096 354 RIL-GRGAFGNVYKAYFA---S---SGSVAAVKRSKHSH---E-GKTEFLAELSIIACLR-H--KNLVQLLGWCAEK--- 416 (645)
Q Consensus 354 ~~l-G~G~fg~Vy~g~~~---~---~~~~vavK~~~~~~---~-~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~--- 416 (645)
+.| +.|....+|+.... + ++..+++|+..... . ....+.+|+.+++.|. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 557 78888999998764 1 14678888765422 1 2356788999998885 3 3567788887665
Q ss_pred CeEEEEEecCCCCCHhH
Q 041096 417 GELLLVYEYMPNGSLDR 433 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~ 433 (645)
+..++||||+++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0013 Score=67.72 Aligned_cols=73 Identities=15% Similarity=0.265 Sum_probs=42.4
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCC--CCeeeeee------eeeeCCeEEEEEec
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRH--KNLVQLLG------WCAEKGELLLVYEY 425 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g------~~~~~~~~~lV~Ey 425 (645)
+.|+.|..+.||+.... +..+++|+..... .....|..++..|.. -.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 34666778899999875 3458899887532 334455565555531 12333333 12345678999999
Q ss_pred CCCCCH
Q 041096 426 MPNGSL 431 (645)
Q Consensus 426 ~~~gsL 431 (645)
+++..+
T Consensus 113 i~G~~~ 118 (346)
T 2q83_A 113 IEGRPF 118 (346)
T ss_dssp CCCBCC
T ss_pred ecCccC
Confidence 998654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0013 Score=67.45 Aligned_cols=75 Identities=20% Similarity=0.199 Sum_probs=59.7
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC---CCCeeeeeeeeeeCCeEEEEEecCCCC
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR---HKNLVQLLGWCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~g 429 (645)
.+.|+.|....+|+.... +..+++|+.... ....+..|.+.|+.|. ...+.+.++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESS--SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEEC--CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 456899999999998763 567888876542 3567889999998884 356888888888888899999999987
Q ss_pred CH
Q 041096 430 SL 431 (645)
Q Consensus 430 sL 431 (645)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.009 Score=60.15 Aligned_cols=78 Identities=19% Similarity=0.188 Sum_probs=55.0
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-chhHhHHHHHHHHhhcCCC---CeeeeeeeeeeCCeEEEEEe
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-EGKTEFLAELSIIACLRHK---NLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~~~~~lV~E 424 (645)
.....+.+|.|..+.||+.++.+ |+.+++|+..... .....|..|...|+.|.-. -+.+++++. .-++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 34456779999999999999875 7788999865432 2344678999999988522 344455543 2378999
Q ss_pred cCCCCCH
Q 041096 425 YMPNGSL 431 (645)
Q Consensus 425 y~~~gsL 431 (645)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0061 Score=65.09 Aligned_cols=67 Identities=13% Similarity=0.129 Sum_probs=43.9
Q ss_pred CCCeeeCCCCCCcEEEcCCCCeeeeccccccccC-------------CcccCcccccCC---CCCcchhHHHHHHHHHHH
Q 041096 469 EQQVIHRDIKASNIMLDANFNARLESSFTLTAGT-------------MGYLAPEYLQYG---TATEKTDVFSYGVVVLEV 532 (645)
Q Consensus 469 ~~~ivHrDlkp~NIlld~~~~~kl~d~~~~~~gt-------------~~y~APE~~~~~---~~t~ksDV~SfGvvl~El 532 (645)
...++|+|+++.|||++.+. ..+.|......|. ..|++|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 47899999999999999876 7777743333332 235666655321 112345666888888887
Q ss_pred HcCC
Q 041096 533 ACGR 536 (645)
Q Consensus 533 ~tG~ 536 (645)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.42 E-value=0.047 Score=52.22 Aligned_cols=104 Identities=15% Similarity=0.044 Sum_probs=68.1
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccccccccCCcccC
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTLTAGTMGYLA 507 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~~~~~gt~~y~A 507 (645)
.-||.++|..... ++...+++.++.|.+++|.-+-... .. ..+=+.|..|+|..+|++........ .....+.|
T Consensus 32 ~vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~~~s~-~~~~~~~~ 105 (229)
T 2yle_A 32 ALSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAPAADD-AGEPPPVA 105 (229)
T ss_dssp EEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECCC------------
T ss_pred cccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccccccc-ccccCCCC
Confidence 3479999987654 4999999999999999987762100 11 12234468999999999988653321 23345778
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHcCCCC
Q 041096 508 PEYLQYGTATEKTDVFSYGVVVLEVACGRRP 538 (645)
Q Consensus 508 PE~~~~~~~t~ksDV~SfGvvl~El~tG~~P 538 (645)
||... ...+.+.=|||+|+++|.-+-=..|
T Consensus 106 pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 106 GKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred hhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 88763 3557899999999999998864433
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0069 Score=61.47 Aligned_cols=71 Identities=11% Similarity=0.027 Sum_probs=44.5
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCe-eeeeeeeeeCCeEEEEEecC-CCCC
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNL-VQLLGWCAEKGELLLVYEYM-PNGS 430 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~gs 430 (645)
.+.|+.|....+|+. ..+++|+............+|...++.+....+ .++++++.+ .-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCcc
Confidence 567888999999998 346788766532222334578888777753222 455555433 347899999 6555
Q ss_pred H
Q 041096 431 L 431 (645)
Q Consensus 431 L 431 (645)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.32 E-value=0.016 Score=59.10 Aligned_cols=156 Identities=14% Similarity=0.141 Sum_probs=85.4
Q ss_pred ccCHHHHHHHhcCCCcC-----ceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCC--eeee
Q 041096 337 EFSYRELRSATRGFHSN-----RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKN--LVQL 409 (645)
Q Consensus 337 ~~~~~~l~~~~~~f~~~-----~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l 409 (645)
.++.+++......|... +.|+.|....+|+....+ + .+++|..... .....+..|+.++..|.... +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 35566777777767652 346678888999998753 3 5788887652 22345667888877774222 2333
Q ss_pred eee------eeeCCeEEEEEecCCCCCHhH--------------HhhhcCC----CC----ccCCHHHHHH---------
Q 041096 410 LGW------CAEKGELLLVYEYMPNGSLDR--------------MLYQDSE----NG----VLLSWYHRLN--------- 452 (645)
Q Consensus 410 ~g~------~~~~~~~~lV~Ey~~~gsL~~--------------~l~~~~~----~~----~~l~~~~~~~--------- 452 (645)
+.. ....+..+++++|+++..+.. .++.... .. ....|...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 122356799999998865421 1121110 00 0112433111
Q ss_pred ---HHHHHHHHHHHHhhc----CCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 453 ---IVVGLASALTYLHQE----CEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 453 ---i~~~ia~gL~yLH~~----~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
+...+.+.++.+++. ....++|+|+.+.|||++.+....+.|.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf 212 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDF 212 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCC
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecc
Confidence 011244455666532 2357999999999999987644445553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.03 E-value=0.12 Score=52.49 Aligned_cols=94 Identities=12% Similarity=0.047 Sum_probs=57.8
Q ss_pred cccCHHHHHHHhcCCCc-----CceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCC--eee
Q 041096 336 REFSYRELRSATRGFHS-----NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKN--LVQ 408 (645)
Q Consensus 336 ~~~~~~~l~~~~~~f~~-----~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~ 408 (645)
...+.+++..+...|.. ...++ |....||+....+ |..+++|...........+..|..++..|.... +.+
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~-g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDED-RRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTT-CCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCC-CCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecc
Confidence 34455566555544432 23466 7788999886643 557889988643334556777888888774222 344
Q ss_pred eeee-----eeeCCeEEEEEecCCCCCH
Q 041096 409 LLGW-----CAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 409 l~g~-----~~~~~~~~lV~Ey~~~gsL 431 (645)
++.. ....+..+++|||+++..+
T Consensus 87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 87 PVAFNGQTLLNHQGFYFAVFPSVGGRQF 114 (328)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred eeecCCcEEEEECCEEEEEEEecCCCCC
Confidence 4433 1224567899999987543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.01 E-value=0.01 Score=63.70 Aligned_cols=73 Identities=18% Similarity=0.260 Sum_probs=50.0
Q ss_pred ceeccCCceEEEEEEECC-------CCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCe-eeeeeeeeeCCeEEEEEec
Q 041096 354 RILGRGAFGNVYKAYFAS-------SGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNL-VQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~-------~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey 425 (645)
+.|+.|....+|+..... .+..+++|+.... .....+..|..++..|...++ .++++.+.+ .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 457888889999998753 2467888887432 112456689999988853333 566776543 289999
Q ss_pred CCCCCH
Q 041096 426 MPNGSL 431 (645)
Q Consensus 426 ~~~gsL 431 (645)
+++.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.02 Score=61.90 Aligned_cols=75 Identities=16% Similarity=0.094 Sum_probs=49.2
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCe-eeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNL-VQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
.+.|+.|-...+|+....+.+..+++|+........-+..+|..++..|...++ .++++.+.. .+||||+++.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 356888888999999886545788898875422222223689999998865444 467776632 259999987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.96 E-value=0.012 Score=61.82 Aligned_cols=137 Identities=15% Similarity=0.115 Sum_probs=76.7
Q ss_pred ceeccCCceEEEEEEECC-------CCeEEEEEeccCCcchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCeEEEEEec
Q 041096 354 RILGRGAFGNVYKAYFAS-------SGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~-------~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+.|..|-...+|+....+ .+..+++|+............+|..+++.|. +.-..++++++.++ +||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence 456667778899988742 3467889886443334556778999998885 33335667666542 99999
Q ss_pred CCCCCHhHH-----------------hhhcC-CCCccC--CHHHHHHHHHHHH-------------------HHHHHHhh
Q 041096 426 MPNGSLDRM-----------------LYQDS-ENGVLL--SWYHRLNIVVGLA-------------------SALTYLHQ 466 (645)
Q Consensus 426 ~~~gsL~~~-----------------l~~~~-~~~~~l--~~~~~~~i~~~ia-------------------~gL~yLH~ 466 (645)
+++.+|..- |+.-. ...... -|.+..+...++. ..+..|.+
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 988665321 11111 001112 2444444443332 12333332
Q ss_pred -----cCCCCeeeCCCCCCcEEEcCC----CCeeeec
Q 041096 467 -----ECEQQVIHRDIKASNIMLDAN----FNARLES 494 (645)
Q Consensus 467 -----~~~~~ivHrDlkp~NIlld~~----~~~kl~d 494 (645)
.....++|+|+.+.|||++.+ ....+.|
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~ID 248 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVD 248 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECC
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEe
Confidence 123568999999999999876 4555555
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.55 E-value=0.024 Score=59.25 Aligned_cols=74 Identities=9% Similarity=0.104 Sum_probs=44.8
Q ss_pred ceeccCCceEEEEEEECCC--------CeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCe-eeeeeeeeeCCeEEEEEe
Q 041096 354 RILGRGAFGNVYKAYFASS--------GSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNL-VQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~--------~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 424 (645)
+.|+.|..-.+|+....+. +..+++|+.........+...|..+++.|...++ .++++.. . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 4577787889999987531 2578888776533322234678888888853343 3566543 2 268999
Q ss_pred cCCCCCH
Q 041096 425 YMPNGSL 431 (645)
Q Consensus 425 y~~~gsL 431 (645)
|+++.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.37 E-value=0.12 Score=52.78 Aligned_cols=76 Identities=13% Similarity=0.130 Sum_probs=39.8
Q ss_pred eeccCCceE-EEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCC--CCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 355 ILGRGAFGN-VYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRH--KNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 355 ~lG~G~fg~-Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
.|+.|.... +|+....+ +..+++|...... ..++..|+.++..+.. -.+.+++.++.+.+ +++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~-~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPT-GAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTT-CCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCC-CCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 455554443 66765432 4556677544322 1345567777777642 23456666654444 789999977776
Q ss_pred hHHh
Q 041096 432 DRML 435 (645)
Q Consensus 432 ~~~l 435 (645)
.+++
T Consensus 100 ~~~l 103 (333)
T 3csv_A 100 TEVI 103 (333)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 5544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.11 E-value=0.66 Score=47.61 Aligned_cols=66 Identities=20% Similarity=0.134 Sum_probs=41.9
Q ss_pred CCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCC---CCeeeeeee------eeeCCeEEEEEecCCCC
Q 041096 359 GAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRH---KNLVQLLGW------CAEKGELLLVYEYMPNG 429 (645)
Q Consensus 359 G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~------~~~~~~~~lV~Ey~~~g 429 (645)
|....||+....+ + .+++|+...... ..|+..+..|.. +++.+.+.. +...+..+++|||+++.
T Consensus 34 g~~N~vy~v~~~~-g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 34 DTNAFAYQADSES-K-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp CSSCEEEEEECSS-C-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred ccccceEEEEeCC-C-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 3357899998654 4 788997665331 356666666632 224454432 23356789999999987
Q ss_pred CH
Q 041096 430 SL 431 (645)
Q Consensus 430 sL 431 (645)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 65
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=89.72 E-value=1.2 Score=47.33 Aligned_cols=74 Identities=8% Similarity=0.036 Sum_probs=47.8
Q ss_pred ceeccCCceEEEEEEECCC-------CeEEEEEeccCCcchhHhHHHHHHHHhhcCC-CCeeeeeeeeeeCCeEEEEEec
Q 041096 354 RILGRGAFGNVYKAYFASS-------GSVAAVKRSKHSHEGKTEFLAELSIIACLRH-KNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~-------~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey 425 (645)
+.|..|-...+|+...... +..+++|+........-+..+|..+++.+.- .-..++++.+. -++||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 4566777889999987531 4678888865433223344678888888853 22345555332 2789999
Q ss_pred CCCCCH
Q 041096 426 MPNGSL 431 (645)
Q Consensus 426 ~~~gsL 431 (645)
+++.+|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998664
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.29 E-value=0.06 Score=37.31 Aligned_cols=29 Identities=14% Similarity=0.248 Sum_probs=16.7
Q ss_pred eeeecchhHHHHHHHHHhheeeeEEeecc
Q 041096 292 GLGLGIAGPAFFCVVLAVFGYISIKKWKN 320 (645)
Q Consensus 292 ~i~~~i~~~~~~~~~~~~~~~~~~rk~~~ 320 (645)
.|+.+++++++++++++++.++++||++.
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 46667776666655555555555554443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.20 E-value=0.076 Score=36.69 Aligned_cols=29 Identities=14% Similarity=0.248 Sum_probs=16.0
Q ss_pred eeeecchhHHHHHHHHHhheeeeEEeecc
Q 041096 292 GLGLGIAGPAFFCVVLAVFGYISIKKWKN 320 (645)
Q Consensus 292 ~i~~~i~~~~~~~~~~~~~~~~~~rk~~~ 320 (645)
.|+.+++++++++++++++.++++||++.
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 46666666666555555554555554443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.51 E-value=0.1 Score=56.34 Aligned_cols=58 Identities=5% Similarity=0.028 Sum_probs=16.1
Q ss_pred CceeccCCceEEEEEEECCCCeEEEE------EeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeee
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAV------KRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWC 413 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vav------K~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 413 (645)
.+.|| ||.||+|.+.....+||+ |..+. +.+....|.+|..+++.++|+|+++.+++.
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 45566 999999999765567888 65544 233345788999999999999999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 645 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-56 | |
| d1hqla_ | 236 | b.29.1.1 (A:) Legume lectin {Griffonia simplicifol | 1e-55 | |
| d1g8wa_ | 233 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 8e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-54 | |
| d1avba_ | 226 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 2e-54 | |
| d1gzca_ | 239 | b.29.1.1 (A:) Legume lectin {Cockspur coral tree ( | 2e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-54 | |
| d1leda_ | 243 | b.29.1.1 (A:) Legume lectin {West-central african | 2e-53 | |
| d1fx5a_ | 240 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 3e-53 | |
| d1g7ya_ | 253 | b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos | 5e-53 | |
| d1qnwa_ | 237 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 5e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-53 | |
| g1qmo.1 | 230 | b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich | 1e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-51 | |
| d2d3sa1 | 237 | b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso | 3e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-50 | |
| d1fnya_ | 237 | b.29.1.1 (A:) Legume lectin {Black locust (Robinia | 4e-50 | |
| d1v6ia_ | 232 | b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog | 1e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-49 | |
| d1f9ka_ | 234 | b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca | 9e-49 | |
| d1ukga_ | 241 | b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero | 1e-48 | |
| d1n47a_ | 233 | b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi | 2e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-48 | |
| g2ltn.1 | 229 | b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum | 2e-48 | |
| d1g9fa_ | 251 | b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) | 3e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-46 | |
| d1dbna_ | 239 | b.29.1.1 (A:) Legume lectin {Maackia amurensis, le | 3e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-45 | |
| d1ioaa_ | 228 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 2e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-40 | |
| d1dhkb_ | 204 | b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar | 2e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-35 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 3e-34 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 7e-19 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-27 | |
| d1gv9a_ | 228 | b.29.1.13 (A:) Carbohydrate-recognition domain of | 7e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-25 | |
| d2a6va1 | 218 | b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake | 2e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-15 | |
| d2a6za1 | 221 | b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake | 4e-11 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-57
Identities = 59/284 (20%), Positives = 116/284 (40%), Gaps = 38/284 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+ +G G+FG VYK + +V + + + + F E+ ++ RH N++ +G+
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+L +V ++ SL L+ ++I A + YLH + +I
Sbjct: 74 -TAPQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 474 HRDIKASNIMLDANFNARL--------------ESSFTLTAGTMGYLAPEYLQY---GTA 516
HRD+K++NI L + ++ F +G++ ++APE ++
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 517 TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576
+ ++DV+++G+V+ E+ G+ P N D + + G + K +
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNI-------NNRDQIIFMVGRGYLSPDLSKVRSNC- 238
Query: 577 NEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPK 620
MKRL+ C RP ++ + A L PK
Sbjct: 239 -PKAMKRLM---AECLKKKRDERPLFPQILASIELLARSL--PK 276
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (484), Expect = 3e-56
Identities = 70/305 (22%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 338 FSYRELRSATRGFHSN---------RILGRGAFGNVYKAYFASSGS---VAAVKR--SKH 383
F++ + A R F +++G G FG V + G A+K S +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 384 SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGV 443
+ + + +FL+E SI+ H N++ L G + ++++ E+M NGSLD L Q+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 444 LLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL----------- 492
+ + ++ G+A+ + YL +HRD+ A NI++++N ++
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 493 ------ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLE-VACGRRPIERETEG 545
+S + + APE +QY T +DV+SYG+V+ E ++ G RP T
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-- 238
Query: 546 HKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRV 605
+I A ++ D L + L C D + RP ++
Sbjct: 239 ---------------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 606 FQILN 610
L+
Sbjct: 284 VNTLD 288
|
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Score = 187 bits (475), Expect = 1e-55
Identities = 77/240 (32%), Positives = 126/240 (52%), Gaps = 15/240 (6%)
Query: 24 NMNFDFTSFN---LRNITLLGDSYLRNGVIGLTRELGVP---ASSSGSLIYNNPVPFFDQ 77
+++F F +F +I GD+ G + L + S+G +Y++PV +D
Sbjct: 1 SVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDN 60
Query: 78 ETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSS---QLTKN 134
+T + ASF + F+F + + DGLAFF++P + + AG LGL N S Q +KN
Sbjct: 61 KTESVASFYTEFTFFLKI-TGNGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKN 119
Query: 135 KFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKND 194
+ VA+EFDT +P+F +P HIG++++S+ S+ T + D+ SG + TA I Y
Sbjct: 120 QVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKR--WEDSDIFSGKIATARISYDGS 177
Query: 195 LRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTEL-HMIQSWSFQTS 253
+L V +SY +L ++D+ L ++ VG SAST + L I SW F ++
Sbjct: 178 AEILTVVLSYP--DGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFSSN 235
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 184 bits (468), Expect = 8e-55
Identities = 79/239 (33%), Positives = 119/239 (49%), Gaps = 15/239 (6%)
Query: 22 SNNMNFDFTSFNLRNITLLGD-SYLRNGVIGLTRELG---VPASSSGSLIYNNPVPFFDQ 77
SN++ F+F FN N+ L D S +G + LT G S G Y+ P+ +D
Sbjct: 1 SNDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDN 60
Query: 78 ETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFV 137
T T ASF + F+F+I N + DGLAF + P GG LGL + S + V
Sbjct: 61 TTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKDKGGFLGLFDGSN-SNFHTV 119
Query: 138 AIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRM 197
A+EFDT + + DP E HIG+D++S+ SIKT D +G I Y + +
Sbjct: 120 AVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRW-----DFVNGENAEVLITYDSSTNL 173
Query: 198 LKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQTS 253
L + Y + + + ++ +DL L + VGFSA+T +G+ E + + SWSF +
Sbjct: 174 LVASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASK 231
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-54
Identities = 60/274 (21%), Positives = 108/274 (39%), Gaps = 36/274 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+ +G G FG V+ Y+ + VA +K + + +F+ E ++ L H LVQL G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
E+ + LV+E+M +G L L + L + + + + E VI
Sbjct: 70 LEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEG---MAYLEEACVI 123
Query: 474 HRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEKT 520
HRD+ A N ++ N ++ +S T T + + +PE + + K+
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 521 DVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDE 580
DV+S+GV++ EV + ++V + + LY
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY----------------KPRLA 227
Query: 581 MKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614
+ + C RP+ R+ + L AE
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (471), Expect = 2e-54
Identities = 65/290 (22%), Positives = 117/290 (40%), Gaps = 34/290 (11%)
Query: 335 PREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAE 394
P +Y + LG G +G VY+ + AVK K EFL E
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 63
Query: 395 LSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIV 454
+++ ++H NLVQLLG C + ++ E+M G+L L + N +S L +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMA 121
Query: 455 VGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAG 501
++SA+ YL + + IHRD+ A N ++ N ++ ++
Sbjct: 122 TQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 502 TMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE 561
+ + APE L Y + K+DV+++GV++ E+A + ++ L+
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------- 229
Query: 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+K E +++ + +C + S RPS + Q
Sbjct: 230 -------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 183 bits (465), Expect = 2e-54
Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 16/236 (6%)
Query: 22 SNNMNFDFTSFNLRNITLLGD-SYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETN 80
SN+ +F+ +FN N+ L GD + G + LT G S G Y+ P+ D+ +
Sbjct: 1 SNDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTID 60
Query: 81 TTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIE 140
ASF++ F+F IN N + GLAF + P G LGL N+ +
Sbjct: 61 NLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKLKGRYLGLFNT--------TNYD 112
Query: 141 FDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLKV 200
D D N I +D++S+ I T +G I Y + L+V
Sbjct: 113 RDAHTVAVVFDTVSNRIEIDVNSIRPIATESC---NFGHNNGEKAEVRITYDSPKNDLRV 169
Query: 201 FMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQTS 253
+ Y + + + L ++ + VGFSA++ + +TE H + SWSF ++
Sbjct: 170 SLLYPS-SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSN 224
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Score = 183 bits (466), Expect = 2e-54
Identities = 78/240 (32%), Positives = 116/240 (48%), Gaps = 18/240 (7%)
Query: 26 NFDFTSFNL--RNITLLGDSYL-RNGVIGLTRE---LGVPASSSGSLIYNNPVPFFDQET 79
+F F+ F N+TL G + + ++GV+ LT+ S+G +Y PV +D T
Sbjct: 5 SFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTT 64
Query: 80 NTTASFTSRFSFSINNVNPSSFG-DGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFV 137
T ASF +RFSFSI DGL FF+ P G LG+ N+S+ + +
Sbjct: 65 GTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDNSYQTL 124
Query: 138 AIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRM 197
A+EFDT +P +D P HIG+D++S+ SIKT L +G V I Y ++
Sbjct: 125 AVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQPF-----QLDNGQVANVVIKYDAPSKI 178
Query: 198 LKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQTSG 254
L V + Y + + +D+ L + VG S +T + E H + SWSFQ S
Sbjct: 179 LHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQASL 237
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-54
Identities = 66/312 (21%), Positives = 121/312 (38%), Gaps = 47/312 (15%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLV 407
F LG G G V+K SG V A K + + + + EL ++ +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
G GE+ + E+M GSLD++L + + + + + LTYL ++
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREK 123
Query: 468 CEQQVIHRDIKASNIMLDANFNARL----------ESSFTLTAGTMGYLAPEYLQYGTAT 517
+++HRD+K SNI++++ +L +S GT Y++PE LQ +
Sbjct: 124 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 518 EKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577
++D++S G+ ++E+A GR PI + V G AE R ++
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 578 EDEMKRLLLVGL--------------------------SCANPDSSARPSMRRVFQ---I 608
D + + L C + + R ++++ I
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 609 LNNEAEPLVVPK 620
++AE +
Sbjct: 302 KRSDAEEVDFAG 313
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-54
Identities = 60/271 (22%), Positives = 119/271 (43%), Gaps = 36/271 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
LG G FG V+ Y+ + + AVK K FLAE +++ L+H+ LV+L
Sbjct: 19 ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
+ + ++ EYM NGSL L +G+ L+ L++ +A + ++ E+ I
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 474 HRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEKT 520
HRD++A+NI++ + ++ ++ + + APE + YGT T K+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 521 DVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDE 580
DV+S+G+++ E+ R +++ ++ + + +E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-------------PEE 238
Query: 581 MKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+ +L+ C RP+ + +L +
Sbjct: 239 LYQLM---RLCWKERPEDRPTFDYLRSVLED 266
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Score = 181 bits (460), Expect = 2e-53
Identities = 78/243 (32%), Positives = 120/243 (49%), Gaps = 19/243 (7%)
Query: 23 NNMNFDFTSF------NLRNITLLGDSYLRNGVIGLTRELGVP---ASSSGSLIYNNPVP 73
N +NF + F N IT LGD+ G + LT+ SS+G Y+ PV
Sbjct: 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVF 61
Query: 74 FFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQL-- 131
+D T ASF + F+F + + DGLAFF++P + + GG LGL
Sbjct: 62 LWDS-TGKAASFYTSFTF-LLKNYGAPTADGLAFFLAPVDSSVKDYGGFLGLFRHETAAD 119
Query: 132 -TKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWID 190
+KN+ VA+EFDT ++ ++DP HIG+D++S+ S+ T + D ++ TA I
Sbjct: 120 PSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTR--WENDDAYGSSIATAHIT 177
Query: 191 YKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSF 250
Y ++L V +SY +L +DL+ L + +GFSA G E+ I SW F
Sbjct: 178 YDARSKILTVLLSYE--HGRDYILSHVVDLAKVLPQKVRIGFSAGV-GYDEVTYILSWHF 234
Query: 251 QTS 253
++
Sbjct: 235 FST 237
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Score = 180 bits (458), Expect = 3e-53
Identities = 71/240 (29%), Positives = 119/240 (49%), Gaps = 12/240 (5%)
Query: 22 SNNMNFDFTSF--NLRNITLLGD-SYLRNGVIGLTREL-GVPASSSGSLIYNNPVPFFDQ 77
S++++F F +F N ++++ G+ S + GV+ L + +P + G Y P+ ++
Sbjct: 1 SDDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNC 60
Query: 78 ETNTTASFTSRFSF-SINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQL-TKNK 135
T ASF + FSF + NP + DGL FF++P + L AGG GL N ++ + +
Sbjct: 61 NTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTKCDSSYQ 120
Query: 136 FVAIEFDTRLDP-HFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKND 194
VA+EFDT P +F DP HIG+D++ ++SI NV I Y+
Sbjct: 121 TVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAER---WNKRYGLNNVANVEIIYEAS 177
Query: 195 LRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST-EGSTELHMIQSWSFQTS 253
+ L ++Y + + + +DL L + VGFS ST G H + +W F ++
Sbjct: 178 SKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFTST 236
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Score = 180 bits (458), Expect = 5e-53
Identities = 72/239 (30%), Positives = 122/239 (51%), Gaps = 14/239 (5%)
Query: 22 SNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELG---VPASSSGSLIYNNPVPFFDQE 78
++ +F F +FN + L GD+ + + + LT+ G SS G Y++P+ +D+
Sbjct: 1 ADIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKS 60
Query: 79 TNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLT-KNKFV 137
T AS+ + F+ +I N SS DG+AF + P S G LG+ +S + V
Sbjct: 61 TGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDNSAQTV 120
Query: 138 AIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRM 197
A+EFDT + + DP HIG+D++S++SI+TA L +G I Y +
Sbjct: 121 AVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASW-----GLANGQNAEILITYNAATSL 174
Query: 198 LKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQTS 253
L + + + + + ++ +D++ L + +GFSA+T EG TE H + SWSF +
Sbjct: 175 LVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASK 232
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Score = 179 bits (456), Expect = 5e-53
Identities = 80/242 (33%), Positives = 128/242 (52%), Gaps = 17/242 (7%)
Query: 22 SNNMNFDFTSF--NLRNITLLGD-SYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQE 78
S++++F+F F N +NI GD S GV+ +T+ +S G +Y P+ +D
Sbjct: 1 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSI 60
Query: 79 TNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQIL--GSAGGCLGLVNSS-QLTKNK 135
T ASF + FSF + + S DGLAFF++P N + GS+ G GL +SS + N+
Sbjct: 61 TGKVASFATSFSFVVKA-DKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQ 119
Query: 136 FVAIEFDTRLDPHFD--DPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKN 193
+A+EFDT ++ DPD HIG+D++S++SIKT D ++G V I Y+
Sbjct: 120 IIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVK-----WDWRNGEVADVVITYRA 174
Query: 194 DLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGST--ELHMIQSWSFQ 251
+ L V +SY + + ++ ++DL L + VGFS + E H + SW F
Sbjct: 175 PTKSLTVCLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFT 233
Query: 252 TS 253
++
Sbjct: 234 SN 235
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 8e-53
Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 34/268 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+ +G+G FG+V + G+ AVK K+ + FLAE S++ LRH NLVQLLG
Sbjct: 13 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ-AFLAEASVMTQLRHSNLVQLLGVI 69
Query: 414 AE-KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
E KG L +V EYM GSL L S +L L + + A+ YL
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 124
Query: 473 IHRDIKASNIMLDANFNAR---------LESSFTLTAGTMGYLAPEYLQYGTATEKTDVF 523
+HRD+ A N+++ + A+ S+ + + APE L+ + K+DV+
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 184
Query: 524 SYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKR 583
S+G+++ E+ R +V V+ +G ++A D +
Sbjct: 185 SFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPDGC------PPAVYE 231
Query: 584 LLLVGLSCANPDSSARPSMRRVFQILNN 611
++ +C + D++ RPS ++ + L +
Sbjct: 232 VM---KNCWHLDAAMRPSFLQLREQLEH 256
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-52
Identities = 58/273 (21%), Positives = 113/273 (41%), Gaps = 36/273 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE---FLAELSIIACLRHKNLVQLL 410
+G G++G K S G + K + + E ++E++++ L+H N+V+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 411 GWCAEK--GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ-- 466
++ L +V EY G L ++ + ++ L L ++ L AL H+
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 467 ECEQQVIHRDIKASNIMLDANFNARL------------ESSFTLTAGTMGYLAPEYLQYG 514
+ V+HRD+K +N+ LD N +L S GT Y++PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM 189
Query: 515 TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574
+ EK+D++S G ++ E+ P ++ G+I E +R+
Sbjct: 190 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-------------GKIREGKFRRIPY 236
Query: 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607
++ DE+ ++ N RPS+ + +
Sbjct: 237 RYS-DELNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 9e-52
Identities = 68/308 (22%), Positives = 112/308 (36%), Gaps = 44/308 (14%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR----SKHSHEGKTEFLAELSIIACLRHKN 405
F R +G G+FG VY A + V A+K+ K S+E + + E+ + LRH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+Q G + LV EY + D + L + G L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLH 132
Query: 466 QECEQQVIHRDIKASNIMLDANFN--------ARLESSFTLTAGTMGYLAPEYLQ---YG 514
+IHRD+KA NI+L A + + GT ++APE + G
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEG 189
Query: 515 TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574
K DV+S G+ +E+A + P+ + + I + L
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-------------IAQNESPALQS 236
Query: 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPLVVPKLKPCLTFSSVSLTL 634
+ + + SC RP+ +L + V+ + P + + T
Sbjct: 237 GHWSEYFRNFV---DSCLQKIPQDRPTSE---VLLKH---RFVLRERPPTVIMDLIQRTK 287
Query: 635 EDIVSEDE 642
+ + D
Sbjct: 288 DAVRELDN 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-51
Identities = 59/270 (21%), Positives = 110/270 (40%), Gaps = 38/270 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+ LG G FG V + VA +K K + EF+ E ++ L H+ LVQL G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVA-IKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
++ + ++ EYM NG L L + L + + A+ YL +Q +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 474 HRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEKT 520
HRD+ A N +++ ++ +S + + + PE L Y + K+
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 521 DVFSYGVVVLEV-ACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED 579
D++++GV++ E+ + G+ P ER T E + L
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSE-----------------TAEHIAQGLRLYRPHL 225
Query: 580 EMKRLLLVGLSCANPDSSARPSMRRVFQIL 609
+++ + SC + + RP+ + + +
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Score = 175 bits (444), Expect = 3e-51
Identities = 81/242 (33%), Positives = 114/242 (47%), Gaps = 23/242 (9%)
Query: 26 NFDFTSF--NLRNITLLGD-SYLRNGVIGLTRELGVPAS--SSGSLIYNNPVPFFDQETN 80
+F+F F N + L D N V+ LT+ + + S+G +Y PV +D T
Sbjct: 4 SFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTG 63
Query: 81 TTASFTSRFSFSINNVNPSSFG-DGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAI 139
ASF +RFSFSI P DGL FFI+P N G GG G+ N + FVA+
Sbjct: 64 NVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPL--SPYPFVAV 121
Query: 140 EFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLK 199
EFDT + DP HIG+D++S+ S KT L +G + I Y ++L
Sbjct: 122 EFDTFRNT--WDPQIPHIGIDVNSVISTKTVP-----FTLDNGGIANVVIKYDASTKILH 174
Query: 200 VFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST-------EGSTELHMIQSWSFQT 252
V + + + + +DL L ++ VGFSA+T +TE H I SWSF
Sbjct: 175 VVLVFPS-LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSFSA 233
Query: 253 SG 254
S
Sbjct: 234 SL 235
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 7e-51
Identities = 57/293 (19%), Positives = 113/293 (38%), Gaps = 42/293 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
+G+G FG V++ + G AVK E AE+ LRH+N++ +
Sbjct: 9 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 414 AEKG----ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC- 468
+ +L LV +Y +GSL L + + ++ + + + AS L +LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 469 ----EQQVIHRDIKASNIMLDANFNARL----------------ESSFTLTAGTMGYLAP 508
+ + HRD+K+ NI++ N + + + GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 509 EYLQ------YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKM---VNLVDWVWGLY 559
E L + + ++ D+++ G+V E+A + + D
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 560 AEGRIIEAADKRLNGAFNEDEMKRLLL-VGLSCANPDSSARPSMRRVFQILNN 611
+ + + + E R++ + C + +AR + R+ + L+
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-50
Identities = 57/282 (20%), Positives = 115/282 (40%), Gaps = 43/282 (15%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGS----VAAVKRSK--HSHEGKTEFLAELSIIACLRH 403
+++G G FG VYK +S A+K K ++ + + +FL E I+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 404 KNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
N+++L G ++ ++++ EYM NG+ + E S + ++ G+A+ + Y
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGA---LDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARL---------------ESSFTLTAGTMGYLAP 508
L +HRD+ A NI++++N ++ + + + + AP
Sbjct: 126 LA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 509 EYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568
E + Y T +DV+S+G+V+ EV E H+++ +
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---------------- 226
Query: 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610
+ D + + + C + + RP + IL+
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-50
Identities = 59/275 (21%), Positives = 110/275 (40%), Gaps = 36/275 (13%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQL 409
LG+G FG V+ + + VA +K K FL E ++ LRH+ LVQL
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVA-IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
+ + +V EYM GSL + E G L +++ +AS + Y+ +
Sbjct: 78 YAVV-SEEPIYIVTEYMSKGSLL--DFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 470 QQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTA 516
+HRD++A+NI++ N ++ ++ + + APE YG
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 517 TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576
T K+DV+S+G+++ E+ R ++++ V ++
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV----------------ERGYRMPC 235
Query: 577 NEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+ + L + C + RP+ + L +
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Score = 172 bits (436), Expect = 4e-50
Identities = 71/242 (29%), Positives = 121/242 (50%), Gaps = 16/242 (6%)
Query: 22 SNNMNFDFTSF--NLRNITLLGDSYLR-NGVIGLTRELGVPAS--SSGSLIYNNPVPFFD 76
+ +++F F F N + GD+ + GV+ LT + S S G +Y P +D
Sbjct: 1 TGSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWD 60
Query: 77 QETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSS-QLTKNK 135
T ASF + F+F I NP++ DGLAFF++P + GG LG+ N+
Sbjct: 61 STTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNKSNQ 120
Query: 136 FVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDL 195
VA+EFDT + + DP H+G++++S+ESIKT + +G V +I Y+
Sbjct: 121 IVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPW-----NWTNGEVANVFISYEAST 174
Query: 196 RMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQT 252
+ L + Y + + ++ +D+ L + GFSA+T +G + + + SWSF++
Sbjct: 175 KSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFES 233
Query: 253 SG 254
+
Sbjct: 234 NL 235
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Score = 170 bits (432), Expect = 1e-49
Identities = 70/237 (29%), Positives = 119/237 (50%), Gaps = 14/237 (5%)
Query: 22 SNNMNFDFTSFNLRN--ITLLGD-SYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQE 78
+ ++F+F SF+ N I GD + L NG I LT +S G ++Y PV +
Sbjct: 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTN--LNKVNSVGRVLYAMPVRIWSSA 58
Query: 79 TNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFV 137
T ASF + FSF + ++ DG+ FFI+P++ + + G + S FV
Sbjct: 59 TGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKGAGHFV 118
Query: 138 AIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRM 197
+EFDT + ++DP +H+G+D++S++S+KT + SG V+ + Y + +
Sbjct: 119 GVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW-----NSVSGAVVKVTVIYDSSTKT 173
Query: 198 LKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST-EGSTELHMIQSWSFQTS 253
L V ++ + +DL L + GFSAS G ++H+I+SWSF ++
Sbjct: 174 LSVAVTND--NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTST 228
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 2e-49
Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 44/297 (14%)
Query: 336 REFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGS---VAAVKRSKH--SHEGKTE 390
+ + + ++ H N ++GRG FG VY + AVK ++
Sbjct: 15 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 74
Query: 391 FLAELSIIACLRHKNLVQLLGWCAE-KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYH 449
FL E I+ H N++ LLG C +G L+V YM +G L + ++ N +
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKD 131
Query: 450 RLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL----------------E 493
+ + +A + ++ +HRD+ A N MLD F ++
Sbjct: 132 LIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188
Query: 494 SSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVD 553
+ T + ++A E LQ T K+DV+S+GV++ E+ P + N D
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFD 242
Query: 554 WVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610
L R+ L + D + ++ L C +P + RPS + ++
Sbjct: 243 ITVYLLQGRRL-------LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 289
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-49
Identities = 64/272 (23%), Positives = 111/272 (40%), Gaps = 39/272 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
LG GAFG VYKA + +AA K S E +++ E+ I+A H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
+ L ++ E+ G++D ++ E L+ + AL YLH + ++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 473 IHRDIKASNIMLDANFNARL------------ESSFTLTAGTMGYLAPEYLQYGTA---- 516
IHRD+KA NI+ + + +L GT ++APE + T+
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 517 -TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575
K DV+S G+ ++E+A P ++ + A+ + K
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF--- 248
Query: 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607
+K+ L + AR + ++ Q
Sbjct: 249 -----LKKCL-------EKNVDARWTTSQLLQ 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-49
Identities = 78/317 (24%), Positives = 127/317 (40%), Gaps = 50/317 (15%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGS--VAAVKRSK--HSHEGKTEFLAELSIIACL-RHK 404
++G G FG V KA G AA+KR K S + +F EL ++ L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQ------------DSENGVLLSWYHRLN 452
N++ LLG C +G L L EY P+G+L L + + LS L+
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 453 IVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLTAG 501
+A + YL ++Q IHRD+ A NI++ N+ A++ T+
Sbjct: 132 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188
Query: 502 TMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE 561
+ ++A E L Y T +DV+SYGV++ E+ ++ + +
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-------Q 241
Query: 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN---EAEPLVV 618
G +E +DE+ L+ C RPS ++ LN E + V
Sbjct: 242 GYRLEKPLNC------DDEVYDLM---RQCWREKPYERPSFAQILVSLNRMLEERKTYVN 292
Query: 619 PKLKPCLTFSSVSLTLE 635
L T++ + + E
Sbjct: 293 TTLYEKFTYAGIDCSAE 309
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Score = 168 bits (426), Expect = 9e-49
Identities = 75/239 (31%), Positives = 111/239 (46%), Gaps = 22/239 (9%)
Query: 27 FDFTSF--NLRNITLLGD-SYLRNGVIGLTRELG---VPASSSGSLIYNNPVPFFDQETN 80
F+F F N + + L S NGV+ LT+ S+G +Y P+ +D T
Sbjct: 5 FNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTG 64
Query: 81 TTASFTSRFSFSINNVNP-SSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAI 139
ASF +RFSF+I DGL FF+ P N G GG LG+ + A+
Sbjct: 65 NVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGEDGGNLGVFKPP--EGDNAFAV 122
Query: 140 EFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLK 199
EFDT + DP HIG+D++S+ S KT L++G V I Y + ++L
Sbjct: 123 EFDTFQN--TWDPQVPHIGIDVNSIVSSKTLH-----FQLENGGVANVVIKYDSPTKILN 175
Query: 200 VFMSYSNLKPVTPLLKVNIDLSGYLKGN--MYVGFSAST---EGSTELHMIQSWSFQTS 253
V +++ + L +DL + + VG SA+T + + E H I SWSF +S
Sbjct: 176 VVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFTSS 233
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Score = 168 bits (425), Expect = 1e-48
Identities = 66/242 (27%), Positives = 121/242 (50%), Gaps = 18/242 (7%)
Query: 23 NNMNFDFTSF--NLRNITLLGDSYLRNGVIGLTRELGVP---ASSSGSLIYNNPVPFFDQ 77
++++F F +F + +N+ GD+ ++N + LT+ AS+ G ++++ V +++
Sbjct: 2 DSLSFGFPTFPSDQKNLIFQGDAQIKNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEK 61
Query: 78 ETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQI-LGSAGGCLGLVNSSQL---TK 133
++ A+F S+FSFS+ + + F PD I GS GG LGL +
Sbjct: 62 SSSRVANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSA 121
Query: 134 NKFVAIEFDTRLDPHFD--DPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDY 191
N+ +A+EFDT + DP+ HIG+D++S+ S+KT D + G + + +
Sbjct: 122 NQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVK-----WDRRDGQSLNVLVTF 176
Query: 192 KNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQ 251
R L V +YS + +D+ L + VGFSA++ + H ++SWSF
Sbjct: 177 NPSTRNLDVVATYS--DGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWSFT 234
Query: 252 TS 253
++
Sbjct: 235 ST 236
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Score = 167 bits (424), Expect = 2e-48
Identities = 75/241 (31%), Positives = 111/241 (46%), Gaps = 19/241 (7%)
Query: 22 SNNMNFDFTSF--NLRNITLLGDSYLR-NGVIGLTREL--GVPASSSGSLIYNNPVPFFD 76
+ + +F FT+F N N+ L D+ + G + LT S G +Y P+ D
Sbjct: 1 TESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHD 60
Query: 77 QETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVN-SSQLTKNK 135
T ASFT+ FSF + ++ DGLAFF++P + + GG LGL + +
Sbjct: 61 NTT--LASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHDASYQ 118
Query: 136 FVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDL 195
VA+EFDT + DP+ HIG+D + +ES KT D+ G I Y+
Sbjct: 119 TVAVEFDTYS--NAWDPNYTHIGIDTNGIESKKTTP-----FDMVYGEKANIVITYQAST 171
Query: 196 RMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQT 252
+ L + + + + +DL L + VGFSA+T G E H I SWSF
Sbjct: 172 KALAASLVFPV-SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAV 230
Query: 253 S 253
S
Sbjct: 231 S 231
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-48
Identities = 72/268 (26%), Positives = 114/268 (42%), Gaps = 39/268 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT----EFLAELSIIACLRHKNLVQL 409
R LG+G FGNVY A S + A+K + K + E+ I + LRH N+++L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
G+ + + L+ EY P G++ R L + S+ + LA+AL+Y H
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCH---S 124
Query: 470 QQVIHRDIKASNIMLDANFNARL----------ESSFTLTAGTMGYLAPEYLQYGTATEK 519
++VIHRDIK N++L + ++ S T GT+ YL PE ++ EK
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 184
Query: 520 TDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED 579
D++S GV+ E G+ P E T + I + E
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFEANTYQETY--------------KRISRVEFTFPDFVTE- 229
Query: 580 EMKRLLLVGLSCANPDSSARPSMRRVFQ 607
+ L+ + S RP +R V +
Sbjct: 230 GARDLI---SRLLKHNPSQRPMLREVLE 254
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Score = 167 bits (424), Expect = 3e-48
Identities = 71/244 (29%), Positives = 119/244 (48%), Gaps = 17/244 (6%)
Query: 22 SNNMNFDFTSF--NLRNITLLGD-SYLRNGVIGLTRELG---VPASSSGSLIYNNPVPFF 75
+ ++F + F N+ L GD +G + L + SS G +Y+ P+ +
Sbjct: 1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW 60
Query: 76 DQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNK 135
D+ET + ASF + F+F+ + DGLAFF++P + + G LGL N ++ + ++
Sbjct: 61 DKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQTHAGYLGLFNENE-SGDQ 119
Query: 136 FVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDL 195
VA+EFDT + DP HIG++++S+ SIKT DL + V I Y
Sbjct: 120 VVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTSW-----DLANNKVAKVLITYDAST 172
Query: 196 RMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGST--ELHMIQSWSFQTS 253
+L + Y + + + +L +DL L + +GFSA+T E H + SWSF ++
Sbjct: 173 SLLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASN 231
Query: 254 GFRP 257
Sbjct: 232 LPHA 235
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 5e-48
Identities = 59/295 (20%), Positives = 111/295 (37%), Gaps = 54/295 (18%)
Query: 354 RILGRGAFGNVYKAYF-----ASSGSVAAVKRSKHSH--EGKTEFLAELSIIACL-RHKN 405
+ LG GAFG V +A + + AVK K S + ++EL +++ L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQ--------------DSENGVLLSWYHRL 451
+V LLG C G L++ EY G L L + ++ + L L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 452 NIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL--------------ESSFT 497
+ +A + +L + IHRD+ A NI+L ++
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 498 LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG 557
+ ++APE + T ++DV+SYG+ + E+ G
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------PYPG 250
Query: 558 LYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612
+ + + + + E + + +C + D RP+ +++ Q++ +
Sbjct: 251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-47
Identities = 55/278 (19%), Positives = 99/278 (35%), Gaps = 39/278 (14%)
Query: 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHK 404
R + +GRG+F VYK + A K + + F E ++ L+H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 405 NLVQLLGWCAE----KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASA 460
N+V+ K ++LV E M +G+L L + + + +
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKG 124
Query: 461 LTYLHQECEQQVIHRDIKASNIMLDANFN---------ARLESSFTLT--AGTMGYLAPE 509
L +LH +IHRD+K NI + A L+ + GT ++APE
Sbjct: 125 LQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPE 183
Query: 510 YLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569
+ E DV+++G+ +LE+A P ++ R+
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR------------RVTSGVK 230
Query: 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607
E+K ++ C + R S++ +
Sbjct: 231 PASFDKVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 2e-47
Identities = 68/306 (22%), Positives = 123/306 (40%), Gaps = 60/306 (19%)
Query: 350 FHSNRILGRGAFGNVYKAYF-----ASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLR 402
R +G GAFG V++A ++ AVK + + S + + +F E +++A
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 403 HKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL------------------ 444
+ N+V+LLG CA + L++EYM G L+ L S + V
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 445 --LSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL---------- 492
LS +L I +A+ + YL E++ +HRD+ N ++ N ++
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 493 ----ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKM 548
+ A + ++ PE + Y T ++DV++YGVV+ E+ ++
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 549 VNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI 608
+ V +G I+ E+ L + C + + RPS + +I
Sbjct: 252 IYYV-------RDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 609 LNNEAE 614
L E
Sbjct: 296 LQRMCE 301
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-47
Identities = 60/280 (21%), Positives = 108/280 (38%), Gaps = 46/280 (16%)
Query: 353 NRILGRGAFGNVYKAYFA--SSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLV 407
++ LG G FG V K Y+ AVK + K E LAE +++ L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
+++G C E +LV E G L++ L Q+ + + + +V ++ + YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEE- 125
Query: 468 CEQQVIHRDIKASNIMLDANFNARL---------------ESSFTLTAGTMGYLAPEYLQ 512
+HRD+ A N++L A++ + T + + APE +
Sbjct: 126 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 513 YGTATEKTDVFSYGVVVLE-VACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571
Y + K+DV+S+GV++ E + G++P + +K
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----------------GSEVTAMLEKG 226
Query: 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+ + + C D RP V L N
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-47
Identities = 60/271 (22%), Positives = 98/271 (36%), Gaps = 39/271 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK--RSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
+ LG GA+G V A + AVK K + + E+ I L H+N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
E L EY G L + D + + L + + YLH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH---GIG 123
Query: 472 VIHRDIKASNIMLDANFNARL--------------ESSFTLTAGTMGYLAPEYLQYGT-A 516
+ HRDIK N++LD N ++ E GT+ Y+APE L+
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 517 TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576
E DV+S G+V+ + G P ++ ++ + + E
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS------------DWKEKKTYLNPWKK 231
Query: 577 NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607
+ LL + SAR ++ + +
Sbjct: 232 IDSAPLALL---HKILVENPSARITIPDIKK 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-47
Identities = 58/291 (19%), Positives = 114/291 (39%), Gaps = 45/291 (15%)
Query: 341 RELRSATRGFH-SNRILGRGAFGNVYKAYFASSGS--VAAVKRSKHSHEGKT--EFLAEL 395
++L ++ LG G FG+V + + A+K K E E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 396 SIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVV 455
I+ L + +V+L+G C + L+LV E G L + L E + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116
Query: 456 GLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLE---------------SSFTLTA 500
++ + YL + + +HRD+ A N++L A++ ++ +
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 501 GTMGYLAPEYLQYGTATEKTDVFSYGVVVLEV-ACGRRPIERETEGHKMVNLVDWVWGLY 559
+ + APE + + + ++DV+SYGV + E + G++P ++ V
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFI 225
Query: 560 AEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610
+G+ +E + E+ L+ C RP V Q +
Sbjct: 226 EQGKRMECPPECP------PELYALM---SDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 6e-47
Identities = 65/287 (22%), Positives = 116/287 (40%), Gaps = 45/287 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
+G+GA G VY A ++G A+++ + K + E+ ++ ++ N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
EL +V EY+ GSL ++ + + AL +LH QV
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFLHS---NQV 137
Query: 473 IHRDIKASNIMLDANFNARL------------ESSFTLTAGTMGYLAPEYLQYGTATEKT 520
IHRDIK+ NI+L + + +L +S + GT ++APE + K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 521 DVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDE 580
D++S G++ +E+ G P E + + G ++L+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-------NGTPELQNPEKLS-----AI 245
Query: 581 MKRLLLVGLSCANPDSSARPSMRRVFQILNNE----AEPLVVPKLKP 623
+ L C + D R S + ++L ++ A+PL L P
Sbjct: 246 FRDFL---NRCLDMDVEKRGSAK---ELLQHQFLKIAKPL--SSLTP 284
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (422), Expect = 9e-47
Identities = 60/289 (20%), Positives = 109/289 (37%), Gaps = 39/289 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE-FLAELSIIACLRHKNLVQLLGW 412
LG GAFG V++ ++G+ A K HE E E+ ++ LRH LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
+ E++++YE+M G L + +S + + + L ++H E
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMH---ENNY 145
Query: 473 IHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEK 519
+H D+K NIM + L + S +T GT + APE +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205
Query: 520 TDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED 579
TD++S GV+ + G P E + + N+ W + ++A ++ +
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------NMDDSAFSGIS-----E 254
Query: 580 EMKRLLLVGLSCANPDSSARPSMRRV-----FQILNNEAEPLVVPKLKP 623
+ K + D + R ++ + N +P +
Sbjct: 255 DGKDFI---RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRY 300
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-46
Identities = 62/301 (20%), Positives = 107/301 (35%), Gaps = 61/301 (20%)
Query: 354 RILGRGAFGNVYKAYFASSGSVA-----AVKR--SKHSHEGKTEFLAELSIIA-CLRHKN 405
++LG GAFG V A AVK K + ++EL ++ H+N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLY-------------------QDSENGVLLS 446
+V LLG C G + L++EY G L L ++ E+ +L+
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 447 WYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL-------------- 492
+ L +A + +L + +HRD+ A N+++ ++
Sbjct: 163 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 493 ESSFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLE-VACGRRPIERETEGHKMVNL 551
+ ++APE L G T K+DV+SYG+++ E + G P L
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279
Query: 552 VDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+ + + ++ SC DS RPS + L
Sbjct: 280 I----------------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323
Query: 612 E 612
+
Sbjct: 324 Q 324
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Score = 161 bits (409), Expect = 3e-46
Identities = 79/244 (32%), Positives = 122/244 (50%), Gaps = 18/244 (7%)
Query: 22 SNNMNFDFTSF--NLRNITLLGD-SYLRNGVIGLTRELG--VPASSSGSLIYNNPVPFFD 76
S+ ++F +F N ++ G+ S GV+ LT+ S G +Y PV +
Sbjct: 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWG 60
Query: 77 QETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILG--SAGGCLGLVNSSQ-LTK 133
T + ASF++ F+F + NP DGLAF+++P + + S LGL N+S +
Sbjct: 61 NTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSS 120
Query: 134 NKFVAIEFDTRLDPHFD--DPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDY 191
N+ VA+EFDT +D DP+ HIG+D++ +ESIKT D +G V A I Y
Sbjct: 121 NQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQW-----DWINGGVAFATITY 175
Query: 192 KNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGST--ELHMIQSWS 249
+ L + Y + T + ++DL L + VGFSA+T T E H + SWS
Sbjct: 176 LAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWS 234
Query: 250 FQTS 253
F ++
Sbjct: 235 FTST 238
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 163 bits (414), Expect = 1e-45
Identities = 54/268 (20%), Positives = 100/268 (37%), Gaps = 34/268 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
LG GAFG V++ ++G V K + K E+SI+ L H L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 413 CAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
+K E++L+ E++ G L + +S +N + L ++H E +
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMH---EHSI 148
Query: 473 IHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEK 519
+H DIK NIM + + + + +T T + APE +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208
Query: 520 TDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNED 579
TD+++ GV+ + G P E + + N+ + E A ++
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KRCDWEFDEDAFSSVS-----P 257
Query: 580 EMKRLLLVGLSCANPDSSARPSMRRVFQ 607
E K + + + R ++ +
Sbjct: 258 EAKDFI---KNLLQKEPRKRLTVHDALE 282
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-45
Identities = 64/327 (19%), Positives = 118/327 (36%), Gaps = 57/327 (17%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVK------RSKHSHEGKTEFLAELSIIACLRH 403
F ++LG GAFG VYK + G + R S + E L E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 404 KNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTY 463
++ +LLG C + L+ + MP G L + + +N + LN V +A + Y
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQIAKGMNY 126
Query: 464 LHQECEQQVIHRDIKASNIMLDANFNARL--------------ESSFTLTAGTMGYLAPE 509
L ++++HRD+ A N+++ + ++ E + ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 510 YLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569
+ + T ++DV+SYGV V E+ + I +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISSILE 227
Query: 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQIL--------------NNEAEP 615
K + ++ + C D+ +RP R + +E
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287
Query: 616 LVVPKLKPCLTFSSVSLTLEDIVSEDE 642
L P ++D+V DE
Sbjct: 288 LPSPTDSNFYRALMDEEDMDDVVDADE 314
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-45
Identities = 63/293 (21%), Positives = 114/293 (38%), Gaps = 46/293 (15%)
Query: 350 FHSNRILGRGAFGNVYKAYF-----ASSGSVAAVKRSK--HSHEGKTEFLAELSIIACLR 402
+R LG+G+FG VY+ + A+K S + EFL E S++
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 403 HKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQ------DSENGVLLSWYHRLNIVVG 456
++V+LLG ++ L++ E M G L L ++ S + +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 457 LASALTYLHQECEQQVIHRDIKASNIMLDANFNARLE--------------SSFTLTAGT 502
+A + YL + +HRD+ A N M+ +F ++
Sbjct: 142 IADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 503 MGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG 562
+ +++PE L+ G T +DV+S+GVV+ E+A + +++ V EG
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-------MEG 251
Query: 563 RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615
+++ D D + L+ C + RPS + + E EP
Sbjct: 252 GLLDKPDNCP------DMLFELM---RMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-45
Identities = 57/267 (21%), Positives = 103/267 (38%), Gaps = 33/267 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
LGRG FG V++ SS K K + E+SI+ RH+N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 414 AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVI 473
EL++++E++ + + + + L+ ++ V + AL +LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 474 HRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATEKT 520
H DI+ NI+ ++ + +F L Y APE Q+ + T
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 521 DVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDE 580
D++S G +V + G P ET + N+++ AE E A K ++ E
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMN------AEYTFDEEAFKEIS-----IE 233
Query: 581 MKRLLLVGLSCANPDSSARPSMRRVFQ 607
+ + +R + Q
Sbjct: 234 AMDFV---DRLLVKERKSRMTASEALQ 257
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Score = 156 bits (395), Expect = 2e-44
Identities = 59/241 (24%), Positives = 100/241 (41%), Gaps = 24/241 (9%)
Query: 22 SNNMNFDFTSFNLR-NITLLGD-SYLRNGVIGLTRELG---VPASSSGSLIYNNPVPFFD 76
+ +F+F +F+ + L G+ + G + LT S G Y++P+ D
Sbjct: 1 ATETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD 60
Query: 77 QETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNK 135
+N ASF + F+F I N S GLAF + P N LG+ N++ +
Sbjct: 61 --SNNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQKKQEFLGIFNTNNPEPNAR 118
Query: 136 FVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDL 195
VA+ F+T + D D+N I ++ +G I Y +
Sbjct: 119 TVAVVFNT--FKNRIDFDKNFIKPYVNENCD----------FHKYNGEKTDVQITYDSSN 166
Query: 196 RMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQT 252
L+VF+ ++ V + + L + + VGFS ++ E +TE H + SWSF +
Sbjct: 167 NDLRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSS 225
Query: 253 S 253
Sbjct: 226 K 226
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-43
Identities = 63/295 (21%), Positives = 122/295 (41%), Gaps = 57/295 (19%)
Query: 354 RILGRGAFGNVYKAY-------FASSGSVAAVK--RSKHSHEGKTEFLAELSIIACL-RH 403
+ LG GAFG V A + + AVK +S + + ++ ++E+ ++ + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 404 KNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVL------------LSWYHRL 451
KN++ LLG C + G L ++ EY G+L L G+ LS +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 452 NIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL--------------ESSFT 497
+ +A + YL ++ IHRD+ A N+++ + ++ T
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 498 LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLE-VACGRRPIERETEGHKMVNLVDWVW 556
+ ++APE L T ++DV+S+GV++ E G P V+ ++
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEELF 247
Query: 557 GLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
L EG ++ + L ++ C + S RP+ +++ + L+
Sbjct: 248 KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-42
Identities = 47/213 (22%), Positives = 86/213 (40%), Gaps = 25/213 (11%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKN 405
F +ILG G+F V A ++ A+K + H E +++ L H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
V+L + +L Y NG L + + + + SAL YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLH 125
Query: 466 QECEQQVIHRDIKASNIMLDANFNARL--------------ESSFTLTAGTMGYLAPEYL 511
+ +IHRD+K NI+L+ + + ++ ++ GT Y++PE L
Sbjct: 126 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPIERETE 544
+A + +D+++ G ++ ++ G P E
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-42
Identities = 59/283 (20%), Positives = 105/283 (37%), Gaps = 45/283 (15%)
Query: 354 RILGRGAFGNVYKAYFASS---GSVAAVKRSK----HSHEGKTEFLAELSIIACLRHKNL 406
LG G+FG V + + + AVK K E +F+ E++ + L H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
++L G + +V E P GSL L + + V +A + YL
Sbjct: 74 IRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLE- 128
Query: 467 ECEQQVIHRDIKASNIMLDANFNARL---------------ESSFTLTAGTMGYLAPEYL 511
++ IHRD+ A N++L ++ + APE L
Sbjct: 129 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571
+ T + +D + +GV + E+ + G ++++ I+ +R
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-------------IDKEGER 233
Query: 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614
L ED + + V + C RP+ + L EA+
Sbjct: 234 L--PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL-LEAQ 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-41
Identities = 53/276 (19%), Positives = 105/276 (38%), Gaps = 41/276 (14%)
Query: 354 RILGRGAFGNVYKAYFAS---SGSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQ 408
R +G G FG+V++ + S A+K K+ S + +FL E + H ++V+
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
L+G + + ++ E G L L + L + L++AL YL
Sbjct: 73 LIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLE--- 125
Query: 469 EQQVIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGT 515
++ +HRDI A N+++ +N +L + + ++APE + +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 516 ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575
T +DV+ +GV + E+ + + + ++ ++ L
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC----------- 234
Query: 576 FNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+ L+ C D S RP + L+
Sbjct: 235 --PPTLYSLM---TKCWAYDPSRRPRFTELKAQLST 265
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (374), Expect = 1e-40
Identities = 58/294 (19%), Positives = 110/294 (37%), Gaps = 45/294 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTE-FLAELSIIACLRHKNLVQLLG 411
+LG GAF V A + + A+K +K + EGK E++++ ++H N+V L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
G L L+ + + G L + + + ++ + A+ YL +
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYL---HDLG 127
Query: 472 VIHRDIKASNIMLDANFN-----------ARLESSFTLT---AGTMGYLAPEYLQYGTAT 517
++HRD+K N++ + +++E ++ GT GY+APE L +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 518 EKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577
+ D +S GV+ + CG P E + ++ AE ++
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK------AEYEFDSPYWDDIS---- 237
Query: 578 EDEMKRLLLVGLSCANPDSSARPSMRRVFQ--------ILNNEAEPLVVPKLKP 623
D K + D R + + Q L+ V ++K
Sbjct: 238 -DSAKDFI---RHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKK 287
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 147 bits (371), Expect = 2e-40
Identities = 50/271 (18%), Positives = 93/271 (34%), Gaps = 44/271 (16%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE----FLAELSIIACLRHKNLVQL 409
ILG G V+ A AVK + F E A L H +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 410 LGWCAEKGE----LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
+ +V EY+ +L +++ + ++ + ++ AL +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFS- 127
Query: 466 QECEQQVIHRDIKASNIMLDANFNARL---------------ESSFTLTAGTMGYLAPEY 510
+ +IHRD+K +NIM+ A ++ + GT YL+PE
Sbjct: 128 --HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 511 LQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570
+ + ++DV+S G V+ EV G P ++ V + A +
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPIPPSARHE 239
Query: 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPS 601
L+ ++ ++ L + R
Sbjct: 240 GLS-----ADLDAVV---LKALAKNPENRYQ 262
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 144 bits (363), Expect = 2e-40
Identities = 52/236 (22%), Positives = 88/236 (37%), Gaps = 37/236 (15%)
Query: 22 SNNMNFDFTSFNLRNITLLGDSYLR-NGVIGLTRELGVPASSSGSLIYNNPVPFFDQETN 80
+ +F +FN N+ L GD+ + NG + L+ S Y+ P+ D T
Sbjct: 1 ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYN---SYDSMSRAFYSAPIQIRDSTTG 57
Query: 81 TTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIE 140
ASF + F+ +I ++ GL F + P +K V +E
Sbjct: 58 NVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPE----------------SKGDTVTVE 101
Query: 141 FDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLKV 200
FDT L D + N I + G I Y + ++ V
Sbjct: 102 FDTFLSRISIDVNNNDIKSVPWDV-------------HDYDGQNAEVRITYNSSTKVFSV 148
Query: 201 FMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSAST---EGSTELHMIQSWSFQTS 253
+S + + + ++L + + VGFSA++ + S E H + SWSF +
Sbjct: 149 SLSNPS-TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSK 203
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 67/293 (22%), Positives = 115/293 (39%), Gaps = 53/293 (18%)
Query: 354 RILGRGAFGNVYKAYFA-----SSGSVAAVKRSKHS--HEGKTEFLAELSIIA-CLRHKN 405
+ LGRGAFG V +A ++ AVK K H ++EL I+ H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 406 LVQLLGWCAEKGE-LLLVYEYMPNGSLDRMLYQDSENGV------------LLSWYHRLN 452
+V LLG C + G L+++ E+ G+L L V L+ H +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 453 IVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL--------------ESSFTL 498
+A + +L ++ IHRD+ A NI+L ++
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 499 TAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558
+ ++APE + T ++DV+S+GV++ E+ + V + +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP------YPGVKIDEEFCRR 249
Query: 559 YAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
EG + A D + EM + + L C + + S RP+ + + L N
Sbjct: 250 LKEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 293
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 47/273 (17%), Positives = 99/273 (36%), Gaps = 36/273 (13%)
Query: 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGW 412
+++LG G G V + + + A+K + + + E + ++V+++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDV 73
Query: 413 C----AEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
A + LL+V E + G L + + + I+ + A+ YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLH--- 128
Query: 469 EQQVIHRDIKASNIMLDANFNARL--------------ESSFTLTAGTMGYLAPEYLQYG 514
+ HRD+K N++ + + +S T T Y+APE L
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 515 TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574
+ D++S GV++ + CG P + G+ R+ +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIRMGQYEFPNPEW 241
Query: 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607
+ +E+K L+ + + + R ++
Sbjct: 242 SEVSEEVKMLI---RNLLKTEPTQRMTITEFMN 271
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 146 bits (368), Expect = 3e-39
Identities = 64/307 (20%), Positives = 108/307 (35%), Gaps = 56/307 (18%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAE---LSIIACLR 402
F +RI+GRG FG VY A +G + A+K +G+T L E LS+++
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 403 HKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
+V + +L + + M G L L Q S + L
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILGLE 121
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARL----------ESSFTLTAGTMGYLAPEYLQ 512
++H + V++RD+K +NI+LD + + R+ + + GT GY+APE LQ
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ 178
Query: 513 YGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571
G A D FS G ++ ++ G P + K + +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVF----------------QILNNEAEP 615
L ++ LL D + R + + P
Sbjct: 239 L--------LEGLL-------QRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 283
Query: 616 LVVPKLK 622
++P
Sbjct: 284 PLIPPRG 290
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (364), Expect = 3e-39
Identities = 55/284 (19%), Positives = 108/284 (38%), Gaps = 26/284 (9%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE----FLAELSIIACLRHKNLVQL 409
R LG G+FG V+ +G A+K K + + E +++ + H ++++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
G + ++ ++ +Y+ G L +L + + AL YLH
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF----PNPVAKFYAAEVCLALEYLH---S 122
Query: 470 QQVIHRDIKASNIMLDANFNARL---------ESSFTLTAGTMGYLAPEYLQYGTATEKT 520
+ +I+RD+K NI+LD N + ++ GT Y+APE + +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSI 182
Query: 521 DVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDE 580
D +S+G+++ E+ G P +++ E L+ D
Sbjct: 183 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF--FNEDVKDLLSRLITRDL 240
Query: 581 MKRLLLVGLSCANPDSSARPSMRRV--FQILNNEAEPLVVPKLK 622
+RL + D P + V ++L+ E P ++
Sbjct: 241 SQRLGNLQNGTE--DVKNHPWFKEVVWEKLLSRNIETPYEPPIQ 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 142 bits (359), Expect = 6e-39
Identities = 56/286 (19%), Positives = 98/286 (34%), Gaps = 49/286 (17%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR----------SKHSHEGKTEFLAELSIIA 399
+ ILGRG V + + AVK ++ E + L E+ I+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 400 CLR-HKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLA 458
+ H N++QL LV++ M G L L + LS I+ L
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALL 120
Query: 459 SALTYLHQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLTAGTMGYLA 507
+ LH + ++HRD+K NI+LD + N +L GT YLA
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 177
Query: 508 PEYLQ------YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE 561
PE ++ + ++ D++S GV++ + G P + + ++
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG------N 231
Query: 562 GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607
+ + D +K L+ R +
Sbjct: 232 YQFGSPEWDDYS-----DTVKDLV---SRFLVVQPQKRYTAEEALA 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-38
Identities = 67/339 (19%), Positives = 114/339 (33%), Gaps = 55/339 (16%)
Query: 335 PREFSYRELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAE 394
P+E SY + + ++G G+FG VY+A SG + A+K+ E
Sbjct: 17 PQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRE 63
Query: 395 LSIIACLRHKNLVQLLGWCAEKGE------LLLVYEYMPNGSLDRMLYQDSENGVLLSWY 448
L I+ L H N+V+L + GE L LV +Y+P + L
Sbjct: 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVI 122
Query: 449 HRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL---------- 498
+ + L +L Y+H + HRDIK N++LD + F
Sbjct: 123 YVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 499 --TAGTMGYLAP-EYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV 555
+ Y AP T DV+S G V+ E+ G+ ++ ++V ++ V
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK-V 238
Query: 556 WGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANP------------DSSARPSMR 603
G +I E F + + V P +AR +
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
Query: 604 RVFQ------ILNNEAEPLVVPKLKPCLTFSSVSLTLED 636
+ + + F++ L+
Sbjct: 299 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 58/298 (19%), Positives = 105/298 (35%), Gaps = 54/298 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR----SKHSHEGKTEFLAELSIIA-CLRHKNLVQ 408
++LG+G+FG V+ A F + A+K + + E +++ H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 409 LLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC 468
+ K L V EY+ G L + + + L +L
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFL---H 120
Query: 469 EQQVIHRDIKASNIMLDANFNARL------------ESSFTLTAGTMGYLAPEYLQYGTA 516
+ +++RD+K NI+LD + + ++ ++ GT Y+APE L
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 517 TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576
D +S+GV++ E+ G+ P + E L + D +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIR-----------MDNPFYPRW 225
Query: 577 NEDEMKRLLLVGLSCANPDSSARPSMRRVF------------QILNNEAEPLVVPKLK 622
E E K LL + + R +R ++ E +P PK+K
Sbjct: 226 LEKEAKDLL---VKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVK 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 60/306 (19%), Positives = 119/306 (38%), Gaps = 47/306 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE------FLAELSIIACLRHKNLV 407
LG G F VYKA ++ + A+K+ K H + + L E+ ++ L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 408 QLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQE 467
LL K + LV+++M + +N ++L+ H ++ L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-- 117
Query: 468 CEQQVIHRDIKASNIMLDANFNARL------------ESSFTLTAGTMGYLAPEYLQYGT 515
+ ++HRD+K +N++LD N +L ++T T Y APE L
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 516 A-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574
D+++ G ++ E+ + +++ ++ + + G E + +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE-TLGTPTEEQWPDMCSLPDYV 235
Query: 575 AFNE--------------DEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPLVV 618
F D++ L+ + AR + + + +N P
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLI---QGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
Query: 619 PKL-KP 623
+L +P
Sbjct: 293 CQLPRP 298
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 8e-37
Identities = 52/279 (18%), Positives = 96/279 (34%), Gaps = 49/279 (17%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-------SKHSHEGKTEFLAELSIIACLRHKNL 406
LG G F V K S+G A K S + + E+SI+ ++H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
+ L K +++L+ E + G L L + L+ + + + ++
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNG---VYY 128
Query: 467 ECEQQVIHRDIKASNIMLDANFNARL---------------ESSFTLTAGTMGYLAPEYL 511
Q+ H D+K NIML + + F GT ++APE +
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 512 QYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571
Y + D++S GV+ + G P +T+ + N + A +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN--------------VSAVNYE 234
Query: 572 LNGAFNED---EMKRLLLVGLSCANPDSSARPSMRRVFQ 607
+ + K + D R +++ Q
Sbjct: 235 FEDEYFSNTSALAKDFI---RRLLVKDPKKRMTIQDSLQ 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-36
Identities = 58/321 (18%), Positives = 112/321 (34%), Gaps = 40/321 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR-SKHSHEGKTE-FLAELSIIACLRHKNLVQLLG 411
+G GA+G V AY + A+K+ S H+ + L E+ I+ RH+N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
+ Y+ + LY+ + LS H + + L Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIH---SAN 129
Query: 472 VIHRDIKASNIMLDANFNARL---------------ESSFTLTAGTMGYLAPEYLQYGTA 516
V+HRD+K SN++L+ + ++ T T Y APE +
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 517 -TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGA 575
T+ D++S G ++ E+ R + ++ +++ + E K N
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 576 FNEDEMKRLLLVGL-------------SCANPDSSARPSMRRVFQ--ILNNEAEPLVVPK 620
+ ++ L + R + + L +P P
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 309
Query: 621 LKPCLTFSSVSLTLEDIVSED 641
+ F + L+D+ E
Sbjct: 310 AEAPFKF---DMELDDLPKEK 327
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (343), Expect = 2e-36
Identities = 51/293 (17%), Positives = 97/293 (33%), Gaps = 42/293 (14%)
Query: 342 ELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL 401
ELR R + R +G G+FG++Y ++G A+K + + E I +
Sbjct: 2 ELRVGNR-YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-QLHIESKIYKMM 59
Query: 402 RHKNLVQLLGWCAEKGE-LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASA 460
+ + + WC +G+ ++V E + D + + S L + + S
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISR 115
Query: 461 LTYLHQECEQQVIHRDIKASNIM------------LDANFNARLESSFTLT--------- 499
+ Y+H + IHRD+K N + +D + + T
Sbjct: 116 IEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 500 -AGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558
GT Y + + + D+ S G V++ G P + K
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI---- 228
Query: 559 YAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611
+ + + L + E L C + +P + Q+ N
Sbjct: 229 --SEKKMSTPIEVLCKGYPS-EFATYL---NFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-36
Identities = 51/283 (18%), Positives = 99/283 (34%), Gaps = 32/283 (11%)
Query: 354 RILGRGAFGNVYKAY-FASSGSVAAVKRSKHSHEGKTE------FLAELSIIACLRHKNL 406
+G GA+G V+KA + G A+KR + + +A L + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSL--DRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
V+L C + + D Y D + +++ L L +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLTAGTMGYLAPEYLQY 513
H +V+HRD+K NI++ ++ +L + + T T+ Y APE L
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573
+ D++S G + E+ + ++ ++ ++D + E + A R
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 574 GAFNEDEMKRLLLVGLS---------CANPDSSARPSMRRVFQ 607
+ + + C + + R S
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-35
Identities = 57/305 (18%), Positives = 113/305 (37%), Gaps = 43/305 (14%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNL 406
F +G G +G VYKA +G V A+K+ + + + E+S++ L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 407 VQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQ 466
V+LL + +L LV+E++ M + + + L L +
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC-- 118
Query: 467 ECEQQVIHRDIKASNIMLDANFNARL------------ESSFTLTAGTMGYLAPE-YLQY 513
+V+HRD+K N++++ +L ++T T+ Y APE L
Sbjct: 119 -HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573
+ D++S G + E+ R ++E ++ + + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 574 GAFNE--------------DEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPLV 617
+F + ++ + LL + D + R S + + +P
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLL---SQMLHYDPNKRISAKAALAHPFFQDVTKP-- 292
Query: 618 VPKLK 622
VP L+
Sbjct: 293 VPHLR 297
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-35
Identities = 52/275 (18%), Positives = 88/275 (32%), Gaps = 51/275 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-------EGKTEFLAELSIIACLR--HK 404
+LG G FG+VY S A+K + T E+ ++ +
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 405 NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
+++LL W +L+ E + L + + A+ +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHC 126
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARLESSF-----------TLTAGTMGYLAPEYLQY 513
V+HRDIK NI++D N F T GT Y PE+++Y
Sbjct: 127 ---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 514 GTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572
V+S G+++ ++ CG P E + E I
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------------IIRGQVFF 223
Query: 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607
+ E + L+ C S RP+ +
Sbjct: 224 RQRVSS-ECQHLI---RWCLALRPSDRPTFEEIQN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 4e-35
Identities = 61/335 (18%), Positives = 117/335 (34%), Gaps = 40/335 (11%)
Query: 338 FSYRELRSATRGFHSN----RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTE 390
F +E+ + + +G GA+G V A +G+ A+K R S
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 391 FLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHR 450
EL ++ +RH+N++ LL L ++ L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 451 LNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR---------LESSFTLTAG 501
+V + L Y+H +IHRD+K N+ ++ + + +S T
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 180
Query: 502 TMGYLAPE-YLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYA 560
T Y APE L + T+ D++S G ++ E+ G+ + ++ ++ A
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240
Query: 561 EGRIIEAADKRLNGAFNEDEMKRLLLVGL-------------SCANPDSSARPSMRRV-- 605
E +D+ N E+++ + D+ R +
Sbjct: 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
Query: 606 ---FQILNNEAEPLVVPKLKPCLTFSSVSLTLEDI 637
F+ L++ + V K +F V TL++
Sbjct: 301 HPYFESLHDTEDEPQVQKYDD--SFDDVDRTLDEW 333
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 128 bits (322), Expect = 3e-34
Identities = 41/120 (34%), Positives = 60/120 (50%), Gaps = 7/120 (5%)
Query: 134 NKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKN 193
+ VA+E DT + DP HIG+DI S+ S KTA ++++G V TA I Y +
Sbjct: 2 DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK-----WNMQNGKVGTAHIIYNS 56
Query: 194 DLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTS 253
+ L +SY + + ++DL L + VG SAST E + I SWSF +
Sbjct: 57 VDKRLSAVVSYP--NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSK 114
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 83.8 bits (207), Expect = 7e-19
Identities = 33/110 (30%), Positives = 54/110 (49%), Gaps = 8/110 (7%)
Query: 26 NFDFTSFNLRNITLLGD-SYLRNGVIGLTRE---LGVPASSSGSLIYNNPVPFFDQETNT 81
F+ S + +++ L GD + +G + LTR SS G ++ PV ++ +
Sbjct: 129 MFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAV 187
Query: 82 TASFTSRFSFSINNVNPSSFGDGLAFFISPDNQIL--GSAGGCLGLVNSS 129
ASF + F+F I + + DG+AFFIS + + GS G LGL +
Sbjct: 188 VASFEATFTFLIKSPDSHP-ADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 7e-34
Identities = 56/295 (18%), Positives = 96/295 (32%), Gaps = 48/295 (16%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTE----FLAELSIIACLRHKNLVQL 409
+ LG G+FG V SG+ A+K K + L E I+ + LV+L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 410 LGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECE 469
+ L +V EY+ G + L + S H + YLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLH---S 159
Query: 470 QQVIHRDIKASNIMLDANFNARLE---------SSFTLTAGTMGYLAPEYLQYGTATEKT 520
+I+RD+K N+++D ++ GT LAPE + +
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAV 219
Query: 521 DVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAE--GRIIEAADKRLNGAFNE 578
D ++ GV++ E+A G P + + + + + L
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 579 DEMKRLLLVGLSCANPDSSARPSMRRVFQ-----------ILNNEAEPLVVPKLK 622
D KR + + + + I + E +PK K
Sbjct: 276 DLTKRF-----------GNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK 319
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 6e-33
Identities = 51/211 (24%), Positives = 83/211 (39%), Gaps = 23/211 (10%)
Query: 350 FHSNRILGRGAFGNVYKAYFASSGSVAAVKRSK----HSHEGKTEFLAELSIIACLRHKN 405
F ++LG+G FG V ++G A+K + + + + E ++ RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 406 LVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLH 465
L L L V EY G L L ++ + + + SAL
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSAL---E 119
Query: 466 QECEQQVIHRDIKASNIMLDANFNARL------------ESSFTLTAGTMGYLAPEYLQY 513
+ V++RDIK N+MLD + + ++ ++ GT YLAPE L+
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPIERETE 544
D + GVV+ E+ CGR P +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (308), Expect = 1e-31
Identities = 38/288 (13%), Positives = 84/288 (29%), Gaps = 43/288 (14%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
R +G G+FG +++ + A+K + + E L + + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-QLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 414 AEKGE-LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQV 472
++G +LV + + D + G S + + + +H+ + +
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQSIHE---KSL 122
Query: 473 IHRDIKASNIMLDANFNAR------------------------LESSFTLTAGTMGYLAP 508
++RDIK N ++ + +GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 509 EYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568
+ + D+ + G V + G P + +
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL----- 237
Query: 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616
+ L F E E + + N A P + + + E L
Sbjct: 238 -RELCAGFPE-EFYKYM---HYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 121 bits (305), Expect = 2e-31
Identities = 46/280 (16%), Positives = 100/280 (35%), Gaps = 33/280 (11%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAA--VKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLG 411
+G G +G VYKA + A ++ K + + E+SI+ L+H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ 471
K L+LV+E++ + + L + ++ L + + Y H +++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCH---DRR 120
Query: 472 VIHRDIKASNIMLDANFNARL-------------ESSFTLTAGTMGYLAPEYLQYGTATE 518
V+HRD+K N++++ ++ + +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 519 KTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG--RIIEAADKRLNGAF 576
D++S G + E+ G +E +++ + + ++ + E N
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 577 NEDEMKRLLLVGLS---------CANPDSSARPSMRRVFQ 607
E L GL D + R + ++ +
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 5e-31
Identities = 49/282 (17%), Positives = 95/282 (33%), Gaps = 35/282 (12%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKR---SKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+G G +G V+KA + + A+KR + L E+ ++ L+HKN+V+L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
+L LV+E+ + + L L L +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 471 QVIHRDIKASNIMLDANFNARL------------ESSFTLTAGTMGYLAPEYL-QYGTAT 517
V+HRD+K N++++ N +L ++ T+ Y P+ L +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 518 EKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577
D++S G + E+A RP+ + + + + G E + +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 578 EDEMKRLLLVGL------------SCANPDSSARPSMRRVFQ 607
L+ + + + R S Q
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-30
Identities = 52/299 (17%), Positives = 110/299 (36%), Gaps = 55/299 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKT---EFLAELSIIACLRHKNLVQLL 410
+G+G FG V+KA +G A+K+ +E + L E+ I+ L+H+N+V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 411 GWCAE--------KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
C KG + LV+++ + + + + ++ L +
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNG-- 129
Query: 463 YLHQECEQQVIHRDIKASNIMLDANFNARL----------------ESSFTLTAGTMGYL 506
L+ +++HRD+KA+N+++ + +L + +T T+ Y
Sbjct: 130 -LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 507 APEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV---------- 555
PE L D++ G ++ E+ ++ TE H++ +
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 556 ---WGLYAEGRIIEAADK----RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607
+ LY + +++ + RL + L+ D + R
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI---DKLLVLDPAQRIDSDDALN 304
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 6e-29
Identities = 58/334 (17%), Positives = 105/334 (31%), Gaps = 61/334 (18%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+ +G GA G V AY A A+K R + EL ++ C+ HKN++ LL
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 411 GWCA------EKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYL 464
E ++ LV E M + + ++ + + +L
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-------RMSYLLYQMLCGIKHL 135
Query: 465 HQECEQQVIHRDIKASNIMLDANFNARL-----------ESSFTLTAGTMGYLAPEYLQY 513
H +IHRD+K SNI++ ++ ++ T T Y APE +
Sbjct: 136 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 514 GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573
E D++S G ++ E+ + + +++ + G + + N
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL-GTPCPEFMKKLQPTVRN 251
Query: 574 GAFNEDEMKRLLLVGL-------------------------SCANPDSSARPSMRRV--- 605
N + L L D + R S+
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
Query: 606 --FQILNNEAEPLVVPKLKPCLTFSSVSLTLEDI 637
+ + AE P T+E+
Sbjct: 312 PYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW 345
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-27
Identities = 60/315 (19%), Positives = 111/315 (35%), Gaps = 36/315 (11%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVK---RSKHSHEGKTEFLAELSIIACLRHKNLVQLL 410
+G GA+G+V A+ +G AVK R S EL ++ ++H+N++ LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 411 GWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
L + L + L+ H ++ + L Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140
Query: 471 QVIHRDIKASNIM---------LDANFNARLESSFTLTAGTMGYLAPE-YLQYGTATEKT 520
+IHRD+K SN+ LD + T T Y APE L + +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 521 DVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDE 580
D++S G ++ E+ GR ++ ++ V AE +++ N + +
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260
Query: 581 MKRLLLVGL-------------SCANPDSSARPSMRRV-----FQILNNEAEPLVVPKLK 622
M ++ + DS R + + F ++ + V
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYD 320
Query: 623 PCLTFSSVSLTLEDI 637
+F S L +++
Sbjct: 321 Q--SFESRDLLIDEW 333
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-27
Identities = 62/323 (19%), Positives = 116/323 (35%), Gaps = 53/323 (16%)
Query: 341 RELRSATRGFHSNRI----------LGRGAFGNVYKAYFAS---SGSVAAVKRSKHSH-- 385
ELR+A H+ ++ LG GA+G V+ S +G + A+K K +
Sbjct: 7 HELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66
Query: 386 ---EGKTEFLAELSIIACLRHK-NLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSEN 441
+ E ++ +R LV L + +L L+ +Y+ G L L Q
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF 126
Query: 442 GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARL--------- 492
+ + + L + +I+RDIK NI+LD+N + L
Sbjct: 127 TEHEVQIY-------VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
Query: 493 ----ESSFTLTAGTMGYLAPEYLQYGTA--TEKTDVFSYGVVVLEVACGRRPIERETEGH 546
GT+ Y+AP+ ++ G + + D +S GV++ E+ G P + E +
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239
Query: 547 KMVNLVDWVWGLYAE--GRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSS---ARPS 601
+ + + A + +D KR L C D+
Sbjct: 240 SQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR-----LGCGPRDADEIKEHLF 294
Query: 602 MRRV--FQILNNEAEPLVVPKLK 622
+++ + + P ++
Sbjct: 295 FQKINWDDLAAKKVPAPFKPVIR 317
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 111 bits (277), Expect = 2e-27
Identities = 47/241 (19%), Positives = 90/241 (37%), Gaps = 28/241 (11%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HKNLVQLLGW 412
R LGRG + V++A ++ VK K K + E+ I+ LR N++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADI 98
Query: 413 CAEKGE--LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQ 470
+ LV+E++ N ++ L+ Y + + AL Y H
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHS---M 148
Query: 471 QVIHRDIKASNIMLDANFNARLESSF------------TLTAGTMGYLAPE-YLQYGTAT 517
++HRD+K N+M+D + + + + PE + Y
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 518 EKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFN 577
D++S G ++ + + P + + + + V G I+ + L+ FN
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 578 E 578
+
Sbjct: 269 D 269
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 7e-27
Identities = 32/239 (13%), Positives = 63/239 (26%), Gaps = 25/239 (10%)
Query: 17 FSFVLSNNMNFDFTS-FNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFF 75
F + S S + G++ I + L S GS+ F
Sbjct: 5 FEYKYSFKGPHLVQSDGTVPFWAHAGNAIPSADQIRIAPSLK---SQRGSVWTKTKAAF- 60
Query: 76 DQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNK 135
++ +F + DGLA + + + + G G
Sbjct: 61 -------ENWEVEVTFRVTGRGRIG-ADGLAIWYTENQGLDGPVFGSAD--------MWN 104
Query: 136 FVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKS----GNVITAWIDY 191
V I FD+ + + + + + D Q +
Sbjct: 105 GVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRAKI 164
Query: 192 KNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSF 250
+ L V ++ + + + G SA+T G + H + S+
Sbjct: 165 TYYQKTLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLT 223
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 4e-25
Identities = 44/229 (19%), Positives = 79/229 (34%), Gaps = 30/229 (13%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWC 413
R LG G F V+ A + + A+K + E+ ++ + + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 414 AEKGELLLVY--EYMPNGSLDRMLYQDSENGVLL----------SWYHRLNIVVGLASAL 461
A LL + PNG M+++ +L + I L L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 462 TYLHQECEQQVIHRDIKASNIMLDANFNARLESSFTL---------------TAGTMGYL 506
Y+H+ C +IH DIK N++++ + + + T Y
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 507 APEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV 555
+PE L D++S ++ E+ G E + EGH D +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD-EGHSYTKDDDHI 244
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 79.3 bits (195), Expect = 2e-17
Identities = 41/245 (16%), Positives = 70/245 (28%), Gaps = 43/245 (17%)
Query: 15 LNFSFVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPF 74
N + L N + L TL L G LT ++ GSL
Sbjct: 2 WNKGYSLPNLLEVTDQQKELSQWTLGDKVKLEEGRFVLTP----GKNTKGSLWLKPEYSI 57
Query: 75 FDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKN 134
D + T ++F S+ GLAF++ N+ + + L
Sbjct: 58 KD-------AMTIEWTFRSFGFRGST-KGGLAFWLKQGNEGDSTELFGGSSKKFNGL--- 106
Query: 135 KFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKND 194
I DD + ++ D S + Y++
Sbjct: 107 ---MILLRL------DDKLGESVTAYLN--------DGTKDLDIESSPYFASCLFQYQDS 149
Query: 195 LRMLKVFMSYSNLKPVTPLLKVNIDLSGYLK---------GNMYVGFSASTEGSTELHMI 245
+ + ++Y+ L LLK+ +D + +G SA + S E I
Sbjct: 150 MVPSTLRLTYNPLD--NHLLKLQMDNRVCFQTRKVKFMGSSPFRIGTSAINDASKESFEI 207
Query: 246 QSWSF 250
Sbjct: 208 LKMKL 212
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.7 bits (175), Expect = 6e-15
Identities = 23/143 (16%), Positives = 46/143 (32%), Gaps = 22/143 (15%)
Query: 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKHS-----------HEGKTEFLAELSIIACLR 402
+++G G V+ Y + VK K G F A
Sbjct: 6 KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 403 HKNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALT 462
+ L +L G K VY + N L M D++ + + ++ + +
Sbjct: 65 FRALQKLQGLAVPK-----VYAWEGNAVL--MELIDAKELYRVRVENPDEVLDMILEEVA 117
Query: 463 YLHQECEQQVIHRDIKASNIMLD 485
+ ++H D+ N+++
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVS 137
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 61.2 bits (148), Expect = 4e-11
Identities = 37/237 (15%), Positives = 62/237 (26%), Gaps = 43/237 (18%)
Query: 15 LNFSFVLSNNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPF 74
L+ + L + +N N + L G I LT +S GSL
Sbjct: 6 LSSDYSLPDLINTRKVP---NNWQTGEQASLEEGRIVLTS----NQNSKGSLWLKQGFDL 58
Query: 75 FDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKN 134
D SFT ++F + + G++F+ D +
Sbjct: 59 KD-------SFTMEWTFRSVGYSGQT-DGGISFWFVQD--------SNIPRDKQLYNGPV 102
Query: 135 KF--VAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQ--GIDLK---SGNVITA 187
+ + + D + L+ KT + S T
Sbjct: 103 NYDGLQLLVDN----NGPLGPTLRGQLNDGQKPVDKTKIYDQSFASCLMGYQDSSVPSTI 158
Query: 188 WIDY-KNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELH 243
+ Y D +LKV + KV Y +G +A
Sbjct: 159 RVTYDLEDDNLLKVQVDNKVCFQTR---KVRFPSGSY-----RIGVTAQNGAVNNNA 207
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 645 | |||
| d1hqla_ | 236 | Legume lectin {Griffonia simplicifolia, lectin I-b | 100.0 | |
| d1leda_ | 243 | Legume lectin {West-central african legume (Griffo | 100.0 | |
| d1fx5a_ | 240 | Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI | 100.0 | |
| d1qnwa_ | 237 | Legume lectin {Furze (Ulex europaeus), UEA-II [Tax | 100.0 | |
| d1gzca_ | 239 | Legume lectin {Cockspur coral tree (Erythrina cris | 100.0 | |
| d2d3sa1 | 237 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1g7ya_ | 253 | Legume lectin {Horse gram (Dolichos biflorus), dif | 100.0 | |
| d1g8wa_ | 233 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1g9fa_ | 251 | Legume lectin {Soybean (Glycine max) [TaxId: 3847] | 100.0 | |
| d1f9ka_ | 234 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| g1qmo.1 | 230 | Legume lectin {Field bean (Dolichos lablab), Fril | 100.0 | |
| d1dbna_ | 239 | Legume lectin {Maackia amurensis, leukoagglutinin | 100.0 | |
| d1v6ia_ | 232 | Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3 | 100.0 | |
| d1fnya_ | 237 | Legume lectin {Black locust (Robinia pseudoacacia) | 100.0 | |
| d1n47a_ | 233 | Legume lectin {Hairy vetch (Vicia villosa), isolec | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| g2ltn.1 | 229 | Legume lectin {Garden pea (Pisum sativum) [TaxId: | 100.0 | |
| d1ukga_ | 241 | Legume lectin {Bloodwood tree (Pterocarpus angolen | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1avba_ | 226 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1ioaa_ | 228 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1dhkb_ | 204 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.96 | |
| d1gv9a_ | 228 | Carbohydrate-recognition domain of P58/ERGIC-53 {R | 99.95 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.9 | |
| d2a6za1 | 221 | Emp47p N-terminal domain {Baker's yeast (Saccharom | 99.84 | |
| d2a6va1 | 218 | Emp46p N-terminal domain {Baker's yeast (Saccharom | 99.82 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.8 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.15 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.27 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.05 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.92 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 92.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.0 |
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Probab=100.00 E-value=1.3e-56 Score=442.65 Aligned_cols=225 Identities=34% Similarity=0.558 Sum_probs=201.7
Q ss_pred ceeEEeCCCCC---CCeEEecceEeeCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCC
Q 041096 24 NMNFDFTSFNL---RNITLLGDSYLRNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVN 97 (645)
Q Consensus 24 ~~~f~~~~f~~---~~~~l~G~a~~~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 97 (645)
+++|+|++|+. ++|+|+|||.+.+|.|+||+.... ...++|||+|++||+||+..+++++||+|+|+|.|....
T Consensus 1 ~~sF~f~~F~~~~~~~l~l~G~A~~~~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~~t~~~asFsT~F~F~i~~~~ 80 (236)
T d1hqla_ 1 SVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKITG 80 (236)
T ss_dssp CCEEEESCSCSCGGGTEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEECS
T ss_pred CEEEEeCCCCCCCcCCEEEeccEEecCCEEEEecCCCCCcccccceEEEEECCCEEeecCCCCceeEEEEEEEEEEeCCC
Confidence 47999999973 689999999999999999986432 356899999999999999999999999999999998754
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccccCCCCC---CCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCc
Q 041096 98 PSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLT---KNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPIL 174 (645)
Q Consensus 98 ~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~---~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~ 174 (645)
..+||||||||+|....++..|++||+++..+.+ .+++|||||||++|.+++||++||||||+||+.|.++.++.
T Consensus 81 -~~~gDGlAFvl~p~~~~~~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHIgIdvns~~s~~~~~~~- 158 (236)
T d1hqla_ 81 -NGPADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWE- 158 (236)
T ss_dssp -SCCCCEEEEEEECTTCCCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEECC-
T ss_pred -CCCCceEEEEEeCCCCCCCCCccccccccccccCCcccCceEEEEeeCccCCCCCCCCCCEEEEEcCCcccccccccc-
Confidence 6789999999999888788899999999876543 38999999999999999999999999999999998887764
Q ss_pred cccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc-cceeeeeeeeeeec
Q 041096 175 QGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS-TELHMIQSWSFQTS 253 (645)
Q Consensus 175 ~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~-~~~~~i~sw~f~~~ 253 (645)
..++.+|+.++|||+||+.+++|+|+|++. ++..|+|++.|||+.+|+++||||||||||.. .+.|+|++|+|+++
T Consensus 159 -~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~--~~~~~~ls~~vdL~~~l~~~v~vGFSasTG~~~~~~h~I~sWsF~s~ 235 (236)
T d1hqla_ 159 -DSDIFSGKIATARISYDGSAEILTVVLSYP--DGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFSSN 235 (236)
T ss_dssp -HHHHTSCSCEEEEEEEETTTTEEEEEEEET--TTEEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEEEEEEEEEE
T ss_pred -cccccCCCEEEEEEEEeCCCcEEEEEEecC--CCCCeeEEEEeCHHHhCCCcEEEEEEeECCCCCceEEEEEEeEeEec
Confidence 356889999999999999999999999975 46688999999999999999999999999975 67899999999975
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Probab=100.00 E-value=1.3e-55 Score=436.87 Aligned_cols=224 Identities=34% Similarity=0.551 Sum_probs=199.9
Q ss_pred CceeEEeCCCC------CCCeEEecceEeeCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEE
Q 041096 23 NNMNFDFTSFN------LRNITLLGDSYLRNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSI 93 (645)
Q Consensus 23 ~~~~f~~~~f~------~~~~~l~G~a~~~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i 93 (645)
++++|+|++|+ ..||+|+|||.+.+|.|+||+.... ..+++|||+|++||+||++ +++++||+|+|+|.|
T Consensus 2 ~s~sF~f~~F~~~~~~~~~~l~l~G~A~~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~-t~~~asFsT~F~f~i 80 (243)
T d1leda_ 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVFLWDS-TGKAASFYTSFTFLL 80 (243)
T ss_dssp CCCEEEESCBCCTTSCTTTSEEEEETCEEETBEEECSCBCTTSCBCSSEEEEEEESSCEECBCT-TSCBCEEEEEEEEEE
T ss_pred CceEEEcCCCCCCCCCCCCcEEEeeeeEEcCCEEEeccCCCCCCccccceEEEEeCCCeEecCC-CCcEeeEEEEEEEEc
Confidence 57899999995 4689999999999999999985422 3568999999999999995 789999999999988
Q ss_pred eeCCCCCCCCceEEEEecCCCCCCCCCCccccccCCCCC---CCcEEEEEeeCCCCCCCCCCCCCeeeeecCCccccccc
Q 041096 94 NNVNPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLT---KNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTA 170 (645)
Q Consensus 94 ~~~~~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~---~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~ 170 (645)
.+.. ..+||||||||+|....++..|++||+++..+.+ .+++|||||||++|.+++||++||||||+|++.|.++.
T Consensus 81 ~~~~-~~~gdGlAF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d~~~nHVgIdvns~~s~~~~ 159 (243)
T d1leda_ 81 KNYG-APTADGLAFFLAPVDSSVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATT 159 (243)
T ss_dssp EESS-SSCBCEEEEEEEETTCCCCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEE
T ss_pred CCCC-CCCCCceEEEEcCCCCCCCCCccccccccccccCCCccCcEEEEEEeCccccccCCCCCCceEEEecCccccccc
Confidence 7764 5679999999999888778899999999876543 38999999999999999999999999999999999888
Q ss_pred CCCccccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeeee
Q 041096 171 DPILQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSF 250 (645)
Q Consensus 171 ~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f 250 (645)
++.. .++.+|+.++|||+||+.+++|+|+|++. ++..|++++.|||+.+|+++||||||||||. .|.|+|++|+|
T Consensus 160 ~~~~--~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~--~~~~p~ls~~idL~~~l~~~vyvGFSAsTG~-~~~h~I~sWsF 234 (243)
T d1leda_ 160 RWEN--DDAYGSSIATAHITYDARSKILTVLLSYE--HGRDYILSHVVDLAKVLPQKVRIGFSAGVGY-DEVTYILSWHF 234 (243)
T ss_dssp ECCH--HHHTSCCEEEEEEEEETTTTEEEEEEEET--TSCEEEEEEECCHHHHSCSEEEEEEEEEECB-SEEEEEEEEEE
T ss_pred cccc--CCcccCceeEEEEEEECCCCEEEEEEeeC--CCCCceEEEecCHHHhcCCcEEEEEEcccCC-cceeeEEEEEE
Confidence 7643 46888999999999999999999999875 4678999999999999999999999999995 69999999999
Q ss_pred eec
Q 041096 251 QTS 253 (645)
Q Consensus 251 ~~~ 253 (645)
+++
T Consensus 235 ~s~ 237 (243)
T d1leda_ 235 FST 237 (243)
T ss_dssp EEE
T ss_pred Eee
Confidence 986
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Probab=100.00 E-value=5e-54 Score=426.68 Aligned_cols=227 Identities=30% Similarity=0.508 Sum_probs=200.2
Q ss_pred CceeEEeCCCC--CCCeEEecceEe-eCCcEEccCCCCC-CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC-C
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYL-RNGVIGLTRELGV-PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV-N 97 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~-~~~~~~Lt~~~~~-~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~-~ 97 (645)
++++|+|++|+ ..||+|+|||.+ .+|.|+||+.... ..+++|||+|++||+||++.+++++||+|+|+|.|... +
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~G~a~y~~Pv~l~~~~t~~~~sF~t~F~f~i~~~~~ 81 (240)
T d1fx5a_ 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSAN 81 (240)
T ss_dssp CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESSC
T ss_pred CceEEECCCCCCCCCCEEEeeeeEecCCCEEEccCCCCCCccceeEEEecCCCceeecCCCCceeeeEEEEEEEEeCCCC
Confidence 57899999997 468999999987 5789999986432 35688999999999999999999999999999999765 3
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccccCCCC-CCCcEEEEEeeCCCCC-CCCCCCCCeeeeecCCcccccccCCCcc
Q 041096 98 PSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQL-TKNKFVAIEFDTRLDP-HFDDPDENHIGLDIDSLESIKTADPILQ 175 (645)
Q Consensus 98 ~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~-~~~~~vAVEFDt~~n~-~~~d~~~~Hvgi~vns~~s~~~~~~~~~ 175 (645)
+..+||||||||+|...+.+..|++||+++..+. +.+++|||||||++|. +++||++||||||+||+.+..+.++.
T Consensus 82 ~~~ggdG~AFvl~p~~~~~~~~g~~lGl~~~~~~~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~s~~~~~~~-- 159 (240)
T d1fx5a_ 82 PKAATDGLTFFLAPPDSPLRRAGGYFGLFNDTKCDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWN-- 159 (240)
T ss_dssp GGGCCCEEEEEEECTTCCCCBCGGGTTTBSSSCCCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEECC--
T ss_pred CCCCCCcEEEEECCCCCCCCCCCccccccccCCCCccCceEEEEeeccccccccCCCCCCceEEccCCcccccccccc--
Confidence 4568999999999987777889999999987653 3478999999999985 67799999999999999988776653
Q ss_pred ccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCC-ccceeeeeeeeeeec
Q 041096 176 GIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEG-STELHMIQSWSFQTS 253 (645)
Q Consensus 176 ~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~-~~~~~~i~sw~f~~~ 253 (645)
..+.+|+.++|||+||+.+++|.|+|++.. ++..|+++..|||+.+|+++||||||||||. ..|.|+|++|+|+++
T Consensus 160 -~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~~~~H~I~sWsFsst 236 (240)
T d1fx5a_ 160 -KRYGLNNVANVEIIYEASSKTLTASLTYPS-DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFTST 236 (240)
T ss_dssp -CCCSGGGCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSCEEEEEEEEEEEEE
T ss_pred -cccCCCCeEEEEEEEcCCCCEEEEEEecCC-CceeeEEeEEEchHHhCCCcEEEEEEeECCCCCCceEEEEEEEeEEe
Confidence 467789999999999999999999999765 6778999999999999999999999999995 678999999999986
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Probab=100.00 E-value=4.8e-53 Score=419.11 Aligned_cols=224 Identities=34% Similarity=0.620 Sum_probs=197.4
Q ss_pred CceeEEeCCCC--CCCeEEecceEee-CCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPS 99 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~~-~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~ 99 (645)
++++|+|++|. ..||+|+|||.+. +|.|+||+.......++|||+|++||+||++.+++++||+|+|+|.|.++. .
T Consensus 2 ~~lsF~f~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~-~ 80 (237)
T d1qnwa_ 2 DDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKADK-S 80 (237)
T ss_dssp CSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBSS-S
T ss_pred CcEEEEcCCCCCCCCCEEEeeceEEcCCCeEEeccCCCCccccEEEEEECCCEEecCCCCcceeeEEEEEEEEEecCC-C
Confidence 57899999996 5689999999984 789999997544467899999999999999999999999999999997764 5
Q ss_pred CCCCceEEEEecCCCC--CCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCC--CCCCCeeeeecCCcccccccCCCc
Q 041096 100 SFGDGLAFFISPDNQI--LGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFD--DPDENHIGLDIDSLESIKTADPIL 174 (645)
Q Consensus 100 ~~g~G~aF~l~p~~~~--~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~--d~~~~Hvgi~vns~~s~~~~~~~~ 174 (645)
.+||||||||+|.... .++.|+++|+.+..+ .+.++.|||||||++|.+++ ||+++|||||+|++.|.++.++
T Consensus 81 ~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~~~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns~~s~~~~~~-- 158 (237)
T d1qnwa_ 81 DGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKW-- 158 (237)
T ss_dssp CCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSSCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEEEC--
T ss_pred CCcceeEEEEeCCCCCCCCCCccccccccCCCCCCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCCCCccccccc--
Confidence 6899999999998873 367788899988654 45689999999999998765 5899999999999999877664
Q ss_pred cccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCcc--ceeeeeeeeeee
Q 041096 175 QGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGST--ELHMIQSWSFQT 252 (645)
Q Consensus 175 ~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~--~~~~i~sw~f~~ 252 (645)
++.+|+.++|||+||+.+++|+|+|++.. +|..|+|++.|||+++|+++||||||||||... |.|+|++|+|++
T Consensus 159 ---~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~~q~h~I~sWsF~s 234 (237)
T d1qnwa_ 159 ---DWRNGEVADVVITYRAPTKSLTVCLSYPS-DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFTS 234 (237)
T ss_dssp ---CCCTTCCEEEEEEEEGGGTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCEEEEEEEEE
T ss_pred ---ccCCCcEEEEEEEEcCCCcEEEEEEecCC-CCccceEEEEEChHHhCCCcEEEEEEeECCCCCCccEeEEEEeEeEE
Confidence 57889999999999999999999998655 788999999999999999999999999999864 899999999998
Q ss_pred c
Q 041096 253 S 253 (645)
Q Consensus 253 ~ 253 (645)
+
T Consensus 235 ~ 235 (237)
T d1qnwa_ 235 N 235 (237)
T ss_dssp E
T ss_pred e
Confidence 6
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Probab=100.00 E-value=4.3e-53 Score=419.62 Aligned_cols=224 Identities=34% Similarity=0.558 Sum_probs=198.7
Q ss_pred CceeEEeCCCC--CCCeEEecceEee-CCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV 96 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~~-~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 96 (645)
++++|+|++|+ ..||+|+|||.+. +|.|+||+.... ..+++|||+|++||+||++.+++++||+|+|+|.|...
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~~~~~~~~~sFst~F~f~i~~~ 81 (239)
T d1gzca_ 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQP 81 (239)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCC
T ss_pred eeEEEEeCCCCCCCCCeEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEecCCCCCceeeEEEEEEEEEecC
Confidence 46899999998 4689999999985 789999996432 24689999999999999999999999999999999754
Q ss_pred -CCCCCCCceEEEEecCCCCCCCCCCccccccCCCC-CCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCc
Q 041096 97 -NPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQL-TKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPIL 174 (645)
Q Consensus 97 -~~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~-~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~ 174 (645)
+...+||||||+|+|.+...+..|++||+++..+. +.++.|||||||++| +++||+++|||||+|++.|.++.++
T Consensus 82 ~~~~~g~dG~aF~l~p~~~~~~~~~g~lg~~~~~~~~~~~~~vaVEFDT~~n-~~~d~~~~HvgI~vn~~~s~~t~~~-- 158 (239)
T d1gzca_ 82 YTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDNSYQTLAVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQPF-- 158 (239)
T ss_dssp CSSSCCCEEEEEEEECSSCCCCCCGGGTTTCSSSSCCGGGCCEEEEEECSCC-TTSCSSSSEEEEEESSSSCSEEEEC--
T ss_pred CCCCCCCCeEEEEECCCCCCCCCCcccccccccCCCCCccceEEEEEEcccc-CCCCCCCCEEEEEECCccccccCCc--
Confidence 34578999999999998877788999999876543 347899999999999 4689999999999999999887763
Q ss_pred cccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCC---ccceeeeeeeeee
Q 041096 175 QGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEG---STELHMIQSWSFQ 251 (645)
Q Consensus 175 ~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~---~~~~~~i~sw~f~ 251 (645)
++.+|+.++|||+||+.+++|+|+|++.. +|..|.++..|||+++|+++|||||||+||. ..|.|+|++|+|+
T Consensus 159 ---~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~V~sWsF~ 234 (239)
T d1gzca_ 159 ---QLDNGQVANVVIKYDAPSKILHVVLVYPS-SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQ 234 (239)
T ss_dssp ---CCCTTCEEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEE
T ss_pred ---cccCCCEEEEEEEEeCCCcEEEEEEecCC-CCcceeeeeEechHHhcCCcEEEEEEEEcCCCCCCceeeEEEEEEeE
Confidence 68899999999999999999999998765 7889999999999999999999999999994 5689999999999
Q ss_pred ec
Q 041096 252 TS 253 (645)
Q Consensus 252 ~~ 253 (645)
++
T Consensus 235 s~ 236 (239)
T d1gzca_ 235 AS 236 (239)
T ss_dssp EE
T ss_pred ee
Confidence 86
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Probab=100.00 E-value=1.7e-52 Score=414.53 Aligned_cols=220 Identities=36% Similarity=0.594 Sum_probs=195.1
Q ss_pred ceeEEeCCCC--CCCeEEecceEee-CCcEEccCCCCC--CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC-C
Q 041096 24 NMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTRELGV--PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV-N 97 (645)
Q Consensus 24 ~~~f~~~~f~--~~~~~l~G~a~~~-~~~~~Lt~~~~~--~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~-~ 97 (645)
+++|+|++|. .+||+|+|||.+. +|.|+||+.... ..+++|||+|++||+||++.+++++||+|+|+|.|... +
T Consensus 2 t~sF~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sF~t~F~f~i~~~~~ 81 (237)
T d2d3sa1 2 TISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPFP 81 (237)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSCC
T ss_pred eEEEEeCCCCCCCCCEEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEeecCCCCceeeEEEEEEEEeecCCC
Confidence 6899999995 5789999999985 679999985321 24799999999999999999999999999999999764 3
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCcccc
Q 041096 98 PSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGI 177 (645)
Q Consensus 98 ~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~ 177 (645)
...+||||||+|+|.+...+..|++||+++.. +.+++|||||||++|.+ ||++||||||+|++.|.++.+ .
T Consensus 82 ~~~g~dGlaFvl~p~~~~~~~~gg~lG~~~~~--~~~~~vaVEFDT~~n~~--d~~~nHvgI~vns~~s~~~~~-----~ 152 (237)
T d2d3sa1 82 RPHPADGLVFFIAPPNTQTGEGGGYFGIYNPL--SPYPFVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKTVP-----F 152 (237)
T ss_dssp SSCCCEEEEEEEECSSCCCCBCGGGTTTBCTT--SCCCCEEEEEECSCCTT--CCSSSEEEEEESSSSCSEEEE-----C
T ss_pred CCCCCCeEEEEeCCCCccCCccccccccccCC--CcCceEEEEEEeecCCC--CCCCCcEEEEcCCCccccccc-----e
Confidence 45678999999999888778899999998763 45789999999999974 999999999999999987765 3
Q ss_pred ccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCC-------ccceeeeeeeee
Q 041096 178 DLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEG-------STELHMIQSWSF 250 (645)
Q Consensus 178 ~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~-------~~~~~~i~sw~f 250 (645)
++.+|+.++|||+||+.+++|+|+|++.. +|..|+++..|||+.+|+++||||||||||. ..|.|+|++|+|
T Consensus 153 ~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~~~~~~~~e~h~I~sWsF 231 (237)
T d2d3sa1 153 TLDNGGIANVVIKYDASTKILHVVLVFPS-LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSF 231 (237)
T ss_dssp CCCTTCEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCCCCEEEEEEE
T ss_pred eecCCCEEEEEEEEECCCCEEEEEEEcCC-CCcccceeeEechHHhCCCcEEEEEEeECCCCccCccccceeeEEEEeEe
Confidence 68899999999999999999999999765 5778899999999999999999999999995 468999999999
Q ss_pred eec
Q 041096 251 QTS 253 (645)
Q Consensus 251 ~~~ 253 (645)
+++
T Consensus 232 ss~ 234 (237)
T d2d3sa1 232 SAS 234 (237)
T ss_dssp EEE
T ss_pred Eee
Confidence 886
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Probab=100.00 E-value=5e-52 Score=416.43 Aligned_cols=224 Identities=32% Similarity=0.521 Sum_probs=202.2
Q ss_pred CceeEEeCCCCCCCeEEecceEeeCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCC
Q 041096 23 NNMNFDFTSFNLRNITLLGDSYLRNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPS 99 (645)
Q Consensus 23 ~~~~f~~~~f~~~~~~l~G~a~~~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~ 99 (645)
...+|+|++|+..||+|+|||.+.++.|+||++... ...++|||+|++||+||++.+++++||+|+|+|+|.+.+..
T Consensus 2 ~~~sF~f~~F~~~~l~l~GdA~~~~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~~~~~~~~~sF~t~F~F~i~~~~~~ 81 (253)
T d1g7ya_ 2 DIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAPNKS 81 (253)
T ss_dssp EEEEEEESSCCSSCEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSSGG
T ss_pred cccEEecCCCCcccEEEEeeeEEcCCEEEeCCCCCCCCcccceeEEEEeCCCeEeecCCCCceeeEEEEEEEEEecCCCC
Confidence 457999999999999999999999999999986432 24689999999999999999999999999999999988777
Q ss_pred CCCCceEEEEecCCCCCCCCCCccccccCCCC-CCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccccc
Q 041096 100 SFGDGLAFFISPDNQILGSAGGCLGLVNSSQL-TKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGID 178 (645)
Q Consensus 100 ~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~-~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~~ 178 (645)
.+||||||+|+|.+..++..||++|+++..+. +.++.+||||||++|.++ ||+++|||||+|++.|.++.+ ..
T Consensus 82 ~ggDGlAF~l~~~~~~~~~~~g~lgl~~~~~~~~~~~~vaVEFDT~~n~~~-d~~~~Hvgi~~ns~~s~~~~~-----~~ 155 (253)
T d1g7ya_ 82 SSADGIAFALVPVGSEPKSNSGFLGVFDSDVYDNSAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTAS-----WG 155 (253)
T ss_dssp GCCCEEEEEEEETTCCCCCCGGGTTTCSCSSCCGGGCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEEE-----CC
T ss_pred CCCCceEEEEeCCCCCCCCCcccccccccCCCCCcCceEEEEEeceecCCC-CCCCCcEEEeeCCcccccccC-----CC
Confidence 89999999999998878888999999986543 447899999999999875 999999999999999987765 36
Q ss_pred cCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccC---Cccceeeeeeeeeeec
Q 041096 179 LKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTE---GSTELHMIQSWSFQTS 253 (645)
Q Consensus 179 ~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg---~~~~~~~i~sw~f~~~ 253 (645)
+.+|+.++|||+||+.+++|.|++++.. +|..|+++..+||+.+|+++|||||||+|| ...|.|+|++|+|++.
T Consensus 156 ~~~g~~~~v~I~Yd~~~~~L~v~l~~~~-~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~H~IlsWsF~s~ 232 (253)
T d1g7ya_ 156 LANGQNAEILITYNAATSLLVASLVHPS-RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASK 232 (253)
T ss_dssp CCTTSEEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCEEEEEEEEEE
T ss_pred ccCCCEEEEEEEEeCCcEEEEEEEecCC-CCCceEEEEEechhhcCCCcEEEEEEeEcCCCCCcccccEEEEEEeEEe
Confidence 7899999999999999999999998754 788899999999999999999999999999 4679999999999885
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=5.3e-52 Score=410.53 Aligned_cols=224 Identities=34% Similarity=0.551 Sum_probs=201.4
Q ss_pred CCceeEEeCCCCCCCeEEecceEee-CCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCC
Q 041096 22 SNNMNFDFTSFNLRNITLLGDSYLR-NGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVN 97 (645)
Q Consensus 22 ~~~~~f~~~~f~~~~~~l~G~a~~~-~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 97 (645)
+++++|+|++|+..||+|+|||.+. +|.|+||+.... ..+++|||+|++||+||++.+++++||+|+|+|+|.+.+
T Consensus 1 ~~~~sF~f~~F~~~nl~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~f~f~i~~~~ 80 (233)
T d1g8wa_ 1 SNDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVPN 80 (233)
T ss_dssp CEEEEEEESSCCGGGEEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECBCTTTCCBEEEEEEEEEECCCCS
T ss_pred CCceEEECCCCCcCcEEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEeecCCCCceeeEEEEEEEEEecCC
Confidence 3578999999999999999999984 789999986432 246899999999999999999999999999999999887
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCcccc
Q 041096 98 PSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGI 177 (645)
Q Consensus 98 ~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~ 177 (645)
...+||||||+|+|.+..++..|++||+++.. .++++.|||||||+.|.++ ||+++||||++|++.|..+.+ .
T Consensus 81 ~~~~gDGlAF~l~~~~~~~g~~g~~lG~~~g~-~~~~~~vaVEFDT~~N~~~-d~~~~Hvgi~~n~~~s~~~~~-----~ 153 (233)
T d1g8wa_ 81 NAGPADGLAFALVPVGSQPKDKGGFLGLFDGS-NSNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTR-----W 153 (233)
T ss_dssp SCBCCEEEEEEEEETTCCCCCCGGGTTTCCSS-CCCCCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSEEEE-----C
T ss_pred CCCCCCeEEEEEecCCCCCCcccccCCccccC-CCcccEEEEEeecccCCCC-CCCCCeEEEECCCcceeeecc-----c
Confidence 77889999999999988788899999998764 4567899999999999886 999999999999999877665 3
Q ss_pred ccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCC---ccceeeeeeeeeeec
Q 041096 178 DLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEG---STELHMIQSWSFQTS 253 (645)
Q Consensus 178 ~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~---~~~~~~i~sw~f~~~ 253 (645)
++.+|+.++|||+||+.+++|.|++.+.. ++..|+++..+||+.+||++|||||||+||. ..|.|+|++|+|+++
T Consensus 154 ~~~~g~~~~~~I~yd~~~~~l~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~h~I~sWsFss~ 231 (233)
T d1g8wa_ 154 DFVNGENAEVLITYDSSTNLLVASLVYPS-QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASK 231 (233)
T ss_dssp CCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCEEEEEEEEEE
T ss_pred cccCCcEEEEEEEEeCCCcEEEEEEEeCC-CCCcEEEEEEechhHcCCCcEEEEEEEEcCCCCCCceeeEEEEEEEEEE
Confidence 67899999999999999999999998766 6788899999999999999999999999994 557899999999985
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Probab=100.00 E-value=9.1e-52 Score=413.10 Aligned_cols=223 Identities=32% Similarity=0.544 Sum_probs=193.6
Q ss_pred CceeEEeCCCC--CCCeEEecceEe-eCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYL-RNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV 96 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~-~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 96 (645)
.+++|+|++|+ ..||+|+|||.+ .+|.|+||++... ...++|||+|++||+||++.+++.+||+|+|+|.|...
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sf~t~f~F~i~~~ 81 (251)
T d1g9fa_ 2 ETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYAP 81 (251)
T ss_dssp EEEEEEESSCCC-CTTEEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECBCC-CCCBCEEEEEEEEEEECS
T ss_pred ceEEEEeCCCCCCCCCEEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEccCCCCccceeeEEEEEEEEecC
Confidence 56899999998 458999999998 4789999986432 24689999999999999999999999999999999988
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccc
Q 041096 97 NPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176 (645)
Q Consensus 97 ~~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~ 176 (645)
+...+||||||+|+|....++..||+||+++.. .+.++.|||||||++|.+ ||+++|||||+|++.|..+..
T Consensus 82 ~~~~~gDGlAFvl~p~~~~~~~~~g~lG~~~~~-~~~~~~vaVEFDT~~n~~--D~~~~Hvgi~~n~~~s~~~~~----- 153 (251)
T d1g9fa_ 82 DTKRLADGLAFFLAPIDTKPQTHAGYLGLFNEN-ESGDQVVAVEFDTFRNSW--DPPNPHIGINVNSIRSIKTTS----- 153 (251)
T ss_dssp CC--CCEEEEEEEEETTCCCCCCGGGTTTCCTT-SCCCSCEEEEEECC-CTT--SCSSSEEEEEESSSSCSEEEE-----
T ss_pred CCCCCCCceEEEEecCCCCCCCccCccCccccc-CCCcceEEEEEecccCCC--CCCCCcEeEEecCcccccccc-----
Confidence 888899999999999888778889999998764 345789999999999974 999999999999999987765
Q ss_pred cccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCcc--ceeeeeeeeeeecC
Q 041096 177 IDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGST--ELHMIQSWSFQTSG 254 (645)
Q Consensus 177 ~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~--~~~~i~sw~f~~~~ 254 (645)
.++.+|+.++|||+||+..++|+|++.+.. +|..|+++..|||+.+|+++||||||||||... |.|+|++|+|++..
T Consensus 154 ~~l~~g~~~~v~I~Yd~~~~~L~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~h~I~sWsF~s~~ 232 (251)
T d1g9fa_ 154 WDLANNKVAKVLITYDASTSLLVASLVYPS-QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASNL 232 (251)
T ss_dssp CCCCTTCCEEEEEEEETTTTEEEEEEEEGG-GTEEEEEEEECCC-CCSCSEEEEEEEEEECSSSCCCEEEEEEEEEEEEE
T ss_pred eEecCCCEEEEEEEEECCccEEEEEEecCC-CCcceeEEEEecchhhCCCcEEEEEEeecCCCCCCceeEEEEeEeECCC
Confidence 368899999999999999999999998765 788899999999999999999999999999755 88999999999874
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Probab=100.00 E-value=2.2e-51 Score=406.04 Aligned_cols=220 Identities=33% Similarity=0.538 Sum_probs=193.7
Q ss_pred ceeEEeCCCC--CCCeEEecceEe-eCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCC
Q 041096 24 NMNFDFTSFN--LRNITLLGDSYL-RNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVN 97 (645)
Q Consensus 24 ~~~f~~~~f~--~~~~~l~G~a~~-~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 97 (645)
++||+|++|. .+||+|+|||.+ .+|.|+||+.... ..+++|||+|++||+||++.+++++||+|+|+|.|.+..
T Consensus 2 ~~SF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sFsT~F~f~i~~~~ 81 (234)
T d1f9ka_ 2 TQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQPY 81 (234)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCC
T ss_pred ceEEEeCCCCCCCCCEEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEeeCCCCCcCcceEEEEEEEEECCC
Confidence 5799999997 578999999998 5789999996432 246899999999999999999999999999999998653
Q ss_pred -CCCCCCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccc
Q 041096 98 -PSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176 (645)
Q Consensus 98 -~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~ 176 (645)
...+||||||+|+|...+.+..|+++|+++.. +.++.|||||||++|. +||++||||||+|++.|.++.+
T Consensus 82 ~~~~g~dG~aF~i~p~~~~~~~~g~~~g~~~~~--~~~~~vaVEFDT~~n~--~Dp~~nHvgi~~ns~~s~~~~~----- 152 (234)
T d1f9ka_ 82 AYPEPADGLTFFMVPPNSPQGEDGGNLGVFKPP--EGDNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLH----- 152 (234)
T ss_dssp SSSCCCEEEEEEEECTTCCCCCSGGGTTTCCSS--CCSCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE-----
T ss_pred CCCCccceEEEEECCCCCCcccccccccccCCC--CccceEEEEEeccccC--CCCCCCcEeEecCCcccccccc-----
Confidence 45678999999999888778899999998763 4578899999999997 4999999999999999887765
Q ss_pred cccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCC--CccEEeEEeccCC---ccceeeeeeeeee
Q 041096 177 IDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLK--GNMYVGFSASTEG---STELHMIQSWSFQ 251 (645)
Q Consensus 177 ~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~--~~~~vGfsastg~---~~~~~~i~sw~f~ 251 (645)
+++.+|+.++|||+||+.+++|+|++++.. ++..|.|++.|||+.+|+ ++|||||||+||. ..|.|+|++|+|+
T Consensus 153 ~~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~-~~~~~~ls~~idL~~~l~~~~~v~vGFSasTG~~~~~~~~h~I~sWsF~ 231 (234)
T d1f9ka_ 153 FQLENGGVANVVIKYDSPTKILNVVLAFHS-VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFT 231 (234)
T ss_dssp CCCCTTCCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCEEEEEEEEEE
T ss_pred ccccCCCEEEEEEEEcCCCcEEEEEEEeCC-CCccceEEEEEcHHHhcCCCCEEEEEEEeecCCCCCceeeeEEEEEEeE
Confidence 478899999999999999999999999765 567789999999999997 5699999999994 5689999999998
Q ss_pred ec
Q 041096 252 TS 253 (645)
Q Consensus 252 ~~ 253 (645)
++
T Consensus 232 s~ 233 (234)
T d1f9ka_ 232 SS 233 (234)
T ss_dssp EE
T ss_pred Ee
Confidence 75
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Probab=100.00 E-value=4.1e-50 Score=399.96 Aligned_cols=226 Identities=34% Similarity=0.556 Sum_probs=198.3
Q ss_pred CCceeEEeCCCC--CCCeEEecceEee-CCcEEccCCCCC--CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC
Q 041096 22 SNNMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTRELGV--PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV 96 (645)
Q Consensus 22 ~~~~~f~~~~f~--~~~~~l~G~a~~~-~~~~~Lt~~~~~--~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 96 (645)
+++++|+|++|. ..||+|+|||.+. +|.||||++... ...++|||+|++||+||++.+++++||+|+|+|+|.+.
T Consensus 1 ~~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sFst~F~F~i~~~ 80 (239)
T d1dbna_ 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAP 80 (239)
T ss_dssp CCEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred CCceEEEeCCCCCCCCCEEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEccCCCCccceEEEEEEEEEEECC
Confidence 357999999996 4689999999985 679999986432 35689999999999999999999999999999999988
Q ss_pred CCCCCCCceEEEEecCCCC--CCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCC--CCCCCeeeeecCCcccccccC
Q 041096 97 NPSSFGDGLAFFISPDNQI--LGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFD--DPDENHIGLDIDSLESIKTAD 171 (645)
Q Consensus 97 ~~~~~g~G~aF~l~p~~~~--~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~--d~~~~Hvgi~vns~~s~~~~~ 171 (645)
....+||||||+|+|.... .++.|++||+++..+ ++.++.+||||||++|.+++ ||+++|||||+|++.|.++..
T Consensus 81 ~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~n~~~s~~~~~ 160 (239)
T d1dbna_ 81 NPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQ 160 (239)
T ss_dssp STTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSCCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCCCCEEEEEeCCCccCCcccCccccccccccCCCcccCeeeeEEeeeecCCCCCCCCCCceeeEEcCCcccccccc
Confidence 7788999999999998763 467789999998654 34589999999999998764 789999999999999877665
Q ss_pred CCccccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc--cceeeeeeee
Q 041096 172 PILQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS--TELHMIQSWS 249 (645)
Q Consensus 172 ~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~--~~~~~i~sw~ 249 (645)
. .+.+|+.++|||+|++.+++|.|++.+.. ++..|.++..+||+.+|+++||||||||||.. .|.|+|++|+
T Consensus 161 ~-----~~~~g~~~~~~i~y~~~~~~l~v~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~H~I~sWs 234 (239)
T d1dbna_ 161 W-----DWINGGVAFATITYLAPNKTLIASLVYPS-NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWS 234 (239)
T ss_dssp C-----CCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEEEEE
T ss_pred c-----eEeCCceeEEEEEEcCCCCEEEEEEEecC-CCccEEEEEecchHHhcCCcEEEEEEEeCCCCCCcceeEEEEEE
Confidence 3 46689999999999999999999998765 67788999999999999999999999999965 5789999999
Q ss_pred eeec
Q 041096 250 FQTS 253 (645)
Q Consensus 250 f~~~ 253 (645)
|+++
T Consensus 235 Fss~ 238 (239)
T d1dbna_ 235 FTST 238 (239)
T ss_dssp EEEE
T ss_pred eEEe
Confidence 9975
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Probab=100.00 E-value=7.2e-50 Score=395.69 Aligned_cols=223 Identities=30% Similarity=0.528 Sum_probs=191.5
Q ss_pred CCceeEEeCCCCCC--CeEEecceEee-CCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCC
Q 041096 22 SNNMNFDFTSFNLR--NITLLGDSYLR-NGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNP 98 (645)
Q Consensus 22 ~~~~~f~~~~f~~~--~~~l~G~a~~~-~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 98 (645)
+.+++|+|++|+.. +|+|+|||.+. +|.|+||++. ..+++|||+|++||+||++.+++.+||+|+|+|.|.+.+.
T Consensus 1 a~~~sF~~~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~--~~~~~G~a~y~~Pi~l~~~~~~~~~sf~t~f~f~i~~~~~ 78 (232)
T d1v6ia_ 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLN--KVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKD 78 (232)
T ss_dssp CEEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTT--STTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSS
T ss_pred CccEEEECCCCCCCCCCEEEeeeeEEcCCCEEEeCCCC--CCCceEEEEcCCCEEccCCCCCccceeEEEEEEEeccCCC
Confidence 35789999999965 59999999974 7899999863 3478999999999999999999999999999999998888
Q ss_pred CCCCCceEEEEecCCCCCCCCCCccccccC-CCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCcccc
Q 041096 99 SSFGDGLAFFISPDNQILGSAGGCLGLVNS-SQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGI 177 (645)
Q Consensus 99 ~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~-~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~ 177 (645)
..+||||||+|+|.....+..|+.+|+... ..++.++.|||||||++|.+++||+++|||||+|++.+.+... .
T Consensus 79 ~~~gDG~AF~l~~~~~~~~~~~~~g~~~~~~~~~~~~~~~aVEfDT~~n~~~~d~~~~Higid~n~~~s~~~~~-----~ 153 (232)
T d1v6ia_ 79 YDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVP-----W 153 (232)
T ss_dssp SBCCCEEEEEEEETTCCCCTTCCCGGGTTTSCTTSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEE-----C
T ss_pred CCCCCeEEEEEECCCCCCCCCccCCcccccccCCCCCceEEEEEEeEecCCCCCCCCccEeEeeCCcccccccc-----c
Confidence 889999999999988754333332233222 1234578999999999999988999999999999998877654 3
Q ss_pred ccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc-cceeeeeeeeeeec
Q 041096 178 DLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS-TELHMIQSWSFQTS 253 (645)
Q Consensus 178 ~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~-~~~~~i~sw~f~~~ 253 (645)
++.+|+.++|||+||+.+++|.|++++. ++..|.++..|||+.+|+++|||||||+||.. .|.|+|++|+|+++
T Consensus 154 ~~~~g~~~~v~I~Yd~~~~~L~V~~~~~--~~~~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~I~sWsFss~ 228 (232)
T d1v6ia_ 154 NSVSGAVVKVTVIYDSSTKTLSVAVTND--NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTST 228 (232)
T ss_dssp CCCTTCEEEEEEEEETTTTEEEEEEECT--TSCEEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEEEEEEEEEEE
T ss_pred ccCCCCEEEEEEEEeCCceEEEEEEecC--CCCcceEEEEEchhhccCCcEEEEEEEECCCCCCcccEEEEeEeEEe
Confidence 6789999999999999999999999864 46678899999999999999999999999975 59999999999986
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Probab=100.00 E-value=7.8e-50 Score=397.58 Aligned_cols=224 Identities=31% Similarity=0.557 Sum_probs=198.9
Q ss_pred CceeEEeCCCC--CCCeEEecceEee-CCcEEccCCCCC--CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTRELGV--PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVN 97 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~~-~~~~~Lt~~~~~--~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 97 (645)
.++||+|++|. ..|++|+|||.+. +|.||||++... ..+++|||+|++||+||++.+++++||+|+|+|+|.+.+
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~F~i~~~~ 81 (237)
T d1fnya_ 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPN 81 (237)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred ceEEEEeCCCCCCCCCeEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEcccCCCCcceeeEEEEEEEEecCC
Confidence 46899999997 4689999999985 689999986321 357899999999999999999999999999999999888
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccc
Q 041096 98 PSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176 (645)
Q Consensus 98 ~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~ 176 (645)
...+||||||+|+|.+...+..||+||+++..+ .+.++.+||||||+.|.++ ||+++||||++|++.|..+.+
T Consensus 82 ~~~~gDG~AF~l~~~~~~~~~~gg~lg~~~~~~~~~~~~~~aVefDT~~n~~~-d~~~~Higi~~n~~~s~~~~~----- 155 (237)
T d1fnya_ 82 PATTADGLAFFLAPVDTQPLDLGGMLGIFKDGYFNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVP----- 155 (237)
T ss_dssp TTSCCEEEEEEEEETTCCCCCCGGGTTTCC---CCTTSCCEEEEEECSCCTTT-CCSSSEEEEEESSSSCSEEEE-----
T ss_pred CCCCCCeeEEEEcCCCCCcccccCcccccCCCCccCccceEEEEeccccccCC-CCCCceEEEecCCCccccccc-----
Confidence 788999999999998887788899999987643 4568899999999999886 999999999999999887665
Q ss_pred cccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccC---Cccceeeeeeeeeeec
Q 041096 177 IDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTE---GSTELHMIQSWSFQTS 253 (645)
Q Consensus 177 ~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg---~~~~~~~i~sw~f~~~ 253 (645)
.++.+|+.++|||+||+..++|.|++.+.. ++..|+++..+||+.+||++|||||||+|| ...|.|+|+||+|+++
T Consensus 156 ~~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~~~e~H~I~sWsF~s~ 234 (237)
T d1fnya_ 156 WNWTNGEVANVFISYEASTKSLTASLVYPS-LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFESN 234 (237)
T ss_dssp CCCCTTCCEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred ccccCCcEEEEEEEEeCCccEEEEEEEeCC-CCcceeEEEEechhhcCCCcEEEEEEEECCCCCCcccccEEEEeEeEEe
Confidence 357789999999999999999999999866 677899999999999999999999999999 4668999999999986
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Probab=100.00 E-value=2e-49 Score=392.70 Aligned_cols=221 Identities=34% Similarity=0.535 Sum_probs=195.6
Q ss_pred CceeEEeCCCC--CCCeEEecceEee-CCcEEccCCCCC--CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYLR-NGVIGLTRELGV--PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVN 97 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~~-~~~~~Lt~~~~~--~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 97 (645)
.+++|+|++|+ ..||+|+|||.+. +|.|+||++... .++++|||||++||+||+.. ..+||+|+|+|.|.+..
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~~~~--~~~sF~t~f~f~i~~~~ 79 (233)
T d1n47a_ 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNT--TLASFTTSFSFVMAAPA 79 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSS--CBCEEEEEEEEECCCSS
T ss_pred CceEEEeCCCCCCCCCeEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEccCCC--eeeeEEEEEEEEEeCCC
Confidence 46899999996 5799999999985 679999986432 34689999999999999863 57999999999999888
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccc
Q 041096 98 PSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQG 176 (645)
Q Consensus 98 ~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~ 176 (645)
...+||||||+|+|....++..|++||+++..+ ++.++.|||||||++|.+ ||++||||||+|++.|.++.++
T Consensus 80 ~~~~gDGlAF~l~~~~~~~~~~gg~lGl~~~~~~~~~~~~~aVefDT~~n~~--d~~~~higi~~n~~~s~~~~~~---- 153 (233)
T d1n47a_ 80 AAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHDASYQTVAVEFDTYSNAW--DPNYTHIGIDTNGIESKKTTPF---- 153 (233)
T ss_dssp TTSCCEEEEEEEECTTCCCCCCGGGTTTCSSSSCCGGGCCEEEEEECSCCTT--SCSSCEEEEEESSSSCSEEEEC----
T ss_pred CCCCCCceEEEECCCCCCCCCCCCccccccccCCCCcCceEEEEEEeeecCC--CCCCCceeEccCCccccccccc----
Confidence 788999999999998887788899999997654 445889999999999973 9999999999999998877664
Q ss_pred cccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccC---Cccceeeeeeeeeeec
Q 041096 177 IDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTE---GSTELHMIQSWSFQTS 253 (645)
Q Consensus 177 ~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg---~~~~~~~i~sw~f~~~ 253 (645)
++.+|+.++|||+||+.+++|.|++.+.. ++..|.++..+||+.+|+++|||||||+|| ...|.|+|++|+|+++
T Consensus 154 -~l~~g~~~~v~I~Y~~~~~~l~v~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~I~sWsFss~ 231 (233)
T d1n47a_ 154 -DMVYGEKANIVITYQASTKALAASLVFPV-SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVS 231 (233)
T ss_dssp -CCCTTSCEEEEEEEETTTTEEEEEEEETT-TTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred -eecCCCEEEEEEEEcCCCeEEEEEEEeCC-CCccEEEEEEechHHhcCCcEEEEEEEecCCCCCcccccEEEEEEeEEE
Confidence 67889999999999999999999999765 688899999999999999999999999999 4578999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-50 Score=413.47 Aligned_cols=254 Identities=27% Similarity=0.478 Sum_probs=207.8
Q ss_pred cCHHHHHHHhcCC---------CcCceeccCCceEEEEEEECCCC---eEEEEEeccC--CcchhHhHHHHHHHHhhcCC
Q 041096 338 FSYRELRSATRGF---------HSNRILGRGAFGNVYKAYFASSG---SVAAVKRSKH--SHEGKTEFLAELSIIACLRH 403 (645)
Q Consensus 338 ~~~~~l~~~~~~f---------~~~~~lG~G~fg~Vy~g~~~~~~---~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H 403 (645)
++|+++..++++| +..++||+|+||+||+|.+..++ ..||||++.. .....++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4666777776554 44578999999999999987554 3689998765 34456789999999999999
Q ss_pred CCeeeeeeeeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 041096 404 KNLVQLLGWCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIM 483 (645)
Q Consensus 404 ~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIl 483 (645)
||||+++|+|.+.+..++|||||++|+|.+++..... .++|.+++.++.|||+||+|||+ ++|+||||||+|||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNIL 160 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEE
Confidence 9999999999999999999999999999999876443 39999999999999999999999 99999999999999
Q ss_pred EcCCCCeeeecccc-----------------ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccc
Q 041096 484 LDANFNARLESSFT-----------------LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEG 545 (645)
Q Consensus 484 ld~~~~~kl~d~~~-----------------~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~ 545 (645)
|+.++.+||+|..- ...||+.|||||.+.++.++.++|||||||+||||+| |+.||......
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 99999999988321 1246889999999999999999999999999999998 89999764321
Q ss_pred cchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 546 HKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 546 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
.+. ..+....+...+.+++..+.+++..||+.||++||||+||++.|+.+.+
T Consensus 241 ----~~~-------------~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 241 ----DVI-------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ----HHH-------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----HHH-------------HHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 121 1222222334455567788999999999999999999999999987644
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=402.60 Aligned_cols=243 Identities=23% Similarity=0.375 Sum_probs=202.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|+..+.||+|+||+||+|.+.+ +..||||++.......++|.+|++++++++|||||+++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467788999999999999999874 6789999998877777899999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----------- 496 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----------- 496 (645)
+|+|.+++..... .++|..++.++.|||+||+|||+ ++|+||||||+|||||.++.+||+|..
T Consensus 84 ~g~L~~~l~~~~~---~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 9999999876543 38999999999999999999999 999999999999999999999998822
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....||+.|+|||++.+..++.++|||||||++|||+|++.|+...... ..+.. .+....+.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~-------------~i~~~~~~ 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVE-------------DISTGFRL 221 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHH-------------HHHHTCCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHH-------------HHHhcCCC
Confidence 1245889999999999999999999999999999999965544332211 11111 12222222
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
..+..+...+.+++..||+.||++||||+||++.|+++.
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 334445677889999999999999999999999998654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-49 Score=408.47 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=212.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 346 ATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 346 ~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
..++|+..+.||+|+||+||+|++..++..||||+++......++|.+|+++|++++|||||+++|+|.+++..+|||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 34678889999999999999999998899999999988777778899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc---------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF--------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~--------- 496 (645)
|++|+|.+++..... ..++|..++.++.|||+||+|||+ ++|+||||||+||||+.++.+||+|..
T Consensus 95 ~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 95 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999976432 348999999999999999999999 999999999999999999999998822
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....|++.|+|||++.++.++.++|||||||++|||++|+.|+....... . +.+.+....
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~---~-------------~~~~i~~~~ 233 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---Q-------------VYELLEKDY 233 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H-------------HHHHHHTTC
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH---H-------------HHHHHhcCC
Confidence 11247889999999999999999999999999999999877765432211 1 122233333
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
+...+...+..+.+++..||+.||++||||++|++.|+...+.
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 3445555677889999999999999999999999999876543
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Probab=100.00 E-value=1.3e-47 Score=382.53 Aligned_cols=223 Identities=31% Similarity=0.590 Sum_probs=194.5
Q ss_pred CceeEEeCCCC--CCCeEEecceEeeCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCC
Q 041096 23 NNMNFDFTSFN--LRNITLLGDSYLRNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVN 97 (645)
Q Consensus 23 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 97 (645)
.+++|+|++|. ..||+|+|||.+.++.|+||++... ...++|||+|++||+||++.+++++||+|+|+|+|....
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~ 81 (241)
T d1ukga_ 2 DSLSFGFPTFPSDQKNLIFQGDAQIKNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSSRVANFQSQFSFSLKSPL 81 (241)
T ss_dssp CEEEEEESSCCSCCSSEEEEETCEEETTEEECSCBCTTSCBCSSEEEEEEESSCEECEETTTTEEEEEEEEEEEEEECSS
T ss_pred ccEEEEeCCCCCCCCCEEEeeeEEEeCCEEEeCCCCCCCCccccceEEEEeCCCeecccCCCCceeeeEEEEEEEEecCC
Confidence 46899999996 4689999999999999999986432 357999999999999999999999999999999998765
Q ss_pred CCCCCCceEEEEecCCCC--CCCCCCccccccCCC---CCCCcEEEEEeeCCCCCCCC--CCCCCeeeeecCCccccccc
Q 041096 98 PSSFGDGLAFFISPDNQI--LGSAGGCLGLVNSSQ---LTKNKFVAIEFDTRLDPHFD--DPDENHIGLDIDSLESIKTA 170 (645)
Q Consensus 98 ~~~~g~G~aF~l~p~~~~--~~~~g~~lGl~~~~~---~~~~~~vAVEFDt~~n~~~~--d~~~~Hvgi~vns~~s~~~~ 170 (645)
..+|||||||++|.... .+..|+++|+++... .+.++.+||||||++|.+.+ ||+++|||||+|++.|.++.
T Consensus 82 -~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid~n~~~s~~~~ 160 (241)
T d1ukga_ 82 -SNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTV 160 (241)
T ss_dssp -SSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred -CCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCCccEeeecCCccccccc
Confidence 56799999999986653 356778888876543 33488999999999987654 58999999999999988765
Q ss_pred CCCccccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeeee
Q 041096 171 DPILQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSF 250 (645)
Q Consensus 171 ~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f 250 (645)
. .++.+|..++|||+||+..++|+|++++. ++..|.++..|||+.+|+++||||||||||...|.|+|++|+|
T Consensus 161 ~-----~~~~~g~~~~v~I~Yd~~~~~L~v~~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF 233 (241)
T d1ukga_ 161 K-----WDRRDGQSLNVLVTFNPSTRNLDVVATYS--DGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWSF 233 (241)
T ss_dssp E-----CCCCTTCCEEEEEEEETTTTEEEEEEEET--TCCEEEEEEECCGGGTSCSEEEEEEEEEESSSCCEEEEEEEEE
T ss_pred c-----cccCCCcEEEEEEEEeCCCcEEEEEEccC--CCCceEEEEEEehHHhCCCcEEEEEEEecCCCCceeEEEEeEE
Confidence 5 36789999999999999999999999875 4677889999999999999999999999999999999999999
Q ss_pred eec
Q 041096 251 QTS 253 (645)
Q Consensus 251 ~~~ 253 (645)
+++
T Consensus 234 ss~ 236 (241)
T d1ukga_ 234 TST 236 (241)
T ss_dssp EEE
T ss_pred EEE
Confidence 986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=389.67 Aligned_cols=241 Identities=24% Similarity=0.385 Sum_probs=207.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|+..++||+|+||+||+|+++ ++..||||.++......++|.+|++++++++||||++++|+|.+.+.+++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999999999999986 57889999998877777899999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----------- 496 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----------- 496 (645)
+|+|..++..... .+++..+.+++.|+|+||+|||+ .+|+||||||+||||+.++.+||+|..
T Consensus 83 ~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999876544 38999999999999999999999 999999999999999999999998822
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ +. ..+....+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~----~~-------------~~i~~~~~ 219 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TA-------------EHIAQGLR 219 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----HH-------------HHHHTTCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH----HH-------------HHHHhCCC
Confidence 12457889999999999999999999999999999998 899997654321 11 11112222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
...+...+..+.+++..||+.||++|||++++++.|.++
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 334445567889999999999999999999999998653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=397.51 Aligned_cols=246 Identities=22% Similarity=0.378 Sum_probs=198.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
.++|+..++||+|+||+||+|+++ ..||||+++. .....+.|.+|++++++++|||||+++|++.+ ++.+|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 357888999999999999999875 3589999865 34456789999999999999999999999865 4689999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
|||++|+|.+++..... .++|.+++.++.|||+||+|||+ ++|+||||||+||||+.++.+||+|..
T Consensus 83 Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999975443 39999999999999999999999 999999999999999999999998822
Q ss_pred -------cccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 -------TLTAGTMGYLAPEYLQY---GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~---~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....||+.|||||++.+ ..++.++|||||||+||||+||+.||........ +...+......
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~---~~~~~~~~~~~----- 228 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS----- 228 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHHTSCC-----
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCCC-----
Confidence 22468999999999864 3589999999999999999999999976533211 11111111110
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
+.+ ...+.++++.+.+++..||+.||++||||+||++.|+.+..
T Consensus 229 ---p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 229 ---PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ---CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111 12233456678899999999999999999999999986543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=397.30 Aligned_cols=246 Identities=24% Similarity=0.431 Sum_probs=204.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCC----eEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSG----SVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~----~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
..|+..++||+|+||.||+|.++.++ ..||||++... .....+|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 45778899999999999999987544 47999998653 3345679999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
||||+.+++|.+++..... .++|.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|..
T Consensus 87 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998876543 39999999999999999999999 999999999999999999999998822
Q ss_pred ----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 ----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 ----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....||+.|||||++.++.++.++|||||||++|||++|..|+...... .. +.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~---~~-------------~~~ 224 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HE-------------VMK 224 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HH-------------HHH
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH---HH-------------HHH
Confidence 1135788999999999999999999999999999999976665432211 11 222
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
.+....+...+.+++..+.+++.+||+.||++||||.||++.|+.+.+.
T Consensus 225 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 3334444455666778899999999999999999999999999876544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=395.51 Aligned_cols=242 Identities=24% Similarity=0.411 Sum_probs=201.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.++|+..+.||+|+||+||+|.++ ++..||||+++......+.|.+|++++++++|||||+++|+|.+ +..+|||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 356888899999999999999986 47889999998877777889999999999999999999998865 5679999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++|+|.+++..... ..++|.++++|+.|||+||+|||+ ++|+||||||+||||+.++.+||+|..
T Consensus 90 ~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp TTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999998865432 248999999999999999999999 999999999999999999999998721
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....||+.|+|||++.++.++.++|||||||++|||+||..|+...... ..+.. .+....+
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~---~~~~~-------------~i~~~~~ 228 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQ-------------NLERGYR 228 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH-------------HHHTTCC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH---HHHHH-------------HHHhcCC
Confidence 2246889999999999999999999999999999999976665432211 11111 1222222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
...+...+..+.+++..||+.||++||||++|++.|+.
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 33344556678899999999999999999999998874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=394.48 Aligned_cols=240 Identities=22% Similarity=0.361 Sum_probs=198.7
Q ss_pred cCCCcCce-eccCCceEEEEEEECC--CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRI-LGRGAFGNVYKAYFAS--SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~-lG~G~fg~Vy~g~~~~--~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
++|...+. ||+|+||+||+|.++. ++..||||+++.. ....++|.+|+++|++++|||||+++|+|.. +..|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555664 9999999999998753 4568999998763 3446789999999999999999999999865 568999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
||||++|+|.+++..... .+++.+++.++.|||+||+|||+ ++|+||||||+||||+.++.+||.|..
T Consensus 87 mE~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999865443 39999999999999999999999 999999999999999999999998821
Q ss_pred ---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 ---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+. .
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----~~~-------------~ 223 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVM-------------A 223 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHH-------------H
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH----HHH-------------H
Confidence 12357899999999999999999999999999999998 99999765321 111 1
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
.+....+...+...+..+.+++..||+.||++||||.+|++.|+.
T Consensus 224 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 224 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 122222234455666788999999999999999999999998874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=393.57 Aligned_cols=243 Identities=22% Similarity=0.334 Sum_probs=191.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeee--CCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAE--KGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 422 (645)
++|+..+.||+|+||+||+|....+|+.||||.+... ....+.+.+|++++++++|||||++++++.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5788999999999999999999999999999998663 3345678999999999999999999999865 4568999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeeCCCCCCcEEEcCCCCeeeecc-----
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC--EQQVIHRDIKASNIMLDANFNARLESS----- 495 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlkp~NIlld~~~~~kl~d~----- 495 (645)
||||++|+|.+++.+.......+++..++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765444456999999999999999999999831 234999999999999999999999871
Q ss_pred -------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 496 -------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 496 -------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....+||+.|||||++.+..++.++|||||||++|||++|+.||...+.. .+...+ .
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~----~~~~~i------------~ 227 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAGKI------------R 227 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHH------------H
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH----HHHHHH------------H
Confidence 22357999999999999999999999999999999999999999764321 111111 0
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
... ....+......+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 228 EGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 11223334556888999999999999999999975
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=5.9e-48 Score=381.16 Aligned_cols=220 Identities=29% Similarity=0.427 Sum_probs=198.5
Q ss_pred CCceeEEeCCCCCCCeEEecceEee-CCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCC
Q 041096 22 SNNMNFDFTSFNLRNITLLGDSYLR-NGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSS 100 (645)
Q Consensus 22 ~~~~~f~~~~f~~~~~~l~G~a~~~-~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~ 100 (645)
+++++|+|++|+..||+|+|||.+. +|.||||+..+...+++|||+|++||+||++.+++++||+|+|+|+|.+.+...
T Consensus 1 ~~~~sf~f~~F~~~nl~l~GdA~v~~~g~i~LT~~~~~~~~~~G~~~y~~Pv~l~~~~~~~~~sF~t~f~f~i~~~~~~~ 80 (226)
T d1avba_ 1 SNDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIEN 80 (226)
T ss_dssp CEEEEEEESSCCGGGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTTS
T ss_pred CCceEEECCCCCccceeEecceEECCCCeEEccCCCCCCccceEEEEeCCCeEcccCCCCcccceEEEEEEEEecCCCCC
Confidence 3578999999999999999999985 579999987655678999999999999999999999999999999999988888
Q ss_pred CCCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccccccC
Q 041096 101 FGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLK 180 (645)
Q Consensus 101 ~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~~~~ 180 (645)
+||||||+|+|.....+..||++|+++. ++|||||+.|....|+..|||||++|+..+..+.+. ...+.
T Consensus 81 ~gDG~aF~i~~~~~~~g~~gg~~gl~~~--------~~v~fdt~~~~~~~d~~~nhi~i~~n~~~s~~~~~~---~~~~~ 149 (226)
T d1avba_ 81 SAYGLAFALVPVGSRPKLKGRYLGLFNT--------TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESC---NFGHN 149 (226)
T ss_dssp CCEEEEEEEEETTCCCCCCGGGTTTCSC--------SSCCGGGCCEEEEEETTTTEEEEEESSSSCSEEEEC---CSGGG
T ss_pred CCceEEEEEccCCCCCCCccccCCcccc--------ccccccceeccccccCCCCEEEEeCCCCcccccccc---ccccC
Confidence 9999999999998878888999999754 479999999876669999999999999998777664 35678
Q ss_pred CCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCC---ccceeeeeeeeeeec
Q 041096 181 SGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEG---STELHMIQSWSFQTS 253 (645)
Q Consensus 181 ~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~---~~~~~~i~sw~f~~~ 253 (645)
+|+.++|||+||+.+++|+|++++.. ++..|.++..+||+.+||++|||||||+||. ..|.|+|+||+|+++
T Consensus 150 ~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~~~~~H~IlsWsF~s~ 224 (226)
T d1avba_ 150 NGEKAEVRITYDSPKNDLRVSLLYPS-SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSN 224 (226)
T ss_dssp TTCEEEEEEEEEGGGTEEEEEEEETT-TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEEEEEEEE
T ss_pred CCeEEEEEEEEcCCCcEEEEEEEeCC-CCccEEEEEEecHHHccCCcEEEEEEEEcCCCCCCeeeeEEEEEEeEEe
Confidence 99999999999999999999999876 6888899999999999999999999999995 467899999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=388.10 Aligned_cols=235 Identities=29% Similarity=0.428 Sum_probs=200.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||+||+|+.+.+++.||+|++... ....+.+.+|++++++++|||||++++++.+++..||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4688899999999999999999999999999988642 234567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-------- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-------- 495 (645)
|||++|+|.+++..... +++.++..++.||++||+|||+ ++|+||||||+||||+.++..|+.|.
T Consensus 86 Ey~~~g~L~~~l~~~~~----l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999986543 8999999999999999999999 99999999999999999999999872
Q ss_pred --ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 496 --FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 496 --~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...+.. .+...+ ... .
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i------------~~~--~ 220 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRI------------SRV--E 220 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHH------------HTT--C
T ss_pred CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH----HHHHHH------------HcC--C
Confidence 23347999999999999999999999999999999999999999764321 111111 011 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..++....+.+.+++..||+.||++|||++|+++
T Consensus 221 ~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1233334566788899999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=390.79 Aligned_cols=233 Identities=26% Similarity=0.391 Sum_probs=193.1
Q ss_pred ceeccCCceEEEEEEECC--CCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCCC
Q 041096 354 RILGRGAFGNVYKAYFAS--SGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMPN 428 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~--~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 428 (645)
++||+|+||+||+|.+.. .++.||||+++.. ....++|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998754 4578999998652 2335679999999999999999999999965 467899999999
Q ss_pred CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------------
Q 041096 429 GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------------ 496 (645)
Q Consensus 429 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------------ 496 (645)
|+|.+++..... ++|.+++.++.|||+||+|||+ ++|+||||||+||||+.++.+|+.|..
T Consensus 92 g~L~~~l~~~~~----l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhccC----CCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999986543 9999999999999999999999 999999999999999999999998721
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....||+.|+|||.+.++.++.++|||||||++|||++ |+.||...... .+. +.+....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----~~~-------------~~i~~~~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVT-------------AMLEKGE 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHH-------------HHHHTTC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH----HHH-------------HHHHcCC
Confidence 12358899999999999999999999999999999998 89999764321 111 1222222
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
+...+..++..+.+++.+||+.||++||||++|++.|+.
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 334455566788899999999999999999999988864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=389.36 Aligned_cols=238 Identities=25% Similarity=0.330 Sum_probs=194.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
++|+..++||+|+||+||+|+...+++.||||++... ....+.+.+|++++++++|||||++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5688899999999999999999999999999998653 33456799999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc----------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS---------- 495 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~---------- 495 (645)
+++|+|.+++.... .+++.++..++.|+++||+|||+ ++|+||||||+||||+.++.+||.|.
T Consensus 85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999996543 39999999999999999999999 99999999999999999999999882
Q ss_pred ----ccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 496 ----FTLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 496 ----~~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....+||+.|||||++.+..+ +.++|||||||++|||++|+.||......... +.... ..
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~~~~-------------~~ 222 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWK-------------EK 222 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HHHHH-------------TT
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HHHHh-------------cC
Confidence 123479999999999988776 67899999999999999999999764432211 11110 00
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.............+.+++..||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000111122355678889999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=387.77 Aligned_cols=237 Identities=24% Similarity=0.326 Sum_probs=199.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
++|+..+.||+|+||+||+|....+|+.||||++... ....+.+.+|++++++++|||||++++++.+.+..|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999999999999999998653 334567999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS----------- 495 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~----------- 495 (645)
++|+|.+++.+.. +++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+|+.|.
T Consensus 100 ~gg~L~~~~~~~~-----l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhccC-----CCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 9999999886532 8999999999999999999999 99999999999999999999999872
Q ss_pred -ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 496 -FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 496 -~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ... .....
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~~---~~~--------~~~~~ 236 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLI---ATN--------GTPEL 236 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHH---HHH--------CSCCC
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH----HHHHH---HhC--------CCCCC
Confidence 223469999999999999999999999999999999999999997643211 11100 000 00011
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
..+......+.+++..||+.||.+|||++|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222334566788999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=387.74 Aligned_cols=239 Identities=25% Similarity=0.319 Sum_probs=199.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC-CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
+.|+..+.||+|+||+||+|....++..||||++.. .....+.+.+|+++|++++|||||++++++.+.+..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 457888999999999999999999999999999876 4455678999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++|+|.+++.+... .+++.++..++.||++||+|||+ ++|+||||||+||||+.++.+||.|..
T Consensus 92 ~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp TTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 99999999876443 39999999999999999999999 999999999999999999999998832
Q ss_pred --cccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 --TLTAGTMGYLAPEYLQ-----YGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~-----~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
....||+.|+|||++. ...|+.++|||||||++|||++|+.||......+....+. . . . .
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~----~---~-~-----~ 232 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA----K---S-E-----P 232 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH----H---S-C-----C
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH----c---C-C-----C
Confidence 2357999999999984 4568999999999999999999999997654322111110 0 0 0 0
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+. ...+......+.+++..||+.||++|||++|+++
T Consensus 233 ~~--~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 PT--LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CC--CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC--CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 1122334567788999999999999999999976
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Probab=100.00 E-value=5.6e-47 Score=374.46 Aligned_cols=217 Identities=27% Similarity=0.410 Sum_probs=187.8
Q ss_pred CCceeEEeCCCCC-CCeEEecceEee-CCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeC
Q 041096 22 SNNMNFDFTSFNL-RNITLLGDSYLR-NGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNV 96 (645)
Q Consensus 22 ~~~~~f~~~~f~~-~~~~l~G~a~~~-~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 96 (645)
+++++|+|++|+. ++|+|+|||.+. +|.|+||++... ...++|||+|++||+||+ +++++||+|+|+|.|.+.
T Consensus 1 a~~~sF~f~~F~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~~--~~~~~sFst~F~f~i~~~ 78 (228)
T d1ioaa_ 1 ATETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD--SNNVASFNTNFTFIIRAK 78 (228)
T ss_dssp CCCCEEEESSCCTTSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBC--SSCBEEEEEEEEEECCBS
T ss_pred CccceEEcCCCCCCCcEEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEecC--CCceeeEEEEEEEEEecC
Confidence 3578999999985 469999999984 789999986432 236899999999999998 478999999999999998
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCccccccCCC-CCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCcc
Q 041096 97 NPSSFGDGLAFFISPDNQILGSAGGCLGLVNSSQ-LTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQ 175 (645)
Q Consensus 97 ~~~~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~-~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~ 175 (645)
+...+||||||+|+|.+..++..|++||+++... ++.++.|||||||+.|.. |++.+|+++++++..+
T Consensus 79 ~~~~~gDGlAF~l~~~~~~~~~~g~~lgl~~~~~~~~~~~~vave~dt~~n~~--~~~~~~~~~~~~~~~~--------- 147 (228)
T d1ioaa_ 79 NQSISAYGLAFALVPVNSPPQKKQEFLGIFNTNNPEPNARTVAVVFNTFKNRI--DFDKNFIKPYVNENCD--------- 147 (228)
T ss_dssp CTTSCCEEEEEEEEETTCCCCCCGGGTTTCCCSSCCGGGCCEEEEEETTTTEE--EEEESSSSCSEEEECC---------
T ss_pred CCCCCCCEEEEEEeCCCCCCCCCccccccccccCCCCcceeEEEEecCccccc--cCCCCccceecccccc---------
Confidence 8788999999999999888888999999987653 334788999999998853 7888888888875432
Q ss_pred ccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccC---Cccceeeeeeeeeee
Q 041096 176 GIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTE---GSTELHMIQSWSFQT 252 (645)
Q Consensus 176 ~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg---~~~~~~~i~sw~f~~ 252 (645)
.++.+|+.++|||+||+.+++|+|++++.. ++..|.++..+||+.+|+++|||||||+|| ...|.|+|++|+|++
T Consensus 148 -~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~-~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~h~I~sWsFss 225 (228)
T d1ioaa_ 148 -FHKYNGEKTDVQITYDSSNNDLRVFLHFTV-SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSS 225 (228)
T ss_dssp -HHHHCSSCEEEEEEEETTTTEEEEEEEETT-TCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCCEEEEEEEEE
T ss_pred -cccccCcEEEEEEEEcCCCCEEEEEEEeCC-CCceeeEEEEEchHHcCCCcEEEEEEeecCCCCCCceEEEEEEEEeEE
Confidence 356789999999999999999999999764 788899999999999999999999999999 556899999999997
Q ss_pred c
Q 041096 253 S 253 (645)
Q Consensus 253 ~ 253 (645)
+
T Consensus 226 ~ 226 (228)
T d1ioaa_ 226 K 226 (228)
T ss_dssp E
T ss_pred e
Confidence 5
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=396.62 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=201.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCC-----eEEEEEeccC--CcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSG-----SVAAVKRSKH--SHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGEL 419 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~-----~~vavK~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 419 (645)
++|+..++||+|+||+||+|++...+ ..||+|.+.. .......+.+|+.++.++ +|||||+++|+|.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 57888999999999999999986433 3689998865 334456799999999998 899999999999999999
Q ss_pred EEEEecCCCCCHhHHhhhcCCC-------------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 041096 420 LLVYEYMPNGSLDRMLYQDSEN-------------------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKAS 480 (645)
Q Consensus 420 ~lV~Ey~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~ 480 (645)
+||||||++|+|.++|...... ...++|..++.++.||++||+|||+ ++|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 9999999999999999765321 2358999999999999999999999 99999999999
Q ss_pred cEEEcCCCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccc
Q 041096 481 NIMLDANFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEG 545 (645)
Q Consensus 481 NIlld~~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~ 545 (645)
|||++.++.+||+|.. ....||+.|||||++.++.++.++|||||||+||||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999998832 12357899999999999999999999999999999998 89999764432
Q ss_pred cchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 041096 546 HKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILN 610 (645)
Q Consensus 546 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~ 610 (645)
.. + .+++....+...+...+..+.+++..||+.||++||||+||+++|.
T Consensus 274 ~~---~-------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 AN---F-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HH---H-------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH---H-------------HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 1 1222223333445556678899999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=386.82 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=204.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYMP 427 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 427 (645)
++|+..+.||+|+||+||+|++++ +..||||++.......+.|.+|+.++++++|||||+++|+|.+ ++.++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 568889999999999999999976 4679999998877777889999999999999999999999965 56899999999
Q ss_pred CCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----------
Q 041096 428 NGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----------- 496 (645)
Q Consensus 428 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----------- 496 (645)
+|+|..++..... ..++|.+++.++.||+.||+|||+ ++|+||||||+|||||.++.+||+|..
T Consensus 95 ~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 95 KGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999999876432 239999999999999999999999 999999999999999999999998832
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 497 --TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....||+.|+|||++..+.++.++|||||||++|||++|+.|+...... ..+.. .+....+.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~---~~~~~-------------~i~~~~~~ 233 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLD-------------QVERGYRM 233 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH-------------HHHTTCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH---HHHHH-------------HHHhcCCC
Confidence 1245889999999999999999999999999999999977776543221 11222 12222233
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCCC
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEPL 616 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~~ 616 (645)
..+....+.+.+++.+||+.||++||+|++|+++|+......
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 445556678899999999999999999999999998765443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=391.76 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=199.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.++|+..++||+|+||+||+|....+++.||+|+++.. ....+.+.+|+.+|++++|||||+++++|.+.++.|||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 56799999999999999999999999999999998653 3345679999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS--------- 495 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~--------- 495 (645)
||++|+|.+++.+... +++..+..++.|+++||+|||+. ++|+||||||+||||+.++.+||.|.
T Consensus 85 y~~gg~L~~~l~~~~~----l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999986543 89999999999999999999971 48999999999999999999999882
Q ss_pred -ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh----------------
Q 041096 496 -FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL---------------- 558 (645)
Q Consensus 496 -~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~---------------- 558 (645)
....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+...............
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 234589999999999999999999999999999999999999997643221100000000000
Q ss_pred ------hccCchhHHhhhhccC---CCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 559 ------YAEGRIIEAADKRLNG---AFNE-DEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 559 ------~~~~~~~~~~d~~l~~---~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.......+..+..... ..+. .....+.+++..||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000111111111100 0110 12345778899999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-46 Score=389.08 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=207.7
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeee
Q 041096 342 ELRSATRGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCA 414 (645)
Q Consensus 342 ~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 414 (645)
+|+-..++|+..+.||+|+||+||+|++.. ++..||||++... ....++|.+|++++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 344456789999999999999999999753 4578999998763 334577999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHhHHhhhcCC--------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 041096 415 EKGELLLVYEYMPNGSLDRMLYQDSE--------------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIH 474 (645)
Q Consensus 415 ~~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 474 (645)
+.+..++||||+++|+|.+++..... ....++|.+++.|+.|++.||+|||+ ++++|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEe
Confidence 99999999999999999999975331 12348999999999999999999999 99999
Q ss_pred CCCCCCcEEEcCCCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCC-CCC
Q 041096 475 RDIKASNIMLDANFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGR-RPI 539 (645)
Q Consensus 475 rDlkp~NIlld~~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~-~P~ 539 (645)
|||||+|||||.++.+||+|.. +...||+.|+|||.+.+..++.++|||||||++|||++|. .||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999998822 2346788999999999999999999999999999999986 466
Q ss_pred CccccccchhhHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 540 ERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 540 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
...... .+... +........+...+..+.+|+..||+.+|++||||.||+++|+++.+
T Consensus 244 ~~~~~~----e~~~~-------------v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 244 YGMAHE----EVIYY-------------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTSCHH----HHHHH-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCHH----HHHHH-------------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 654321 11111 11111223445556778999999999999999999999999997653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=390.61 Aligned_cols=241 Identities=24% Similarity=0.400 Sum_probs=198.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCe----EEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGS----VAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLL 421 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~----~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 421 (645)
.+|+..++||+|+||+||+|.+..+++ .||+|++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 358889999999999999999876664 688998765 344567899999999999999999999999875 5678
Q ss_pred EEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-----
Q 041096 422 VYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF----- 496 (645)
Q Consensus 422 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~----- 496 (645)
++||+.+|+|.+++..... .+++..+++++.|||+||+|||+ ++|+||||||+||||+.++.+||+|..
T Consensus 88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999998876543 39999999999999999999999 999999999999999999999998821
Q ss_pred ---------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 497 ---------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 497 ---------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....||+.|+|||++.++.++.++|||||||++|||+| |+.||....... +..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-----------------~~~ 224 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------ISS 224 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-----------------HHH
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-----------------HHH
Confidence 12357999999999999999999999999999999998 788887643221 122
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
.+....+...+..++..+.+++.+||+.||.+||||+||++.|+..
T Consensus 225 ~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 2222333344556677889999999999999999999999988754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=378.68 Aligned_cols=234 Identities=22% Similarity=0.354 Sum_probs=188.8
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEeccC---CcchhHhHHHHHHHHhhcCCCCeeeeeeeeee----CCeEEEEE
Q 041096 351 HSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH---SHEGKTEFLAELSIIACLRHKNLVQLLGWCAE----KGELLLVY 423 (645)
Q Consensus 351 ~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 423 (645)
+..+.||+|+||+||+|.+..++..||+|.+.. .....+.|.+|+++|++++|||||++++++.+ ...+||||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 455689999999999999999999999998765 33345679999999999999999999999865 34689999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEEc-CCCCeeeecc-----
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQ--VIHRDIKASNIMLD-ANFNARLESS----- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NIlld-~~~~~kl~d~----- 495 (645)
||+++|+|.+++.+... +++..+..++.||++||+|||+ ++ |+||||||+||||+ .++.+||+|.
T Consensus 92 E~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhcccc----ccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 99999999999986543 8999999999999999999998 66 99999999999997 4789999872
Q ss_pred -----ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 496 -----FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 496 -----~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....+||+.|||||++.+ +++.++|||||||++|||++|+.||....... .+...+ ..+... .
T Consensus 165 ~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~---~~~~~i----~~~~~~----~ 232 (270)
T d1t4ha_ 165 KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIYRRV----TSGVKP----A 232 (270)
T ss_dssp CCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHHHH----TTTCCC----G
T ss_pred ccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH---HHHHHH----HcCCCC----c
Confidence 223479999999998875 69999999999999999999999997543211 111111 111000 0
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.++......+.+++..||+.||++|||++|+++
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111122345778899999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=378.99 Aligned_cols=240 Identities=30% Similarity=0.433 Sum_probs=197.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeee-CCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAE-KGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 426 (645)
++|+..+.||+|+||.||+|.++ +..||||+++.. ...+.|.+|++++++++||||++++|+|.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45677899999999999999985 788999999763 345789999999999999999999999865 45689999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---------cc
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS---------FT 497 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~---------~~ 497 (645)
++|+|.++|..... ..++|..+++++.||++||+|||+ .+|+||||||+|||++.++.+|+.|. ..
T Consensus 84 ~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~ 158 (262)
T d1byga_ 84 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158 (262)
T ss_dssp TTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCCc
Confidence 99999999976432 248999999999999999999999 99999999999999999999999772 22
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccCCC
Q 041096 498 LTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNGAF 576 (645)
Q Consensus 498 ~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 576 (645)
...+|..|+|||++.++.++.++|||||||++|||+| |+.||...... .+..+ +....+...
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----~~~~~-------------i~~~~~~~~ 221 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPR-------------VEKGYKMDA 221 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHH-------------HTTTCCCCC
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH----HHHHH-------------HHcCCCCCC
Confidence 3467889999999999999999999999999999998 67777654322 22222 222233445
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 577 NEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 577 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+......+.+++.+||+.||++||||.+++++|+.+
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 555667888999999999999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-46 Score=387.07 Aligned_cols=241 Identities=25% Similarity=0.317 Sum_probs=198.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc----chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH----EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
+.|+..+.||+|+||+||+|+...++..||||++.... ...+.+.+|+++|++++|||||++++++.+.+..||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34888999999999999999999999999999986532 23457899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-------- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-------- 495 (645)
|||++|+|..++.... .+++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|.
T Consensus 95 E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987776543 39999999999999999999999 99999999999999999999999883
Q ss_pred ccccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 496 FTLTAGTMGYLAPEYLQY---GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 496 ~~~~~gt~~y~APE~~~~---~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.||....... ... .......
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~----~~~------------~i~~~~~ 231 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALY------------HIAQNES 231 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHH------------HHHHSCC
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH----HHH------------HHHhCCC
Confidence 233579999999999864 468999999999999999999999997643211 111 0111111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNN 611 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~ 611 (645)
....+....+.+.+++..||+.||++|||++|+++ .|..
T Consensus 232 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 11112233456888899999999999999999987 4543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=385.34 Aligned_cols=248 Identities=30% Similarity=0.445 Sum_probs=201.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCe--EEEEEeccC--CcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGS--VAAVKRSKH--SHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~--~vavK~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 422 (645)
++|+..++||+|+||+||+|++..++. .||||++.. .....+.|.+|+++|+++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567888999999999999999987776 467887754 344567899999999999 799999999999999999999
Q ss_pred EecCCCCCHhHHhhhcC------------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 041096 423 YEYMPNGSLDRMLYQDS------------ENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNA 490 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~ 490 (645)
|||+++|+|.++|+... .....++|.++++++.|||+||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 99999999999997542 223459999999999999999999999 999999999999999999999
Q ss_pred eeeccc-----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCC-CCCccccccchhhHHHHHHhh
Q 041096 491 RLESSF-----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRR-PIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 491 kl~d~~-----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~-P~~~~~~~~~~~~l~~~~~~~ 558 (645)
||+|.. ....||..|+|||.+..+.++.++|||||||++|||++|.. ||...+. ..+.
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~----~~~~------ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELY------ 236 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHH------
T ss_pred EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH----HHHH------
Confidence 998832 23468999999999999999999999999999999999765 5654321 1111
Q ss_pred hccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 559 YAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 559 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
+.+....+...+...+..+.+++.+||+.||++||||++|++.|+++.+.
T Consensus 237 -------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 237 -------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp -------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11222223344455667889999999999999999999999998876543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=383.22 Aligned_cols=234 Identities=21% Similarity=0.286 Sum_probs=197.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||+||+|....+++.||||++... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688999999999999999999989999999998642 233467999999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc-------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------- 496 (645)
||+++|+|.+++..... +++..+..++.|++.||+|||+ ++|+||||||+||||+.++.+|+.|..
T Consensus 88 Ey~~gg~L~~~~~~~~~----l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccCC----CCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999886553 9999999999999999999999 999999999999999999999998722
Q ss_pred -------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 497 -------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+...+ ..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i------------~~ 224 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY----LIFQKI------------IK 224 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH------------HT
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH----HHHHHH------------Hc
Confidence 1246999999999999999999999999999999999999999764321 111111 11
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVF 606 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl 606 (645)
.. ..++......+.+++..||+.||++|||++|++
T Consensus 225 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 225 LE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp TC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 11 123333455678899999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-46 Score=382.70 Aligned_cols=244 Identities=20% Similarity=0.338 Sum_probs=193.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
.+.|+..+.||+|+||+||+|....+++.||||++... ......+.+|+++|++++|||||++++++.+++..|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35688999999999999999999999999999998653 2334568899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc---CCCCeeeecc------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD---ANFNARLESS------ 495 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld---~~~~~kl~d~------ 495 (645)
||++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+. .++.+|+.|.
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997643 39999999999999999999999 9999999999999994 5778999872
Q ss_pred -----ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 496 -----FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 496 -----~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....+||+.|||||++.+..++.++|||||||++|||++|+.||...... .+...+.. + +.
T Consensus 161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i~~----~------~~ 226 (307)
T d1a06a_ 161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA----KLFEQILK----A------EY 226 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHT----T------CC
T ss_pred cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHhc----c------CC
Confidence 12346999999999999999999999999999999999999999764321 11111110 0 00
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcC
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNN 611 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~ 611 (645)
........+....+.+++..||+.||++|||++|+++ .|.+
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 1111122234466788999999999999999999998 4554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=374.13 Aligned_cols=241 Identities=23% Similarity=0.361 Sum_probs=198.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCC---CeEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASS---GSVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~---~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 422 (645)
++|+..+.||+|+||.||+|++..+ +..||||.++. .....+.|.+|++++++++|||||+++|+|.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 5688889999999999999998643 45789998865 33345779999999999999999999999964 678999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF------ 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~------ 496 (645)
|||+++|+|.+++..... .+++.+++.++.||++||+|||+ ++|+||||||+||+++.++.+|++|..
T Consensus 86 ~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999998876543 38999999999999999999999 999999999999999999999998821
Q ss_pred -------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCchhHHh
Q 041096 497 -------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA 568 (645)
Q Consensus 497 -------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 568 (645)
....||+.|+|||++.++.++.++|||||||++|||++ |+.||......+ +... +
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----~~~~-------------i 222 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGR-------------I 222 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHH-------------H
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----HHHH-------------H
Confidence 22357899999999999999999999999999999998 888987654321 2111 1
Q ss_pred hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 569 DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 569 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
........+.+.+..+.+++..||+.||++|||++||++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11112234455667788999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=377.40 Aligned_cols=239 Identities=22% Similarity=0.284 Sum_probs=196.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC-------cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS-------HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~-------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
++|+..+.||+|+||+||+|....+|..||||++... ....+.+.+|+++|++++|||||++++++.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5789999999999999999999999999999987542 123567999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC----eeeecc-
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN----ARLESS- 495 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~----~kl~d~- 495 (645)
||||||++|+|.+++..... +++.++..++.|++.||+|||+ ++|+||||||+|||++.++. .|+.|.
T Consensus 90 iv~E~~~gg~L~~~i~~~~~----l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhccccc----cchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999976543 9999999999999999999999 99999999999999987764 788762
Q ss_pred ----------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchh
Q 041096 496 ----------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRII 565 (645)
Q Consensus 496 ----------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 565 (645)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+ ....+... .....
T Consensus 163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~--~~~~~ 236 (293)
T d1jksa_ 163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANVSAV--NYEFE 236 (293)
T ss_dssp TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHTT--CCCCC
T ss_pred hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH----HHHHHHhc--CCCCC
Confidence 223468999999999999999999999999999999999999997643221 11111000 00000
Q ss_pred HHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 566 EAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 566 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.. ...+....+.+++..||+.||++|||++|+++
T Consensus 237 ~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 237 DE--------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HH--------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ch--------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00122356778999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=378.32 Aligned_cols=240 Identities=26% Similarity=0.390 Sum_probs=195.0
Q ss_pred CceeccCCceEEEEEEECCCC---eEEEEEeccC--CcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-CeEEEEEecC
Q 041096 353 NRILGRGAFGNVYKAYFASSG---SVAAVKRSKH--SHEGKTEFLAELSIIACLRHKNLVQLLGWCAEK-GELLLVYEYM 426 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~---~~vavK~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 426 (645)
.++||+|+||+||+|++..++ ..||||+++. .....++|.+|+++|++++||||++++|+|.+. ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 468999999999999986533 4689999875 344457899999999999999999999998764 5899999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
++|+|.+++..... .+++..+++++.|+|+||.|||+ .+|+||||||+|||||+++.+||+|..
T Consensus 112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999876543 37899999999999999999999 999999999999999999999998822
Q ss_pred ------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 497 ------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
....||..|+|||.+..+.++.++||||||+++|||++|+.||....... .+..++ ..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~---~~~~~i-------------~~ 249 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYL-------------LQ 249 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHH-------------HT
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH---HHHHHH-------------Hc
Confidence 11357899999999999999999999999999999999888876532211 111111 11
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
..+...+..++..+.+++..||+.||++||+|+||++.|+++..
T Consensus 250 g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11222334455678899999999999999999999999987643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.4e-45 Score=384.13 Aligned_cols=245 Identities=22% Similarity=0.286 Sum_probs=200.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEec
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 425 (645)
.++|+..+.||+|+||.||+|....+|..||||++.... ...+.+.+|+++|++++|||||++++++.+.+..||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999999999999999987643 4456789999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC--CCCeeeeccc-------
Q 041096 426 MPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA--NFNARLESSF------- 496 (645)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~--~~~~kl~d~~------- 496 (645)
|++|+|.+++..... .+++..+..++.||+.||+|||+ ++|+||||||+||||+. ++.+||.|..
T Consensus 105 ~~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999965432 39999999999999999999999 99999999999999964 5678998722
Q ss_pred ----cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhc
Q 041096 497 ----TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRL 572 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 572 (645)
....||+.|||||++.+..++.++|||||||++|||++|+.||...+..+ +...+... +...
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~----------~~~~ 244 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLRNVKSC----------DWNM 244 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHT----------CCCS
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHHhC----------CCCC
Confidence 22478999999999999999999999999999999999999997643221 11111000 0000
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HcC
Q 041096 573 NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI--LNN 611 (645)
Q Consensus 573 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~--L~~ 611 (645)
.........+.+.+++..||+.||++|||++|+++. |..
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~ 285 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 001111223567788899999999999999999984 543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=375.25 Aligned_cols=241 Identities=23% Similarity=0.314 Sum_probs=191.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCC---CeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASS---GSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~---~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
++|+..+.||+|+||.||+|++... ...||||++... ....++|.+|+++|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 4688889999999999999987432 347899988652 3345689999999999999999999999976 4678
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---- 496 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---- 496 (645)
+||||+++|+|.+++..... .+++..++.++.|+|+||+|||+ ++|+||||||+||||+.++.+|+.|..
T Consensus 87 lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999998876543 39999999999999999999999 999999999999999999999998731
Q ss_pred -----------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 -----------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....|+..|+|||++.+..++.++|||||||++|||+| |+.||...+.. ....++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----~~~~~i--------- 227 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKI--------- 227 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHH---------
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----HHHHHH---------
Confidence 12357889999999999999999999999999999998 89999764322 111111
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcC
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNN 611 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~ 611 (645)
.....+...+...+..+.+++..||+.||++||||.+|++.|++
T Consensus 228 ---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 228 ---DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ---HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11122223344455678899999999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4e-45 Score=372.89 Aligned_cols=244 Identities=23% Similarity=0.277 Sum_probs=195.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC----e
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG----E 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~ 418 (645)
.++|+..+.||+|+||+||+|+...+++.||||++... ....+.|.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999999999999999998753 223457899999999999999999999987654 4
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS--- 495 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~--- 495 (645)
.||||||+++++|.+++..... +++.+++.++.||++||+|||+ ++|+||||||+||||+.++..++.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~----l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccCC----CCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhh
Confidence 8999999999999999876543 9999999999999999999999 99999999999999999999988662
Q ss_pred ------------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc
Q 041096 496 ------------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR 563 (645)
Q Consensus 496 ------------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 563 (645)
....+||+.|+|||++.+..++.++|||||||++|||+||+.||....... + .......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~---~~~~~~~~~ 231 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----V---AYQHVREDP 231 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----H---HHHHHHCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH----H---HHHHHhcCC
Confidence 123468999999999999999999999999999999999999997643211 1 111111111
Q ss_pred hhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHcC
Q 041096 564 IIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARP-SMRRVFQILNN 611 (645)
Q Consensus 564 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~~vl~~L~~ 611 (645)
. .......+.+..+.+++.+||++||.+|| |++++++.|..
T Consensus 232 ~-------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 232 I-------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp C-------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred C-------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0 00011122345678888999999999999 89999888764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=377.92 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=198.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCC-------eEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSG-------SVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKG 417 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~-------~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 417 (645)
++|...+.||+|+||.||+|+....+ ..||||++... .....++.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 56788899999999999999875433 47999998763 34457899999999998 7999999999999999
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCC------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSEN------------GVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld 485 (645)
..++||||+++|+|.++|...... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 999999999999999999765421 2458999999999999999999999 9999999999999999
Q ss_pred CCCCeeeecc--------------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccccccchhh
Q 041096 486 ANFNARLESS--------------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVAC-GRRPIERETEGHKMVN 550 (645)
Q Consensus 486 ~~~~~kl~d~--------------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~t-G~~P~~~~~~~~~~~~ 550 (645)
.++..|+.|. .....||+.|+|||.+.++.++.++|||||||++|||++ |+.||...... .
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~----~ 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----E 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----H
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----H
Confidence 9999999872 122468899999999999999999999999999999998 68888653321 1
Q ss_pred HHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 551 LVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 551 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+ .+.+....+...+...+..+.+++.+||+.||++||||.||++.|+++
T Consensus 246 ~-------------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 246 L-------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp H-------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-------------HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 122222333344445567789999999999999999999999999865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=376.60 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=198.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccC--CcchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeC-C
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKH--SHEGKTEFLAELSIIACL-RHKNLVQLLGWCAEK-G 417 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 417 (645)
.++|+..++||+|+||.||+|.+.. +++.||||+++. .....+.+.+|...+.++ +|+||+.+++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 3678889999999999999999753 346899999875 334456788898888887 689999999998765 4
Q ss_pred eEEEEEecCCCCCHhHHhhhcCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSE------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD 485 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld 485 (645)
..++|||||++|+|.++|..... ....++|.+++.++.||++||+|||+ ++|+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 68999999999999999976532 12348999999999999999999999 9999999999999999
Q ss_pred CCCCeeeeccc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCC-CCCCccccccchhh
Q 041096 486 ANFNARLESSF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGR-RPIERETEGHKMVN 550 (645)
Q Consensus 486 ~~~~~kl~d~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~-~P~~~~~~~~~~~~ 550 (645)
.++.+||+|.. ....||+.|+|||++.++.++.++|||||||++|||++|. .||........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--- 245 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--- 245 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 99999998821 2246899999999999999999999999999999999975 56765432211
Q ss_pred HHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 551 LVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 551 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
+ ...+....+...+......+.+++.+||+.||++||||+||+++|+++.
T Consensus 246 ~-------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 246 F-------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp H-------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-------------HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1 1122222223344455667889999999999999999999999998653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=376.62 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=204.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-----CCCeEEEEEeccCC--cchhHhHHHHHHHHhhc-CCCCeeeeeeeeeeCCe
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFA-----SSGSVAAVKRSKHS--HEGKTEFLAELSIIACL-RHKNLVQLLGWCAEKGE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~-----~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 418 (645)
.++|+..++||+|+||.||+|++. .++..||||+++.. .....+|.+|+.+++++ +|||||+++|+|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 367888999999999999999863 35678999998763 33456799999999999 69999999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCC--------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSE--------------NGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIML 484 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIll 484 (645)
.+||||||++|+|.++++.... ....+++..++.++.||++||+|||+ ++++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence 9999999999999999976542 12358999999999999999999999 999999999999999
Q ss_pred cCCCCeeeecc--------------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCC-CCccccccchh
Q 041096 485 DANFNARLESS--------------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRP-IERETEGHKMV 549 (645)
Q Consensus 485 d~~~~~kl~d~--------------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P-~~~~~~~~~~~ 549 (645)
+.++..|+.|. .....||+.|+|||++.++.++.++|||||||++|||+|++.| +........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-- 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 99999999772 1234689999999999999999999999999999999995544 544322111
Q ss_pred hHHHHHHhhhccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 550 NLVDWVWGLYAEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 550 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
+.+.++...+...+...+..+.+|+.+||+.||++||||.+|+++|++.
T Consensus 257 --------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 --------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp --------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1223333344444555667889999999999999999999999999854
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-44 Score=380.69 Aligned_cols=245 Identities=21% Similarity=0.246 Sum_probs=202.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
++|+..+.||+|+||+||+|....+++.||||++.... ...+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999999899999999987643 34567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc--CCCCeeeeccc--------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLD--ANFNARLESSF-------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld--~~~~~kl~d~~-------- 496 (645)
++|+|.+++..... .+++.++..++.||+.||+|||+ .+|+||||||+||||+ .++.+||.|..
T Consensus 109 ~gg~L~~~~~~~~~---~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCTTC---CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999988765432 39999999999999999999999 9999999999999998 56788998732
Q ss_pred ---cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 497 ---TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 497 ---~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+...+.. .+....
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~----------~~~~~~ 248 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKR----------CDWEFD 248 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHH----------CCCCCC
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHh----------CCCCCC
Confidence 2246899999999999999999999999999999999999999764321 11111110 011111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HcCC
Q 041096 574 GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI--LNNE 612 (645)
Q Consensus 574 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~--L~~~ 612 (645)
..........+.+++..||+.||.+|||++|+++. |++.
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 12222345567889999999999999999999873 6543
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.3e-44 Score=348.22 Aligned_cols=199 Identities=25% Similarity=0.408 Sum_probs=165.9
Q ss_pred CCceeEEeCCCCCCCeEEecceEee-CCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCC
Q 041096 22 SNNMNFDFTSFNLRNITLLGDSYLR-NGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSS 100 (645)
Q Consensus 22 ~~~~~f~~~~f~~~~~~l~G~a~~~-~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~ 100 (645)
+++++|+|++|+..||+|+|||.+. +|.||||++ .++++|||+|++||+||++.+++++||+|+|+|+|.+.+...
T Consensus 1 a~~~sF~~~~F~~~~l~l~GdA~v~~~g~i~LT~~---~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~~~~ 77 (204)
T d1dhkb_ 1 ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYN---SYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQAN 77 (204)
T ss_dssp CCCCEEEESSCCGGGEEEESSEEECTTSCEEESSS---CSSEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---
T ss_pred CccceEECCCCCccCeeEecceEEcCCCeEEeCCC---CCCCEEEEEeCCCEeccCCCCcccccEEEEEEEEEecCCCCC
Confidence 3578999999999999999999984 679999997 567999999999999999999999999999999999988778
Q ss_pred CCCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccccccC
Q 041096 101 FGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLK 180 (645)
Q Consensus 101 ~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~~~~ 180 (645)
+||||||+|+|.... ..++.+||||||+.| |+++|+++....... ....+.
T Consensus 78 ~gdGlaf~~~~~~~~----------------~~~~~~~vefDt~~n---------~~~~d~~~~~~~~~~----~~~~~~ 128 (204)
T d1dhkb_ 78 SAVGLDFVLVPVQPE----------------SKGDTVTVEFDTFLS---------RISIDVNNNDIKSVP----WDVHDY 128 (204)
T ss_dssp CCSEEEEEEEEC----------------------CCEEEEEETTTT---------EEEEEETTEEEEEEE----CCGGGT
T ss_pred CCceEEEEecCCCCC----------------CCCcEeeEeeEcccc---------cccCccccccccccc----cccEec
Confidence 999999999986531 224679999999864 666666654332221 135678
Q ss_pred CCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCc---cceeeeeeeeeeec
Q 041096 181 SGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGS---TELHMIQSWSFQTS 253 (645)
Q Consensus 181 ~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~sw~f~~~ 253 (645)
+|+.++|||+||+..++|.|++++.+ ++..+.|+..+||+.+||++|||||||+||.. .|+|+|++|+|+++
T Consensus 129 ~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H~IlsWsFss~ 203 (204)
T d1dhkb_ 129 DGQNAEVRITYNSSTKVFSVSLSNPS-TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSK 203 (204)
T ss_dssp TTSCEEEEEEEETTTTEEEEEEECTT-TCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEEEEEE
T ss_pred CCCEEEEEEEEcCCCEEEEEEEecCC-CCCceeEEEEecchhccCCcEEEEEEeecCCCCCCceeeEEEEEEEEec
Confidence 89999999999999999999999766 56778999999999999999999999999964 57899999999974
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=374.46 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=203.4
Q ss_pred cCCCcCceeccCCceEEEEEEECC-----CCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFAS-----SGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
++|...+.||+|+||+||+|.+.. .+..||||+++.. ......|.+|++++++++|||||+++|+|...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 567788999999999999998752 3578999998763 334456999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcC------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec
Q 041096 421 LVYEYMPNGSLDRMLYQDS------ENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES 494 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d 494 (645)
+||||+++|+|.+++.... .....++|.++.+++.|+|+||.|||+ ++|+||||||+|||||.++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 9999999999999987542 112347999999999999999999999 9999999999999999999999988
Q ss_pred cc--------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCC-CCCCccccccchhhHHHHHHhhh
Q 041096 495 SF--------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGR-RPIERETEGHKMVNLVDWVWGLY 559 (645)
Q Consensus 495 ~~--------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~-~P~~~~~~~~~~~~l~~~~~~~~ 559 (645)
.. ....||+.|+|||.+.+..++.++|||||||++|||+||+ .||......+ ...
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~----~~~------ 246 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----VLR------ 246 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH----HHH------
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH----HHH------
Confidence 22 2235889999999999999999999999999999999985 6665433211 111
Q ss_pred ccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCCC
Q 041096 560 AEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAEP 615 (645)
Q Consensus 560 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~~ 615 (645)
.+........+...+..+.+++..||+.+|.+||||++|+++|++..++
T Consensus 247 -------~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 247 -------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp -------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -------HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1111112233444567899999999999999999999999999987663
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=372.65 Aligned_cols=251 Identities=23% Similarity=0.307 Sum_probs=193.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC----eEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG----ELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 423 (645)
+.|...+.||+|+||.||+|++. |..||||++.........+..|+..+.+++|||||+++|+|.+.+ .+|+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 45667789999999999999975 789999998764433333445566667889999999999998754 689999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeeCCCCCCcEEEcCCCCeeeeccc--
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC-----EQQVIHRDIKASNIMLDANFNARLESSF-- 496 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlkp~NIlld~~~~~kl~d~~-- 496 (645)
|||++|+|.++|++.. ++|.++++++.|+|.||+|||+.. .++|+||||||+||||+.++.+||+|..
T Consensus 81 Ey~~~g~L~~~l~~~~-----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecccCCCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999997642 899999999999999999999732 3699999999999999999999998731
Q ss_pred --------------cccccCCcccCcccccCCC------CCcchhHHHHHHHHHHHHcCCCCCCccccccchhh------
Q 041096 497 --------------TLTAGTMGYLAPEYLQYGT------ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVN------ 550 (645)
Q Consensus 497 --------------~~~~gt~~y~APE~~~~~~------~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~------ 550 (645)
....||++|+|||++.+.. ++.++|||||||+||||+||..|+...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 2246899999999987643 57799999999999999999988765332211100
Q ss_pred -HHHHHHhhhccCchhHHhhhhccCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCC
Q 041096 551 -LVDWVWGLYAEGRIIEAADKRLNGAF-----NEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEA 613 (645)
Q Consensus 551 -l~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~ 613 (645)
..+.... ...++.++... +.+.+..+.+++..||+.||++||||.||++.|+++.
T Consensus 236 ~~~~~~~~--------~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 236 PSVEEMRK--------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHH--------HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chHHHHHH--------HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0011111 11122222222 2345677999999999999999999999999998653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-44 Score=372.11 Aligned_cols=235 Identities=25% Similarity=0.335 Sum_probs=199.9
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||+|+...++..||||++.+. ....+.+.+|+.+|++++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5789999999999999999999999999999998752 234567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-------- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-------- 495 (645)
|||++|+|.+++..... ++......++.||+.||+|||+ ++|+||||||+||||+.++..||.|.
T Consensus 85 ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhcccC----CcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999987654 8999999999999999999999 99999999999999999999999872
Q ss_pred ----ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhh
Q 041096 496 ----FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKR 571 (645)
Q Consensus 496 ----~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 571 (645)
....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+... +.... ....
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~i------------~~~~ 221 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELI------------LMEE 221 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH------------HHCC
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH----HHHHH------------hcCC
Confidence 123579999999999999999999999999999999999999998654211 11110 0111
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 041096 572 LNGAFNEDEMKRLLLVGLSCANPDSSARPS-----MRRVFQ 607 (645)
Q Consensus 572 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~~vl~ 607 (645)
..++......+.+++..||+.||++||+ ++|+++
T Consensus 222 --~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1233344456778899999999999995 788876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-44 Score=372.55 Aligned_cols=235 Identities=21% Similarity=0.282 Sum_probs=199.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||+||+|+.+.+|..||||++... ....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5688999999999999999999999999999998642 234567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-------- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-------- 495 (645)
|||++|+|..++..... +++.....++.||+.||+|||+ ++|+||||||+||||+.++.+||.|.
T Consensus 84 E~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999987654 7889999999999999999999 99999999999999999999999882
Q ss_pred -ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 496 -FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 496 -~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
....+||+.|||||++.+..++.++||||+||++|||++|+.||...+... +... +.... .
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~------------i~~~~--~ 218 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TYEK------------ILNAE--L 218 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHH------------HHHCC--C
T ss_pred ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH----HHHH------------HHcCC--C
Confidence 234579999999999999999999999999999999999999997643211 1111 11111 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
.++......+.+++..||..||.+|| |++++++
T Consensus 219 ~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 22333445678889999999999996 8999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-44 Score=370.25 Aligned_cols=242 Identities=22% Similarity=0.289 Sum_probs=201.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.++|...+.||+|+||+||+|....+++.||||.++........+.+|+++|++++|||||++++++.+.+.+|||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 36788999999999999999999999999999999887666778999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC--Ceeeecc---------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF--NARLESS--------- 495 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~--~~kl~d~--------- 495 (645)
++|+|.+++..... .+++.++..++.||++||+|||+ .+|+||||||+|||++.+. ..|+.|.
T Consensus 84 ~gg~L~~~i~~~~~---~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 99999999975432 38999999999999999999999 9999999999999998544 6777762
Q ss_pred --ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhcc
Q 041096 496 --FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLN 573 (645)
Q Consensus 496 --~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 573 (645)
.....||+.|+|||.+.+..++.++||||+||++|||++|+.||...........+ .....
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i----------------~~~~~- 220 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI----------------MNAEY- 220 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----------------HHTCC-
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH----------------HhCCC-
Confidence 12246899999999999999999999999999999999999999765432111111 11000
Q ss_pred CCCCHH----HHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 574 GAFNED----EMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 574 ~~~~~~----~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
.++.. ....+.+++..|+..||++|||++|+++ .+++.
T Consensus 221 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 221 -TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 11211 2345778899999999999999999998 45543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-43 Score=371.11 Aligned_cols=235 Identities=22% Similarity=0.255 Sum_probs=199.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVY 423 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 423 (645)
++|+..+.||+|+||.||+|.+..+|+.||||++... ....+.+.+|+++|+.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4789999999999999999999999999999988642 233467899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--------
Q 041096 424 EYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-------- 495 (645)
Q Consensus 424 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-------- 495 (645)
||+.+|+|..++..... +++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|.
T Consensus 121 e~~~~g~l~~~l~~~~~----l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcCC----CCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999977543 8999999999999999999999 99999999999999999999999872
Q ss_pred -ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhhhccC
Q 041096 496 -FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADKRLNG 574 (645)
Q Consensus 496 -~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 574 (645)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...+.. .+...+ .... .
T Consensus 194 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i------------~~~~--~ 255 (350)
T d1rdqe_ 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYEKI------------VSGK--V 255 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH------------HHCC--C
T ss_pred ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH----HHHHHH------------hcCC--C
Confidence 23357999999999999999999999999999999999999999764321 111111 1111 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCC-----CCHHHHHH
Q 041096 575 AFNEDEMKRLLLVGLSCANPDSSAR-----PSMRRVFQ 607 (645)
Q Consensus 575 ~~~~~~~~~l~~l~~~Cl~~dP~~R-----Pt~~~vl~ 607 (645)
..+......+.+++..||+.||.+| ||++++++
T Consensus 256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 2233345567888999999999999 48999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-43 Score=361.46 Aligned_cols=239 Identities=23% Similarity=0.315 Sum_probs=196.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc----------hhHhHHHHHHHHhhcC-CCCeeeeeeeeeeC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE----------GKTEFLAELSIIACLR-HKNLVQLLGWCAEK 416 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~----------~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 416 (645)
++|+..+.||+|+||+||+|+...+++.||||++..... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 578899999999999999999998999999999865321 1245889999999997 99999999999999
Q ss_pred CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-
Q 041096 417 GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS- 495 (645)
Q Consensus 417 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~- 495 (645)
+..|||||||++|+|.++|..... +++.++..++.||++||+|||+ ++|+||||||+||||+.++..||+|.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~----l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999976543 9999999999999999999999 99999999999999999999999872
Q ss_pred ----------ccccccCCcccCcccccC------CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhh
Q 041096 496 ----------FTLTAGTMGYLAPEYLQY------GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLY 559 (645)
Q Consensus 496 ----------~~~~~gt~~y~APE~~~~------~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~ 559 (645)
.....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...........+.
T Consensus 156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~------- 228 (277)
T d1phka_ 156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM------- 228 (277)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------
T ss_pred heeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH-------
Confidence 233568999999998853 457889999999999999999999998643211111110
Q ss_pred ccCchhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 560 AEGRIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 560 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.+. ............+.+.+++.+||++||++|||++||++
T Consensus 229 -~~~------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 -SGN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -HTC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -hCC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000 00111112234457888999999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=369.41 Aligned_cols=235 Identities=23% Similarity=0.339 Sum_probs=196.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHHHHHHh-hcCCCCeeeeeeeeeeCCeEEEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAELSIIA-CLRHKNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 422 (645)
++|...+.||+|+||+||+|+...+++.||||++.+. ....+.+..|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5788999999999999999999999999999998652 233456777777765 68999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-------
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS------- 495 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~------- 495 (645)
|||+++|+|.+++..... ++..++..++.||+.||+|||+ ++|+||||||+|||++.++.+|+.|.
T Consensus 82 mEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999987554 8999999999999999999999 99999999999999999999999872
Q ss_pred -----ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhhh
Q 041096 496 -----FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAADK 570 (645)
Q Consensus 496 -----~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 570 (645)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+...+ ..+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i----~~~-------- 218 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSI----RMD-------- 218 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----HHC--------
T ss_pred cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHH----HcC--------
Confidence 22347899999999999999999999999999999999999999764321 111111 000
Q ss_pred hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 041096 571 RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMR-RVFQ 607 (645)
Q Consensus 571 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-~vl~ 607 (645)
...++......+.+++..||+.||++|||++ ++++
T Consensus 219 --~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 --NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1123333455678899999999999999996 6753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.8e-43 Score=370.01 Aligned_cols=238 Identities=25% Similarity=0.315 Sum_probs=193.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC----cchhHhHHHH---HHHHhhcCCCCeeeeeeeeeeCCeEE
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS----HEGKTEFLAE---LSIIACLRHKNLVQLLGWCAEKGELL 420 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~E---i~~l~~l~H~niv~l~g~~~~~~~~~ 420 (645)
++|+..++||+|+||.||+|+...+|..||||++... ......+.+| +++++.++|||||++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6799999999999999999999999999999988642 1223334444 66777778999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS----- 495 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~----- 495 (645)
||||||++|+|.++|..... +++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|.
T Consensus 84 ivmE~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhccc----ccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999987543 8899999999999999999999 99999999999999999999999882
Q ss_pred -----ccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHhh
Q 041096 496 -----FTLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAAD 569 (645)
Q Consensus 496 -----~~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 569 (645)
....+||+.|+|||++.. ..++.++|||||||+||||++|+.||........ ..+.. ..
T Consensus 157 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~---~~----------- 221 (364)
T d1omwa3 157 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR---MT----------- 221 (364)
T ss_dssp CSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHH---HS-----------
T ss_pred cCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH---hc-----------
Confidence 233579999999999975 5689999999999999999999999976433211 11110 00
Q ss_pred hhccCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 041096 570 KRLNGAFNEDEMKRLLLVGLSCANPDSSARPS-----MRRVFQ 607 (645)
Q Consensus 570 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~~vl~ 607 (645)
.......+......+.+++..||+.||++||| ++|+++
T Consensus 222 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 222 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00011222334456788999999999999999 688875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-43 Score=361.40 Aligned_cols=260 Identities=20% Similarity=0.279 Sum_probs=195.9
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..++||+|+||+||+|++..+++.||||++.... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57889999999999999999999899999999986532 335679999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS--------- 495 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~--------- 495 (645)
|+.+ ++..++.... ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++..|++|.
T Consensus 82 ~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9965 5555554332 2239999999999999999999999 99999999999999999999999882
Q ss_pred ---ccccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh-hh
Q 041096 496 ---FTLTAGTMGYLAPEYLQYGT-ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA-DK 570 (645)
Q Consensus 496 ---~~~~~gt~~y~APE~~~~~~-~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-d~ 570 (645)
.....||+.|+|||.+.... ++.++||||+||++|||++|+.||...+.............. ..+....... .+
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT-PDEVVWPGVTSMP 234 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTTGGGST
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC-Cchhhcccccccc
Confidence 22347999999999877655 588999999999999999999999765432211111111000 0000000000 00
Q ss_pred hccCCC-----------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HcCCCC
Q 041096 571 RLNGAF-----------NEDEMKRLLLVGLSCANPDSSARPSMRRVFQI--LNNEAE 614 (645)
Q Consensus 571 ~l~~~~-----------~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~--L~~~~~ 614 (645)
...... .......+.+++.+|++.||++|||++|+++. |++..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 000000 01123567788899999999999999999984 765543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=364.84 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=190.5
Q ss_pred CceeccCCceEEEEEEECCCCeEEEEEeccCCcc------hhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEecC
Q 041096 353 NRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE------GKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 353 ~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
.++||+|+||+||+|.+..+++.||||+++.... ..+.+.+|+.++++++|||||++++++.+++..||||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 5789999999999999999999999999865321 2356899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc----------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF---------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~---------- 496 (645)
.++++..+..... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++..||+|..
T Consensus 83 ~~~~~~~~~~~~~----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 8887776654332 38889999999999999999999 999999999999999999999998822
Q ss_pred --cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh---hh
Q 041096 497 --TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA---DK 570 (645)
Q Consensus 497 --~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---d~ 570 (645)
...+||+.|+|||++... .++.++|||||||++|||++|+.||......+....+.+.. .........+.. ..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~-~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL-GTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-CCCCTTTSSSTTSSTTC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhc-CCCChhhccchhccchh
Confidence 224689999999998754 57999999999999999999999997654322221111110 000000000000 00
Q ss_pred h---ccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCC
Q 041096 571 R---LNGAFN-----EDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNE 612 (645)
Q Consensus 571 ~---l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~ 612 (645)
. .....+ ....+.+.+++..||+.||++|||++|+++ .|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 000011 112356788999999999999999999997 57643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=367.30 Aligned_cols=252 Identities=17% Similarity=0.239 Sum_probs=194.7
Q ss_pred hcCCCcC-ceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhc-CCCCeeeeeeeeee----CCeEE
Q 041096 347 TRGFHSN-RILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACL-RHKNLVQLLGWCAE----KGELL 420 (645)
Q Consensus 347 ~~~f~~~-~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~~ 420 (645)
.++|... ++||+|+||+||+|++..+++.||||+++. ...+.+|++++.++ +|||||++++++.+ +..+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 3578776 469999999999999998999999999865 34577899987655 89999999999865 45789
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCeeeecc--
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA---NFNARLESS-- 495 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~---~~~~kl~d~-- 495 (645)
||||||++|+|.++|..... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++. ++.+|+.|.
T Consensus 86 ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccce
Confidence 99999999999999976432 349999999999999999999999 99999999999999986 445888772
Q ss_pred ---------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhH
Q 041096 496 ---------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIE 566 (645)
Q Consensus 496 ---------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 566 (645)
....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...........+. .....+.
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~----~~i~~~~--- 233 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----TRIRMGQ--- 233 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCS---
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH----HHHhcCC---
Confidence 233479999999999999999999999999999999999999997644322111110 0000000
Q ss_pred HhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCCC
Q 041096 567 AADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPLV 617 (645)
Q Consensus 567 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~~ 617 (645)
..+...........+.+++..||+.||++|||++|+++ .+.+....+.
T Consensus 234 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 283 (335)
T d2ozaa1 234 ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283 (335)
T ss_dssp ---SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCC
T ss_pred ---CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCC
Confidence 00000001233467888999999999999999999998 3554444333
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=358.15 Aligned_cols=255 Identities=21% Similarity=0.270 Sum_probs=190.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-CCeEEEEEeccC---CcchhHhHHHHHHHHhhc---CCCCeeeeeeeeee----
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFAS-SGSVAAVKRSKH---SHEGKTEFLAELSIIACL---RHKNLVQLLGWCAE---- 415 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~-~~~~vavK~~~~---~~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~---- 415 (645)
.++|+..+.||+|+||+||+|.+.. +++.||||++.. .......+.+|+.+++.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 4689999999999999999999854 467899998764 222344677888887766 79999999999853
Q ss_pred -CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeec
Q 041096 416 -KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLES 494 (645)
Q Consensus 416 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d 494 (645)
....+++|||+.++++........ ..+++.....++.|++.||+|||+ ++|+||||||+|||++.++..|+.|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecc
Confidence 347899999998877765544332 238999999999999999999999 9999999999999999999999987
Q ss_pred c-----------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh----h
Q 041096 495 S-----------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL----Y 559 (645)
Q Consensus 495 ~-----------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~----~ 559 (645)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+....... +
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 2 234578999999999999999999999999999999999999998654322222222111000 0
Q ss_pred cc-CchhHHhhhhc----cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 560 AE-GRIIEAADKRL----NGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 560 ~~-~~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.. ........... ...+.....+.+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00000000000 00111223356778889999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=352.46 Aligned_cols=229 Identities=23% Similarity=0.394 Sum_probs=189.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc-------chhHhHHHHHHHHhhcC--CCCeeeeeeeeeeCCe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH-------EGKTEFLAELSIIACLR--HKNLVQLLGWCAEKGE 418 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~-------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~ 418 (645)
++|+..++||+|+||+||+|+...+++.||||++.... .....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57899999999999999999999999999999876421 12345789999999997 8999999999999999
Q ss_pred EEEEEecCCC-CCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeeeecc-
Q 041096 419 LLLVYEYMPN-GSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDAN-FNARLESS- 495 (645)
Q Consensus 419 ~~lV~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~-~~~kl~d~- 495 (645)
.++||||+.+ +++.+++..... +++.++..++.||++||+|||+ ++|+||||||+||||+.+ +.+|+.|.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~----l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccc
Confidence 9999999975 678888876543 8999999999999999999999 999999999999999855 68889872
Q ss_pred ---------ccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchh
Q 041096 496 ---------FTLTAGTMGYLAPEYLQYGTA-TEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRII 565 (645)
Q Consensus 496 ---------~~~~~gt~~y~APE~~~~~~~-t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 565 (645)
.....||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... +.. +
T Consensus 157 ~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~--------~--- 219 (273)
T d1xwsa_ 157 SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--------G--- 219 (273)
T ss_dssp TCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--------C---
T ss_pred cceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhh--------c---
Confidence 233579999999999987765 5779999999999999999999975311 100 0
Q ss_pred HHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 566 EAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 566 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.. .++......+.+++.+||+.||++|||++|+++
T Consensus 220 ---~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 ---QV----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---CC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---cc----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 112223456778889999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.2e-42 Score=349.88 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=191.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..++||+|+||+||+|+++ +++.||||++.... ...+.+.+|+.+|++++|||||++++++...+..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 57888999999999999999986 57899999986632 235679999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS--------- 495 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~--------- 495 (645)
|+.++.+..+..... .++..++..++.||+.||+|||+ .+|+||||||+||||+.++..|+.|.
T Consensus 81 ~~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 998776666654433 39999999999999999999999 99999999999999999999999882
Q ss_pred ---ccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc---hhHHh
Q 041096 496 ---FTLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR---IIEAA 568 (645)
Q Consensus 496 ---~~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~ 568 (645)
.....|++.|+|||.+... .++.++|||||||++|||++|+.||......+........ ........ ..+..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI-LGTPNSKNWPNVTELP 232 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCTTTSTTGGGST
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHh-hCCCChhhccchhhhh
Confidence 2234688999999998754 5699999999999999999999999765432211111110 00000000 00000
Q ss_pred --hhhcc-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 569 --DKRLN-------GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 569 --d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
+.... ..........+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0111222356778899999999999999999984
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=344.55 Aligned_cols=254 Identities=20% Similarity=0.266 Sum_probs=189.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeee--------
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAE-------- 415 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-------- 415 (645)
.++|+..+.||+|+||+||+|++..+++.||||++... ....+.+.+|+++|++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36889999999999999999999989999999987653 3345678999999999999999999998865
Q ss_pred CCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc
Q 041096 416 KGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS 495 (645)
Q Consensus 416 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~ 495 (645)
.+..++||||+.++.+..+..... .++......++.|+++||+|||+ ++|+||||||+||||+.++.+|+.|.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~----~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhccc----ccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 346899999998877765554332 38889999999999999999999 99999999999999999999999772
Q ss_pred c----------------cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh
Q 041096 496 F----------------TLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL 558 (645)
Q Consensus 496 ~----------------~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~ 558 (645)
. ...+||+.|+|||++.+. .++.++||||+||++|||++|+.||...........+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 1 224689999999998765 68999999999999999999999997654322221111111100
Q ss_pred hc-------cCchhHHhhhhccCCCCH-H------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 559 YA-------EGRIIEAADKRLNGAFNE-D------EMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 559 ~~-------~~~~~~~~d~~l~~~~~~-~------~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
.. .................. + ....+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 000000000000000111 1 1234567899999999999999999997
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=349.75 Aligned_cols=261 Identities=18% Similarity=0.240 Sum_probs=191.5
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC------
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG------ 417 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 417 (645)
.++|+..+.||+|+||+||+|....+++.||||++... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 36788999999999999999999999999999998753 233567899999999999999999999987654
Q ss_pred eEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc--
Q 041096 418 ELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS-- 495 (645)
Q Consensus 418 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~-- 495 (645)
++|+||||+ +.+|..+..... +++..+..++.||+.||+|||+ ++|+||||||+|||++.++..|+.|.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccc
Confidence 579999999 667887775432 9999999999999999999999 99999999999999999999999872
Q ss_pred -------ccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHH-------Hhhhc
Q 041096 496 -------FTLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWV-------WGLYA 560 (645)
Q Consensus 496 -------~~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~-------~~~~~ 560 (645)
.+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||...+............ +....
T Consensus 168 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 168 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp CEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred eeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 3445799999999998764 56899999999999999999999997654322111111100 00000
Q ss_pred cCchhHHhhhhcc-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HcCCCCCCC
Q 041096 561 EGRIIEAADKRLN-------GAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQI--LNNEAEPLV 617 (645)
Q Consensus 561 ~~~~~~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~--L~~~~~~~~ 617 (645)
..........+. ..........+.+++..||+.||++|||++|+++. |++..+...
T Consensus 248 -~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~ 312 (346)
T d1cm8a_ 248 -SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312 (346)
T ss_dssp -CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred -chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence 000000000000 00111223456788899999999999999999984 776654443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=338.73 Aligned_cols=257 Identities=19% Similarity=0.241 Sum_probs=197.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 424 (645)
++|+..+.||+|+||+||+|++..+++.||||+++.. ......+.+|+.++++++||||++++++|.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5788999999999999999999999999999998653 2345778999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-------- 496 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-------- 496 (645)
++.+++|..++..... +++..+..++.|++.||+|||+ ++|+||||||+|||++.++..|+.|..
T Consensus 82 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTTC----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccccccc----cchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999998888765433 8899999999999999999999 999999999999999999999998722
Q ss_pred ----cccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch---hHHh
Q 041096 497 ----TLTAGTMGYLAPEYLQYGT-ATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI---IEAA 568 (645)
Q Consensus 497 ----~~~~gt~~y~APE~~~~~~-~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~ 568 (645)
....++..|+|||.+.... ++.++||||+||++|||++|+.||............+............ ....
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 2235678899999987665 6999999999999999999999976533222111111111110000000 0000
Q ss_pred hh---------hccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcC
Q 041096 569 DK---------RLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNN 611 (645)
Q Consensus 569 d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~ 611 (645)
+. .-...........+.+++.+|++.||++|||++|+++ .|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 00 0000112223356778889999999999999999987 4554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-40 Score=343.97 Aligned_cols=265 Identities=18% Similarity=0.218 Sum_probs=193.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC--cchhHhHHHHHHHHhhcCCCCeeeeeeeeeeCC----eEE
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS--HEGKTEFLAELSIIACLRHKNLVQLLGWCAEKG----ELL 420 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~ 420 (645)
+.+|+..+.||+|+||+||+|+...+++.||||++... ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35688999999999999999999989999999998753 334567899999999999999999999987643 234
Q ss_pred EEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc-----
Q 041096 421 LVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS----- 495 (645)
Q Consensus 421 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~----- 495 (645)
++++|+.+|+|.+++..+. +++..+..++.|++.||+|||+ ++|+||||||+||||+.++..||.|.
T Consensus 87 ~l~~~~~~g~L~~~l~~~~-----l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcCC-----CCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4455667999999997542 8999999999999999999999 99999999999999999999999872
Q ss_pred ----------ccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC--
Q 041096 496 ----------FTLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG-- 562 (645)
Q Consensus 496 ----------~~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~-- 562 (645)
....+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.... ...........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH-ILGILGSPSQEDL 237 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCSCCHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH-HhhhccCCChhhh
Confidence 223468999999999854 5678999999999999999999999976432111111 10000000000
Q ss_pred ------chhHHhhhh-ccCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HcCCCCCCCCCC
Q 041096 563 ------RIIEAADKR-LNGAFNE-----DEMKRLLLVGLSCANPDSSARPSMRRVFQI--LNNEAEPLVVPK 620 (645)
Q Consensus 563 ------~~~~~~d~~-l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~--L~~~~~~~~~p~ 620 (645)
......... .....+. .....+.+++..|++.||++|||++|+++. |+...++...|.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~ 309 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 309 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCC
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCcc
Confidence 000000000 0000111 112357789999999999999999999984 665555444443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-40 Score=338.60 Aligned_cols=249 Identities=14% Similarity=0.131 Sum_probs=198.3
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCC-CCeeeeeeeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRH-KNLVQLLGWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~ 426 (645)
++|+..+.||+|+||+||+|++..+++.||||++... .....+.+|++.++.|+| +|++.+++++.++...++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 5789999999999999999999989999999987553 234567889999999975 89999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-----CCCeeeeccc-----
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA-----NFNARLESSF----- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~-----~~~~kl~d~~----- 496 (645)
+++|.+++..... .+++.++..++.|++.||+|||+ ++|+||||||+||||+. ++.+|+.|..
T Consensus 84 -~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 84 -GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp -CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred -CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 7899999876543 38999999999999999999999 99999999999999975 4567886621
Q ss_pred --------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccC
Q 041096 497 --------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEG 562 (645)
Q Consensus 497 --------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~ 562 (645)
...+||+.|||||.+.+..++.++|||||||++|||++|+.||............ ..+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~i~~~~~~~ 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQST 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHHHHHS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HHHHhccCCC
Confidence 1236999999999999999999999999999999999999999765433222111 1110000000
Q ss_pred chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCCCC
Q 041096 563 RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNEAE 614 (645)
Q Consensus 563 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~~~ 614 (645)
. -+.+.. +.++.+.+++..|+..+|++||+++.+.+.|++..+
T Consensus 236 ~-----~~~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 236 P-----LRELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp C-----HHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred C-----hHHhcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 0 011111 234567888899999999999999999888876543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-40 Score=339.43 Aligned_cols=247 Identities=18% Similarity=0.175 Sum_probs=189.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeee-eeeeeCCeEEEEEecC
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLL-GWCAEKGELLLVYEYM 426 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~-g~~~~~~~~~lV~Ey~ 426 (645)
++|+..+.||+|+||.||+|++..+++.||||++.... ..+++..|++++++++|+|++..+ ++..+.+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 46899999999999999999999899999999876533 345688999999999877655554 5556778899999999
Q ss_pred CCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCeeeeccc-------
Q 041096 427 PNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDA---NFNARLESSF------- 496 (645)
Q Consensus 427 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~---~~~~kl~d~~------- 496 (645)
+++|...+..... .+++..+..++.|++.||+|||+ ++|+||||||+|||++. +..+++.|..
T Consensus 86 -~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 86 -GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp -CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred -CCchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 6677776654433 38999999999999999999999 99999999999999863 4467776621
Q ss_pred ------------cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCch
Q 041096 497 ------------TLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRI 564 (645)
Q Consensus 497 ------------~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 564 (645)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---- 234 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---- 234 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH----
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC----
Confidence 2236999999999999999999999999999999999999999765433322222111100000
Q ss_pred hHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcCC
Q 041096 565 IEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQILNNE 612 (645)
Q Consensus 565 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~~L~~~ 612 (645)
...+.+ ....+..+.+++..||+.+|++||++.++.+.|+..
T Consensus 235 --~~~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 235 --TPIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp --SCHHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred --CChhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 000111 112345688889999999999999999998888754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=350.36 Aligned_cols=257 Identities=23% Similarity=0.291 Sum_probs=188.7
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCeeeeeeeeeeC------CeEEEE
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNLVQLLGWCAEK------GELLLV 422 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~lV 422 (645)
+|+..++||+|+||+||+|++..+++.||||++..... ...+|+++|++++|+||++++++|... ..++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 46677899999999999999999999999999876432 334799999999999999999998543 358999
Q ss_pred EecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-Ceeeeccc-----
Q 041096 423 YEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-NARLESSF----- 496 (645)
Q Consensus 423 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~-~~kl~d~~----- 496 (645)
||||+++ +...+.........+++.++..++.||+.||+|||+ ++|+||||||+||||+.++ ..||.|..
T Consensus 98 ~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999765 444443322223459999999999999999999998 9999999999999999775 78898722
Q ss_pred ------cccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCchhHHh-
Q 041096 497 ------TLTAGTMGYLAPEYLQY-GTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGRIIEAA- 568 (645)
Q Consensus 497 ------~~~~gt~~y~APE~~~~-~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~- 568 (645)
....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.... +........+..
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~-g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-GTPTREQIREMNP 252 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH-CCCCHHHHHHHCC
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHh-CCChHHhhhhhcc
Confidence 23468999999998775 568999999999999999999999997654322221111110 000000000000
Q ss_pred ---hhh--------ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCC
Q 041096 569 ---DKR--------LNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEA 613 (645)
Q Consensus 569 ---d~~--------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~ 613 (645)
+.. ............+.+++.+||+.||++|||++|+++ +|++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000 000111223445778889999999999999999997 455543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=338.94 Aligned_cols=239 Identities=23% Similarity=0.289 Sum_probs=196.0
Q ss_pred cCCCcCceeccCCceEEEEEEE---CCCCeEEEEEeccCC-----cchhHhHHHHHHHHhhcCC-CCeeeeeeeeeeCCe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYF---ASSGSVAAVKRSKHS-----HEGKTEFLAELSIIACLRH-KNLVQLLGWCAEKGE 418 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~---~~~~~~vavK~~~~~-----~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 418 (645)
++|+..+.||+|+||+||+|.. +.+|+.||||.++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999987 446899999988652 2235678999999999977 899999999999999
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeeccc--
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESSF-- 496 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~~-- 496 (645)
.+++|||+.+|+|.+++..... +.......++.|++.||+|||+ .+|+||||||+||||+.++.+||.|..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999987654 6788899999999999999999 999999999999999999999998722
Q ss_pred -----------cccccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhhhccCc
Q 041096 497 -----------TLTAGTMGYLAPEYLQYG--TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGLYAEGR 563 (645)
Q Consensus 497 -----------~~~~gt~~y~APE~~~~~--~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 563 (645)
....|++.|+|||.+... .++.++|||||||+||||++|+.||...........+....
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-------- 248 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-------- 248 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--------
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--------
Confidence 234689999999999764 46889999999999999999999998765433322222111
Q ss_pred hhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 041096 564 IIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARP-----SMRRVFQ 607 (645)
Q Consensus 564 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~~vl~ 607 (645)
... ...++.+....+.+++..||++||++|| |++|+++
T Consensus 249 ----~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 249 ----LKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----ccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011 1123344567788899999999999999 4889886
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-40 Score=344.81 Aligned_cols=250 Identities=21% Similarity=0.225 Sum_probs=188.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCC---cchhHhHHHHHHHHhhcCCCCeeeeeeeeee------CCe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHS---HEGKTEFLAELSIIACLRHKNLVQLLGWCAE------KGE 418 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 418 (645)
++|+..++||+|+||+||+|.+..+++.||||++... ....+.+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999999999999999998763 3344578899999999999999999999864 368
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS--- 495 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~--- 495 (645)
.|+||||+.++ +.+.+.. .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++..++.|.
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhhc------CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhh
Confidence 99999999655 4444432 28999999999999999999999 99999999999999999999999772
Q ss_pred --------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh----hhc---
Q 041096 496 --------FTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG----LYA--- 560 (645)
Q Consensus 496 --------~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~----~~~--- 560 (645)
.....||+.|+|||++.+..++.++||||+||+++||++|+.||...+.......+...... .+.
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 23346899999999999999999999999999999999999999764322111111110000 000
Q ss_pred --------------cCchhHHhhhhccCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 561 --------------EGRIIEAADKRLNGAF---NEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 561 --------------~~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
................ .......+.+++.+|++.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0001111111111111 1234567889999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-39 Score=337.19 Aligned_cols=248 Identities=20% Similarity=0.271 Sum_probs=188.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-CCCeeeeeeeeee--CCeEEEEEe
Q 041096 348 RGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-HKNLVQLLGWCAE--KGELLLVYE 424 (645)
Q Consensus 348 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~E 424 (645)
++|+..++||+|+||+||+|+...+++.||||+++.. ..+.+.+|+++|++++ ||||+++++++.. ....++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5789999999999999999999999999999998753 3567899999999996 9999999999874 356999999
Q ss_pred cCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-Ceeeecc--------
Q 041096 425 YMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANF-NARLESS-------- 495 (645)
Q Consensus 425 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~-~~kl~d~-------- 495 (645)
|+.+++|..+.. .++..++..++.||+.||+|||+ ++|+||||||+||||+.++ ..|+.|.
T Consensus 113 ~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999977642 28999999999999999999999 9999999999999999765 4788772
Q ss_pred ---ccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHh------hhc---cC
Q 041096 496 ---FTLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWG------LYA---EG 562 (645)
Q Consensus 496 ---~~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~------~~~---~~ 562 (645)
.....||+.|+|||.+.+. .++.++||||+||+++||++|+.||............+..... ... ..
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 2334689999999998765 4799999999999999999999999764332111111100000 000 00
Q ss_pred ---chhHHh--------hhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 041096 563 ---RIIEAA--------DKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ 607 (645)
Q Consensus 563 ---~~~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~ 607 (645)
...... ...............+.+++..|++.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000000111122345778899999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-39 Score=338.84 Aligned_cols=263 Identities=18% Similarity=0.228 Sum_probs=197.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCc---chhHhHHHHHHHHhhcCCCCeeeeeeeeeeC-----Ce
Q 041096 347 TRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSH---EGKTEFLAELSIIACLRHKNLVQLLGWCAEK-----GE 418 (645)
Q Consensus 347 ~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 418 (645)
.++|+..++||+|+||+||+|....+++.||||++.... ...+.+.+|+++|++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 457999999999999999999999899999999987633 3345788999999999999999999998633 34
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeeeecc---
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNARLESS--- 495 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~kl~d~--- 495 (645)
.++++||+.+|+|.+++..+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++..|+.|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchh
Confidence 46677788899999999643 29999999999999999999999 99999999999999999999999772
Q ss_pred ------ccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccccccchhhHHHHHHhh----hc--cC
Q 041096 496 ------FTLTAGTMGYLAPEYLQYG-TATEKTDVFSYGVVVLEVACGRRPIERETEGHKMVNLVDWVWGL----YA--EG 562 (645)
Q Consensus 496 ------~~~~~gt~~y~APE~~~~~-~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~~~l~~~~~~~----~~--~~ 562 (645)
.....||+.|+|||...+. .++.++||||+||++|||++|+.||...+.......+....... .. ..
T Consensus 169 ~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 169 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp -CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred cccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 2234688999999987765 46899999999999999999999997654322211111110000 00 00
Q ss_pred chhHHhhhhcc--CCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHcCCCCCCC
Q 041096 563 RIIEAADKRLN--GAFN-----EDEMKRLLLVGLSCANPDSSARPSMRRVFQ--ILNNEAEPLV 617 (645)
Q Consensus 563 ~~~~~~d~~l~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~--~L~~~~~~~~ 617 (645)
.........+. .... ......+.+++..|++.||++|||++|+++ .|++...+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~ 312 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence 00000000000 0000 012345678899999999999999999998 5776544433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-35 Score=309.66 Aligned_cols=259 Identities=18% Similarity=0.199 Sum_probs=189.7
Q ss_pred CCCcCceeccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcC-----------CCCeeeeeeeeeeC-
Q 041096 349 GFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLR-----------HKNLVQLLGWCAEK- 416 (645)
Q Consensus 349 ~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~~- 416 (645)
+|+..++||+|+||+||+|+...+++.||||+++......+.+.+|+++++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 488999999999999999999999999999999876666677889999988875 57899999987653
Q ss_pred -CeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC------
Q 041096 417 -GELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFN------ 489 (645)
Q Consensus 417 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~------ 489 (645)
...+++++++..+.......... ....+++..+..++.||++||+|||+ ..+|+||||||+||||+.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 46677777766554433332222 23348899999999999999999997 378999999999999986653
Q ss_pred eeeec---------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccccccch---hhHHHHHHh
Q 041096 490 ARLES---------SFTLTAGTMGYLAPEYLQYGTATEKTDVFSYGVVVLEVACGRRPIERETEGHKM---VNLVDWVWG 557 (645)
Q Consensus 490 ~kl~d---------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SfGvvl~El~tG~~P~~~~~~~~~~---~~l~~~~~~ 557 (645)
.++.| .....+||+.|+|||.+....++.++||||+||+++||++|+.||......... ..+...++.
T Consensus 171 ~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~ 250 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250 (362)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred eeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence 55655 223356899999999999999999999999999999999999999754322111 111111111
Q ss_pred hhc-------cC----------------------chhHHhhhhccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH-
Q 041096 558 LYA-------EG----------------------RIIEAADKRLNGAFNEDEMKRLLLVGLSCANPDSSARPSMRRVFQ- 607 (645)
Q Consensus 558 ~~~-------~~----------------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~~vl~- 607 (645)
+-. .. ...+... ............+.+++..|++.||.+|||++|+++
T Consensus 251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc--cccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 00 0000111 122345677888999999999999999999999998
Q ss_pred -HHcCC
Q 041096 608 -ILNNE 612 (645)
Q Consensus 608 -~L~~~ 612 (645)
.|++.
T Consensus 329 p~f~~~ 334 (362)
T d1q8ya_ 329 PWLKDT 334 (362)
T ss_dssp GGGTTC
T ss_pred cccCCC
Confidence 36644
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.96 E-value=4.9e-30 Score=249.55 Aligned_cols=114 Identities=36% Similarity=0.478 Sum_probs=105.9
Q ss_pred CcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccccCCCccccccCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcce
Q 041096 134 NKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKTADPILQGIDLKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPL 213 (645)
Q Consensus 134 ~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~ 213 (645)
|++|||||||++|.+++||++||||||+|++.|.++.++ ++.+|+.++|||+||+.+++|+|++++. ++..|+
T Consensus 2 n~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~~~-----~l~~G~~~~v~I~Yd~~~~~L~V~~~~~--~~~~~~ 74 (237)
T d1nlsa_ 2 DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW-----NMQNGKVGTAHIIYNSVDKRLSAVVSYP--NADSAT 74 (237)
T ss_dssp CCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-----CCCTTCEEEEEEEEETTTTEEEEEEECT--TSCCEE
T ss_pred CCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCccceecc-----cccCCCEEEEEEEEecCCcEEEEEEecC--CCCCeE
Confidence 689999999999998889999999999999999877664 6889999999999999999999999864 567889
Q ss_pred EEEeecCCccCCCccEEeEEeccCCccceeeeeeeeeeecC
Q 041096 214 LKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQTSG 254 (645)
Q Consensus 214 l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~~~~ 254 (645)
+++.|||+.+|+++||||||||||...|.|+|++|+|++..
T Consensus 75 ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~ 115 (237)
T d1nlsa_ 75 VSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL 115 (237)
T ss_dssp EEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred EEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeec
Confidence 99999999999999999999999999999999999999863
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=2e-27 Score=234.00 Aligned_cols=204 Identities=16% Similarity=0.087 Sum_probs=143.5
Q ss_pred eeEEeCCCC-----CCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCC
Q 041096 25 MNFDFTSFN-----LRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPS 99 (645)
Q Consensus 25 ~~f~~~~f~-----~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~ 99 (645)
.+|+.|.+. ..++.+.|+|.+.++.|+||++ .++++|+++|++|+++- +|+|+|+|.+.... .
T Consensus 9 ~sf~~P~~~~~~~~~~~w~~~G~a~i~~~~i~LT~~---~~~~~G~v~~~~p~~~~--------~F~~~f~f~~~~~~-~ 76 (228)
T d1gv9a_ 9 YSFKGPHLVQSDGTVPFWAHAGNAIPSADQIRIAPS---LKSQRGSVWTKTKAAFE--------NWEVEVTFRVTGRG-R 76 (228)
T ss_dssp GCEECSSCSCTTSCBTTEEEEETCEECSSCEEEECS---STTCEEEEEESSCBCCS--------SEEEEEEEEEECSS-S
T ss_pred eccCCCcccCCCCCccceEEeeeEEEECCEEEECCC---CCCCEEEEEeCCCcccc--------CcEEEEEEeccCCC-C
Confidence 456656543 2468999999999999999997 56799999999999873 69999999998654 5
Q ss_pred CCCCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCccccc-cc------CC
Q 041096 100 SFGDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIK-TA------DP 172 (645)
Q Consensus 100 ~~g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~-~~------~~ 172 (645)
.+||||||+|+|... ..|+.+|. .+..+.+||||||+.|.+ +++.+|+.+++|...... .. ..
T Consensus 77 ~ggdG~aF~i~~~~~---~~g~~~G~-----~~~~~glaVefDt~~n~~--~~~~~~~~~~~n~~~~~~~~~~~~~~~~~ 146 (228)
T d1gv9a_ 77 IGADGLAIWYTENQG---LDGPVFGS-----ADMWNGVGIFFDSFDNDG--KKNNPAIVVVGNNGQINYDHQNDGATQAL 146 (228)
T ss_dssp CCCCEEEEEEESSCC---CEEEETTE-----CSCCEEEEEEEECCCC-------CCEEEEEEEESCCCCCHHHHHHHHCS
T ss_pred CCCCEEEEEEecCCC---CCCCccCc-----CCCCceEEEEEEcccccC--CCCCCcEEEEecCCcceeeecCCCccccc
Confidence 679999999998753 35666665 334567999999999964 777788888776433111 00 01
Q ss_pred Cccccc-cCCCCeEEEEEEecCCCceEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeeeee
Q 041096 173 ILQGID-LKSGNVITAWIDYKNDLRMLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQ 251 (645)
Q Consensus 173 ~~~~~~-~~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~ 251 (645)
...... ...+..+++||+|+ .+.|+|++.........+...........+++++||||||+||...+.|.|++|.+.
T Consensus 147 ~~~~~~~~~~~~~~~i~~~~~--~~~l~v~i~~~~~~~~~~~~~~~~~~~~~l~~~~y~GFTAsTG~~~~~H~I~s~~~~ 224 (228)
T d1gv9a_ 147 ASCQRDFRNKPYPVRAKITYY--QKTLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLTF 224 (228)
T ss_dssp EEECCCCBSCSSCEEEEEEEE--TTEEEEEEECSSCCCTTCCEEEEEETTCCCCSSBEEEEEEECCSSCCEEEEEEEEEE
T ss_pred cceeeeecCCceEEEEEEEec--CCEEEEEEeccccCCCcceeEEEEecccccCCCEEEEEEEeCCCCcCeEEEEEEEEE
Confidence 000111 12345567777776 588999998554333333333333346678999999999999999999999999875
Q ss_pred e
Q 041096 252 T 252 (645)
Q Consensus 252 ~ 252 (645)
.
T Consensus 225 ~ 225 (228)
T d1gv9a_ 225 Q 225 (228)
T ss_dssp E
T ss_pred E
Confidence 4
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.90 E-value=4.2e-24 Score=207.38 Aligned_cols=107 Identities=34% Similarity=0.571 Sum_probs=92.4
Q ss_pred CCceeEEeCCCC--CCCeEEecceEe-eCCcEEccCCCCC---CCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEee
Q 041096 22 SNNMNFDFTSFN--LRNITLLGDSYL-RNGVIGLTRELGV---PASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINN 95 (645)
Q Consensus 22 ~~~~~f~~~~f~--~~~~~l~G~a~~-~~~~~~Lt~~~~~---~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 95 (645)
++.++|+|++|+ ..||+|+|||.+ .+|.|+||+.+.+ ...++|||+|++||+|||+ +++++||+|+|+|.|.+
T Consensus 123 sn~~~F~f~~F~~~~~nl~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~d~-t~~~~SFsT~F~F~I~~ 201 (237)
T d1nlsa_ 123 TNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFLIKS 201 (237)
T ss_dssp EEEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEECCC
T ss_pred cccceEEeeecCCCCCCEEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEECC-CCcEeeEEEEEEEEEec
Confidence 456999999997 679999999998 5899999986432 3578999999999999996 88999999999999988
Q ss_pred CCCCCCCCceEEEEecCCC--CCCCCCCccccccCCC
Q 041096 96 VNPSSFGDGLAFFISPDNQ--ILGSAGGCLGLVNSSQ 130 (645)
Q Consensus 96 ~~~~~~g~G~aF~l~p~~~--~~~~~g~~lGl~~~~~ 130 (645)
.+ ..+||||||||+|... +.++.|+||||||.++
T Consensus 202 ~~-~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~n 237 (237)
T d1nlsa_ 202 PD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDAN 237 (237)
T ss_dssp SS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSCC
T ss_pred CC-CCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCCC
Confidence 65 5689999999999765 4588999999998753
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.84 E-value=3.4e-20 Score=180.25 Aligned_cols=192 Identities=16% Similarity=0.108 Sum_probs=128.6
Q ss_pred EEeCCCC-----CCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCC
Q 041096 27 FDFTSFN-----LRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSF 101 (645)
Q Consensus 27 f~~~~f~-----~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 101 (645)
|++|.+- ..++.+.|+|.+.++.|+||++ .++.|.+|++.|+++++ +|+++|.|+|.... ..+
T Consensus 10 ~s~p~~~~~~~~~~~W~~~g~a~~~~~~i~LTp~----~~~~G~~w~~~~i~~~~-------~f~~~~~F~i~g~~-~~g 77 (221)
T d2a6za1 10 YSLPDLINTRKVPNNWQTGEQASLEEGRIVLTSN----QNSKGSLWLKQGFDLKD-------SFTMEWTFRSVGYS-GQT 77 (221)
T ss_dssp GCBCCCTTCCSCCTTEEEEETCEEETTEEESCCS----TTCEEEEEESSCEECCS-------CEEEEEEEEEESCC-SCC
T ss_pred ccCCCccccccCCCccEEcceeEEECCEEEECCC----CCCceEEEECCccccCC-------CeEEEEEEEEeCCC-CCC
Confidence 6777652 4689999999999999999985 35789999999999975 49999999998654 567
Q ss_pred CCceEEEEecCCCCCCCCCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccccc----cCCCcccc
Q 041096 102 GDGLAFFISPDNQILGSAGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESIKT----ADPILQGI 177 (645)
Q Consensus 102 g~G~aF~l~p~~~~~~~~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~~~----~~~~~~~~ 177 (645)
||||||++++... .+..|+.+|. .+...-+||||||+.|.. ...|+.++-++..-... ........
T Consensus 78 gdG~af~~~~~~~-~~~~g~~~G~-----~~~~~GlaV~fDt~~n~~----~~~~~~~ndgt~~~~~~~~~~~~~~~~~~ 147 (221)
T d2a6za1 78 DGGISFWFVQDSN-IPRDKQLYNG-----PVNYDGLQLLVDNNGPLG----PTLRGQLNDGQKPVDKTKIYDQSFASCLM 147 (221)
T ss_dssp SCEEEEEEEECSS-SCCCCTBTTB-----CTTCEEEEEEEESCSTTS----SEEEEEEEESSSCCCGGGHHHHCSEEEEC
T ss_pred CCcEEEEEEcCCC-cccccccccc-----CCCCceEEEEEECCCCCC----CceEEEecCCCccccccCCcccccceeee
Confidence 9999999997543 2334555555 233566999999998732 12233333333221111 11111112
Q ss_pred c-cCCCCeEEEEEEecCCCce-EEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeee
Q 041096 178 D-LKSGNVITAWIDYKNDLRM-LKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSW 248 (645)
Q Consensus 178 ~-~~~g~~~~~~I~Y~~~~~~-l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw 248 (645)
. ..++...+++|.|+..++. |.|.+.. ..++. ++--.+-++++|+||||+||...+.|.+..+
T Consensus 148 ~~~~~~~~~~~~I~y~~~~~~~l~v~id~------~~c~~--~~~v~lp~~~~~fG~SA~TG~~~~~hd~~~i 212 (221)
T d2a6za1 148 GYQDSSVPSTIRVTYDLEDDNLLKVQVDN------KVCFQ--TRKVRFPSGSYRIGVTAQNGAVNNNAESFEI 212 (221)
T ss_dssp CCTTEEEEEEEEEEEEGGGTSEEEEEETT------EEEEE--ESCCCCCSSEEEEEEEEECCSGGGCCCEEEE
T ss_pred cccCCCCCEEEEEEEecCccceEEEEecC------cEeEE--ECCeecCCCCEEEEEEEccCCccCCCceEEE
Confidence 2 2356678999999866544 7777731 11222 2222233567899999999999998886554
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.82 E-value=1.6e-19 Score=174.74 Aligned_cols=186 Identities=19% Similarity=0.156 Sum_probs=128.4
Q ss_pred CCCeEEecceEeeCCcEEccCCCCCCCCceEEEEeCCCcccccCCCCceeeEEEEEEEEEeeCCCCCCCCceEEEEecCC
Q 041096 34 LRNITLLGDSYLRNGVIGLTRELGVPASSSGSLIYNNPVPFFDQETNTTASFTSRFSFSINNVNPSSFGDGLAFFISPDN 113 (645)
Q Consensus 34 ~~~~~l~G~a~~~~~~~~Lt~~~~~~~~~~Gr~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G~aF~l~p~~ 113 (645)
..++.+.|+|.+.++.|+||++ .++.|++|++.|+++++ +|+++|+|+|.... ..+||||||.+++..
T Consensus 21 ~~~W~~~G~~~~~~~~i~LTp~----~~~~G~~w~~~~i~~~~-------~f~i~~~F~i~g~~-~~~~dG~afw~~~~~ 88 (218)
T d2a6va1 21 LSQWTLGDKVKLEEGRFVLTPG----KNTKGSLWLKPEYSIKD-------AMTIEWTFRSFGFR-GSTKGGLAFWLKQGN 88 (218)
T ss_dssp TTTEEEEETCEEETTEEESCCS----TTCEEEEEESSCBCCSS-------CEEEEEEEEEESCC-SCCSCEEEEEEECSC
T ss_pred cCccEECCCEEEECCEEEECCC----CCCeeEEEeCCcccccc-------cceEEEEEEEeCCC-CCCCCcEEEEEEcCC
Confidence 4789999999999999999986 24689999999999875 49999999998654 567999999999755
Q ss_pred CCCCC--CCCccccccCCCCCCCcEEEEEeeCCCCCCCCCCCCCeeeeecCCcccc-ccc-CCCccc--c-ccCCCCeEE
Q 041096 114 QILGS--AGGCLGLVNSSQLTKNKFVAIEFDTRLDPHFDDPDENHIGLDIDSLESI-KTA-DPILQG--I-DLKSGNVIT 186 (645)
Q Consensus 114 ~~~~~--~g~~lGl~~~~~~~~~~~vAVEFDt~~n~~~~d~~~~Hvgi~vns~~s~-~~~-~~~~~~--~-~~~~g~~~~ 186 (645)
...+. .+|..+.+ .-+||||||+.|. .+||.+.+|.-... ... ...... . ...++...+
T Consensus 89 ~~~~~~~~~G~~~~f--------~GlaV~fDt~~n~------~~~i~~~~ndGs~~~~~~~d~~~g~c~~~~~~~~~~~~ 154 (218)
T d2a6va1 89 EGDSTELFGGSSKKF--------NGLMILLRLDDKL------GESVTAYLNDGTKDLDIESSPYFASCLFQYQDSMVPST 154 (218)
T ss_dssp CCCCCTBTTTBCSSC--------EEEEEEEEEETTT------EEEEEEEEEESSSCCCTTTSCCSEEEECCCSSCSSCEE
T ss_pred cccCCCcccccCCCc--------ceEEEEEECCCCC------CCeEEEEeCCCCccccccCCcccceEEecccCCCCcEE
Confidence 43221 22323322 3489999998773 36888877642211 000 101111 1 134567788
Q ss_pred EEEEecCCCc-eEEEEEEeCCCCCCcceEEEeecCCccCCCccEEeEEeccCCccceeeeeeeeeee
Q 041096 187 AWIDYKNDLR-MLKVFMSYSNLKPVTPLLKVNIDLSGYLKGNMYVGFSASTEGSTELHMIQSWSFQT 252 (645)
Q Consensus 187 ~~I~Y~~~~~-~l~v~~~~~~~~~~~~~l~~~vdl~~~l~~~~~vGfsastg~~~~~~~i~sw~f~~ 252 (645)
++|.|+.... .++|.+. . ..|+. ..++.-..++++|+||||+||...+.|.|++|++-.
T Consensus 155 ~~i~Y~~~~~~~l~v~id--~----~~c~~-t~~i~lp~~~~~yfG~SA~Tg~~~d~~dIls~~~~~ 214 (218)
T d2a6va1 155 LRLTYNPLDNHLLKLQMD--N----RVCFQ-TRKVKFMGSSPFRIGTSAINDASKESFEILKMKLYD 214 (218)
T ss_dssp EEEEEEGGGTSEEEEEET--T----EEEEE-ESCCCGGGTSCBEEEEEEECCTTCCEEEEEEEEEES
T ss_pred EEEEEECcccceEEEEeC--C----cEEEE-ECCeecCCCCcEEEEEEECCCCCcCcEEEEEEEEEe
Confidence 9999976554 4666653 1 22332 222333345679999999999999999999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.80 E-value=5.6e-20 Score=175.01 Aligned_cols=158 Identities=14% Similarity=0.136 Sum_probs=113.3
Q ss_pred CcCceeccCCceEEEEEEECCCCeEEEEEeccCCcc-------------------hhHhHHHHHHHHhhcCCCCeeeeee
Q 041096 351 HSNRILGRGAFGNVYKAYFASSGSVAAVKRSKHSHE-------------------GKTEFLAELSIIACLRHKNLVQLLG 411 (645)
Q Consensus 351 ~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-------------------~~~~~~~Ei~~l~~l~H~niv~l~g 411 (645)
...++||+|+||+||+|... +|..||||+++.... .......|...+.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 34688999999999999986 488999997653110 1233456888899999999998876
Q ss_pred eeeeCCeEEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCee
Q 041096 412 WCAEKGELLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQECEQQVIHRDIKASNIMLDANFNAR 491 (645)
Q Consensus 412 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIlld~~~~~k 491 (645)
+.. .+++|||+++..+.+ ++......++.|++++|+|||+ .+|+||||||+|||+++++ ++
T Consensus 82 ~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~~-~~ 142 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEEG-IW 142 (191)
T ss_dssp EET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETTE-EE
T ss_pred ecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCCC-EE
Confidence 542 279999998765432 3334456789999999999999 9999999999999999654 77
Q ss_pred eeccccccccCCcccCccccc----------CCCCCcchhHHHHHHHH
Q 041096 492 LESSFTLTAGTMGYLAPEYLQ----------YGTATEKTDVFSYGVVV 529 (645)
Q Consensus 492 l~d~~~~~~gt~~y~APE~~~----------~~~~t~ksDV~SfGvvl 529 (645)
+.|. +....+....+.+++. .++|..++||||..--+
T Consensus 143 liDF-G~a~~~~~~~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDF-PQSVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCC-TTCEETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EEEC-CCcccCCCCCcHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 7763 3322222223333321 24578889999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.15 E-value=4.2e-06 Score=81.13 Aligned_cols=143 Identities=14% Similarity=0.079 Sum_probs=96.0
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEECCCCeEEEEEeccC-CcchhHhHHHHHHHHhhcC-CCCeeeeeeeeeeCCe
Q 041096 341 RELRSATRGFHSNRILGRGAFGNVYKAYFASSGSVAAVKRSKH-SHEGKTEFLAELSIIACLR-HKNLVQLLGWCAEKGE 418 (645)
Q Consensus 341 ~~l~~~~~~f~~~~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 418 (645)
.|+++....|+..+..+-++.+.||+.... +..+++|+... .......+.+|...+..+. +--+.+++.++.+.+.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~--~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC--CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 467777777876665444445789988643 55667887654 2333456788998888774 4446777888888889
Q ss_pred EEEEEecCCCCCHhHHhhhcCCCCccCCHHHHHHHHHHHHHHHHHHhhcC------------------------------
Q 041096 419 LLLVYEYMPNGSLDRMLYQDSENGVLLSWYHRLNIVVGLASALTYLHQEC------------------------------ 468 (645)
Q Consensus 419 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------ 468 (645)
.++||+++++.++.+...... +...++.++++.|+.||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~~---------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDEQ---------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTCS---------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEecccccccccccccc---------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 999999999988866543211 12234555566666666420
Q ss_pred --------------------------CCCeeeCCCCCCcEEEcCCCCeeeec
Q 041096 469 --------------------------EQQVIHRDIKASNIMLDANFNARLES 494 (645)
Q Consensus 469 --------------------------~~~ivHrDlkp~NIlld~~~~~kl~d 494 (645)
...++|+|+.|.|||++++...-+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lID 207 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFID 207 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECC
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEee
Confidence 12368999999999999765555655
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.27 E-value=0.0002 Score=68.41 Aligned_cols=75 Identities=19% Similarity=0.148 Sum_probs=52.5
Q ss_pred eeccCCc-eEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCC--CCeeeeeeeeeeCCeEEEEEecCCCCCH
Q 041096 355 ILGRGAF-GNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRH--KNLVQLLGWCAEKGELLLVYEYMPNGSL 431 (645)
Q Consensus 355 ~lG~G~f-g~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL 431 (645)
.+..|.. +.||+..... +..+++|...... ...+..|...++.+.. -.+.++++++.+.+..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-SCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCC-CCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 6799988754 6667888765432 3457788888887743 3356678888888889999999987665
Q ss_pred h
Q 041096 432 D 432 (645)
Q Consensus 432 ~ 432 (645)
.
T Consensus 94 ~ 94 (255)
T d1nd4a_ 94 L 94 (255)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.05 E-value=0.0012 Score=67.52 Aligned_cols=75 Identities=13% Similarity=0.076 Sum_probs=46.8
Q ss_pred ceeccCCceEEEEEEECCCCeEEEEEeccC----Cc----chhHhHHHHHHHHhhcC-C--CCeeeeeeeeeeCCeEEEE
Q 041096 354 RILGRGAFGNVYKAYFASSGSVAAVKRSKH----SH----EGKTEFLAELSIIACLR-H--KNLVQLLGWCAEKGELLLV 422 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~~~~vavK~~~~----~~----~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~lV 422 (645)
+.||.|..-.||+.....++..++||.... .. ........|.+.|+.+. + ..+.+++.+. .+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 458999999999999877778889995432 11 12233456777777663 2 3455666554 3455889
Q ss_pred EecCCCCC
Q 041096 423 YEYMPNGS 430 (645)
Q Consensus 423 ~Ey~~~gs 430 (645)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.92 E-value=0.037 Score=54.29 Aligned_cols=68 Identities=15% Similarity=0.097 Sum_probs=46.6
Q ss_pred eEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCe-----eeee--eeeeeCCeEEEEEecCCCCC
Q 041096 362 GNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNL-----VQLL--GWCAEKGELLLVYEYMPNGS 430 (645)
Q Consensus 362 g~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-----v~l~--g~~~~~~~~~lV~Ey~~~gs 430 (645)
=.||+.+..+ |..+++|.........+++..|...+..|....+ +..- ......+..+.++++++|..
T Consensus 36 N~vy~v~~~d-g~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDED-RRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTT-CCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCC-CCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 3799998854 7788999987665566778899998888853222 1111 12234567889999997643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=92.90 E-value=0.11 Score=52.06 Aligned_cols=73 Identities=18% Similarity=0.255 Sum_probs=49.2
Q ss_pred ceeccCCceEEEEEEECCC-------CeEEEEEeccCCcchhHhHHHHHHHHhhcCCCCe-eeeeeeeeeCCeEEEEEec
Q 041096 354 RILGRGAFGNVYKAYFASS-------GSVAAVKRSKHSHEGKTEFLAELSIIACLRHKNL-VQLLGWCAEKGELLLVYEY 425 (645)
Q Consensus 354 ~~lG~G~fg~Vy~g~~~~~-------~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey 425 (645)
+.|+.|-.=.+|+....+. ...+++++.... .......+|..+++.+.-.++ .++++++.+ .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4577777788999987542 345677766532 233456688888888853344 477777754 589999
Q ss_pred CCCCCH
Q 041096 426 MPNGSL 431 (645)
Q Consensus 426 ~~~gsL 431 (645)
+++.+|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.00 E-value=0.43 Score=45.69 Aligned_cols=89 Identities=11% Similarity=0.101 Sum_probs=50.7
Q ss_pred cCHHHHHHHhcCCCcCcee-----ccCCceEEEEEEECCCCeEEEEEeccCCcchhHhHHHHHHHHhhcCCCC-----ee
Q 041096 338 FSYRELRSATRGFHSNRIL-----GRGAFGNVYKAYFASSGSVAAVKRSKHSHEGKTEFLAELSIIACLRHKN-----LV 407 (645)
Q Consensus 338 ~~~~~l~~~~~~f~~~~~l-----G~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~Ei~~l~~l~H~n-----iv 407 (645)
.+.+|+.....+|...++. ..|--=+.|+.+..+ | .+++|+.... ...++...|++++..|.+.+ .+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccc
Confidence 4678888888889775543 345456789988764 3 4788987542 23445566777777774322 21
Q ss_pred eee-e--eeeeCCeEEEEEecCCCC
Q 041096 408 QLL-G--WCAEKGELLLVYEYMPNG 429 (645)
Q Consensus 408 ~l~-g--~~~~~~~~~lV~Ey~~~g 429 (645)
... | +.........++.++.+.
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~ 104 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGM 104 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCB
T ss_pred eecCCCcceeeecccceeeeecccc
Confidence 111 1 112234567777777654
|